PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Weera, MM; Shackett, RS; Kramer, HM; Middleton, JW; Gilpin, NW				Weera, Marcus M.; Shackett, Rosetta S.; Kramer, Hannah M.; Middleton, Jason W.; Gilpin, Nicholas W.			Central Amygdala Projections to Lateral Hypothalamus Mediate Avoidance Behavior in Rats	JOURNAL OF NEUROSCIENCE			English	Article						avoidance; central amygdala; HCN channels; lateral hypothalamus; stress	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; CENTRAL NUCLEUS; COPING STYLE; CHANNELS; NEURONS; ORGANIZATION; CONNECTIONS; INHIBITION	Persistent avoidance of stress-related stimuli following acute stress exposure predicts negative outcomes such as substance abuse and traumatic stress disorders. Previous work using a rat model showed that the central amygdala (CeA) plays an important role in avoidance of a predator odor stress-paired context. Here, we show that CeA projections to the lateral hypothalamus (LH) are preferentially activated in male rats that show avoidance of a predator odor-paired context (termed Avoider rats), that chemogenetic inhibition of CeA-LH projections attenuates avoidance in male Avoider rats, that chemogenetic stimulation of the CeA-LH circuit produces conditioned place avoidance (CPA) in otherwise naive male rats, and that avoidance behavior is associated with intrinsic properties of LH-projecting CeA cells. Collectively, these data show that CeALH projections are important for persistent avoidance of stress-related stimuli following acute stress exposure.	[Weera, Marcus M.; Shackett, Rosetta S.; Kramer, Hannah M.; Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA 70112 USA; [Middleton, Jason W.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Cell Biol, New Orleans, LA 70112 USA; [Middleton, Jason W.; Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Middleton, Jason W.; Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, New Orleans, LA 70112 USA; [Gilpin, Nicholas W.] Southeast Louisiana VA Healthcare Syst SLVHCS, New Orleans, LA 70119 USA		Weera, MM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA 70112 USA.	mweera@lsuhsc.edu		Middleton, Jason/0000-0002-4309-5252	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AA023305, AA026531, AA026022, AA027145, AA007577]; United States Department of Veterans Affairs, Biomedical Laboratory Research and Development ServiceUS Department of Veterans Affairs [I01 BX003451]	This work was supported by National Institutes of Health Grants AA023305 (to N.W.G.), AA026531 (to N.W.G.), AA026022 (to N.W.G.), AA027145 (to M.M.W.), and AA007577. This work was also supported in part by a Merit Review Award #I01 BX003451 (to N.W.G.) from the United States Department of Veterans Affairs, Biomedical Laboratory Research and Development Service.	Albrechet-Souza L, 2019, BEHAV PHARMACOL, V30, P105, DOI 10.1097/FBP.0000000000000460; Altomare C, 2003, J PHYSIOL-LONDON, V549, P347, DOI 10.1113/jphysiol.2002.027698; Avegno EM, 2018, J NEUROSCI, V38, P7761, DOI 10.1523/JNEUROSCI.0483-18.2018; Barbier M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00688; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOBKER DH, 1989, NEURON, V2, P1535, DOI 10.1016/0896-6273(89)90041-X; Bouret S, 2003, J NEUROSCI, V23, P3491; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; BROWN H, 1980, J PHYSIOL-LONDON, V308, P331, DOI 10.1113/jphysiol.1980.sp013474; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Edwards S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.70; Feldman S, 1998, BRAIN RES BULL, V45, P389, DOI 10.1016/S0361-9230(97)00384-5; Ferrante M, 2017, CEREB CORTEX, V27, P2111, DOI 10.1093/cercor/bhw058; Giardino WJ, 2018, NAT NEUROSCI, V21, P1084, DOI 10.1038/s41593-018-0198-x; Gill CH, 2004, BRIT J PHARMACOL, V143, P411, DOI 10.1038/sj.bjp.0705945; GRAY TS, 1989, NEUROENDOCRINOLOGY, V50, P433, DOI 10.1159/000125260; Itoga CA, 2016, NEUROPSYCHOPHARMACOL, V41, P2463, DOI 10.1038/npp.2016.44; IWATA J, 1986, BRAIN RES, V368, P161, DOI 10.1016/0006-8993(86)91055-3; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Joshi A, 2015, J NEUROSCI, V35, P3112, DOI 10.1523/JNEUROSCI.0836-14.2015; KOTLER M, 1993, PSYCHIAT RES, V47, P281, DOI 10.1016/0165-1781(93)90085-U; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; Lazaridis I, 2019, MOL PSYCHIATR, V24, P1351, DOI 10.1038/s41380-019-0369-5; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LINEHAN MM, 1986, J CONSULT CLIN PSYCH, V54, P880, DOI 10.1037/0022-006X.54.6.880; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McCall JG, 2015, NEURON, V87, P605, DOI 10.1016/j.neuron.2015.07.002; MEZZICH AC, 1995, ADDICT BEHAV, V20, P181, DOI 10.1016/0306-4603(94)00056-5; Moos R. H., 1993, HDB STRESS THEORETIC; Nakamura S, 2009, BRAIN RES, V1278, P66, DOI 10.1016/j.brainres.2009.04.049; Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320; Pomrenze MB, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00487; Radulovic J, 1998, J NEUROSCI RES, V54, P507, DOI 10.1002/(SICI)1097-4547(19981115)54:4<507::AID-JNR8>3.0.CO;2-E; Rau AR, 2015, J NEUROSCI, V35, P9730, DOI 10.1523/JNEUROSCI.0384-15.2015; Reppucci CJ, 2016, BRAIN STRUCT FUNCT, V221, P2937, DOI 10.1007/s00429-015-1081-0; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Shin KM, 2015, J AFFECT DISORDERS, V184, P145, DOI 10.1016/j.jad.2015.05.051; Smith KS, 2016, BEHAV NEUROSCI, V130, P137, DOI 10.1037/bne0000135; Spierling SR, 2017, PSYCHOPHARMACOLOGY, V234, P1467, DOI 10.1007/s00213-017-4556-2; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Stuber GD, 2016, NAT NEUROSCI, V19, P198, DOI 10.1038/nn.4220; Taylor S, 2001, J CONSULT CLIN PSYCH, V69, P541, DOI 10.1037//0022-006X.69.3.541; Tsumori T, 2006, NEUROSCI RES, V56, P261, DOI 10.1016/j.neures.2006.07.005; Ventura-Silva AP, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00032; Villarroel HS, 2018, J NEUROSCI, V38, P4505, DOI 10.1523/JNEUROSCI.3528-17.2018; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Weera MM, 2020, NEUROPHARMACOLOGY, V166, DOI 10.1016/j.neuropharm.2020.107979; Whitaker AM, 2015, PHYSIOL BEHAV, V147, P16, DOI 10.1016/j.physbeh.2015.03.033; Zhou M, 2018, NAT NEUROSCI, V21, P1515, DOI 10.1038/s41593-018-0248-4	55	4	4	2	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	JAN 6	2021	41	1					61	72		10.1523/JNEUROSCI.0236-20.2020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PQ9JX	WOS:000606858800007	33188067	Green Published, Bronze			2022-02-06	
J	Bittencourt-Villalpando, M; van der Horn, HJ; Maurits, NM; van der Naalt, J				Bittencourt-Villalpando, M.; van der Horn, H. J.; Maurits, N. M.; van der Naalt, J.			Disentangling the effects of age and mild traumatic brain injury on brain network connectivity: A resting state fMRI study	NEUROIMAGE-CLINICAL			English	Article						Brain connectivity; fMRI; mTBI; Aging; Resting-state	COMPLAINTS	Introduction: Cognitive complaints are common shortly after mild traumatic brain injury (mTBI) but may persist up to years. Age-related cognitive decline can worsen these symptoms. However, effects of age on mTBI sequelae have scarcely been investigated. Methods: Fifty-four mTBI patients (median age: 35 years, range 19-64 years, 67% male) and twenty age- and sex-matched healthy controls were studied using resting state functional magnetic resonance imaging in the sub-acute phase. Independent component analysis was used to identify intrinsic connectivity networks (ICNs). A multivariate approach was adopted to evaluate the effects of age and group on the ICNs in terms of (static) functional network connectivity (FNC), intensities of spatial maps (SMs) and time-course spectral power (TC). Results: We observed significant age-related changes for a) FNC: changes between 10 pairs of ICNs, mostly involving the default mode (DM) and/or the cognitive-control (CC) domains; b) SMs: intensity decrease in clusters across three domains and intensity increase in clusters across two domains, including the CC but not the DM and c) TC: spectral power decrease within the 0-0.15 Hz range and increase within the 0.20-0.25 Hz range for increasing age within networks located in frontal areas, including the anterior DM. Groups only differed for TC within the 0.065-0.10 Hz range in the cerebellar ICN and no age x group interaction effect was found. Conclusions: We showed robust effects of age on connectivity between and within ICNs that are associated with cognitive functioning. Differences between mTBI patients and controls were only found for activity in the cerebellar network, increasingly recognized to participate in cognition. Our results suggest that to allow for capturing the true effects related to mTBI and its effects on cognitive functioning, age should be included as a covariate in mTBI studies, in addition to age-matching groups.	[Bittencourt-Villalpando, M.; van der Horn, H. J.; Maurits, N. M.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol AB51, NL-9700 RB Groningen, Netherlands		Bittencourt-Villalpando, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol AB51, NL-9700 RB Groningen, Netherlands.	m.bittencourt.villalpando@umcg.nl	; Bittencourt, Mayra/D-3634-2015	van der Naalt, Joukje/0000-0001-9873-2418; Bittencourt, Mayra/0000-0001-5248-9272	Dutch Brain Foundation	The study was funded by the Dutch Brain Foundation (grant no. Ps2012-06).	Abreu R, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00323; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alexander MP, 2012, CORTEX, V48, P980, DOI 10.1016/j.cortex.2011.03.012; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Balsters JH, 2013, NEUROBIOL AGING, V34, P2194, DOI 10.1016/j.neurobiolaging.2013.03.004; Balsters JH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00207; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Burianova H, 2013, NEUROBIOL AGING, V34, P2759, DOI 10.1016/j.neurobiolaging.2013.06.016; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Chen JYE, 2015, NEUROIMAGE, V107, P207, DOI 10.1016/j.neuroimage.2014.12.012; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Du YH, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102375; Du YH, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00267; Du YH, 2014, IEEE ENG MED BIO, P1517, DOI 10.1109/EMBC.2014.6943890; Du YH, 2013, NEUROIMAGE, V69, P157, DOI 10.1016/j.neuroimage.2012.11.008; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fryer SL, 2015, NEUROPSYCHOPHARMACOL, V40, P2705, DOI 10.1038/npp.2015.119; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glerean E, 2012, BRAIN CONNECT, V2, P91, DOI 10.1089/brain.2011.0068; Gohel SR, 2015, BRAIN CONNECT, V5, P23, DOI 10.1089/brain.2013.0210; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He Z, 2013, PSYCHOL MED, V43, P769, DOI 10.1017/S0033291712001638; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jahanian H, 2019, J NEUROSCI METH, V311, P122, DOI 10.1016/j.jneumeth.2018.09.033; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klimesch W, 2018, EUR J NEUROSCI, V48, P2431, DOI 10.1111/ejn.14192; Koen JD, 2020, CURR OPIN BEHAV SCI, V32, P7, DOI 10.1016/j.cobeha.2020.01.006; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li YO, 2007, HUM BRAIN MAPP, V28, P1251, DOI 10.1002/hbm.20359; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mitra P., 2009, OBSERVED BRAIN DYNAM, DOI [10.1093/acprof:oso/9780195178081.001.0001., DOI 10.1093/ACPROF:OSO/9780195178081.001.0001, 10.1093/acprof:oso/9780195178081.001.0001]; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Palva JM, 2012, NEUROIMAGE, V62, P2201, DOI 10.1016/j.neuroimage.2012.02.060; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Puig J, 2020, J NEUROTRAUM, V37, P1761, DOI 10.1089/neu.2019.6623; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Sadaghiani S, 2020, NETW NEUROSCI, V4, P1, DOI 10.1162/netn_a_00114; Sala-Llonch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00663; Schmahmann JD, 2019, NEUROSCI LETT, V688, P62, DOI 10.1016/j.neulet.2018.07.005; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Zhan J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00027; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	87	4	4	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	29								102534	10.1016/j.nicl.2020.102534			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QK1EC	WOS:000620121700019	33360020	Green Published, gold			2022-02-06	
J	Blank, LJ; Acton, EK; Thibault, D; Willis, AW				Blank, Leah J.; Acton, Emily K.; Thibault, Dylan; Willis, Allison W.			Neurodegenerative disease is associated with increased incidence of epilepsy: a population based study of older adults	AGE AND AGEING			English	Article						Epilepsy; Dementia; Alzheimer; Parkinson; Incidence; Epidemiology	PARKINSON DISEASE; SEIZURES; STIMULATION; MORTALITY; QUALITY; CARE	Objective: To determine the incidence of epilepsy among Medicare beneficiaries with a new diagnosis of Alzheimer dementia (AD) or Parkinson disease (PD). Methods: Retrospective cohort study of Medicare beneficiaries with an incident diagnosis of AD or PD in the year 2009. The 5-year incidence of epilepsy was examined by sociodemographic characteristics, comorbidities and neurodegenerative disease status. Cox regression models examined the association of neurodegenerative disease with incident epilepsy, adjusting for demographic characteristics and medical comorbidities. Results: We identified 178,593 individuals with incident AD and 104,157 individuals with incident PD among 34,054,293 Medicare beneficiaries with complete data in 2009. Epilepsy was diagnosed in 4.45% (7,956) of AD patients and 4.81% (5,010) of PD patients between 2009 and 2014, approximately twice as frequently as in the control sample. Minority race/ethnicity was associated with increased risk of incident epilepsy. Among individuals with AD and PD, stroke was associated with increased epilepsy risk. Traumatic brain injury (TBI) was associated with increased epilepsy risk for individuals with PD. Depression was also associated with incident epilepsy (AD adjusted hazard ratio (AHR): 1.23 (1.17-1.29), PD AHR: 1.45 (1.37-1.54)). In PD only, a history of hip fracture (AHR, 1.35 (1.17-1.57)) and diabetes (AHR, 1.11 (1.05-1.18) were also associated with increased risk of epilepsy. Conclusion: Incident epilepsy is more frequently diagnosed among neurodegenerative disease patients, particularly when preceded by a diagnosis of depression, TBI or stroke. Further studies into the differences in epilepsy risk between these two populations may help elucidate different mechanisms of epileptogenesis.	[Blank, Leah J.] Icahn Sch Med Mt Sinai, Dept Neurol, Div Hlth Outcomes & Knowledge Translat Res, New York, NY 10029 USA; [Blank, Leah J.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Acton, Emily K.; Thibault, Dylan; Willis, Allison W.] Univ Penn Perelman Sch Med, Dept Neurol, Philadelphia, PA USA; [Acton, Emily K.; Thibault, Dylan; Willis, Allison W.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Acton, Emily K.; Thibault, Dylan; Willis, Allison W.] Univ Penn, Dept Neurol, Perelman Sch Med, Translat Ctr Excellence Neuroepidemiol & Neurol O, Philadelphia, PA 19104 USA; [Acton, Emily K.; Thibault, Dylan; Willis, Allison W.] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Willis, Allison W.] Univ Penn, Leonard Davis Inst Hlth Econ, Perelman Sch Med, Philadelphia, PA 19104 USA		Blank, LJ (corresponding author), Icahn Sch Med Mt Sinai, 1468 Madison Ave Annenberg Bldg,2nd Floor, New York, NY 10029 USA.	leah.blank@mssm.edu		Blank, Leah J/0000-0001-8719-6752; Acton, Emily/0000-0002-5150-5995	Mirowski Family Fund; Pharmacoepidemiology Training Grant [T32-NS-061779]; Department of Neurology at the University of Pennsylvania	The first author was supported by the Mirowski Family Fund as well as the Pharmacoepidemiology Training Grant (T32-NS-061779) and the Department of Neurology at the University of Pennsylvania.	Erdem E, 2014, J PUBLIC HEALTH MAN, V20, P445, DOI 10.1097/PHH.0b013e3182a3e958; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Granbichler CA, 2017, EUR J NEUROL, V24, P667, DOI 10.1111/ene.13267; Gruntz K, 2018, ANN NEUROL, V83, P363, DOI 10.1002/ana.25157; Hussain SA, 2006, EPILEPSY RES, V71, P195, DOI 10.1016/j.eplepsyres.2006.06.018; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Jallon P, 2001, EPILEPSIA, V42, P464, DOI 10.1046/j.1528-1157.2001.31400.x; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Marsh L, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0409-5; Martinez-Juarez Iris E, 2017, Epilepsia Open, V2, P453, DOI 10.1002/epi4.12082; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Odenheimer G, 2013, NEUROLOGY, V81, P1545, DOI 10.1212/WNL.0b013e3182a956bf; Ortman JM, 2014, CURERENT POPULATION; Reuben DB, 2010, J AM GERIATR SOC, V58, P324, DOI 10.1111/j.1532-5415.2009.02678.x; Salanova V, 2015, NEUROLOGY, V84, P1017, DOI 10.1212/WNL.0000000000001334; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Sillanpaa M, 2011, EPILEPSIA, V52, P1857, DOI 10.1111/j.1528-1167.2011.03186.x; Sperling MR, 2016, NEUROLOGY, V86, P1938, DOI 10.1212/WNL.0000000000002700; Tu K, 2014, EPILEPSIA, V55, P335, DOI 10.1111/epi.12506; Vossler DG, 2018, EPILEPSY CURR, V18, DOI 10.5698/1535-7597.18.4s1.1; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Willis AW, 2011, NEUROLOGY, V77, P851, DOI 10.1212/WNL.0b013e31822c9123	23	4	4	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-0729	1468-2834		AGE AGEING	Age Ageing	JAN	2021	50	1					205	212		10.1093/ageing/afaa194			8	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	RW9OI	WOS:000646848300035	33030514	Green Published			2022-02-06	
J	Bouldin, ED; Swan, AA; Norman, RS; Tate, DF; Tumminello, C; Amuan, ME; Eapen, BC; Wang, CP; Trevino, A; Pugh, MJ				Bouldin, Erin D.; Swan, Alicia A.; Norman, Rocio S.; Tate, David F.; Tumminello, Christa; Amuan, Megan E.; Eapen, Blessen C.; Wang, Chen-Pin; Trevino, Amira; Pugh, Mary Jo			Health Phenotypes and Neurobehavioral Symptom Severity Among Post-9/11 Veterans With Mild Traumatic Brain Injury: A Chronic Effects of Neurotrauma Consortium Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective; health status; health trajectory; neurobehavioral manifestations; phenotype; traumatic brain injury; Veterans	AFGHANISTAN; IRAQ	Objective: To evaluate whether neurobehavioral symptoms differ between groups of veterans with mild traumatic brain injury (mTBI) classified by health characteristics. Participants: A total of 71 934 post-9/11 veterans with mTBI from the Chronic Effects of Neurotrauma Consortium Epidemiology warfighter cohort. Design: Cross-sectional analysis of retrospective cohort. Main Measures: Health phenotypes identified using latent class analysis of health and function over 5 years. Symptom severity measured using Neurobehavioral Symptom Inventory; domains included vestibular, somatic, cognitive, and affective. Results: Veterans classified as moderately healthy had the lowest symptom burden while the polytrauma phenotype group had the highest. After accounting for sociodemographic and injury characteristics, polytrauma phenotype veterans had about 3 times the odds of reporting severe symptoms in each domain compared with moderately healthy veterans. Those veterans who were initially moderately healthy but whose health declined over time had about twice the odds of severe symptoms as consistently healthier Veterans. The strongest associations were in the affective domain. Compared with the moderately healthy group, veterans in other phenotypes were more likely to report symptoms substantially interfered with their daily lives (odds ratio range: 1.3-2.8). Conclusion: Symptom severity and interference varied by phenotype, including between veterans with stable and declining health. Ameliorating severe symptoms, particularly in the affective domain, could improve health trajectories following mTBI.	[Bouldin, Erin D.] Appalachian State Univ, Dept Hlth & Exercise Sci, Boone, NC 28608 USA; [Swan, Alicia A.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Norman, Rocio S.] Univ Texas Hlth Sci Ctr San Antonio, Sch Hlth Profess, Speech Language Pathol Program, San Antonio, TX 78229 USA; [Tate, David F.] George E Whalen VA Med Ctr, Salt Lake City, UT USA; [Tate, David F.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Tumminello, Christa] Lees McRae Coll, Banner Elk, NC USA; [Amuan, Megan E.; Trevino, Amira; Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT USA; [Eapen, Blessen C.] Univ Calif Los Angeles, Dept Phys Med & Rehabil, VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Wang, Chen-Pin] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA		Bouldin, ED (corresponding author), Appalachian State Univ, Dept Hlth & Exercise Sci, Boone, NC 28608 USA.	bouldinel@appstate.edu; alicia.swan@utsa.edu; NormanR@uthscsa.edu; David.Tate@hsc.utah.edu; cmtumminello@gmail.com; Megan.Amuan@va.gov; Blessen.Eapen2@va.gov; WangC3@uthscsa.edu; Amira.Trevino@hsc.utah.edu; MaryJo.Pugh@hsc.utah.edu	Swan, Alicia A/O-3536-2018; Tate, David/G-5166-2011	Swan, Alicia A/0000-0003-2412-0499; Bouldin, Erin/0000-0001-7550-309X; Tate, David/0000-0003-0213-1920; Trevino, Amira/0000-0003-4376-8434	Chronic Effects of Neurotrauma Consortium (CENC) by joint US Department of Defense [W81XWH-13-2-0095-04]; US Department of Veterans Affairs funds [I01CX001246]	This work was supported by the Chronic Effects of Neurotrauma Consortium (CENC) by joint US Department of Defense W81XWH-13-2-0095-04 (Yaffe) and the US Department of Veterans Affairs funds, I01CX001246 (Pugh)	Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; COGAN AM, 2019, PM&R 0930, DOI DOI 10.1002/pmrj.12237; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Defense and Veterans Brain Injury Center, 2018, RES REV MILD TRAUM B; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; DVBIC, 2016, DOD WORLDW NUMB TBI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine (US) Committee on the Initial Assessment of Readjustment Needs of Military Personnel V, 2010, OP END FREED OP IR F; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Pugh MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222674; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU, P133; US Department of Health & Human Services; Centers for Disease Control (CDC); National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344	27	4	4	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		10	19		10.1097/HTR.0000000000000574			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300002	32472834				2022-02-06	
J	Bumber, JR; Pilipovic, K; Jankovic, T; Dolenec, P; Grzeta, N; Kriz, J; Zupan, G				Bumber, Jelena Rajic; Pilipovic, Kristina; Jankovic, Tamara; Dolenec, Petra; Grzeta, Nika; Kriz, Jasna; Zupan, Gordana			Repetitive Traumatic Brain Injury Is Associated With TDP-43 Alterations, Neurodegeneration, and Glial Activation in Mice	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Brain concussion; Mouse; Nerve degeneration; Neuroglia; TDP-43 protein	TAR-DNA-BINDING; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; CYTOPLASMIC INCLUSIONS; PATHOLOGICAL TDP-43; SIGNATURE PROTEIN; FLUORO-JADE; FTLD-U; DISEASE	Increasing evidence points to a relationship between repetitive mild traumatic brain injury (mTBI), the Tar DNA binding protein 43 (TDP-43) pathology and some neurodegenerative diseases, but the underlying pathophysiological mechanisms are still unknown. We examined TDP-43 regulation, neurodegeneration, and glial responses following repetitive mTBI in nontransgenic mice and in animals with overexpression of human mutant TDP-43 protein (TDP-43(G348C)) In the frontal cortices of the injured nontransgenic animals, early TDP-43 cytoplasmatic translocation and overexpression of the protein and its pathological forms were detected. In the injured animals of both genotypes, neurodegeneration and pronounced glial activity were detected in the optic tract. In TDP-43(G348C) mice, these changes were significantly higher at day 7 after the last mTBI compared with the values in the nontransgenic animals. Results of this study suggest that the changes in the TDP-43 regulation in the frontal cortices of the nontransgenic animals were a transient stress response to the brain injury. Repetitive mTBI did not produce additional TDP-43 dysregulation or neurodegeneration or pronounced gliosis in the frontal cortex of TDP-43(G348C) mice. Our research also suggests that overexpression of mutated human TDP-43 possibly predisposes the brain to more intense neurodegeneration and glial activation in the optic tract after repetitive mTBI.	[Bumber, Jelena Rajic; Pilipovic, Kristina; Jankovic, Tamara; Dolenec, Petra; Grzeta, Nika; Zupan, Gordana] Univ Rijeka, Fac Med, Dept Pharmacol, Brace Branchetta 20, Rijeka 51000, Croatia; [Kriz, Jasna] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ, Canada		Zupan, G (corresponding author), Univ Rijeka, Fac Med, Dept Pharmacol, Brace Branchetta 20, Rijeka 51000, Croatia.	gordana.zupan@medri.uniri.hr	Grzeta, Nika/R-8848-2018; Zupan, Gordana/AAO-7020-2021; Dolenec, Petra/AAV-1118-2021; Pilipovic, Kristina/Q-5974-2018; Zupan, Gordana/AAO-7057-2021	Grzeta, Nika/0000-0002-4110-4784; Dolenec, Petra/0000-0002-9960-0385; Pilipovic, Kristina/0000-0002-7129-1621; Zupan, Gordana/0000-0002-4422-9021	Croatian Science Foundation [IP-2016-06-4602]	This study has been fully supported by the Croatian Science Foundation under the project number IP-2016-06-4602 to G.Z.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Agel J, 2007, J ATHL TRAINING, V42, P249; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Askar MH, 2019, CNS NEUROL DISORD-DR, V18, P156, DOI 10.2174/1871527317666180816095707; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Berning BA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00335; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Chidlow G, 2009, EXP EYE RES, V88, P426, DOI 10.1016/j.exer.2008.10.015; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cragnaz L, 2014, NEUROBIOL DIS, V71, P74, DOI 10.1016/j.nbd.2014.07.009; Crippa V, 2016, HUM MOL GENET, V25, P3908, DOI 10.1093/hmg/ddw232; Das M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1499-z; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Fang YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5824; Furukawa A, 2016, CNS NEUROSCI THER, V22, P7, DOI 10.1111/cns.12471; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2010.01060.x, 10.1111/j.1365-2990.2009.01060.x]; Giordana MT, 2010, BRAIN PATHOL, V20, P351, DOI 10.1111/j.1750-3639.2009.00284.x; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hatanpaa KJ, 2008, J NEUROPATH EXP NEUR, V67, P271, DOI 10.1097/NEN.0b013e31816a12a6; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lancon JA, 1998, ANAT REC, V253, P13, DOI 10.1002/(SICI)1097-0185(199802)253:1<13::AID-AR8>3.0.CO;2-F; Laufer T., 2014, THESIS; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liachko NF, 2013, ANN NEUROL, V74, P39, DOI 10.1002/ana.23870; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Luo LL, 2019, CNS NEUROSCI THER, V25, P1030, DOI 10.1111/cns.13184; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nonaka T, 2016, J BIOL CHEM, V291, P5473, DOI 10.1074/jbc.M115.695379; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Pinarbasi ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25008-4; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Roufayel R, 2019, CURR MOL MED, V19, P315, DOI 10.2174/1566524019666190326114720; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tan XL, 2019, J NEUROTRAUM, V36, P87, DOI 10.1089/neu.2017.5491; Thammisetty SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1350-y; Tremblay C, 2011, J NEUROPATH EXP NEUR, V70, P788, DOI 10.1097/NEN.0b013e31822c62cf; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615; Wilson RS, 2019, NEUROLOGY, V92, pE831, DOI 10.1212/WNL.0000000000006949; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	98	4	4	1	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JAN	2021	80	1					2	14		10.1093/jnen/nlaa130			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	PQ9ER	WOS:000606845200001	33212475				2022-02-06	
J	Campbell-Sills, L; Jain, S; Sun, XY; Fisher, LB; Agtarap, SD; Dikmen, S; Nelson, LD; Temkin, N; McCrea, M; Yuh, E; Giacino, JT; Manley, GT				Campbell-Sills, Laura; Jain, Sonia; Sun, Xiaoying; Fisher, Lauren B.; Agtarap, Stephanie D.; Dikmen, Sureyya; Nelson, Lindsay D.; Temkin, Nancy; McCrea, Michael; Yuh, Esther; Giacino, Joseph T.; Manley, Geoffrey T.		TRACK-TBI Investigators	Risk Factors for Suicidal Ideation Following Mild Traumatic Brain Injury: A TRACK-TBI Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; depression; postconcussive symptoms; suicidal ideation; traumatic brain injury	CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; PREVALENCE; VETERANS; VALIDITY; RATES; IRAQ	Objective: To identify risk factors for suicidal ideation (SI) following mild traumatic brain injury (mTBI). Setting: Eleven US level 1 trauma centers. Participants: A total of 1158 emergency department patients with mTBI (Glasgow Coma Scale score = 13-15) enrolled in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study. Design: Prospective observational study; weights-adjusted multivariable logistic regression models (n's = 727-883) estimated associations of baseline factors and post-TBI symptoms with SI at 2 weeks and 3, 6, and 12 months postinjury. Main Measures: Patient Health Questionnaire, Rivermead Post-Concussion Symptoms Questionnaire. Results: Preinjury psychiatric history predicted SI at all follow-ups (adjusted odds ratios [AORs] = 2.26-6.33, P values <.05) and history of prior TBI predicted SI at 2 weeks (AOR = 2.36, 95% confidence interval [CI] = 1.16-4.81, P = .018), 3 months (AOR = 2.62, 95% CI = 1.33-5.16, P = .005), and 6 months postinjury (AOR = 2.54, 95% CI = 1.19-5.42, P = .016). Adjusting for these baseline factors, post-TBI symptoms were strongly associated with SI at concurrent (AORs = 1.91-2.88 per standard deviation unit increase in Rivermead Post-Concussion Symptoms Questionnaire score; P values <.0005) and subsequent follow-up visits (AORs = 1.68-2.53; P values <.005). Most of the associations between post-TBI symptoms and SI were statistically explained by co-occurring depression. Conclusion: Screening for psychiatric and prior TBI history may help identify patients at risk for SI following mTBI. Awareness of the strong associations of post-TBI symptoms with SI may facilitate interventions to prevent suicide-related outcomes in patients with mTBI.	[Campbell-Sills, Laura; Agtarap, Stephanie D.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Fisher, Lauren B.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Fisher, Lauren B.] Harvard Med Sch, Boston, MA 02115 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Nelson, Lindsay D.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Yuh, Esther] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Yuh, Esther; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA; VA San Diego Healthcare Syst, San Diego, CA USA		Campbell-Sills, L (corresponding author), UCSD, Dept Psychiat, 9500 Gilman Dr,Mail Code 0855, La Jolla, CA 92093 USA.	l2campbellsills@ucsd.edu; sojain@ucsd.edu; xisun@ucsd.edu; Fisher.Lauren@mgh.harvard.edu; sagtarap@gmail.com; dikmen@uw.edu; linelson@mcw.edu; temkin@neurosurgery.washington.edu; mmccrea@mcw.edu; Esther.Yuh@ucsf.edu; jgiacino@mgh.harvard.edu; ManleyG@ucsf.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS086090]; US Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; Abbott LaboratoriesAbbott Laboratories; One Mind	This research was supported by the National Institutes of Health (grant U01NS086090) and US Department of Defense (grant W81XWH-14-2-0176). Abbott Laboratories provided funding for add-in TRACK-TBI clinical studies. One Mind provided funding for TRACK-TBI patients' stipends and support to clinical sites.	Agtarap S, 2021, ASSESSMENT, V28, P1656, DOI 10.1177/1073191120913941; Agtarap S, 2019, PSYCHOL ASSESSMENT, V31, P1340, DOI 10.1037/pas0000756; Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; [Anonymous], 2016, R LANG ENV STAT COMP; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; Boggs JM, 2018, PSYCHIAT SERV, V69, P677, DOI 10.1176/appi.ps.201700237; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2016, J CLIN PSYCHIAT, V77, pE648, DOI 10.4088/JCP.14m09661; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Campbell-Sills L, 2020, J HEAD TRAUMA REHAB, V35, P14, DOI 10.1097/HTR.0000000000000516; Centers for Disease Control and Prevention, TBI REL EM DEP ED VI; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Derogatis LR., 2001, BSI 18 BRIEF SYMPTOM; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Glenn CR, 2014, AM J PREV MED, V47, pS176, DOI 10.1016/j.amepre.2014.06.004; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klonsky ED, 2016, ANNU REV CLIN PSYCHO, V12, P307, DOI 10.1146/annurev-clinpsy-021815-093204; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lipari RN., 2019, KEY SUBSTANCE USE ME; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Phillips CJ, 2017, AM J EPIDEMIOL, V186, P668, DOI 10.1093/aje/kwx117; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Qaseem A, 2016, ANN INTERN MED, V164, P350, DOI 10.7326/M15-2570; Shura RD, 2019, PSYCHOL SERV, V16, P312, DOI 10.1037/ser0000208; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Substance Abuse and Mental Health Services Administration, 2019, KEY SUBSTANCE USE ME, VH-54; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	46	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		E30	E39		10.1097/HTR.0000000000000602			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300006	32769835				2022-02-06	
J	Caron, JG; Benson, AJ; Steins, R; McKenzie, L; Bruner, MW				Caron, Jeffrey G.; Benson, Alex J.; Steins, Rebecca; McKenzie, Laura; Bruner, Mark W.			The social dynamics involved in recovery and return to sport following a sport-related concussion: A study of three athlete-teammate-coach triads	PSYCHOLOGY OF SPORT AND EXERCISE			English	Article						Traumatic brain injury; Qualitative methods; Social identity; Social support; Psychological readiness	NARRATIVE INQUIRY; IDENTITY THEORY; PSYCHOLOGY; EXERCISE; YOUTH; SELF; EXPERIENCES; FEMALE; INJURY	An athlete's connection to their team and team members is an important part of their sport experience. However, researchers currently know little about the nature of these social dynamics with respect to concussed athletes. Our study explored athletes' recovery and reintegration into the team environment following a sport-related concussion. We conducted semi-structured interviews with each member of three athlete-teammate-coach triads (N = 9). We analysed the data using thematic narrative analysis and present the results as three stories that focused on each athlete's experience. For Cassie, we found two major plot points in her story: the transition in her role (and shift in identity) from athlete to student assistant coach/team manager and, once recovered, back to an athlete on the team. For Jess, we found that the main plot in her story was "pressure". Specifically, the interplay between internal (placed on herself) and external (perceived from teammates and coaches) pressures to return to sport. In the third and final story, the main plot point was the tensions that arose from Jaden's preferences for social support and the type of support that his teammates and coaches believed he needed during his recovery. Our results highlight the interplay between athlete's personal and social identities, feelings of pressure to return and readiness, and the challenges of providing the right amount and type of social support. This research contributes to our limited understanding of the social dynamics involved in athletes' return to sport following a concussion.	[Caron, Jeffrey G.] Univ Montreal, Montreal, PQ, Canada; [Benson, Alex J.] Western Univ, London, ON, Canada; [Steins, Rebecca] McGill Univ, Montreal, PQ, Canada; [McKenzie, Laura] Univ Ottawa, Ottawa, ON, Canada; [Bruner, Mark W.] Nipissing Univ, North Bay, ON, Canada; [Caron, Jeffrey G.] Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada		Caron, JG (corresponding author), Univ Montreal, Montreal, PQ, Canada.	jeffrey.caron@umontreal.ca		Benson, Alex/0000-0002-5978-065X			Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benson AJ, 2018, PSYCHOL SPORT EXERC, V34, P119, DOI 10.1016/j.psychsport.2017.10.008; Benson AJ, 2014, SPORT EXERC PERFORM, V3, P228, DOI 10.1037/spy0000016; Boroumand S, 2018, J APPL SPORT PSYCHOL, V30, P358, DOI 10.1080/10413200.2017.1384939; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Bruner MW, 2014, PSYCHOL SPORT EXERC, V15, P56, DOI 10.1016/j.psychsport.2013.09.003; BURKE PJ, 1980, SOC PSYCHOL QUART, V43, P18, DOI 10.2307/3033745; Burke S, 2016, ROUT INT HANDB, P330; Caron J. G., 2019, DICT SPORT PSYCHOL S, P58; Caron JG, 2018, BRIT J SPORT MED, V52, P1, DOI 10.1136/bjsports-2017-098319; Caron JG, 2017, J LOSS TRAUMA, V22, P501, DOI 10.1080/15325024.2017.1335150; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Donnelly Peter., 2004, SPORTING BODIES DAMA, P29, DOI DOI 10.1016/S1476-2854(04)02001-1; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Freeman P, 2014, J SPORT EXERCISE PSY, V36, P189, DOI 10.1123/jsep.2013-0080; Graupensperger SA, 2018, J SPORT EXERCISE PSY, V40, P117, DOI 10.1123/jsep.2017-0339; Haslam SA, 2018, SOC SCI MED, V198, P14, DOI 10.1016/j.socscimed.2017.12.020; Hogg MA, 1995, SOC PSYCHOL QUART, V58, P255, DOI 10.2307/2787127; Hornsey MJ, 2008, SOC PERSONAL PSYCHOL, V2, P204, DOI 10.1111/j.1751-9004.2007.00066.x; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2017, SPORT EXERC PERFORM, V6, P215, DOI 10.1037/spy0000108; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lickel B, 2000, J PERS SOC PSYCHOL, V78, P223, DOI 10.1037/0022-3514.78.2.223; McGannon KR, 2021, INT J SPORT EXERC PS, V19, P359, DOI 10.1080/1612197X.2019.1655779; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McGuckin M. E., 2016, J SPORT BEHAV, V39, P426; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; O'Rourke DJ, 2017, SPORT EXERC PERFORM, V6, P262, DOI 10.1037/spy0000097; Park S, 2013, INT REV SPORT EXER P, V6, P22, DOI 10.1080/1750984X.2012.687053; Podlog L, 2015, SPORT PSYCHOL, V29, P1, DOI 10.1123/tsp.2014-0063; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Poucher ZA, 2020, INT REV SPORT EXER P, V13, P163, DOI 10.1080/1750984X.2019.1656276; Praharso NF, 2017, PSYCHIAT RES, V247, P265, DOI 10.1016/j.psychres.2016.11.039; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Rees T, 2015, SPORTS MED, V45, P1083, DOI 10.1007/s40279-015-0345-4; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ronkainen NJ, 2016, INT REV SPORT EXER P, V9, P45, DOI 10.1080/1750984X.2015.1096414; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Smith B, 2009, PSYCHOL SPORT EXERC, V10, P1, DOI 10.1016/j.psychsport.2008.01.004; Smith B, 2016, ROUT INT HANDB, P260; Surya M, 2015, J APPL SPORT PSYCHOL, V27, P52, DOI 10.1080/10413200.2014.941512; Tator C, 2019, CAN J NEUROL SCI, V46, P351, DOI 10.1017/cjn.2019.14; Wiese-Bjornstal D.M., 2015, KINESIOL REV, V4, P169, DOI [https://doi.org/10.1123/kr.2015-0012, DOI 10.1123/KR.2015-0012]; Young, 2004, SPORTING BODIES DAMA, P59	52	4	4	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1469-0292	1878-5476		PSYCHOL SPORT EXERC	Psychol. Sport Exerc.	JAN	2021	52								101824	10.1016/j.psychsport.2020.101824			10	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	PH5KV	WOS:000600452200018					2022-02-06	
J	Chio, JCT; Wang, J; Surendran, V; Li, LJ; Zavvarian, MM; Pieczonka, K; Fehlings, MG				Chio, Jonathon Chon Teng; Wang, Jian; Surendran, Vithushan; Li, Lijun; Zavvarian, Mohammad-Masoud; Pieczonka, Katarzyna; Fehlings, Michael G.			Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier	NEUROBIOLOGY OF DISEASE			English	Article						Rat; Spinal cord injury; Human immunoglobulin G; High dose; Neuroinflammation; Immunomodulation; Time window of administration; Blood-spinal cord-barrier; Neutrophils; Tissue preservation; Neuroprotection; Functional recovery; Sensory recovery	SYSTEMIC INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; TNF-ALPHA; BEHAVIORAL RECOVERY; BRAIN; CELLS; NEUTROPHILS; RECEPTOR; IVIG; IMMUNOMODULATION	Background/introduction: The neuroinflammatory response plays a major role in the secondary injury cascade after traumatic spinal cord injury (SCI). To date, systemic anti-inflammatory medications such as methylprednisolone sodium succinate (MP55) have shown promise in SCI. However, systemic immunosuppression can have detrimental side effects. Therefore, immunomodulatory approaches including the use of human immunoglobulin G (hIgG) could represent an attractive alternative. While emerging preclinical data suggests that hIgG is neuroprotective after SCI, the optimal time window of administration and the mechanism of action remain incompletely understood. These knowledge gaps were the focus of this research study. Methods: Female adult Wistar rats received a clip compression-contusion SCI at the C7/T1 level of the spinal cord. Injured rats were randomized, in a blinded manner, to receive a single intravenous bolus of hIgG (2 g/kg) or control buffer at 15 minutes (min), 1 hour (h) or 4 h post-SCI. At 24 h and 8 weeks post-SCI, molecular, histological and neurobehavioral analyses were undertaken. Results: At all 3 administration time points, hIgG (2 g/kg) resulted in significantly better short-term and long-term outcomes as compared to control buffer. No significant differences were observed when comparing outcomes between the different time points of administration. At 24 h post-injury, hIgG (2 g/kg) administration enhanced the integrity of the blood spinal cord barrier (BSCB) by increasing expression of tight junction proteins and reducing inflammatory enzyme expression. Improvements in BSCB integrity were associated with reduced immune cell infiltration, lower amounts of albumin and Evans Blue in the injured spinal cord and greater expression of anti-inflammatory cytokines. Furthermore, hIgG (2 g/kg) increased expression of neutrophil chemoattractants in the spleen and sera. After hIgG (2 g/kg) treatment, there were more neutrophils in the spleen and fewer neutrophils in the blood. hIgG also co-localized with endothelial cell ligands that mediate neutrophil extravasation into the injured spinal cord. Importantly, short-term effects of delayed hIgG (2 g/kg) administration were associated with enhanced tissue and neuron preservation, as well as neurobehavioral and sensory recovery at 8 weeks post-SCI. Discussion and conclusion: hIgG (2 g/kg) shows promise as a therapeutic approach for SCI. The anti-inflammatory effects mediated by hIgG (2 g/kg) in the injured spinal cord might be explained in twofold. First, hIgG might antagonize neutrophil infiltration into the spinal cord by co-localizing with endothelial cell ligands that mediate various steps in neutrophil extravasation. Second, hIgG could traffic neutrophils towards the spleen by increasing expression of neutrophil chemoattractants in the spleen and sera. Overall, we demonstrate that delayed administration of hIgG (2 g/kg) at 1 and 4-h post-injury enhances short-term and long-term benefits after SCI by modulating local and systemic neuroinflammatory cascades.	[Chio, Jonathon Chon Teng; Wang, Jian; Surendran, Vithushan; Li, Lijun; Zavvarian, Mohammad-Masoud; Pieczonka, Katarzyna; Fehlings, Michael G.] Univ Hlth Network, Krembil Res Inst, Div Translat & Expt Neurosci, Toronto, ON, Canada; [Chio, Jonathon Chon Teng; Zavvarian, Mohammad-Masoud; Pieczonka, Katarzyna; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Chio, Jonathon Chon Teng; Wang, Jian; Surendran, Vithushan; Li, Lijun; Zavvarian, Mohammad-Masoud; Pieczonka, Katarzyna] Krembil Discovery Tower, 60 Leonard Ave,7KD-430, Toronto, ON M5T 2S8, Canada		Fehlings, MG (corresponding author), Univ Hlth Network, Toronto Western Hosp, 399 Bathurst St,M5T 2S8, Toronto, ON, Canada.	jct.chio@mail.utoronto.ca; jian.wang@uhnresearch.ca; vithushan.surendran@outlook.com; lijun.li@uhnresearch.ca; mohammad.zavvarian@mail.utoronto.ca; k.pieczonka@mail.utoronto.ca; michael.fehlings@uhn.ca		Chio, Jonathon Chon Teng/0000-0002-9914-5538; Fehlings, Michael/0000-0002-5722-6364	Paralyzed Veterans of America: Research Foundation Grant; Ontario Graduate ScholarshipOntario Graduate Scholarship; Takeda through the Baxter BioScience Grant	Takeda is responsible for providing material support through the Baxter BioScience Grant. This project is also supported by the Paralyzed Veterans of America: Research Foundation Grant. Jonathon Chio holds the Ontario Graduate Scholarship.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Aube B, 2014, J IMMUNOL, V193, P2438, DOI 10.4049/jimmunol.1400401; Badner A, 2016, STEM CELL TRANSL MED, V5, P991, DOI 10.5966/sctm.2015-0295; Ballow M, 2014, CURR OPIN ALLERGY CL, V14, P509, DOI 10.1097/ACI.0000000000000116; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Bao F, 2012, J NEUROTRAUM, V29, P1626, DOI 10.1089/neu.2011.2190; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Bracchi-Ricard V, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-92; Brennan FH, 2016, ANN CLIN TRANSL NEUR, V3, P495, DOI 10.1002/acn3.318; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Carpenter RS, 2015, EXP NEUROL, V271, P432, DOI 10.1016/j.expneurol.2015.07.011; Chio JCT, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1518-0; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; De Luca C, 2016, CELL MOL NEUROBIOL, V36, P37, DOI 10.1007/s10571-015-0218-2; DePaul MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16795; Ditor DS, 2006, J NEUROSURG-SPINE, V5, P343, DOI 10.3171/spi.2006.5.4.343; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Nguyen DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-224; Fehlings MG, 2017, GLOB SPINE J, V7, p203S, DOI 10.1177/2192568217703085; Fehlings MG, 2010, J CLIN IMMUNOL, V30, pS109, DOI 10.1007/s10875-010-9404-7; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Forgione N, 2017, J NEUROTRAUM, V34, P1227, DOI 10.1089/neu.2016.4708; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gill V, 2005, CIRCULATION, V112, P2031, DOI 10.1161/CIRCULATIONAHA.105.546150; Gok B, 2009, J CLIN NEUROSCI, V16, P549, DOI 10.1016/j.jocn.2008.04.024; Griffiths M, 2007, INT REV NEUROBIOL, V82, P29, DOI 10.1016/S0074-7742(07)82002-2; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Halbwachs L, 2012, J AM SOC NEPHROL, V23, P1449, DOI 10.1681/ASN.2012020119; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Issekutz AC, 2011, CLIN IMMUNOL, V141, P187, DOI 10.1016/j.clim.2011.08.003; Jin LL, 2018, J IMMUNOL, V200; Johnstone JT, 2013, J NEUROSCI RES, V91, P828, DOI 10.1002/jnr.23208; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kooijman E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090584; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Labombarda F, 2015, J STEROID BIOCHEM, V154, P274, DOI 10.1016/j.jsbmb.2015.09.011; Langereis JD, 2013, CELL ADHES MIGR, V7, P476, DOI 10.4161/cam.27293; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lee JY, 2014, BBA-MOL BASIS DIS, V1842, P2403, DOI 10.1016/j.bbadis.2014.09.006; Lee SY, 2014, ARTHRITIS RHEUMATOL, V66, P1768, DOI 10.1002/art.38627; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Macmillan HF, 2010, AUTOIMMUNITY, V43, P619, DOI 10.3109/08916931003599062; Maldonado-Bouchard S, 2016, BRAIN BEHAV IMMUN, V51, P176, DOI 10.1016/j.bbi.2015.08.009; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Massoud AH, 2017, J IMMUNOL, V198, P2760, DOI 10.4049/jimmunol.1502361; Mercadante A.A., 2020, NEUROANATOMY GRAY MA; Mitchell AJ, 2014, CELL IMMUNOL, V291, P22, DOI 10.1016/j.cellimm.2014.05.010; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neirinckx V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0150-2; Neumann J, 2015, ACTA NEUROPATHOL, V129, P259, DOI 10.1007/s00401-014-1355-2; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Papastefanaki F, 2015, GLIA, V63, P1101, DOI 10.1002/glia.22809; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Saghazadeh A, 2017, BIOMED PHARMACOTHER, V92, P128, DOI 10.1016/j.biopha.2017.05.048; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Sun X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0736-y; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tiruppathi C, 2004, P NATL ACAD SCI USA, V101, P7699, DOI 10.1073/pnas.0401712101; Tzekou A, 2014, J CLIN IMMUNOL, V34, pS132, DOI 10.1007/s10875-014-0021-8; Ueno K, 2015, CIRC J, V79, P1349, DOI 10.1253/circj.CJ-14-1323; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Vidal PM, 2013, IMMUNOBIOLOGY, V218, P281, DOI 10.1016/j.imbio.2012.05.007; Wilcox JT, 2014, STEM CELL TRANSL MED, V3, P1148, DOI 10.5966/sctm.2014-0029; Wilson J.R., 2014, SPINE SURG, V15, P1; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; Zhang B, 2014, EXP NEUROL, V258, P112, DOI 10.1016/j.expneurol.2014.04.007; Zozulya A, 2008, BRAIN RES, V1189, P1, DOI 10.1016/j.brainres.2007.10.099	82	4	4	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JAN	2021	148								105187	10.1016/j.nbd.2020.105187			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PR9VF	WOS:000607577600003	33249350	gold			2022-02-06	
J	Dekker, SE; Biesterveld, B; Bambakidis, T; Williams, AM; Tagett, R; Johnson, CN; Sillesen, M; Liu, BL; Li, YQ; Alam, HB				Dekker, Simone E.; Biesterveld, Ben E.; Bambakidis, Ted; Williams, Aaron M.; Tagett, Rebecca; Johnson, Craig N.; Sillesen, Martin; Liu, Baoling; Li, Yongqing; Alam, Hasan B.			Modulation of Brain Transcriptome by Combined Histone Deacetylase Inhibition and Plasma Treatment Following Traumatic Brain Injury and Hemorrhagic Shock	SHOCK			English	Article						Epigenetic modulation; fresh frozen plasma; hemorrhage; histone acetylation; neuroprotection; neurotrauma; prosurvival strategies; valproic acid	FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; DIFFERENT RESUSCITATION STRATEGIES; VALPROIC ACID TREATMENT; GENE-EXPRESSION; PHARMACOLOGICAL RESUSCITATION; SWINE MODEL; APOPTOSIS; RECOVERY; DEATH	Introduction: We previously showed that the addition of valproic acid (VPA), a histone deacetylase inhibitor, to fresh frozen plasma (FFP) resuscitation attenuates brain lesion size and swelling following traumatic brain injury (TBI) and hemorrhagic shock (HS). The goal of this study was to use computational biology tools to investigate the effects of FFP+VPA on the brain transcriptome following TBI+HS. Methods: Swine underwent TBI+HS, kept in shock for 2 h, and resuscitated with FFP or FFP + VPA (n = 5/group). After 6 h of observation, brain RNA was isolated and gene expression was analyzed using a microarray. iPathwayGuide, Gene Ontology (GO), Gene-Set Enrichment Analysis, and Enrichment Mapping were used to identify significantly impacted genes and transcriptomic networks. Results: Eight hundred differentially expressed (DE) genes were identified out of a total of 9,118 genes. Upregulated genes were involved in promotion of cell division, proliferation, and survival, while downregulated genes were involved in autophagy, cell motility, neurodegenerative diseases, tumor suppression, and cell cycle arrest. Seven hundred ninety-one GO terms were significantly enriched. A few major transcription factors, such as TP53, NFKB3, and NEUROD1, were responsible for modulating hundreds of other DE genes. Network analysis revealed attenuation of interconnected genes involved in inflammation and tumor suppression, and an upregulation of those involved in cell proliferation and differentiation. Conclusion: Overall, these results suggest that VPA treatment creates an environment that favors production of new neurons, removal of damaged cells, and attenuation of inflammation, which could explain its previously observed neuroprotective effects.	[Dekker, Simone E.; Biesterveld, Ben E.; Bambakidis, Ted; Williams, Aaron M.; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97201 USA; [Tagett, Rebecca; Johnson, Craig N.] Univ Michigan, Bioinformat Core Facil, Ann Arbor, MI 48109 USA; [Sillesen, Martin] Rigshosp, Copenhagen Univ Hosp, Dept Surg Gastroenterol, Copenhagen, Denmark; [Sillesen, Martin] Rigshosp, Copenhagen Univ Hosp, Ctr Surg Translat & Artificial Intelligence Res C, Copenhagen, Denmark		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Johnson, Craig/0000-0003-3955-7394	US Army Medical Research Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]	This study was funded by a grant from the US Army Medical Research Material Command GRANTT00521959 (to HBA). In addition, Dr BEB was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number F32GM130010.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aubrey BJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026062; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brochier C, 2013, J NEUROSCI, V33, P8621, DOI 10.1523/JNEUROSCI.5214-12.2013; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Centers for Disease Control and Prevention, 2014, TBI DAT STAT; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Dekker SE, 2018, J NEUROSCI RES, V96, P711, DOI 10.1002/jnr.24125; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; Dekker SE, 2014, J SURG RES, V190, P312, DOI 10.1016/j.jss.2014.02.049; Desai KH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001093; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Guyette FX., 2019, ANN SURG; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hu QD, 2018, ONCOTARGET, V9, P4223, DOI 10.18632/oncotarget.23786; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Li RR, 2015, CRIT CARE MED, V43, pE567, DOI 10.1097/CCM.0000000000001203; Luo QQ, 2015, INT J CLIN ONCOL, V20, P508, DOI 10.1007/s10147-014-0752-9; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Munoz-Pinedo C, 2012, ADV EXP MED BIOL, V738, P124, DOI 10.1007/978-1-4614-1680-7_8; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Sillesen M, 2017, J AM COLL SURGEONS, V224, P49, DOI 10.1016/j.jamcollsurg.2016.09.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Williams AM, 2019, J TRAUMA ACUTE CARE, V87, P393, DOI 10.1097/TA.0000000000002281; Williams AM, 2019, SHOCK, V52, P300, DOI 10.1097/SHK.0000000000001308; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	45	4	4	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2021	55	1					110	120		10.1097/SHK.0000000000001605			11	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	SV3NF	WOS:000663728500015	32925172				2022-02-06	
J	Gao, BX; Xue, T; Rong, XC; Yang, YB; Wang, ZL; Chen, ZQ; Wang, Z				Gao, Bixi; Xue, Tao; Rong, Xiaoci; Yang, Yanbo; Wang, Zilan; Chen, Zhouqing; Wang, Zhong			Tranexamic Acid Inhibits Hematoma Expansion in Intracerebral Hemorrhage and Traumatic Brain Injury. Does Blood Pressure Play a Potential Role? A Meta-Analysis from Randmized Controlled Trials	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Tranexamic acid; Spontaneous hemorrhage; Traumatic hemorrhage; Hematoma expansion; Hematoma volume change; Meta-analysis	SUBARACHNOID HEMORRHAGE; GROWTH	Background: Tranexamic acid (TXA) is an antifibrinolytic agent, which has shown an effect on reducing blood loss in many diseases. Many studies focus on the effect of TXA on cerebral hemorrhage, however, whether TXA can inhibit hematoma expansion is still controversial. Our meta-analysis performed a quantitative analysis to evaluate the efficacy of TXA for the hematoma expansion in spontaneous and traumatic intracranial hematoma. Method: Pubmed (MEDLINE), Embase, and Cochrane Library were searched from January 2001 to May 2020 for randomized controlled trials (RCTs). Result: We pooled 3102 patients from 7 RCTs to evaluate the efficacy of TXA for hematoma expansion. Hematoma expansion (HE) rate and hematoma volume (HV) change from baseline were used to analyze. We found that TXA led to a significant reduction in HE rate (P = 0.002) and HV change (P = 0.03) compared with the placebo. Patients with moderate or serious hypertension benefit more from TXA. (HE rate: P = 0.02, HV change: P = 0.04) TXA tends to have a better efficacy on HV change in intracerebral hemorrhage (ICH). (P = 0.06) Conclusions: TXA showed good efficacy for hematoma expansion in spontaneous and traumatic intracranial hemorrhage. Patients with moderate/severe hypertension and ICH may be more suitable for TXA administration in inhibiting hematoma expansion.	[Gao, Bixi; Xue, Tao; Rong, Xiaoci; Yang, Yanbo; Wang, Zilan; Chen, Zhouqing; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi St, Suzhou 215006, Jiangsu, Peoples R China; [Gao, Bixi; Xue, Tao; Rong, Xiaoci; Yang, Yanbo; Wang, Zilan; Chen, Zhouqing] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou 215006, Jiangsu, Peoples R China		Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi St, Suzhou 215006, Jiangsu, Peoples R China.	wangzhong761@163.com		XUE, TAO/0000-0002-1443-2475	Suzhou Health Talents Training Project [GSWS2019002]	This work was supported by the Suzhou Health Talents Training Project (GSWS2019002).	Arumugam A, 2015, MALAYS J MED SCI, V22, P62; Chakroun-Walha O, 2019, EUR J TRAUMA EMERG S, V45, P719, DOI 10.1007/s00068-018-0974-z; CHANDRA B, 1978, ANN NEUROL, V3, P502, DOI 10.1002/ana.410030607; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Damade C, 2019, NEUROCHIRURGIE, V65, P377, DOI 10.1016/j.neuchi.2019.05.003; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; De Silva MJ, 2009, INT J EPIDEMIOL; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Hu WY, 2019, CNS DRUGS, V33, P327, DOI 10.1007/s40263-019-00608-4; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Leiblich A, 2011, EMERG MED J, V28, P115, DOI 10.1136/emj.2009.079442; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Morotti A, 2017, JAMA NEUROL, V74, P950, DOI 10.1001/jamaneurol.2017.1014; Mousavinejad M, 2020, REV RECENT CLIN TRIA, V15, P70, DOI 10.2174/1574887114666191118111826; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pabinger I, 2017, WIEN KLIN WOCHENSCHR, V129, P303, DOI 10.1007/s00508-017-1194-y; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roos Y, 2000, NEUROLOGY, V54, P77, DOI 10.1212/WNL.54.1.77; Sprigg N, 2018, LANCET, V391, P2107, DOI 10.1016/S0140-6736(18)31033-X; Sprigg N, 2014, J STROKE CEREBROVASC, V23, P1312, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.007; Steiner T, 2010, STROKE, V41, P402, DOI 10.1161/STROKEAHA.109.552919; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Suri MFK, 2008, NEUROCRIT CARE, V9, P177, DOI 10.1007/s12028-008-9106-7; Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214; White CC, 2018, J KNEE SURG, V31, P594, DOI 10.1055/s-0038-1648223; Yao RZ, 2019, ORTHOP SURG, V11, P545, DOI 10.1111/os.12515; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	33	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2021	30	1							105436	10.1016/j.jstrokecerebrovasdis.2020.105436			8	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	PI8BO	WOS:000601309800005	33171426				2022-02-06	
J	Hecht, JP; Han, EJ; Cain-Nielsen, AH; Scott, JW; Hemmila, MR; Wahl, WL				Hecht, Jason P.; Han, Emily J.; Cain-Nielsen, Anne H.; Scott, John W.; Hemmila, Mark R.; Wahl, Wendy L.			Association of timing of initiation of pharmacologic venous thromboembolism prophylaxis with outcomes in trauma patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	79th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 08-18, 2020	ELECTR NETWORK	Amer Assoc Surg Trauma		Venous thromboembolism; venous thrombosis; pulmonary embolism; heparin; low-molecular-weight heparin		BACKGROUND Patients are at a high risk for developing venous thromboembolism (VTE) following traumatic injury. We examined the relationship between timing of initiation of pharmacologic prophylaxis with VTE complications. METHODS Trauma quality collaborative data from 34 American College of Surgeons Committee on Trauma-verified levels I and II trauma centers were analyzed. Patients were excluded if they were on anticoagulant therapy at the time of injury, had hospitalization <48 hours, or received no or nonstandard pharmacologic VTE prophylaxis (heparin drip). Patient comparison groups were based on timing of initiation of VTE prophylaxis relative to hospital presentation (0 to <24 hours, 24 to <48 hours, >= 48 hours). Risk-adjusted rates of VTE events were calculated accounting for patient factors including type of pharmacologic agent in addition to standard trauma patient confounders. A sensitivity analysis was performed excluding patients who received blood in the first 4 hours and/or patients with a significant traumatic brain injury. RESULTS Within the 79,386 patients analyzed, there were 1,495 (1.9%) who experienced a VTE complication and 1,437 (1.8%) who died. After adjusting for type of prophylaxis and patient factors, the risk of a VTE event was significantly increased in the 24- to <48-hour (odds ratio, 1.26; 95% confidence interval, 1.09-1.47; p = 0.002) and >= 48-hour (odds ratio, 2.35; 95% confidence interval, 2.04-2.70; p < 0.001) cohorts relative to patients initiated at 0 to CONCLUSION Early initiation of pharmacologic VTE prophylaxis in stable trauma patients is associated with lower rates of VTE.	[Hecht, Jason P.] St Joseph Mercy Hosp, Inpatient Pharm, 5301 E Huron River Dr, Ann Arbor, MI 48106 USA; [Han, Emily J.] Univ Michigan, Dept Pharm, Ann Arbor, MI 48109 USA; [Cain-Nielsen, Anne H.; Scott, John W.; Hemmila, Mark R.] Univ Michigan, Ctr Hlth Outcomes & Policy, Ann Arbor, MI 48109 USA; [Scott, John W.; Hemmila, Mark R.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Wahl, Wendy L.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA		Hecht, JP (corresponding author), St Joseph Mercy Hosp, Inpatient Pharm, 5301 E Huron River Dr, Ann Arbor, MI 48106 USA.	Jason.hecht@stjoeshealth.org; emilyjinahan@gmail.com; annecn@med.umich.edu; jwsco@med.umich.edu; mhemmila@med.umich.edu; wendy.wahl@osumc.edu		Scott, John/0000-0002-9916-6523	Blue Cross Blue Shield of Michigan; Blue Care Network Collaborative Quality Initiatives	A. H. C. -N. andM. R. H. receive salary support fromBlue Cross Blue Shield of Michigan/Blue Care Network (a nonprofit mutual company) and the Michigan Department of Health and Human Services through grant funding of the MTQIP. For the remaining authors, no conflicts of interest are declared. This study was supported by a Blue Cross Blue Shield of Michigan and Blue Care Network Collaborative Quality Initiatives grant awarded toM.R.H. for administration of theMTQIP. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; and decision to submit the article for publication.	Benjamin E, 2019, INJURY, V50, P697, DOI 10.1016/j.injury.2019.02.009; Brakenridge SC, 2011, AM J SURG, V201, P209, DOI 10.1016/j.amjsurg.2009.12.005; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P1086, DOI 10.1097/TA.0b013e31826fc7a0; Coleman JJ, 2015, J AM COLL SURGEONS, V220, P731, DOI 10.1016/j.jamcollsurg.2014.12.032; DiGiorgio AM, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17437; Frisoli FA, 2017, NEUROSURGERY, V81, P1016, DOI 10.1093/neuros/nyx164; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Haut ER, 2009, J TRAUMA, V66, P994, DOI 10.1097/TA.0b013e3181991adc; Hemmila MR, 2018, JAMA SURG, V153, P747, DOI 10.1001/jamasurg.2018.0985; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Hemmila MR, 2015, J TRAUMA ACUTE CARE, V78, P78, DOI 10.1097/TA.0000000000000494; Hemmila MR, 2010, ARCH SURG-CHICAGO, V145, P939, DOI 10.1001/archsurg.2010.193; Hemmila MR, 2017, J TRAUMA ACUTE CARE, V82, P867, DOI 10.1097/TA.0000000000001401; Jacobs BN, 2017, J TRAUMA ACUTE CARE, V83, P151, DOI 10.1097/TA.0000000000001494; Jakubus JL, 2018, CURR TRAUMA REP, V4, P1, DOI 10.1007/s40719-018-0116-4; Jakubus JL, 2020, J TRAUMA ACUTE CARE, V89, P199, DOI 10.1097/TA.0000000000002579; Jehan F, 2017, J SURG RES, V219, P360, DOI 10.1016/j.jss.2017.06.049; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Khan M, 2018, J AM COLL SURGEONS, V226, P760, DOI 10.1016/j.jamcollsurg.2018.01.006; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kwok AM, 2016, AM J SURG, V212, P1231, DOI 10.1016/j.amjsurg.2016.09.026; Machado-Aranda DA, 2015, J AM COLL SURGEONS, V221, P661, DOI 10.1016/j.jamcollsurg.2015.05.006; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Murphy PB, 2016, CAN J SURG, V59, P118, DOI 10.1503/cjs.010815; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Sumislawski JJ, 2018, J TRAUMA ACUTE CARE, V85, P907, DOI 10.1097/TA.0000000000002048; Van Haren RM, 2014, J TRAUMA ACUTE CARE, V76, P443, DOI 10.1097/TA.0b013e3182a9d11d; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P387, DOI 10.1097/TA.0000000000001916	33	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2021	90	1					54	63		10.1097/TA.0000000000002912			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	QE2YY	WOS:000616078100011	32890341				2022-02-06	
J	Henry, MK; French, B; Feudtner, C; Zonfrillo, MR; Lindberg, DM; Anderst, JD; Berger, RP; Wood, JN				Henry, M. Katherine; French, Benjamin; Feudtner, Chris; Zonfrillo, Mark R.; Lindberg, Daniel M.; Anderst, James D.; Berger, Rachel P.; Wood, Joanne N.			Cervical Spine Imaging and Injuries in Young Children With Non-Motor Vehicle Crash-Associated Traumatic Brain Injury	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; child abuse; spinal injuries		Objectives The aim of this study was to evaluate cervical magnetic resonance imaging (MRI) and computed tomography (CT) practices and cervical spine injuries among young children with non-motor vehicle crash (MVC)-associated traumatic brain injury (TBI). Methods We performed a retrospective study of a stratified, systematic random sample of 328 children younger than 2 years with non-MVC-associated TBI at 4 urban children's hospitals from 2008 to 2012. We defined TBI etiology as accidental, indeterminate, or abuse. We reported the proportion, by etiology, who underwent cervical MRI or CT, and had cervical abnormalities identified. Results Of children with non-MVC-associated TBI, 39.4% had abusive head trauma (AHT), 52.2% had accidental TBI, and in 8.4% the etiology was indeterminate. Advanced cervical imaging (CT and/or MRI) was obtained in 19.1% of all children with TBI, with 9.3% undergoing MRI and 11.7% undergoing CT. Cervical MRI or CT was performed in 30.9% of children with AHT, in 11.7% of accidental TBI, and in 10.7% of indeterminate-cause TBI. Among children imaged by MRI or CT, abnormal cervical findings were found in 22.1%, including 31.3% of children with AHT, 7.1% of children with accidental TBI, and 0% of children with indeterminate-cause TBI. Children with more severe head injuries who underwent cervical imaging were more likely to have cervical injuries. Conclusions Abusive head trauma victims appear to be at increased risk of cervical injuries. Prospective studies are needed to define the risk of cervical injury in children with TBI concerning for AHT and to inform development of imaging guidelines.	[Henry, M. Katherine; Feudtner, Chris; Wood, Joanne N.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Henry, M. Katherine; Feudtner, Chris; Wood, Joanne N.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [French, Benjamin] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Feudtner, Chris; Wood, Joanne N.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Injury Prevent Ctr, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA; [Lindberg, Daniel M.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Lindberg, Daniel M.] Univ Colorado, Sch Med, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Aurora, CO USA; [Anderst, James D.] Univ Missouri, Sch Med, Dept Pediat, Div Child Abuse & Neglect, Kansas City, MO 64108 USA; [Anderst, James D.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Berger, Rachel P.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res,Dept Pediat, Pittsburgh, PA 15213 USA; [Wood, Joanne N.] Childrens Hosp Philadelphia, PolicyLab, Philadelphia, PA 19104 USA		Henry, MK (corresponding author), Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd,12NW93, Philadelphia, PA 19104 USA.	henrym2@email.chop.edu; bcfrench@mail.med.upenn.edu; feudtner@email.chop.edu; zonfrillo@brown.edu; DANIEL.LINDBERG@UCDENVER.EDU; jdanderst@cmh.edu; Rachel.Berger@chp.edu; woodjo@email.chop.edu		Wood, Joanne/0000-0001-6431-8024	National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development institutional [5T32H060550-05]; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development Career Development Awards [1K23HD071967, K08HD073241]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32HS024194]	This study was supported through salary support by the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development institutional training grant 5T32H060550-05 (Dr Henry), National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development Career Development Awards 1K23HD071967 (Dr Wood) and K08HD073241 (Dr Zonfrillo), and Agency for Healthcare Research and Quality F32HS024194 (Dr Henry). The Children's Hospital of Philadelphia has received payment for Dr Wood's and Dr Henry's expert testimony after subpoenas in cases for suspected child abuse. Dr Lindberg has provided paid expert witness testimony in cases of alleged child physical abuse. This project was supported by grant number F32HS024194 fromthe Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Study sponsors were not involved in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication.	Altman DG., 1999, PRACTICAL STAT MEDIC; [Anonymous], 2008, ABBREVIATED INJURY S; Baerg J, 2017, J PEDIATR SURG, V52, P816, DOI 10.1016/j.jpedsurg.2017.01.049; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; FESMIRE F M, 1989, Journal of Emergency Medicine, V7, P133, DOI 10.1016/0736-4679(89)90258-8; Fisher BT, 2012, PHARMACOEPIDEM DR S, P244, DOI DOI 10.1002/9781119959946.CH16; Flynn JM, 2002, J PEDIATR ORTHOPED, V22, P573, DOI 10.1097/00004694-200209000-00002; Henry MK, 2016, ACAD PEDIATR, V16, P684, DOI 10.1016/j.acap.2016.01.017; Injury Prevention & Control: Traumatic Brain Injury & Concussion, 2014, PERCENT DISTRIBUTION; Jacob R., 2016, AJNR AM J NEURORADIO; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Khanna G, 2007, SKELETAL RADIOL, V36, P477, DOI 10.1007/s00256-006-0223-0; Leonard JR, 2014, PEDIATRICS, V133, pE1179, DOI 10.1542/peds.2013-3505; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Oh A, 2017, J NEUROSURG-PEDIATR, V20, P271, DOI 10.3171/2017.2.PEDS16644; Piatt JH, 2015, J NEUROSURG-PEDIATR, V16, P463, DOI 10.3171/2015.2.PEDS1515; Pieretti-Vanmarcke R, 2009, J TRAUMA, V67, P543, DOI 10.1097/TA.0b013e3181b57aa1; The American College of Radiology, 2014, ACR SPR PRACTICE PAR	25	4	4	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2021	37	1					E1	E6		10.1097/PEC.0000000000001455			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	QE4VI	WOS:000616204900001	29461428	Green Accepted			2022-02-06	
J	Iverson, GL; Gardner, AJ				Iverson, Grant L.; Gardner, Andrew J.			Symptoms of traumatic encephalopathy syndrome are common in the US general population	BRAIN COMMUNICATIONS			English	Article						athletes; epidemiology; chronic traumatic encephalopathy; traumatic brain injury; depression		There are no validated criteria for diagnosing chronic traumatic encephalopathy, or traumatic encephalopathy syndrome, in a living person. The purpose of this study is to examine symptom reporting resembling the research criteria for traumatic encephalopathy syndrome in men and women from the US general population. This is a retrospective analysis of publicly available data from a cross-sectional epidemiological study. The National Comorbidity Survey Replication was designed to examine the prevalence and correlates of mental disorders in the USA. The study included a nationally representative sample of 9282 adults (4139 men and 5143 women). An in-person interview and survey were conducted in the homes of men and women from the general population. The study was conducted with participants residing in New York City, Los Angeles, Chicago, Philadelphia, Detroit, San Francisco, Washington DC, Dallas/Fort Worth, Houston, Boston, Nassau-Suffolk NY, St. Louis, Pittsburgh, Baltimore, Minneapolis and Atlanta. Symptoms from the research criteria for the diagnosis of traumatic encephalopathy syndrome were applied to men and women in the general population and in sub-groups of people with health problems and mental health problems. A small percentage of the US general population met symptom criteria for traumatic encephalopathy syndrome (6.6-11.9%, depending on the definition applied). People with chronic pain were much more likely to meet criteria (i.e. 14.8-30.5%), and two out of three people who have experienced suicidality in the past year met symptom criteria for traumatic encephalopathy syndrome (65.2-72.2%). The majority of women with a mood disorder and chronic pain met criteria (62.7-89.8%). This is the largest study, to date, examining the aspects of the research criteria for the diagnosis of traumatic encephalopathy syndrome in the general population, and the first study to examine these criteria in women. This study has important clinical and public health implications. The potential rate for misdiagnosing traumatic encephalopathy syndrome in adults who are experiencing chronic pain, idiopathic mental health problems or both is high.	[Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Spaulding Res Inst, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.] Home Base, Charlestown, MA 02129 USA; [Gardner, Andrew J.] Hunter New England Local Hlth Dist, Sports Concuss Program, Waratah, NSW 2298, Australia; [Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Sentre Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia		Iverson, GL (corresponding author), Harvard Med Sch, Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu		Iverson, Grant/0000-0001-7348-9570	National Football League; ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; National Rugby League; Spaulding Research Institute	The authors are funded in part by the National Football League for a program of research entitled `The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects'. Unrestricted philanthropic support was provided by ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, the National Rugby League and the Spaulding Research Institute.	Ahern E, 2017, NEUROPSYCHOLOGY, V31, P52, DOI 10.1037/neu0000319; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belleville S, 2017, NEUROPSYCHOL REV, V27, P328, DOI 10.1007/s11065-017-9361-5; Borges G, 2006, PSYCHOL MED, V36, P1747, DOI 10.1017/S0033291706008786; Cardenas SA, 2016, NEUROSCI BIOBEHAV R, V69, P193, DOI 10.1016/j.neubiorev.2016.08.002; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Higgins DM, 2018, CLIN J PAIN, V34, P262, DOI 10.1097/AJP.0000000000000536; Iverson GL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00739; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2020, J NEUROPSYCH CLIN N, V32, P139, DOI 10.1176/appi.neuropsych.19010021; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Jester DJ, 2020, AGING MENT HEALTH, V24, P1769, DOI 10.1080/13607863.2019.1660852; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Laffey M, 2018, NEUROREHABILITATION, V43, P431, DOI 10.3233/NRE-182452; Li JQ, 2016, J NEUROL NEUROSUR PS, V87, P476, DOI 10.1136/jnnp-2014-310095; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moszczynski AJ, 2018, NEUROLOGY, V90, pE380, DOI 10.1212/WNL.0000000000004899; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Niermeyer MA, 2018, CLIN NEUROPSYCHOL, V32, P1256, DOI 10.1080/13854046.2017.1414306; Olaithe M, 2018, SLEEP MED REV, V38, P39, DOI 10.1016/j.smrv.2017.03.005; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; Sadanand S, 2016, DIABETES-METAB RES, V32, P132, DOI 10.1002/dmrr.2664; Saredakis D, 2019, PARKINSONISM RELAT D, V65, P20, DOI 10.1016/j.parkreldis.2019.04.020; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; Semkovska M, 2019, LANCET PSYCHIAT, V6, P851, DOI 10.1016/S2215-0366(19)30291-3; SPILLANE J D, 1962, Br Med J, V2, P1205; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stubbs B, 2016, J AFFECT DISORDERS, V197, P259, DOI 10.1016/j.jad.2016.02.060; Sudo Felipe Kenji, 2012, Dement. neuropsychol., V6, P145, DOI 10.1590/S1980-57642012DN06030006; Tsitsipa E, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0081-z; Vaessen TJA, 2015, SLEEP MED REV, V19, P51, DOI 10.1016/j.smrv.2014.03.008; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Weissberger GH, 2017, NEUROPSYCHOL REV, V27, P354, DOI 10.1007/s11065-017-9360-6; World Health Organization, 2004, ICD 10 INT STAT CLAS	65	4	4	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	1							fcab001	10.1093/braincomms/fcab001			16	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RV0UT	WOS:000645553500030	33842882	Green Published, gold			2022-02-06	
J	Jogia, T; Lubstorf, T; Jacobson, E; Scriven, E; Atresh, S; Nguyen, QH; Liebscher, T; Schwab, JM; Kopp, MA; Walsham, J; Campbell, KE; Ruitenberg, MJ				Jogia, Trisha; Luebstorf, Tom; Jacobson, Esther; Scriven, Elissa; Atresh, Sridhar; Nguyen, Quan H.; Liebscher, Thomas; Schwab, Jan M.; Kopp, Marcel A.; Walsham, James; Campbell, Kate E.; Ruitenberg, Marc J.			Prognostic value of early leukocyte fluctuations for recovery from traumatic spinal cord injury	CLINICAL AND TRANSLATIONAL MEDICINE			English	Article						neurotrauma; neutrophils; monocytes; lymphocytes; acute phase response; immune depression syndrome; pneumonia		Background Acute traumatic spinal cord injury (SCI) induces a systemic immune response involving circulating white blood cells (WBCs). How this response is influenced by overall trauma severity, the neurological level of injury and/or correlates with patient outcomes is poorly understood. The objective of this study was to identify relationships between early changes in circulating WBCs, injury characteristics and long-term patient outcomes in individuals with traumatic SCI. Methods We retrospectively analysed data from 161 SCI patients admitted to Brisbane's Princess Alexandra Hospital (exploration cohort). Logistic regression models in conjunction with receiver operating characteristic (ROC) analyses were used to assess the strength of specific links between the WBC response, respiratory infection incidence and neurological outcomes (American Spinal Injury Association Impairment Scale (AIS) grade conversion). An independent validation cohort from the Trauma Hospital Berlin, Germany (n = 49) was then probed to assess the robustness of effects and disentangle centre effects. Results We find that the extent of acute neutrophilia in human SCI patients is positively correlated with New Injury Severity Scores but inversely with the neurological outcome (AIS grade). Multivariate analysis demonstrated that acute SCI-induced neutrophilia is an independent predictor of AIS grade conversion failure, with an odds ratio (OR) of 4.16 and ROC area under curve (AUC) of 0.82 (P < 0.0001). SCI-induced lymphopenia was separately identified as an independent predictor of better recovery (OR = 24.15; ROC AUC = 0.85, P < 0.0001). Acute neutrophilia and increased neutrophil-lymphocyte ratios were otherwise significantly associated with respiratory infection presentation in both patient cohorts. Conclusions Our findings demonstrate the prognostic value of modelling early circulating neutrophil and lymphocyte counts with patient characteristics for predicting the longer term recovery after SCI.	[Jogia, Trisha; Jacobson, Esther; Ruitenberg, Marc J.] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Luebstorf, Tom; Schwab, Jan M.; Kopp, Marcel A.] Charite Univ Med Berlin, Dept Neurol & Expt Neurol, Clin & Expt Spinal Cord Injury Res Neuroparaplegi, D-10117 Berlin, Germany; [Scriven, Elissa] Princess Alexandra Hosp, Trauma Serv, Brisbane, Qld, Australia; [Atresh, Sridhar] Princess Alexandra Hosp, Spinal Injuries Unit, Brisbane, Qld, Australia; [Atresh, Sridhar; Walsham, James; Campbell, Kate E.] Univ Queensland, Fac Med, Southside Clin Sch, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Nguyen, Quan H.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Liebscher, Thomas] Trauma Hosp Berlin, Treatment Ctr Spinal Cord Injuries, Berlin, Germany; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Dept Neurol, Spinal Cord Injury Div, Wexner Med Ctr, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Neurosci Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Kopp, Marcel A.] Berlin Inst Hlth, QUEST Ctr Transforming Biomed Res, Berlin, Germany; [Walsham, James] Princess Alexandra Hosp, Intens Care Unit, Brisbane, Qld, Australia; [Campbell, Kate E.] Princess Alexandra Hosp, Orthopaed Dept, Brisbane, Qld, Australia; [Ruitenberg, Marc J.] Brisbane Diamantina Hlth Partners, Trauma Crit Care & Recovery, Brisbane, Qld, Australia		Ruitenberg, MJ (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld 4072, Australia.; Kopp, MA (corresponding author), Charite Univ Med Berlin, Dept Neurol & Expt Neurol, Clin & Expt Spinal Cord Injury Res Neuroparaplegi, D-10117 Berlin, Germany.	marcel.kopp@charite.de; m.ruitenberg@uq.edu.au	Kopp, Marcel/AAX-3960-2020	Kopp, Marcel/0000-0001-6832-9599; Schwab, Jan/0000-0001-6784-4919; Jogia, Trisha/0000-0002-6303-369X	Spinal Cure Australia; Research Training Program Scholarship (Australian Government); National Institute of Disability, Independent Living and Rehabilitation Research [90SI5020]; National Institutes of Neurological Disorders-NIH [R01NS118200-01]; European UnionEuropean Commission [01EW170A]; Craig H. Neilsen Foundation [596764]; Wings for Life Foundation	Spinal Cure Australia; Research Training Program Scholarship (Australian Government); National Institute of Disability, Independent Living and Rehabilitation Research, Grant/Award Number: 90SI5020; National Institutes of Neurological Disorders-NIH, Grant/Award Number: R01NS118200-01; European Union, Grant/Award Number: 01EW170A; Craig H. Neilsen Foundation, Grant/Award Number: 596764; Wings for Life Foundation	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Brennan FH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.98254; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9; Campagnolo DI, 1997, AM J PHYS MED REHAB, V76, P276, DOI 10.1097/00002060-199707000-00005; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; David S, 2018, J NEUROIMMUNOL, V321, P97, DOI 10.1016/j.jneuroim.2018.06.003; de Paleville DGLT, 2011, TRANSL STROKE RES, V2, P463, DOI 10.1007/s12975-011-0114-0; Druschel C, 2020, SPINAL CORD, V58, P873, DOI 10.1038/s41393-020-0435-5; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gillespie ER, 2022, J NEUROTRAUM, V39, P320, DOI 10.1089/neu.2019.6952; Greenhalgh AD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005264; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Iversen PO, 2000, BLOOD, V96, P2081; Jaja BNR, 2019, J NEUROTRAUM, V36, P3044, DOI 10.1089/neu.2018.6245; Jogia T., 2020, CLIN TRANSL MED, V11, pE272; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Kanyilmaz S, 2013, ARCH PHYS MED REHAB, V94, P369, DOI 10.1016/j.apmr.2012.09.015; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kopp MA, 2018, NEUROLOGY, V91, P476, DOI 10.1212/WNL.0000000000006123; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Kopp MA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-168; Kubota K, 2012, SPINE, V37, P1363, DOI 10.1097/BRS.0b013e31824b9e77; Kyritsis N., 2020, BLOOD RNA PROFILES D, DOI [10.1101/2020.2004.2015.037325, DOI 10.1101/2020.2004.2015.037325]; Liebscher T, 2015, J SPINAL CORD MED, V38, P607, DOI 10.1179/2045772314Y.0000000254; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Martin ND, 2011, J TRAUMA, V71, P380, DOI 10.1097/TA.0b013e318228221f; Neirinckx V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0150-2; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Safdar N., 2013, INT J INFECT CONTROL, V9, DOI [10.3396/ijic.v9i1.10817, DOI 10.3396/IJIC.V9I1.10817]; Savage KE, 2016, GLOB SPINE J, V6, P607, DOI 10.1055/s-0035-1570751; Savic G, 2017, SPINAL CORD, V55, P891, DOI 10.1038/sc.2017.64; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Smith CJ, 2015, STROKE, V46, P2335, DOI 10.1161/STROKEAHA.115.009617; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Stephan K, 2015, SPINE J, V15, P1994, DOI 10.1016/j.spinee.2015.04.041; ter Wengel PV, 2020, GLOB SPINE J, V10, P324, DOI 10.1177/2192568219844990; Terzi N, 2018, RESP CARE, V63, P1577, DOI 10.4187/respcare.06700; Wu B, 2012, EXP NEUROL, V237, P274, DOI 10.1016/j.expneurol.2012.07.016	50	4	4	2	2	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	2001-1326			CLIN TRANSL MED	Clin. Transl. Med.	JAN	2021	11	1							e272	10.1002/ctm2.272			23	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	PV3GH	WOS:000609878700022	33463065	Green Submitted, Green Published, gold			2022-02-06	
J	Kerr, ZY; Pierpoint, LA; Rosene, JM				Kerr, Zachary Y.; Pierpoint, Lauren A.; Rosene, John M.			Epidemiology of Concussions in High School Boys' Ice Hockey, 2008/09 to 2016/17 School Years	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						checking; fatigue; athletes; adolescents	INJURY SURVEILLANCE SYSTEM; RISK-FACTORS; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; SPORTS INJURIES; YOUTH SPORTS; MENS; HEAD; PREVENTION	Objective:This study examined the epidemiology of concussions in high school boys' ice hockey during the 2008/09 to 2016/17 school years. Design:Prospective cohort study. Athletic trainers from an average 33 high schools annually reported boys' ice hockey concussion and athlete-exposure (AE) data for the High School Reporting Information Online system. Setting:Convenience sample of high school boys' ice hockey programs during the 2008/09 to 2016/17 school years. Patients or Other Participants: High school boys' ice hockey players (aged similar to 14-18 years). Independent Variables:Concussion data on event type, injury mechanism, symptom resolution time, and time loss were obtained. Main Outcome Measures:Concussion rates with 95% confidence intervals (CIs) and distributions were calculated. Results:Overall, 348 concussions were reported in boys' ice hockey during the 2008/09 to 2016/17 academic years, leading to a concussion rate of 0.68/1000 AEs (95% CI, 0.61-0.75). Most occurred in competitions (85.6%), particularly after the first period (72.1% of all competition concussions). Among practice concussions, most occurred after the first hour of practice (60.0%). Most concussions were due to player contact (47.7%) and boards/glass contact (31.9%). Although 69.0% of concussed athletes had symptoms resolve in less than 7 days, only 14.1% returned to activity within a week. Conclusions: Most concussions occurred within the second and third periods. Preventive strategies that counter an increased risk of concussion due to a greater intensity of gameplay coupled with increased fatigue may be warranted. Moreover, athletes may further benefit from prevention efforts that focus on anticipating impacts during gameplay.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Pierpoint, Lauren A.] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Rosene, John M.] Univ New England, Dept Exercise & Sport Performance, Biddeford, ME USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack	The content of this report representing data collection by the National High School Sports-Related Injury Surveillance Study (High School Reporting Information Online) was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01. The authors also acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Blake TA., 2017, BR J SPORTS MED, V51, pA19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Dick R, 2007, J ATHL TRAINING, V42, P173; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Green L., 2014, LEGAL PERSPECTIVES R; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; National Federation of High Schools, 2017, 2016 17 HIGH SCH ATH; National Soccer Coaches Association of America, 2017, GET AHEAD SAF SOCC; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Petersen J, 2011, AM J SPORT MED, V39, P2296, DOI 10.1177/0363546511419277; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Schneider KJ., 2017, BR J SPORTS MED, V51, pA39; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; USA Hockey, 2016, RULE 604 BODY CHECKI; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645	54	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					E21	E28		10.1097/JSM.0000000000000697			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800007	30451700				2022-02-06	
J	Li, W; Qiu, JH; Li, XL; Aday, S; Zhang, JD; Conley, G; Xu, J; Joseph, J; Lan, HY; Langer, R; Mannix, R; Karp, JM; Joshi, N				Li, Wen; Qiu, Jianhua; Li, Xiang-Ling; Aday, Sezin; Zhang, Jingdong; Conley, Grace; Xu, Jun; Joseph, John; Lan, Haoyue; Langer, Robert; Mannix, Rebekah; Karp, Jeffrey M.; Joshi, Nitin			BBB pathophysiology-independent delivery of siRNA in traumatic brain injury	SCIENCE ADVANCES			English	Article							IN-VIVO; DRUG-DELIVERY; MOUSE MODEL; NANOPARTICLES; BARRIER; NEUROINFLAMMATION; NEURODEGENERATION; PHARMACOKINETICS; DOXORUBICIN; DISEASE	Small interfering RNA (siRNA)-based therapeutics can mitigate the long-term sequelae of traumatic brain injury (TBI) but suffer from poor permeability across the blood-brain barrier (BBB). One approach to overcoming this challenge involves treatment administration while BBB is transiently breached after injury. However, it offers a limited window for therapeutic intervention and is applicable to only a subset of injuries with substantially breached BBB. We report a nanoparticle platform for BBB pathophysiology-independent delivery of siRNA in TBI. We achieved this by combined modulation of surface chemistry and coating density on nanoparticles, which maximized their active transport across BBB. Engineered nanoparticles injected within or outside the window of breached BBB in TBI mice showed threefold higher brain accumulation compared to nonengineered PEGylated nanoparticles and 50% gene silencing. Together, our data suggest that this nanoparticle platform is a promising next-generation drug delivery approach for the treatment of TBI.	[Li, Wen; Li, Xiang-Ling; Aday, Sezin; Xu, Jun; Joseph, John; Lan, Haoyue; Karp, Jeffrey M.; Joshi, Nitin] Brigham & Womens Hosp, Ctr Nanomed, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Li, Wen; Aday, Sezin; Langer, Robert; Joshi, Nitin] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Li, Wen; Aday, Sezin; Langer, Robert; Joshi, Nitin] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Li, Wen; Qiu, Jianhua; Xu, Jun; Joseph, John; Mannix, Rebekah; Karp, Jeffrey M.; Joshi, Nitin] Harvard Med Sch, Boston, MA 02115 USA; [Qiu, Jianhua; Zhang, Jingdong; Conley, Grace; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Zhang, Jingdong] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Langer, Robert; Karp, Jeffrey M.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Karp, Jeffrey M.] Broad Inst, Cambridge, MA 02142 USA; [Karp, Jeffrey M.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA		Karp, JM; Joshi, N (corresponding author), Brigham & Womens Hosp, Ctr Nanomed, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.; Joshi, N (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Joshi, N (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Mannix, R; Karp, JM; Joshi, N (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.; Karp, JM (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Karp, JM (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; Karp, JM (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	rebekah.mannix@childrens.harvard.edu; jmkarp@bwh.harvard.edu; njoshi@bwh.harvard.edu	Aday, Sezin/I-5901-2019; Xu, Jun/AAB-8989-2021; JOSEPH, JOHN/AAS-6527-2021	Aday, Sezin/0000-0003-4396-7812; JOSEPH, JOHN/0000-0002-0232-6042; Xu, Jun/0000-0002-4477-1670; Langer, Robert/0000-0003-4255-0492; Conley, Grace/0000-0002-2920-9735	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL095722]; Fundacao para a Ciencia e a Tecnologia through MIT-Portugal [TB/ECE/0013/2013]; Football Players Health Study at Harvard; National Football League Players Association	This work was supported by the National Institutes of Health grant HL095722 (to J.M.K.) and Fundacao para a Ciencia e a Tecnologia through MIT-Portugal-TB/ECE/0013/2013 (to J.M.K.). This work was also conducted with the support of the Football Players Health Study at Harvard (to R.M.). The Football Players Health Study is funded by a grant from the National Football League Players Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliated academic health care centers, the National Football League Players Association, Boston Children's Hospital, or the Brigham and Women's Hospital.	Ambruosi A, 2006, J DRUG TARGET, V14, P97, DOI 10.1080/10611860600636135; Anraku Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00952-3; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Calcul L, 2012, FUTURE MED CHEM, V4, P1751, DOI [10.4155/FMC.12.124, 10.4155/fmc.12.124]; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cheng J. S., 2014, PLOS ONE, V9; Chiasseu M, 2016, J NEUROSCI, V36, P5785, DOI 10.1523/JNEUROSCI.3986-15.2016; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Dowdy SF, 2017, NAT BIOTECHNOL, V35, P222, DOI 10.1038/nbt.3802; Fukuda AM, 2013, GENES-BASEL, V4, P435, DOI 10.3390/genes4030435; Furtado D, 2018, ADV MATER, V30, DOI 10.1002/adma.201801362; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hoshyar N, 2016, NANOMEDICINE-UK, V11, P673, DOI 10.2217/nnm.16.5; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Huang JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15144; Islam MA, 2018, NAT BIOMED ENG, V2, P850, DOI 10.1038/s41551-018-0284-0; Jaffer H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03117; Kang JY, 2016, ADV MATER, V28, P7962, DOI 10.1002/adma.201600634; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Kwon EJ, 2016, ACS NANO, V10, P7926, DOI 10.1021/acsnano.6b03858; Lam FC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04315-4; Li J, 2014, ACS NANO, V8, P9925, DOI 10.1021/nn501069c; Li XD, 2018, VIRUS RES, V254, P10, DOI 10.1016/j.virusres.2017.09.005; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Maussang David, 2016, Drug Discov Today Technol, V20, P59, DOI 10.1016/j.ddtec.2016.09.003; McHugh KJ, 2017, SCIENCE, V357, P1138, DOI 10.1126/science.aaf7447; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Naito M., 2018, NANOPARTICLE TECHNOL; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Nowak M., 2019, ADV THERAP, V3; Oller-Salvia B, 2016, CHEM SOC REV, V45, P4690, DOI 10.1039/c6cs00076b; Rip J, 2014, J DRUG TARGET, V22, P460, DOI 10.3109/1061186X.2014.888070; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Sahyouni Ronald, 2017, J Concussion, V1, DOI 10.1177/2059700216684518; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Siahaan Andre Marolop Pangihutan, 2018, Open Access Maced J Med Sci, V6, P1953, DOI 10.3889/oamjms.2018.440; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suk JS, 2016, ADV DRUG DELIVER REV, V99, P28, DOI 10.1016/j.addr.2015.09.012; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu JPJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah6228; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu H, 2014, CURR GENE THER, V14, P343, DOI 10.2174/156652321405140926160602; Xu XY, 2013, P NATL ACAD SCI USA, V110, P18638, DOI 10.1073/pnas.1303958110; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Zheng CY, 2015, INT J CLIN EXP MED, V8, P1658; Zheng M, 2018, TRENDS BIOTECHNOL, V36, P562, DOI 10.1016/j.tibtech.2018.01.006	59	4	4	28	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	JAN	2021	7	1							eabd6889	10.1126/sciadv.abd6889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PO4SX	WOS:000605159200028	33523853	Green Published, gold, Green Submitted			2022-02-06	
J	Marklund, N; Vedung, F; Lubberink, M; Tegner, Y; Johansson, J; Blennow, K; Zetterberg, H; Fahlstrom, M; Haller, S; Stenson, S; Larsson, EM; Wall, A; Antoni, G				Marklund, Niklas; Vedung, Fredrik; Lubberink, Mark; Tegner, Yelverton; Johansson, Jakob; Blennow, Kaj; Zetterberg, Henrik; Fahlstrom, Markus; Haller, Sven; Stenson, Staffan; Larsson, Elna-Marie; Wall, Anders; Antoni, Gunnar			Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients-A PET/ MR study	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Sports-related concussion; Inflammation; Tau; Positron emission tomography (PET)	ENCEPHALOPATHY PATHOLOGY; MICROGLIAL ACTIVATION; AXONAL INJURY; SINGLE; NEUROPATHOLOGY; ABNORMALITIES; DEGENERATION; INFLAMMATION; ASSOCIATION; BIOMARKER	Traumatic brain injury (TBI) and repeated sports-related concussions (rSRCs) are associated with an increased risk for neurodegeneration. Autopsy findings of selected cohorts of long-term TBI survivors and rSRC athletes reveal increased tau aggregation and a persistent neuroinflammation. To assess in vivo tau aggregation and neuroinflammation in young adult TBI and rSRC cohorts, we evaluated 9 healthy controls (mean age 26 +/- 5 years; 4 males, 5 females), 12 symptomatic athletes (26 +/- 7 years; 6 males, 6 females) attaining >3 previous SRCs, and 6 moderate-to severe TBI patients (27 +/- 7 years; 4 males, 2 females) in a combined positron emission tomography (PET)/magnetic resonance (MR) scanner >6 months post-injury. Dual PET tracers, [18F]THK5317 for tau aggregation and [11C]PK11195 for neuroinflammation/microglial activation, were investigated on the same day. The Repeated Battery Assessment of Neurological Status (RBANS) scores, used for cognitive evaluation, were lower in both the rSRC and TBI groups (p < 0.05). Neurofilament-light (NF-L) levels were increased in plasma and cerebrospinal fluid (CSF; p < 0.05), and serum tau levels lower, in TBI although not in rSRC. In rSRC athletes, PET imaging showed increased neuroinflammation in the hippocampus and tau aggregation in the corpus callosum. In TBI patients, tau aggregation was observed in thalami, temporal white matter and midbrain; widespread neuroinflammation was found e.g. in temporal white matter, hippocampus and corpus callosum. In mixed-sex cohorts of young adult athletes with persistent post-concussion symptoms and in TBI patients, increased tau aggregation and neuroinflammation are observed at >6 months post-injury using PET. Studies with extended clinical follow-up, biomarker examinations and renewed PET imaging are needed to evaluate whether these findings progress to a neurodegenerative disorder or if spontaneous resolution is possible.	[Marklund, Niklas; Vedung, Fredrik] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden; [Lubberink, Mark] Uppsala Univ Hosp, Med Phys, Uppsala, Sweden; [Lubberink, Mark; Wall, Anders] Uppsala Univ, Dept Surg Sci, Nucl Med & PET, Uppsala, Sweden; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden; [Johansson, Jakob] Uppsala Univ, Dept Surg Sci, Anesthesiol, Uppsala, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UK Dementia Res Inst UCL, London, England; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Fahlstrom, Markus; Haller, Sven; Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Haller, Sven] CIMC Ctr Imagerie Med Cornavin, Pl Cornavin 18, CH-1201 Geneva, Switzerland; [Stenson, Staffan] Uppsala Univ Hosp, Rehabil Med PET Ctr, Dept Neurosci, Uppsala, Sweden; [Wall, Anders; Antoni, Gunnar] Uppsala Univ, Dept Med Chem, Uppsala, Sweden		Marklund, N (corresponding author), Lund Univ, Dept Clin Sci Lund, Neurosurg, S-22220 Lund, Sweden.	niklas.marklund@med.lu.se		Marklund, Niklas/0000-0002-9797-5626; Haller, Sven/0000-0001-7433-0203; Tegner, Yelverton/0000-0003-3628-0705	Swedish Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Bissen Brain Walk and Selander Foundation; Swedish Research Council for Sport Science; European Research CouncilEuropean Research Council (ERC)European Commission; Swedish State Support for Clinical Research; Swedish Alzheimer Foundation, Hjadrnfonden, Sweden; Swedish government; ALF-agreement; Tohoku Medical and Pharmaceutical University [THK5317]	We are indebted to Prof. Nobuyuki Okamura, Tohoku Medical and Pharmaceutical University for supporting us with chemicals for synthesis of [18F] THK5317; . The study was funded by the Swedish Brain Foundation, Swedish Research Council and Swedish Research Council under the framework of EU-ERA-NET NEURON CnsAFlame, Bissen Brain Walk and Selander Foundation, Swedish Research Council for Sport Science (all to Niklas Marklund) . Dr. Zetterberg is a Wallenberg Academy Fellow supported by grants from the Swedish Research Council, the European Research Council and Swedish State Support for Clinical Research. KB holds the Torsten Sodderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, and is supported by the Swedish Research Council, the Swedish Alzheimer Foundation, Hjadrnfonden, Sweden, and a grant from the Swedish state under the agreement between the Swedish government and the County Councils, the ALFagreement.	American Psychiatric Association, 2000, DSMIVTR AM PSYCH ASS, V4th; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Caprelli MT, 2018, J NEUROTRAUM, V35, P1929, DOI 10.1089/neu.2017.5495; Chaban V, 2020, J NEUROTRAUM, V37, P2120, DOI 10.1089/neu.2019.6963; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Dani M, 2018, BRAIN, V141, P2740, DOI 10.1093/brain/awy188; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; HARRINGTON CR, 1994, LANCET, V343, P993, DOI 10.1016/S0140-6736(94)90124-4; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Lee BG, 2018, J NEUROTRAUM, V35, P2015, DOI 10.1089/neu.2017.5558; Lemoine L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45496; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mathis CA, 2017, SEMIN NUCL MED, V47, P553, DOI 10.1053/j.semnuclmed.2017.06.003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Murugan NA, 2019, EUR J NUCL MED MOL I, V46, P1369, DOI 10.1007/s00259-019-04305-8; Ng KP, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0253-y; Okamura N, 2005, J NEUROSCI, V25, P10857, DOI 10.1523/JNEUROSCI.1738-05.2005; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sousa JM, 2018, EJNMMI PHYS, V5, DOI 10.1186/s40658-018-0220-0; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takahata K, 2019, BRAIN, V142, P3265, DOI 10.1093/brain/awz238; Turkheimer FE, 2007, J NUCL MED, V48, P158; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Wu YC, 2020, NEUROLOGY, V95, pE781, DOI 10.1212/WNL.0000000000009930; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yaqub M, 2012, J CEREBR BLOOD F MET, V32, P1600, DOI 10.1038/jcbfm.2012.59; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193	59	4	4	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	30								102665	10.1016/j.nicl.2021.102665			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TE9KA	WOS:000670324000007	33894460	Green Published, gold			2022-02-06	
J	Menon, G; Johnson, SE; Hegde, A; Rathod, S; Nayak, R; Nair, R				Menon, Girish; Johnson, Sarah Estar; Hegde, Ajay; Rathod, Sanjeev; Nayak, Raghavendra; Nair, Rajesh			Neutrophil to lymphocyte ratio - A novel prognostic marker following spontaneous intracerebral haemorrhage	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Neutrophil-to-lymphocyte ratio; Intracerebral haemorrhage; Mortality; Prognosis; Risk factors	GRADING SCALE; STROKE; SCORE; MORTALITY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; INFLAMMATION; PREDICTION; SYSTEM; EDEMA	Background: Inflammation plays a role in secondary brain injury after intracerebral haemorrhage (ICH). Peripheral biomarkers of inflammation especially the neutrophil-to-lymphocyte ratio (NLR) have been shown to influence outcome following ischemic stroke and traumatic brain injury. Role of NLR in outcome prognostication following haemorrhagic stroke has not yet been conclusively established. This study analyses the prognostic significance of admission neutrophil to lymphocyte ratio on mortality and 90-day outcome in patients admitted with acute SICH. Material and methods: A total of 851 patients with spontaneous ICH were retrospectively investigated. Admission haematological parameters were retrieved from our hospital laboratory systems and NLR was then calculated using the formula ANC/ALC. (Absolute neutrophil count/Absolute lymphocyte count) Clinical outcome was assessed by modified Rankin Scale at 90 days. Logistic regression was performed to identify independent risk factors of mortality and 90-day outcome. Receiver operator curve (ROC) test was used to determine the predictive value of NLR for 30-day death. Results: A total of 851 patients enrolled in the study. Our 30 day and 90 day mortality were 125 (17.7 %) and 244 (28.7 %) respectively. The mean NLR in the entire cohort was 9.03 +/- 7.6. NLR was significantly higher in the mortality group compared to the survivors (11.98 +/- 9.91 vs 8.52 +/- 7.05) P < 0.001. NLR in patients with a good outcome at 90 days (7.21 +/- 6.06) was a lower in comparison to patients with poor outcome(10.66 +/- 8.48). (p= 0.001). NLR was dichotomised at 8.2 which was computed based on ROC curve. Mortality and poor outcome were higher in the NLR 8, Volume of Hematoma, Intra ventricular extension of hematoma and NLR 8.2 were found to be independent predictors of outcome. GCS < 8 had a greater predictive value (5.236) compared to NLR.8.2 (1.78). Conclusion: Elevated levels of admission NLR were independently related to poor mortality and 90-day outcome after ICH. NLR is a novel, easily available and cost effective prognostic biomarker following ICH.	[Menon, Girish; Johnson, Sarah Estar; Hegde, Ajay; Rathod, Sanjeev; Nayak, Raghavendra; Nair, Rajesh] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Neurosurg, Manipal, India; [Hegde, Ajay] Inst Neurol Sci, Glasgow, Lanark, Scotland		Menon, G (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Neurosurg, Manipal, India.	neuron1967@gmail.com; Sarah.esthar@learner.manipal.edu; Dr.ajayhegde@gmail.com; sanjeevrt@gmail.com; nayakraghu@gmail.com; neurodoc39@gmail.com	Hegde, Ajay/N-3334-2017	Hegde, Ajay/0000-0001-6970-2260; Nayak, Raghavendra/0000-0002-3877-0751; Johnson, Sarah Esthar/0000-0002-8452-3751; Nair, Rajesh Parameshwaran/0000-0001-7911-4972			Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Giede-Jeppe A, 2017, CEREBROVASC DIS, V44, P26, DOI 10.1159/000468996; Gokhan S, 2013, EUR REV MED PHARMACO, V17, P653; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hegde A, 2020, STROKE RES TREAT, V2020, DOI 10.1155/2020/2192709; Hegde A, 2018, ANN INDIAN ACAD NEUR, V21, P270, DOI 10.4103/aian.AIAN_419_17; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Lattanzi S, 2019, TRANSL STROKE RES, V10, P137, DOI 10.1007/s12975-018-0649-4; Lattanzi S, 2018, J NEUROL SCI, V387, P98, DOI 10.1016/j.jns.2018.01.038; Lattanzi S, 2017, ONCOTARGET, V8, P57489, DOI 10.18632/oncotarget.15423; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Merali Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171558; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Song SY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01032; Sun YM, 2017, AM J EMERG MED, V35, P429, DOI 10.1016/j.ajem.2016.11.037; Tao CY, 2017, BIOMARK MED, V11, P33, DOI 10.2217/bmm-2016-0187; van Asch CJJ, 2013, STROKE, V44, P2904, DOI 10.1161/STROKEAHA.113.002386; Volbers B, 2018, NEUROLOGY, V90, pE1005, DOI 10.1212/WNL.0000000000005167; Wang F, 2019, CNS NEUROSCI THER, V25, P30, DOI 10.1111/cns.12977; Wang F, 2018, NEUROTOX RES, V34, P347, DOI 10.1007/s12640-018-9890-6; Wang F, 2016, J STROKE CEREBROVASC, V25, P182, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.013; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Ye ZPP, 2017, ONCOTARGET, V8, P90380, DOI 10.18632/oncotarget.20120; Zhang F, 2018, WORLD NEUROSURG, V116, pE100, DOI 10.1016/j.wneu.2018.04.089; Zhang J, 2017, ONCOTARGET, V8, P77752, DOI 10.18632/oncotarget.20776	37	4	4	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JAN	2021	200								106339	10.1016/j.clineuro.2020.106339			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PS7TD	WOS:000608127700019	33183885				2022-02-06	
J	Sueiras, M; Thonon, V; Santamarina, E; Sanchez-Guerrero, A; Poca, MA; Quintana, M; Riveiro, M; Sahuquillo, J				Sueiras, Maria; Thonon, Vanessa; Santamarina, Estevo; Sanchez-Guerrero, Angela; Poca, Maria A.; Quintana, Manuel; Riveiro, Marilyn; Sahuquillo, Juan			Cortical Spreading Depression Phenomena Are Frequent in Ischemic and Traumatic Penumbra: A Prospective Study in Patients With Traumatic Brain Injury and Large Hemispheric Ischemic Stroke	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Spreading depolarization; Spreading depression; Brain trauma; Malignant stroke; Craniectomy	FOCAL CEREBRAL-ISCHEMIA; PERIINFARCT DEPOLARIZATIONS; HEMORRHAGE	Purpose: Spreading depolarization (SD) phenomena are waves of neuronal depolarization, which propagate slowly at a velocity of 1 to 5 mm/minute and can occur in patients with ischemic or hemorrhagic stroke, traumatic brain injury, and migraine with aura. They form part of secondary injury, occurring after spreading ischemia. The purposes of this study were to describe the frequency and characteristics of SD phenomena and to define whether a correlation existed between SD and outcome in a group of patients with TBI and large hemispheric ischemic stroke. Methods: This was a prospective observational study of 39 adult patients, 17 with malignant middle cerebral artery infarction and 22 with moderate or severe traumatic brain injury, who underwent decompressive craniectomy and multimodal neuromonitoring including electrocorticography. Identification, classification, and interpretation of SDs were performed using the published recommendations from the Cooperative Study on Brain Injury Depolarization group. The outcomes assessed were functional disability at 6 and 12 months after injury, according to the extended Glasgow outcome scale, Barthel index, and modified Rankin scale. Results: Four hundred eighty-three SDs were detected, in 58.9% of the patients. Spreading depolarizations were more common, particularly the isoelectric SD type, in patients with malignant middle cerebral artery infarction (P < 0.04). In 65.21% of patients with SDs on electrocorticography, the "peak" day of depolarization was day 0 (the first 24 hours of recording). Spreading depolarization convulsions were present in 26.08% of patients with SDs. Patients with more SDs and higher depolarization indices scored worse on extended Glasgow outcome scale (6 months) and Barthel index (6 and 12 months) (P < 0.05). Conclusions: Evidence on SD phenomena is important to ensure continued progress in understanding their pathophysiology, in the search for therapeutic targets to avoid additional damage from these secondary injuries.	[Sueiras, Maria; Thonon, Vanessa] Vall dHebron Univ Hosp, Dept Clin Neurophysiol, Paseo Vall dHebron 119-129, Barcelona 08035, Spain; [Sueiras, Maria; Sanchez-Guerrero, Angela; Poca, Maria A.; Sahuquillo, Juan] Vall dHebron Res Inst VHIR, Neurotrauma & Neurosurg Res Unit UNINN, Barcelona, Spain; [Sueiras, Maria; Poca, Maria A.; Sahuquillo, Juan] Univ Autonoma Barcelona UAB, Barcelona, Spain; [Santamarina, Estevo; Quintana, Manuel] Vall dHebron Univ Hosp, Dept Neurol, Epilepsy Unit, Barcelona, Spain; [Poca, Maria A.; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Riveiro, Marilyn] Vall dHebron Univ Hosp, Neurotrauma Intens Care Unit, Barcelona, Spain		Sueiras, M (corresponding author), Vall dHebron Univ Hosp, Dept Clin Neurophysiol, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	msueiras@vhebron.net	Poca, Maria A./B-8475-2008; Sueiras-Gil, Maria/N-5396-2014; Thonon, Vanessa/ABE-2636-2021; Sahuquillo, Juan/B-3577-2008; Riveiro, Marilyn/S-5242-2016	Poca, Maria A./0000-0002-3831-0536; Sueiras-Gil, Maria/0000-0003-3184-5615; Sahuquillo, Juan/0000-0003-0713-5875; Thonon, Vanessa/0000-0001-8898-2608; Quintana, Manuel/0000-0003-0288-9088; Riveiro, Marilyn/0000-0002-1645-3720	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [FIS PI08/0480]; European Regional Development FundEuropean Commission	J. Sahuquillo is a recipient of a grant from the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) (FIS PI08/0480) cofinanced by the European Regional Development Fund. The remaining authors have no funding or conflicts of interest to disclose.	ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Baron JC, 2018, NAT REV NEUROL, V14, P325, DOI 10.1038/s41582-018-0002-2; Caney N., 2016, GUIDELINES MANAGEMEN; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Eikermann-Haerter K, 2013, REV NEUROSCIENCE, V24, P353, DOI 10.1515/revneuro-2013-0005; Eising E, 2017, MOL NEUROBIOL, V54, P2986, DOI 10.1007/s12035-015-9681-5; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Gyngell ML, 1995, NMR BIOMED, V8, P206, DOI 10.1002/nbm.1940080505; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2006, J CEREBR BLOOD F MET, V26, P696, DOI 10.1038/sj.jcbfm.9600223; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Iadecola C, 2009, NAT MED, V15, P1131, DOI 10.1038/nm1009-1131; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leng LZ, 2011, ARCH NEUROL-CHICAGO, V68, P31, DOI 10.1001/archneurol.2010.226; Martinez-Valverde T, 2017, J NEUROTRAUM, V34, P74, DOI 10.1089/neu.2015.4334; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Santamarina E, 2015, EPILEPSY RES, V112, P130, DOI 10.1016/j.eplepsyres.2015.02.016; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Vilalta A, 2010, REV NEUROLOGIA, V51, P95, DOI 10.33588/rn.5102.2009643; Winkler MKL, 2017, J CEREBR BLOOD F MET, V37, P1841, DOI 10.1177/0271678X16641424; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932	41	4	4	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JAN	2021	38	1					47	55		10.1097/WNP.0000000000000648			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SL0TC	WOS:000656627900006	31702708				2022-02-06	
J	McCarty, MF; Lerner, A				McCarty, Mark F.; Lerner, Aaron			Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress	EXPERT REVIEW OF NEUROTHERAPEUTICS			English	Article						Brain trauma; ischemic stroke; excitotoxicity; nmda receptors; nadph oxidase; peroxynitrite; heme oxygenase-1; bilirubin; carbon monoxide; cGMP; phase 2 inducers	PROTECTION	Introduction: Ischemic stroke and traumatic brain injury are leading causes of acute mortality, and in the longer run, major causes of significant mental and physical impairment. Most of the brain neuronal cell death in the minutes and hours following an ischemic stroke or brain trauma is mediated by the process of excitotoxicity, in which sustained elevations of extracellular glutamate, reflecting a failure of ATP-dependent mechanism which sequester glutamate in neurons and astrocytes, drive excessive activation of NMDA receptors. Areas covered: A literature search was undertaken to clarify the molecular mechanisms whereby excessive NMDA activation leads to excitotoxic neuronal death, and to determine what safe nutraceutical agents might have practical potential for rescuing at-risk neurons by intervening in these mechanisms. Expert opinion: Activation of both NADPH oxidase and neuronal nitric oxide synthase in the microenvironment of activated NMDA receptors drives production of superoxide and highly toxic peroxynitrite. This leads to excessive activation of PARP and p38 MAP kinase, mitochondrial dysfunction, and subsequent neuronal death. Heme oxygenase-1 (HO-1) induction offers protection via inhibition of NADPH oxidase and promotion of cGMP generation. Phase 2-inductive nutraceuticals can induce HO-1, and other nutraceuticals can mimic the effects of its products biliverdin and carbon monoxide.	[McCarty, Mark F.] Catalyt Longev, San Diego, CA USA; [Lerner, Aaron] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med Res, IL-32000 Haifa, Israel		Lerner, A (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med Res, IL-32000 Haifa, Israel.	aaronlerner1948@gmail.com		lerner, aaron/0000-0002-6779-4090			Abdoli Ali, 2019, Bull Emerg Trauma, V7, P124, DOI 10.29252/beat-070206; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Akassoglou K, 2005, MOL PHARMACOL, V68, P952, DOI 10.1124/mol.105.017277; Al-Gayyar MMH, 2010, AM J PATHOL, V177, P1187, DOI 10.2353/ajpath.2010.091289; An S, 2013, BIOMATERIALS, V34, P8949, DOI 10.1016/j.biomaterials.2013.07.060; Assis LC, 2014, NEUROSCIENCE, V279, P220, DOI 10.1016/j.neuroscience.2014.08.043; Ayata C, 1997, J NEUROSCI, V17, P6908; Baburina Y, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120576; Barros-Minones L, 2013, BRIT J PHARMACOL, V168, P1820, DOI 10.1111/bph.12071; Barros-Minones L, 2013, BBA-MOL BASIS DIS, V1832, P705, DOI 10.1016/j.bbadis.2013.02.002; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Beez T, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0994-z; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Biegon A, 2018, CURR OPIN NEUROL, V31, P687, DOI 10.1097/WCO.0000000000000612; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Cervantes-Llanos M, 2018, LIFE SCI, V194, P130, DOI 10.1016/j.lfs.2017.12.032; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chen HS, 2018, TRANSL STROKE RES, V9, P515, DOI 10.1007/s12975-017-0598-3; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Chen XM, 2014, CNS NEUROSCI THER, V20, P40, DOI 10.1111/cns.12162; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Cheng CY, 2008, AM J CHINESE MED, V36, P1105, DOI 10.1142/S0192415X08006570; Cherian L, 2004, J NEUROTRAUM, V21, P1196; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; CHRISTODOULIDES N, 1995, CIRCULATION, V91, P2306, DOI 10.1161/01.CIR.91.9.2306; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; CLARK GD, 1987, NEUROSCIENCE, V21, P665, DOI 10.1016/0306-4522(87)90027-3; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Culmsee C, 2005, MOL PHARMACOL, V68, P1006, DOI 10.1124/mol.105.013086; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deguchi K, 2008, BRAIN RES, V1188, P1, DOI 10.1016/j.brainres.2007.07.104; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eardley I, 2002, INT J CLIN PRACT, V56, P300; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Erbil G, 2019, BRATISL MED J, V120, P372, DOI 10.4149/BLL_2019_061; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Fetoni AR, 2011, ACTA OTO-LARYNGOL, V131, P419, DOI 10.3109/00016489.2010.539263; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Gammella E, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8629024; Garcia-Barroso C, 2013, NEUROPHARMACOLOGY, V64, P114, DOI 10.1016/j.neuropharm.2012.06.052; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; GUNASEKAR PG, 1995, J NEUROCHEM, V65, P2016; Ha KS, 2003, FASEB J, V17, P1036, DOI 10.1096/fj.02-0738com; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Itoh T, 2013, J NEURAL TRANSM, V120, P767, DOI 10.1007/s00702-012-0918-4; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jiang F, 2006, HYPERTENSION, V48, P950, DOI 10.1161/01.HYP.0000242336.58387.1f; Jin LM, 2006, J PHARMACOL EXP THER, V318, P288, DOI 10.1124/jpet.105.100735; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim HW, 2011, BRAIN RES, V1412, P73, DOI 10.1016/j.brainres.2011.07.018; Kim SH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091137; Kitamura Y, 2003, J NEUROSCI RES, V71, P544, DOI 10.1002/jnr.10514; Koh PO, 2015, NEUROSCI LETT, V588, P18, DOI 10.1016/j.neulet.2014.12.047; Koh PO, 2013, NEUROSCI LETT, V555, P7, DOI 10.1016/j.neulet.2013.09.001; Koh Phil-Ok, 2012, Lab Anim Res, V28, P273, DOI 10.5625/lar.2012.28.4.273; Koh PO, 2012, NEUROSCI LETT, V507, P156, DOI 10.1016/j.neulet.2011.12.012; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Kosugi T, 2006, NEUROCHEM RES, V31, P933, DOI 10.1007/s11064-006-9099-6; Kylarova S, 2016, FEBS J, V283, P3821, DOI 10.1111/febs.13893; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lanone S, 2005, FASEB J, V19, P1890, DOI 10.1096/fj.04-2368fje; Lee SY, 2015, J PHYSIOL-LONDON, V593, P2793, DOI 10.1113/JP270060; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Li JJ, 2017, EXP THER MED, V14, P671, DOI 10.3892/etm.2017.4549; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Lia CY, 2007, CELL MOL LIFE SCI, V64, P1861, DOI 10.1007/s00018-007-7189-5; Liu LY, 2005, J PHARM PHARMACOL, V57, P1019, DOI 10.1211/0022357056622; Liu XY, 2008, CELL MOL NEUROBIOL, V28, P769, DOI 10.1007/s10571-007-9219-0; Liu XB, 2009, FORUM NUTR, V61, P129, DOI 10.1159/000212745; Liu XB, 2009, BRAIN RES, V1254, P18, DOI 10.1016/j.brainres.2008.11.076; Liu Y, 2012, AM J PHYSIOL-ENDOC M, V303, pE841, DOI 10.1152/ajpendo.00075.2012; Liu Y, 2015, J NEUROL SCI, V351, P88, DOI 10.1016/j.jns.2015.02.045; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Luo MJ, 2019, INT J BIOL MACROMOL, V126, P549, DOI 10.1016/j.ijbiomac.2018.12.252; Lv CM, 2017, CELL PHYSIOL BIOCHEM, V43, P1273, DOI 10.1159/000481840; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Mandir AS, 2000, J NEUROSCI, V20, P8005; Marin-Prida J, 2013, TOXICOL APPL PHARM, V272, P49, DOI 10.1016/j.taap.2013.05.021; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; McCarty MF, 2007, J MED FOOD, V10, P566, DOI 10.1089/jmf.2007.621; McCarty MF, 2019, MED HYPOTHESES, V132, DOI 10.1016/j.mehy.2019.109356; McCarty MF, 2018, MED HYPOTHESES, V118, P114, DOI 10.1016/j.mehy.2018.06.032; McCarty MF, 2017, MED HYPOTHESES, V109, P145, DOI 10.1016/j.mehy.2017.10.012; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; Mejia-Garcia TA, 2013, CELL SIGNAL, V25, P2424, DOI 10.1016/j.cellsig.2013.08.001; Minnella AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35725-5; Mo SF, 2016, BRAIN RES, V1648, P250, DOI 10.1016/j.brainres.2016.07.012; Mock DM, 2017, J NUTR, V147, P1487, DOI 10.3945/jn.116.238956; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Nakajima Y, 2008, J PHARM PHARMACOL, V60, P1365, DOI 10.1211/jpp/60.10.0013; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Ozdegirmenci O, 2011, J MATERN-FETAL NEO M, V24, P317, DOI 10.3109/14767058.2010.492061; Parastan Rovie Hikari, 2020, Asian J Neurosurg, V15, P10, DOI 10.4103/ajns.AJNS_231_19; Pavon-Fuentes N, 2020, CLIN EXP PHARMACOL P, V47, P383, DOI 10.1111/1440-1681.13214; Penton-Rol G, 2018, BEHAV SCI, V8, DOI 10.3390/bs8010015; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Ren ZK, 2017, INT J MOL MED, V40, P1444, DOI 10.3892/ijmm.2017.3127; Rodriguez AI, 2010, ARTERIOSCL THROM VAS, V30, P98, DOI 10.1161/ATVBAHA.109.197822; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Samary CS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1573-1; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Schulz JB, 1995, J NEUROSCI, V15, P8419; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Son TG, 2013, BIOCHEM BIOPH RES CO, V433, P602, DOI 10.1016/j.bbrc.2013.03.041; Song JJ, 2003, J CELL BIOCHEM, V90, P304, DOI 10.1002/jcb.10619; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sung JH, 2012, J VET MED SCI, V74, P1401, DOI 10.1292/jvms.12-0063; Szabo C, 2017, AM J PHYSIOL-CELL PH, V312, pC3, DOI 10.1152/ajpcell.00282.2016; Tan, 2018, MOLECULES; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Tang W, 2004, PHYTOMEDICINE, V11, P277, DOI 10.1078/0944711041495173; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tourbah A, 2016, MULT SCLER J, V22, P1719, DOI 10.1177/1352458516667568; Uddin MS, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.135624; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VESELY DL, 1982, SCIENCE, V216, P1329, DOI 10.1126/science.6123152; Vilches-Flores A, 2010, J NUTR BIOCHEM, V21, P606, DOI 10.1016/j.jnutbio.2009.03.009; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wang BH, 2005, CARDIOVASC DRUG REV, V23, P161; Wang J, 2018, FREE RADICAL BIO MED, V123, P62, DOI 10.1016/j.freeradbiomed.2018.05.069; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wang K, 2013, REJUV RES, V16, P377, DOI 10.1089/rej.2013.1437; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang Qiang, 2005, Chin J Traumatol, V8, P297; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Watanabe-Kamiyama M, 2008, BRIT J NUTR, V99, P756, DOI 10.1017/S0007114507841122; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wolf AM, 2010, J NUTR BIOCHEM, V21, P381, DOI 10.1016/j.jnutbio.2009.01.011; Xiao SJ, 2019, MINI-REV MED CHEM, V19, P1544, DOI 10.2174/1389557519666190730110600; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu MJ, 2013, J ETHNOPHARMACOL, V150, P116, DOI 10.1016/j.jep.2013.08.020; Xue Y, 2017, BRAIN RES BULL, V131, P221, DOI 10.1016/j.brainresbull.2017.04.019; Yang JS, 2014, SCI WORLD J, DOI 10.1155/2014/459549; Yin T, 2010, J MOL CELL CARDIOL, V49, P354, DOI 10.1016/j.yjmcc.2010.05.002; Yu LJ, 2006, EUR NEUROPSYCHOPHARM, V16, P170, DOI 10.1016/j.euroneuro.2005.08.006; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491; Zhang HF, 2015, N-S ARCH PHARMACOL, V388, P953, DOI 10.1007/s00210-015-1125-2; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang YS, 2018, EUR J PHARMACOL, V822, P1, DOI 10.1016/j.ejphar.2018.01.007; Zhang YS, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0494-5; Zhao JJ, 2016, NEUROCHEM RES, V41, P1939, DOI 10.1007/s11064-016-1904-2; Zheng J, 2013, AM J PHYSIOL-REG I, V304, pR110, DOI 10.1152/ajpregu.00648.2011; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; Zhou ZM, 2016, PHARMACOL RES, V111, P556, DOI 10.1016/j.phrs.2016.06.029	170	4	4	2	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1473-7175	1744-8360		EXPERT REV NEUROTHER	Expert Rev. Neurother.	FEB 1	2021	21	2					157	168		10.1080/14737175.2021.1861940		DEC 2020	12	Clinical Neurology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	QF9SI	WOS:000603763600001	33287596				2022-02-06	
J	Krishnadas, N; Dore, V; Lamb, F; Groot, C; McCrory, P; Guzman, R; Mulligan, R; Huang, K; O'Donnell, M; Ponsford, J; Hopwood, M; Villemagne, VL; Rowe, CC				Krishnadas, Natasha; Dore, Vincent; Lamb, Fiona; Groot, Colin; McCrory, Paul; Guzman, Rodney; Mulligan, Rachel; Huang, Kun; O'Donnell, Meaghan; Ponsford, Jennie; Hopwood, Malcolm; Villemagne, Victor L.; Rowe, Christopher C.			Case Report: F-18-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player	FRONTIERS IN NEUROLOGY			English	Article						Positron Emission Tomography (PET); Alzheimer&apos; s Disease (AD); tau; case report; Chronic Traumatic Encephalopathy (CTE)	DEPRESSION; DIAGNOSIS; SPECTRUM	Introduction: It remains unclear if tau imaging may assist diagnosis of chronic traumatic encephalopathy (CTE). Flortaucipir PET has shown superior frontal with medial temporal tau binding consistent with the provisional neuropathological criteria for mid-stage CTE in group-level analyses of retired symptomatic NFL players and in one individual with pathologically confirmed CTE. F-18-MK6240 is a new PET ligand that has high affinity for tau. We present the case of a 63-year-old cognitively impaired, former Australian rules football player with distinct superior frontal and medial temporal F-18-MK6240 binding and show it to be significantly different to the pattern seen in prodromal Alzheimer's disease (AD). Findings: The participant was recruited for a study of amyloid-beta and tau several decades after traumatic brain injury. He had multiple concussions during his football career but no cognitive complaints at retirement. A thalamic stroke in his mid 50s left stable mild cognitive deficits but family members reported further short-term memory, behavioral, and personality decline preceding the study. Imaging showed extensive small vessel disease on MRI, a moderate burden of amyloid-beta plaques, and F-18-MK6240 binding in bilateral superior frontal and medial temporal cortices. Voxel-wise analysis demonstrated that the frontally predominant pattern of the participant was significantly different to the posterior temporo-parietal predominant pattern of prodromal AD. Conclusion: Although lacking neuropathological examination to distinguish CTE from a variant of AD, the clear demonstration of a CTE-like tau pattern in a single at-risk individual suggests further research on the potential of F-18-MK6240 PET for identifying CTE is warranted.	[Krishnadas, Natasha] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Parkville, Vic, Australia; [Krishnadas, Natasha; Dore, Vincent; Lamb, Fiona; Guzman, Rodney; Mulligan, Rachel; Huang, Kun; Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Dept Mol Imaging & Therapy, Heidelberg, Vic, Australia; [Dore, Vincent] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Parkville, Vic, Australia; [Groot, Colin] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam Neurosci, Amsterdam, Netherlands; [McCrory, Paul; Rowe, Christopher C.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [O'Donnell, Meaghan] Phoenix Australia, Parkville, Vic, Australia; [O'Donnell, Meaghan; Hopwood, Malcolm] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia; [Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Ctr, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia		Rowe, CC (corresponding author), Austin Hlth, Dept Mol Imaging & Therapy, Heidelberg, Vic, Australia.; Rowe, CC (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	christopher.rowe@austin.org.au	Rowe, Christopher/AAX-8748-2021; Dore, Vincent/A-7750-2011	Dore, Vincent/0000-0002-8051-0558; McCrory, Paul/0000-0003-4850-0568; Krishnadas, Natasha/0000-0002-5374-2839	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [NHMRC APP1127007]; Australian Rotary Health/Bartolina Peluso	This study was supported by the National Health and Medical Research Council (NHMRC APP1127007). NK was supported by a cofunded PhD scholarship from Australian Rotary Health/Bartolina Peluso.	Aguero C, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0686-6; Arena JD, 2020, BRAIN, V143, P1572, DOI 10.1093/brain/awaa071; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0751-1; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Iverson GL, 2019, J NEUROPSYCH CLIN N, V31, P328, DOI 10.1176/appi.neuropsych.18110280; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Jack CR, 2018, BRAIN, V141, P1517, DOI 10.1093/brain/awy059; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Lesman-Segev OH, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102025; LoBue C, 2020, J NEUROL NEUROSUR PS, V91, P586, DOI 10.1136/jnnp-2019-321567; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mantyh WG, 2020, JAMA NEUROL, V77, P517, DOI 10.1001/jamaneurol.2019.4509; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Pearce AJ, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0895-z; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Villemagne V, 2017, J MOL MED THER, V1, P25; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	4	4	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 22	2020	11								598980	10.3389/fneur.2020.598980			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PN6RT	WOS:000604604800001	33414760	gold, Green Published			2022-02-06	
J	Rubio, JE; Skotak, M; Alay, E; Sundaramurthy, A; Subramaniam, DR; Kote, VB; Yeoh, S; Monson, K; Chandra, N; Unnikrishnan, G; Reifman, J				Rubio, Jose E.; Skotak, Maciej; Alay, Eren; Sundaramurthy, Aravind; Subramaniam, Dhananjay Radhakrishnan; Kote, Vivek Bhaskar; Yeoh, Stewart; Monson, Kenneth; Chandra, Namas; Unnikrishnan, Ginu; Reifman, Jaques			Does Blast Exposure to the Torso Cause a Blood Surge to the Brain?	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						traumatic brain injury; indirect mechanism; blast overpressure; fluid-structure interaction; shock tube	POSSIBLE DAMAGE MECHANISM; MISSILE EXTREMITY IMPACT; PRESSURE WAVE INJURIES; CENTRAL-NERVOUS-SYSTEM; SHEAR-STRESS; SHOCK WAVE; INTRACRANIAL-PRESSURE; DIFFERENT PARTS; FLOW; RAT	The interaction of explosion-induced blast waves with the torso is suspected to contribute to brain injury. In this indirect mechanism, the wave-torso interaction is assumed to generate a blood surge, which ultimately reaches and damages the brain. However, this hypothesis has not been comprehensively and systematically investigated, and the potential role, if any, of the indirect mechanism in causing brain injury remains unclear. In this interdisciplinary study, we performed experiments and developed mathematical models to address this knowledge gap. First, we conducted blast-wave exposures of Sprague-Dawley rats in a shock tube at incident overpressures of 70 and 130 kPa, where we measured carotid-artery and brain pressures while limiting exposure to the torso. Then, we developed three-dimensional (3-D) fluid-structure interaction (FSI) models of the neck and cerebral vasculature and, using the measured carotid-artery pressures, performed simulations to predict mass flow rates and wall shear stresses in the cerebral vasculature. Finally, we developed a 3-D finite element (FE) model of the brain and used the FSI-computed vasculature pressures to drive the FE model to quantify the blast-exposure effects in the brain tissue. The measurements from the torso-only exposure experiments revealed marginal increases in the peak carotid-artery overpressures (from 13.1 to 28.9 kPa). Yet, relative to the blast-free, normotensive condition, the FSI simulations for the blast exposures predicted increases in the peak mass flow rate of up to 255% at the base of the brain and increases in the wall shear stress of up to 289% on the cerebral vasculature. In contrast, our simulations suggest that the effect of the indirect mechanism on the brain-tissue-strain response is negligible (<1%). In summary, our analyses show that the indirect mechanism causes a sudden and abundant stream of blood to rapidly propagate from the torso through the neck to the cerebral vasculature. This blood surge causes a considerable increase in the wall shear stresses in the brain vasculature network, which may lead to functional and structural effects on the cerebral veins and arteries, ultimately leading to vascular pathology. In contrast, our findings do not support the notion of strain-induced brain-tissue damage due to the indirect mechanism.	[Rubio, Jose E.; Sundaramurthy, Aravind; Subramaniam, Dhananjay Radhakrishnan; Kote, Vivek Bhaskar; Unnikrishnan, Ginu; Reifman, Jaques] US Army, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA; [Rubio, Jose E.; Sundaramurthy, Aravind; Subramaniam, Dhananjay Radhakrishnan; Kote, Vivek Bhaskar; Unnikrishnan, Ginu] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Skotak, Maciej; Alay, Eren; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, Newark, NJ USA; [Skotak, Maciej] Walter Reed Army Inst Res, Blast Induced Neurotrauma Div, Silver Spring, MD USA; [Yeoh, Stewart; Monson, Kenneth] Univ Utah, Coll Engn, Dept Biomed Engn, Salt Lake City, UT USA; [Monson, Kenneth] Univ Utah, Coll Engn, Dept Mech Engn, Salt Lake City, UT USA		Reifman, J (corresponding author), US Army, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil	Rubio, Jose E./AAS-2201-2020; Sundaramurthy, Aravind/O-2047-2019; Subramaniam, Dhananjay Radhakrishnan/AAI-5686-2020; Lang, Steven/AAE-8102-2021	Rubio, Jose E./0000-0002-6320-2086; Subramaniam, Dhananjay Radhakrishnan/0000-0002-1037-4378; Lang, Steven/0000-0003-1669-9146; Sundaramurthy, Aravind/0000-0002-0359-8680	United States Department of DefenseUnited States Department of Defense; Defense Health Program	We acknowledge support from the United States Department of Defense and the Defense Health Program managed by the U.S. Army Military Operational Medicine Program Area Directorate (Ft. Detrick, MD, United States).	Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Ambrosi D., 2012, MODELING PHYSL FLOWS; Aoki T, 2011, BRIT J PHARMACOL, V163, P1237, DOI 10.1111/j.1476-5381.2011.01358.x; Assari S., 2013, P ASME 2013 INT MECH, V03AT03A016; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bell ED, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039625; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; CLEMEDSON CJ, 1955, AM J PHYSIOL, V181, P471, DOI 10.1152/ajplegacy.1955.181.3.471; Cosson E, 2007, AM J PHYSIOL-HEART C, V292, pH2506, DOI 10.1152/ajpheart.00732.2006; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HARPER SL, 1984, HYPERTENSION, V6, P408, DOI 10.1161/01.HYP.6.3.408; Haslach HW, 2017, J MECH BEHAV BIOMED, V68, P88, DOI 10.1016/j.jmbbm.2017.01.036; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lehoux S, 2006, J INTERN MED, V259, P381, DOI 10.1111/j.1365-2796.2006.01624.x; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Liu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3290, DOI 10.1152/ajpheart.00666.2007; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; MAIER GW, 1984, CIRCULATION, V70, P86, DOI 10.1161/01.CIR.70.1.86; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; RUDIKOFF MT, 1980, CIRCULATION, V61, P345, DOI 10.1161/01.CIR.61.2.345; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Schierling W, 2009, J CEREBR BLOOD F MET, V29, P726, DOI 10.1038/jcbfm.2008.165; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sriram K, 2014, MICROCIRCULATION, V21, P628, DOI 10.1111/micc.12141; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; SUNESON A, 1990, J TRAUMA, V30, P281, DOI 10.1097/00005373-199003000-00006; Szymanski MP, 2008, ANN BIOMED ENG, V36, P1681, DOI 10.1007/s10439-008-9540-x; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825; Vrselja Z, 2014, J CEREBR BLOOD F MET, V34, P578, DOI 10.1038/jcbfm.2014.7; Wang SH, 2001, J ACOUST SOC AM, V109, P390, DOI 10.1121/1.1333419; WEISFELDT ML, 1981, CRIT CARE MED, V9, P377, DOI 10.1097/00003246-198105000-00012; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	56	4	4	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	DEC 17	2020	8								573647	10.3389/fbioe.2020.573647			14	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	PM2NX	WOS:000603643900001	33392161	Green Published, gold			2022-02-06	
J	Abujaber, A; Fadlalla, A; Gammoh, D; Abdelrahman, H; Mollazehi, M; El-Menyar, A				Abujaber, Ahmad; Fadlalla, Adam; Gammoh, Diala; Abdelrahman, Husham; Mollazehi, Monira; El-Menyar, Ayman			Prediction of in-hospital mortality in patients on mechanical ventilation post traumatic brain injury: machine learning approach	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Traumatic brain injury; Machine learning predictive model; Mechanical ventilation; Mortality	ARTIFICIAL NEURAL-NETWORK; LOGISTIC-REGRESSION; VENOUS THROMBOEMBOLISM; OUTCOME PREDICTION; MODELS; COMA	Background The study aimed to introduce a machine learning model that predicts in-hospital mortality in patients on mechanical ventilation (MV) following moderate to severe traumatic brain injury (TBI). Methods A retrospective analysis was conducted for all adult patients who sustained TBI and were hospitalized at the trauma center from January 2014 to February 2019 with an abbreviated injury severity score for head region (HAIS) >= 3. We used the demographic characteristics, injuries and CT findings as predictors. Logistic regression (LR) and Artificial neural networks (ANN) were used to predict the in-hospital mortality. Accuracy, area under the receiver operating characteristics curve (AUROC), precision, negative predictive value (NPV), sensitivity, specificity and F-score were used to compare the models` performance. Results Across the study duration; 785 patients met the inclusion criteria (581 survived and 204 deceased). The two models (LR and ANN) achieved good performance with an accuracy over 80% and AUROC over 87%. However, when taking the other performance measures into account, LR achieved higher overall performance than the ANN with an accuracy and AUROC of 87% and 90.5%, respectively compared to 80.9% and 87.5%, respectively. Venous thromboembolism prophylaxis, severity of TBI as measured by abbreviated injury score, TBI diagnosis, the need for blood transfusion, heart rate upon admission to the emergency room and patient age were found to be the significant predictors of in-hospital mortality for TBI patients on MV. Conclusions Machine learning based LR achieved good predictive performance for the prognosis in mechanically ventilated TBI patients. This study presents an opportunity to integrate machine learning methods in the trauma registry to provide instant clinical decision-making support.	[Abujaber, Ahmad] Hamad Med Corp, Nursing, Doha, Qatar; [Fadlalla, Adam] Qatar Univ, Management Informat Syst Business & Econ Fac, Doha, Qatar; [Gammoh, Diala] Univ Cent Florida, Ind Engn, Orlando, FL 32816 USA; [Abdelrahman, Husham; Mollazehi, Monira] Hamad Med Corp, Dept Surg, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Hamad Med Corp, Dept Surg, Trauma Surg, Clin Res, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Med Corp, Dept Surg, Trauma Surg, Clin Res, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Ayer T, 2010, RADIOGRAPHICS, V30, P13, DOI 10.1148/rg.301095057; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Boutin A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014472; Bratton S, 2007, J NEUROTRAUM, V24, P7; Chen CJ, 2013, AM J CRIT CARE, V22, P506, DOI 10.4037/ajcc2013950; Dag A, 2017, DECIS SUPPORT SYST, V94, P42, DOI 10.1016/j.dss.2016.10.005; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Domingues CD, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0171-8; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; East JM, 2018, CURR OPIN ANESTHESIO, V31, P219, DOI 10.1097/ACO.0000000000000566; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Garcia-Laencina PJ, 2015, COMPUT BIOL MED, V59, P125, DOI 10.1016/j.compbiomed.2015.02.006; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Humble SS, 2018, J TRAUMA ACUTE CARE, V85, P155, DOI 10.1097/TA.0000000000001852; Inoue A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2276-6; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Margolick J, 2018, CAN J NEUROL SCI, V45, P432, DOI 10.1017/cjn.2017.275; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Rached MAKB, 2019, INJURY, V50, P65, DOI 10.1016/j.injury.2018.08.022; Rau C, 2016, INT J ENV RES PUBLIC, V13; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Schumacher P, 2010, J EDUC BUS, V85, P258, DOI 10.1080/08832320903449477; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; TEASDALE G, 1974, LANCET, V2, P81; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Wang CH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009165; Zolbanin HM, 2015, DECIS SUPPORT SYST, V74, P150, DOI 10.1016/j.dss.2015.04.003	41	4	4	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	DEC 14	2020	20	1							336	10.1186/s12911-020-01363-z			11	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	PG5PR	WOS:000599787300003	33317528	Green Published, gold			2022-02-06	
J	Ponsford, J; Carrier, S; Hicks, A; McKay, A				Ponsford, Jennie; Carrier, Sarah; Hicks, Amelia; McKay, Adam			Assessment and Management of Patients in the Acute Stages of Recovery after Traumatic Brain Injury in Adults: A Worldwide Survey	JOURNAL OF NEUROTRAUMA			English	Article						assessment; management; post-traumatic amnesia; traumatic brain injury	POSTTRAUMATIC AMNESIA; ACUTE CONFUSION; REHABILITATION; MEMORY; ORIENTATION; AGITATION; SEVERITY; SCALE; HALOPERIDOL; COGNITION	Most individuals with traumatic brain injury (TBI) experience a period of confusion after emergence from coma, termed post-traumatic amnesia, post-traumatic confusional state, or delirium. Recent guidelines suggest the importance of assessment and consistent management during this phase, but current practice worldwide remains unknown. This survey aimed to elucidate current international practice in assessment and treatment of patients in the acute stages of recovery after TBI. The web-based survey was distributed to clinicians working with patients with acute TBI. There were 400 participants (68.8% females), from 41 countries, mostly neuropsychologists, rehabilitation physicians, and occupational therapists (OTs), with an average 12.8 years of experience. Of those working with adults (n = 376, 94%), most described this acute period as post-traumatic amnesia and used its duration to indicate injury severity. More than 85% used a tool to assess patients; in order of frequency, the Glasgow Coma Scale (GCS), Westmead PTA Scale (WPTAS), Galveston Orientation and Amnesia Test, Rancho Los Amigos Scale, and O-Log. Meeting criteria on the assessment tool or clinical judgment determined emergence from this phase, indicated by recovery of orientation, day-to-day memories, and ability to follow commands or participate in rehabilitation. Most patients had physiotherapy, OT, speech therapy, and environmental changes, with a third of participants indicating sedating medication was prescribed during this phase. Findings suggest that, consistent with guidelines, PTA is a widely recognized and measured TBI recovery phase, used to determine injury severity and readiness for therapy.	[Ponsford, Jennie; Carrier, Sarah; Hicks, Amelia; McKay, Adam] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Ponsford, Jennie; Carrier, Sarah; Hicks, Amelia; McKay, Adam] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie; McKay, Adam] Epworth Healthcare, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovation Walk, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu					Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; Hicks AJ, 2018, J NEUROTRAUM, V35, P2755, DOI 10.1089/neu.2018.5738; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McKay A, 2020, NEUROPSYCHOL REHABIL, V30, P579, DOI 10.1080/09602011.2018.1479276; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Patton G, 1992, NEUROPSYCHOL REHABIL, V2, P169; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Roberts CM, 2018, J INT NEUROPSYCH SOC, V24, P1064, DOI 10.1017/S1355617718000565; Roberts CM, 2015, NEUROPSYCHOLOGY, V29, P522, DOI 10.1037/neu0000178; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Spiteri C.J., J INT NEUROPSYCHOLOG; Spiteri C.J., 2020, J HEAD TRAUMA REHABI; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	49	4	4	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1060	1067		10.1089/neu.2020.7299		DEC 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000599324900001	33121375				2022-02-06	
J	Shafi, R; Poublanc, J; Venkatraghavan, L; Crawley, AP; Sobczyk, O; McKetton, L; Bayley, M; Chandra, T; Foster, E; Ruttan, L; Comper, P; Tartaglia, MC; Tator, CH; Duffin, J; Mutch, WA; Fisher, J; Mikulis, DJ				Shafi, Reema; Poublanc, Julien; Venkatraghavan, Lashmi; Crawley, Adrian P.; Sobczyk, Olivia; McKetton, Larissa; Bayley, Mark; Chandra, Tharshini; Foster, Evan; Ruttan, Lesley; Comper, Paul; Tartaglia, Maria Carmela; Tator, Charles H.; Duffin, James; Mutch, W. Alan; Fisher, Joseph; Mikulis, David J.			A Promising Subject-Level Classification Model for Acute Concussion Based on Cerebrovascular Reactivity Metrics	JOURNAL OF NEUROTRAUMA			English	Article						blood oxygen level dependent imaging; cerebral blood flow; cerebrovascular reactivity; concussion; sex differences	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SEX-DIFFERENCES; YOUNG-PEOPLE; HEAD-INJURY; DYSFUNCTION; VALIDITY; GENDER; RESPONSIVENESS; IDENTIFICATION	Concussion imaging research has primarily focused on neuronal disruption with lesser emphasis directed toward vascular dysfunction. However, blood flow metrics may be more sensitive than measures of neuronal integrity. Vascular dysfunction can be assessed by measuring cerebrovascular reactivity (CVR)-the change in cerebral blood flow per unit change in vasodilatory stimulus. CVR metrics, including speed and magnitude of flow responses to a standardized well-controlled vasoactive stimulus, are potentially useful for assessing individual subjects following concussion given that blood flow dysregulation is known to occur with traumatic brain injury. We assessed changes in CVR metrics to a standardized vasodilatory stimulus during the acute phase of concussion. Using a case control design, 20 concussed participants and 20 healthy controls (HCs) underwent CVR assessment measuring blood oxygen-level dependent (BOLD) magnetic resonance imaging using precise changes in end-tidal partial pressure of CO2 (PETCO2). Metrics were calculated for the whole brain, gray matter (GM), and white matter (WM) using sex-stratification. A leave-one-out receiver operating characteristic (ROC) analysis classified concussed from HCs based on CVR metrics. CVR magnitude was greater and speed of response faster in concussed participants relative to HCs, with WM showing higher classification accuracy compared with GM. ROC analysis for WM-CVR metrics revealed an area under the curve of 0.94 in males and 0.90 in females for speed and magnitude of response respectively. These greater than normal responses to a vasodilatory stimulus warrant further investigation to compare the predictive ability of CVR metrics against structural injury metrics for diagnosis and prognosis in acute concussion.	[Shafi, Reema; Poublanc, Julien; Crawley, Adrian P.; Sobczyk, Olivia; McKetton, Larissa; Mikulis, David J.] Univ Toronto, Joint Dept Med Imaging, Toronto, ON, Canada; [Venkatraghavan, Lashmi; Duffin, James; Fisher, Joseph; Mikulis, David J.] Univ Toronto, Dept Anesthesiol & Pain Med, Toronto, ON, Canada; [Ruttan, Lesley] Univ Toronto, Grad Dept Psychol Clin Sci, Toronto, ON, Canada; [Comper, Paul] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Bayley, Mark; Chandra, Tharshini; Foster, Evan; Ruttan, Lesley; Comper, Paul] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Ruttan, Lesley; Tartaglia, Maria Carmela; Tator, Charles H.; Mikulis, David J.] Univ Hlth Network, Canadian Concuss Ctr, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Mutch, W. Alan] Univ Manitoba, Dept Anesthesiol Perioperat & Pain Med, Winnipeg, MB, Canada; [Ruttan, Lesley; Tartaglia, Maria Carmela; Tator, Charles H.; Mikulis, David J.] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada		Mikulis, DJ (corresponding author), Toronto Western Hosp, Joint Dept Med Imaging, 3MC-431,399 Bathurst St,M5T 2S8000, Toronto, ON, Canada.	David.Mikulis@uhn.ca		Mutch, W. Alan/0000-0001-7174-7839; McKetton, Larissa/0000-0002-1065-7503; Shafi, Reema/0000-0002-1034-980X	Canadian Concussion Centre from the Toronto General and Western Hospital Foundation; Academic Health Sciences CentreAlternative Funding Plan (AHSC AFP) Innovation fund; Holt-Hornsby and Andreae Vascular Dementia Research Unit in the Joint Department of Medical Imaging, Toronto Western Hospital	This work was supported by Canadian Concussion Centre funding from the Toronto General and Western Hospital Foundation, a grant from the Academic Health Sciences CentreAlternative Funding Plan (AHSC AFP) Innovation fund and the Holt-Hornsby and Andreae Vascular Dementia Research Unit in the Joint Department of Medical Imaging, Toronto Western Hospital.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; BORGES N, 1994, EUR J PHARM-MOLEC PH, V269, P243, DOI 10.1016/0922-4106(94)90092-2; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Dodd AB, 2020, J CEREBR BLOOD F MET, V40, P2491, DOI 10.1177/0271678X19896883; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; EDVINSSON L, 1982, BRAIN RES BULL, V9, P799, DOI 10.1016/0361-9230(82)90187-3; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Fierstra J, 2018, STROKE, V49, P621, DOI 10.1161/STROKEAHA.117.020010; Flatt A.A., 2019, SPORTS BASEL, P7; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Ito S, 2008, J PHYSIOL-LONDON, V586, P3675, DOI 10.1113/jphysiol.2008.154716; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lecrux C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0350; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LI XF, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/108691; Ling DI, 2020, CLIN ORTHOP RELAT R, V478, P1469, DOI 10.1097/CORR.0000000000000995; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Mutch WAC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2800-3; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Panwar J, 2020, J NEUROTRAUM, V37, P1190, DOI 10.1089/neu.2019.6809; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Pillai JJ, 2015, AM J NEURORADIOL, V36, P7, DOI 10.3174/ajnr.A3941; Poublanc J, 2015, J CEREBR BLOOD F MET, V35, P1746, DOI 10.1038/jcbfm.2015.114; Purkayastha S, 2019, J NEUROTRAUM, V36, P2385, DOI 10.1089/neu.2018.5861; Purkayastha S, 2019, AUTON NEUROSCI-BASIC, V220, DOI 10.1016/j.autneu.2019.04.004; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; Riedel K, 2019, AM J PHYSIOL-HEART C, V317, pH243, DOI 10.1152/ajpheart.00456.2018; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ryan CM, 2018, J STROKE CEREBROVASC, V27, P162, DOI 10.1016/j.jstrokecerebrovasdis.2017.08.015; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sobczyk O, 2016, AM J NEURORADIOL, V37, P818, DOI 10.3174/ajnr.A4679; Somogyi RB, 2005, ANAESTH INTENS CARE, V33, P726, DOI 10.1177/0310057X0503300604; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tator C, 2019, CAN J NEUROL SCI, V46, P351, DOI 10.1017/cjn.2019.14; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Wang FX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00376; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Woodson BT, 2004, OTOLARYNG HEAD NECK, V130, P643, DOI 10.1016/S0194-5998(03)01318-4; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	82	4	4	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1036	1047		10.1089/neu.2020.7272		DEC 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000599323100001	33096952				2022-02-06	
J	Alqahtani, F; Assiri, MA; Mohany, M; Imran, I; Javaid, S; Rasool, MF; Shakeel, W; Sivandzade, F; Alanazi, AZ; Al-Rejaie, SS; Alshammari, MA; Alasmari, F; Alanazi, MM; Alamri, FF				Alqahtani, Faleh; Assiri, Mohammed A.; Mohany, Mohamed; Imran, Imran; Javaid, Sana; Rasool, Muhammad Fawad; Shakeel, Waleed; Sivandzade, Farzane; Alanazi, Ahmed Z.; Al-Rejaie, Salim S.; Alshammari, Musaad A.; Alasmari, Fawaz; Alanazi, Mohammed Mufadhe; Alamri, Faisal F.			Coadministration of Ketamine and Perampanel Improves Behavioral Function and Reduces Inflammation in Acute Traumatic Brain Injury Mouse Model	BIOMED RESEARCH INTERNATIONAL			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ANTAGONIST PERAMPANEL; KAPPA-B; INHIBITION; ANXIETY; EXPRESSION; NEUROPROTECTION; PEROXIDATION; MACROPHAGES	Traumatic brain injury (TBI) is among the most debilitating neurological disorders with inadequate therapeutic options. It affects all age groups globally leading to post-TBI behavioral challenges and life-long disabilities requiring interventions for these health issues. In the current study, C57BL/6J mice were induced with TBI through the weight-drop method, and outcomes of acutely administered ketamine alone and in combination with perampanel were observed. The impact of test drugs was evaluated for post-TBI behavioral changes by employing the open field test (OFT), Y-maze test, and novel object recognition test (NOR). After that, isolated plasma and brain homogenates were analyzed for inflammatory modulators, i.e., NF-kappa B and iNOS, through ELISA. Moreover, metabolomic studies were carried out to further authenticate the TBI rescuing potential of drugs. The animals treated with ketamine-perampanel combination demonstrated improved exploratory behavior in OFT (P<0.05), while ketamine alone as well as in combination yielded anxiolytic effect (P<0.05-0.001) in posttraumatic mice. Similarly, the % spontaneous alternation and % discrimination index were increased after the administration of ketamine alone (P<0.05) and ketamine-perampanel combination (P<0.01-0.001) in the Y-maze test and NOR test, respectively. ELISA demonstrated the reduced central and peripheral expression of NF-kappa B (P<0.05) and iNOS (P<0.01-0.0001) after ketamine-perampanel polypharmacy. The TBI-imparted alteration in plasma metabolites was restored by drug combination as evidenced by metabolomic studies. The outcomes were fruitful with ketamine, but the combination therapy proved more significant in improving all studied parameters. The benefits of this new investigated polypharmacy might be due to their antiglutamatergic, antioxidant, and neuroprotective capacity.	[Alqahtani, Faleh; Assiri, Mohammed A.; Mohany, Mohamed; Alanazi, Ahmed Z.; Al-Rejaie, Salim S.; Alshammari, Musaad A.; Alasmari, Fawaz; Alanazi, Mohammed Mufadhe] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh 11451, Saudi Arabia; [Imran, Imran; Javaid, Sana; Shakeel, Waleed] Bahauddin Zakariya Univ, Dept Pharmacol, Fac Pharm, Multan 60800, Pakistan; [Javaid, Sana] Women Univ, Dept Pharm, Multan 60000, Pakistan; [Rasool, Muhammad Fawad] Bahauddin Zakariya Univ, Dept Pharm Practice, Fac Pharm, Multan 60800, Pakistan; [Sivandzade, Farzane] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA; [Alamri, Faisal F.] King Saud bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Jeddah, Saudi Arabia; [Alamri, Faisal F.] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia		Alqahtani, F (corresponding author), King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh 11451, Saudi Arabia.; Imran, I (corresponding author), Bahauddin Zakariya Univ, Dept Pharmacol, Fac Pharm, Multan 60800, Pakistan.	afaleh@ksu.edu.sa; moassiri@ksu.edu.sa; mmohany@ksu.edu.sa; imran.ch@bzu.edu.pk; sana.javaid@wum.edu.pk; fawadrasool@bzu.edu.pk; waleed.shakeel@yahoo.com; farzane.sivandzade@ttuhsc.edu; azalanazi@ksu.edu.sa; rejaie@ksu.edu.sa; malshammari@ksu.edu.sa; ffalasmari@ksu.edu.sa; momalanazi@ksu.edu.sa; alamrif@ksau-hs.edu.sa	Alanazi, Mohammed/AAM-1831-2020; Imran, Imran/AAL-5734-2020; Mohany, Mohamed/M-9898-2013; Rasool, Muhammad Fawad/I-6610-2013; Alqahtani, Faleh/AAF-3545-2019; ALASMARI, FAWAZ/X-5686-2018	Alanazi, Mohammed/0000-0002-2370-3660; Imran, Imran/0000-0003-1337-8574; Rasool, Muhammad Fawad/0000-0002-8607-8583; Alqahtani, Faleh/0000-0003-3924-593X; ALASMARI, FAWAZ/0000-0003-2382-5892; Assiri, Mohammed/0000-0002-9527-229X; Sivandzade, Farzane/0000-0001-8649-3712; Alamri, Faisal/0000-0003-4309-8215; alanazi, ahmed/0000-0002-2937-540X	Deanship of Scientific Research at King Saud UniversityKing Saud University [RG-1441-340]	Thanks to the two B. Pharm students (Azzam Saleh AlZogaibi and Nawaf Abdulaziz Alrsheed affiliated to the College of Pharmacy at King Saud University, Riyadh, Saudi Arabia) for their help as caretakers subsequent to TBI induction. We are thankful to Dr. Syed Rizwan Ahamad from the Central Laboratory, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, for his help in processing the samples for metabolic results. We are thankful to Mr. Waqar Ahmad and Mr. Muhammad Suhaib Afzal from the Department of Pharmacology, Bahauddin Zakariya University, Multan, for analyzing the behavioral videos on ANY-maze behavioral tracking software. The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group No. RG-1441-340.	Aida V, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113222; Akamatsu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28649; Alzarea S, 2019, BEHAV BRAIN RES, V366, P19, DOI 10.1016/j.bbr.2019.03.019; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bektas N, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118359; Bell JD, 2017, ANESTH ANALG, V124, P1237, DOI 10.1213/ANE.0000000000001856; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Centers for Disease Control and Prevention, 2019, TBI GET FACTS CONC T; Chen CY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092271, 10.1371/journal.pone.0108021, 10.1371/journal.pone.0106248]; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; de Lima MNM, 2005, EUR J NEUROSCI, V21, P2521, DOI 10.1111/j.1460-9568.2005.04083.x; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; DING AH, 1988, J IMMUNOL, V141, P2407; Ding MZ, 1997, J NEUROIMMUNOL, V77, P99, DOI 10.1016/S0165-5728(97)00065-9; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Fedoce AD, 2018, FREE RADICAL RES, V52, P737, DOI 10.1080/10715762.2018.1475733; Fusco R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9090238; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Haider S, 2015, BRAIN RES BULL, V115, P1, DOI 10.1016/j.brainresbull.2015.04.001; Hecker M, 1996, BRIT J PHARMACOL, V118, P2178, DOI 10.1111/j.1476-5381.1996.tb15660.x; Holscher C, 1997, TRENDS NEUROSCI, V20, P298, DOI 10.1016/S0166-2236(97)01065-5; Huffman J. C., 2010, MASSACHUSETTS GEN HO, P237, DOI [10.1016/b978-1-4377-1927-7.00019-4, DOI 10.1016/B978-1-4377-1927-7.00019-4]; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Jean-Louis E., 2016, AIDE SOIGNANTE, V30, P31, DOI [10.1016/j.aidsoi.2015.11.009, DOI 10.1016/J.AIDSOI.2015.11.009]; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Li YN, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00139; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Miller OH, 2014, ELIFE, V3, DOI 10.7554/eLife.03581; Mohany M, 2020, PEERJ, V8, DOI 10.7717/peerj.9196; Nakagami Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7469326; Peters AJ, 2018, ANESTHESIOLOGY, V129, P278, DOI 10.1097/ALN.0000000000002197; Rammal H, 2008, BRAIN BEHAV IMMUN, V22, P1156, DOI 10.1016/j.bbi.2008.06.005; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Sivandzade F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01818-0; Spiteller G, 2001, MECH AGEING DEV, V122, P617, DOI 10.1016/S0047-6374(01)00220-2; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Suda S, 2019, NEURAL REGEN RES, V14, P1525, DOI 10.4103/1673-5374.255964; Tao L., 2015, ADV FOOD TECHNOL NUT, DOI [10.17140/AFTNSOJ-1-123, DOI 10.17140/AFTNSOJ-1-123]; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO, P43, DOI [10.1201/b18126, DOI 10.1201/B18126]; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Visser E, 2006, BIOMED PHARMACOTHER, V60, P341, DOI 10.1016/j.biopha.2006.06.021; Wang B, 2018, CEREBELLUM, V17, P477, DOI 10.1007/s12311-018-0934-5; Whelan J, 2013, ADV NUTR, V4, P311, DOI 10.3945/an.113.003772; Willenborg DO, 2007, J NEUROIMMUNOL, V191, P16, DOI 10.1016/j.jneuroim.2007.09.007; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zhang H, 2001, CLIN CHEM, V47, P1458; Zheng F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182025	66	4	4	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.	DEC 12	2020	2020								3193725	10.1155/2020/3193725			12	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	PI6QL	WOS:000601213100006	33381547	Green Published, gold			2022-02-06	
J	Iverson, GL; Terry, DP; Caccese, JB; Buttner, F; Merz, ZC				Iverson, Grant L.; Terry, Douglas P.; Caccese, Jaclyn B.; Buttner, Fionn; Merz, Zachary C.			Age of First Exposure to Football Is Not Associated with Midlife Brain Health Problems	JOURNAL OF NEUROTRAUMA			English	Article						age; concussion; behavior; cognitive function; head trauma; traumatic brain injury	MECHANICAL TURK; LATER-LIFE; PHQ-9; DEPRESSION; SYMPTOMS; VALIDITY; QUALITY	The purpose of this study was to determine if earlier age of first exposure (AFE) to football is associated with worse brain health in middle-aged men who played high school football. We assessed 123 men 35-55 years of age, who played high school football, using (1) a survey of demographic information as well as medical, sport participation, and concussion history; (2) the Patient Health Questionnaire-8 (PHQ-8); and (3) the British Columbia Post-Concussion Symptom Inventory (BC-PSI). Sixty-two (50.4%) men reported football participation starting before the age of 12 (i.e., AFE <12 years) and 61 (49.6%) reported football participation at or after the age of 12 (AFE > 12 years). Compared with those with AFE >12 years, a similar proportion of former high school football players who began playing tackle football before age 12 reported that they had been prescribed medications for mental health problems or that they had recently experienced symptoms of anxiety, depression, memory loss, chronic pain, or headaches. Moreover, there was no significant difference in their lifetime history of treatment by a mental health professional. The groups did not differ significantly on PHQ-8 (U = 1839.0, p = 0.791) or BC-PSI total scores (U = 1828.5, p = 0.751). These findings suggest that earlier AFE to football is not associated with worse brain health in middle-aged men in this sample who played high school football.	[Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Terry, Douglas P.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Home Base, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Ctr Hlth & Rehabil Res, 79-96 Thirteenth St, Charlestown, MA 02129 USA; [Caccese, Jaclyn B.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Buttner, Fionn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Merz, Zachary C.] Univ N Carolina, UNC Mem Hosp, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu	Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603	ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; Spaulding Research Institute	This study received unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Caccese J.B., NEUROLOGY, V50, P1377; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2020, SPORTS MED, V50, P1377, DOI 10.1007/s40279-020-01261-4; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009; Difallah DE, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P238, DOI 10.1145/2736277.2741685; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2020, CLIN NEUROPSYCHOL, V34, P561, DOI 10.1080/13854046.2019.1666923; Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kees J, 2017, J ADVERTISING, V46, P141, DOI 10.1080/00913367.2016.1269304; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lund E.M., 2018, SAGE RES METHODS C 2; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mortensen K, 2018, J GEN INTERN MED, V33, P533, DOI 10.1007/s11606-017-4246-0; National Federation of State High School Associations, 2020, HIGH SCH ATHL PART S; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shin C, 2019, PSYCHIAT INVEST, V16, P300, DOI 10.30773/pi.2019.02.01; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Thomas KB, 2015, J AGGRESS MALTREAT T, V24, P623, DOI 10.1080/10926771.2015.1049766; World Health Organization, 2004, ICD 10 INT STAT CLAS; Wu Y., 2019, PSYCHOL MED	38	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					538	545		10.1089/neu.2020.7041		DEC 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000598572100001	33126834				2022-02-06	
J	Karr, JE; Iverson, GL				Karr, Justin E.; Iverson, Grant L.			The structure of post-concussion symptoms in adolescent student athletes: confirmatory factor analysis and measurement invariance	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Brain concussion; post-concussion syndrome; athletes; psychometrics; factor analysis; statistical	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; GOODNESS-OF-FIT; POSTCONCUSSIVE SYMPTOMS; CONSTRUCT-VALIDITY; NORMATIVE DATA; QUESTIONNAIRE; INDEXES; RECOVERY; PREDICTORS	Objective: This study examined factor models for the Post-Concussion Symptom Scale (PCSS) at baseline and after suspected sport-related concussion, and measurement invariance from pre-injury to post-injury assessments and across age, gender, and health history groups (e.g., attention-deficit/hyperactivity disorder, psychiatric history). Methods: Adolescent student athletes (ages 13-18) completed a baseline PCSS (n = 39,015; 54.3% boys) and a subsample within 21 days of a suspected concussion (n = 1,554; 56.7% boys) completed a post-injury PCSS. Five models were evaluated for fit and invariance. Results: Confirmatory factor analyses showed good baseline and post-injury model fit for a previously supported four-factor model (i.e., cognitive-sensory, sleep-arousal, vestibular-somatic, and affective), an alternative four-factor model (i.e., cognitive, sleep-arousal, physical, and affective), and an incomplete bifactor model with vestibular-somatic and affective specific factors, along with partial invariance from pre-injury to post-injury assessments. Partial-to-full invariance was established for each model at baseline across demographic and health history groups. Conclusions: Results showed empirical and conceptual support for both PCSS subscales (i.e., cognitive, sleep-arousal, physical, and affective) and a total score for use in pre-injury to post-injury assessments and across demographic and health history groups at baseline. Future normative data, stratified by demographics and health history, could provide more precise symptom assessments for concussion management.	[Karr, Justin E.] Univ Kentucky, Dept Psychol, 171 Funkhouser Dr,012D Kastle Hall, Lexington, KY 40506 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Iverson, Grant L.] MassGen Hosp Children, Spaulding Res Inst, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA		Karr, JE (corresponding author), Univ Kentucky, Dept Psychol, 171 Funkhouser Dr,012D Kastle Hall, Lexington, KY 40506 USA.	jkarr@uky.edu		Iverson, Grant/0000-0001-7348-9570; Karr, Justin/0000-0003-3653-332X	Spaulding Research Institute Leadership Catalyst Fellowship; ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; National Rugby League; Spaulding Research Institute	Justin E. Karr, Ph.D. acknowledges financial support from the Spaulding Research Institute Leadership Catalyst Fellowship. Grant Iverson, Ph.D. acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, National Rugby League, and the Spaulding Research Institute.	Agtarap S, 2021, ASSESSMENT, V28, P1656, DOI 10.1177/1073191120913941; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bontempo D., 2007, OXFORD HDB METHODS P, V1st, P153; Bontempo D. E., 2012, LONGITUDINAL DATA AN, P97; Brown M.W., 1993, SOCIOL METHOD RES, P136; Bryant FB, 2012, STRUCT EQU MODELING, V19, P372, DOI 10.1080/10705511.2012.687671; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Finney SJ, 2013, QUANT METH EDUC BEHA, P439; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; ImPACT Applications Inc, 2011, IMM POSTC ASS COGN T; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P1109, DOI 10.1093/arclin/acaa030; Iverson GL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00175; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P262; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Nelson LD, 2018, J INT NEUROPSYCH SOC, V24, P793, DOI 10.1017/S1355617718000462; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Satorra A, 2000, ADV ST THEO, V36, P233; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.2307/1130296; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Yu C.Y., 2002, EVALUATING CUTOFF CR; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	57	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2020.1850867		DEC 2020	40	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	PD5HT	WOS:000597716100001	33295242				2022-02-06	
J	Cherry, JD; Meng, GY; Daley, S; Xia, WM; Svirsky, S; Alvarez, VE; Nicks, R; Pothast, M; Kelley, H; Huber, B; Tripodis, Y; Alosco, ML; Mez, J; McKee, AC; Stein, TD				Cherry, Jonathan D.; Meng, Gaoyuan; Daley, Sarah; Xia, Weiming; Svirsky, Sarah; Alvarez, Victor E.; Nicks, Raymond; Pothast, Morgan; Kelley, Hunter; Huber, Bertrand; Tripodis, Yorghos; Alosco, Michael L.; Mez, Jesse; McKee, Ann C.; Stein, Thor D.			CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy	JOURNAL OF NEUROINFLAMMATION			English	Article						CTE; Chemokine; Neuroinflammation; Tau; Head impacts; TBI; American football; Microglia	ALZHEIMERS-DISEASE; NATIONAL INSTITUTE; INJURY; NEUROINFLAMMATION; CHEMOATTRACTANT; ACCUMULATION; INFLAMMATION; PROGRESSION; DEFICIENCY; EXPRESSION	Background Neuroinflammation has been implicated in the pathogenesis of chronic traumatic encephalopathy (CTE), a progressive neurodegenerative disease association with exposure to repetitive head impacts (RHI) received though playing contact sports such as American football. Past work has implicated early and sustained activation of microglia as a potential driver of tau pathology within the frontal cortex in CTE. However, the RHI induced signals required to recruit microglia to areas of damage and pathology are unknown. Methods Postmortem brain tissue was obtained from 261 individuals across multiple brain banks. Comparisons were made using cases with CTE, cases with Alzheimer's disease (AD), and cases with no neurodegenerative disease and lacked exposure to RHI (controls). Recruitment of Iba1+ cells around the CTE perivascular lesion was compared to non-lesion vessels. TMEM119 staining was used to characterize microglia or macrophage involvement. The potent chemoattractant CCL2 was analyzed using frozen tissue from the dorsolateral frontal cortex (DLFC) and the calcarine cortex. Finally, the amounts of hyperphosphorylated tau (pTau) and A beta(42) were compared to CCL2 levels to examine possible mechanistic pathways. Results An increase in Iba1+ cells was found around blood vessels with perivascular tau pathology compared to non-affected vessels in individuals with RHI. TMEM119 staining revealed the majority of the Iba1+ cells were microglia. CCL2 protein levels in the DLFC were found to correlate with greater years of playing American football, the density of Iba1+ cells, the density of CD68+ cells, and increased CTE severity. When comparing across multiple brain regions, CCL2 increases were more pronounced in the DLFC than the calcarine cortex in cases with RHI but not in AD. When examining the individual contribution of pathogenic proteins to CCL2 changes, pTau correlated with CCL2, independent of age at death and A beta(42) in AD and CTE. Although levels of A beta(42) were not correlated with CCL2 in cases with CTE, in males in the AD group, A beta(42) trended toward an inverse relationship with CCL2 suggesting possible gender associations. Conclusion Overall, CCL2 is implicated in the pathways recruiting microglia and the development of pTau pathology after exposure to RHI, and may represent a future therapeutic target in CTE.	[Cherry, Jonathan D.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Dept Pathol & Lab Med, Sch Med, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand; Alosco, Michael L.; Mez, Jesse; McKee, Ann C.] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA; [Cherry, Jonathan D.; Svirsky, Sarah; Alvarez, Victor E.; Nicks, Raymond; Pothast, Morgan; Kelley, Hunter; Huber, Bertrand; Tripodis, Yorghos; Alosco, Michael L.; Mez, Jesse; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Cherry, Jonathan D.; Svirsky, Sarah; Alvarez, Victor E.; Nicks, Raymond; Pothast, Morgan; Kelley, Hunter; Huber, Bertrand; McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [Meng, Gaoyuan; Daley, Sarah; Xia, Weiming; Svirsky, Sarah; Alvarez, Victor E.; Nicks, Raymond; Pothast, Morgan; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Daley, Sarah; Xia, Weiming] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02215 USA; [Huber, Bertrand] Natl Ctr PTSD VA Boston Healthcare Syst, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA		Cherry, JD; Stein, TD (corresponding author), Boston Univ, Dept Pathol & Lab Med, Sch Med, Boston, MA 02118 USA.; Cherry, JD; Stein, TD (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA.; Cherry, JD; Stein, TD (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.; Stein, TD (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.	jdcherry@bu.edu; tdstein@bu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U19-AG068753, AG08122, AG054076]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG057902, AG06234, RF1AG054156, RF1AG057768, K23AG046377]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS115266, U01NS086659, K23NS102399]; National Institute of Aging Boston University AD Center [P30AG013846, 0572063345-5, 75N92019D00031, HHSN2682015000011]; Department of Veterans Affairs BiorepositoryUS Department of Veterans Affairs [BX002466]; Department of Veterans Affairs Merit AwardUS Department of Veterans Affairs [I01-CX001038]; Department of Veterans Affairs Career Development AwardUS Department of Veterans Affairs [BX004349]; Nick and Lynn Buoniconti Foundation; Alzheimer's AssociationAlzheimer's Association [AARF-17529888]	This work was supported by grant funding from NIH (U19-AG068753, AG08122, AG054076), NIA (AG057902, AG06234, RF1AG054156, RF1AG057768, K23AG046377), NINDS (U54NS115266, U01NS086659, and K23NS102399), National Institute of Aging Boston University AD Center (P30AG013846; supplement 0572063345-5); Contracts 75N92019D00031 and HHSN2682015000011; Department of Veterans Affairs Biorepository (BX002466) Department of Veterans Affairs Merit Award (I01-CX001038), Department of Veterans Affairs Career Development Award (BX004349), the Nick and Lynn Buoniconti Foundation, and the Alzheimer's Association (AARF-17529888). The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation. Funders did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Chen DM, 2003, AM J TRANSPLANT, V3, P1216, DOI 10.1046/j.1600-6143.2003.00207.x; Cherry JD, 2020, SEMIN NEUROL, V40, P430, DOI 10.1055/s-0040-1713620; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chung J, 2018, ALZHEIMERS DEMENT, V14, P623, DOI 10.1016/j.jalz.2017.11.006; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Marinelli S, 2019, SEMIN CELL DEV BIOL, V94, P138, DOI 10.1016/j.semcdb.2019.05.017; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Standring OJ, 2019, ACTA NEUROPATHOL, V138, P401, DOI 10.1007/s00401-019-02031-x; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41; Tsao CW, 2015, INT J EPIDEMIOL, V44, P1800, DOI 10.1093/ije/dyv337; Tu J, 2015, J MOL NEUROSCI, V56, P509, DOI 10.1007/s12031-015-0553-2; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	44	4	4	5	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 5	2020	17	1							370	10.1186/s12974-020-02036-4			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	PA8FI	WOS:000595864900001	33278887	gold, Green Published			2022-02-06	
J	Arnsten, AFT				Arnsten, Amy F. T.			Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Intuniv; alpha 2A-adrenoceptor; Norepinephrine; Working memory; ADHD; Schizophrenia	WORKING-MEMORY PERFORMANCE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; POSTTRAUMATIC-STRESS-DISORDER; EXTENDED-RELEASE; SEX-DIFFERENCES; ALPHA-2-ADRENERGIC AGONIST; DENDRITIC SPINES; COGNITIVE ENHANCEMENT	The selective norepinephrine (NE) alpha 2A-adrenoceptor (alpha 2A-AR) agonist, guanfacine (IntunivTM), is FDA-approved for treating Attention Deficit Hyperactivity Disorder (ADHD) based on research in animals, a translational success story. Guanfacine is also widely used off-label in additional mental disorders that involve impaired functioning of the prefrontal cortex (PFC), including stress-related disorders such as substance abuse, schizotypic cognitive deficits, and traumatic brain injury. The PFC subserves high order cognitive and executive functions including working memory, abstract reasoning, insight and judgment, and top-down control of attention, action and emotion. These abilities arise from PFC microcircuits with extensive recurrent excitation through NMDAR synapses. There is powerful modulation of these synapses, where cAMP-PKA opening of nearby potassium (K+) channels can rapidly and dynamically alter synaptic strength to coordinate arousal state with cognitive state, e.g. to take PFC "offline" during uncontrollable stress. A variety of evidence shows that guanfacine acts within the PFC via post-synaptic alpha 2A-AR on dendritic spines to inhibit cAMP-PKA-K+ channel signaling, thus strengthening network connectivity, enhancing PFC neuronal firing, and improving PFC cognitive functions. Although guanfacine's beneficial effects are present in rodent, they are especially evident in primates, where the PFC greatly expands and differentiates. In addition to therapeutic actions in PFC, stress-related disorders may also benefit from additional alpha 2-AR actions, such as weakening plasticity in the amygdala, reducing NE release, and antiinflammatory actions by deactivating microglia. Altogether, these NE alpha 2-AR actions optimize top-down control by PFC networks, which may explain guanfacine's benefits in a variety of mental disorders.	[Arnsten, Amy F. T.] Yale Med Sch, Dept Neurosci, 333 Cedar St, New Haven, CT 06510 USA		Arnsten, AFT (corresponding author), Yale Med Sch, Dept Neurosci, 333 Cedar St, New Haven, CT 06510 USA.	amy.arnsten@yale.edu					Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; ARNSTEN AFT, 1992, PSYCHOPHARMACOLOGY, V108, P159, DOI 10.1007/BF02245302; Arnsten AFT, 1996, ARCH GEN PSYCHIAT, V53, P448; ARNSTEN AFT, 1991, NEUROPHARMACOLOGY, V30, P1279, DOI 10.1016/0028-3908(91)90024-6; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Arnsten AFT, 2019, NEUROBIOL STRESS, V11, DOI 10.1016/j.ynstr.2019.100187; Arnsten AFT, 2015, NAT NEUROSCI, V18, P1376, DOI 10.1038/nn.4087; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Avery RA, 2000, NEUROPSYCHOPHARMACOL, V23, P240, DOI 10.1016/S0893-133X(00)00111-1; Bangasser DA, 2012, CELL MOL NEUROBIOL, V32, P709, DOI 10.1007/s10571-012-9824-4; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Barcelos NM, 2018, NEUROBIOL AGING, V70, P117, DOI 10.1016/j.neurobiolaging.2018.05.033; Bardoloi P., 2018, ARCH NEUROL-CHICAGO, V1, P27; Bardoloi P. S., 2020, ACTA SCI NEUROLOGY, V3, P19; Biederman J, 2008, PEDIATRICS, V121, pE73, DOI 10.1542/peds.2006-3695; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Birnbaum SG, 2000, PHARMACOL BIOCHEM BE, V67, P397, DOI 10.1016/S0091-3057(00)00306-3; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; CAI JX, 1993, BRAIN RES, V614, P191; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Carlyle BC, 2014, P NATL ACAD SCI USA, V111, P5036, DOI 10.1073/pnas.1322360111; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Clerkin SM, 2009, BIOL PSYCHIAT, V66, P307, DOI 10.1016/j.biopsych.2009.04.013; Coleman D. M., 2019, J CHILD ADOLESCENT P; Connor DF, 2013, J CHILD ADOL PSYCHOP, V23, P244, DOI 10.1089/cap.2012.0119; Connor DF, 2010, CNS DRUGS, V24, P755, DOI 10.2165/11537790-000000000-00000; Dakwar E, 2020, AM J DRUG ALCOHOL AB, V46, P44, DOI 10.1080/00952990.2019.1620259; Davis L, 2008, PSYCHOPHARMACOL BULL, V41, P8; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; DeBock F, 2003, EUR J NEUROSCI, V17, P1411, DOI 10.1046/j.1460-9568.2003.02544.x; DOCHERTY NM, 1994, J NERV MENT DIS, V182, P98, DOI 10.1097/00005053-199402000-00006; Duggins P, 2017, TOP COGN SCI, V9, P117, DOI 10.1111/tops.12247; Ferry B, 1999, J NEUROSCI, V19, P5119; Findling RL, 2014, J CHILD ADOL PSYCHOP, V24, P245, DOI 10.1089/cap.2013.0103; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; Fox H., 2015, J PSYCHOPHARMACOLOGY; Fox HC, 2012, J PSYCHOPHARMACOL, V26, P958, DOI 10.1177/0269881111430746; Franowicz JS, 2002, J NEUROSCI, V22, P8771; Friedman JI, 2001, NEUROPSYCHOPHARMACOL, V25, P402, DOI 10.1016/S0893-133X(01)00249-4; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Galvin VC, 2020, NEURON, V106, P649, DOI 10.1016/j.neuron.2020.02.030; Gamo NJ, 2015, BIOL PSYCHIAT, V78, P860, DOI 10.1016/j.biopsych.2015.01.009; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Graybiel A M, 1991, Curr Opin Neurobiol, V1, P644, DOI 10.1016/S0959-4388(05)80043-1; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Hains AB, 2015, NEUROBIOL STRESS, V2, P1, DOI 10.1016/j.ynstr.2015.01.001; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Haney M, 2019, ADDICT BIOL, V24, P707, DOI 10.1111/adb.12621; Hasan A, 2020, EUR ARCH PSY CLIN N, V270, P403, DOI 10.1007/s00406-019-01068-z; Hassani SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40606; Havekes R, 2016, J NEUROSCI, V36, P8936, DOI 10.1523/JNEUROSCI.0248-16.2016; Haynes WIA, 2013, J NEUROSCI, V33, P4804, DOI 10.1523/JNEUROSCI.4674-12.2013; Heneka MT, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00640-3; Hervas A, 2014, EUR NEUROPSYCHOPHARM, V24, P1861, DOI 10.1016/j.euroneuro.2014.09.014; Holst M, 2019, AM J ADDICTION, V28, P455, DOI 10.1111/ajad.12959; Hunt R D, 1990, J Child Adolesc Psychopharmacol, V1, P87, DOI 10.1089/cap.1990.1.87; HUNT RD, 1995, J AM ACAD CHILD PSY, V34, P50, DOI 10.1097/00004583-199501000-00013; Issler O, 2020, NEURON, V106, P912, DOI 10.1016/j.neuron.2020.03.023; Iwanami A., 2020, J CLIN PSYCHIAT, V81; Jakala P, 1999, NEUROPSYCHOPHARMACOL, V20, P460, DOI 10.1016/S0893-133X(98)00127-4; Jakala P, 1999, NEUROPSYCHOPHARMACOL, V20, P119, DOI 10.1016/S0893-133X(98)00055-4; Jin LE, 2018, CEREB CORTEX, V28, P974, DOI 10.1093/cercor/bhx005; Kauser H, 2016, BRAIN RES, V1636, P152, DOI 10.1016/j.brainres.2016.01.053; Kauser H, 2013, NEUROSCIENCE, V254, P110, DOI 10.1016/j.neuroscience.2013.09.023; Kawaura K, 2014, BEHAV BRAIN RES, V270, P349, DOI 10.1016/j.bbr.2014.05.044; Kim S, 2012, PSYCHOPHARMACOLOGY, V219, P363, DOI 10.1007/s00213-011-2520-0; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kobori N, 2015, J NEUROTRAUM, V32, P139, DOI 10.1089/neu.2014.3487; Krienen F. M., 2019, BIORXIV PREPRINT, DOI [10.1101/709501v1, DOI 10.1101/709501, 10.1101/709501, DOI 10.1101/709501V1]; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Lencesova L, 2012, GEN PHYSIOL BIOPHYS, V31, P119, DOI 10.4149/gpb_2012_014; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Li BM, 1999, NEUROPSYCHOPHARMACOL, V21, P601, DOI 10.1016/S0893-133X(99)00070-6; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Ma CL, 2005, BIOL PSYCHIAT, V57, P192, DOI 10.1016/j.biopsych.2004.11.004; Ma CL, 2003, NEUROREPORT, V14, P1013, DOI 10.1097/01.wnr.0000070831.57864.7b; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; Malhotra PA, 2006, ANN NEUROL, V59, P186, DOI 10.1002/ana.20701; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Mathai DS, 2018, J NEUROPSYCH CLIN N, V30, P66, DOI 10.1176/appi.neuropsych.16120328; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McClure MM, 2007, BIOL PSYCHIAT, V61, P1157, DOI 10.1016/j.biopsych.2006.06.034; McClure MM, 2019, AM J PSYCHIAT, V176, P307, DOI 10.1176/appi.ajp.2018.18030349; McCracken JT, 2016, J AM ACAD CHILD PSY, V55, P657, DOI 10.1016/j.jaac.2016.05.015; McKee SA, 2003, ADDICTION, V98, P847, DOI 10.1046/j.1360-0443.2003.00408.x; Mckee SA, 2015, J PSYCHOPHARMACOL, V29, P300, DOI 10.1177/0269881114562091; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Milivojevic V, 2017, DRUG ALCOHOL DEPEN, V179, P275, DOI 10.1016/j.drugalcdep.2017.07.017; Moda-Sava RN, 2019, SCIENCE, V364, P147, DOI 10.1126/science.aat8078; Mongan D, 2020, EARLY INTERV PSYCHIA, V14, P385, DOI 10.1111/eip.12859; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Muller U, 2005, PSYCHOPHARMACOLOGY, V182, P205, DOI 10.1007/s00213-005-0078-4; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; O'Neill J, 2000, LIFE SCI, V67, P877, DOI 10.1016/S0024-3205(00)00681-0; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Opler LA, 2016, CNS SPECTRUMS, V21, P12, DOI 10.1017/S1092852914000686; Paspalas CD, 2013, CEREB CORTEX, V23, P1643, DOI 10.1093/cercor/bhs152; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Pinna P, 2020, J NEUROL SCI, V415, DOI 10.1016/j.jns.2020.116969; Politte LC, 2018, NEUROPSYCHOPHARMACOL, V43, P1772, DOI 10.1038/s41386-018-0039-3; Propper L, 2018, J PSYCHIATR NEUROSCI, V43, P359, DOI 10.1503/jpn.180039; Qin SZ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00016; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rama P, 1996, PHARM BIOCH BEHAV, V54, P1; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Ren WW, 2012, MOL CELL NEUROSCI, V49, P205, DOI 10.1016/j.mcn.2011.10.001; Rincon-Cortes M, 2019, NEUROBIOL STRESS, V10, DOI 10.1016/j.ynstr.2019.100155; Rubia K., 2011, BIOL PSYCHIAT; Rudebeck PH, 2017, NEURON, V95, P1208, DOI 10.1016/j.neuron.2017.07.042; Russell VA, 2002, BEHAV BRAIN RES, V130, P191, DOI 10.1016/S0166-4328(01)00425-9; Sagvolden Terje, 2006, Behav Brain Funct, V2, P41, DOI 10.1186/1744-9081-2-41; Saini SM, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.172; Sallee FR, 2009, J AM ACAD CHILD PSY, V48, P155, DOI 10.1097/CHI.0b013e318191769e; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; SELEMON LD, 1985, J NEUROSCI, V5, P776; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Shansky RM, 2004, MOL PSYCHIATR, V9, P531, DOI 10.1038/sj.mp.4001435; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2009, ARCH GEN PSYCHIAT, V66, P888, DOI 10.1001/archgenpsychiatry.2009.103; Singh-Curry V, 2011, J NEUROL NEUROSUR PS, V82, P688, DOI 10.1136/jnnp.2009.195792; Sinha Rajita, 2007, Curr Psychiatry Rep, V9, P388, DOI 10.1007/s11920-007-0050-6; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; Swartz BE, 2008, CLIN NEUROPHARMACOL, V31, P251, DOI 10.1097/WNF.0B013E3181633461; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Taylor FB, 2001, J CLIN PSYCHOPHARM, V21, P223, DOI 10.1097/00004714-200104000-00015; Taylor JR, 1999, J NEUROSCI, V19; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Tunbridge EM, 2010, INT REV NEUROBIOL, V95, P7, DOI [10.1016/B978-0-12-381326-8-00002-8, 10.1016/B978-0-12-381326-8.00002-8]; Velikonja T, 2019, ACTA PSYCHIAT SCAND, V140, P50, DOI 10.1111/acps.13032; Verplaetse TL, 2019, J CLIN PSYCHOPHARM, V39, P124, DOI 10.1097/JCP.0000000000001004; Vyas A, 2002, J NEUROSCI, V22, P6810; Wallis CU, 2017, P NATL ACAD SCI USA, V114, pE4075, DOI 10.1073/pnas.1620115114; Wang M, 2004, BRAIN RES, V1024, P176, DOI 10.1016/j.brainres.2004.07.062; Wang M, 2004, NEUROPSYCHOPHARMACOL, V29, P86, DOI 10.1038/sj.npp.1300278; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Wang XJ, 1999, J NEUROSCI, V19, P9587; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wimmer M. E., 2020, NEUROBIOLOGY LEARNIN, V169, P107; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Yang ST, 2018, CEREB CORTEX, V28, P1458, DOI 10.1093/cercor/bhx357; Yang Y., 2013, P NATL ACAD SCI US, V110; Zhang WC, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00678; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898; Zink C., 2020, AM J PSYCHIAT PRESS, P12078	173	4	4	3	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	DEC	2020	176								107327	10.1016/j.nlm.2020.107327			15	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	PB5PF	WOS:000596372100006	33075480	Green Published, hybrid			2022-02-06	
J	Cavanagh, JF; Rieger, RE; Wilson, JK; Gill, D; Fullerton, L; Brandt, E; Mayer, AR				Cavanagh, James F.; Rieger, Rebecca E.; Wilson, J. Kevin; Gill, Darbi; Fullerton, Lynne; Brandt, Emma; Mayer, Andrew R.			Joint analysis of frontal theta synchrony and white matter following mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						mTBI; DTI; EEG; Theta; Control; Executive; Brain injury	COGNITIVE CONTROL; CONCUSSION; EEG; SYMPTOMS; OUTCOMES; DTI; TBI; METAANALYSES; DYSFUNCTION; ANISOTROPY	Some of the most disabling aspects of mild traumatic brain injury (mTBI) include lingering deficits in executive functioning. It is known that mTBI can damage white matter tracts, but it remains unknown how this structural brain damage translates into cognitive deficits. This experiment utilized theta band phase synchrony to identify the dysfunctional neural operations that contribute to cognitive problems following mTBI. Sub-acute stage (< 2 weeks) mTBI patients (N = 52) and healthy matched controls (N = 32) completed a control-demanding task with concurrent EEG. Structural MRI was also collected. While there were no performance-specific behavioral differences between groups in the dot probe expectancy task, the degree of theta band phase synchrony immediately following injury predicted the degree of symptom recovery two months later. Although there were no differences in fractional anisotropy (FA) between groups, joint independent components analysis revealed that a smaller network of lower FA-valued voxels contributed to a diminished frontal theta phase synchrony network in the mTBI group. This finding suggests that frontal theta band markers of cognitive control are sensitive to sub-threshold structural aberrations following mTBI.	[Cavanagh, James F.; Rieger, Rebecca E.; Wilson, J. Kevin; Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA; [Rieger, Rebecca E.; Wilson, J. Kevin; Gill, Darbi; Brandt, Emma] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, 1101 Yale Blvd,MSC 084740, Albuquerque, NM 87131 USA; [Fullerton, Lynne] Univ New Mexico, Dept Emergency Med, Hlth Sci Ctr, 1101 Yale Blvd,MSC 116025, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Neurol, Hlth Sci Ctr, 1101 Yale Blvd,MSC 084740, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychiat, Hlth Sci Ctr, 1101 Yale Blvd,MSC 084740, Albuquerque, NM 87131 USA		Cavanagh, JF (corresponding author), Univ New Mexico, Dept Psychol, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA.	jcavanagh@unm.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM109089, P20GM109089] Funding Source: Medline		Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P136, DOI 10.1093/schbul/sbn153; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blackman RK, 2016, J NEUROSCI, V36, P4067, DOI 10.1523/JNEUROSCI.3578-15.2016; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Calhoun V, 2006, P 14 SCI M INT SOC M, P832, DOI [10.1109/CISS.2014.6814108, DOI 10.1109/CISS.2014.6814108]; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cavanagh J. F., NEUROPSYCHOLOGIA; Cavanagh JF, 2017, BIOL PSYCHIAT-COGN N, V2, P413, DOI 10.1016/j.bpsc.2017.01.004; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2019, ELECTROPHYSIOLOGY TH, P1, DOI [10.1111/psyp.13314, DOI 10.1111/PSYP.13314]; Cavanagh JF, 2019, HDB EEG FREQUENCY; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Cooper PS, 2019, NEUROIMAGE, V189, P130, DOI 10.1016/j.neuroimage.2019.01.022; Cooper SR, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01482; De La Vega A, 2016, LARGE SCALE META ANA, DOI 10.1523/JNEUROSCI.4402-15; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gaetz M, 2000, BRAIN INJURY, V14, P815; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Kaltiainen H, 2018, BRAIN TOPOGR, V31, P1037, DOI 10.1007/s10548-018-0667-2; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu P, 2017, NEUROSCIENCE, V366, P162, DOI 10.1016/j.neuroscience.2017.10.017; MacDonald AW, 2005, NEUROPSYCHOLOGY, V19, P814, DOI 10.1037/0894-4105.19.6.814; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer A. R., 2017, EVALUATION TRANSFORM, DOI [10.1007/s11682-017-9702-2, DOI 10.1007/S11682-017-9702-2]; Mayer AR, 2018, BIOL PSYCHIAT-COGN N, V3, P294, DOI 10.1016/j.bpsc.2017.09.012; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moosmann M, 2008, INT J PSYCHOPHYSIOL, V67, P212, DOI 10.1016/j.ijpsycho.2007.05.016; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Niehorster, 2007, WHATS NEW PSYCHTOOLB; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ryman SG, 2018, BIOL PSYCHIAT, V84, P675, DOI 10.1016/j.biopsych.2018.04.021; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Singh A, 2018, NEUROPSYCHOLOGIA, V117, P113, DOI 10.1016/j.neuropsychologia.2018.05.020; Smith EE, 2019, J INT NEUROPSYCH SOC, V25, P314, DOI 10.1017/S135561771800108X; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Souza A. D., 2019, MEASURING CHANGE TIM, P10, DOI [10.3389/fneur.2019.00353, DOI 10.3389/FNEUR.2019.00353]; Stephen JM, 2013, NEUROIMAGE, V83, P418, DOI 10.1016/j.neuroimage.2013.06.038; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Sui J, 2010, NEUROIMAGE, V51, P123, DOI 10.1016/j.neuroimage.2010.01.069; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wilson MJ, 2014, DEV NEUROPSYCHOL, V39, P113, DOI 10.1080/87565641.2013.870177; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zhao WX, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.966	89	4	4	1	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2020	14	6					2210	2223		10.1007/s11682-019-00171-y			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OO1HQ	WOS:000587138100012	31368085	Green Accepted			2022-02-06	
J	Corwin, DJ; Arbogast, KB; Haber, RA; Pettijohn, KW; Zonfrillo, MR; Grady, MF; Master, CL				Corwin, Daniel J.; Arbogast, Kristy B.; Haber, Rebecca A.; Pettijohn, Kevin W.; Zonfrillo, Mark R.; Grady, Matthew F.; Master, Christina L.			CHARACTERISTICS AND OUTCOMES FOR DELAYED DIAGNOSIS OF CONCUSSION IN PEDIATRIC PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT	JOURNAL OF EMERGENCY MEDICINE			English	Article						concussion; pediatric mild traumatic brain injury; persistent post-concussive symptoms; visio-vestibular examination	RECOVERY; CHILDREN; ZURICH	Background: Concussions are common pediatric injuries. Previous studies have found concussed youth may be underdiagnosed in the emergency department (ED), but outcomes for those with delayed diagnosis have yet to be described. Objective: Our aim was to compare visit characteristics and outcomes of patients who present to the ED with head injury who receive immediate vs. delayed diagnosis. Methods: Retrospective chart review of patients aged 6 to 18 years diagnosed with concussion on their first ED or urgent care (UC) visit and patients requiring a second visit for diagnosis between July 1, 2017 and June 20, 2019. We compared demographic information, ED or UC visit features, and recovery outcomes using c2 tests, Student's t-tests, andWilcoxon rank-sum tests. Results: Overall, we included 85 patients with delayed concussion diagnosis and 159 with immediate diagnosis. Those with immediate diagnosis had more symptoms inquired at initial visit (5 vs. 4; p = 0.003) and a higher likelihood of receiving concussion-specific physical examinations (80% vs. 36.5%; p < 0.001); 76.5% of delayed diagnosis patients had at least 1 symptom at follow-up visit that was not inquired about at initial visit. Those with delayed diagnosis had more medical visits during recovery (3 vs. 2; p < 0.001), longer average time to symptom resolution (21 vs. 11 days; p = 0.004), and a higher likelihood of having persistent concussion symptoms (odds ratio 2.9; 95% confidence interval 1.4-5.9). Conclusions: Concussed children evaluated acutely for head injury who do not receive an immediate diagnosis may be at risk for persistent symptoms. Performance of a concussion-specific physical examination and use of a standardized symptom scale may aid in identification of concussed youth acutely. (C) 2020 Elsevier Inc. All rights reserved.	[Corwin, Daniel J.; Arbogast, Kristy B.; Haber, Rebecca A.; Pettijohn, Kevin W.; Master, Christina L.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Arbogast, Kristy B.; Zonfrillo, Mark R.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Arbogast, Kristy B.; Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Roberts Ctr Pediat Res, 2716 South St, Philadelphia, PA 19103 USA.				National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549]; Pennsylvania Department of Health	We would like to thank Peter Camacho, MS, for his assistance in identifying study participants. Research reported in this publication was also supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award R01NS097549. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was also supported by grant funding from the Pennsylvania Department of Health.	Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Boutis K, 2018, J EMERG MED, V54, P757, DOI 10.1016/j.jemermed.2018.02.041; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, 2019, TBI REL EM DEP VIS; Corwin DJ, 2020, CLIN J SPORT MED, V30, pE154, DOI 10.1097/JSM.0000000000000732; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lishchynsky JT, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00588; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mannix R, 2019, SEMIN PEDIATR NEUROL, V30, P35, DOI 10.1016/j.spen.2019.03.006; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	34	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2020	59	6					795	804		10.1016/j.jemermed.2020.09.017			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	PQ8WS	WOS:000606824300015	33036827	Green Accepted			2022-02-06	
J	He, JC; Huang, YK; Liu, H; Sun, XC; Wu, JC; Zhang, ZS; Liu, L; Zhou, C; Jiang, SQ; Huang, ZJ; Zhong, JJ; Guo, ZD; Jiang, L; Cheng, CJ				He, Junchi; Huang, Yike; Liu, Han; Sun, Xiaochuan; Wu, Jingchuan; Zhang, Zhaosi; Liu, Liu; Zhou, Chao; Jiang, Shaoqiu; Huang, Zhijian; Zhong, Jianjun; Guo, Zongduo; Jiang, Li; Cheng, Chongjie			Bexarotene promotes microglia/macrophages - Specific brain - Derived Neurotrophic factor expression and axon sprouting after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Brain derived neurotrophic factor; Axon sprouting; Microglia/macrophages	WHITE-MATTER; OLIGODENDROCYTE DIFFERENTIATION; MICROGLIAL ACTIVATION; POLARIZATION DYNAMICS; FUNCTIONAL RECOVERY; NEURONAL SURVIVAL; NEUROPROTECTION; RAT; PROLIFERATION; REGENERATION	Traumatic brain injury (TBI) has been regarded as one of the leading cause of injury-related death and disability. White matter injury after TBI is characterized by axon damage and demyelination, resulting in neural network impairment and neurological deficit. Brain-derived neurotrophic factor (BDNF) can promote white matter repair. The activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) has been reported to promote microglia/macrophages towards anti-inflammatory state and therefore to promote axon regeneration. Bexarotene, an agonist of retinoid X receptor (RXR), can activate RXR/PPAR gamma heterodimers. The aim of the present study was to identify the effect of bexarotene on BDNF in microglia/macrophages and axon sprouting after TBI in mice. Bexarotene was administered intraperitoneally in C57BL/6 mice undergoing controlled cortical impact (CCI). PPAR gamma dependency was determined by intraperitoneal administration of a PPAR gamma antagonist T0070907. We found that bexarotene promoted axon regeneration indicated by increased growth associated protein 43 (GAP43) expression, myelin basic protein (MBP) expression, and biotinylated dextran amine (BDA)(+) axon sprouting. Bexarotene also increased microglia/macrophages-specific brain derived neurotrophic factor (BDNF) expression after TBI. In addition, bexarotene reduced the number of pro-inflammatory microglia/macrophages while increased the number of anti-inflammatory microglia/macrophages after TBI. Moreover, bexaortene inhibited pro-inflammatory cytokine secretion. In addition, bexarotene treatment improved neurological scores and cognitive function of CCI-injured mice. These effects of bexarotene were partially abolished by T0070907. In conclusion, bexarotene promotes axon sprouting, increases microglia/macrophages-specific BDNF expression, and induces microglia/macrophages from a pro-inflammatory state towards an anti-inflammatory one after TBI at least partially in a PPAR gamma-dependent manner.	[He, Junchi; Liu, Han; Sun, Xiaochuan; Wu, Jingchuan; Zhang, Zhaosi; Liu, Liu; Zhou, Chao; Huang, Zhijian; Zhong, Jianjun; Guo, Zongduo; Jiang, Li; Cheng, Chongjie] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Huang, Yike] Army Med Univ, Daping Hosp, Army Med Ctr, Dept Ophthalmol, Chongqing, Peoples R China; [Jiang, Shaoqiu] Chongqing Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Chongqing, Peoples R China		Cheng, CJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	chengcj@hospital.cqmu.edu.cn		He, Junchi/0000-0002-4662-3639; Wu, Jingchuan/0000-0002-1213-4888; Zhang, Zhaosi/0000-0002-4988-501X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159, 81601072, 81701226]	This work was supported by National Natural Science Foundation of China (grant No. 81571159, No. 81601072 and 81701226).	Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Certo M, 2015, PHARMACOL RES, V102, P298, DOI 10.1016/j.phrs.2015.10.009; Chen T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2198-5; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Drew PD, 2015, ALCOHOL CLIN EXP RES, V39, P445, DOI 10.1111/acer.12639; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kalkman HO, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10040095; Kariharan T, 2015, NEUROBIOL AGING, V36, P1451, DOI 10.1016/j.neurobiolaging.2014.09.028; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Knezovic A, 2015, J NEURAL TRANSM, V122, P577, DOI 10.1007/s00702-015-1394-4; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Liao PL, 2010, TOXICOL LETT, V197, P88, DOI 10.1016/j.toxlet.2010.05.002; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Liu SW, 2017, ACTA BIOMATER, V60, P167, DOI 10.1016/j.actbio.2017.07.024; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Marciano DP, 2015, PPAR RES, V2015, DOI 10.1155/2015/254560; Mariani MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42270; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Morecraft RJ, 2016, J COMP NEUROL, V524, P380, DOI 10.1002/cne.23861; Mounier A, 2015, J NEUROSCI, V35, P11862, DOI 10.1523/JNEUROSCI.1001-15.2015; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Piaton G, 2010, J NEUROCHEM, V114, P1243, DOI 10.1111/j.1471-4159.2010.06831.x; Qi FF, 2016, BRAIN BEHAV IMMUN, V53, P72, DOI 10.1016/j.bbi.2015.11.006; Ramos-Cejudo J, 2015, STROKE, V46, P221, DOI 10.1161/STROKEAHA.114.006692; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang SH, 2011, TOXICOL LETT, V206, P339, DOI 10.1016/j.toxlet.2011.07.026; Wang XX, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0270-16.2016; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yuan CL, 2020, NEUROCHEM RES, V45, P1500, DOI 10.1007/s11064-020-03012-3; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zuo YC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1432-5	71	4	4	3	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2020	334								113462	10.1016/j.expneurol.2020.113462			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OO4ZW	WOS:000587389600018	32916173				2022-02-06	
J	MacMullin, P; Hodgson, N; Damar, U; Lee, HHC; Hameed, MQ; Dhamne, SC; Hyde, D; Conley, GM; Morriss, N; Qiu, JH; Mannix, R; Hensch, TK; Rotenberg, A				MacMullin, Paul; Hodgson, Nathaniel; Damar, Ugur; Lee, Henry Hing Cheong; Hameed, Mustafa Q.; Dhamne, Sameer C.; Hyde, Damon; Conley, Grace M.; Morriss, Nicholas; Qiu, Jianhua; Mannix, Rebekah; Hensch, Takao K.; Rotenberg, Alexander			Increase in Seizure Susceptibility After Repetitive Concussion Results from Oxidative Stress, Parvalbumin-Positive Interneuron Dysfunction and Biphasic Increases in Glutamate/GABA Ratio	CEREBRAL CORTEX			English	Article						concussion; repetitive mild traumatic brain injury; seizure	TRAUMATIC BRAIN-INJURY; FAST-SPIKING INTERNEURONS; PERINEURONAL NETS; GAMMA RHYTHM; CHRONIC PAIN; MOUSE MODEL; EPILEPSY; EPIDEMIOLOGY; MECHANISMS; INHIBITION	Chronic symptoms indicating excess cortical excitability follow mild traumatic brain injury, particularly repetitive mild traumatic brain injury (rmTBI). Yet mechanisms underlying post-traumatic excitation/inhibition (E/I) ratio abnormalities may differ between the early and late post-traumatic phases. We therefore measured seizure threshold and cortical gamma-aminobutyric acid (GABA) and glutamate (Glu) concentrations, 1 and 6 weeks after rmTBI in mice. We also analyzed the structure of parvalbumin-positive interneurons (PVIs), their perineuronal nets (PNN5), and their electroencephalography (EEG) signature (gamma frequency band power). For mechanistic insight, we measured cortical oxidative stress, reflected in the reduced/oxidized glutathione (GSH/GSSG) ratio. We found that seizure susceptibility increased both early and late after rmTBI. However, whereas increased Glu dominated the E/I 1 week after rmTBI, Glu concentration normalized and the E/I was instead characterized by depressed GABA, reduced per-PVI parvalbumin expression, and reduced gamma EEG power at the 6-week post-rmTBI time point. Oxidative stress was increased early after rmTBI, where transient PNN degradation was noted, and progressed throughout the monitoring period. We conclude that GSH depletion, perhaps triggered by early Glu-mediated excitotoxicity, leads to late post-rmTBI loss of PVI-dependent cortical inhibitory tone. We thus propose dampening of Glu signaling, maintenance of redox state, and preservation of PVI inhibitory capacity as therapeutic targets for post-rmTBI treatment.	[MacMullin, Paul; Hodgson, Nathaniel; Damar, Ugur; Lee, Henry Hing Cheong; Hameed, Mustafa Q.; Dhamne, Sameer C.; Hyde, Damon; Hensch, Takao K.; Rotenberg, Alexander] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Neurol, Boston, MA 02115 USA; [Hameed, Mustafa Q.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Conley, Grace M.; Morriss, Nicholas; Qiu, Jianhua; Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Dept Emergency Med, Boston, MA 02115 USA		Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	alexander.rotenberg@childrens.harvard.edu		Hyde, Damon/0000-0001-6686-5646	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS088583]; Japan Society for the Promotion of Science (JSPS) (WPI-IRCN)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; National Football League Players Association (NFLPA)	This work was part of the Football Players Health Study at Harvard, funded by a grant from the National Football League Players Association (NFLPA), NIH R01NS088583 (to A.R.) and Japan Society for the Promotion of Science (JSPS) (WPI-IRCN to T.K.H.)	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Biagianti B, 2020, J AFFECT DISORDERS, V262, P71, DOI 10.1016/j.jad.2019.10.058; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cole W. R., 2016, TRANSLATIONAL RES TR; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dhamne SC, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0142-z; Dhamne SC, 2015, ANN CLIN TRANSL NEUR, V2, P843, DOI 10.1002/acn3.226; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elliott J, 2019, PHARMACOECONOMICS, V37, P1261, DOI 10.1007/s40273-019-00816-2; Favuzzi E, 2017, NEURON, V95, P639, DOI 10.1016/j.neuron.2017.06.028; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Franklin KBJ, 2013, PAXINOS FRANKLINS MO; Gersner R, 2015, EPILEPSY RES, V117, P97, DOI 10.1016/j.eplepsyres.2015.08.012; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hameed MQ, 2019, CEREB CORTEX, V29, P4506, DOI 10.1093/cercor/bhy328; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Kelly E, 2018, NEUROPSYCHOPHARMACOL, V43, P1457, DOI 10.1038/npp.2017.295; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Lanza G, 2019, ADV PHARMACOL, V84, P101, DOI 10.1016/bs.apha.2018.12.002; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lissemore JI, 2018, NEUROPSYCHOPHARMACOL, V43, P2277, DOI 10.1038/s41386-018-0093-x; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Luscher Bernhard, 2015, Adv Pharmacol, V73, P97, DOI 10.1016/bs.apha.2014.11.003; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Main BS, 2017, JOVE-J VIS EXP, V124, pe55713, DOI [10.3791/55713(2017), DOI 10.3791/55713(2017)]; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McNair LF, 2019, J NEUROSCI, V39, P4847, DOI 10.1523/JNEUROSCI.0894-18.2019; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Parker RS, 2016, BRAIN STIMUL, V9, P488, DOI 10.1016/j.brs.2016.03.020; Powell SB, 2012, NEUROPHARMACOLOGY, V62, P1322, DOI 10.1016/j.neuropharm.2011.01.049; Purtell H, 2018, EPILEPSY BEHAV, V89, P94, DOI 10.1016/j.yebeh.2018.09.003; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sorg BA, 2016, J NEUROSCI, V36, P11459, DOI 10.1523/JNEUROSCI.2351-16.2016; Spatazza J, 2013, CELL REP, V3, P1815, DOI 10.1016/j.celrep.2013.05.014; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Steullet P, 2017, MOL PSYCHIATR, V22, P936, DOI 10.1038/mp.2017.47; Suttkus A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.25; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Trevelyan AJ, 2015, J CLIN NEUROPHYSIOL, V32, P227, DOI 10.1097/WNP.0000000000000160; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Volman V, 2011, J NEUROSCI, V31, P18137, DOI 10.1523/JNEUROSCI.3041-11.2011; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010	75	4	4	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	DEC	2020	30	12					6108	6120		10.1093/cercor/bhaa157			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OW6KG	WOS:000592992600004	32676666	Green Published			2022-02-06	
J	Naugle, KM; Carey, C; Evans, E; Saxe, J; Overman, R; White, FA				Naugle, Kelly M.; Carey, Christopher; Evans, Eric; Saxe, Jonathan; Overman, Ryan; White, Fletcher A.			The role of deficient pain modulatory systems in the development of persistent post-traumatic headaches following mild traumatic brain injury: an exploratory longitudinal study	JOURNAL OF HEADACHE AND PAIN			English	Article						Mild traumatic brain injury; Pain modulation; Conditioned pain modulation; Pain catastrophizing; Posttraumatic headache	RISK; RECOMMENDATIONS; SENSITIZATION; INDIVIDUALS; POPULATION; PREVALENCE; DEPRESSION; SUMMATION; MIGRAINE; MODEL	Background Post-traumatic headache (PTH) is one of the most common and long-lasting symptoms following mild traumatic brain injury (TBI). However, the pathological mechanisms underlying the development of persistent PTH remain poorly understood. The primary purpose of this prospective pilot study was to evaluate whether early pain modulatory profiles (sensitization and endogenous pain inhibitory capacity) and psychological factors after mild TBI predict the development of persistent PTH in mild TBI patients. Methods Adult mild TBI patients recruited from Level I Emergency Department Trauma Centers completed study sessions at 1-2 weeks, 1-month, and 4-months post mild TBI. Participants completed the following outcome measures during each session: conditioned pain modulation to measure endogenous pain inhibitory capacity, temporal summation of pain and pressure pain thresholds of the head to measure sensitization of the head, Pain Catastrophizing Scale, Center for Epidemiological Studies - Depression Scale, and a standardized headache survey. Participants were classified into persistent PTH (PPTH) and no-PPTH groups based on the 4-month data. Results The results revealed that mild TBI patients developing persistent PTH exhibited significantly diminished pain inhibitory capacity, and greater depression and pain catastrophizing following injury compared to those who do not develop persistent PTH. Furthermore, logistic regression indicated that headache pain intensity at 1-2 weeks and pain inhibitory capacity on the conditioned pain modulation test at 1-2 weeks predicted persistent PTH classification at 4 months post injury. Conclusions Overall, the results suggested that persistent PTH is characterized by dysfunctional alterations in endogenous pain modulatory function and psychological processes in the early stages following mild TBI, which likely exacerbate risk for the maintenance of PTH.	[Naugle, Kelly M.; Carey, Christopher] Indiana Univ Purdue Univ Indianapolis IUPUI, Sch Hlth & Human Sci, Dept Kinesiol, 901 West New York St, Indianapolis, IN 46202 USA; [Evans, Eric] IUPUI, Sch Hlth & Human Sci, Dept Hlth Sci, 250 Univ Blvd, Indianapolis, IN 46202 USA; [Saxe, Jonathan] Ascens St Vincent Indianapolis Hosp, Trauma Dept, 2001 W 86th St, Indianapolis, IN 46260 USA; [Overman, Ryan] Indiana Univ Sch Med, Dept Neurol, GH 4700 Neur, Indianapolis, IN 46202 USA; [White, Fletcher A.] Indiana Univ, Sch Med, Dept Anesthesia, 320 West 15th St, Indianapolis, IN 46202 USA; [White, Fletcher A.] Indiana Univ, Sch Med, Stark Neurosci Res Inst, 320 West 15th St, Indianapolis, IN 46202 USA		Naugle, KM (corresponding author), Indiana Univ Purdue Univ Indianapolis IUPUI, Sch Hlth & Human Sci, Dept Kinesiol, 901 West New York St, Indianapolis, IN 46202 USA.	kmnaugle@iupui.edu	Naugle, Kelly/AAQ-1628-2021	Evans, Eric/0000-0003-3751-0269	Indiana State Department of Health's Indiana Spinal Cord and Brain Injury Fund Research Grant Program; St. Vincent Foundation	This research was funded by the Indiana State Department of Health's Indiana Spinal Cord and Brain Injury Fund Research Grant Program (KMN and FAW) and the St. Vincent Foundation (FAW). These funding bodies did not have a role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.	Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bree D, 2020, CEPHALALGIA, V40, P748, DOI 10.1177/0333102420907597; Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Carey C, 2019, PAIN MED, V20, P2198, DOI 10.1093/pm/pnz058; Carlesso LC, 2019, ARTHRITIS RHEUMATOL, V71, P542, DOI 10.1002/art.40752; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Colman I, 2016, HEADACHE, V56, P132, DOI 10.1111/head.12710; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Filatova E, 2008, J HEADACHE PAIN, V9, P295, DOI 10.1007/s10194-008-0061-7; George SZ, 2006, J OCCUP REHABIL, V16, P95, DOI 10.1007/s10926-005-9007-y; Gopinath B, 2019, J PAIN, V20, P676, DOI 10.1016/j.jpain.2018.11.011; Graven-Nielsen T, 2012, ARTHRITIS RHEUM-US, V64, P2907, DOI 10.1002/art.34466; Guglielmetti M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114024; Hoffman JM, 2020, PM&R, V12, P967, DOI 10.1002/pmrj.12338; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kuperman P, 2018, NEUROLOGY, V91, pE931, DOI 10.1212/WNL.0000000000006120; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Laglois JA, 2006, TRAUMATIC BRAIN INJU; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Maruish M., 2004, USE PSYCHOL TESTING, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Mehta SP, 2015, J ORTHOP SPORT PHYS, V45, P119, DOI 10.2519/jospt.2015.5129; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; Nahman-Averbuch H, 2013, HEADACHE, V53, P1104, DOI 10.1111/head.12117; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pergolizzi JV, 2014, PAIN MANAG NURS, V15, P380, DOI 10.1016/j.pmn.2012.07.004; Sahbaie P, 2018, J PAIN, V19, P1392, DOI 10.1016/j.jpain.2018.06.004; Scott W, 2014, CLIN J PAIN, V30, P183, DOI 10.1097/AJP.0b013e31828eee6c; Seo JG, 2019, J CLIN NEUROSCI, V69, P21, DOI 10.1016/j.jocn.2019.08.084; Serafini G, 2012, EUR REV MED PHARMACO, V16, P1389; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarnitsky D, 2015, EUR J PAIN, V19, P805, DOI 10.1002/ejp.605; Yarnitsky D, 2015, PAIN, V156, pS24, DOI 10.1097/01.j.pain.0000460343.46847.58; Yarnitsky D, 2015, ANESTHESIOLOGY, V122, P734, DOI 10.1097/ALN.0000000000000594; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Zeilig G, 2012, BRAIN, V135, P418, DOI 10.1093/brain/awr270	55	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC	2020	21	1							138	10.1186/s10194-020-01207-1			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PA3YA	WOS:000595574100001	33272206	gold, Green Published			2022-02-06	
J	Olaya, J; Noe, E; Navarro, MD; O'Valle, M; Colomer, C; Moliner, B; Ippoliti, C; Ferri, J; Maza, A; Llorens, R				Olaya, Jose; Noe, Enrique; Navarro, Maria Dolores; O'Valle, Myrtha; Colomer, Carolina; Moliner, Belen; Ippoliti, Camilla; Ferri, Joan; Maza, Anny; Llorens, Roberto			When, How, and to What Extent Are Individuals with Unresponsive Wakefulness Syndrome Able to Progress? Functional Independence	BRAIN SCIENCES			English	Article						unresponsive wakefulness syndrome; vegetative state; minimally conscious state; disorders of consciousness; brain damage; disability; independence; functionality	TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; VEGETATIVE STATE; LATE RECOVERY; UNEXPECTED RECOVERY; NATIONAL INSTITUTE; NATURAL-HISTORY; SPANISH VERSION; CONSCIOUSNESS; DISORDERS	Accurate estimation of the functional independence of patients with unresponsive wakefulness syndrome (UWS) is essential to adjust family and clinical expectations and plan long-term necessary resources. Although different studies have described the clinical course of these patients, they have methodological limitations that could restrict generalization of the results. This study investigates the neurobehavioral progress of 100 patients with UWS consecutively admitted to a neurorehabilitation center using systematic weekly assessments based on standardized measures, and the functional independence staging of those patients who emerged from a minimally conscious state (MCS) during the first year post-emergence. Our results showed that one year after emergence, most patients were severely dependent, although some of them showed extreme or moderate severity. Clinically meaningful functional improvement was less likely to occur in cognitively-demanding activities, such as activities of daily living and executive function. Consequently, the use of specific and staging functional independence measures, with domain-specific evaluations, are recommended to detect the functional changes that might be expected in these patients. The information provided by these instruments, together with that obtained from repeated assessments of the preserved consciousness with standardized instruments, could help clinicians to adjust expectations and plan necessary resources for this population.	[Olaya, Jose; Noe, Enrique; Navarro, Maria Dolores; O'Valle, Myrtha; Colomer, Carolina; Moliner, Belen; Ippoliti, Camilla; Ferri, Joan; Llorens, Roberto] Fdn Vithas, Serv Neurorrehabil Hosp Vithas, NEURORHB, Callosa En Sarria 12, Valencia 46007, Spain; [Maza, Anny; Llorens, Roberto] Univ Politecn Valencia, Inst Invest & Innovac Bioingn, Neurorehabil & Brain Res Grp, Camino Vera S-N, Valencia 46011, Spain		Noe, E (corresponding author), Fdn Vithas, Serv Neurorrehabil Hosp Vithas, NEURORHB, Callosa En Sarria 12, Valencia 46007, Spain.	olaya@neurorhb.com; quique@neurorhb.com; loles@neurorhb.com; myrtha@neurorhb.com; carol@neurorhb.com; belen@neurorhb.com; camila@neurorhb.com; joan@neurorhb.com; amaza@i3b.upv.es; roberto@neurorhb.com	Llorens, Roberto/AAL-2604-2021	Llorens, Roberto/0000-0002-8677-8707; Noe Sebastian, Enrique/0000-0002-2547-8727	program RISE-Marie-Slodowska-Curie of the European Commission [778234]; Conselleria de Educacion, Investigacion, Cultura y Deporte of Generalitat Valenciana [SEJI/2019/017]; Vicerrectorado de Investigacion, Innovacion y transferencia of Universitat Politecnica de Valencia [PAID-06-18]	This research was funded by the program RISE-Marie-Slodowska-Curie of the European Commission (Grant agreement 778234), by Conselleria de Educacion, Investigacion, Cultura y Deporte of Generalitat Valenciana (SEJI/2019/017), and by Vicerrectorado de Investigacion, Innovacion y transferencia of Universitat Politecnica de Valencia (PAID-06-18).	[Anonymous], 1996, ASP CONS C WORKGR VE; Burke WJ, 2002, NEUROLOGY, V59, P1473, DOI 10.1212/WNL.59.9.1473; Casarett D, 2005, BMJ-BRIT MED J, V331, P1537, DOI 10.1136/bmj.331.7531.1537; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; De Tanti A, 2016, BRAIN INJURY, V30, P1029, DOI 10.3109/02699052.2016.1147078; Dhamapurkar SK, 2016, BRAIN INJURY, V30, P230, DOI 10.3109/02699052.2015.1094132; Estraneo A, 2019, BRAIN INJURY, V33, P1633, DOI 10.1080/02699052.2019.1658220; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Farisco M., 2017, MIND MATTER, V15, P197; Ferri J, 2015, BRAIN INJURY, V29, P1002, DOI 10.3109/02699052.2015.1022884; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Illman NA, 2018, NEUROPSYCHOL REHABIL, V28, P1360, DOI 10.1080/09602011.2017.1313167; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Naro A, 2017, NEUROREHABILITATION, V41, P735, DOI 10.3233/NRE-172160; Noe E., 2020, BRAIN SCI; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Pincherle A, 2021, J NEUROL, V268, P178, DOI 10.1007/s00415-020-10125-w; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Septien S, 2018, SEMIN NEUROL, V38, P548, DOI 10.1055/s-0038-1667384; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P38, DOI 10.1053/apmr.2003.50060; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wright J., 2011, ENCY CLIN NEUROPSYCH, P862	41	4	4	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2020	10	12							990	10.3390/brainsci10120990			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ4AB	WOS:000601711700001	33339138	Green Published, gold			2022-02-06	
J	Rameshkumar, R; Bansal, A; Singhi, S; Singhi, P; Jayashree, M				Rameshkumar, Ramachandran; Bansal, Arun; Singhi, Sunit; Singhi, Pratibha; Jayashree, Muralidharan			Randomized Clinical Trial of 20% Mannitol Versus 3% Hypertonic Saline in Children With Raised Intracranial Pressure Due to Acute CNS Infections*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; coma; intracranial hypertension; outcome; osmotherapy		Objectives: Mannitol is a commonly used osmotherapy agent in raised intracranial pressure. However, the side effects of mannitol are significant. In traumatic brain injury (adult and pediatric), hypertonic saline (3%) shows varied results in comparison with 20% mannitol. We compared the effect of 3% hypertonic saline versus 20% mannitol (using common dosing strategies) on raised intracranial pressure in pediatric acute CNS infections. Design: Open-label randomized controlled trial. Setting: PICU of a quaternary care academic institute. Patients: Children 1-12 years old, with raised intracranial pressure and modified-Glasgow Coma Scale scores less than or equal to 8, were enrolled. Interventions: Patients were randomly assigned to 20%-mannitol (n = 28), 0.5 gram/kg/dose versus 3%-hypertonic saline (n = 29), 10 mL/kg loading followed by 0.5-1 mL/kg/hr infusion. An intraparenchymal catheter was used to monitor the intracranial pressure. The primary outcome was the proportion of patients achieved target average intracranial pressure less than 20 mm Hg during 72 hours. Secondary outcomes were interventions, morbidity, and mortality. Measurements and Main Results: The proportion of patients with target average intracranial pressure (< 20 mm Hg) was higher in hypertonic saline-group as compared to mannitol-group (79.3% vs 53.6%; adjusted hazard ratio 2.63; 95% CI: 1.23-5.61). Mean (+/- se) reduction of intracranial pressure (-14.3 +/- 1.7 vs -5.4 +/- 1.7 mm Hg; p <= 0.001) and elevation of cerebral perfusion pressure (15.4 +/- 2.4 vs 6 +/- 2.4 mm Hg; p = 0.007) from baseline were significant in hypertonic saline-group. Mean (+/- se) intracranial pressure over 72 hours was lower (14 +/- 2 vs 22 +/- 2 mm Hg; p = 0.009), and cerebral perfusion pressure was higher (65 +/- 2.2 vs 58 +/- 2.2; p = 0.032) in hypertonic saline-group. Hypertonic saline-group had higher modified-Glasgow Coma Scale score at 72 hours (median, interquartile range 10; 7-11 vs 7; 3-9; p = 0.003), lower mortality (20.7% vs 35.7%; p = 0.21), shorter duration of mechanical ventilation (5 vs 15 d; p = 0.002), and PICU stay (11 vs 19 d; p = 0.016) and less severe neurodisability at discharge (31% vs 61%; p = 0.049). Conclusions: In pediatric acute CNS infections, 3%-hypertonic saline was associated with a greater reduction of intracranial pressure as compared to 20% mannitol.	[Rameshkumar, Ramachandran; Bansal, Arun; Singhi, Sunit; Singhi, Pratibha; Jayashree, Muralidharan] Postgrad Inst Med Educ & Res PGIMER, Adv Pediat Ctr, Dept Pediat, Chandigarh, India		Bansal, A (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Adv Pediat Ctr, Dept Pediat, Chandigarh, India.	drarunbansal@gmail.com					Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; CABRAL DA, 1987, J PEDIATR-US, V111, P201, DOI 10.1016/S0022-3476(87)80067-7; Chinchankar Nandita, 2002, Indian Pediatr, V39, P914; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Dung NM, 2009, J NEUROL, V256, P2052, DOI 10.1007/s00415-009-5249-5; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Efird J, 2011, INT J ENV RES PUB HE, V8, P15, DOI 10.3390/ijerph8010015; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Gu JJ, 2019, NEUROSURG REV, V42, P499, DOI 10.1007/s10143-018-0991-8; Gwer S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-23; Hinson HE, 2013, J INTENSIVE CARE MED, V28, P3, DOI 10.1177/0885066611400688; Kumar G, 2009, CLIN NEUROL NEUROSUR, V111, P399, DOI 10.1016/j.clineuro.2009.03.004; Kumar R, 2014, CRIT CARE MED, V42, P1775, DOI 10.1097/CCM.0000000000000298; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; MINNS RA, 1989, ARCH DIS CHILD, V64, P814, DOI 10.1136/adc.64.6.814; Overturf Gary D, 2005, Pediatr Crit Care Med, V6, pS14, DOI 10.1097/01.PCC.0000161933.42822.86; Patil H, 2019, WORLD NEUROSURG, V125, pE221, DOI 10.1016/j.wneu.2019.01.051; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Shetty R, 2008, J CHILD NEUROL, V23, P192, DOI 10.1177/0883073807308716; Singhi SC, 2004, ANN TROP PAEDIATR, V24, P133, DOI 10.1179/027249304225013402; Singhi S, 2015, PEDIATR CRIT CARE ME, V16, P453, DOI 10.1097/PCC.0000000000000353; Thirumoorthi M. C., 1995, Indian Journal of Pediatrics, V62, P265, DOI 10.1007/BF02753587; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Upadhyay P, 2010, J PEDIATR NEUROSCI, V5, P18, DOI 10.4103/1817-1745.66673; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Witherspoon B, 2017, NURS CLIN N AM, V52, P249, DOI 10.1016/j.cnur.2017.01.002; Yildizdas D, 2006, INDIAN PEDIATR, V43, P771; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	30	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	DEC	2020	21	12					1071	1080		10.1097/PCC.0000000000002557			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	PB5TK	WOS:000596383000011	33003179				2022-02-06	
J	Salinas, CM; Edgar, VB; Siervo, GB; Bender, HA				Salinas, Christine M.; Edgar, Veronica Bordes; Siervo, Gretchen Berrios; Bender, Heidi A.			Transforming pediatric neuropsychology through video-based teleneuropsychology: an innovative private practice model pre-COVID-19	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Teleneuropsychology; Pediatric; Private practice; Design thinking; Neuropsychology	NAN POLICY; CHILDREN; TELEHEALTH	Objective: In pediatric neuropsychology multiple barriers such as long wait times until an appointment, insurance coverage, and limited providers who are bilingual/bicultural or who sub-specialize in pediatric neuropsychology, often slow families from receiving diagnoses and interventions in a timely and affordable manner. This paper focuses on increasing accessibility through the development of a video-based, pediatric teleneuropsychology (TeleNP) practice model that was developed in a private practice 2 years before the COVID-19 pandemic. Method: 'Design thinking' methodology to problem-solving was utilized to innovate the traditional neuropsychology practice model in under-served areas who may have limited financial and healthcare resources. The practice model approach to include a virtual diagnostic clinic with increased patient and provider efficiency was created to enhance accessibility for patients and sustainability for providers. Results: Video-based TeleNP screenings were conducted for 67 children with developmental (i.e., attention deficit hyperactivity disorder, autism spectrum disorder) and language disorders, as well as concussion and psychiatric diagnoses. Additional comorbidities were identified in 65.6% of children. Follow-up data approximately 2 months later revealed 98.5% of children were receiving new interventions as a result of the video-based TeleNP assessment. Conclusion: Video-based TeleNP benefits the consumer as it can reduce wait times, decrease family financial burden (i.e., travel and parent time off work), expedite referrals for interventions, and provide geographically under-served populations access to providers who are linguistically and culturally responsive. For providers, this model revealed improvements with direct implications for cost-saving, thereby facilitating long-term economic sustainability within a private practice healthcare marketplace.	[Salinas, Christine M.] Neuropsychol Concierge, Indialantic, FL USA; [Edgar, Veronica Bordes] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, FL USA; [Siervo, Gretchen Berrios] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Bender, Heidi A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Salinas, CM (corresponding author), 322 5th Ave,Suite B, Indialantic, FL 32903 USA.	drcristisalinas@gmail.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2020, Q GLOBAL; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Canas A, 2020, DEV NEUROPSYCHOL, V45, P211, DOI 10.1080/87565641.2020.1746314; Cullum CM, 2014, J INT NEUROPSYCH SOC, V20, P1028, DOI 10.1017/S1355617714000873; Delis DC., 2001, DELIS KAPLAN EXECUTI; Estes A, 2009, AUTISM, V13, P375, DOI 10.1177/1362361309105658; Garrido D, 2018, SPAN J PSYCHOL, V21, DOI 10.1017/sjp.2018.64; Harder L, 2020, ARCH CLIN NEUROPSYCH, V35, P1266, DOI 10.1093/arclin/acaa070; Health Resources and Services Administration, 2020, HLTH PROF SHORT AR H; Hodge MA, 2019, J TELEMED TELECARE, V25, P431, DOI 10.1177/1357633X18776095; Jimenez ME, 2017, J DEV BEHAV PEDIATR, V38, P228, DOI 10.1097/DBP.0000000000000427; Korkman M., 2007, NEPSY 2 EDITION NEPS; Loving H, 2008, INNOVATIONS AND ADVANCED TECHNIQUES IN SYSTEMS, COMPUTING SCIENCES AND SOFTWARE ENGINEERING, P81, DOI 10.1007/978-1-4020-8735-6_16; Postal K, 2018, CLIN NEUROPSYCHOL, V32, P326, DOI 10.1080/13854046.2017.1373859; Pritchard AE, 2012, NEUROPSYCHOL REV, V22, P54, DOI 10.1007/s11065-011-9185-7; Ransom D. M., ARCH CLIN NEUROPSYCH; Ringeisen Heather, 2002, Paediatr Drugs, V4, P697, DOI 10.2165/00148581-200204110-00001; Rutter M., 2012, AUTISM DIAGNOSTIC OB; Salinas C.M., 2016, STUDIES NEUROPSYCHOL, P229; Sharma SR, 2018, PHARMACOL THERAPEUT, V190, P91, DOI 10.1016/j.pharmthera.2018.05.007; Siang, 2020, WHAT IS DESIGN THINK; Silver CH, 2006, ARCH CLIN NEUROPSYCH, V21, P741, DOI 10.1016/j.acn.2006.08.006; Sparrow S.S., 2016, VINELAND ADAPTIVE BE, V3rd ed.; Suarez P., 2016, CALIFORNIA PSYCHOL, V49, P16; Sutherland R, 2019, INT J LANG COMM DIS, V54, P281, DOI 10.1111/1460-6984.12440; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; US Census Bureau, 2019, BREV COUNT; Van Bourgondien ME, 2010, CHILDHOOD AUTISM RAT; van Stralen J, 2016, ADHD-ATTEND DEFICIT, V8, P175, DOI 10.1007/s12402-016-0199-0; Wadsworth HE, 2018, ARCH CLIN NEUROPSYCH, V33, P1040, DOI 10.1093/arclin/acx140; Waite MC, 2010, LANG SPEECH HEAR SER, V41, P445, DOI 10.1044/0161-1461(2009/08-0131)	32	4	4	4	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2020	35	8			SI		1189	1195		10.1093/arclin/acaa101			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	PA2QS	WOS:000595479000002	33159508	Green Published, Bronze			2022-02-06	
J	Schnakers, C; Hirsch, M; Noe, E; Llorens, R; Lejeune, N; Veeramuthu, V; De Marco, S; Demertzi, A; Duclos, C; Morrissey, AM; Chatelle, C; Estraneo, A				Schnakers, Caroline; Hirsch, Michaela; Noe, Enrique; Llorens, Roberto; Lejeune, Nicolas; Veeramuthu, Vigneswaran; De Marco, Sabrina; Demertzi, Athena; Duclos, Catherine; Morrissey, Ann-Marie; Chatelle, Camille; Estraneo, Anna			Covert Cognition in Disorders of Consciousness: A Meta-Analysis	BRAIN SCIENCES			English	Article						severe brain injury; consciousness; vegetative state; minimally conscious state; covert cognition; cognitive motor dissociation	BRAIN-COMPUTER INTERFACE; AWARENESS; RESPONSES; RECOVERY; INJURY; STATE	Covert cognition in patients with disorders of consciousness represents a real diagnostic conundrum for clinicians. In this meta-analysis, our main objective was to identify clinical and demographic variables that are more likely to be associated with responding to an active paradigm. Among 2018 citations found on PubMed, 60 observational studies were found relevant. Based on the QUADAS-2, 49 studies were considered. Data from 25 publications were extracted and included in the meta-analysis. Most of these studies used electrophysiology as well as counting tasks or mental imagery. According to our statistical analysis, patients clinically diagnosed as being in a vegetative state and in a minimally conscious state minus (MCS-) show similar likelihood in responding to active paradigm and responders are most likely suffering from a traumatic brain injury. In the future, multi-centric studies should be performed in order to increase sample size, with similar methodologies and include structural and functional neuroimaging in order to identify cerebral markers related to such a challenging diagnosis.	[Schnakers, Caroline] Casa Colina Hosp & Ctr Healthcare, Pomona, CA 91769 USA; [Hirsch, Michaela] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Noe, Enrique; Llorens, Roberto] Hosp Vithas, NEURORHB, Serv Neurorrehab, Valencia 46011, Spain; [Llorens, Roberto] Univ Politecn Valencia, Inst Invest & Innovac Bioingn, Neurorehabil & Brain Res Grp, Valencia 46022, Spain; [Lejeune, Nicolas; Demertzi, Athena; Chatelle, Camille] Univ Liege, Coma Sci Grp, GIGA Consciousness, B-4000 Liege, Belgium; [Veeramuthu, Vigneswaran] ReGen Rehabil Hosp, Petaling Jaya 46200, Malaysia; [De Marco, Sabrina] Univ Catolica Cordoba, Clin Univ Reina Fabiola, Serv Terapia Ocupac, X5000 IYG, Cordoba, Argentina; [Duclos, Catherine] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3A 0G4, Canada; [Morrissey, Ann-Marie] Univ Limerick, Hlth Res Inst, Sch Allied Hlth, Ageing Res Ctr, Limerick V94 T9PX, Ireland; [Estraneo, Anna] IRCCS Fdn Don Carlo Gnocchi, I-50143 Florence, Italy; [Estraneo, Anna] Santa Maria della Pieta Gen Hosp, Neurol Unit, I-80035 Nola, Italy		Schnakers, C (corresponding author), Casa Colina Hosp & Ctr Healthcare, Pomona, CA 91769 USA.	cschnakers@casacolina.org; hirschm92@gmail.com; quique@neurorhb.com; roberto@neurorhb.com; nicolas.lejeune@chnwl.be; vicveera@gmail.com; sabri.dmarco@gmail.com; a.demertzi@ulg.ac.be; catherine.duclos@mail.mcgill.ca; a.morrissey2@gmail.com; camille.chatelle@uclouvain.be; aestraneo@gmail.com	Laureys, Steven/A-3349-2011; Demertzi, Athena/I-1251-2019; Llorens, Roberto/AAL-2604-2021; Veeramuthu, Vigneswaran/F-2220-2015	Demertzi, Athena/0000-0001-8021-3759; Llorens, Roberto/0000-0002-8677-8707; Veeramuthu, Vigneswaran/0000-0003-2052-0858; Morrissey, Ann-Marie/0000-0003-2301-2920; Lejeune, Nicolas/0000-0001-6059-606X; Duclos, Catherine/0000-0002-8406-5228; De Marco, Sabrina/0000-0002-5292-5588	Casa Colina Foundation; International Brain Injury Association	C.S. would like to thank Felice Loverso, the Casa Colina Board of Directors, the Casa Colina Foundation and the International Brain Injury Association for supporting this research.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Aubinet C, 2020, NEUROREHAB NEURAL RE, V34, P172, DOI 10.1177/1545968319899914; Aubinet C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00665; Aubinet C, 2018, HUM BRAIN MAPP, V39, P4519, DOI 10.1002/hbm.24303; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Chatelle C, 2018, CLIN NEUROPHYSIOL, V129, P1519, DOI 10.1016/j.clinph.2018.04.747; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Fernandez-Espejo D, 2015, JAMA NEUROL, V72, P1442, DOI 10.1001/jamaneurol.2015.2614; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; Habbal D, 2014, BRAIN INJURY, V28, P1171, DOI 10.3109/02699052.2014.920519; Hauger SL, 2017, J HEAD TRAUMA REHAB, V32, P185, DOI 10.1097/HTR.0000000000000267; Hauger SL, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/145913; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Li YF, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-6; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Owen AM, 2019, NEURON, V102, P526, DOI 10.1016/j.neuron.2019.03.024; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Pincherle A, 2021, J NEUROL, V268, P178, DOI 10.1007/s00415-020-10125-w; Pincherle A, 2019, ANN NEUROL, V85, P443, DOI 10.1002/ana.25417; Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2020, EXPERT REV NEUROTHER, V20, P997, DOI 10.1080/14737175.2020.1796641; Schnakers C, 2017, CURR OPIN NEUROL, V30, P573, DOI 10.1097/WCO.0000000000000495; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P308, DOI 10.1177/1545968314547767; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Spataro R, 2018, CLIN NEUROPHYSIOL, V129, P1130, DOI 10.1016/j.clinph.2018.02.131; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; Vogel D, 2013, ARCH PHYS MED REHAB, V94, P1891, DOI 10.1016/j.apmr.2012.11.053; Wade DT, 2018, EUR J NEUROL, V25, P619, DOI 10.1111/ene.13572; Wang F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09962; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xie QY, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1144-y; Yu T, 2013, NEUROLOGY, V80, P345, DOI 10.1212/WNL.0b013e31827f0846	48	4	4	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2020	10	12							930	10.3390/brainsci10120930			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ4SG	WOS:000601759000001	33276451	Green Published, gold			2022-02-06	
J	Shrestha, S; Parks, CG; Umbach, DM; Richards-Barber, M; Hofmann, JN; Chen, HL; Blair, A; Freeman, LEB; Sandler, DP				Shrestha, Srishti; Parks, Christine G.; Umbach, David M.; Richards-Barber, Marie; Hofmann, Jonathan N.; Chen, Honglei; Blair, Aaron; Freeman, Laura E. Beane; Sandler, Dale P.			Pesticide use and incident Parkinson's disease in a cohort of farmers and their spouses	ENVIRONMENTAL RESEARCH			English	Article						Pesticides; Parkinson's disease; Agricultural health study; Farmers	TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; HEAD-INJURY; FOLLOW-UP; RISK; EXPOSURE; ASSOCIATION; APPLICATORS; PARAQUAT; 2,4-D	Background: Extensive literature suggests an association between general pesticide use and Parkinson's disease (PD). However, with few exceptions, little is known about associations between specific pesticides and PD. Objective: We evaluated use of pesticides and incident PD in 38,274 pesticide applicators and 27,836 of their spouses in the Agricultural Health Study cohort followed over 20 years. Methods: We used self-reported information on ever-use of 50 specific pesticides as of enrollment for both applicators and spouses, and considered intensity-weighted lifetime days (IWLD) reported at enrollment and through the first 5-year follow-up among applicators. We estimated covariate-adjusted hazard ratios (HR) and 95% confidence intervals (CI) using Cox regression. We also examined heterogeneity in associations by history of head injury and chemical resistant glove use. Results: A total of 373 applicators and 118 spouses self-reported incident doctor-diagnosed PD. Ever-use of the insecticide terbufos (HR:1.31, 95%CI:1.02-1.68) and the herbicides trifluralin (HR:1.29, 95%CI: 0.99-1.70) and 2,4,5-T (HR:1.57, 95%0:1.21-2.04) was associated with elevated PD risk. On the other hand, diazinon (HR:0.73, 95%CI: 0.58-0.94) and 2,4,5-TP (HR:0.39, 95%CI:0.25-0.62) were associated with reduced risk. We observed heterogeneity in ever-use associations by head injury and chemical-resistant glove use for some pesticides, with higher risk among those who reported a history of head injury, or who did not use gloves. PD risk was also elevated for applicators in the highest category of IWLD for dichlorvos, permethrin (animal use), and benomyl. Conclusions: We found evidence of increased PD risk for some pesticides. Our results also suggest higher susceptibility for pesticide-associated PD among individuals with head injury as well as protection with use of chemical resistant gloves, although further research is needed to understand the impact of head injury. Research on current and newer pesticides, including mechanisms relevant to PD, is important given widespread pesticide use.	[Shrestha, Srishti; Parks, Christine G.; Sandler, Dale P.] NIEHS, Epidemiol Branch, 111 TW Alexander Dr,MD A3-05, Res Triangle Pk, NC 27709 USA; [Umbach, David M.] NIEHS, Biostat & Computat Biol Branch, Res Triangle Pk, NC USA; [Richards-Barber, Marie] Westat Corp, Durham, NC USA; [Hofmann, Jonathan N.; Blair, Aaron; Freeman, Laura E. Beane] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Chen, Honglei] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI USA		Sandler, DP (corresponding author), NIEHS, Epidemiol Branch, 111 TW Alexander Dr,MD A3-05, Res Triangle Pk, NC 27709 USA.	sandler@niehs.nih.gov	Shrestha, Srishti/ABF-6248-2021		Intramural Research Program of the National Institute of Health, National Institute of Environmental Health Sciences [Z01 -ES-049030]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01-CP-010119]	This work was supported by the Intramural Research Program of the National Institute of Health, National Institute of Environmental Health Sciences (Z01 -ES-049030) and National Cancer Institute (Z01-CP-010119).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; [Anonymous], 1988, REV ENVIRON CONTAM T, V104, P195; Atwood D., 2017, PESTICIDES IND SALES; Binukumar BK, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-35; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; Bradberry Sally M, 2004, Toxicol Rev, V23, P65, DOI 10.2165/00139709-200423020-00001; Coble J, 2011, INT J ENV RES PUB HE, V8, P4608, DOI 10.3390/ijerph8124608; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Fitzmaurice AG, 2014, NEUROLOGY, V82, P419, DOI 10.1212/WNL.0000000000000083; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; Furlong M, 2015, ENVIRON INT, V75, P144, DOI 10.1016/j.envint.2014.11.002; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GINTAUTAS PA, 1992, ENVIRON SCI TECHNOL, V26, P517, DOI 10.1021/es00027a011; Goldman SM, 2017, ADV NEUROTOXICOL, P83, DOI 10.1016/bs.ant.2017.07.004; Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216; Heltshe SL, 2012, J EXPO SCI ENV EPID, V22, P409, DOI 10.1038/jes.2012.31; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Hines CJ, 2011, ANN OCCUP HYG, V55, P620, DOI 10.1093/annhyg/mer008; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hoppin JA, 2002, J EXPO ANAL ENV EPID, V12, P313, DOI 10.1038/sj.jea.7500232; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jain Samay, 2015, Am J Epidemiol, V181, P185, DOI 10.1093/aje/kwu326; Jones BC, 2014, J BIOCHEM MOL TOXIC, V28, P191, DOI 10.1002/jbt.21552; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kamel F, 2014, PARKINSONISM RELAT D, V20, P82, DOI 10.1016/j.parkreldis.2013.09.023; Kanthasamy AG, 2005, NEUROTOXICOLOGY, V26, P701, DOI 10.1016/j.neuro.2004.07.010; Kenborg L, 2015, NEUROLOGY, V84, P1098, DOI 10.1212/WNL.0000000000001362; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; Lash T. L., 2008, MODERN EPIDEMIOLOGY, V3, P128; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; LILIENFELD DE, 1989, EPIDEMIOL REV, V11, P28, DOI 10.1093/oxfordjournals.epirev.a036044; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Narayan S, 2013, INT J EPIDEMIOL, V42, P1476, DOI 10.1093/ije/dyt170; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277; SAS Institute Inc, 2015, P MIANALYZE PROC SAS; Shrestha S, 2019, OCCUP ENVIRON MED, V76, P632, DOI 10.1136/oemed-2019-105724; Shrestha S, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP3713; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Terry AV, 2012, PHARMACOL THERAPEUT, V134, P355, DOI 10.1016/j.pharmthera.2012.03.001; Thomas KW, 2010, J EXPO SCI ENV EPID, V20, P119, DOI 10.1038/jes.2009.6; US Administration on Aging, 2012, PROF OLD AM 2012; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; van der Mark M, 2014, OCCUP ENVIRON MED, V71, P757, DOI 10.1136/oemed-2014-102170; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Wang A, 2014, OCCUP ENVIRON MED, V71, P275, DOI 10.1136/oemed-2013-101394; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93	55	4	4	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	DEC	2020	191								110186	10.1016/j.envres.2020.110186			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	OP3GW	WOS:000587971600141	32919961	Green Accepted			2022-02-06	
J	Wallace, J; Moran, R; Bretzin, A; Hileman, B; Huang, GS				Wallace, Jessica; Moran, Ryan; Bretzin, Abigail; Hileman, Barbara; Huang, Gregory S.			EXAMINATION OF RACIAL DISPARITIES IN ADOLESCENTS SEEN IN THE EMERGENCY DEPARTMENT FOR HEAD, NECK, OR BRAIN INJURY	JOURNAL OF EMERGENCY MEDICINE			English	Article						concussion; head injury; brain injury; health disparity; TBI; emergency department	UNITED-STATES; FUNCTIONAL OUTCOMES; FIREARM INJURIES; CARE; CHILDREN; RACE; EPIDEMIOLOGY; CONCUSSION; VISITS; SPORT	Background: Given the frequency, severity, and attention of traumatic brain injury in children, benchmarking disparities and injury characteristics for adolescent patients is pivotal in understanding and enhancing both clinical care and outcomes. Objectives: The purpose of this study was to investigate racial disparities on mechanism of injury, clinical outcomes, and social-health factors among adolescents treated in the emergency department (ED) for a head, neck, or brain injury. Methods: This study is the result of a retrospective chart review of head-, neck-, and brain-injured adolescent patients (n = 2857) treated at three community hospital EDs and one stand-alone ED. Outcome measures included patient demographics (gender, race/ethnicity, age), Glasgow Coma Scale score, hospital length of stay, intensive care unit length of stay, mechanism of injury, primary diagnosis, secondary diagnosis of a concussion, ventilation days, discharge disposition, and primary insurance. Results: There were racial differences in primary diagnosis, mechanism of injury, and insurance status. Results indicated that a higher proportion of white patients were diagnosed with a concussion compared with black patients (p < 0.001). Moreover, a higher proportion of white patients were seen in the ED for head, neck, or brain injury as a result of a sports or motor vehicle incident, whereas a leading mechanism among black patients was assault (p = 0.01). More white patients had private insurance, whereas more black patients had Medicaid (p < 0.001). Conclusion: The disparities in mechanisms for which black and white adolescent patients are seeking care at the ED for head, neck, or brain injury help to identify social-health risks of sustaining a head, neck, or brain injury. These racial disparities between black and white adolescents seen at the ED for head, neck, or brain injury suggest the need for further research to better understand the national representation of these disparities. (C) 2020 Elsevier Inc. All rights reserved.	[Wallace, Jessica; Moran, Ryan] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA; [Wallace, Jessica] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bretzin, Abigail] Univ Penn, Dept Epidemiol, Philadelphia, PA 19104 USA; [Hileman, Barbara] St Elizabeth Youngstown Hosp, Mercy Hlth, Trauma & Neurosci Res, Youngstown, OH USA; [Huang, Gregory S.] St Elizabeth Youngstown Hosp, Mercy Hlth, Dept Trauma, Youngstown, OH USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA.			Bretzin, Abigail/0000-0003-3730-2849			Aggarwal SS, 2019, APPL NEUROPSYCH-CHIL, V8, P50, DOI 10.1080/21622965.2017.1381099; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bachier-Rodriguez M, 2017, AM J SURG, V213, P785, DOI 10.1016/j.amjsurg.2016.10.004; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bernard Stephanie J., 2007, Morbidity and Mortality Weekly Report, V56, P1; Carter PM, 2017, ACAD EMERG MED, V24, P803, DOI 10.1111/acem.13200; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; DiMaggio CJ, 2017, ACAD EMERG MED, V24, P1244, DOI 10.1111/acem.13223; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; GLIK DC, 1993, J PEDIATR PSYCHOL, V18, P115, DOI 10.1093/jpepsy/18.1.115; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hanson Holly R, 2019, Inj Epidemiol, V6, P23, DOI 10.1186/s40621-019-0207-x; Hargraves JL, 2001, HEALTH SERV RES, V36, P853; Hawley C, 2013, INJURY, V44, P1855, DOI 10.1016/j.injury.2013.07.021; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Johnston LD, 2007, AM J PREV MED, V33, pS195, DOI 10.1016/j.amepre.2007.07.015; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Laing GJ, 1999, PUBLIC HEALTH, V113, P291, DOI 10.1016/S0033-3506(99)00182-1; Lee J, 2013, J TRAUMA ACUTE CARE, V75, P50, DOI 10.1097/TA.0b013e3182999b7a; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Ly N, 2000, ADV DATA VITAL HLTH, V327, P1; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moffet EW, 2018, SURGERY, V163, P251, DOI 10.1016/j.surg.2017.09.006; Monuteaux MC, 2017, J TRAUMA ACUTE CARE, V83, P310, DOI [10.1097/TA.0000000000001525, 10.1097/ta.0000000000001525]; Pines JM, 2009, ACAD EMERG MED, V16, P403, DOI 10.1111/j.1553-2712.2009.00381.x; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Saadi A, 2017, NEUROLOGY, V88, P2268, DOI [10.1212/WNL.0000000000004025, 10.1212/wnl.0000000000004025]; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sheats KJ, 2018, AM J PREV MED, V55, P462, DOI 10.1016/j.amepre.2018.05.017; Simon TD, 2004, ACAD EMERG MED, V11, P1042, DOI 10.1197/j.aem.2004.04.013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; United States Census Bureau, 2020, QUICKFACTS MAH COUN; United States Census Bureau, 2018, AM COMM SURV 5 YEAR, P2020; US Census Bureau, 2019, 2013 2017 AM COMM SU; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	47	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2020	59	6					783	794		10.1016/j.jemermed.2020.07.002			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	PQ8WS	WOS:000606824300014	32893067				2022-02-06	
J	Gagnon-Roy, M; Bier, N; Couture, M; Giroux, S; Pigot, H; Zarshenas, S; Bottari, C				Gagnon-Roy, M.; Bier, N.; Couture, M.; Giroux, S.; Pigot, H.; Zarshenas, S.; Bottari, C.			Facilitators and obstacles to the use of a cognitive orthosis for meal preparation within the homes of adults with a moderate to severe traumatic brain injury: Informal caregivers and health-care professionals' perspectives	ASSISTIVE TECHNOLOGY			English	Article; Early Access						assistive technology; meal preparation; qualitative study; rehabilitation; traumatic brain injury	PROMPTING SYSTEM; PEOPLE; TECHNOLOGY; EFFICACY	A cognitive orthosis named COOK was developed and implemented to facilitate meal preparation for adults with severe traumatic brain injury (TBI) living in an alternative housing unit. This study aimed to explore facilitators and barriers to the potential use and implementation of COOK in a new context (i.e., within the homes of people living with a TBI in the community). For this purpose, 20 stakeholders (e.g., health-care professionals, clinical coordinators, informal caregivers of individuals with TBI) were interviewed. Participants identified various potential benefits of this technology (e.g., improving independence and confidence of people with TBI) and facilitators (e.g., clinical and technical supports, helpful functionalities) that could facilitate the use and implementation of COOK within a home environment. However, numerous questions remained unanswered regarding the logistics surrounding the implementation of such technology. Thus, further studies and modifications are required to facilitate future implementation of this technology among individuals living in their own homes.	[Gagnon-Roy, M.; Bier, N.; Zarshenas, S.; Bottari, C.] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Gagnon-Roy, M.; Zarshenas, S.; Bottari, C.] Ctr Sud de Ile Montreal, CIUSSS, Inst Univ Readaptat Deficience Phys Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Bier, N.] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Couture, M.] Ctr Res & Expertise Social Gerontol, Cote St Luc, PQ, Canada; [Giroux, S.; Pigot, H.] Univ Sherbrooke, DOMUS Lab, Montreal, PQ, Canada		Bottari, C (corresponding author), 6363 Ch Hudson,514-340-2085 4720, Montreal, PQ, Canada.	Carolina.bottari@umontreal.ca		Gagnon-Roy, Mireille/0000-0001-9668-7289; Giroux, Sylvain/0000-0003-0602-5957; Bier, Nathalie/0000-0002-2940-694X	FRQS [252232]	We would like to thank all participants for their time and insight. We would like to thank Erika Dubuc for her implication in the data collection and analysis. N. Bier is supported by a salary award from the FRQS. M. Gagnon-Roy is supported by a doctoral bursary from the FRQS (#252232).	Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Best C, 2013, HDB RES ICTS HUMAN C, DOI [10.4018/978-1-4666-3986-7, DOI 10.4018/978-1-4666-3986-7]; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Boucher N, 2006, RAPPORT RECHERCHE RE; Bray G. M., 2014, MAPPING CONNECTIONS; Chang YJ, 2011, RES DEV DISABIL, V32, P2669, DOI 10.1016/j.ridd.2011.06.006; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Corbiere M., 2014, METHODES QUALITATIVE; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; Dubuc E, 2019, AUST OCCUP THER J, V66, P720, DOI 10.1111/1440-1630.12611; Farmer N, 2018, HEALTH EDUC BEHAV, V45, P167, DOI 10.1177/1090198117736352; Giroux S, 2015, PAPER PRESENTED AAAI; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Hedman A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0245-y; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; INESSS-ONF, 2016, CLIN PRACT GUID REH; Jamieson M, 2020, DISABIL REHABIL-ASSI, V15, P453, DOI 10.1080/17483107.2019.1594402; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Kettlewell J, 2019, CLIN REHABIL, V33, P1705, DOI 10.1177/0269215519865774; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levasseur M, 2016, DISABIL REHABIL-ASSI, V11, P636, DOI 10.3109/17483107.2015.1029536; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Nam JH, 2018, DISABIL REHABIL-ASSI, V13, P305, DOI 10.1080/17483107.2017.1358304; O'Neill B, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000358; Peek STM, 2014, INT J MED INFORM, V83, P235, DOI 10.1016/j.ijmedinf.2014.01.004; Pinard S, 2021, DISABIL REHABIL-ASSI, V16, P687, DOI 10.1080/17483107.2019.1696898; Ross J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0510-7; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Vaezipour A, 2019, J HEAD TRAUMA REHAB, V34, pE67, DOI 10.1097/HTR.0000000000000462; Wang J, 2014, 12 INT C SMART HOM H; Wang J, 2019, DISABIL REHABIL-ASSI, V14, P817, DOI 10.1080/17483107.2018.1499144; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; World Health Organization, 2019, WHO GUID REC DIG INT, DOI [10.1016/S1474-4422(17)30279-X, DOI 10.1016/S1474-4422(17)30279-X]; Yaddaden A, 2020, J REHABIL ASSIST TER, V7, DOI 10.1177/2055668320909074	36	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.												10.1080/10400435.2020.1809552		NOV 2020	8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	PN8JL	WOS:000604718800001	32795215				2022-02-06	
J	Balachandran, N; Goodman, AM; Allendorfer, JB; Martin, AN; Tocco, K; Vogel, V; LaFrance, WC; Szaflarski, JP				Balachandran, Neha; Goodman, Adam M.; Allendorfer, Jane B.; Martin, Amber N.; Tocco, Krista; Vogel, Valerie; LaFrance, W. Curt, Jr.; Szaflarski, Jerzy P.			Relationship between neural responses to stress and mental health symptoms in psychogenic nonepileptic seizures after traumatic brain injury	EPILEPSIA			English	Article						functional MRI; mental health; pathophysiology; psychogenic nonepileptic seizures; traumatic brain injury	ACUTE PSYCHOSOCIAL STRESS; CORTICAL THICKNESS; DISSOCIATION; CONNECTIVITY; EPILEPSY; EMOTION; TASK	Objective To utilize traumatic brain injury (TBI) as a model for investigating functioning during acute stress experiences in psychogenic nonepileptic seizures (PNES) and to identify neural mechanisms underlying the link between changes in processing of stressful experiences and mental health symptoms in PNES. Methods We recruited 94 participants: 50 with TBI only (TBI-only) and 44 with TBI and PNES (TBI + PNES). Participants completed mood (Beck Depression Inventory-II), anxiety (Beck Anxiety Inventory), and posttraumatic stress disorder (PTSD) symptom (PTSD Checklist-Specific Event) assessments before undergoing functional magnetic resonance imaging during an acute psychosocial stress task. Linear mixed-effects analyses identified clusters of significant interactions between group and neural responses to stressful math performance and stressful auditory feedback conditions within limbic brain regions (volume-corrected alpha = .05). Spearman rank correlation tests compared mean cluster signals to symptom assessments (false discovery rate-corrected alpha = .05). Results Demographic and TBI-related measures were similar between groups; TBI + PNES demonstrated worse clinical symptom severity compared to TBI-only. Stressful math performance induced relatively greater reactivity within dorsomedial prefrontal cortex (PFC) and right hippocampal regions and relatively reduced reactivity within left hippocampal and dorsolateral PFC regions for TBI + PNES compared to TBI-only. Stressful auditory feedback induced relatively reduced reactivity within ventral PFC, cingulate, hippocampal, and amygdala regions for TBI + PNES compared to TBI-only. Changes in responses to stressful math within hippocampal and dorsal PFC regions were correlated with increased mood, anxiety, and PTSD symptom severity. Significance Corticolimbic functions underlying processing of stressful experiences differ between patients with TBI + PNES and those with TBI-only. Relationships between these neural responses and symptom assessments suggest potential pathophysiologic mechanisms in PNES.	[Balachandran, Neha; Goodman, Adam M.; Allendorfer, Jane B.; Martin, Amber N.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, UAB Epilepsy Ctr, Dept Neurol, 312 Civitan Int Res Ctr, Birmingham, AL 35294 USA; [Balachandran, Neha] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Balachandran, Neha] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Tocco, Krista; Vogel, Valerie; LaFrance, W. Curt, Jr.] Brown Univ, Rhode Isl Hosp, Providence Vet Adm Med Ctr, Providence, RI 02903 USA		Goodman, AM (corresponding author), Univ Alabama Birmingham, UAB Epilepsy Ctr, Dept Neurol, 312 Civitan Int Res Ctr, Birmingham, AL 35294 USA.	agoodman@uabmc.edu	Goodman, Adam/AAI-3643-2021; LaFrance, W Curt/AAN-6707-2021	Goodman, Adam/0000-0002-7550-679X; LaFrance, W Curt/0000-0002-4901-3852	U.S. Department of DefenseUnited States Department of Defense [W81XWH-17-1-0619]	U.S. Department of Defense, Grant/Award Number: W81XWH-17-1-0619. PIs: LaFrance Jr WC, Szaflarski JP.	Allendorfer JB, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101967; Allendorfer JB, 2014, EPILEPSY BEHAV, V36, P115, DOI 10.1016/j.yebeh.2014.05.003; Aybek S, 2014, JAMA PSYCHIAT, V71, P52, DOI 10.1001/jamapsychiatry.2013.2842; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Brown RJ, 2016, CLIN PSYCHOL REV, V47, P55, DOI 10.1016/j.cpr.2016.06.003; BrownGuedira GL, 1996, THEOR APPL GENET, V93, P1291, DOI 10.1007/BF00223462; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; Diez I, 2019, J NEUROL NEUROSUR PS, V90, P929, DOI 10.1136/jnnp-2018-319657; Ding JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063850; Dworetzky BA, 2017, SEMIN NEUROL, V37, P624, DOI 10.1055/s-0037-1607971; Feinstein A, 2001, NEUROPSY NEUROPSY BE, V14, P169; Fobian AD, 2020, ANN CLIN TRANSL NEUR, V7, P1410, DOI 10.1002/acn3.51138; Fobian AD, 2019, J PSYCHIATR NEUROSCI, V44, P8, DOI 10.1503/jpn.170190; Goodman AM, 2019, HUM BRAIN MAPP, V40, P3415, DOI 10.1002/hbm.24606; Hernando KA, 2015, EPILEPSY BEHAV, V45, P68, DOI 10.1016/j.yebeh.2015.02.022; Hofer A, 2006, NEUROIMAGE, V32, P854, DOI 10.1016/j.neuroimage.2006.03.053; Jalilianhasanpour R, 2018, J PSYCHOSOM RES, V107, P55, DOI 10.1016/j.jpsychores.2018.02.005; Khalili-Mahani N, 2010, HIPPOCAMPUS, V20, P323, DOI 10.1002/hipo.20623; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; Lee S, 2015, BRAIN RES, V1620, P169, DOI 10.1016/j.brainres.2015.04.050; Mellers JDC, 2005, POSTGRAD MED J, V81, P498, DOI 10.1136/pgmj.2004.029785; Orem TR, 2019, BEHAV NEUROSCI, V133, P203, DOI 10.1037/bne0000305; Osborne-Crowley K, 2018, J NEUROPSYCHOL, V12, P176, DOI 10.1111/jnp.12113; Perez DL, 2018, J NEUROL NEUROSUR PS, V89, P1221, DOI 10.1136/jnnp-2017-317305; Perez DL, 2018, HUM BRAIN MAPP, V39, P428, DOI 10.1002/hbm.23853; Perez DL, 2017, J NEUROL NEUROSUR PS, V88, P1052, DOI 10.1136/jnnp-2017-316359; Perez DL, 2017, J NEUROL NEUROSUR PS, V88, P491, DOI 10.1136/jnnp-2016-314998; Philippi CL, 2014, J PSYCHIATR RES, V54, P55, DOI 10.1016/j.jpsychires.2014.03.004; Pick S, 2019, J NEUROL NEUROSUR PS, V90, P704, DOI 10.1136/jnnp-2018-319201; Popkirov S, 2018, SEIZURE-EUR J EPILEP, V58, P127, DOI 10.1016/j.seizure.2018.04.009; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Reuber M, 2003, EPILEPSY RES, V57, P159, DOI 10.1016/j.eplepsyres.2003.11.004; Steer RA, 1993, BAI BECK ANXIETY INV; Szaflarski JP, 2018, EPILEPSY CURR, V18, P211, DOI 10.5698/1535-7597.18.4.211; Szaflarski JP, 2018, EPILEPSY BEHAV, V79, P193, DOI 10.1016/j.yebeh.2017.12.004; van der Kruijs SJM, 2014, J PSYCHIATR RES, V54, P126, DOI 10.1016/j.jpsychires.2014.03.010; van der Kruijs SJM, 2012, J NEUROL NEUROSUR PS, V83, P239, DOI 10.1136/jnnp-2011-300776; Weathers F.W., 1993, 9 ANN C ISTSS; Wheelock MD, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00583; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049	43	4	4	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JAN	2021	62	1					107	119		10.1111/epi.16758		NOV 2020	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PR5ZH	WOS:000592059200001	33238045				2022-02-06	
J	Sweeney, E; Howell, DR; Seehusen, CN; Tilley, D; Casey, E				Sweeney, Emily; Howell, David R.; Seehusen, Corrine N.; Tilley, David; Casey, Ellen			Health outcomes among former female collegiate gymnasts: the influence of sport specialization, concussion, and disordered eating	PHYSICIAN AND SPORTSMEDICINE			English	Article						Early sport specialization; gymnastics; injury; NCAA; concussion; eating disorder	CONSEQUENCES; INJURIES; INCREASE; RISK	Objective: Gymnastics is a popular sport with high injury rates, especially at the collegiate level. There is limited evidence, however, regarding the risks of early specialization in this sport, the rate of concussions in gymnasts, and the long-term effects of disordered eating in gymnasts. We sought to describe health-related outcomes of former collegiate gymnasts and the association with early sport specialization, concussion history, and disordered eating. Methods: We distributed an online survey through social media outlets. A total of 473 former female collegiate gymnasts completed the survey and were grouped according to early (<14 years) specialization, presence or absence of concussion history, and history of disordered eating. We determined the number of participants who had time-loss injuries, injuries requiring surgery, and injuries resulting in retirement. We also evaluated menstrual history, reasons for sport retirement, functional outcome measures, and mental health. Results: The median age of gymnastics specialization was 8 years [interquartile range = 6-11 years]. The proportion of injuries sustained during college did not significantly differ by specialization age. A significantly greater proportion of early specializers required surgery for college sports-related injuries (60% vs. 44%; p = 0.02). Forty-two percent of the respondents reported concussion history, and a greater proportion of those with concussion history reported seeking mental health treatment during college (32% vs. 23%; p = 0.03), and anxiety disorder diagnosis (16% vs. 9%; p = 0.01). Disordered eating history was reported by 34% of the respondents, and this group had a higher proportion of time-loss injury (78% vs 65%; p = 0.004), and osteoporosis (4% vs 0%; p = 0.003) during college, and worse current pain (11.5 vs 10.2; p = 0.007) and physical function (12.2 vs 11.0; p = 0.01) than those without disordered eating. Conclusion: Athletes and clinicians should be aware of the long-term effects of early specialization, concussions, and disordered eating in gymnastics as these issues are common in female collegiate gymnasts.	[Sweeney, Emily; Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA; [Sweeney, Emily; Howell, David R.; Seehusen, Corrine N.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Tilley, David] Champ Phys Therapy & Performance, Waltham, MA USA; [Casey, Ellen] Hosp Special Surg, Dept Physiatry, 535 E 70th St, New York, NY 10021 USA		Sweeney, E (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA.	Emily.sweeney@childrenscolorado.org					Akesdotter C, 2020, J SCI MED SPORT, V23, P329, DOI 10.1016/j.jsams.2019.10.022; [Anonymous], 2020, NCAA sports sponsorship and participation rates database; Battle DE, 2013, CODAS, V25, P191; Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; Bergeron MF, 2015, BRIT J SPORT MED, V49, P843, DOI 10.1136/bjsports-2015-094962; Buckley PS, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117703944; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Campbell R, 2019, BRIT J SPORT MED, V53, P1056, DOI 10.1136/bjsports-2018-099547; Cheng YL, 2000, J CLIN EPIDEMIOL, V53, P315, DOI 10.1016/S0895-4356(99)00168-7; De Souza MJ, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093218; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Francisco R, 2012, SPAN J PSYCHOL, V15, P265, DOI 10.5209/rev_SJOP.2012.v15.n1.37333; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Jayanthi NA, 2019, J ATHL TRAINING, V54, P1040, DOI 10.4085/1062-6050-380-18; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Krentz EM, 2013, SCAND J MED SCI SPOR, V23, P303, DOI 10.1111/j.1600-0838.2011.01380.x; L Rn Z, 2019, ASIAN J SPORTS MED, V10; Moseid CH, 2019, SCAND J MED SCI SPOR, V29, P460, DOI 10.1111/sms.13338; Myer GD, 2015, SPORTS HEALTH, V7, P437, DOI 10.1177/1941738115598747; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; O'Kane JW, 2011, CLIN J SPORT MED, V21, P486, DOI 10.1097/JSM.0b013e31822e89a8; Papageorgiou M, 2018, EUR J NUTR, V57, P847, DOI 10.1007/s00394-017-1498-8; Rauh MJ, 2010, J ATHL TRAINING, V45, P243, DOI 10.4085/1062-6050-45.3.243; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Simon JE, 2019, J SPORT REHABIL, V28, P33, DOI 10.1123/jsr.2017-0115; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Stracciolini A, 2020, CLIN J SPORT MED, V30, P526, DOI 10.1097/JSM.0000000000000645; Sweeney EA, 2020, BRAIN INJURY, V34, P928, DOI 10.1080/02699052.2020.1763464; Thein-Nissenbaum J, 2013, MATURITAS, V75, P107, DOI 10.1016/j.maturitas.2013.02.010; Thompson A, 2017, J SCI MED SPORT, V20, P808, DOI 10.1016/j.jsams.2017.03.005; USA Gymnastics Statistics, MEMB CAT	35	4	4	6	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT 2	2021	49	4					438	444		10.1080/00913847.2020.1850150		NOV 2020	7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	WN3QO	WOS:000591751300001	33186080				2022-02-06	
J	Jiang, JP; Liu, XY; Chen, H; Dai, C; Niu, XG; Dai, LJ; Chen, XY; Zhang, S				Jiang, Jipeng; Liu, Xiaoyin; Chen, Hui; Dai, Chen; Niu, Xuegang; Dai, Lujia; Chen, Xuyi; Zhang, Sai			3D printing collagen/heparin sulfate scaffolds boost neural network reconstruction and motor function recovery after traumatic brain injury in canine	BIOMATERIALS SCIENCE			English	Article							STEM-CELLS; TRANSPLANTATION; PROTECTION; H-1-MRS	Tissue engineering is considered highly promising for the repair of traumatic brain injury (TBI), and accumulating evidence has proved the efficacy of biomaterials and 3D printing. Although collagen is famous for its natural properties, some defects still restrict its potential applications in tissue repair. In this experimental study, we fabricated a kind of scaffold with collagen and heparin sulfate via 3D printing, which possesses favorable physical properties and suitable degradation rate along with satisfactory cytocompatibility. After implantation, the results of motor evoked potentials (MEPs) showed that the latency and amplitude can both be improved in hemiplegic limbs, and the structural integrity of the cerebral cortex and corticospinal tract can be enhanced significantly under magnetic resonance imaging (MRI) evaluation. Additionally, the results of in situ hybridization (ISH) and immunofluorescence staining also revealed the facilitating role of 3D printing collagen/heparin sulfate scaffolds on vascular and neural regeneration. Moreover, the individuals implanted with this kind of scaffold present better gait characteristics and preferable electromyography and myodynamia. In general, 3D printed collagen/heparin sulfate scaffolds have superb performance in both structural repair and functional improvement and may offer a new strategy for the repair of TBI.	[Jiang, Jipeng] Med Sch Chinese PLA, Postgrad Sch, Beijing 100853, Peoples R China; [Jiang, Jipeng] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Thorac Surg, Beijing 100853, Peoples R China; [Liu, Xiaoyin] Sichuan Univ, West China Med Sch, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Chen, Hui] Sichuan Friendship Hosp, Dept Neurosurg, Shangshahepu St 96, Chengdu 610066, Peoples R China; [Dai, Chen; Chen, Xuyi; Zhang, Sai] Chinese Peoples Armed Police Force PAP, Ctr Neurol & Neurosurg, Characterist Med Ctr, Tianjin Key Lab Neurotrauma Repair,Inst Traumat B, Chenglin Rd 220, Tianjin 300162, Peoples R China; [Niu, Xuegang] Tianjin Fourth Cent Hosp, Dept Neurosurg, Zhongshan Rd 1, Tianjin 300143, Peoples R China; [Dai, Lujia] Armed Police Corps Hosp Zhejiang Prov, Dept Neurol, Hangzhou 310000, Peoples R China		Chen, XY; Zhang, S (corresponding author), Chinese Peoples Armed Police Force PAP, Ctr Neurol & Neurosurg, Characterist Med Ctr, Tianjin Key Lab Neurotrauma Repair,Inst Traumat B, Chenglin Rd 220, Tianjin 300162, Peoples R China.	13502034360@163.com; chenxuyi1979@sina.com.cn; zhangsai718@vip.126.com		Jiang, Jipeng/0000-0002-8954-7277	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11672332, 11932013]; Science and Technology Project of Tianjin, China [17YFZCSY00620]; Major Project of Tianjin Science and Technology Military and Civilian Integration [18ZXJMTG00260]	This work was supported by the National Natural Science Foundation of China (11672332 and 11932013), Science and Technology Project of Tianjin, China (17YFZCSY00620), and the Major Project of Tianjin Science and Technology Military and Civilian Integration (18ZXJMTG00260).	Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Bardakova KN, 2020, MAT SCI ENG C-MATER, V107, DOI 10.1016/j.msec.2019.110300; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646; Cunniffe GM, 2016, ACS APPL MATER INTER, V8, P23477, DOI 10.1021/acsami.6b06596; Deng WS, 2020, NEURAL REGEN RES, V15, P1686, DOI 10.4103/1673-5374.276340; Dong CJ, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8020042; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Gu LS, 2019, TRENDS BIOTECHNOL, V37, P464, DOI 10.1016/j.tibtech.2018.10.007; Helme M, 2019, J STRENGTH COND RES, V33, P3269, DOI 10.1519/JSC.0000000000003378; Igarashi M, 2018, NEUROCHEM INT, V119, P77, DOI 10.1016/j.neuint.2017.10.001; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jiang JP, 2019, NEURAL REGEN RES, V14, P991, DOI 10.4103/1673-5374.250578; Jiang JP, 2018, J NEUROSCI METH, V307, P95, DOI 10.1016/j.jneumeth.2018.06.025; Kirdponpattara S, 2015, CARBOHYD POLYM, V132, P146, DOI 10.1016/j.carbpol.2015.06.059; Lai BQ, 2016, BIOMATERIALS, V109, P40, DOI 10.1016/j.biomaterials.2016.08.005; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Ma YH, 2018, BIOMATERIALS, V160, P37, DOI 10.1016/j.biomaterials.2018.01.015; Mari S, 2014, CEREBELLUM, V13, P226, DOI 10.1007/s12311-013-0533-4; Papadopoulos D, 2006, EXP NEUROL, V197, P373, DOI 10.1016/j.expneurol.2005.10.033; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; SHIN DY, 1989, ARCH PHYS MED REHAB, V70, P189; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Silva C, 2017, ACTA BIOMATER, V63, P283, DOI 10.1016/j.actbio.2017.08.042; Sonesson S, 2017, KNEE SURG SPORT TR A, V25, P2337, DOI 10.1007/s00167-015-3714-5; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Sun Y, 2019, J BIOMED MATER RES A, V107, P1898, DOI 10.1002/jbm.a.36675; Szentivanyi A, 2011, ADV DRUG DELIVER REV, V63, P209, DOI 10.1016/j.addr.2010.12.002; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Valentin S, 2016, J ELECTROMYOGR KINES, V28, P167, DOI 10.1016/j.jelekin.2015.12.005; Wang HZ, 2012, CLIN RADIOL, V67, P340, DOI 10.1016/j.crad.2011.09.008; Xiao Y, 2017, MED SCI MONITOR, V23, P2365, DOI 10.12659/MSM.904788; You J, 2014, ADV HEALTHC MATER, V3, P126, DOI 10.1002/adhm.201300054; Zagra L, 2013, CLIN ORTHOP RELAT R, V471, P3830, DOI 10.1007/s11999-013-2926-6; Zhang S, 2018, ACTA BIOMATER, V77, P15, DOI 10.1016/j.actbio.2018.06.038	36	4	4	4	20	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	NOV 21	2020	8	22					6362	6374		10.1039/d0bm01116a			13	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	OP7JD	WOS:000588260700015	33026366				2022-02-06	
J	Kunzmann, K; Wernisch, L; Richardson, S; Steyerberg, EW; Lingsma, H; Ercole, A; Maas, AIR; Menon, D; Wilson, L				Kunzmann, Kevin; Wernisch, Lorenz; Richardson, Sylvia; Steyerberg, Ewout W.; Lingsma, Hester; Ercole, Ari; Maas, Andrew I. R.; Menon, David; Wilson, Lindsay			Imputation of Ordinal Outcomes: A Comparison of Approaches in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						GOSe; imputation; missing data; traumatic brain injury	MULTISTATE MODELS; PROGESTERONE; VALIDATION; PACKAGE	Loss to follow-up and missing outcomes data are important issues for longitudinal observational studies and clinical trials in traumatic brain injury. One popular solution to missing 6-month outcomes has been to use the last observation carried forward (LOCF). The purpose of the current study was to compare the performance of model-based single-imputation methods with that of the LOCF approach. We hypothesized that model-based methods would perform better as they potentially make better use of available outcome data. The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study (n = 4509) included longitudinal outcome collection at 2 weeks, 3 months, 6 months, and 12 months post-injury; a total of 8185 Glasgow Outcome Scale extended (GOSe) observations were included in the database. We compared single imputation of 6-month outcomes using LOCF, a multiple imputation (MI) panel imputation, a mixed-effect model, a Gaussian process regression, and a multi-state model. Model performance was assessed via cross-validation on the subset of individuals with a valid GOSe value within 180 +/- 14 days post-injury (n = 1083). All models were fit on the entire available data after removing the 180 +/- 14 days post-injury observations from the respective test fold. The LOCF method showed lower accuracy (i.e., poorer agreement between imputed and observed values) than model-based methods of imputation, and showed a strong negative bias (i.e., it imputed lower than observed outcomes). Accuracy and bias for the model-based approaches were similar to one another, with the multi-state model having the best overall performance. All methods of imputation showed variation across different outcome categories, with better performance for more frequent outcomes. We conclude that model-based methods of single imputation have substantial performance advantages over LOCF, in addition to providing more complete outcome data.	[Kunzmann, Kevin; Wernisch, Lorenz; Richardson, Sylvia] Univ Cambridge, Cambridge Inst Publ Hlth, MRC Biostat Unit, Forvie Site,Robinson Way,Cambridge Biomed Campus, Cambridge CB2 0SR, England; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lingsma, Hester] Erasmus MC, Ctr Med Decis Sci, Rotterdam, Netherlands; [Steyerberg, Ewout W.] LUMC, Dept Biomed Data Sci, Leiden, Netherlands; [Ercole, Ari; Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland		Kunzmann, K (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, MRC Biostat Unit, Forvie Site,Robinson Way,Cambridge Biomed Campus, Cambridge CB2 0SR, England.	kevin.kunzmann@mrc-bsu.cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Kunzmann, Kevin/0000-0002-1140-7143	European Union (EC)European CommissionEuropean Commission Joint Research Centre [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_00002/10] Funding Source: UKRI	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA).	Agresti A., 2003, CATEGORICAL DATA ANA, V482; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Burkner PC, 2017, ARXIV170511123; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Devroye L., 1986, NONUNIFORM RANDOM VA, P83; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; Jackson CH, 2011, J STAT SOFTW, V38, P1; Kirkness CJ, 2006, AM J CRIT CARE, V15, P600; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Molenberghs G., 2000, LINEAR MIXED MODELS; R Core Team, 2020, R LANG ENV STAT COMP; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yeatts S.D., 2018, HDB NEUROEMERGENCY C, P167	32	4	4	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					455	463		10.1089/neu.2019.6858		NOV 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000591049100001	33108942	Green Submitted, hybrid, Green Published			2022-02-06	
J	Bohnert, S; Reinert, C; Trella, S; Schmitz, W; Ondruschka, B; Bohnert, M				Bohnert, Simone; Reinert, Christoph; Trella, Stefanie; Schmitz, Werner; Ondruschka, Benjamin; Bohnert, Michael			Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system-related pathological processes	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						CSF; Cerebrospinal fluid; Forensic neuropathology; Forensic neurotraumatology; Biomarker; Metabolomics	TRAUMATIC BRAIN-INJURY; BIOCHEMICAL MARKERS; MOLECULAR PATHOLOGY; BIOMARKERS; AUTOPSY; UPDATE	In the last few years, quantitative analysis of metabolites in body fluids using LC/MS has become an established method in laboratory medicine and toxicology. By preparing metabolite profiles in biological specimens, we are able to understand pathophysiological mechanisms at the biochemical and thus the functional level. An innovative investigative method, which has not yet been used widely in the forensic context, is to use the clinical application of metabolomics. In a metabolomic analysis of 41 samples of postmortem cerebrospinal fluid (CSF) samples divided into cohorts of four different causes of death, namely, cardiovascular fatalities, isoIated torso trauma, traumatic brain injury, and multi-organ failure, we were able to identify relevant differences in the metabolite profile between these individual groups. According to this preliminary assessment, we assume that information on biochemical processes is not gained by differences in the concentration of individual metabolites in CSF, but by a combination of differently distributed metabolites forming the perspective of a new generation of biomarkers for diagnosing (fatal) TBI and associated neuropathological changes in the CNS using CSF samples.	[Bohnert, Simone; Reinert, Christoph; Trella, Stefanie; Bohnert, Michael] Univ Wurzburg, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany; [Schmitz, Werner] Biozentrum Hubland, Inst Biochem & Mol Biol 1, D-97078 Wurzburg, Germany; [Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Butenfeld 34, D-22529 Hamburg, Germany		Bohnert, S (corresponding author), Univ Wurzburg, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany.	simone.bohnert@uni-wuerzburg.de			Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. We would like to thank our technical assistants Heiko Besenfelder and Max Perschneck, Institute of Forensic Medicine University of Wuerzburg, for their excellent support in collecting the specimens.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Berg J, 2014, STRYER BIOCH, P499; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohnert S, 2019, INT J LEGAL MED, V133, P1141, DOI 10.1007/s00414-019-02050-z; Deutschen Gesellschaft fur Rechtsmedizin, 2017, RECHTSM LEICH; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Ferrara SD, 2017, INT J LEGAL MED, V131, P1085, DOI 10.1007/s00414-017-1585-7; Friedrich G, 1986, PRAXIS RECHTSMEDIZIN, P789; Garland J, 2020, AUST J FORENSIC SCI, V52, P626, DOI 10.1080/00450618.2019.1642956; Gonzalez-Riano C, 2017, BRAIN STRUCT FUNCT, V222, P2831, DOI 10.1007/s00429-017-1375-5; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harel A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0139-16.2016; Hilbig H, 2004, EXP TOXICOL PATHOL, V56, P159, DOI 10.1016/j.etp.2004.08.002; Ivanisevic J, 2014, CHEM BIOL, V21, P1575, DOI 10.1016/j.chembiol.2014.09.016; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Kauferstein S, 2014, RECHTSMEDIZIN, V24, P513, DOI 10.1007/s00194-014-0975-0; Kaymak I, 2020, CANCER RES, V80, P189, DOI 10.1158/0008-5472.CAN-19-0650; KERNBACH G, 1983, PATHOLOGE, V4, P235; Kernbach-Wighton G, 2004, HDB GERICHTLICHE MED, P141; Madea B, 2014, RECHTSGRUNDLAGEN PRA; Madea B, 2009, LEGAL MED, V11, P36, DOI DOI 10.1016/j.legalmed.2009.01.111; Maeda H, 2014, LEGAL MED-TOKYO, V16, P61, DOI 10.1016/j.legalmed.2014.01.002; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Mayer A, 2019, SCI SIGNAL, V6, P593; Merkley ED, 2019, FORENSIC SCI INT, V297, P350, DOI 10.1016/j.forsciint.2019.01.022; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Oerter S, 2019, INT J LEGAL MED, V133, P1107, DOI 10.1007/s00414-018-1893-6; Olczak M, 2018, FOLIA NEUROPATHOL, V56, P97, DOI 10.5114/fn.2018.76613; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Ottens AK, 2014, J NEUROTRAUM, V31, P782, DOI 10.1089/neu.2013.3116; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; PERRY TL, 1981, J NEUROCHEM, V36, P406, DOI 10.1111/j.1471-4159.1981.tb01608.x; Peyron PA, 2019, CRIT REV CL LAB SCI, V56, P274, DOI 10.1080/10408363.2019.1619158; SPOKES EGS, 1979, BRAIN, V102, P333, DOI 10.1093/brain/102.2.333; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Tester DJ, 2006, CURR OPIN CARDIOL, V21, P166, DOI 10.1097/01.hco.0000221576.33501.83; Ussher JR, 2016, J AM COLL CARDIOL, V68, P2850, DOI 10.1016/j.jacc.2016.09.972; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Xia HP, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1619-x; Xiao SY, 2017, INT J ONCOL, V51, P5, DOI 10.3892/ijo.2017.4000; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	49	4	4	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2021	135	1					183	191		10.1007/s00414-020-02462-2		NOV 2020	9	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	PO2HY	WOS:000589020700002	33180198	hybrid, Green Published			2022-02-06	
J	Wu, BM; Bargaineer, J; Zhang, L; Yang, T; Xiong, ZG; Leng, TD				Wu, Bao-ming; Bargaineer, Jaree; Zhang, Ling; Yang, Tao; Xiong, Zhi-gang; Leng, Tian-dong			Upregulation of acid sensing ion channel 1a (ASIC1a) by hydrogen peroxide through the JNK pathway	ACTA PHARMACOLOGICA SINICA			English	Article						acid-sensing ion channels (ASICs); hydrogen peroxide (H2O2); reactive oxygen species (ROS); mitogen-activated protein kinase (MAPK); c-Jun N-terminal kinase (JNK)	ACTIVATED PROTEIN-KINASE; BRAIN; H2O2; HYPERGLYCEMIA; CONTRIBUTES; INHIBITION; APOPTOSIS; ISCHEMIA; SUBUNIT; NEURONS	Oxidative stress is intimately tied to neurodegenerative diseases, including Parkinson's disease and amyotrophic lateral sclerosis, and acute injuries, such as ischemic stroke and traumatic brain injury. Acid sensing ion channel 1a (ASIC1a), a proton-gated ion channel, has been shown to be involved in the pathogenesis of these diseases. However, whether oxidative stress affects the expression of ASIC1a remains elusive. In the current study, we examined the effect of hydrogen peroxide (H2O2), a major reactive oxygen species (ROS), on ASIC1a protein expression and channel function in NS20Y cells and primary cultured mouse cortical neurons. We found that treatment of the cells with H2O2 (20 mu M) for 6 h or longer increased ASIC1a protein expression and ASIC currents without causing significant cell injury. H2O2 incubation activated mitogen-activated protein kinases (MAPKs) pathways, including the extracellular signal-regulated kinase1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 pathways. We found that neither inhibition of the MEK/ERK pathway by U0126 nor inhibition of the p38 pathway by SB203580 affected H2O2-induced ASIC1a expression, whereas inhibition of the JNK pathway by SP600125 potently decreased ASIC1a expression and abolished the H2O2-mediated increase in ASIC1a expression and ASIC currents. Furthermore, we found that H2O2 pretreatment increased the sensitivity of ASIC currents to the ASIC1a inhibitor PcTx1, providing additional evidence that H2O2 increases the expression of functional ASIC1a channels. Together, our data demonstrate that H2O2 increases ASIC1a expression/activation through the JNK signaling pathway, which may provide insight into the pathogenesis of neurological disorders that involve both ROS and activation of ASIC1a.	[Wu, Bao-ming; Bargaineer, Jaree; Zhang, Ling; Yang, Tao; Xiong, Zhi-gang; Leng, Tian-dong] Morehouse Sch Med, Neurosci Inst, Dept Neurobiol, Atlanta, GA 30310 USA		Xiong, ZG; Leng, TD (corresponding author), Morehouse Sch Med, Neurosci Inst, Dept Neurobiol, Atlanta, GA 30310 USA.	zxiong@msm.edu; tleng@msm.edu		Wu, Baoming/0000-0001-6597-4437	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [SC3GM122593 (tl)]; National Center for Minority Health and Health Disparities of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007602]	ASIC1a antibody was a gift from Dr. Xiang-ming Zha (University of South Alabama, USA). This study was supported by National Institutes of Health (NIH) Grants SC3GM122593 (tl) and National Center for Minority Health and Health Disparities of the National Institutes of Health (U54MD007602).	Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Cadiou H, 2007, J NEUROSCI, V27, P13251, DOI 10.1523/JNEUROSCI.2135-07.2007; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; Du J, 2007, BRAIN RES, V1163, P10, DOI 10.1016/j.brainres.2007.06.002; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Forman HJ, 2016, ARCH BIOCHEM BIOPHYS, V607, P7, DOI 10.1016/j.abb.2016.08.011; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; Konyalioglu S, 2013, NEURAL REGEN RES, V8, P485, DOI 10.3969/j.issn.1673-5374.2013.06.001; Leng TD, 2015, CNS NEUROSCI THER, V21, P32, DOI 10.1111/cns.12318; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Li MH, 2014, J GEN PHYSIOL, V143, P719, DOI 10.1085/jgp.201310990; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mastrocola R, 2005, J ENDOCRINOL, V187, P37, DOI 10.1677/joe.1.06269; O'Bryant Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0249-8; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Roberts CK, 2005, J APPL PHYSIOL, V98, P203, DOI 10.1152/japplphysiol.00463.2004; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; STEVENSON MA, 1994, CANCER RES, V54, P12; Vann KT, 2018, BEHAV BRAIN RES, V337, P246, DOI 10.1016/j.bbr.2017.09.014; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Weinstain R, 2014, J AM CHEM SOC, V136, P874, DOI 10.1021/ja411547j; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; WIERUSZWYSOCKA B, 1995, DIABETES RES CLIN PR, V27, P193, DOI 10.1016/0168-8227(95)01043-D; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu YY, 2018, FASEB J, V32, P3832, DOI 10.1096/fj.201701367R; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	41	4	4	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1671-4083	1745-7254		ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	AUG	2021	42	8					1248	1255		10.1038/s41401-020-00559-3		NOV 2020	8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	TJ2RT	WOS:000589036100001	33184449				2022-02-06	
J	Ciurleo, R; De Salvo, S; Bonanno, L; Marino, S; Bramanti, P; Caminiti, F				Ciurleo, Rosella; De Salvo, Simona; Bonanno, Lilla; Marino, Silvia; Bramanti, Placido; Caminiti, Fabrizia			Parosmia and Neurological Disorders: A Neglected Association	FRONTIERS IN NEUROLOGY			English	Article						parosmia; epilepsy; multiple sclerosis; traumatic brain injury; mesial temporal sclerosis (MTS); sniffin sticks test	OLFACTORY-BULB VOLUME; DYSFUNCTION; PERCEPTION; DISCRIMINATION; ANOSMIA; LESION; SYSTEM	Parosmia is a distorted olfactory sensation in the presence of an odor. This olfactory disorder can affect the quality of life of most patients who experience it. Qualitative olfactory dysfunctions, such as parosmia and phantosmia, may be clinical conditions secondary to neurological diseases. The incidence of parosmia is underestimated, as well as its association with neurological diseases, due to poor self-reporting of patients and lack of objective methods for its measure. In this paper, we show selected clinical cases of parosmia associated with neurological disorders, such as traumatic brain injury and multiple sclerosis. These clinical cases show how the correct diagnosis of parosmia can represent the tip of the iceberg of important underlying neurological disorders and be a good prognostic indicator of their progression or recovery.	[Ciurleo, Rosella; De Salvo, Simona; Bonanno, Lilla; Marino, Silvia; Bramanti, Placido; Caminiti, Fabrizia] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy		De Salvo, S (corresponding author), IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy.	simona.desalvo@irccsme.it	Marino, Silvia/T-5118-2019	Marino, Silvia/0000-0002-1088-6808			Acharya V, 1998, NEUROLOGY, V51, P56, DOI 10.1212/WNL.51.1.56; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Bitter T, 2011, NEUROSCIENCE, V177, P177, DOI 10.1016/j.neuroscience.2011.01.016; Bonfils P, 2005, ARCH OTOLARYNGOL, V131, P107, DOI 10.1001/archotol.131.2.107; Caminiti F, 2016, NEUROCASE, V22, P357, DOI 10.1080/13554794.2016.1176203; Caminiti F, 2014, BRAIN INJURY, V28, P1776, DOI 10.3109/02699052.2014.945960; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Chen C, 2003, EPILEPSIA, V44, P257, DOI 10.1046/j.1528-1157.2003.25902.x; Cho Seok Hyun, 2014, Hanyang Medical Reviews, V34, P107, DOI 10.7599/hmr.2014.34.3.107; CONSTANTINESCU CS, 1994, J NEUROL NEUROSUR PS, V57, P1011, DOI 10.1136/jnnp.57.8.1011; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Desai M, 2015, J CLIN NEUROSCI, V22, P1614, DOI 10.1016/j.jocn.2015.03.035; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOUEK E, 1970, Journal of Laryngology and Otology, V84, P1185, DOI 10.1017/S0022215100072935; Fleiner F, 2010, AM J RHINOL ALLERGY, V24, pE93, DOI 10.2500/ajra.2010.24.3506; Frasnelli J, 2004, EUR ARCH OTO-RHINO-L, V261, P411, DOI 10.1007/s00405-003-0703-y; Furukawa M, 2004, JMAJ, V47, P38; Haehner A, 2019, J NEUROL, V266, P339, DOI 10.1007/s00415-018-9135-x; Haehner A, 2012, EPILEPSY BEHAV, V25, P477, DOI 10.1016/j.yebeh.2012.09.011; Hirsch AR, 2009, ARCH NEUROL-CHICAGO, V66, P538, DOI 10.1001/archneurol.2009.38; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Hong SC, 2012, ACTA OTO-LARYNGOL, V132, pS27, DOI 10.3109/00016489.2012.659759; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; HUMMEL T, 1995, EPILEPSIA, V36, P79, DOI 10.1111/j.1528-1157.1995.tb01670.x; Iannilli E, 2019, ORL J OTO-RHINO-LARY, V81, P185, DOI 10.1159/000500558; Jacek S, 2007, EPILEPSY BEHAV, V11, P466, DOI 10.1016/j.yebeh.2007.05.016; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kohler CG, 2001, NEUROPSY NEUROPSY BE, V14, P83; Landis BN, 2008, ARCH NEUROL-CHICAGO, V65, P1237, DOI 10.1001/archneur.65.9.1237; Lehrner J, 1997, EPILEPSIA, V38, P1042, DOI 10.1111/j.1528-1157.1997.tb01490.x; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; Lotsch J, 2016, NEUROIMAGE-CLIN, V11, P99, DOI 10.1016/j.nicl.2016.01.011; Marin C, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0796-4; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Muller A, 2006, AM J RHINOL, V20, P485, DOI 10.2500/ajr.2006.20.2876; Nordin S, 2008, CURR OPIN ALLERGY CL, V8, P10, DOI 10.1097/ACI.0b013e3282f3f473; Pinto Jayant M, 2011, Proc Am Thorac Soc, V8, P46, DOI 10.1513/pats.201005-035RN; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Rivlin, 1986, CLIN MEASUREMENT TAS, P451; Rombaux P, 2006, NEUROPHYSIOL CLIN, V36, P53, DOI 10.1016/j.neucli.2006.03.005; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Singh S, 2009, ARCH NEUROL-CHICAGO, V66, P805, DOI 10.1001/archneurol.2009.87; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; ZATORRE RJ, 1991, BRAIN, V114, P71	48	4	4	3	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 9	2020	11								543275	10.3389/fneur.2020.543275			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OU1MX	WOS:000591300100001	33240192	Green Published, gold			2022-02-06	
J	Liu, MT; Wang, AJ; Chen, Y; Zhao, GX; Jiang, ZF; Wang, XB; Shi, DL; Zhang, TS; Sun, BM; He, H; Williams, Z; Hu, KJ				Liu, Motao; Wang, Amy J.; Chen, Yu; Zhao, Gexin; Jiang, Zhifeng; Wang, Xinbang; Shi, Dongliang; Zhang, Tiansong; Sun, Bomin; He, Hua; Williams, Ziv; Hu, Kejia			Efficacy and safety of erythropoietin for traumatic brain injury	BMC NEUROLOGY			English	Article						Erythropoietin; Traumatic brain injury; Mortality; Neurological function improvement; Adverse events; Meta-analysis	DOUBLE-BLIND; NEUROPROTECTION; RECOVERY; BARRIER; IMPACT	Background Recent studies regarding the effects of erythropoietin (EPO) for treating traumatic brain injury (TBI) have been inconsistent. This study conducts a meta-analysis of randomized controlled trials (RCTs) to assess the safety and efficacy of EPO for TBI patients at various follow-up time points. Methods A literature search was performed using PubMed, Web of Science, MEDLINE, Embase, Google Scholar and the Cochrane Library for RCTs studying EPO in TBI patients published through March 2019. Non-English manuscripts and non-human studies were excluded. The assessed outcomes include mortality, neurological recovery and associated adverse effects. Dichotomous variables are presented as risk ratios (RR) with a 95% confidence interval (CI). Results A total of seven RCTs involving 1197 TBI patients (611 treated with EPO, 586 treated with placebo) were included in this study. Compared to the placebo arm, treatment with EPO did not improve acute hospital mortality or short-term mortality. However, there was a significant improvement in mid-term (6 months) follow-up survival rates. EPO administration was not associated with neurological function improvement. Regarding adverse effects, EPO treatment did not increase the incidence of thromboembolic events or other associated adverse events. Conclusions This meta-analysis indicates a slight mortality benefit for TBI patients treated with EPO at mid-term follow-up. EPO does not improve in-hospital mortality, nor does it increase adverse events including thrombotic, cardiovascular and other associated complications. Our analysis did not demonstrate a significant beneficial effect of EPO intervention on the recovery of neurological function. Future RCTs are required to further characterize the use of EPO in TBI.	[Liu, Motao; Sun, Bomin; Hu, Kejia] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurosurg, 197 Second Ruijin St, Shanghai 200025, Peoples R China; [Liu, Motao; Sun, Bomin; Hu, Kejia] Shanghai Jiao Tong Univ, Ruijin Hosp, Ctr Funct Neurosurg, Sch Med, Shanghai 200025, Peoples R China; [Liu, Motao] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Wang, Amy J.; Williams, Ziv; Hu, Kejia] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Chen, Yu] Chongqing Med Univ, Dept Orthoped Surg, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Zhao, Gexin] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China; [Jiang, Zhifeng] Ji Zhong Energy Fengfeng Grp Gen Hosp, Dept Neurosurg, Handan City 056200, Peoples R China; [Wang, Xinbang] PLA Navy Anqing Hosp, Dept Neurosurg, Anqing City 246000, Peoples R China; [Shi, Dongliang] 904th Hosp Peoples Liberat Army Joint Logist Supp, Dept Neurosurg, Wuxi 214000, Jiangsu, Peoples R China; [Zhang, Tiansong] Jing An Dist Cent Hosp, Dept Tradit Chinese Med, Shanghai 200437, Peoples R China; [He, Hua] Second Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Shanghai 200438, Peoples R China; [Williams, Ziv; Hu, Kejia] Harvard Med Sch, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA		Hu, KJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurosurg, 197 Second Ruijin St, Shanghai 200025, Peoples R China.; Hu, KJ (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Ctr Funct Neurosurg, Sch Med, Shanghai 200025, Peoples R China.; Hu, KJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.; He, H (corresponding author), Second Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Shanghai 200438, Peoples R China.; Hu, KJ (corresponding author), Harvard Med Sch, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA.	hehua1624@smmu.edu.cn; dockejiahu@gmail.com		Hu, Kejia/0000-0003-4036-5197	Shanghai Pujiang ProgramShanghai Pujiang Program [19PJ1407500]; Medical and Engineering Cross Research Fund from Shanghai Jiao Tong University [YG2019QNA31]; Shanghai Municipal Health Commission Clinical Study Special Fund [20194Y0067]; Ruijin Hospital Guangci Excellence Youth Training Program [GCQN-2019-B10]; Ruijin Youth NSFC Cultivation Fund [2019QNPY01031]	This work was supported by Shanghai Pujiang Program (KH, 19PJ1407500), Medical and Engineering Cross Research Fund from Shanghai Jiao Tong University (KH, YG2019QNA31), Shanghai Municipal Health Commission Clinical Study Special Fund (KH, 20194Y0067), Ruijin Hospital Guangci Excellence Youth Training Program (K.H, GCQN-2019-B10); Ruijin Youth NSFC Cultivation Fund (K.H, 2019QNPY01031).	Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Bai XF, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009532; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chu HL, 2014, LAB INVEST, V94, P1042, DOI 10.1038/labinvest.2014.84; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; de Vries RBM, 2014, ILAR J, V55, P427, DOI 10.1093/ilar/ilu043; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2015, WORLD NEUROSURG, V84, P1491, DOI 10.1016/j.wneu.2015.05.056; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Moher D, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0087-2; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Noxon V, 2017, J ONCOL PRACT, V13, P387, DOI 10.1200/JOP.2016.019364; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; Saatian Mohamadreza, 2018, Bull Emerg Trauma, V6, P45, DOI 10.29252/beat-060107; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	40	4	4	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	NOV 2	2020	20	1							399	10.1186/s12883-020-01958-z			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OP7SB	WOS:000588285800001	33138778	gold, Green Submitted, Green Published			2022-02-06	
J	Dixon, AL; McCully, BH; Rick, EA; Dewey, E; Farrell, DH; Morrison, LJ; McMullan, J; Robinson, BRH; Callum, J; Tibbs, B; Dries, DJ; Jui, JN; Gandhi, RR; Garrett, JS; Weisfeldt, ML; Wade, CE; Aufderheide, TP; Frascone, RJ; Tallon, JM; Kannas, D; Williams, C; Rowell, SE; Schreiber, MA				Dixon, Alexandra L.; McCully, Belinda H.; Rick, Elizabeth A.; Dewey, Elizabeth; Farrell, David H.; Morrison, Laurie J.; McMullan, Jason; Robinson, Bryce R. H.; Callum, Jeannie; Tibbs, Brian; Dries, David J.; Jui, Jonathan; Gandhi, Rajesh R.; Garrett, John S.; Weisfeldt, Myron L.; Wade, Charles E.; Aufderheide, Tom P.; Frascone, Ralph J.; Tallon, John M.; Kannas, Delores; Williams, Carolyn; Rowell, Susan E.; Schreiber, Martin A.			Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	50th Annual Meeting of the Western-Trauma-Association	FEB 23-29, 2020	Sun Valley, ID	Western Trauma Assoc		Thromboelastography; fibrinolysis; conventional coagulation assays; tranexamic acid; traumatic brain injury	ENDOTHELIAL GLYCOCALYX; FIBRINOLYSIS SHUTDOWN; HEMORRHAGE; HYPERFIBRINOLYSIS; ACTIVATION; CRASH-2	BACKGROUND No Food and Drug Administration-approved medication improves outcomes following traumatic brain injury (TBI). A forthcoming clinical trial that evaluated the effects of two prehospital tranexamic acid (TXA) dosing strategies compared with placebo demonstrated no differences in thromboelastography (TEG) values. We proposed to explore the impact of TXA on markers of coagulation and fibrinolysis in patients with moderate to severe TBI. METHODS Data were extracted from a placebo-controlled clinical trial in which patients 15 years or older with TBI (Glasgow Coma Scale, 3-12) and systolic blood pressure of >= 90 mm Hg were randomized prehospital to receive placebo bolus/placebo infusion (placebo), 1 g of TXA bolus/1 g of TXA infusion (bolus maintenance), or 2 g of TXA bolus/placebo infusion (bolus only). Thromboelastography was performed, and coagulation measures including prothrombin time, activated partial thromboplastin time, international ratio, fibrinogen, D-dimer, plasmin-antiplasmin (PAP), thrombin antithrombin, tissue plasminogen activator, and plasminogen activator inhibitor 1 were quantified at admission and 6 hours later. RESULTS Of 966 patients receiving study drug, 700 had laboratory tests drawn at admission and 6 hours later. There were no statistically significant differences in TEG values, including LY30, between groups (p > 0.05). No differences between prothrombin time, activated partial thromboplastin time, international ratio, fibrinogen, thrombin antithrombin, tissue plasminogen activator, and plasminogen activator inhibitor 1 were demonstrated across treatment groups. Concentrations of D-dimer in TXA treatment groups were less than placebo at 6 hours (p < 0.001). Concentrations of PAP in TXA treatment groups were less than placebo on admission (p < 0.001) and 6 hours (p = 0.02). No differences in D-dimer and PAP were observed between bolus maintenance and bolus only. CONCLUSION While D-dimer and PAP levels reflect a lower degree of fibrinolysis following prehospital administration of TXA when compared with placebo in a large prehospital trial of patients with TBI, TEG obtained on admission and 6 hours later did not demonstrate any differences in fibrinolysis between the two TXA dosing regimens and placebo.	[Dixon, Alexandra L.; McCully, Belinda H.; Rick, Elizabeth A.; Dewey, Elizabeth; Farrell, David H.; McMullan, Jason; Rowell, Susan E.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd,L611, Portland, OR 97239 USA; [McMullan, Jason; Jui, Jonathan] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Morrison, Laurie J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Robinson, Bryce R. H.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [McCully, Belinda H.; Kannas, Delores] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Tibbs, Brian] Texas Hlth Presbyterian Hosp, Trauma Surg, Dallas, TX USA; [Garrett, John S.] Baylor Univ, Med Ctr, Dept Emergency Med, Dallas, TX USA; [Weisfeldt, Myron L.] Johns Hopkins Sch Med, Baltimore, MD USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Callum, Jeannie; Tallon, John M.] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Rowell, Susan E.] Scripps Mem Hosp La Jolla, Dept Surg, La Jolla, CA USA; Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Callum, Jeannie] Providence Hlth Care Res Inst, Vancouver, BC, Canada; [Morrison, Laurie J.] St Michaels Hosp, Rescu, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Rowell, Susan E.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada; [Morrison, Laurie J.] Univ Toronto, Div Emergency Med, Dept Med, Fac Med, Toronto, ON, Canada; [Frascone, Ralph J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Dries, David J.] Regions Hosp, Dept Surg, St Paul, MN USA; [Williams, Carolyn] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Houston, TX 77030 USA; [Callum, Jeannie] Sunnybrook Hlth Sci Ctr, Dept Lab Med & Mol Diagnost, Toronto, ON, Canada; John Peter Hlth Network, Dept Emergency Med, Ft Worth, TX USA; [Gandhi, Rajesh R.] John Peter Hlth Network, Dept Surg, Ft Worth, TX USA; Mayo Clin, Dept Surg, Rochester, MN USA; [Tallon, John M.; Rowell, Susan E.] British Columbia Emergency Hlth Serv, Vancouver, BC, Canada; Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Rowell, Susan E.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada; Med City Plano, Dept Emergency Med, Plano, TX USA; [Rowell, Susan E.] Methodist Dallas Med Ctr, Emergency Med, Dallas, TX USA; [Garrett, John S.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; Texas Hlth Harris Methodist Hosp, Dept Trauma Surg, Ft Worth, TX USA		Dixon, AL; Schreiber, MA (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd,L611, Portland, OR 97239 USA.	dixoal@ohsu.edu; houghtob@ohsu.edu; rickb@ohsu.edu; deweye@ohsu.edu; farrelld@ohsu.edu; morrisonl@smh.ca; mcmulljo@ucmail.uc.edu; brobinso@uw.edu; jeannie.callum@sunnybrook.ca; briantibbs@texashealth.org; david.j.dries@healthpartners.com; jui@ohsu.edu; rgandhi@jpshealth.org; john.garrett@bswhealth.org; mlw5@jhmi.edu; Charles.e.wade@uth.tmc.edu; taufderh@mcw.edu; ralph.j.frascone@healthpartners.com; john.tallon@dal.ca; dkannas@comcast.net; cswilliams@uabmc.edu; rowells@ohsu.edu; schreibm@ohsu.edu	McMullan, Jason/ABB-9691-2020; morrison, laurie J/A-6325-2012	McMullan, Jason/0000-0002-7656-7447; morrison, laurie J/0000-0001-8369-9774	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HL1265585]; Department of DefenseUnited States Department of Defense [W81WH-13-2-0090]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01 HL077863, U01 HL077866, U01 HL077871, U01 HL077873, U01 HL077881, U01 HL077887]	L.J.M. holds the Robert and Dorothy Pitts Chair in Acute Care and Emergency Medicine, St. Michael's Hospital and University of Toronto. M.A.S. is a consultant for Haemonetics. For all other authors, no conflicts are declared. This work was funded by grants from the National Institutes of Health (1R01HL1265585) and Department of Defense (W81WH-13-2-0090). The Resuscitation Outcomes Consortium institutions participating in the trial were supported by a series of cooperative agreements from the National Heart, Lung and Blood Institute, including U01 HL077863 (University of Washington Data Coordinating Center), U01 HL077866 (Medical College of Wisconsin), U01 HL077871 (University of Pittsburgh), U01 HL077873 (Oregon Health and Science University), U01 HL077881 (University of Alabama at Birmingham), and U01 HL077887 (University of Texas Southwestern Medical Center/Dallas). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.	Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Diebel LN, 2017, J TRAUMA ACUTE CARE, V82, P1080, DOI 10.1097/TA.0000000000001445; Diebel ME, 2018, J TRAUMA ACUTE CARE, V84, P75, DOI 10.1097/TA.0000000000001726; Foley JH, 2017, SEMIN THROMB HEMOST, V43, P135, DOI 10.1055/s-0036-1592302; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; Madurska MJ, 2018, EUR J TRAUMA EMERG S, V44, P35, DOI 10.1007/s00068-017-0833-3; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Moore EE, 2015, J TRAUMA ACUTE CARE, V78, pS65, DOI 10.1097/TA.0000000000000634; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Ostrowski SR, 2017, J TRAUMA ACUTE CARE, V82, P293, DOI 10.1097/TA.0000000000001304; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Prudovsky I, 2019, J CELL PHYSIOL, V234, P19121, DOI 10.1002/jcp.28603; Pusateri AE, 2013, SHOCK, V39, P121, DOI 10.1097/SHK.0b013e318280409a; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Ruhl H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145012; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	23	4	4	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2020	89	5					900	907		10.1097/TA.0000000000002932			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	OM5WX	WOS:000586095800019	33105308	Green Accepted			2022-02-06	
J	Gallagher, VT; Murthy, P; Stocks, J; Vesci, B; Colegrove, D; Mjaanes, J; Chen, YF; Breiter, H; LaBella, C; Herrold, AA; Reilly, JL				Gallagher, Virginia T.; Murthy, Prianka; Stocks, Jane; Vesci, Brian; Colegrove, Danielle; Mjaanes, Jeffrey; Chen, Yufen; Breiter, Hans; LaBella, Cynthia; Herrold, Amy A.; Reilly, James L.			Differential Change in Oculomotor Performance among Female Collegiate Soccer Players versus Non-Contact Athletes from Pre- to Post-Season	NEUROTRAUMA REPORTS			English	Article						oculomotor; repetitive head impacts; saccade testing; soccer subconcussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; SUBCONCUSSIVE HEAD IMPACTS; BRAIN-INJURY; EYE-MOVEMENT; COGNITIVE DYSFUNCTION; NEUROLOGIC FUNCTION; CLINICAL MEASURES; FOOTBALL SEASON; ANTI-SACCADES; INVENTORY-II	Sensitive and reliable tools are needed to evaluate potential behavioral and cognitive changes following head impact exposure in contact and collision sport participation. We evaluated change in oculomotor testing performance among female, varsity, collegiate athletes following variable exposure to head impacts across a season. Female, collegiate, contact sport (soccer, CONT) and non-contact sport (NON-CONT) athletes were assessed pre-season and post-season. Soccer athletes were grouped according to total season game headers into low dose (<= 40 headers; CONT-Low Dose) or high dose (> 40 headers; CONT-High Dose) groups. Performance on pro-saccade (reflexive visual response), anti-saccade (executive inhibition), and memory-guided saccade (MGS, spatial working memory) computer-based laboratory tasks were assessed. Primary saccade measures included latency/reaction time, inhibition error rate (anti-saccade only), and spatial accuracy (MGS only). NON-CONT (n = 20), CONT-Low Dose (n = 17), and CONT-High Dose (n = 7) groups significantly differed on pre-season versus post-season latency on tasks with executive functioning demands (anti-saccade and MGS, p <= 0.001). Specifically, NON-CONT and CONT-Low Dose demonstrated shorter (i.e., faster) anti-saccade (1.84% and 2.68%, respectively) and MGS (5.74% and 2.76%, respectively) latencies from pre-season to post-season, whereas CONT-High Dose showed 1.40% average longer anti-saccade, and 0.74% shorter MGS, latencies. NON-CONT and CONT-Low Dose demonstrated reduced (i.e., improved) inhibition error rate on the anti-saccade task at post-season versus pre-season, whereas CONT-High Dose demonstrated relative stability (p = 0.021). The results of this study suggest differential exposure to subconcussive head impacts in collegiate female athletes is associated with differential change in reaction time and inhibitory control performances on executive saccadic oculomotor testing.	[Gallagher, Virginia T.; Murthy, Prianka; Stocks, Jane; Breiter, Hans; Herrold, Amy A.; Reilly, James L.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, 710 N Lake Shore Dr, Chicago, IL 60611 USA; [Vesci, Brian; Colegrove, Danielle; Mjaanes, Jeffrey] Northwestern Univ, Dept Sports Med, Evanston, IL USA; [Chen, Yufen] Northwestern Univ, Ctr Translat Imaging, Chicago, IL 60611 USA; [LaBella, Cynthia] Ann & Robert H Lurie Childrens Hosp Chicago, Div Orthoped & Sports Med, Chicago, IL 60611 USA; [Herrold, Amy A.] Edward Hines Jr VA Hosp, Hines, IL USA		Gallagher, VT (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, 710 N Lake Shore Dr, Chicago, IL 60611 USA.	Va.t.gallagher@gmail.com			Eleanor Wood-Prince Grant Initiative: A Project of the Woman's Board of Northwestern Memorial Hospital; National Institute Of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS106840]	This work was funded by the Eleanor Wood-Prince Grant Initiative: A Project of the Woman's Board of Northwestern Memorial Hospital (to A.A.H. and J.L.R.) and supported by the National Institute Of Neurological Disorders and Stroke of the National Institutes of Health under award number F31NS106840 (to V.T.G.).	[Anonymous], 2017, IBM SPSS STAT WINDOW; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cornelissen FW, 2002, EXP BRAIN RES, V145, P270, DOI 10.1007/s00221-002-1136-3; Davenport Elizabeth M, 2016, Concussion, V1, pCNC19, DOI 10.2217/cnc-2016-0003; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; de Weijer AD, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00041; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Diakogeorgiou E, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118761031; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ferron J, 2002, MULTIVAR BEHAV RES, V37, P379, DOI 10.1207/S15327906MBR3703_4; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; HEDBERG AG, 1972, PROF PSYCHOL, V3, P389, DOI 10.1037/h0020743; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Jamadar SD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00653; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Karpouzian-Rogers T, 2020, SCHIZOPHR RES, V215, P314, DOI 10.1016/j.schres.2019.10.008; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Landry AP, 2019, J NEUROSURG, V131, P1235, DOI 10.3171/2018.6.JNS18607; Ledwidge PS, 2019, CLIN J SPORT MED, V29, P292, DOI 10.1097/JSM.0000000000000512; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Long A.S., 2019, ATHL TRAIN SPORTS HL, V11, P28; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lunn J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160508; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McDowell JE, 2005, NEUROREPORT, V16, P663, DOI 10.1097/00001756-200505120-00002; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medendorp WP, 2005, J NEUROPHYSIOL, V94, P734, DOI 10.1152/jn.01331.2004; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Munoz Douglas P., 2007, P99, DOI 10.1016/B978-008044980-7/50007-0; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Pierrot-Deseilligny C., 2002, ANN NY ACAD SCI, V956, P216; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Reilly JL, 2008, BIOL PSYCHIAT, V63, P776, DOI 10.1016/j.biopsych.2007.11.009; Reilly JL, 2014, SCHIZOPHRENIA BULL, V40, P1011, DOI 10.1093/schbul/sbt132; Schaeffer DJ, 2013, PSYCHOPHYSIOLOGY, V50, P325, DOI 10.1111/psyp.12030; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Vogelpohl RE, 2017, INT J ATHL THER TRAI, V22, P49, DOI 10.1123/ijatt.2016-0083; Ware AL, 2019, J NEUROTRAUM, V36, P686, DOI 10.1089/neu.2018.5725; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; White-Schwoch T, 2020, BRAIN INJURY, V34, P236, DOI 10.1080/02699052.2019.1683899; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	76	4	4	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2020	1	1					169	180		10.1089/neur.2020.0051			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WU7FW	WOS:000716708100003	33274345	Green Published, hybrid			2022-02-06	
J	Ham, EI; Kim, J; Kanmounye, US; Lartigue, JW; Gupta, S; Esene, IN; Park, KB				Ham, Edward I.; Kim, Jeongyoon; Kanmounye, Ulrick Sidney; Lartigue, Jean Wilguens; Gupta, Saksham; Esene, Ignatius N.; Park, Kee B.			Cohesion Between Research Literature and Health System Level Efforts to Address Global Neurosurgical Inequity: A Scoping Review	WORLD NEUROSURGERY			English	Article						Global health; Global neurosurgery; Health systems; LMIC; Scoping review	TRAUMATIC BRAIN-INJURY; DEVELOPING-COUNTRIES; COST-EFFECTIVENESS; SURGICAL-TREATMENT; DEVELOPING-WORLD; ADDIS-ABABA; CARE; EPIDEMIOLOGY; PERSPECTIVE; EDUCATION	BACKGROUND: Research output on global neurosurgery (GNS) has exponentially increased in recent years. As research efforts increase, we must first analyze how the current body of GNS literature fits into the macroscopic schema of systems-based policies. The aim of this study was to identify and categorize GNS research based on health system domains. METHODS: PubMed, CINAHL, and Embase were searched for GNS literature published from 1999 to 2019. Then, health system domains were defined and itemized based on publicly available documents from the Program in Global Surgery and Social Change. This items chart was subsequently used to categorize the GNS literature into health system domains. RESULTS: A total 63 articles were determined to focus on a health system domain. Of these articles, 6 focused on multiple domains, yielding an adjusted total of 70 articles. Overall, the most represented health system domain was service delivery (21 articles), followed by workforce (19), infrastructure (15), financing (12) and information man-agement (3). A total of 30 low- and middle-income countries (LMICs) were represented across all articles. In addition, the first author was affiliated with an institution from a high-income country for 71.4% of the articles. CONCLUSIONS: This review highlighted the pressing need for more research into information management in the context of GNS. In addition, health system-focused GNS literature represented only 20% of all LMICs (30/143). The trends in authorship should be noted, because many ethical (and practical) issues may arise if there is a disconnect in the objectives of the authors and the neurosurgeons in LMICs.	[Ham, Edward I.] Stony Brook Sch Med, Stony Brook, NY 11794 USA; [Ham, Edward I.; Kanmounye, Ulrick Sidney; Lartigue, Jean Wilguens; Gupta, Saksham; Park, Kee B.] Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA; [Kim, Jeongyoon] Bowdoin Coll, Brunswick, ME 04011 USA; [Gupta, Saksham] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Esene, Ignatius N.] Univ Bamenda, Neurosurg Div, Fac Hlth Sci, Bamenda, Cameroon		Ham, EI (corresponding author), Stony Brook Sch Med, Stony Brook, NY 11794 USA.; Ham, EI (corresponding author), Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA.	edward.ham@stonybrookmedicine.edu	ESENE, IGNATIUS/AAX-8716-2020; Kanmounye, Ulrick Sidney/AAY-6123-2020	ESENE, IGNATIUS/0000-0001-8785-8875; Kanmounye, Ulrick Sidney/0000-0001-6791-1018; Lartigue, Jean Wilguens/0000-0001-9889-7976			Abdelgadir J, 2017, WORLD NEUROSURG, V101, P651, DOI 10.1016/j.wneu.2017.02.048; Abimbola S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-002068; Agrawal A, 2008, SURG NEUROL, V69, P652, DOI 10.1016/j.surneu.2007.03.047; Ament JD, 2017, WORLD NEUROSURG, V104, P407, DOI 10.1016/j.wneu.2017.05.046; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Awori J, 2016, J NEUROSURG-PEDIATR, V18, P116, DOI 10.3171/2015.11.PEDS15445; Badke GL, 2018, ARQ NEURO-PSIQUIAT, V76, P257, DOI [10.1590/0004-282x20180016, 10.1590/0004-282X20180016]; Barthelemy EJ, 2019, WORLD NEUROSURG, V126, pE232, DOI 10.1016/j.wneu.2019.02.019; Barthelemy EJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.10.012; Bentounsi Z, 2019, BMJ GH BLOGS; Bernstein M, 2006, SURG NEUROL, V66, P117, DOI 10.1016/j.surneu.2005.12.033; Berven SH, 2018, EUR SPINE J, V27, P585, DOI 10.1007/s00586-017-5241-1; Bhattacharjee S, 2014, CHILD NERV SYST, V30, P1953; Cadotte DW, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.09.001; Cadotte DW, 2013, CAN J SURG, V56, pE19, DOI 10.1503/cjs.027011; Cadotte DW, 2010, WORLD NEUROSURG, V73, P270, DOI 10.1016/j.wneu.2010.02.017; Chemmanam T, 2009, J CLIN NEUROPHYSIOL, V26, P123, DOI 10.1097/WNP.0b013e31819d8030; Corley J, 2019, WORLD NEUROSURG, V132, P434, DOI 10.1016/j.wneu.2019.08.240; Dadlani R, 2014, WORLD NEUROSURG, V82, P270, DOI 10.1016/j.wneu.2014.05.027; Davis MC, 2017, J NEUROSURG-PEDIATR, V20, P204, DOI 10.3171/2017.3.PEDS16433; Davis MC, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.038; Davis MC, 2016, WORLD NEUROSURG, V86, P103, DOI 10.1016/j.wneu.2015.08.053; Dewan MC, 2018, CHILD NERV SYST, V34, P2017; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1098, DOI 10.3171/2017.10.JNS17347; Dewan MC, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18272; Duenas VJ, 2012, CHILD NERV SYST, V28, P1227, DOI 10.1007/s00381-012-1771-3; Vuong DA, 2012, WORLD NEUROSURG, V77, P321, DOI 10.1016/j.wneu.2011.05.050; Ellegala DB, 2014, J NEUROSURG, V121, P1526, DOI 10.3171/2014.7.JNS122153; Faried A, 2018, WORLD NEUROSURG, V116, pE239, DOI 10.1016/j.wneu.2018.04.180; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Gandaho HJT, 2016, J NEUROSCI RURAL PRA, V7, pS52, DOI 10.4103/0976-3147.196442; Gigineishvili T, 2011, EUR J CANCER, V47, pS253, DOI 10.1016/S0959-8049(11)71180-7; Godil Saniya Siraj, 2010, Surg Neurol Int, V1, P69, DOI 10.4103/2152-7806.72246; Goldstein LN, 2017, AFR J EMERG MED, V7, P100, DOI 10.1016/j.afjem.2017.04.012; Gupta T, 2017, NEUROL INDIA, V65, P315, DOI 10.4103/0028-3886.201841; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Hashem SA, 2011, INT J RADIAT ONCOL, V81, pS283, DOI 10.1016/j.ijrobp.2011.06.492; Hendrickson P, 2018, WORLD NEUROSURG, V110, pE952, DOI 10.1016/j.wneu.2017.11.142; Hernandes Rocha TA, J NEUROSURG, DOI [10.3171/2019.2.JNS182098, DOI 10.3171/2019.2.JNS182098,]; Hessissen L, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26737; Houkin K, 1999, NEUROL MED-CHIR, V39, P773, DOI 10.2176/nmc.39.773; Howe KL, 2013, WORLD NEUROSURG, V80, pE171, DOI [10.1016/j.wneu.2013.07.003, 10.1016/j.wneu.2013.02.087]; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jourdain VA, 2014, STEREOT FUNCT NEUROS, V92, P71, DOI 10.1159/000355215; Kaptigau WM, 2016, WORLD J SURG, V40, P251, DOI 10.1007/s00268-015-3268-1; Kinasha A, 2012, WORLD NEUROSURG, V78, DOI [10.1016/J.WNEU.2011.06.008, 10.1016/j.wneu.2011.06.008]; Leidinger A, 2019, J NEUROSURG-SPINE, V31, P103, DOI 10.3171/2018.12.SPINE18635; Leidinger A, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18287; Magarik J, 2012, WORLD NEUROSURG, V77, P28, DOI 10.1016/j.wneu.2010.05.039; Malomo TA, 2018, J NEUROSCI RURAL PRA, V9, P545, DOI 10.4103/jnrp.jnrp_502_17; Mangat HS, 2018, WORLD NEUROSURG, V113, P411, DOI 10.1016/j.wneu.2018.01.086; Mansouri A, 2018, WORLD NEUROSURG, V117, pE679, DOI 10.1016/j.wneu.2018.06.111; Mansur A, 2018, WORLD NEUROSURG, V118, P332, DOI 10.1016/j.wneu.2018.07.149; Muhoza B, 2019, STUD HEALTH TECHNOL, V264, P1732, DOI 10.3233/SHTI190620; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; Ntsambi-Eba G, 2017, MED SANTE TROP, V27, P415, DOI 10.1684/mst.2017.0742; Ormond DR, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18239; Park KB, 2019, J NEUROSURG, V130, P1053, DOI 10.3171/2019.2.JNS19295; Piquer J, 2015, J NEUROSURG-PEDIATR, V15, P552, DOI 10.3171/2014.10.PEDS14318; Ploss B, 2017, WORLD NEUROSURG, V108, P844, DOI 10.1016/j.wneu.2017.08.045; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Rabadan Alejandra T, 2017, Surg Neurol Int, V8, P118, DOI 10.4103/sni.sni_497_16; Robertson FC, 2019, WORLD NEUROSURG X, V6; Robertson FC, 2019, WORLD NEUROSURG X, V6; Rock J, 2018, WORLD NEUROSURG, V113, pE239, DOI 10.1016/j.wneu.2018.02.001; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Sader E, 2017, WORLD NEUROSURG, V98, P397, DOI 10.1016/j.wneu.2016.07.098; Samano AG, 2018, J CLIN NEUROPHYSIOL, V35, P242, DOI 10.1097/WNP.0000000000000453; Santos MM, 2017, SINAPSE, V17, P62; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Smith E, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-42; Tahir MZ, 2009, SURG NEUROL, V72, P355, DOI 10.1016/j.surneu.2008.11.003; Thapa A, 2016, WORLD NEUROSURG, V95, P270, DOI 10.1016/j.wneu.2016.08.001; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Truche P, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-019-0531-5; Uche EO, 2018, WORLD NEUROSURG, V120, pE80, DOI 10.1016/j.wneu.2018.07.165; Ulu-Kilic A, 2015, AM J INFECT CONTROL, V43, P44, DOI 10.1016/j.ajic.2014.09.010; Vaca SD, 2019, J NEUROSURG-PEDIATR, V23, P125, DOI 10.3171/2018.7.PEDS17601; Venturini S, 2018, WORLD NEUROSURG, V109, P98, DOI 10.1016/j.wneu.2017.09.117; Vissoci JRN, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1283-9; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; World Federation of Neurosurgical Societies, 2016, GLOB NEUR WORKF MAP; World Federation of Neurosurgical Societies, 2020, GLOB NEUR; World Federation of Neurosurgical Societies, NEUR CAP ACC COUNTR; Zhou DB, 2008, PEDIATR NEUROSURG, V44, P97, DOI 10.1159/000113110	86	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2020	143						E88	E105		10.1016/j.wneu.2020.06.237			18	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OS2GK	WOS:000589984400001	32673809				2022-02-06	
J	He, XH; Guan, YG; Zhai, F; Zhou, J; Li, TF; Luan, GM				He, Xinghui; Guan, Yuguang; Zhai, Feng; Zhou, Jian; Li, Tianfu; Luan, Guoming			Resective surgery for drug-resistant posttraumatic epilepsy: predictors of seizure outcome	JOURNAL OF NEUROSURGERY			English	Article						drug-resistant epilepsy; epilepsy surgery; posttraumatic epilepsy; traumatic brain injury; bipolar electrocoagulation	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; HOC TASK-FORCE; RISK; HOSPITALIZATION; CLASSIFICATION; RECURRENCE; PROPOSAL	OBJECTIVE: The object of this study was to evaluate surgical outcomes and prognosis factors in patients with drug-resistant posttraumatic epilepsy (PTE) who had undergone resective surgery. METHODS: The authors retrospectively reviewed the records of all patients with drug-resistant PTE who had undergone resective surgery at Sanbo Brain Hospital, Capital Medical University, in the period from January 2008 to December 2016. All patients had a follow-up period of at least 2 years. Seizure outcomes were evaluated according to the International League Against Epilepsy (ILAE) classification. Patients in ILAE classes 1 and 2 during the last 2 years of follow-up were classified as having a favorable outcome; patients in all other classes were considered to have an unfavorable outcome. Univariate analysis and a multivariate logistic regression model in a backward fashion were used to identify the potential predictors of seizure outcomes. RESULTS: Among 90 patients with a follow-up of 2-10 years (mean +/- standard deviation, 5.79 +/- 2.84 years), 70% (63 patients) were seizure free, of whom 68.9% (62 patients) had an ILAE class 1 outcome and 1.1% (1 patient) had an ILAE class 2 outcome. Permanent neurological deficits were observed in 10 patients (11.1%). Univariate and multivariate analyses revealed that only the duration of seizures <= 8 years was an independent predictor of a favorable seizure outcome (OR 0.34, 95% CI 0.13-0.92). CONCLUSIONS: Resective surgery is an effective treatment for patients with drug-resistant PTE with an acceptable incidence of complications. The information on prognosis factors suggests that early surgery may offer more benefits to patients with drug-resistant PTE.	[He, Xinghui; Guan, Yuguang; Zhai, Feng; Zhou, Jian; Li, Tianfu; Luan, Guoming] Capital Med Univ, Sanbo Brain Hosp, Beijing Key Lab Epilepsy, Beijing, Peoples R China; [He, Xinghui; Guan, Yuguang; Zhai, Feng; Zhou, Jian; Luan, Guoming] Capital Med Univ, Sanbo Brain Hosp, Epilepsy Ctr, Dept Neurosurg, Beijing, Peoples R China; [Li, Tianfu; Luan, Guoming] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China		Luan, GM (corresponding author), Capital Med Univ, Sanbo Brain Hosp, Beijing, Peoples R China.	luangm3@163.com	guan, yuguang/AAO-9253-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81790654, 81790650]; Capital Health Research and Development of Special Fund [2016-1-8012]	This work was supported by the National Natural Science Foundation of China (81790654, 81790650; G.L.) and Capital Health Research and Development of Special Fund (2016-1-8012; G. L.).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cukiert A, 1996, CAN J NEUROL SCI, V23, P114, DOI 10.1017/S0317167100038828; Dalmagro CL, 2005, EPILEPSIA, V46, P1442, DOI 10.1111/j.1528-1167.2005.70904.x; Delev D, 2019, NEUROSURGERY, V84, P242, DOI 10.1093/neuros/nyy099; Elsharkawy AE, 2008, NEUROSURGERY, V63, P516, DOI 10.1227/01.NEU.0000324732.36396.E9; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Foerster O, 1930, BRAIN, V53, P99, DOI 10.1093/brain/53.2.99; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hanakova P, 2014, SEIZURE-EUR J EPILEP, V23, P266, DOI 10.1016/j.seizure.2013.12.003; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hitti FL, 2019, OPER NEUROSURG HAGER; Horsley V, 1886, BMJ, V2, P670; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Janszky J, 2005, BRAIN, V128, P395, DOI 10.1093/brain/awh358; Jobst BC, 2015, JAMA-J AM MED ASSOC, V313, P285, DOI 10.1001/jama.2014.17426; Jokeit H, 1999, J NEUROL, V246, P926, DOI 10.1007/s004150050484; Kim DW, 2017, JAMA NEUROL, V74, P322, DOI 10.1001/jamaneurol.2016.4439; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lin WJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040589; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; MORRELL F, 1985, ARCH NEUROL-CHICAGO, V42, P318, DOI 10.1001/archneur.1985.04060040028009; Ramantani G, 2017, EPILEPSIA, V58, P412, DOI 10.1111/epi.13654; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Schuh LA, 1998, ARCH NEUROL-CHICAGO, V55, P1325, DOI 10.1001/archneur.55.10.1325; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Sperling MR, 2016, NEUROLOGY, V86, P1938, DOI 10.1212/WNL.0000000000002700; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Zhai F, 2015, STEREOT FUNCT NEUROS, V93, P1, DOI 10.1159/000363146	38	4	4	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2020	133	5					1568	1575		10.3171/2019.7.JNS191233			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM6AS	WOS:000586105700034	31585428				2022-02-06	
J	Li, Y; Zhang, LM; Zhang, DX; Zheng, WC; Bai, Y; Bai, J; Fu, L; Wang, XP				Li, Yan; Zhang, Li-Min; Zhang, Dong-Xue; Zheng, Wei-Chao; Bai, Yang; Bai, Jing; Fu, Lan; Wang, Xu-Peng			CORM-3 ameliorates neurodegeneration in the amygdala and improves depression- and anxiety-like behavior in a rat model of combined traumatic brain injury and hemorrhagic shock	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Hemorrhage shock; Depression; Anxiety; Carbon monoxide	CARBON-MONOXIDE; IN-VIVO; INFLAMMATORY RESPONSE; COGNITIVE IMPAIRMENT; CORTICAL-NEURONS; PROTECTS; ACID; MRI; SEVOFLURANE; INVOLVEMENT	Objective: Emotional disturbances characterized by depression and anxiety among survivors of traumatic brain injury (TBI) impact the quality of life severely. Currently, there is a lack of effective drug treatment for neurodegeneration induced by TBI, mainly due to failed efficacy of compounds such as corticosteroids, calcium channel blockers, and excitatory amino acid inhibitors. Thus, we sought to continue with our investigation on CORM-3, a water-soluble exogenous carbon monoxide-releasing molecule with excellent anti-inflammatory actions employed in a previous study using a rat model of combined TBI with hemorrhage shock and resuscitation (HSR). Methods: Rats were administrated with CORM-3 after induction of TBI and HSR and examined depressive and anxiety-like behaviors, along with cerebral function employing functional magnetic resonance imaging (MRI) 30-days post-trauma. Also, the following variables were measured: 1) neuronal pyroptosis and apoptosis 24 h post-trauma, 2) the roles of PKG-ERK1/2 signaling pathways with the use of the protein kinase G (PKG) specific inhibitor, KT5823. Results: CORM-3-treated rats displayed significant ameliorated depression- and anxiety-like behaviors, improved cerebral blood flow, and fractional anisotropy (FA), showed less neuronal pyroptosis and apoptosis in the amygdala, and upregulated the phosphorylation of Vasodilator-stimulated phosphoprotein (VASP) and ERK1/2. However, CORM-3 neuroprotective effects against trauma were only partially reversed by KT5823. Conclusion: CORM-3 ameliorated the emotional deficits and neuronal death induced in the amygdala post-TBI and HSR rat model, and PKG-ERK1/2 signaling might be implicated in the underlying mechanism.	[Li, Yan; Zhang, Li-Min; Zheng, Wei-Chao; Bai, Yang; Bai, Jing; Wang, Xu-Peng] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Zhang, Dong-Xue] Cangzhou Cent Hosp, Dept Gerontol, Cangzhou, Peoples R China; [Fu, Lan] Cangzhou Cent Hosp, Dept Radiodiag, Cangzhou, Peoples R China		Zhang, LM (corresponding author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.	azai2010@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701296]	The present study is supported by National Natural Science Foundation of China (81701296).	Abdul HM, 2007, FREE RADICAL BIO MED, V42, P371, DOI 10.1016/j.freeradbiomed.2006.11.006; Akassoglou K, 2005, MOL PHARMACOL, V68, P952, DOI 10.1124/mol.105.017277; Bae S, 2020, BRAIN IMAGING BEHAV, V14, P1850, DOI 10.1007/s11682-019-00127-2; Beitchman JA, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01434; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Chalimoniuk M, 2009, J NEUROCHEM, V110, P307, DOI 10.1111/j.1471-4159.2009.06147.x; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Davis M., 2010, PHASIC VS SUSTAINED; Figueiredo TH, 2018, MOL NEUROBIOL, V55, P187, DOI 10.1007/s12035-017-0732-y; Fu L, 2020, INT J MOL MED, V45, P1176, DOI 10.3892/ijmm.2020.4493; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Hung SY, 2010, NEUROPHARMACOLOGY, V58, P321, DOI 10.1016/j.neuropharm.2009.11.003; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jindal A, 2017, NEUROCHEM INT, V111, P3, DOI 10.1016/j.neuint.2016.12.004; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kumai K, 2017, 19TH INTERNATIONAL CONFERENCE ON INFORMATION INTEGRATION AND WEB-BASED APPLICATIONS & SERVICES (IIWAS2017), P23, DOI 10.1145/3151759.3151767; Lee K.H., 2017, PLOS ONE, V12; Lee ML, 2019, MOLECULES, V24, DOI 10.3390/molecules24071376; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; Mahan VL, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-32; McKinley TO, 2018, J TRAUMA ACUTE CARE, V85, P1063, DOI 10.1097/TA.0000000000002069; Mohamed AZ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102136; Motterlini R, 2017, AM J PHYSIOL-CELL PH, V312, pC302, DOI 10.1152/ajpcell.00360.2016; Motterlini R, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-28; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Wilson JL, 2017, FREE RADICAL BIO MED, V104, P311, DOI 10.1016/j.freeradbiomed.2017.01.022; Xu XE, 2019, BRAIN BEHAV IMMUN, V80, P859, DOI 10.1016/j.bbi.2019.05.038; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zhang LM, 2019, WORLD NEUROSURG, V132, pE21, DOI 10.1016/j.wneu.2019.09.024; Zhang LM, 2019, FREE RADICAL BIO MED, V141, P299, DOI 10.1016/j.freeradbiomed.2019.06.031; Zhang LM, 2019, J SURG RES, V235, P591, DOI 10.1016/j.jss.2018.10.046; Zhang LM, 2015, J NEUROL SCI, V357, P80, DOI 10.1016/j.jns.2015.06.070; Zheng G, 2019, EBIOMEDICINE, V40, P643, DOI 10.1016/j.ebiom.2018.12.059	44	4	4	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2020	140								104842	10.1016/j.neuint.2020.104842			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	OD2NJ	WOS:000579689600024	32858089				2022-02-06	
J	Lutkenhoff, ES; Shrestha, V; Tejeda, JR; Real, C; McArthur, DL; Duncan, D; La Rocca, M; Garner, R; Toga, AW; Vespa, PM; Monti, MM				Lutkenhoff, Evan S.; Shrestha, Vikesh; Ruiz Tejeda, Jesus; Real, Courtney; McArthur, David L.; Duncan, Dominique; La Rocca, Marianna; Garner, Rachael; Toga, Arthur W.; Vespa, Paul M.; Monti, Martin M.		EpiBioS4Rx Study Grp	Early brain biomarkers of post-traumatic seizures: initial report of the multicentre epilepsy bioinformatics study for antiepileptogenic therapy (EpiBioS4Rx) prospective study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						traumatic brain injury; epilepsy; MRI	CONSCIOUSNESS; INJURY	Background Traumatic brain injury (TBI) causes early seizures and is the leading cause of post-traumatic epilepsy. We prospectively assessed structural imaging biomarkers differentiating patients who develop seizures secondary to TBI from patients who do not. Design Multicentre prospective cohort study starting in 2018. Imaging data are acquired around day 14 post-injury, detection of seizure events occurred early (within 1 week) and late (up to 90 days post-TBI). Results From a sample of 96 patients surviving moderate-to-severe TBI, we performed shape analysis of local volume deficits in subcortical areas (analysable sample: 57 patients; 35 no seizure, 14 early, 8 late) and cortical ribbon thinning (analysable sample: 46 patients; 29 no seizure, 10 early, 7 late). Right hippocampal volume deficit and inferior temporal cortex thinning demonstrated a significant effect across groups. Additionally, the degree of left frontal and temporal pole thinning, and clinical score at the time of the MRI, could differentiate patients experiencing early seizures from patients not experiencing them with 89% accuracy. Conclusions and relevance Although this is an initial report, these data show that specific areas of localised volume deficit, as visible on routine imaging data, are associated with the emergence of seizures after TBI.	[Lutkenhoff, Evan S.; Monti, Martin M.] Univ Calif Los Angeles, Psychol, Los Angeles, CA 90095 USA; [Lutkenhoff, Evan S.; Shrestha, Vikesh; Ruiz Tejeda, Jesus; Real, Courtney; McArthur, David L.; Vespa, Paul M.; Monti, Martin M.] Univ Calif Los Angeles, David Geffen Sch Med, Neurosurg, Brain Injury Res Ctr BIRC, Los Angeles, CA 90095 USA; [Duncan, Dominique; La Rocca, Marianna; Garner, Rachael; Toga, Arthur W.] Univ Southern Calif, Keck Sch Med, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA; [Vespa, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Neurol, Los Angeles, CA 90095 USA; [Monti, Martin M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA		Monti, MM (corresponding author), Univ Calif Los Angeles, Psychol, Los Angeles, CA 90095 USA.	monti@psych.ucla.edu	La Rocca, Marianna/ABG-1214-2021	La Rocca, Marianna/0000-0002-2254-1583; Duncan, Dominique/0000-0002-6154-9262	NINDS Center without Walls [U54 NS100064]; Tiny Blue Dot foundation	This work was funded by NINDS Center without Walls, U54 NS100064 (EpiBioS4Rx), and by Tiny Blue Dot foundation.	Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Gibson LM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4577; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Ottman R, 2010, EPILEPSIA, V51, P191, DOI 10.1111/j.1528-1167.2009.02274.x; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Schnakers C, 2019, J NEUROL NEUROSUR PS, V90, P617, DOI 10.1136/jnnp-2017-317829; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; TEASDALE G, 1974, LANCET, V2, P81; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2019, NEUROBIOL DIS, V123, P110, DOI 10.1016/j.nbd.2018.07.025	14	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2020	91	11					1154	1157		10.1136/jnnp-2020-322780			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	OI6EG	WOS:000583368600010	32848013	Green Accepted, Bronze			2022-02-06	
J	Mihalik, JP; Amalfe, SA; Roby, PR; Ford, CB; Lynall, RC; Riegler, KE; Teel, EF; Wasserman, EB; Putukian, M				MIHALIK, J. A. S. O. N. P.; AMALFE, S. T. E. P. H. A. N. I. E. A.; ROBY, P. A. T. R. I. C. I. A. R.; FORD, C. A. S. S. I. E. B.; LYNALL, R. O. B. E. R. T. C.; RIEGLER, K. A. I. T. L. I. N. E.; TEEL, E. L. I. Z. A. B. E. T. H. F.; WASSERMAN, E. R. I. N. B.; PUTUKIAN, M. A. R. G. O. T.			Sex and Sport Differences in College Lacrosse and Soccer Head Impact Biomechanics	MEDICINE & SCIENCE IN SPORTS & EXERCISE			English	Article						CONCUSSION; FOOTBALL; HEAD IMPACT FORCES; INJURY PREVENTION; SPORTS INJURY; SPORTS SAFETY	HIGH-SCHOOL; FOOTBALL PLAYERS; EPIDEMIOLOGY; INJURIES; MENS; CONCUSSIONS; POSITION; CONTACT; DEVICES	Purpose Sport-related head impact biomechanics research has been male-centric and focused primarily on American football and ice hockey, which do not address popular sports in which both sexes participate. The purpose of this study was to quantify college female and male lacrosse and soccer head impact biomechanics. Methods Head impact biomechanics were collected from college lacrosse and soccer players across two Division 1 college athletic programs (96 female athletes, 141 male athletes; age, 19.8 +/- 1.3 yr; height, 174.8 +/- 9.2 cm; mass, 72.4 +/- 11.7 kg). We deployed helmetless head impact measurement devices (X2 Biosystems xPatch) before each event. Peak linear and rotational accelerations were log-transformed for random intercepts general linear mixed models, and subsequently categorized based on impact magnitude for additional categorical analyses. Results Most linear (69.4%) and rotational (72.3%) head impact accelerations sustained by our study cohort were categorized as mild. On average, male athletes sustained impacts with higher linear accelerations than females (P= 0.04), and lacrosse athletes sustained higher linear acceleration impacts than soccer athletes (P= 0.023). Soccer athletes sustained significantly higher-magnitude impacts during competitions versus practices (linear,P< 0.001, rotational, P< 0.001), whereas lacrosse athletes sustained higher-magnitude impacts during practices versus competition (linear,P< 0.001; rotational,P< 0.001). Male athletes sustained higher accelerations in competitions versus practice (linear,P= 0.004; rotational,P< 0.001), whereas female athletes sustained higher accelerations in practice versus competitions (linear,P< 0.001; rotational,P= 0.02). There were no interactions between sex and sport on impact magnitude. Conclusions Male athletes and lacrosse athletes experience higher-magnitude head impacts. Given the limited literature in this area, future research should continue characterizing head impact biomechanics in women's and nonhelmeted sports as well as validate nonhelmeted head impact technologies.	[MIHALIK, J. A. S. O. N. P.; ROBY, P. A. T. R. I. C. I. A. R.; FORD, C. A. S. S. I. E. B.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [MIHALIK, J. A. S. O. N. P.; ROBY, P. A. T. R. I. C. I. A. R.] Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Sch Med, Chapel Hill, NC 27515 USA; [AMALFE, S. T. E. P. H. A. N. I. E. A.; RIEGLER, K. A. I. T. L. I. N. E.; PUTUKIAN, M. A. R. G. O. T.] Princeton Univ, Univ Hlth Serv, Athlet Med, Princeton, NJ 08544 USA; [AMALFE, S. T. E. P. H. A. N. I. E. A.] Fairleigh Dickinson Univ, Sch Psychol, Teaneck, NJ USA; [FORD, C. A. S. S. I. E. B.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [LYNALL, R. O. B. E. R. T. C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [RIEGLER, K. A. I. T. L. I. N. E.] Penn State Univ, Dept Psychol, State Coll, PA USA; [TEEL, E. L. I. Z. A. B. E. T. H. F.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [WASSERMAN, E. R. I. N. B.] IQVIA, Injury Surveillance & Anal, Durham, NC USA; [PUTUKIAN, M. A. R. G. O. T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Family Med & Community Hlth, New Brunswick, NJ USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Stallings Evans Sports Med Ctr 2201, Campus Box 8700, Chapel Hill, NC 27599 USA.		Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Roby, Patricia/0000-0003-0166-4274; Wasserman, Erin/0000-0001-5957-5878	Princeton University - National Operating Committee on Standards for Athletic Equipment (NOCSAE)	The authorship team would like to acknowledge sports medicine colleagues and staff at the University of North Carolina at Chapel Hill [Alain Aguilar, Kyra Busque, Kody Campbell, Kim Chase, Nicole Fava, Justin Fegley, Missy Fraser, Chris Hirth, Yuri Jean-Baptiste, Grace Jungclas, Jacob Mir, Jacob Powell, Emily Quatromoni, Kim (Chase) Stevens, Jackie Stucker, Catherine (Lenhardt) Van Eeden, and Nina Walker] and Princeton University [Jasper Chang, Casey Maxwell, George O'Neil, and Russell Steves] for assistance with team logistics and data collection. We also want to acknowledge the consultation provided by Ruben Echemendia, PhD, related to study design and methodology. This project was funded by an investigator-initiated sponsored research grant awarded by the National Operating Committee on Standards for Athletic Equipment (NOCSAE) to Princeton University and UNC-Chapel Hill. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the NOCSAE.	Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marchesseault ER, 2018, PHYSICIAN SPORTSMED, V46, P324, DOI 10.1080/00913847.2018.1470888; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pierpoint LA, 2019, J ATHL TRAINING, V54, P42, DOI 10.4085/1062-6050-201-17; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sakamoto K, 2014, PROCEDIA ENGINEER, V72, P50, DOI 10.1016/j.proeng.2014.06.011; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Urban JE, 2019, J NEUROSURG-PEDIATR, V24, P190, DOI 10.3171/2019.2.PEDS18558; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	35	4	4	5	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2020	52	11					2349	2356		10.1249/MSS.0000000000002382			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OA3UT	WOS:000577715400009	33064408				2022-02-06	
J	Price, J; Sandbach, DD; Ercole, A; Wilson, A; Barnard, EBG				Price, James; Sandbach, Daniel D.; Ercole, Ari; Wilson, Alastair; Barnard, Ed Benjamin Graham			End-tidal and arterial carbon dioxide gradient in serious traumatic brain injury after prehospital emergency anaesthesia: a retrospective observational study	EMERGENCY MEDICINE JOURNAL			English	Article							INTRACRANIAL-PRESSURE; AIRWAY MANAGEMENT; HEAD-INJURY; HYPERVENTILATION; VENTILATION; UTILITY	Objectives In the UK, 20% of patients with severe traumatic brain injury (TBI) receive prehospital emergency anaesthesia (PHEA). Current guidance recommends an end-tidal carbon dioxide (ETCO2) of 4.0-4.5 kPa (30.0-33.8 mm Hg) to achieve a low-normal arterial partial pressure of CO2 (PaCO2), and reduce secondary brain injury. This recommendation assumes a 0.5 kPa (3.8 mm Hg) ETCO2-PaCO2 gradient. However, the gradient in the acute phase of TBI is unknown. The primary aim was to report the ETCO2-PaCO2 gradient of TBI patients at hospital arrival. Methods A retrospective cohort study of adult patients with serious TBI, who received a PHEA by a prehospital critical care team in the East of England between 1 April 2015 and 31 December 2017. Linear regression was performed to test for correlation and reported as R-squared (R-2). A Bland-Altman plot was used to test for paired ETCO2 and PaCO2 agreement and reported with 95% CI. ETCO2-PaCO2 gradient data were compared with a two-tailed, unpaired, t-test. Results 107 patients were eligible for inclusion. Sixty-seven patients did not receive a PaCO2 sample within 30 min of hospital arrival and were therefore excluded. Forty patients had complete data and were included in the final analysis; per protocol. The mean ETCO2-PaCO2 gradient was 1.7 (+/- 1.0) kPa (12.8 mm Hg), with moderate correlation (R-2=0.23, p=0.002). The Bland-Altman bias was 1.7 (95% CI 1.4 to 2.0) kPa with upper and lower limits of agreement of 3.6 (95% CI 3.0 to 4.1) kPa and -0.2 (95% CI -0.8 to 0.3) kPa, respectively. There was no evidence of a larger gradient in more severe TBI (p=0.29). There was no significant gradient correlation in patients with a coexisting serious thoracic injury (R-2=0.13, p=0.10), and this cohort had a larger ETCO2-PaCO2 gradient, 2.0 (+/- 1.1) kPa (15.1 mm Hg), p=0.01. Patients who underwent prehospital arterial blood sampling had an arrival PaCO2 of 4.7 (+/- 0.2) kPa (35.1 mm Hg). Conclusion There is only moderate correlation of ETCO2 and PaCO2 at hospital arrival in patients with serious TBI. The mean ETCO2-PaCO2 gradient was 1.7 (+/- 1.0) kPa (12.8 mm Hg). Lower ETCO2 targets than previously recommended may be safe and appropriate, and there may be a role for prehospital PaCO2 measurement.	[Price, James; Sandbach, Daniel D.; Ercole, Ari; Wilson, Alastair; Barnard, Ed Benjamin Graham] East Anglian Air Ambulance, Dept Res Audit Innovat & Dev RAID, Norwich, Norfolk, England; [Price, James; Barnard, Ed Benjamin Graham] Addenbrookes Hosp, Emergency Dept, Cambridge, England; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Wilson, Alastair] Royal London Hosp, Emergency Dept, London, England; [Barnard, Ed Benjamin Graham] Royal Ctr Def Med Res & Acad, Acad Dept Mil Emergency Med, Birmingham, W Midlands, England		Price, J (corresponding author), East Anglian Air Ambulance, Dept Res Audit Innovat & Dev RAID, Norwich, Norfolk, England.	james.price@eaaa.org.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Price, James/0000-0002-9643-692X			Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barnard E, 2014, J ROY ARMY MED CORPS, V160, P245, DOI 10.1136/jramc-2013-000117; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; BINDER N, 1994, AM J PERINAT, V11, P237, DOI 10.1055/s-2008-1040754; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burgess MR, 2018, EMERG MED J, V35, P532, DOI 10.1136/emermed-2017-206592; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Cooper CJ, 2013, PREHOSP DISASTER MED, V28, P87, DOI 10.1017/S1049023X12001768; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Feldmann E, 1999, J Stroke Cerebrovasc Dis, V8, P176, DOI 10.1016/S1052-3057(99)80024-X; FLETCHER R, 1984, BRIT J ANAESTH, V56, P109, DOI 10.1093/bja/56.2.109; Gaur Pallavi, 2017, Asian J Neurosurg, V12, P475, DOI 10.4103/1793-5482.180959; Holmes J, 2012, PREHOSP EMERG CARE, V16, P210, DOI 10.3109/10903127.2011.640416; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Lockey DJ, 2017, ANAESTHESIA, V72, P379, DOI 10.1111/anae.13779; Lockey DJ, 2015, BRIT J ANAESTH, V114, P657, DOI 10.1093/bja/aeu412; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nathanson MH, 2020, ANAESTHESIA, V75, P234, DOI 10.1111/anae.14866; Prause, 1997, Crit Care, V1, P79, DOI 10.1186/cc108; Price J, 2020, EMERG MED J, V37, P674, DOI 10.1136/emermed-2019-209077; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Razi E, 2012, ARCH TRAUMA RES, V1, P58, DOI 10.5812/atr.6444; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Walrath BD, 2018, MIL MED, V183, P29, DOI 10.1093/milmed/usy124; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Yang JT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9448; Zavorsky GS, 2007, RESP PHYSIOL NEUROBI, V155, P268, DOI 10.1016/j.resp.2006.07.002	32	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	NOV	2020	37	11					674	+		10.1136/emermed-2019-209077			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OJ5LQ	WOS:000584003100004	32928874	Green Published, hybrid			2022-02-06	
J	Sarmiento, K; Waltzman, D; Lumba-Brown, A; Yeates, KO; Putukian, M; Herring, S				Sarmiento, Kelly; Waltzman, Dana; Lumba-Brown, Angela; Yeates, Keith O.; Putukian, Margot; Herring, Stanley			CDC Guideline on Mild Traumatic Brain Injury in Children: Important Practice Takeaways for Sports Medicine Providers	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; brain; injury; guideline; athlete	POSTCONCUSSIVE SYMPTOMS; SOCIAL SUPPORT; RISK-FACTORS; CONCUSSION; EPIDEMIOLOGY; DEPRESSION; RECOVERY	Objectives: The Centers for Disease Control and Prevention (CDC) published an evidence-based guideline on the diagnosis and management of pediatric mild traumatic brain injury (mTBI) in 2018. This commentary provides key practice takeaways for sports medicine providers outlined in the Guideline recommendations. Data Sources: The CDC Pediatric mTBI Guideline was developed through a rigorous scientific process using a modified Grading of Recommendations, Assessment, Development and Evaluations (GRADE) methodology. A systematic review of the scientific literature published over a 25-year period for all causes of pediatric mTBI formed the basis of the Guideline. Main Results: The key practice takeaways for sports medicine providers focus on preseason evaluations, neuroimaging, symptom-based assessment, managing recovery, monitoring for persistent symptoms, and return to activity, including sport and school. Conclusions: Sports medicine providers play an integral part in the implementation of evidence-based practices that promote appropriate diagnosis and management of mTBI in children. This commentary highlights key practice takeaways that sports medicine providers can implement.	[Sarmiento, Kelly; Waltzman, Dana] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Hwy NE,Mail Stop F62, Atlanta, GA 30341 USA; [Lumba-Brown, Angela] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA 94305 USA; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Putukian, Margot] Princeton Univ, Dept Athlet Med, Univ Hlth Serv, Princeton, NJ 08544 USA; [Herring, Stanley] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Herring, Stanley] Univ Washington, Sch Med, Dept Orthopaed, Seattle, WA USA; [Herring, Stanley] Univ Washington, Sch Med, Dept Sports Med, Seattle, WA USA; [Herring, Stanley] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Hwy NE,Mail Stop F62, Atlanta, GA 30341 USA.	KSarmiento@cdc.gov	Yeates, Keith/AAJ-4223-2020		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Brain Canada; Alberta Health Services; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Research Institute at Nationwide Children's Hospital in Columbus, Ohio; National Collegiate Athletics Association-Department of Defense Grand Alliance; National Operating Committee on Standards for Athletic Equipment	No funding supported the development of this commentary. K. O. Yates is the President of the International Neuropsychological Society. He receives speaker honorarium and book royalties from Guilford Press and Cambridge University Press. He also discloses his research grant support from the National Institutes of Health, Brain Canada, Alberta Health Services, and the Canadian Institutes of Health Research, and his research support from the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. M. Putukian works as a consultant to the USA Football Medical Advisory Committee, National Football League Head Neck and Spine Committee, US Lacrosse Sports Science & Safety Committee, National Collegiate Athletics Association Concussion Task Force, the US Soccer Medical Advisory Committee, and serves as a medical consultant for Major League Soccer. She also reports receiving a research grant support from the National Collegiate Athletics Association-Department of Defense Grand Alliance and the National Operating Committee on Standards for Athletic Equipment. S. Herring reports stock options from VICIS, a helmet manufacturer. The remaining authors report no conflicts of interest.	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lumba-Brown A, 2018, JAMA PEDIAT, V173, pe182853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	40	4	4	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2020	30	6					612	615		10.1097/JSM.0000000000000704			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	OP0UO	WOS:000587794700023	30489330	Green Accepted			2022-02-06	
J	Vazifehkhah, S; Khanizadeh, AM; Mojarad, TB; Nikbakht, F				Vazifehkhah, Somayeh; Khanizadeh, Ali Mohammad; Mojarad, Tourandokht Balouchnejad; Nikbakht, Farnaz			The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Metformin; Inflammation; Astrogiosis; Progranulin; Temporal lobe epilepsy	TRAUMATIC BRAIN-INJURY; INFLAMMATORY CYTOKINES; EXPRESSION; SEIZURES; DISEASE	Temporal lobe epilepsy (TLE) is the most prevalent and drug-resistant form of parietal epilepsy. TLE is accompanied by neuroinflammation in the brain, which involves reactive glial cells. Metformin is an old antidiabetic drug with anti-inflammatory and neuroprotective effects. Considering the importance of inflammation in epilepsy, we have investigated the effect of metformin on astrogliosis markers as well as pro and anti-inflammatory cytokines and its effect on progranulin expression (an important neuroprotective protein in epilepsy) in a rat TLE model. TLE was induced by intracerebroventricular microinjection of kainic acid. Metformin was orally administered for two weeks before the induction of epilepsy. Astrogliosis markers (GFAP and S100B), as well as IL-15 and IL-10 levels, were detected by ELISA. The progranulin level was measured by Western blotting and immunohistochemistry in the hippocampus. Our results showed basal levels of GFAP, S100B, and pro-inflammatory cytokine increased in the epileptic rats but were significantly ameliorated after pretreatment with metformin. However, anti-inflammatory cytokine and progranulin also increased in the pre-treated rats and metformin alone group. An increment in the progranulin level emphasizes the importance of this protein in epilepsy. Hence, metformin may exert at least some of its anti-inflammatory effects by increasing progranulin level. In sum, we have concluded that progranulin can be a key mediator in epilepsy, and the anti-inflammatory action of metformin in status epilepticus is through increasing the secretion of IL-10 and inhibiting IL-1 beta and astrogliosis.	[Vazifehkhah, Somayeh; Khanizadeh, Ali Mohammad; Mojarad, Tourandokht Balouchnejad; Nikbakht, Farnaz] Iran Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Tehran, Iran; [Vazifehkhah, Somayeh; Khanizadeh, Ali Mohammad; Mojarad, Tourandokht Balouchnejad; Nikbakht, Farnaz] Iran Univ Med Sci, Dept Physiol, Sch Med, Tehran, Iran		Nikbakht, F (corresponding author), Iran Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Tehran, Iran.	Nikbakht.f@iums.ac.ir			Iran University of Medical Sciences [29683]; Hemmat Highway, Tehran, Iran	This work was supported by a grant (No: 29683) from the Iran University of Medical Sciences (Vice Chancellor for Research & Technology), Hemmat Highway, Tehran, Iran.	Al Sufiani Fahd, 2012, Epilepsy Res Treat, V2012, P624519, DOI 10.1155/2012/624519; Amaral GF, 2016, BRAZ J PHARM SCI, V52, P623, DOI [10.1590/s1984-82502016000400006, 10.1590/S1984-82502016000400006]; Asadbegi M, 2016, BRAIN RES BULL, V121, P178, DOI 10.1016/j.brainresbull.2016.02.005; Burmeister AR, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00458; Chiavegato A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00155; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Fu WY, 2017, FASEB J, V31, P1354, DOI 10.1096/fj.201601134R; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Guo DJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03032-0; Hu SX, 2000, NEUROIMMUNOMODULAT, V7, P153, DOI 10.1159/000026433; Jia J, 2015, CURR NEUROPHARMACOL, V13, P389, DOI 10.2174/1570159X13666150205143555; Kanazawa M, 2015, BRAIN, V138, P1932, DOI 10.1093/brain/awv079; Kessler B, 2017, SCI REP-UK, V7, DOI 10.1038/srep42791; Kortvelyessy P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030490; Largani SHH, 2019, J MOL HISTOL, V50, P263, DOI 10.1007/s10735-019-09824-0; Levin S G, 2007, Neurosci Behav Physiol, V37, P467, DOI 10.1007/s11055-007-0036-1; Lin YF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00227; Markowicz-Piasecka M, 2017, PHARM RES-DORDR, V34, P2614, DOI 10.1007/s11095-017-2199-y; Mehrabi S, 2018, METAB BRAIN DIS, V33, P107, DOI 10.1007/s11011-017-0132-z; Mohamed MA, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106893; Muri L, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1549-6; Nikbakht F, 2019, NEUROPEPTIDES, V76, DOI 10.1016/j.npep.2019.05.003; Pan YB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0754-9; Patil SP, 2014, NEUROSCIENCE, V277, P747, DOI 10.1016/j.neuroscience.2014.07.046; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Piscopo P, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00031; Rindflesch TC, 2018, J BIOMED SEMANT, V9, DOI 10.1186/s13326-018-0192-y; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Su J, 2015, NEUROCHEM RES, V40, P621, DOI 10.1007/s11064-014-1504-y; Sun Y, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1452-1; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tao J, 2012, BRAIN RES, V1436, P130, DOI 10.1016/j.brainres.2011.11.063; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Terrone G, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107742; Vazifekhah S., 2019, J ALZHEIMERS NEURODE; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Vezzani Annamaria, 2007, Epilepsy Curr, V7, P45, DOI 10.1111/j.1535-7511.2007.00165.x; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang Z.-J., 2018, J HAINAN MED U, V24, P48; Yimer EM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/6234758; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	43	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	NOV	2020	109								101849	10.1016/j.jchemneu.2020.101849			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	OH1XM	WOS:000582364400014	32679167				2022-02-06	
J	Liston, TE; Hinz, S; Muller, CE; Holstein, DM; Wendling, J; Melton, RJ; Campbell, M; Korinek, WS; Suresh, RR; Sethre-Hofstad, DA; Gao, ZG; Tosh, DK; Jacobson, KA; Lechleiter, JD				Liston, Theodore E.; Hinz, Sonja; Mueller, Christa E.; Holstein, Deborah M.; Wendling, Jay; Melton, Roger J.; Campbell, Mary; Korinek, William S.; Suresh, R. Rama; Sethre-Hofstad, Dane A.; Gao, Zhan-Guo; Tosh, Dilip K.; Jacobson, Kenneth A.; Lechleiter, James D.			Nucleotide P2Y(1) receptor agonists are in vitro and in vivo prodrugs of A(1)/A(3) adenosine receptor agonists: implications for roles of P2Y(1) and A(1)/A(3) receptors in physiology and pathology	PURINERGIC SIGNALLING			English	Article						P2Y(1) receptor; Prodrug; Adenosine; Ectonucleotidase; A(3) receptor; A(1) receptor	ASTROCYTE MITOCHONDRIAL METABOLISM; P2Y1 RECEPTOR; ANTAGONISTS; RAT; DERIVATIVES; IDENTIFICATION; STIMULATION; ANALOGS; AMP; ATP	Rapid phosphoester hydrolysis of endogenous purine and pyrimidine nucleotides has challenged the characterization of the role of P2 receptors in physiology and pathology. Nucleotide phosphoester stabilization has been pursued on a number of medicinal chemistry fronts. We investigated the in vitro and in vivo stability and pharmacokinetics of prototypical nucleotide P2Y(1) receptor (P2Y(1)R) agonists and antagonists. These included the riboside nucleotide agonist 2-methylthio-ADP and antagonist MRS2179, as well as agonist MRS2365 and antagonist MRS2500 containing constrained (N)-methanocarba rings, which were previously reported to form nucleotides that are more slowly hydrolyzed at the alpha-phosphoester compared with the ribosides. In vitro incubations in mouse and human plasma and blood demonstrated the rapid hydrolysis of these compounds to nucleoside metabolites. This metabolism was inhibited by EDTA to chelate divalent cations required by ectonucleotidases for nucleotide hydrolysis. This rapid hydrolysis was confirmed in vivo in mouse pharmacokinetic studies that demonstrate that MRS2365 is a prodrug of the nucleoside metabolite AST-004 (MRS4322). Furthermore, we demonstrate that the nucleoside metabolites of MRS2365 and 2-methylthio-ADP are adenosine receptor (AR) agonists, notably at A(3) and A(1)ARs. In vivo efficacy of MRS2365 in murine models of traumatic brain injury and stroke can be attributed to AR activation by its nucleoside metabolite AST-004, rather than P2Y(1)R activation. This research suggests the importance of reevaluation of previous in vitro and in vivo research of P2YRs and P2XRs as there is a potential that the pharmacology attributed to nucleotide agonists is due to AR activation by active nucleoside metabolites.	[Liston, Theodore E.; Korinek, William S.; Sethre-Hofstad, Dane A.] Astrocyte Pharmaceut Inc, Suite 1800,245 First St, Cambridge, MA 02142 USA; [Hinz, Sonja; Mueller, Christa E.] Univ Bonn, Pharmaceut Inst, PharmaCtr Bonn, Pharmaceut & Med Chem, Bonn, Germany; [Holstein, Deborah M.; Lechleiter, James D.] Univ Texas Hlth San Antonio, San Antonio, TX USA; [Wendling, Jay; Melton, Roger J.; Campbell, Mary] Inotiv, Maryland Hts, MO USA; [Suresh, R. Rama; Gao, Zhan-Guo; Tosh, Dilip K.; Jacobson, Kenneth A.] NIDDK, NIH, Bethesda, MD 20892 USA		Liston, TE (corresponding author), Astrocyte Pharmaceut Inc, Suite 1800,245 First St, Cambridge, MA 02142 USA.	liston@astrocytepharma.com	Jacobson, Kenneth A./A-1530-2009	Jacobson, Kenneth A./0000-0001-8104-1493; Liston, Theodore/0000-0002-0828-797X; Korinek, William/0000-0002-6293-1623	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS093756]; NIDDK Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [ZIADK31117]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R41NS093756, the NIDDK Intramural Research Program (ZIADK31117) and the Deutsche Forschungsgemeinschaft (DFG).	Alnouri MW, 2015, PURINERG SIGNAL, V11, P389, DOI 10.1007/s11302-015-9460-9; Aslam M, 2013, THROMB RES, V132, P548, DOI 10.1016/j.thromres.2013.08.021; Azran S, 2015, J MED CHEM, V58, P8427, DOI 10.1021/acs.jmedchem.5b00575; Azran S, 2013, J MED CHEM, V56, P4938, DOI 10.1021/jm400197m; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Behrenswerth A, 2009, BIOORGAN MED CHEM, V17, P2842, DOI 10.1016/j.bmc.2009.02.027; BINET L, 1950, PRESSE MED, V58, P1201; Bird JE, 2012, J THROMB THROMBOLYS, V34, P199, DOI 10.1007/s11239-012-0745-3; Boeynaems JM, 2005, SEMIN THROMB HEMOST, V31, P139, DOI 10.1055/s-2005-869519; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Borrmann T, 2009, J MED CHEM, V52, P3994, DOI 10.1021/jm900413e; Bourdon DM, 2006, J THROMB HAEMOST, V4, P861, DOI 10.1111/j.1538-7836.2006.01866.x; BURNSTOCK G, 1970, BRIT J PHARMACOL, V40, P668, DOI 10.1111/j.1476-5381.1970.tb10646.x; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; Burnstock GA, 1978, CELL MEMBRANE RECEPT, P107; Caiazzo E, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00775; Cattaneo M, 2004, BIOCHEM PHARMACOL, V68, P1995, DOI 10.1016/j.bcp.2004.06.026; Chen J, 2012, ACTA BIOCH BIOPH SIN, V44, P367, DOI 10.1093/abbs/gms007; Ciancetta A, 2017, J CHEM INF MODEL, V57, P3104, DOI 10.1021/acs.jcim.7b00528; Conroy S, 2016, J MED CHEM, V59, P9981, DOI 10.1021/acs.jmedchem.5b01972; Dias DA, 2017, CELL BIOCHEM FUNCT, V35, P358, DOI 10.1002/cbf.3281; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Dunne H, 2015, BMC P S1, V9, pA2, DOI [10.1186/1753-6561-9-S1-A2, DOI 10.1186/1753-6561-9-S1-A2]; Durnin L, 2014, P NATL ACAD SCI USA, V111, P15821, DOI 10.1073/pnas.1409078111; El-Tayeb A, 2006, J MED CHEM, V49, P7076, DOI 10.1021/jm060848j; Eliahu SE, 2009, EUR J MED CHEM, V44, P1525, DOI 10.1016/j.ejmech.2008.07.015; FOX IH, 1978, ANNU REV BIOCHEM, V47, P655, DOI 10.1146/annurev.bi.47.070178.003255; GALINDO A, 1967, J PHYSIOL-LONDON, V192, P359, DOI 10.1113/jphysiol.1967.sp008305; Gao ZG, 2003, BIOCHEM PHARMACOL, V65, P1675, DOI 10.1016/S0006-2952(03)00153-9; Gao ZG, 2002, J MED CHEM, V45, P4471, DOI 10.1021/jm020211+; Gao ZG, 2004, CURR TOP MED CHEM, V4, P855, DOI 10.2174/1568026043450989; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Hechler B, 2006, J PHARMACOL EXP THER, V316, P556, DOI 10.1124/jpet.105.094037; Houston D, 2006, BRIT J PHARMACOL, V147, P459, DOI 10.1038/sj.bjp.0706453; HUMPHRIES RG, 1995, BRIT J PHARMACOL, V115, P1110, DOI 10.1111/j.1476-5381.1995.tb15925.x; Ingall AH, 1999, J MED CHEM, V42, P213, DOI 10.1021/jm981072s; Jensen K, 2012, N-S ARCH PHARMACOL, V385, P519, DOI 10.1007/s00210-011-0719-6; Koch H, 2015, NEUROPSYCHOPHARMACOL, V40, P305, DOI 10.1038/npp.2014.173; Kochanek P.M., 2013, ADENOSINE, P307, DOI [10.1007/978-1-4614-3903-5_, DOI 10.1007/978-1-4614-3903-5]; Kuboyama K, 2011, J CEREBR BLOOD F MET, V31, P1930, DOI 10.1038/jcbfm.2011.49; MAGUIRE MH, 1984, PLACENTA, V5, P21, DOI 10.1016/S0143-4004(84)80046-6; Mane N, 2016, NEUROPHARMACOLOGY, V110, P376, DOI 10.1016/j.neuropharm.2016.07.033; Obach RS, 1997, J PHARMACOL EXP THER, V283, P46; Ohno M, 2004, BIOORGAN MED CHEM, V12, P2995, DOI 10.1016/j.bmc.2004.03.031; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; Ravi RG, 2002, J MED CHEM, V45, P2090, DOI 10.1021/jm010538v; Reichenbach N, 2018, J EXP MED, V215, P1649, DOI 10.1084/jem.20171487; Shen JB, 2007, AM J PHYSIOL-HEART C, V292, pH1077, DOI 10.1152/ajpheart.00515.2006; Shigetomi E, 2018, J NEUROSCI, V38, P1383, DOI 10.1523/JNEUROSCI.2625-17.2017; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Vetri F, 2011, AM J PHYSIOL-HEART C, V301, pH1369, DOI 10.1152/ajpheart.00556.2011; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Wenker IC, 2013, HYPERTENSION, V62, P263, DOI 10.1161/HYPERTENSIONAHA.113.01487; Wong PC, 2016, J THROMB THROMBOLYS, V41, P514, DOI 10.1007/s11239-015-1302-7; Wu J, 2017, WORLD J GASTROENTERO, V23, P6339, DOI 10.3748/wjg.v23.i34.6339; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Yegutkin GG, 1999, J RECEPT SIGNAL TR R, V19, P437, DOI 10.3109/10799899909036663; Zheng W, 2013, J CEREBR BLOOD F MET, V33, P600, DOI 10.1038/jcbfm.2012.214; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097; Zimmermann H., 2006, NOVART FDN SYMP, V276, P275; Zimmermann H, 2006, NOVART FDN SYMP, V276, P233; Zimmermann H., 2006, NOVART FDN SYMP, V276, P128; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113; ZIMMET J, 1993, NUCLEOS NUCLEOT, V12, P1, DOI 10.1080/07328319308016190	64	4	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1573-9538	1573-9546		PURINERG SIGNAL	Purinergic Signal.	DEC	2020	16	4					543	559		10.1007/s11302-020-09732-z		OCT 2020	17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QB4GE	WOS:000583124000001	33129204	Green Published			2022-02-06	
J	Khosdelazad, S; Jorna, LS; McDonald, S; Rakers, SE; Huitema, RB; Buunk, AM; Spikman, JM				Khosdelazad, Sara; Jorna, Lieke S.; McDonald, Skye; Rakers, Sandra E.; Huitema, Rients B.; Buunk, Anne M.; Spikman, Jacoba M.			Comparing static and dynamic emotion recognition tests: Performance of healthy participants	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SOCIAL COGNITION; INTERPERSONAL-BEHAVIOR; FACIAL EXPRESSIONS; ALZHEIMERS-DISEASE; SEX-DIFFERENCES; NEURAL SYSTEMS; PERCEPTION; DEFICITS; ABILITY	Facial expressions have a communicatory function and the ability to read them is a prerequisite for understanding feelings and thoughts of other individuals. Impairments in recognition of facial emotional expressions are frequently found in patients with neurological conditions (e.g. stroke, traumatic brain injury, frontotemporal dementia). Hence, a standard neuropsychological assessment should include measurement of emotion recognition. However, there is debate regarding which tests are most suitable. The current study evaluates and compares three different emotion recognition tests. 84 healthy participants were included and assessed with three tests, in varying order: a. Ekman 60 Faces Test (FEEST) b. Emotion Recognition Task (ERT) c. Emotion Evaluation Test (EET). The tests differ in type of stimuli from static photographs (FEEST) to more dynamic stimuli in the form of morphed photographs (ERT) to videos (EET). Comparing performances on the three tests, the lowest total scores (67.3% correct answers) were found for the ERT. Significant, but moderate correlations were found between the total scores of the three tests, but nearly all correlations between the same emotions across different tests were not significant. Furthermore, we found cross-over effects of the FEEST and EET to the ERT; participants attained higher total scores on the ERT when another emotion recognition test had been administered beforehand. Moreover, the ERT proved to be sensitive to the effects of age and education. The present findings indicate that despite some overlap, each emotion recognition test measures a unique part of the construct. The ERT seemed to be the most difficult test: performances were lowest and influenced by differences in age and education and it was the only test that showed a learning effect after practice with other tests. This highlights the importance of appropriate norms.	[Khosdelazad, Sara; Jorna, Lieke S.; Rakers, Sandra E.; Huitema, Rients B.; Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia		Khosdelazad, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands.	s.khosdelazad@umcg.nl		Khosdelazad, Sara/0000-0001-7674-352X; Jorna, Lieke/0000-0001-6276-539X			Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2008, DOCENCIA, V34, P63; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Buunk AM, 2017, NEUROPSYCHOLOGIA, V103, P131, DOI 10.1016/j.neuropsychologia.2017.07.015; Calder A. J., 2002, PSYCHOLOGY, V126, P420; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Campbell R, 2002, NEUROPSYCHOLOGIA, V40, P575, DOI 10.1016/S0028-3932(01)00164-6; Christidi F, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/1849794; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Gazzaley A, 2007, NEUROPSYCHOLOGY, V21, P532, DOI 10.1037/0894-4105.21.5.532; Genova HM, 2017, SOC NEUROSCI-UK, V12, P303, DOI 10.1080/17470919.2016.1173584; Goldberg Terry E, 2015, Alzheimers Dement (Amst), V1, P103, DOI 10.1016/j.dadm.2014.11.003; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hendriks M, 2014, NEUROPSYCHOLOGICAL D, DOI [10.1159/000357778, DOI 10.1159/000357778]; Herrera E, 2011, J NEUROL SCI, V310, P237, DOI 10.1016/j.jns.2011.06.034; HOLM S, 1979, SCAND J STAT, V6, P65; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Horning SM, 2012, AGING NEUROPSYCHOL C, V19, P657, DOI 10.1080/13825585.2011.645011; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jenkins LM, 2014, PSYCHIAT RES-NEUROIM, V224, P192, DOI 10.1016/j.pscychresns.2014.08.007; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kim K, 2014, J PHYS THER SCI; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Lavenu I, 2005, DEMENT GERIATR COGN, V19, P37, DOI 10.1159/000080969; Lee NC, 2013, EMOTION, V13, P1030, DOI 10.1037/a0033560; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mill A, 2009, EMOTION, V9, P619, DOI 10.1037/a0016562; Montagne B, 2008, EUR PSYCHIAT, V23, P26, DOI 10.1016/j.eurpsy.2007.07.007; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Neale Jeffrey A, 2011, Clin Colon Rectal Surg, V24, P149, DOI 10.1055/s-0031-1285999; Nijsse B, 2019, ARCH PHYS MED REHAB, V100, P1300, DOI 10.1016/j.apmr.2019.01.023; Okosun IS, 2014, DIABETES METAB SYND, V8, P75, DOI 10.1016/j.dsx.2014.04.026; Phillips LH, 2010, PSYCHOL AGING, V25, P38, DOI 10.1037/a0017369; Pietschnig J, 2016, INT PSYCHOGERIATR, V28, P477, DOI 10.1017/S1041610215001520; Rahman Q, 2004, BRAIN COGNITION, V54, P179, DOI 10.1016/j.bandc.2004.01.002; Rigon A, 2018, NEUROPSYCHOLOGY, V32, P476, DOI 10.1037/neu0000368; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Shimokawa A, 2001, BRAIN COGNITION, V47, P423, DOI 10.1006/brcg.2001.1318; Smith A, 2010, SYMBOL DIGIT MODALIT; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Statistics Netherlands CBS, 2018, TRENDS NETH SOC FIG; Stinissen J., 1970, MANUAL DUTCH VERSION; Trauffer N.M., 2013, PSYCHOL TOPICS, V22, P237; Tumanski S, 2007, MEAS SCI TECHNOL, V18, pR31, DOI 10.1088/0957-0233/18/3/R01; Wasser CI, 2018, NEUROPSYCHOLOGY, V32, P230, DOI 10.1037/neu0000400; Westerhof-Evers HJ, 2014, J CLIN EXP NEUROPSYC, V36, P1031, DOI 10.1080/13803395.2014.966661; Whitaker DK, 2011, BEST PRACT RES-CLIN, V25, P277, DOI 10.1016/j.bpa.2011.02.001; Williams LM, 2009, J CLIN EXP NEUROPSYC, V31, P257, DOI 10.1080/13803390802255635; Wingenbach TSH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190634; 2005, EUROPEAN PUBLIC LAW, V0011, P00392	67	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241297	10.1371/journal.pone.0241297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	WOS:000588374000025	33112932	gold, Green Published			2022-02-06	
J	Minta, K; Brinkmalm, G; Al Nimer, F; Thelin, EP; Piehl, F; Tullberg, M; Jeppsson, A; Portelius, E; Zetterberg, H; Blennow, K; Andreasson, U				Minta, Karolina; Brinkmalm, Gunnar; Al Nimer, Faiez; Thelin, Eric P.; Piehl, Fredrik; Tullberg, Mats; Jeppsson, Anna; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf			Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury	SCIENTIFIC REPORTS			English	Article								Matrix metalloproteinases (MMPs) are extracellular enzymes involved in the degradation of extracellular matrix (ECM) proteins. Increased expression of MMPs have been described in traumatic brain injury (TBI) and may contribute to additional tissue injury and blood-brain barrier damage. The objectives of this study were to determine longitudinal changes in cerebrospinal fluid (CSF) concentrations of MMPs after acute TBI and in relation to clinical outcomes, with patients with idiopathic normal pressure hydrocephalus (iNPH) serving as a contrast group. The study included 33 TBI patients with ventricular CSF serially sampled, and 38 iNPH patients in the contrast group. Magnetic bead-based immunoassays were utilized to measure the concentrations of eight MMPs in ventricular human CSF. CSF concentrations of MMP-1, MMP-3 and MMP-10 were increased in TBI patients (at baseline) compared with the iNPH group (p < 0.001), while MMP-2, MMP-9 and MMP-12 did not differ between the groups. MMP-1, MMP-3 and MMP-10 concentrations decreased with time after trauma (p = 0.001-0.04). Increased concentrations of MMP-2 and MMP-10 in CSF at baseline were associated with an unfavourable TBI outcome (p = 0.002-0.02). Observed variable pattern of changes in MMP concentrations indicates that specific MMPs serve different roles in the pathophysiology following TBI, and are in turn associated with clinical outcomes.	[Minta, Karolina; Brinkmalm, Gunnar; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Brinkmalm, Gunnar; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Al Nimer, Faiez; Thelin, Eric P.; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric P.] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Tullberg, Mats; Jeppsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Minta, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden.	karolina.minta@neuro.gu.se	Brinkmalm, Gunnar/AAH-3914-2021; Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364; Tullberg, Mats/0000-0003-4997-5266; Al Nimer, Faiez/0000-0003-0937-5995	Gothenburg University Library	Open Access funding provided by Gothenburg University Library.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Ahmed S. H., [Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease, 113, 2089-2096. https://doi.org/10.1161/CIRCULATIONAHA.105.573865]; AKAI K, 1987, ACTA PATHOL JAPON, V37, P97; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Castellazzi M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01080; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Dewan M. C, 2018, J NEUROSURG, P352, DOI [10.3171/2017.10.JNS17, DOI 10.3171/2017.10.JNS17]; Fingleton B, 2017, BBA-MOL CELL RES, V1864, P2036, DOI 10.1016/j.bbamcr.2017.05.010; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; JENNETT B, 1975, LANCET, V1, P480; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minta K, 2019, CLIN CHEM LAB MED, V57, P1565, DOI 10.1515/cclm-2019-0034; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; TEASDALE G, 1974, LANCET, V2, P81; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Tullberg M, 1998, NEUROLOGY, V50, P1122, DOI 10.1212/WNL.50.4.1122; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258	51	4	5	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 22	2020	10	1							18075	10.1038/s41598-020-75233-z			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD2UK	WOS:000615379800068	33093584	Green Published, gold			2022-02-06	
J	Tiwari, S; Kazemi-Moridani, A; Zheng, Y; Barney, CW; McLeod, KR; Dougan, CE; Crosby, AJ; Tew, GN; Peyton, SR; Cai, SQ; Lee, JH				Tiwari, Sacchita; Kazemi-Moridani, Amir; Zheng, Yue; Barney, Christopher W.; McLeod, Kelly R.; Dougan, Carey E.; Crosby, Alfred J.; Tew, Gregory N.; Peyton, Shelly R.; Cai, Shengqiang; Lee, Jae-Hwang			Seeded laser-induced cavitation for studying high-strain-rate irreversible deformation of soft materials	SOFT MATTER			English	Article							MECHANICAL CHARACTERIZATION; ELASTIC PROPERTIES; INDENTATION; HYDROGELS; MODULUS; NANOINDENTATION; FRACTURE; CRYSTALLIZATION; DYNAMICS; RHEOLOGY	Characterizing the high-strain-rate and high-strain mechanics of soft materials is critical to understanding the complex behavior of polymers and various dynamic injury mechanisms, including traumatic brain injury. However, their dynamic mechanical deformation under extreme conditions is technically difficult to quantify and often includes irreversible damage. To address such challenges, we investigate an experimental method, which allows quantification of the extreme mechanical properties of soft materials using ultrafast stroboscopic imaging of highly reproducible laser-induced cavitation events. As a reference material, we characterize variably cross-linked polydimethylsiloxane specimens using this method. The consistency of the laser-induced cavitation is achieved through the introduction of laser absorbing seed microspheres. Based on a simplified viscoelastic model, representative high-strain-rate shear moduli and viscosities of the soft specimens are quantified across different degrees of crosslinking. The quantified rheological parameters align well with the time-temperature superposition prediction of dynamic mechanical analysis. The presented method offers significant advantages with regard to quantifying high-strain rate, irreversible mechanical properties of soft materials and tissues, compared to other methods that rely upon the cyclic dynamics of cavitation. These advances are anticipated to aid in the understanding of how damage and injury develop in soft materials and tissues.	[Tiwari, Sacchita; Kazemi-Moridani, Amir; Lee, Jae-Hwang] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Zheng, Yue; Cai, Shengqiang] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Barney, Christopher W.; McLeod, Kelly R.; Crosby, Alfred J.; Tew, Gregory N.] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA; [Dougan, Carey E.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA		Lee, JH (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.	leejh@umass.edu	Lee, Jae-Hwang/F-7595-2014	Lee, Jae-Hwang/0000-0002-2546-1044; zheng, yue/0000-0002-0492-5946; Crosby, Alfred/0000-0001-8850-8869; Tiwari, Sacchita/0000-0002-7572-0526; Kazemi-Moridani, Amir/0000-0003-4496-9553	Office of Naval ResearchOffice of Naval Research [N00014-17-1-2056]	This research was supported by the Office of Naval Research under grant N00014-17-1-2056.	Akhtar R, 2011, MATER TODAY, V14, P96, DOI 10.1016/S1369-7021(11)70059-1; Bae J, 2015, ACS APPL MATER INTER, V7, P14734, DOI 10.1021/acsami.5b02567; Barney CW, 2020, P NATL ACAD SCI USA, V117, P9157, DOI 10.1073/pnas.1920168117; Barney CW, 2019, SOFT MATTER, V15, P7390, DOI 10.1039/c9sm01173k; Bosq N, 2014, PHYS CHEM CHEM PHYS, V16, P7830, DOI 10.1039/c4cp00164h; Bush BG, 2015, SOFT MATTER, V11, P7191, DOI 10.1039/c5sm01210d; Chen DTN, 2010, ANNU REV CONDEN MA P, V1, P301, DOI 10.1146/annurev-conmatphys-070909-104120; Chen WNW, 2011, MECH ENG SER, P1, DOI 10.1007/978-1-4419-7982-7; Cicuta P, 2007, SOFT MATTER, V3, P1449, DOI 10.1039/b706004c; Constantinides G, 2008, J BIOMECH, V41, P3285, DOI 10.1016/j.jbiomech.2008.08.015; Del Giudice F, 2017, MACROMOLECULES, V50, P2951, DOI 10.1021/acs.macromol.6b02727; Delavoipiere J, 2016, SOFT MATTER, V12, P8049, DOI 10.1039/c6sm01448h; Dollet B, 2019, ANNU REV FLUID MECH, V51, P331, DOI 10.1146/annurev-fluid-010518-040352; Drira Z, 2013, J MECH BEHAV BIOMED, V18, P20, DOI 10.1016/j.jmbbm.2012.09.015; Dutta SK, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4810015; Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096; Elder RM, 2016, SOFT MATTER, V12, P4418, DOI 10.1039/c6sm00691d; Estrada JB, 2018, J MECH PHYS SOLIDS, V112, P291, DOI 10.1016/j.jmps.2017.12.006; Gaudron R, 2015, J FLUID MECH, V766, DOI 10.1017/jfm.2015.7; Genovese A, 2006, THERMOCHIM ACTA, V443, P235, DOI 10.1016/j.tca.2006.02.008; GENT AN, 1970, POLYM ENG SCI, V10, P48, DOI 10.1002/pen.760100110; Guglielmi PO, 2015, J MECH BEHAV BIOMED, V46, P1, DOI 10.1016/j.jmbbm.2015.02.009; Hu YH, 2012, J MATER RES, V27, P152, DOI 10.1557/jmr.2011.368; Hu YH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3370354; Hutchens SB, 2016, SOFT MATTER, V12, P2557, DOI 10.1039/c5sm02055g; Johnson BD, 2004, MAT SCI ENG C-BIO S, V24, P575, DOI 10.1016/j.msec.2003.11.002; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnston ID, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035017; Kalcioglu ZI, 2011, PHILOS MAG, V91, P1339, DOI 10.1080/14786435.2010.512574; Kang JT, 2017, SOFT MATTER, V13, P6372, DOI 10.1039/c7sm01479a; Kaufman JD, 2008, J MATER RES, V23, P1472, DOI 10.1557/JMR.2008.0185; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilpatrick JI, 2015, ADV HEALTHC MATER, V4, P2456, DOI 10.1002/adhm.201500229; Kim J., 2013, NAT COMMUN, V4, P1, DOI [10.1038/ncomms2697, DOI 10.1038/NCOMMS2697]; Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771; Kundu S, 2009, SOFT MATTER, V5, P3963, DOI 10.1039/b909237d; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Liu W, 2018, MACROMOL CHEM PHYS, V219, DOI 10.1002/macp.201700307; Marra SP, 2001, MAT SCI ENG C-BIO S, V14, P25, DOI 10.1016/S0928-4931(01)00205-3; Matzelle TR, 2003, MACROMOLECULES, V36, P2926, DOI 10.1021/ma021719p; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Morse JD, 2014, ANN BIOMED ENG, V42, P2501, DOI 10.1007/s10439-014-1091-8; Muniz EC, 2001, MACROMOLECULES, V34, P4480, DOI 10.1021/ma001192l; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Palyulin VV, 2018, SOFT MATTER, V14, P8475, DOI 10.1039/c8sm01468j; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pommella A, 2013, LANGMUIR, V29, P9224, DOI 10.1021/la4015948; Ramasamy A, 2011, J R SOC INTERFACE, V8, P689, DOI 10.1098/rsif.2010.0476; Sakarya S, 2003, SENSOR ACTUAT A-PHYS, V108, P271, DOI 10.1016/j.sna.2003.08.010; Song B, 2004, EXP MECH, V44, P622, DOI 10.1177/0014485104048911; Song B, 2004, EXP MECH, V44, P300, DOI 10.1177/0014485104041543; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; TRELOAR LRG, 1954, T FARADAY SOC, V50, P881, DOI 10.1039/tf9545000881; Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d; Vogel A, 1997, PHYS MED BIOL, V42, P895, DOI 10.1088/0031-9155/42/5/011; Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878; VOGEL A, 1990, IEEE J QUANTUM ELECT, V26, P2240, DOI 10.1109/3.64361; WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008; Zhao XH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3343265; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a; Zorner S, 2010, J BIOMECH, V43, P1540, DOI 10.1016/j.jbiomech.2010.01.035	64	4	4	4	12	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1744-683X	1744-6848		SOFT MATTER	Soft Matter	OCT 21	2020	16	39					9006	9013		10.1039/d0sm00710b			8	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Multidisciplinary; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Materials Science; Physics; Polymer Science	OA4BZ	WOS:000577734200018	33021618				2022-02-06	
J	Murugan, M; Zheng, JY; Wu, GX; Mogilevsky, R; Zheng, X; Hu, PW; Wu, JF; Wu, LJ				Murugan, Madhuvika; Zheng, Jiaying; Wu, Gongxiong; Mogilevsky, Rochelle; Zheng, Xin; Hu, Peiwen; Wu, Junfang; Wu, Long-Jun			The voltage-gated proton channel Hv1 contributes to neuronal injury and motor deficits in a mouse model of spinal cord injury	MOLECULAR BRAIN			English	Article						Microglia; Spinal cord injury; Hv1; Voltage-gated proton channel; ROS; Neuroinflammation; Interleukin-1 beta	CELLULAR INFLAMMATORY RESPONSE; NADPH OXIDASE; BRAIN-DAMAGE; MICROGLIA; MACROPHAGE; ACTIVATION; NEUTROPHIL; RECOVERY; LESIONS; ROS	Traumatic injury to the spinal cord initiates a series of pathological cellular processes that exacerbate tissue damage at and beyond the original site of injury. This secondary damage includes oxidative stress and inflammatory cascades that can lead to further neuronal loss and motor deficits. Microglial activation is an essential component of these secondary signaling cascades. The voltage-gated proton channel, Hv1, functionally expressed in microglia has been implicated in microglia polarization and oxidative stress in ischemic stroke. Here, we investigate whether Hv1 mediates microglial/macrophage activation and aggravates secondary damage following spinal cord injury (SCI). Following contusion SCI, wild-type (WT) mice showed significant tissue damage, white matter damage and impaired motor recovery. However, mice lacking Hv1 (Hv1(-/-)) showed significant white matter sparing and improved motor recovery. The improved motor recovery inHv1(-/-)mice was associated with decreased interleukin-1 beta, reactive oxygen/ nitrogen species production and reduced neuronal loss. Further, deficiency of Hv1 directly influenced microglia activation as noted by decrease in microglia numbers, soma size and reduced outward rectifier K(+)current density inHv1(-/-)mice compared to WT mice at 7 d following SCI. Our results therefore implicate that Hv1 may be a promising potential therapeutic target to alleviate secondary damage following SCI caused by microglia/macrophage activation.	[Murugan, Madhuvika; Zheng, Jiaying; Wu, Long-Jun] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Murugan, Madhuvika; Zheng, Jiaying; Mogilevsky, Rochelle; Zheng, Xin; Hu, Peiwen; Wu, Long-Jun] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Wu, Gongxiong] Inst Hlth, One Harvard St, Brookline, MA 02446 USA; [Wu, Junfang] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA; [Wu, Long-Jun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Wu, Long-Jun] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA		Wu, LJ (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.; Wu, JF (corresponding author), Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA.	junfang.wu@som.umaryland.edu; wu.longjun@mayo.edu	Wu, Long-Jun/AAK-7113-2020	Wu, Long-Jun/0000-0001-8019-3380; zheng, jiaying/0000-0002-7457-6198	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS110825, R01NS088627]	The work was supported by the National Institutes of Health Grants R01NS110825 (J.W and L.J.W) and R01NS088627 (L.J.W).	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Bosco DB, 2020, FEBS J, V287, P4822, DOI 10.1111/febs.15428; Chen TJ, 2020, J CLIN INVEST, V130, P4025, DOI 10.1172/JCI134816; Cohen-Adad J, 2011, NEUROIMAGE, V57, P1068, DOI 10.1016/j.neuroimage.2011.04.068; David S, 2018, J NEUROIMMUNOL, V321, P97, DOI 10.1016/j.jneuroim.2018.06.003; Di Lucente J, 2018, GLIA, V66, P1881, DOI 10.1002/glia.23457; Ejlerskov P, 2012, J BIOL CHEM, V287, P4835, DOI 10.1074/jbc.M111.293696; El Chemaly A, 2014, J LEUKOCYTE BIOL, V95, P827, DOI 10.1189/jlb.0513251; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Gu N, 2016, BRAIN BEHAV IMMUN, V55, P82, DOI 10.1016/j.bbi.2015.11.007; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Kawai T, 2018, CHANNELS, V12, P1, DOI 10.1080/19336950.2017.1385684; KEARNEY P A, 1988, Journal of Neurotrauma, V5, P187, DOI 10.1089/neu.1988.5.187; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Leskovar A, 2000, J EXP BIOL, V203, P1783; Li G, 2020, NEUROSCI BULL, V36, P372, DOI 10.1007/s12264-019-00442-0; Li X, 2020, BIOCH BIOPHYS RES CO; Liu JL, 2015, J NEUROCHEM, V135, P347, DOI 10.1111/jnc.13242; Mawhinney LA, 2012, J NEUROPATH EXP NEUR, V71, P180, DOI 10.1097/NEN.0b013e3182479b41; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Peng JY, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0492-x; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Plemel JR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6324; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Qin C, 2019, NEUROSCI BULL, V35, P921, DOI 10.1007/s12264-019-00388-3; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Schilling T, 2002, J PHYSIOL-LONDON, V545, P93, DOI 10.1113/jphysiol.2002.028878; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tian DS, 2017, J NEUROSCI, V37, P7878, DOI 10.1523/JNEUROSCI.0315-17.2017; Tian DS, 2016, J NEUROCHEM, V139, P96, DOI 10.1111/jnc.13751; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Wu LJ, 2014, NEUROSCIENTIST, V20, P599, DOI 10.1177/1073858413519864; Wu LJ, 2014, TRANSL STROKE RES, V5, P99, DOI 10.1007/s12975-013-0289-7; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Xu JM, 2008, INT J CARDIOL, V128, P413, DOI 10.1016/j.ijcard.2007.06.025; Zeng WZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14125; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang ZJ, 2020, CNS NEUROSCI THER, V26, P374, DOI 10.1111/cns.13271; Zhou X, 2020, NAT NEUROSCI, V23, P337, DOI 10.1038/s41593-020-0597-7; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423	52	4	4	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	OCT 20	2020	13	1							143	10.1186/s13041-020-00682-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OD4IE	WOS:000579815300001	33081841	gold, Green Published, Green Submitted			2022-02-06	
J	Bennett, M; Chin, A; Lee, HJ; Cestero, EM; Strazielle, N; Ghersi-Egea, JF; Threlkeld, SW; Schmidt, TA; Richendrfer, HA; Szmydynger-Chodobska, J; Jay, GD; Chodobski, A				Bennett, Marissa; Chin, Andrea; Lee, Hyung Jin; Morales Cestero, Emma; Strazielle, Nathalie; Ghersi-Egea, Jean-Francois; Threlkeld, Steven W.; Schmidt, Tannin A.; Richendrfer, Holly A.; Szmydynger-Chodobska, Joanna; Jay, Gregory D.; Chodobski, Adam			Proteoglycan 4 Reduces Neuroinflammation and Protects the Blood-Brain Barrier after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; CD44; neuroinflammation; proteoglycan 4; Toll-like receptors	IMMUNE-RESPONSE; GENE-EXPRESSION; RECEPTOR; INFLAMMATION; CD44; DEGENERATION; METABOLISM; ACTIVATION; MICROGLIA; LUBRICIN	Neuroinflammation and dysfunction of the blood-brain barrier (BBB) are two prominent mechanisms of secondary injury in neurotrauma. It has been suggested that Toll-like receptors (TLRs) play important roles in initiating and propagating neuroinflammation resulting from traumatic brain injury (TBI), but potential beneficial effects of targeting these receptors in TBI have not been broadly studied. Here, we investigated the effect of targeting TLRs with proteoglycan 4 (PRG4) on post-traumatic neuroinflammation and BBB function. PRG4 is a mucinous glycoprotein with strong anti-inflammatory properties, exerting its biological effects by interfering with TLR2/4 signaling. In addition, PRG4 has the ability to inhibit activation of cluster of differentiation 44 (CD44), a cell-surface glycoprotein playing an important role in inflammation. Using the controlled cortical impact model of TBI in rats, we showed a rapid and prolonged upregulation of message for TLR2/4 and CD44 in the injured cortex. In thein vitromodel of the BBB, recombinant human PRG4 (rhPRG4) crossed the endothelial monolayers through a high-capacity, saturable transport system. In rats sustaining TBI, PRG4 delivery to the brain was enhanced by post-traumatic increase in BBB permeability. rhPRG4 injected intravenously at 1 h post-TBI potently inhibited post-traumatic activation of nuclear factor kappa B and extracellular signal-regulated kinases 1/2, the two major signal transduction pathways associated with TLR2/4 and CD44, and curtailed the post-traumatic influx of monocytes. In addition, PRG4 restored normal BBB function after TBI by preventing the post-traumatic loss of tight junction protein claudin 5 and reduced neuronal death. Our observations provide support for therapeutic strategies targeting TLRs in TBI.	[Bennett, Marissa; Chin, Andrea; Lee, Hyung Jin; Szmydynger-Chodobska, Joanna; Chodobski, Adam] Brown Univ, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA; [Richendrfer, Holly A.; Jay, Gregory D.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Coro Ctr West,Room 112,1 Hoppin St, Providence, RI 02903 USA; [Morales Cestero, Emma; Threlkeld, Steven W.] Regis Coll, Dept Neurosci, Weston, MA USA; [Strazielle, Nathalie] Brain I, Lyon, France; [Ghersi-Egea, Jean-Francois] Lyon 1 Univ, FLUID Team, Lyon Neurosci Res Ctr, INSERM U1028,CNRS UMR5292, Lyon, France; [Ghersi-Egea, Jean-Francois] Lyon 1 Univ, BIP Facil, Lyon Neurosci Res Ctr, INSERM U1028,CNRS UMR5292, Lyon, France; [Schmidt, Tannin A.] Univ Connecticut, Ctr Hlth, Dept Biomed Engn, Farmington, CT USA		Chodobski, A (corresponding author), Brown Univ, Alpert Med Sch, Dept Emergency Med, Coro Ctr West,Room 112,1 Hoppin St, Providence, RI 02903 USA.	adam_chodobski@brown.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS94440, NS99605]; NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [AR067748]; Department of Emergency Medicine at the Alpert Medical School of Brown University	This work was supported by the NINDS (NS94440 and NS99605 to A.C.), NIAMS (AR067748 to G.D.J.), and by funds from Diane N. Weiss and from the Department of Emergency Medicine at the Alpert Medical School of Brown University.	Al-Ahmad AJ, 2019, J CEREBR BLOOD F MET, V39, P1759, DOI 10.1177/0271678X18767748; Al-Sharif A, 2015, ARTHRITIS RHEUMATOL, V67, P1503, DOI 10.1002/art.39087; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Alquraini A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0877-x; Aninwene GE, 2015, J BIOMED MATER RES A, V103, P451, DOI 10.1002/jbm.a.35195; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Chodobski A., 2015, BLOOD BRAIN BARRIER, V2, P156; Duperray A, 2015, INT IMMUNOL, V27, P545, DOI 10.1093/intimm/dxv025; Dzwonek J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00175; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Elsaid KA, 2015, OSTEOARTHR CARTILAGE, V23, P114, DOI 10.1016/j.joca.2014.09.006; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fiebich BL, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00329; Fujimoto M, 2016, J NEUROSURG, V124, P1693, DOI 10.3171/2015.4.JNS15484; Gee K, 2002, J IMMUNOL, V169, P5660, DOI 10.4049/jimmunol.169.10.5660; Greene C, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0123-z; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Molino Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51278; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Qadri M, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1693-x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Richendrfer Holly A, 2020, Crit Care Explor, V2, pe0126, DOI 10.1097/CCE.0000000000000126; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Sarkar A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219697; Singh AK, 2004, TOXICOLOGY, V201, P197, DOI 10.1016/j.tox.2004.04.015; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Strazielle N, 1999, J NEUROSCI, V19, P6275; Szmydynger-Chodobska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167677; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Thorson C, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619828113; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; Weigand S, 2012, CANCER RES, V72, P4329, DOI 10.1158/0008-5472.CAN-12-0136; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309	61	4	4	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					385	398		10.1089/neu.2020.7229		OCT 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000581640100001	32940130	hybrid, Green Published			2022-02-06	
J	Lessley, DJ; Kent, RW; Cormier, JM; Sherwood, CP; Funk, JR; Crandall, JR; Myers, BS; Arbogast, KB				Lessley, David J.; Kent, Richard W.; Cormier, Joseph M.; Sherwood, Christopher P.; Funk, James R.; Crandall, Jeff R.; Myers, Barry S.; Arbogast, Kristy B.			Position-Specific Circumstances of Concussions in the NFL: Toward the Development of Position-Specific Helmets	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head injury; Biomechanics; Helmet design	COLLEGIATE FOOTBALL PLAYERS; HEAD IMPACT EXPOSURES; SYSTEM; EPIDEMIOLOGY; ACCURACY; INJURIES; LOCATION	Consideration of position-specific features of the NFL concussion environment could enable improved risk mitigation through the design of position-specific helmets to improve self-protection as well as protection for the other player with whom the contact occurs. The purpose of this paper is to quantify position-specific features of scenarios resulting in concussions to NFL players, and the players they contact, by reviewing all game footage (broadcast and non-broadcast) over 4 seasons. Position-specific features were documented for 647 concussions in which a primary exposure could be visualized, including impact source, helmet impact location, activity, and the other player with whom the contact occurred. Findings include the over-representation of helmet-to-ground impacts to the rear of the quarterback's helmet, the high frequency of impacts to the side (upper) location of both concussed players and the players they contacted regardless of position, and distinct differences in the circumstances of concussions to cornerbacks and safeties. The study shows that some features of concussion scenarios are common to all positions, but several position-specific features exist and can inform the design of position-specific helmets for NFL players.	[Lessley, David J.; Kent, Richard W.; Cormier, Joseph M.; Sherwood, Christopher P.; Funk, James R.; Crandall, Jeff R.] Biomech Consulting & Res Biocore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA; [Myers, Barry S.] Duke Univ, Biomed Engn, Box 90083,267 Hudson Hall Annex, Durham, NC 27708 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Roberts Pediat Res Bldg,2716 South St,Room 13471, Philadelphia, PA 19146 USA; [Kent, Richard W.] Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA		Lessley, DJ (corresponding author), Biomech Consulting & Res Biocore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA.	DLessley@biocorellc.com			Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Dick R, 2007, J ATHL TRAINING, V42, P221; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabler H. C, 1998, P ESV; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Meyerson S. L, 2001, P SOC AUTOMO ENG; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; NFL Player Health and Safety, 2018, NFL ENG ROADM FACT S; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Siegmund G, 2015, 2015 IRCOBI CON P; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243	22	4	4	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2542	2554		10.1007/s10439-020-02657-z		OCT 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000579677200002	33078366				2022-02-06	
J	Rauen, K; Spani, CB; Tartaglia, MC; Ferretti, MT; Reichelt, L; Probst, P; Schapers, B; Muller, F; Jahn, K; Plesnila, N				Rauen, Katrin; Spaeni, Claudia B.; Tartaglia, Maria Carmela; Ferretti, Maria Teresa; Reichelt, Lara; Probst, Philipp; Schaepers, Barbara; Mueller, Friedemann; Jahn, Klaus; Plesnila, Nikolaus			Quality of life after traumatic brain injury: a cross-sectional analysis uncovers age- and sex-related differences over the adult life span	GEROSCIENCE			English	Article						Aging; Health-related quality of life; QOLIBRI; Psychiatric disorders; Age; and sex-related outcomes; Traumatic brain injury	COMMUNITY-BASED SAMPLE; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; QOLIBRI; NEUROPROTECTION; DISABILITY; MODERATE; DISEASE; PEOPLE; COHORT	Traumatic brain injury (TBI) is the leading cause of disability in the working population and becomes increasingly prevalent in the elderly. Thus, TBI is a major global health burden. However, age- and sex-related long-term outcome regarding patient's health-related quality of life (HRQoL) is yet not clarified. In this cross-sectional study, we present age- and sex-related demographics and HRQoL up to 10 years after TBI using the Quality of Life after Brain Injury (QOLIBRI) instrument. The QOLIBRI total score ranges from zero to 100 indicating good (>= 60), moderate (40-59) or unfavorable (< 40) HRQoL. Two-thirds of the entire chronic TBI cohort (102 males; 33 females) aged 18-85 years reported good HRQoL up to 10 years after TBI. TBI etiology differed between sexes with females suffering more often from traffic- than fall-related TBI (p = 0.01) with increasing prevalence during aging (p = < 0.001). HRQoL (good/moderate/unfavorable) differed between sexes (p < 0.0001) with 17% more females reporting moderate outcome (p = 0.01). Specifically, older females (54-76-years at TBI) were affected, while males constantly reported good HRQoL (p = 0.017). Cognition (p = 0.014), self-perception (p = 0.009), and emotions (p = 0.016) rather than physical problems (p = 0.1) constrained older females' HRQoL after TBI. Experiencing TBI during aging does not influence HRQoL outcome in males but females suggesting that female brains cope less well with a traumatic injury during aging. Therefore, older females need long-term follow-ups after TBI to detect neuropsychiatric sequels that restrict their quality of life. Further investigations are necessary to uncover the mechanisms of this so far unknown phenomenon.	[Rauen, Katrin; Reichelt, Lara; Schaepers, Barbara; Mueller, Friedemann; Jahn, Klaus] Schoen Clin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany; [Rauen, Katrin; Reichelt, Lara; Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res ISD, Med Ctr, Feodor Lynen Str 17, D-81377 Munich, Germany; [Rauen, Katrin] Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Minervastr 145, CH-8032 Zurich, Switzerland; [Rauen, Katrin; Ferretti, Maria Teresa] Univ Zurich, Inst Regenerat Med IREM, Wagistr 12, CH-8952 Schlieren, Switzerland; [Rauen, Katrin; Tartaglia, Maria Carmela; Ferretti, Maria Teresa] Womens Brain Project, Pfisterwisstr 14, CH-8357 Guntershausen, Switzerland; [Spaeni, Claudia B.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, 310 East Super St, Chicago, IL 60611 USA; [Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave,6KDT407, Toronto, ON M5T 2S8, Canada; [Probst, Philipp] Inst Med Informat Biometry & Epidemiol IBE, Marchiortinistr 15, D-81377 Munich, Germany; [Jahn, Klaus] Univ Munich, German Ctr Vertigo & Balance Disorders, Med Ctr, Marchioninistr 15, D-81377 Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany		Rauen, K (corresponding author), Schoen Clin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany.; Rauen, K (corresponding author), Univ Munich, Inst Stroke & Dementia Res ISD, Med Ctr, Feodor Lynen Str 17, D-81377 Munich, Germany.; Rauen, K (corresponding author), Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Minervastr 145, CH-8032 Zurich, Switzerland.; Rauen, K (corresponding author), Univ Zurich, Inst Regenerat Med IREM, Wagistr 12, CH-8952 Schlieren, Switzerland.; Rauen, K (corresponding author), Womens Brain Project, Pfisterwisstr 14, CH-8357 Guntershausen, Switzerland.	katrin.rauen@uzh.ch	Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010	Jahn, Klaus/0000-0002-1669-3652; Rauen, Katrin/0000-0003-4555-6697	University of Zurich	Open access funding provided by University of Zurich.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; [Anonymous], 2020, LANCET; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Chang FH, 2017, J HEAD TRAUMA REHAB, V32, pE11, DOI 10.1097/HTR.0000000000000258; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Ellert U, 2013, BUNDESGESUNDHEITSBLA, V56, P643, DOI 10.1007/s00103-013-1700-y; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Klosinski LP, 2015, EBIOMEDICINE, V2, P1888, DOI 10.1016/j.ebiom.2015.11.002; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Maas A, 2020, CTR TBI FACTS FIGURE; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McGuire C, 2018, J AGING HEALTH, V30, P1156, DOI 10.1177/0898264317708072; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mollayeva Tatyana, 2017, Healthc Q, V20, P6; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Osborn AJ, 2018, J HEAD TRAUMA REHAB, V33, P62, DOI 10.1097/HTR.0000000000000311; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Paus T, 2010, HORM BEHAV, V57, P63, DOI 10.1016/j.yhbeh.2009.08.004; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rauen K, 2020, CRIT CARE MED, V48, P1157, DOI 10.1097/CCM.0000000000004387; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Svingos AM, 2019, J CLIN EXP NEUROPSYC, V41, P775, DOI 10.1080/13803395.2019.1620695; TEASDALE G, 1974, LANCET, V2, P81; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2020, QOLIBRI; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wang YW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65402-5; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WHO, 2019, WHO DEF QUAL LIF; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	54	4	4	2	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2509-2715	2509-2723		GEROSCIENCE	GeroScience	FEB	2021	43	1			SI		263	278		10.1007/s11357-020-00273-2		OCT 2020	16	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	RN7UO	WOS:000579023800001	33070278	hybrid, Green Published, Green Accepted			2022-02-06	
J	Skaansar, O; Tverdal, C; Ronning, PA; Skogen, K; Brommeland, T; Roise, O; Aarhus, M; Andelic, N; Helseth, E				Skaansar, Ola; Tverdal, Cathrine; Ronning, Pal Andre; Skogen, Karoline; Brommeland, Tor; Roise, Olav; Aarhus, Mads; Andelic, Nada; Helseth, Eirik			Traumatic brain injury-the effects of patient age on treatment intensity and mortality	BMC NEUROLOGY			English	Article						Traumatic brain injury; Neurosurgery; Age; Treatment; Mortality; Management intensity	OLDER-ADULTS; DECOMPRESSIVE CRANIECTOMY; CENTER-TBI; OUTCOMES; CARE; EPIDEMIOLOGY; ASSOCIATION; MULTICENTER; MANAGEMENT; COMORBIDITIES	Background Ageing is associated with worse treatment outcome after traumatic brain injury (TBI). This association may lead to a self-fulfilling prophecy that affects treatment efficacy. The aim of the current study was to evaluate the role of treatment bias in patient outcomes by studying the intensity of diagnostic procedures, treatment, and overall 30-day mortality in different age groups of patients with TBI. Methods Included in this study was consecutively admitted patients with TBI, aged >= 15 years, with a cerebral CT showing intracranial signs of trauma, during the time-period between 2015-2018. Data were extracted from our prospective quality control registry for admitted TBI patients. As a measure of management intensity in different age groups, we made a composite score, where placement of intracranial pressure monitor, ventilator treatment, and evacuation of intracranial mass lesion each gave one point. Uni- and multivariate survival analyses were performed using logistic multinomial regression. Results A total of 1,571 patients with TBI fulfilled the inclusion criteria. The median age was 58 years (range 15-98), 70% were men, and 39% were >= 65 years. Head injury severity was mild in 706 patients (45%), moderate in 437 (28%), and severe in 428 (27%). Increasing age was associated with less management intensity, as measured using the composite score, irrespective of head injury severity. Multivariate analyses showed that the following parameters had a significant association with an increased risk of death within 30 days of trauma: increasing age, severe comorbidities, severe TBI, Rotterdam CT-score >= 3, and low management intensity. Conclusion The present study indicates that the management intensity of hospitalised patients with TBI decreased with advanced age and that low management intensity was associated with an increased risk of 30-day mortality. This suggests that the high mortality among elderly TBI patients may have an element of treatment bias and could in the future be limited with a more aggressive management regime.	[Skaansar, Ola; Tverdal, Cathrine; Roise, Olav; Helseth, Eirik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Tverdal, Cathrine; Ronning, Pal Andre; Brommeland, Tor; Aarhus, Mads; Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Skogen, Karoline] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Roise, Olav] Oslo Univ Hosp, Div Orthopaed Surg, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Inst Hlth & Soc, Oslo, Norway		Skaansar, O (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	o.f.skaansar@studmed.uio.no		Tverdal, Cathrine/0000-0002-1094-3825	Faculty of Medicine at the University of Oslo	A scholarship to OFS was given by the Faculty of Medicine at the University of Oslo. The Department of Neurosurgery, OUH provided office space at the hospital from 2017-2020. None of the funders did take any role or had any demands regarding the study design, data collection, analysis or interpretation of the data.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; [Anonymous], **NON-TRADITIONAL**; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bernardi D, 2006, J AM GERIATR SOC, V54, P372, DOI 10.1111/j.1532-5415.2005.00592_5.x; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gulati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202575; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Kumar R, 2017, INDIAN J UROL, V33, P1, DOI 10.4103/0970-1591.197328; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Lykissas MG, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.03.18; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Nicolini F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/736298; Okazaki T, 2016, WORLD NEUROSURG, V93, P336, DOI 10.1016/j.wneu.2016.06.070; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111378; Robertsen A, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0648-9; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Ronning P, 2019, J NEUROSURG, V131, P1896, DOI 10.3171/2018.7.JNS18270; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shahrokni A, 2017, J ONCOL PRACT, V13, P95, DOI 10.1200/JOP.2016.017608; Siman-Tov M, 2016, BRAIN INJURY, V30, P83, DOI 10.3109/02699052.2015.1104551; Statistics Norway Statbank, 2018, 01222 STAT NORW STAT; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; WHO Regional Office for Europe Copenhagen, 2004, WHAT AR MAIN RISK FA; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; [No title captured]	59	4	4	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	OCT 17	2020	20	1							376	10.1186/s12883-020-01943-6			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OB3TI	WOS:000578394700001	33069218	gold, Green Published, Green Submitted			2022-02-06	
J	Fung, FW; Parikh, DS; Jacobwitz, M; Vala, L; Donnelly, M; Wang, Z; Xiao, R; Topjian, AA; Abend, NS				Fung, France W.; Parikh, Darshana S.; Jacobwitz, Marin; Vala, Lisa; Donnelly, Maureen; Wang, Zi; Xiao, Rui; Topjian, Alexis A.; Abend, Nicholas S.			Validation of a model to predict electroencephalographic seizures in critically ill children	EPILEPSIA			English	Article						EEG monitoring; electroencephalogram; pediatric; seizure; status epilepticus	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CONTINUOUS VIDEO-EEG; ELECTROGRAPHIC SEIZURES; INTERRATER AGREEMENT; COMATOSE CHILDREN; COMMON; TERMINOLOGY; GUIDELINES; STATEMENT	Objective Electroencephalographic seizures (ESs) are common in encephalopathic critically ill children, but identification requires extensive resources for continuous electroencephalographic monitoring (CEEG). In a previous study, we developed a clinical prediction rule using three clinical variables (age, acute encephalopathy category, clinically evident seizure[s] prior to CEEG initiation) and two electroencephalographic (EEG) variables (EEG background category and interictal discharges within the first 30 minutes of EEG) to identify patients at high risk for ESs for whom CEEG might be essential. In the current study, we aimed to validate the ES prediction model using an independent cohort. Methods The prospectively acquired validation cohort consisted of 314 consecutive critically ill children treated in the Pediatric Intensive Care Unit of a quaternary care referral hospital with acute encephalopathy undergoing clinically indicated CEEG. We calculated test characteristics using the previously developed prediction model in the validation cohort. As in the generation cohort study, we selected a 0.10 cutpoint to emphasize sensitivity. Results The incidence of ESs in the validation cohort was 22%. The generation and validation cohorts were alike in most clinical and EEG characteristics. The ES prediction model was well calibrated and well discriminating in the validation cohort. The model had a sensitivity of 90%, specificity of 37%, positive predictive value of 28%, and negative predictive value of 93%. If applied, the model would limit 31% of patients from undergoing CEEG while failing to identify 10% of patients with ESs. The model had similar performance characteristics in the generation and validation cohorts. Significance A model employing five readily available clinical and EEG variables performed well when validated in a new consecutive cohort. Implementation would substantially reduce CEEG utilization, although some patients with ESs would not be identified. This model may serve a critical role in targeting limited CEEG resources to critically ill children at highest risk for ESs.	[Fung, France W.; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fung, France W.; Parikh, Darshana S.; Jacobwitz, Marin; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Vala, Lisa; Donnelly, Maureen; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Neurodiagnost, Philadelphia, PA 19104 USA; [Wang, Zi; Xiao, Rui; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Wang, Zi; Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Topjian, Alexis A.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA		Fung, FW (corresponding author), CTRB, CHOP Neurol, 1200-15,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	fungf@email.chop.edu		Abend, Nicholas/0000-0001-6166-2663	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K02NS096058]; Wolfson Family Foundation - National Institutes of Health [U54HD086984]	N.S.A. is funded by National Institutes of Health K02NS096058 and the Wolfson Family Foundation. R.X. is funded by National Institutes of Health U54HD086984.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P251, DOI 10.1097/WNP.0000000000000459; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P246, DOI 10.1097/WNP.0000000000000458; Abend NS, 2017, J CLIN NEUROPHYSIOL, V34, P534, DOI 10.1097/WNP.0000000000000424; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Amorim E, 2018, J CLIN NEUROPHYSIOL, V35, P510, DOI 10.1097/WNP.0000000000000517; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Fernandez IS, 2014, J PEDIATR-US, V164, P339, DOI 10.1016/j.jpeds.2013.09.032; Fung FW, 2020, NEUROLOGY, V95, pE1599, DOI 10.1212/WNL.0000000000010421; Fung FW, 2020, EPILEPSIA, V61, P498, DOI 10.1111/epi.16448; Fung FW, 2019, EPILEPSIA, V60, P2095, DOI 10.1111/epi.16341; Gaspard N, 2014, EPILEPSIA, V55, P1366, DOI 10.1111/epi.12653; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Kirschen MP, 2019, CRIT CARE NURSE, V39, P20, DOI 10.4037/ccn2019198; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Fernandez IS, 2018, SEIZURE-EUR J EPILEP, V54, P19, DOI 10.1016/j.seizure.2017.11.013; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Sansevere AJ, 2017, J CLIN NEUROPHYSIOL, V34, P421, DOI 10.1097/WNP.0000000000000379; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012; Vlachy J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00303; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Yang A, 2015, SEIZURE-EUR J EPILEP, V25, P104, DOI 10.1016/j.seizure.2014.09.013	50	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	DEC	2020	61	12					2754	2762		10.1111/epi.16724		OCT 2020	9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PB5ZC	WOS:000577540400001	33063870				2022-02-06	
J	Baekgaard, JS; Abback, PS; Boubaya, M; Moyer, JD; Garrigue, D; Raux, M; Champigneulle, B; Dubreuil, G; Pottecher, J; Laitselart, P; Laloum, F; Bloch-Queyrat, C; Adnet, F; Paugam-Burtz, C; Pirracchio, R; Godier, A; Harrois, A; Geeraerts, T; Meaudre, E; Ausse, S; Gauss, T; Meyer, A; Hamada, S; Neuschwander, A; Cook, F; Vinour, H; Hanouz, JL; Foucrier, A; Boutonnet, M; Raclot, P; Arthur, J; Bruneau, N; Cotte, J; Leone, M; Audibert, G; Steinmetz, J; Rasmussen, LS				Baekgaard, Josefine S.; Abback, Paer-Selim; Boubaya, Marouane; Moyer, Jean-Denis; Garrigue, Delphine; Raux, Mathieu; Champigneulle, Benoit; Dubreuil, Guillaume; Pottecher, Julien; Laitselart, Philippe; Laloum, Fleur; Bloch-Queyrat, Coralie; Adnet, Frederic; Paugam-Burtz, Catherine; Pirracchio, Romain; Godier, Anne; Harrois, Anatole; Geeraerts, Thomas; Meaudre, Eric; Ausse, Sylvain; Gauss, Tobias; Meyer, Alain; Hamada, Sophie; Neuschwander, Arthur; Cook, Fabrice; Vinour, Helene; Hanouz, Jean Luc; Foucrier, Arnaud; Boutonnet, Mathieu; Raclot, Pascal; Arthur, James; Bruneau, Nathalie; Cotte, Jean; Leone, Marc; Audibert, Gerard; Steinmetz, Jacob; Rasmussen, Lars S.		Traumabase Study Grp	Early hyperoxemia is associated with lower adjusted mortality after severe trauma: results from a French registry	CRITICAL CARE			English	Article						Hyperoxemia; Hyperoxia; Trauma; Critical care; Oxygen	CRITICALLY-ILL PATIENTS; CEREBRAL-BLOOD-FLOW; ARTERIAL HYPEROXIA; OXYGEN-THERAPY; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; INSPIRED OXYGEN; BRAIN-INJURY; INFLAMMATION; FRACTION	Background Hyperoxemia has been associated with increased mortality in critically ill patients, but little is known about its effect in trauma patients. The objective of this study was to assess the association between early hyperoxemia and in-hospital mortality after severe trauma. We hypothesized that a PaO2 >= 150 mmHg on admission was associated with increased in-hospital mortality. Methods Using data issued from a multicenter prospective trauma registry in France, we included trauma patients managed by the emergency medical services between May 2016 and March 2019 and admitted to a level I trauma center. Early hyperoxemia was defined as an arterial oxygen tension (PaO2) above 150 mmHg measured on hospital admission. In-hospital mortality was compared between normoxemic (150 > PaO2 >= 60 mmHg) and hyperoxemic patients using a propensity-score model with predetermined variables (gender, age, prehospital heart rate and systolic blood pressure, temperature, hemoglobin and arterial lactate, use of mechanical ventilation, presence of traumatic brain injury (TBI), initial Glasgow Coma Scale score, Injury Severity Score (ISS), American Society of Anesthesiologists physical health class > I, and presence of hemorrhagic shock). Results A total of 5912 patients were analyzed. The median age was 39 [26-55] years and 78% were male. More than half (53%) of the patients had an ISS above 15, and 32% had traumatic brain injury. On univariate analysis, the in-hospital mortality was higher in hyperoxemic patients compared to normoxemic patients (12% versus 9%,p < 0.0001). However, after propensity score matching, we found a significantly lower in-hospital mortality in hyperoxemic patients compared to normoxemic patients (OR 0.59 [0.50-0.70],p < 0.0001). Conclusion In this large observational study, early hyperoxemia in trauma patients was associated with reduced adjusted in-hospital mortality. This result contrasts the unadjusted in-hospital mortality as well as numerous other findings reported in acutely and critically ill patients. The study calls for a randomized clinical trial to further investigate this association.	[Baekgaard, Josefine S.; Adnet, Frederic] Avicenne Hosp, AP HP, INSERM U942, Urgences & Samu 93, F-93000 Bobigny, France; [Baekgaard, Josefine S.; Steinmetz, Jacob; Rasmussen, Lars S.] Univ Copenhagen, Dept Anesthesia, Ctr Head & Orthoped, Sect 4231, Juliane Maries Vej 10, DK-2100 Copenhagen, Denmark; [Abback, Paer-Selim; Moyer, Jean-Denis; Paugam-Burtz, Catherine; Gauss, Tobias; Foucrier, Arnaud] Univ Paris, Beaujon Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France; [Boubaya, Marouane; Bloch-Queyrat, Coralie] Avicenne Hosp, CRC, Bobigny, France; [Garrigue, Delphine] CHU Lille, Dept Anesthesia & Crit Care, Lille, France; [Raux, Mathieu] Sorbonne Univ, UMR S 1158 Neurophysiol Resp Expt & Clin, Dept Anesthesie Reanimat, Grp Hosp Univ,APHP,INSERM, F-75013 Paris, France; [Champigneulle, Benoit] Georges Pompidou European Hosp, AP HP, Surg Intens Care Unit, Paris, France; [Dubreuil, Guillaume] Bicetre Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France; [Pottecher, Julien] Strasbourg Univ Hosp, Dept Anesthesia & Surg Crit Care, Strasbourg, France; [Laitselart, Philippe] Percy Army Training Hosp, Dept Anesthesia, Paris, France; [Laloum, Fleur] Univ Hosp Reims, Dept Anesthesia & Crit Care, Reims, France; [Pirracchio, Romain; Neuschwander, Arthur] Univ Paris 05, Serv Anesthesie Reanimat, Hop Europeen Georges Pompidou, Paris, France; [Godier, Anne] Univ Paris Saclay, Bicetre Hop Univ Paris Sud, Dept Anesthesiol & Crit Care, Univ Paris Sud, 78 rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France; [Harrois, Anatole; Geeraerts, Thomas] Univ Toulouse Sabatier, Univ Hosp Toulouse, Anesthesiol & Crit Care Dept, Toulouse, France; [Meaudre, Eric; Cotte, Jean] Mil Hosp, Dept Anesthesiol & Intens Care, Hop Instruct Armees St Anne, Toulon, France; Mil Hosp, Emergency Dept, Hop dInstruct Armees Sainte Anne, Toulon, France; [Ausse, Sylvain; Boutonnet, Mathieu] Percy Mil Hosp, Dept Anesthesiol & Crit Care, Clamart, France; [Meyer, Alain] Hop Univ Strasbourg, Unites Reanimat Chirurg & Surveillance Continue, Strasbourg, France; [Hamada, Sophie; Cook, Fabrice] Henri Mondor Univ Hosp, Dept Anaesthesia & Intens Care Med, Creteil, France; [Vinour, Helene] Univ Toulouse Sabatier, Univ Hosp Toulouse, Anaesthesiol & Crit Care Dept, Toulouse, France; [Hanouz, Jean Luc] Caen Univ Hosp, Dept Anesthesiol & Crit Care Med, Pole Reanimat Anesthesie SAMU, Caen, France; [Raclot, Pascal] Robert Debre Hosp, Univ Hosp, Intens Care Unit, Reims, France; [Arthur, James] Sorbonne Univ, Paris, France; [Arthur, James] Hop Univ Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Bruneau, Nathalie] CHU Lille, Pole Anesthesie Reanimat, Lille, France; [Leone, Marc] Aix Marseille Univ, Dept Anesthesiol & Intens Care Med, Hop Nord, AP HM, Marseille, France; [Audibert, Gerard] Univ Hosp Nancy, Dept Anesthesiol & Surg Intens Care, Nancy, France		Baekgaard, JS (corresponding author), Avicenne Hosp, AP HP, INSERM U942, Urgences & Samu 93, F-93000 Bobigny, France.; Baekgaard, JS (corresponding author), Univ Copenhagen, Dept Anesthesia, Ctr Head & Orthoped, Sect 4231, Juliane Maries Vej 10, DK-2100 Copenhagen, Denmark.	josefinebeakgaard@me.com	Leone, Marc/P-4835-2016	Leone, Marc/0000-0002-3097-758X; Harrois, Anatole/0000-0002-5098-4656	Regional Health Agency of Ile de France	The Traumabase (R) has been sponsored by the Regional Health Agency of Ile de France for 2014-2017.	Aboab J, 2006, INTENS CARE MED, V32, P1979, DOI 10.1007/s00134-006-0382-4; Alali AS, 2020, J NEUROSURG, V132, P537, DOI 10.3171/2018.10.JNS18964; American College of Surgeons, 2012, ATLS ADV TRAUM LIF S; Andrade PV, 2014, INFLAMMATION, V37, P486, DOI 10.1007/s10753-013-9762-4; [Anonymous], 2016, R LANG ENV STAT COMP; Asfar P, 2015, INTENS CARE MED, V41, P1118, DOI 10.1007/s00134-015-3670-z; Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Borzage MT, 2016, J APPL PHYSIOL, V120, P976, DOI 10.1152/japplphysiol.00994.2015; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Cornet AD, 2013, CRIT CARE, V17, DOI 10.1186/cc12554; Cost of Injury & Calculators, 2018, COST INJURY CALCULAT; Damiani E, 2018, CURR OPIN ANESTHESIO, V31, P129, DOI 10.1097/ACO.0000000000000559; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Eskesen TG, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020880; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Hamada SR, 2014, J TRAUMA ACUTE CARE, V76, P1476, DOI 10.1097/TA.0000000000000239; Harpso M, 2019, OPEN ACCESS EMERG M, V11, P57, DOI 10.2147/OAEM.S181629; Helmerhorst HJF, 2017, CRIT CARE MED, V45, P187, DOI 10.1097/CCM.0000000000002084; Helmerhorst HJF, 2016, CRIT CARE MED, V44, P554, DOI 10.1097/CCM.0000000000001461; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Helmerhorst HJF, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0023-y; Jouffroy R, 2019, AM J EMERG MED, V37, P56, DOI 10.1016/j.ajem.2018.04.050; Kelly C, 2014, THER ADV RESPIR DIS, V8, P191, DOI 10.1177/1753465814549011; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Lang M, 2018, ACTA ANAESTH SCAND, V62, P801, DOI 10.1111/aas.13093; Michalski D, 2011, ACTA NEUROL SCAND, V123, P85, DOI 10.1111/j.1600-0404.2010.01363.x; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; Mosby, 2003, PHTLS BAS ADV PREH T; Nagato AC, 2012, INT J EXP PATHOL, V93, P269, DOI 10.1111/j.1365-2613.2012.00823.x; Ni YN, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0810-1; Page D, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1926-4; Patel JK, 2018, RESUSCITATION, V127, P83, DOI 10.1016/j.resuscitation.2018.04.008; Pountain SJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6976; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Schwingshackl A, 2017, AM J PHYSIOL-LUNG C, V313, pL1030, DOI 10.1152/ajplung.00121.2017; Singhal AB, 2006, INT J STROKE, V1, P191, DOI 10.1111/j.1747-4949.2006.00058.x; Staehr-Rye AK, 2017, BRIT J ANAESTH, V119, P140, DOI 10.1093/bja/aex128; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Suzuki S, 2013, J CRIT CARE, V28, P647, DOI 10.1016/j.jcrc.2013.03.010; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; You JY, 2018, J CRIT CARE, V47, P260, DOI 10.1016/j.jcrc.2018.07.014	54	4	4	5	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	OCT 12	2020	24	1							604	10.1186/s13054-020-03274-x			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OH6YT	WOS:000582742300001	33046127	Green Submitted, Green Published, gold			2022-02-06	
J	Pape, TBL; Livengood, SL; Kletzel, SL; Blabas, B; Guernon, A; Bhaumik, DK; Bhaumik, R; Mallinson, T; Weaver, JA; Higgins, JP; Wang, X; Herrold, AA; Rosenow, JM; Parrish, T				Bender Pape, Theresa L.; Livengood, Sherri L.; Kletzel, Sandra L.; Blabas, Brett; Guernon, Ann; Bhaumik, Dulal K.; Bhaumik, Runa; Mallinson, Trudy; Weaver, Jennifer A.; Higgins, James P.; Wang, Xue; Herrold, Amy A.; Rosenow, Joshua M.; Parrish, Todd			Neural Connectivity Changes Facilitated by Familiar Auditory Sensory Training in Disordered Consciousness: A TBI Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						attention; consciousness disorders; language; traumatic brain injury; white matter	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; WHITE-MATTER TRACTS; FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; VEGETATIVE STATE; RIGHT-HEMISPHERE; RECOVERY; SYSTEM; COMA	For people with disordered consciousness (DoC) after traumatic brain injury (TBI), relationships between treatment-induced changes in neural connectivity and neurobehavioral recovery have not been explored. To begin building a body of evidence regarding the unique contributions of treatments to changes in neural network connectivity relative to neurobehavioral recovery, we conducted a pilot study to identify relationships meriting additional examination in future research. To address this objective, we examined previously unpublished neural connectivity data derived from a randomized clinical trial (RCT). We leveraged these data because treatment efficacy, in the RCT, was based on a comparison of a placebo control with a specific intervention, the familiar auditory sensory training (FAST) intervention, consisting of autobiographical auditory-linguistic stimuli. We selected a subgroup of RCT participants with high-quality imaging data (FASTn= 4 and placebon= 4) to examine treatment-related changes in brain network connectivity and how and if these changes relate to neurobehavioral recovery. To discover promising relationships among the FAST intervention, changes in neural connectivity, and neurobehavioral recovery, we examined 26 brain regions and 19 white matter tracts associated with default mode, salience, attention, and language networks, as well as three neurobehavioral measures. Of the relationships discovered, the systematic filtering process yielded evidence supporting further investigation of the relationship among the FAST intervention, connectivity of the left inferior longitudinal fasciculus, and auditory-language skills. Evidence also suggests that future mechanistic research should focus on examining the possibility that the FAST supports connectivity changes by facilitating redistribution of brain resources. For a patient population with limited treatment options, the reported findings suggest that a simple, yet targeted, passive sensory stimulation treatment may have altered functional and structural connectivity. If replicated in future research, then these findings provide the foundation for characterizing the unique contributions of the FAST intervention and could inform development of new treatment strategies. For persons with severely damaged brain networks, this report represents a first step toward advancing understanding of the unique contributions of treatments to changing brain network connectivity and how these changes relate to neurobehavioral recovery for persons with DoC after TBI.	[Bender Pape, Theresa L.; Livengood, Sherri L.; Kletzel, Sandra L.; Blabas, Brett; Guernon, Ann; Herrold, Amy A.] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Dept Vet Affairs VA, Hines, IL 60141 USA; [Bender Pape, Theresa L.; Livengood, Sherri L.; Kletzel, Sandra L.; Blabas, Brett; Guernon, Ann; Herrold, Amy A.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Bender Pape, Theresa L.; Livengood, Sherri L.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Guernon, Ann] Marianjoy Rehabil Hosp Part Northwestern Med, Wheaton, IL USA; [Bhaumik, Dulal K.; Bhaumik, Runa] Univ Illinois, Dept Psychiat, Biostat Res Ctr, Div Epidemiol & Biostat, Chicago, IL 60612 USA; [Bhaumik, Dulal K.] Edward Hines Jr VA Hosp, Cooperat Studies Program, Coordinating Ctr, Res Serv, Hines, IL USA; [Mallinson, Trudy; Weaver, Jennifer A.] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA; [Higgins, James P.; Wang, Xue; Parrish, Todd] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Herrold, Amy A.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Rosenow, Joshua M.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Rosenow, Joshua M.] Northwestern Mem Hosp, Chicago, IL 60611 USA		Pape, TBL (corresponding author), Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Dept Vet Affairs VA, Hines, IL 60141 USA.; Pape, TBL (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.; Pape, TBL (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA.	theresa.benderpape@va.gov	Mallinson, Trudy/S-7381-2019; Weaver, Jennifer/M-1478-2017	Mallinson, Trudy/0000-0002-4888-5579; Higgins, James/0000-0002-7916-8468; Parrish, Todd/0000-0002-1184-1572; Weaver, Jennifer/0000-0002-3964-1441	US Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [B4591R, B4949N]; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741]; Nick Kot Charity for TBI	This work was supported by the US Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development (#B4591R and #B4949N to TBP) and by the National Center for Research Resources, National Institutes of Health (#UL1RR025741 to Northwestern University's Clinical and Translation Sciences Institute). Financial support of unanticipated research expenses was also provided by the Nick Kot Charity for TBI (www.nkc4tbi.com).In-kind contributions from the Edward Hines Jr. VA hospital and Northwestern's Departments of Neurosurgery and PM&R also made this work possible. The funding agencies and organizations played no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, and in the decision to submit the article for publication. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the United States Department of Veterans Affairs or the United States government.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Bayne T, 2017, ANN NEUROL, V82, P866, DOI 10.1002/ana.25088; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhaumik Dulal K, 2009, Stat Methodol, V6, P133, DOI 10.1016/j.stamet.2008.05.003; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Bond T.G., 2015, APPL RASCH MODEL FUN, V3rd ed., DOI [10.4324/9781315814698, DOI 10.4324/9781315814698]; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calvert GA, 2000, BRAIN LANG, V71, P391, DOI 10.1006/brln.1999.2272; Cardebat D, 2003, STROKE, V34, P2900, DOI 10.1161/01.STR.0000099965.99393.83; Chechlacz M, 2015, J NEUROSCI, V35, P10647, DOI 10.1523/JNEUROSCI.0210-15.2015; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; Cocquyt EM, 2017, J NEUROLINGUIST, V44, P68, DOI 10.1016/j.jneuroling.2017.03.004; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; CRONE JS, 2013, FRONT HUM NEUROSCI, V0007; Crone JS, 2018, J NEUROSCI RES, V96, P671, DOI 10.1002/jnr.24115; Crone JS, 2017, CEREB CORTEX, V27, P2727, DOI 10.1093/cercor/bhw112; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Dick AS, 2014, NEUROSCIENTIST, V20, P453, DOI 10.1177/1073858413513502; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Duffau H, 2015, NAT REV NEUROL, V11, P255, DOI 10.1038/nrneurol.2015.51; Eckes T, 2009, REFERENCE MANUAL R S REFERENCE MANUAL R S, P1; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Farrokhi F., 2012, JALT J, V34, P79; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-77; Fischer DB, 2016, NEUROLOGY, V87, P2427, DOI 10.1212/WNL.0000000000003404; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Giacino JT, 2020, ARCH PHYS MED REHAB, V101, P1072, DOI 10.1016/j.apmr.2020.01.013; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Granger C., 2008, RASCH MEAS T, V21, P1122; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hedeker D., 2006, LONGITUDINAL DATA AN; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Higgins J, 2018, SEQUENCE SCANNER EFF; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hodkinson DJ, 2014, J CEREBR BLOOD F MET, V34, P1493, DOI 10.1038/jcbfm.2014.109; Ivanova MV, 2016, CORTEX, V85, P165, DOI 10.1016/j.cortex.2016.04.019; JANG SH, 2013, FRONT HUM NEUROSCI, V0007; Kozlowski AJ, 2016, ARCH PHYS MED REHAB, V97, P650, DOI 10.1016/j.apmr.2015.12.010; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Lin Y, 2008, J MAGN RESON IMAGING, V28, P598, DOI 10.1002/jmri.21464; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Mai JK., 2008, ATLAS HUMAN BRAIN; Martin Paula I., 2004, Seminars in Speech and Language, V25, P181; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S., 2010, MRI ATLAS HUMAN WHIT; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Myford Carol M, 2003, J Appl Meas, V4, P386; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2008, FUNCT NEUROL, V23, P189; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Pape TLB, 2014, ARCH PHYS MED REHAB, V95, P1672, DOI 10.1016/j.apmr.2014.04.015; Pape TLB, 2012, J REHABIL RES DEV, V49, P1137, DOI 10.1682/JRRD.2011.08.0154; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qin SZ, 2016, BRAIN STRUCT FUNCT, V221, P3237, DOI 10.1007/s00429-015-1098-4; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; Rappaport M, 1996, MED REHABILITATION T, P271; RAPPAPORT M, 1986, J HEAD TRAUMA REHABI, P00015, DOI DOI 10.1097/00001199-198603000-00005; Rijntjes M, 2002, PROG NEUROBIOL, V66, P109, DOI 10.1016/S0301-0082(01)00027-2; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shannon BJ, 2013, J NEUROPHYSIOL, V109, P1444, DOI 10.1152/jn.00651.2012; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sharp DJ, 2004, ANN NEUROL, V56, P836, DOI 10.1002/ana.20294; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Siegel JS, 2016, P NATL ACAD SCI USA, V113, pE4367, DOI 10.1073/pnas.1521083113; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sullivan EG, 2018, DISABIL REHABIL, V40, P945, DOI 10.1080/09638288.2016.1277403; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tate MC, 2014, BRAIN, V137, P2773, DOI 10.1093/brain/awu168; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Tomaiuolo F, 2016, J INT NEUROPSYCH SOC, V22, P620, DOI 10.1017/S1355617716000485; Tremblay P, 2016, BRAIN LANG, V162, P60, DOI 10.1016/j.bandl.2016.08.004; Turkeltaub PE, 2012, CORTEX, V48, P1179, DOI 10.1016/j.cortex.2011.06.010; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yao S, 2015, J NEUROL SCI, V356, P168, DOI 10.1016/j.jns.2015.06.044	114	4	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 8	2020	11								1027	10.3389/fneur.2020.01027			19	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OE4ZZ	WOS:000580541700001	33132997	gold, Green Published			2022-02-06	
J	Feld, K; Feld, D; Karger, B; Helmus, J; Schwimmer-Okike, N; Pfeiffer, H; Banaschak, S; Wittschieber, D				Feld, Katharina; Feld, Dustin; Karger, Bernd; Helmus, Janine; Schwimmer-Okike, Nneka; Pfeiffer, Heidi; Banaschak, Sibylle; Wittschieber, Daniel			Abusive head trauma in court: a multi-center study on criminal proceedings in Germany	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Child abuse; Clinical forensic medicine; Perpetrator's confessions; Perpetrator's profile; Legal assessment	SHAKEN-BABY-SYNDROME; BRAIN-INJURY; YOUNG-CHILDREN; INFANTS; PERPETRATORS; HEMORRHAGES; ADMISSIONS; SHAKING; STATES	The shaken baby syndrome (SBS) is a common variant of abusive head trauma (AHT) in infants and toddlers. Data on the legal outcome of such cases are still sparse. By means of a retrospective multi-center analysis, 72 cases of living children diagnosed with SBS/AHT from three German university institutes of legal medicine were identified. Forty-six of these cases with 68 accused individuals were available and could be evaluated with regard to basic data on the course of the criminal proceedings as well as the profile of the defendants (sub-divided into suspects, convicts, and confessed perpetrators). Criminal proceedings predominantly commenced with a complaint by the treating hospital (62%) and were found to be closed (without judgment) in 50% of the cases, mostly due to a "lack of sufficient suspicion." Of the 23 cases with judgment, the court decided on acquittal in 4 cases (17%). Imprisonment was the most frequent sentence (16 out of 19 cases with conviction, 84%), whereby the sentence has been suspended on probation in 63% of the cases. Suspects and perpetrators were mostly male and derived from the close family environment of the injured children. All confessed perpetrators stated an "excessive demand" as the reason for the violent shaking of the child. The results of the present study are in line with data from other studies with other legal systems. As many criminal proceedings were closed and the 4 acquittals occurred because the perpetration could not be ascribed to a specific perpetrator, improving the forensic methods for such an unequivocal assignment would be desirable.	[Feld, Katharina; Banaschak, Sibylle] Univ Hosp Cologne, Inst Legal Med, Cologne, Germany; [Feld, Dustin] AdiutaByte GmbH, Business Campus, St Augustin, Germany; [Karger, Bernd; Pfeiffer, Heidi] Univ Hosp Munster, Inst Legal Med, Munster, Germany; [Helmus, Janine] Univ Hosp Essen, Inst Legal Med, Essen, Germany; [Schwimmer-Okike, Nneka; Wittschieber, Daniel] Friedrich Schiller Univ, Jena Univ Hosp, Inst Legal Med, Klinikum 1, D-07747 Jena, Germany		Wittschieber, D (corresponding author), Friedrich Schiller Univ, Jena Univ Hosp, Inst Legal Med, Klinikum 1, D-07747 Jena, Germany.	daniel.wittschieber@med.uni-jena.de		Feld, Katharina/0000-0003-2699-2741	German Research Fund (DFG)German Research Foundation (DFG) [WI 5034/2-1]	The present work is part of a project funded by the German Research Fund (DFG), project number: WI 5034/2-1.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Al-Saadoon Muna, 2011, Sultan Qaboos Univ Med J, V11, P322; [Anonymous], 2001, Paediatr Child Health, V6, P663; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Barr RG, 2018, CHILD ABUSE NEGLECT, V84, P106, DOI 10.1016/j.chiabu.2018.07.004; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; CAFFEY J, 1974, PEDIATRICS, V54, P396; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Clauss D, 2013, KLIN PADIATR, V225, P283, DOI 10.1055/s-0033-1349064; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P130, DOI 10.1097/PAF.0b013e31828629ca; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Feld K, 2018, RECHTSMEDIZIN, V28, P514, DOI 10.1007/s00194-018-0276-0; Hahnemann ML, 2015, EUR RADIOL, V25, P299, DOI 10.1007/s00330-014-3443-z; Homa A, 2018, RECHTSMEDIZIN, V28, P500, DOI 10.1007/s00194-018-0277-z; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Orman G, 2020, J NEUROIMAGING, V30, P15, DOI 10.1111/jon.12670; Ricci L, 2003, CHILD ABUSE NEGLECT, V27, P271, DOI 10.1016/S0145-2134(03)00006-1; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Sperhake JP, 2008, RECHTSMEDIZIN, V18, P48, DOI 10.1007/s00194-007-0485-4; Sperhake JP, 2014, FORENSIC SCI MED PAT, V10, P251, DOI 10.1007/s12024-014-9546-7; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; Talvik I, 2008, ACTA PAEDIATR, V97, P782, DOI 10.1111/j.1651-2227.2008.00778.x; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Tieder JS, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0591; Wittschieber D, 2019, AM J NEURORADIOL, V40, P388, DOI 10.3174/ajnr.A5855; Wittschieber D, 2018, RECHTSMEDIZIN, V28, P486, DOI 10.1007/s00194-018-0274-2	39	4	4	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2021	135	1					235	244		10.1007/s00414-020-02435-5		OCT 2020	10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	PO2HY	WOS:000576879300002	33030617	Green Published, hybrid			2022-02-06	
J	Asmar, S; Lokhandwala, A; Richards, J; Bible, L; Avila, M; Castanon, L; Ditillo, M; Douglas, M; Joseph, B				Asmar, Samer; Lokhandwala, Adil; Richards, Joseph; Bible, Letitia; Avila, Mauricio; Castanon, Lourdes; Ditillo, Michael; Douglas, Molly; Joseph, Bellal			The neuroprotective effect of quetiapine in critically ill traumatic brain injury patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Military Health Systems Research Symposium	AUG 19-22, 2019	Kissimmee, FL			Traumatic brain injury; quetiapine; atypical antipsychotic; intensive care unit	ANTIPSYCHOTIC AGENTS; HALOPERIDOL; AGITATION; RISPERIDONE; MANAGEMENT; RECOVERY; OLANZAPINE; PRESSURE; DELIRIUM; CARE	INTRODUCTION Quetiapine is an atypical antipsychotic commonly used in critical care. Cellular and animal models demonstrated its novel anti-inflammatory properties in traumatic brain injury (TBI). Our study aimed to assess the effect of quetiapine on outcomes in critically ill TBI patients. We hypothesize that quetiapine improves neurological outcomes. METHODS The Multiparameter Intelligent Monitoring in Intensive Care database was queried, and all adult (age, >= 18 years) isolated TBI patients (extracranial Abbreviated Injury Scale, < 2) admitted to the intensive care unit for a period of >48 hours. Patients were stratified into quetiapine (+) and no-quetiapine (-) groups. Propensity score matching was performed (1:2 ratio). Outcome measures were intensive care unit length of stay, discharge Glasgow Coma Scale (GCS), and mortality. A subanalysis was performed for patients who underwent intracranial pressure (ICP) monitoring to ascertain the effect of quetiapine dose on ICP, and cerebral perfusion pressure (CPP). Survival curves and regression analyses were performed. RESULTS A matched cohort of (quetiapine, 116 vs. no-quetiapine, 232) patients was obtained. Mean +/- SD age was 65 +/- 21 years, median head Abbreviated Injury Scale was 3 (3-4), and median GCS was 10 (9-16). The median quetiapine dose given was 50 (25-125) mg. Patients who received quetiapine had lower mortality (17.2% vs. 27.6%;p= 0.03) and a higher median GCS at discharge (12 [11-14] vs. 11 [10-13];p< 0.04) but no difference in intensive care unit length of stay (4.1 days vs. 4.7 days;p= 0.75) or discharge to skilled nursing facility (34.5% vs. 31.9%;p= 0.63). On subanalysis of patients who received quetiapine, 40% had ICP monitoring. Higher doses of quetiapine were independently associated with progressively lower ICP (beta= -0.022 mm Hg/mg of quetiapine;p= 0.01) and higher CPP (beta= 0.031 mm Hg/mg quetiapine;p= 0.01). CONCLUSION Quetiapine may decrease mortality and improve neurological outcomes in critically ill TBI patients. It has a dose-dependent effect to decrease ICP and increase CPP. Quetiapine may be a potential therapeutic modality in critically ill TBI patients, but further studies are required to explore these mechanisms.	[Asmar, Samer; Lokhandwala, Adil; Richards, Joseph; Bible, Letitia; Avila, Mauricio; Castanon, Lourdes; Ditillo, Michael; Douglas, Molly; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care & Emergency Surg, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Avila, Mauricio J/G-9359-2013	Avila, Mauricio J/0000-0001-5855-2033			Burnett DM, 1999, NEUROREHABILITATION, V13, P165; Daniels JP, 2008, J CLIN PSYCHIAT, V69, P497, DOI 10.4088/JCP.v69n0324a; Deal N, 2015, EMERG MED CLIN N AM, V33, P739, DOI 10.1016/j.emc.2015.07.003; DeVane CL, 2001, CLIN PHARMACOKINET, V40, P509, DOI 10.2165/00003088-200140070-00003; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Fleminger S, 2003, BMJ-BRIT MED J, V327, P4, DOI 10.1136/bmj.327.7405.4; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hallman MR., 2013, CURR ANESTHESIOL REP, V3, P89; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Jaehne EJ, 2015, PHARMACOL BIOCHEM BE, V135, P136, DOI 10.1016/j.pbb.2015.05.021; Johnsen E, 2013, EUR PSYCHIAT, V28, P174, DOI 10.1016/j.eurpsy.2011.10.003; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kapur S, 2000, ARCH GEN PSYCHIAT, V57, P553, DOI 10.1001/archpsyc.57.6.553; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P1, DOI 10.1016/j.rehab.2016.01.001; Mark R., 2016, SECONDARY ANAL ELECT, P43; Morra JA, 2020, INT J PSYCHIAT MED, V55, P67, DOI 10.1177/0091217419838105; Nikiforuk A, 2012, PSYCHOPHARMACOLOGY, V220, P65, DOI 10.1007/s00213-011-2487-x; Oropello JM, 2015, PRINCIPLES CRITICAL; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Robinson BD, 2018, J TRAUMA ACUTE CARE, V85, P968, DOI 10.1097/TA.0000000000002011; Rodriguez-Yanez M, 2008, CURR OPIN NEUROL, V21, P353, DOI 10.1097/WCO.0b013e3282ffafbf; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scarff Jonathan R, 2011, P T, V36, P832; Schatzberg AF., 2013, ESSENTIALS CLIN PSYC; Srivastava AK, 2018, NEUROMETHODS, V139, P1, DOI 10.1007/978-1-4939-8564-7_1; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Velligan DI, 2003, J CLIN PSYCHIAT, V64, P524, DOI 10.4088/JCP.v64n0505; Velligan DI, 2002, SCHIZOPHR RES, V53, P239, DOI 10.1016/S0920-9964(01)00268-7; Verma SD, 1998, J CLIN PSYCHIAT, V59, P50; Wang HN, 2010, PHYSIOL RES, V59, P263, DOI 10.33549/physiolres.931756; Weeks JJ, 2018, BEHAV BRAIN RES, V340, P159, DOI 10.1016/j.bbr.2016.09.049; Williamson DR, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0374-6; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB	47	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2020	89	4					775	782		10.1097/TA.0000000000002866			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NX3RR	WOS:000575629900045	32649611				2022-02-06	
J	Bigler, ED; Skiles, M; Wade, BSC; Abildskov, TJ; Tustison, NJ; Scheibel, RS; Newsome, MR; Mayer, AR; Stone, JR; Taylor, BA; Tate, DF; Walker, WC; Levin, HS; Wilde, EA				Bigler, Erin D.; Skiles, Marc; Wade, Benjamin S. C.; Abildskov, Tracy J.; Tustison, Nick J.; Scheibel, Randall S.; Newsome, Mary R.; Mayer, Andrew R.; Stone, James R.; Taylor, Brian A.; Tate, David F.; Walker, William C.; Levin, Harvey S.; Wilde, Elisabeth A.			FreeSurfer 5.3 versus 6.0: are volumes comparable? A Chronic Effects of Neurotrauma Consortium study	BRAIN IMAGING AND BEHAVIOR			English	Article						FreeSurfer; Version 5.3; Version 6.0; Quantitative neuroimaging; MRI volumetrics	TRAUMATIC BRAIN-INJURY; CORTICAL THICKNESS; ALZHEIMERS-DISEASE; ACCURACY; MILITARY; VETERANS; VERSION; HEALTH; ADULTS	Automated neuroimaging methods like FreeSurfer (https://surfer.nmr.mgh.harvard.edu/) have revolutionized quantitative neuroimaging analyses. Such analyses provide a variety of metrics used for image quantification, including magnetic resonance imaging (MRI) volumetrics. With the release of FreeSurfer version 6.0, it is important to assess its comparability to the widely-used previous version 5.3. The current study used data from the initial 249 participants in the ongoing Chronic Effects of Neurotrauma Consortium (CENC) multicenter observational study to compare the volumetric output of versions 5.3 and 6.0 across various regions of interest (ROI). In the current investigation, the following ROIs were examined: total intracranial volume, total white matter volume, total ventricular volume, total gray matter volume, and right and left volumes for the thalamus, pallidum, putamen, caudate, amygdala and hippocampus. Absolute ROI volumes derived from FreeSurfer 6.0 differed significantly from those obtained using version 5.3. We also employed a clinically-based evaluation strategy to compare both versions in their prediction of age-mediated volume reductions (or ventricular increase) in the aforementioned structures. Statistical comparison involved both general linear modeling (GLM) and random forest (RF) methods, where cross-validation error was significantly higher using segmentations from FreeSurfer version 5.3 versus version 6.0 (GLM:t = 4.97, df = 99,pvalue = 2.706e-06; RF:t = 4.85, df = 99,pvalue = 4.424e-06). Additionally, the relative importance of ROIs used to predict age using RFs differed between FreeSurfer versions, indicating substantial differences in the two versions. However, from the perspective of correlational analyses, fitted regression lines and their slopes were similar between the two versions, regardless of version used. While absolute volumes are not interchangeable between version 5.3 and 6.0, ROI correlational analyses appear to yield similar results, suggesting the interchangeability of ROI volume for correlational studies.	[Bigler, Erin D.; Skiles, Marc; Abildskov, Tracy J.] Brigham Young Univ, Psychol Dept, Provo, UT 84602 USA; [Bigler, Erin D.; Skiles, Marc; Abildskov, Tracy J.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Wade, Benjamin S. C.; Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Wade, Benjamin S. C.] Univ Southern Calif, Imaging Genet Ctr, Marina Del Rey, CA USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Tustison, Nick J.; Stone, James R.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Scheibel, Randall S.; Newsome, Mary R.; Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Newsome, Mary R.; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Houston, TX 77030 USA; [Mayer, Andrew R.] Univ New Mexico, Albuquerque, NM 87131 USA; [Taylor, Brian A.; Walker, William C.] Virginia Commonwealth Univ, Richmond, VA USA; [Wilde, Elisabeth A.] Univ Utah, Salt Lake City, UT USA		Bigler, ED (corresponding author), Brigham Young Univ, Psychol Dept, Provo, UT 84602 USA.; Bigler, ED (corresponding author), Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA.	erin_bigler@byu.edu	Tate, David/G-5166-2011	Tate, David/0000-0003-0213-1920; Taylor, Brian/0000-0001-9745-1075; TUSTISON, NICHOLAS/0000-0001-9418-5103; Wade, Benjamin/0000-0003-2461-6101	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; CENC Neuroimaging Core [1I01RX001062]	This material is based in part upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095 and the CENC Neuroimaging Core under 1I01RX001062. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred. Dr. Bigler received royalties from Oxford University Press, and honorarium from the American Psychological Association for editorial work and, during the time of this investigation, directed the Neuropsychological Assessment and Research Lab at Brigham Young University, which did provide forensic consultation.	Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Chepkoech JL, 2016, HUM BRAIN MAPP, V37, P1831, DOI 10.1002/hbm.23139; Cifu DX, 2016, BRAIN INJURY, V30, P1397, DOI 10.1080/02699052.2016.1219065; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Jack CR, 2015, ALZHEIMERS DEMENT, V11, P740, DOI 10.1016/j.jalz.2015.05.002; Jahanshad N, 2017, J NEUROSCI RES, V95, P371, DOI 10.1002/jnr.23919; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Makowski C, 2018, NEUROIMAGE, V170, P182, DOI 10.1016/j.neuroimage.2017.02.069; Makris N, 2003, J COGNITIVE NEUROSCI, V15, P584, DOI 10.1162/089892903321662967; Marizzoni M, 2015, HUM BRAIN MAPP, V36, P3516, DOI 10.1002/hbm.22859; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Perez-Carrillo GJG, 2017, J NEUROSURG-PEDIATR, V19, P720, DOI 10.3171/2016.12.PEDS16335; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Stelmokas J, 2017, J ALZHEIMERS DIS, V60, P1499, DOI 10.3233/JAD-170306; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Visser E, 2016, NEUROIMAGE, V125, P479, DOI 10.1016/j.neuroimage.2015.10.013; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilde EA, 2016, BRAIN INJURY, V30, P1442, DOI 10.1080/02699052.2016.1219063; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	33	4	4	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2020	14	5					1318	1327		10.1007/s11682-018-9994-x			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC9YM	WOS:000579512100002	30511116				2022-02-06	
J	Burrell, JC; Browne, KD; Dutton, JL; Laimo, FA; Das, S; Brown, DP; Roberts, S; Petrov, D; Ali, Z; Ledebur, HC; Rosen, JM; Kaplan, HM; Wolf, JA; Smith, DH; Chen, HI; Cullen, DK				Burrell, Justin C.; Browne, Kevin D.; Dutton, John L.; Laimo, Franco A.; Das, Suradip; Brown, Daniel P.; Roberts, Sanford; Petrov, Dmitriy; Ali, Zarina; Ledebur, Harry C.; Rosen, Joseph M.; Kaplan, Hilton M.; Wolf, John A.; Smith, Douglas H.; Chen, H. Isaac; Cullen, D. Kacy			A Porcine Model of Peripheral Nerve Injury Enabling Ultra-Long Regenerative Distances: Surgical Approach, Recovery Kinetics, and Clinical Relevance	NEUROSURGERY			English	Article						Autografts; Nerve regeneration; Peripheral nerves; Peripheral nerve injuries; Peroneal nerve; Swine; Translational medical research	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR DELIVERY; CARTILAGE REPAIR; FUNCTIONAL RECOVERY; OUTCOME MEASURES; STEPPING-STONE; ANIMAL-MODELS; MOTOR; RAT; DISRUPTION	BACKGROUND: Millions of Americans experience residual deficits from traumatic peripheral nerve injury (PNI). Despite advancements in surgical technique, repair typically results in poor functional outcomes due to prolonged periods of denervation resulting from long regenerative distances coupled with slow rates of axonal regeneration. Novel surgical solutions require valid preclinical models that adequately replicate the key challenges of clinical PNI. OBJECTIVE: To develop a preclinical model of PNI in swine that addresses 2 challenging, clinically relevant PNI scenarios: long segmental defects (>= 5 cm) and ultra-long regenerative distances (20-27cm). Thus, we aim to demonstrate that a porcine model of major PNI is suitable as a potential framework to evaluate novel regenerative strategies prior to clinical deployment. METHODS: A 5-cm-long common peroneal nerve or deep peroneal nerve injury was repaired using a saphenous nerve or sural nerve autograft, respectively. Histological and electrophysiological assessments were performed at 9 to 12 mo post repair to evaluate nerve regeneration and functional recovery. Relevant anatomy, surgical approach, and functional/histological outcomes were characterized for both repair techniques. RESULTS: Axons regenerated across the repair zone and were identified in the distal stump. Electrophysiological recordings confirmed these findings and suggested regenerating axons reinnervated target muscles. CONCLUSION: The models presented herein provide opportunities to investigate peripheral nerve regeneration using different nerves tailored for specific mechanisms of interest, such as nerve modality (motor, sensory, and mixed fiber composition), injury length (short/long gap), and total regenerative distance (proximal/distal injury).	[Burrell, Justin C.; Browne, Kevin D.; Dutton, John L.; Laimo, Franco A.; Das, Suradip; Brown, Daniel P.; Roberts, Sanford; Petrov, Dmitriy; Ali, Zarina; Wolf, John A.; Smith, Douglas H.; Chen, H. Isaac; Cullen, D. Kacy] Univ Penn, Ctr Brain Injury & Repair, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Burrell, Justin C.; Browne, Kevin D.; Laimo, Franco A.; Das, Suradip; Brown, Daniel P.; Roberts, Sanford; Petrov, Dmitriy; Wolf, John A.; Chen, H. Isaac; Cullen, D. Kacy] Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA; [Burrell, Justin C.; Cullen, D. Kacy] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Ledebur, Harry C.; Smith, Douglas H.; Cullen, D. Kacy] Axonova Med, Philadelphia, PA USA; [Rosen, Joseph M.] Dartmouth Coll, Div Plast Surg, Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Kaplan, Hilton M.] Rutgers State Univ, New Jersey Ctr Biomat, New Brunswick, NJ USA		Cullen, DK (corresponding author), Univ Penn, Dept Neurosurg, 105E Hayden Hall,320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@pennmedicine.upenn.edu	Burrell, Justin C./AAW-2310-2020	Burrell, Justin C./0000-0002-5361-9224; Laimo, Franco/0000-0003-1147-2348	U.S. Department of DefenseUnited States Department of Defense [W81XWH-16-1-0796, W81XWH-15-1-0466, W81XWH-13-207004]; Department of Veterans AffairsUS Department of Veterans Affairs [IK2-RX001479, IK2-RX002013]; American Association of Neurological Surgeons and Congress of Neurological Surgeons [Codman Fellowship in Neurotrauma and Critical Care (Petrov)]	The authors acknowledge Laura Struzyna, Kritika Katiyar, Cassidy Fetterman, Chelsea Wallace, Joseph Maggiore, Gabe DeSantis, and Vishal Tien for technical contributions, Alexander I. Evins for technical advice, and the University Laboratory Animal Resources staff at the University of Pennsylvania for their animal care. Financial support provided by the U.S. Department of Defense [CDMRP/JPC8-CRMRP #W81XWH-16-1-0796 (Cullen), MRMC #W81XWH-15-1-0466 (Cullen), JWMRP #W81XWH-13-207004 (Cullen)], Department of Veterans Affairs [Career Development Awards #IK2-RX001479 (Wolf) and #IK2-RX002013 (Chen)], and American Association of Neurological Surgeons and Congress of Neurological Surgeons [Codman Fellowship in Neurotrauma and Critical Care (Petrov)].	Ahlawat S, 2018, J COMPUT ASSIST TOMO, V42, P580, DOI 10.1097/RCT.0000000000000730; Ali ZS, 2015, J NEUROSURG, V122, P195, DOI 10.3171/2014.9.JNS132823; Ali ZS, 2014, J NEUROSURG-PEDIATR, V13, P462, DOI 10.3171/2013.12.PEDS13382; Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056; Badia J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036023; Boyer RB, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.6.FOCUS1590; Brenner MJ, 2004, PLAST RECONSTR SURG, V114, P1802, DOI 10.1097/01.PRS.0000143575.88064.D0; Brown JM, 2010, NEUROSURGERY, V66, P75, DOI 10.1227/01.NEU.0000354364.13224.C8; Brown JM, 2009, NEUROSURGERY, V65, P966, DOI 10.1227/01.NEU.0000358951.64043.73; Brown JM, 2008, HAND CLIN, V24, P319, DOI 10.1016/j.hcl.2008.08.002; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Callaghan JP, 2001, CLIN BIOMECH, V16, P28, DOI 10.1016/S0268-0033(00)00063-2; Chhabra Avneesh, 2014, Indian J Radiol Imaging, V24, P217, DOI 10.4103/0971-3026.137025; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Fisher MB, 2015, TISSUE ENG PT A, V21, P850, DOI [10.1089/ten.TEA.2014.0384, 10.1089/ten.tea.2014.0384]; Fisher MB, 2016, CARTILAGE, V7, P174, DOI 10.1177/1947603515623030; Forden J, 2011, NEUROSURGERY, V68, P1354, DOI 10.1227/NEU.0b013e31820c08de; Friedman JM, 2018, CARTILAGE, V9, P428, DOI 10.1177/1947603517700953; Gallagher TA, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.6.FOCUS15211; Gonzalez-Perez F, 2017, NEUROSURGERY, V80, P465, DOI 10.1093/neuros/nyw068; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Hachmann JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081443; Hess JR, 2007, PLAST RECONSTR SURG, V119, P246, DOI 10.1097/01.prs.0000245341.71666.97; Hoben GM, 2018, PLAST RECONSTR SURG, V142, P952, DOI 10.1097/PRS.0000000000004759; Hort-Legrand C, 2006, LAB ANIM-UK, V40, P53, DOI 10.1258/002367706775404345; Hundepool CA, 2015, PLAST RECONSTR SURG, V136, p633E, DOI 10.1097/PRS.0000000000001681; Jensen JN, 2005, ANN PLAS SURG, V54, P420, DOI 10.1097/01.sap.0000151461.60911.c0; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kantsevoy SV, 2005, GASTROINTEST ENDOSC, V62, P287, DOI 10.1016/S0016-5107(05)01565-8; Kaplan HM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5558-4; Kemp SWP, 2017, EXP NEUROL, V287, P348, DOI 10.1016/j.expneurol.2016.04.011; Kemp SWP, 2013, J PERIPHER NERV SYST, V18, P220, DOI 10.1111/jns5.12035; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kim D, 2012, ATLAS PERIPHERAL NER; Kim IL, 2015, TISSUE ENG PT A, V21, P2680, DOI 10.1089/ten.tea.2015.0150; Lachapelle JR, 2016, IEEE ENG MED BIO, P1794, DOI 10.1109/EMBC.2016.7591066; MAEDA T, 1993, BRAIN RES, V618, P196, DOI 10.1016/0006-8993(93)91266-U; Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1; Mikityansky I, 2012, MAGN RESON IMAGING C, V20, P791, DOI 10.1016/j.mric.2012.08.003; Morisaki S, 2011, J MAGN RESON IMAGING, V33, P535, DOI 10.1002/jmri.22442; Navarro X, 2016, EUR J NEUROSCI, V43, P271, DOI 10.1111/ejn.13033; Patel NP, 2018, NEURAL REGEN RES, V13, P764, DOI 10.4103/1673-5374.232458; Pfeifer CG, 2017, TISSUE ENG PART C-ME, V23, P745, DOI [10.1089/ten.TEC.2017.0109, 10.1089/ten.tec.2017.0109]; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81; Roberts SE, 2017, MICROSURG, V37, P169, DOI 10.1002/micr.30133; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; Rupp A, 2007, J NEUROSCI METH, V166, P266, DOI 10.1016/j.jneumeth.2007.07.015; Scherman P, 2001, J NEUROSURG, V95, P316, DOI 10.3171/jns.2001.95.2.0316; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4; Shapira Y, 2019, NEUROSURGERY, V85, P156, DOI 10.1093/neuros/nyy221; Simon NG, 2016, HAND CLINIC, V136, P811, DOI 10.1016/B978-0-444-53486-6.00040-5; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; Toussaint CP, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e31820958e8; Ulyanova AV, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0102-18.2018; Vasudevan S, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000118; Vasudevan S, 2013, PLAST RECONSTR SURG, V132, P871, DOI 10.1097/PRS.0b013e31829fe515; Wang EG, 2017, J TRAUMA ACUTE CARE, V83, P875, DOI 10.1097/TA.0000000000001570; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; Wright AS, 2005, RADIOLOGY, V236, P132, DOI 10.1148/radiol.2361031249; Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x; Yan Y, 2018, MUSCLE NERVE, V57, P260, DOI 10.1002/mus.25659; Zager EL, 2014, WORLD NEUROSURG, V82, P333, DOI 10.1016/j.wneu.2013.10.054; Zilic L, 2015, J ANAT, V227, P302, DOI 10.1111/joa.12341	67	4	4	3	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2020	87	4					833	846		10.1093/neuros/nyaa106			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8HR	WOS:000593121100050	32392341	Green Submitted, Bronze			2022-02-06	
J	Cecchi, NJ; Monroe, DC; Phreaner, JJ; Small, SL; Hicks, JW				Cecchi, Nicholas J.; Monroe, Derek C.; Phreaner, Jenna J.; Small, Steven L.; Hicks, James W.			Patterns of head impact exposure in men's and women's collegiate club water polo	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Head injury; Head impact sensor; Peak acceleration; Sex differences	FOOTBALL; SPORT	Objectives: Recent reports have demonstrated a risk of concussion and subconcussive head impacts in collegiate varsity and international elite water polo. We sought to characterize patterns of head impact exposure at the collegiate club level of water polo. Design: Prospective cohort study. Methods: Head impact sensors (SIM-G, Triax Technologies) were worn by men's (n = 16) and women's (n = 15) collegiate club water polo players during 11 games. Peak linear acceleration (PLA) and peak rotational acceleration (PRA) of head impacts were recorded by the sensors. Two streams of competition video were used to verify and describe the nature of head impacts. Results: Men's players sustained 52 verified head impacts of magnitude 39.7 +/- 16.3 g PLA and 5.2 +/- 3.2 krad/s(2) PRA, and women's players sustained 43 verified head impacts of magnitude 33.7 +/- 12.6 g PLA and 4.0 +/- 2.8 krad/s(2) PRA. Impacts sustained by men had greater PLA than those sustained by women (p = .045). Athletes were impacted most frequently at the offensive center position, to the back of the head, and by an opponent's torso or limb. Conclusions: Our cohort of male and female athletes sustained relatively infrequent head impacts during water polo competitions played at the collegiate club level. The amount of head impact exposure in our cohort was dependent on player position, with offensive centers prone to sustaining the most impacts. Head impact sensors are subject to large amounts of false positives and should be used in conjunction with video recordings to verify the validity of impact data. (c) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Cecchi, Nicholas J.; Phreaner, Jenna J.; Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Monroe, Derek C.; Small, Steven L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Small, Steven L.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX USA		Monroe, DC (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	dcmonroe@uci.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163; Small, Steven/0000-0002-5293-6172; Monroe, Derek/0000-0003-3885-6878	Center for Exercise Medicineand Sport Sciences at the University of California, Irvine [5T32AR047752-15]	This work was supported by the Center for Exercise Medicineand Sport Sciences at the University of California, Irvine and theNational Institutes of Health [5T32AR047752-15]. The funders hadno role in study design, data collection and analysis, decision topublish, or preparation of the manuscript. NJC is founder and CEOof Counter, Inc, a company that manufactures and sells water poloequipment including protective headgear.	Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; BRAINARD LL, 2012, NEUROSURGERY, V44, P297, DOI DOI 10.1249/MSS.0B013E31822B0AB4; Cecchi NJ, 2019, FRONT SPORTS ACT LIV, V1, DOI 10.3389/fspor.2019.00002; Cecchi NJ, 2020, P I MECH ENG P-J SPO, V234, P162, DOI 10.1177/1754337120901974; Cecchi NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216369; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Gabbett TJ, 2005, J SCI MED SPORT, V8, P111, DOI 10.1016/S1440-2440(05)80031-3; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCuen E, 2015, J BIOMECH; Monroe DC, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00218; Mountjoy M, 2019, BRIT J SPORT MED, V53, P25, DOI 10.1136/bjsports-2018-099349; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	24	4	3	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	OCT	2020	23	10					927	931		10.1016/j.jsams.2020.03.008			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK7HZ	WOS:000566905200007	32303477	Green Accepted			2022-02-06	
J	Faulkner, JW; Theadom, A; Mahon, S; Snell, DL; Barker-Collo, S; Cunningham, K				Faulkner, Josh W.; Theadom, Alice; Mahon, Susan; Snell, Deborah L.; Barker-Collo, Suzanne; Cunningham, Kay			Psychological flexibility: A psychological mechanism that contributes to persistent symptoms following mild traumatic brain injury?	MEDICAL HYPOTHESES			English	Article						Mild traumatic brain injury; Psychological flexibility; Post-concussion symptoms; Recovery	DEFAULT MODE NETWORK; POST-CONCUSSION SYNDROME; FEAR-AVOIDANCE MODEL; MINOR HEAD-INJURY; POSTCONCUSSION SYNDROME; COMMITMENT THERAPY; RISK-FACTORS; NEUROPSYCHOLOGICAL OUTCOMES; EXPERIENTIAL AVOIDANCE; POSTTRAUMATIC-STRESS	Persistent symptoms following a mild traumatic brain injury (mTBI) can have profound implications on all aspects of an individual's functioning. Psychological factors have a significant role in contributing to the development of persistent post-concussion symptoms and predicting outcomes. Biopsychosocial explanations have therefore been applied to prognostic models of mTBI. What is not evident in the literature to date is an understanding of the psychological mechanisms that may be important in mediating the various psychological factors in these models. The construct of psychological flexibility holds promise in this regard. Psychological flexibility is the ability to act in alignment with values in the presence of inner discomfort such as pain and distress. It is hypothesised that psychological flexibility has a significant role in the development and maintenance of persistent symptoms following mild traumatic brain injury. The rationale that forms the basis of this hypothesis is as follows: a relationship exists between psychological flexibility and pre-injury psychological risk factors; psychological flexibility is vulnerable to the pathophysiology associated with mTBI; post-injury psychological and neuropsychological factors exacerbate and maintain psychological inflexibility; and psychological flexibility underlies psychological responses to mTBI that contribute to unfavourable outcomes. A discussion of the literature that pertains to each of these points is presented. Based on this hypothesis, we conclude, that there is rationale to empirically explore the role of psychological flexibility in mTBI and its relationship to outcomes. This may also lead to evaluation of specific interventions that target this psychological mechanism in mTBI, such as Acceptance and Commitment Therapy, and improve outcomes for this population.	[Faulkner, Josh W.; Theadom, Alice; Mahon, Susan] Auckland Univ Technol, Univ Technol, TBI Network, 90 Akoranga Dr, Auckland, New Zealand; [Snell, Deborah L.] Univ Otago, 2 Riccarton Ave, Christchurch 8011, New Zealand; [Barker-Collo, Suzanne] Auckland Univ, Auckland CDB, Auckland 1010, New Zealand; [Faulkner, Josh W.; Mahon, Susan; Cunningham, Kay] Wakefield Specialist Ctr, Proact Rehab, Florence St, Wellington 6021, New Zealand		Faulkner, JW (corresponding author), Auckland Univ Technol, Sch Clin Sci, Dept Psychol, 90 Akoranga Dr, Auckland, New Zealand.	josh.faulkner@aut.ac.nz		Faulkner, Josh/0000-0001-9555-4628	New Zealand Health Research Council Foxley Clinical Fellowship [20/041]	No potential conflict of interest was reported by the authors. The project is funded by the New Zealand Health Research Council Foxley Clinical Fellowship (20/041).	Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Barker-Collo S, 2013, BRAIN IMPAIR, V14, P425, DOI 10.1017/BrImp.2013.27; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Bohlmeijer ET, 2011, BEHAV RES THER, V49, P62, DOI 10.1016/j.brat.2010.10.003; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brinkborg H, 2011, BEHAV RES THER, V49, P389, DOI 10.1016/j.brat.2011.03.009; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan CJ, 2015, J CONTEXT BEHAV SCI, V4, P263, DOI 10.1016/j.jcbs.2015.10.002; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chawla N, 2007, J CLIN PSYCHOL, V63, P871, DOI 10.1002/jclp.20400; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Dahl J, 2004, BEHAV THER, V35, P785, DOI 10.1016/S0005-7894(04)80020-0; DeGaetano JJ, 2016, J CLIN SPORT PSYCHOL, V10, P192, DOI 10.1123/jcsp.2014-0023; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dindo L, 2020, CONTEMP CLIN TRIALS, V90, DOI 10.1016/j.cct.2020.105954; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Elbin RJ, 2016, APPL NEUROPSYCH-CHIL, V5, P294, DOI 10.1080/21622965.2015.1077334; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Flaxman PE, 2010, BEHAV RES THER, V48, P816, DOI 10.1016/j.brat.2010.05.004; Gentili C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02016; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glascher J, 2012, P NATL ACAD SCI USA, V109, P14681, DOI 10.1073/pnas.1206608109; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 1999, PSYCHOL REC, V49, P33, DOI 10.1007/BF03395305; Hayrapetyan A, 2015, TISSUE ENG PART B-RE, V21, P75, DOI [10.1089/ten.TEB.2014.0119, 10.1089/ten.teb.2014.0119]; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; Lee JK, 2014, J BEHAV THER EXP PSY, V45, P208, DOI 10.1016/j.jbtep.2013.10.008; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; Leonidou C, 2019, J HEALTH PSYCHOL, V24, P175, DOI 10.1177/1359105316666657; Levin ME, 2012, J AM COLL HEALTH, V60, P443, DOI 10.1080/07448481.2012.673522; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Linkowski DC, 1971, REHAB COUNSELING B; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Luoma J, 2011, ADDICT RES THEORY, V19, P3, DOI 10.3109/16066359.2010.524956; Lyons J.A., 1991, J TRAUMA STRESS, V4, P93, DOI [DOI 10.1007/BF00976011, 10.1002/jts.2490040108, DOI 10.1002/JTS.2490040108]; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Mantua J, 2019, BRAIN INJURY, V33, P1467, DOI 10.1080/02699052.2019.1646434; Masuda A, 2014, ASIAN AM J PSYCHOL, V5, P230, DOI 10.1037/a0034437; Masuda A, 2012, J EVID-BASED INTEGR, V17, P66, DOI 10.1177/2156587211423400; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCracken LM, 2014, J PAIN, V15, P221, DOI 10.1016/j.jpain.2013.10.014; McCracken LM, 1998, PAIN, V74, P21, DOI 10.1016/S0304-3959(97)00146-2; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merwin Rhonda M, 2011, Eat Disord, V19, P62, DOI 10.1080/10640266.2011.533606; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moitra E, 2016, J CONTEXT BEHAV SCI, V5, P252, DOI 10.1016/j.jcbs.2016.10.003; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Peterson RA., 1987, J ANXIETY DISORD, V1, P117, DOI [10.1016/0887-6185(87)90002-8, DOI 10.1016/0887-6185(87)90002-8]; Pierson H, 2004, FUNCTIONAL ACC UNPUB; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ravn SL, 2018, PAIN MED, V19, P1764, DOI 10.1093/pm/pnx223; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruiz FJ., 2010, INT J PSYCHOL PSYCHO, V10, P125, DOI DOI 10.1080/028457199439937; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Sandera AM, 2021, NEUROPSYCHOL REHABIL, V31, P1105, DOI 10.1080/09602011.2020.1762670; Schmidt AJM, 2003, BEHAV RES THER, V41, P1243, DOI 10.1016/S0005-7967(03)00155-4; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Scott W, 2016, J CONTEMP PSYCHOTHER, V46, P139, DOI 10.1007/s10879-016-9328-5; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Silberstein LR, 2012, INT J COGN THER, V5, P406, DOI 10.1521/ijct.2012.5.4.406; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sylvester M, 2011, THESIS; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tsai MC, 2014, J PEDIATR-US, V164, P136, DOI 10.1016/j.jpeds.2013.08.042; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vazquez C, 2010, BEHAV PSYCHOL, V18, P139; Venzala E, 2013, EUR NEUROPSYCHOPHARM, V23, P697, DOI 10.1016/j.euroneuro.2012.05.010; Wagnild G., 1993, J NURSING MEASUREMEN, V1, P165; Waugh CE, 2011, EMOTION, V11, P1059, DOI 10.1037/a0021786; Wersebe H, 2018, INT J CLIN HLTH PSYC, V18, P60, DOI 10.1016/j.ijchp.2017.09.002; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wicksell RK, 2008, EUR J PAIN, V12, P491, DOI 10.1016/j.ejpain.2007.08.003; Widiger TA, 2018, CURR OPIN PSYCHOL, V21, P18, DOI 10.1016/j.copsyc.2017.09.007; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yehene E, 2020, APPL NEUROPSYCH-ADUL, V27, P468, DOI 10.1080/23279095.2019.1569523; Young KS, 2018, NEUROSCI BIOBEHAV R, V84, P424, DOI 10.1016/j.neubiorev.2017.08.003	155	4	4	1	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2020	143								110141	10.1016/j.mehy.2020.110141			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	OA0UL	WOS:000577511800089	32759012				2022-02-06	
J	Hicks, SD; Olympia, RP; Onks, C; Kim, RY; Zhen, KVJ; Fedorchak, G; DeVita, S; Rangnekar, A; Heller, M; Zwibel, H; Monteith, C; Gagnon, Z; McLoughlin, CD; Randall, J; Madeira, M; Campbell, TR; Fengler, E; Dretsch, MN; Neville, C; Middleton, FA				Hicks, Steven D.; Olympia, Robert P.; Onks, Cayce; Kim, Raymond Y.; Zhen, Kevin J.; Fedorchak, Gregory; DeVita, Samantha; Rangnekar, Aakanksha; Heller, Matthew; Zwibel, Hallie; Monteith, Chuck; Gagnon, Zofia; McLoughlin, Callan D.; Randall, Jason; Madeira, Miguel; Campbell, Thomas R.; Fengler, Elise; Dretsch, Michael N.; Neville, Christopher; Middleton, Frank A.			Saliva microRNA Biomarkers of Cumulative Concussion	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						saliva; microRNA; sports-related concussion; mild traumatic brain injury; biomarker	PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; HIGH-SCHOOL; SPORTS; INJURY; EPIDEMIOLOGY; ASSOCIATION; PERFORMANCE; EXPRESSION	Recurrent concussions increase risk for persistent post-concussion symptoms, and may lead to chronic neurocognitive deficits. Little is known about the molecular pathways that contribute to persistent concussion symptoms. We hypothesized that salivary measurement of microribonucleic acids (miRNAs), a class of epitranscriptional molecules implicated in concussion pathophysiology, would provide insights about the molecular cascade resulting from recurrent concussions. This hypothesis was tested in a case-control study involving 13 former professional football athletes with a history of recurrent concussion, and 18 age/sex-matched peers. Molecules of interest were further validated in a cross-sectional study of 310 younger individuals with a history of no concussion (n = 230), a single concussion (n = 56), or recurrent concussions (n = 24). There was no difference in neurocognitive performance between the former professional athletes and their peers, or among younger individuals with varying concussion exposures. However, younger individuals without prior concussion outperformed peers with prior concussion on three balance assessments. Twenty salivary miRNAs differed (adj. p < 0.05) between former professional athletes and their peers. Two of these (miR-28-3p and miR-339-3p) demonstrated relationships (p < 0.05) with the number of prior concussions reported by younger individuals. miR-28-3p and miR-339-5p may play a role in the pathophysiologic mechanism involved in cumulative concussion effects.	[Hicks, Steven D.; Zhen, Kevin J.] Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Olympia, Robert P.] Penn State Coll Med, Dept Emergency Med, Hershey, PA 17033 USA; [Onks, Cayce] Penn State Coll Med, Dept Family Med, Hershey, PA 17033 USA; [Kim, Raymond Y.] Penn State Coll Med, Dept Orthoped & Rehabil, Hershey, PA 17033 USA; [Fedorchak, Gregory; DeVita, Samantha; Rangnekar, Aakanksha] Inst Human Performance, Quadrant Biosci, Syracuse, NY 13210 USA; [Heller, Matthew; Zwibel, Hallie] New York Inst Technol, Dept Family Med, Coll Osteopath Med, Old Westbury, NY 11568 USA; [Monteith, Chuck] Colgate Univ, Dept Athlet Training, Hamilton, NY 13346 USA; [Gagnon, Zofia; McLoughlin, Callan D.; Randall, Jason; Madeira, Miguel] Marist Coll, Sch Sci, Poughkeepsie, NY 12601 USA; [Campbell, Thomas R.] Old Dominion Univ, Sch Rehabil Sci, Norfolk, VA 23529 USA; [Fengler, Elise] Syracuse Univ, Dept Exercise Sci, Syracuse, NY 13210 USA; [Dretsch, Michael N.] US Army, Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis Mcchord, WA 98433 USA; [Neville, Christopher] SUNY Upstate Med Univ, Dept PT Educ Orthoped & Neurosci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA		Hicks, SD (corresponding author), Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA.	kzhen@pennstatehealth.psu.edu; rolympia@pennstatehealth.psu.edu; conks@pennstatehealth.psu.edu; rkim@pennstatehealth.psu.edu; kzhen@pennstatehealth.psu.edu; gregory.fedorchak@quadrantbiosciences.com; samantha.devita@quadrantbiosciences.com; aakanksha.rangnekar@quadrantbiosciences.com; mheller@nyit.edu; hzwibel@nyit.edu; cmonteith@colgate.edu; zofia.gagnon@marist.edu; cmcloughlin8864@gmail.com; jrandall2323@gmail.com; miguelmaymone@gmail.com; tcamp012@odu.edu; fenglere@chc.edu; michael.n.dretsch.mil@mail.mil; nevillec@upstate.edu; middletf@upstate.edu		Hicks, Steven/0000-0002-9579-6798; DeVita, Samantha/0000-0002-4843-7709; Kim, Raymond/0000-0003-4229-904X	Quadrant Biosciences; Penn State College of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR002015, UL1 TR002014]	This project was supported by a sponsored research agreement between Quadrant Biosciences and the Penn State College of Medicine. S.D.H's time was supported by the National Center for Advancing Translational Sciences, grant KL2 TR002015 and grant UL1 TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Dretsch MN, 2019, APPL NEUROPSYCH-ADUL, V26, P76, DOI 10.1080/23279095.2017.1362406; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldie BJ, 2014, NUCLEIC ACIDS RES, V42, P9195, DOI 10.1093/nar/gku594; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lee H, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10124131; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Rangaprakash D, 2018, HUM BRAIN MAPP, V39, P264, DOI 10.1002/hbm.23841; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Zhao XH, 2020, EXP THER MED, V20, P2218, DOI 10.3892/etm.2020.8920	45	4	4	3	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2020	21	20							7758	10.3390/ijms21207758			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	OI0WN	WOS:000583007300001	33092191	gold, Green Published			2022-02-06	
J	Lasocki, S; Pene, F; Ait-Oufella, H; Aubron, C; Ausset, S; Buffet, P; Huet, O; Launey, Y; Legrand, M; Lescot, T; Dessap, AM; Piagnerelli, M; Quintard, H; Velly, L; Kimmoun, A; Chanques, G				Lasocki, Sigismond; Pene, Frederic; Ait-Oufella, Hafid; Aubron, Cecile; Ausset, Sylvain; Buffet, Pierre; Huet, Olivier; Launey, Yoann; Legrand, Matthieu; Lescot, Thomas; Dessap, Armand Mekontso; Piagnerelli, Michael; Quintard, Herve; Velly, Lionel; Kimmoun, Antoine; Chanques, Gerald			Management and prevention of anemia (acute bleeding excluded) in adult critical care patients	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article						Guidelines; Anemia; Blood transfusion; Erythropoietin; Iron	RECOMBINANT-HUMAN-ERYTHROPOIETIN; BLOOD-CELL TRANSFUSION; GOAL-DIRECTED RESUSCITATION; HIGHER HEMOGLOBIN THRESHOLD; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; ILL PATIENTS; DOUBLE-BLIND; RESTRICTIVE TRANSFUSION; IRON SUPPLEMENTATION	Objective: Anemia is very common in critical care patients, on admission (affecting about two thirds of patients), but also during and after their stay, due to repeated blood loss, the effects of inflammation on erythropoiesis, a decreased red blood cell life span, and haemodilution. Anemia is associated with severity of illness and length of stay. Methods: A committee composed of 16 experts from four scientific societies, SFAR, SRLF, SFTS and SFVTT, evaluated three fields: (1) anaemia prevention, (2) transfusion strategies and (3) non-transfusion treatment of anaemia. Population, Intervention, Comparison, and Outcome (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Analysis of the literature and formulation of recommendations were then conducted according to the GRADE (R) methodology. Results: The SFAR-SRLF guideline panel provided ten statements concerning the management of anemia in adult critical care patients. Acute haemorrhage and chronic anemia were excluded from the scope of these recommendations. After two rounds of discussion and various amendments, a strong consensus was reached for ten recommendations. Three of these recommendations had a high level of evidence (GRADE 1 +/- ) and four had a low level of evidence (GRADE 2 +/-). No GRADE recommendation could be provided for two questions in the absence of strong consensus. Conclusions: The experts reached a substantial consensus for several strong recommendations for optimal patient management. The experts recommended phlebotomy reduction strategies, restrictive red blood cell transfusion and a single-unit transfusion policy, the use of red blood cells regardless of storage time, treatment of anemic patients with erythropoietin, especially after trauma, in the absence of contraindications and avoidance of iron therapy (except in the context of erythropoietin therapy). (C) 2020 The Author(s). Published by Elsevier Masson SAS on behalf of Societe francaise d'anesthesie et de reanimation (Sfar).	[Lasocki, Sigismond] Univ Angers, Dept Anesthesie Reanimat, CHU Angers, Angers, France; [Pene, Frederic] Univ Paris, Hop Cochin, AP HP, Serv Med Intens & Reanimat, Paris, France; [Ait-Oufella, Hafid] Univ Pierre & Marie Curie Paris, Hop St Antoine, AP HP, Serv Med Intens & Reanimat, Paris, France; [Aubron, Cecile] Univ Bretagne Occident, Med Intens Reanimat, CHRU Brest, F-29200 Brest, France; [Ausset, Sylvain] Ecoles Mil Sante Lyon Bron, F-69500 Bron, France; [Buffet, Pierre] Univ Paris, INSERM, UMRS 1134, F-75015 Paris, France; [Buffet, Pierre] Lab Excellence GREx, F-75015 Paris, France; [Huet, Olivier] CHRU Brest, Dept Anesthesie Reanimat, Hop Cavale Blanche, F-29200 Brest, France; [Huet, Olivier] Univ Bretagne Occidentale, UFR Med Brest, F-29200 Brest, France; [Launey, Yoann] Rennes Univ Hosp, Dept Anaesthesia Crit Care Med & Perioperat Med, Crit Care Unit, 2 Rue Henri Le Guilloux, F-35033 Rennes, France; [Legrand, Matthieu] Univ Calif San Francisco, Dept Anaesthesiol & Perioperat Care, San Francisco, CA 94143 USA; [Lescot, Thomas] Sorbonne Univ, Dept Anesthesie Reanimat, Hop St Antoine, AP HP, Paris, France; [Dessap, Armand Mekontso] Hop Univ Henri Mondor, AP HP, DMU Med, Serv Med Intens Reanimat, F-94010 Creteil, France; [Piagnerelli, Michael] Univ Libre Bruxelles ULB, Intens Care, Expt Med Lab, CHU Charleroi Marie Curie, 222 Unit,140 Chaussee Bruxelles, B-6042 Charleroi, Belgium; [Quintard, Herve] CHU Nice, Hop Pasteur 2, Reanimat Medicochirurg, 30 Voie Romaine, Nice, France; [Velly, Lionel] Aix Marseille Univ, Dept Anaesthesiol & Crit Care Med, Univ Hosp Timone, AP HM, F-13005 Marseille, France; [Velly, Lionel] Aix Marseille Univ, Inst Neurosci Timone, UMR7289, CNRS, Marseille, France; [Kimmoun, Antoine] Univ Lorraine, Serv Med Intens & Reanimat Brabois, Inserm U1116, CHRU Nancy, Nancy, France; [Chanques, Gerald] Univ Montpellier, Dept Anaesthesia & Intens Care, St Eloi Hosp, Montpellier, France; [Chanques, Gerald] Univ Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France		Lasocki, S (corresponding author), LUNAM Univ Angers, Dept Anesthesie Reanimat, CHU Angers, Pole ASUR,UMR INSERM 1084,CNRS 6214, F-49000 Angers, France.	sigismond@lasocki.com					Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Aubron C, 2012, TRANSFUSION, V52, P1196, DOI 10.1111/j.1537-2995.2011.03437.x; Bateman AP, 2009, CRIT CARE MED, V37, P1906, DOI 10.1097/CCM.0b013e3181a000cf; Bennett-Guerrero E, 2009, TRANSFUSION, V49, P1375, DOI 10.1111/j.1537-2995.2009.02152.x; Bergamin FS, 2017, CRIT CARE MED, V45, P766, DOI 10.1097/CCM.0000000000002283; Berger MD, 2012, HAEMATOL-HEMATOL J, V97, P116, DOI 10.3324/haematol.2011.047035; BOLES JM, 1989, CLIN NUTR, V8, P69, DOI 10.1016/0261-5614(89)90048-4; Boutin A, 2018, J CRIT CARE, V45, P133, DOI 10.1016/j.jcrc.2018.01.023; CAMPILLO B, 1988, INTENS CARE MED, V14, P640, DOI 10.1007/BF00256769; Carson JL, 2018, AM HEART J, V200, P96, DOI 10.1016/j.ahj.2018.04.007; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Chantepie SP, 2017, TRANSFUSION, V57, P296, DOI 10.1111/trf.13908; Chen QH, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2062-5; Chicella Michael F, 2006, J Pediatr Pharmacol Ther, V11, P101, DOI 10.5863/1551-6776-11.2.101; Cirocco W, 2015, SURGERY, V158, P1087; Cooper DJ, 2017, NEW ENGL J MED, V377, P1858, DOI 10.1056/NEJMoa1707572; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Corwin HL, 1999, CRIT CARE MED, V27, P2346, DOI 10.1097/00003246-199911000-00004; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; de Almeida JP, 2015, ANESTHESIOLOGY, V122, P29, DOI 10.1097/ALN.0000000000000511; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Docherty AB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1351; Dolman HS, 2015, SURGERY, V158, P1083, DOI 10.1016/j.surg.2015.05.018; Duranteau J, 2015, ANESTH REANIM, V1, P62, DOI 10.1016/j.anrea.2014.12.007; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; French CJ, 2017, ANN SURG, V265, P54, DOI 10.1097/SLA.0000000000001746; Georgopoulos D, 2005, CRIT CARE, V9, pR508, DOI 10.1186/cc3786; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Harber CR, 2006, ANAESTH INTENS CARE, V34, P434, DOI 10.1177/0310057X0603400414; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lasocki S, 2011, ANESTHESIOLOGY, V114, P688, DOI 10.1097/ALN.0b013e3182065c57; Lehot J, 2017, PERTINENCE PRESCRIPT; Litton E, 2019, INTENS CARE MED, V45, P1190, DOI 10.1007/s00134-019-05686-y; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; LOW LL, 1995, CHEST, V108, P216, DOI 10.1378/chest.108.1.216; Lyon AW, 2013, COMPUT BIOL MED, V43, P84, DOI 10.1016/j.compbiomed.2012.11.008; MacIsaac CM, 2003, ANAESTH INTENS CARE, V31, P653, DOI 10.1177/0310057X0303100607; Mazer CD, 2018, NEW ENGL J MED, V379, P1224, DOI 10.1056/NEJMoa1808561; Mazer CD, 2017, NEW ENGL J MED, V377, P2133, DOI 10.1056/NEJMoa1711818; McQuilten ZK, 2018, TRANSFUS MED REV, V32, P77, DOI [10.1016/j.tmry.2018.02.002, 10.1016/j.tmrv.2018.02.002]; Mesgarpour B, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010969.pub2; Mesgarpour B, 2013, INTENS CARE MED, V39, P1896, DOI 10.1007/s00134-013-3030-9; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Oliver JC, 2014, TRANSFUSION, V54, P2617, DOI 10.1111/trf.12536; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; PERUZZI WT, 1993, CRIT CARE MED, V21, P501, DOI 10.1097/00003246-199304000-00007; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Piagnerelli M, 2003, CRIT CARE MED, V31, P2156, DOI 10.1097/01.CCM.0000079608.00875.14; Pieracci FM, 2006, CRIT CARE MED, V34, P1898, DOI 10.1097/01.CCM.0000220495.10510.C1; Pieracci FM, 2014, CRIT CARE MED, V42, P2048, DOI 10.1097/CCM.0000000000000408; Pieracci FM, 2009, SURG INFECT, V10, P9, DOI 10.1089/sur.2008.043; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rygard SL, 2017, ACTA ANAESTH SCAND, V61, P166, DOI 10.1111/aas.12837; Rygard SL, 2018, INTENS CARE MED, V44, P204, DOI 10.1007/s00134-018-5069-0; Rygard SL, 2016, INTENS CARE MED, V42, P1685, DOI 10.1007/s00134-016-4437-x; Sanchez-Giron F, 2008, ARCH PATHOL LAB MED, V132, P1916, DOI 10.1043/1543-2165-132.12.1916; Shah A, 2019, J CRIT CARE, V49, P162, DOI 10.1016/j.jcrc.2018.11.005; Shah A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1486-z; Shehata N, 2019, EUR HEART J, V40, P1081, DOI 10.1093/eurheartj/ehy435; Shih AW, 2018, TRANSFUSION, V58, P2841, DOI 10.1111/trf.14952; Siegal DM, 2020, J INTENSIVE CARE MED, V35, P1074, DOI 10.1177/0885066618810374; Silver M, 2006, CRIT CARE MED, V34, P2310, DOI 10.1097/01.CCM.0000233873.17954.42; SMOLLER BR, 1989, AM J CLIN PATHOL, V91, P701, DOI 10.1093/ajcp/91.6.701; van Iperen CE, 2000, CRIT CARE MED, V28, P2773, DOI 10.1097/00003246-200008000-00015; Vincent JL, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2018-9; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; von Ahsen N, 1999, CRIT CARE MED, V27, P2630, DOI 10.1097/00003246-199912000-00005; Wang CL, 2015, JAMA-J AM MED ASSOC, V314, P2062, DOI 10.1001/jama.2015.15572; Wang YS, 2018, INTERN EMERG MED, V13, P231, DOI 10.1007/s11739-016-1594-4; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Yang WW, 2017, TRANSFUSION, V57, P1163, DOI 10.1111/trf.14000; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yoshida T, 2019, BLOOD TRANSFUS-ITALY, V17, P27, DOI 10.2450/2019.0217-18; Zarychanski R, 2007, CAN MED ASSOC J, V177, P725, DOI 10.1503/cmaj.071055	82	4	4	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	OCT	2020	39	5					655	664		10.1016/j.accpm.2020.04.004			10	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	OE6PM	WOS:000580650500032	32713688	Green Published, Green Submitted, hybrid			2022-02-06	
J	Mayilsamy, K; Markoutsa, E; Das, M; Chopade, P; Puro, D; Kumar, A; Gulick, D; Willing, AE; Mohapatra, SS; Mohapatra, S				Mayilsamy, Karthick; Markoutsa, Eleni; Das, Mahasweta; Chopade, Pratik; Puro, Durga; Kumar, Akanksha; Gulick, Danielle; Willing, Alison E.; Mohapatra, Shyam S.; Mohapatra, Subhra			Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						rTBI; Dendriplex; hMSC; CCL20; CCR6; BDNF	CLINICAL-TRIALS; PAMAM DENDRIMERS; MOUSE MODEL; ENCEPHALOPATHY; ERYTHROPOIETIN; SPECTRUM; DELIVERY; SURFACE; REPAIR; RISK	Traumatic brain injury (TBI) is a devastating neurological disorder, although the underlying pathophysiology is poorly understood. TBI causes blood-brain barrier (BBB) disruption, immune cell trafficking, neuroinflammation and neurodegeneration. CCL20 is an important chemokine mediating neuroinflammation. Human mesenchymal stem cell (hMSC) therapy is a promising regenerative approach but the inflammatory microenvironment in the brain tends to decrease the efficacy of the hMSC transplantation. Reducing the inflammation prior to hMSC therapy improves the outcome. We developed a combined nano-cell therapy by using dendrimers complexed with plasmids (dendriplexes) targeting CCL20 and its sole receptor CCR6 to reduce inflammation followed by hMSC transplantation. Treatment of TBI mice with shRNA conjugated dendriplexes followed by hMSC administration downregulated the inflammatory markers and significantly increased brain-derived neurotrophic factor (BDNF) expression in the cerebral cortex indicating future possible neurogenesis and improved behavioral deficits. Taken together, this nano-cell therapy ameliorates neuroinflammation and promotes brain tissue repair after TBI. Published by Elsevier Inc.	[Mayilsamy, Karthick; Das, Mahasweta; Kumar, Akanksha; Gulick, Danielle; Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA; [Markoutsa, Eleni; Mohapatra, Shyam S.; Mohapatra, Subhra] Univ S Florida, Dept Internal Med, Ctr Res & Educ Nanobioengn, Tampa, FL 33620 USA; [Markoutsa, Eleni; Chopade, Pratik; Puro, Durga; Mohapatra, Shyam S.] Univ S Florida, Coll Pharm, Grad Programs, Tampa, FL 33620 USA; [Willing, Alison E.] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Mayilsamy, Karthick; Markoutsa, Eleni; Das, Mahasweta; Mohapatra, Shyam S.; Mohapatra, Subhra] James A Haley VA Hosp, Tampa, FL 33612 USA		Mohapatra, S (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.; Mohapatra, S (corresponding author), James A Haley VA Hosp, Tampa, FL 33612 USA.	smohapa2@usf.edu	Willing, Alison/AAP-7759-2021		Veterans Affairs Merit Review grantUS Department of Veterans Affairs [BX002668]; Research Career Scientist Awards [IK6BX004212, IK6 BX003778]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs	This work is supported by a Veterans Affairs Merit Review grant (BX002668) to Subhra Mohapatra, and Research Career Scientist Awards to Dr. Subhra Mohapatra (IK6BX004212) and Dr. Shyam Mohapatra (IK6 BX003778). Though this report is based upon work supported, in part, by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, the contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government.	Albertazzi L, 2013, MOL PHARMACEUT, V10, P249, DOI 10.1021/mp300391v; Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buja LM, 2010, J AM COLL CARDIOL, V56, P1693, DOI 10.1016/j.jacc.2010.06.041; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Das M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49428-y; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Das M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1499-z; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; del Zoppo Gregory J., 2009, V25, P34, DOI 10.1159/000209471; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Florendo M, 2018, MOLECULES, V23, DOI 10.3390/molecules23092238; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kambhampati SP, 2015, EUR J PHARM BIOPHARM, V95, P239, DOI 10.1016/j.ejpb.2015.02.013; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Karolczak K, 2012, INT J PHARMACEUT, V436, P508, DOI 10.1016/j.ijpharm.2012.06.033; Kim ID, 2010, J CONTROL RELEASE, V142, P422, DOI 10.1016/j.jconrel.2009.11.011; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lee JH, 2003, BIOCONJUGATE CHEM, V14, P1214, DOI 10.1021/bc034095g; Leonardo CC, 2012, TRANSL STROKE RES, V3, P357, DOI 10.1007/s12975-012-0203-8; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mastorakos P, 2017, J CONTROL RELEASE, V262, P37, DOI 10.1016/j.jconrel.2017.07.009; Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Peterson A.B. Xu, 2014, SURVEILLANCE REPORT, P1; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Phatnani H, 2015, COLD SPRING HARB PER, V7, P6; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Redondo-Castro E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0531-4; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rowe RK, 2019, J NEUROTRAUM, V36, P1318, DOI 10.1089/neu.2018.5980; Sah DWY, 2006, LIFE SCI, V79, P1773, DOI 10.1016/j.lfs.2006.06.011; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Seyhan AA, 2011, HUM GENET, V130, P583, DOI 10.1007/s00439-011-0995-8; Shakhbazau A, 2010, MOL BIOL REP, V37, P2003, DOI 10.1007/s11033-009-9651-y; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toledo-Rodriguez M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00017; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Win-Shwe TT, 2014, TOXICOL LETT, V228, P207, DOI 10.1016/j.toxlet.2014.04.020; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yang H, 2010, PHARM RES-DORDR, V27, P1759, DOI 10.1007/s11095-010-0141-7	64	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	OCT	2020	29								102247	10.1016/j.nano.2020.102247			12	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Research & Experimental Medicine	NT7DF	WOS:000573096000010	32599163				2022-02-06	
J	Sheridan, DC; Pettersson, D; Newgard, CD; Selden, NR; Jafri, MA; Lin, A; Rowell, S; Hansen, ML				Sheridan, David C.; Pettersson, David; Newgard, Craig D.; Selden, Nathan R.; Jafri, Mubeen A.; Lin, Amber; Rowell, Susan; Hansen, Matthew L.			Can QuickBrain MRI replace CT as first-line imaging for select pediatric head trauma?	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						imaging; MRI; pediatric; trauma	CHILDREN; HEMORRHAGE; RADIATION; MODALITY	ObjectiveThe current standard of care for initial neuroimaging in injured pediatric patients suspected of having traumatic brain injury is computed tomography (CT) that carries risks associated with radiation exposure. The primary objective of this trial was to evaluate the ability of a QuickBrain MRI (qbMRI) protocol to detect clinically important traumatic brain injuries in the emergency department (ED). The secondary objective of this trial was to compare qbMRI to CT in identifying radiographic traumatic brain injury. MethodsThis was a prospective study of trauma patients less than 15 years of age with suspected traumatic brain injury at a level 1 pediatric trauma center in Portland, Oregon between August 2017 and March 2019. All patients in whom a head CT was deemed clinically necessary were approached for enrollment to also obtain a qbMRI in the acute setting. Clinically important traumatic brain injury was defined as the need for neurological surgery procedure, intubation, pediatric intensive care unit stay greater than 24 hours, a total hospital length of stay greater than 48 hours, or death. ResultsA total of 73 patients underwent both CT and qbMRI. The median age was 4 years (interquartile range [IQR] = 1-10 years). Twenty-two patients (30%) of patients had a clinically important traumatic brain injury, and of those, there were 2 deaths (9.1%). QbMRI acquisition time had a median of 4 minutes and 52 seconds (IQR = 3 minutes 49 seconds-5 minutes 47 seconds). QbMRI had sensitivity for detecting clinically important traumatic brain injury of 95% (95% confidence interval [CI] = 77%-99%). For any radiographic injury, qbMRI had a sensitivity of 89% (95% CI = 78%-94%). ConclusionOur results suggest that qbMRI has good sensitivity to detect clinically important traumatic brain injuries. Further multi-institutional, prospective trials are warranted to either support or refute these findings.	[Sheridan, David C.; Newgard, Craig D.; Lin, Amber; Hansen, Matthew L.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, Portland, OR 97239 USA; [Pettersson, David] Oregon Hlth & Sci Univ, Dept Radiol, Div Neuroradiol, Portland, OR 97239 USA; [Selden, Nathan R.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Div Pediat Neurosurg, Portland, OR 97239 USA; [Jafri, Mubeen A.] Oregon Hlth & Sci Univ, Dept Surg, Div Pediat Surg, Portland, OR 97239 USA; [Rowell, Susan] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Surg, Portland, OR 97239 USA		Sheridan, DC (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, 707 SW Gaines Rd Mail Code CDRC W, Portland, OR 97239 USA.	sheridda@ohsu.edu			Friends of Doernbecher Children's Hospital Foundation	This study was funded by a grant from the Friends of Doernbecher Children's Hospital Foundation.	Amukotuwa SA, 2020, INT J STROKE, V15, P216, DOI 10.1177/1747493019858781; Antonucci MC, 2017, J PEDIATR-US, V182, P210, DOI 10.1016/j.jpeds.2016.11.051; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Cho HH, 2020, PEDIATR RADIOL, V50, P242, DOI 10.1007/s00247-019-04532-z; Christy A, 2018, PEDIATR NEUROL, V78, P55, DOI 10.1016/j.pediatrneurol.2017.09.020; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Niederhauser BD, 2013, AM J NEURORADIOL, V34, P1836, DOI 10.3174/ajnr.A3510; Ohana O, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170434; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pan J, 2018, J NEUROSURG-PEDIATR, V22, P158, DOI 10.3171/2018.2.PEDS17523; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Ryan ME, 2016, NEURORADIOLOGY, V58, P793, DOI 10.1007/s00234-016-1686-x; Tang MY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/312142; Thompson EM, 2014, J NEUROSURG-PEDIATR, V13, P636, DOI 10.3171/2014.2.PEDS13567; Wagner MW, 2016, J NEUROIMAGING, V26, P68, DOI 10.1111/jon.12310; Yue EL, 2015, J NEUROSURG-PEDIATR, V15, P420, DOI 10.3171/2014.9.PEDS14207	24	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	OCT	2020	1	5					965	973		10.1002/emp2.12113			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GP	WOS:000648695300041	33145547	gold, Green Published			2022-02-06	
J	Streith, L; Silverberg, J; Kirkpatrick, AW; Hameed, SM; Bathe, OF; Ball, CG				Streith, Lucas; Silverberg, Jenna; Kirkpatrick, Andrew W.; Hameed, S. Morad; Bathe, Oliver F.; Ball, Chad G.			Optimal treatments for hepato-pancreato-biliary trauma in severely injured patients: a narrative scoping review	CANADIAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	Canadian Surgery Forum	SEP 05-07, 2019	Montreal, CANADA				ASSOCIATION; EXPERIENCE; MANAGEMENT; PACKING	Hepato-pancreato-biliary (HPB) injuries can be extremely challenging to manage. This scoping review (8438 citations) offers a number of recommendations. If diagnosis and therapy are rapid, patients with major hepatic injuries who present in physiologic extremis have high survival rates despite prolonged hospital stays. Nonoperative management of major liver injuries, as diagnosed using computed tomography, is typically successful. Adjuncts (e.g., angioembolization, laparoscopic washouts, biliary stents) are essential in managing high-grade injuries. Injury to the extrahepatic biliary tree is rare. Cholecystectomy is indicated for all gallbladder trauma. Full-thickness common bile duct injuries require a hepaticojejunostomy, although damage control remains closed suction drainage. Injuries to the pancreatic head often involve concurrent trauma to regional vasculature. Damage control necessitates drainage after stopping hemorrhage. Injury to the left pancreas commonly requires a distal pancreatectomy. Outcomes for high-grade pancreatic and liver injuries are improved by involving an HPB team. Complications are multidisciplinary and should be managed without delay.	[Streith, Lucas; Silverberg, Jenna; Kirkpatrick, Andrew W.; Bathe, Oliver F.; Ball, Chad G.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Hameed, S. Morad] Univ British Columbia, Dept Surg, Vancouver, BC, Canada		Ball, CG (corresponding author), Foothills Med Ctr, 1403-29 St NW, Calgary, AB T2N 5A1, Canada.	ball.chad@gmail.com					Asensio JA, 2016, J TRAUMA ACUTE CARE, V80, P1023, DOI 10.1097/TA.0000000000001010; Ball CG, 2010, J TRAUMA MANAG OUTCO, V4, P3, DOI DOI 10.1186/1752-2897-4-3.[; Ball CG, 2014, CAN J SURG, V57, P55, DOI 10.1503/cjs.020312; Ball CG, 2011, J TRAUMA, V70, P330, DOI 10.1097/TA.0b013e318203285c; Biffl WL, 2013, J TRAUMA ACUTE CARE, V75, P941, DOI 10.1097/TA.0b013e3182a96572; CALNE RY, 1979, BRIT J SURG, V66, P338, DOI 10.1002/bjs.1800660512; Daudt HML, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-48; FELICIANO DV, 1986, J TRAUMA, V26, P738, DOI 10.1097/00005373-198608000-00010; Ho VP, 2017, J TRAUMA ACUTE CARE, V82, P185, DOI 10.1097/TA.0000000000001300; Roberts DJ, 2016, ANN SURG, V265, P1034	10	4	5	0	0	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	OCT	2020	63	5					E431	E434		10.1503/cjs.013919			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	OP8ZE	WOS:000588378600011	33009897	gold, Green Published			2022-02-06	
J	Trevisi, G; Sturiale, CL; Scerrati, A; Rustemi, O; Ricciardi, L; Raneri, F; Tomatis, A; Piazza, A; Auricchio, AM; Stifano, V; Romano, C; De Bonis, P; Mangiola, A				Trevisi, Gianluca; Sturiale, Carmelo Lucio; Scerrati, Alba; Rustemi, Oriela; Ricciardi, Luca; Raneri, Fabio; Tomatis, Alberto; Piazza, Amedeo; Auricchio, Anna Maria; Stifano, Vito; Romano, Carmine; De Bonis, Pasquale; Mangiola, Annunziato			Acute subdural hematoma in the elderly: outcome analysis in a retrospective multicentric series of 213 patients	NEUROSURGICAL FOCUS			English	Article						acute subdural hematoma; antithrombotic drugs; comorbidity; elderly; surgery; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MORTALITY; ADULTS	OBJECTIVE The objective of this study was to analyze the risk factors associated with the outcome of acute subdural hematoma (ASDH) in elderly patients treated either surgically or nonsurgically. METHODS The authors performed a retrospective multicentric analysis of clinical and radiological data on patients aged >= 70 years who had been consecutively admitted to the neurosurgical department of 5 Italian hospitals for the management of posttraumatic ASDH in a 3-year period. Outcome was measured according to the Glasgow Outcome Scale (GOS) at discharge and at 6 months' follow-up. A GOS score of 1-3 was defined as a poor outcome and a GOS score of 4-5 as a good outcome. Univariate and multivariate statistics were used to determine outcome predictors in the entire study population and in the surgical group. RESULTS Overall, 213 patients were admitted during the 3-year study period. Outcome was poor in 135 (63%) patients, as 65 (31%) died during their admission, 33 (15%) were in a vegetative state, and 37 (17%) had severe disability at discharge. Surgical patients had worse clinical and radiological findings on arrival or during their admission than the patients undergoing conservative treatment Surgery was performed in 147 (69%) patients, and 114 (78%) of them had a poor outcome. In stratifying patients by their Glasgow Coma Scale (GCS) score, the authors found that surgery reduced mortality but not the frequency of a poor outcome in the patients with a moderate to severe GCS score. The GCS score and midline shift were the most significant predictors of outcome. Antiplatelet drugs were associated with better outcomes; however, patients taking such medications had a better GCS score and better radiological findings, which could have influenced the former finding. Patients with fixed pupils never had a good outcome. Age and Charlson Comorbidity Index were not associated with outcome. CONCLUSIONS Traumatic ASDH in the elderly is a severe condition, with the GCS score and midline shift the stronger outcome predictors, while age per se and comorbidities were not associated with outcome. Antithrombotic drugs do not seem to negatively influence pretreatment status or posttreatment outcome. Surgery was performed in patients with a worse clinical and radiological status, reducing the rate of death but not the frequency of a poor outcome.	[Trevisi, Gianluca; Tomatis, Alberto; Mangiola, Annunziato] Osped Santo Spirito, Neurosurg Unit, Pescara, Italy; [Sturiale, Carmelo Lucio; Auricchio, Anna Maria; Stifano, Vito] Fdn Policlin Univ A Gemelli IRCSS, Dept Neurosurg, Rome, Italy; [Scerrati, Alba; Romano, Carmine; De Bonis, Pasquale] S Anna Univ Hosp, Dept Neurosurg, Ferrara, Italy; [Scerrati, Alba; De Bonis, Pasquale] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Rustemi, Oriela; Raneri, Fabio] Azienda ULSS 8 Berica Osped San Bortolo, UOC Neurochirurg 1, Vicenza, Italy; [Ricciardi, Luca; Piazza, Amedeo] Azienda Osped St Andrea, UOC Neurochirurg, Dipartimento NESMOS, Sapienza Roma, Italy; [Mangiola, Annunziato] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy		Trevisi, G (corresponding author), Osped Santo Spirito, Pescara, Italy.	trevisi.gianluca@gmail.com	Sturiale, Carmelo Lucio/K-6412-2016; Stifano, Vito/I-9032-2019; Ricciardi, Luca/L-5405-2019; Scerrati, Alba/Z-2079-2019	Sturiale, Carmelo Lucio/0000-0002-4080-2492; Stifano, Vito/0000-0002-5509-9592; Ricciardi, Luca/0000-0001-5110-8386; Scerrati, Alba/0000-0002-8607-5323; AURICCHIO, ANNA MARIA/0000-0002-4186-4476; Tomatis, Alberto/0000-0003-4738-0496			Akbik OS, 2019, WORLD NEUROSURG, V126, pE1235, DOI 10.1016/j.wneu.2019.02.234; Bartek J, 2019, NEUROSURGERY, V84, P799, DOI 10.1093/neuros/nyy173; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Gernsback JE, 2018, WORLD NEUROSURG, V120, pE414, DOI 10.1016/j.wneu.2018.08.095; Greuter L, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19546; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Kaestner S, 2019, J NEUROL SURG PART A, V80, P359, DOI 10.1055/s-0039-1685188; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lee H, 2020, J NEUROTRAUM, V37, P2499, DOI 10.1089/neu.2019.6943; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Sufaro Y, 2019, J CLIN NEUROSCI, V67, P167, DOI 10.1016/j.jocn.2019.05.015; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Trevisi G, 2018, WORLD NEUROSURG, V118, pE316, DOI 10.1016/j.wneu.2018.06.185; Unterhofer C, 2018, NEUROSURG REV, V41, P183, DOI 10.1007/s10143-017-0833-0; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Whitehouse KJ, 2016, WORLD NEUROSURG, V94, P493, DOI 10.1016/j.wneu.2016.07.057; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421	30	4	4	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2020	49	4							E21	10.3171/2020.7.FOCUS20437			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OG2DX	WOS:000581702500021	33002873	gold, Green Submitted			2022-02-06	
J	Zhu, J; Yang, LK; Wang, QH; Lin, W; Feng, Y; Xu, YP; Chen, WL; Xiong, K; Wang, YH				Zhu, Jie; Yang, Li-Kun; Wang, Qiu-Hong; Lin, Wei; Feng, Yi; Xu, Ye-Ping; Chen, Wei-Liang; Xiong, Kun; Wang, Yu-Hai			NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1	MOLECULAR MEDICINE REPORTS			English	Article						N-myc downstream-regulated gene 2; receptor interacting protein kinase 1; necroptosis; necrostatin-1; astrocyte	TRAUMATIC BRAIN-INJURY; REGULATED GENE 2; CELL-DEATH; COLORECTAL-CANCER; DOWNSTREAM; EXPRESSION; MYC; CONTRIBUTES; PROTEIN; STROKE	Cerebral ischemia results in severe brain damage, and is a leading cause of death and long-term disability. Previous studies have investigated methods to activate astrocytes in order to promote repair in injured brain tissue and inhibit cell death. It has previously been shown that N-myc downstream-regulated gene 2 (NDRG2) was highly expressed in astrocytes and associated with cell activity, but the underlying mechanism is largely unknown. The present study generated NDRG2 conditional knockout (Ndrg2-/-) mice to investigate whether NDRG2 can block ischemia-induced astrocyte necroptosis by suppressing receptor interacting protein kinase 1 (RIPK1) expression. This study investigated astrocyte activity in cerebral ischemia, and identified that ischemic brain injuries could trigger RIP-dependent astrocyte necroptosis. The depletion of NDRG2 was found to accelerate permanent middle cerebral artery occlusion-induced necroptosis in the brain tissue of Ndrg2-/- mice, indicating that NDRG2 may act as a neuroprotector during cerebral ischemic injury. The present study suggested that NDRG2 attenuated astrocytic cell death via the suppression of RIPK1. The pharmacological inhibition of astrocyte necroptosis by necrostatin-1 provided neuroprotection against ischemic brain injuries after NDRG2 knockdown. Therefore, NDRG2 could be considered as a potential target for the treatment of cerebral ischemia.	[Zhu, Jie; Yang, Li-Kun; Lin, Wei; Feng, Yi; Xu, Ye-Ping; Chen, Wei-Liang; Wang, Yu-Hai] Anhui Med Univ, Hosp PLA 101, Sch Med, Dept Neurosurg, 101 Xingyuan North Rd, Wuxi 214044, Jiangsu, Peoples R China; [Wang, Qiu-Hong] Nanjing Med Univ, Dept Ophthalmol, Wuxi Hosp 2, Wuxi 214002, Jiangsu, Peoples R China; [Xiong, Kun] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China		Wang, YH (corresponding author), Anhui Med Univ, Hosp PLA 101, Sch Med, Dept Neurosurg, 101 Xingyuan North Rd, Wuxi 214044, Jiangsu, Peoples R China.	yuhaiwang@yeah.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601719]	This work was financially supported by the National Natural Science Foundation of China (grant no. 81601719).	Alamri FF, 2018, BEHAV BRAIN RES, V336, P250, DOI 10.1016/j.bbr.2017.09.008; Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chu D, 2011, MOL CANCER THER, V10, P47, DOI 10.1158/1535-7163.MCT-10-0614; Davila D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00272; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Flugge G, 2014, CELL TISSUE RES, V357, P31, DOI 10.1007/s00441-014-1837-5; Hao FL, 2019, BIOMED PHARMACOTHER, V109, P181, DOI 10.1016/j.biopha.2018.10.064; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kim SJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.238; King Melanie D, 2014, Int J Cell Biol, V2014, P495817, DOI 10.1155/2014/495817; Li Y, 2017, J CLIN INVEST, V127, P4270, DOI 10.1172/JCI94455; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; NAKASHIMA MN, 1995, CELL MOL NEUROBIOL, V15, P341, DOI 10.1007/BF02089944; Ni Y, 2018, NEUROSCIENCE, V371, P60, DOI 10.1016/j.neuroscience.2017.10.038; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Piper LC, 2015, JAMA SURG, V150, P1013, DOI 10.1001/jamasurg.2015.1838; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Shen LL, 2018, ONCOGENE, V37, P1759, DOI 10.1038/s41388-017-0118-7; Shi H, 2009, BIOL PHARM BULL, V32, P968, DOI 10.1248/bpb.32.968; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Smith CCT, 2011, J CELL MOL MED, V15, P1797, DOI 10.1111/j.1582-4934.2011.01341.x; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Takahashi K, 2005, INT J NEUROPSYCHOPH, V8, P381, DOI 10.1017/S1461145705005134; Takarada-Iemata M, 2018, GLIA, V66, P1432, DOI 10.1002/glia.23315; Takeichi T, 2011, NEUROCHEM INT, V59, P21, DOI 10.1016/j.neuint.2011.03.019; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Zhu H, 2012, DEV BIOL, V369, P308, DOI 10.1016/j.ydbio.2012.07.001	38	4	4	0	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2020	22	4					3103	3110		10.3892/mmr.2020.11421			8	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	NW4US	WOS:000575004300055	32945444	hybrid, Green Published			2022-02-06	
J	Eyolfson, E; Carr, T; Khan, A; Wright, DK; Mychasiuk, R; Lohman, AW				Eyolfson, Eric; Carr, Thomas; Khan, Asher; Wright, David K.; Mychasiuk, Richelle; Lohman, Alexander W.			Repetitive Mild Traumatic Brain Injuries in Mice during Adolescence Cause Sexually Dimorphic Behavioral Deficits and Neuroinflammatory Dynamics	JOURNAL OF NEUROTRAUMA			English	Article						concussion; development; microglia; MRI; neuroinflammation	WIDESPREAD MICROGLIAL ACTIVATION; ANXIETY-LIKE BEHAVIOR; AMYLOID-BETA; HIGH-SCHOOL; COMPLEMENT CASCADE; PERSISTENT CHANGES; TELOMERE LENGTH; SOCIAL-BEHAVIOR; SEX-DIFFERENCES; CONCUSSION	Adolescent brain injuries have devastating impacts on lifelong health given that adolescence is a critical period for brain development. Adolescents are susceptible to mild traumatic brain injuries (mTBIs) acquired from collisions in contact sports, which are often sustained in a repetitive nature (repetitive mild traumatic brain injuries; RmTBIs), and cause compounding, sexually dimorphic neurological deficits. Neuroinflammation accompanies RmTBIs and may be a central driving force for chronic neurological decline. To date, the impact of neuroinflammation and sex-specific dynamics during adolescent RmTBIs has been understudied. A lateral impact model (LIM) was developed that mimics the biomechanical forces commonly experienced in human mTBIs. Here, we report novel sexually dimorphic neurobehavioral and -inflammatory responses using LIM to model adolescent RmTBIs. We first subjected adolescent male C57Bl/6 mice to one, three, or five RmTBIs at 24-h intervals and quantified neurobehavioral deficits, and brain volumetric and structural changes by magnetic resonance imaging. Five RmTBIs caused significant motor deficits, increased brain volume in cortex, hippocampus, and corpus callosum, and reduced white matter integrity in the corpus callosum. We then compared neurobehavioral deficits in adolescent male and female mice and observed sex-specific deficits in motor function, whereas both sexes had dysfunction in learning and memory. Flow cytometric quantification of neuroinflammatory responses revealed time- and sex-dependent infiltration of peripheral macrophages and T cells and male-specific decreases in microglia number. Using immunohistochemistry, we report specific microglia density decreases in male mice in the motor cortex and thalamus. We show novel neuroinflammatory responses after adolescent brain injuries that expands the current understanding of RmTBI pathophysiology in this critical neurodevelopmental period.	[Eyolfson, Eric; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Khan, Asher; Lohman, Alexander W.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Carr, Thomas; Khan, Asher; Mychasiuk, Richelle; Lohman, Alexander W.] Univ Calgary, Hotchkiss Brain Inst HBI, Calgary, AB, Canada; [Wright, David K.; Mychasiuk, Richelle] Alberta Childrens Hosp Res Inst ACHRI, Calgary, AB, Canada; [Eyolfson, Eric; Carr, Thomas; Khan, Asher; Mychasiuk, Richelle; Lohman, Alexander W.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia		Lohman, AW (corresponding author), Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, HMRB 159,3330 Hosp Dr Northwest, Calgary, AB T2N 4N1, Canada.	alex.lohman@ucalgary.ca		Eyolfson, Eric/0000-0002-2201-5444	Hotchkiss Brain Institute; Alberta Children's Hospital Research Institute; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); National Scientific and Engineering Research Council	The authors thank the Hotchkiss Brain Institute, the Alberta Children's Hospital Research Institute, Canadian Institute of Health Research, and National Scientific and Engineering Research Council for their financial contributions.	Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brooks DM, 2017, EXP NEUROL, V297, P62, DOI 10.1016/j.expneurol.2017.07.015; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Christensen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63022-7; Christensen J, 2020, SYNAPSE, V74, DOI 10.1002/syn.22142; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Eyolfson E., 2020, CEREB CORTEX COMMUN, V1, ptgaa002; Eyolfson E, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00098; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Greenhalgh AD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005264; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kopec AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06118-z; Kosari-Nasab M, 2019, BEHAV PHARMACOL, V30, P282, DOI 10.1097/FBP.0000000000000480; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mills KL, 2014, DEV NEUROSCI-BASEL, V36, P147, DOI 10.1159/000362328; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; MYCHASIUK R, 2014, JOVE-J VIS EXP, V94, DOI [10.3791/51820, DOI 10.3791/51820]; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; PELLIS SM, 1990, DEV PSYCHOBIOL, V23, P215, DOI 10.1002/dev.420230303; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pont-Lezica L, 2014, EUR J NEUROSCI, V39, P1551, DOI 10.1111/ejn.12508; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Salberg S, 2018, J NEUROTRAUM, V35, P1895, DOI 10.1089/neu.2018.5744; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soares HD, 1995, J NEUROSCI, V15, P8223; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Su E, 2015, FRONT NEUROSCI, V57, P41; Sun M, 2020, NEUROSCI BIOBEHAV R, V109, P114, DOI 10.1016/j.neubiorev.2019.12.027; Sun MJ, 2019, BRAIN BEHAV IMMUN, V80, P536, DOI 10.1016/j.bbi.2019.04.038; Tabor J, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050258; Tabor J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00481; Tanaka S, 2012, BEHAV BRAIN RES, V233, P55, DOI 10.1016/j.bbr.2012.04.045; Thion MS, 2018, SCIENCE, V362, P185, DOI 10.1126/science.aat0474; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yamakawa GR, 2020, BEHAV BRAIN RES, V382, DOI 10.1016/j.bbr.2020.112472; Yamakawa GR, 2019, NEUROSCIENCE, V413, P264, DOI 10.1016/j.neuroscience.2019.06.022; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; YANKELEVITCHYAHAV, 2015, JOVE J VIS EXP MAR, DOI DOI 10.3791/52587; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	122	4	5	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2718	2732		10.1089/neu.2020.7195		SEP 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000575394400001	32772786				2022-02-06	
J	Giannetto, M; Xia, MS; Staeger, FF; Metcalfe, T; Vinitsky, HS; Dang, JAML; Xavier, ALR; Kress, BT; Nedergaard, M; Hablitz, LM				Giannetto, Michael; Xia, Maosheng; Staeger, Frederik Filip; Metcalfe, Tanner; Vinitsky, Hanna S.; Dang, Juliana A. M. L.; Xavier, Anna L. R.; Kress, Benjamin T.; Nedergaard, Maiken; Hablitz, Lauren M.			Biological sex does not predict glymphatic influx in healthy young, middle aged or old mice	SCIENTIFIC REPORTS			English	Article							WHEEL-RUNNING ACTIVITY; BRAIN; IMPAIRMENT; DIMORPHISM; CLEARANCE; RESPONSES; STEROIDS; INJURY; MODEL	Sexual dimorphism is evident in brain structure, size, and function throughout multiple species. Here, we tested whether cerebrospinal fluid entry into the glymphatic system, a network of perivascular fluid transport that clears metabolic waste from the brain, was altered between male and female mice. We analyze glymphatic influx in 244 young reproductive age (2-4 months) C57BL/6 mice. We found no male/female differences in total influx under anesthesia, or across the anterior/posterior axis of the brain. Circadian-dependent changes in glymphatic influx under ketamine/xylazine anesthesia were not altered by sex. This was not true for diurnal rhythms under pentobarbital and avertin, but both still showed daily oscillations independent of biological sex. Finally, although glymphatic influx decreases with age there was no sex difference in total influx or subregion-dependent tracer distribution in 17 middle aged (9-10 months) and 36 old (22-24 months) mice. Overall, in healthy adult C57BL/6 mice we could not detect male/female differences in glymphatic influx. This finding contrasts the gender differences in common neurodegenerative diseases. We propose that additional sex-dependent co-morbidities, such as chronic stress, protein misfolding, traumatic brain injury or other pathological mechanisms may explain the increased risk for developing proteinopathies rather than pre-existing suppression of glymphatic influx.	[Giannetto, Michael; Metcalfe, Tanner; Vinitsky, Hanna S.; Nedergaard, Maiken; Hablitz, Lauren M.] Univ Rochester, Ctr Translat Neuromed, Med Ctr, Rochester, NY 14642 USA; [Staeger, Frederik Filip; Dang, Juliana A. M. L.; Xavier, Anna L. R.; Kress, Benjamin T.; Nedergaard, Maiken] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark; [Xia, Maosheng] China Med Univ, Inst Metab Dis Res & Drug Dev, Lab Brain Metab Dis, 77 Puhe St, Shenyang 110177, Peoples R China; [Xia, Maosheng] China Med Univ, Dept Orthopaed, Hosp 1, Shenyang, Peoples R China		Nedergaard, M (corresponding author), Univ Rochester, Ctr Translat Neuromed, Med Ctr, Rochester, NY 14642 USA.; Nedergaard, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark.	Nedergaard@urmc.rochester.edu	Hablitz, Lauren M/L-2357-2016	Hablitz, Lauren/0000-0001-6159-7742; Ribeiro Xavier, Anna Lenice/0000-0001-5143-6531; Dang, Juliana Aurelie Mai Linh/0000-0002-3010-7779; Staeger, Frederik Filip/0000-0002-2295-8637; Giannetto, Michael/0000-0002-4338-8709	United States Department of Defense, United States Army, U.S. Army Research, Development and Engineering Command, Army Research Office (ARO) - MURI [W911NF1910280]; U.S. Department of Health & Human Services, NIH, National Institute of Neurological Disorders and Stroke (NINDS) [R01NS100366, RF1AG057575]; Fondation Leducq Transatlantic Networks of Excellence Program; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited; Lundbeck FoundationLundbeckfonden; EUEuropean Commission [666881]	United States Department of Defense, United States Army, U.S. Army Research, Development and Engineering Command, Army Research Office (ARO) - MURI W911NF1910280 [Nedergaard]. U.S. Department of Health & Human Services, NIH, National Institute of Neurological Disorders and Stroke (NINDS) - R01NS100366 [Nedergaard]. U.S. Department of Health & Human Services, NIH, National Institute of Neurological Disorders and Stroke (NINDS) - RF1AG057575 [Nedergaard]. Fondation Leducq Transatlantic Networks of Excellence Program, Novo Nordisk and Lundbeck Foundations, and the EU Horizon 2020 research and innovation program (grant no. 666881; SVDs@target)[Nedergaard].	Austad SN, 2016, GERONTOLOGY, V62, P40, DOI 10.1159/000381472; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Cholerton B, 2018, PARKINSONISM RELAT D, V50, P29, DOI 10.1016/j.parkreldis.2018.02.007; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Ferretti MT, 2018, NAT REV NEUROL, V14, P457, DOI 10.1038/s41582-018-0032-9; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Hablitz LM, 2014, J PHYSIOL-LONDON, V592, P5079, DOI 10.1113/jphysiol.2014.282079; Hablitz LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18115-2; Hablitz LM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5447; Harrison IF, 2018, ELIFE, V7, DOI 10.7554/eLife.34028; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Koshibu K, 2004, NEUROIMAGE, V22, P1636, DOI 10.1016/j.neuroimage.2004.03.051; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Laws KR, 2018, CURR OPIN PSYCHIATR, V31, P133, DOI 10.1097/YCO.0000000000000401; Leise TL, 2011, J BIOL RHYTHM, V26, P454, DOI 10.1177/0748730411416330; Luine V, 2017, PHARMACOL BIOCHEM BE, V152, P13, DOI 10.1016/j.pbb.2016.08.005; Ma QL, 2019, ACTA NEUROPATHOL, V137, P151, DOI 10.1007/s00401-018-1916-x; McEwen Bruce S, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017692328; McEwen BS, 2017, J NEUROSCI RES, V95, P24, DOI 10.1002/jnr.23809; Mestre H, 2018, ELIFE, V7, DOI 10.7554/eLife.40070; Mestre H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07318-3; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Pilorz V, 2009, PHYSIOL BEHAV, V96, P57, DOI 10.1016/j.physbeh.2008.08.010; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Schain AJ, 2017, J NEUROSCI, V37, P2904, DOI 10.1523/JNEUROSCI.3390-16.2017; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; TAKAHASHI JS, 1980, AM J PHYSIOL, V239, pR497, DOI 10.1152/ajpregu.1980.239.5.R497; Vest RS, 2013, HORM BEHAV, V63, P301, DOI 10.1016/j.yhbeh.2012.04.006; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Westerman S, 2016, CLIN SCI, V130, P551, DOI 10.1042/CS20150586; WOLLNIK F, 1988, PHYSIOL BEHAV, V43, P389, DOI 10.1016/0031-9384(88)90204-1; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yan Y, 2018, NEUROBIOL STRESS, V8, P120, DOI 10.1016/j.ynstr.2018.03.002; Zou WY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0147-y	41	4	4	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 30	2020	10	1							16073	10.1038/s41598-020-72621-3			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NZ6JL	WOS:000577212000001	32999319	Green Published, gold			2022-02-06	
J	Khokhar, B; Jorgensen-Wagers, K; Marion, D; Kiser, S				Khokhar, Bilal; Jorgensen-Wagers, Kendra; Marion, Donald; Kiser, Seth			Military Acute Concussion Evaluation: A Report on Clinical Usability, Utility, and User's Perceived Confidence	JOURNAL OF NEUROTRAUMA			English	Article						concussion; evaluation; mild traumatic brain injury; military; service members	TRAUMATIC BRAIN-INJURY; SERVICE MEMBERS; TOOL; RELIABILITY; PERFORMANCE	The signs and symptoms of concussion may not always be clear. Therefore, the Military Acute Concussion Evaluation (MACE) tool was created to help deployed medics and corpsmen identify concussions, particularly in deployed settings. Since 2008, the MACE has been updated multiple times, but each new version of the tool is more complex and takes longer to complete. The objective of this study was to assess the usability, utility, and perceived confidence among military healthcare providers for the latest version, MACE 2. Therefore, a semi-structured interview, including Likert-scale and open-ended questions, was conducted among military healthcare providers at Landstuhl Regional Medical Center in order to assess the usability, utility and perceived confidence of the MACE 2. All of the providers had completed a training course on the MACE 2 and had used it for at least 3 months in their clinics. A total of 28 participants were recruited, including 22 medics, two physicians, three nurses, and one physician assistant. Average scores of usability, utility, and confidence were 5.7, 6.6, and 6.3, respectively, with 7.0 being the most positive score, and thus indicating positive assessments in all categories. The open-ended questions revealed high usability and confidence and the desire for additional training on the tool. In conclusion, despite the increased complexity and duration of the MACE 2 compared with the previous version of this tool, military providers and army medics found the new MACE 2 very useable and had a high degree of confidence in its performance.	[Khokhar, Bilal; Marion, Donald; Kiser, Seth] Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA; [Jorgensen-Wagers, Kendra] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Khokhar, Bilal; Jorgensen-Wagers, Kendra; Marion, Donald; Kiser, Seth] Gen Dynam Informat Technol, Falls Church, VA USA		Khokhar, B (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA.	bilal.r.khokhar.ctr@mail.mil			DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014.	Agimi Y, 2018, AM J PUBLIC HEALTH, V108, P683, DOI 10.2105/AJPH.2018.304347; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Defense and Veterans Brain Injury Center (DVBIC), 2019, MIL AC CONC EV 2 MAC; Defense and Veterans Brain Injury Center (DVBIC), 2019, DVBIC WORLDW TOT 200; Defense Health Agency (DHA), 2019, DEF VET BRAIN INJ CT; Department of Defense, 2018, 649011 DEP DEF; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; French L., 2009, J SPEC OPER MED, V8, P68; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Holt P., 1996, CLIN PRACTICE GUIDEL; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M., 2009, VALIDATION MILITARY; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pagliari H., 2001, CONCERTED ACTION NET; Scott IA, 2003, INTERN MED J, V33, P273, DOI 10.1046/j.1445-5994.2003.00366.x; Stone ME, 2015, J TRAUMA ACUTE CARE, V79, P147, DOI 10.1097/TA.0000000000000679; Storzbach D., 2013, VA EVIDENCE BASED SY; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	26	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					210	217		10.1089/neu.2020.7176		SEP 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000575393400001	32808563				2022-02-06	
J	Salmon, DM; Romanchuk, J; Sullivan, SJ; Walters, S; Clacy, A; Register-Mihalik, JK; Kerr, ZY; Whatman, C; Keung, S				Salmon, Danielle M.; Romanchuk, Janelle; Sullivan, S. John; Walters, Simon; Clacy, Amanda; Register-Mihalik, Johna K.; Kerr, Zachary Y.; Whatman, Chris; Keung, Sierra			Concussion knowledge, attitude and reporting intention in rugby coaches and high school rugby players	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Ethnicity; gender; head injury; rugby union; youth sport	SPORT-RELATED CONCUSSION; EXTREMITY MUSCULOSKELETAL INJURY; DISCLOSURE BEHAVIOR; FOOTBALL PLAYERS; SYSTEMS-APPROACH; UNION PLAYERS; PREVENTION; EDUCATION; RISK; MANAGEMENT	The aim of this study was to evaluate New Zealand high school rugby union players' and community coaches' concussion knowledge (CK), concussion attitude (CA) and concussion reporting intentions (CRI) and to explore the impact gender, age, ethnicity, socio-economic status, experience, and concussion history had on these outcome measures. This cross-sectional study utilised the Rosenbaum Concussion Knowledge and Attitudes survey to evaluate CK, CA and CRI. The survey and demographic information were completed by 533 high school players (61.5% male,M = 16.2 yrs) and 733 community rugby coaches (93.0% male,M = 42.2 yrs). Coaches displayed greater awareness, safer attitudes, and stronger reporting intentions towards concussion than players. Among players, differences in CK, CA and CRI were observed by gender, ethnicity, and socio-economic status. Among coaches, differences in CRI were found by age and coaching experience. No differences were observed for age or concussion history in players. Gender, ethnicity, and grade coached were not significant for coaches. Players who identified as Maori or Pasifika and those from schools in low socio-economic areas displayed poorer CK and CA. Years of experience for both players and coaches played a critical role in improving CA and is a factor that should be considered when welcoming new participants to either role. Concussion non-disclosure is a systemic issue and is common across gender, ethnicity and socio-economic status and appears to worsen as the playing season progresses. More work is needed to develop educational strategies that are both culturally responsive, sustainable, and address reporting behaviours.	[Salmon, Danielle M.; Romanchuk, Janelle; Sullivan, S. John] New Zealand Rugby, Wellington, New Zealand; [Walters, Simon; Whatman, Chris; Keung, Sierra] Auckland Univ Technol, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Clacy, Amanda] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Australia; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Salmon, DM (corresponding author), New Zealand Rugby Union, New Zealand Rugby, POB 2171, Wellington 6140, New Zealand.	danielle.salmon@nzrugby.co.nz			Accident Compensation Corporation through the RugbySmart program	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this study as part of New Zealand Rugby's National Concussion Initiative was provided by Accident Compensation Corporation through the RugbySmart program.	Ajzen I., 2012, HDB THEORIES SOCIAL, P438, DOI DOI 10.4135/9781446249215.N22; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Brown JC, 2015, INJURY PREV, V21, P173, DOI 10.1136/injuryprev-2014-041326; Carter M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h26; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Clacy A, 2019, APPL ERGON, V80, P256, DOI 10.1016/j.apergo.2017.06.010; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Dietzen C J, 1999, Phys Med Rehabil Clin N Am, V10, P159; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Gallagher C, 2017, BRIT J SPORT MED, V51, pA603; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Hachem LD, 2016, CAN J NEUROL SCI, V43, P554, DOI 10.1017/cjn.2016.41; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hokowhitu B, 2008, MAI REV, V1, P1; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Hunt C, 2018, PUBLIC HEALTH NURS, V35, P202, DOI 10.1111/phn.12407; Hutchinson S, 2019, INT J SPORTS SCI COA, V14, P153, DOI 10.1177/1747954119826515; Karmali A, 2019, J CONTEMP CHIROPR, V2, P86; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kemp JL, 2016, J SCI MED SPORT, V19, P305, DOI 10.1016/j.jsams.2015.03.010; Kerr SH, 2020, INT SPORT COACH J, V7, P31, DOI 10.1123/iscj.2018-0030; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2018, INJ EPIDEMIOL, V5, P1; King D, 2019, J SCI MED SPORT, V22, P532, DOI 10.1016/j.jsams.2018.10.015; King D, 2019, BRIT J SPORT MED, V53, P1026, DOI 10.1136/bjsports-2017-098533; Kirk B, 2018, SPORTS, V6, DOI 10.3390/sports6040102; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kraak W J, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30i1a4404; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Nanos KN, 2017, MAYO CLIN PROC, V92, P1782, DOI 10.1016/j.mayocp.2017.10.003; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P186, DOI 10.1080/00913847.2019.1671141; Olutende M, 2019, EUR J PUBLIC HLTH ST, V1, P25; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Quarrie K, 2020, SPORTS MED, V50, P415, DOI 10.1007/s40279-019-01176-9; Quarrie K, 2020, SPORTS MED, V50, P227, DOI 10.1007/s40279-019-01177-8; Rasmussen J, 1997, SAFETY SCI, V27, P183, DOI 10.1016/S0925-7535(97)00052-0; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Salmon D, 2020, BRIT J SPORT MED, V54, P300, DOI 10.1136/bjsports-2019-100949; Salmon DM, 2020, J SPORT SCI, V38, P1585, DOI 10.1080/02640414.2020.1749409; Sewry N, 2019, J SCI MED SPORT, V22, P54, DOI 10.1016/j.jsams.2018.06.007; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tsao J., 2014, ATHLETIC INSIGHT, V6, P93; van Vuuren H, 2020, INT J SPORTS SCI COA, V15, P297, DOI 10.1177/1747954120913175; Viljoen C T, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1942; Walker SP., 2016, S AFR J SPORTS MED, V27, P50; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	85	4	4	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	FEB	2021	16	1					54	69	1747954120961200	10.1177/1747954120961200		SEP 2020	16	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	QC0SH	WOS:000575466300001					2022-02-06	
J	D'Souza, A; Fabricius, A; Amodio, V; Colquhoun, H; Lewko, J; Haag, H; Quilico, E; Archambault, P; Colantonio, A; Mollayeva, T				D'Souza, Andrea; Fabricius, Alexis; Amodio, Vanessa; Colquhoun, Heather; Lewko, John; Haag, Halina (Lin); Quilico, Enrico; Archambault, Patrick; Colantonio, Angela; Mollayeva, Tatyana			Men's gendered experiences of rehabilitation and recovery following traumatic brain injury: A reflexive thematic analysis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury (TBI); Rehabilitation; Gender; Masculinity; Qualitative methods	MASCULINITY; WORK; CARE	Research shows that gender influences men's health-related beliefs and behaviours - including those within the context of traumatic brain injury (TBI) - making it a factor that should be considered when designing and implementing interventions for this population. To incorporate an understanding of such gendered influences in future educational materials for men with TBI, as well as their caregivers and clinicians, this qualitative study was informed by social constructionism, and aimed to explore how gender is related to men's post-TBI perceptions and behaviours in rehabilitation and recovery. Semi-structured interviews were conducted with 22 men with mild and moderate-severe TBI at the acute (<= 3 months post-TBI) and chronic (> 3 months post-TBI) phases of injury. A reflexive thematic analysis approach was applied to interview data, guided by the concept of hegemonic masculinity as described by Connell, R.W. (2005.Masculinities[2nd ed.]. Polity). Three key themes were identified: (1) "I'm a man, I'm a rock": Undermining treatment, (2) "I'm going to face that challenge": Facilitation of recovery, and (3) "I don't feel as useful as a guy as I was before": Perceptions on return to work. These findings may be translated into gender-informed therapy strategies and materials.	[D'Souza, Andrea; Colquhoun, Heather; Haag, Halina (Lin); Quilico, Enrico; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [D'Souza, Andrea; Fabricius, Alexis; Amodio, Vanessa; Colantonio, Angela; Mollayeva, Tatyana] Univ Hlth Network, Toronto Rehabil Inst, Acquired Brain Injury & Soc Lab, Toronto, ON, Canada; [D'Souza, Andrea; Fabricius, Alexis; Amodio, Vanessa; Quilico, Enrico; Colantonio, Angela; Mollayeva, Tatyana] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Colquhoun, Heather; Colantonio, Angela; Mollayeva, Tatyana] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lewko, John] Laurentian Univ, Sch Rural & Northern Hlth, Sudbury, ON, Canada; [Haag, Halina (Lin)] Wilfrid Laurier Univ, Lyle S Hallman Fac Social Work, Waterloo, ON, Canada; [Archambault, Patrick] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada		D'Souza, A (corresponding author), Rehabil Sci Inst, 500 Univ Ave,Suite 160, Toronto, ON, Canada.	andreaseverina.dsouza@mail.utoronto.ca	, Mollayeva/A-4522-2018	Colquhoun, Heather/0000-0002-6226-2511; D'Souza, Andrea/0000-0003-2611-2548; Mollayeva, Tatyana/0000-0002-2787-1848; Archambault, Patrick/0000-0002-5090-6439; Fabricius, Alexis/0000-0003-0881-1273; Quilico, Enrico/0000-0002-1958-0303	Canadian Institutes of Health Research (CIHR) Institute of Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	This work was supported by the Canadian Institutes of Health Research (CIHR) Institute of Gender and Health under Grant #CGW-126580.	American Psychological Association Boys and Men Guidelines Group, 2018, APA GUID PSYCH PRACT; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Butler J., 1990, GENDER TROUBLE; Canadian Institutes of Health Research, 2014, WHAT IS GEND WHAT IS; Centers for Disease Control and Prevention, GLASG COM SCAL; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Connell R.W., 2005, MASCULINITIES; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dale CM, 2015, QUAL HEALTH RES, V25, P1648, DOI 10.1177/1049732314566323; Evans J, 2011, J MENS HEALTH, V8, P7, DOI 10.1016/j.jomh.2010.09.227; Fabricius AM, 2020, QUAL HEALTH RES, V30, P1033, DOI 10.1177/1049732319900163; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Haag H, 2019, BRAIN IMPAIR, V20, P197, DOI 10.1017/BrImp.2019.16; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Jones JA, 2011, DISABIL REHABIL, V33, P1568, DOI 10.3109/09638288.2010.537803; Kivunja C., 2017, INT J HIGHER ED, V6, P26, DOI [10.5430/ijhe.v6n5p26, DOI 10.5430/IJHE.V6N5P26]; KUZEL AJ, 1992, RES METH PR, V3, P31; Lorber J., 1994, PARADOXES GENDER; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacQueen R, 2020, NEUROPSYCHOL REHABIL, V30, P298, DOI 10.1080/09602011.2018.1466714; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2018, CONCUSSION, V3; Mollayeva T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024674; National Institutes of Health, SEX GENDER; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oliffe JL, 2013, QUAL HEALTH RES, V23, P1626, DOI 10.1177/1049732313509408; Sallee MW, 2011, QUAL RES, V11, P409, DOI 10.1177/1468794111404322; Schopp LH, 2006, BRAIN INJURY, V20, P1155, DOI 10.1080/02699050600983735; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002	33	4	4	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1822882		SEP 2020	22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NR9XC	WOS:000571914400001	32960149				2022-02-06	
J	Kent, R; Forman, J; Bailey, A; Cormier, J; Park, G; Crandall, J; Arbogast, KB; Myers, B				Kent, Richard; Forman, Jason; Bailey, Ann; Cormier, Joseph; Park, Gwansik; Crandall, Jeff; Arbogast, Kristy B.; Myers, Barry			Surface Contact Features, Impact Obliquity, and Preimpact Rotational Motion in Concussive Helmet-to-Ground Impacts: Assessmentviaa New Impact Test Device	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; American football; Helmets; Ground impact; Test devices	PROFESSIONAL FOOTBALL; INJURY; PERFORMANCE; RISK	This paper reports the development of a test device for replicating unique features of concussion-causing helmet-to-ground impacts. Helmet-to-ground impacts are characterized by an oblique impact velocity vector, preimpact rotational motion of the helmeted head, and an impact into a compliant frictional surface of unknown effective mass. No helmet assessment testing program replicates these impact characteristics, yet they influence brain injury risk and therefore may influence helmet design priorities. To replicate these mechanics, the carriage of a drop tower was modified by the addition of a curvilinear bearing track and a hinged torso-neck fixture to which a helmeted head of a Hybrid III anthropomorphic test device was mounted. Preimpact rotational motion of the head was imparted by forcing a link arm to follow the curvilinear path as the carriage fell under gravity. At impact, the rotating helmeted head struck a vertically mounted surface. The ground impact features of head kinematics are illustrated by comparing rear impacts into a rigid, low-friction surface against those into a compliant frictional surface simulating turf. With the rigid, low-friction surface, the head experienced a change in rotational rate of approximately 40 rad/s, which corresponded to a peak rotational acceleration of approximately alpha(y)= - 4000 rad/s(2). In contrast, peak rotational acceleration with the compliant frictional surface was approximately alpha(y)= - 1000 rad/s(2)while the helmet was in contact with the surface. Neck loads were significantly greater with the compliant frictional surface. Translational head acceleration was less sensitive to the surface characteristics, with the peak of the anterior-posterior component essentially unchanged.	[Kent, Richard; Bailey, Ann; Cormier, Joseph; Park, Gwansik; Crandall, Jeff] Biomech Consulting & Res, Charlottesville, VA 22911 USA; [Kent, Richard; Forman, Jason] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Myers, Barry] Duke Univ, Durham, NC USA		Kent, R (corresponding author), Biomech Consulting & Res, Charlottesville, VA 22911 USA.	rwk3c@virginia.edu		Forman, Jason/0000-0001-8705-3997	Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a Grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources. The authors gratefully acknowledge the testing assistance of Peter Young and Brian McEwen.	Bailey A, 2020, SPORT BIOMECH, V19, P678, DOI 10.1080/14763141.2018.1513059; Bass C, 2006, C P INT RES COUNC BI, V75-91, P2006; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Beusenberg M, 2001, C P INT RES COUNC BI, V1-17, P2001; Biocore, 2020, HELM TEST PROT; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Clark JM, 2018, ANN BIOMED ENG, V46, P986, DOI 10.1007/s10439-018-2017-7; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Kent R, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109551; Kerrigan J., 2009, P ENH SAF VEH, P2009; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Meng SY, 2019, INT J CRASHWORTHINES, V24, P399, DOI 10.1080/13588265.2018.1464545; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; NOCSAE, 2015, 08712M15A NOCSAE DOC; Parent Daniel, 2017, Stapp Car Crash J, V61, P227; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Perez E., 2014, P INT CYCL SAF C GOT, P1; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Stefanyshyn D.J., 2003, SPORTS SURFACES, P49; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Theobald P, 2010, SPORT BIOMECH, V9, P29, DOI 10.1080/14763141003690245; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Withnall, 2019, NFL LINEAR IMPACTOR; Withnall C, 2020, F086513 ASTM	30	4	4	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2639	2651		10.1007/s10439-020-02621-x		SEP 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000571999400001	32964361				2022-02-06	
J	Adans-Dester, C; Hankov, N; O'Brien, A; Vergara-Diaz, G; Black-Schaffer, R; Zafonte, R; Dy, J; Lee, SI; Bonato, P				Adans-Dester, Catherine; Hankov, Nicolas; O'Brien, Anne; Vergara-Diaz, Gloria; Black-Schaffer, Randie; Zafonte, Ross; Dy, Jennifer; Lee, Sunghoon I.; Bonato, Paolo			Enabling precision rehabilitation interventions using wearable sensors and machine learning to track motor recovery	NPJ DIGITAL MEDICINE			English	Article							FUGL-MEYER ASSESSMENT; TRAUMATIC BRAIN-INJURY; STROKE SURVIVORS; UNITED-STATES; RELIABILITY; DISABILITY; PREVALENCE; ADULTS	The need to develop patient-specific interventions is apparent when one considers that clinical studies often report satisfactory motor gains only in a portion of participants. This observation provides the foundation for "precision rehabilitation". Tracking and predicting outcomes defining the recovery trajectory is key in this context. Data collected using wearable sensors provide clinicians with the opportunity to do so with little burden on clinicians and patients. The approach proposed in this paper relies on machine learning-based algorithms to derive clinical score estimates from wearable sensor data collected during functional motor tasks. Sensor-based score estimates showed strong agreement with those generated by clinicians. Score estimates of upper-limb impairment severity and movement quality were marked by a coefficient of determination of 0.86 and 0.79, respectively. The application of the proposed approach to monitoring patients' responsiveness to rehabilitation is expected to contribute to the development of patient-specific interventions, aiming to maximize motor gains.	[Adans-Dester, Catherine; Hankov, Nicolas; O'Brien, Anne; Vergara-Diaz, Gloria; Black-Schaffer, Randie; Zafonte, Ross; Bonato, Paolo] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Adans-Dester, Catherine] MGH Inst Hlth Profess, Sch Hlth & Rehabil Sci, Boston, MA USA; [Dy, Jennifer] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Lee, Sunghoon I.] Univ Massachusetts, Coll Informat & Comp Sci, Amherst, MA 01003 USA; [Bonato, Paolo] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA		Bonato, P (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Bonato, P (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	pbonato@mgh.harvard.edu	Bonato, Paolo/AAH-6111-2019; Black-Schaffer, Randie/AAY-4671-2021	Bonato, Paolo/0000-0002-1818-1714; Adans-Dester, Catherine/0000-0001-6816-0586	National Institute of Child Health and Human Development, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050821, R24HD065688]	The authors would like to thank the research assistants and research therapists in the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital for their help during the data collections, and the research participants who volunteered their time. This work was partially supported by the grant number R24HD050821 (Engineering for Neurologic Rehabilitation) and the grant number R24HD065688 (Improving Outcome Measurement for Medical Rehabilitation Clinical Trials) by the National Institute of Child Health and Human Development, National Institutes of Health.	Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bergen DC, 2002, ARCH NEUROL-CHICAGO, V59, P1194, DOI 10.1001/archneur.59.7.1194; Bonato Paolo, 2005, J Neuroeng Rehabil, V2, P2, DOI 10.1186/1743-0003-2-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Byblow WD, 2015, ANN NEUROL, V78, P848, DOI 10.1002/ana.24472; Centers for Disease Control, 2003, MMWR-MORBID MORTAL W, P106; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Del Din S, 2011, IEEE ENG MED BIO, P5839, DOI 10.1109/IEMBS.2011.6091444; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng WW, 2015, ANN NEUROL, V78, P860, DOI 10.1002/ana.24510; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Groisser BN, 2014, NEUROREHAB NEURAL RE, V28, P751, DOI 10.1177/1545968314521896; Hall M. A., 1999, CORRELATION BASED FE; HOLM S, 1979, SCAND J STAT, V6, P65; Hulsen T, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00034; Inouye M, 2000, AM J PHYS MED REHAB, V79, P513, DOI 10.1097/00002060-200011000-00007; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lang CE, 2016, ANN NEUROL, V80, P342, DOI 10.1002/ana.24734; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lannin NA, 2008, BRAIN IMPAIR, V9, P237, DOI 10.1375/brim.9.3.237; Lee S. I., 2016, ARCH PHYS MED REHABI, V97, pe117; Lee SI, 2018, IEEE J TRANSL ENG HE, V6, DOI 10.1109/JTEHM.2018.2829208; Lee SI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212484; Maceira-Elvira P, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0612-y; Meagher C, 2017, ARCH PHYS MED REHABI, V98; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Niederberger E, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910917; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Patel S, 2010, P IEEE, V98, P450, DOI 10.1109/JPROC.2009.2038727; Pearson-Fuhrhop KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061197; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reinkensmeyer DJ, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0148-3; Rosenthal O, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0513-0; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Taub E., 2011, WOLF MOTOR FUNCTION; Teasell RW, 2014, ARCH PHYS MED REHAB, V95, P595, DOI 10.1016/j.apmr.2013.11.014; Tran DA, 2016, AM J PHYS MED REHAB, V95, P459, DOI 10.1097/PHM.0000000000000438; Miranda JGV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29470-y; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Waddell KJ, 2017, NEUROREHAB NEURAL RE, V33, P836; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Ward NS, 2019, J NEUROL NEUROSUR PS, V90, P498, DOI 10.1136/jnnp-2018-319954; Winstein C, 2018, NEUROREHABILITATION, V43, P3, DOI 10.3233/NRE-172412; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; World Health Organization, 2007, INT CLASS FUNCT DIS; Yu L, 2016, COMPUT METH PROG BIO, V128, P100, DOI 10.1016/j.cmpb.2016.02.012; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zarshenas S, 2019, ARCH PHYS MED REHAB, V100, P1274, DOI 10.1016/j.apmr.2018.11.023	56	4	4	4	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2398-6352			NPJ DIGIT MED	npj Digit. Med.	SEP 21	2020	3	1							121	10.1038/s41746-020-00328-w			10	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	NR9KI	WOS:000571881100001		gold, Green Published			2022-02-06	
J	Conrick, KM; Moore, M; Abbotts, L; Widdice, L; Hoag, S; Kroshus, E; Philipson, EB; Jinguji, T; Weiner, BJ; Glang, A; Rivara, FP; Chrisman, SPD; Dickason, CQ; Vavilala, MS				Conrick, Kelsey McGuire; Moore, Megan; Abbotts, Laurel; Widdice, Laura; Hoag, Samara; Kroshus, Emily; Philipson, Erik Bruce; Jinguji, Thomas; Weiner, Bryan Jeffrey; Glang, Ann; Rivara, Frederick Peter; Chrisman, Sara Powell Dow; Dickason, Celeste Quitiquit; Vavilala, Monica Shanta			Community-Engaged Approach to the Development and Implementation of a Student-Centered Return to Learn Care Plan After Concussion	JOURNAL OF SCHOOL HEALTH			English	Article						return to learn; concussion; school nurses; school health services; child and adolescent health	CHILDREN; SCHOOL; MANAGEMENT	BACKGROUND Current return to learn(RTL) after concussion guidelines lack specificity for individualized student care, limiting potential for adoption and implementation. We used a community-engaged research framework to develop and evaluate the implementation of a student-centered care plan that assists school personnel in facilitating RTL. METHODS We used best-practice RTL guidelines and input from administrators and medical experts to iteratively develop a flexible student-centered care plan. Thirteen schools participated. Coding completion of care plans indicated feasibility and fidelity; interviews with RTL coordinators indicated acceptability. RESULTS The care plan includes educational materials, symptom checklists, and guidelines for classroom adjustments linked to student symptoms. Care plans were initiated for 24 (70.6%) of 34 students with concussions, indicating feasibility. Fidelity was high, with the following subsections completed: Action Checklist (90%), Symptom Evaluation (91%), Temporary Adjustment Recommendations (95%). Qualitative analysis of interviews suggested care plans were acceptable and facilitate consistent communication, prioritization of individual needs of students, and increased ability to delegate tasks to other school staff. CONCLUSIONS Implementation of a student-centered, individually tailored care plan for RTL is feasible and acceptable in public high schools. Future research should examine how to expediently initiate student-centered concussion care plans after diagnosis to optimize recovery.	[Conrick, Kelsey McGuire] Univ Washington, Sch Social Work, Harbor View Injury Prevent & Res Ctr, 325 Ninth Ave Box 359960, Seattle, WA 98101 USA; [Moore, Megan] Univ Washington, Sch Social Work, Direct Practice, Harbor View Injury Prevent & Res Ctr,Core Fac, Seattle, WA 98105 USA; [Abbotts, Laurel; Philipson, Erik Bruce] Harbor View Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Widdice, Laura] Renton Sch Dist, Hlth Serv, Renton, WA 98057 USA; [Hoag, Samara] Seattle Publ Sch, Hlth Serv, Renton, WA 98134 USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98121 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA; [Jinguji, Thomas] Univ Washington, Dept Pediat, Div Orthoped & Sports Med, Seattle Childrens Hosp,Ambulatory Serv, Seattle, WA 98145 USA; [Weiner, Bryan Jeffrey] Univ Washington, Dept Global Heath & Hlth Serv, Seattle, WA 98105 USA; [Glang, Ann] Univ Oregon, Ctr Brain Injury Res & Iraining, Eugene, OR 97403 USA; [Rivara, Frederick Peter] Univ Washington, Dept Pediat, Pediat Res, Seattle, WA 98104 USA; [Chrisman, Sara Powell Dow] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Dickason, Celeste Quitiquit] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Dickason, Celeste Quitiquit] Univ Washington, Gen Pediat & Sparts Med Orthoped, Seattle, WA 98105 USA; [Dickason, Celeste Quitiquit] Univ Washington, Pediat Residency Program, Seattle, WA 98105 USA; [Dickason, Celeste Quitiquit] Seattle Childrens Hosp, 4800 Sand Point Way NE, Seattle, WA 98105 USA; [Vavilala, Monica Shanta] Univ Washington, Anesthesiol & Pediat, Seattle, WA 98104 USA; [Vavilala, Monica Shanta] Univ Washington, Harbor View Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Anesthesiol & Pediat, Seattle, WA 98104 USA.; Vavilala, MS (corresponding author), Univ Washington, Harbor View Injury Prevent & Res Ctr, Seattle, WA 98104 USA.	kmc621@uw.edu; mm99@uw.edu; labbotts@uw.edu; laura.widdice@rentonschools.us; shoag@seattleschools.org; ekroshus@uw.edu; erikbp@uw.edu; tom.jinguji@seattlechildrens.org; bjweiner@uw.edu; aglang@uoregon.edu; fpr@uw.edu; sara.chrisman@seattlechildrens.org; celeste.quitiquit@seattlechildrens.org; vavilala@uw.edu		Kroshus, Emily/0000-0002-7484-2601; Philipson, Erik/0000-0001-8138-1762; Conrick, Kelsey/0000-0001-5460-9952; Chrisman, Sara/0000-0001-5373-7223			Balls-Berry JE, 2017, P R HEALTH SCI J, V36, P84; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davies SC, 2016, EXCEPTIONALITY ED IN, V26, P1; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Grady MF, 2017, PEDIATR ANN, V46, pE93, DOI 10.3928/19382359-20170220-04; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HEADS UP to Brain Injury Awareness, HEADS BRAIN INJ AW; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; McAvoy K, REAPCONCUSSION; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Neill JA, 2017, REHABIL PSYCHOL, V62, P300, DOI 10.1037/rep0000155; Rakes L, 2016, BMJ QUAL IMPROV REP, V5, P1; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; Wallerstein N, 2010, AM J PUBLIC HEALTH, V100, pS40, DOI 10.2105/AJPH.2009.184036; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	25	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	NOV	2020	90	11					842	848		10.1111/josh.12948		SEP 2020	7	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	NX6AV	WOS:000571348600001	32959394				2022-02-06	
J	Carlson, SW; Yan, HQ; Li, Y; Henchir, J; Ma, X; Young, MS; Ikonomovic, MD; Dixon, CE				Carlson, S. W.; Yan, H. Q.; Li, Y.; Henchir, J.; Ma, X.; Young, M. S.; Ikonomovic, M. D.; Dixon, C. E.			Differential Regional Responses in Soluble Monomeric Alpha Synuclein Abundance Following Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; alpha-synuclein; Neurodegeneration; Synapse	SYNAPTIC PLASTICITY; MICE LACKING; PARKINSONS-DISEASE; LEWY BODIES; IN-VIVO; SNARE; GENE; SIMVASTATIN; MULTIMERS; PATHOLOGY	Alpha synuclein (alpha-synuclein) is a neuronal protein found predominately in presynaptic terminals. While the pathological effect of alpha-synuclein aggregates has been a topic of intense study in several neurodegenerative conditions, less attention has been placed on changes in monomeric alpha-synuclein and related physiological consequences on neuronal function. A growing body of evidence supports an important physiological role of alpha-synuclein in neurotransmission. In the context of traumatic brain injury (TBI), we hypothesized that the regional abundance of soluble monomeric alpha-synuclein is altered over a chronic time period post-injury. To this end, we evaluated alpha-synuclein in the cortex, hippocampus, and striatum of adult rats at 6 h, 1 day, 1, 2, 4, and 8 weeks after controlled cortical impact (CCI) injury. Western blot analysis demonstrated decreased levels of monomer alpha-synuclein protein in the ipsilateral hippocampus at 6 h, 1 day, 1, 2, and 8 weeks, as well as in the ipsilateral cortex at 1 and 2 weeks and in the ipsilateral striatum at 6 h after CCI compared with sham animals. Immunohistochemical analysis revealed lower alpha-synuclein and a modest reduction in synaptophysin staining in the ipsilateral hippocampus at 1 week after CCI compared with sham animals, with no evidence of intracellular or extracellular alpha-synuclein aggregates. Collectively, these findings demonstrate that monomeric alpha-synuclein protein abundance in the hippocampus is reduced over an extensive (acute-to-chronic) post-injury interval. This deficit may contribute to the chronically impaired neurotransmission known to occur after TBI.	[Carlson, S. W.; Yan, H. Q.; Li, Y.; Henchir, J.; Ma, X.; Young, M. S.; Dixon, C. E.] Univ Pittsburgh, Neurol Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Ikonomovic, M. D.] Univ Pittsburgh, Neurol, 200 Lothrop St, Pittsburgh, PA 15261 USA; [Ikonomovic, M. D.; Dixon, C. E.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Neurol Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Dixon, CE (corresponding author), VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.	dixonec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NS091062, NIH-NS079061, NIH-NS111099, 1-F32NS090748]; Veterans Administration Healthcare System [VAI01RX001127, VAI01RX001778]; Walter L. Copeland Fund of The Pittsburgh Foundation	This work was supported by the National Institutes of Health NIH-NS091062 (CED), NIH-NS079061 (CED), NIH-NS111099 (SWC), 1-F32NS090748 (SWC), Veterans Administration Healthcare System VAI01RX001127 (CED) and VAI01RX001778 (MDI/CED), and the Walter L. Copeland Fund of The Pittsburgh Foundation (SWC).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Baba M, 1998, AM J PATHOL, V152, P879; Bales James W, 2010, Open Drug Discov J, V2, P119; Bernis ME, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0254-7; Betzer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116473; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Byrd M, 2018, J NEUROL PSYCHOL, V6, P1; Cabin DE, 2002, J NEUROSCI, V22, P8797; Carlson SW, 2018, J NEUROTRAUM, V35, P2827, DOI 10.1089/neu.2017.5509; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chiba-Falek O, 2017, CURR OPIN GENET DEV, V44, P110, DOI 10.1016/j.gde.2017.01.014; Choi I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15119-w; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Gureviciene I, 2009, J NEURAL TRANSM, V116, P13, DOI 10.1007/s00702-008-0149-x; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ikonomovic MD, 2019, NEUROPHARMACOLOGY, V145, P160, DOI 10.1016/j.neuropharm.2018.06.021; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Kanaan NM, 2012, J PARKINSON DIS, V2, P249, DOI 10.3233/JPD-012138; Kiechle M, 2019, CELL REP, V29, P2862, DOI 10.1016/j.celrep.2019.10.089; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nuber S, 2018, NEURON, V100, P75, DOI 10.1016/j.neuron.2018.09.014; Nuber S, 2013, BRAIN, V136, P412, DOI 10.1093/brain/aws358; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Steidl JV, 2003, NEUROREPORT, V14, P219, DOI 10.1097/00001756-200302100-00012; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; SUDHOF TC, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005637; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Trojanowski JQ, 2001, PARKINSONISM RELAT D, V7, P247, DOI 10.1016/S1353-8020(00)00065-1; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Watson JB, 2009, NEUROSCIENCE, V159, P501, DOI 10.1016/j.neuroscience.2009.01.021; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Wu N, 2010, J NEUROSCI RES, V88, P1764, DOI 10.1002/jnr.22327; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	75	4	4	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2021	58	1					362	374		10.1007/s12035-020-02123-w		SEP 2020	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PE6QW	WOS:000570820900001	32948930	Green Accepted			2022-02-06	
J	Thangavelu, B; Wilfred, BS; Johnson, D; Gilsdorf, JS; Shear, DA; Boutte, AM				Thangavelu, Bharani; Wilfred, Bernard S.; Johnson, David; Gilsdorf, Janice S.; Shear, Deborah A.; Boutte, Angela M.			Penetrating Ballistic-Like Brain Injury Leads to MicroRNA Dysregulation, BACE1 Upregulation, and Amyloid Precursor Protein Loss in Lesioned Rat Brain Tissues	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; neurodegenerative diseases; microRNA; amyloid precursor protein; beta-site amyloid precursor protein cleaving enzyme 1	ALZHEIMERS-DISEASE; BETA-SECRETASE; GAMMA-SECRETASE; UNITED-STATES; HEAD-INJURY; EXPRESSION; TRAUMA; MODEL; OVEREXPRESSION; METABOLISM	Severe traumatic brain injury (TBI) is a risk factor for neurodegenerative diseases. Yet, the molecular events involving dysregulated miRNAs that may be associated with protein degradation in the brain remains elusive. Quantitation of more than 800 miRNAs was conducted using rat ipsilateral coronal brain tissues collected 1, 3, or 7 days after penetrating ballistic-like brain injury (PBBI). As a control for each time-point, Sham-operated animals received craniotomy alone. Microarray and systems biology analysis indicated that the amplitude and complexity of miRNAs affected were greatest 7 day after PBBI. Arrays and Q-PCR inferred that dysregulation of miR-135a, miR-328, miR-29c, and miR-21 were associated with altered levels of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), PSEN1, PSEN2, and amyloid precursor protein (APP) genes. These events were followed by increased levels of mature BACE1 protein and concomitant loss of full length APP within 3-7 days, then elevation of amyloid beta (A beta)-40 7 days after PBBI. This study indicates that miRNA arrays, coupled with systems biology, may be used to guide study design prior validation of miRNA dysregulation. Associative analysis of miRNAs, mRNAs, and proteins within a proposed pathway are poised for further validation as biomarkers and therapeutic targets relevant to TBI-induced APP loss and subsequent A beta peptide generation during neurodegeneration.	[Thangavelu, Bharani; Wilfred, Bernard S.; Gilsdorf, Janice S.; Shear, Deborah A.; Boutte, Angela M.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Johnson, David] Landstuhl Reg Med Ctr, Dept Pathol & Area Lab Serv, Landstuhl, Germany		Thangavelu, B (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	bharani.thangavelu.ctr@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense	This research was funded by Combat Casualty Care Research Program.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Boutte AM, 2020, J NEUROTRAUM, V37, P1574, DOI 10.1089/neu.2019.6537; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; Cartagena CM, 2013, J MOL NEUROSCI, V49, P301, DOI 10.1007/s12031-012-9828-z; Che H, 2017, MOL NEUROBIOL, V54, P2595, DOI 10.1007/s12035-016-9856-8; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Choo KB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0095-x; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; DeBoer SR, 2014, J NEUROSCI, V34, P12313, DOI 10.1523/JNEUROSCI.2255-14.2014; DeDominicis KE, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00490; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farr RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10375; Franz CK, 2019, J NEUROPHYSIOL, V122, P1174, DOI 10.1152/jn.00572.2018; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gotz J, 2018, NAT REV NEUROSCI, V19, P583, DOI 10.1038/s41583-018-0054-8; Goldstein L, 2018, JAMA-J AM MED ASSOC, V320, P554, DOI 10.1001/jama.2018.10825; Gong M, 2014, MOL CANCER RES, V12, P101, DOI 10.1158/1541-7786.MCR-13-0136; Gouras GK, 2015, NEUROTHERAPEUTICS, V12, P3, DOI 10.1007/s13311-014-0313-y; Grigorenko EV, 2011, METHODS MOL BIOL, V676, P101, DOI 10.1007/978-1-60761-863-8_8; Hartig W, 2010, J CHEM NEUROANAT, V40, P82, DOI 10.1016/j.jchemneu.2010.03.006; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hu XY, 2015, J NEUROSCI, V35, P3806, DOI 10.1523/JNEUROSCI.5207-14.2015; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Johnson D, 2017, J TRAUMA ACUTE CARE, V83, pS145, DOI 10.1097/TA.0000000000001475; Karnati HK, 2015, J ALZHEIMERS DIS, V48, P563, DOI 10.3233/JAD-150395; Khoshnam SE, 2017, J NEUROPATH EXP NEUR, V76, P548, DOI 10.1093/jnen/nlx036; Nguyen KV, 2019, AIMS NEUROSCI, V6, P273, DOI 10.3934/Neuroscience.2019.4.273; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lei XF, 2015, INT J CLIN EXP PATHO, V8, P1565; Liu CG, 2014, BRAIN RES, V1583, P55, DOI 10.1016/j.brainres.2014.04.026; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Lu XCM, 2016, THER HYPOTHERMIA TEM, V6, P30, DOI 10.1089/ther.2015.0017; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2017, J TRAUMA ACUTE CARE, V83, pS16, DOI 10.1097/TA.0000000000001471; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Martin-Alonso A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29721-y; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Niederst ED, 2015, MOL BIOL CELL, V26, P205, DOI 10.1091/mbc.E14-06-1049; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Segall SK, 2015, PAIN, V156, P1965, DOI 10.1097/j.pain.0000000000000258; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Shin RW, 1997, J NEUROSCI, V17, P8187; Shin SD, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1663-5; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thounaojam MC, 2013, MOL NEUROBIOL, V47, P1034, DOI 10.1007/s12035-013-8400-3; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Williams AJ, 2005, J NEUROTRAUM, V22, P1185; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035	101	4	4	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 18	2020	14								915	10.3389/fnins.2020.00915			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NY6GP	WOS:000576485700001	33071724	Green Published, gold			2022-02-06	
J	Wang, ZM; Liu, C; Wang, YY; Deng, YS; He, XC; Du, HZ; Liu, CM; Teng, ZQ				Wang, Zhi-Meng; Liu, Cong; Wang, Ying-Ying; Deng, Yu-Sen; He, Xuan-Cheng; Du, Hong-Zhen; Liu, Chang-Mei; Teng, Zhao-Qian			SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury	CELL DEATH DISCOVERY			English	Article							TRAUMATIC BRAIN-INJURY; MATRIX METALLOPROTEINASES; EXPRESSION; INFLAMMATION; MODEL	Traumatic brain injury is a global leading cause of disability and death, which puts patients at high risk for developing dementia. Early intervention is believed as the key to minimize the development of brain damages that could aggravate the symptoms. Here, we report that the serine protease inhibitor SerpinA3N is upregulated in hippocampal neurons in the early stage of hippocampal stab injury (HSI), while its deficiency causes a greater degree of neuronal apoptosis and severer impairments of spatial learning and memory in mice after HSI. We further show that MMP2 is a key substrate of SerpinA3N, and MMP2 specific inhibitor (ARP100) can protect against neuronal apoptosis and cognitive dysfunction in mice after HSI. These findings demonstrate a critical role for SerpinA3N in neuroprotection, suggesting that SerpinA3N and MMP2 inhibitors might be a novel therapeutic agents for neurotrauma.	[Wang, Zhi-Meng; Liu, Cong; Wang, Ying-Ying; Deng, Yu-Sen; He, Xuan-Cheng; Du, Hong-Zhen; Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Wang, Zhi-Meng; Liu, Cong; Wang, Ying-Ying; Deng, Yu-Sen; Liu, Chang-Mei; Teng, Zhao-Qian] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100408, Peoples R China; [He, Xuan-Cheng; Du, Hong-Zhen; Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China		Liu, CM; Teng, ZQ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Liu, CM; Teng, ZQ (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100408, Peoples R China.	liuchm@ioz.ac.cn; tengzq@ioz.ac.cn	Teng, Zhao-Qian/AAD-1033-2021	Teng, Zhao-Qian/0000-0002-7232-3381	National Key Research and Development Program of China [2018YFA0108001]; Strategic Priority Research Program of the Chinese Academy of SciencesChinese Academy of Sciences [XDA16010300]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7182107]; Open Project Program of State Key Laboratory of Stem Cell and Reproductive Biology	This work was supported by grants from the National Key Research and Development Program of China Project (2018YFA0108001), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16010300), the Beijing Natural Science Foundation (7182107), and the Open Project Program of State Key Laboratory of Stem Cell and Reproductive Biology.	Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Andries L, 2017, MOL NEUROBIOL, V54, P2114, DOI 10.1007/s12035-016-9801-x; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Aujla PK, 2014, J COMP NEUROL, V522, P1249, DOI 10.1002/cne.23468; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Chang DI, 2003, J CEREBR BLOOD F MET, V23, P1408, DOI 10.1097/01.WCB.0000091765.61714.30; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Cheng Y, 2018, NAT NEUROSCI, V21, P1689, DOI 10.1038/s41593-018-0261-7; Clark AW, 1997, NEUROSCI LETT, V238, P53, DOI 10.1016/S0304-3940(97)00859-8; Gaublomme D, 2014, J NEUROCHEM, V129, P966, DOI 10.1111/jnc.12703; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haile Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0376-7; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Horvath AJ, 2004, J MOL EVOL, V59, P488, DOI 10.1007/s00239-004-2640-9; Hsu I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.423; Krishnaswamy VR, 2019, CELL MOL LIFE SCI, V76, P3229, DOI 10.1007/s00018-019-03182-6; Liu C, 2019, STEM CELL RES, V39, DOI 10.1016/j.scr.2019.101501; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu PP, 2017, STEM CELL REP, V9, P190, DOI 10.1016/j.stemcr.2017.05.007; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Montaner J, 2019, CELL MOL LIFE SCI, V76, P3117, DOI 10.1007/s00018-019-03175-5; Muri L, 2019, CELL MOL LIFE SCI, V76, P3097, DOI 10.1007/s00018-019-03174-6; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Ransohoff RM, 2003, NAT NEUROSCI, V6, P1009, DOI 10.1038/nn1003-1009; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schepici G, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56030137; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; Sipione S, 2006, J IMMUNOL, V177, P5051, DOI 10.4049/jimmunol.177.8.5051; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Takamiya A, 2002, NEUROSCIENCE, V113, P387, DOI 10.1016/S0306-4522(02)00198-7; Tang GB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00267; Tjondrokoesoemo A, 2016, HUM MOL GENET, V25, P1192, DOI 10.1093/hmg/ddw005; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Venkatesh HS, 2017, NATURE, V549, P533, DOI 10.1038/nature24014; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Vicuna L, 2015, NAT MED, V21, P518, DOI 10.1038/nm.3852; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Yan HL, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00260; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zibara K, 2019, NEUROPHARMACOLOGY, V145, P177, DOI 10.1016/j.neuropharm.2018.09.032	49	4	4	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2058-7716		CELL DEATH DISCOV	Cell Death Discov.	SEP 18	2020	6	1							88	10.1038/s41420-020-00325-8			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	NV9KK	WOS:000574630600003		Green Published, gold			2022-02-06	
J	Tseng, HW; Kulina, I; Salga, M; Fleming, W; Vaquette, C; Genet, F; Levesque, JP; Alexander, KA				Tseng, Hsu-Wen; Kulina, Irina; Salga, Marjorie; Fleming, Whitney; Vaquette, Cedryck; Genet, Francois; Levesque, Jean-Pierre; Alexander, Kylie A.			Neurogenic Heterotopic Ossifications Develop Independently of Granulocyte Colony-Stimulating Factor and Neutrophils	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEOIMMUNOLOGY; CYTOKINES; DISEASES AND DISORDERS OF; RELATED TO BONE (OTHER); ANIMAL MODELS	SPINAL-CORD-INJURY; FACTOR G-CSF; PROMOTES FUNCTIONAL RECOVERY; STEM-CELL MOBILIZATION; BONE-MARROW; SKELETAL-MUSCLE; FACTOR-RECEPTOR; RISK-FACTORS; ACTIVATION; APOPTOSIS	Neurogenic heterotopic ossifications (NHOs) are incapacitating heterotopic bones in periarticular muscles that frequently develop following traumatic brain or spinal cord injuries (SCI). Using our unique model of SCI-induced NHO, we have previously established that mononucleated phagocytes infiltrating injured muscles are required to trigger NHO via the persistent release of the pro-inflammatory cytokine oncostatin M (OSM). Because neutrophils are also a major source of OSM, we investigated whether neutrophils also play a role in NHO development after SCI. We now show that surgery transiently increased granulocyte colony-stimulating factor (G-CSF) levels in blood of operated mice, and that G-CSF receptor mRNA is expressed in the hamstrings of mice developing NHO. However, mice defective for the G-CSF receptor geneCsf3r, which are neutropenic, have unaltered NHO development after SCI compared to C57BL/6 control mice. Because the administration of recombinant human G-CSF (rhG-CSF) has been trialed after SCI to increase neuroprotection and neuronal regeneration and has been shown to suppress osteoblast function at the endosteum of skeletal bones in human and mice, we investigated the impact of a 7-day rhG-CSF treatment on NHO development. rhG-CSF treatment significantly increased neutrophils in the blood, bone marrow, and injured muscles. However, there was no change in NHO development compared to saline-treated controls. Overall, our results establish that unlike monocytes/macrophages, neutrophils are dispensable for NHO development following SCI, and rhG-CSF treatment post-SCI does not impact NHO development. Therefore, G-CSF treatment to promote neuroregeneration is unlikely to adversely promote or affect NHO development in SCI patients. (c) 2020 American Society for Bone and Mineral Research.	[Tseng, Hsu-Wen; Kulina, Irina; Salga, Marjorie; Fleming, Whitney; Levesque, Jean-Pierre; Alexander, Kylie A.] Univ Queensland, Translat Res Inst, Mater Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia; [Salga, Marjorie; Genet, Francois] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Vaquette, Cedryck] Univ Queensland, Sch Dent, Herston, Qld, Australia; [Vaquette, Cedryck] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Regenerat Med, Kelvin Grove, Qld, Australia; [Genet, Francois] Univ Versailles St Quentin Yvelines, Evolut Neuromuscular Dis Innovat Concepts & Pract, INSERM, Unite Format & Rech Simone Veil Sante,U1179, Montigny Le Bretonneux, France		Alexander, KA (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia.	kylie.alexander@mater.uq.edu.au	Alexander, Kylie/P-2666-2016; Levesque, Jean-Pierre/C-5426-2011	Alexander, Kylie/0000-0001-5772-0277; Levesque, Jean-Pierre/0000-0002-7299-6025	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia [1101620]; US Department of DefenseUnited States Department of Defense [W81XWH15-1-0606]; Mater Foundation; NHMRCNational Health and Medical Research Council of Australia [1044091]; University of QueenslandUniversity of Queensland; French Society of Physical and Rehabilitation Medicine; Therapeutic Innovation Australia (TIA); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) programAustralian GovernmentDepartment of Industry, Innovation and Science	This research was funded in parts by a Project Grant 1101620 from the National Health and Medical Research Council of Australia (NHMRC) to JPL and FG, and award W81XWH15-1-0606 Congressionally Approved Spinal Cord Injury Research Program of the US Department of Defense to JPL and FG, and by funds from the Mater Foundation. JPL is supported by Research Fellowship 1044091 from the NHMRC. IK was supported by an international student scholarship from The University of Queensland. MS was supported by a student scholarship from the French Society of Physical and Rehabilitation Medicine. We also acknowledge the scientific and technical assistance at the Translational Research Institute: The University of Queensland biological resources TRI facility, histology facility, flow cytometry facility, microscopy facility, and the preclinical imaging facility, which is supported by Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program.	Alexander KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00377; Barbier Valerie, 2012, Methods Mol Biol, V904, P117, DOI 10.1007/978-1-61779-943-3_11; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; CEBON J, 1994, BRIT J HAEMATOL, V86, P265, DOI 10.1111/j.1365-2141.1994.tb04725.x; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; dela Pena IC, 2015, J CEREBR BLOOD F MET, V35, P338, DOI 10.1038/jcbfm.2014.208; Derakhshanrad N, 2015, BASIC CLIN NEUROSCI, V6, P299; Derakhshanrad N, 2013, CELL TRANSPLANT, V22, pS139, DOI 10.3727/096368913X672109; Dietrich J, 2018, J CLIN INVEST, V128, P281, DOI 10.1172/JCI90647; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2015, BRAIN INJURY, V29, P866, DOI 10.3109/02699052.2015.1005133; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Guo Y, 2013, NEUROSCIENCE, V238, P1, DOI 10.1016/j.neuroscience.2013.01.047; Guo YJ, 2014, J NEUROSCI RES, V92, P751, DOI 10.1002/jnr.23362; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Hayashiji N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7745; Herrmann M, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00005; Inada T, 2014, SPINE, V39, P213, DOI 10.1097/BRS.0000000000000121; Ishida K, 2010, TISSUE ENG PT A, V16, P3271, DOI 10.1089/ten.tea.2009.0268; Kawabe J, 2011, J NEUROSURG-SPINE, V15, P414, DOI 10.3171/2011.5.SPINE10421; KAWAKAMI M, 1990, BLOOD, V76, P1962; Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058; Kotto-Kome AC, 2004, PHARMACOL RES, V50, P55, DOI 10.1016/j.phrs.2003.12.011; Levesque JP, 2002, EXP HEMATOL, V30, P440, DOI 10.1016/S0301-472X(02)00788-9; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu FL, 1997, BLOOD, V90, P2522, DOI 10.1182/blood.V90.7.2522.2522_2522_2528; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; LORD BI, 1991, BLOOD, V77, P2154; MOLINEUX G, 1990, BLOOD, V75, P563; Mooren FC, 2012, J APPL PHYSIOL, V113, P1082, DOI 10.1152/japplphysiol.00797.2012; Naito T, 2009, EUR J APPL PHYSIOL, V105, P643, DOI 10.1007/s00421-008-0946-9; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Ohlmeier M, 2017, SPINE J, V17, P1519, DOI 10.1016/j.spinee.2017.04.021; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Pitzer C, 2010, J NEUROCHEM, V113, P930, DOI 10.1111/j.1471-4159.2010.06659.x; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Saberi H, 2014, CELL TRANSPLANT, V23, pS19, DOI 10.3727/096368914X684943; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Stratos I, 2007, J APPL PHYSIOL, V103, P1857, DOI 10.1152/japplphysiol.00066.2007; Takahashi H, 2012, EUR SPINE J, V21, P2580, DOI 10.1007/s00586-012-2213-3; Takamatsu Y, 1998, BLOOD, V92, P3465, DOI 10.1182/blood.V92.9.3465.421k35_3465_3473; Tay J, 2017, INT J HEMATOL, V105, P129, DOI 10.1007/s12185-016-2162-4; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Torossian F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96034; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wallner S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00048; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wu CKA, 2009, J BIOMED MATER RES A, V91A, P845, DOI 10.1002/jbm.a.32238	64	4	6	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	NOV	2020	35	11					2242	2251		10.1002/jbmr.4118		SEP 2020	10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	OP6IX	WOS:000569911900001	32568412	Green Published, Bronze			2022-02-06	
J	Fung, FW; Fan, JX; Vala, L; Jacobwitz, M; Parikh, DS; Donnelly, M; Topjian, AA; Xiao, R; Abend, NS				Fung, France W.; Fan, Jiaxin; Vala, Lisa; Jacobwitz, Marin; Parikh, Darshana S.; Donnelly, Maureen; Topjian, Alexis A.; Xiao, Rui; Abend, Nicholas S.			EEG monitoring duration to identify electroencephalographic seizures in critically ill children	NEUROLOGY			English	Article							NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CONTINUOUS VIDEO-EEG; ELECTROGRAPHIC SEIZURES; CONSENSUS STATEMENT; COMATOSE CHILDREN; COMMON; PROBABILITY; TERMINOLOGY; PREDICTORS	Objectives To determine the optimal duration of continuous EEG monitoring (CEEG) for electrographic seizure (ES) identification in critically ill children. Methods We performed a prospective observational cohort study of 719 consecutive critically ill children with encephalopathy. We evaluated baseline clinical risk factors (age and prior clinically evident seizures) and emergent CEEG risk factors (epileptiform discharges and ictal-interictal continuum patterns) using a multistate survival model. For each subgroup, we determined the CEEG duration for which the risk of ES was Results ES occurred in 184 children (26%). Patients achieved <5% risk of ES after (1) 6 hours if >= 1 year without prior seizures or EEG risk factors; (2) 1 day if <1 year without prior seizures or EEG risks; (3) 1 day if >= 1 year with either prior seizures or EEG risks; (4) 2 days if >= 1 year with prior seizures and EEG risks; (5) 2 days if <1 year without prior seizures but with EEG risks; and (6) 2.5 days if <1 year with prior seizures regardless of the presence of EEG risks. Patients achieved <2% risk of ES at the same durations except patients without prior seizures or EEG risk factors would require longer CEEG (1.5 days if <1 year of age, 1 day if >= 1 year of age). Conclusions A model derived from 2 baseline clinical risk factors and emergent EEG risk factors would allow clinicians to implement personalized strategies that optimally target limited CEEG resources. This would enable more widespread use of CEEG-guided management as a potential neuroprotective strategy. ClinicalTrials.gov identifier NCT03419260.	[Parikh, Darshana S.; Topjian, Alexis A.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA USA; [Fung, France W.; Jacobwitz, Marin; Parikh, Darshana S.; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Vala, Lisa; Donnelly, Maureen; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Neurodiagnost, Philadelphia, PA USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Abend, Nicholas S.] Univ Penn, Dept Anesthesia & Crit Care, Perelman Sch Med, Philadelphia, PA USA; [Fan, Jiaxin; Xiao, Rui; Abend, Nicholas S.] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA		Fung, FW (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA.; Fung, FW (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Fung, FW (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	fungf@email.chop.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K02NS096058]	N.S. Abend is funded by NIH K02NS096058.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P251, DOI 10.1097/WNP.0000000000000459; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P246, DOI 10.1097/WNP.0000000000000458; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, SEIZURE-EUR J EPILEP, V22, P467, DOI 10.1016/j.seizure.2013.03.008; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Children's Hospital of Philadelphia, CRIT CAR PATH EEG MO; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Fung FW, 2020, EPILEPSIA, V61, P498, DOI 10.1111/epi.16448; Fung FW, 2019, EPILEPSIA, V60, P2095, DOI 10.1111/epi.16341; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Fernandez IS, 2018, SEIZURE-EUR J EPILEP, V54, P19, DOI 10.1016/j.seizure.2017.11.013; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Sansevere AJ, 2017, J CLIN NEUROPHYSIOL, V34, P421, DOI 10.1097/WNP.0000000000000379; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Struck AF, 2017, JAMA NEUROL, V74, P1419, DOI 10.1001/jamaneurol.2017.2459; Struck AF, 2017, ANN NEUROL, V82, P177, DOI 10.1002/ana.24985; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012; Vlachy J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00303; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Yang A, 2015, SEIZURE-EUR J EPILEP, V25, P104, DOI 10.1016/j.seizure.2014.09.013	50	4	4	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 15	2020	95	11					E1599	E1608		10.1212/WNL.0000000000010421			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX9ML	WOS:000576025700027	32690798	Green Published			2022-02-06	
J	Jones, RC; Creutzfeldt, CJ; Cox, CE; Haines, KL; Hough, CL; Vavilala, MS; Williamson, T; Hernandez, A; Raghunathan, K; Bartz, R; Fuller, M; Krishnamoorthy, V				Jones, Rayleen C.; Creutzfeldt, Claire J.; Cox, Christopher E.; Haines, Krista L.; Hough, Catherine L.; Vavilala, Monica S.; Williamson, Theresa; Hernandez, Adrian; Raghunathan, Karthik; Bartz, Raquel; Fuller, Matt; Krishnamoorthy, Vijay			Racial and Ethnic Differences in Health Care Utilization Following Severe Acute Brain Injury in the United States	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						severe acute brain injury; disparities; health care utilization; ethnicity	INSURANCE STATUS; SOCIOECONOMIC DISPARITIES; TUBE PLACEMENT; OUTCOMES; RACE; BLUNT; HOME; MORTALITY; DEATHS	Objective: To examine racial and ethnic differences in the utilization of 3 interventions (tracheostomy placement, gastrostomy tube placement, and hospice utilization) among patients with severe acute brain injury (SABI). Design: Retrospective cohort study. Setting: Data from the National Inpatient Sample, from 2002 to 2012. Patients: Adult patients with SABI defined as a primary diagnosis of stroke, traumatic brain injury, or post-cardiac arrest who received greater than 96 hours of mechanical ventilation. Exposure: Race/ethnicity, stratified into 5 categories (white, black, Hispanic, Asian, and other). Measurements and Main Results: Data from 86 246 patients were included in the cohort, with a mean (standard deviation) age of 60 (18) years. In multivariable analysis, compared to white patients, black patients had an 20% increased risk of tracheostomy utilization (relative risk [RR]: 1.20, 95% CI: 1.16-1.24,P< .001), Hispanic patients had a 10% increased risk (RR: 1.10, 95% CI: 1.06-1.14,P< .001), Asian patients had an 8% increased risk (RR: 1.08, 95% CI: 1.01-1.16,P= .02), and other race patients had an 10% increased risk (RR: 1.10, 95% CI: 1.04-1.16,P< .001). A similar relationship was observed for gastrostomy utilization. In multivariable analysis, compared to white patients, black patients had a 25% decreased risk of hospice discharge (RR: 0.75, 95% CI: 0.67-0.85,P< .001), Hispanic patients had a 20% decreased risk (RR: 0.80, 95% CI: 0.69-0.94,P< .01), and Asian patients had a 47% decreased risk (RR: 0.53, 95% CI: 0.39-0.73,P< .001). There was no observed relationship between race/ethnicity and in-hospital mortality. Conclusions: Minority race was associated with increased utilization of tracheostomy and gastrostomy, as well as decreased hospice utilization among patients with SABI. Further research is needed to better understand the mechanisms underlying these race-based differences in critical care.	[Jones, Rayleen C.] Duke Univ, Sch Nursing, Durham, NC USA; [Jones, Rayleen C.; Haines, Krista L.; Raghunathan, Karthik; Bartz, Raquel; Fuller, Matt; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Crit Care & Perioperat Epidemiol Res CAPER Unit, Durham, NC USA; [Creutzfeldt, Claire J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Cox, Christopher E.; Hernandez, Adrian] Duke Univ, Dept Med, Durham, NC USA; [Haines, Krista L.] Duke Univ, Dept Surg, Durham, NC USA; [Hough, Catherine L.] Univ Washington, Dept Med, Seattle, WA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Williamson, Theresa] Duke Univ, Dept Neurosurg, Durham, NC USA; [Raghunathan, Karthik; Bartz, Raquel; Fuller, Matt; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, 2301 Erwin Rd, Durham, NC 27710 USA		Krishnamoorthy, V (corresponding author), Duke Univ, Dept Anesthesiol, 2301 Erwin Rd, Durham, NC 27710 USA.	vijay.krishnamoorthy@duke.edu	Cox, Christopher/ABH-7957-2020	Cox, Christopher/0000-0002-4486-0681	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS109274]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NIH K23 NS109274.	Ali MT, 2013, SURGERY, V154, P461, DOI 10.1016/j.surg.2013.05.036; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Born Wendi, 2004, J Palliat Med, V7, P247, DOI 10.1089/109662104773709369; Cooper LA, 2012, AM J PUBLIC HEALTH, V102, P979, DOI 10.2105/AJPH.2011.300558; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Cruz-Flores S, 2019, INT J STROKE, V14, P686, DOI 10.1177/1747493019835335; Faigle R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191293; Faigle R, 2016, JAMA NEUROL, V73, P1151, DOI 10.1001/jamaneurol.2016.1914; Faigle R, 2016, STROKE, V47, P964, DOI 10.1161/STROKEAHA.115.011712; Fat SC, 2019, AM J SURG, V218, P842, DOI 10.1016/j.amjsurg.2019.03.024; Faul M, 2010, TRAUMATIC BRAIN INJU; George BP, 2014, NEUROLOGY, V83, P874, DOI 10.1212/WNL.0000000000000764; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haines KL, 2019, J SURG RES, V240, P60, DOI 10.1016/j.jss.2019.02.040; Haines KL, 2019, J SURG RES, V235, P131, DOI 10.1016/j.jss.2018.09.072; Haines KL, 2018, AM J HOSP PALLIAT ME, V35, P1081, DOI 10.1177/1049909117753377; Haines KL, 2018, J SURG RES, V224, P160, DOI 10.1016/j.jss.2017.11.071; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Johnson KS, 2013, J PALLIAT MED, V16, P1329, DOI 10.1089/jpm.2013.9468; Karim K, 2000, PALLIATIVE MED, V14, P471, DOI 10.1191/026921600701536390; Krishnamoorthy V, 2019, NEUROCRIT CARE, V30, P546, DOI 10.1007/s12028-019-00697-5; Losonczy LI, 2014, J HEALTH CARE POOR U, V25, P308, DOI 10.1353/hpu.2014.0021; Lyn-Sue J, 2006, J NATL MED ASSOC, V98, P1940; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Moffet EW, 2018, SURGERY, V163, P251, DOI 10.1016/j.surg.2017.09.006; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Suri DN, 1999, J GERONTOL A-BIOL, V54, pM225, DOI 10.1093/gerona/54.5.M225; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Weygandt PL, 2012, J SURG RES, V177, P288, DOI 10.1016/j.jss.2012.07.003	34	4	4	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	OCT	2021	36	11					1258	1263	0885066620945911	10.1177/0885066620945911		SEP 2020	6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WC1KN	WOS:000568864100001	32912070				2022-02-06	
J	Zeiler, FA; Ercole, A; Cabeleira, M; Stocchetti, N; Hutchinson, PJ; Smielewski, P; Czosnyka, M; Anke, A; Beer, R; Bellander, BM; Beqiri, E; Buki, A; Carbonara, M; Chieregato, A; Citerio, G; Clusmann, H; Czeiter, E; Depreitere, B; Frisvold, S; Helbok, R; Jankowski, S; Kondziella, D; Koskinen, LO; Kowark, A; Menon, DK; Meyfroidt, G; Moeller, K; Nelson, D; Piippo-Karjalainen, A; Radoi, A; Ragauskas, A; Raj, R; Rhodes, J; Rocka, S; Rossaint, R; Sahuquillo, J; Sakowitz, O; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Cabeleira, Manuel; Stocchetti, Nino; Hutchinson, Peter J.; Smielewski, Peter; Czosnyka, Marek; Anke, Audny; Beer, Ronny; Bellander, Bo Michael; Beqiri, Erta; Buki, Andras; Carbonara, Marco; Chieregato, Arturo; Citerio, Giuseppe; Clusmann, Hans; Czeiter, Endre; Depreitere, Bart; Frisvold, Shirin; Helbok, Raimund; Jankowski, Stefan; Kondziella, Danile; Koskinen, Lars-Owe; Kowark, Ana; Menon, David K.; Meyfroidt, Geert; Moeller, Kirsten; Nelson, David; Piippo-Karjalainen, Anna; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rhodes, Jonathan; Rocka, Saulius; Rossaint, Rolf; Sahuquillo, Juan; Sakowitz, Oliver; Sundstroem, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefan; Younsi, Alexander		CENTER-TBI High Resolution Hr Icu	Descriptive analysis of low versus elevated intracranial pressure on cerebral physiology in adult traumatic brain injury: a CENTER-TBI exploratory study	ACTA NEUROCHIRURGICA			English	Article						Cerebral physiology; Cerebrovascular reactivity; ICP extremes; Outcomes	CEREBROVASCULAR REACTIVITY; CLASSIFICATION; MANAGEMENT; AUTOREGULATION; OXYGEN; INDEX	Background To date, the cerebral physiologic consequences of persistently elevated intracranial pressure (ICP) have been based on either low-resolution physiologic data or retrospective high-frequency data from single centers. The goal of this study was to provide a descriptive multi-center analysis of the cerebral physiologic consequences of ICP, comparing those with normal ICP to those with elevated ICP. Methods The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) High-Resolution Intensive Care Unit (HR-ICU) sub-study cohort was utilized. The first 3 days of physiologic recording were analyzed, evaluating and comparing those patients with mean ICP < 15 mmHg versus those with mean ICP > 20 mmHg. Various cerebral physiologic parameters were derived and evaluated, including ICP, brain tissue oxygen (PbtO(2)), cerebral perfusion pressure (CPP), pulse amplitude of ICP (AMP), cerebrovascular reactivity, and cerebral compensatory reserve. The percentage time and dose above/below thresholds were also assessed. Basic descriptive statistics were employed in comparing the two cohorts. Results 185 patients were included, with 157 displaying a mean ICP below 15 mmHg and 28 having a mean ICP above 20 mmHg. For admission demographics, only admission Marshall and Rotterdam CT scores were statistically different between groups (p = 0.017 andp = 0.030, respectively). The high ICP group displayed statistically worse CPP, PbtO(2), cerebrovascular reactivity, and compensatory reserve. The high ICP group displayed worse 6-month mortality (p < 0.0001) and poor outcome (p = 0.014), based on the Extended Glasgow Outcome Score. Conclusions Low versus high ICP during the first 72 h after moderate/severe TBI is associated with significant disparities in CPP, AMP, cerebrovascular reactivity, cerebral compensatory reserve, and brain tissue oxygenation metrics. Such ICP extremes appear to be strongly related to 6-month patient outcomes, in keeping with previous literature. This work provides multi-center validation for previously described single-center retrospective results.	[Zeiler, Frederick A.; Ercole, Ari; Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Zeiler, Frederick A.; Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Zeiler, Frederick A.; Bellander, Bo Michael; Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Zeiler, Frederick A.; Beqiri, Erta; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Zeiler, Frederick A.; Buki, Andras] Univ Pecs, Hungary & Neurotrauma Res Grp, Janos Szentagothai Res Ctr, Dept Neurosurg,Med Sch, Pecs, Hungary; [Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek; CENTER-TBI High Resolution Hr Icu] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England; [Stocchetti, Nino; Carbonara, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Stocchetti, Nino; Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, Dept Anesthesia & Intens Care, NeuroIntens Care Unit, Monza, Italy; [Hutchinson, Peter J.; Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Czosnyka, Marek; Clusmann, Hans] Rhein Westfal TH Aachen, Dept Neurosurg, Med Fac, Aachen, Germany; [Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Czeiter, Endre] Univ Pecs, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program Grant KTIA NAP A 2 8, Janos Szentagothai Res Ctr, Pecs, Hungary; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Kondziella, Danile] Rigshosp, Dept Neurol, Copenhagen, Region Hovedsta, Denmark; [Kondziella, Danile] Rigshosp, Dept Clin Neurophysiol, Copenhagen, Region Hovedsta, Denmark; [Kondziella, Danile; Moeller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Copenhagen, Region Hovedsta, Denmark; [Koskinen, Lars-Owe] Umea Univ, Dept Clin Neurosci, Neurosurg, Umea, Sweden; [Kowark, Ana; Rossaint, Rolf] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Piippo-Karjalainen, Anna; Raj, Rahul] Helsinki Univ Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vali dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] NHS Lothian, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Stocchetti, Nino] Milan Univ, Dept Pathophysiol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci ICU, Milan, Italy; [Sundstroem, Nina] Umea Univ, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Takala, Riikka] Turku Univ, Perioperat Serv Intens Care Med & Pain Management, Cent Hosp, Turku, Finland; [Takala, Riikka] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ, Rehabil & Brain Trauma, Cent Hosp, Turku, Finland; [Vajkoczy, Peter] Charlie Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Wolf, Stefan] Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany; [Wolf, Stefan] Free Univ Berlin, Berlin, Germany; [Wolf, Stefan] Humboldt Univ, Berlin, Germany; [Wolf, Stefan] Berlin Inst Hlth, Berlin, Germany; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada		Zeiler, FA (corresponding author), Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway.; Zeiler, FA (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria.; Zeiler, FA (corresponding author), Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden.; Zeiler, FA (corresponding author), Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy.; Zeiler, FA (corresponding author), Univ Pecs, Hungary & Neurotrauma Res Grp, Janos Szentagothai Res Ctr, Dept Neurosurg,Med Sch, Pecs, Hungary.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca; ae105@cam.ac.uk; mc916@cam.ac.uk; nino.stocchetti@policlinico.mi.it; pjah2@cam.ac.uk; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk	Helbok, Raimund/AAA-8361-2021; Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Raj, Rahul/K-7693-2012; Moller, Kirsten/A-4751-2009; Stocchetti, Nino/O-7444-2017	Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Raj, Rahul/0000-0003-4243-9591; Zeiler, Frederick/0000-0003-1737-0510; Sakowitz, Oliver/0000-0003-3248-6335; Kondziella, Daniel/0000-0001-5562-9808; Moller, Kirsten/0000-0003-3058-1072; Radoi, Andreea/0000-0002-0677-3544; Stocchetti, Nino/0000-0003-3250-6834; Nelson, David/0000-0003-2530-8207	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA).	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bernard J, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.926.48741; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Thelin EP, 2020, J CLIN MONIT COMPUT, V34, P971, DOI 10.1007/s10877-019-00392-y; Tymko MM, 2019, CLIN AUTON RES, V29, P123, DOI 10.1007/s10286-018-0579-y; Zeiler FA, 2019, ACTA NEUROCHIR WIEN; Zeiler FA, 2020, J NEUROTRAUMA; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1275, DOI 10.1007/s00701-019-03915-3; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595	37	4	4	1	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2020	162	11					2695	2706		10.1007/s00701-020-04485-5		SEP 2020	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OC5DX	WOS:000566038700005	32886226	Green Published, Green Accepted, hybrid			2022-02-06	
J	Cecchi, NJ; Monroe, DC; Moscoso, WX; Hicks, JW; Reinkensmeyer, DJ				Cecchi, Nicholas J.; Monroe, Derek C.; Moscoso, Wyatt X.; Hicks, James W.; Reinkensmeyer, David J.			Effects of soccer ball inflation pressure and velocity on peak linear and rotational accelerations of ball-to-head impacts	SPORTS ENGINEERING			English	Article						Football; Biomechanics; Concussion; Head acceleration; Head impact kinematics; Header	SCENARIO	Exposure to head impacts is common in soccer and, in some cases, has been associated with neurocognitive and physiological consequences in soccer players. Ball-to-head impacts are particularly frequent, as soccer players regularly use their heads to pass, clear, and shoot the ball during game play and practice. The attenuation of head accelerations resulting from impact is of interest to promoting athlete brain health and numerical models have suggested that reducing soccer ball inflation pressure can lower head accelerations from ball-to-head impacts. The present study sought to test the effect of ball inflation pressure on peak linear acceleration and peak rotational acceleration of the head in a biomechanical reconstruction of ball-to-head impacts using an anthropomorphic testing device head and neck. Adult-sized soccer balls were inflated to five different pressures (34, 48, 55, 62, and 76 kPa), a range that spanned the lower bound on inflation pressure regulated by Federation Internationale de Football Association and the National Collegiate Athletic Association (60 kPa). Balls were then thrown via a ball launcher at the forehead of the anthropomorphic testing device at three different velocities (17.3, 19.7, and 22.2 m/s). Repeated-measures analyses of variance, with pressure and velocity as repeated measures, revealed an increase in peak linear acceleration (p = 0.001) and peak rotational acceleration (p = 0.002) with higher ball velocities, and a decrease in peak linear acceleration (p < 0.001) and peak rotational acceleration (p < 0.001) with lower ball pressures. Consistent with previous numerical models, the results of this study suggest that reducing soccer ball inflation pressure may reduce head accelerations of ball-to-head impacts.	[Cecchi, Nicholas J.] Impact Sports Co LLC, Anaheim, CA USA; [Cecchi, Nicholas J.; Moscoso, Wyatt X.; Reinkensmeyer, David J.] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA; [Monroe, Derek C.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA		Hicks, JW (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	jhicks@uci.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163	Center for Exercise Medicine and Sport Sciences at the University of California, IrvineUniversity of California System; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5TL1TR001415-04]	Funding for this study was provided by the Center for Exercise Medicine and Sport Sciences at the University of California, Irvine. DM was supported by NIH Grant 5TL1TR001415-04.	[Anonymous], 2014, J211 SAE SAE INT; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cecchi NJ, 2019, FRONT SPORTS ACT LIV, V1, DOI 10.3389/fspor.2019.00002; Cecchi NJ, 2020, P I MECH ENG P-J SPO, V234, P162, DOI 10.1177/1754337120901974; de Grau S, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00325-y; Dunn M, 2020, EFFECT FOOTBALL SIZE, V49, P29, DOI [10.3390/proceedings2020049029, DOI 10.3390/PROCEEDINGS2020049029]; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A, 2019, MUSCULOSKEL SCI PRAC, V40, P53, DOI 10.1016/j.msksp.2019.01.009; King AI, 2003, IRCOBI C LISB PORT; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lees A, 1998, J SPORT SCI, V16, P211, DOI 10.1080/026404198366740; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	24	4	4	1	7	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	SEP 2	2020	23	1							16	10.1007/s12283-020-00331-0			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	NN1QE	WOS:000568564500001					2022-02-06	
J	Loughan, AR; Braun, SE; Lanoye, A				Loughan, Ashlee R.; Braun, Sarah E.; Lanoye, Autumn			Executive dysfunction in neuro-oncology: Behavior Rating Inventory of Executive Function in adult primary brain tumor patients	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						BRIEF-A; cognitive functioning; executive function; primary brain tumor	MILD COGNITIVE IMPAIRMENT; HIGH-GRADE GLIOMA; QUALITY-OF-LIFE; WORKING-MEMORY; SURVIVORS; INJURY; REHABILITATION; DEFICITS; INTERVENTIONS; PERFORMANCE	Adult primary brain tumor (PBT) survivors report persistent cognitive difficulties before, during, and after treatment, which are problematic for everyday functioning. Cognitive domains often affected by cancer treatment appear to be attention and executive functioning (EF). One validated measure developed to assess an individual's EF within daily living is the Behavior Rating Inventory of Executive Function-Adult (BRIEF-A). To date, no published research has investigated the EF profile of PBT patients using the BRIEF-A. Seventy-four PBT patients completed the BRIEF-A. Descriptive analyses were conducted to determine the self-reported EF profile in PBT patients. T-tests preliminarily compared the performance of PBT patients to four other comparison groups: mild cognitive impairment (MCI;n = 23), attention-deficit/hyperactivity disorder-unmedicated (ADHD-U;n = 27), traumatic brain injury (TBI;n = 23), and healthy controls (HC;n = 26). PBT BRIEF-A group means were average across subscales and indexes, yet the prevalence of significant elevations ranged from 12 to 50%. The Metacognition Index demonstrated 38% elevation prevalence compared to 22% in Behavioral Regulation. Approximately 61% of the sample had at least one clinically elevated scaled score. PBT patients reported significantly more EF impairment than HC and significantly less than ADHD-U. No significant differences were found between the PBT and MCI groups or PBT and TBI groups. Despite group means not reaching clinical impairment, a substantial proportion of patients with PBTs endorse executive dysfunction. Elevations were most prominent in metacognitive abilities over behavioral dysregulation. Notably, the EF profile of PBT patients was remarkably similar to that of MCI and TBI, increased when compared to HC, and well below ADHD-U.	[Loughan, Ashlee R.; Braun, Sarah E.] Virginia Commonwealth Univ, Dept Neurol, Div Neurooncol, 1201 East Marshall St, Richmond, VA 23298 USA; [Loughan, Ashlee R.; Braun, Sarah E.] McGlothlin Med Educ Ctr, Massey Canc Ctr, 1201 East Marshall St, Richmond, VA 23298 USA; [Braun, Sarah E.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; [Lanoye, Autumn] Virginia Commonwealth Univ, Dept Hlth Behav & Policy, Sch Med, Richmond, VA 23298 USA		Loughan, AR (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Div Neurooncol, 1201 East Marshall St, Richmond, VA 23298 USA.; Loughan, AR (corresponding author), McGlothlin Med Educ Ctr, Massey Canc Ctr, 1201 East Marshall St, Richmond, VA 23298 USA.	ashlee.loughan@vcuhealth.org	Lanoye, Autumn/AAF-9433-2019	Lanoye, Autumn/0000-0003-3705-0880			Abrey LE, 2012, J NEURO-ONCOL, V108, P285, DOI 10.1007/s11060-012-0807-6; Ahles TA, 2003, PSYCHO-ONCOL, V12, P612, DOI 10.1002/pon.742; Almkvist O, 1999, EUR ARCH PSY CLIN N, V249, P3; Asher A, 2015, CLIN ADV HEMATOLOGY, V13, P1; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001190.pub3; Boele FW, 2013, NEURO-ONCOLOGY, V15, P1420, DOI 10.1093/neuonc/not102; Boele FW, 2013, J NEURO-ONCOL, V111, P303, DOI 10.1007/s11060-012-1012-3; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Cabrera S, 2016, NEURO-ONCOL PRACT, V3, P113, DOI 10.1093/nop/npv055; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Conklin HM, 2012, J INT NEUROPSYCH SOC, V18, P996, DOI 10.1017/S1355617712000793; Correa DD, 2007, J NEURO-ONCOL, V81, P175, DOI 10.1007/s11060-006-9212-3; Correa DD, 2014, NEUROLOGY, V83, P320, DOI 10.1212/WNL.0000000000000617; Correa DD, 2010, CURR NEUROL NEUROSCI, V10, P232, DOI 10.1007/s11910-010-0108-4; De Ruiter MA, 2013, DEV MED CHILD NEUROL, V55, P408, DOI 10.1111/dmcn.12020; de Vries M, 2018, CHILD NEUROPSYCHOL, V24, P844, DOI 10.1080/09297049.2017.1350262; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Farina N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002854.pub3; Gehring K, 2008, LANCET NEUROL, V7, P548, DOI 10.1016/S1474-4422(08)70111-X; Gehring K, 2015, NEURO-ONCOL PRACT, V2, P20, DOI 10.1093/nop/npu035; Gehring K, 2009, J CLIN ONCOL, V27, P3712, DOI 10.1200/JCO.2008.20.5765; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hassler MR, 2010, J NEURO-ONCOL, V97, P109, DOI 10.1007/s11060-009-0006-2; Hofmann M, 2003, COMPR PSYCHIAT, V44, P213, DOI 10.1016/S0010-440X(03)00006-3; Howarth RA, 2013, J INT NEUROPSYCH SOC, V19, P380, DOI 10.1017/S1355617712001567; Isquith PK, 2013, APPL NEUROPSYCH-CHIL, V2, P125, DOI 10.1080/21622965.2013.748389; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; King TZ, 2015, ARCH CLIN NEUROPSYCH, V30, P394, DOI 10.1093/arclin/acv033; Loughan A.R., 2018, HDB BRAIN TUMOR CHEM, P783, DOI DOI 10.1016/B978-0-12-812100-9.00062-0; Manivannan S., 2018, EFFECTIVENESS VIRTUA, DOI [10.1097/HTR.0000000000000412, DOI 10.1097/HTR.0000000000000412]; McAleer MF, 2015, SEMIN RADIAT ONCOL, V25, P210, DOI 10.1016/j.semradonc.2015.02.005; McCurdy MD, 2016, J NEURO-ONCOL, V127, P137, DOI 10.1007/s11060-015-2021-9; Meinzer M, 2015, ALZHEIMERS DEMENT, V11, P1032, DOI 10.1016/j.jalz.2014.07.159; Meyers CA, 2000, J CLIN ONCOL, V18, P646, DOI 10.1200/JCO.2000.18.3.646; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Morris J., 1994, MDS COGNITIVE PERFOR; Noll KR, 2016, J NEURO-ONCOL, V128, P323, DOI 10.1007/s11060-016-2114-0; Pahlson A, 2003, J NEURO-ONCOL, V65, P149, DOI 10.1023/B:NEON.0000003727.09448.dd; Pearson, 2009, ADV CLIN SOL WAIS 4; Richard F, 2001, EUR J PHARMACOL, V412, P1, DOI 10.1016/S0014-2999(00)00903-1; Rodakowski J, 2015, MOL ASPECTS MED, V43-44, P38, DOI 10.1016/j.mam.2015.06.003; Roth R. M., 2005, BEHAV RATING INVENTO, DOI [10.1093/arclin/act031, DOI 10.1093/ARCLIN/ACT031]; Royall DR, 2004, NEUROEPIDEMIOLOGY, V23, P185, DOI 10.1159/000078504; Russ TC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009132.pub2; Salander P, 1996, SOC SCI MED, V42, P985, DOI 10.1016/0277-9536(95)00204-9; Schagen S B, 2014, EJC Suppl, V12, P29, DOI 10.1016/j.ejcsup.2014.03.003; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P357, DOI 10.1007/978-0-387-76978-3_14; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Stevens G., 2016, J CANC THER, V07, P857, DOI [10.4236/jct.2016.712085, DOI 10.4236/JCT.2016.712085]; Stewart AL, 1992, MEASURING FUNCTIONIN; Stuss D.T., 2000, PSYCHOL RES, DOI [10.1007/s004269900007, DOI 10.1007/s004269900007]; Swier-Vosnos A, 2013, NEUROPSYCHOLOGY CANC, P263; TAPHOORN MJB, 1992, J NEUROL NEUROSUR PS, V55, P372, DOI 10.1136/jnnp.55.5.372; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Teixidor P, 2007, J NEURO-ONCOL, V81, P305, DOI 10.1007/s11060-006-9233-y; Tierney MC, 2000, ARCH FAM MED, V9, P527, DOI 10.1001/archfami.9.6.527; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Winblad B, 2004, J INTERN MED, V256, P181; Wochos G. C., 2015, DIFFERENCES PARENT T, DOI [10.1080/13854046.2014.971875 ., DOI 10.1080/13854046.2014.971875]; Wolfe KR, 2013, CHILD NEUROPSYCHOL, V19, P370, DOI 10.1080/09297049.2012.669470; Yue JR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008827.pub2; Zucchella C, 2013, J NEURO-ONCOL, V114, P93, DOI 10.1007/s11060-013-1153-z	64	4	4	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 2	2020	27	5					393	402		10.1080/23279095.2018.1553175			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NC2YP	WOS:000561082300001	30714410				2022-02-06	
J	Belluscio, V; Bergamini, E; Tramontano, M; Formisano, R; Buzzi, MG; Vannozzi, G				Belluscio, Valeria; Bergamini, Elena; Tramontano, Marco; Formisano, Rita; Buzzi, Maria Gabriella; Vannozzi, Giuseppe			Does Curved Walking Sharpen the Assessment of Gait Disorders? An Instrumented Approach Based on Wearable Inertial Sensors	SENSORS			English	Article						straight walking; curved trajectories; gait quality; body accelerations; figure of 8 walk test; traumatic brain injury; steering of locomotion; dynamic balance; mobility evaluation; turning	ORIENTATION; MOBILITY; FALLS	Gait and balance assessment in the clinical context mainly focuses on straight walking. Despite that curved trajectories and turning are commonly faced in our everyday life and represent a challenge for people with gait disorders. The adoption of curvilinear trajectories in the rehabilitation practice could have important implications for the definition of protocols tailored on individual's needs. The aim of this study was to contribute toward the quantitative characterization of straight versus curved walking using an ecological approach and focusing on healthy and neurological populations. Twenty healthy adults (control group (CG)) and 20 patients with Traumatic Brain Injury (TBI) (9 severe, sTBI-S, and 11 very severe, sTBI-VS) performed a 10 m and a Figure-of-8 Walk Test while wearing four inertial sensors that were located on both tibiae, sternum and pelvis. Spatiotemporal and gait quality indices that were related to locomotion stability, symmetry, and smoothness were obtained. The results show that spatiotemporal, stability, and symmetry-related gait patterns are challenged by curved walking both in healthy subjects and sTBI-S, whereas no difference was displayed for sTBI-VS. The use of straight walking alone to assess gait disorders is thus discouraged, particularly in patients with good walking abilities, in favor of the adoption of complementary tests that were also based on curved paths.	[Belluscio, Valeria; Bergamini, Elena; Tramontano, Marco; Vannozzi, Giuseppe] Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Dept Movement Human & Hlth Sci, Piazza Lauro Bosis 15, I-00135 Rome, Italy; [Belluscio, Valeria; Tramontano, Marco; Formisano, Rita; Buzzi, Maria Gabriella] IRCCS Santa Lucia Fdn, Via Ardeatina 306, I-00179 Rome, Italy		Bergamini, E (corresponding author), Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Dept Movement Human & Hlth Sci, Piazza Lauro Bosis 15, I-00135 Rome, Italy.	valeria.belluscio@gmail.com; elena.bergamini@uniroma4.it; m.tramontano@studenti.uniroma4.it; r.formisano@hsantalucia.it; mg.buzzi@hsantalucia.it; giuseppe.vannozzi@uniroma4.it	TRAMONTANO, MARCO/K-4373-2018; Vannozzi, Giuseppe/G-9897-2013	TRAMONTANO, MARCO/0000-0001-6034-0638; Vannozzi, Giuseppe/0000-0002-2359-6076; Buzzi, Maria Gabriella/0000-0003-1307-8707; Formisano, Rita/0000-0002-2516-0540			Balasubramanian S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0090-9; Balasubramanian S, 2012, IEEE T BIO-MED ENG, V59, P2126, DOI 10.1109/TBME.2011.2179545; Belluscio V, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19235315; Bergamini E, 2017, J BIOMECH, V61, P208, DOI 10.1016/j.jbiomech.2017.07.034; Bergamini E, 2014, SENSORS-BASEL, V14, P18625, DOI 10.3390/s141018625; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Dite W, 2002, AM J PHYS MED REHAB, V81, P857, DOI 10.1097/00002060-200211000-00010; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Formisano R, 2014, J HEAD TRAUMA REHAB, V29, P387, DOI 10.1097/HTR.0000000000000027; Godi M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00532; Godi M, 2010, J REHABIL MED, V42, P858, DOI [10.2340/16501977-0594, 10.2340/16501977.0594]; Guglielmetti S, 2009, MOVEMENT DISORD, V24, P598, DOI 10.1002/mds.22424; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Hess RJ, 2010, PHYS THER, V90, P89, DOI 10.2522/ptj.20080121; Higashi Y, 2008, IEEE ENG MED BIOL, V27, P38, DOI 10.1109/MEMB.2008.919494; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Mazza C, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-30; Pasciuto I, 2017, J BIOMECH, V53, P84, DOI 10.1016/j.jbiomech.2017.01.005; Segal AD, 2008, J BIOMECH, V41, P1486, DOI 10.1016/j.jbiomech.2008.02.012; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Song HS, 2015, J PHYS THER SCI, V27, P1365, DOI 10.1589/jpts.27.1365; Stuart S, 2020, J NEUROTRAUM, V37, P139, DOI 10.1089/neu.2019.6450; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tramontano M, 2018, NEUROREHABILITATION, V43, P247, DOI 10.3233/NRE-182427; Turcato AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197264; Turcato AM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-4; Vielledent S, 2001, NEUROSCI LETT, V305, P65, DOI 10.1016/S0304-3940(01)01798-0; Wong SST, 2013, DISABIL REHABIL, V35, P1896, DOI 10.3109/09638288.2013.766274	35	4	4	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	SEP	2020	20	18							5244	10.3390/s20185244			11	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Instruments & Instrumentation	OD8HO	WOS:000580088000001	32937877	Green Published, gold			2022-02-06	
J	Chan, V; Sutton, M; Mollayeva, T; Escobar, MD; Hurst, M; Colantonio, A				Chan, Vincy; Sutton, Mitchell; Mollayeva, Tatyana; Escobar, Michael D.; Hurst, Mackenzie; Colantonio, Angela			Data Mining to Understand How Health Status Preceding Traumatic Brain Injury Affects Functional Outcome: A Population-Based Sex-Stratified Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INPATIENT REHABILITATION OUTCOMES; OLDER-ADULTS; CENTERS	Objectives: To understand how health status preceding traumatic brain injury (TBI) affects relative functional gain after inpatient rehabilitation using a data mining approach. Design: Population-based, sex-stratified, retrospective cohort study using health administrative data from Ontario, Canada (39% of the Canadian population). Setting: Inpatient rehabilitation. Participants: Patients 14 years or older (NZ5802; 63.4% male) admitted to inpatient rehabilitation within 1 year of a TBI-related acute care discharge between April 1, 2008, and March 31, 2015. Interventions: Not applicable. Main Outcome Measures: Relative functional gain (RFG) in percentage, calculated as ([discharge FIM-admission FIM]/[126-admission FIM]x 100). Health status prior to TBI was identified and internally validated using a data mining approach that categorized all International Classification of Diseases, 10th revision, codes for each patient. Results: The average RFG was 52.8%+/- 27.6% among male patients and 51.6%+/- 27.1% among female patients. Sex-specific Bonferroni adjusted multivariable linear regressions identified 10 factors of preinjury health status related to neurology, emergency medicine, cardiology, psychiatry, geriatrics, and gastroenterology that were significantly associated with reduced RFG in FIM for male patients. Only 1 preinjury health status category, geriatrics, was significantly associated with RFG in female patients. Conclusions: Comorbid health conditions present up to 5 years preceding the TBI event were significantly associated with RFG. These findings should be considered when planning and executing interventions to maximize functional gain and to support an interdisciplinary approach. Best practices guidelines and clinical interventions for older male and female patients with TBI should be developed given the increasingly aging population with TBI. (c) 2020 by the American Congress of Rehabilitation Medicine	[Chan, Vincy; Sutton, Mitchell; Mollayeva, Tatyana; Hurst, Mackenzie; Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada; [Escobar, Michael D.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] ICES, Toronto, ON, Canada		Chan, V (corresponding author), 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	vincy.chan@uhn.ca	, Mollayeva/A-4522-2018		Eunice Kennedy Shriver National Institutes of Child Health & Human Development of the National Institutes of Health [R21HD089106]; Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]	Supported by the Eunice Kennedy Shriver National Institutes of Child Health & Human Development of the National Institutes of Health (award no. R21HD089106). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. T.M. was supported by the postdoctoral research grant from the Alzheimer's Association (no. AARF-16-442937). The funders had no role in the study design, data collection, decision to publish, or preparation of the manuscript.	Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Association of Public Health Epidemiologists in Ontario, REC ICD 10 CA COD IN; Canadian Institute for Health Information, 2018, REH MIN DAT SET MAN; Canadian Institute for Health Information, DISCH ABSTRACT DAT M; Canadian Institute for Health Information, 2018, NAT REH REP SYST DAT; Centers for Disease Control and Prevention, ICD INJ MATR; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Chen AQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-85; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Dahdah MN, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000270; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483; Kucukboyaci NE, 2018, ARCH PHYS MED REHAB, V99, P2365, DOI 10.1016/j.apmr.2017.11.016; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Ng R., 2015, BRAIN DISORDERS ONTA; Resource for Indicator Standards, ALT LEV CAR ALC DAYS; Salter K, 2017, EVIDENCE BASED REV M, P1; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016	28	4	4	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2020	101	9					1523	1531		10.1016/j.apmr.2020.05.017			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	NT6YT	WOS:000573084400007	32544398	Green Accepted			2022-02-06	
J	DeBaun, MR; Ziino, C; LaPrade, C; Pun, S; Avedian, RS; Bellino, MJ				DeBaun, Malcolm R.; Ziino, Chason; LaPrade, Christopher; Pun, Stephanie; Avedian, Raffi S.; Bellino, Michael J.			Y An anatomic classification for heterotopic ossification about the hip	JOURNAL OF ORTHOPAEDICS			English	Article						Hip; Acetabulum; Heterotopic ossification; Hip replacement; Trauma	ACETABULAR FRACTURE; ECTOPIC OSSIFICATION; PROPHYLAXIS; ARTHROPLASTY; PREVENTION	Study design: Retrospective cohort. Summary of background data: Heterotopic ossification (HO) about the hip is a debilitating condition that can occur after fixation for acetabular fractures, total hip replacement, or polytrauma with closed head injuries. No classification exists that informs surgical treatment. Purpose: To establish a classification system for HO about the hip by reviewing a consecutive series of HO at a single institution. It was hypothesized that HO about the hip could be grouped into a novel classification scheme based upon the location and involved structures of the hip. Methods: Retrospective chart review of single center's case log for HO excision from 2004 to 2018 was performed. Inclusion criteria included all patients undergoing excision of heterotopic bone excision about the hip. Demographic data, pre and post hip range of motion, surgical approach for each surgery, index surgery date and interval to excision are reported as well as presence and location of HO and Brooker classification. Results: A total of 36 patients (21 men and 15 women) and 40 hips were identified meeting inclusion criteria. The mean age at the time of the index surgery was 47 (range, 16-77 years). Traumatic injury with fracture (35%) included 9 acetabular fractures (22%), 2 long bone fractures (5%) treated with intramedullary devices, one displaced femoral neck fracture (2%), and one pelvic ring injury (2%). Total hip arthroplasty accounted for 32% of patients. Brooker classification was type 4 (35%), 3 (25%), 2 (23%), 1(17%) which translated to 55% anterior, 48% posterior, 3% medial with respect to location. Average improvement in hip flexion and abduction was 22 and 8, respectively. Conclusion: This study identified discrete locations for heterotopic ossification following hip or acetabulum surgery. Both posterior and anterior structures are implicated in the formation of HO, and this investigation presents a novel classification to guide surgical approach for HO excision based upon location.	[DeBaun, Malcolm R.; Ziino, Chason; LaPrade, Christopher; Pun, Stephanie; Avedian, Raffi S.; Bellino, Michael J.] Stanford Univ, Dept Orthopaed Surg, Med Ctr, Palo Alto, CA 94304 USA		DeBaun, MR (corresponding author), Stanford Univ, Dept Orthopaed Surg, 450 Broadway St, Redwood City, CA 94063 USA.	mdebaun@stanford.edu		Pun, Stephanie/0000-0002-6910-5746; DeBaun, Malcolm/0000-0002-4391-5708			Anglen JO, 1996, J ORTHOP TRAUMA, V10, P258, DOI 10.1097/00005131-199605000-00006; Board TN, 2007, J BONE JOINT SURG BR, V89B, P434, DOI 10.1302/0301-620X.89B4.18845; Borrelli J, 2002, J ORTHOP TRAUMA, V16, P449, DOI 10.1097/00005131-200208000-00001; BOSSE MJ, 1988, J BONE JOINT SURG AM, V70A, P1231, DOI 10.2106/00004623-198870080-00016; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Burd TA, 2001, J BONE JOINT SURG AM, V83A, P1783, DOI 10.2106/00004623-200112000-00003; Davis JA, 2016, CLIN ORTHOP RELAT R, V474, P1430, DOI 10.1007/s11999-015-4609-y; DELEE J, 1976, CLIN ORTHOP RELAT R, P53; Firoozabadi R, 2014, CLIN ORTHOP RELAT R, V472, P3383, DOI 10.1007/s11999-014-3719-2; Iorio Richard, 2002, J Am Acad Orthop Surg, V10, P409; Jr Borrelli J, 2002, J ORTHOP TRAUMA, V16, P56; Legosz P, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3860142; Liu JZ, 2017, J ARTHROPLASTY, V32, P1328, DOI 10.1016/j.arth.2016.10.030; Mauffrey C, 2018, J AM ACAD ORTHOP SUR, V26, P83, DOI 10.5435/JAAOS-D-15-00666; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Rath EMS, 2002, INJURY, V33, P751, DOI 10.1016/S0020-1383(01)00194-2; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230	18	4	4	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0972-978X			J ORTHOP	J. Orthop.	SEP-OCT	2020	21						228	231		10.1016/j.jor.2020.03.038			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	OE2WJ	WOS:000580396900041	32273662	Green Published			2022-02-06	
J	Fuller, GW; Raftery, M				Fuller, Gordon W.; Raftery, Martin			Sport Concussion Assessment Tool: Fifth Edition Normative Reference Values for Professional Rugby Union Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; SCAT-5; Rugby; normative values	SCAT3	Objective: To describe distributions and establish normative ranges for new or changed subcomponents of the Sports Concussion Assessment Tool (SCAT)-5. Design: Cross-sectional study. Setting and Participants: Professional Rugby Union players performing 2017 preseason baseline SCAT-5 testing. Independent Variables: Subcomponent tests newly introduced or changed in the SCAT-5. Main Measurements: The 10-word immediate and delayed recall tests and the rapid neurological screen. Results: Thousand two hundred three players were included in complete case analyses. The 10-word immediate recall test [median score 15, interquartile range (IQR) 15-22, range 3-30] showed an asymmetrical, bimodal distribution. The delayed recall test (median score 7, IQR 5-9, range 0-10) demonstrated a left skewed distribution. The diplopia and reading/following instruction tests of the neurological screen were performed normally by virtually all participants (98.5% and 99.6%, respectively). Normative classification ranges for each SCAT-5 subcomponents of interest were determined. Conclusions: The increased spread of scores, with improved midrange centering, suggests that the increase to 10-word list lengths should improve the performance of immediate and delayed recall tests. Normative ranges will provide a distribution against which postinjury SCAT-5 scores can be compared and interpreted.	[Fuller, Gordon W.] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Raftery, Martin] World Rugby, Dublin, Ireland		Fuller, GW (corresponding author), Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Fuller, Gordon Ward/0000-0001-8532-3500	World Rugby	The authors acknowledge the assistance of team doctors and physicians performing the SCAT-5 assessments. Data collection was funded by World Rugby. There was no influence of any sponsor in study design, data collection, analysis, interpretation of data, writing of the report, or the decision to submit the article for publication.	Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Harrison AG, 2014, ARCH CLIN NEUROPSYCH, V29, P737, DOI 10.1093/arclin/acu048; Lewis-Beck MS, 2004, CEILING EFFECT SAGE; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Connor P J, 1990, Fam Med, V22, P307	7	4	4	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					E150	E153		10.1097/JSM.0000000000000713			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300009	30589747	Green Accepted			2022-02-06	
J	Horne, K; Henshall, K; Golden, C				Horne, Kirsten; Henshall, Katharine; Golden, Charles			Intimate partner violence and deficits in executive function	AGGRESSION AND VIOLENT BEHAVIOR			English	Article							TRAUMATIC BRAIN-INJURY; RISK-FACTORS; DOMESTIC VIOLENCE; HEAD-INJURY; ALCOHOL-USE; AGGRESSION; NEUROPSYCHOLOGY; HEALTH; MEN; PERPETRATORS	Intimate Partner Violence (IPV) is a pervasive issue within society which has negatively impacted millions of individuals. Previous literature has focused on the potential risk factors associated with IPV perpetration such as substance use, childhood maltreatment, and higher levels of inattention symptom severity. However, few studies have considered the potential correlation between executive function deficits, such as cognitive flexibility, and IPV. The present literature indicates executive function deficits may lead to higher levels of violence or aggression in children and adults. Research on the neuropsychological aspects of IPV have focused on alcohol use and head injury and their link to executive function deficits and violence, however, other research studies have shown executive function deficits related to IPV go above and beyond these specific causes. Although the literature is inconsistent, findings suggest executive function deficits may account for a significant difference between perpetrators, in comparison to non-perpetrators, even when accounting for alcohol use and head injury.	[Horne, Kirsten; Henshall, Katharine; Golden, Charles] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA		Horne, K (corresponding author), Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA.	kh1499@mynsu.nova.edu; kh1483@mynsu.nova.edu					Ali PA, 2013, AGGRESS VIOLENT BEH, V18, P373, DOI 10.1016/j.avb.2013.01.003; Becerra-Garcia JA, 2015, MED SCI LAW, V55, P35, DOI 10.1177/0025802414525148; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Bosch J, 2017, J INTERPERS VIOLENCE, V32, P3402, DOI 10.1177/0886260515599162; Bueso-Izquierdo N, 2016, SOC COGN AFFECT NEUR, V11, P852, DOI 10.1093/scan/nsw020; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Corvo K., 2006, J AGGRESS MALTREAT T, V13, P49; Diamond A, 2006, LIFESPAN COGNITION M, P70; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Easton CJ, 2008, AM J DRUG ALCOHOL AB, V34, P29, DOI 10.1080/00952990701764326; Field CA, 2004, J FAM VIOLENCE, V19, P249, DOI 10.1023/B:JOFV.0000032635.42145.66; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fuster J. M., 2015, PREFRONTAL CORTEX; Giancola PR, 1998, RECENT DEV ALCOHOL, V14, P227, DOI 10.1007/0-306-47148-5_10; Godlaski AJ, 2009, PSYCHOL ADDICT BEHAV, V23, P391, DOI 10.1037/a0016582; Granvald V, 2016, CHILD NEUROPSYCHOL, V22, P537, DOI 10.1080/09297049.2015.1018152; Grissom NM, 2019, NEUROPSYCHOPHARMACOL, V44, P86, DOI 10.1038/s41386-018-0179-5; Houston RJ, 2014, ADDICT BEHAV, V39, P345, DOI 10.1016/j.addbeh.2013.09.032; King AR, 2018, APPL NEUROPSYCH-ADUL, V25, P400, DOI 10.1080/23279095.2017.1320555; Lipsky S, 2005, DRUG ALCOHOL DEPEN, V78, P39, DOI 10.1016/j.drugalcdep.2004.08.028; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Murphy CM, 2001, J CONSULT CLIN PSYCH, V69, P528, DOI 10.1037//0022-006X.69.3.528; Nixon SJ, 2013, CURR OPIN PSYCHIATR, V26, P305, DOI 10.1097/YCO.0b013e328361ea3c; Parrott DJ, 2017, DRUG ALCOHOL REV, V36, P88, DOI 10.1111/dar.12454; Persampiere J, 2014, J FAM VIOLENCE, V29, P625, DOI 10.1007/s10896-014-9614-5; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Piechatzek M, 2009, HUM PSYCHOPHARM CLIN, V24, P650, DOI 10.1002/hup.1069; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Rohlf HL, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00027; Roizen J., 1993, NIAAA RES MONOGRAPH, V1, P7, DOI DOI 10.1007/0-306-47141-8_2; Romero-Martinez A, 2013, REV NEUROLOGIA, V57, P515, DOI 10.33588/rn.5711.2013141; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Shorey Ryan C, 2018, Transl Issues Psychol Sci, V4, P108, DOI 10.1037/tps0000140; Silveri MM, 2012, HARVARD REV PSYCHIAT, V20, P189, DOI 10.3109/10673229.2012.714642; Smith S. G., 2018, NATL INTIMATE PARTNE; Sprague J, 2011, EMOTION, V11, P61, DOI 10.1037/a0021788; Stanford MS, 2007, PERS INDIV DIFFER, V43, P365, DOI 10.1016/j.paid.2006.12.011; Sunday S, 2011, J INTERPERS VIOLENCE, V26, P3773, DOI 10.1177/0886260511403760; Teichner G, 2001, INT J NEUROSCI, V111, P241, DOI 10.3109/00207450108994235; Villemarette-Pittman N. R., 2002, PERSONALITY INDIVIDU, V34, P1533, DOI DOI 10.1016/S0191-8869(02)00136-8; Vitoria-Estruch S, 2018, ALCOHOL, V70, P61, DOI 10.1016/j.alcohol.2018.01.006; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; Westby MD, 1999, GENET SOC GEN PSYCH, V125, P71; Whitfield CL, 2003, J INTERPERS VIOLENCE, V18, P166, DOI 10.1177/0886260502238733; Wymbs BT, 2017, J INTERPERS VIOLENCE, V32, P659, DOI 10.1177/0886260515586371; Xu X, 2005, AM J PUBLIC HEALTH, V95, P78, DOI 10.2105/AJPH.2003.023978	53	4	4	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-1789	1873-6335		AGGRESS VIOLENT BEH	Aggress. Violent Behav.	SEP-OCT	2020	54				SI				101412	10.1016/j.avb.2020.101412			8	Criminology & Penology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	NW4NE	WOS:000574984400014					2022-02-06	
J	Lieshout, K; Oates, J; Baker, A; Unsworth, CA; Cameron, ID; Schmidt, J; Lannin, NA				Lieshout, Kirsten; Oates, Joanne; Baker, Anne; Unsworth, Carolyn A.; Cameron, Ian D.; Schmidt, Julia; Lannin, Natasha A.			Burden and Preparedness amongst Informal Caregivers of Adults with Moderate to Severe Traumatic Brain Injury	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; caregivers; burden	ASSESSING SUPPORT NEEDS; ROLE STRAIN; CARE; SCALE; MUTUALITY; PEOPLE; RELIABILITY; PREDICTORS; DEMENTIA; DEMAND	This study examined the patterns of informal (unpaid) caregiving provided to people after moderate to severe traumatic brain injury (TBI), explore the self-reported burden and preparedness for the caregiving role, and identify factors predictive of caregiver burden and preparedness. A cross-sectional cohort design was used. Informal caregivers completed the Demand and Difficulty subscales of the Caregiving Burden Scale; and the Mutuality, Preparedness, and Global Strain subscales of the Family Care Inventory. Chi-square tests and logistic regression were used to examine the relationships between caregiver and care recipient variables and preparedness for caregiving. Twenty-nine informal caregivers who reported data on themselves and people with a moderate to severe TBI were recruited (referred to as a dyad). Most caregivers were female (n= 21, 72%), lived with the care recipient (n= 20, 69%), and reported high levels of burden on both scales. While most caregivers (n= 21, 72%) felt "pretty well" or "very well" prepared for caregiving, they were least prepared to get help or information from the health system, and to deal with the stress of caregiving. No significant relationships or predictors for caregiver burden or preparedness were identified. While caregivers reported the provision of care as both highly difficult and demanding, further research is required to better understand the reasons for the variability in caregiver experience, and ultimately how to best prepare caregivers for this long-term role.	[Lieshout, Kirsten; Unsworth, Carolyn A.; Schmidt, Julia; Lannin, Natasha A.] La Trobe Univ, Sch Allied Hlth, Occupat Therapy, Melbourne, Vic 3086, Australia; [Lieshout, Kirsten] Kids Plus Fdn, Melbourne, Vic 3216, Australia; [Oates, Joanne] Evaluate, Sydney, NSW 2089, Australia; [Baker, Anne; Unsworth, Carolyn A.] Federat Univ, Sch Hlth, Occupat Therapy, Melbourne, Vic 3000, Australia; [Unsworth, Carolyn A.; Lannin, Natasha A.] Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Dept Rehabil, SE-55111 Jonkoping, Sweden; [Cameron, Ian D.; Lannin, Natasha A.] Univ Sydney, Fac Med & Hlth, John Walsh Inst Rehabil Res, St Leonards, NSW 2065, Australia; [Schmidt, Julia] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V6T 1Z4, Canada; [Lannin, Natasha A.] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic 3004, Australia		Lannin, NA (corresponding author), La Trobe Univ, Sch Allied Hlth, Occupat Therapy, Melbourne, Vic 3086, Australia.; Lannin, NA (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia.; Lannin, NA (corresponding author), Univ Sydney, Fac Med & Hlth, John Walsh Inst Rehabil Res, St Leonards, NSW 2065, Australia.; Lannin, NA (corresponding author), Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic 3004, Australia.	kirsten.lieshout@gmail.com; joanne@evaluate.com.au; a.baker@federation.edu.au; carolyn.unsworth@monash.edu; ian.cameron@sydney.edu.au; julia.schmidt@ubc.ca; natasha.lannin@monash.edu	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345; Schmidt, Julia/0000-0003-2004-4871; Baker, Anne/0000-0002-3779-5463	iCare Foundation; National Heart Foundation of AustraliaNational Heart Foundation of Australia [102055]	Data collection for this project was supported by the NSW Lifetime Care and Support Scheme (now iCare Foundation). N.A.L. is supported by a Future Leader Fellowship (Award ID 102055) from the National Heart Foundation of Australia.	[Anonymous], 2011, DIS CAR SUPP; [Anonymous], 2010, ACC EC EC VAL INF CA; [Anonymous], 2005, ACC NSW AD HIGH CAR; Archbold P., KEY ASPECTS ELDER CA, P328; Archbold P.G., 1986, FAMILY CAREGIVING IN; ARCHBOLD PG, 1990, RES NURS HEALTH, V13, P375, DOI 10.1002/nur.4770130605; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bishop G.M., 2019, YOUNG PEOPLE RESIDEN; Brauer J, 2011, OCCUP THER HEALTH CA, V25, P119, DOI 10.3109/07380577.2011.570420; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cameron C, 2001, AUST NZ J PUBL HEAL, V25, P261, DOI 10.1111/j.1467-842X.2001.tb00574.x; Carey P J, 1991, Oncol Nurs Forum, V18, P1341; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hajek A, 2019, AGING MENT HEALTH, V23, P1539, DOI 10.1080/13607863.2018.1506739; Hendrix CC, 2016, SUPPORT CARE CANCER, V24, P327, DOI 10.1007/s00520-015-2797-3; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; IBM Corp, 2019, IBM SPSS STAT WIND V; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jacob L, 2020, J GERONTOL A-BIOL, V75, P1572, DOI 10.1093/gerona/glaa017; Jennett B, 1981, MANAGEMENT HEAD INJU; King J, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2441-6; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Lannin N., 2012, NEUROREHAB NEURAL RE, V26, P778; Magasi S, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.117.004414; Marosszeky N.E.V., 1988, PTA PROTOCOL GUIDELI; McCluskey A., 2004, CARE DECISION MAKING; McDaid D, 2001, INT J GERIATR PSYCH, V16, P400, DOI 10.1002/gps.353; OBERST MT, 1989, CANCER NURS, V12, P209; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Portney LG, 2020, FDN CLIN RES APPL PR; Samartkit N, 2010, PAC RIM INT J NURS R, V14, P297; Schumacher KL, 2008, ONCOL NURS FORUM, V35, P49, DOI 10.1188/08.ONF.49-56; Schumacher KL, 2007, NURS RES, V56, P425, DOI 10.1097/01.NNR.0000299852.75300.03; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; van den Berg B, 2006, HEALTH ECON, V15, P447, DOI 10.1002/hec.1075; Yang CT, 2014, INT J NURS STUD, V51, P593, DOI 10.1016/j.ijnurstu.2013.09.001	44	4	4	3	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2020	17	17							6386	10.3390/ijerph17176386			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	NP7QD	WOS:000570366600001	32887272	Green Published, gold			2022-02-06	
J	Liu, ZH; Chen, NY; Tu, PH; Wu, CT; Chiu, SC; Huang, YC; Lim, SN; Yip, PK				Liu, Zhuo-Hao; Chen, Nan-Yu; Tu, Po-hsun; Wu, Chen-Te; Chiu, Shao-Chieh; Huang, Ying-Cheng; Lim, Siew-Na; Yip, Ping K.			DHA Attenuates Cerebral Edema Following Traumatic Brain Injury via the Reduction in Blood-Brain Barrier Permeability	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; docosahexaenoic acid; edema; blood-brain barrier; aquaporin 4; metalloproteinase 9	DOCOSAHEXAENOIC ACID; MATRIX METALLOPROTEINASES; ENDOTHELIAL DYSFUNCTION; IMMUNE-RESPONSE; EXPRESSION; AQUAPORIN-4; MATRIX-METALLOPROTEINASE-9; MODEL; MICE; SYNAPTOGENESIS	Traumatic brain injury (TBI) could result in edema and cause an increase in intracranial pressure of the brain resulting in mortality and morbidity. Although there is hyperosmolarity therapy available for this pathophysiological event, it remains controversial. Recently, several groups have shown docosahexaenoic acid (DHA) to improve functional and histological outcomes following brain injury based on reduction of neuroinflammation and apoptosis. However, the effect of DHA on blood-brain barrier (BBB) dysfunction after brain injury has not been fully studied. Here, a controlled cortical impact rat model was used to test the effect of a single dose of DHA administered 30 min post injury. Modified neurological severity score (mNSS) and forelimb asymmetry were used to determine the functional outcomes. Neuroimaging and histology were used to characterize the edema and BBB dysfunction. The study showed that DHA-treated TBI rats had better mNSS and forelimb asymmetry score than vehicle-treated TBI rats. Temporal analysis of edema using MRI revealed a significant reduction in edema level with DHA treatment compared to vehicle in TBI rats. Histological analysis using immunoglobulin G (IgG) extravasation showed that there was less extravasation, which corresponded with a reduction in aquaporin 4 and astrocytic metalloprotease 9 expression, and greater endothelial occludin expression in the peri-contusional site of the TBI rat brain treated with DHA in comparison to vehicle treatment. In conclusion, the study shows that DHA can exert its functional improvement by prevention of the edema formation via prevention of BBB dysfunction after TBI.	[Liu, Zhuo-Hao; Tu, Po-hsun; Huang, Ying-Cheng] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan 333, Taoyuan County, Taiwan; [Chen, Nan-Yu] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp Linkou, Dept Internal Med, Taoyuan 333, Taoyuan County, Taiwan; [Wu, Chen-Te] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan 333, Taoyuan County, Taiwan; [Chiu, Shao-Chieh] Chang Gung Mem Hosp Linkou, Ctr Adv Mol Imaging & Translat, Taoyuan 333, Taoyuan County, Taiwan; [Lim, Siew-Na] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp Linkou, Dept Neurol, Taoyuan 333, Taoyuan County, Taiwan; [Yip, Ping K.] Queen Mary Univ London, Ctr Neurosci Surg & Trauma, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England		Liu, ZH (corresponding author), Chang Gung Med Coll & Univ, Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan 333, Taoyuan County, Taiwan.; Yip, PK (corresponding author), Queen Mary Univ London, Ctr Neurosci Surg & Trauma, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.	b8402022@gmail.com; nellychen@gmail.com; albert3343@gmail.com; melik@adm.cgmh.org.tw; jeff17342001@gmail.com; ns3068@gmail.com; siewna.lim@gmail.com; p.yip@qmul.ac.uk		Liu, Zhuo-Hao/0000-0003-4079-8697	Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPG3K0751]; National Health Research InstitutesNational Health Research Institutes, Japan [NHRI-EX107-10715EC, NHRI-EX108-10715EC, NHRI-EX109-10715EC]; Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 107-2314-B-182A-049]	This research was funded by Chang Gung Memorial Hospital, Taiwan (CMRPG3K0751), National Health Research Institutes (NHRI-EX107-10715EC) (NHRI-EX108-10715EC) (NHRI-EX109-10715EC), Ministry of Science and Technology of Taiwan (MOST 107-2314-B-182A-049).	Adams Charles A, 2018, Trauma Surg Acute Care Open, V3, pe000142, DOI 10.1136/tsaco-2017-000142; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Badenes R, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033913; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Brilha S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16250-3; Brodsky SV, 2002, CIRCULATION, V106, P2372, DOI 10.1161/01.CIR.0000033972.90653.AF; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Calder PC, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000448262; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen HW, 2013, ARCH TOXICOL, V87, P857, DOI 10.1007/s00204-012-1003-3; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Clark AW, 1997, NEUROSCI LETT, V238, P53, DOI 10.1016/S0304-3940(97)00859-8; Collins MA, 2013, NEUROTOX RES, V23, P105, DOI 10.1007/s12640-012-9360-5; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Diaz-Sanchez M, 2006, ACTA NEUROPATHOL, V111, P289, DOI 10.1007/s00401-006-0045-0; Fenn Norman E 3rd, 2019, J Pediatr Pharmacol Ther, V24, P465, DOI 10.5863/1551-6776-24.6.465; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hwang JK, 2017, ONCOL LETT, V13, P243, DOI 10.3892/ol.2016.5382; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kamat PK, 2014, THER TARGETS NEUROL, V1, pe243, DOI DOI 10.14800/TTND.243; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Laskowitz D., 2016, TRANSLATIONAL RES TR; Leonardo CC, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-13; Lindberg RLP, 2001, BRAIN, V124, P1743, DOI 10.1093/brain/124.9.1743; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2003, ACT NEUR S, V86, P7; Michael-Titus AT, 2009, CLIN LIPIDOL, V4, P343, DOI 10.2217/CLP.09.19; Michalak Z, 2012, J NEUROPATH EXP NEUR, V71, P826, DOI 10.1097/NEN.0b013e31826809a6; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Muellner A, 2003, J NEUROTRAUM, V20, P745, DOI 10.1089/089771503767869971; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Nguyen JH, 2006, J HEPATOL, V44, P1105, DOI 10.1016/j.jhep.2005.09.019; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Pirici I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010046; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tajuddin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101223; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Thau-Zuchman O, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6420; Trueman RC, 2017, J CEREBR BLOOD F MET, V37, P1349, DOI 10.1177/0271678X16654921; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wang H, 2018, NEUROPATHOLOGY, V38, P484, DOI 10.1111/neup.12509; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Yamagata K, 2016, PROSTAG LEUKOTR ESS, V104, P11, DOI 10.1016/j.plefa.2015.10.006; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yip PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061626; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zhang WT, 2016, NEUROBIOL DIS, V91, P37, DOI 10.1016/j.nbd.2016.02.020; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z; Zhu W, 2017, EXP THER MED, V14, P4411, DOI 10.3892/etm.2017.5054	77	4	4	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	SEP	2020	21	17							6291	10.3390/ijms21176291			18	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	NO6TU	WOS:000569622900001	32878052	Green Published, gold, Green Submitted			2022-02-06	
J	Nasution, RA; Islam, AA; Hatta, M; Prihantono; Warsinggih; Ludong, DH; Ismail; Wangi, H; Massi, MN; Nasution, KI				Nasution, Rizha Anshori; Islam, Andi Asadul; Hatta, Mochammad; Prihantono; Warsinggih; Ludong, Dany H.; Ismail; Wangi, Harakati; Massi, Muh Nassrum; Nasution, Khairul Ihsan			Effects of caffeic acid phenethyl ester in reducing cerebral edema in rat subjects experiencing brain injury: An in vivo study	ANNALS OF MEDICINE AND SURGERY			English	Article						Experimental traumatic brain injury; Caffeic acid phenethyl ester; Blood serum; AQP4; Rat model	PATHWAY; CAPE	Background: A head injury is a very dangerous condition that threatens human life. This study examines the use of caffeic acid phenethyl ester (CAPE) in reducing cerebral edema in cases of head injury. The purpose of this study is to demonstrate whether CAPE can improve various parameters related to the expression of Aquaporin-4 (AQP4) mRNA and the serum AQP4 levels in rat subjects. Methods: This is a randomized controlled study using a posttest-only control group design that uses experimental animals-specifically, male Rattus norvegicus (Sprague Dawley strain) rats aged 10-12 weeks and weighing 200-300 g. This study used a head injury model according to Marmarou (1994) with minor modifications to the animal model fixation tool. The parameters of the AQP4 mRNA were examined with real-time PCR, while serum AQP4 levels were examined with sandwich ELISA. Results: The AQP4 mRNA expression in rats that were given CAPE was lower than those not given CAPE, both on the fourth and seventh days; serum AQP4 levels in rats that were given CAPE were also lower than those not given CAPE, both on the fourth and seventh days. Conclusion: Administration of CAPE in a rat model with head injury can reduce cerebral edema, mediated by AQP4.	[Nasution, Rizha Anshori] Pelamonia Hosp, Dept Neurosurg, Jalan Jend Sudirman 27, Makassar 90157, Indonesia; [Islam, Andi Asadul] Hasanuddin Univ, Fac Med, Dept Neurosurg, Makassar, Indonesia; [Hatta, Mochammad] Hasanuddin Univ, Fac Med, Clin Microbiologist Program, Makassar, Indonesia; [Prihantono; Warsinggih] Hasanuddin Univ, Dept Surg, Fac Med, Makassar, Indonesia; [Ludong, Dany H.; Ismail] Hasanuddin Univ, Fac Med, Doctoral Program Med Sci, Makassar, Indonesia; [Wangi, Harakati] Pelamonia Hosp, Dept Interna Med, Makassar, Indonesia; [Massi, Muh Nassrum] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar, Indonesia; [Nasution, Khairul Ihsan] Putri Hijau Hosp, Dept Neurosurg, Medan, Indonesia		Nasution, RA (corresponding author), Pelamonia Hosp, Dept Neurosurg, Jalan Jend Sudirman 27, Makassar 90157, Indonesia.	rizha_nst@yahoo.com; andiasadul@yahoo.com; hattaram@yahoo.com; prihantono.md@gmail.com; kbd.warsinggih@gmail.com; ludong412@gmail.com; ismailskep@gmail.com; gizha_lubis@yahoo.com; nasrum2000@yahoo.com; qiconnast@yahoo.com	, prihantono/AAK-2259-2020; Hatta, Mochammad/D-3742-2019	, prihantono/0000-0002-8247-0457; Hatta, Mochammad/0000-0002-8456-4203; massi, muhammad nasrum/0000-0002-3347-6529; Warsinggih, Warsinggih/0000-0002-1756-9039			Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Aloutaibi G. T., 2017, African Journal of Traditional, Complementary and Alternative Medicines, V14, P138, DOI 10.21010/ajtcam.v14i5.17; Armutcu F, 2015, EXP THER MED, V9, P1582, DOI 10.3892/etm.2015.2346; Ayla S, 2018, ACTA HISTOCHEM, V120, P117, DOI 10.1016/j.acthis.2018.01.001; Branton, 2017, INT J CLIN DEV ANAT, V3, P9, DOI [10.11648/j.ijcda.20170303.11, DOI 10.11648/J.IJCDA.20170303.11]; Cheng H, 2018, J PAIN RES, V11, P2709, DOI 10.2147/JPR.S166274; Clement T, 2020, J NEUROSCI RES, V98, P9, DOI 10.1002/jnr.24354; Doiron JA, 2017, CHEM BIOL DRUG DES, V89, P514, DOI 10.1111/cbdd.12874; Du Q, 2016, EXP THER MED, V11, P1433, DOI 10.3892/etm.2016.3070; Gocmez C, 2015, J NEUROL SURG PART A, V76, P20, DOI 10.1055/s-0034-1371513; Gulcin I, 2016, J ENZYM INHIB MED CH, V31, P1095, DOI 10.3109/14756366.2015.1094470; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Keep RF., 2017, PRIMER CEREBROVASCUL, P145, DOI [10.1016/B978-0-12-803058-5.00029-1, DOI 10.1016/B978-0-12-803058-5.00029-1]; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kotch S.R., 2019, CLIN ALGORITHMS GEN, P619, DOI [10.1007/978-3-319-98497-1_151, DOI 10.1007/978-3-319-98497-1_151]; Leary S., 2020, AVMA GUIDELINES EUTH; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Maroli N, 2019, J CHEM INF MODEL, V59, P4942, DOI 10.1021/acs.jcim.9b00711; Mohanty S., 2019, ANN NATL ACAD MED SC, V55, P189, DOI [10.1055/s-0040-1701154, DOI 10.1055/S-0040-1701154]; Moretti R, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P393, DOI 10.1016/B978-0-12-803196-4.00021-7; Nasution RA, 2020, ANN MED SURG, V57, P118, DOI 10.1016/j.amsu.2020.07.036; Nasution RA, 2020, ANN MED SURG, V57, P109, DOI 10.1016/j.amsu.2020.07.029; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Salmas RE, 2017, CELL BIOCHEM FUNCT, V35, P304, DOI 10.1002/cbf.3277; Smith AJ, 2019, J PHYSIOL-LONDON, V597, P4421, DOI 10.1113/JP277636; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Wadhwa R, 2016, J CANCER, V7, P1755, DOI 10.7150/jca.15170; Xu Mengmeng, 2017, Adv Exp Med Biol, V969, P81, DOI 10.1007/978-94-024-1057-0_5; Yajima T, 1998, CLIN CHEM, V44, P2441; Yang N, 2017, BIOCHEM BIOPH RES CO, V486, P22, DOI 10.1016/j.bbrc.2017.02.057; Yang N, 2017, WORLD J GASTROENTERO, V23, P1203, DOI 10.3748/wjg.v23.i7.1203; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1	36	4	4	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	SEP	2020	57						328	333		10.1016/j.amsu.2020.08.016			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NP4FF	WOS:000570132300026	32874565	gold, Green Published			2022-02-06	
J	Shakya, I; Bergen, G; Haddad, YK; Kakara, R; Moreland, BL				Shakya, Iju; Bergen, Gwen; Haddad, Yara K.; Kakara, Ramakrishna; Moreland, Briana L.			Fall-related emergency department visits involving alcohol among older adults	JOURNAL OF SAFETY RESEARCH			English	Article						Aged; Accidental falls; Alcohol drinking; Wounds and injuries; Emergency service; Hospital	TRAUMATIC BRAIN-INJURY; UNITED-STATES; RISK-FACTORS; HIP FRACTURE; CONSUMPTION; DRINKING; IMPACT; PATTERN; DEATHS; AGE	Problem: Falls are the leading cause of injury deaths among adults aged 65 years and older. Characteristics of these falls may vary with alcohol use. Objective: Describe and compare characteristics of older adult fall-related emergency department (ED) visits with indication of alcohol to visits with no indication. Methods: Using nationally-representative 2015 National Electronic Injury Surveillance System-All Injury Program data, we compared demographic characteristics for fall-related ED visits by indication of alcohol consumption. Alcohol-indicated ED visits were matched on age group, sex, treatment month, and treatment day to ED visits with no alcohol indication using a 1:4 ratio and injury characteristics (i.e., diagnosis, body part injured, disposition) were compared. Results and discussion: Of 38,640 ED records, 906 (1.9%) indicated use of alcohol. Fall-related ED visits among women were less likely to indicate alcohol (1.0%) compared to ED visits among men (3.8%). ED visits indicating alcohol decreased with age from 4.1% for those 65-74 years to 1.5% for those 75-84 and <1% for those 85+. After controlling for age-group, sex, and month and day of treatment, 17.0% of ED visits with no alcohol indication had a traumatic brain injury compared to 34.8% of alcohol-indicated ED visits. (C) 2020 National Safety Council and Elsevier Ltd. All rights reserved.	[Shakya, Iju; Kakara, Ramakrishna] Oak Ridge Associated Univ ORAU, Natl Ctr Injury Prevent & Control, Ctr Dis Control & Prevent, Div Injury Prevent, Atlanta, GA USA; [Bergen, Gwen] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Haddad, Yara K.] Ctr Dis Control & Prevent, TJFACT Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Moreland, Briana L.] Ctr Dis Control & Prevent, Synergy Amer Inc, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Shakya, I (corresponding author), 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	ois6@cdc.gov		Shakya, Iju/0000-0003-4631-3478	Intramural CDC HHS [CC999999] Funding Source: Medline		Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barry KL, 2016, ALCOHOL RES-CURR REV, V38, P115; Bell AJ, 2000, MED J AUSTRALIA, V173, P179, DOI 10.5694/j.1326-5377.2000.tb125596.x; Bergen G, 2021, AM J LIFESTYLE MED, V15, P580, DOI 10.1177/1559827619880529; Castle IJP, 2014, J STUD ALCOHOL DRUGS, V75, P299, DOI 10.15288/jsad.2014.75.299; Cawthon PM, 2006, J AM GERIATR SOC, V54, P1649, DOI 10.1111/j.1532-5415.2006.00912.x; Centers for Disease Control and Prevention, 2019, STEADI OLD AD FALL P; Centers for Disease Control and Prevention, 2020, WEB BAS INJ STAT QUE; Chang VC, 2015, AM J EPIDEMIOL, V181, P521, DOI 10.1093/aje/kwu268; Chatha H, 2018, TRAUMA, V20, P169, DOI 10.1177/1460408617720948; Cherpitel CJ, 2015, ADDICTION, V110, P279, DOI 10.1111/add.12755; Choi Y, 2009, AM J EMERG MED, V27, P956, DOI 10.1016/j.ajem.2008.07.035; Cunningham RM, 2010, ANN EMERG MED, V55, P556, DOI 10.1016/j.annemergmed.2010.03.004; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Glover Jon, 2017, WMJ, V116, P182; Grundstrom AC, 2012, ARCH GERONTOL GERIAT, V54, P421, DOI 10.1016/j.archger.2011.06.008; Heuberger Roschelle A., 2009, Journal of Nutrition for the Elderly, V28, P203, DOI 10.1080/01639360903140106; Holton AE, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0532-2; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kanny D, 2018, AM J PREV MED, V54, P486, DOI 10.1016/j.amepre.2017.12.021; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Merrick EL, 2008, J AM GERIATR SOC, V56, P214, DOI 10.1111/j.1532-5415.2007.01539.x; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x; Mortensen L. Q., 2019, FRONT BIG DATA, V2; Mukamal KJ, 2004, J AM GERIATR SOC, V52, P1174, DOI 10.1111/j.1532-5415.2004.52318.x; National Institute on Alcohol Abuse and Alcoholism, 2020, SPEC POP COC DIS OLD; Paniagua MA, 2006, AM J EMERG MED, V24, P413, DOI 10.1016/j.ajem.2005.12.005; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Peterson AB, 2020, MMWR-MORBID MORTAL W, V69, P225, DOI 10.15585/mmwr.mm6909a2; Reid M Carrington, 2002, Subst Abus, V23, P149; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; SULLIVAN EV, 1995, ALCOHOL HEALTH RES W, V19, P138; Tait RJ, 2013, INT PSYCHOGERIATR, V25, P901, DOI 10.1017/S1041610213000173; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U.S. Consumer Product Safety Commission, 2001, NEISS SAMPL DES IMPL; U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015, 2015 2020 DIET GUID; White AM, 2018, ALCOHOL CLIN EXP RES, V42, P352, DOI 10.1111/acer.13559; Woods C, 2019, AUSTRALAS EMERG CARE, V22, P22, DOI 10.1016/j.auec.2018.11.001; Zhang X, 2015, OSTEOPOROSIS INT, V26, P531, DOI 10.1007/s00198-014-2879-y	43	4	4	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2020	74						125	131		10.1016/j.jsr.2020.06.001			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	NW7AP	WOS:000575169200015	32951773	Green Accepted			2022-02-06	
J	Thompson, HJ; Martha, SR; Wang, J; Becker, KJ				Thompson, Hilaire J.; Martha, Sarah R.; Wang, Jin; Becker, Kyra J.			Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aged; chemokine; cytokine; head injury; prospective cohort study	CEREBROSPINAL-FLUID; OLDER-ADULTS; FRACTALKINE; INTERLEUKIN-6; ACTIVATION; CHEMOKINES; EXPRESSION; CYTOKINES; RECEPTOR; IL-6	Objective: To compare plasma inflammatory biomarker concentrations to 6 months in young and older adults with and without mild traumatic brain injury (TBI). Setting: Level 1 trauma center. Participants: Younger (21-54 years) and older (55+) adults diagnosed with mild TBI along with age-/sex-matched noninjured controls (n= 313). Design: Prospective cohort study. Main Measures: Multiplex assays were used to quantify concentrations of selected plasma inflammatory markers at day 0, months 1 and 6. Results: Persistent aging-related differences were found between control groups in concentrations of 4 cytokines up to 6 months. At day 0, interleukin-6 (IL-6), IL-8, and fractalkine were higher in the older TBI compared with older control as well as the younger TBI groups, while IL-10 was higher in older TBI compared with controls. At month 1, significantly higher concentrations of IL-8, fractalkine, and tumor necrosis factor-alpha (TNF-alpha) were seen. At 6 months postinjury, significantly higher concentrations of IL-6 and IL-8 were seen, while a lower concentration of IL-7 was found in older versus younger TBI groups. Conclusion: The neuroinflammatory signature that accompanies mild TBI in older adults differs from that of younger adults. The differences seen are notable for their roles in neutrophil attraction (IL-8), neuronal-microglial-immune cell interactions (fractalkine), and chronic inflammation (IL-6).	[Thompson, Hilaire J.] Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Martha, Sarah R.] Univ Washington, Sch Nursing, Omics & Symptom Sci Training Program, Seattle, WA 98195 USA; [Thompson, Hilaire J.; Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Becker, Kyra J.] Univ Washington, Neurol & Neurol Surg, Seattle, WA 98195 USA		Thompson, HJ (corresponding author), Univ Washington, Box 357266, Seattle, WA 98195 USA.	hilairet@uw.edu		Martha, Sarah R./0000-0002-1882-1419	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [4R01NS077913]; NIH/NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR016913]	Dr Thompson received grant funding for the work from the NIH/NINDS 4R01NS077913 and Dr Martha is currently supported by NIH/NINR T32NR016913 as a postdoctoral fellow.	Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Banks WA, 2016, BRAIN BEHAV IMMUN, V52, P81, DOI 10.1016/j.bbi.2015.10.002; Bartlett A, 2016, EXP THER MED, V12, P33, DOI 10.3892/etm.2016.3263; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015; BICKEL M, 1993, J PERIODONTOL, V64, P456; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Buchanan JB, 2008, PSYCHONEUROENDOCRINO, V33, P755, DOI 10.1016/j.psyneuen.2008.02.013; BUTTERFIELD JH, 1992, BLOOD, V79, P688; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Degan D, 2018, CURR PHARM DESIGN, V24, P1485, DOI 10.2174/1381612824666180327170632; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; ElKassar N, 2010, J IMMUNOTOXICOL, V7, P1, DOI 10.3109/15476910903453296; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Franceschi C, 2018, SEMIN IMMUNOL, V40, P1, DOI 10.1016/j.smim.2018.10.008; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gosain A, 2005, J BURN CARE REHABIL, V26, P7, DOI 10.1097/01.BCR.0000150214.72984.44; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Luk AOY, 2011, ATHEROSCLEROSIS, V215, P130, DOI 10.1016/j.atherosclerosis.2010.11.042; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Lynch AM, 2002, EUR J NEUROSCI, V15, P1779, DOI 10.1046/j.1460-9568.2002.02012.x; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Moors M, 2010, GENES IMMUN, V11, P11, DOI 10.1038/gene.2009.77; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morrisette-Thomas V, 2014, MECH AGEING DEV, V139, P49, DOI 10.1016/j.mad.2014.06.005; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Osuka A, 2014, ACUTE MED SURG, V1, P63, DOI 10.1002/ams2.17; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; SEHMI R, 1992, BLOOD, V79, P2952; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Stein ML, 2008, J ALLERGY CLIN IMMUN, V121, P1473, DOI 10.1016/j.jaci.2008.02.033; Tan S, 2019, FASEB J, V33, P4376, DOI 10.1096/fj.201801595RR; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson T, 2019, POSTHUMAN FOLKLORE, P3; Todd MA, 2017, BIODEMOGR SOC BIOL, V63, P309, DOI 10.1080/19485565.2017.1403305; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Warren KN, 2018, J GERONTOL A-BIOL, V73, P770, DOI 10.1093/gerona/glx199; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Zhang YY, 2017, EUR J HEART FAIL, V19, P1379, DOI 10.1002/ejhf.942; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	63	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		324	331		10.1097/HTR.0000000000000606			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100005	32881766	Green Accepted			2022-02-06	
J	Wang, C; Xian, L; Chen, XR; Li, ZF; Fang, Y; Xu, WM; Wei, LF; Chen, WQ; Wang, SS				Wang, Cheng; Xian, Liang; Chen, Xiangrong; Li, Zuanfang; Fang, Yi; Xu, Weiming; Wei, Liangfeng; Chen, Weiqiang; Wang, Shousen			Visualization of cortical cerebral blood flow dynamics during craniotomy in acute subdural hematoma using laser speckle imaging in a rat model	BRAIN RESEARCH			English	Article						Acute subdural hematoma; Laser speckle imaging; Cerebral blood flow; Craniotomy; Brain swelling	TRAUMATIC BRAIN-INJURY; DECOMPRESSION; SEVERITY; ISCHEMIA; DAMAGE; CARE	Mass evacuation with decompressive craniotomy is considered a standard intervention for acute subdural hematoma (ASDH). However, hemispheric swelling complicates the intraoperative and postoperative management of ASDH patients, and previous studies have revealed that this approach can damage ischemic/reperfusion (I/R) injury. Few studies have focused on the cerebrovascular response following traumatic brain injury (TBI). To characterize the relative cerebral blood flow (rCBF) before and after removal of the hematoma, rats were injured by a subdural infusion of 400 mu L of venous blood or paraffin oil. MRI scans were performed. Then, we monitored cortical rCBF during hematoma removal in real time using laser speckle imaging (LSCI) in ASDH rats. The CBF of arteriovenous and capillary regions were quantified and normalized to their own baseline values via a custom algorithm. In the sham group, the cortical CBF was higher post-craniotomy than pre-craniotomy. However, in the hematoma injection group, the CBF of arteries and capillaries was higher while the venous CBF was lower post-craniotomy than pre-craniotomy. The difference in the changes in vein CBF that occurred between the two groups was statistically significant. The three components of the vascular system showed heterogeneous responses to craniotomy, which may be the basis for secondary brain injury.	[Wang, Cheng; Fang, Yi; Wang, Shousen] Fujian Med Univ, Fuzong Clin Med Coll, Xierhuanbei Rd 156, Fuzhou 350025, Fujian, Peoples R China; [Xian, Liang] Bengbu Med Coll, Bengbu, Anhui, Peoples R China; [Chen, Xiangrong] Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 2, Fuzhou, Peoples R China; [Li, Zuanfang] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Peoples R China; [Xu, Weiming] Hosp Changle, Dept Neurosurg, Fuzhou, Peoples R China; [Wei, Liangfeng; Wang, Shousen] 900th Hosp, Dept Neurosurg, Fuzhou, Peoples R China; [Chen, Weiqiang] Shantou Univ, Dept Neurosurg, Affiliated Hosp 1, Med Coll, Shantou, Peoples R China		Wang, SS (corresponding author), Fujian Med Univ, Fuzong Clin Med Coll, Xierhuanbei Rd 156, Fuzhou 350025, Fujian, Peoples R China.	wshsen@126.com		Wang, Cheng/0000-0001-9626-8586	Key Project of Science and Technology Plan of Fujian Province, China [2014Y0036]; Major Science and Technology Projects of General Logistics Department [AHJ14J001]	This work was financially supported by Key Project of Science and Technology Plan of Fujian Province, China (No. 2014Y0036); Major Science and Technology Projects of General Logistics Department (No. AHJ14J001).	Al-Mufti F, 2017, NEUROSURG CLIN N AM, V28, P267, DOI 10.1016/j.nec.2016.11.009; Baechli H, 2010, J CEREBR BLOOD F MET, V30, P576, DOI 10.1038/jcbfm.2009.230; Bashkatov AN, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.9.091416; Chen HS, 2018, ACTA PHARMACOL SIN, V39, P669, DOI 10.1038/aps.2018.27; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Elkin B.S., 2007, SAE TECHNICAL PAPER; Hamahata NT, 2020, NEUROCRIT CARE, V32, P633, DOI 10.1007/s12028-019-00873-7; He JY, 2019, J CEREBR BLOOD F MET, V39, P1161, DOI 10.1177/0271678X17748787; Horie N, 2011, AM J NEURORADIOL, V32, P1697, DOI 10.3174/ajnr.A2568; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jiang YZ, 2014, CELL BIOCHEM BIOPHYS, V69, P461, DOI 10.1007/s12013-014-9818-6; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Liu H, 2018, BRAIN RES, V1700, P118, DOI 10.1016/j.brainres.2018.07.006; Liu W, 2019, J NEUROTRAUM, V36, P2213, DOI 10.1089/neu.2018.5970; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Mucke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120801; Pabon MM, 2016, CNS NEUROSCI THER, V22, P200, DOI 10.1111/cns.12485; Park MG, 2014, CEREBROVASC DIS, V38, P254, DOI 10.1159/000367709; Ronning P, 2019, J NEUROSURG, V131, P1896, DOI 10.3171/2018.7.JNS18270; Sagoo RS, 2017, J CEREBR BLOOD F MET, V37, P319, DOI 10.1177/0271678X15625350; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Shi WC, 2016, J CELL MOL MED, V20, P1139, DOI 10.1111/jcmm.12803; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Sun HS, 2017, J PHYSIOL-LONDON, V595, P3077, DOI 10.1113/JP273709; Takeshima Y, 2015, J STROKE CEREBROVASC, V24, P2200, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.048; Toro EF, 2016, APPL MATH COMPUT, V272, P542, DOI 10.1016/j.amc.2015.06.066; Unnerback M, 2019, NEUROCRIT CARE, V31, P273, DOI 10.1007/s12028-019-00733-4; Van Essen TA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033513; Wang W, 2019, J NEUROSCI METH, V328, DOI 10.1016/j.jneumeth.2019.108448; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Yokobori S, 2018, BEHAV BRAIN RES, V340, P23, DOI 10.1016/j.bbr.2016.05.055; Yu H, 2016, PROC SPIE, V9690, DOI 10.1117/12.2213989; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yuan Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00269; Zhu H, 2007, J NEUROSCI RES, V85, P2783, DOI 10.1002/jnr.21257	41	4	4	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2020	1742								146901	10.1016/j.brainres.2020.146901			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW4ZE	WOS:000539155100010	32445715				2022-02-06	
J	Wang, RR; He, M; Ou, XF; Xie, XQ; Kang, Y				Wang, Ruo Ran; He, Min; Ou, Xiao Feng; Xie, Xiao Qi; Kang, Yan			The predictive value of RDW in AKI and mortality in patients with traumatic brain injury	JOURNAL OF CLINICAL LABORATORY ANALYSIS			English	Article						acute kidney injury; brain trauma; marker; red blood cell distribution width	ACUTE KIDNEY INJURY; CELL DISTRIBUTION WIDTH; RHEUMATOID-ARTHRITIS; ORGAN DYSFUNCTION; ERYTHROPOIESIS; NEUTROPHIL; ANEMIA; RISK; HYPOALBUMINEMIA; CATECHOLAMINES	Background Red blood cell distribution width (RDW) has been validated valuable in predicting outcome and acute kidney injury (AKI) in several clinical settings. The aim of this study was to explore whether RDW is associated with outcome and AKI in patients with traumatic brain injury (TBI). Methods Patients admitted to our hospital for TBI from January 2015 to August 2018 were included in this study. Multivariate logistic regression analysis was performed to identify risk factors of AKI and outcome in patients with TBI. The value of RDW in predicting AKI and outcome was evaluated by receiver operating characteristic (ROC) curve. Results Three hundred and eighteen patients were included in this study. The median of RDW was 14.25%. We divided subjects into two groups based on the median and compared difference of variables between two groups. The incidence of AKI and mortality was higher in high RDW (RDW > 14.25) group (31.45% vs 9.43%,P < .001; 69.81% vs 29.56%,P < .001). Spearman's method showed RDW was moderately associated with 90-day Glasgow Outcome Scale (GOS) (P < .001). In multivariate logistic regression analysis, RDW, lymphocyte, chlorine, and serum creatinine were risk factors of AKI. And Glasgow Coma Scale (GCS), glucose, chlorine, AKI, and RDW were risk factors of mortality. The area under the ROC curve (AUC) of RDW for predicting AKI and mortality was 0.724 (0.662-0.786) and 0.754 (0.701-0.807), respectively. Patients with higher RDW were likely to have shorter median survival time (58 vs 70,P < .001). Conclusions Red blood cell distribution width is an independent risk factor of AKI and mortality in patients with TBI.	[Wang, Ruo Ran; He, Min; Ou, Xiao Feng; Xie, Xiao Qi; Kang, Yan] Sichuan Univ, Dept Crit Care Med, West China Hosp, Chengdu, Peoples R China		Kang, Y (corresponding author), Sichuan Univ, West China Hosp, West China Med Sch, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.	kangyan@scu.edu.cn					Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Akin F, 2015, CORONARY ARTERY DIS, V26, P289, DOI 10.1097/MCA.0000000000000223; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bang JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206731; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Bonavia A, 2018, PEDIATR NEPHROL, V33, P1629, DOI 10.1007/s00467-017-3774-5; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; E ZG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55648-z; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Gossmann J, 2001, KIDNEY INT, V60, P83, DOI 10.1046/j.1523-1755.2001.00773.x; Goyal K, 2018, INDIAN J CRIT CARE M, V22, P632, DOI 10.4103/ijccm.IJCCM_156_18; Gravito-Soares M, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0834-7; Hu YG, 2017, KIDNEY BLOOD PRESS R, V42, P1193, DOI 10.1159/000485866; Hunziker S, 2012, CRIT CARE, V16, DOI 10.1186/cc11351; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Kim K, 2018, J NEUROSURG, V128, P1115, DOI 10.3171/2016.11.JNS162237; Kinsey GR, 2014, CURR OPIN NEPHROL HY, V23, P9, DOI 10.1097/01.mnh.0000436695.29173.de; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Koo CH, 2018, J CARDIOTHOR VASC AN, V32, P212, DOI 10.1053/j.jvca.2017.08.033; Li JM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8914617; Li N, 2013, J NEPHROL, V26, P1083, DOI 10.5301/jn.5000282; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MAURY CPJ, 1988, ANN RHEUM DIS, V47, P972, DOI 10.1136/ard.47.12.972; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Nishiyama Y, 2016, INT HEART J, V57, P553, DOI 10.1536/ihj.16-015; Oh TK, 2019, WORLD NEUROSURG, V125, pE1226, DOI 10.1016/j.wneu.2019.02.015; Oh TK, 2019, J NEUROSURG ANESTH, V31, P311, DOI 10.1097/ANA.0000000000000512; Parlar H, 2018, BRAZ J CARDIOVA SURG, V33, P233, DOI 10.21470/1678-9741-2017-0164; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Pavlakou P, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6193694; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sadaka Farid, 2018, J Clin Med Res, V10, P9, DOI 10.14740/jocmr3173w; Sadan O, 2017, CRIT CARE MED, V45, P1382, DOI 10.1097/CCM.0000000000002497; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Suetrong B, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1499-7; Sureshbabu A, 2015, REDOX BIOL, V4, P208, DOI 10.1016/j.redox.2015.01.001; VREUGDENHIL G, 1992, EUR J CLIN INVEST, V22, P488, DOI 10.1111/j.1365-2362.1992.tb01495.x; VREUGDENHIL G, 1990, RHEUMATOL INT, V10, P127, DOI 10.1007/BF02274827; Wiedermann CJ, 2010, INTENS CARE MED, V36, P1657, DOI 10.1007/s00134-010-1928-z; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Xanthopoulos A, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0563-1; Yang BH, 2019, ACTA NEUROCHIR, V161, P1783, DOI 10.1007/s00701-019-04006-z; Yilmaz H, 2015, RENAL FAILURE, V37, P225, DOI 10.3109/0886022X.2014.982477; Zhang B, 2015, INT J CLIN EXP MED, V8, P19172; Zhang Lin, 2018, Zhongguo Dang Dai Er Ke Za Zhi, V20, P559; Zou ZP, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0903-4; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	56	4	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0887-8013	1098-2825		J CLIN LAB ANAL	J. Clin. Lab. Anal.	SEP	2020	34	9							e23373	10.1002/jcla.23373		AUG 2020	10	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	NY8FZ	WOS:000562383300001	32844458	gold, Green Published			2022-02-06	
J	Rezagholizadeh, A; Karimi, SA; Hosseinmardi, N; Janahmadi, M; Sayyah, M				Rezagholizadeh, Amir; Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Sayyah, Mohammad			The effects of glial cells inhibition on spatial reference, reversal and working memory deficits in a rat model of traumatic brain injury (TBI)	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Early Access						Traumatic brain injury; cognitive dysfunction; learning and memory; glial cells; fluorocitrate	REACTIVE ASTROCYTES; REGENERATION; PATHOPHYSIOLOGY; DISRUPTION; METABOLISM; NEUROCAN; SEQUELAE; ROLES; SCAR	Aims Evidence suggests that glial cells are influenced by Traumatic brain injury (TBI). Both protective and damaging roles have been attributed to reactive glial cells, but their role after TBI has not been well understood. In this study, the role of glial cells in TBI-induced cognitive impairment was investigated. Materials and methods Male rats were randomly assigned to the following groups: Sham + PBS, sham + FC, TBI + PBS, and TBI + FC. FC (1 nmol/1 mu l), a glial cell inhibitor, was injected into the lateral ventricle 10 min after TBI induction and it was repeated every 24 h until the seventh day. On days 8-13 post-injury, reference and reverse memory and on days 8-16 post-injury, working memory was assessed using the Morris water maze test. Results Brain-injured rats exhibited significant impairments in acquisition and retrieval phases of reference and reverse memory compared to sham rats and FC administration could not attenuate the deteriorative effect of TBI in different learning tasks. TBI rats showed impairment in acquisition (but not retrieval) of working memory. Sham animals which received FC showed a deficit in reversal memory acquisition and retrieval of reference memory compared to sham + PBS rats. Conclusion The present study demonstrates that memory deficit induced by TBI cannot be improved by FC, and glial cells inhibition in uninjured animals causes impairments in reversal memory acquisition and retrieval of reference memory. Our results suggest that in addition to essential role of glial cells for memory formation in normal situation, their responses after TBI may have preventive effect against memory impairments.	[Rezagholizadeh, Amir; Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Rezagholizadeh, Amir; Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Sch Med, Tehran, Iran; [Karimi, Seyed Asaad] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Hamadan, Iran; [Karimi, Seyed Asaad] Hamadan Univ Med Sci, Sch Sci & Adv Technol Med, Dept Neurosci, Hamadan, Hamadan, Iran; [Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran		Hosseinmardi, N (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran.	nhosseinmardi@sbmu.ac.ir	Janahmadi, Mahyar/AAU-6425-2021; Karimi, Seyed Asaad/V-9287-2018	Karimi, Seyed Asaad/0000-0002-8663-6485	Shahid Beheshti University of Medical Sciences and Pasteur Institute, Tehran, Iran	The research was supported in part by grants of Shahid Beheshti University of Medical Sciences and Pasteur Institute, Tehran, Iran.	Adamsky A, 2018, NEUROSCIENCE, V370, P14, DOI 10.1016/j.neuroscience.2017.05.033; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gholamipour-Badie H, 2013, BEHAV BRAIN RES, V237, P190, DOI 10.1016/j.bbr.2012.09.045; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HASSEL B, 1994, J NEUROCHEM, V62, P2187; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hirose S, 2007, NEUROSCI LETT, V415, P259, DOI 10.1016/j.neulet.2007.01.031; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Karimi SA, 2019, BEHAV BRAIN RES, V359, P630, DOI 10.1016/j.bbr.2018.10.002; Karimi SA, 2017, BRAIN RES BULL, V134, P177, DOI 10.1016/j.brainresbull.2017.07.014; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Largo C, 1996, J NEUROSCI, V16, P1219; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nategh M, 2015, PHYSIOL BEHAV, V139, P112, DOI 10.1016/j.physbeh.2014.11.014; Patt S, 1999, EXP TOXICOL PATHOL, V51, P119, DOI 10.1016/S0940-2993(99)80084-0; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shohami E, 1999, CYTOKINE GROWTH FACT, V10; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Verkhratsky A, 2007, GLIAL NEUROBIOLOGY T; Wang L, 2009, SCI CHINA SER C, V52, P701, DOI 10.1007/s11427-009-0101-9; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	54	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.												10.1080/00207454.2020.1807544		AUG 2020	11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC2XT	WOS:000561080100001	32799586				2022-02-06	
J	Jones, C; O'Toole, K; Jones, K; Bremault-Phillips, S				Jones, Chelsea; O'Toole, Kaitlin; Jones, Kevin; Bremault-Phillips, Suzette			Quality of Psychoeducational Apps for Military Members With Mild Traumatic Brain Injury: An Evaluation Utilizing the Mobile Application Rating Scale	JMIR MHEALTH AND UHEALTH			English	Article						psychoeducation; mTBI; military; app; smartphone; mHealth; concussion; Mobile App Rating Scale; MARS; mobile phone	SERVICE MEMBERS; SMARTPHONE APPS; CONCUSSION; SOLDIERS	Background: Military personnel have an elevated risk of sustaining mild traumatic brain injuries (mTBI) and postconcussion symptoms (PCS). Smartphone apps that provide psychoeducation may assist those with mTBI or PCS to overcome unique barriers that military personnel experience with stigma and access to health care resources. Objective: This study aims to (1) use the Mobile Application Rating Scale (MARS) to evaluate smartphone apps purporting to provide psychoeducation for those who have sustained an mTBI or a PCS; (2) explore the relevance, utility, and effectiveness of these apps in facilitating symptom management and overall recovery from mTBI and PCS among military personnel; and (3) discuss considerations pertinent to health care professionals and patients with mTBI when considering the use of mobile health (mHealth), including apps for mTBI psychoeducation. Methods: A five-step systematic search for smartphone apps for military members with mTBI or PCS was conducted on January 31, 2020. Cost-free apps meeting the inclusion criteria were evaluated using the MARS and compared with evidence-based best practice management protocols for mTBI and PCS. Results: The search yielded a total of 347 smartphone apps. After applying the inclusion and exclusion criteria, 13 apps were subjected to evaluation. Two apps were endorsed by the US Department of Veterans Affairs and the US Department of Defense; all the others (n=11) were developed for civilians. When compared with evidence-based best practice resources, the apps provided various levels of psychoeducational content. There are multiple considerations that health care professionals and those who sustain an mTBI or a PCS have to consider when choosing to use mHealth and selecting a specific app for mTBI psychoeducation. These may include factors such as the app platform, developer, internet requirement, cost, frequency of updates, language, additional features, acknowledgment of mental health, accessibility, military specificity, and privacy and security of data. Conclusions: Psychoeducational interventions have a good evidence base as a treatment for mTBI and PCS. The use of apps for this purpose may be clinically effective, cost-effective, confidential, user friendly, and accessible. However, more research is needed to explore the effectiveness, usability, safety, security, and accessibility of apps designed for mTBI management.	[Jones, Chelsea; O'Toole, Kaitlin; Bremault-Phillips, Suzette] Univ Alberta, Fac Rehabil Med, Heroes Mind Advocacy & Res Consortium HiMARC, 8205-114 St NW, Edmonton, AB T6G 2G4, Canada; [Jones, Chelsea] Govt Canada, Canadian Forces Hlth Serv, Dept Natl Def, Ottawa, ON, Canada; [Jones, Kevin] Edmonton North Primary Care Network, Edmonton, AB, Canada		Jones, C (corresponding author), Univ Alberta, Fac Rehabil Med, Heroes Mind Advocacy & Res Consortium HiMARC, 8205-114 St NW, Edmonton, AB T6G 2G4, Canada.	cweiman@ualberta.ca	Bremault-Phillips, Suzette/H-8258-2015	Bremault-Phillips, Suzette/0000-0003-4167-1815; Jones, Kevin/0000-0002-2299-6772; Jones, Chelsea/0000-0001-7713-4099; O'Toole, Kaitlin/0000-0003-3176-3265			Abroms LC, 2013, AM J PREV MED, V45, P732, DOI 10.1016/j.amepre.2013.07.008; [Anonymous], [No title captured]; [Anonymous], 2019, FDA REC ONL US CLEAR; [Anonymous], 2012, COLORECTAL DIS, DOI DOI 10.1111/J.1463-1318.2012.03088; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Armstrong C, 2017, DEP DEFENSE MOBILE H; Balebako R, 2014, IEEE SECUR PRIV, V12, P55, DOI 10.1109/MSP.2014.70; Besemann M, 2019, CANADIAN I MILITARY; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Buijink Arthur Willem Gerard, 2013, Evid Based Med, V18, P90, DOI 10.1136/eb-2012-100885; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Crowle C, 2010, LOW VISION REHABILIT; Doneva SP, 2018, J MIL VETERAN FAM HL, V4, P121, DOI [10.3138/jmvfh.2017-0012, DOI 10.3138/JMVFH.2017-0012]; Eghdam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159362; Fitzgerald S., 2019, NEUROLOGY, V19, P5, DOI [10.1097/01.nt.0000559865.92231.19, DOI 10.1097/01.NT.0000559865.92231.19]; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huckvale K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0444-y; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Jones C, 2019, J MIL VETERAN FAM HL, V5, P131, DOI 10.3138/jmvfh.2018-0005; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Kwan V, 2019, J HEAD TRAUMA REHAB, V34, pE45, DOI 10.1097/HTR.0000000000000425; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; Lewis TL, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3133; Marshall S, 2018, GUIDELINES CONCUSSIO; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Neill S, 2012, COLORECTAL DIS, V14, pe530, DOI 10.1111/j.1463-1318.2012.03088.x; OToole K, 2020, J MIL VETERAN FAM HL, V2020; Owings-Fonner N., 2019, REV MEDITATION APPS; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Radomski M, 2019, MILD TRAUMATIC BRAIN; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Stec M, 2020, ADV FAMILY PRACTICE, V2, P87, DOI [10.1016/j.yfpn.2020.01.003, DOI 10.1016/J.YFPN.2020.01.003]; Stoyanov S., 2016, MARS TRAINING VIDEO; Stoyanov SR, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3422; Tam-Seto Linna, 2018, Mhealth, V4, P57, DOI 10.21037/mhealth.2018.12.01; TEASDALE G, 1974, LANCET, V2, P81; Wyatt JC, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1211-7	44	4	4	1	3	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	AUG 18	2020	8	8							e19807	10.2196/19807			16	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	QG6OD	WOS:000617702300001	32808937	gold, Green Published			2022-02-06	
J	Wang, A; Zhou, GW; Lipson, S; Kawai, K; Corcoran, M; Brodsky, JR				Wang, Alicia; Zhou, Guangwei; Lipson, Sophie; Kawai, Kosuke; Corcoran, Meghan; Brodsky, Jacob R.			Multifactorial Characteristics of Pediatric Dizziness and Imbalance	LARYNGOSCOPE			English	Article						Vestibular; dizziness; vertigo; balance; vestibular migraine; PPPD; BPPV; concussion	PAROXYSMAL POSITIONAL VERTIGO; SPORT-RELATED CONCUSSION; VESTIBULAR DISORDERS; CLINICAL CHARACTERISTICS; BALANCE DISORDERS; DIZZY PATIENT; CHILDREN; MIGRAINE; ADOLESCENTS; POPULATION	Objectives To examine the relative prevalence of individual diagnoses in children and adolescents presenting with dizziness and/or imbalance, and to assess the proportion of patients assigned multiple contributing diagnoses. Study Design Retrospective cohort study. Methods We retrospectively reviewed our internal database of all patients seen at our pediatric vestibular program between January 2012 and March 2019 to determine the incidence of common diagnoses and groups of diagnoses for patients ages 21 or younger. Results One thousand twenty-one patients were included with a mean age of 12.5 +/- 4.9 years (range: 9 months-21 years). Of this total, 624 patients were female and 397 were male. Common diagnoses included vestibular migraine (VM; 35.0%), benign paroxysmal positional vertigo (BPPV; 21.6%), primary dysautonomia (15.7%), anxiety disorder (13.5%), and persistent postural perceptual dizziness (PPPD; 11.2%). A high proportion of patients (44.4%) received multiple contributing diagnoses. VM was frequently diagnosed with BPPV or PPPD, and 22 patients were diagnosed with all three concurrently. Conclusion The causes of dizziness and imbalance in the pediatric population are diverse, and many patients have multiple diagnoses that are often interrelated. It is important that providers recognize that the causes of vestibular symptoms in children and adolescents may be multifactorial and may span across multiple specialties. Level of Evidence 4Laryngoscope, 2020	[Wang, Alicia; Zhou, Guangwei; Lipson, Sophie; Kawai, Kosuke; Corcoran, Meghan; Brodsky, Jacob R.] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA 02115 USA; [Zhou, Guangwei; Kawai, Kosuke; Brodsky, Jacob R.] Harvard Med Sch, Boston, MA 02115 USA; [Lipson, Sophie] Tufts Sch Med, Boston, MA USA		Brodsky, JR (corresponding author), 300 Longwood Ave, Boston, MA 02115 USA.	jacob.brodsky@childrens.harvard.edu		Wang, Alicia/0000-0003-4137-8547; Lipson, Sophie/0000-0001-5609-8156; Brodsky, Jacob/0000-0001-9656-5855	Department of Otolaryngology and Communication Enhancement at Boston Children's Hospital	All financial support for this study was provided by the Department of Otolaryngology and Communication Enhancement at Boston Children's Hospital.	Sommerfleck PA, 2016, INT J PEDIATR OTORHI, V87, P148, DOI 10.1016/j.ijporl.2016.06.020; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Best C, 2009, NEUROSCIENCE, V164, P1579, DOI 10.1016/j.neuroscience.2009.09.034; Brodsky JR, 2020, OTOLARYNG HEAD NECK, V162, P241, DOI 10.1177/0194599819887375; Brodsky JR, 2018, OTOLARYNG HEAD NECK, V159, P365, DOI 10.1177/0194599818770618; Brodsky JR, 2018, OTOL NEUROTOL, V39, P344, DOI 10.1097/MAO.0000000000001673; Brodsky JR, 2016, EUR J PAEDIATR NEURO, V20, P85, DOI 10.1016/j.ejpn.2015.09.011; Carlson JM, 2020, BRAIN INJURY, V34, P363, DOI 10.1080/02699052.2020.1723698; Choung YH, 2003, INT J PEDIATR OTORHI, V67, P889, DOI 10.1016/S0165-5876(03)00136-8; Chu CH, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0547-z; Deissler A, 2017, NEUROPEDIATRICS, V48, P91, DOI 10.1055/s-0037-1598645; Edelman S, 2012, AM J OTOLARYNG, V33, P395, DOI 10.1016/j.amjoto.2011.10.009; Erbek SH, 2006, INT J PEDIATR OTORHI, V70, P1547, DOI 10.1016/j.ijporl.2006.04.001; Faralli M, 2014, B-ENT, V10, P133; Ferster APO, 2017, AURIS NASUS LARYNX, V44, P249, DOI [10.1016/j.an1.2017.01.014, 10.1016/j.anl.2017.01.014]; Gioacchini FM, 2014, INT J PEDIATR OTORHI, V78, P718, DOI 10.1016/j.ijporl.2014.02.009; Hanley K, 2002, BRIT J GEN PRACT, V52, P809; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Horii A, 2004, OTOL NEUROTOL, V25, P536, DOI 10.1097/00129492-200407000-00022; Jahn K, 2016, HAND CLINIC, V137, P353, DOI 10.1016/B978-0-444-63437-5.00025-X; Journal of Vestibular Research, 2019, J VESTIBULAR RES; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Koo JW, 2006, CEPHALALGIA, V26, P1310, DOI 10.1111/j.1468-2982.2006.01208.x; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lauritsen CG, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0476-z; Lee JD, 2017, INT J PEDIATR OTORHI, V94, P36, DOI 10.1016/j.ijporl.2017.01.012; Mattsson P, 2003, HEADACHE, V43, P27, DOI 10.1046/j.1526-4610.2003.03005.x; McCaslin DL, 2011, OTOLARYNG CLIN N AM, V44, P291, DOI 10.1016/j.otc.2011.01.003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Bittar RSM, 2015, BRAZ J OTORHINOLAR, V81, P276, DOI 10.1016/j.bjorl.2014.08.012; Muelleman T, 2017, OTOL NEUROTOL, V38, P870, DOI 10.1097/MAO.0000000000001429; Murofushi T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00749; Niemensivu R, 2006, INT J PEDIATR OTORHI, V70, P259, DOI 10.1016/j.ijporl.2005.06.015; O'Reilly RC, 2011, OTOLARYNG HEAD NECK, V144, P142, DOI 10.1177/0194599810393679; O'Reilly RC, 2010, OTOL NEUROTOL, V31, P1441, DOI 10.1097/MAO.0b013e3181f20673; Pan Q, 2018, EUR NEUROL, V79, P287, DOI 10.1159/000489639; Popkirov S, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0535-0; Popkirov Stoyan, 2018, Pract Neurol, V18, P5, DOI 10.1136/practneurol-2017-001809; Ravid S, 2003, PEDIATR NEUROL, V29, P317, DOI 10.1016/S0887-8994(03)00278-9; Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y; Scott BR, 2020, HEADACHE, V60, P526, DOI 10.1111/head.13709; Simon N M, 1998, Ann Clin Psychiatry, V10, P75, DOI 10.1023/A:1026167000066; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Staab JP, 2004, LARYNGOSCOPE, V114, P1637, DOI 10.1097/00005537-200409000-00025; Staab JP, 2002, ARCH OTOLARYNGOL, V128, P554, DOI 10.1001/archotol.128.5.554; Teixido M, 2017, J LARYNGOL OTOL, V131, P508, DOI 10.1017/S0022215117000536; Turk B, 2021, ENT-EAR NOSE THROAT, V100, P532, DOI 10.1177/0145561319871234; Uneri Alev, 2004, Ear Nose Throat J, V83, P814; van Leeuwen RB, 2017, NEUROLOGIST, V22, P69, DOI 10.1097/NRL.0000000000000116; von Brevern M, 2016, HAND CLINIC, V137, P301, DOI 10.1016/B978-0-444-63437-5.00022-4; Wang FZ, 2020, REGION ANESTH PAIN M, V45, P323, DOI 10.1136/rapm-2019-101207; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358; Yetiser Sertac, 2015, Int Tinnitus J, V19, P64, DOI 10.5935/0946-5448.20150011; Zhu RT, 2019, ANN OTO RHINOL LARYN, V128, P869, DOI 10.1177/0003489419845014	58	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	APR	2021	131	4					E1308	E1314		10.1002/lary.29024		AUG 2020	7	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	QU0KJ	WOS:000560141900001	32809223				2022-02-06	
J	Rodney, T; Taylor, P; Dunbar, K; Perrin, N; Lai, C; Roy, M; Gill, J				Rodney, Tamar; Taylor, Patricia; Dunbar, Kerri; Perrin, Nancy; Lai, Chen; Roy, Michael; Gill, Jessica			High IL-6 in military personnel relates to multiple traumatic brain injuries and post-traumatic stress disorder	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Post-traumatic stress disorder (PTSD); Inflammation; Cytokines; Military; interleukin-6 (IL-6)	COMBAT-RELATED PTSD; SYMPTOMS; NEUROINFLAMMATION; INFLAMMATION; DEPRESSION; DEFICITS; RELIABILITY; BIOMARKER; VETERANS; VALIDITY	Repetitive traumatic brain injuries (TBIs) among military personnel have been linked to chronic behavioral and neurological symptoms, and poor health outcomes. Repetitive TBIs may impact inflammation, which may offer some explanation of the biological basis of these long-term risks, and may improve the care that is provided to these individuals. This study examines the concentrations of TNF alpha, IL-6 and IL-10 and associations with behavioral symptoms, including post-traumatic stress disorder symptoms and depression in a cohort of 106 military personnel and Veterans with a history of TBI. Group comparisons conducted for those with repetitive TBIs ( >= 3; n = 44), to participants with less than three TBIs (n = 29), and controls with no TBIs (n = 33). The primary outcomes were serum levels of inflammatory related proteins TNF-alpha, IL-6 and IL-10, TBI history, and PTSD symptoms. IL-6 mean concentration was significantly higher in the repetitive TBI group compared to those with 1-2 TBI or no TBI history (p = 0.050). Additionally, for participants with a history of TBI, PTSD symptom severity, specifically, intrusion (p = .006 and p = .007) and avoidance (p = .034 and .009), were significant predictors of higher IL-6 and IL-10 concentrations respectively. These findings suggest that repetitive TBIs concurrent with high PTSD symptoms in military personnel and Veterans are associated with chronic inflammation, and specifically elevated concentrations of IL-6. Examining the changes in inflammatory processes may identify potential therapeutic targets for early intervention after TBI in order to prevent the development of neurological deficits and disorders.	[Rodney, Tamar; Perrin, Nancy] Johns Hopkins Univ, Sch Nursing, 525 N Wolfe St, Baltimore, MD 21205 USA; [Lai, Chen; Gill, Jessica] NINR, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Taylor, Patricia; Dunbar, Kerri] Henry M Jackson Fdn, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Taylor, Patricia; Dunbar, Kerri; Roy, Michael; Gill, Jessica] Ctr Neurosci & Regenerat Med, 12725 Twinbrook Pkwy, Rockville, MD 20852 USA; [Roy, Michael] Uniformed Serv Univ Hlth Sci, Dept Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Rodney, T (corresponding author), Johns Hopkins Univ, Sch Nursing, 525 N Wolfe St, Baltimore, MD 21205 USA.	trodney1@jhu.edu			Geneva Foundation/Jonas Veterans Healthcare Scholarship, USA	Geneva Foundation/Jonas Veterans Healthcare Scholarship, USA	[Anonymous], 2015, SIM SCI; Association A.P, 2013, DIAGN STAT MAN MENT; Bob P, 2010, J AFFECT DISORDERS, V120, P231, DOI 10.1016/j.jad.2009.03.017; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Bruenig D, 2017, COMPR PSYCHIAT, V74, P125, DOI 10.1016/j.comppsych.2017.01.015; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Devoto C, 2016, CELL TRANSPLANT; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Duivis HE, 2011, AM J PSYCHIAT, V168, P913, DOI 10.1176/appi.ajp.2011.10081163; Gill J., 2017, BRAIN BEHAV IMMUN; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Larner S.F., 2016, BIOMARKERS FUTURE DI; Lindqvist D, 2017, BRAIN BEHAV IMMUN, V59, P260, DOI 10.1016/j.bbi.2016.09.012; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Olivera A., 2015, JAMA NEUROL; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Weathers FW., 2008, ENCY PSYCHOL TRAUMA, P491; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	43	4	4	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 17	2020	392								112715	10.1016/j.bbr.2020.112715			6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	MQ1JW	WOS:000552654000014	32470481				2022-02-06	
J	White, AJ; Parry, KD; Humphries, C; Phelan, S; Batten, J; Magrath, R				White, Adam J.; D. Parry, Keith; Humphries, Connor; Phelan, Simon; Batten, John; Magrath, Rory			Duty of Karius: Media Framing of Concussion Following the 2018 UEFA Champions League Final	COMMUNICATION & SPORT			English	Article; Early Access						concussion; soccer; mild traumatic brain injury; framing	SPORTS; INJURY; WORLD; NEWS; MASCULINITY; NARRATIVES; DIAGNOSIS; COVERAGE; TRAUMA; RISK	Concussion is a growing issue within sport, including within soccer. Despite the developing medical understanding of concussion, there is still an array of sociocultural discourses and misconceptions around it. In the 2018 UEFA Champions League Final, Liverpool Football Club goalkeeper Loris Karius suffered a head collision in the 48th minute. Postmatch, he was subsequently diagnosed as being concussed. As a result of his concussion, Karius' performance was arguably impeded, with suggestions that this may have resulted in him making some key errors in the game. Through an analysis of media framing in 52 news articles in the days following the incident, four dominant frames were identified:deflection away from concussion,misunderstanding concussion,education on concussion, and recommendations. Frames that focussed on the lack of awareness and preventative measures that are present in soccer served to highlight the lack of significance afforded to concussion at this particular point in time. In particular, we highlight differences in concussion discourses between those working inside and outside the soccer industry. Overall, these findings contribute to the growing body of sociological work examining concussion in sport.	[White, Adam J.; Humphries, Connor; Phelan, Simon] Oxford Brookes Univ, Oxford, England; [D. Parry, Keith; Batten, John] Univ Winchester, Winchester, Hants, England; [Magrath, Rory] Solent Univ, Southampton, Hants, England		White, AJ (corresponding author), Oxford Brookes Univ, Dept Sport Hlth Sci & Social Work, Fac Hlth & Life Sci, Oxford, England.	adamwhite@brookes.ac.uk	Batten, John/ABD-7384-2021	Batten, John/0000-0001-7499-7817; Parry, Keith D./0000-0001-9025-9101; White, Adam/0000-0002-6865-8197			Adams A, 2010, J LANG SOC PSYCHOL, V29, P278, DOI 10.1177/0261927X10368833; AFP, 2018, AFP; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Amako U., 2018, DAILY EXPRESS; Anderson EH, 2018, SHAKESPEARE AND THE LEGACY OF LOSS, P1; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; [Anonymous], 2018, JUV NEUR PLAYS KAR C; Barnett B, 2020, MEDIA WAR CONFL, V13, P336, DOI 10.1177/1750635219836126; BBC Sport, 2018, BBC SPORT; Beesley C., 2018, LIVERPOOL ECHO  0825; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cusimano MD, 2017, JAMA-J AM MED ASSOC, V317, P2548, DOI 10.1001/jama.2017.6204; Das S., 2018, L KARIUS DAZED CONFU; Davis C., 2018, L KARIUS LEFT TEARS; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dines J., 2018, CONCUSSION MAY EXPLA; Doyle I., 2018, LIVERPOOL ECHO  0825; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; ENTMAN RM, 1991, J COMMUN, V41, P6, DOI 10.1111/j.1460-2466.1991.tb02328.x; Entman RM, 2007, J COMMUN, V57, P163, DOI 10.1111/j.1460-2466.2006.00336.x; Entman Robert M., 2010, JOURNALISM, V11, P389, DOI DOI 10.1177/1464884910367587; Fromme J., 2006, MEDIENPADAGOGIK, V11, DOI [10.21240/mpaed/11/2006.01.17.X, DOI 10.21240/MPAED/11/2006.01.17.X]; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gonzalez J., 2018, AS; Grundlingh A., 1994, International Journal of the History of Sport, V11, P408, DOI 10.1080/09523369408713871; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hodder, 1994, INTERPRETATION DOCUM; Holstein J. A., 2014, IS THERE LIFE FOOTBA; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Jarlenski M, 2013, HEALTH COMMUN, V28, P209, DOI 10.1080/10410236.2012.669670; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P1, DOI 10.1007/s12152-015-9233-8; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Karimipour N., 2017, Journal of Sports Media, V12, P45; Kennard M, 2018, AUST PSYCHOL, V53, P97, DOI 10.1111/ap.12272; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lewis N, 2015, COMMUN SPORT, V3, P219, DOI 10.1177/2167479513508273; Li YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171563; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; MacInnes P, 2020, GUARDIAN; Mackay D., 2019, NEW ENGLAND J MED, V381; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Malcolm D., 2017, SPORT MED HLTH MED S; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Massachusetts General Hospital, 2018, COMMUNICATION; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee Alan, 2001, METRO, V127, P138; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; Meehan W. P., 2017, CONCUSSIONS; Mirer M., 2017, Journal of Sports Media, V12, P21, DOI 10.1353/jsm.2017.0001; Nauright J., 1996, MAKING MEN RUGBY MAS, V10; Neeley S, 2005, YOUNG CONSUM, V6, P63, DOI 10.1108/17473610510701115; Nixon Howard L., 2004, SPORTING BODIES DAMA; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Nowinski C., 2012, HEAD GAMES GLOBAL CO; Nyanja R., 2018, STANDARD MEDIA; Ofcom, 2018, NEWS CONS UK 2018; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parrott S., 2019, COMMUNICATION SPORT, DOI 10.1177/2167479519852605; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Preece D., 2018, INEWS; Roderick M, 2006, SOCIOL HEALTH ILL, V28, P76, DOI 10.1111/j.1467-9566.2005.00483.x; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sanderson J., 2019, Journal of Sports Media, V14, P1, DOI 10.1353/jsm.2019.0002; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Santos C. A., 2013, International Journal of Sport Communication, V6, P66; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schacht SP, 1996, GENDER SOC, V10, P550, DOI 10.1177/089124396010005004; Sherwood M, 2020, COMMUN SPORT, V8, P545, DOI 10.1177/2167479519901118; Smith L, 2014, CAMB IMP POST-COL ST, P192; Stewart W, 2015, QJM, V109, P11; talkSPORT, 2018, TALKSPORT; Union European Football Association, 2014, NEW CONC PROC; Van den Bulck H, 2017, INT J COMMUN-US, V11, P4965; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Waddington I., 2017, INT REV SOCIOL SPORT, V54, P649; White A.J., 2019, INT REV SOCIOL SPORT, V54, P1020, DOI [10.1177/1012690219839909, DOI 10.1177/1012690219839909]; White AJ, 2018, J PHYS EDUC RECREAT, V89, P5, DOI 10.1080/07303084.2018.1431463; White AJ, 2018, INJURY PREV, V24, P114, DOI 10.1136/injuryprev-2017-042672; Yin R., 2017, CASE STUDY RES DESIG; Young, 2004, SPORTING BODIES DAMA, P59; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373	94	4	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport											2167479520948048	10.1177/2167479520948048		AUG 2020	23	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	ND5DD	WOS:000561919700001		hybrid, Green Published, Green Accepted			2022-02-06	
J	Gao, Y; Zhang, Y; Li, Z; Ma, LL; Yang, J				Gao, Yu; Zhang, Yi; Li, Zhuo; Ma, Linlin; Yang, Jing			Persistent vegetative state after severe cerebral hemorrhage treated with amantadine A retrospective controlled study	MEDICINE			English	Article						amantadine; cerebral hemorrhage; persistent vegetative state	TRAUMATIC BRAIN-INJURY; RECEPTOR ANTAGONIST; CONSCIOUSNESS; DISORDERS	Amantadine is currently recommended for use in patients of posttraumatic brain injury with unconsciousness. However, the application of amantadine in consciousness disturbance after cerebral hemorrhage has only been rarely reported. This allows for a further exploration of the role of amantadine in the treatment of PVS resulting from severe cerebral hemorrhage. Retrospective cohort study from 1/2015 to 7/2019 in Beijing Chaoyang hospital. We included adult patients treated with amantadine after severe cerebral hemorrhage in PVS. Primary outcome was time of consciousness recovery and Glasgow Out Scale scores after 5 months from onset. We compared characteristics and outcomes to a control cohort. matched on age, Coma Recovery Scale-Revised score, volume and location of hemorrhage. Among the 12 patients who received amantadine treatment, 6 patients regained consciousness (50%) after 5 months of disease onset, but were still severely disabled. Besides, the time for regaining consciousness was within 3 months of disease onset. The remaining 6 patients were still in a PVS. Compared with the amantadine group, the consciousness recovery rate (50% vs 33.3%,P = .68) after 5 months in the nested control group was not significantly different. The awakening time for patients in the amantadine group was earlier than the control group (100% vs 25%,P = .03). In this study, amantadine can accelerate the recovery of consciousness in patients following severe cerebral hemorrhage. We recommend further randomized controlled studies to determine the efficacy of amantadine.	[Gao, Yu; Zhang, Yi; Li, Zhuo; Ma, Linlin; Yang, Jing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen Med, Beijing, Peoples R China		Yang, J (corresponding author), Beijing Chaoyang Hosp, Beijing, Peoples R China.	yangjing20170@qq.com					[Anonymous], 2003, PACK INS SYMM AM HYD; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avecillas-Chasin JM, 2014, ACTA NEUROCHIR, V156, P1375, DOI 10.1007/s00701-014-2077-x; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mura E, 2014, CURR PHARM DESIGN, V20, P4121; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schneider WN, 1999, BRAIN INJURY, V13, P863; Sennfalt S, 2018, STROKE; STOOF JC, 1992, CLIN NEUROL NEUROSUR, V94, pS4; Zafonte RD, 1998, BRAIN INJURY, V12, P617	18	4	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG 14	2020	99	33							e21822	10.1097/MD.0000000000021822			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OB9OZ	WOS:000578793300117	32872083	Green Published, gold			2022-02-06	
J	Olsen, A; Babikian, T; Bigler, ED; Caeyenberghs, K; Conde, V; Dams-O'Connor, K; Dobryakova, E; Genova, H; Grafman, J; Haberg, AK; Heggland, I; Hellstrom, T; Hodges, CB; Irimia, A; Jha, RM; Johnson, PK; Koliatsos, VE; Levin, H; Li, LM; Lindsey, HM; Livny, A; Lovstad, M; Medaglia, J; Menon, DK; Mondello, S; Monti, MM; Newcombe, VF; Petroni, A; Ponsford, J; Sharp, D; Spitz, G; Westlye, LT; Thompson, PM; Dennis, EL; Tate, DF; Wilde, EA; Hillary, FG				Olsen, Alexander; Babikian, Talin; Bigler, Erin D.; Caeyenberghs, Karen; Conde, Virginia; Dams-O'Connor, Kristen; Dobryakova, Ekaterina; Genova, Helen; Grafman, Jordan; Haberg, Asta K.; Heggland, Ingrid; Hellstrom, Torgeir; Hodges, Cooper B.; Irimia, Andrei; Jha, Ruchira M.; Johnson, Paula K.; Koliatsos, Vassilis E.; Levin, Harvey; Li, Lucia M.; Lindsey, Hannah M.; Livny, Abigail; Lovstad, Marianne; Medaglia, John; Menon, David K.; Mondello, Stefania; Monti, Martin M.; Newcombe, Virginia Fj; Petroni, Agustin; Ponsford, Jennie; Sharp, David; Spitz, Gershon; Westlye, Lars T.; Thompson, Paul M.; Dennis, Emily L.; Tate, David F.; Wilde, Elisabeth A.; Hillary, Frank G.			Toward a global and reproducible science for brain imaging in neurotrauma: the ENIGMA adult moderate/severe traumatic brain injury working group	BRAIN IMAGING AND BEHAVIOR			English	Article						Brain injury; Radiology; Open Science; Neurodegeneration; Rehabilitation; ENIGMA	DEFAULT MODE NETWORK; COMMON DATA ELEMENTS; SINGLE NUCLEOTIDE POLYMORPHISMS; PERSISTENT VEGETATIVE STATE; PERCENT-ALPHA-VARIABILITY; WHITE-MATTER INTEGRITY; ALZHEIMERS-DISEASE; HEAD-INJURY; POSTTRAUMATIC SEIZURES; AXONAL INJURY	The global burden of mortality and morbidity caused by traumatic brain injury (TBI) is significant, and the heterogeneity of TBI patients and the relatively small sample sizes of most current neuroimaging studies is a major challenge for scientific advances and clinical translation. The ENIGMA (Enhancing NeuroImaging Genetics through Meta-Analysis) Adult moderate/severe TBI (AMS-TBI) working group aims to be a driving force for new discoveries in AMS-TBI by providing researchers world-wide with an effective framework and platform for large-scale cross-border collaboration and data sharing. Based on the principles of transparency, rigor, reproducibility and collaboration, we will facilitate the development and dissemination of multiscale and big data analysis pipelines for harmonized analyses in AMS-TBI using structural and functional neuroimaging in combination with non-imaging biomarkers, genetics, as well as clinical and behavioral measures. Ultimately, we will offer investigators an unprecedented opportunity to test important hypotheses about recovery and morbidity in AMS-TBI by taking advantage of our robust methods for large-scale neuroimaging data analysis. In this consensus statement we outline the working group's short-term, intermediate, and long-term goals.	[Olsen, Alexander; Conde, Virginia; Petroni, Agustin] Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Babikian, Talin] UCLA, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Babikian, Talin] UCLA, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Bigler, Erin D.; Hodges, Cooper B.; Johnson, Paula K.; Lindsey, Hannah M.; Dennis, Emily L.; Tate, David F.; Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Bigler, Erin D.; Hodges, Cooper B.; Lindsey, Hannah M.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Johnson, Paula K.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Caeyenberghs, Karen] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Burwood, Australia; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dobryakova, Ekaterina; Genova, Helen] Kessler Fdn, Ctr Traumat Brain Injury, E Hanover, NJ USA; [Dobryakova, Ekaterina] Rutgers New Jersey Med Sch, Newark, NJ USA; [Grafman, Jordan] Shirley Ryan AbilityLab, Cognit Neurosci Lab, Chicago, IL USA; [Grafman, Jordan] Feinberg Sch Med, Dept Phys Med & Rehabil, Neurol, Chicago, IL USA; [Grafman, Jordan] Feinberg Sch Med, Dept Psychol, Cognit Neurol & Alzheimers Ctr, Chicago, IL USA; [Haberg, Asta K.] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, Dept Radiol & Nucl Med, St Olavs Hopsital, Trondheim, Norway; [Heggland, Ingrid] Norwegian Univ Sci & Technol, NTNU Univ Lib, Sect Collect & Digital Serv, Trondheim, Norway; [Hellstrom, Torgeir] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Hodges, Cooper B.; Lindsey, Hannah M.; Tate, David F.; Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Irimia, Andrei] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA; [Jha, Ruchira M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Jha, Ruchira M.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Jha, Ruchira M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Jha, Ruchira M.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Jha, Ruchira M.] Clin & Translat Sci Inst, Pittsburgh, PA USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol Neuropathol, Baltimore, MD USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Sheppard & Enoch Pratt Hosp, Neuropsychiat Program, Baltimore, MD 21204 USA; [Levin, Harvey; Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Li, Lucia M.] Imperial Coll London, C3NL, London, England; [Li, Lucia M.] Imperial Coll London, UK DRI Ctr Hlth Care & Technol, London, England; [Livny, Abigail] Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel; [Livny, Abigail] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesodden, Norway; [Lovstad, Marianne; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Medaglia, John] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Medaglia, John] Drexel Univ, Dept Neurol, Philadelphia, PA 19104 USA; [Menon, David K.; Newcombe, Virginia Fj] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Monti, Martin M.] UCLA, Brain Injury Res Ctr BIRC, Dept Neurosurg, Los Angeles, CA USA; [Petroni, Agustin] Univ Buenos Aires, Fac Exact & Nat Sci, Dept Comp Sci, Buenos Aires, DF, Argentina; [Petroni, Agustin] Natl Sci & Tech Res Council, Inst Res Comp Sci, Buenos Aires, DF, Argentina; [Ponsford, Jennie; Spitz, Gershon] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Sharp, David] Imperial Coll London, Dept Brain Sci, London, England; [Sharp, David] UK Dementia Res Inst, Care Res & Technol Ctr, London, England; [Westlye, Lars T.] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT, Oslo, Norway; [Thompson, Paul M.; Dennis, Emily L.] USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Keck Sch Med, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, State Coll, PA 16803 USA		Olsen, A (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway.; Olsen, A (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway.; Hillary, FG (corresponding author), Hershey Med Ctr, Dept Neurol, State Coll, PA 16803 USA.	alexander.olsen@ntnu.no; fhillary@psu.edu	Dobryakova, Ekaterina/ABD-2853-2021; Hellstrom, Torgeir/AAW-4301-2021; Irimia, Andrei/B-8275-2008; Hellstrom, Torgeir/AAY-6043-2021; Mondello, Stefania/A-1813-2012; Dennis, Emily/AAD-5223-2021; Hillary, Frank/AAN-8622-2021; Thompson, Paul M/C-4194-2018; Tate, David/G-5166-2011; Spitz, Gershon/H-7755-2014	Dobryakova, Ekaterina/0000-0002-6005-2115; Irimia, Andrei/0000-0002-9254-9388; Hellstrom, Torgeir/0000-0003-0831-3274; Mondello, Stefania/0000-0002-8587-3614; Dennis, Emily/0000-0001-7112-4009; Thompson, Paul M/0000-0002-4720-8867; Tate, David/0000-0003-0213-1920; Petroni, Agustin/0000-0001-7352-6300; Livny, Abigail/0000-0003-2216-7357; Conde, Virginia/0000-0002-0309-0393; Spitz, Gershon/0000-0002-7810-1480; Newcombe, Virginia/0000-0001-6044-9035; Olsen, Alexander/0000-0001-8691-3860	National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia; ACURF Program grant by the Australian Catholic University (ACU); NIH/NINDS/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086625-01]; PA Health Research Grant SAP [4100077082]; NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973]; DoDUnited States Department of Defense [W81XWH-18-1-0413]; NIH/NINDS award [K23NS101036]; DOD USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC)United States Department of Defense [PT13078]; Israel Innovation Authority, "Magneton" Grant; NIH/NIMH/NINDS [DP5-OD-021352, R01-DC016800, R01-DC014960]; CENTER-TBI grant from the European Union; Academy of Medical Science / The Health Foundation Clinician Scientist Fellowship; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC) [802998]; Research Council of NorwayResearch Council of Norway [249795];  [K99NS096116];  [U54 EB020403];  [R01 MH116147];  [R56 AG058854];  [P41 EB015922];  [R01 MH111671]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	National Health and Medical Research Council Career Development Fellowship and an ACURF Program grant by the Australian Catholic University (ACU) to Dr. Caeyenberghs. NIH/NINDS/NICHD 1U01NS086625-01 to Dr. Dams-O'Connor. K99NS096116 to Dr. Dennis. PA Health Research Grant SAP #4100077082 to Dr. Hillary. High Impact Doctoral Research Assistantship from Brigham Young University to Cooper Hodges. NIH grant R01 NS 100973 and DoD contract W81XWH-18-1-0413 to Dr. Irimia. NIH/NINDS award K23NS101036 to Dr. Jha. TBI Endpoints Development (TED) to Dr. Levin. DOD USAMRMC (PT13078) to Dr. Li. Israel Innovation Authority, "Magneton" Grant to Dr. Livny. NIH/NIMH/NINDS through grant numbers DP5-OD-021352, R01-DC016800, R01-DC014960 to Dr. Medaglia. DKM is an Emeritus Senior Investigator of the National Institute for Health Research, UK, and is supported by the CENTER-TBI grant from the European Union. Tiny Blue Dot Foundation to Dr. Monti. Academy of Medical Science / The Health Foundation Clinician Scientist Fellowship to Dr. Newcombe. Transport Accident Commission to Dr. Ponsford. UK Dementia Research Institute to Dr. Sharp. NHMRC Early Career Fellowship to Dr. Spitz. U54 EB020403, R01 MH116147, R56 AG058854, P41 EB015922, R01 MH111671 to Dr. Thompson. The European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC Starting Grant, Grant agreement No. 802998) and the Research Council of Norway (249795) to Dr. Westlye.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Alfaro-Almagro F, 2018, NEUROIMAGE, V166, P400, DOI 10.1016/j.neuroimage.2017.10.034; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Anderson R, 2015, COLLECTION LINKING U, DOI [10.17863/CAM.31760, DOI 10.17863/CAM.31760]; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bartnik-Olson B., 2019, CLIN UTILITY MAGNETI, DOI [10.31234/osf.io/gesvh, DOI 10.31234/OSF.IO/GESVH]; Bearden CE, 2017, NEURON, V94, P232, DOI 10.1016/j.neuron.2017.03.033; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bernier RA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00297; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Bodart O, 2017, NEUROIMAGE-CLIN, V14, P354, DOI 10.1016/j.nicl.2017.02.002; Boedhoe PSW, 2017, AM J PSYCHIAT, V174, P60, DOI 10.1176/appi.ajp.2016.16020201; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Braiman C, 2018, CURR BIOL, V28, P3833, DOI 10.1016/j.cub.2018.10.057; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Buchsbaum MS, 2015, J NEUROTRAUM, V32, P1736, DOI 10.1089/neu.2014.3660; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter Cameron S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P99, DOI 10.1016/j.bpsc.2016.01.005; Carter EL, 2013, J NEUROSURG, V119, P1082, DOI 10.3171/2012.11.JNS122090; Cavaliere C, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01028; Chiaravalloti ND, 2015, J HEAD TRAUMA REHAB, V30, P261, DOI 10.1097/HTR.0000000000000164; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crone JS, 2018, J NEUROSCI RES, V96, P671, DOI 10.1002/jnr.24115; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Faried A, 2018, WORLD NEUROSURG, V116, pE239, DOI 10.1016/j.wneu.2018.04.180; Feczko E, 2019, TRENDS COGN SCI, V23, P584, DOI 10.1016/j.tics.2019.03.009; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fisher AJ, 2018, P NATL ACAD SCI USA, V115, pE6106, DOI 10.1073/pnas.1711978115; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Guadalupe T, 2017, BRAIN IMAGING BEHAV, V11, P1497, DOI 10.1007/s11682-016-9629-z; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Hawkins BE, 2020, J NEUROTRAUM, V37, P2414, DOI 10.1089/neu.2018.6192; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Hemphill M, 2020, J NEUROTRAUM, V37, P2424, DOI 10.1089/neu.2018.6220; Hibar DP, 2016, MOL PSYCHIATR, V21, P1710, DOI 10.1038/mp.2015.227; Hibar DP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13624; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00024; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia A, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00009; Irimia A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00051; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; JENNETT B, 1972, LANCET, V1, P734; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Jones DT, 2016, BRAIN, V139, P547, DOI 10.1093/brain/awv338; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Komura A, 2019, J NEUROTRAUM, V36, P641, DOI 10.1089/neu.2018.5641; Koon-Pong Wong, 2016, Brain Informatics, V3, P1, DOI 10.1007/s40708-015-0026-y; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Krudop WA, 2015, PSYCHOPATHOLOGY, V48, P222, DOI 10.1159/000381986; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2008, NAT CLIN PRACT NEURO, V4, P544, DOI 10.1038/ncpneuro0887; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Li X, 2020, ARXIV200105647CSEESS; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lima FPS, 2011, NEUROL SCI, V32, P633, DOI 10.1007/s10072-011-0604-6; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Lupi A, 2011, CURR RADIOPHARM, V4, P167, DOI 10.2174/1874471011104020167; Lutkenhoff E, 2016, BRAIN FUNCTION RESPO; Lutkenhoff E. S., 2019, THALAMIC BASIS OUTCO, DOI [10.1101/669390, DOI 10.1101/669390]; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Markos SM, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000224; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Molenaar PCM, 2009, DEV PSYCHOL, V45, P260, DOI 10.1037/a0014170; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Monti MM, 2013, HUM BRAIN MAPP, V34, P1245, DOI 10.1002/hbm.21507; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, J PSYCHOPHYSIOL, V24, P76, DOI 10.1027/0269-8803/a000016; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Monti MM, 2009, ANN NY ACAD SCI, V1157, P81, DOI 10.1111/j.1749-6632.2008.04121.x; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; National Institute of Neurological Disorders and Stroke, 2018, NEW UPC OPP ALZH DIS; Newcombe V, 2016, EMAGRES, V5, P1219, DOI 10.1002/9780470034590.emrstm1473; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Nichols TE, 2017, NAT NEUROSCI, V20, P299, DOI 10.1038/nn.4500; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Olsen A, 2020, J NEUROTRAUM, V37, P397, DOI 10.1089/neu.2019.6532; Olsen A, 2015, CEREB CORTEX, V25, P2170, DOI 10.1093/cercor/bhu023; Ostberg A, 2018, J HEAD TRAUMA REHAB, V33, P25, DOI 10.1097/HTR.0000000000000279; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pinker K, 2018, J MAGN RESON IMAGING, V47, P604, DOI 10.1002/jmri.25870; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rajtmajer SM, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.7015.00097, 10.3389/fnana.2015.00097]; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; Roy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00146; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sanchez E, 2019, BRAIN, V142, P674, DOI 10.1093/brain/awy348; Sandvig I, 2018, EUR J NEUROSCI, V47, P1414, DOI 10.1111/ejn.13959; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Schnakers C, 2019, J NEUROL NEUROSUR PS, V90, P617, DOI 10.1136/jnnp-2017-317829; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silva S, 2019, ARXIV181008553CSQBIO; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Spadoni AD, 2015, PSYCHIAT RES-NEUROIM, V233, P367, DOI 10.1016/j.pscychresns.2015.06.007; Spitz G, 2019, J NEUROTRAUM, V36, P2533, DOI 10.1089/neu.2018.5850; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stevens RD, 2014, CURR OPIN CRIT CARE, V20, P168, DOI 10.1097/MCC.0000000000000069; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sullivan DR, 2019, J NEUROTRAUM, V36, P3264, DOI 10.1089/neu.2019.6489; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Szucs D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000797; TEASDALE G, 1974, LANCET, V2, P81; The Royal College of Radiologists, 2017, GUID US PAT IM OBT P; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Thurman DJ., 1995, GUIDELINES SURVEILLA; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Turkeltaub PE, 2019, J SPEECH LANG HEAR R, V62, P3907, DOI 10.1044/2019_JSLHR-L-RSNP-19-0032; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van Erp TGM, 2016, MOL PSYCHIATR, V21, P585, DOI 10.1038/mp.2015.118; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Vander Linden C, 2019, EUR J PHYS REHAB MED, V55, P585, DOI 10.23736/S1973-9087.18.05548-X; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123; Venkalesan UM, 2019, NEUROPSYCHOLOGY, V33, P893, DOI 10.1037/neu0000553; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wagner AK, 2019, NEUROPHARMACOLOGY, V145, P133, DOI 10.1016/j.neuropharm.2018.09.011; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wang Bo, 2013, Multimodal Brain Image Anal (2013), V8159, P31, DOI 10.1007/978-3-319-02126-3_4; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Wiberg A, 2019, BRAIN, V142, P2938, DOI 10.1093/brain/awz257; Wilde EA., 2019, ENIGMA BRAIN INJURY, DOI [10.31234/osf.io/t96xb, DOI 10.31234/OSF.IO/T96XB]; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Wu X, 2016, ARXIV161108310QBIO; Xu L, 2017, CHINESE NEUROSURGICA, V3, P1, DOI [10.1186/s41016-017-0079-2, DOI 10.1186/S41016-017-0079-2]; Yamaki T, 2018, J CLIN NEUROSCI, V57, P20, DOI 10.1016/j.jocn.2018.08.052; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zheng ZS, 2017, HUM BRAIN MAPP, V38, P431, DOI 10.1002/hbm.23370; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	261	4	4	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					526	554		10.1007/s11682-020-00313-7		AUG 2020	29	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RK3RJ	WOS:000559706400001	32797398	Green Published, hybrid, Green Submitted			2022-02-06	
J	Raikwar, SP; Thangavel, R; Ahmed, ME; Selvakumar, GP; Kempuraj, D; Wu, K; Khan, O; Bazley, K; Bussinger, B; Kukulka, K; Zaheer, S; Iyer, SS; Govindarajan, R; Burton, C; James, D; Zaheer, A				Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Wu, Kristopher; Khan, Osaid; Bazley, Kieran; Bussinger, Bret; Kukulka, Klaudia; Zaheer, Smita; Iyer, Shankar S.; Govindarajan, Raghav; Burton, Casey; James, Donald; Zaheer, Asgar			Real-Time Noninvasive Bioluminescence, Ultrasound and Photoacoustic Imaging in NF kappa B-RE-Luc Transgenic Mice Reveal Glia Maturation Factor-Mediated Immediate and Sustained Spatio-Temporal Activation of NF kappa B Signaling Post-Traumatic Brain Injury in a Gender-Specific Manner	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Bioluminescence imaging; Glia maturation factor; microRNA; NF kappa B; Photoacoustic imaging; Traumatic brain injury; Ultrasound	ALZHEIMERS-DISEASE; MICRORNA EXPRESSION; DEEP-TISSUE; CELLS; NEUROINFLAMMATION; INFLAMMATION; MICROGLIA; ESTROGEN; MIR-21; SEX	Neurotrauma especially traumatic brain injury (TBI) is the leading cause of death and disability worldwide. To improve upon the early diagnosis and develop precision-targeted therapies for TBI, it is critical to understand the underlying molecular mechanisms and signaling pathways. The transcription factor, nuclear factor kappa B (NF kappa B), which is ubiquitously expressed, plays a crucial role in the normal cell survival, proliferation, differentiation, function, as well as in disease states like neuroinflammation and neurodegeneration. Here, we hypothesized that real-time noninvasive bioluminescence molecular imaging allows rapid and precise monitoring of TBI-induced immediate and rapid spatio-temporal activation of NF kappa B signaling pathway in response to Glia maturation factor (GMF) upregulation which in turn leads to neuroinflammation and neurodegeneration post-TBI. To test and validate our hypothesis and to gain novel mechanistic insights, we subjected NF kappa B-RE-Luc transgenic male and female mice to TBI and performed real-time noninvasive bioluminescence imaging (BLI) as well as photoacoustic and ultrasound imaging (PAI). Our BLI data revealed that TBI leads to an immediate and sustained activation of NF kappa B signaling. Further, our BLI data suggest that especially in male NF kappa B-RE-Luc transgenic mice subjected to TBI, in addition to brain, there is widespread activation of NF kappa B signaling in multiple organs. However, in the case of the female NF kappa B-RE-Luc transgenic mice, TBI induces a very specific and localized activation of NF kappa B signaling in the brain. Further, our microRNA data suggest that TBI induces significant upregulation of mir-9-5p, mir-21a-5p, mir-34a-5p, mir-16-3p, as well as mir-155-5p within 24 h and these microRNAs can be successfully used as TBI-specific biomarkers. To the best of our knowledge, this is one of the first and unique study of its kind to report immediate and sustained activation of NF kappa B signaling post-TBI in a gender-specific manner by utilizing real-time non-invasive BLI and PAI in NF kappa B-RE-Luc transgenic mice. Our study will prove immensely beneficial to gain novel mechanistic insights underlying TBI, unravel novel therapeutic targets, as well as enable us to monitor in real-time the response to innovative TBI-specific precision-targeted gene and stem cell-based precision medicine.	[Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Wu, Kristopher; Khan, Osaid; Bazley, Kieran; Bussinger, Bret; Kukulka, Klaudia; Zaheer, Smita; Iyer, Shankar S.; Govindarajan, Raghav; Zaheer, Asgar] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA; [Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Wu, Kristopher; Khan, Osaid; Bazley, Kieran; Bussinger, Bret; Kukulka, Klaudia; Zaheer, Smita; Iyer, Shankar S.; Zaheer, Asgar] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65211 USA; [Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Zaheer, Smita; Iyer, Shankar S.; Zaheer, Asgar] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Burton, Casey; James, Donald] Phelps Hlth, Rolla, MO USA		Raikwar, SP; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA.; Raikwar, SP; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65211 USA.; Raikwar, SP; Zaheer, A (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	raikwars@health.missouri.edu; zaheera@health.missouri.edu	Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570	Leonard Wood Institute; US Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG048205]; VA Research Career Scientist Award	Research was sponsored by the Leonard Wood Institute in cooperation with the US Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034. This research was also supported by NIH grant AG048205 and VA Research Career Scientist Award to AZ.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Aelvoet SA, 2014, J NEUROSCI, V34, P16518, DOI 10.1523/JNEUROSCI.4933-13.2014; Ahmed ME, 2021, J NEUROIMMUNE PHARM, V16, P363, DOI 10.1007/s11481-020-09929-4; Ahmed ME, 2020, J NEUROTRAUM, V37, P1645, DOI 10.1089/neu.2019.6932; Ahmed ME, 2017, J ALZHEIMERS DIS, V60, P1143, DOI 10.3233/JAD-170634; Akimoto H, 2009, BIOCHEM BIOPH RES CO, V380, P844, DOI 10.1016/j.bbrc.2009.01.181; [Anonymous], 2013, REP C TRAUM BRAIN IN; Aswendt M, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.2.025006; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Buckley SMK, 2015, SCI REP-UK, V5, DOI 10.1038/srep11842; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Cordeau P, 2012, METHOD ENZYMOL, V506, P117, DOI 10.1016/B978-0-12-391856-7.00031-7; Cordeau P, 2008, STROKE, V39, P935, DOI 10.1161/STROKEAHA.107.501460; Cui GH, 2018, FASEB J, V32, P654, DOI 10.1096/fj.201700600R; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; de Heredia LL, 2011, NEUROSCI LETT, V497, P134, DOI 10.1016/j.neulet.2011.04.046; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dohlen G, 2005, PEDIATR RES, V58, P941, DOI 10.1203/01.PDR.0000182595.62545.EE; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Fricke IB, 2017, EUR J NEUROSCI, V45, P975, DOI 10.1111/ejn.13540; Fukuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05297-x; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Giustetto P, 2015, JOVE-J VIS EXP, DOI 10.3791/52162; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hochgrafe K, 2013, MOL NEUROBIOL, V47, P868, DOI 10.1007/s12035-012-8379-1; Hoey C, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1920-5; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Klose AD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06288-w; Kuchimaru T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11856; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; LIM R, 1981, P NATL ACAD SCI-BIOL, V78, P4373, DOI 10.1073/pnas.78.7.4373; LIM R, 1977, SCIENCE, V195, P195, DOI 10.1126/science.188136; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Lucke-Wold B, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.42; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Morlacchi S, 2011, J IMMUNOL, V186, P6807, DOI 10.4049/jimmunol.1003265; Mukherjee S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01854-w; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Raikwar SP, 2019, MOL NEUROBIOL, V56, P378, DOI 10.1007/s12035-018-1068-y; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rogall R, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0927-9; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roth DJ, 2006, TRANSPLANTATION, V81, P1185, DOI 10.1097/01.tp.0000203808.84963.13; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Selvakumar GP, 2020, EXP NEUROBIOL, V29, P230, DOI 10.5607/en20017; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Tennstaedt A, 2013, METHODS MOL BIOL, V1052, P153, DOI 10.1007/7651_2013_14; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Thangavel R, 2018, J ALZHEIMERS DIS, V61, P553, DOI 10.3233/JAD-170777; Thangavel R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00150; Thangavel R, 2013, NEUROCHEM RES, V38, P1777, DOI 10.1007/s11064-013-1080-6; Toffolo K, 2019, NEUROPHARMACOLOGY, V145, P199, DOI 10.1016/j.neuropharm.2018.08.028; Upputuri PK, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.4.040901; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; White DL, 2020, ANN NEUROL, V88, P33, DOI 10.1002/ana.25726; Wu JC, 2020, NEUROSCIENCE, V440, P160, DOI 10.1016/j.neuroscience.2020.05.045; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yin ZY, 2020, BRAIN BEHAV IMMUN, V83, P270, DOI 10.1016/j.bbi.2019.11.004; Zaheer A, 2001, NEUROCHEM RES, V26, P1293, DOI 10.1023/A:1014241300179; Zaheer A, 2002, BIOCHEM BIOPH RES CO, V294, P238, DOI 10.1016/S0006-291X(02)00467-9; Zaheer A, 2008, BRAIN RES, V1208, P192, DOI 10.1016/j.brainres.2008.02.093; Zaheer A, 2007, J NEUROCHEM, V101, P364, DOI 10.1111/j.1471-4159.2006.04385.x; Zaheer S, 2011, NEUROSCIENCE, V194, P227, DOI 10.1016/j.neuroscience.2011.07.069; Zaheer S, 2012, NEUROCHEM RES, V37, P1578, DOI 10.1007/s11064-012-0753-x; Zaheer S, 2011, BRAIN RES, V1373, P230, DOI 10.1016/j.brainres.2010.12.003	104	4	4	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2021	41	8					1687	1706		10.1007/s10571-020-00937-9		AUG 2020	20	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	WE2JU	WOS:000559327600001	32785863	Green Accepted			2022-02-06	
J	Kerr, NA; Vaccari, JPD; Weaver, C; Dietrich, WD; Ahmed, T; Keane, RW				Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Weaver, Cailey; Dietrich, W. Dalton; Ahmed, Tahir; Keane, Robert W.			Enoxaparin Attenuates Acute Lung Injury and Inflammasome Activation after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						acute lung injury; enoxaparin; inflammasome; traumatic brain injury	EXTRACELLULAR VESICLES; IMMUNE-RESPONSE; HEPARIN; IMPACT; MODEL	Traumatic brain injury (TBI) patients frequently develop cardiopulmonary system complications such as acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). However, the mechanism by which TBI causes ALI/ARDS is not fully understood. Here, we used a severe TBI model to examine the effects of a low-molecular-weight heparin, enoxaparin, on inflammasome activation and lung injury damage. We investigated whether enoxaparin inhibits ALI and inflammasome signaling protein expression in the brain and lungs after TBI in mice. C57/BL6 mice were subjected to severe TBI and were treated with vehicle or 1 mg/kg of enoxaparin 30 min after injury. Lung and brain tissue were collected 24 h post-TBI and were analyzed by immunoblotting for expression of the inflammasome proteins, caspase-1 and interleukin (IL)-1 beta. In addition, lung tissue was collected for histological analysis to determine ALI scoring and neutrophil and macrophage infiltration post-injury. Our data show that severe TBI induces increased expression of inflammasome proteins caspase-1 and IL-1 beta in the brain and lungs of mice after injury. Treatment with enoxaparin attenuated inflammasome expression in the brain and lungs 24 h after injury. Enoxaparin significantly decreased ALI score as well as neutrophil and macrophage infiltration in lungs at 24 h after injury. This study demonstrates that enoxaparin attenuates ALI and inhibits inflammasome expression in the brain and lungs after TBI. These findings support the hypothesis that inhibition of the neural-respiratory inflammasome axis that is activated after TBI may have therapeutic potential.	[Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Dietrich, W. Dalton; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Weaver, Cailey; Keane, Robert W.] Univ Miami, Dept Physiol & Biophys, Miller Sch Med, 1600 Northwest 10th Ave,RMSB 5054, Miami, FL 33136 USA; [Ahmed, Tahir] Mt Sinai Med Ctr, Pulm Div, Miami Beach, FL 33140 USA		Keane, RW (corresponding author), Univ Miami, Dept Physiol & Biophys, Miller Sch Med, 1600 Northwest 10th Ave,RMSB 5054, Miami, FL 33136 USA.	rkeane@miami.edu	de Rivero Vaccari, Juan Pablo/ABE-3248-2020; de Rivero Vaccari, Juan Pablo/H-5718-2019	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; 	R01 grant; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS113969-01]; NINDS NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 0421133]	This project was supported by an R01 grant to R.W.K. and J.P.d.R.V., NINDS: R01NS113969-01 and WDD NINDS NIH RO1 0421133.	AHMED T, 1994, J APPL PHYSIOL, V76, P893, DOI 10.1152/jappl.1994.76.2.893; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Baharvahdat Humain, 2019, Surg Neurol Int, V10, P10, DOI 10.4103/sni.sni_112_18; Beard K, 2020, J NEUROTRAUM, V37, P2045, DOI 10.1089/neu.2020.6990; Campo C, 1999, J APPL PHYSIOL, V86, P549, DOI 10.1152/jappl.1999.86.2.549; Campolo M, 2018, METHODS MOL BIOL, V1727, P385, DOI 10.1007/978-1-4939-7571-6_30; Chi W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0360-2; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Gupta N, 2017, P NATL ACAD SCI USA, V114, P4763, DOI 10.1073/pnas.1620458114; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Huang XF, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1264913; Kerr N, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113080; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Kerr NA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010069; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kokiko-Cochran ON, 2018, J NEUROTRAUM, V35, P73, DOI 10.1089/neu.2017.5203; LANE DA, 1993, NEW ENGL J MED, V329, P129, DOI 10.1056/NEJM199307083290212; Laskin DL, 2019, TOXICOL SCI, V168, P287, DOI 10.1093/toxsci/kfy309; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mahida RY, 2020, AM J RESP CELL MOL, V63, P15, DOI 10.1165/rcmb.2019-0447TR; Margolis L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000363; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mousavi S, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/507151; Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841; NELSON RM, 1993, BLOOD, V82, P3253; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Pegtel DM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0516; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Shastri MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126763; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; van der Merwe Yolandi, 2017, Curr Ophthalmol Rep, V5, P276, DOI 10.1007/s40135-017-0153-0; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yates AG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02723; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	54	4	4	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					646	654		10.1089/neu.2020.7257		AUG 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000558955200001	32669032				2022-02-06	
J	Pilkar, R; Karunakaran, KK; Veerubhotla, A; Ehrenberg, N; Ibironke, O; Nolan, KJ				Pilkar, Rakesh; Karunakaran, Kiran K.; Veerubhotla, Akhila; Ehrenberg, Naphtaly; Ibironke, Oluwaseun; Nolan, Karen J.			Evaluating Sensory Acuity as a Marker of Balance Dysfunction After a Traumatic Brain Injury: A Psychophysical Approach	FRONTIERS IN NEUROSCIENCE			English	Article						sensory threshold detection; posturography; traumatic brain injury; balance; rehabilitation	PERTURBATIONS; SWAY; PROPRIOCEPTION; DEFICITS	There is limited research on sensory acuity i.e., ability to perceive external perturbations via body-sway during standing in individuals with a traumatic brain injury (TBI). It is unclear whether sensory acuity diminishes after a TBI and if it is a contributing factor to balance dysfunction. The objective of this investigation is to first objectively quantify the sensory acuity in terms of perturbation perception threshold (PPT) and determine if it is related to functional outcomes of static and dynamic balance. Ten individuals with chronic TBI and 11 age-matched healthy controls (HC) performed PPT assessments at 0.33, 0.5, and 1 Hz horizontal perturbations to the base of support in the anterior-posterior direction, and a battery of functional assessments of static and dynamic balance and mobility [Berg balance scale (BBS), timed-up and go (TUG) and 5-m (5MWT) and 10-m walk test (10MWT)]. A psychophysical approach based on Single Interval Adjustment Matrix Protocol (SIAM), i.e., ayes-notask, was used to quantify the multi-sensory thresholds of perceived external perturbations to calculate PPT. A mixed-design analysis of variance (ANOVA) andpost-hocanalyses were performed using independent and paired t-tests to evaluate within and between-group differences. Pearson correlation was computed to determine the relationship between the PPT and functional measures. The PPT values were significantly higher for the TBI group (0.33 Hz: 2.97 +/- 1.0, 0.5 Hz: 2.39 +/- 0.7, 1 Hz: 1.22 +/- 0.4) compared to the HC group (0.33 Hz: 1.03 +/- 0.6, 0.5 Hz: 0.89 +/- 0.4, 1 Hz: 0.42 +/- 0.2) for all three perturbation frequencies (p< 0.006 post Bonferroni correction). For the TBI group, the PPT for 1 Hz perturbations showed significant correlation with the functional measures of balance (BBS:r= -0.66,p= 0.037; TUG:r= 0.78,p= 0.008; 5MWT:r= 0.67,p= 0.034, 10MWT:r= 0.76,p= 0.012). These findings demonstrate that individuals with TBI have diminished sensory acuity during standing which may be linked to impaired balance function after TBI.	[Pilkar, Rakesh; Karunakaran, Kiran K.; Veerubhotla, Akhila; Ehrenberg, Naphtaly; Ibironke, Oluwaseun; Nolan, Karen J.] Kessler Fdn, Ctr Mobil & Rehabil Engn Res, W Orange, NJ 07052 USA; [Pilkar, Rakesh; Veerubhotla, Akhila; Nolan, Karen J.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Karunakaran, Kiran K.] New Jersey Inst Technol, Newark, NJ 07102 USA; [Karunakaran, Kiran K.; Nolan, Karen J.] Childrens Specialized Hosp, New Brunswick, NJ USA		Pilkar, R (corresponding author), Kessler Fdn, Ctr Mobil & Rehabil Engn Res, W Orange, NJ 07052 USA.; Pilkar, R (corresponding author), Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA.	rpilkar@kessklerfoundation.org	Karunakaran, Kiran/AAW-8583-2021	Veerubhotla, Akhila/0000-0003-1740-8144; Nolan, PhD, Karen J./0000-0002-4667-0873	New Jersey Commission on Brain Injury Research (NJCBIR) Multi-Investigator Grant [CBIR15MIG004]	This study was supported by the New Jersey Commission on Brain Injury Research (NJCBIR) Multi-Investigator Grant CBIR15MIG004.	Algom D., 1992, PSYCHOPHYSICAL APPRO; Allison L., 1999, NEUROLOGY REPORT, V23, P13, DOI DOI 10.1097/01253086-199923010-00010; Berg R.L., 1992, 2 50 YEARS PROMOTING; Charkhkar H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63936-2; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Han J, 2016, J SPORT HEALTH SCI, V5, P80, DOI 10.1016/j.jshs.2014.10.004; Hillier SL, 1997, BRAIN INJURY, V11, P661; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Huang H, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-11; KAERNBACH C, 1990, J ACOUST SOC AM, V88, P2645, DOI 10.1121/1.399985; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Peterka RJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01045; Petrini FM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8939; Pilkar R., 2011, ANAL HUMAN POSTURAL; Pilkar R, 2016, IEEE ENG MED BIO, P25, DOI 10.1109/EMBC.2016.7590631; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Puntkattalee MJ, 2016, GAIT POSTURE, V48, P77, DOI 10.1016/j.gaitpost.2016.04.008; Richerson SJ, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-2; Richerson SJ, 2003, GAIT POSTURE, V18, P11, DOI 10.1016/S0966-6362(02)00189-3; ROBBINS S, 1995, AGE AGEING, V24, P67, DOI 10.1093/ageing/24.1.67; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Straudi S, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0871-9; Tanis Daniel, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P5594, DOI 10.1109/EMBC.2018.8513663; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	32	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 11	2020	14								836	10.3389/fnins.2020.00836			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NI5AG	WOS:000565363800001	32848585	gold, Green Published			2022-02-06	
J	Kulesza, B; Mazurek, M; Nogalski, A; Rola, R				Kulesza, Bartlomiej; Mazurek, Marek; Nogalski, Adam; Rola, Radoslaw			Factors with the strongest prognostic value associated with in-hospital mortality rate among patients operated for acute subdural and epidural hematoma	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Epidural hematoma; Subdural hematoma; In-hospital mortality rate	TRAUMATIC BRAIN-INJURY; COMPUTERIZED-TOMOGRAPHY SCAN; HEAD-INJURY; SURGICAL-MANAGEMENT; PREDICTIVE-VALUE; COAGULOPATHY; ALCOHOL; MODERATE; TIME; VALIDATION	Introduction Traumatic brain injury (TBI) still remains a serious health problem and is called a "silent epidemic". Each year in Europe 262 per 100,000 individuals suffer from TBI. The most common consequence of severe head injuries include acute subdural (SDH) and epidural hematomas (EDH), which usually require immediate surgically treatment. The aim of our study is to identify factors which have the strongest prognostic value in relation to in-hospital mortality rate among of patients undergoing surgery for EDH and SDH. Patients and methods Cohort included 128 patients with isolated craniocerebral injuries who underwent surgery for EDH (28 patients) and SDH (100 patients) in a single, tertiary care Department of Neurosurgery. The data were collected on admission of patients to the Emergency Department and retrospectively analyzed. The following factors were analyzed: demographic data, physiological parameters, laboratory variables, computed tomography scan characteristics and the time between trauma and surgery. Likewise, we have investigated the in-hospital mortality of patients at the time of discharge. Results We found that the factors with the strongest prognostic values were: the initial GCS score, respiratory rate, glycaemia, blood saturation, systolic blood pressure, midline shift and type of hematoma. Additionally, we proved that a drop by one point in the GCS score almost doubles the risk of in-hospital death while the presence of coagulopathy increases the risk of in-hospital death almost six times. Conclusion Most of the factors with the strongest prognostic value are factors that the emergency team can treat prior to the hospital admission. Coagulopathy, however that has the strongest influence on in-hospital death rate can only be efficiently treated in a hospital setting.	[Kulesza, Bartlomiej; Mazurek, Marek; Rola, Radoslaw] Med Univ Lublin, Chair & Dept Neurosurg & Paediat Neurosurg, Independent Publ Clin Hosp Lublin 4, Jaczewskiego 8, PL-20954 Lublin, Poland; [Nogalski, Adam] Med Univ Lublin, Chair & Dept Trauma Surg & Emergency Med, Independent Publ Clin Hosp Lublin Poland 1, Stanislawa Sztaszica 16, PL-20400 Lublin, Poland		Kulesza, B (corresponding author), Med Univ Lublin, Chair & Dept Neurosurg & Paediat Neurosurg, Independent Publ Clin Hosp Lublin 4, Jaczewskiego 8, PL-20954 Lublin, Poland.	kuleszabartek88@gmail.com; marekmazurek@hotmail.com; chirurgiaurazowalublin@tlen.pl; rola.radoslaw@gmail.com	Kulesza, Bartlomiej/AAY-3156-2020; Rola, Radoslaw/AAQ-5587-2021	Kulesza, Bartlomiej/0000-0002-9973-9571; Rola, Radoslaw/0000-0003-0613-6593; Nogalski, Adam/0000-0003-0720-4690			Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Arifin MZ, 2013, J NEUROSURG SCI, V57, P277; Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; Bernier RA, 2016, BRAIN INJURY, V30, P414, DOI 10.3109/02699052.2015.1127998; Bhaskar Naidu P, 2016, INT SUR J, V3, P1306; Bobeff EJ, 2019, J NEUROL SURG PART A, V80, P460, DOI 10.1055/s-0039-1692672; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fujii T, 2016, J CLIN NEUROSCI, V31, P152, DOI 10.1016/j.jocn.2016.03.007; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grigorakos L., 2016, J NEUROSCI CLIN RES, V1, P1; Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0; Gurkanlar D, 2009, TURK NEUROSURG, V19, P211; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Kada AY, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.29.16354; Kalayci M, 2013, J PAK MED ASSOC, V63, P38; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Khan KA, 2019, WORLD NEUROSURG, V126, pE699, DOI 10.1016/j.wneu.2019.02.126; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kotwica Z, 1993, Acta Neurochir (Wien), V121, P95; Kulesza B, 2021, INDIAN J SURG, V83, pS96, DOI 10.1007/s12262-020-02304-w; Kulesza Bartlomiej, 2020, Folia Med (Plovdiv), V62, P94, DOI 10.3897/folmed.62.e47743; Kulesza B, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030174; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mohindra S, 2008, SURG NEUROL, V69, P474, DOI 10.1016/j.surneu.2007.02.031; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Rejeb I, 2015, J ACUTE DIS, V4, P68, DOI 10.1016/S2221-6189(14)60087-1; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sergides IG, 2006, BRIT J NEUROSURG, V20, P301, DOI 10.1080/02688690600999976; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wood RL, 1981, APPL CONDITIONING TH, P81; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0	73	4	4	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1517	1525		10.1007/s00068-020-01460-8		AUG 2020	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000558883200003	32776246	Green Published, hybrid			2022-02-06	
J	Tang, YL; Dong, XY; Chen, GF; Ye, W; Kang, JW; Tang, Y; Feng, Z				Tang, Yunliang; Dong, Xiaoyang; Chen, Gengfa; Ye, Wen; Kang, Junwei; Tang, Yang; Feng, Zhen			Vagus Nerve Stimulation Attenuates Early Traumatic Brain Injury by Regulating the NF-kappa B/NLRP3 Signaling Pathway	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						NF-kappa B/NLRP3 pathway; traumatic brain injury; vagus nerve stimulation; TBI weight-dropping model; oxidative stress; inflammation	NLRP3 INFLAMMASOME; OXIDATIVE STRESS; RAT MODEL; NEUROINFLAMMATION; CONTRIBUTES; MECHANISMS; MODERATE; OUTCOMES; SENSOR	Background. Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Oxidative stress, inflammation, and apoptosis are vital pathophysiological features post-TBI. Objectives. Research has shown that vagus nerve stimulation (VNS) can attenuate oxidative stress in various diseases. However, the critical role of VNS in TBI is still not completely understood. This study investigated the protective effects and potential mechanism of VNS on TBI. Methods Male Sprague-Dawley rats were randomized into 3 groups: sham, TBI, and TBI + VNS. The TBI model was induced in rats by the free-fall drop method. The vagal nerve trunk was separated, and VNS was performed after establishing the TBI model. Results.The results showed that VNS significantly ameliorated tissue damage, neurological deficits, and cerebral edema, compared with the sham VNS group. Additionally, VNS alleviated oxidative stress, inflammation, and apoptosis in the pericontusive cortex of rats after TBI. VNS also significantly suppressed expression of the nuclear factor-kappa B (NF-kappa B) protein in the nucleus and activation of the nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome. Conclusions.Taken together, the present study indicates that VNS may attenuate brain damage after TBI by inhibiting oxidative stress, inflammation, and apoptosis, possibly through the NF-kappa B/NLRP3 signaling pathway.	[Tang, Yunliang; Dong, Xiaoyang; Chen, Gengfa; Ye, Wen; Kang, Junwei; Tang, Yang; Feng, Zhen] Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China.	fengzhen@email.ncu.edu.cn		Tang, Yunliang/0000-0002-9431-1912	National Natural Science Funds of ChinaNational Natural Science Foundation of China (NSFC) [81860409, 81660382]; Youth Foundation of Science and Technology Research of Jiangxi Educational Committee [GJJ190125]; Graduate Students Innovation Fund Project in Jiangxi Province [YC2019-B036]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Support was provided by grants from the National Natural Science Funds of China (No. 81860409 and No. 81660382), the Youth Foundation of Science and Technology Research of Jiangxi Educational Committee (No. GJJ190125), and Graduate Students Innovation Fund Project in Jiangxi Province (No. YC2019-B036).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Borckardt Jeffrey J, 2005, Pain Res Manag, V10, P9; Caravaca AS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carteri RB, 2019, J NEUROTRAUM, V36, P2246, DOI 10.1089/neu.2018.6266; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cimpianu CL, 2017, J NEURAL TRANSM, V124, P145, DOI 10.1007/s00702-016-1642-2; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Dong XY, 2018, NEURAL REGEN RES, V13, P244, DOI 10.4103/1673-5374.226395; Ehsaei M, 2015, ACTA NEUROL BELG, V115, P69, DOI 10.1007/s13760-014-0300-4; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Gan L, 2015, BIOMED ENVIRON SCI, V28, P148, DOI 10.3967/bes2015.019; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Johnson RL, 2018, J INFLAMM RES, V11, P203, DOI 10.2147/JIR.S163248; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Morris GL, 2013, NEUROLOGY, V81, P1453, DOI 10.1212/WNL.0b013e3182a393d1; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Neren D, 2016, NEUROCRIT CARE, V24, P308, DOI 10.1007/s12028-015-0203-0; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tang YL, 2020, NEURAL REGEN RES, V15, P2262, DOI 10.4103/1673-5374.284996; Tang YL, 2020, BIOCHEM BIOPH RES CO, V521, P77, DOI 10.1016/j.bbrc.2019.10.076; Vijgen GHEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077221; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Xu X, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1655-x; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Xue T, 2012, TOXICOL APPL PHARM, V261, P280, DOI 10.1016/j.taap.2012.04.010; Yang LY, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113135; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763	48	4	4	3	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	SEP	2020	34	9					831	843	1545968320948065	10.1177/1545968320948065		AUG 2020	13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NQ2IX	WOS:000558807000001	32772884				2022-02-06	
J	Lin, C; Wu, W; Lu, H; Li, WT; Bao, ZY; Wang, YY; Zhao, L; Guo, TW; Cai, N; Li, Z; Ji, J; Hou, LJ; You, YP; Liu, N				Lin, Chao; Wu, Wei; Lu, Hua; Li, Wentao; Bao, Zhongyuan; Wang, Yingyi; Zhao, Lin; Guo, Tianwei; Cai, Ning; Li, Zheng; Ji, Jing; Hou, Lijun; You, Yongping; Liu, Ning			MMP-9 Inhibitor GM6001 Prevents the Development of ssTBI-Induced Parkinson's Disease via the Autophagy Pathway	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Blood-brain barrier; MMP-9; Mitophagy; Parkinson's disease	BLOOD-BRAIN-BARRIER; ALPHA-SYNUCLEIN; INJURY; DEGRADATION; PINK1; IMPAIRMENTS; PATHOLOGY; TARGET	Concussion is a widely recognized environmental risk factor for neurodegenerative diseases, including Parkinson's disease (PD). Small-vessel disease of the brain has been reported to contribute to neurodegenerative diseases. In this study, we observed BBB disruption in wild-type (WT) mice, but not in matrix metalloproteinase 9 (MMP-9) knockout mice, subjected to single severe traumatic brain injury (ssTBI). Furthermore, treating ssTBI mice with the MMP-9 inhibitor GM6001 effectively maintained BBB integrity, promoted the elimination of damaged mitochondria via mitophagy, and then prevented neuronal death and progressive neurodegeneration. However, we did not observe this neuroprotective effect of MMP-9 inhibition in beclin-1(-/+)mice. Collectively, these findings revealed that concussion led to BBB disruption via MMP-9, and that GM6001 prevented the development of PD via the autophagy pathway.	[Lin, Chao; Wu, Wei; Lu, Hua; Li, Wentao; Bao, Zhongyuan; Wang, Yingyi; Zhao, Lin; Li, Zheng; Ji, Jing; You, Yongping; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Peoples R China; [Lin, Chao; Wu, Wei; Lu, Hua; Li, Wentao; Bao, Zhongyuan; Wang, Yingyi; Zhao, Lin; Li, Zheng; Ji, Jing; You, Yongping; Liu, Ning] Jiangsu Prov Hosp, Dept Neurosurg, Nanjing 210029, Peoples R China; [Guo, Tianwei] Nanjing Univ Chinese Med, ChangShu Hosp, Dept Pathol, Huanghe Rd 6, Changshu, Jiangsu, Peoples R China; [Cai, Ning] Jiangsu Univ, Affiliated Hosp, Dept Neurosurg, Zhenjiang 212002, Jiangsu, Peoples R China; [Hou, Lijun] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China		Lin, C; Ji, J; Liu, N (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Peoples R China.; Lin, C; Ji, J; Liu, N (corresponding author), Jiangsu Prov Hosp, Dept Neurosurg, Nanjing 210029, Peoples R China.	410linchao@163.com; jijing@njmu.edu.cn; liuning_0853@163.com		Guo, Tianwei/0000-0002-2028-320X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901258, 81972153]; National Natural Science Foundation of Zhenjiang [SH2019030]	This work was supported by a grant from the National Natural Science Foundation of China (Grant No. 81901258, Chao Lin, and 81972153, Jing Ji) and Zhenjiang (Grant No. SH2019030, Cai Ning).	Abudu YP, 2019, AUTOPHAGY, V15, P1845, DOI 10.1080/15548627.2019.1637642; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Charkviani M, 2019, EUR J NEUROSCI, V50, P2860, DOI 10.1111/ejn.14390; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Engelender S, 2012, AUTOPHAGY, V8, P418, DOI 10.4161/auto.19085; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Heckmann BL, 2019, CELL, V178, P536, DOI 10.1016/j.cell.2019.05.056; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lahiri V, 2017, AUTOPHAGY, V13, P1259, DOI 10.1080/15548627.2017.1327512; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Navaratna D, 2013, J CLIN INVEST, V123, P3373, DOI 10.1172/JCI65767; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Walchli T, 2015, NAT PROTOC, V10, P53, DOI 10.1038/nprot.2015.002; Wang LM, 2018, CELL RES, V28, P787, DOI 10.1038/s41422-018-0056-0; Wu S, 2018, P NATL ACAD SCI USA, V115, pE5669, DOI 10.1073/pnas.1721173115; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	32	4	4	1	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2021	41	8					1651	1663		10.1007/s10571-020-00933-z		AUG 2020	13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	WE2JU	WOS:000557124700001	32770297				2022-02-06	
J	Robba, C; Asgari, S; Gupta, A; Badenes, R; Sekhon, M; Bequiri, E; Hutchinson, PJ; Pelosi, P; Gupta, A				Robba, Chiara; Asgari, Shadnaz; Gupta, Amit; Badenes, Rafael; Sekhon, Mypinder; Bequiri, Erta; Hutchinson, Peter J.; Pelosi, Paolo; Gupta, Arun			Lung Injury Is a Predictor of Cerebral Hypoxia and Mortality in Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mortality outcome; traumatic brain injury; cerebral oxygenation; partial arterial oxygen pressure; lung injury; hypoxia threshold	RESPIRATORY-DISTRESS-SYNDROME; TISSUE OXYGEN; PERFUSION-PRESSURE; NEUROCRITICAL CARE; METABOLISM; OUTCOMES; THERAPY; AUTOREGULATION; MANAGEMENT; HYPEROXIA	Background:A major contributor to unfavorable outcome after traumatic brain injury (TBI) is secondary brain injury. Low brain tissue oxygen tension (PbtO2) has shown to be an independent predictor of unfavorable outcome. Although PbtO2 provides clinicians with an understanding of the ischemic and non-ischemic derangements of brain physiology, its value does not take into consideration systemic oxygenation that can influence patients' outcomes. This study analyses brain and systemic oxygenation and a number of related indices in TBI patients: PbtO2, partial arterial oxygenation pressure (PaO2), PbtO2/PaO2, ratio of PbtO2 to fraction of inspired oxygen (FiO2), and PaO2/FiO2. The primary aim of this study was to identify independent risk factors for cerebral hypoxia. Secondary goal was to determine whether any of these indices are predictors of mortality outcome in TBI patients. Materials and Methods:A single-centre retrospective cohort study of 70 TBI patients admitted to the Neurocritical Care Unit (NCCU) at Cambridge University Hospital in 2014-2018 and undergoing advanced neuromonitoring including invasive PbtO2 was conducted. Three hundred and three simultaneous measurements of PbtO2, PaO2, PbtO2/PaO2, PbtO2/FiO2, PaO2/FiO2 were collected and mortality at discharge from NCCU was considered as outcome. Generalized estimating equations were used to analyse the longitudinal data. Results:Our results showed PbtO2 of 28 mmHg as threshold to define cerebral hypoxia. PaO2/FiO2 found to be a strong and independent risk factor for cerebral hypoxia when adjusting for confounding factor of intracranial pressure (ICP) with adjusted odds ratio of 1.78, 95% confidence interval of (1.10-2.87) andp-value = 0.019. With respect to TBI outcome, compromised values of PbtO2, PbtO2/PaO2, PbtO2/FiO2, and PaO2/FiO2 were all independent predictors of mortality while considered individually and adjusting for confounding factors of ICP, age, gender, and cerebral perfusion pressure (CPP). However, when considering all the compromised values together, only PaO2/FiO2 became an independent predictor of mortality with adjusted odds ratio of 3.47 (1.20-10.04) andp-value = 0.022. Conclusions:Brain and Lung interaction in TBI patients is a complex interrelationship. PaO2/FiO2 seems to be a major determinant of cerebral hypoxia and mortality. These results confirm the importance of employing ventilator strategies to prevent cerebral hypoxia and improve the outcome in TBI patients.	[Robba, Chiara] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anaesthesia & Intens Care, Genoa, Italy; [Asgari, Shadnaz] Calif State Univ Long Beach, Biomed Engn Dept, Long Beach, CA 90840 USA; [Asgari, Shadnaz] Calif State Univ Long Beach, Comp Engn & Comp Sci Dept, Long Beach, CA 90840 USA; [Gupta, Amit] Midessex Hosp Trust, Broomfield Hosp, Emergency Dept, United Kingdom, Essex, England; [Badenes, Rafael] Univ Valencia, Dept Surg, Valencia, Spain; [Sekhon, Mypinder] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Bequiri, Erta; Hutchinson, Peter J.] Hills Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge, England; [Bequiri, Erta] Milan Univ, Dept Physiol & Transplantat, Milan, Italy; [Pelosi, Paolo] Univ Genoa, Dipartimento Sci Chirurg & Diagnost Integrate, Genoa, Italy; [Gupta, Arun] Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England		Robba, C (corresponding author), San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anaesthesia & Intens Care, Genoa, Italy.	kiarobba@gmail.com		Badenes, Rafael/0000-0001-7017-0150	NIHR (Research Professorship, Senior Investigator Award, Cambridge BRC); Royal College of Surgeons of England	PH is supported by the NIHR (Research Professorship, Senior Investigator Award, Cambridge BRC) and the Royal College of Surgeons of England.	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Arikan F, 2015, NEUROSURGERY, V76, P302, DOI 10.1227/NEU.0000000000000609; Arikan F, 2014, J NEUROSURG ANESTH, V26, P328, DOI 10.1097/ANA.0000000000000033; Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Brown SM, 2017, THORAX, V72, P1094, DOI 10.1136/thoraxjnl-2017-210337; Carney N, 2016, NEUROSURGERY, DOI [DOI 10.1227/NEU.0000000000001432, 10.1227/NEU.0000000000001432, 10.1227/neu.0000000000001432]; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Frisvold SK, 2019, INTENS CARE MED, V45, P683, DOI 10.1007/s00134-019-05556-7; Griesdale DE, 2015, NEUROCRIT CARE, V23, P78, DOI 10.1007/s12028-014-0096-3; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hirschi R, 2019, J NEUROSURG, V131, P1216, DOI 10.3171/2018.4.JNS172604; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y	39	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 7	2020	11								771	10.3389/fneur.2020.00771			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NI4SU	WOS:000565344400001	32849225	gold, Green Published			2022-02-06	
J	Edwards, KA; Leete, JJ; Tschiffely, AE; Moore, CY; Dell, KC; Statz, JK; Carr, W; Walker, PB; LoPresti, ML; Ahlers, ST; Yarnell, AM; Gill, J				Edwards, Katie A.; Leete, Jacqueline J.; Tschiffely, Anna E.; Moore, Candace Y.; Dell, Kristine C.; Statz, Jonathan K.; Carr, Walter; Walker, Peter B.; LoPresti, Matthew L.; Ahlers, Stephen T.; Yarnell, Angela M.; Gill, Jessica			Blast exposure results in tau and neurofilament light chain changes in peripheral blood	BRAIN INJURY			English	Article						Blast exposure; tau; peripheral biomarkers; military; neurofilament light chain (NFL)	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; BIOMARKERS; SYMPTOMS; MODEL	Objectives To evaluate how blast exposure impacts peripheral biomarkers in military personnel enrolled in 10-day blast training. Methods On day 7, 21 military personnel experienced peak overpressure <2 pounds per square inch (psi); while 29 military personnel experienced peak overpressure >= 5 psi. Blood samples were collected each day to measure changes in amyloid beta (A beta), neurofilament light chain (NFL), and tau concentrations. Results Within 24 hours following exposure >= 5 psi, the >= 5 psi group had lower A beta 42 (p= .004) and NFL (p< .001) compared to the <2 psi group and lower A beta 42 (9.35%) and NFL (22.01%) compared to baseline. Twenty-four hours after >= 5 psi exposure, the >= 5 psi group had lower tau (p< .001) and NFL (p< .001) compared to the <2 psi group and baseline. Seventy-two hours after exposure >= 5 psi, tau increased in the >= 5 psi group compared to the <2 psi group (p= .02) and baseline. The tau:A beta 42 ratio 24 hours after blast (p= .012), and the A beta 40:A beta 42 ratio 48 hours after blast (p= .04) differed in the >= 5 psi group compared to the Conclusions These findings provide an initial report of acute alterations in biomarker concentrations following blast exposure.	[Edwards, Katie A.; Leete, Jacqueline J.; Moore, Candace Y.; Gill, Jessica] NINR, NIH, Bethesda, MD 20814 USA; [Edwards, Katie A.; Statz, Jonathan K.] Henry M Jackson Fdn, Bethesda, MD USA; [Tschiffely, Anna E.; Statz, Jonathan K.] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD USA; [Dell, Kristine C.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [LoPresti, Matthew L.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Walker, Peter B.] Joint Artificial Intelligence Ctr, Arlington, VA USA; NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Yarnell, Angela M.] Uniformed Serv Univ Hlth Sci, Mil Emergency Med Dept, Bethesda, MD 20814 USA; [Gill, Jessica] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Silver Spring, MD USA		Gill, J (corresponding author), NINR, NIH, Bethesda, MD 20814 USA.	gillj@mail.nih.gov			National Institute of Nursing Research Intramural Program; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Navy Bureau of Medicine [WUN 603115HP.2380.001.A1304]; U.S. Defense Health Program Joint Project Committee (JPC) 5	This work was supported by the National Institute of Nursing Research Intramural Program, the US Army Medical Research and Materiel Command, the US Navy Bureau of Medicine (WUN 603115HP.2380.001.A1304.), and by the U.S. Defense Health Program Joint Project Committee (JPC) 5.	Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee BG, 2018, J NEUROTRAUM, V35, P2015, DOI 10.1089/neu.2017.5558; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Rosenberg RN, 2016, JAMA NEUROL, V73, P867, DOI 10.1001/jamaneurol.2016.0301; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	38	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1213	1221		10.1080/02699052.2020.1797171		AUG 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000555639900001	32755419				2022-02-06	
J	Fan, GX; Wang, HL; Ding, JK; Xu, C; Liu, YL; Wang, C; Li, ZF				Fan, Gangxian; Wang, Henglu; Ding, Jinke; Xu, Chao; Liu, Yongliang; Wang, Chao; Li, Zefu			Application of Absolute Alcohol in the Treatment of Traumatic Intracranial Hemorrhage via Interventional Embolization of Middle Meningeal Artery	FRONTIERS IN NEUROLOGY			English	Article						absolute alcohol; embolization; acute epidural hematoma; chronic subdural hematoma; middle meningeal artery	CHRONIC SUBDURAL-HEMATOMA; ACUTE EPIDURAL HEMATOMA; ETHANOL SCLEROTHERAPY; ENDOVASCULAR EMBOLIZATION; VENOUS MALFORMATIONS; MANAGEMENT; THERAPY; FISTULA; SURGERY; LEVEL	Background:Traumatic brain injury is a common condition in neurosurgery. Traditional methods of treatment include conservative treatment and surgical evacuation using burr-holes or craniotomy; however, studies have reported problems such as high re-expansion rates after conservative treatment of epidural hematoma and high postoperative recurrence rates of subdural hematoma. Solutions to these problems are lacking, and research into new treatment methods is ongoing. Among the potential new treatments, middle meningeal arterial embolization is an option. This study involved patients with acute epidural hematoma and chronic subdural hematoma. The purpose was to evaluate the use and effects of absolute alcohol to embolize the middle meningeal artery to treat intracranial hematoma. Material and Methods:A retrospective description study was 12 cases of intracranial hematoma who treated with absolute alcohol interventional therapy from our hospital between June 2018 and October 2019. Five patients with acute epidural hematoma and seven patients with chronic subdural hematoma were treated using absolute alcohol to embolize the middle meningeal artery. Patients' clinical data, imaging results, surgical results, and prognosis were recorded and analyzed. Results:All patients underwent absolute alcohol embolization of the middle meningeal artery, in combination with burr-hole drainage. All imaging data were confirmed preoperatively. We successfully used absolute alcohol to embolize the middle meningeal artery intraoperatively and confirmed these results by postoperative angiography. All patients achieved symptomatic relief without complications, and no recurrence or re-expansion was seen with follow-up computed tomography. Our study has been registered in the Chinese Clinical Trial Registry ((http://www.chictr.org.cn,, ChiCTR1800018714). Conclusion:The use of absolute alcohol to embolize the middle meningeal artery could be used as an attempt to treat acute epidural hematoma and chronic subdural hematoma.	[Fan, Gangxian; Wang, Henglu; Ding, Jinke; Xu, Chao; Liu, Yongliang; Wang, Chao; Li, Zefu] Binzhou Med Univ Hosp, Dept Neurosurg, Binzhou, Peoples R China		Wang, C; Li, ZF (corresponding author), Binzhou Med Univ Hosp, Dept Neurosurg, Binzhou, Peoples R China.	chaowang_0628@163.com; lizefu163@163.com			Shandong Province Natural Science Foundation of China [ZR2017LH033, ZR2018LH007]; Binzhou Medical University Scientific Research Foundation [BY2016KYQD15, BY2018KJ02]	This work was supported by Shandong Province Natural Science Foundation of China (ZR2017LH033, ZR2018LH007) and Binzhou Medical University Scientific Research Foundation (BY2016KYQD15, BY2018KJ02).	Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Andersen-Ranberg NC, 2017, J NEUROSURG, V126, P1905, DOI 10.3171/2016.4.JNS152642; Barbier C, 2008, J NEURORADIOLOGY, V35, P230, DOI 10.1016/j.neurad.2008.01.001; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Cantwell Colin P, 2008, Semin Intervent Radiol, V25, P319, DOI 10.1055/s-0028-1085932; Chen H, 2009, J VASC SURG, V49, P429, DOI 10.1016/j.jvs.2008.08.051; Clarencon F, 2012, AM J NEURORADIOL, V33, P148, DOI 10.3174/ajnr.A2735; de Andrade AF, 2008, NEUROSURGERY, V62, P416, DOI 10.1227/01.neu.0000316008.11388.f2; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Ernemann U, 2004, AM J NEURORADIOL, V25, P1792; Guo C, 2017, NEUROL SCI, V38, P2111, DOI 10.1007/s10072-017-3121-4; Hammer FD, 2001, J VASC INTERV RADIOL, V12, P595, DOI 10.1016/S1051-0443(07)61482-1; Hashimoto Takao, 2013, Surg Neurol Int, V4, P104, DOI 10.4103/2152-7806.116679; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishihara H, 2007, Interv Neuroradiol, V13 Suppl 1, P141; Kim Dong Ho, 2015, Korean J Neurotrauma, V11, P167, DOI 10.13004/kjnt.2015.11.2.167; Kim E, 2017, WORLD NEUROSURG, V101, P520, DOI 10.1016/j.wneu.2017.02.070; Kim IS, 2007, MINIM INVAS NEUROSUR, V50, P86, DOI 10.1055/s-2007-982503; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; Kung WM, 2012, INJURY, V43, P598, DOI 10.1016/j.injury.2010.07.240; Lammy S, 2013, BRIT J NEUROSURG, V27, P383, DOI 10.3109/02688697.2012.717981; Lan M, 2020, WORLD NEUROSURG, V133, pE757, DOI 10.1016/j.wneu.2019.09.148; Lee CH, 2005, BRIT J PLAST SURG, V58, P1073, DOI 10.1016/j.bjps.2005.04.014; Lee CH, 2004, ANZ J SURG, V74, P1126, DOI 10.1111/j.1445-1433.2004.03255.x; Link TW, 2018, WORLD NEUROSURG, V118, pE570, DOI 10.1016/j.wneu.2018.06.241; Link TW, 2018, OPER NEUROSURG, V14, P556, DOI 10.1093/ons/opx154; LINK TW, 2018, INTERV NEURORADIOL, V0024; Liu WG, 2008, BRAIN INJURY, V22, P199, DOI 10.1080/02699050801895407; Marvin Eric, 2016, Surg Neurol Int, V7, pS23, DOI 10.4103/2152-7806.173564; Misaki K, 2008, NEUROL MED-CHIR, V48, P208, DOI 10.2176/nmc.48.208; Nelson JA, 2011, ACAD EMERG MED, V18, P78, DOI 10.1111/j.1553-2712.2010.00949.x; Paramasivam S, 2013, J NEUROINTERV SURG, V5, P321, DOI 10.1136/neurintsurg-2012-010318; Peres CMA, 2018, J NEUROSURG, V128, P1044, DOI 10.3171/2016.11.JNS161398; Prasetyono TOH, 2010, J PLAST RECONSTR AES, V63, P1071, DOI 10.1016/j.bjps.2009.04.020; Rimon U, 2004, EUR J RADIOL, V52, P283, DOI 10.1016/j.ejrad.2003.09.010; Ross IB, 2009, J NEUROSURG, V110, P1247, DOI 10.3171/2008.7.JNS0883; SAKAI H, 1988, J NEUROSURG, V68, P566, DOI 10.3171/jns.1988.68.4.0566; Singh P, 2011, NEUROSURGERY, V68, P78, DOI 10.1227/NEU.0b013e3181fc60e9; Suzuki S, 2004, AM J NEURORADIOL, V25, P1177; Takizawa K, 2016, J NEUROSURG, V124, P1679, DOI 10.3171/2015.5.JNS1567; Tempaku A, 2015, INTERV NEURORADIOL, V21, P366, DOI 10.1177/1591019915583224; Unnikrishnan KP, 2007, CAN J ANAESTH, V54, P908, DOI 10.1007/BF03026795; Van Ornam J, 2019, AM J EMERG MED, V37, P1694, DOI 10.1016/j.ajem.2018.12.012; Yu JL, 2016, INT J MED SCI, V13, P790, DOI 10.7150/ijms.16489; Zhang YH, 2018, WORLD NEUROSURG, V110, P206, DOI 10.1016/j.wneu.2017.11.047	45	4	4	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 6	2020	11								824	10.3389/fneur.2020.00824			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NF5NH	WOS:000563342900001	32903661	gold, Green Published			2022-02-06	
J	Fang, YJ; Lu, JN; Wang, XY; Wu, HJ; Mei, SH; Zheng, JW; Xu, SB; Lenahan, C; Chen, S; Zhang, JM; Hong, Y				Fang, Yuanjian; Lu, Jianan; Wang, Xiaoyu; Wu, Haijian; Mei, Shuhao; Zheng, Jingwei; Xu, Shenbin; Lenahan, Cameron; Chen, Sheng; Zhang, Jianmin; Hong, Yuan			HIF-1 alpha Mediates TRAIL-Induced Neuronal ApoptosisviaRegulating DcR1 Expression Following Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; tumor necrosis factor-related apoptosis-inducing ligand; death receptor 5; decoy receptor; hypoxia-induced factor-1 alpha	CENTRAL-NERVOUS-SYSTEM; LIGAND TRAIL; UP-REGULATION; CELL-DEATH; HYPOXIA; APOPTOSIS; INHIBITION; NEUROPROTECTION; MECHANISMS; RECEPTORS	Background: Neuronal apoptosis involved in secondary injury following traumatic brain injury (TBI) significantly contributes to the poor outcomes of patients with TBI. The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis of tumor cells. Hypoxia factor (HIF) 1 alpha is a controversial factor that mediates the neuronal apoptotic pathway. Herein, we hypothesize that HIF-1 alpha may mediate the TRAIL-induced neuronal apoptosis after TBI. Methods: We used Western blots and immunofluorescence to study the expression and cell localization of TRAIL and death receptor 5 (DR5) after TBI in rats. Soluble DR5 (sDR5) administration was used to block the TRAIL-induced neuronal death and neural deficits. HIF-1 alpha inhibitor 2ME and agonist DMOG were used to study the role of HIF-1 alpha in TRAIL-induced neuronal death. Meanwhile, HIF-1 alpha siRNA was used to investigate the role of HIF-1 alpha in TRAIL-induced neuronal deathin vitro. Results: The expressions of microglia-located TRAIL and neuron-located DR5 were significantly upregulated after TBI. sDR5 significantly attenuated TRAIL-induced neuronal apoptosis and neurological deficits. 2ME decreased neuronal apoptosis, lesion area, and brain edema and improved neurological functionviaincreased expression of TRAIL decoy receptor 1 (DcR1), which inhibited TRAIL-induced apoptosis after TBI. The administration of DMOG produced the opposite effect than did 2ME. Similarly, HIF-1 alpha siRNA attenuated TRAIL-induced neuronal deathviaincreased DcR1 expressionin vitro. Conclusion: Our findings suggested that the TRAIL/DR5 signaling pathway plays an important role after neuronal apoptosis after TBI. HIF-1 alpha mediates TRAIL-induced neuronal apoptosis by regulating DcR1 expression following TBI.	[Fang, Yuanjian; Lu, Jianan; Wang, Xiaoyu; Wu, Haijian; Mei, Shuhao; Zheng, Jingwei; Xu, Shenbin; Chen, Sheng; Zhang, Jianmin; Hong, Yuan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China; [Lenahan, Cameron] Loma Linda Univ, Sch Med, Ctr Neurosci Res, Loma Linda, CA USA; [Lenahan, Cameron] Burrell Coll Osteopath Med, Las Cruces, NM USA; [Zhang, Jianmin] Zhejiang Univ, Brain Res Inst, Hangzhou, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Peoples R China		Zhang, JM; Hong, Y (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China.; Zhang, JM (corresponding author), Zhejiang Univ, Brain Res Inst, Hangzhou, Peoples R China.; Zhang, JM (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Peoples R China.	zjm135@zju.edu.cn; hy0904@zju.edu.cn	Fang, Yuanjian/AAH-1971-2020	Fang, Yuanjian/0000-0002-0035-6045	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870964, 81870916]; Natural Science Foundation of ZhejiangNatural Science Foundation of Zhejiang Province [LY17H090012]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019QNA7038]	This research was supported by the National Natural Science Foundation of China (81870964 and 81870916), Natural Science Foundation of Zhejiang (LY17H090012), and Fundamental Research Funds for the Central Universities (2019QNA7038).	Akakura N, 2001, CANCER RES, V61, P6548; Althaus J, 2006, NEUROCHEM INT, V48, P687, DOI 10.1016/j.neuint.2005.12.008; Aminova LR, 2008, ANTIOXID REDOX SIGN, V10, P1989, DOI 10.1089/ars.2008.2039; Bianciardi P, 2006, BIOCHEM BIOPH RES CO, V342, P875, DOI 10.1016/j.bbrc.2006.02.042; Bossi F, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/680749; Cantarella G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.286; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Cui M, 2010, NEUROBIOL DIS, V39, P138, DOI 10.1016/j.nbd.2010.03.018; Dessein PH, 2015, CLIN EXP RHEUMATOL, V33, P491; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo ZN, 2016, MOL NEUROBIOL, V53, P3606, DOI 10.1007/s12035-015-9308-x; Hoffmann O, 2009, J MOL MED, V87, P753, DOI 10.1007/s00109-009-0484-x; Huang ZH, 2011, DEV NEUROSCI-BASEL, V33, P519, DOI 10.1159/000334475; Jeong JK, 2010, BIOCHEM BIOPH RES CO, V399, P379, DOI 10.1016/j.bbrc.2010.07.082; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Khan M, 2017, NEURAL REGEN RES, V12, P696, DOI 10.4103/1673-5374.206632; Kichev A, 2014, J BIOL CHEM, V289, P9430, DOI 10.1074/jbc.M113.512350; Lawrie A, 2014, VASC PHARMACOL, V63, P114, DOI 10.1016/j.vph.2014.10.002; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Lopez-Gomez C, 2016, J NEUROL NEUROSUR PS, V87, P130, DOI 10.1136/jnnp-2014-309932; Lu JN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01360; Mannelli LD, 2018, NEUROPHARMACOLOGY, V131, P166, DOI 10.1016/j.neuropharm.2017.12.020; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Muzio M, 1998, INT J CLIN LAB RES, V28, P141, DOI 10.1007/s005990050035; Panneerselvam M, 2011, LIFE SCI, V88, P670, DOI 10.1016/j.lfs.2011.02.004; Pei GT, 2010, BIOCHEM BIOPH RES CO, V391, P1274, DOI 10.1016/j.bbrc.2009.12.058; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Rui Q, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113044; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Schumacker PT, 2005, CRIT CARE MED, V33, pS423, DOI 10.1097/01.CCM.0000191716.38566.E0; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tisato V, 2016, CELL MOL LIFE SCI, V73, P2017, DOI 10.1007/s00018-016-2164-7; Wittko-Schneider IM, 2013, CELL MOL LIFE SCI, V70, P1705, DOI 10.1007/s00018-013-1279-3; Wu GS, 1999, CANCER RES, V59, P2770; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu YY, 2015, DEMENT GER COGN D EX, V5, P424, DOI 10.1159/000439214; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; ZHOU YX, 2020, CELL COMMUN SIGNAL, V0018	54	4	4	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 3	2020	14								192	10.3389/fncel.2020.00192			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ND9LH	WOS:000562221400001	32848609	Green Published, gold			2022-02-06	
J	Arcara, G; Tonini, E; Muriago, G; Mondin, E; Sgarabottolo, E; Bertagnoni, G; Semenza, C; Bambini, V				Arcara, Giorgio; Tonini, Elisabetta; Muriago, Giulia; Mondin, Elisabetta; Sgarabottolo, Edda; Bertagnoni, Gianettore; Semenza, Carlo; Bambini, Valentina			Pragmatics and figurative language in individuals with traumatic brain injury: fine-grained assessment and relevance-theoretic considerations	APHASIOLOGY			English	Article						Pragmatic language disorder; cognitive-communication disorder; figurative language; APACS; Relevance Theory	CLOSED-HEAD-INJURY; WORKING-MEMORY; COMMUNICATIVE IMPAIRMENT; PROVERB COMPREHENSION; IDIOM COMPREHENSION; DISCOURSE ABILITIES; METAPHOR; MIND; DEFICITS; SKILLS	Background Difficulties in the pragmatic aspects of language are considered a hallmark of Traumatic Brain Injury (TBI). However, this claim is mostly based on assessments of discourse production, neglecting another relevant pragmatic aspect, namely the comprehension of figurative expressions such as idioms, metaphors, and proverbs. Accounts developed in the framework of Relevance Theory might help framing an investigation in this domain, by describing a continuum of loose uses for idioms and metaphors and the echoing of general wisdom in proverbs. Aims First, we aimed at sketching a detailed pragmatic profile of individuals with TBI, by using the Assessment of Pragmatic Abilities and Cognitive Substrates (APACS) test, a standardized tool evaluating both production and comprehension. Second, we aimed at doing a fine-grained investigation of figurative language comprehension skills, by taking into account different figurative types and task-related issues. Methods and Procedures Thirty-nine individuals with TBI were administered the APACS test and compared to a sample of matched controls. Six subtasks considering three figurative types (idioms, metaphors, and proverbs) in two response-formats (multiple-choice and verbal explanation) were derived from the APACS test and analyzed with a mixed model approach. Outcomes and Results Results showed a diffuse pragmatic language disorder both in the expressive and receptive modality, with 56% of individuals with TBI performing below normative cut-off in the APACS Total score. The analysis of the figurative language subtasks confirmed the difficulties of the TBI group with figurative expressions compared to controls. A further model restricted to the TBI group showed that verbal explanation was more difficult than the multiple-choice format. However, we did not observe robust differences between figurative types. The only noticeable effect was related to proverbs in the verbal explanation format, which were more difficult than all other subtasks. Conclusions This study shows two main aspects. First, the pragmatic language disorder of people with TBI encompasses not only the well-known difficulties in discourse production but also a disruption of figurative language understanding. Second, such a disruption affects different figurative types, indicating a general problem in inferring the speaker's meaning from non-literal language. Relevance-theoretic considerations helped us highlighting the commonalities across figurative types, rather than the differences, and the enhanced meta-representational efforts linked to proverbs in open response formats. Intervention could capitalize on these findings and implement training programs that target pragmatic inferences across different types of expressions to promote the most successful return to communication in its variety of situations.	[Arcara, Giorgio; Semenza, Carlo] IRCCS San Camillo Hosp, Venice, Italy; [Tonini, Elisabetta; Bambini, Valentina] Univ Sch Adv Studies IUSS Pavia, Ctr Neurocognit Epistemol & Theoret Syntax NEtS, Pavia, Italy; [Muriago, Giulia] Univ Padua, Dept Psychol, Padua, Italy; [Mondin, Elisabetta] Cooperat Sogno & Vita, Vicenza, Italy; [Sgarabottolo, Edda; Bertagnoni, Gianettore] Osped S Bortolo, Unita Gravi Cerebrolesioni, Vicenza, Italy; [Semenza, Carlo] Univ Padua, Padova Neurosci Ctr, Padua, Italy		Bambini, V (corresponding author), Sch Adv Studies IUSS Pavia, Ctr Neurocognit Epistemol & Theoret Syntax NEtS, Piazza Vittoria 15, I-27100 Pavia, Italy.	valentina.bambini@iusspavia.it	Bambini, Valentina/K-6643-2016	Bambini, Valentina/0000-0001-5770-228X; Tonini, Elisabetta/0000-0002-8766-068X			Adamczyk P, 2016, SCHIZOPHR RES, V176, P331, DOI 10.1016/j.schres.2016.08.015; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Arcara G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00070; Baayen R.H., 2008, ANAL LINGUISTIC DATA; Bambini V, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00559; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bambini V, 2016, BRAIN LANG, V153, P1, DOI 10.1016/j.bandl.2015.12.002; Bambini V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00938; Bates D., 2015, ARXIV150604967STATME; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisiacchi PS, 2011, ESAME NEUROPSICOLOGI; Body R., 1999, BRAIN DAM B; Bohrn IC, 2012, NEUROPSYCHOLOGIA, V50, P2669, DOI 10.1016/j.neuropsychologia.2012.07.021; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; Brownell H, 2013, J HEAD TRAUMA REHAB, V28, P446, DOI 10.1097/HTR.0b013e31825b5e85; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Cappelli G, 2018, DYSLEXIA, V24, P294, DOI 10.1002/dys.1588; Carotenuto A, 2018, BRAIN LANG, V185, P47, DOI 10.1016/j.bandl.2018.08.003; Carotenuto A, 2018, ARCH CLIN NEUROPSYCH, V33, P194, DOI 10.1093/arclin/acx061; Carston R., 2012, CAMBRIDGE HDB PRAGMA, P469, DOI [10.1017/CBO9781139022453.025., DOI 10.1017/CBO9781139022453.025]; Carston R., 2010, P ARISTOTELIAN SOC 3, V110, P295, DOI [DOI 10.1111/J.1467-9264.2010.00288.X, 10.1111/j.1467-9264.2010.00288.x]; Carston R, 2011, LANG COGN, V3, P283, DOI 10.1515/LANGCOG.2011.010; Chakrabarty M, 2014, LANG SCI, V44, P1, DOI 10.1016/j.langsci.2014.01.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Chiappe DL, 2007, J MEM LANG, V56, P172, DOI 10.1016/j.jml.2006.11.006; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Columbus G, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01057; Cummings L., 2014, PRAGMATIC DISORDERS; Demir SO, 2006, J REHABIL MED, V38, P68, DOI 10.1080/16501970510041262; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DiSciullo AM, 2016, BIOLINGUISTIC INVEST, P213, DOI [10.1075/la.235.10bos, DOI 10.1075/LA.235.10BOS]; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Fauconnier G., 2009, COGNITIVE SEMIOTICS, V5, P393, DOI [10.1515/cogsem.2013.5.12.393, DOI 10.1515/COGSEM.2013.5.12.393]; Flexner SB, 1987, RANDOM HOUSE DICT EN; Fox J, 2011, NY TIMES BK REV, P22; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gibbs R. W., 2012, OXFORD HDB COGNITIVE, P697, DOI [10.1093/oxfordhb/9780199738632.013.0027, DOI 10.1093/OXFORDHB/9780199738632.013.0027]; Gibbs RW, 2011, DISCOURSE PROCESS, V48, P529, DOI 10.1080/0163853X.2011.606103; GIBBS RW, 1995, PSYCHOL BULL, V118, P133, DOI 10.1037/0033-2909.118.1.133; Glucksberg S, 2003, TRENDS COGN SCI, V7, P92, DOI 10.1016/S1364-6613(02)00040-2; Glucksberg S., 2001, UNDERSTANDING FIGURA; Grindrod CM, 2019, AGING NEUROPSYCHOL C, V26, P842, DOI 10.1080/13825585.2018.1537437; Guazzotti P., 2006, GRANDE DIZIONARIO PR; HARROW M, 1974, ARCH GEN PSYCHIAT, V31, P27; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; Kalandadze T., SYSTEMATIC REV UNPUB; Lakoff G, 2008, METAPHORS WE LIVE; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Mashal N, 2011, AGING NEUROPSYCHOL C, V18, P527, DOI 10.1080/13825585.2011.575202; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Messer Rachel H., 2015, HLTH AGING CLIN CARE, DOI [10.4137/hacce.s22981, DOI 10.4137/HACCE.S22981, 10.4137/HACCE.S22981]; Monetta L, 2007, BRAIN LANG, V101, P80, DOI 10.1016/j.bandl.2006.06.007; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Moran CA, 2006, BRAIN INJURY, V20, P417, DOI 10.1080/02699050500488223; Norrick N. R., 1994, WISE WORDS ESSAYS PR, P143; Ortony A., 1993, METAPHOR THOUGHT, DOI [10.1017/CB09781139173865, DOI 10.1017/CB09781139173865]; Papagno C, 2007, BRAIN LANG, V100, P208, DOI 10.1016/j.bandl.2006.01.002; Papagno C, 2004, BRAIN LANG, V89, P226, DOI 10.1016/S0093-934X(03)00398-5; Papagno C, 2010, NEUROPSYCHOLOGY OF COMMUNICATION, P111, DOI 10.1007/978-88-470-1584-5_6; Papagno C, 2010, ITAL J LINGUIST, V22, P21; Perlini C, 2018, PSYCHIAT RES, V260, P78, DOI 10.1016/j.psychres.2017.11.032; Rapp AM, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02251; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Rubio-Fernandez P, 2015, METAPHOR SYMBOL, V30, P24, DOI 10.1080/10926488.2015.980699; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 2017, PERSP PRAGMAT PHILO, V11, P617, DOI 10.1007/978-3-319-47489-2_23; Sperber D., 1995, RELEVANCE COMMUNICAT; Sperber D, 2008, CAMB HANDB PSYCHOL, P84; Tabossi P, 2011, BEHAV RES METHODS, V43, P110, DOI 10.3758/s13428-010-0018-z; Tendahl M, 2008, J PRAGMATICS, V40, P1823, DOI 10.1016/j.pragma.2008.02.001; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; TOMPKINS CA, 1992, J SPEECH HEAR RES, V35, P626, DOI 10.1044/jshr.3503.626; Turkstra LS, 2017, PERSP PRAGMAT PHILO, V11, P291, DOI 10.1007/978-3-319-47489-2_12; Uekermann J, 2008, BRAIN COGNITION, V67, P51, DOI 10.1016/j.bandc.2007.11.003; Vega-Moreno R. E., 2007, CREATIVITY CONVENTIO; Wilson D, 2011, INTERCULT PRAGMAT, V8, P177, DOI 10.1515/IPRG.2011.009; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011	89	4	4	3	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	AUG 2	2020	34	8					1070	1100		10.1080/02687038.2019.1615033			31	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	NO3UW	WOS:000569412300008					2022-02-06	
J	Anthonissen, J; Steffen, CT; Alessandri, B; Baranowski, A; Rommens, PM; Victor, J; Hofmann, A				Anthonissen, Joris; Steffen, Clara Theressa; Alessandri, Beat; Baranowski, Andreas; Rommens, Pol Maria; Victor, Jan; Hofmann, Alexander			Traumatic brain injury enhances the formation of heterotopic ossification around the hip: an animal model study	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Traumatic brain injury; Animal model; Musculoskeletal trauma; Heterotopic ossification	SPINAL-CORD; CEREBROSPINAL-FLUID; HEAD-INJURY; SERUM; BONE; RISK; INCREASES; FRACTURE	Introduction The incidence of heterotopic ossification (HO) is at its highest when trauma of the hip or pelvis concurs with traumatic brain injury (TBI). The pathogenic mechanisms underlying the neurogenic enhancement of the formation of HO remain, however, poorly understood. Hence, the goal of the present study was to develop a novel small animal model that combines hip and brain trauma that can prove the enhancement of HO around the hip after TBI. Materials and methods Forty male Wistar rats were divided into four groups, to undergo hip surgery alone (group 1), hip surgery + moderate TBI (group 2), hip surgery + severe TBI (group 3) and only severe TBI (group 4). The femoral canal was reamed up to 2 mm and a muscle lesion was made to simulate hip surgery. An established controlled cortical impact model was used to create a TBI. Twelve weeks after surgery, the hip with the proximal half of the femur and the pelvic bone was removed and subjected to micro-computed tomography (mu CT) analysis. A quantitative analysis using a modified Brooker score as well as a quantitative analysis using a bone-to-tissue ratio was used. Results No HO could be found in all the ten animals that did not undergo hip surgery (group 4). In the animals that did undergo surgery to the hip, no HO was found in only one animal (group 1). All the other animals developed HO. In this study, significantly more HO was found in animals that underwent an additional severe TBI. Conclusion The newly developed rat model, with a combined hip and brain trauma, showed an enhancement of the HO formation around the hip after severe TBI.	[Anthonissen, Joris; Steffen, Clara Theressa; Baranowski, Andreas; Rommens, Pol Maria; Hofmann, Alexander] Univ Hosp Mainz, Dept Orthopaed & Trauma Surg, Langenbeckstr 1, D-55131 Mainz, Germany; [Anthonissen, Joris; Victor, Jan] Ghent Univ Hosp, Dept Orthopaed Surg & Traumatol, De Pintelaan 185, B-9000 Ghent, Belgium; [Alessandri, Beat] Univ Hosp Mainz, Inst Neurosurg Pathophysiol, Langenbeckstr 1, D-55131 Mainz, Germany		Anthonissen, J (corresponding author), Univ Hosp Mainz, Dept Orthopaed & Trauma Surg, Langenbeckstr 1, D-55131 Mainz, Germany.; Anthonissen, J (corresponding author), Ghent Univ Hosp, Dept Orthopaed Surg & Traumatol, De Pintelaan 185, B-9000 Ghent, Belgium.	anthonissenjoris@gmail.com	Hofmann, Alexander/C-3943-2013	Anthonissen, Joris/0000-0002-9149-4127			Anthonissen J, 2016, INJURY, V47, P613, DOI 10.1016/j.injury.2015.11.019; Anthonissen J, 2015, ACTA ORTHOP TRAUMATO, V49, P197, DOI 10.3944/AOTT.2015.14.0271; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Dattatreyamurty B, 2001, EXP NEUROL, V172, P273, DOI 10.1006/exnr.2001.7728; DELEE JG, 1976, CLIN ORTHOP RELAT R, P20; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Gennarelli T A, 1988, Brain Inj, V2, P175, DOI 10.3109/02699058809150942; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; JENSEN LL, 1987, AM J PHYS MED REHAB, V66, P351; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Lazard ZW, 2015, CLIN ORTHOP RELAT R, V473, P2790, DOI 10.1007/s11999-015-4323-9; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Mourad WF, 2013, J ORTHOP RES, V31, P944, DOI 10.1002/jor.22309; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Smith E, 2016, IRISH J MED SCI, V185, P473, DOI 10.1007/s11845-016-1399-5; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235	31	4	4	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	AUG	2020	140	8					1029	1035		10.1007/s00402-019-03326-0			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	MH8CQ	WOS:000546950400003	31834481				2022-02-06	
J	Caccese, JB; Santos, FV; Yamaguchi, F; Jeka, JJ				Caccese, Jaclyn B.; Santos, Fernando V.; Yamaguchi, Felipe; Jeka, John J.			Age of First Exposure to Soccer Heading and Sensory Reweighting for Upright Stance	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion; subconcussion; balance; postural control; neurodevelopment	POSTURAL CONTROL; LATER-LIFE; FOOTBALL; CONCUSSION; ACCELERATION; IMPAIRMENT; BRAIN	US Soccer eliminated soccer heading for youth players ages 10 years and younger and limited soccer heading for children ages 11-13 years. Limited empirical evidence associates soccer heading during early adolescence with medium-to-long-term behavioral deficits. The purpose of this study was to compare sensory reweighting for upright stance between college-aged soccer players who began soccer heading ages 10 years and younger (AFE <= 10) and those who began soccer heading after age 10 (AFE > 10). Thirty soccer players self-reported age of first exposure (AFE) to soccer heading. Sensory reweighting was compared between AFE <= 10 and AFE > 10. To evaluate sensory reweighting, we simultaneously perturbed upright stance with visual, vestibular, and proprioceptive stimulation. The visual stimulus was presented at two different amplitudes to measure the change in gain to vision, an intra-modal effect; and change in gain to galvanic vestibular stimulus (GVS) and vibration, both inter-modal effects. There were no differences in gain to vision (p=0.857, eta 2=0.001), GVS (p=0.971, eta 2=0.000), or vibration (p=0.974, eta 2=0.000) between groups. There were no differences in sensory reweighting for upright stance between AFE <= 10 and AFE > 10, suggesting that soccer heading during early adolescence is not associated with balance deficits in college-aged soccer players, notwithstanding potential deficits in other markers of neurological function	[Caccese, Jaclyn B.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA; [Santos, Fernando V.] Bertec Corp, Columbus, OH USA; [Yamaguchi, Felipe; Jeka, John J.] Univ Delaware, Coll Hlth Sci Kinesiol & Appl Physiol, Newark, DE USA		Caccese, JB (corresponding author), Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu	Caccese, Jaclyn B./AAH-4571-2020	Caccese, Jaclyn B./0000-0003-2329-3603	NIH-NINDS R01 [NS102157-01]	This study was supported by the NIH-NINDS R01 (NS102157-01) grant, "Behavioral-and bio-markers of subconcussion with controlled human head impact."	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Barela JA, 1999, INFANT BEHAV DEV, V22, P87, DOI 10.1016/S0163-6383(99)80007-1; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Foster EC, 1996, J MOTOR BEHAV, V28, P101, DOI 10.1080/00222895.1996.9941737; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Hwang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088132; Kerr ZY, 2019, J NEUROTRAUM, V36, P2073, DOI 10.1089/neu.2017.5319; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; O'Kane JW, 2016, PHYSICIAN SPORTSMED, V44, P190, DOI 10.1080/00913847.2016.1149423; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Putukian Margot, 2004, Curr Sports Med Rep, V3, P9; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	40	4	4	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2020	41	09					616	625		10.1055/a-1141-3553			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MU6UM	WOS:000555806200008	32365387	Green Accepted			2022-02-06	
J	Genrikhs, EE; Stelmashook, EV; Voronkov, DN; Novikova, SV; Alexandrova, OP; Fedorov, AV; Isaev, NK				Genrikhs, Elizaveta E.; Stelmashook, Elena, V; Voronkov, Dmitriy N.; Novikova, Svetlana, V; Alexandrova, Olga P.; Fedorov, Artem, V; Isaev, Nickolay K.			The single intravenous administration of methylene blue after traumatic brain injury diminishes neurological deficit, blood-brain barrier disruption and decrease in the expression of S100 protein in rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Neuroprotection; Methylene blue; Blood-brain barrier	NEURONAL CELL-DEATH; NITRIC-OXIDE; NEUROPROTECTION; MITOCHONDRIA; ACTIVATION; RESPONSES; TOXICITY	The protective effect of methylene blue (MB) was investigated on the model of focal one-sided traumatic brain injury (TBI) of the sensorimotor cortex region from 1 to 7 days after the injury. TBI caused a reliable disruption of the functions of the limbs contralateral to injury focus, an increase in the expression of 5100 protein and blood-brain barrier (BBB) permeability in the ipsilateral hemisphere. The single intravenous injection of MB (1 mg/kg body weight) 30 min after TBI significantly reduced the limb function impairment as well as a TBIinduced increase in the expression of inflammatory marker 5100 protein, and BBB permeability. When modeling inflammation in vitro, MB was found to protect cultured neurons from the toxic effects of lipopolysaccharide. In conclusion, the preservation of blood-brain barrier and a decrease in the expression of S100 protein may be an important mechanism by means of which MB improves neurological outcome. Our data demonstrate that MB can be a very promising pharmacological compound with neuroprotective properties for TBI treatment.	[Genrikhs, Elizaveta E.; Stelmashook, Elena, V; Voronkov, Dmitriy N.; Novikova, Svetlana, V; Alexandrova, Olga P.; Isaev, Nickolay K.] Res Ctr Neurol, Volokolamskoe Shosse 80, Moscow 125367, Russia; [Fedorov, Artem, V; Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, Biol Fac, Leninskiye Gory 1,B 12, Moscow 119234, Russia		Isaev, NK (corresponding author), Moscow MV Lomonosov State Univ, Biol Fac, Leninskiye Gory 1,B 12, Moscow 119234, Russia.	isaev@genebee.msu.ru	Genrikhs, Elizaveta E/C-3854-2012; Stelmashook, Elena V/B-4442-2012; Alexandrova, Olga P./AAN-8475-2020; Fedorov, Artem/AAZ-6811-2020; Voronkov, Dmitry N/B-3910-2012; Isaev, Nikolay K/B-4194-2012	Voronkov, Dmitry N/0000-0001-5222-5322; Genrikhs, Elizaveta/0000-0002-3203-0250	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]; Russian Science FoundationRussian Science Foundation (RSF) [19-15-13004] Funding Source: Russian Science Foundation	This work was supported by the Russian Science Foundation grant No. 16-15-10108.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Chang RCC, 2001, J NEUROCHEM, V76, P1042, DOI 10.1046/j.1471-4159.2001.00111.x; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chesnut R M, 1995, New Horiz, V3, P366; Cirillo C, 2011, WORLD J GASTROENTERO, V17, P1261, DOI 10.3748/wjg.v17.i10.1261; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hu JR, 1997, J NEUROCHEM, V69, P2294; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Isaev NK, 2016, TOXICOL LETT, V250, P29, DOI 10.1016/j.toxlet.2016.04.002; Isaev NK, 2020, Patent RU, Patent No. [RU 2714479, 2714479]; Isaev NK., 2019, Patent RU, Patent No. [RU 2697791, 2697791]; Jeohn GH, 2000, BRAIN RES, V880, P173, DOI 10.1016/S0006-8993(00)02737-2; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0; Li L, 2017, J NEUROTRAUM, V34, P182, DOI 10.1089/neu.2015.4315; McNaught KSP, 1999, J NEUROCHEM, V73, P2469, DOI 10.1046/j.1471-4159.1999.0732469.x; OkadaFukui Y., 2001, JAPAN J REANIMATOL, V20, P24; Osier ND, 2018, J NEUROTRAUM, V35, P2684, DOI 10.1089/neu.2017.5268; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Paxinos G., 1997, ATLAS ANATOMY RAT BR; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Stelmashook EV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P205, DOI 10.1134/S0006297920020078; Stelmashook EV, 2019, B EXP BIOL MED+, V167, P455, DOI 10.1007/s10517-019-04548-3; Tucker D, 2018, MOL NEUROBIOL, V55, P5137, DOI 10.1007/s12035-017-0712-2; Batista MMV, 2016, CNS NEUROL DISORD-DR, V15, P976, DOI 10.2174/1871527315666160720120326; Wainwright M, 2005, TROP MED INT HEALTH, V10, P501, DOI 10.1111/j.1365-3156.2005.01417.x; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551	44	4	5	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 1	2020	1740								146854	10.1016/j.brainres.2020.146854			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LS1KR	WOS:000536151100010	32339501				2022-02-06	
J	Mariani, M; Alosco, ML; Mez, J; Stern, RA				Mariani, Megan; Alosco, Michael L.; Mez, Jesse; Stern, Robert A.			Clinical Presentation of Chronic Traumatic Encephalopathy	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; neurodegenerative disease; tauopathy; traumatic encephalopathy syndrome; repetitive head impacts; football players; biomarkers	DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; PROFESSIONAL FIGHTERS; BRAIN-INJURY; COGNITIVE IMPAIRMENT; EXOSOMAL TAU; 1ST EXPOSURE; PUNCH-DRUNK; FOOTBALL; DIAGNOSIS	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head impacts (RHI), such as those received in contact/collision sports, blast injury in military veterans, and domestic violence. Currently, CTE can only be diagnosed following death. Although the clinical features of former boxers have been described for almost a century, and there is increasing evidence of long-term cognitive and neuropsychiatric impairments in living former American football players, the specific clinical presentation associated with underlying CTE neuropathology remains unclear. These features include diverse and nonspecific changes in cognition, mood, behavior, and motor functioning. Currently, there are no validated and widely accepted clinical diagnostic criteria. Proposed criteria are primarily based on retrospective telephonic interviews with the next of kin of individuals who were diagnosed with CTE postmortem. Prospective studies involving individuals presumably at high risk for CTE are underway; these will hopefully clarify the clinical features and course of CTE, allow the diagnostic criteria to be refined, and lead to the development and validation of in vivo biomarkers. This article reviews what is currently known about the clinical presentation of CTE and describes the evolution of this knowledge from early case reports of "punch drunk" boxers through larger case series of neuropathologically confirmed CTE. This article concludes with a discussion of gaps in research and future directions to address these areas.	[Mariani, Megan; Alosco, Michael L.; Mez, Jesse; Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Mariani, Megan; Alosco, Michael L.; Mez, Jesse; Stern, Robert A.] Boston Univ, Sch Med, CTE Ctr, 72 E Concord St,Suite 87800, Boston, MA 02118 USA; [Alosco, Michael L.; Mez, Jesse; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol Neurosurg & Anat, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Neurobiol, Boston, MA 02118 USA		Stern, RA (corresponding author), Boston Univ, Sch Med, CTE Ctr, 72 E Concord St,Suite 87800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020				ALOSCO M, 2017, ALZHEIMERS DEMENT, V10, P56, DOI DOI 10.1016/J.DADM.2017.10.003; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Azad TD, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.10.032; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Bowman KM, 1940, INJURIES SKULL BRAIN, P309; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Byrd M, 2018, J NEUROL PSYCHOL, V6, P1; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M, 1964, BLACK HOLE OTHER ESS; Critchley M, 1949, PUNCH DRUNK SYNDROME; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Homeopathic Medical Society of the State of Pennsylvania, 1933, HAHNEMANNIAN MON, V68, P305; Iverson GL, 2019, J NEUROPSYCH CLIN N, V31, P328, DOI 10.1176/appi.neuropsych.18110280; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; Jokl E, 1950, BMJ-BRIT MED J, V2, P1291; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; LACAVA G, 1954, DEUT MED WOCHENSCHR, V79, P817; Lee JK, 2020, JAMA NEUROL, V77, P35, DOI 10.1001/jamaneurol.2019.2861; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Lepreux S, 2015, CLIN NEUROPATHOL, V34, P193, DOI 10.5414/NP300838; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-24; Mahalingam S, 2019, SEMIN NEUROL, V39, P188, DOI 10.1055/s-0039-1678580; Martland H, 1928, N Y PATHOL SOC T ARC, V6, P542; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Muraoka S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01059; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Pontecorvo MJ, 2019, BRAIN, V142, P1723, DOI 10.1093/brain/awz090; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ravina A, 1937, PRESSE MED, V45, P1362; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Scully F, 1937, MILWAUKEE J     0929, P3; Scully F, 1937, LIBERTY, V14, P35; SERCL M., 1962, WORLD NEUROL, V3, P351; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Wang YT, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0962-7; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	94	4	5	5	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					370	383		10.1055/s-0040-1713624			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900005	32740900				2022-02-06	
J	Master, CL; Curry, AE; Pfeiffer, MR; Metzger, KB; Kessler, RS; Haarbauer-Krupa, J; DePadilla, L; Greenspan, A; Breiding, MJ; Arbogast, KB				Master, Christina L.; Curry, Allison E.; Pfeiffer, Melissa R.; Metzger, Kristina B.; Kessler, Ronni S.; Haarbauer-Krupa, Juliet; DePadilla, Lara; Greenspan, Arlene; Breiding, Matthew J.; Arbogast, Kristy B.			Characteristics of Concussion in Elementary School-Aged Children: Implications for Clinical Management	JOURNAL OF PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; RECOVERY-TIME; SYMPTOMS; REHABILITATION; PREDICTORS	Objective To comprehensively characterize the clinical presentation and course of care for concussion among 5- to 11-year-old children, identifying preinjury and injury factors potentially influencing clinical outcomes. Study design A single-institution retrospective cohort study using electronic health record data from children ages 5- to 11 years with a concussion from July 1, 2014, through June 30, 2015. Electronic health record data were abstracted for a 20% random sample of 292 patients. Results Three-fourths of patients (74.3%) presenting for concussion care had a standardized visiovestibular assessment performed. Almost all of those who eventually sought specialty care (92.9%) also had such an assessment, and only 42.9% patients initially seen in the emergency department or urgent care were examined in this manner. Of those assessed, 62.7% (n = 136) demonstrated deficits, with children ages 9-11 years more frequently exhibiting deficits than their younger counterparts (67.9% vs 53.2%; P = .03). Almost all patients (95.9%) reported at least 1 somatic symptom (eg, headache, dizziness), and one-half to two-thirds reported problems with sleep (54.1%) and visiovestibular symptoms (66.1%). Only 11.6% of children were referred for rehabilitation therapies and less than one-half of concussed patients (43.8%) were provided with a letter recommending school accommodations. Conclusions Somatic symptoms, sleep problems, and visiovestibular deficits are common in elementary schoolaged children with concussion, but specific visiovestibular clinical assessments are often not performed, particularly in the emergency department setting. Recommendations for school accommodations are often not provided at the time of concussion diagnosis. Incorporating a standardized visiovestibular assessment into practice could facilitate early targeted school accommodations and thereby improve return to learning for elementary school-aged children with concussion.	[Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Master, Christina L.; Curry, Allison E.; Pfeiffer, Melissa R.; Metzger, Kristina B.; Kessler, Ronni S.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Curry, Allison E.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Haarbauer-Krupa, Juliet; DePadilla, Lara; Greenspan, Arlene; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Master, CL (corresponding author), Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Div Orthoped, 2nd Floor Wood Bldg, Philadelphia, PA 19104 USA.	masterc@email.chop.edu			US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Children's Hospital of Philadelphia	Supported by an intergovernmental personnel act agreement between the US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and Children's Hospital of Philadelphia. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The authors declare no conflicts of interest.	Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Blackwell LS, 2017, J CHILD NEUROL, V32, P327, DOI 10.1177/0883073816681351; Centers for Disease Control and Prevention, CHILD DEV MIDDL CHIL; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Master C. L., 2017, CLIN J SPORT MED, V28, P1, DOI [10.1097/JSM.0000000000000507, DOI 10.1097/JSM.0000000000000507]; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Mucha A, 2019, PHYS THER, V99, P1278, DOI 10.1093/ptj/pzz085; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murdaugh DL, 2018, J CHILD NEUROL, V33, P474, DOI 10.1177/0883073818766815; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Putukian M, 2018, CLIN J SPORT MED; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Snedden TR, 2019, J PEDIATR-US, V209, P168, DOI 10.1016/j.jpeds.2019.01.041; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Suskauer SJ, 2019, J HEAD TRAUMA REHAB, V34, P215, DOI 10.1097/HTR.0000000000000455; Suskauer SJ, 2018, J PEDIATR REHAB MED, V11, P7, DOI 10.3233/PRM-160424; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	48	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2020	223						128	135		10.1016/j.jpeds.2020.04.001			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MO1GM	WOS:000551283500028	32507622	Green Accepted			2022-02-06	
J	Mullally, K; McLachlan, K; MacKillop, E; Pei, J				Mullally, Katelyn; McLachlan, Kaitlyn; MacKillop, Emily; Pei, Jacqueline			Performance Validity Testing in Justice-Involved Adults with Fetal Alcohol Spectrum Disorder	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Fetal alcohol spectrum disorder; Performance validity testing; Forensic assessment; Neuropsychological assessment; Non-credible responding; Reliability; Validity; Prenatal alcohol exposure	WORD MEMORY TEST; TRAUMATIC BRAIN-INJURY; ADVANCED CLINICAL SOLUTIONS; RELIABLE DIGIT SPAN; INTELLIGENCE SCALE; INTRAINDIVIDUAL VARIABILITY; RESPONSE BIAS; SYMPTOM; PREVALENCE; SCORES	Objectives: A number of commonly used performance validity tests (PVTs) may be prone to high failure rates when used for individuals with severe neurocognitive deficits. This study investigated the validity of 10 PVT scores in justice-involved adults with fetal alcohol spectrum disorder (FASD), a neurodevelopmental disability stemming from prenatal alcohol exposure and linked with severe neurocognitive deficits. Method: The sample comprised 80 justice-involved adults (ages 19-40) including 25 with confirmed or possible FASD and 55 where FASD was ruled out. Ten PVT scores were calculated, derived from Word Memory Test, Genuine Memory Impairment Profile, Advanced Clinical Solutions (Word Choice), the Wechsler Adult Intelligence Scale - Fourth Edition (Reliable Digit Span and age-corrected scaled scores (ACSS) from Digit Span, Coding, Symbol Search, Coding - Symbol Search, Vocabulary - Digit Span), and the Wechsler Memory Scale - Fourth Edition (Logical Memory II Recognition). Results: Participants with diagnosed/possible FASD were more likely to failanysingle PVT, and failed a greater number of PVTs overall, compared to those without FASD. They were also more likely to fail based on Word Memory Test, Digit Span ACSS, Coding ACSS, Symbol Search ACSS, and Logical Memory II Recognition, compared to controls (35-76%). Across both groups, substantially more participants with IQ <70 failed two or more PVTs (90%), compared to those with an IQ >= 70 (44%). Conclusions: Results highlight the need for additional research examining the use of PVTs in justice-involved populations with FASD.	[Mullally, Katelyn; McLachlan, Kaitlyn] Univ Guelph, Dept Psychol, MacKinnon 3011,50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [MacKillop, Emily] St Josephs Healthcare Hamilton, Dept Clin Neuropsychol Serv, Hamilton, ON L8N 3K7, Canada; [MacKillop, Emily] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4L8, Canada; [Pei, Jacqueline] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2G5, Canada		McLachlan, K (corresponding author), Univ Guelph, Dept Psychol, MacKinnon 3011,50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	kmclac02@uoguelph.ca			Department of Justice, Territorial Government	Funding for the primary study was provided by the Department of Justice, Territorial Government in the study jurisdiction. There are no conflicts of interest to report for the authors.	A general report on national scientific expert by Chinese Academy of Sciences between, 2004, CHINA HIST MAT SCI T, V25, P228; Agrawal R. P., 2010, AUSTR J MED HERBALIS, V22, P50; Ali S, 2018, CHILD NEUROPSYCHOL, V24, P617, DOI 10.1080/09297049.2017.1302579; Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Allen MD, 2011, PSYCHOL INJ LAW, V4, P140, DOI 10.1007/s12207-011-9105-4; Alverson WA, 2019, CLIN NEUROPSYCHOL, V33, P1420, DOI 10.1080/13854046.2019.1599071; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; [Anonymous], 2017, PHARMACOEPIDEMIO SS2, V26, P1, DOI DOI 10.1007/s11665-016-2478-5; [Anonymous], 2016, EUR J PREV CARDIOL, V23, pNP1; [Anonymous], 2012, MAARAV, V19, P21; [Anonymous], 2014, J NEUROSURG, V21, P618; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Astley, 2004, DIAGNOSTIC GUIDE FET; Astley SJ, 2010, CAN J CLIN PHARM, V17, P132; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Bain KM, 2021, APPL NEUROPSYCH-ADUL, V28, P24, DOI 10.1080/23279095.2019.1585352; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CARR A., 2016, HDB INTELLECTUAL DIS, V2; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; Cohen J, 1998, STAT POWER ANAL BEHA; Coles CD, 2016, ALCOHOL CLIN EXP RES, V40, P1000, DOI 10.1111/acer.13032; Cook JL, 2016, CAN MED ASSOC J, V188, P191, DOI 10.1503/cmaj.141593; Cox LV, 2008, J POPUL THER CLIN PH, V15, pE306; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dwyer CA, 1996, PSYCHOL ASSESSMENT, V8, P360, DOI 10.1037/1040-3590.8.4.360; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Flannigan K, 2018, INT J LAW PSYCHIAT, V57, P42, DOI 10.1016/j.ijlp.2017.12.008; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2003, MANUAL WORD MEMORY T; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Hellenbach M, 2017, J APPL RES INTELLECT, V30, P230, DOI 10.1111/jar.12234; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kodituwakku P., 2014, CURRENT DEV DISORDER, V1, P149, DOI [10.1007/s40474-014-0022-6, DOI 10.1007/S40474-014-0022-6]; LaDuke C.C., 2016, ARCH CLIN NEUROPSYCH, V31, P573, DOI [10.1093/arclin/acw042, DOI 10.1093/ARCLIN/ACW042]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; Mattson SN, 2019, ALCOHOL CLIN EXP RES, V43, P1046, DOI 10.1111/acer.14040; Mattson SN, 2011, NEUROPSYCHOL REV, V21, P81, DOI 10.1007/s11065-011-9167-9; May PA, 2018, JAMA-J AM MED ASSOC, V319, P474, DOI 10.1001/jama.2017.21896; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; McLachlan K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6292-x; McLachlan K, 2016, ALCOHOL, V53, P9, DOI 10.1016/j.alcohol.2016.03.003; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mukherjee RAS, 2006, J ROY SOC MED, V99, P298, DOI 10.1258/jrsm.99.6.298; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson Assessment, 2009, ADV CLIN SOL WAIS 4; Pei J, 2011, J MENT HEALTH, V20, P473, DOI 10.3109/09638237.2011.577113; Popova S., 2018, WHO INT STUDY PREVAL; Popova S, 2019, ADDICTION, V114, P1150, DOI 10.1111/add.14598; Popova S, 2016, LANCET, V387, P978, DOI 10.1016/S0140-6736(15)01345-8; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Rienstra A, 2013, ARCH CLIN NEUROPSYCH, V28, P463, DOI 10.1093/arclin/act026; Simon MJ, 2007, J CLIN PSYCHOL, V63, P339, DOI 10.1002/jclp.20351; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Soble JR, 2019, APPL NEUROPSYCH-ADUL, V26, P311, DOI 10.1080/23279095.2017.1418744; Sokol R.J., 2003, JAMA-J AM MED ASSOC, V290, P22; Spencer RJ, 2017, BRAIN INJURY, V31, P32, DOI 10.1080/02699052.2016.1218546; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Task Force on Sudden Infant Death Syndrome, 2016, PEDIATRICS, V138, pe2016; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; World Health Organization, 2007, INT CLASS DIS REL HL; Zenisek R, 2016, ARCH CLIN NEUROPSYCH, V31, P426, DOI 10.1093/arclin/acw025	89	4	4	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2020	26	7					701	713	PII S1355617720000132	10.1017/S1355617720000132			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	MY2TG	WOS:000558272100007	32063252	Green Submitted			2022-02-06	
J	Qiu, XC; Ping, SN; Kyle, M; Chin, L; Zhao, LR				Qiu, Xuecheng; Ping, Suning; Kyle, Michele; Chin, Lawrence; Zhao, Li-Ru			Long-term beneficial effects of hematopoietic growth factors on brain repair in the chronic phase of severe traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; SCF; G-CSF; Chronic phase; Brain repair	NF-KAPPA-B; COLONY-STIMULATING FACTOR; STEM-CELL FACTOR; WHITE-MATTER DAMAGE; C-KIT RECEPTOR; HEAD-INJURY; EXPRESSION; PLASTICITY; REHABILITATION; ACTIVATION	Severe traumatic brain injury (TBI) is the major cause of long-term, even life-long disability and cognitive impairments in young adults. The lack of therapeutic approaches to improve recovery in the chronic phase of severe TBI is a big challenge to the medical research field. Using a single severe TBI model in young adult mice, this study examined the restorative efficacy of two hematopoietic growth factors, stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF), on brain repair in the chronic phase of TBI. SCF and G-CSF alone or combination (SCF + G-CSF) treatment was administered at 3 months post-TBI. Functional recovery was evaluated by neurobehavioral tests during the period of 21 weeks after treatment. Neuropathology was examined 22 weeks after treatment. We observed that severe TBI caused persistent impairments in spatial learning/memory and somatosensory-motor function, long-term and widespread neuropathology, including dendritic reduction, decrease and overgrowth of axons, over-generated excitatory synapses, and demyelination in the cortex, hippocampus and striatum. SCF, G-CSF, and SCF + G-CSF treatments ameliorated severe TBI-induced widespread neuropathology. SCF + G-CSF treatment showed superior efficacy in improving long-term functional outcome, enhancing neural plasticity, rebalancing neural structure networks disturbed by severe TBI, and promoting remyelination. These novel findings demonstrate the therapeutic potential of SCF and G-CSF in enhancing recovery in the chronic phase of severe TBI	[Qiu, Xuecheng; Ping, Suning; Kyle, Michele; Chin, Lawrence; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA; [Zhao, Li-Ru] Syracuse VA Med Ctr, VA Hlth Care Upstate New York, Syracuse, NY USA		Zhao, LR (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.	ZHAOL@upstate.edu			Merit Review AwardUS Department of Veterans Affairs [I01RX002125]; United States Department of Veterans Affairs Rehabilitation Research & Development Service	This study was supported by Merit Review Award (I01RX002125 to L.R.Z.) from the United States Department of Veterans Affairs Rehabilitation Research & Development Service. The authors are grateful to Karen Hughes and Sandy McGillis for editorial assistance.	[Anonymous], 2015, TRAUMATIC BRAIN INJU; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Coronado V.G., 2012, BRAIN INJURY MED PRI; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cui LL, 2016, ASN NEURO, V8, DOI 10.1177/1759091416655010; Cui LL, 2015, EXP NEUROL, V263, P17, DOI 10.1016/j.expneurol.2014.08.026; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Das AV, 2004, DEV BIOL, V273, P87, DOI 10.1016/j.ydbio.2004.05.023; Dum RP, 2016, P NATL ACAD SCI USA, V113, P9922, DOI 10.1073/pnas.1605044113; El-Hussein AE, 2000, SCIENCE, V290, P1364; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Finkelstein E., 2006, INCIDENCE EC BURDEN; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; FISHMAN MC, 1991, PROG BRAIN RES, V89, P89; Gao M, 2018, MOL NEUROBIOL, V55, P5913, DOI 10.1007/s12035-017-0814-x; Giacino JTC, 2016, REHABILITATION ACCES; Goodroe SC, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00250; Hagan CE, 2011, COMPARATIVE ANATOMY AND HISTOLOGY: A MOUSE AND HUMAN ATLAS, P339; Hidalgo-Balbuena AE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12075-y; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Imielski Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030838; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Larkum ME, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00056; Leisman G, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00094; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Luo H, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00115; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MANOVA K, 1992, J NEUROSCI, V12, P4663; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Peirson SN, 2018, J NEUROSCI METH, V300, P26, DOI 10.1016/j.jneumeth.2017.04.007; Piao Chun-Shu, 2012, Exp Transl Stroke Med, V4, P25, DOI 10.1186/2040-7378-4-25; Piao CS, 2009, J CEREBR BLOOD F MET, V29, P759, DOI 10.1038/jcbfm.2008.168; PISA M, 1988, NEUROSCIENCE, V24, P453, DOI 10.1016/0306-4522(88)90341-7; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Quiquempoix M, 2018, CELL REP, V24, P2799, DOI 10.1016/j.celrep.2018.08.038; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stoltz RA, 1996, P NATL ACAD SCI USA, V93, P2832, DOI 10.1073/pnas.93.7.2832; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075562; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tewari A, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00017; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang KKW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020030; Ying Z, 2004, EPILEPSIA, V45, P314, DOI 10.1111/j.0013-9580.2004.37703.x; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	75	4	4	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2020	330								113335	10.1016/j.expneurol.2020.113335			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8YA	WOS:000539428100017	32360282				2022-02-06	
J	Rauen, K; Reichelt, L; Probst, P; Schapers, B; Muller, F; Jahn, K; Plesnila, N				Rauen, Katrin; Reichelt, Lara; Probst, Philipp; Schaepers, Barbara; Mueller, Friedemann; Jahn, Klaus; Plesnila, Nikolaus			Decompressive Craniectomy Is Associated With Good Quality of Life Up to 10 Years After Rehabilitation From Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						anxiety and depressive disorder; decompressive craniectomy; health-related quality of life; long-term outcome after traumatic brain injury; psychiatric disorders; traumatic brain injury	INTENSITY; COMA; CARE	Objectives: Traumatic brain injury is the number one cause of death in children and young adults and has become increasingly prevalent in the elderly. Decompressive craniectomy prevents intracranial hypertension but does not clearly improve physical outcome 6 months after traumatic brain injury. However, it has not been analyzed if decompressive craniectomy affects traumatic brain injury patients' quality of life in the long term. Design: Therefore, we conducted a cross-sectional study assessing health-related quality of life in traumatic brain injury patients with or without decompressive craniectomy up to 10 years after injury. Setting: Former critical care patients. Patients: Chronic traumatic brain injury patients having not (n= 37) or having received (n= 98) decompressive craniectomy during the acute treatment. Measurements and Main Results: Decompressive craniectomy was necessary in all initial traumatic brain injury severity groups. Eight percent more decompressive craniectomy patients reported good health-related quality of life with a Quality of Life after Brain Injury total score greater than or equal to 60 compared with the no decompressive craniectomy patients up to 10 years after traumatic brain injury (p= 0.004). Initially, mild classified traumatic brain injury patients had a median Quality of Life after Brain Injury total score of 83 (decompressive craniectomy) versus 62 (no decompressive craniectomy) (p= 0.028). Health-related quality of life regarding physical status was better in decompressive craniectomy patients (p= 0.025). Decompressive craniectomy showed a trend toward better health-related quality of life in the 61-85-year-old reflected by median Quality of Life after Brain Injury total scores of 62 (no decompressive craniectomy) versus 79 (decompressive craniectomy) (p= 0.06). Conclusions: Our results suggest that decompressive craniectomy is associated with good health-related quality of life up to 10 years after traumatic brain injury. Thus, decompressive craniectomy may have an underestimated therapeutic potential after traumatic brain injury.	[Rauen, Katrin; Reichelt, Lara; Schaepers, Barbara; Mueller, Friedemann; Jahn, Klaus] Schoen Clin Bad Aibling, Bad Aibling, Germany; [Rauen, Katrin; Reichelt, Lara; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Munich, Germany; [Rauen, Katrin] Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Minervastr 145, Zurich, Switzerland; [Rauen, Katrin] Univ Zurich, Inst Regenerat Med IREM, Schlieren, Switzerland; [Probst, Philipp] Univ Munich, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany; [Jahn, Klaus] Univ Munich, Med Ctr, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany		Rauen, K (corresponding author), Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Minervastr 145, Zurich, Switzerland.	katrin.rauen@uzh.ch	Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010	Jahn, Klaus/0000-0002-1669-3652; Rauen, Katrin/0000-0003-4555-6697	European Research Area Networks Network of European Funding for Neuroscience Research/Federal Ministry of Education and Research CnsAflame	Dr. Plesnila was supported by European Research Area Networks Network of European Funding for Neuroscience Research/Federal Ministry of Education and Research CnsAflame. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Alali AS, 2014, CRIT CARE MED, V42, P2235, DOI 10.1097/CCM.0000000000000500; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marmarou A, 2005, ACT NEUR S, V95, P277; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; Moskowitz E, 2018, AM SURGEON, V84, P1314; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Qarony W, 2018, ADV THEOR SIMUL, V1, DOI 10.1002/adts.201800030; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Rauen K, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P353, DOI 10.1016/B978-0-12-803196-4.00019-9; Rickels E, 2006, SCHADEL HIRN VERLETZ, P149; Sauvigny T, 2016, WORLD NEUROSURG, V88, P519, DOI 10.1016/j.wneu.2015.10.072; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; Waqas M, 2018, WORLD NEUROSURG, V116, pE783, DOI 10.1016/j.wneu.2018.05.092; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	34	4	4	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2020	48	8					1157	1164		10.1097/CCM.0000000000004387			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7JC	WOS:000562776400024	32697486				2022-02-06	
J	Zhu, W; Zhao, L; Li, T; Xu, H; Ding, YX; Cui, GQ				Zhu, Wei; Zhao, Li; Li, Tuo; Xu, Hao; Ding, Yuexia; Cui, Guangqiang			Docosahexaenoic acid ameliorates traumatic brain injury involving JNK-mediated Tau phosphorylation signaling	NEUROSCIENCE RESEARCH			English	Article						Docosahexaenoic acid; Traumatic brain injury; JNK; Tau; Hippocampus	AMYLOID-BETA; ACCUMULATION; INHIBITION; PLASTICITY; TAUOPATHY; MODEL; RAT	Hyperphosphorylation of Tau has been found in patients with traumatic brain injury (TBI). Inhibition of c-Jun N-terminal kinases (JNKs) improves neurological function by suppressing Tau phosphorylation. By inhibiting JNK, docosahexaenoic acid (DHA) protects against cognitive decline in a mouse model of Alzheimers disease (AD). We hypothesize that DHA protects against neuronal damage and behavioral deficits by inhibition of JNK mediated Tau phosphorylation. We induced TBI in mice and examined the phosphorylation status of JNK and Tau. We treated TBI and sham operated mice with DHA, and investigated the effects of DHA on JNK and Tau phosphorylation, hippocampal long term potentiation (LTP), learning and memory, and motor function by Western blot analysis, electrophysiology recording and behavioral assessments including Morris water maze test, beam-balance test, beam-walk test and rotarod test. We found that TBI induction lead to increased phosphorylation of JNK and Tau. DHA suppressed TBI induced JNK and Tau hyperphosphorylation, rescued TBI mediated hippocampal LTP deficits and hippocampus dependent learning and memory dysfunction, and improved motor function. Inhibition of JNK and Tau phosphorylation by DHA may represent a potential therapeutic strategy for TBI induced neurological dysfunction and Tauopathy. (C) 2019 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.	[Zhu, Wei; Li, Tuo; Xu, Hao; Cui, Guangqiang] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 Yuhuangding East Rd, Yantai 264000, Shangdong, Peoples R China; [Zhao, Li; Ding, Yuexia] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Pharm, Yantai 264000, Shangdong, Peoples R China		Cui, GQ (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 Yuhuangding East Rd, Yantai 264000, Shangdong, Peoples R China.	cuiguangqiang@126.com					Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen BB, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00273; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Connor S, 2012, APPL PHYSIOL NUTR ME, V37, P880, DOI [10.1139/h2012-062, 10.1139/H2012-062]; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Linder-Lucht M, 2007, PEDIATRICS, V120, P880, DOI 10.1542/peds.2006-2258; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mazzocchi-Jones D, 2015, BRAIN RES BULL, V111, P69, DOI 10.1016/j.brainresbull.2014.12.010; McCann JC, 2005, AM J CLIN NUTR, V82, P281, DOI 10.1093/ajcn/82.2.281; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Takeuchi K, 2015, BRAIN RES, V1621, P222, DOI 10.1016/j.brainres.2014.11.016; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vela S, 2019, MOL NEUROBIOL, V56, P1618, DOI 10.1007/s12035-018-1185-7; Vela S., 2019, MOL PUS EXP BRAIN RE, V165, P250; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; Yarza R, 2016, FRONT PHARMACOL, V6, DOI [10.3389/fphys.2015.00321, 10.3389/fphar.2015.00321]; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z; Zhu W, 2017, EXP THER MED, V14, P4411, DOI 10.3892/etm.2017.5054	30	4	4	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	AUG	2020	157						44	50		10.1016/j.neures.2019.07.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH3IL	WOS:000564567300004	31348997				2022-02-06	
J	Mira, RG; Lira, M; Quintanilla, RA; Cerpa, W				Mira, Rodrigo G.; Lira, Matias; Quintanilla, Rodrigo A.; Cerpa, Waldo			Alcohol consumption during adolescence alters the hippocampal response to traumatic brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Alcohol; Traumatic brain injury; Oxidative stress; Mitochondria; Dendritic spine	OXIDATIVE STRESS; NEURONAL DEATH; BINGE ETHANOL; MITOFUSIN 2; NEURODEGENERATION; MECHANISMS; MICROGLIA; DRINKING; PHOSPHOLIPASE-A2; MITOCHONDRIA	Binge drinking is the consumption of large volumes of alcohol in short periods and exerts its effects on the central nervous system, including the hippocampus. We have previously shown that binge drinking alters mitochondrial dynamics and induces neuroinflammation in the hippocampus of adolescent rats. Mild traumatic brain injury (mTBI), is regularly linked to alcohol consumption and share mechanisms of brain damage. In this context, we hypothesized that adolescent binge drinking could prime the development of brain damage generated by mTBI. We found that alcohol binge drinking induced by the "drinking in the dark" (DID) paradigm increases oxidative damage and astrocyte activation in the hippocampus of adolescent mice. Interestingly, adolescent animals submitted to DID showed decreased levels of mitofusin 2 that controls mitochondrial dynamics. When mTBI was evaluated as a second challenge, hippocampi from animals previously submitted to DID showed a reduction in dendritic spine number and a different spine profile. Mitochondrial performance could be compromised by alterations in mitochondrial fission in DID-mTBI animals. These data suggest that adolescent alcohol consumption can modify the progression of mTBI pathophysiology. We propose that mitochondrial impairment and oxidative damage could act as priming factors, modifying predisposition against mTBI effects. (C) 2020 Elsevier Inc. All rights reserved.	[Mira, Rodrigo G.; Lira, Matias; Cerpa, Waldo] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Func & Patol Neuronal, Santiago, Chile; [Mira, Rodrigo G.; Quintanilla, Rodrigo A.; Cerpa, Waldo] Ctr Invest & Estudio Consumo Alcohol Adolescentes, Santiago, Chile; [Quintanilla, Rodrigo A.] Univ Autonoma Chile, Fac Ciencias Salud, Lab Enfermedades Neurodegenerat, Santiago, Chile; [Cerpa, Waldo] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile		Cerpa, W (corresponding author), Lab Func & Patol Neuronal, Santiago, Chile.	wcerpa@bio.puc.cl	QUINTANILLA, RODRIGO/ABG-8829-2021	Cerpa, Waldo/0000-0001-7344-0144; Lira, Matias/0000-0002-3698-4553	Research Team Project in Science and Technology [ACT1411]; Basal Center for Excellence in Science and TechnologyComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL [AFB 170005, PFB 12/2007]; Sociedad Quimica y Minera de Chile (SQM); BMBFFederal Ministry of Education & Research (BMBF) [20150065]; FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1170441, 1190620]	This work has been supported by grants: Research Team Project in Science and Technology (ACT1411), Basal Center for Excellence in Science and Technology (AFB 170005, PFB 12/2007), Sociedad Quimica y Minera de Chile (SQM) for special grant "The role of lithium in human health and disease" and BMBF 20150065 (PCI) to WC, FONDECYT: 1170441 (to RAQ), 1190620 (to WC).	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonet-Ponce L, 2015, BBA-MOL BASIS DIS, V1852, P1400, DOI 10.1016/j.bbadis.2015.03.006; Cardoso S, 2017, EXPERT REV NEUROTHER, V17, P77, DOI 10.1080/14737175.2016.1205488; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Christensen J, 2020, J NEUROTRAUM, V37, P273, DOI 10.1089/neu.2019.6656; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Dinkova-Kostova AT, 2017, NEURODEGENER DIS MAN, V7, P97, DOI 10.2217/nmt-2017-0011; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Karelina K, 2018, BRAIN BEHAV IMMUN, V69, P532, DOI 10.1016/j.bbi.2018.01.012; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Knapp DJ, 1999, ALCOHOL CLIN EXP RES, V23, P633, DOI 10.1097/00000374-199904001-00010; Lamarche F, 2013, CHEM RES TOXICOL, V26, P78, DOI 10.1021/tx300395w; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Mayer AR, 2018, BIOL PSYCHIAT-COGN N, V3, P294, DOI 10.1016/j.bpsc.2017.09.012; McCrory P., 2013, OFF J ASS CHARTERED, V14, pe1; Merrill JE, 2016, ALCOHOL RES-CURR REV, V38, P103; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Moon KH, 2014, ALCOHOL CLIN EXP RES, V38, P161, DOI 10.1111/acer.12221; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Peng C, 2015, INT J BIOCHEM CELL B, V69, P29, DOI 10.1016/j.biocel.2015.09.011; Pian JP, 2010, NEUROSCIENCE, V170, P645, DOI 10.1016/j.neuroscience.2010.06.065; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Ramos-Zuniga R, 2018, WORLD NEUROSURG, V114, pE477, DOI 10.1016/j.wneu.2018.02.194; Reddy VD, 2013, MOL CELL BIOCHEM, V375, P39, DOI 10.1007/s11010-012-1526-1; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shabab T, 2017, INT J NEUROSCI, V127, P624, DOI 10.1080/00207454.2016.1212854; Slawecki CJ, 2004, ANN NY ACAD SCI, V1021, P448, DOI 10.1196/annals.1308.062; Sloan F, 2011, J STUD ALCOHOL DRUGS, V72, P459, DOI 10.15288/jsad.2011.72.459; Spear LP, 2014, NEUROTOXICOL TERATOL, V41, P51, DOI 10.1016/j.ntt.2013.11.006; Tajuddin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101223; Tapia-Rojas C, 2018, MOL NEUROBIOL, V55, P4473, DOI 10.1007/s12035-017-0613-4; Thiele TE, 2014, CURR PROTOC NEUROSCI, V68, p9 49 1; Thiele TE, 2014, ALCOHOL, V48, P235, DOI 10.1016/j.alcohol.2013.08.005; Topper LA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0382-9; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Who, 2014, REPORTGLOBAL STAT RE; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052	50	4	4	3	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUL 30	2020	528	3					514	519		10.1016/j.bbrc.2020.05.160			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	MA3AH	WOS:000541789500017	32505350				2022-02-06	
J	Lu, LY; Li, FF; Wang, P; Chen, HY; Chen, YC; Yin, XD				Lu, Liyan; Li, Fengfang; Wang, Peng; Chen, Huiyou; Chen, Yu-Chen; Yin, Xindao			Altered hypothalamic functional connectivity in post-traumatic headache after mild traumatic brain injury	JOURNAL OF HEADACHE AND PAIN			English	Article						Functional connectivity; Hypothalamus; Post-traumatic headache; Mild traumatic brain injury	MATTER VOLUME; MIGRAINE; ABNORMALITIES; NETWORK	Background Post-traumatic headache (PTH) is one of the most frequent symptoms following mild traumatic brain injury (mTBI). Neuroimaging studies implicate hypothalamic function connectivity (FC) disruption as an important factor in pain disorders. However, it is unknown whether there are alterations in the hypothalamus-based resting state FC within PTH following mTBI at the acute stage and its relationship with headache symptom measurement. Methods Forty-four mTBI patients with PTH, 27 mTBI patients without PTH and 43 healthy controls who were well matched for age, gender, and years of education were enrolled in this study. All participants underwent resting-state functional magnetic resonance imaging (fMRI) scanning as well as headache symptom measurement and cognitive assessment. Hypothalamic resting state networks were characterized by using a standard seed-based whole-brain correlation method. The bilateral hypothalamic FC was compared among the three groups. Furthermore, the correlations between hypothalamic resting state networks and headache frequency, headache intensity and MoCA scores was investigated in mTBI patients with PTH using Pearson rank correlation. Results Compared with mTBI patients without PTH, mTBI patients with PTH at the acute stage presented significantly decreased left hypothalamus-based FC with the right middle frontal gyrus (MFG) and right medial superior frontal gyrus (mSFG), and significantly decreased right hypothalamus-based FC with the right MFG. Decreased FC of the right MFG was significantly positively associated with headache frequency and headache intensity (r = 0.339,p = 0.024;r = 0.408,p = 0.006, respectively). Decreased FC of the right mSFG was significantly positively associated with headache frequency and headache intensity (r = 0.740,p < 0.0001;r = 0.655,p < 0.0001, respectively). Conclusion Our data provided evidence of disrupted hypothalamic FC in patients with acute mTBI with PTH, while abnormal FC significantly correlated with headache symptom measurement. Taken together, these changes may play an essential role in the neuropathological mechanism of mTBI patients with PTH.	[Lu, Liyan; Li, Fengfang; Wang, Peng; Chen, Huiyou; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China.	chenyuchen1989@126.com; y.163yy@163.com		Chen, Yu-Chen/0000-0002-8539-7224	333 High-level Talents Training Project of Jiangsu Province [BRA2019122]; Nanjing Medical University [2017NJMU123]	This study was supported by 333 High-level Talents Training Project of Jiangsu Province (No. BRA2019122) and Nanjing Medical University grant (No, 2017NJMU123).	Absinta M, 2012, CEPHALALGIA, V32, P109, DOI 10.1177/0333102411431334; Bonanno L, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01109-2; Capi M, 2020, INT J ENV RES PUB HE, V17, P7; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen C, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1425-z; Chen ZY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00606; Coppola G, 2020, J NEUROL, V267, P185, DOI 10.1007/s00415-019-09571-y; Dahlberg LS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00061; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Ha SY, 2019, J CLIN NEUROSCI, V62, P60, DOI 10.1016/j.jocn.2019.01.007; Huang XB, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1058-0; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Kocsel N, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00085; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Magon S, 2019, CEPHALALGIA, V39, P665, DOI 10.1177/0333102418795163; Messina R, 2018, CURR OPIN NEUROL, V31, P379, DOI 10.1097/WCO.0000000000000573; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Petrusic I, 2018, KOREAN J RADIOL, V19, P767, DOI 10.3348/kjr.2018.19.4.767; Raemaekers M, 2018, BRAIN STRUCT FUNCT, V223, P1909, DOI 10.1007/s00429-017-1604-y; Russo A, 2012, CEPHALALGIA, V32, P1041, DOI 10.1177/0333102412457089; Santangelo G, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0667-0; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Schulte LH, 2017, NEUROLOGY, V88, P2011, DOI 10.1212/WNL.0000000000003963; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Schwedt TJ, 2014, CEPHALALGIA, V34, P947, DOI 10.1177/0333102414526069; Skorobogatykh K, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1047-3; Su J, 2019, J HEADACHE PAIN, V20, P019; Szabo E, 2019, NEUROIMAGE-CLIN, V22, P26; Tessitore A, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-89; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Varndell W, 2017, J CLIN NURS, V26, P7, DOI 10.1111/jocn.13594; Wang P, 2014, NEUROSCI BULL, V30, P949, DOI 10.1007/s12264-013-1468-6; Yang FC, 2015, J NEUROL NEUROSUR PS, V86, P437, DOI 10.1136/jnnp-2014-308122; Yang FC, 2013, PAIN, V154, P801, DOI 10.1016/j.pain.2013.02.005; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	38	4	6	1	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	JUL 28	2020	21	1							93	10.1186/s10194-020-01164-9			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MQ6NP	WOS:000553010100001	32723299	gold, Green Published			2022-02-06	
J	Oyesanya, TO				Oyesanya, Tolu O.			Selection of discharge destination for patients with moderate-to-severe traumatic brain injury	BRAIN INJURY			English	Article						Patient discharge; traumatic brain injury; clinical decision-making	ACUTE-CARE; REHABILITATION; DISPARITIES; GUIDELINES; STROKE	Objectives To investigate criteria acute care interdisciplinary providers use to select discharge destination for patients with traumatic brain injury (TBI). Design Cross-sectional, exploratory survey study. Methods Data were collected from interdisciplinary providers at a U.S. Level I trauma centre via electronic survey. We invited 199 providers to participate and 27 responded (13.5% response rate). Responses were received from physicians and physical, occupational, and speech therapists. Results Findings showed variability in standard criteria and clinical judgment criteria providers used to select discharge destination for patients with TBI receiving acute care. There was limited agreement on standard criteria used to select discharge destination. Findings showed some agreement between providers on clinical judgment criteria used to select home as discharge destination and to prevent discharge to home. Most common clinical judgment criteria included therapists' recommendations on discharge location, patient's level of independence in activities of daily living, planned family support and ventilator dependence. Agreement on clinical judgment criteria became more limited when stratifying by discipline, frequency of patient care and experience. Conclusions Findings on clinical judgment criteria providers use to select acute care discharge destination for patients with TBI are inconclusive.	[Oyesanya, Tolu O.] Duke Univ, Sch Nursing, Durham, NC 27710 USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510	Shepherd Center Intramural Research Award	This study was funded by a Shepherd Center Intramural Research Award.	American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; American college of surgeons trauma quality improvement program, 2015, BEST PRACT MANAG JAN; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bettger JAP, 2013, ARCH PHYS MED REHAB, V94, P38, DOI 10.1016/j.apmr.2012.06.029; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Croskerry P., 2017, INDIVIDUAL VARIABILI; Cunningham CT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0016-z; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Department of Veterans Affairs, 2013, VHA HDB, V1172; Ebert JF, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8353; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Longley V, 2019, CLIN REHABIL, V33, P304, DOI 10.1177/0269215518808000; Lynch EA, 2016, DISABIL REHABIL, V38, P1415, DOI 10.3109/09638288.2015.1103791; Lynch EA, 2015, ARCH PHYS MED REHAB, V96, P782, DOI 10.1016/j.apmr.2014.12.009; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Patel J., 2018, LEVEL 1 VERSUS LEVEL; Pidcoke H, 2018, JOINT TRAUMA SYSTEM; Recker A, 2018, J ACUTE CARE PHYS TH, V9, P35, DOI 10.1097/JAT.0000000000000068; Rogers S, 2015, ARCH PHYS MED REHAB, V96, P276, DOI 10.1016/j.apmr.2014.09.018; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Starfield B, 2002, J AM BOARD FAM MED, V15; Swaine B, 2018, DISABIL REHABIL, V40, P697, DOI 10.1080/09638288.2016.1262911; Taherdoost H, 2016, INT J ACAD RES MANAG, DOI [DOI 10.2139/SSRN.3205040, 10.2139/ssrn.3205040]; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	33	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1222	1228		10.1080/02699052.2020.1797172		JUL 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000552532700001	32715771				2022-02-06	
J	Thiesler, H; Beimdiek, J; Hildebrandt, H				Thiesler, Hauke; Beimdiek, Julia; Hildebrandt, Herbert			Polysialic acid and Siglec-E orchestrate negative feedback regulation of microglia activation	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Immune balance; Inflammatory activation; Innate immune response; Traumatic brain injury; Sialic acid-binding immunoglobulin-like lectins	TRAUMATIC BRAIN-INJURY; SYNCAM 1; CELLS; POLYSIALYLATION; NEUROPILIN-2; MACROPHAGES; SUPPRESSION; MODULATION; GENERATION; RECEPTORS	Polysialic acid (polySia) emerges as a novel regulator of microglia activity. We recently identified polysialylated proteins in the Golgi compartment of murine microglia that are released in response to inflammatory stimulation. Since exogenously added polySia is able to attenuate the inflammatory response, we proposed that the release of polysialylated proteins constitutes a mechanism for negative feedback regulation of microglia activation. Here, we demonstrate that translocation of polySia from the Golgi to the cell surface can be induced by calcium depletion of the Golgi compartment and that polysialylated proteins are continuously released for at least 24 h after the onset of inflammatory stimulation. The latter was unexpected, because polySia signals detected by immunocytochemistry are rapidly depleted. However, it indicates that the amount of released polySia is much higher than anticipated based on immunostaining. This may be crucial for microglial responses during traumatic brain injury (TBI), as we detected polySia signals in activated microglia around a stab wound in the adult mouse brain. In BV2 microglia, the putative polySia receptor Siglec-E is internalized during lipopolysaccharide (LPS)-induced activation and in response to polySia exposure, indicating interaction. Correspondingly, CRISPR/Cas9-mediated Siglec-E knockout prevents inhibition of pro inflammatory activation by exogenously added polySia and leads to a strong increase of the LPS response. A comparable increase of LPS-induced activation has been observed in microglia with abolished polySia synthesis. Together, these results indicate that the release of the microglia-intrinsic polySia pool, as implicated in TBI, inhibits the inflammatory response by acting as atrans-activating ligand of Siglec-E.	[Thiesler, Hauke; Beimdiek, Julia; Hildebrandt, Herbert] Inst Clin Biochem, Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Thiesler, Hauke; Hildebrandt, Herbert] Ctr Syst Neurosci Hannover ZSN, Bunteweg 2, D-30559 Hannover, Germany		Hildebrandt, H (corresponding author), Inst Clin Biochem, Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany.; Hildebrandt, H (corresponding author), Ctr Syst Neurosci Hannover ZSN, Bunteweg 2, D-30559 Hannover, Germany.	hildebrandt.herbert@mh-hannover.de	Hildebrandt, Herbert/A-7873-2010	Hildebrandt, Herbert/0000-0002-1044-0881; Beimdiek, Julia/0000-0001-5366-9208	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [324633948, 432236295, Hi 678/9-1, Hi 678/10-1]	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project numbers 324633948 and 432236295 (DFG grants Hi 678/9-1 and Hi 678/10-1 to H.H.).	Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Aslanidis A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0296-6; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bhide GP, 2016, J BIOL CHEM, V291, P9444, DOI 10.1074/jbc.M116.714329; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Chen GY, 2014, ELIFE, V3, DOI 10.7554/eLife.04066; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Franco L, 2006, J NEUROCHEM, V99, P165, DOI 10.1111/j.1471-4159.2006.04031.x; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harlow E, 2006, CSH PROTOC, DOI [10.1101/pdb.prot4283.10.1101/pdb.prot4283, DOI 10.1101/PDB.PROT4283.10.1101/PDB.PROT4283]; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hildebrandt H, 2010, ADV EXP MED BIOL, V663, P95, DOI 10.1007/978-1-4419-1170-4_6; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Jeong JW, 2014, CHEM-BIOL INTERACT, V212, P30, DOI 10.1016/j.cbi.2014.01.012; Kallolimath S, 2016, P NATL ACAD SCI USA, V113, P9498, DOI 10.1073/pnas.1604371113; Kane BA, 2014, J INNATE IMMUN, V6, P727, DOI 10.1159/000363449; Karlstetter M, 2017, EMBO MOL MED, V9, P154, DOI 10.15252/emmm.201606627; Klegeris A, 2007, J NEUROSCI RES, V85, P2207, DOI 10.1002/jnr.21361; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Konze SA, 2014, MOL CELL PROTEOMICS, V13, P990, DOI 10.1074/mcp.M113.033423; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Linnartz-Gerlach B, 2014, GLYCOBIOLOGY, V24, P794, DOI 10.1093/glycob/cwu044; Lissandron V, 2010, P NATL ACAD SCI USA, V107, P9198, DOI 10.1073/pnas.1004702107; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Nagala M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01926; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Pakdel M, 2018, MOL BIOL CELL, V29, P235, DOI 10.1091/mbc.E17-02-0117; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pizzo P, 2011, CELL CALCIUM, V50, P184, DOI 10.1016/j.ceca.2011.01.006; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Redelinghuys P, 2011, J BIOL CHEM, V286, P34522, DOI 10.1074/jbc.M111.243410; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schidlitzki A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12368-6; Schiff M, 2009, J NEUROCHEM, V110, P1661, DOI 10.1111/j.1471-4159.2009.06267.x; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schwarz F, 2017, EMBO J, V36, P751, DOI 10.15252/embj.201695581; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shahraz A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16800; Spence S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3459; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Tantra M, 2014, BEHAV BRAIN RES, V275, P166, DOI 10.1016/j.bbr.2014.08.062; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Twele F, 2016, EPILEPSY BEHAV, V55, P47, DOI 10.1016/j.yebeh.2015.11.027; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varki A., 2017, ESSENTIALS GLYCOBIOL, P453; Varki A., 2017, ESSENTIALS GLYCOBIOL, V3rd ed., P179, DOI DOI 10.1101/GLYC0BI0L0; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Werneburg S, 2016, GLIA, V64, P1314, DOI 10.1002/glia.23004; Werneburg S, 2015, GLIA, V63, P1240, DOI 10.1002/glia.22815; Wu Y, 2016, J IMMUNOL, V197, P3336, DOI 10.4049/jimmunol.1600772; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222	64	4	4	1	2	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	FEB	2021	78	4					1637	1653		10.1007/s00018-020-03601-z		JUL 2020	17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QM1UA	WOS:000553320900001	32725371	hybrid, Green Published			2022-02-06	
J	Smirl, JD; Peacock, D; Wright, AD; Bouliane, KJ; Dierijck, J; Burma, JS; Kennefick, M; Wallace, C; van Donkelaar, P				Smirl, Jonathan D.; Peacock, Dakota; Wright, Alexander D.; Bouliane, Kevin J.; Dierijck, Jill; Burma, Joel S.; Kennefick, Michael; Wallace, Colin; van Donkelaar, Paul			An Acute Bout of Soccer Heading Subtly Alters Neurovascular Coupling Metrics	FRONTIERS IN NEUROLOGY			English	Article						repetitive football; soccer heading; sub-concussive impacts; cerebral blood flow; sport concussion assessment tool 3; SCAT3	TRANSCRANIAL DOPPLER ULTRASOUND; CHRONIC TRAUMATIC ENCEPHALOPATHY; POSITRON-EMISSION-TOMOGRAPHY; BLOOD-PRESSURE; CEREBRAL AUTOREGULATION; POSTURAL CONTROL; SEX-DIFFERENCES; FLOW VELOCITY; CONCUSSION; SPORT	Objective: The current investigation examined how a bout of soccer heading may impact brain function. Design: Semi-randomized crossover cohort. Setting: Controlled soccer heading. Participants: Seven male soccer players (24.1 +/- 1.5 years). Intervention: 40 successful soccer headers were performed in 20 min (25 m, launch velocity similar to 80 km/h). X2 xPatch recorded linear and rotational head accelerations during each impact. A contact control "sham"condition - ball made body contact, but not by the head; and a no activity time "control"condition were also completed. Main Outcome Measures: Posterior and middle cerebral artery (PCA and MCA, respectively), cerebral blood velocity (CBV) was recorded during a visual task (neurovascular coupling: NVC) alongside SCAT3 symptoms scores pre/post a controlled bout of soccer heading. Results: Cumulative linear and rotational accelerations were 1,574 +/- 97.9 g and 313,761 +/- 23,966 rads/s(2), respectively, during heading and changes in SCAT3 symptom number (pre: 2.6 +/- 3.0; post: 6.7 +/- 6.2, p=0.13) and severity (pre: 3.7 +/- 3.6, post: 9.4 +/- 7.6, p=0.11) were unchanged. In the PCA, no NVC differences were observed, including: relative CBV increase (28.0 +/- 7.6%, p=0.71) and total activation (188.7 +/- 68.1 cm, p=0.93). However, MCA-derived NVC metrics were blunted following heading, demonstrating decreased relative CBV increase (7.8 +/- 3.1%, p=0.03) and decreased total activation (26.7 +/- 45.3 cm, p=0.04). Conclusion: Although an acute bout of soccer heading did not result in an increase of concussion-like symptoms, there were alterations in NVC responses within the MCA during a visual task. This suggests an acute bout of repetitive soccer heading can alter CBV regulation within the region of the brain associated with the header impacts.	[Smirl, Jonathan D.; Wright, Alexander D.; Bouliane, Kevin J.; Dierijck, Jill; Burma, Joel S.; Kennefick, Michael; Wallace, Colin; van Donkelaar, Paul] Univ British Columbia, Concuss Res Lab, Kelowna, BC, Canada; [Smirl, Jonathan D.; Burma, Joel S.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Smirl, Jonathan D.; Burma, Joel S.] Univ Calgary, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Smirl, Jonathan D.; Burma, Joel S.] Univ Calgary, Human Performance Lab, Calgary, AB, Canada; [Smirl, Jonathan D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Smirl, Jonathan D.] Univ Calgary, Integrated Concuss Res Program, Calgary, AB, Canada; [Smirl, Jonathan D.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Smirl, Jonathan D.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Peacock, Dakota; Wright, Alexander D.] Univ British Columbia, Southern Med Program, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Expt Med, Vancouver, BC, Canada; [Dierijck, Jill] Dalhousie Univ, Fac Hlth, Sch Physiotherapy, Halifax, NS, Canada		Smirl, JD (corresponding author), Univ British Columbia, Concuss Res Lab, Kelowna, BC, Canada.; Smirl, JD (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.; Smirl, JD (corresponding author), Univ Calgary, Sport Injury Prevent Res Ctr, Calgary, AB, Canada.; Smirl, JD (corresponding author), Univ Calgary, Human Performance Lab, Calgary, AB, Canada.; Smirl, JD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Smirl, JD (corresponding author), Univ Calgary, Integrated Concuss Res Program, Calgary, AB, Canada.; Smirl, JD (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.; Smirl, JD (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada.	jonathan.smirl@ucalgary.ca	Burma, Joel/AAL-1073-2021	Burma, Joel/0000-0001-9756-5793; Peacock, Dakota/0000-0001-6135-6551	MITACS; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CFICanada Foundation for Innovation	MITACS, NSERC, and CFI for the work presented in the current investigation.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ainslie PN, 2014, J APPL PHYSIOL, V117, P1081, DOI 10.1152/japplphysiol.00854.2014; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bevilacqua ZW, 2019, JOVE-J VIS EXP, DOI 10.3791/59381; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Bunc Gorazd, 2017, Med Arch, V71, P356, DOI 10.5455/medarh.2017.71.356-359; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gommer ED, 2014, MED ENG PHYS, V36, P613, DOI 10.1016/j.medengphy.2014.01.006; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; OMBONI S, 1993, HYPERTENSION, V22, P26, DOI 10.1161/01.HYP.22.1.26; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Reed WF, 2002, ARCH PEDIAT ADOL MED, V156, P337, DOI 10.1001/archpedi.156.4.337; Rodrigues AC, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00209; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rosenegger DG, 2015, MICROCIRCULATION, V22, P197, DOI 10.1111/micc.12184; Rosengarten B, 2001, ULTRASOUND MED BIOL, V27, P189, DOI 10.1016/S0301-5629(00)00332-X; Sammons EL, 2007, J APPL PHYSIOL, V103, P369, DOI 10.1152/japplphysiol.00271.2007; Siberry GK, 2000, PEDIATRICS, V105, P659, DOI [10.1542/peds.105.3.659, DOI 10.1542/PEDS.105.3.659]; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Smirl JD, 2015, J APPL PHYSIOL, V119, P487, DOI 10.1152/japplphysiol.00264.2015; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wright AD, 2020, CLIN J SPORT MED, V30, pS53, DOI 10.1097/JSM.0000000000000578; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	57	4	4	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 24	2020	11								738	10.3389/fneur.2020.00738			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NB5AJ	WOS:000560524700001	32849205	Green Published, gold			2022-02-06	
J	Thangavelu, B; LaValle, CR; Egnoto, MJ; Nemes, J; Boutte, AM; Kamimori, GH				Thangavelu, Bharani; LaValle, Christina R.; Egnoto, Michael J.; Nemes, Jeffrey; Boutte, Angela M.; Kamimori, Gary H.			Overpressure Exposure From .50-Caliber Rifle Training Is Associated With Increased Amyloid Beta Peptides in Serum	FRONTIERS IN NEUROLOGY			English	Article						50 caliber rifle training; overpressure; low-level blast; occupational exposure; traumatic brain injury; serum biomarkers; amyloid beta peptides	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; C-TERMINAL HYDROLASE-L1; FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; MILD; TAU; PLASMA; SYMPTOMS	Background:Overpressure (OP) is an increase in air pressure above normal atmospheric levels. Military personnel are repeatedly exposed to low levels of OP caused by various weapon systems. Repeated OP may increase risk of neurological disease or psychological disorder diagnoses. A means to detect early phase effects that may be relevant to brain trauma remain elusive. Therefore, development of quantitative and objective OP-mediated effects during acute timeframes would vastly augment point-of-care or field-based decisions. This pilot study evaluated the amplitude of traumatic brain injury (TBI)-associated biomarkers in serum as a consequence of repeated OP exposure from .50-caliber rifle use over training multiple days. Objective:To determine the acute temporal profile of TBI-associated serum biomarkers and their relationship with neurocognitive decrements or self-reported symptoms among participants exposed to low-level, repeated OP from weapons used in a training environment. Methods:Study participants were enrolled in .50-caliber sniper rifle training and exposed to mild OP (peak pressure 3.8-4.5 psi, impulse 19.27-42.22 psi-ms per day) for three consecutive days (D1-D3). Defense automated neurobehavioral assessment (DANA) neurocognitive testing, symptom reporting, and blood collection were conducted 2-3 h before (pre-) and again 0.45-3 h after (post-) OP exposure. The TBI-associated serum biomarkers, glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase-L1 (UCH-L1), neurofilament light (Nf-L), tau, and amyloid beta peptides (A beta-40 and A beta-42) were measured using digital ELISAs. Results:Serum GFAP decreased on D1 and D3 but not D2 after OP exposure. Nf-L was suppressed on D3 alone. A beta-40 was elevated on D2 alone while A beta-42 was elevated each day after OP exposure. Suppression of GFAP and elevation of A beta-42 correlated to OP-mediated impulse levels measured on D3. Conclusions:Acute measurement of A beta-peptides may have utility as biomarkers of subconcussive OP caused by rifle fire. Fluctuation of GFAP, Nf-L, and particularly A beta peptide levels may have utility as acute, systemic responders of subconcussive OP exposure caused by rifle fire even in the absence of extreme operational deficits or clinically defined concussion.	[Thangavelu, Bharani; Boutte, Angela M.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [LaValle, Christina R.; Egnoto, Michael J.; Nemes, Jeffrey; Kamimori, Gary H.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Thangavelu, B (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	bharani.thangavelu.ctr@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; U.S. Army Medical Research and Materiel Command Military Operational Medicine Research ProgramU.S. Army Medical Research & Materiel Command (USAMRMC); Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award [W81XWH-16-2-0001]	This work was supported by the Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3), and Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award No. W81XWH-16-2-0001.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Arrieux JP, 2017, CONCUSSION, V2, DOI [10.2217/cnc-2016-002130202572, DOI 10.2217/CNC-2016-002130202572]; Aziz N, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0313-0; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Boutte AM, 2018, J NEUROTRAUM, V35, pA213; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J NEUROTRAUM, V32, pA109; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cole W. R., 2016, TRANSLATIONAL RES TR; DEAN PJA, 2013, FRONT HUM NEUROSCI, V0007; DeDominicis KE, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00490; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Fish L., 2018, PROTECTING WARFIGHTE; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Jorolemon MR, 2019, BLAST INJURIES; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lang M, 2018, J SPECIAL OPER MED P, V18, P87; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MISHRA V, 2016, SCI REP UK, V0006; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Puig KL, 2012, J NEUROIMMUNE PHARM, V7, P215, DOI 10.1007/s11481-011-9327-y; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shi J, 2007, NEUROLOGY, V69, P1063, DOI 10.1212/01.wnl.0000284702.01399.56; Singh AK, 2016, RADIOGRAPHICS, V36, P295, DOI 10.1148/rg.2016150114; SKOTAK M, 2019, FRONT NEUROL, V0010; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wiri S, 2017, SHOCK WAVES, V27, P849, DOI 10.1007/s00193-017-0755-3; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	63	4	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 24	2020	11								620	10.3389/fneur.2020.00620			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NB5BF	WOS:000560526900001	32849168	Green Published, gold			2022-02-06	
J	Griffiths, DR; Jenkins, TM; Addington, CP; Stabenfeldt, SE; Lifshitz, J				Griffiths, Daniel R.; Jenkins, Taylor M.; Addington, Caroline P.; Stabenfeldt, Sarah E.; Lifshitz, Jonathan			Extracellular matrix proteins are time-dependent and regional-specific markers in experimental diffuse brain injury	BRAIN AND BEHAVIOR			English	Article						extracellular matrix; primary somatosensory barrel cortex; protein; S1BF; traumatic brain injury; ventral posterior medial; ventral posterior medial thalamus	TENASCIN-C; FIBRONECTIN; APOER2; THROMBOSPONDINS; INCREASE; RECEPTOR	Introduction: The extracellular matrix (ECM) provides structural support for neuronal, glial, and vascular components of the brain, and regulates intercellular signaling required for cellular morphogenesis, differentiation and homeostasis. We hypothesize that the pathophysiology of diffuse brain injury impacts the ECM in a multi-dimensional way across brain regions and over time, which could facilitate damage and repair processes. Methods: Experimental diffuse TBI was induced in male Sprague-Dawley rats (325-375 g) by midline fluid percussion injury (FPI); uninjured sham rats serve as controls. Tissue from the cortex, thalamus, and hippocampus was collected at 15 min, 1, 2, 6, and 18 hr postinjury as well as 1, 3, 7, and 14 days postinjury. All samples were quantified by Western blot for glycoproteins: fibronectin, laminin, reelin, and tenascin-C. Band intensities were normalized to sham and relative to beta-actin. Results: In the cortex, fibronectin decreased significantly at 15 min, 1 hr, and 2 hr postinjury, while tenascin-C decreased significantly at 7 and 14 days postinjury. In the thalamus, reelin decreased significantly at 2 hr, 3 and 14 days postinjury. In the hippocampus, tenascin-C increased significantly at 15 min and 7 days postinjury. Conclusion: Acute changes in the levels of these glycoproteins suggest involvement in circuit dismantling, whereas postacute levels may indicate a restorative or regenerative response associated with recovery from TBI.	[Griffiths, Daniel R.; Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ USA; [Griffiths, Daniel R.; Jenkins, Taylor M.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Addington, Caroline P.; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Ira A Fulton Sch Engn, Tempe, AZ USA; [Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA		Lifshitz, J (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Translat Neurotrauma Res Program, Phoenix, AZ 85016 USA.	jlifshitz@email.arizona.edu		Griffiths, Daniel/0000-0001-6558-261X	Barrow Neurological Institute at Phoenix Children's Hospital; School of Biological and Health Systems Engineering at Arizona State University	We are grateful to Jessica Flores for assistance with tissue processing and Western blotting. We would like to thank Megan Evilsizor for her help with animal procedures. Research reported in this publication was supported, in part, by a pilot project grant from Barrow Neurological Institute at Phoenix Children's Hospital and School of Biological and Health Systems Engineering at Arizona State University.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Bharadwaj VN, 2018, NANOMED-NANOTECHNOL, V14, P2155, DOI 10.1016/j.nano.2018.06.004; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; D'Arcangelo G, 2005, NEURON, V47, P471, DOI 10.1016/j.neuron.2005.08.001; D'Arcangelo G., 2014, ADV NEUROSCI, V2014, P1, DOI DOI 10.1155/2014/597395; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; George N, 2018, J NEUROSCI RES, V96, P573, DOI 10.1002/jnr.24151; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Holley JE, 2005, GLIA, V52, P53, DOI 10.1002/glia.20231; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.0.CO;2-G; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0; Knoblach SM, 2005, PROTEAS BIOL DIS, V3, P79, DOI 10.1007/0-387-23101-3_4; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NIQUET J, 1995, J NEUROCYTOL, V24, P611, DOI 10.1007/BF01257376; Ogle S, 2016, J NEUROTRAUM, V33, pA76; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Strekalova T, 2002, MOL CELL NEUROSCI, V21, P173, DOI 10.1006/mcne.2002.1172; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Tate CC, 2007, J NEUROTRAUM, V24, P226, DOI 10.1089/neu.2006.0043; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	35	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	SEP	2020	10	9							e01767	10.1002/brb3.1767		JUL 2020	10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	NU8NS	WOS:000563842300001	32705814	Green Published, gold			2022-02-06	
J	Liang, F; Sun, L; Yang, J; Liu, XH; Zhang, J; Zhu, WQ; Yang, L; Nan, D				Liang, Fang; Sun, Lei; Yang, Jing; Liu, Xue-Hua; Zhang, Jing; Zhu, Wan-Qiu; Yang, Lu; Nan, Ding			The effect of different atmosphere absolute hyperbaric oxygen on the expression of extracellular histones after traumatic brain injury in rats	CELL STRESS & CHAPERONES			English	Article						Hyperbaric oxygen; Traumatic brain injury; Extracellular histones	INFLAMMATION; CELLS	By observing the dynamic changes of extracellular histones H1, H2A, H4, and NF-kappa B expression in brain tissues after brain injury in rats, we explore the association among the expression of extracellular histones H1, H2A, H4, and NF-kappa B following traumatic brain injury (TBI), as well as the effect of different atmospheres absolute hyperbaric oxygen (HBO) intervention on the expression and possible mechanisms. A total of 120 SD rats were randomly divided into 4 groups: Sham-operated (SH), TBI (traumatic brain injury) group, traumatic brain injury and hyperbaric oxygen treatment 1.6ATA (TBI + HBO1) group, and traumatic brain injury and hyperbaric oxygen treatment2.2ATA (TBI + HBO2) group, with 30 rats in each group. The rats in each group were then randomly divided into five smaller time-specific sub-groups: 3 h, 6 h, 12 h, 24 h, and 48 h after surgery. TBI models were established, and the brain tissue around the lesion was taken at different time points. On the one hand,we detected the level of local histones H1, H2A, H4, and NF-kappa B by RT-PCR and Western Blot. On the other hand, we used immunohistochemical methods to detect the expression of NF-kappa B, while using the TUNEL method to observe the cell apoptosis in experimental groups after brain injury. Extracellular histones H1, H2A, H4, and NF-kappa B proteins were highly expressed at 3 h, then with a slight fluctuation, reached to peak at 48 h after the injury. HBO can affect the expression of histones H1, H2A, H4, and NF-kappa B. The decline of each indicator in the 1.6ATA group was significantly lower than that in the 2.2ATA group, especially within 6 h (P < 0. 05). In addition, NF-kappa B expression was consistent with the pathological changes of apoptosis in experimental groups. Hyperbaric oxygen therapy with relatively low pressure (1.6ATA) at the early stage can significantly inhibit the expression of extracellular histones H1, H2A, H4, and NF-kappa B around the lesion, reduce the apoptosis of nerve cells, and thus play an important role in alleviating secondary brain injury.	[Liang, Fang; Sun, Lei; Yang, Jing; Liu, Xue-Hua; Zhang, Jing; Zhu, Wan-Qiu; Yang, Lu; Nan, Ding] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen, 8 South Gongti Rd, Beijing 100020, Peoples R China		Yang, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen, 8 South Gongti Rd, Beijing 100020, Peoples R China.	JYANG2postgraduate@yeah.net					Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Bitterman H, 2012, J EXP INTEGR MED, V2, P283, DOI [10.5455/jeim.070912.ed.015, DOI 10.5455/JEIM.070912.ED.015]; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P450, DOI 10.1038/jcbfm.2013.217; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Hamam HJ, 2019, BIOMOLECULES, P9; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Holdenrieder S, 2001, ANN NY ACAD SCI, V945, P93; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41749; Liu SL, 2014, LIFE SCI, V98, P44, DOI 10.1016/j.lfs.2013.12.207; Narotam PK, 2013, CRIT CARE, V17, DOI 10.1186/cc13065; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rosin DL, 2012, J AM SOC NEPHROL, V23, P1275, DOI 10.1681/ASN.2012060615; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Silvestre-Roig C, 2019, NATURE, V569, P236, DOI 10.1038/s41586-019-1167-6; Takeda Kiyoshi, 2015, Curr Protoc Immunol, V109, DOI 10.1002/0471142735.im1412s109; Ward, 2014, INFLAMM CELL SIGNAL, P1, DOI DOI 10.14800/ics.131; Wen ZM, 2013, J CELL BIOCHEM, V114, P2384, DOI 10.1002/jcb.24588; Xu ZH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/205054	26	4	4	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	NOV	2020	25	6					1013	1024		10.1007/s12192-020-01137-6		JUL 2020	12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	OK3XP	WOS:000551794300001	32705509	Green Published, hybrid			2022-02-06	
J	Hall, TA; Leonard, S; Bradbury, K; Holding, E; Lee, J; Wagner, A; Duvall, S; Williams, CN				Hall, Trevor A.; Leonard, Skyler; Bradbury, Kathryn; Holding, Emily; Lee, Justin; Wagner, Amanda; Duvall, Susanne; Williams, Cydni N.			Post-intensive care syndrome in a cohort of infants & young children receiving integrated care via a pediatric critical care & neurotrauma recovery program: A pilot investigation	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Pediatrics; critical care; early brain injury; post-intensive care syndrome; cross-collaboration; inter-professional; multidisciplinary; outcome	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; EARLY INTERVENTION; SLEEP DISTURBANCE; OUTCOMES; BEHAVIOR; RISK; PAIN; RELIABILITY; VALIDATION	Objective Children treated in the pediatric intensive care unit (PICU) often face difficulties with long-term morbidities associated with neurologic injuries and lifesaving PICU interventions termed Post-Intensive Care Syndrome (PICS). In an effort to identify and address critical issues related to PICS, we developed an integrated model of care whereby children and families participate in follow-up clinics with a neuropsychologist and a critical care physician. To demonstrate preliminary impact, we present pilot findings on the early identification and treatment of PICS in a cohort of infants and young children in our program through a combination of multi-professional direct assessment and parent proxy questionnaires. Method Thirty-three infants and children, ages 3-72 months, participated in our initial follow-up clinic where issues related to physical health/recovery, development/cognition, mood/behavior, and quality of life were screened 1-3 months after discharge from the PICU. Results In comparison to pre-hospitalization functioning, direct assessment revealed new neurological concerns identified by the critical care physician in 33.3% of participants and new neurocognitive concerns identified by the neuropsychologist in 36.4% of participants. Caregiver reported measures showed significant issues with patient cognitive functioning, emotional functioning, sleep, and impact on the family. Participants and families experienced significant difficulties related to changes in functioning and disability. Parents/caregivers and clinicians demonstrated agreement on functioning across a variety of indicators; however, important divergence in assessments were also found highlighting the importance of multiple assessments and perspectives. Conclusions New PICS morbidities are common in the early phase of recovery after discharge in infants, young children and their families. Results demonstrate the benefits and need for timely PICU follow-up care that involves collaboration/integration of physicians, neuropsychologists, and families to identify and treat PICS issues.	[Hall, Trevor A.] Oregon Hlth & Sci Univ, Div Pediat Psychol, Inst Dev & Disabil, Dept Pediat,Doernbecher Childrens Hosp,Pediat Cri, Portland, OR 97239 USA; [Leonard, Skyler; Bradbury, Kathryn; Holding, Emily; Lee, Justin; Duvall, Susanne] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Inst Dev & Disabil, Dept Pediat,Div Pediat Psychol, Portland, OR 97239 USA; [Wagner, Amanda] Child Mind Inst, Learning & Dev Ctr, San Mateo, CA USA; [Williams, Cydni N.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Pediat Crit Care & Neurotrauma Recovery Program P, Dept Pediat,Div Pediat Crit Care, Portland, OR 97239 USA		Hall, TA (corresponding author), Oregon Hlth & Sci Univ, Div Pediat Psychol, Inst Dev & Disabil, Dept Pediat,Doernbecher Childrens Hosp,Pediat Cri, Portland, OR 97239 USA.	halltr@ohsu.edu					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Atkins KL, 2017, MATERN CHILD HLTH J, V21, P290, DOI 10.1007/s10995-016-2113-y; Baum KT, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26446; Bayley N., 2006, BAYLEY SCALES INFANT; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bertisch H, 2017, QUAL LIFE RES, V26, P1887, DOI 10.1007/s11136-017-1524-6; Blasco PM, 2017, INFANT YOUNG CHILD, V30, P190, DOI 10.1097/IYC.0000000000000097; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Cunningham NR, 2017, PAIN, V158, P1323, DOI 10.1097/j.pain.0000000000000914; Devine H, 2019, J REHABIL MED, V51, P451, DOI 10.2340/16501977-2558; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Dodd JN, 2018, PEDIATR NEUROL, V89, P58, DOI 10.1016/j.pediatrneurol.2018.09.007; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Elliott C.D., 2007, DIFFERENTIAL ABILITI; Elliott D, 2014, CRIT CARE MED, V42, P2518, DOI 10.1097/CCM.0000000000000525; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hardy KK, 2017, J PEDIATR PSYCHOL, V42, P815, DOI 10.1093/jpepsy/jsx060; Hartman ME, 2020, PEDIATR NEUROL, V108, P47, DOI 10.1016/j.pediatrneurol.2020.02.003; Hebbeler K., 2007, FINAL REPORT NATL EA; Herrup Elizabeth A, 2017, World J Crit Care Med, V6, P124, DOI 10.5492/wjccm.v6.i2.124; Hinds PS, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27606; Huang IC, 2009, VALUE HEALTH, V12, P773, DOI 10.1111/j.1524-4733.2008.00487.x; IBM Corp, 2017, SPSS STAT WIND; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kyranou M, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-36; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Oakland, 2015, ADAPTIVE BEHAV ASSES; Ong C, 2016, PEDIAT CRIT CARE MED, V17, pe247, DOI DOI https://doi.org/10.1097/PCC.000000000000076; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Cordts KMP, 2020, NEUROCRIT CARE, V33, P196, DOI 10.1007/s12028-019-00883-5; Reeve BB, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28160; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; Singh A, 2019, BLOOD ADV, V3, P2244, DOI 10.1182/bloodadvances.2019000381; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Tang BG, 2012, PEDIATRICS, V129, P1027, DOI 10.1542/peds.2011-2720; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, HEALTH QUAL LIFE OUT, V2, P1, DOI DOI https://doi.org/10.1186/1477-7525-2-55; Waber DP, 2017, J PEDIATR PSYCHOL, V42, P823, DOI 10.1093/jpepsy/jsx068; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wainwright MS, 2016, CURR OPIN CRIT CARE, V22, P106, DOI 10.1097/MCC.0000000000000288; Wechsler D., 2012, WECHSLER PRIMARY PRE; WILLIAMS CN, 2017, CHILDREN BASEL, V4, DOI DOI https://doi.org/10.3390/children4090083; WILLIAMS CN, 2019, CURR TREAT OPTION NE, V21, DOI DOI https://doi.org/10.1007/s11940-019-0586-x; Williams Cydni N, 2019, Hosp Pediatr, V9, P958, DOI 10.1542/hpeds.2019-0173; Williams Cydni N, 2018, J Pediatr Intensive Care, V7, P173, DOI 10.1055/s-0038-1637005; Williams CN, 2018, NAT SCI SLEEP, V10, P225, DOI 10.2147/NSS.S174608; Zwaigenbaum L, 2015, PEDIATRICS, V136, pS60, DOI 10.1542/peds.2014-3667E	55	4	4	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2020.1797176		JUL 2020	25	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MO5YH	WOS:000551600600001	32703075				2022-02-06	
J	Waltzman, D; Daugherty, J; Snedekar, K; Bouton, J; Wang, D				Waltzman, Dana; Daugherty, Jill; Snedekar, Katherine; Bouton, Jason; Wang, David			Concussion reporting, return to learn, and return to play experiences in a sample of private preparatory high school students	BRAIN INJURY			English	Article						Private school; high school; concussion; reporting; return to learn; return to school	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; UNITED-STATES; YOUTH; KNOWLEDGE; EPIDEMIOLOGY; EDUCATION; FOOTBALL; MANAGEMENT; SYMPTOMS	Objective The objective of this study is to describe concussion reporting and return to learn and play among high school students. Methods Self-reported survey data of 1,999 New England private preparatory high school students who played sports or engaged in recreational activities were collected in 2018. Descriptive and bivariate statistics are presented. Results Three in ten respondents (31.4%) reported ever sustaining a concussion and 22.0% did not report at least one concussion to an adult. The most common reasons for not reporting included wanting to keep playing their sport (58.0%) and not thinking the injury was that serious (53.6%). Girls and students in higher grades took longer to return to school and sports. A quarter of students reported pretending to have a faster recovery in order to return to school or sports. Conclusion Private school students who play sports or engage in recreational activity may be at risk of sustaining concussions and may not report their symptoms due to a lack of understanding the seriousness of concussion, not wanting to fall behind in school, or out of desire to continue playing their sport. Teachers, coaches, and parents can stress reporting as the first step in recovery.	[Waltzman, Dana; Daugherty, Jill] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA 30341 USA; [Snedekar, Katherine; Bouton, Jason] PINK Concuss, Norwalk, CT USA; [Bouton, Jason] King Sch, Stamford, CT USA; [Wang, David] Connecticut Childrens Med Ctr, Elite Sports Med, Hartford, CT USA; [Wang, David] Quinnipiac Univ, Sports Med, Hamden, CT 06518 USA		Waltzman, D (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA 30341 USA.	DWaltzman@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Boswell D, 2004, ARCH CLIN NEUROPSYCH, V19, P958; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Centers for Disease Control and Prevention, 2018, SPORTS FACTS BEN YOU; CHOY SP, 1997, 0160492211 NAT CTR E; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen J., 2013, STAT POWER ANAL BEHA; Comstock R. D. C. D., 2017, NATL HIGH SCH SPORTS; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Currie DW, 2017, J HEAD TRAUMA REHAB, V32, P90, DOI 10.1097/HTR.0000000000000240; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Daugherty J, 2020, J SCHOOL HEALTH, V90, P527, DOI 10.1111/josh.12899; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; DESSY A, 2015, NEUROSURG QUART, V25, P423, DOI DOI 10.1097/WNQ.0000000000000085; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galloway M, 2013, J EXP EDUC, V81, P490, DOI 10.1080/00220973.2012.745469; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; HUGGINS RA, 2018, ATHLETIC TRAINING LO; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kennedy R., 2016, PRIVATE SCH REV; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Leonard NR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01028; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Mirabelli MH, 2015, AM FAM PHYSICIAN, V92, P371; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; MOSES S, 2018, SPORTS CONTACT LEVEL; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Pearce AJ, 2017, J SPORT SCI, V35, P1911, DOI 10.1080/02640414.2016.1241420; Prasad D S, 2009, Indian J Med Sci, V63, P33; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Shendell DG, 2019, J SCHOOL HEALTH, V89, P527, DOI 10.1111/josh.12775; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	71	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1193	1201		10.1080/02699052.2020.1793388		JUL 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000551301800001	32697613	Green Accepted			2022-02-06	
J	Ashina, H; Al-Khazali, HM; Iljazi, A; Ashina, S; Jorgensen, NR; Amin, FM; Ashina, M; Schytz, HW				Ashina, Hakan; Al-Khazali, Haidar Muhsen; Iljazi, Afrim; Ashina, Sait; Jorgensen, Niklas Rye; Amin, Faisal Mohammad; Ashina, Messoud; Schytz, Henrik Winther			Low plasma levels of calcitonin gene-related peptide in persistent post-traumatic headache attributed to mild traumatic brain injury	CEPHALALGIA			English	Article						Biomarkers; concussion; head trauma; pathophysiology	PERIPHERAL-BLOOD; CGRP; CAPSAICIN; BIOMARKER; PAIN; MIGRAINE; MODEL	Objective To investigate the role of calcitonin gene-related peptide (CGRP) in persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (TBI). Methods A total of 100 individuals with persistent PTH attributed to mild TBI and 100 age- and gender-matched healthy controls were enrolled between July 2018 and June 2019. Blood was drawn from the antecubital vein and subsequently analyzed using a validated radioimmunoassay for human CGRP. Measurements were performed on coded samples by a board-certified laboratory technician who was blind to clinical information. Results CGRP plasma levels were lower in subjects with persistent PTH (mean, 75.8 pmol/L; SD, 26.4 pmol/L), compared with age- and gender-matched healthy controls (mean, 88.0 pmol/L; SD, 34.1 pmol/L) (p = 0.04). No correlation was found of CGRP plasma levels with monthly headache days (r = -0.11;p = 0.27), monthly migraine-like days (r = 0.15;p = 0.13), headache quality (r = -0.14;p = 0.15), or a chronic migraine-like headache phenotype (r = -0.02;p = 0.85). Conclusions CGRP plasma measurements are unlikely a feasible blood-based biomarker of persistent PTH. Future studies should assess whether CGRP plasma measurements can be used to predict development of persistent PTH.	[Ashina, Hakan; Al-Khazali, Haidar Muhsen; Iljazi, Afrim; Amin, Faisal Mohammad; Ashina, Messoud; Schytz, Henrik Winther] Univ Copenhagen, Danish Headache Ctr, Dept Neurol, Rigshosp Glostrup,Fac Hlth & Med Sci, Copenhagen, Denmark; [Ashina, Sait] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia, Boston, MA 02115 USA; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Crit Care, Boston, MA 02115 USA; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pain Med, Boston, MA 02115 USA; [Jorgensen, Niklas Rye] Univ Copenhagen, Dept Clin Biochem, Rigshosp Glostrup, Fac Hlth & Med Sci, Copenhagen, Denmark		Schytz, HW (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache Ctr,Dept Neurol, Valdemar Hansens Vej 5, DK-2600 Glostrup, Denmark.	henrik.winther.schytz.01@regionh.dk	Ashina, Sait/AAC-7681-2019	Schytz, Henrik Winther/0000-0002-6262-2986; Ashina, Sait/0000-0003-3973-6640; Amin, Faisal Mohammad/0000-0003-3803-3599; Ashina, Hakan/0000-0002-6268-727X; Ashina, Messoud/0000-0003-0951-5804	Rigshospitalet Research Foundation [F-23340-02]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by a grant from the Rigshospitalet Research Foundation (F-23340-02).	Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashina M, 2019, LANCET NEUROL, V18, P795, DOI 10.1016/S1474-4422(19)30185-1; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Cernuda-Morollon E, 2013, NEUROLOGY, V81, P1191, DOI 10.1212/WNL.0b013e3182a6cb72; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Donnerer J, 1996, BRAIN RES, V741, P103, DOI 10.1016/S0006-8993(96)00905-5; Guo S, 2017, CEPHALALGIA, V37, P136, DOI 10.1177/0333102416639517; JansenOlesen I, 1996, CEPHALALGIA, V16, P310, DOI 10.1046/j.1468-2982.1996.1605310.x; Kee Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01249; Labastida-Ramirez A, 2019, CEPHALALGIA, V39, P435, DOI 10.1177/0333102417739584; Lee MJ, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0883-x; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Ramon C, 2017, CURR OPIN NEUROL, V30, P281, DOI 10.1097/WCO.0000000000000440; Schicho R, 1999, BRAIN RES, V815, P60, DOI 10.1016/S0006-8993(98)01094-4; SCHIFTER S, 1991, PEPTIDES, V12, P365, DOI 10.1016/0196-9781(91)90027-M; SHENKIN HA, 1948, ARCH NEURO PSYCHIATR, V60, P240, DOI 10.1001/archneurpsyc.1948.02310030021002; Snoer A, 2019, CEPHALALGIA, V39, P575, DOI 10.1177/0333102419837154; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; VALDEMARSSON S, 1990, SCAND J CLIN LAB INV, V50, P385, DOI 10.3109/00365519009091595; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Zhou Y, 2016, J APPL ORAL SCI, V24, P597, DOI 10.1590/1678-775720160150	24	4	4	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2020	40	12					1276	1282	0333102420941115	10.1177/0333102420941115		JUL 2020	7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OA8DV	WOS:000555477700001	32689824				2022-02-06	
J	Sportisse, A; Boyer, C; Josse, J				Sportisse, Aude; Boyer, Claire; Josse, Julie			Imputation and low-rank estimation with Missing Not At Random data	STATISTICS AND COMPUTING			English	Article						Informative missing values; Denoising; Matrix completion; Accelerated proximal gradient method; EM algorithm; Nuclear norm penalty	THRESHOLDING ALGORITHM; MAXIMUM-LIKELIHOOD; MATRIX COMPLETION; SHRINKAGE; MODELS	Missing values challenge data analysis because many supervised and unsupervised learning methods cannot be applied directly to incomplete data. Matrix completion based on low-rank assumptions are very powerful solution for dealing with missing values. However, existing methods do not consider the case of informative missing values which are widely encountered in practice. This paper proposes matrix completion methods to recover Missing Not At Random (MNAR) data. Our first contribution is to suggest a model-based estimation strategy by modelling the missing mechanism distribution. An EM algorithm is then implemented, involving a Fast Iterative Soft-Thresholding Algorithm (FISTA). Our second contribution is to suggest a computationally efficient surrogate estimation by implicitly taking into account the joint distribution of the data and the missing mechanism: the data matrix is concatenated with the mask coding for the missing values; a low-rank structure for exponential family is assumed on this new matrix, in order to encode links between variables and missing mechanisms. The methodology that has the great advantage of handling different missing value mechanisms is robust to model specification errors. The performances of our methods are assessed on the real data collected from a trauma registry (TraumaBase (R)) containing clinical information about over twenty thousand severely traumatized patients in France. The aim is then to predict if the doctors should administrate tranexomic acid to patients with traumatic brain injury, that would limit excessive bleeding.	[Sportisse, Aude; Boyer, Claire] Sorbonne Univ, Lab Probabilites Stat & Modelisat, Paris, France; [Sportisse, Aude; Josse, Julie] Ecole Polytech, Ctr Math Appl, Palaiseau, France; [Boyer, Claire] Ecole Normale Super, Dept Math & Applicat, Paris, France; [Josse, Julie] INRIA Saclay, XPOP, Palaiseau, France		Sportisse, A (corresponding author), Sorbonne Univ, Lab Probabilites Stat & Modelisat, Paris, France.; Sportisse, A (corresponding author), Ecole Polytech, Ctr Math Appl, Palaiseau, France.	aude.sportisse@upmc.fr		josse, julie/0000-0001-9547-891X	Data Analytics and Models for Insurance chair; PEPS project (Projet Exploratoire Premier Soutien) of AMIES (the mathematical agency in interaction with companies and society)	Julie Josse was supported by the Data Analytics and Models for Insurance chair and Aude Sportisse was funded by a PEPS project (Projet Exploratoire Premier Soutien) of AMIES (the mathematical agency in interaction with companies and society).	Audigier V, 2016, ADV DATA ANAL CLASSI, V10, P5, DOI 10.1007/s11634-014-0195-1; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Cai T, 2013, J MACH LEARN RES, V14, P3619; Candes EJ, 2013, IEEE T SIGNAL PROCES, V61, P4643, DOI 10.1109/TSP.2013.2270464; Candes EJ, 2010, P IEEE, V98, P925, DOI 10.1109/JPROC.2009.2035722; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gavish M, 2017, IEEE T INFORM THEORY, V63, P2137, DOI 10.1109/TIT.2017.2653801; GORDON NJ, 1993, IEE PROC-F, V140, P107, DOI 10.1049/ip-f-2.1993.0015; Harel O, 2009, BIOMETRIKA, V96, P37, DOI 10.1093/biomet/asn069; Hastie T., 2015, SOFTIMPUTE MATRIX CO; Hastie T, 2015, J MACH LEARN RES, V16, P3367; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; HECKMAN J, 1974, ECONOMETRICA, V42, P679, DOI 10.2307/1913937; Ibrahim JG, 1999, J ROY STAT SOC B, V61, P173, DOI 10.1111/1467-9868.00170; Josse J., 2016, J STAT SOFTW; Josse J, 2012, COMPUT STAT DATA AN, V56, P1869, DOI 10.1016/j.csda.2011.11.012; Kallus N., 2018, ARXIV180600811; Kumar NK, 2017, LINEAR MULTILINEAR A, V65, P2212, DOI 10.1080/03081087.2016.1267104; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Little RJ, 2014, STAT ANAL MISSING DA, V2nd; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Liu LT, 2018, ANN APPL STAT, V12, P2121, DOI 10.1214/18-AOAS1146; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Miao W., 2017, STAT SINICA; Mohan K., 2018, ARXIV180103583; Mohan K., 2018, P 27 INT JOINT C ART, P5082; Morikawa K, 2017, CAN J STAT, V45, P393, DOI 10.1002/cjs.11340; Murray J.S, 2018, ARXIV180104058; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robin G., 2018, ARXIV180609734; Rubin D.B., 2004, MULTIPLE IMPUTATION; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Seaman S, 2013, STAT SCI, V28, P257, DOI 10.1214/13-STS415; Tang F, 2017, STAT ANAL DATA MIN, V10, P363, DOI 10.1002/sam.11348; Twala BETH, 2008, PATTERN RECOGN LETT, V29, P950, DOI 10.1016/j.patrec.2008.01.010; Udell M., 2017, ARXIV170507474; Udell M, 2016, FOUND TRENDS MACH LE, V9, P2, DOI 10.1561/2200000055; Varoquaux G, 2019, ARXIV190206931; Verbanck M, 2015, STAT COMPUT, V25, P471, DOI 10.1007/s11222-013-9444-y; Yang C, 2018, ARXIV180803233	42	4	5	1	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0960-3174	1573-1375		STAT COMPUT	Stat. Comput.	NOV	2020	30	6					1629	1643		10.1007/s11222-020-09963-5		JUL 2020	15	Computer Science, Theory & Methods; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematics	NV4GM	WOS:000552766100001		Green Submitted			2022-02-06	
J	Cisneros-Mejorado, AJ; Garay, E; Ortiz-Retana, J; Concha, L; Moctezuma, JP; Romero, S; Arellano, RO				Cisneros-Mejorado, Abraham J.; Garay, Edith; Ortiz-Retana, Juan; Concha, Luis; Moctezuma, Juan P.; Romero, Samuel; Arellano, Rogelio O.			Demyelination-Remyelination of the Rat Caudal Cerebellar Peduncle Evaluated with Magnetic Resonance Imaging	NEUROSCIENCE			English	Article						OPC; diffusion tensor imaging; white matter; GABAergic signaling; beta-carbolines	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; WHITE-MATTER ABNORMALITIES; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; CORTICAL DEMYELINATION; OPTIC-NERVE; SPINAL-CORD; DIFFUSION; PATHOLOGY	Remyelination is common under physiological conditions and usually occurs as a response to a pathological demyelinating event. Its potentiation is an important goal for the development of therapies against pathologies such as multiple sclerosis and white matter injury. Visualization and quantification in vivo of demyelination and remyelination processes are essential for longitudinal studies that will allow the testing and development of pro-myelinating strategies. In this study, ethidium bromide (EB) was stereotaxically injected into the caudal cerebellar peduncle (c.c.p.) in rats to produce demyelination; the resulting lesion was characterized (i) transversally through histology using Black-Gold II (BGII) staining, and (ii) longitudinally through diffusion-weighted magnetic resonance imaging (dMRI), by computing fractional anisotropy (FA) and diffusivity parameters to detect microstructural changes. Using this characterization, we evaluated, in the lesioned c.c.p., the effect of N-butyl-beta-carboline-3-carboxylate (beta-CCB), a potentiator of GABAergic signaling in oligodendrocytes. The dMRI analysis revealed significant changes in the anisotropic and diffusivity properties of the c.c.p. A decreased FA and increased radial diffusivity (lambda(perpendicular to)) were evident following c.c.p. lesioning. These changes correlated strongly with an apparent decrease in myelin content as evidenced by BGII. Daily systemic beta-CCB administration for 2 weeks in lesioned animals increased FA and decreased.., suggesting an improvement in myelination, which was supported by histological analysis. This study shows that structural changes in the demyelination-remyelination of the caudal cerebellar peduncle (DRCCP) model can be monitored longitudinally by MRI, and it suggests that remyelination is enhanced by beta-CCB treatment. This article is part of a Special Issue entitled: Honoring Ricardo Miledi - outstanding neuroscientist of XX-XXI centuries. (c) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Cisneros-Mejorado, Abraham J.; Garay, Edith; Ortiz-Retana, Juan; Concha, Luis; Moctezuma, Juan P.; Romero, Samuel; Arellano, Rogelio O.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Blvd Juriquilla 3001, Juriquilla Queretaro 76230, Queretaro, Mexico		Arellano, RO (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Blvd Juriquilla 3001, Juriquilla Queretaro 76230, Queretaro, Mexico.	arellano.ostoa@comunidad.unam.mx	Concha, Luis/M-5720-2019; Concha, Luis/G-5161-2011	Arellano, Rogelio O./0000-0002-8646-250X; Concha, Luis/0000-0002-7842-3869; Cisneros-Mejorado, Abraham/0000-0003-3654-0159	CONACYT-MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [252121]; PAPIIT-UNAM-MexicoPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN203519]	We thank Jessica Gonzalez Norris for editing this manuscript. We also thank Felipe Cornejo Ortiz, Nydia Hernandez Rios, Martin Garcia Servin, Fernando Rodriguez, and Ramon Martinez Olvera for their expert technical support. We appreciate the important help of Dr. Isaac Silva during the initial experimental stage. This study was supported by grants from CONACYT-Mexico No. 252121 and PAPIIT-UNAM-Mexico No. IN203519 to R.O. A. laboratory. A. C-M is a researcher from Catedras-CONACYT commissioned at Instituto de Neurobiologia at Universidad Nacional Autonoma de Mexico (UNAM).	Anjari M, 2009, PEDIATRICS, V124, P268, DOI 10.1542/peds.2008-1294; Arellano RO, 2016, MOL PHARMACOL, V89, P63, DOI 10.1124/mol.115.100594; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BLAKEMORE WF, 1974, J NEUROL SCI, V22, P121, DOI 10.1016/0022-510X(74)90059-8; Bora E, 2011, J PSYCHIATR NEUROSCI, V36, P42, DOI 10.1503/jpn.100082; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cammer W, 1999, BRAIN RES, V837, P188, DOI 10.1016/S0006-8993(99)01621-2; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Concha L, 2014, NEUROSCIENCE, V276, P14, DOI 10.1016/j.neuroscience.2013.09.004; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; DALCANTO MC, 1995, MICROSC RES TECHNIQ, V32, P215, DOI 10.1002/jemt.1070320305; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Farzin D, 2006, NEUROPSYCHOPH J, V11, P126, DOI [10.1016/j.euroneuro.2005.08.005, DOI 10.1016/J.EURONEURO.2005.08.005]; Fatemi SH, 2009, SCHIZOPHR RES, V112, P46, DOI 10.1016/j.schres.2009.04.014; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; GODFRAIND C, 1989, J CELL BIOL, V109, P2405, DOI 10.1083/jcb.109.5.2405; Goudarzi S, 2016, ASN NEURO, V8, DOI 10.1177/1759091416668430; Grella B, 1998, DRUG ALCOHOL DEPEN, V50, P99, DOI 10.1016/S0376-8716(97)00163-4; Hakkarainen H, 2016, MAGN RESON MED, V75, P161, DOI 10.1002/mrm.25590; Hamilton NB, 2017, GLIA, V65, P309, DOI 10.1002/glia.23093; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Kassmann CM, 2008, CURR OPIN NEUROL, V21, P235, DOI 10.1097/WCO.0b013e328300c71f; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Larm JA, 1996, EUR J PHARMACOL, V314, P249, DOI 10.1016/S0014-2999(96)00633-4; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Li QQ, 2010, NEUROENDOCRINOL LETT, V31, P747; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Manterola A, 2018, BIOCHEM PHARMACOL, V157, P189, DOI 10.1016/j.bcp.2018.07.042; Matute C, 1998, P NATL ACAD SCI USA, V95, P10229, DOI 10.1073/pnas.95.17.10229; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; MEESON AP, 1994, EXP NEUROL, V129, P299, DOI 10.1006/exnr.1994.1172; Miller DJ, 1996, ACTA NEUROPATHOL, V91, P559, DOI 10.1007/s004010050467; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; PENA C, 1986, P NATL ACAD SCI USA, V83, P4952, DOI 10.1073/pnas.83.13.4952; Perez-Samartin A, 2017, NEUROCHEM RES, V42, P2443, DOI 10.1007/s11064-017-2242-8; Perry VH, 1999, PHILOS T ROY SOC B, V354, P1641, DOI 10.1098/rstb.1999.0509; RAINE CS, 1974, LAB INVEST, V31, P369; Raul RC, 2018, EPILEPSY BEHAV, V79, P138, DOI 10.1016/j.yebeh.2017.11.040; SASAKI M, 1989, J NEUROCYTOL, V18, P225, DOI 10.1007/BF01206664; Saxena A, 2011, FEBS LETT, V585, P3758, DOI 10.1016/j.febslet.2011.08.047; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P717, DOI 10.1177/38.5.1692056; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Thomet U, 1999, BRIT J PHARMACOL, V127, P1231, DOI 10.1038/sj.bjp.0702639; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Sanchez-Gomez MV, 2018, METHODS MOL BIOL, V1791, P95, DOI 10.1007/978-1-4939-7862-5_8; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Yeh TY, 2017, J CHEM NEUROANAT, V79, P38, DOI 10.1016/j.jchemneu.2016.11.005; Yurgelun-Todd DA, 2007, BIPOLAR DISORD, V9, P504, DOI 10.1111/j.1399-5618.2007.00395.x; Zhao C, 2008, NEUROBIOL DIS, V31, P209, DOI 10.1016/j.nbd.2008.04.007; Zonouzi M, 2015, NAT NEUROSCI, V18, P674, DOI 10.1038/nn.3990	71	4	4	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 15	2020	439						255	267		10.1016/j.neuroscience.2019.06.042			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MF4ER	WOS:000545298200003	31299350				2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Cerebrovascular Reactivity After Sport Concussion: From Acute Injury to 1 Year After Medical Clearance	FRONTIERS IN NEUROLOGY			English	Article						BOLD fMRI; cerebrovascular reactivity; longitudinal study; concussion; brain injury	CEREBRAL-BLOOD-FLOW; BOLD SIGNAL; PATHOPHYSIOLOGY; CHALLENGE; RECOVERY; MRI; CO2	Neuroimaging has identified significant disturbances in cerebrovascular reactivity (CVR) in the early symptomatic phase of sport-related concussion. However, less is known about how whole-brain alterations in CVR evolve after concussion and whether they remain present beyond medical clearance to return to play (RTP). In the present study, CVR was evaluated using blood-oxygenation-level-dependent functional magnetic resonance imaging (BOLD fMRI) during a respiratory challenge. Imaging data were collected for 110 university-level athletes, including 39 concussed athletes and 71 athletic controls. The concussed athletes were imaged at the acute phase of injury (1-7 days post-injury), the subacute phase (8-14 days post-injury), medical clearance to RTP, 1 month post-RTP, and 1 year post-RTP. Enhanced negative BOLD response to controlled breathing was seen at acute injury, with attenuation of the effect mainly occurring by 1 year post-RTP. Secondary analyses showed that greater symptom severity and prolonged recovery were associated with enhanced BOLD response in the acute phase of injury, but a more attenuated BOLD response in the subacute phase. This study provides novel information characterizing the CVR response after concussion and shows CVR to be a sensitive technique for evaluating long-term brain recovery.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Res Inst, Sunnybrook Hlth Sci Ctr, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342-401065, RN294001-367456]; Defence Research and Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada, Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) (grant numbers RN356342-401065 and RN294001-367456), the Defence Research and Development Canada (DRDC), and the Canadian Institutes of Military and Veterans Health (CIMVHR) (grant numberW7714-145967) and pilot funding from Siemens Canada, Ltd.	Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2020, SCI REP, V10, P1, DOI [10.1038/s41598-020-58073-932015365, DOI 10.1038/S41598-020-58073-932015365]; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Graham D, 2002, GREENFIELDS NEUROPAT, P767; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Ito H, 2002, J CEREBR BLOOD F MET, V22, P997, DOI 10.1097/00004647-200208000-00011; Kassner A, 2010, J MAGN RESON IMAGING, V31, P298, DOI 10.1002/jmri.22044; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Scouten A, 2008, NEUROIMAGE, V43, P250, DOI 10.1016/j.neuroimage.2008.03.052; Smith KJ, 2017, EXP PHYSIOL, V102, P1356, DOI 10.1113/EP086249; Sobczyk O, 2015, J CEREBR BLOOD F MET, V35, P213, DOI 10.1038/jcbfm.2014.184; Spano VR, 2013, RADIOLOGY, V266, P592, DOI 10.1148/radiol.12112795; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO, P85; Urback AL, 2017, NEUROSCI BIOBEHAV R, V79, P27, DOI 10.1016/j.neubiorev.2017.05.003; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	34	4	4	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 14	2020	11								558	10.3389/fneur.2020.00558			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MV4DS	WOS:000556311100001	32760336	Green Published, gold			2022-02-06	
J	Liu, J; Zhu, ZK; Wang, LB; Du, JX; Zhang, B; Feng, XQ; Zhang, GB				Liu, Jun; Zhu, Zhengkun; Wang, Leibo; Du, Jixiang; Zhang, Biao; Feng, Xuequan; Zhang, Guobin			Functional suppression of Ripk1 blocks the NF-kappa B signaling pathway and induces neuron autophagy after traumatic brain injury	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Ripk1; NF-kappa b; Traumatic brain injury; Neurons; Autophagy; Apoptosis	CELLS; CASPASE-8; PROTECTS	Traumatic brain injury (TBI), known as intracranial injury, has been a serious threat to human health. Evidence exists indicating that autophagy and inflammatory responses contribute to secondary brain injury after TBI. Notably, receptor-interacting protein kinase 1 (Ripk1) exerts an important role in cell autophagy. Therefore, this study aims to explore the effect of Ripk1 on neuron autophagy and apoptosis in TBI. Initially, blood samples of patients with TBI and healthy persons were collected to detect the expression of Ripk1, nuclear factor-kappa B (NF-kappa B), and NF-kappa B inhibitor alpha (IKB alpha). Then rat models with TBI were successfully established and, respectively, treated with shRNA targeting Ripk1 (sh-Ripk1), Ripk1 overexpression plasmid (oe-Ripk1), or IKK alpha inhibitor (BAY 11-7082). Subsequently, reverse transcription quantitative polymerase chain reaction and Western blot analysis were conducted to detect the expression of Ripk1, IKB alpha, NF-kappa B signaling pathway-, and apoptosis-related factors. Enzyme-linked immunosorbent assay was used to detect the expression of inflammatory cytokines. Compared with healthy persons, the expression of Ripk1, NF-kappa B and IKB alpha in blood of TBI patients was significantly upregulated. After silencing of Ripk1 or inhibition of the NF-kappa B signaling pathway, the expression of IL-1 beta, IL-6, TNF-alpha Bax, and cleaved-caspase-3 was downregulated, and the expression of Bcl-2, ATG5, and LC3II/LC3I was upregulated. Furthermore, neuron injury and apoptosis were notably reduced and neuron autophagy increased significantly by Ripk1 downregulation or IKK alpha inhibitor. Ripk1 overexpression contributed to activation of NF-kappa B signaling pathway, whereby aggravating TBI-induced damage. Silencing Ripk1 suppresses TBI by inhibiting inflammation and promoting autophagy of neurons via inhibition of NF-kappa B signaling pathway.	[Liu, Jun; Wang, Leibo; Zhang, Guobin] Tianjin Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin 300350, Peoples R China; [Liu, Jun; Wang, Leibo; Zhang, Biao; Zhang, Guobin] Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300350, Peoples R China; [Zhu, Zhengkun] Tianjin Dongli Hosp, Clin Lab, Tianjin 300300, Peoples R China; [Du, Jixiang] Tianjin First Ctr Hosp, Dept Neurol, Tianjin 300192, Peoples R China; [Zhang, Biao] Tianjin Huanhu Hosp, Clin Lab, Tianjin 300350, Peoples R China; [Feng, Xuequan] Tianjin First Ctr Hosp, Dept Neurosurg, Tianjin 300192, Peoples R China		Zhang, GB (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin 300350, Peoples R China.; Zhang, GB (corresponding author), Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300350, Peoples R China.	breeze-moon@163.com; zhuzhengkundlyy@163.com; wangliliqiang@sina.cn; jixiangmx@163.comt; zhangbiao0902@aliyun.com; fengxuequan@126.com; cntjzgb@hotmail.com			Fund of Tianjin First Center Hospital	This study was supported by the Fund of Tianjin First Center Hospital (No. FCH CM201802).	ALCORN JL, 1990, J BACTERIOL, V172, P6885, DOI 10.1128/jb.172.12.6885-6891.1990; Anderton H, 2019, CELL DEATH DIFFER, V26, P877, DOI 10.1038/s41418-018-0166-8; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Degterev A, 2019, P NATL ACAD SCI USA, V116, P9714, DOI 10.1073/pnas.1901179116; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Green DR, 2015, EMBO REP, V16, P674, DOI 10.15252/embr.201540470; Guida N, 2017, BIOCHEM PHARMACOL, V142, P229, DOI 10.1016/j.bcp.2017.06.135; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Yang X, 2015, INT J CLIN EXP MED, V8, P15630; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984; Zhang YY, 2019, N-S ARCH PHARMACOL, V392, P1085, DOI 10.1007/s00210-019-01656-9	27	4	4	1	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	SEP	2020	472	1-2					105	114		10.1007/s11010-020-03789-5		JUL 2020	10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	NB4NZ	WOS:000548494700001	32666312				2022-02-06	
J	Caccese, JB; Santos, FV; Yamaguchi, F; Jeka, JJ				Caccese, Jaclyn B.; Santos, Fernando, V; Yamaguchi, Felipe; Jeka, John J.			Sensory Reweighting for Upright Stance in Soccer Players: A Comparison of High and Low Exposure to Soccer Heading	JOURNAL OF NEUROTRAUMA			English	Article						balance; concussion; mild traumatic brain injury; postural control subconcussion	HIGH-SCHOOL FOOTBALL; POSTURAL CONTROL; ACCELERATION; RISK	The purpose of this study was to compare sensory reweighting for upright stance between soccer players who report higher soccer heading exposure to those who report lower soccer heading exposure. Thirty participants completed a self-reported questionnaire to estimate the number of soccer headers experienced over the previous year and were divided into "low exposure" and "high exposure" groups based on their responses. Sensory reweighting for upright stance was assessed by simultaneously perturbing visual, vestibular, and proprioceptive systems. The visual stimulus was a sinusoidal translation of the visual scene at 0.2 Hz, the vestibular stimulus was +/- 1mA binaural monopolar galvanic vestibular stimulation (GVS) at 0.36 Hz, and the proprioceptive stimulus was Achilles tendon vibration at 0.28 Hz. The visual stimulus was presented at two amplitudes (0.2 m, 0.8 m). Center of mass (COM) gain/phase to each modality, total power, 95% area and velocity were compared between low exposure (N = 15, six males, 21.5 +/- 1.9 years, 27.7 +/- 31.6 headers) and high exposure groups (N = 15, 10 males, 22.1 +/- 3.5years, 734.9 +/- 877.7 headers). Without vibration, COM 95% area (F = 5.861,p = 0.022*, partial eta(2) = 0.173), velocity (F = 14.198,p = 0.001, partial eta(2) = 0.336), and total power (F = 13.491,p = 0.001, partial eta(2) = 0.325) for the "high exposure" group were higher than for the "low exposure" group, and postural sway lagged the vestibular stimulus in the "high exposure" group rather than leading it as in the "low exposure" group (F = 4.765,p = 0.038, partial eta(2) = 0.145). There were no differences in sensory reweighting and no differences in COM gain/phase between groups. These findings lend empirical evidence to a detrimental effect of soccer heading exposure on balance control during upright stance.	[Caccese, Jaclyn B.] Ohio State Univ, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA; [Santos, Fernando, V] Bertec Corp, Columbus, OH USA; [Yamaguchi, Felipe; Jeka, John J.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		Caccese, JB (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu	Caccese, Jaclyn B./AAH-4571-2020	Caccese, Jaclyn B./0000-0003-2329-3603; Santos, Fernando/0000-0002-8637-792X	NIH-NINDS R01 [NS102157-01]	This study was supported by the NIH-NINDS R01 (NS102157-01) grant, "Behavioral-and bio-markers of subconcussion with controlled human head impact.''	Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Caccese JB, 2018, CLIN J SPORT MED; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hwang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088132; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Manor B, 2020, ANN NEUROL, V87, P75, DOI 10.1002/ana.25638; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montero-Odasso M, 2019, J GERONTOL A-BIOL, V74, P897, DOI 10.1093/gerona/gly148; Peterka RJ, 2018, HAND CLINIC, V159, P27, DOI 10.1016/B978-0-444-63916-5.00002-1; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646	26	4	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2656	2663		10.1089/neu.2020.7001		JUL 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000552046500001	32571175	Green Published			2022-02-06	
J	Hale, C; Yonan, J; Batarseh, R; Chaar, R; Jonak, CR; Ge, SK; Binder, D; Rodgers, VGJ				Hale, Christopher; Yonan, Jennifer; Batarseh, Ramsey; Chaar, Roman; Jonak, Carrie R.; Ge, Shaokui; Binder, Devin; Rodgers, Victor G. J.			Implantable Osmotic Transport Device Can Reduce Edema After Severe Contusion Spinal Cord Injury	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						spinal cord injury; edema; severe contusion; implantable device; membrane separations; osmotic transport device (OTD)	TRAUMATIC BRAIN-INJURY; MR-IMAGING FINDINGS; INTRASPINAL PRESSURE; PERFUSION-PRESSURE; NEUROLOGICAL RECOVERY; CEREBRAL EDEMA; METHYLPREDNISOLONE; VISUALIZATION; EVOLUTION; MODEL	Recent findings from the ISCoPe study indicate that, after severe contusion to the spinal cord, edema originating in the spinal cord accumulates and compresses the tissue against the surrounding dura mater, despite decompressive laminectomy. It is hypothesized that this compression results in restricted flow of cerebrospinal fluid (CSF) in the subarachnoid space and central canal and ultimately collapses local vasculature, exacerbating ischemia and secondary injury. Here we developed a surgically mounted osmotic transport device (OTD) that rests on the dura and can osmotically remove excess fluid at the injury site. Tests were performed in 4-h studies immediately following severe (250 kD) contusion at T8 in rats using the OTD. A 3-h treatment with the OTD after 1-h post injury significantly reduced spinal cord edema compared to injured controls. A first approximation mathematical interpretation implies that this modest reduction in edema may be significant enough to relieve compression of local vasculature and restore flow of CSF in the region. In addition, we determined the progression of edema up to 28 days after insult in the rat for the same injury model. Results showed peak edema at 72 h. These preliminary results suggest that incorporating the OTD to operate continuously at the site of injury throughout the critical period of edema progression, the device may significantly improve recovery following contusion spinal cord injury.	[Hale, Christopher; Batarseh, Ramsey; Chaar, Roman; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Yonan, Jennifer; Jonak, Carrie R.; Binder, Devin] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA; [Ge, Shaokui] Univ Calif Riverside, Sch Med, Div Biostat & Bioinformat, Riverside, CA 92521 USA		Rodgers, VGJ (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	victor.rodgers@ucr.edu	Rodgers, Victor G. J./AAF-3838-2021	Rodgers, Victor G. J./0000-0002-1857-8025; Batarseh, Ramsey/0000-0002-1587-1779	Craig H. Neilsen Foundation [382387]; Jacques S. Yeager, Sr. Professorship; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R21NS106949-02]	Financial support from the Craig H. Neilsen Foundation (Project Number 382387) and from the Jacques S. Yeager, Sr. Professorship. VR was supported in part by NIH 5R21NS106949-02.	Barker RN, 2009, SPINAL CORD, V47, P149, DOI 10.1038/sc.2008.82; Beggs LA, 2015, J BONE MINER RES, V30, P681, DOI 10.1002/jbmr.2396; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; Cayli SR, 2004, EUR SPINE J, V13, P724, DOI 10.1007/s00586-003-0550-y; Chen SL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00493; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Fehlings MG, 2006, SPINE, V31, pS28, DOI 10.1097/01.brs.0000217973.11402.7f; Festing Michael F W, 2002, ILAR J, V43, P244; Flanders AE, 1996, RADIOLOGY, V201, P649, DOI 10.1148/radiology.201.3.8939210; FLANDERS AE, 1990, RADIOLOGY, V177, P25, DOI 10.1148/radiology.177.1.2399326; Flanders AE, 1999, AM J NEURORADIOL, V20, P926; Gallagher MJ, 2019, J NEUROTRAUM, V36, P919, DOI 10.1089/neu.2018.5961; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; Hale CS, 2019, AIP ADV, V9, DOI 10.1063/1.5122953; HALL ED, 1984, J NEUROSURG, V61, P124, DOI 10.3171/jns.1984.61.1.0124; Hogg FRA, 2019, NEUROCRIT CARE, V30, P421, DOI 10.1007/s12028-018-0616-7; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Khaing ZZ, 2018, J NEUROSURG-SPINE, V29, P306, DOI 10.3171/2018.1.SPINE171202; Khaing ZZ, 2017, J NEUROTRAUM, V34, P645, DOI 10.1089/neu.2016.4490; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; McBride DW, 2016, ACTA NEUROCHIR SUPPL, V121, P285, DOI 10.1007/978-3-319-18497-5_49; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; McBride DW, 2012, J NEUROSURG, V116, P1389, DOI 10.3171/2012.2.JNS111540; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Nout YS, 2009, CRIT CARE MED, V37, P2160, DOI 10.1097/CCM.0b013e3181a05d41; Papadopoulos MC, 2015, NEUROSURGERY, V77, pE500, DOI 10.1227/NEU.0000000000000862; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Rozet I, 2008, J NEUROSURG ANESTH, V20, P137, DOI 10.1097/01.ana.0000314441.63823.b0; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2020, NEUROTHERAPEUTICS, V17, P511, DOI 10.1007/s13311-019-00820-6; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Shepard MJ, 1999, SPINAL CORD, V37, P833, DOI 10.1038/sj.sc.3100927; Soubeyrand M, 2014, J NEUROTRAUM, V31, P1767, DOI 10.1089/neu.2013.3319; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Streijger F, 2017, J NEUROTRAUM, V34, P3336, DOI 10.1089/neu.2017.5034; Tonda-Turo C, 2017, J TISSUE ENG REGEN M, V11, P197, DOI 10.1002/term.1902; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; World Health Organization and International Spinal Cord Society, 2013, INT PERSP SPIN CORD, VGeneva, pSwitzerland; Zheng ZL, 2016, NEUROSURGERY, V78, P868, DOI 10.1227/NEU.0000000000001063	55	4	4	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	JUL 10	2020	8								806	10.3389/fbioe.2020.00806			10	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	MU6MN	WOS:000555785400001	32754586	Green Published, gold			2022-02-06	
J	Abujaber, A; Fadlalla, A; Gammoh, D; Abdelrahman, H; Mollazehi, M; El-Menyar, A				Abujaber, Ahmad; Fadlalla, Adam; Gammoh, Diala; Abdelrahman, Husham; Mollazehi, Monira; El-Menyar, Ayman			Using trauma registry data to predict prolonged mechanical ventilation in patients with traumatic brain injury: Machine learning approach	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; EXTERNAL VALIDATION; LATE TRACHEOSTOMY; RISK-FACTORS; IMPACT; MORTALITY; OUTCOMES; SUPPORT; SURGERY; MODELS	Objectives We aimed to build a machine learning predictive model to predict the risk of prolonged mechanical ventilation (PMV) for patients with Traumatic Brain Injury (TBI). Methods This study included TBI patients who were hospitalized in a level 1 trauma center between January 2014 and February 2019. Data were analyzed for all adult patients who received mechanical ventilation following TBI with abbreviated injury severity (AIS) score for the head region of >= 3. This study designed three sets of machine learning models: set A defined PMV to be greater than 7 days, set B (PMV > 10 days) and set C (PMV >14 days) to determine the optimal model for deployment. Patients' demographics, injury characteristics and CT findings were used as predictors. Logistic regression (LR), Artificial neural networks (ANN) Support vector machines (SVM), Random Forest (RF) and C.5 Decision Tree (C.5 DT) were used to predict the PMV. Results The number of eligible patients that were included in the study were 674, 643 and 622 patients in sets A, B and C respectively. In set A, LR achieved the optimal performance with accuracy 0.75 and Area under the curve (AUC) 0.83. SVM achieved the optimal performance among other models in sets B with accuracy/AUC of 0.79/0.84 respectively. ANNs achieved the optimal performance in set C with accuracy/AUC of 0.76/0.72 respectively. Machine learning models in set B demonstrated more stable performance with higher prediction success and discrimination power. Conclusion This study not only provides evidence that machine learning methods outperform the traditional multivariate analytical methods, but also provides a perspective to reach a consensual definition of PMV.	[Abujaber, Ahmad] Hamad Med Corp, Nursing, Doha, Qatar; [Fadlalla, Adam] Qatar Univ, Management Informat Syst Business & Econ Fac, Doha, Qatar; [Gammoh, Diala] Univ Cent Florida, Ind Engn, Orlando, FL 32816 USA; [Abdelrahman, Husham; Mollazehi, Monira] Hamad Med Corp, Dept Surg, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Hamad Med Corp, Dept Surg Trauma Surg Clin Res, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Med Corp, Dept Surg Trauma Surg Clin Res, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Agle SC, 2006, AM J SURG, V192, P822, DOI 10.1016/j.amjsurg.2006.08.051; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Andriolo BNG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub3; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Blaser AR, 2019, CRIT CARE MED, V47, P535, DOI 10.1097/CCM.0000000000003623; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Chang YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24028-4; Cinotti R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.16; Clark PA, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.03.013; Cui SZ, 2018, COMPUT METH PROG BIO, V166, P123, DOI 10.1016/j.cmpb.2018.10.012; Dag A, 2017, DECIS SUPPORT SYST, V94, P42, DOI 10.1016/j.dss.2016.10.005; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Dimopoulou I, 2003, INTENS CARE MED, V29, P1101, DOI 10.1007/s00134-003-1813-0; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Figueroa-Casas JB, 2015, J CRIT CARE, V30, P502, DOI 10.1016/j.jcrc.2015.01.020; Gershengorn HB, 2015, ANN AM THORAC SOC, V12, P1831, DOI 10.1513/AnnalsATS.201506-366BC; Ghiani A, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-1009-1; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Han J, 2012, MOR KAUF D, P1; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hellyer Thomas P, 2016, J Intensive Care Soc, V17, P238, DOI 10.1177/1751143716644461; Herritt B, 2018, J CRIT CARE, V44, P285, DOI 10.1016/j.jcrc.2017.11.037; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Huttmann SE, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0384-8; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kao JH, 2013, RESP CARE, V58, P2093, DOI 10.4187/respcare.02273; Kim HI, 2019, TUBERC RESPIR DIS, V82, P6, DOI 10.4046/trd.2018.0041; Lai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073743; Lakshmi BN, 2016, PROC TECH, V24, P1542, DOI 10.1016/j.protcy.2016.05.128; Luetz A, 2012, CURR OPIN ANESTHESIO, V25, P164, DOI 10.1097/ACO.0b013e32834f8ce7; Okabe Y, 2018, ACUTE MED SURG, V5, P166, DOI 10.1002/ams2.331; Pandian Vinciya, 2014, ORL Head Neck Nurs, V32, P6; Parreco J, 2018, J SURG RES, V228, P179, DOI 10.1016/j.jss.2018.03.028; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121203; Rose L, 2017, RESP CARE, V62, P1324, DOI 10.4187/respcare.05485; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Shaikhina T, 2019, BIOMED SIGNAL PROCES, V52, P456, DOI 10.1016/j.bspc.2017.01.012; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Trouillet JL, 2011, ANN INTERN MED, V154, P373, DOI 10.7326/0003-4819-154-6-201103150-00002; Wang CH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009165; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154; Zilberberg MD, 2012, CRIT CARE MED, V40, P18, DOI 10.1097/CCM.0b013e31822e9ffd; Zolbanin HM, 2015, DECIS SUPPORT SYST, V74, P150, DOI 10.1016/j.dss.2015.04.003; Zubrow ME, 2018, PEDIATR CRIT CARE ME, V19, pE88, DOI 10.1097/PCC.0000000000001399	54	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2020	15	7							e0235231	10.1371/journal.pone.0235231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MQ0QI	WOS:000552601500039	32639971	Green Published, gold			2022-02-06	
J	Albrecht, JS; Lydecker, A; Peters, ME; Rao, VI				Albrecht, Jennifer S.; Lydecker, Alison; Peters, Matthew E.; Rao, Vani			Treatment of Depression after Traumatic Brain Injury Reduces Risk of Neuropsychiatric Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						antidepressants; anxiety; depression; insomnia; substance dependence disorder; traumatic brain injury	ALCOHOL-USE DISORDER; MAJOR DEPRESSION; ADMINISTRATIVE DATA; 1ST YEAR; MEDICARE BENEFICIARIES; SERTRALINE; SYMPTOMS; ILLNESS; ASSOCIATION; PREDICTORS	The objectives of this study were to identify characteristics associated with receipt of antidepressants for treatment of incident depression diagnosed following traumatic brain injury (TBI) and to assess the impact of receipt of treatment for depression on risk of other neuropsychiatric outcomes associated with TBI. We conducted a retrospective cohort study of individuals with TBI who were subsequently diagnosed with incident depression between 2008 and 2014 using data from the OptumLabs(R)Data Warehouse. We identified factors associated with receipt of antidepressants and compared risk of new diagnosis of alcohol dependence disorder, anxiety, insomnia, and substance dependence disorder between those who received antidepressants and those who did not over a maximum 2-year follow-up, controlling for duration of use and clinical and demographic characteristics. Of 9581 individuals newly diagnosed with depression following TBI, 4103 (43%) received at least one antidepressant. Moderate-severe TBI (odds ratio [OR] 1.44; 95% confidence interval [CI]: 1.39, 1.50), female sex (OR 1.21; 95% CI: 1.19, 1.24), diagnosis of Alzheimer's disease (OR 1.39; 95% CI: 1.35, 1.44), and anxiety (OR 1.35; 95% CI: 1.31, 1.38) were associated with receipt of antidepressants. Longer duration of antidepressant use was associated with decreased risk of newly diagnosed anxiety (hazard ratio [HR] 0.92; 95% CI: 0.89, 0.96), insomnia (HR 0.94; 95% CI: 0.91, 0.98), and substance dependence disorder (HR 0.92; 95% CI: 0.88, 0.97). These results provide evidence of a beneficial effect of antidepressant use on incidence of outcomes associated with poorer recovery from TBI.	[Albrecht, Jennifer S.; Lydecker, Alison] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St,MSTF 334 C, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] OptumLabs, Cambridge, MA USA; [Peters, Matthew E.; Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St,MSTF 334 C, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	Agency for Healthcare Quality and ResearchUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560]; American Sleep Medicine Foundation; MerckMerck & Company; ResMed; PCORIPatient-Centered Outcomes Research Institute - PCORI [7136]	JSA is supported by Agency for Healthcare Quality and Research grant K01HS024560. JSA's institution (University of Maryland) has received research funding from the American Sleep Medicine Foundation, Merck, and ResMed. VR is supported by PCORI grant 7136 (Johns Hopkins University). The supporters had no role in the design, analysis, interpretation, or publication of this study.	Albrecht JS, 2019, AM J GERIAT PSYCHIAT, V27, P301, DOI 10.1016/j.jagp.2018.10.017; Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2017, AM J GERIAT PSYCHIAT, V25, P415, DOI 10.1016/j.jagp.2016.11.018; Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Allison PaulD., 1982, SOCIOLOGICAL METHODO, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Davis KAS, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0963-x; Deb S, 1999, AM J PSYCHIAT, V156, P374; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Duhoux A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-142; Fann, 2000, J NEUROPSYCHIATRY CL, V12, P226; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fiest KM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0289-5; Frayne SM, 2010, AM J MED QUAL, V25, P42, DOI 10.1177/1062860609346347; Gao CB, 2019, AM J EMERG MED, V37, P1778, DOI 10.1016/j.ajem.2019.06.050; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Johnson LA, 2015, MIL MED, V180, P208, DOI 10.7205/MILMED-D-14-00268; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; KATON W, 1990, Journal of Clinical Psychiatry, V51, P3; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE47, DOI 10.1097/HTR.0000000000000439; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Marr A., 2004, CENTRAL NERVOUS SYST; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Olfson M, 2016, JAMA INTERN MED, V176, P1482, DOI 10.1001/jamainternmed.2016.5057; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; OptumLabs, 2020, OPTUMLABS OPTUMLABS; Peng MK, 2017, HEALTH INFORM J, V23, P260, DOI 10.1177/1460458216647089; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Singh JA, 2009, PREV CHRONIC DIS, V6; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; Thurman DJ., 1995, GUIDELINES SURVEILLA; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weil ZM, 2018, ALCOHOL RES-CURR REV, V39, P171; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243	62	4	4	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2542	2548		10.1089/neu.2019.6957		JUL 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547886800001	32394786				2022-02-06	
J	Lee, H; Tan, C; Tran, V; Mathew, J; Fitzgerald, M; Leong, R; Kambourakis, T; Gantner, D; Udy, A; Hunn, M; Rosenfeld, JV; Tee, J				Lee, Hui; Tan, Caleb; Tran, Vanessa; Mathew, Joseph; Fitzgerald, Mark; Leong, Ronald; Kambourakis, Tony; Gantner, Dashiell; Udy, Andrew; Hunn, Martin; Rosenfeld, Jeffrey, V; Tee, Jin			The Utility of the Modified Frailty Index in Outcome Prediction for Elderly Patients with Acute Traumatic Subdural Hematoma	JOURNAL OF NEUROTRAUMA			English	Article						acute subdural hematoma; elderly; frailty; mortality; prognosis	POSTOPERATIVE OUTCOMES; SURGICAL-TREATMENT; 30-DAY MORBIDITY; MORTALITY; SURGERY; AGE; ANTICOAGULATION; COMPLICATIONS; MANAGEMENT; TRENDS	This study aimed to evaluate the utility of the 11-variable modified Frailty Index (mFI) in prognosticating elderly patients with traumatic acute subdural hematomas (aSDHs). A state-service level 1 trauma center registry was interrogated to investigate consecutive patients >= 65 years of age presenting with traumatic aSDH, with or without major extracranial injury, between January 2013 and December 2017. mFI on admission, demographics, and admission details, including Glasgow Coma Scale (GCS) and pupillary status and radiological findings, were retrospectively retrieved from institutional records. Clinical outcome data were retrieved from medical records and the Victorian State Trauma Registry (VSTR). Outcome measures were 1) 30-day mortality and 2) 6-month unfavorable outcome, defined by the Extended Glasgow Outcome Scale (GOS-E). Five hundred twenty-nine consecutive cases were identified from the registry. Demographic data included: 1) age (median; interquartile range) = 80.46; 74.17-85.89; 2) mFI (mean +/- standard deviation) = 1.96 +/- 1.42 of 11 variables. Four hundred sixteen cases (79%) had complete outcome data. As mFI increased from 0/11 variables to >= 5/11 variables (>= 0.45), 30-day mortality risk increased from 17.72% to 39.29% (p = 0.023) and 6-month unfavorable outcome risk increased from 40.51% to 96.43% (p < 0.001). Multi-variate analysis showed that greater mFI score of >= 3/11 variables (>= 0.27) suggested a significantly higher risk of 30-day mortality (p = 0.009) and unfavorable outcome (p < 0.001). We conclude that increasing frailty, as measured by the mFI, was associated with significantly higher risk of 30-day mortality and 6-month unfavorable outcome in elderly patients presenting with aSDH to a level 1 neurotrauma center. Assessment of mFI in elderly patients with aSDH may be a useful determinant of outcome for this rapidly growing population.	[Lee, Hui; Tan, Caleb; Tran, Vanessa; Mathew, Joseph; Fitzgerald, Mark; Tee, Jin] Natl Trauma Res Inst NTRI, Melbourne, Vic, Australia; [Lee, Hui; Hunn, Martin; Rosenfeld, Jeffrey, V; Tee, Jin] Alfred Hlth, Dept Neurosurg, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Mathew, Joseph; Fitzgerald, Mark] Alfred Hlth, Trauma Serv, Melbourne, Vic, Australia; [Leong, Ronald] Alfred Hlth, Aged Care Serv, Melbourne, Vic, Australia; [Kambourakis, Tony] Alfred Hlth, Med Serv, Melbourne, Vic, Australia; [Gantner, Dashiell; Udy, Andrew] Alfred Hlth, Intens Care Unit, Melbourne, Vic, Australia; [Gantner, Dashiell; Udy, Andrew] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Hunn, Martin; Rosenfeld, Jeffrey, V; Tee, Jin] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA		Tee, J (corresponding author), Alfred Hlth, Dept Neurosurg, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	Jin.tee@ntrispine.com			Department of Health and Human Services, State Government of Victoria; Transport Accident Commission	The Victorian State Trauma Registry (VSTR) is a Department of Health and Human Services, State Government of Victoria and Transport Accident Commission funded project.	Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Adams P, 2013, JAMA OTOLARYNGOL, V139, P783, DOI 10.1001/jamaoto.2013.3969; Ali R, 2016, J NEUROSURG-SPINE, V25, P537, DOI 10.3171/2015.10.SPINE14582; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Benedetto N, 2017, BRIT J NEUROSURG, V31, P244, DOI 10.1080/02688697.2016.1244249; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Cipolle Mark D, 2014, Del Med J, V86, P237; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Curtis E, 2018, J SURG RES, V230, P13, DOI 10.1016/j.jss.2018.04.017; de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001; Ehlert BA, 2016, J VASC SURG, V63, P1595, DOI 10.1016/j.jvs.2015.12.023; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Greuter L, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19546; Hamidi M, 2019, AM J SURG, V218, P484, DOI 10.1016/j.amjsurg.2019.01.035; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; JAMJOOM A, 1992, INJURY, V23, P518, DOI 10.1016/0020-1383(92)90149-M; Karam J, 2013, ANN VASC SURG, V27, P904, DOI 10.1016/j.avsg.2012.09.015; Lavrador Jose Pedro, 2018, Asian J Neurosurg, V13, P565, DOI 10.4103/ajns.AJNS_51_16; Lee L, 2017, GERIATR GERONTOL INT, V17, P1358, DOI 10.1111/ggi.12955; Leven DM, 2017, GLOB SPINE J, V7, P529, DOI 10.1177/2192568217700099; Leven DM, 2016, SPINE, V41, pE1394, DOI 10.1097/BRS.0000000000001886; Lin HS, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0329-8; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Marion DW, 2006, NEUROSURGERY, V58, P655; McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Neukamp M, 2013, EUR SPINE J, V22, pS767, DOI 10.1007/s00586-013-2943-x; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Phan K, 2017, SPINE J, V17, P538, DOI 10.1016/j.spinee.2016.10.023; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Shin JI, 2017, SPINE, V42, P304, DOI 10.1097/BRS.0000000000001755; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Tee JW, 2012, GLOB SPINE J, V2, P71, DOI 10.1055/s-0032-1319772; Traven SA, 2019, J ORTHOP TRAUMA, V33, P319, DOI 10.1097/BOT.0000000000001455; Tsiouris A, 2013, J SURG RES, V183, P40, DOI 10.1016/j.jss.2012.11.059; United Nations  Department of Economic and Social Affairs  Population Division, 2017, WORLD POPULATION AGE; Velanovich V, 2013, J SURG RES, V183, P104, DOI 10.1016/j.jss.2013.01.021; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Vu CCL, 2017, INJURY, V48, P2443, DOI 10.1016/j.injury.2017.08.026; Wahl TS, 2017, JAMA SURG, V152, P749, DOI 10.1001/jamasurg.2017.1025; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Yagi M, 2019, SPINE, V44, pE1083, DOI 10.1097/BRS.0000000000003063	55	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2499	2506		10.1089/neu.2019.6943		JUL 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000556939700001	32349611				2022-02-06	
J	MacGregor, AJ; Joseph, AR; Walker, GJ; Dougherty, AL				MacGregor, Andrew J.; Joseph, Antony R.; Walker, G. Jay; Dougherty, Amber L.			Co-occurrence of hearing loss and posttraumatic stress disorder among injured military personnel: a retrospective study	BMC PUBLIC HEALTH			English	Article						Hearing loss; PTSD; Military; Veteran	MENTAL-HEALTH DISORDERS; TRAUMATIC BRAIN-INJURY; SEVERITY SCORE; UNITED-STATES; VETERANS; PTSD; IRAQ; WAR; AFGHANISTAN; IMPAIRMENT	BackgroundPosttraumatic stress disorder (PTSD) and hearing loss are hallmark public health issues related to military service in Iraq and Afghanistan. Although both are significant individual contributors to disability among veterans, their co-occurrence has not been specifically explored.MethodsA total of 1179 male U.S. military personnel who sustained an injury between 2004 and 2012 during operations in Iraq or Afghanistan were identified from clinical records. Pre- and postinjury audiometric data were used to define new-onset hearing loss, which was categorized as unilateral or bilateral. Diagnosed PTSD was abstracted from electronic medical records. Logistic regression analysis examined the relationship between hearing loss and PTSD, while adjusting for age, year of injury, occupation, injury severity, injury mechanism, and presence of concussion.ResultsThe majority of the study sample were aged 18-25years (79.9%) and sustained mild-moderate injuries (94.6%). New-onset hearing loss was present in 14.4% of casualties (10.3% unilateral, 4.1% bilateral). Rates of diagnosed PTSD were 9.1, 13.9, and 29.2% for those with no hearing loss, unilateral hearing loss, and bilateral hearing loss, respectively. After adjusting for covariates, those with bilateral hearing loss had nearly three-times higher odds of PTSD (odds ratio=2.92; 95% CI, 1.47-5.81) compared to those with no hearing loss. Unilateral hearing loss was not associated with PTSD.ConclusionsBoth PTSD and hearing loss are frequent consequences of modern warfare that adversely affect the overall health of the military. Bilateral, but not unilateral, hearing loss was associated with a greater burden of PTSD. This has implications for warfighter rehabilitation and should encourage collaboration between audiology and mental health professionals.	[MacGregor, Andrew J.; Walker, G. Jay; Dougherty, Amber L.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92152 USA; [Joseph, Antony R.] Illinois State Univ, Hearing Loss Prevent Lab, Commun Sci & Disorders Dept, Normal, IL 61761 USA; [Joseph, Antony R.; Walker, G. Jay; Dougherty, Amber L.] Leidos Inc, San Diego, CA USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92152 USA.	andrewmacgregor@protonmail.com		MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60808]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery under work unit no. 60808.	Abrams TE, 2006, J AM GERIATR SOC, V54, P1475, DOI 10.1111/j.1532-5415.2006.00875.x; [Anonymous], 1977, INT CLASSIFICATION D; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P4; Aubert-Khalfa S, 2010, J AFFECT DISORDERS, V127, P169, DOI 10.1016/j.jad.2010.05.011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYLE CA, 1989, EPIDEMIOL REV, V11, P1; Clifford RE, 2019, MIL MED, V184, P839, DOI 10.1093/milmed/usz016; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dobie R.A., 2005, HEARING LOSS DETERMI; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; El-Gabalawy R, 2018, J AFFECT DISORDERS, V227, P849, DOI 10.1016/j.jad.2017.11.058; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Fukunishi I, 1999, PSYCHOTHER PSYCHOSOM, V68, P82, DOI 10.1159/000012317; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Greer N, 2016, PREVALENCE EPIDEMIOL; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Groenewold Matthew R., 2011, Morbidity and Mortality Weekly Report, V60, P955; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hsu WT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005312; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; Joseph AR, 2016, J REHABIL RES DEV, V53, P295, DOI 10.1682/JRRD.2015.02.0031; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Laroche C, 2000, J ACAD REHABIL AUDIO, V23, P63; MacGregor AJ, 2013, INJURY, V44, P1458, DOI 10.1016/j.injury.2012.10.009; Madianos MG, 2001, PSYCHOTHER PSYCHOSOM, V70, P30, DOI 10.1159/000056222; MAHAPATRA SB, 1974, ACTA PSYCHIAT SCAND, V50, P596, DOI 10.1111/j.1600-0447.1974.tb07523.x; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Meadow-Orlans KP, 1985, ADJUSTMENT ADULT HEA, P35; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Oh JH, 2007, OTOLARYNG HEAD NECK, V136, P87, DOI 10.1016/j.otohns.2006.05.015; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Schein S, 2001, REHABIL PSYCHOL, V46, P322; Schroedel JG, 2000, AM ANN DEAF, V145, P303, DOI 10.1353/aad.2012.0099; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; SHALEV A, 1988, BIOL PSYCHIAT, V24, P522, DOI 10.1016/0006-3223(88)90163-1; Shoham N, 2019, SOC PSYCH PSYCH EPID, V54, P649, DOI 10.1007/s00127-018-1638-3; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Stimpson NJ, 2003, BRIT J PSYCHIAT, V182, P391, DOI 10.1192/bjp.182.5.391; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Tseng CC, 2016, J AFFECT DISORDERS, V197, P94, DOI 10.1016/j.jad.2016.03.020; U.S. Department of Defense Office of the Under Secretary of Defense for Personnel and Readiness, 2019, DOD INSTR 6055 12 HE; U.S. Department of Defense Office of the Under Secretary of Defense Personnel and Readiness, 1997, DOD INSTR 1312 1 1; U.S. Department of Veterans Affairs, 2013, ANN BEN REP FISC YEA; Van Campen L E, 1999, J Am Acad Audiol, V10, P231; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; YOVELL Y, 1995, J NEUROPSYCH CLIN N, V7, P82; [No title captured]	52	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	JUL 8	2020	20	1							1076	10.1186/s12889-020-08999-6			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	MP2PH	WOS:000552050600002	32641028	gold, Green Published			2022-02-06	
J	To, XV; Benetatos, J; Soni, N; Liu, DD; Abraha, HM; Yan, WY; Panagiotopoulou, O; Nasrallah, FA				To, Xuan Vinh; Benetatos, Joseph; Soni, Neha; Liu, Dedao; Abraha, Hyab Mehari; Yan, Wenyi; Panagiotopoulou, Olga; Nasrallah, Fatima A.			Ultra-High-Field Diffusion Tensor Imaging Identifies Discrete Patterns of Concussive Injury in the Rodent Brain	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diffusion tensor imaging; finite element analysis; neurite orientation dispersion imaging; ultra-high-field magnetic resonance imaging	NEURITE ORIENTATION DISPERSION; HEAD IMPACT MODEL; IN-VIVO; GRAY-MATTER; ROTATIONAL ACCELERATION; DENSITY; NODDI; WHITE; DTI; PERMUTATION	Although concussions can result in persistent neurological post-concussion symptoms, they are typically invisible on routine magnetic resonance imaging (MRI) scans. Our study aimed to investigate the use of ultra-high-field diffusion tensor imaging (UHF-DTI) in discerning severity-dependent microstructural changes in the mouse brain following a concussion. Twenty-three C57BL/6 mice were randomly allocated into three groups: the low concussive (LC,n = 9) injury group, the high concussive (HC,n = 6) injury group, and the sham control (SC,n = 7) group. Mice were perfused on day 2 post-injury, and the brains were scanned on a 16.4T MRI scanner with UHF-DTI and neurite orientation dispersion imaging (NODDI). Finite element analysis (FEA) was performed to determine the pattern and extent of the physical impact on the brain tissue. MRI findings were correlated with histopathological analysis in a subset of mice. In the LC group, increased fractional anisotropy (FA) and decreased orientation dispersion index (ODI) but limited neurite density index (NDI) changes were found in the gray matter, and minimal changes to white matter (WM) were observed. The HC group presented increased mean diffusivity (MD), decreased NDI, and decreased ODI in the WM and gray matter (GM); decreased FA was also found in a small area of the WM. WM changes were associated with WM degeneration and neuroinflammation. FEA showed varying region-dependent degrees of stress, in line with the different imaging findings. This study provides evidence that UHF-DTI combined with NODDI can detect concussions of variable intensities. This has significant implications for the diagnosis of concussion in humans.	[To, Xuan Vinh; Benetatos, Joseph; Soni, Neha; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Nasrallah, Fatima A.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Liu, Dedao; Yan, Wenyi] Monash Univ, Fac Engn, Dept Mech & Aerosp Engn, Melbourne, Vic, Australia; [Abraha, Hyab Mehari; Panagiotopoulou, Olga] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Anat & Dev Biol, Monash Biomedicine Discovery Inst, Melbourne, Vic, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	f.nasrallah@uq.edu.au	Yan, Wenyi/ABC-7161-2021; Panagiotopoulou, Olga/M-5476-2013; Nasrallah, Fatima/N-3398-2016	Panagiotopoulou, Olga/0000-0002-6457-448X; To, Xuan Vinh/0000-0002-6527-7356; Mehari Abraha, Hyab/0000-0003-4842-9271; Nasrallah, Fatima/0000-0002-7385-9559	Motor Accident Insurance Commission (MAIC); Queensland Government, Australia [2014000857]	This research was supported by the Motor Accident Insurance Commission (MAIC), the Queensland Government, Australia (grant number: 2014000857).	Abraha HM, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00269; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Ashburner J., 2003, HUMAN BRAIN FUNCTION, P702; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Baumgartner D, 2005, EUR J COMPUT MECH, V14, P421; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Crombe A, 2018, NEUROIMAGE, V172, P357, DOI 10.1016/j.neuroimage.2018.01.061; Cunningham ME, 2010, CLIN ORTHOP RELAT R, V468, P2695, DOI 10.1007/s11999-010-1421-6; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; de Guzman AE, 2016, NEUROIMAGE, V142, P687, DOI 10.1016/j.neuroimage.2016.06.028; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Dickie DA, 2015, MAGN RESON IMAGING, V33, P1299, DOI 10.1016/j.mri.2015.07.014; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Healy S, 2018, J NEUROSCI METH, V295, P87, DOI 10.1016/j.jneumeth.2017.12.002; Holmes HE, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00020; Jelescu IO, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00061; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kikinis Z, 2017, BRAIN INJURY, V31, P1376, DOI 10.1080/02699052.2017.1318450; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Kurniawan ND, 2018, METHODS MOL BIOL, V1718, P347, DOI 10.1007/978-1-4939-7531-0_21; Lamy Michael, 2011, Ann Adv Automot Med, V55, P125; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Ma D, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00011; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Morrogh-Bernard HC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16621-w; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ni H, 2006, AM J NEURORADIOL, V27, P1776; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Osuka S, 2012, J NEUROSURG, V117, P363, DOI 10.3171/2012.4.JNS112305; Pallotto M, 2015, ELIFE, V4, DOI 10.7554/eLife.08206; Panagiotopoulou O, 2017, ZOOLOGY, V124, P13, DOI 10.1016/j.zool.2017.08.010; Qiu LR, 2013, NEUROIMAGE, V83, P593, DOI 10.1016/j.neuroimage.2013.06.074; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Scholz J, 2015, NEUROIMAGE, V109, P190, DOI 10.1016/j.neuroimage.2015.01.027; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Tariq M, 2016, NEUROIMAGE, V133, P207, DOI 10.1016/j.neuroimage.2016.01.046; Tenkova Tatyana I., 2007, V399, P31, DOI 10.1007/978-1-59745-504-6_3; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Wang N, 2019, BRAIN STRUCT FUNCT, V224, P1797, DOI 10.1007/s00429-019-01877-x; Willis EF, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00197; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Yamada H., 1970, STRENGTH BIOL MAT; Yi SY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00081; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027	90	4	4	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					967	982		10.1089/neu.2019.6944		JUL 2020	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000547879400001	32394788				2022-02-06	
J	Denoix, N; Merz, T; Unmuth, S; Hoffmann, A; Nespoli, E; Scheuerle, A; Huber-Lang, M; Gundel, H; Waller, C; Radermacher, P; McCook, O				Denoix, Nicole; Merz, Tamara; Unmuth, Sarah; Hoffmann, Andrea; Nespoli, Ester; Scheuerle, Angelika; Huber-Lang, Markus; Gundel, Harald; Waller, Christiane; Radermacher, Peter; McCook, Oscar			Cerebral Immunohistochemical Characterization of the H2S and the Oxytocin Systems in a Porcine Model of Acute Subdural Hematoma	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; albumin; cystathionine-E-lyase; barrier dysfunction; edema; complement system; oxytocin receptor; resuscitation	TRAUMATIC BRAIN-INJURY; HYDROGEN-SULFIDE; COMPLEMENT-SYSTEM; BARRIER INTEGRITY; PIG; RECEPTOR; TISSUE; NEUROGENESIS; VASOPRESSIN; DYSFUNCTION	The hydrogen sulfide (H2S) and the oxytocin/oxytocin receptor (OT/OTR) systems interact in trauma and are implicated in vascular protection and regulation of fluid homeostasis. Acute brain injury is associated with pressure-induced edema formation, blood brain barrier disruption, and neuro-inflammation. The similarities in brain anatomy: size, gyrencephalic organization, skull structure, may render the pig a highly relevant model for translational medicine. Cerebral biomarkers for pigs for pathophysiological changes and neuro-inflammation are limited. The current study aims to characterize the localization of OT/OTR and the endogenous H2S producing enzymes together with relevant neuro-inflammatory markers on available porcine brain tissue from an acute subdural hematoma (ASDH) model. In a recent pilot study, anesthetized pigs underwent ASDH by injection of 20 mL of autologous blood above the left parietal cortex and were resuscitated with neuro-intensive care measures. After 54 h of intensive care, the animals were sacrificed, the brain was removed and analyzed via immunohistochemistry. The endogenous H2S producing enzymes cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS), the OTR, and OT were localized in neurons, vasculature and parenchyma at the base of sulci, where pressure-induced injury leads to maximal stress in the gyrencephalic brain. The pathophysiological changes in response to brain injury in humans and pigs, we show here, are comparable. We additionally identified modulators of brain injury to further characterize the pathophysiology of ASDH and which may indicate future therapeutic approaches.	[Denoix, Nicole; Gundel, Harald] Ulm Univ, Clin Psychosomat Med & Psychotherapy, Med Ctr, Ulm, Germany; [Denoix, Nicole; Merz, Tamara; Unmuth, Sarah; Hoffmann, Andrea; Radermacher, Peter; McCook, Oscar] Ulm Univ, Inst Anesthesiol Pathophysiol & Proc Engn, Med Ctr, Ulm, Germany; [Nespoli, Ester] Ulm Univ, Dept Neurol Mol & Translat Neurosci, Ulm, Germany; [Scheuerle, Angelika] Ulm Univ, Inst Pathol, Dept Neuropathol, Med Ctr, Ulm, Germany; [Huber-Lang, Markus] Ulm Univ, Med Ctr, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Waller, Christiane] Paracelsus Med Univ, Nuremberg Gen Hosp, Dept Psychosomat Med & Psychotherapy, Nurnberg, Germany		McCook, O (corresponding author), Ulm Univ, Inst Anesthesiol Pathophysiol & Proc Engn, Med Ctr, Ulm, Germany.	oscar.mccook@uni-ulm.de	Denoix, Nicole/ABE-8057-2020; McCook, Oscar/AAF-1647-2020; Gundel, Harald/AAZ-2905-2020; Merz, Tamara/AAW-2848-2020	Denoix, Nicole/0000-0003-3655-6433; McCook, Oscar/0000-0001-7879-7695; Merz, Tamara/0000-0002-5519-9171	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Collaborative Research Center (CRC) 1149German Research Foundation (DFG) [251293561]	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -Project-ID 251293561 Collaborative Research Center (CRC) 1149.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Blecharz-Lang KG, 2018, TRANSL STROKE RES, V9, P631, DOI 10.1007/s12975-018-0614-2; Boccia ML, 2013, NEUROSCIENCE, V253, P155, DOI 10.1016/j.neuroscience.2013.08.048; Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Brierley J B, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P181; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coletti R, 2015, HORM BEHAV, V67, P12, DOI 10.1016/j.yhbeh.2014.11.008; Datzmann T, 2021, J NEUROSURG, V134, P223, DOI 10.3171/2019.9.JNS191789; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; FUKUDA AM, 2012, J NEUROINFLAMM, V0009; Geng YJ, 2015, J CEREBR BLOOD F MET, V35, P494, DOI 10.1038/jcbfm.2014.223; Goette A, 2009, EUR HEART J, V30, P1411, DOI 10.1093/eurheartj/ehp046; Graham D I, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P170; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Iseri SO, 2005, J SURG RES, V126, P73, DOI 10.1016/j.jss.2005.01.021; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kanaumi Takeshi, 2006, Neuroembryology and Aging, V4, P202, DOI 10.1159/000118930; Kim Bobby, 2014, J Emerg Trauma Shock, V7, P102, DOI 10.4103/0974-2700.130880; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lagraoui M, 2017, BRAIN BEHAV IMMUN, V61, P96, DOI 10.1016/j.bbi.2016.12.005; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Leffler CW, 2011, AM J PHYSIOL-HEART C, V300, pH440, DOI 10.1152/ajpheart.00722.2010; Li HB, 2018, CELL PHYSIOL BIOCHEM, V47, P994, DOI 10.1159/000490166; Mahajan SD, 2015, IMMUNOLOGY, V146, P130, DOI 10.1111/imm.12489; Maniega SM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00784; Marz P, 1996, BRAIN RES, V706, P71, DOI 10.1016/0006-8993(95)01210-9; McKay EC, 2019, J NEUROPATH EXP NEUR, V78, P436, DOI 10.1093/jnen/nlz023; Meissner A, 2011, EUR SURG RES, V47, P141, DOI 10.1159/000330756; MERZ T, 2017, INTENS CARE MED EXP, V0005; MERZ T, 2018, INTENS CARE MED EXP, V0006; MERZ T, 2018, INTENS CARE MED EXP, V0006; Merz T, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00299; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nielsen TH, 2011, NEUROCRIT CARE, V15, P585, DOI 10.1007/s12028-011-9563-2; Patel S, 2018, AM J PHYSIOL-HEART C, V315, pH1759, DOI 10.1152/ajpheart.00451.2018; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Philips T, 2017, J CLIN INVEST, V127, P3277, DOI 10.1172/JCI90610; Prajapati KD, 2010, BRAIN RES, V1327, P118, DOI 10.1016/j.brainres.2010.02.063; Rankin SL, 2003, BRAIN RES, V971, P189, DOI 10.1016/S0006-8993(03)02350-3; Raymond AD, 2006, BRAIN RES, V1102, P44, DOI 10.1016/j.brainres.2006.04.113; Roselli F, 2018, J NEUROTRAUM, V35, P226, DOI 10.1089/neu.2017.5168; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruginsk SG, 2015, PHYSIOLOGY, V30, P127, DOI 10.1152/physiol.00040.2014; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Schwarz H, 2001, CELL TISSUE RES, V305, P411; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stenzel T, 2016, SHOCK, V46, P398, DOI 10.1097/SHK.0000000000000599; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Vink R, 2010, NEUROTHERAPEUTICS, V7, P1, DOI 10.1016/j.nurt.2009.12.001; Wang YL, 2014, J NEUROCHEM, V129, P827, DOI 10.1111/jnc.12695; Wigger DC, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4309605; ZHOU X, 2019, FRONT MOL NEUROSCI, V0012	64	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 7	2020	11								649	10.3389/fneur.2020.00649			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MW1LB	WOS:000556806500001	32754111	Green Published, gold			2022-02-06	
J	Clark, JM; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Event-specific impact test protocol for ice hockey goaltender masks	SPORTS BIOMECHANICS			English	Article						Concussion; impact biomechanics; finite element modelling	LOADING CURVE CHARACTERISTICS; BRAIN DEFORMATION METRICS; AMERICAN FOOTBALL HELMETS; SYSTEMATIC VIDEO ANALYSIS; FINITE-ELEMENT MODELS; ACCIDENT RECONSTRUCTION; INTRACRANIAL-PRESSURE; PROFESSIONAL FOOTBALL; PROTECTIVE CAPACITY; HEAD IMPACTS	Goaltenders in the sport of ice hockey are at high risk for concussions from falls to the ice, player collisions and puck impacts. However, current methods used to certify helmets only consider head accelerations for drop tests which may not describe all common injury mechanisms relating to concussion. The purpose of this study was to describe the characteristics of 3 events associated with concussions for ice hockey goaltenders. A helmeted medium National Operating Committee on Standards for Athletic Equipment (NOCSAE) headform was impacted under conditions representing 3 injury events. Three impact locations' velocities were selected for each event based on video analysis of real-world concussive events. Peak resultant linear acceleration, rotational acceleration and rotational velocity of the headform were measured. The University College Dublin Brain Trauma Model (UCDBTM) was used to calculate maximum principal strain (MPS) and von Mises stress in the cerebrum. Each impact event produced a unique dynamic response and brain stress and strain values. This demonstrates that a single impact event (i.e. falls) cannot adequately describe all impact events. As a result, impact protocols which assess multiple impact events such as the protocol described in this study should be used to evaluate ice hockey goaltender masks.	[Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Coll Engn & Architecture, Dublin, Ireland; [Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada		Clark, JM (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Coll Engn & Architecture, Dublin, Ireland.; Clark, JM (corresponding author), Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada.	michio.clark@ucd.ie					Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Agel J, 2007, J ATHL TRAINING, V42, P241; American Society for Testing and Materials, 2014, STAND SPEC HEAD FAC, DOI [10.1520/f1587, DOI 10.1520/F1587]; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Canadian Standards Association, 2009, IC HOCK HELM Z262 1; Canadian Standards Association, 2009, FAC PROT US IC HOCK, DOI [10.3403/30296821, DOI 10.3403/30296821]; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Forero Rueda M. A., 2009, THESIS; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giordano C, 2014, STAPP CAR CRASH J, V58, P1; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2012, P I MECH ENG P-J SPO, V226, P226, DOI 10.1177/1754337112448765; Hutchison M. G., 2011, THESIS; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; International Standardization Organization, 2003, HEAD FAC PROT US IC, DOI [10.3403/02913916u, DOI 10.3403/02913916U]; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kendall M., 2016, THESIS; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPrade RF, 2009, AM SOC TEST MATER, V1516, P73, DOI 10.1520/JAI101862; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; National Operating Committee on Standards for Athletic Equipment, 2016, 03011M16 NOCSAE DOC, DOI [10.1520/stp24054s, DOI 10.1520/STP24054S]; Newman KM, 2000, MINN REV, P223; Nur Sarah, 2015, Sports Biomech, V14, P459, DOI 10.1080/14763141.2015.1084035; Ouckama R., 2014, IRCOBI P, P62; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2014, P IRCOBI C BERL GERM, P72; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rousseau P, 2014, AM SOC TEST MATER, V1552, P196, DOI 10.1520/STP155220120159; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Ruan J, 1994, THESIS; Seemann M. R., 1986, 861892 SAE, DOI [10.4271/861892, DOI 10.4271/861892]; Walsh E. S., 2012, ASTM S MECH CONC SPO; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2012, P I MECH ENG P-J SPO, V226, P220, DOI 10.1177/1754337112442299; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	84	4	4	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.	JUL 3	2020	19	4					510	531		10.1080/14763141.2018.1510975			22	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	ME7FZ	WOS:000544822300007	30274550				2022-02-06	
J	Wang, RR; He, M; Xu, JG				Wang, Ruoran; He, Min; Xu, Jianguo			Serum bilirubin level correlates with mortality in patients with traumatic brain injury	MEDICINE			English	Article						bilirubin; marker; prognosis; traumatic brain injury	HEME OXYGENASE-1; HEMORRHAGE; DAMAGE	As a catabolic product of hemoglobin, bilirubin has been confirmed playing an important role in the development of various central nervous system disease. The aim of this study is to explore the correlation between serum bilirubin level and mortality in patients with traumatic brain injury (TBI). Patients admitted with traumatic brain injury (TBI) in our hospital between January 2015 and January 2018 were enrolled in this study. Clinical and laboratory data of 361 patients were retrospectively collected to explore the independent risk factors of mortality. The comparison of baseline characteristics showed that non-survivors had lower Glasgow Coma Scale (GCS) (P < .001) and higher level of serum total bilirubin (TBIL) (P < .001) and direct bilirubin (DBIL) (P < .001). We found that only GCS (P < .001), glucose (P < .001), lactate dehydrogenase (LDH) (P = .042) and DBIL (P = .005) were significant risk factors in multivariate logistic regression analysis. GCS and DBIL had comparable AUC value (0.778 vs 0.750,P > .05) on predicting mortality in TBI patients. The AUC value of the combination of GCS and DBIL is higher than the single value of these two factors (P < .05). Moreover, predictive model 1 consisted of GCS, glucose, LDH and DBIL had the highest AUC value of 0.894. DBIL is a significant risk factor of mortality in TBI patients. Assessing the level of DBIL is beneficial for physicians to evaluate severity and predict outcome for TBI patients.	[Wang, Ruoran; He, Min] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China; [Xu, Jianguo] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China		Xu, JG (corresponding author), Sichuan Univ, West China Hosp, West China Med Sch, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.	jianguo_1229@126.com			Key research and development project of science and technology department of Sichuan Province [2019YFS0392]	This research was supported by Key research and development project of science and technology department of Sichuan Province (No: 2019YFS0392).	Almeida AS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00033; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen SC, 2019, CLIN CHIM ACTA, V488, P1, DOI 10.1016/j.cca.2018.10.028; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dohi K, 2005, IN VIVO, V19, P855; Fest S, 2016, INT J CANCER, V138, P2030, DOI 10.1002/ijc.29933; Frikha Z, 2018, AM J CARDIOL, V121, P1015, DOI 10.1016/j.amjcard.2018.01.012; Ghosh C, 2015, ACCOUNTS CHEM RES, V48, P2556, DOI 10.1021/acs.accounts.5b00102; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Guo X, 2019, WORLD NEUROSURG, V128, pE895, DOI 10.1016/j.wneu.2019.05.024; Jian YT, 2020, NEUROL SCI, V41, P903, DOI 10.1007/s10072-019-04182-x; Kamat PK, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.108117; Luo Y, 2013, INT J DEV NEUROSCI, V31, P634, DOI 10.1016/j.ijdevneu.2013.08.002; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mancuso C, 2004, ANTIOXID REDOX SIGN, V6, P878, DOI 10.1089/1523086041798097; Nakamura T, 2003, J NEUROSURG, V15, pEc4; Nitti M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082260; Orozco-Ibarra M, 2009, INT J BIOCHEM CELL B, V41, P1304, DOI 10.1016/j.biocel.2008.11.003; Pineda Sandra, 2008, J Stroke Cerebrovasc Dis, V17, P147, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.009; Potts Mathew B, 2006, NeuroRx, V3, P143; Queiroga CSF, 2015, BRIT J PHARMACOL, V172, P1533, DOI 10.1111/bph.12729; Schallner N, 2017, STROKE, V48, P2565, DOI 10.1161/STROKEAHA.116.016165; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sun HL, 2017, ONCOTARGET, V8, P41305, DOI 10.18632/oncotarget.17181; Suzuki H, 2003, STROKE, V34, P2796, DOI 10.1161/01.STR.0000103743.62248.12; Thakkar M, 2019, MOL NEUROBIOL, V56, P5483, DOI 10.1007/s12035-018-1440-y; Toro-Urrego N, 2019, CURR PHARM DESIGN, V25, P4737, DOI 10.2174/1381612825666191111153802; Wang GQ, 2016, MOL NEUROBIOL, V53, P3576, DOI 10.1007/s12035-015-9302-3; Wang X., 2006, CURR PAEDIAT, V16, P70, DOI [10.1016/j.cupe.2005.10.002, DOI 10.1016/J.CUPE.2005.10.002]	31	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JUL 2	2020	99	27							21020	10.1097/MD.0000000000021020			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MX1TE	WOS:000557508900103	32629724	gold, Green Published			2022-02-06	
J	Chang, DG; Park, JB; Song, KJ; Park, HJ; Kim, WJ; Heu, JY				Chang, Dong-Gune; Park, Jong-Beom; Song, Kyung-Jin; Park, Heui-Jeon; Kim, Whoan Jeang; Heu, Jun Young			Traumatic Atlanto-occipital Dislocation Analysis of 15 Survival Cases With Emphasis on Associated Upper Cervical Spine Injuries	SPINE			English	Article						atlanto-occipital dislocation; brain injuries; survival; tubular retractor; upper cervical spine injuries	ATLANTO-OCCIPITAL DISLOCATION; HORIZONTAL FRACTURE; JEFFERSON FRACTURE; ANTERIOR ARCH; DIAGNOSIS; DISSOCIATION; MANAGEMENT	Study Design. Retrospective case analyses. Objective. The aim of this study was to investigate the incidence and characteristics of associated upper cervical spine injuries in 15 survival cases of traumatic atlanto-occipital dislocation (AOD). Summary of Background Data. Traumatic AOD is a rare and generally fatal injury. Information regarding associated upper cervical spine injuries that may affect treatment methods, outcomes, and prognosis is limited. Methods. Fifteen patients (11 patients with posterior-type AOD and four patients with vertical-type AOD) who survived traumatic AOD were included in this study. Plain radiographs, computed tomography, magnetic resonance imaging, and medical records were reviewed. The incidence and characteristics of associated upper and lower cervical spine and thoracolumbar spine injuries and brain injuries were evaluated. Results. Thirteen patients with traumatic AOD (11 patients with posterior-type AOD and two patients with vertical-type AOD) showed associated upper cervical spine injuries; the overall incidence was 87% (100% in posterior-type AOD and 50% in vertical-type AOD). In posterior-type AOD, eight (72.7%) patients had C1 fractures (four patients had three-part fracture, three patients had two-part fracture, and one patient had four-part fracture), four (36.4%) patients had C1 lateral mass fractures, two (18.2%) patients had transverse atlantal ligament injuries. In vertical-type AOD, two (50%) patients had C1-C2 vertical subluxation with C1 anterior arch horizontal and sagittal split fractures. In posterior-type AOD, two (18%) patients had lower cervical spine injuries and one (9%) patient had brain injury. In vertical-type AOD, one (25%) patient had thoracic spine injury, and three (75%) patients had brain injuries additionally. Conclusion. Survival cases with traumatic AOD showed a high incidence of associated upper cervical spine injuries and brain injuries. High index of suspicion and careful radiologic examination are needed to investigate the presence of associated upper cervical spine injuries and brain injuries in traumatic AOD, which affects treatment, outcome, and prognosis.	[Chang, Dong-Gune] Inje Univ, Dept Orthoped Surg, Sanggye Paik Hosp, Seoul, South Korea; [Park, Jong-Beom; Heu, Jun Young] Catholic Univ Korea, Coll Med, Dept Orthoped Surg, Seoul, South Korea; [Song, Kyung-Jin] Chunbuk Natl Univ, Coll Med, Dept Orthoped Surg, Jeonju, South Korea; [Park, Heui-Jeon] Yonsei Univ, Dept Orthoped Surg, Wonju Coll Med, Wonju, South Korea; [Kim, Whoan Jeang] Eulji Univ Hosp, Dept Orthoped Surg, Daejeon, South Korea		Park, JB (corresponding author), Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Orthopaed Surg, 65-1 Kumho Dong, Uijeongbu Si 480717, Kyunggi Do, South Korea.	spinepjb@catholic.ac.kr					Anderson AJ, 2006, J BONE JOINT SURG BR, V88B, P1464, DOI 10.1302/0301-620X.88B11.18082; Bellabarba C, 2006, J NEUROSURG-SPINE, V4, P429, DOI 10.3171/spi.2006.4.6.429; BUCHOLZ RW, 1979, J BONE JOINT SURG AM, V61, P248, DOI 10.2106/00004623-197961020-00014; Chang DG, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016668; Chang DG, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010189; Chaudhary N, 2013, J NEUROSURG-SPINE, V18, P189, DOI 10.3171/2012.10.SPINE12430; Deliganis AV, 2000, RADIOGRAPHICS, V20, pS237, DOI 10.1148/radiographics.20.suppl_1.g00oc23s237; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P335, DOI 10.1016/j.otsr.2010.10.001; EISMONT FJ, 1978, J BONE JOINT SURG AM, V60, P397, DOI 10.2106/00004623-197860030-00024; Fard SA, 2016, J CLIN NEUROSCI, V33, P63, DOI 10.1016/j.jocn.2016.05.021; Fisher CG, 2001, CAN J SURG, V44, P412; Gire JD, 2013, SPINE J, V13, P510, DOI 10.1016/j.spinee.2013.01.023; Gonzalez LF, 2004, J NEUROSURG-SPINE, V1, P273, DOI 10.3171/spi.2004.1.3.0273; Govender S, 2003, J BONE JOINT SURG BR, V85B, P875, DOI 10.1302/0301-620X.85B6.14092; Hadley MN, 2002, NEUROSURGERY, V50, pS105; Hall GC, 2015, WORLD J ORTHOP, V6, P236, DOI 10.5312/wjo.v6.i2.236; Hamai S, 2006, SPINE, V31, pE421, DOI 10.1097/01.brs.0000220224.01886.b3; HARRIS JH, 1994, AM J ROENTGENOL, V162, P887, DOI 10.2214/ajr.162.4.8141013; Horn EM, 2007, J NEUROSURG-SPINE, V6, P113, DOI 10.3171/spi.2007.6.2.113; Kumar A, 2019, INT J SPINE SURG, V13, P345, DOI 10.14444/6047; LEE C, 1987, AM J NEURORADIOL, V8, P19; LEVINE AM, 1989, CLIN ORTHOP RELAT R, P53; Mendenhall SK, 2015, SPINE J, V15, P2385, DOI 10.1016/j.spinee.2015.07.003; Park JB, 2001, EUR SPINE J, V10, P524, DOI 10.1007/s005860100334; Park JB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008913; POWERS B, 1979, NEUROSURGERY, V4, P12, DOI 10.1097/00006123-197901000-00004; PROUBASTA IR, 1987, SPINE, V12, P615, DOI 10.1097/00007632-198707000-00025; Radcliff K, 2012, CLIN ORTHOP RELAT R, V470, P1602, DOI 10.1007/s11999-011-2151-0; RIASCOS R, 2012, RADIOLOGY, V263, P645; Skala-Rosenbaum J, 2014, EUR SPINE J, V23, pS242, DOI 10.1007/s00586-013-3112-y; STEWART GC, 1977, RADIOLOGY, V122, P349, DOI 10.1148/122.2.349; TRAYNELIS VC, 1986, J NEUROSURG, V65, P863, DOI 10.3171/jns.1986.65.6.0863; WATRIDGE CB, 1985, NEUROSURGERY, V17, P345, DOI 10.1227/00006123-198508000-00021	33	4	4	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JUL 1	2020	45	13					884	894		10.1097/BRS.0000000000003423			11	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	MH5SN	WOS:000546788800015	32049936				2022-02-06	
J	Chen, J; Kouts, J; Rippee, MA; Lauer, S; Smith, D; McDonald, T; Kurylo, M; Filardi, T				Chen, Jamie; Kouts, Jill; Rippee, Michael A.; Lauer, Stephen; Smith, David; McDonald, Tracy; Kurylo, Monica; Filardi, Tanya			Developing a Comprehensive, Interdisciplinary Concussion Program	HEALTH SERVICES INSIGHTS			English	Article						Concussion; mild traumatic brain injury; management; program development; interdisciplinary; administration; health care; virtual clinic; public health; collaboration	TRAUMATIC BRAIN-INJURY; SPORTS; CARE	There has been a growing trend of local and national coverage of and interest in concussion injuries over the past 2 decades. Increasing public concern over potential catastrophic and unknown long-term effects of sports-related concussion injuries has led to an acknowledgment of the strong public health need for addressing all concussion injuries, regardless of mechanism of injury. In efforts to address this need for concussion prevention and management, both in sports and nonsports, The University of Kansas Health System initiated the interdisciplinary Center for Concussion Management program in 2012. The program was created as a virtual clinic concept and includes voluntary participation from various providers across the institution, limited budget, and space obstacles. Since its inception, the program has continued to operate as its initial design of a multidisciplinary team model outside the sole ownership of 1 department, and has expanded to include education and outreach to local and regional schools and groups.	[Chen, Jamie; Kouts, Jill] Univ Kansas Hlth Syst, Ctr Concuss Management, 3901 Rainbow Blvd,MS 2018, Kansas City, KS 66160 USA; [Rippee, Michael A.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Lauer, Stephen] Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66103 USA; [Smith, David] Univ Kansas, Med Ctr, Dept Family Med, Dept Sports Med, Kansas City, KS 66103 USA; [McDonald, Tracy] Univ Kansas, Med Ctr, Dept Trauma Acute Care Surg Burn & Concuss Adm, Kansas City, KS 66103 USA; [Kurylo, Monica] Univ Kansas, Med Ctr, Dept Phys Med & Rehabil, Kansas City, KS 66103 USA; [Filardi, Tanya] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66103 USA		Chen, J (corresponding author), Univ Kansas Hlth Syst, Ctr Concuss Management, 3901 Rainbow Blvd,MS 2018, Kansas City, KS 66160 USA.	jchen2@kumc.edu			University of Kansas (KU) One University Open Access Author Fund - KU; University of Kansas (KU) One University Open Access Author Fund - KUMC	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The article processing charges related to the publication of this article were supported by The University of Kansas (KU) One University Open Access Author Fund sponsored jointly by the KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research and managed jointly by the Libraries at the Medical Center and KU - Lawrence.	[Anonymous], 2009, YOUTH SPORTS CONC HE; Caskey Robert C, 2014, Adv Pediatr, V61, P271, DOI 10.1016/j.yapd.2014.03.006; Centers for Disease Control and Prevention, RET SCH CONC FACT SH; Chang VH, 2011, PM&R, V3, pS387, DOI 10.1016/j.pmrj.2011.08.007; Chase Bailey K, 2019, J NEUROPSYCHIATRY CL, DOI 10.1176/appi.neuropsych.19010002.; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; Doperak J, 2019, CLIN SPORT MED, V38, P497, DOI 10.1016/j.csm.2019.06.003; Ellenbogen Richard G, 2014, Neurosurgery, V75 Suppl 4, pS122, DOI 10.1227/NEU.0000000000000495; Ellis MJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00840; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Enniss Toby M, 2018, Trauma Surg Acute Care Open, V3, pe000153, DOI 10.1136/tsaco-2017-000153; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Kouts J, 2017, AAN SPORTS CONC C JA; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Mack C, 2019, J ATHL TRAINING, V54, P852, DOI 10.4085/1062-6050-181-19; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Mollayeva T, 2018, CONCUSSION, V3, DOI DOI 10.2217/cnc-2017-0015.; National Conference of State Legislatures, 2018, TRAUM BRAIN INJ LEG; NFL, PLAY SMART PLAY SAF; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Peterson AB, 2019, SURVEILLANCE REPORT; Rains Carilyn A, 2010, NASN Sch Nurse, V25, P234; Redelmeier DA, 2019, JAMA NEUROL, V76, P887, DOI 10.1001/jamaneurol.2019.1148; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Sarmiento K, 2019, J SAFETY RES, V68, P223, DOI 10.1016/j.jsr.2018.10.010; Smith AC, 2020, J TELEMED TELECARE, V26, P309, DOI 10.1177/1357633X20916567; Smith AM, 2019, CURR SPORT MED REP, V18, P23, DOI 10.1249/JSR.0000000000000557; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Wood TA, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00053; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	42	4	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1178-6329			HEALTH SERV INSIGHTS	HEALTH SERV. INSIGHTS	JUL	2020	13								1178632920938674	10.1177/1178632920938674			11	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	MW2GQ	WOS:000556862600001	32782428	gold, Green Published			2022-02-06	
J	DePadilla, L; Miller, GF; Jones, SE				DePadilla, Lara; Miller, Gabrielle F.; Jones, Sherry Everett			Characteristics of Schools with Youth Sports Concussion-Related Educational Policies and Practices	JOURNAL OF SCHOOL HEALTH			English	Article						concussion; school sports; school policy; school health policies and practices study; sports concussion	LEGISLATION; SYMPTOMS	BACKGROUND School policies and practices designed to educate athletes, parents, and coaches about youth sports concussions may be a way to reduce concussion risk and improve both the recognition and management of concussions. METHODS Nationally representative data from the 2014 School Health Policies and Practices Study (SHPPS) were used to assess associations between school demographic characteristics (eg, school level, metropolitan status, and school type) and school policies and practices addressing youth sports concussion-related education for athletes, parents, and coaches. RESULTS Overall, many schools had policies and practices that addressed youth sports concussion-related education for athletes, parents, and coaches. There was significant variability in the adoption of policies and practices by some school demographic characteristics. Middle schools, private schools, and urban schools were less likely to adopt many of the policies and practices than high schools, public schools, and rural schools, respectively. For other school characteristics, no consistent patterns of associations emerged. CONCLUSIONS These findings suggest that middle, private, and urban schools, in particular, are more likely to lack youth sports concussion-related educational policies and practices and may need information or resources about the importance of education related to preventing, recognizing, and responding to concussions.	[DePadilla, Lara] Ctr Dis Control & Prevent, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Miller, Gabrielle F.] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Jones, Sherry Everett] Ctr Dis Control & Prevent, Div Adolscent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis SID & IB Preven, Atlanta, GA USA		DePadilla, L (corresponding author), Ctr Dis Control & Prevent, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	lpo9@cdc.gov					Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Centers for Disease Control and Prevention, 2015, RES SCH HLTH POL PRA, P60; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; National Federation of State High School Associations, 2017, ANN REP 2016 17; Potteiger KL, 2018, INTERNET J ALLIED HE, V16; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543	19	4	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	JUL	2020	90	7					520	526		10.1111/josh.12900			7	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	LW3IW	WOS:000539039400003	32350884				2022-02-06	
J	Greco, T; Vespa, PM; Prins, ML				Greco, Tiffany; Vespa, Paul M.; Prins, Mayumi L.			Alternative substrate metabolism depends on cerebral metabolic state following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Alternative substrate; Metabolism; Mitochondria; Sex	ACUTE MITOCHONDRIAL DYSFUNCTION; BETA-HYDROXYBUTYRATE; KETOGENIC DIET; KETONE-BODIES; RAT MODEL; GLUCOSE-UTILIZATION; OXIDATIVE DAMAGE; BLOOD GLUTAMATE; MOUSE MODEL; LACTATE	Decreases in energy metabolism following traumatic brain injury (TBI) are attributed to impairment of glycolytic flux and oxidative phosphorylation. Glucose utilization post-TBI is decreased while administration of alternative substrates has been shown to be neuroprotective. Changes in energy metabolism following TBI happens in two phases; a period of hyper-metabolism followed by prolonged hypo-metabolism. It is not understood how different cerebral metabolic states may impact substrate metabolism and ultimately mitochondrial function. Adult male or female Sprague Dawley rats were given sham surgery or controlled cortical impact (CCI) and were assigned one of two administration schemes. Glucose, lactate or beta-hydroxybutyrate (BHB) were infused i.v. either starting immediately after injury or beginning 6 h post-injury for 3 h to reflect the hyper- and hypo-metabolic stages. Animals were euthanized 24 h post-injury. The peri-contusional cortex was collected and assayed for mitochondrial respiration peroxide production, and citrate synthase activity. Tissue acetyl-CoA, ATP, glycogen and HMGB1 were also quantified. Sex differences were observed in injury pattern. Administration based on cerebral metabolic state identified that only early lactate and late BHB improved mitochondrial function and peroxide production and TCA cycle intermediates in males. In contrast, both early and late BHB had deleterious effects on all aspects of metabolic measurements in females. These data stress there is no one optimal alternative substrate, but rather the fuel type used should be guided by both cerebral metabolic state and sex.	[Greco, Tiffany; Vespa, Paul M.; Prins, Mayumi L.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA; [Prins, Mayumi L.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90024 USA; [Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90024 USA; [Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA		Greco, T (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA.	tgreco@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021	Greco, Tiffany/0000-0002-3463-9617	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS058489, NS104311]; UCLA Brain Injury Research Center; Marilyn and Austin Anderson Fellowship; Easton Labs for Brain Health; Steve Tisch BrainSPORT Program	This work was supported by the National Institutes of Health: NS058489, NS104311; UCLA Brain Injury Research Center, Marilyn and Austin Anderson Fellowship, Easton Labs for Brain Health and Steve Tisch BrainSPORT Program. Funding sources had no involvement in study design; or in the collection, analysis or interpretation of data.	Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Bergendahl M, 1999, J CLIN ENDOCR METAB, V84, P883, DOI 10.1210/jc.84.3.883; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Burns JS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122755; Cali C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00082; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carteron L, 2018, CRIT CARE MED, V46, P1649, DOI 10.1097/CCM.0000000000003274; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Estacio MAC, 1996, BRAIN RES, V717, P55, DOI 10.1016/0006-8993(96)00022-4; Fedorovich SV, 2018, NEURAL REGEN RES, V13, P2060, DOI 10.4103/1673-5374.241442; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; GUIDOTTI A, 1974, NEUROPHARMACOLOGY, V13, P1115, DOI 10.1016/0028-3908(74)90061-6; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Izumi Y, 2010, NEUROSCI LETT, V478, P131, DOI 10.1016/j.neulet.2010.04.078; Jourdain P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21250; Kane DA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00366; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Li HH, 2010, RARE METAL MAT ENG, V39, P146; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li YH, 2014, MOL MED REP, V9, P305, DOI 10.3892/mmr.2013.1793; Llorente-Folch I, 2016, J NEUROSCI, V36, P4443, DOI 10.1523/JNEUROSCI.3691-15.2016; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maudsley AA, 2017, J NEUROIMAGING, V27, P562, DOI 10.1111/jon.12463; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; NAGAI MA, 1988, INT J CANCER, V41, P10, DOI 10.1002/ijc.2910410104; Newman JC, 2014, DIABETES RES CLIN PR, V106, P173, DOI 10.1016/j.diabres.2014.08.009; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Pan JW, 2000, J CEREBR BLOOD F MET, V20, P1502, DOI 10.1097/00004647-200010000-00012; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; ROLLESTON FS, 1967, BIOCHEM J, V104, P519, DOI 10.1042/bj1040519; ROSEN EF, 1974, PHYSIOL BEHAV, V12, P767, DOI 10.1016/0031-9384(74)90012-2; Ryan KK, 2018, ENDOCRINOLOGY, V159, P400, DOI 10.1210/en.2017-00486; Schutkowski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112118; SHARPLESS NS, 1978, BRAIN RES, V140, P171, DOI 10.1016/0006-8993(78)90248-2; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shijo K, 2017, NEUROCHEM INT, V102, P66, DOI 10.1016/j.neuint.2016.11.014; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; STEVENSON RW, 1987, J APPL PHYSIOL, V62, P2237, DOI 10.1063/1.339499; Stubbs BJ, 2018, OBESITY, V26, P269, DOI 10.1002/oby.22051; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sumithran P, 2013, EUR J CLIN NUTR, V67, P759, DOI 10.1038/ejcn.2013.90; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Xu JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep27524; Yellen G, 2018, J CELL BIOL, V217, P2235, DOI 10.1083/jcb.201803152; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Youssef FF, 2015, NEUROL RES, V37, P211, DOI 10.1179/1743132814Y.0000000430; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	82	4	4	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2020	329								113289	10.1016/j.expneurol.2020.113289			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT0MX	WOS:000536772200002	32247790	hybrid, Green Accepted			2022-02-06	
J	Kornblith, ES; Langa, KM; Yaffe, K; Gardner, RC				Kornblith, Erica S.; Langa, Kenneth M.; Yaffe, Kristine; Gardner, Raquel C.			Physical and Functional Impairment Among Older Adults With a History of Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional impairment; physical impairment; traumatic brain injury	LONG-TERM DISABILITY; INPATIENT REHABILITATION; ALZHEIMERS-DISEASE; UNITED-STATES; HEAD-INJURY; RISK; POPULATION; PREVALENCE; OUTCOMES; PAIN	Objectives: To examine the association of lifetime history of traumatic brain injury (TBI) with later-life physical impairment (PI) and functional impairment (FI) and to evaluate the impact of neurobehavioral symptoms that frequently co-occur with TBI on these relations. Participants: A total of 1148 respondents to the 2014 Wave of the Health and Retirement Study, a nationally representative survey of older community-dwelling adults, randomly selected to participate in a TBI exposure survey. They reported no prior TBI (n= 737) or prior TBI (n= 411). Design: Cross-sectional survey study. Main Measures: Physical impairment (self-reported difficulty with >= 1 of 8 physical activities); FI (self-reported difficulty with >= 1 of 11 activities of daily living); self-reported current neurobehavioral symptoms (pain, sleep problems, depression, subjective memory impairment); The Ohio State University TBI Identification Method (OSU-TBI-ID)-short form. Analyses: Stepwise logistic regression models ([1] unadjusted; [2] adjusted for demographics and medical comorbidities; [3] additionally adjusted for neurobehavioral symptoms) compared PI and FI between TBI groups. Results: Traumatic brain injury-exposed (mean: 33.6 years postinjury) respondents were younger, less likely to be female, and reported more comorbidities and neurobehavioral symptoms. Although TBI was significantly associated with increased odds of PI and FI in unadjusted models and models adjusted for demographics/comorbidities (adjusted odds ratio, 95% confidence interval: PI 1.62, 1.21-2.17; FI 1.60, 1.20-2.14), this association was no longer statistically significant after further adjustment for neurobehavioral symptoms. Conclusion: History of TBI is associated with substantial PI and FI among community-dwelling older adults. Further research is warranted to determine whether aggressive management of neurobehavioral symptoms in this population may mitigate long-term PI and FI in this population.	[Kornblith, Erica S.; Yaffe, Kristine; Gardner, Raquel C.] San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA; [Langa, Kenneth M.] Univ Michigan Hlth Syst, Div Gen Med, Ann Arbor, MI USA; [Langa, Kenneth M.] Vet Affairs Ctr Practice Management & Outcomes Re, Washington, DC USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Yaffe, Kristine; Gardner, Raquel C.] Univ Calif San Francisco UCSF, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco UCSF, Dept Psychiat & Epidemiol & Biostat, San Francisco, CA USA		Kornblith, ES (corresponding author), San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA.	erica.kornblith@va.gov		Langa, Kenneth/0000-0002-2798-1836; KORNBLITH, ERICA/0000-0002-2802-7454	Department of Veterans Affairs Office of Academic Affiliation TBI/Polytrauma Rehabilitation Research FellowshipUS Department of Veterans Affairs; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155, P30 AG053760, P30 AG024824]; American Federation for Aging Research; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS095755]	Dr Kornblith was supported by Department of Veterans Affairs Office of Academic Affiliation TBI/Polytrauma Rehabilitation Research Fellowship. Dr Langa was supported by grants from the National Institute on Aging (P30 AG053760 and P30 AG024824). Dr Yaffe was supported by National Institute on Aging K24AG031155. Dr Gardner was supported by theNational Institute of Neurological Disorders and Stroke Beeson K23 NS095755 and the American Federation for Aging Research.	Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Brown RT, 2019, JAMA INTERN MED, V179, P668, DOI 10.1001/jamainternmed.2019.0008; Brown RT, 2017, ANN INTERN MED, V167, P761, DOI 10.7326/M17-0496; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2017, J GERONTOL A-BIOL, V72, P1233, DOI 10.1093/gerona/glw341; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Ilie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188908; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; IMBCorp, 2016, IBM SPSS STAT WIND V; International Traumatic Brain Injury Steering Committee, 2017, COMMON DATA ELEMENTS; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Manchester K, 2020, INJURY PREV, V26, P129, DOI 10.1136/injuryprev-2018-043056; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Min Y, 2016, J AGING RES, V2016, P10; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; Reid MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h532; Salibian-Barrera M, 2002, ANN STAT, V30, P556, DOI 10.1214/aos/1021379865; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shega JW, 2013, J AM GERIATR SOC, V61, P2135, DOI 10.1111/jgs.12554; Stubbs B, 2014, ARCH PHYS MED REHAB, V95, P175, DOI 10.1016/j.apmr.2013.08.241; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Yi A, 2013, NEUROREHABILITATION, V32, P267, DOI 10.3233/NRE-130843; Yi HG, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000352; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	62	4	4	3	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		E320	E329		10.1097/HTR.0000000000000552			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300007	31996604	Green Accepted			2022-02-06	
J	Martindale, SL; Rostami, R; Shura, RD; Taber, KH; Rowland, JA				Martindale, Sarah L.; Rostami, Ramona; Shura, Robert D.; Taber, Katherine H.; Rowland, Jared A.			Brain Volume in Veterans: Relationship to Posttraumatic Stress Disorder and Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anterior cingulate cortex; brain volume; hippocampus; PTSD; TBI; veteran	SMALLER HIPPOCAMPAL VOLUME; SERVICE MEMBERS; EMDR TREATMENT; AMYGDALA; VULNERABILITY; ASSOCIATION; MORPHOLOGY; ATROPHY; RISK; TWIN	Objective: Clarify associations between diagnosis of posttraumatic stress disorder (PTSD) and deployment traumatic brain injury (TBI) on salient regional brain volumes in returning combat veterans. Participants: Iraq and Afghanistan era combat veterans,N= 163, 86.5% male. Main Measures: Clinician-administered PTSD Scale (CAPS-5), Mid-Atlantic MIRECC Assessment of TBI (MMA-TBI), magnetic resonance imaging. Methods: Hierarchical regression analyses evaluated associations and interactions between current and lifetime PTSD diagnosis, deployment TBI, and bilateral volume of hippocampus, anterior cingulate cortex, amygdala, orbitofrontal cortex, precuneus, and insula. Results: Deployment TBI was associated with lower bilateral hippocampal volume (P= .007-.032) and right medial orbitofrontal cortex volume (P= .006). Neither current nor lifetime PTSD diagnosis was associated with volumetric outcomes beyond covariates and deployment TBI. Conclusion: History of deployment TBI is independently associated with lower volumes in hippocampus and medial orbitofrontal cortex. These results support TBI as a potential contributing factor to consider in reduced cortical volume in PTSD.	[Martindale, Sarah L.; Taber, Katherine H.; Rowland, Jared A.] Salisbury VA Med Ctr, Midatlant Mental Illness Res Educ & Clin Ctr MA M, Res & Acad Affairs Serv Line, Salisbury, NC USA; [Rostami, Ramona; Shura, Robert D.] Salisbury VA Med Ctr, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Shura, Robert D.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Rostami, Ramona] Edith Nourse Rogers Bedford VA Med Ctr, Bedford, MA USA		Martindale, SL (corresponding author), Salisbury VA Med Ctr, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Rowland, Jared A./AAN-3030-2021; Martindale, Sarah L/O-8553-2018	Rowland, Jared A./0000-0002-3655-3411; Martindale, Sarah L/0000-0002-0059-3454	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. The authors thank the Veterans and Service members who contributed their time and effort to this research. They also thank Mary Peoples, David J. Curry, MSW, Christine Sortino, MS, andAlana M. Higgins, MA, for their contributions to this project.	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Bossini L, 2011, J NEUROPSYCH CLIN N, V23, pE1, DOI 10.1176/appi.neuropsych.23.2.E1; Boyle E, 2014, ARCH PHYS MED REH S2, V95, P5230; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Eierued C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101793; First M.B., 1996, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Hayes A. F., 2018, INTRO MEDIATION MODE; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Jahn Holger, 2013, Dialogues Clin Neurosci, V15, P445; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kremen WS, 2012, NEUROPHARMACOLOGY, V62, P647, DOI 10.1016/j.neuropharm.2011.03.012; Kuo JR, 2012, ARCH GEN PSYCHIAT, V69, P1080, DOI 10.1001/archgenpsychiatry.2012.73; Laugharne J, 2016, J NEUROPSYCH CLIN N, V28, P312, DOI 10.1176/appi.neuropsych.16010006; Letizia B, 2007, J NEUROPSYCH CLIN N, V19, P475, DOI 10.1176/appi.neuropsych.19.4.475; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morey RA, 2016, NEUROPSYCHOPHARMACOL, V41, P791, DOI 10.1038/npp.2015.205; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Perri R, 2007, NEUROPSYCHOLOGY, V21, P549, DOI 10.1037/0894-4105.21.5.549; Pieper J, 2020, J HEAD TRAUMA REHAB, V35, pE1, DOI 10.1097/HTR.0000000000000492; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	53	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		E330	E341		10.1097/HTR.0000000000000559			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300008	32108709				2022-02-06	
J	Mayr, KA; Kwok, CHT; Eaton, SEA; Baker, GB; Whelan, PJ				Mayr, Kyle A.; Kwok, Charlie H. T.; Eaton, Shane E. A.; Baker, Glen B.; Whelan, Patrick J.			The Effects of a Ketogenic Diet on Sensorimotor Function in a Thoracolumbar Mouse Spinal Cord Injury Model	ENEURO			English	Article						function; ketogenic diet; plasticity; spinal cord injury; therapies	NEUROPATHIC PAIN; AMINO-ACIDS; FATTY-ACIDS; BDNF; NERVE; RATS; EXPRESSION; PLASTICITY; ALLODYNIA; NEURONS	Spinal cord injury and peripheral nerve injuries are traumatic events that greatly impact quality of life. One factor that is being explored throughout patient care is the idea of diet and the role it has on patient outcomes. But the effects of diet following neurotrauma need to be carefully explored in animal models to ensure that they have beneficial effects. The ketogenic diet provides sufficient daily caloric requirements while being potentially neuroprotective and analgesic. In this study, animals were fed a high-fat, low-carbohydrate diet that led to a high concentration of blood ketone that was sustained for as long as the animals were on the diet. Mice fed a ketogenic diet had significantly lower levels of tyrosine and tryptophan, but the levels of other monoamines within the spinal cord remained similar to those of control mice. Mice were fed a standard or ketogenic diet for 7 d before and 28 d following the injury. Our results show that mice hemisected over the T10-T11 vertebrae showed no beneficial effects of being on a ketogenic diet over a 28 d recovery period. Similarly, ligation of the common peroneal and tibial nerve showed no differences between mice fed normal or ketogenic diets. Tests included von Frey, open field, and ladder-rung crossing. We add to existing literature showing protective effects of the ketogenic diet in forelimb injuries by focusing on neurotrauma in the hindlimbs. The results suggest that ketogenic diets need to be assessed based on the type and location of neurotrauma.	[Mayr, Kyle A.; Kwok, Charlie H. T.; Whelan, Patrick J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Mayr, Kyle A.; Kwok, Charlie H. T.; Whelan, Patrick J.] Univ Calgary, Dept Neurosci, Calgary, AB T2N 2T9, Canada; [Mayr, Kyle A.; Kwok, Charlie H. T.; Eaton, Shane E. A.; Whelan, Patrick J.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 1N4, Canada; [Baker, Glen B.] Univ Alberta, Fac Med & Dent, Dept Psychiat NRU, Edmonton, AB T6G 2B7, Canada		Whelan, PJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada.; Whelan, PJ (corresponding author), Univ Calgary, Dept Neurosci, Calgary, AB T2N 2T9, Canada.; Whelan, PJ (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 1N4, Canada.	whelan@ucalgary.ca		Eaton, Shane/0000-0002-8361-1733; Whelan, Patrick/0000-0002-1234-5415; Kwok, Charlie/0000-0002-1595-3504	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Hotchkiss Brain Institute (HBI); Frank Leblanc Chair in Spinal Cord Injury Research; Faculty of Medicine & Dentistry, University of Alberta; Branch out Neurological Foundation; HBI	C.H.T.K. was funded by a Post doctoral fellowship Grant from Canadian Institutes of Health Research and by the Hotchkiss Brain Institute (HBI). K.A.M. was funded by a studentship from the Branch out Neurological Foundation and by the HBI. The research was funded by the Frank Leblanc Chair in Spinal Cord Injury Research. G.B.B. received funding from the Faculty of Medicine & Dentistry, University of Alberta.	Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Ahuja CS, 2016, STEM CELL TRANSL MED, V5, P914, DOI 10.5966/sctm.2015-0381; Azmitia EC, 1999, NEUROPSYCHOPHARMACOL, V21, pS33; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Brown A, 2012, EXP NEUROL, V235, P133, DOI 10.1016/j.expneurol.2011.11.004; Burke D, 2017, EUR J PAIN, V21, P29, DOI 10.1002/ejp.905; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cooper MA, 2018, EXP NEUROL, V306, P149, DOI 10.1016/j.expneurol.2018.05.011; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cullingford TE, 2004, PROSTAG LEUKOTR ESS, V70, P253, DOI 10.1016/j.plefa.2003.09.008; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Finnerup NB, 2012, CURR PAIN HEADACHE R, V16, P207, DOI 10.1007/s11916-012-0259-x; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2001, EXP NEUROL, V171, P361, DOI 10.1006/exnr.2001.7751; Heischmann S, 2018, J LIPID RES, V59, P958, DOI 10.1194/jlr.M079251; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Iwata K, 1999, J NEUROPHYSIOL, V82, P1244, DOI 10.1152/jn.1999.82.3.1244; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Jeong EA, 2011, EXP NEUROL, V232, P195, DOI 10.1016/j.expneurol.2011.09.001; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Kohama I, 2000, J NEUROSCI, V20, P1538; Li J, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900535; MARK RJ, 1995, J NEUROSCI, V15, P6239; Marzo A, 2009, CURR NEUROPHARMACOL, V7, P286, DOI 10.2174/157015909790031193; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Nitsche MA, 2006, EUR J NEUROSCI, V23, P1651, DOI 10.1111/j.1460-9568.2006.04676.x; Parent M, 2001, METHODS, V23, P11, DOI 10.1006/meth.2000.1102; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Ruskin DN, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00033; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Seebach BS, 1999, J NEUROPHYSIOL, V81, P2398, DOI 10.1152/jn.1999.81.5.2398; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Smith J, 2016, BEHAV BRAIN RES, V304, P67, DOI 10.1016/j.bbr.2016.02.015; Streijger F, 2014, J NEUROSCI RES, V92, P870, DOI 10.1002/jnr.23372; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Teasell RW, 2010, ARCH PHYS MED REHAB, V91, P816, DOI 10.1016/j.apmr.2010.01.022; Thompson EL, 2016, CLIN J PAIN, V32, P164, DOI 10.1097/AJP.0000000000000235; TURK DC, 1991, PAIN, V44, P5, DOI 10.1016/0304-3959(91)90142-K; UHLEMANN ER, 1972, J PHARMACOL EXP THER, V180, P231; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Vizuete AF, 2013, LIFE SCI, V92, P923, DOI 10.1016/j.lfs.2013.03.004; WURTMAN RJ, 1975, AM J CLIN NUTR, V28, P638, DOI 10.1093/ajcn/28.6.638; Yang Q, 2017, BRAIN RES, V1667, P11, DOI 10.1016/j.brainres.2017.04.010; Yarar-Fisher Ceren, 2018, Spinal Cord Ser Cases, V4, P88, DOI 10.1038/s41394-018-0121-4; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1111/j.1460-9568.2000.01312.x	56	4	4	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	JUL-AUG	2020	7	4							0178-20.2020	10.1523/ENEURO.0178-20.2020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NR3ZN	WOS:000571502300004	32680835	Green Published, gold			2022-02-06	
J	Morley, M; Menke, AM; Nanji, KC				Morley, Michael; Menke, Anne M.; Nanji, Karen C.			Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008-2018	OPHTHALMOLOGY			English	Article							CATARACT-SURGERY; ADVERSE EVENTS	Purpose: To evaluate the types of anesthesia-related closed claims and their contributing factors, using data from the Ophthalmic Mutual Insurance Company (OMIC). Design: Retrospective analysis of preexisting data. Participants: Plaintiffs who filed a professional liability claim or suit (written demand for money) against OMIC-insured ophthalmologists, ophthalmic practices, or surgicenters in which the surgical case occurred. Methods: Plaintiff claims were collected from the OMIC database from 2008 to 2018 using search queries for terms associated with known complications of ophthalmic anesthesia. Main Outcome Measures: Number and types of anesthesia-related injuries and claims, who administered the anesthesia, the outcomes of the claim or suit, cost to defend, and payments made to plaintiffs. Results: Sixty-three anesthesia-related claims or suits were filed by 50 plaintiffs. Anesthesia-related injuries included globe perforation (n = 17), death (n = 13), retrobulbar hemorrhage (n = 7), optic nerve damage (n = 4), vascular occlusions (n = 2), pain (n = 2), eye or head movement resulting in injury (n = 2), and 1 case each for numbness, diplopia, and tooth loss during intubation. All but 1 patient who died had preexisting, significant comorbidities. Two deaths were related to brainstem anesthesia. Regarding the type of anesthesia in the closed claims, retrobulbar and peribulbar anesthesia were the most common types (n = 16 each), followed by local infiltration around the lids and facial nerve (n = 6), topical anesthesia (n = 5), and general anesthesia (n = 5). In 2 cases, the exact type of anesthesia was unknown but not general. The 5 topical with sedation anesthesia-related claims were due to inadequate pain control (n = 2), ocular movement resulting in capsular rupture (n = 2), or death (n = 1) allegedly related to excessive or inadequate monitoring of sedation. There were 5 claims related to general anesthesia including 4 deaths and 1 tooth loss during intubation. Sedation was alleged to be a factor in 5 cases resulting in death. Anticoagulants were a factor in 3 retrobulbar hemorrhage cases. Conclusions: Although claims and suits were infrequent given the large number of insured ophthalmologists and the large number of surgical cases requiring various types of anesthesia performed over the 10.5-year study period, severe injuries can occur. (C) 2020 by the American Academy of Ophthalmology	[Morley, Michael] Harvard Med Sch, Ophthalm Consultants Boston, Boston, MA 02115 USA; [Menke, Anne M.] Ophthalm Mutual Insurance Co, San Francisco, CA USA; [Nanji, Karen C.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA		Morley, M (corresponding author), Ophthalm Consultants Boston, 50 Staniford St,Suite 600, Boston, MA 02114 USA.	mgmorley@eyeboston.com			AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08 HS024764] Funding Source: Medline		[Anonymous], 2018, MEMB REP; Chen CL, 2015, NEW ENGL J MED, V372, P1530, DOI 10.1056/NEJMsa1410846; Keay L, 2019, COCHRANE DATABASE SY, V1; Lee RMH, 2016, BRIT J OPHTHALMOL, V100, P772, DOI 10.1136/bjophthalmol-2015-307060; Menke A, 2006, OMIC DIGEST SPRING, V16, P1; Menke A, OMIC CONSENTS ANTICO; Menke A, CONSENT FORMS CATARA; Nanji K, 2016, B LEHMAN CTR PATIENT; Nanji KC, 2018, ANESTH ANALG, V126, P1537, DOI 10.1213/ANE.0000000000002529; Pennsylvania Patient safety Advisory, PENNS PAT SAF REP SY, V4; Posner KL, 2014, ASA NEWSL, V78, P28; Roberto SA, 2018, ANESTH ANALG, V126, P1548, DOI 10.1213/ANE.0000000000002526	12	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JUL	2020	127	7					852	858		10.1016/j.ophtha.2019.12.019			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	ND9OC	WOS:000562228700006	32037017	Green Accepted			2022-02-06	
J	Mueller-Buehl, AM; Doepper, H; Grauthoff, S; Kiebler, T; Peters, L; Hurst, J; Kuehn, S; Bartz-Schmidt, KU; Dick, HB; Joachim, SC; Schnichels, S				Mueller-Buehl, Ana M.; Doepper, Hannah; Grauthoff, Sven; Kiebler, Tobias; Peters, Laura; Hurst, Jose; Kuehn, Sandra; Bartz-Schmidt, Karl U.; Dick, H. Burkard; Joachim, Stephanie C.; Schnichels, Sven			Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						cell survival; hypothermia; oxidative stress; porcine retina; retinal ganglion cells	TRAUMATIC BRAIN-INJURY; ORGAN-CULTURE; MICROGLIAL ACTIVATION; DEGENERATION; APOPTOSIS; CELL; PROTECTS; NEURONS; GLUCOSE; DYSFUNCTION	Background Hydrogen peroxide (H2O2) can be used in vitro to simulate oxidative stress. In retinal organ cultures, H(2)O(2)induces strong neurodegeneration of the retina. It is known that oxidative stress plays a role in the development of several retinal diseases including glaucoma and ischemia. Thus, we investigated whether processes underlying oxidative stress can be prevented by hypothermia using an ex vivo organ culture model of porcine retinas. Methods Porcine retinal explants were cultivated for 5 and 8 days. Oxidative stress was induced via 300 mu M H(2)O(2)on day 1 for 3 hours. Hypothermia treatment at 30 degrees C was applied simultaneously with H2O2, for 3 hours. Retinal ganglion cells (RGCs), apoptosis, bipolar and cholinergic amacrine cells, microglia and macroglia were evaluated immunohistologically. Apoptosis rate was additionally analysed via western blot. Results Reduced apoptosis rates through hypothermia led to a preservation of RGCs (P < .001). Amacrine cells were rescued after hypothermia treatment (P= .17), whereas bipolar cells were only protected partly. Additionally, at 8 days, microglial response due to oxidative stress was completely counteracted via hypothermia (P < .001). Conclusions H(2)O(2)induced strong degenerative processes in porcine retinas. The role of oxidative stress in the progression of retinal diseases makes this ex vivo organ culture model suitable to investigate new therapeutic approaches. In the present study, the damaging effect of H(2)O(2)to several retinal cell types was counteracted or strongly alleviated through hypothermia treatment. Especially RGCs, which are affected in glaucoma disease, were protected due to a reduced apoptosis rate through hypothermia.	[Mueller-Buehl, Ana M.; Doepper, Hannah; Grauthoff, Sven; Peters, Laura; Kuehn, Sandra; Dick, H. Burkard; Joachim, Stephanie C.] Ruhr Univ Bochum, Univ Eye Hosp, Expt Eye Res Inst, Bochum, Germany; [Kiebler, Tobias; Hurst, Jose; Bartz-Schmidt, Karl U.; Schnichels, Sven] Univ Eye Hosp Tubingen, Ctr Ophthalmol Tubingen, Tubingen, Germany		Schnichels, S (corresponding author), Univ Eye Hosp Tubingen, Ctr Ophthalmol, Elfriede Aulhorn Str 7, D-72076 Tubingen, Germany.; Joachim, SC (corresponding author), Ruhr Univ Bochum, Univ Eye Hosp, Expt Eye Res, Schornau 23-25, D-44892 Bochum, Germany.	stephanie.joachim@rub.de; sven.schnichels@med.uni-tuebingen.de	Joachim, Stephanie/AAV-5980-2021				Akopian A, 2019, J COMP NEUROL, V527, P159, DOI 10.1002/cne.24074; Akopian A, 2014, J NEUROSCI, V34, P10582, DOI 10.1523/JNEUROSCI.1912-14.2014; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; [Anonymous], 2017, BRIT J OPHTHALMOL, V101, P73, DOI 10.1136/bjophthalmol-2016-EGSguideline.002; Antonic A, 2014, INT J STROKE, V9, P544, DOI 10.1111/ijs.12224; Arrica M, 2007, SEMIN CARDIOTHORAC V, V11, P6, DOI 10.1177/1089253206297409; Bauer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161723; Bausch + Lomb, 2012, GLOB BAR EYE HLTH; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402; Grigsby JG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/705783; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Huang B, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5489476; Hurst J, 2017, ATLA-ALTERN LAB ANIM, V45, P11, DOI 10.1177/026119291704500105; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Klemm P, 2019, CLIN EXP OPHTHALMOL, V47, P1043, DOI 10.1111/ceo.13565; Kuehn S, 2017, EXP EYE RES, V155, P107, DOI 10.1016/j.exer.2017.01.003; Kuehn S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00312; Kuehn S, 2016, ATLA-ALTERN LAB ANIM, V44, P557, DOI 10.1177/026119291604400608; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Liu L, 2008, J NEUROCHEM, V106, P541, DOI 10.1111/j.1471-4159.2008.05411.x; Maliha AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41113-4; McElnea EM, 2011, MOL VIS, V17, P1182; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Mollick T, 2016, BRAIN RES, V1646, P522, DOI 10.1016/j.brainres.2016.06.039; Nishimura Y, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4076518; Peterson LJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/401264; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Reinehr S, 2019, J CELL MOL MED, V23, P5497, DOI 10.1111/jcmm.14433; Reinehr S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28183-6; Reinehr S, 2018, CELL TISSUE RES, V371, P237, DOI 10.1007/s00441-017-2710-0; Reinhard K, 2015, INVEST OPHTH VIS SCI, V57, P658; Rohowetz LJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113362; Salido EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061656; Schnichels S, 2017, BIOL OPEN, V6, P1056, DOI 10.1242/bio.025429; Schnichels S, 2019, ATLA-ALTERN LAB ANIM, V47, P19, DOI 10.1177/0261192919840092; Schultheiss M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148616; Seo JW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-164; Song SS, 2012, CURR TREAT OPTION NE, V14, P541, DOI 10.1007/s11940-012-0201-x; Tang D, 2016, NEUROSCI LETT, V632, P79, DOI 10.1016/j.neulet.2016.08.049; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Taylor L, 2016, EXP EYE RES, V148, P55, DOI 10.1016/j.exer.2016.05.023; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhang FC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1315-1; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhou TE, 2017, BIOCHEM BIOPH RES CO, V486, P1005, DOI 10.1016/j.bbrc.2017.03.153	56	4	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	JUL	2020	48	5					666	681		10.1111/ceo.13731			16	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	MG8KJ	WOS:000546280000013	32077190	hybrid			2022-02-06	
J	Porter, A; Brown, CC; Tilford, JM; Thomas, K; Maxson, RT; Sexton, K; Karim, S; Zohoori, N; Rodriguez, A				Porter, Austin; Brown, Clare C.; Tilford, J. Mick; Thomas, Kevin; Maxson, R. Todd; Sexton, Kevin; Karim, Saleema; Zohoori, Namvar; Rodriguez, Analiz			Association of Insurance Status With Treatment and Outcomes in Pediatric Patients With Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						craniotomy; health disparity; insurance status; intracranial pressure monitoring; pediatric traumatic brain injury	RACIAL DISPARITIES; RACE; CHILDREN; MORTALITY; REHABILITATION; EXPERIENCE; DISCHARGE	Objective: To determine whether a health insurance disparity exists among pediatric patients with severe traumatic brain injury using the National Trauma Data Bank. Design: Retrospective cohort study. Setting: National Trauma Data Bank, a dataset containing more than 800 trauma centers in the United States. Patients: Pediatric patients (< 18 yr old) with a severe isolated traumatic brain injury were identified in the National Trauma Database (years 2007-2016). Isolated traumatic brain injury was defined as patients with a head Abbreviated Injury Scale score of 3+ and excluded those with another regional Abbreviated Injury Scale of 3+. Interventions: None. Measurement and Main Results: Procedure codes were used to identify four primary treatment approaches combined into two classifications: craniotomy/craniectomy and external ventricular draining/intracranial pressure monitoring. Diagnostic criteria and procedure codes were used to identify condition at admission, including hypotension, Glasgow Coma Scale, mechanism and intent of injury, and Injury Severity Score. Children were propensity score matched using condition at admission and other characteristics to estimate multivariable logistic regression models to assess the associations among insurance status, treatment, and outcomes. Among the 12,449 identified patients, 91.0% (n= 11,326) had insurance and 9.0% (n= 1,123) were uninsured. Uninsured patients had worse condition at admission with higher rates of hypotension and higher Injury Severity Score, when compared with publicly and privately insured patients. After propensity score matching, having insurance was associated with a 32% (p= 0.001) and 54% (p< 0.001) increase in the odds of cranial procedures and monitor placement, respectively. Insurance coverage was associated with 25% lower odds of inpatient mortality (p< 0.001). Conclusions: Compared with insured pediatric patients with a traumatic brain injury, uninsured patients were in worse condition at admission and received fewer interventional procedures with a greater odds of inpatient mortality. Equalizing outcomes for uninsured children following traumatic brain injury requires a greater understanding of the factors that lead to worse condition at admission and policies to address treatment disparities if causality can be identified.	[Porter, Austin; Brown, Clare C.; Tilford, J. Mick; Sexton, Kevin; Karim, Saleema] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA; [Porter, Austin; Zohoori, Namvar] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Thomas, Kevin; Rodriguez, Analiz] Univ Arkansas Med Sci, Dept Neurosurg, Little Rock, AR 72205 USA; [Maxson, R. Todd] Arkansas Childrens Hosp, Dept Surg, 800 Marshall St, Little Rock, AR 72202 USA; [Sexton, Kevin] Univ Arkansas Med Sci, Dept Surg, Div Acute Care Surg, Little Rock, AR 72205 USA; [Sexton, Kevin] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Zohoori, Namvar] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA		Porter, A (corresponding author), Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA.; Porter, A (corresponding author), Arkansas Dept Hlth, Little Rock, AR 72205 USA.	aporter@uams.edu		Karim, Saleema/0000-0002-8946-9897; Rodriguez, Analiz/0000-0003-3426-0508; Porter, Austin/0000-0001-5636-5760	U.S. Consumer Product Safety Commission [61320618P0052]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01-HS025703]; Arkansas BlueCross and BlueShield; Vanderbilt University	Dr. Brown's institution received funding from U.S. Consumer Product Safety Commission (61320618P0052), Agency for Healthcare Research and Quality (R01-HS025703), and Arkansas BlueCross and BlueShield. Dr. Sexton received funding from Vanderbilt University (intellectual property licensed to Vanderbilt University by Baxter Healthcare for measuring volume status). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Alban RF, DOES HLTH CARE INSUR; [Anonymous], 2008, NTDB VERS 1 2 2; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Center for Children and Families, NUMB UN CHILDR IS RI; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kannan N, 2017, BRAIN INJURY, V31, P1745, DOI 10.1080/02699052.2017.1346296; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Missios S, 2016, INJURY, V47, P154, DOI 10.1016/j.injury.2015.06.037; Moffet EW, 2018, SURGERY, V163, P251, DOI 10.1016/j.surg.2017.09.006; Moore M, 2018, J HEAD TRAUMA REHAB, V33, P177, DOI 10.1097/HTR.0000000000000348; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; The National Bureau of Economic Research, CMS ICD 9 CM ICD 10; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; 2000, CIRCULATION S1, V102	29	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2020	48	7					E584	E591		10.1097/CCM.0000000000004398			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ME5TS	WOS:000544718700006	32427612				2022-02-06	
J	Shen, JB; Xiang, H; Luna, J; Grishchenko, A; Patterson, J; Strouse, RV; Roland, M; Lundine, JP; Koterba, CH; Lever, K; Groner, JI; Huang, YG; Lin, EJD				Shen, Jiabin; Xiang, Henry; Luna, John; Grishchenko, Alice; Patterson, Jeremy; Strouse, Robert, V; Roland, Maxwell; Lundine, Jennifer P.; Koterba, Christine H.; Lever, Kimberly; Groner, Jonathan, I; Huang, Yungui; Lin, En-Ju Deborah			Virtual Reality-Based Executive Function Rehabilitation System for Children With Traumatic Brain Injury: Design and Usability Study	JMIR SERIOUS GAMES			English	Article						traumatic brain injury; virtual reality; neurological rehabilitation; executive function; cognitive rehabilitation	EMBODIMENT; MEMORY	Background: Traumatic brain injury (TBI) poses a significant threat to children's health. Cognitive rehabilitation for pediatric TBI has the potential to improve the quality of life following the injury. Virtual reality (VR) can provide enriched cognitive training in a life-like but safe environment. However, existing VR applications for pediatric TBIs have primarily focused on physical rehabilitation. Objective: This study aims to design and develop an integrative hardware and software VR system to provide rehabilitation of executive functions (EF) for children with TBI, particularly in 3 core EF: inhibitory control, working memory, and cognitive flexibility. Methods: The VR training system was developed by an interdisciplinary team with expertise in best practices of VR design, developmental psychology, and pediatric TBI rehabilitation. Pilot usability testing of this novel system was conducted among 10 healthy children and 4 children with TBIs. Results: Our VR-based interactive cognitive training system was developed to provide assistive training on core EF following pediatric TBI. Pilot usability testing showed adequate user satisfaction ratings for both the hardware and software components of the VR system. Conclusions: This project designed and tested a novel VR-based system for executive function rehabilitation that is specifically adapted to children following TBI.	[Shen, Jiabin] Nationwide Childrens Hosp, Ctr Biobehav Hlth, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Xiang, Henry; Lever, Kimberly] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Luna, John; Grishchenko, Alice; Patterson, Jeremy; Strouse, Robert, V; Roland, Maxwell; Huang, Yungui; Lin, En-Ju Deborah] Nationwide Childrens Hosp, Res Informat Solut & Innovat, Abigail Wexner Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA; [Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.; Koterba, Christine H.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA; [Groner, Jonathan, I] Nationwide Childrens Hosp, Trauma Program, Columbus, OH USA		Lin, EJD (corresponding author), Nationwide Childrens Hosp, Res Informat Solut & Innovat, Abigail Wexner Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	deborah.lin@nationwidechildrens.org	Koterba, Christine/AAS-9518-2021; Lundine, Jennifer/P-5184-2018	Xiang, Henry/0000-0001-8112-319X; Shen, Jiabin/0000-0001-6625-5215; Patterson, Jeremy/0000-0002-7832-9127; Lundine, Jennifer/0000-0002-9113-7875	Nationwide Children's Hospital Intramural Fund Program, the Clinical and Translational Science Awards [UL1TR002733]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K99HD093814]	The authors would like to thank Colleen Vincent for providing valuable insights into the initial conceptualization of the training content, Madeleine Schroeder for assisting with the literature review, Megan Armstrong for assisting with patient recruitment and data collection, and Dr H Gerry Taylor and Dr Melody Davis for assisting with manuscript edits. This study was supported by Nationwide Children's Hospital Intramural Fund Program, the Clinical and Translational Science Awards (grant number: UL1TR002733). Part of the efforts by JS in analyzing data and writing this paper was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number K99HD093814. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas N, 2004, YB ENGLISH STUDIES, V34, P277, DOI DOI 10.2307/3509518]; Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; [Anonymous], 2015, C TRAUM BRAIN INJ US; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baniqued PL, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01010; Biffi E, 2017, METHOD INFORM MED, V56, P119, DOI 10.3414/ME16-02-0020; Borg G, 1998, BORGS PERCEIVED EXER; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Caglio M, 2012, NEUROCASE, V18, P123, DOI 10.1080/13554794.2011.568499; Cameirao MDS, 2011, RESTOR NEUROL NEUROS, V29, P287, DOI 10.3233/RNN-2011-0599; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Dickey MD, 2006, ETR&D-EDUC TECH RES, V54, P245, DOI 10.1007/s11423-006-8806-y; DiZio P, 1997, CIRCUMVENTING SIDE E; Dumay A C, 1995, Technol Health Care, V3, P75; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kilteni K, 2012, PRESENCE-TELEOP VIRT, V21, P373, DOI 10.1162/PRES_a_00124; Kroesbergen EH, 2009, J PSYCHOEDUC ASSESS, V27, P226, DOI 10.1177/0734282908330586; Lu AS, 2012, GAMES HEALTH J, V1, P37, DOI 10.1089/g4h.2011.0011; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Moline J, 1997, ST HEAL T, V44, P3; Neugnot M, 2015, INT J PHYS MED REHAB, V3, P286, DOI [10.4172/2329-9096.1000286, DOI 10.4172/2329-9096.1000286]]; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Peperkorn HM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00268; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Puente AE, 1985, TEST CRITIQUES, V4, P677; Riva G, 2003, METHOD INFORM MED, V42, P524; Schultze U, 2010, J INF TECHNOL, V25, P434, DOI 10.1057/jit.2010.25; Shapi'i A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/493562; Shen JB, 2020, AM J LIFESTYLE MED, V14, P6, DOI 10.1177/1559827618756588; Ustinova KI, 2014, BRAIN INJURY, V28, P486, DOI 10.3109/02699052.2014.888593; Zaki NAA, 2017, J INF COMMUN TECHNOL, V16, P284; Zelazo P, 2007, HDB EMOTION REGULATI, P135, DOI DOI 10.1177/1545968309354536	36	4	4	7	9	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	2291-9279			JMIR SERIOUS GAMES	JMIR Serious Games	JUL-SEP	2020	8	3							e16947	10.2196/16947			13	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	QS8WI	WOS:000626173500003	32447275	Green Published, gold			2022-02-06	
J	Stanojlovic, M; Stojanovic, IG; Zaric, M; Martinovic, J; Mitrovic, N; Grkovic, I; Drakulic, D				Stanojlovic, Milos; Stojanovic, Ivana Gusevac; Zaric, Marina; Martinovic, Jelena; Mitrovic, Natasa; Grkovic, Ivana; Drakulic, Dunja			Progesterone Protects Prefrontal Cortex in Rat Model of Permanent Bilateral Common Carotid Occlusion via Progesterone Receptors and Akt/Erk/eNOS	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Progesterone; Neuroprotection; Cerebral hypoperfusion; Prefrontal cortex	NITRIC-OXIDE SYNTHASE; CHRONIC CEREBRAL HYPOPERFUSION; TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; COGNITIVE DEFICITS; SIGNALING PATHWAYS; ISCHEMIC-STROKE; CELL-DEATH; ACTIVATION; EXPRESSION	Sustained activation of pro-apoptotic signaling due to a sudden and prolonged disturbance of cerebral blood circulation governs the neurodegenerative processes in prefrontal cortex (PFC) of rats whose common carotid arteries are permanently occluded. The adequate neuroprotective therapy should minimize the activation of toxicity pathways and increase the activity of endogenous protective mechanisms. Several neuroprotectants have been proposed, including progesterone (P-4). However, the underlying mechanism of its action in PFC following permanent bilateral occlusion of common carotid arteries is not completely investigated. We, thus herein, tested the impact of post-ischemic P-4 treatment (1.7 mg/kg for seven consecutive days) on previously reported aberrant neuronal morphology and amount of DNA fragmentation, as well as the expression of progesterone receptors along with the key elements of Akt/Erk/eNOS signal transduction pathway (Bax, Bcl-2, cytochrome C, caspase 3, PARP, and the level of nitric oxide). The obtained results indicate that potential amelioration of histological changes in PFC might be associated with the absence of activation of Bax/caspase 3 signaling cascade and the decline of DNA fragmentation. The study also provides the evidence that P-4 treatment in repeated regiment of administration might be effective in neuronal protection against ischemic insult due to re-establishment of the compromised action of Akt/Erk/eNOS-mediated signaling pathway and the upregulation of progesterone receptors.	[Stanojlovic, Milos; Stojanovic, Ivana Gusevac; Zaric, Marina; Martinovic, Jelena; Mitrovic, Natasa; Grkovic, Ivana; Drakulic, Dunja] Univ Belgrade, Dept Mol Biol & Endocrinol, VINCA Inst Nucl Sci, POB 522, Belgrade 11001, Serbia		Drakulic, D (corresponding author), Univ Belgrade, Dept Mol Biol & Endocrinol, VINCA Inst Nucl Sci, POB 522, Belgrade 11001, Serbia.	drakulic@vinca.rs	Stojanovic, Ivana Gusevac/ABH-4195-2020	Stojanovic, Ivana Gusevac/0000-0001-5307-2970; Grkovic, Ivana/0000-0003-4476-7871; Stanojlovic, Milos/0000-0001-5261-3712; Zaric, Marina/0000-0003-1635-9766; Martinovic, Jelena/0000-0001-8641-1051; Drakulic, Dunja/0000-0003-1448-9639	Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja [41014, 173044] Funding Source: Medline		Abu Nabah YN, 2005, MICROCIRCULATION, V12, P443, DOI 10.1080/10739680590960962; Allen RS, 2016, RESTOR NEUROL NEUROS, V34, P947, DOI 10.3233/RNN-160672; Andrabi SS, 2017, J ENVIRON PATHOL TOX, V36, P191, DOI 10.1615/JEnvironPatholToxicolOncol.2017017156; Boyadjieva NI, 2011, J IMAB, V17, P149, DOI 10.5272/jimab.2011171.149; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Casas S, 2011, PHARMACOL BIOCHEM BE, V99, P614, DOI 10.1016/j.pbb.2011.06.012; Cechetti F, 2012, BRAIN RES BULL, V87, P109, DOI 10.1016/j.brainresbull.2011.10.006; Chang CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/207616; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen ZQ, 2017, MED GAS RES, V7, P194, DOI 10.4103/2045-9912.215750; Clark Lindsay R, 2017, Alzheimers Dement (Amst), V7, P48, DOI 10.1016/j.dadm.2017.01.002; De Jong GI, 1999, NEUROSCIENCE, V91, P203, DOI 10.1016/S0306-4522(98)00659-9; de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drakulic D, 2013, J NEUROENDOCRINOL, V25, P605, DOI 10.1111/jne.12037; Duckles SP, 2010, PFLUG ARCH EUR J PHY, V459, P841, DOI 10.1007/s00424-010-0797-1; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Friguls B, 2002, NEUROBIOL DIS, V11, P443, DOI 10.1006/nbdi.2002.0553; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Guerra-Araiza C, 2009, J NEUROSCI RES, V87, P470, DOI 10.1002/jnr.21848; Hanna RN, 2010, BIOL REPROD, V82, P112, DOI 10.1095/biolreprod.109.078527; Hossain M, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-28; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ito Y, 2010, CURR NEUROVASC RES, V7, P23, DOI 10.2174/156720210790820190; Perez-Alvarez MJ, 2016, CURR PHARM DESIGN, V22, P1334, DOI 10.2174/138161282210160304112834; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Khorram O, 2009, FERTIL STERIL, V91, P2157, DOI 10.1016/j.fertnstert.2008.05.019; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Lange CA, 2008, J STEROID BIOCHEM, V108, P203, DOI 10.1016/j.jsbmb.2007.09.019; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Mani S, 2008, ENDOCRINOLOGY, V149, P2750, DOI 10.1210/en.2008-0097; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Mehla J, 2017, GRADUAL CEREBRAL HYP, DOI [10.1101/177121, DOI 10.1101/177121]; Montes P, 2019, NEUROL RES, V41, P429, DOI 10.1080/01616412.2019.1576356; Moore C, 2011, EUR J PHARMACOL, V651, P152, DOI 10.1016/j.ejphar.2010.11.011; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Pang YF, 2015, AM J PHYSIOL-ENDOC M, V308, pE899, DOI 10.1152/ajpendo.00527.2014; Patel A, 2017, NEUROL RES, V39, P910, DOI 10.1080/01616412.2017.1355423; Perez-Alvarez MJ, 2015, MOL NEUROBIOL, V52, P1690, DOI 10.1007/s12035-014-8963-7; Rius-Perez S, 2018, NEUROLOGIA, V33, P112, DOI 10.1016/j.nrl.2015.07.010; Salazar M, 2016, GENE, V591, P6, DOI 10.1016/j.gene.2016.06.044; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Si DW, 2014, BEHAV BRAIN RES, V264, P135, DOI 10.1016/j.bbr.2014.01.049; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Smith K, 2013, CRIT CARE MED, V41, DOI 10.1097/01.ccm.0000439331.43555.fb; Stanojlovic M, 2015, NEUROSCIENCE, V311, P308, DOI 10.1016/j.neuroscience.2015.10.040; Stanojlovic M, 2014, FOLIA BIOL-PRAGUE, V60, P123; Stanojlovic M, 2015, NEUROCHEM INT, V83-84, P1, DOI 10.1016/j.neuint.2015.03.002; Stanojlovic M, 2014, ARCH BIOL SCI, V66, P1673, DOI 10.2298/ABS1404673S; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Tang H, 2014, MOL CELL ENDOCRINOL, V387, P52, DOI 10.1016/j.mce.2014.01.024; Terada K, 2000, BIOCHEM BIOPH RES CO, V267, P449, DOI 10.1006/bbrc.1999.1955; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wali B, 2016, BEHAV BRAIN RES, V305, P46, DOI 10.1016/j.bbr.2016.02.024; Wang ZQ, 2016, BEHAV BRAIN RES, V301, P243, DOI 10.1016/j.bbr.2015.12.047; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yousuf S, 2017, HORM BEHAV, V96, P21, DOI 10.1016/j.yhbeh.2017.08.004; Yousuf S, 2015, RESTOR NEUROL NEUROS, V33, P251, DOI 10.3233/RNN-140450; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Zaric M, 2018, BRAIN RES, V1688, P73, DOI 10.1016/j.brainres.2018.03.023; Zhao YZ, 2015, NEURAL REGEN RES, V10, P1076, DOI 10.4103/1673-5374.160097	83	4	4	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JUL	2020	40	5					829	843		10.1007/s10571-019-00777-2			15	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	LS5TR	WOS:000536446800013	31865501				2022-02-06	
J	Stemper, BD; Shah, AS; Mihalik, JP; Harezlak, J; Rowson, S; Duma, S; Riggen, LD; Brooks, A; Cameron, KL; Giza, CC; Goldman, J; Houston, MN; Jackson, J; Mcginty, G; Broglio, SP; Mcallister, TW; Mccrea, M				Stemper, Brian D.; Shah, Alok S.; Mihalik, Jason P.; Harezlak, Jaroslaw; Rowson, Steven; Duma, Stefan; Riggen, Larry D.; Brooks, Alison; Cameron, Kenneth L.; Giza, Christopher C.; Goldman, Joshua; Houston, Megan N.; Jackson, Jonathan; Mcginty, Gerald; Broglio, Steven P.; Mcallister, Thomas W.; Mccrea, Michael			Head Impact Exposure in College Football after a Reduction in Preseason Practices	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; BIOMECHANICS; HEAD IMPACT EXPOSURE; AMERICAN FOOTBALL; TRAUMATIC BRAIN INJURY; SUBCONCUSSIVE	RECURRENT CONCUSSION; PLAYERS; BIOMECHANICS	Introduction Regulatory efforts toward reducing concussion risk have begun to focus on decreasing the number of head impacts (i.e., head impact burden) sustained by athletes in contact sports. To that end, in 2018, the NCAA decreased the number of preseason on-field team activities for Division I teams from 29 to 25. The objective of the current study was to quantify changes in practice schedule and head impact exposure between the 2017 and 2018 football preseasons. Methods Athletes from five NCAA Division I football teams (n= 426) were consented and enrolled. Results On average, athletes participated in 10% fewer contact practices in 2018. However, the effect of this ruling on preseason head impact burden was mixed. Across all athletes, the total preseason head impact burden was essentially the same from 2017 to 2018. However, this study revealed significant team-by-team differences in preseason head impact burden, with one team demonstrating a 35% increase in the average number of recorded head impacts from 2017 to 2018, despite a modest decrease in the number of contact practices. Other teams had similar or decreased head impact burden. Conclusions Team-based differences in total preseason head impact burden were attributable to changes in daily practice schedule, with longer practice durations and more intense contact practice sessions contributing to increases in daily head impact exposure that, in turn, led to greater preseason head impact burden. Results of this study have highlighted the difficulty in decreasing contact sport head impact exposure through rule changes targeted at limiting on-field team activities. Future efforts aimed specifically at contact practice duration, daily head impact exposure, or limiting time in specific drills may be more effective at reducing total preseason head impact burden.	[Stemper, Brian D.] Marquette Univ & Med Coll Wisconsin, Joint Dept Biomed Engn, Milwaukee, WI USA; [Stemper, Brian D.; Shah, Alok S.; Mccrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Shah, Alok S.; Mccrea, Michael] Zablocki Vet Affairs Med Ctr, Neurosci Res, Milwaukee, WI USA; [Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Harezlak, Jaroslaw; Riggen, Larry D.] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Rowson, Steven; Duma, Stefan] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madision, WI USA; [Cameron, Kenneth L.; Houston, Megan N.] US Army, Keller Army Hosp, John Feagin Jr Sports Med Fellowship, West Point, NY USA; [Giza, Christopher C.; Goldman, Joshua] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.; Goldman, Joshua] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Pediat, Los Angeles, CA 90095 USA; [Jackson, Jonathan; Mcginty, Gerald] US Air Force Acad, Dept Sports Med, Colorado Springs, CO 80840 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Mcallister, Thomas W.] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA		Stemper, BD (corresponding author), Marquette Univ, Dept Biomed Engn, 5000 West Natl Ave,Res 151, Milwaukee, WI 53295 USA.; Stemper, BD (corresponding author), Med Coll Wisconsin, 5000 West Natl Ave,Res 151, Milwaukee, WI 53295 USA.	bstemper@mcw.edu	Stemper, Brian/AAX-7611-2020; Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity, Ford Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Department of Defense (DHP funds)United States Department of Defense; Tisch BrainSPORT program	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). The authors have no other financial conflicts of interest to disclose. UCLA would like to acknowledge the Tisch BrainSPORT program which provided funds to purchase the HIT System for their team. The team would also like to acknowledge the HIT System operators that participated in this study: Julia Ford (University of North Carolina at Chapel Hill), Gus Hendricks (UCLA), Quinn Lukens (University of Wisconsin), Brett Griesemer (Virginia Tech), Alex Black (Virginia Tech), Lewis Young (Virginia Tech), Dom Calhoun (USAFA), and Sean Roach (USMA). Results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The conclusions herein are those of the authors. They do not represent official policy of the Department of the Air Force, Department of the Army, or the Department of Defense. CARE Consortium Investigators are listed alphabetically by institution: April Marie (Reed) Hoy, MS, ATC (Azusa Pacific University); Joseph B. Hazzard Jr, EdD, ATC (Bloomsburg University); Louise A. Kelly, PhD (California Lutheran University); Justus D. Ortega, PhD (Humboldt State University); Nicholas Port, PhD (Indiana University); Margot Putukian MD (Princeton University); T. Dianne Langford, PhD, and Ryan Tierney, PhD, ATC (Temple University); Christopher C. Giza, MD and Joshua T. Goldman, MD, MBA (University of California, Los Angeles); Holly J. Benjamin MD (University of Chicago); Thomas Buckley, EdD, ATC, and Thomas W. Kaminski, PhD, ATC (University of Delaware); James R. Clugston, MD, MS (University of Florida); Julianne D. Schmidt, PhD, ATC (University of Georgia); Luis A. Feigenbaum, DPT, ATC (University of Miami); James T. Eckner, MD, MS (University of Michigan); Kevin Guskiewicz, PhD, ATC, and Jason P. Mihalik, PhD, CAT(C), ATC (University of North Carolina at Chapel Hill); Jessica Dysart Miles, PhD, ATC (University of North Georgia); Scott Anderson, ATC (University of Oklahoma); Christina L. Master, MD (University of Pennsylvania); Micky Collins, PhD, and Anthony P. Kontos, PhD (University of Pittsburgh Medical Center); Jeffrey J. Bazarian, MD, MPH (University of Rochester); Sara P.O. Chrisman, MD, MPH (University of Washington); Alison Brooks, MD, MPH (University of WisconsinMadison); Jonathan Jackson, MD, and Gerald McGinty, DPT (United States Air Force Academy); Patrick O'Donnell, MHA (United States Coast Guard Academy); Kenneth Cameron, PhD, MPH, ATC; Megan N. Houston, PhD, ATC (United States Military Academy); Adam Susmarski, MD (United States Naval Academy); Stefan Duma, PhD and Steve Rowson, PhD (Virginia Tech); Christopher Todd Bullers, MD, and Christopher M. Miles, MD (Wake Forest University); Brian H. Dykhuizen, MS, ATC (Wilmington College); Laura Lintner DO (Winston-Salem University).; Results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. Results of the present study do not constitute endorsement by ACSM.	Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Belson K, 2016, NY TIMES; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Campbell-McGovern C, 2018, INJURY PREV, V24, P319, DOI 10.1136/injuryprev-2018-042831; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; National Collegiate Athletic Association (NCAA), 2016, NCAA DIV I MAN 2016; National Collegiate Athletic Association (NCAA), 2017, NCAA DIV I MAN 2017; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruestow PS, 2015, J OCCUP ENVIRON HYG, V12, P875, DOI 10.1080/15459624.2015.1072632; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	4	4	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2020	52	7					1629	1638		10.1249/MSS.0000000000002283			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MM2EW	WOS:000549971300023	32541378				2022-02-06	
J	Vos, L; Williams, MW; Poritz, JMP; Ngan, E; Leon-Novelo, L; Sherer, M				Vos, Leia; Williams, Michael W.; Poritz, Julia M. P.; Ngan, Esther; Leon-Novelo, Luis; Sherer, Mark			The Discrepancy Between Cognitive Complaints and Neuropsychological Test Findings in Persons With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; depression; traumatic brain injury; validity	IMPAIRED SELF-AWARENESS; EXECUTIVE FUNCTION; CROSS-VALIDATION; DEPRESSION; SYMPTOMS; VALIDITY; DEFICITS; REHABILITATION; ASSOCIATION; PERFORMANCE	Objective: To better identify variables related to discrepancies between subjective cognitive complaints and objective neuropsychological findings in persons with traumatic brain injury (TBI). Setting: Three rehabilitation centers in the United States. Participants: In total, 504 community-dwelling adult survivors of TBI following discharge from inpatient rehabilitation. Design: Prospective cohort observation study. Main Measures: Wechsler Adult Intelligence Scale, Fourth Edition, Digit Span; Rey Auditory Verbal Learning Test; Trail Making Test, Part B; Word Memory Test; Patient Health Questionnaire-9; Neurobehavioral Symptom Inventory; TBI-Quality of Life item bank. Results: Statistical analyses revealed multiple factors associated with subjective-objective discrepancies in attention, memory, and executive functions. Depression was consistently associated with underestimation of cognitive abilities. However, subjective-objective discrepancies varied by cognitive domains in regard to other factors related to underestimation and overestimation of abilities. Conclusions: Reconciling and interpreting subjective-objective discrepancies regarding cognitive functions following TBI are important tasks for case conceptualization and treatment planning. Depression is an important patient characteristic to consider when discrepancy patterns indicate underestimation of cognitive abilities. This study highlights the importance of assessing mood, a modifiable patient characteristic, with self-report symptom inventories. Future studies are needed to connect these findings with TBI outcomes.	[Vos, Leia] Zablocki VA Med Ctr, 5000 W Natl Ave, Milwaukee, WI 53295 USA; [Williams, Michael W.; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Williams, Michael W.] Univ Houston, Dept Psychol, Houston, TX USA; [Poritz, Julia M. P.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Ngan, Esther; Leon-Novelo, Luis] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Vos, L (corresponding author), Zablocki VA Med Ctr, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	Leia.Vos@Va.gov			US Department of Education National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133B090023, H133120020]	This study was partially supported by the US Department of Education National Institute on Disability and Rehabilitation Research grants H133B090023 and H133120020.	APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cicerone K, 1994, ARCH PHYS MED REHAB, V75, P723; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P., 1996, WORD MEMORY TEST USE; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Griffin KW, 1999, PSYCHOL HEALTH, V14, P295, DOI 10.1080/08870449908407329; Haeffel GJ, 2010, AM J PSYCHOL, V123, P181, DOI 10.5406/amerjpsyc.123.2.0181; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hirsch JK, 2012, QUAL LIFE RES, V21, P187, DOI 10.1007/s11136-011-9933-4; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahr Denise, 2007, Cogn Neuropsychiatry, V12, P25, DOI 10.1080/13546800600714791; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; Merema MR, 2013, AM J GERIAT PSYCHIAT, V21, P729, DOI 10.1016/j.jagp.2013.01.059; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Parker HA, 2018, REHABIL PSYCHOL, V63, P595, DOI 10.1037/rep0000243; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Reitan R. M., 1985, HALSTEAD REITAN NEUR, V4; Rey A, 1958, EXAMIN CLINIQUE PSYC; Sawrie SM, 1999, NEUROLOGY, V53, P1511, DOI 10.1212/WNL.53.7.1511; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Sheppard DP, 2019, AIDS BEHAV, V23, P617, DOI 10.1007/s10461-018-2297-9; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Svendsen AM, 2012, NORD J PSYCHIAT, V66, P248, DOI 10.3109/08039488.2011.626870; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wechsler D., 2008, WECHSLER ADULT INTEL, VVol. 22, P498	57	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		E382	E392		10.1097/HTR.0000000000000557			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300013	32108707				2022-02-06	
J	Yao, HM; Williamson, C; Gryak, J; Najarian, K				Yao, Heming; Williamson, Craig; Gryak, Jonathan; Najarian, Kayvan			Automated hematoma segmentation and outcome prediction for patients with traumatic brain injury	ARTIFICIAL INTELLIGENCE IN MEDICINE			English	Article						Traumatic brain injury; Hematoma segmentation; Outcome prediction; Convolutional neural network; Deep learning	INTRACEREBRAL HEMORRHAGE; VOLUME; MANAGEMENT; DIAGNOSIS	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Automated brain hematoma segmentation and outcome prediction for patients with TBI can effectively facilitate patient management. In this study, we propose a novel Multi-view convolutional neural network with a mixed loss to segment total acute hematoma on head CT scans collected within 24h after the injury. Based on the automated segmentation, the volumetric distribution and shape characteristics of the hematoma were extracted and combined with other clinical observations to predict 6-month mortality. The proposed hematoma segmentation network achieved an average Dice coefficient of 0.697 and an intraclass correlation coefficient of 0.966 between the volumes estimated from the predicted hematoma segmentation and volumes of the annotated hematoma segmentation on the test set. Compared with other published methods, the proposed method has the most accurate segmentation performance and volume estimation. For 6-month mortality prediction, the model achieved an average area under the precision-recall curve (AUCPR) of 0.559 and area under the receiver operating characteristic curve (AUC) of 0.853 using 10-fold cross-validation on a dataset consisting of 828 patients. The average AUCPR and AUC of the proposed model are respectively more than 10% and 5% higher than those of the widely used IMPACT model.	[Yao, Heming; Gryak, Jonathan; Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Williamson, Craig] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA		Yao, HM (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	hemingy@umich.edu; craigaw@med.umich.edu; gryakj@med.umich.edu; kayvan@med.umich.edu		Yao, Heming/0000-0001-9020-5330; Gryak, Jonathan/0000-0002-5125-7741			[Anonymous], 2016, MULTISCALE CONTEXT A; Barras CD, 2009, STROKE, V40, P1325, DOI 10.1161/STROKEAHA.108.536888; Bhadauria HS, 2014, SIGNAL IMAGE VIDEO P, V8, P357, DOI 10.1007/s11760-012-0298-0; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Coronado VG, 2012, BRAIN INJ MED PRINC, V84; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Farzaneh Negar, 2017, Annu Int Conf IEEE Eng Med Biol Soc, V2017, P3069, DOI 10.1109/EMBC.2017.8037505; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee Bruce, 2005, NeuroRx, V2, P372; Liao CC, 2010, COMPUT MED IMAG GRAP, V34, P563, DOI 10.1016/j.compmedimag.2010.03.003; Nag MK, 2019, INT J COMPUT ASS RAD, V14, P259, DOI 10.1007/s11548-018-1873-9; Park HK, 2009, J NEUROL SCI, V279, P43, DOI 10.1016/j.jns.2008.12.020; Prakash KNB, 2012, INT J COMPUT ASS RAD, V7, P785, DOI 10.1007/s11548-012-0670-0; Ren H, 2018, INT MICCAI BRAINL WO, P456; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sharma S., 2013, THESIS; Shen Wei, 2015, Inf Process Med Imaging, V24, P588, DOI 10.1007/978-3-319-19992-4_46; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wang CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102326; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zuiderveld K., 2014, GRAPHICS GEMS, V1994, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	31	4	5	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0933-3657	1873-2860		ARTIF INTELL MED	Artif. Intell. Med.	JUL	2020	107								101910	10.1016/j.artmed.2020.101910			14	Computer Science, Artificial Intelligence; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	NH4AV	WOS:000564615100010	32828449	hybrid			2022-02-06	
J	Yu, XC; Azor, A; Sharp, DJ; Ghajari, M				Yu, Xiancheng; Azor, Adriana; Sharp, David J.; Ghajari, Mazdak			Mechanisms of tensile failure of cerebrospinal fluid in blast traumatic brain injury	EXTREME MECHANICS LETTERS			English	Article						Blast injury; Traumatic brain injury; CSF tensile failure; Computational modelling	POSSIBLE DAMAGE MECHANISM; CAVITATION; SYSTEM; MODEL	Mechanisms of blast-induced Traumatic Brain Injury (BTBI), particularly those linked to the primary pressure wave, are still not fully understood. One possible BTBI mechanism is cavitation in the cerebrospinal fluid (CSF) caused by CSF tensile failure, which is likely to increase strain and strain rate in the brain tissue near the CSF. Blast loading of the head can generate rarefaction (expansion) waves and rapid head motion, which both can produce tensile forces in the CSF. However, it is not clear which of these mechanisms is more likely to cause CSF tensile failure. In this study, we used a high-fidelity 3-dimensional computational model of the human head to test whether the CSF tensile failure increases brain deformation near the brain/CSF boundary and to determine the key failure mechanisms. We exposed the head model to a frontal blast wave and predicted strain and strain rate distribution in the cortex. We found that CSF tensile failure significantly increased strain and strain rate in the cortex. We then studied whether the rapid head motion or the rarefaction wave causes strain and strain rate concentration in cortex. We isolated these two effects by conducting simulations with pure head motion loading (i.e. prescribing the skull velocity but eliminating the pressure wave) and pure blast wave loading (i.e. eliminating head motion by fixing the skull base). Our results showed that the strain increase in the cortex was mainly caused by head motion. In contrast, strain rate increase was caused by both rapid head motion and rarefaction waves, but head motion had a stronger effect on elevating strain rate. Our results show that rapid motion of the head produced by blast wave is the key mechanism for CSF tensile failure and subsequent concentration of strain and strain rate in cortex. This finding suggests that mitigation of rapid head motion caused by blast loading needs to be addressed in the design of protective equipment in order to prevent the tensile failure of CSF. (C) 2020 Elsevier Ltd. All rights reserved.	[Yu, Xiancheng; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, London, England; [Yu, Xiancheng; Azor, Adriana; Sharp, David J.; Ghajari, Mazdak] Imperial Coll London, Ctr Blast Injury Studies, London, England; [Azor, Adriana; Sharp, David J.] Imperial Coll London, Computat Cognit & Clin Imaging Lab, London, England; [Sharp, David J.] Imperial Coll London, UK DRI Ctr Care Res & Technol, London, England		Yu, XC (corresponding author), Dyson Bldg,25 Exhibit Rd, London SW7 2DB, England.	x.yu16@imperial.ac.uk		Yu, Xiancheng/0000-0003-4002-3912; Ghajari, Mazdak/0000-0001-5678-5124	Royal British Legion Centre for Blast Injury Studies at Imperial College London; Royal British Legion; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This work was conducted under the auspices of the Royal British Legion Centre for Blast Injury Studies at Imperial College London. The authors would like to acknowledge the financial support of the Royal British Legion.	[Anonymous], 2007, L D K U S MAN 1, V7374, P354; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Brennen C.E., 1995, OXFORD ENG SCI SERIE; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Bustamante MC, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103400; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; GALLOWAY WJ, 1954, J ACOUST SOC AM, V26, P849, DOI 10.1121/1.1907428; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gong CL, 1998, J ACOUST SOC AM, V104, P2675, DOI 10.1121/1.423851; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Hong Y., 2014, CAVITATION INDUCED D; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kleiven S., 2007, SAE TECHNICAL PAPER; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Morrison B., 2003, SAE TECHNICAL PAPER; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nicolle S., 2004, SAE TECHNICAL PAPER; Pan Z, 2017, P NATL ACAD SCI USA, V114, P8470, DOI 10.1073/pnas.1702502114; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Schiffer A, 2012, P ROY SOC A-MATH PHY, V468, P2807, DOI 10.1098/rspa.2012.0076; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Venkatesh B, 1997, J NEUROL SCI, V147, P5, DOI 10.1016/S0022-510X(96)05304-X; Xiong CH, 2019, 2019 WEARABLE ROBOTICS ASSOCIATION CONFERENCE (WEARRACON), P63, DOI 10.1109/WEARRACON.2019.8719401; Yu XC, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3258; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634	35	4	4	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-4316			EXTREME MECH LETT	EXTREME MECH. LETT.	JUL	2020	38								100739	10.1016/j.eml.2020.100739			9	Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science; Mechanics	MA8MF	WOS:000542164200011					2022-02-06	
J	Zheng, P; Tian, XF; Zhang, W; Yang, ZY; Zhou, J; Zheng, J; Cui, HJ; Tang, T; Luo, JK; Wang, Y				Zheng, Piao; Tian, Xuefei; Zhang, Wei; Yang, Zhaoyu; Zhou, Jing; Zheng, Jun; Cui, Hanjin; Tang, Tao; Luo, Jiekun; Wang, Yang			Rhein Suppresses Neuroinflammation via Multiple Signaling Pathways in LPS-Stimulated BV2 Microglia Cells	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; ACTIVATION; NEUROPROTECTION; INFLAMMATION; MECHANISMS; MEDIATORS; DISEASES; HYPOXIA	As a bioactive absorbed compound of rhubarb, Rhein is applied for the treatment of brain injury. However, the underlying pharmacological mechanisms remain unclear. In this study, we aimed to explore antineuroinflammatory functions and underlying mechanisms of Rhein in vitro. BV2 microglia cells were chosen and irritated by LPS. The influence of Rhein on cell viability was determined using MTT assay. We finely gauged the proinflammatory cytokines of TNF-alpha and IL-1 beta through tests of immunofluorescence staining, ELISA, RT-qPCR, and western blot. Additionally, mediators including IL-6, IL-12, iNOS, and IL-10 were surveyed by ELISA. Furthermore, protein levels of the underlying signaling pathways (PI3K/Akt, p38, ERK1/2, and TLR4/NF-kappa B) were tested adopting western blot. We found that Rhein reduced the secretion of pivotal indicators including TNF-alpha and IL-1 beta, effectively restraining their mRNA and protein expression in LPS-activated BV2 microglial cells. Besides, Rhein treatment demoted the production of IL-6, IL-12, and iNOS and promoted the excretion of IL-10. Subsequent mechanistic experiments revealed that Rhein obviously downregulated the phosphorylation levels of PI3K, Akt, p38, and ERK1/2 and simultaneously upregulated the PTEN expression. In addition, Rhein antagonized the increase of TLR4, p-I kappa B alpha, and NF-kappa B. In summary, Rhein suppresses neuroinflammation via multiple signaling pathways (PI3K/Akt, p38, ERK1/2, and TLR4/NF-kappa B) in LPS-stimulated BV2 microglia cells. This study highlights a natural agent for prevention and treatment of neuroinflammation.	[Zheng, Piao; Yang, Zhaoyu; Cui, Hanjin; Tang, Tao; Luo, Jiekun; Wang, Yang] Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China; [Zheng, Piao; Tian, Xuefei; Zhang, Wei] Hunan Univ Chinese Med, Coll Integrated Tradit Chinese & Western Med, Changsha 410208, Hunan, Peoples R China; [Zhou, Jing] Shanxi Prov Hosp Tradit Chinese Med, Shanxi Prov Inst Tradit Chinese Med, Taiyuan 030012, Shanxi, Peoples R China; [Zheng, Jun] Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China.	zhengpiao9141@hotmail.com; 003640@hnucm.edu.cn; zhangwei1979@hnucm.edu.cn; 348096639@qq.com; 617494717@qq.com; zhengjun@csu.edu.cn; cuihanjin@csu.edu.cn; tangtaotay@csu.edu.cn; luojk4314131@163.com; wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303074, 81673719, 81774032]; Outstanding Youth Foundation of Hunan Provincial Natural Science Foundation of China [2019JJ30042]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2018JJ6142]	The authors would like to extend their sincere gratitude to Yuzuru Hanyu, the figure skater, for his pursuit of competitive sports and his spirit of overcoming difficulties in adversity, which brought support and motivation to their research. This work was supported by the National Natural Science Foundation of China (Grant nos. 81303074, 81673719, and 81774032), the Outstanding Youth Foundation of Hunan Provincial Natural Science Foundation of China (Grant no. 2019JJ30042), and Hunan Provincial Natural Science Foundation of China (Grant no. 2018JJ6142).	Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Averbeck B, 2001, NEUROPHARMACOLOGY, V40, P416, DOI 10.1016/S0028-3908(00)00171-4; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Bachstetter AD, 2010, AGING DIS, V1, P199; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Bueno D, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0029-y; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Depino A, 2005, J NEUROIMMUNOL, V168, P96, DOI 10.1016/j.jneuroim.2005.07.009; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Jung JS, 2017, J AGR FOOD CHEM, V65, P373, DOI 10.1021/acs.jafc.6b05147; Kaminska B, 2016, BBA-MOL BASIS DIS, V1862, P339, DOI 10.1016/j.bbadis.2015.10.026; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee H, 2017, BIOCHEM SOC T, V45, P131, DOI 10.1042/BST20160262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; McIntosh TK, 1996, LAB INVEST, V74, P315; Narayanankutty A, 2019, CURR DRUG TARGETS, V20, P1068, DOI 10.2174/1389450120666190222181506; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Savarin C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0293-9; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sun H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00247; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Y, 2015, J SEP SCI, V38, P1100, DOI 10.1002/jssc.201401197; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11822	38	4	4	4	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.	JUN 29	2020	2020								7210627	10.1155/2020/7210627			12	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	MQ3NP	WOS:000552803800008	32714414	Green Published, gold			2022-02-06	
J	Manninen, E; Chary, K; Lapinlampi, N; Andrade, P; Paananen, T; Sierra, A; Tohka, J; Grohn, O; Pitkanen, A				Manninen, Eppu; Chary, Karthik; Lapinlampi, Niina; Andrade, Pedro; Paananen, Tomi; Sierra, Alejandra; Tohka, Jussi; Grohn, Olli; Pitkanen, Asla			Early Increase in Cortical T(2)Relaxation Is a Prognostic Biomarker for the Evolution of Severe Cortical Damage, but Not for Epileptogenesis, after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						common data element; epilepsy; lateral fluid-percussion injury; magnetic resonance imaging; rat; video-electroencephalography monitoring	POSTTRAUMATIC EPILEPSY; ELECTRICAL-STIMULATION; MRI; SEIZURE; MODEL; IMAGE; RISK	Prognostic biomarkers for post-injury outcome are necessary for the development of neuroprotective and antiepileptogenic treatments for traumatic brain injury (TBI). We hypothesized that T(2)relaxation magnetic resonance imaging (MRI) predicts the progression of perilesional cortical pathology and epileptogenesis. The EPITARGET animal cohort used for MRI analysis included 120 adult male Sprague-Dawley rats with TBI induced by lateral fluid-percussion injury and 24 sham-operated controls. T2MRI was performed at days 2, 7, and 21 post-TBI. The lesioned cortex was outlined, and the T(2)value of each imaging voxel within the lesion area was scored using a five-grade pathology classification. Analysis of 1-month video-electroencephalography recordings initiated 5 months post-TBI indicated that 27% (31 of 114) of the animals with TBI developed epilepsy. Multiple linear regression analysis indicated that T-2-based classification of lesion volume at day 2 and day 7 post-TBI explained the necrotic lesion volume with greatly increased T-2(>102 ms) at day 21 post-TBI (F-(13,F-103) = 52.5;p < 0.001;R-2 = 0.87; adjustedR(2) = 0.85). The volume of moderately increased (78-102 ms) T(2)at day 7 post-TBI predicted the evolution of large (>12 mm(3)) cortical lesions (area under the curve, 0.92;p < 0.001; cutoff, 1.9 mm(3); false positive rate, 0.10; true positive rate, 0.62). Logistic regression analysis, however, showed that the different severities of T(2)lesion volumes at days 2, 7, and 21 post-TBI did not explain the development of epilepsy (chi(2)((18,95)) = 18.4;p = 0.427). In addition, the location of the T(2)abnormality within the cortex did not correlate with epileptogenesis. A single measurement of T(2)relaxation MRI in the acute post-TBI phase is useful for identifying post-TBI subjects at highest risk of developing large cortical lesions, and thus, in the greatest need of neuroprotective therapies after TBI, but not the development of post-traumatic epilepsy.	[Manninen, Eppu; Chary, Karthik; Lapinlampi, Niina; Andrade, Pedro; Paananen, Tomi; Sierra, Alejandra; Tohka, Jussi; Grohn, Olli; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018; Tohka, Jussi/D-2385-2013	Andrade, Pedro/0000-0001-9118-8341; Tohka, Jussi/0000-0002-1048-5860; Chary, Karthik Sampath Kumar/0000-0002-1539-3463; Manninen, Eppu/0000-0002-9353-6079	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909]; European UnionEuropean Commission [602102]; Academy of FinlandAcademy of FinlandEuropean Commission [284544, 312686, 275453]	This study was supported by the Medical Research Council of the Academy of Finland (grants 272249 and 273909) and by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602102 (EPITARGET). Alejandra Sierra wants to thank Academy of Finland for funding support (#284544; #312686, and #275453).	Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baulac M., 2008, EPILEPSIA, V50, P571, DOI [10.1111/j.1528-1167.2008.01811.x, DOI 10.1111/J.1528-1167.2008.01811.X]; Becker C, 2019, EPILEPSIA, V60, P648, DOI 10.1111/epi.14692; Becker C, 2015, ANN NEUROL, V78, P128, DOI 10.1002/ana.24414; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kelley Melinda S, 2009, Epilepsia, V50, P579, DOI 10.1111/j.1528-1167.2008.01813.x; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P465, DOI 10.1016/B978-012088554-1/50039-6; Pitkanen A, 2019, EPILEPSIA, V60, P1281, DOI 10.1111/epi.16091; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/BMM.11.67, 10.2217/bmm.11.67]; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Wang X, 2016, EPILEPSY RES, V128, P35, DOI 10.1016/j.eplepsyres.2016.10.002; World Health Organization (WHO), 2019, EPILEPSY	45	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2580	2594		10.1089/neu.2019.6796		JUN 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547537600001	32349620				2022-02-06	
J	Johnson, SL; Iannucci, J; Seeram, NP; Grammas, P				Johnson, Shelby L.; Iannucci, Jaclyn; Seeram, Navindra P.; Grammas, Paula			Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson's disease	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Parkinson's disease; Dabigatran; Oxidative stress	DOPAMINERGIC-NEURONS; SEX-DIFFERENCES; DEGENERATION; NEUROINFLAMMATION; INFLAMMATION; ACTIVATION; DAMAGE	Parkinson's disease (PD) is a complex neurodegenerative disease characterized by the presence of tremors, loss of dopaminergic neurons and accumulation of alpha-synuclein. While there is no single direct cause of PD, genetic mutations, exposure to pesticides, diet and traumatic brain injury have been identified as risk factors. Increasing evidence suggests that oxidative stress and neuroinflammation contribute to the pathogenesis of neuronal injury in neurodegenerative diseases such as PD and Alzheimer's disease (AD). We have previously documented that the multifunctional inflammatory mediator thrombin contributes to oxidative stress and neuroinflammation in AD. Here, for the first time, we explore the role of thrombin in a transgenic PD model, the LRRK2 mutant Drosophila melanogaster. Transgenic flies were treated with the direct thrombin inhibitor dabigatran for 7 days and locomotor activity and indices of oxidative stress evaluated. Our data show that dabigatran treatment significantly (p < 0.05) improved climbing activity, a measurement of locomotor ability, in male but had no effect on locomotor performance in female flies. Dabigatran treatment had no effect on tyrosine hydroxylase levels. Analysis of oxidative stress in male flies showed that dabigatran was able to significantly (p < 0.01) lower reactive oxygen species levels. Furthermore, Western blot analysis showed that the pro-oxidant proteins iNOS and NOX4 are elevated in LRRK2 male flies compared to wildtype and that treatment with dabigatran reduced expression of these proteins. Our results indicate that dabigatran treatment could improve motor function in PD by reducing oxidative stress. These data suggest that targeting thrombin may improve oxidative stress related pathologies in PD. (C) 2020 Elsevier Inc. All rights reserved.	[Johnson, Shelby L.; Iannucci, Jaclyn; Seeram, Navindra P.; Grammas, Paula] Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA; [Johnson, Shelby L.; Iannucci, Jaclyn; Seeram, Navindra P.; Grammas, Paula] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA		Johnson, SL (corresponding author), 7 Greenhouse Rd, Kingston, RI 02881 USA.	shelby_johnson@uri.edu		Iannucci, Jaclyn/0000-0002-7431-7882; Johnson, Shelby L/0000-0002-9161-3202	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS110628-01]; National Institute of General Medical Sciences of the National Institutes [P20GM103430]	This research was funded by National Institutes of Health grant number 1R21NS110628-01. Research was made possible by the use of Spectramax and LiCor Odyssey available through the Rhode Island Institutional Development Award (IDeA) Network of Research Excellence from the National Institute of General Medical Sciences of the National Institutes under grant number P20GM103430.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cerri S, 2019, J PARKINSON DIS, V9, P501, DOI 10.3233/JPD-191683; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Choi SH, 2003, J NEUROSCI, V23, P5877; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; De Nobrega AK, 2020, EUR J NEUROSCI, V51, P454, DOI 10.1111/ejn.14176; De Rose F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146140; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Emery Patrick, 2007, Methods Mol Biol, V362, P375; Fakhoury M, 2018, CURR NEUROPHARMACOL, V16, P508, DOI 10.2174/1570159X15666170720095240; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grammas P, 2006, J ALZHEIMERS DIS, V9, P51; Hamill CE, 2007, MOL PHARMACOL, V72, P653, DOI 10.1124/mol.107.038158; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Johnson SL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091139; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kandil EA, 2018, MOL NEUROBIOL, V55, P4078, DOI 10.1007/s12035-017-0636-x; Kaur K, 2017, J NEUROL SCI, V381, P308, DOI 10.1016/j.jns.2017.08.3251; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Marras C, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0058-0; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Phom L, 2014, REJUV RES, V17, P481, DOI 10.1089/rej.2014.1591; Poetini MR, 2018, CHEM-BIOL INTERACT, V279, P177, DOI 10.1016/j.cbi.2017.11.018; Rane P, 2019, ACS CHEM NEUROSCI, V10, P44, DOI 10.1021/acschemneuro.8b00180; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Rugbjerg K, 2013, PARKINSONISM RELAT D, V19, P457, DOI 10.1016/j.parkreldis.2013.01.008; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Siani F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00306; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Subhramanyam CS, 2019, SEMIN CELL DEV BIOL, V94, P112, DOI 10.1016/j.semcdb.2019.05.004; Tripathy D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00019; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Zhu XW, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-17	50	4	4	1	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUN 25	2020	527	2					532	538		10.1016/j.bbrc.2020.04.068			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	LR8TN	WOS:000535969500031	32423817				2022-02-06	
J	Kumar, RG; DiSanto, D; Awan, N; Vaughan, LE; Levochkina, MS; Weppner, JL; Wright, DW; Berga, SL; Conley, YP; Brooks, MM; Wagner, AK				Kumar, Raj G.; DiSanto, Dominic; Awan, Nabil; Vaughan, Leah E.; Levochkina, Marina S.; Weppner, Justin L.; Wright, David W.; Berga, Sarah L.; Conley, Yvette P.; Brooks, Maria M.; Wagner, Amy K.			Temporal Acute Serum Estradiol and Tumor Necrosis Factor-alpha Associations and Risk of Death after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						estradiol; non-neurological organ dysfunction; systemic trauma complex; traumatic brain injury; tumor necrosis factor-alpha	MESSENGER-RNA EXPRESSION; ADIPOSE STROMAL CELLS; TNF-ALPHA; CEREBROSPINAL-FLUID; ORGAN DYSFUNCTION; HEMORRHAGIC-SHOCK; GENE-EXPRESSION; AROMATASE GENE; HORMONE-LEVELS; PROGESTERONE	Severe traumatic brain injury (TBI) activates a robust systemic response that involves inflammatory and other factors, including estradiol (E2), associated with increased deaths. Tumor necrosis factor-alpha (TNF alpha) is a significant mediator of systemic shock, and it is an extra-gonadal transcription factor for E2 production. The study objectives were to test the hypotheses: (1) a positive feedback relationship exists between acute serum TNF alpha and E2; and (2) acute concentrations of E2 and TNF alpha are prognostic indicators of death after severe TBI. This prospective cohort study included N = 157 adults with severe TBI. Serum samples were collected for the first five days post-injury. The TNF alpha and E2 levels were averaged into two time epochs: first 72 h (T1) and second 72 h post-injury (T2). A cross-lag panel analysis conducted between T1 and T2 TNF alpha and E2 levels showed significant cross-lag effects: T1 TNF alpha and T1 E2 were related to T2 E2 and T2 TNF alpha, respectively. Cox proportional hazards multi variable regression models determined that increases in T1 E2 (hazard ratio [HR] = 1.79, 95% confidence interval [CI]: 1.15, 2.81), but not T2 E2 (HR = 0.91, 95% CI: 0.56, 1.47), were associated with increased risk of death. Increased T2 TNF alpha (HR = 2.47, 95% CI: 1.35, 4.53), and T1 TNF alpha (HR = 1.47, 95% CI: 0.99, 2.19), to a lesser degree, were associated with increased risk of death. Relationships of death with T2 TNF alpha and T1 E2 were mediated partially by cardiovascular, hepatic, and renal dysfunction. Both E2 and TNF alpha are systemic, reciprocally related biomarkers that may be indicative of systemic compromise and increased risk of death after severe TBI.	[Kumar, Raj G.; DiSanto, Dominic; Vaughan, Leah E.; Levochkina, Marina S.; Weppner, Justin L.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Kumar, Raj G.; Brooks, Maria M.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Awan, Nabil] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wright, David W.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Berga, Sarah L.] Univ Utah, Dept Reprod Endocrinol, Salt Lake City, UT USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil & Neurosci, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	Wagnerak@upmc.edu		DiSanto, Dominic/0000-0002-8815-2169; Conley, Yvette/0000-0002-1784-6067	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01NS030318, TL1 TR001858]; CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]; DODUnited States Department of Defense [W81XWH-071-0701]; NIDILRRUnited States Department of Health & Human Services [90DP0041]	Parts of this article's analyses and writing were previously included in the first author's dissertation in the University of Pittsburgh, Graduate School of Public Health's Department of Epidemiology. The authors acknowledge the UPMC Trauma Registry team for their role in clinical data collection. This work was supported in part by NIH 5P01NS030318, CDC R49 CCR 323155, DOD W81XWH-071-0701, NIDILRR 90DP0041, NIH TL1 TR001858.	Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; [Anonymous], SAS 9 4; Azcoitia I, 2011, NEUROSCIENCE, V191, P139, DOI 10.1016/j.neuroscience.2011.02.012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Dossett LA, 2008, SURG INFECT, V9, P41, DOI 10.1089/sur.2007.037; Edwards P, 2005, LANCET, V365, P1957; Egami R, 2005, EUR J PHARMACOL, V520, P142, DOI 10.1016/j.ejphar.2005.07.028; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Garban HJ, 2004, J CARDIOVASC PHARM, V43, P638, DOI 10.1097/00005344-200405000-00005; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Gilbert K, 2019, J TRAUMA ACUTE CARE, V86, P431, DOI 10.1097/TA.0000000000002152; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Jiang JX, 1997, SHOCK, V7, P206, DOI 10.1097/00024382-199703000-00009; Johns DG, 1998, AM J PHYSIOL-HEART C, V275, pH1592, DOI 10.1152/ajpheart.1998.275.5.H1592; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kemp CD, 2008, AM SURGEON, V74, P866; Kumar R., 2014, J NEUROTRAUM, V32, pA92; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lilley E, 2015, SHOCK, V43, P304, DOI 10.1097/SHK.0000000000000318; Liu MD, 2014, CHIN J TRAUMATOL, V17, P317, DOI 10.3760/cma.j.issn.1008-1275.2014.06.003; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Maier B, 2005, J NEUROTRAUM, V22, P822, DOI 10.1089/neu.2005.22.822; Mair KM, 2014, BRIT J PHARMACOL, V171, P567, DOI 10.1111/bph.12281; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; MATTILA P, 1992, SCAND J IMMUNOL, V36, P159, DOI 10.1111/j.1365-3083.1992.tb03087.x; MAYER LS, 1986, J BUS ECON STAT, V4, P347; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; OFFNER F, 1990, J LAB CLIN MED, V116, P100; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pinto S.M., 2018, ARCH PHYS MED REHAB, V99, pe46; Rakholia MV, 2019, J NEUROTRAUM, V36, P1156, DOI 10.1089/neu.2018.5782; Ranganathan P, 2019, J NEUROTRAUM, V36, P538, DOI 10.1089/neu.2018.5677; Rijnhart JJM, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-018-0654-z; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Selig J.P., 2012, B LAURSEN LITTLE TD; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Simpson ER, 2004, SEMIN REPROD MED, V22, P11; Simpson ER, 1997, RECENT PROG HORM RES, V52, P185; SIMPSON ER, 1993, J STEROID BIOCHEM, V44, P321, DOI 10.1016/0960-0760(93)90235-O; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; StataCorp, 2017, STATACORP; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; STRIETER RM, 1993, CRIT CARE MED, V21, pS447, DOI 10.1097/00003246-199310001-00006; TEASDALE G, 1974, LANCET, V2, P81; Tep-areenan P, 2003, EUR J PHARMACOL, V476, P139, DOI 10.1016/S0014-2999(03)02152-6; Thurman DJ, 2001, HEAD TRAUMA, P327; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Ullman J.S., 2016, GUIDELINES MANAGEMEN; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yokoyama Yukihiro, 2003, Curr Opin Crit Care, V9, P137, DOI 10.1097/00075198-200304000-00010; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340; ZHAO Y, 1995, J BIOL CHEM, V270, P16449, DOI 10.1074/jbc.270.27.16449; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350; Zhou KW, 2013, MOL HUM REPROD, V19, P169, DOI 10.1093/molehr/gas044; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zolin SJ, 2015, J TRAUMA ACUTE CARE, V78, P451, DOI 10.1097/TA.0000000000000550; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	89	4	4	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2198	2210		10.1089/neu.2019.6577		JUN 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000544399100001	32375598	Green Published			2022-02-06	
J	Inyang, E; Kuriakose, AE; Chen, B; Nguyen, KT; Cho, M				Inyang, Edidiong; Kuriakose, Aneetta Elizabeth; Chen, Bo; Kytai Truong Nguyen; Cho, Michael			Engineering Delivery of Nonbiologics Using Poly(lactic-co-glycolic acid) Nanoparticles for Repair of Disrupted Brain Endothelium	ACS OMEGA			English	Article							CONTROLLED DRUG-DELIVERY; ISCHEMIA-REPERFUSION INJURY; GLUCOSE-TRANSPORTER; RELEASE; BARRIER; PLGA; MOLECULES; DISCOVERY; JUNCTIONS; SELECTIN	Traumatic brain injury (TBI) is known to alter the structure and function of the blood-brain barrier (BBB). Blunt force or explosive blast impacting the brain can cause neurological sequelae through the mechanisms that remain yet to be fully elucidated. For example, shockwaves propagating through the brain have been shown to create a mechanical trauma that may disrupt the BBB. Indeed, using tissue engineering approaches, the shockwave-induced mechanical injury has been shown to modulate the organization and permeability of the endothelium tight junctions. Because an injury to the brain endothelium typically induces a high expression of Eselectin, we postulated that upregulation of this protein after an injury can be exploited for diagnosis and potential therapy through targeted nanodelivery to the injured brain endothelium. To test this hypothesis, we engineered poly(lactic-co-glycolic acid) (PLGA) nanoparticles to encapsulate therapeutic nonbiologics and decorated them with ligands to specifically target the E-selectin. A high level of the conjugated nanoparticles was found inside the injured cells. Repair of the injury site was then quantitatively measured and analyzed. To summarize, exploiting the tunable properties of PLGA, a targeted drug delivery strategy has been developed and validated, which combines the specificity of ligand/ receptor interaction with therapeutic reagents. Such a strategy could be used to provide a potential theragnostic approach for the treatment of modulated brain endothelium associated with TBI.	[Inyang, Edidiong; Kuriakose, Aneetta Elizabeth; Chen, Bo; Kytai Truong Nguyen; Cho, Michael] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA		Cho, M (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA.	michael.cho@uta.edu		Cho, Myoung Rae/0000-0002-8191-8045	Office of Naval ResearchOffice of Naval Research [N00014-16-1-2140]; NIH F31 Ruth L. Kirschstein Predoctoral Individual National Research Service AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was supported by a grant (N00014-16-1-2140) from the Office of Naval Research. Edidiong Inyang was a Louis Stokes Alliance for Minority Participation (LSAMP) Fellow. A.E.K. is supported by a NIH F31 Ruth L. Kirschstein Predoctoral Individual National Research Service Award.	Bharadwaj VN, 2018, NANOMED-NANOTECHNOL, V14, P2155, DOI 10.1016/j.nano.2018.06.004; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Bony BA, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11090473; Budhian A, 2008, INT J PHARMACEUT, V346, P151, DOI 10.1016/j.ijpharm.2007.06.011; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen B, 2019, ACS APPL MATER INTER, V11, P4889, DOI 10.1021/acsami.8b21410; Cheng K, 2010, NANO TODAY, V5, P183, DOI 10.1016/j.nantod.2010.04.002; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Cohen-Sela E, 2009, J CONTROL RELEASE, V133, P90, DOI 10.1016/j.jconrel.2008.09.073; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f; Dwivedi C, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11040180; Elgindy EA, 2010, REPROD BIOMED ONLINE, V20, P789, DOI 10.1016/j.rbmo.2010.03.001; FARRELL CL, 1992, J HISTOCHEM CYTOCHEM, V40, P193, DOI 10.1177/40.2.1552163; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6; Impellizzeri D, 2014, EXPERT OPIN THER TAR, V18, P55, DOI 10.1517/14728222.2013.841140; Inyang E., 2020, SCI REP, P3054; Kanagaraj J, 2018, ANN BIOMED ENG, V46, P354, DOI 10.1007/s10439-017-1953-y; Kona S, 2012, INT J PHARMACEUT, V423, P516, DOI 10.1016/j.ijpharm.2011.11.043; Kuriakose AE, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00353; Leibrock L, 2019, TOXICOL RES-UK, V8, P1016, DOI 10.1039/c9tx00179d; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Maskarinec SA, 2005, ANN NY ACAD SCI, V1066, P310, DOI 10.1196/annals.1363.018; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Menon JU, 2014, ACTA BIOMATER, V10, P2643, DOI 10.1016/j.actbio.2014.01.033; Mizuno N, 2003, PHARMACOL REV, V55, P425, DOI 10.1124/pr.55.3.1; Mokhtari V, 2017, CELL J, V19, P11; Moura CC, 2014, INT J NANOMED, V9, P4911, DOI 10.2147/IJN.S68440; Murphy AD, 2010, PLAST RECONSTR SURG, V125, P1651, DOI 10.1097/PRS.0b013e3181ccdbef; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Singh A.V., 2018, VEINS LYMPHATICS, V7, DOI [10.4081/vl.2018.7196, DOI 10.4081/VL.2018.7196]; Steinhardt RA, 2006, CORNEA, V25, P839, DOI 10.1097/01.ico.0000224638.51224.c1; Sun Y, 2015, LASER MED SCI, V30, P127, DOI 10.1007/s10103-014-1619-z; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Van Kampen C, 2001, VET IMMUNOL IMMUNOP, V79, P151, DOI 10.1016/S0165-2427(01)00249-5; Verma A, 2017, WIRES DATA MIN KNOWL, V7, DOI 10.1002/widm.1196; Walters TJ, 2011, J TRAUMA, V70, P1192, DOI 10.1097/TA.0b013e318217879a; Xie J, 2010, ADV DRUG DELIVER REV, V62, P1064, DOI 10.1016/j.addr.2010.07.009; Xu H, 2013, J CARDIOVASC TRANSL, V6, P570, DOI 10.1007/s12265-013-9460-5; Yang B, 2016, CURR DRUG DELIV, V13, P1261, DOI 10.2174/1567201813666160418105703; zur Muhlen A, 1998, EUR J PHARM BIOPHARM, V45, P149, DOI 10.1016/S0939-6411(97)00150-1	45	4	4	4	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	JUN 23	2020	5	24					14730	14740		10.1021/acsomega.0c01517			11	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	MD1MY	WOS:000543740600055	32596610	gold, Green Published			2022-02-06	
J	Hanafy, S; Amodio, V; Haag, H; Colquhoun, H; Lewko, J; Quilico, E; Riopelle, R; Archambault, P; Colantonio, A; Lindsay, S; Mollayeva, T				Hanafy, Sara; Amodio, Vanessa; Haag, Halina (Lin); Colquhoun, Heather; Lewko, John; Quilico, Enrico; Riopelle, Richard; Archambault, Patrick; Colantonio, Angela; Lindsay, Sally; Mollayeva, Tatyana			Is it prime time for sex and gender considerations in traumatic brain injury? Perspectives of rehabilitation care professionals	DISABILITY AND REHABILITATION			English	Article; Early Access						Brain injuries; traumatic; rehabilitation; sex; gender identity; social determinants of health	QUALITATIVE RESEARCH; HEALTH; OUTCOMES; EXPERIENCES; PREVALENCE; PREDICTORS; ADULTS	Purpose:The purpose of this study was to explore rehabilitation clinicians' understanding of how sex and gender facilitate or hinder care provided to patients with traumatic brain injury (TBI). Materials and methods:Sixteen clinicians from various specialities, attending to patients with TBI from a large rehabilitation hospital in Ontario, Canada, were recruited using purposive sampling. Data was collected through semi-structured interviews and thematic analysis was used to identify reoccurring themes. Results:Three themes that facilitate or hinder care of TBI patients were identified: (1) knowledge and evidence; (2) gender and other aspects of recovery; and (3) family caregiving. Lack of education about the topic and inconsistent scientific evidence limited clinicians' attention to sex and gender topics. Social, financial, and cultural characteristics of patients were considered to be more relevant than their sex and gender. The gendered nature of caregiving and its burden on caregivers' health were acknowledged. Conclusions:Currently, attention to topics of sex and gender as they may influence patients' recovery is limited. However, clinicians are willing to be educated on these topics to enhance rehabilitation care. Further research on the gendered nature of interactions between patient, clinician, and family caregiver during recovery is warranted.	[Hanafy, Sara; Colquhoun, Heather; Quilico, Enrico; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Hanafy, Sara; Amodio, Vanessa; Colantonio, Angela; Mollayeva, Tatyana] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Hanafy, Sara; Amodio, Vanessa; Haag, Halina (Lin); Quilico, Enrico; Colantonio, Angela; Mollayeva, Tatyana] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Hanafy, Sara; Lindsay, Sally] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Haag, Halina (Lin)] Wilfrid Laurier Univ, Fac Social Work, Waterloo, ON, Canada; [Colquhoun, Heather; Colantonio, Angela; Lindsay, Sally] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lewko, John] Laurentian Univ, Ctr Res Human Dev, Sudbury, ON, Canada; [Riopelle, Richard] Brain Injury Canada, Ottawa, ON, Canada; [Archambault, Patrick] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada		Hanafy, S (corresponding author), Univ Toronto, KITE Toronto Rehab Univ Hlth Network, Rehabil Sci Inst, 550 Univ Ave,Room 11-127, Toronto, ON M5G 2A2, Canada.	sara.hanafy@mail.utoronto.ca	, Mollayeva/A-4522-2018	Archambault, Patrick/0000-0002-5090-6439	Canadian Institutes of Health Research, Institute of Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	This work was supported by a research grant from the Canadian Institutes of Health Research, Institute of Gender and Health [#CGW-126580].	American Psychological Association, 2018, APA GUID PSYCH PRACT; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Brain Injury Association of America, 2019, BRAIN INJ BRAIN INJ; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Canadian Institutes of Health Research (CIHR), 2019, SCI IS BETT SEX GEND; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Chin EL, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0091-9; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; Disabled Women's Network Canada, 2019, OUR HLTH MATT; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Frier A, 2017, DISABIL REHABIL, V39, P941, DOI 10.3109/09638288.2016.1172672; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Government of Canada, 2019, CONC SYMPT TREATM; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Mollayeva T, 2021, DISABIL REHABIL, V43, P1872, DOI 10.1080/09638288.2019.1683235; Mollayeva T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024674; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Muntinga ME, 2016, ADV HEALTH SCI EDUC, V21, P541, DOI 10.1007/s10459-015-9650-9; National Institutes of Health (NIH), SEX GENDER; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Ontario Neurotrauma Foundation, 2017, GUID CONC MILD TRAUM; Ontario Neurotrauma Foundation, 2015, CLIN PRACT GUID REH; Pink concussions, FEM BRAIN INJ SPORTS; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sansonetti D, 2018, AUST OCCUP THER J, V65, P512, DOI 10.1111/1440-1630.12492; Sav A, 2019, PITUITARY, V22, P201, DOI 10.1007/s11102-019-00958-8; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Singer RR, 2013, PROF PSYCHOL-RES PR, V44, P290, DOI 10.1037/a0034299; SUE DW, 1992, J MULTICULT COUNS D, V20, P64, DOI DOI 10.1002/J.2161-1912.1992.TB00563.X; Swaine B, 2015, ANN PHYS REHABIL MED, V58, pe143; Taylor E, 2014, DISABIL REHABIL, V36, P2127, DOI 10.3109/09638288.2014.892636; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tuval-Mashiach Rivka, 2017, QUALITATIVE PSYCHOL, V4, P126, DOI DOI 10.1037/QUP0000062; Verma Sarita, 2006, J Allied Health, V35, P109	51	4	4	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1774670		JUN 2020	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MI3MZ	WOS:000547316000001	32574090				2022-02-06	
J	Gao, Y; Ma, LL; Liang, F; Zhang, Y; Yang, L; Liu, XH; Yang, J				Gao, Yu; Ma, Linlin; Liang, Fang; Zhang, Yi; Yang, Lin; Liu, Xuehua; Yang, Jing			The use of amantadine in patients with unresponsive wakefulness syndrome after severe cerebral hemorrhage	BRAIN INJURY			English	Article						Amantadine; unresponsive wakefulness syndrome; cerebral hemorrhage	MINIMALLY CONSCIOUS STATE; TRAUMATIC BRAIN-INJURY; CASE-FATALITY	Background Amantadine is currently recommended for use in patients of post-traumatic brain injury with unresponsive wakefulness syndrome (UWS). However, the application of amantadine in UWS after cerebral hemorrhage has only been rarely reported. This allows for a further exploration of the role of amantadine in the treatment of UWS resulting from a severe cerebral hemorrhage. Methods We observed the changes of seven patients with UWS of intracerebral hemorrhage after taking amantadine. We also carried out a detailed neurological examination of the patient with disorders of consciousness to include or exclude subjects for the study. CRS-R score was used to evaluate the neurological recovery. Results An improvement in consciousness was observed within 3-6 days after the start of amantadine administration in all seven cases (n = 7/7; 100%). Five patients recovered conscious and left aphasia, hemiplegia and other sequelae, and two patients recovered from UWS to minimally conscious state (MCS). Conclusions In this study, amantadine administration showed substantial positive effects on recovery following severe cerebral hemorrhage. We recommend further randomized controlled studies to determine the efficacy of amantadine.	[Gao, Yu; Ma, Linlin; Liang, Fang; Zhang, Yi; Yang, Lin; Liu, Xuehua; Yang, Jing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen Med, Beijing, Peoples R China		Yang, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen Med, Beijing, Peoples R China.	yangjing20170@qq.com					Avecillas-Chasin JM, 2014, ACTA NEUROCHIR, V156, P1375, DOI 10.1007/s00701-014-2077-x; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Clauss RP, 2010, MED HYPOTHESES, V75, P287, DOI 10.1016/j.mehy.2010.03.005; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Lai S, 1994, NEW ENGL J MED, V330; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lehnerer Sophie Mirabell, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-220305; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schneider WN, 1999, BRAIN INJURY, V13, P863	15	4	4	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1084	1088		10.1080/02699052.2020.1780315		JUN 2020	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000545735400001	32552090				2022-02-06	
J	Shah, EJ; Gurdziel, K; Ruden, DM				Shah, Ekta J.; Gurdziel, Katherine; Ruden, Douglas M.			DrosophilaExhibit Divergent Sex-Based Responses in Transcription and Motor Function After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						TBI; immune; mitochondria; sex-differences; bimodal recovery	INNATE IMMUNE-RESPONSE; LONG NONCODING RNA; MITOCHONDRIAL BIOGENESIS; ALZHEIMERS-DISEASE; GENDER-DIFFERENCES; MELANOGASTER; ACTIVATION; EXPRESSION; MODELS; GENE	Every year, millions of people in the US suffer brain damage from mild to severe traumatic brain injuries (TBI) that result from a sudden impact to the head. Despite TBI being a leading cause of death and disability worldwide, sex differences that contribute to varied outcomes post-injury are not extensively studied and therefore, poorly understood. In this study, we aimed to explore biological sex as a variable influencing response to TBI usingDrosophila melanogasteras a model, since flies have been shown to exhibit symptoms commonly seen in other mammalian models of TBI. After inflicting TBI using the high-impact trauma device, we isolatedw(1118)fly brains and assessed gene transcription changes in male and female flies at control and 1, 2, and 4 hr after TBI. Our results suggest that overall,Drosophilafemales show more gene transcript changes than males. Females also exhibit upregulated expression changes in immune response and mitochondrial genes across all time-points. In addition, we looked at the impact of injury on mitochondrial health and motor function in both sexes before and after injury. Although both sexes report similar changes in mitochondrial oxidation and negative geotaxis, locomotor activity appears to be more impaired in males than females. These data suggest that sex-differences not only influence the response to TBI but also contribute to varied outcomes post-injury.	[Shah, Ekta J.; Ruden, Douglas M.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Gurdziel, Katherine; Ruden, Douglas M.] Wayne State Univ, Off Vice President Res, Detroit, MI 48201 USA; [Ruden, Douglas M.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA		Ruden, DM (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.; Gurdziel, K; Ruden, DM (corresponding author), Wayne State Univ, Off Vice President Res, Detroit, MI 48201 USA.; Ruden, DM (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA.	gurdziel@wayne.edu; douglasr@wayne.edu	Ruden, Douglas/ABE-1418-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01ES012933, 5P30ES020957, 1UG3OD023285]; Office of the Vice President for Research at Wayne State University	This work was funded by the National Institutes of Health [Grant Nos. 5R01ES012933 (DR), 5P30ES020957 (DR), and 1UG3OD023285 (DR)]. In addition, the Office of the Vice President for Research at Wayne State University provided pilot funds for DR.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Aggarwal A, 2019, P NATL ACAD SCI USA, V116, P24830, DOI 10.1073/pnas.1807456116; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Bardai FH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006265; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barone MC, 2013, JOVE-J VIS EXP, DOI 10.3791/50339; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; Chauhan V, 2019, BEHAV BRAIN FUNCT, V15, DOI 10.1186/s12993-019-0163-1; Ciuffreda KJ., 2016, ADV OPHTHALMOL OPTOM, V1, P307, DOI [10.1016/j.yaoo.2016.03.013, DOI 10.1016/J.YAOO.2016.03.013]; COBB M, 1987, ANIM BEHAV, V35, P705, DOI 10.1016/S0003-3472(87)80106-9; COOK RM, 1973, ANIM BEHAV, V21, P349, DOI 10.1016/S0003-3472(73)80077-6; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Ding LG, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006359; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Escames G, 2013, HORM MOL BIOL CLIN I, V16, P91, DOI 10.1515/hmbci-2013-0026; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fraunberger EA, 2019, BRAIN INJURY, V33, P534, DOI 10.1080/02699052.2019.1565898; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281; Harish G, 2013, NEUROPATH APPL NEURO, V39, P298, DOI 10.1111/j.1365-2990.2012.01285.x; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jain K., 2019, HDB NEUROPROTECTION, P281, DOI DOI 10.1007/978-1-4939-9465-6_4; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson AA, 2013, J NEUROSCI, V33, P7535, DOI 10.1523/JNEUROSCI.3739-12.2013; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim HJ, 2012, BRAIN, V135, P2865, DOI 10.1093/brain/aws208; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Lateef S, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069518824852; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mayfield Brain & Spine, 2018, TRAUMATIC BRAIN INJU; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Monlun M, 2017, J MOL BIOL, V429, P1, DOI 10.1016/j.jmb.2016.10.028; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Ordonez DG, 2018, NEURON, V97, P108, DOI 10.1016/j.neuron.2017.11.036; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Petersen AJ, 2012, FLY, V6, P169, DOI 10.4161/fly.20999; Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820; Posey KL, 2001, GENOME BIOL, V2; R Core Team, 2019, R LANG ENV STAT COMP; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Razmara A, 2008, J PHARMACOL EXP THER, V325, P782, DOI 10.1124/jpet.107.134072; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Ruprecht JJ, 2020, TRENDS BIOCHEM SCI, V45, P244, DOI 10.1016/j.tibs.2019.11.001; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sandhir R, 2017, BBA-MOL BASIS DIS, V1863, P1090, DOI 10.1016/j.bbadis.2016.10.020; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Sen AK, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00175; Sen N, 2019, NEURAL REGEN RES, V14, P1215, DOI 10.4103/1673-5374.251305; Shah EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00409; Shoichet Molly S., 2008, P221; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sudmeier LJ, 2015, G3-GENES GENOM GENET, V5, P2299, DOI 10.1534/g3.115.021782; Sutton JR, 2017, HUM MOL GENET, V26, P1419, DOI 10.1093/hmg/ddx039; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor K, 2007, FLY, V1, P197, DOI 10.4161/fly.5082; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; van Alphen B., 2018, BIORXIV PREPRINT, DOI [10.1101/422535, DOI 10.1101/422535]; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Walker MA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/164309; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang YS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50513-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang LX, 2019, NEURAL REGEN RES, V14, P632, DOI 10.4103/1673-5374.247467; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	107	4	4	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 19	2020	11								511	10.3389/fneur.2020.00511			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ML0JB	WOS:000549162300001	32636795	gold, Green Published			2022-02-06	
J	Carroll, EL; Outtrim, JG; Forsyth, FJ; Manktelow, AE; Hutchinson, PJA; Tenovuo, O; Posti, J; Wilson, L; Sahakian, BJ; Menon, DK; Newcombe, VFJ				Carroll, Ellen L.; Outtrim, Joanne G.; Forsyth, Faye Jane; Manktelow, Anne E.; Hutchinson, Peter J. A.; Tenovuo, Olli; Posti, Jussi; Wilson, Lindsay; Sahakian, Barbara J.; Menon, David K.; Newcombe, Virginia F. J.			Mild traumatic brain injury recovery: a growth curve modelling analysis over 2 years	JOURNAL OF NEUROLOGY			English	Article						Mild traumatic brain injury; Latent growth curve modelling; Cognitive impairment; Outcome	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL OUTCOMES; HEAD-INJURY; DEPRESSION; QUESTIONNAIRE; DEFICITS; DISABILITY; INVENTORY	Background An improved understanding of the trajectory of recovery after mild traumatic brain injury is important to be able to understand individual patient outcomes, for longitudinal patient care and to aid the design of clinical trials. Objective To explore changes in health, well-being and cognition over the 2 years following mTBI using latent growth curve (LGC) modelling. Methods Sixty-one adults with mTBI presenting to a UK Major Trauma Centre completed comprehensive longitudinal assessment at up to five time points after injury: 2 weeks, 3 months, 6 months, 1 year and 2 years. Results Persisting problems were seen with neurological symptoms, cognitive issues and poor quality of life measures including 28% reporting incomplete recovery on the Glasgow Outcome Score Extended at 2 years. Harmful drinking, depression, psychological distress, disability, episodic memory and working memory did not improve significantly over the 2 years following injury. For other measures, including the Rivermead Post-Concussion Symptoms and Quality of Life after Brain Injury (QOLIBRI), LGC analysis revealed significant improvement over time with recovery tending to plateau at 3-6 months. Interpretation Significant impairment may persist as late as 2 years after mTBI despite some recovery over time. Longitudinal analyses which make use of all available data indicate that recovery from mTBI occurs over a longer timescale than is commonly believed. These findings point to the need for long-term management of mTBI targeting individuals with persisting impairment.	[Carroll, Ellen L.; Outtrim, Joanne G.; Forsyth, Faye Jane; Manktelow, Anne E.; Menon, David K.; Newcombe, Virginia F. J.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Hutchinson, Peter J. A.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Tenovuo, Olli; Posti, Jussi] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Tenovuo, Olli; Posti, Jussi] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Posti, Jussi] Turku Univ Hosp, Neuroctr, Dept Neurosurg, Turku, Finland; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Hutchinson, Peter J. A.; Menon, David K.; Newcombe, Virginia F. J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England		Newcombe, VFJ (corresponding author), Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England.; Newcombe, VFJ (corresponding author), Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England.	vfjn2@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Posti, Jussi P./Y-2908-2019; Wilson, Lindsay/A-3659-2009	Sahakian, Barbara/0000-0001-7352-1745; Posti, Jussi P./0000-0002-5925-5193; Wilson, Lindsay/0000-0003-4113-2328; Newcombe, Virginia/0000-0001-6044-9035	European Commission under the 7th Framework Programme [FP7-270259-TBIcare]; UK National Institute of Health Research (NIHR) Biomedical Research Centre at Cambridge; UK Department of Health; NIHR (Research Professorship and Cambridge BRC); Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation; Finnish Brain Foundation; Maire Taponen Foundation; NIHR Brain Injury MedTech Co-operative, Cambridge; NIHR Cambridge Biomedical Research Centre (Mental Health Theme); NIHR through the NIHR Cambridge Biomedical Research Centre Grant; Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship	This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), the UK National Institute of Health Research (NIHR) Biomedical Research Centre at Cambridge and the Technology Platform funding provided by the UK Department of Health. PJH was supported by the NIHR (Research Professorship and Cambridge BRC). JPP received funding from the Academy of Finland (Grant #17379), Government's Special Financial Transfer tied to academic research in Health Sciences (Finland), the Emil Aaltonen Foundation, the Finnish Brain Foundation and the Maire Taponen Foundation. BJS receives funding from the NIHR Brain Injury MedTech Co-operative, Cambridge and the NIHR Cambridge Biomedical Research Centre (Mental Health Theme). DKM was supported by the NIHR through the NIHR Cambridge Biomedical Research Centre Grant and a Senior Investigator Award. VFJN was funded by a Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship.	Albrecht JS, 2020, J NEUROTRAUM, V37, P2542, DOI 10.1089/neu.2019.6957; Andrikopoulos J, 2019, JAMA NEUROL; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Carroll EL, 2020, J HEAD TRAUMA REHAB, V35, pE513, DOI 10.1097/HTR.0000000000000575; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Drummond C, 2016, MENTAL HLTH WELLBEIN; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Flynn Frederick G, 2010, Continuum (Minneap Minn), V16, P79, DOI 10.1212/01.CON.0000391454.15052.e4; Goldstein FC, 1996, NEUROPSYCHOLOGY, V10, P147; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Lunter CM, 2019, EMERG MED AUSTRALAS, V31, P355, DOI 10.1111/1742-6723.13163; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Nelson H.E., 1982, NATL ADULT READING T; Nelson Lindsay D, 2019, JAMA Neurol, DOI 10.1001/jamaneurol.2019.4457; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Ponsford J, 2012, J HEAD TRAUMA REHAB, V27, P342, DOI 10.1097/HTR.0b013e318265a576; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Richter S, 2020, J NEUROTRAUM, V37, P1845, DOI 10.1089/neu.2020.7000; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P42, DOI 10.1100/tsw.2011.2; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tourangeau R, 2004, ANNU REV PSYCHOL, V55, P775, DOI 10.1146/annurev.psych.55.090902.142040; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	58	4	4	2	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	NOV	2020	267	11					3223	3234		10.1007/s00415-020-09979-x		JUN 2020	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OE5VN	WOS:000539964900001	32535683	Green Submitted, hybrid, Green Published			2022-02-06	
J	Kapeliotis, M; Laic, RAG; Penas, AJ; Vander Sloten, J; Vanden Berghe, P; Famaey, N; Depreitere, B				Kapeliotis, Markos; Gavrila Laic, Rebeca Alejandra; Penas, Alvaro Jorge; Vander Sloten, Jos; Vanden Berghe, Pieter; Famaey, Nele; Depreitere, Bart			Collagen fibre orientation in human bridging veins	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Bridging veins; Collagen fibres; Orientation; Multiphoton microscopy; Acute subdural hematoma; Traumatic brain injury	BAYESIAN SENSITIVITY-ANALYSIS; MODEL	Bridging veins (BVs) drain the blood from the cerebral cortex into dural sinuses. BVs have one end attached to the brain and the other to the superior sagittal sinus (SSS), which is attached to the skull. Relative movement between these two structures can cause BV to rupture producing acute subdural haematoma, a head injury with a mortality rate between 30 and 90%. A clear understanding of the BVs microstructure is required to increase the biofidelity of BV models when simulating head impacts. Twelve fresh BV samples draining in the superior sagittal sinus (SSS) from a single human cadaver were cut open along their length and placed on an inverted multiphoton microscope. To ensure that the BVs were aligned with the axial direction an in-house built, uniaxial tension set-up was used. Two scans were performed per sample. Before the first scan, a minor displacement was applied to align the tissue; then, a second scan was taken applying 50% strain. Each BV was scanned for a length of 5 mm starting from the drainage site into the SSS. Imaging was performed on a Zeiss LSM780 microscope with an 25x water immersion objective (NA 0.8), coupled to a tunable MaiTai DS (Spectraphysics) pulsed laser with the wavelength set at 850 nm. Second harmonic and fluorescence signals were captured in forward and backward direction on binary GaAsP (BiG) detectors and stored as four colour Z-stacks. Prior to the calculation of the local orientations, acquired Z-stacks were denoised and enhanced to highlight fibrillar structures from the background. Then, for eachZ-plane of the stack, the ImageJ plugin OrientationJ was used to extract the local 2D orientations of the fibres based on structure tensors. Two kinds of collagen architectures were seen. The most common (8/12 samples) was single layered and had a uniform distribution of collagen. The less common (4/12 samples) had 2 layers and 7 to 34 times thicker collagen bundles on the outer layer. Fibre angle analysis showed that collagen was oriented mainly along the axial direction of the vessel. The von Mises fittings showed that in order to describe the fibre distribution 3 components were needed with mean angles mu at - 0.35, 0.21, -0.02 rad or - 20.2 degrees, 12.12 degrees, - 1.22 degrees relative to the vessel's axial direction which was also the horizontal scan direction.	[Kapeliotis, Markos; Gavrila Laic, Rebeca Alejandra; Penas, Alvaro Jorge; Vander Sloten, Jos; Famaey, Nele] Katholieke Univ Leuven, Biomech Sect, Celestijnenlaan 300 Box 2419, B-3001 Leuven, Belgium; [Depreitere, Bart] Katholieke Univ Leuven, Dept Neurosurg, Univ Hosp Gasthuisberg, Leuven, Belgium; [Vanden Berghe, Pieter] Katholieke Univ Leuven, TARGID, Lab Enter Neurosci LENS, Leuven, Belgium		Kapeliotis, M (corresponding author), Katholieke Univ Leuven, Biomech Sect, Celestijnenlaan 300 Box 2419, B-3001 Leuven, Belgium.	markos.kapeliotis@kuleuven.be		Famaey, Nele/0000-0002-7374-8912; Vanden Berghe, Pieter/0000-0002-0009-2094	European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [642662]; FWOFWO [PDO/12, G0C6713N, G.0929.15]; Hercules [AKUL/11/37]	This work was supported by the European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642662 for HEADS ITN and by a personal FWO fellowship (PDO/12), a FWO grant G0C6713N, a FWO grant G.0929.15 and Hercules AKUL/11/37	Archana J. N., 2016, INT J ENG SCI COMPUT, V6, P8729; Becker W, 2013, MECH SYST SIGNAL PR, V34, P57, DOI 10.1016/j.ymssp.2012.05.010; Becker W, 2012, MECH SYST SIGNAL PR, V32, P18, DOI 10.1016/j.ymssp.2012.03.009; Becker W, 2011, J BIOMECH, V44, P1499, DOI 10.1016/j.jbiomech.2011.03.008; Bentley J, 2006, MODELLING CIRCULAR D; Brockmann C, 2012, CLIN IMAG, V36, P85, DOI 10.1016/j.clinimag.2011.05.003; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Davies E., 1990, MACHINE VISION THEOR; De Alvarenga V, 2019, J NEUROTRAUM, V36, pA4, DOI 10.1089/neu.2018.6143; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Dhillon IS, 2003, TR0306; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Ni Annaidh A, 2012, ANN BIOMED ENG, V40, P1; Nierenberger M, 2015, BIOMECH MODEL MECHAN, V14, P693, DOI 10.1007/s10237-014-0630-4; Nierenberger M, 2013, J MECH BEHAV BIOMED, V23, P32, DOI 10.1016/j.jmbbm.2013.04.001; OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003; Pang Q, 2001, J VASC RES, V38, P83, DOI 10.1159/000051033; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Vesely J, 2011, COMPUTATIONAL PLASTICITY XI: FUNDAMENTALS AND APPLICATIONS, P720; Vignes JR, 2007, J NEUROSURG, V107, P1205, DOI 10.3171/JNS-07/12/1205; Wang Y, 2012, INT J SOLIDS STRUCT, V49, P2914, DOI 10.1016/j.ijsolstr.2012.04.004; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121	26	4	4	2	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	DEC	2020	19	6					2455	2489		10.1007/s10237-020-01349-w		JUN 2020	35	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	OI6BN	WOS:000539943700001	32535740	Green Accepted			2022-02-06	
J	Bonnette, S; Diekfuss, JA; Grooms, D; Myer, GD; Meehan, WP; Howell, DR				Bonnette, Scott; Diekfuss, Jed A.; Grooms, Dustin; Myer, Gregory D.; Meehan, William P., III; Howell, David R.			Integrated linear and nonlinear trunk dynamics identify residual concussion deficits	NEUROSCIENCE LETTERS			English	Article						Recurrence Quantification Analysis (RQA); Mild Traumatic Brain Injury (mTBI); Inertial Sensors; Postural Control	RECURRENCE QUANTIFICATION ANALYSIS; EXTREMITY MUSCULOSKELETAL INJURY; CRUCIATE LIGAMENT RECONSTRUCTION; ERROR SCORING SYSTEM; POSTURAL-CONTROL; CEREBRAL CONCUSSION; AUDIO-BIOFEEDBACK; BALANCE; SWAY; STABILITY	Postural sway is significantly affected by a mild traumatic brain injury, or concussion, and myriad methods have been developed to quantify the severity of concussion symptoms. The current manuscript quantifies postural sway-as measured by an inertial sensor-in youth athletes with concussion (n = 43, age = 14.4 +/- 2.3 years, 56% female, tested median 7 days post-concussion) and healthy controls (n = 38, age = 14.9 +/- 2.0 years, 55% female) during single-task and dual-task postural sway. A nonlinear analysis (i.e., recurrence quantification analysis [RQA]) and several common linear measures were used to quantify postural sway. Respectively, the two complementary types of analyses describe the structure and magnitude of postural sway. We hypothesized that participants who recently experienced a concussion would display differing postural sway dynamics (i.e., different in structure and magnitude) than control participants who had not experienced a concussion. Additionally, a logistic regression was performed to determine which combination of variables (nonlinear and linear) and task (single and dual) would best differentiate concussion and control participants. Significant differences between concussion and control participants were found in percent determinism, laminarity, and standard deviation of postural sway acceleration in both the single and the dual task. In the single task alone, mean diagonal line length and trapping time were additionally significantly different between groups. Moreover, the logistic regression model revealed that a mixture of linear and nonlinear measures across both single and dual tasks best classified concussed and non-concussed participants. Additionally, history of concussion was found to be a significant covariate in the model. These results extend past observations by demonstrating that a combination of posture sway tasks and measurements best differentiate participants with a concussion. These results highlight the need for future studies to replicate the findings in different populations and further determine which combinations of postural sway tasks and measurements best classify participants with concussions.	[Bonnette, Scott; Diekfuss, Jed A.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Grooms, Dustin] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA; [Grooms, Dustin] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat & Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.; Meehan, William P., III; Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA		Bonnette, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA.	scott.bonnette@cchmc.org	Diekfuss, Jed/ABD-7372-2020; Myer, Gregory/H-6572-2016	Diekfuss, Jed/0000-0003-3835-363X; Myer, Gregory/0000-0002-9983-8422			Amoud H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-12; Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bardy BG, 2007, J MOTOR BEHAV, V39, P326, DOI 10.3200/JMBR.39.4.326-336; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bergamin M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00271; Bonnette, 2011, SCI MOTRICITE, V74, P5, DOI [10.1051/sm/2011117, DOI 10.1051/SM/2011117]; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Carello C., 2005, TUTORIALS CONT NONLI, P1; Caudron S, 2014, NEUROPHYSIOL CLIN, V44, P77, DOI 10.1016/j.neucli.2013.10.134; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Clark RA, 2014, J BIOMECH, V47, P1134, DOI 10.1016/j.jbiomech.2013.12.015; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Coubard OA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00017; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Deffeyes JE, 2011, INFANT BEHAV DEV, V34, P81, DOI 10.1016/j.infbeh.2010.10.001; Dierijck J.K., 2019, BRIT J SPORT MED, V51; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Dozza Marco, 2005, J Neuroeng Rehabil, V2, P13, DOI 10.1186/1743-0003-2-13; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Ginis P, 2016, PARKINSONISM RELAT D, V22, P28, DOI 10.1016/j.parkreldis.2015.11.004; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; J. Team, 2018, JASP; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kiefer AW, 2015, NONLIN DYNAM PSYCHOL, V19, P489; Kuznetsov NA, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaa3c2; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mazaheri M, 2010, MED ENG PHYS, V32, P808, DOI 10.1016/j.medengphy.2010.04.019; Mazaheri M, 2010, GAIT POSTURE, V31, P116, DOI 10.1016/j.gaitpost.2009.09.009; McCrory P., 2009, S AFRICAN J SPORTS M, V21; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mirelman A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-35; Nanhoe-Mahabier W, 2012, PARKINSONISM RELAT D, V18, P1017, DOI 10.1016/j.parkreldis.2012.05.018; Nashner L. M, 2014, BALANCE FUNCTION ASS, P431; Negahban H, 2013, NEUROSCI LETT, V553, P126, DOI 10.1016/j.neulet.2013.08.024; Newell KM, 1997, GAIT POSTURE, V6, P56, DOI 10.1016/S0966-6362(96)01103-4; Nicolai S, 2010, Z GERONTOL GERIATR, V43, P224, DOI 10.1007/s00391-010-0125-6; Pai YC, 2003, J NEUROPHYSIOL, V90, P755, DOI 10.1152/jn.01118.2002; Pai YC, 2007, PHYS THER, V87, P1478, DOI 10.2522/ptj.20060326; Pataky Z, 2009, ARCH PHYS MED REHAB, V90, P1435, DOI 10.1016/j.apmr.2009.02.011; Paterno MV, 2013, GAIT POSTURE, V38, P136, DOI 10.1016/j.gaitpost.2012.11.001; Pellecchia GL, 2005, COGNITIVE SCI, V29, P531, DOI 10.1207/s15516709cog0000_12; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Riley M.A., 1997, MOTOR CONTROL, V1, P229, DOI [10.1123/mcj.1.3.229, DOI 10.1123/MCJ.1.3.229]; Riley MA, 2005, J MOTOR BEHAV, V37, P311, DOI 10.3200/JMBR.37.4.311-324; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Riley MA, 1998, ECOL PSYCHOL, V10, P65, DOI 10.1207/s15326969eco1002_1; Riley MA, 1997, EXP BRAIN RES, V117, P165, DOI 10.1007/s002210050211; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Rossi-Izquierdo M, 2013, GAIT POSTURE, V37, P195, DOI 10.1016/j.gaitpost.2012.07.002; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Seimetz Christina, 2012, Biomed Sci Instrum, V48, P386; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Soon KS, 2012, BIOMED ENG-APP BAS C, V24, P461, DOI 10.4015/S1016237212500421; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Vaillancourt DE, 2004, J APPL PHYSIOL, V97, P454, DOI 10.1152/japplphysiol.00244.2004; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Valdes BA, 2018, TOP STROKE REHABIL, V25, P96, DOI 10.1080/10749357.2017.1394633; Valdes BA, 2017, ARCH PHYS MED REHAB, V98, P1932, DOI 10.1016/j.apmr.2017.03.034; van Emmerik REA, 2016, J SPORT HEALTH SCI, V5, P3, DOI 10.1016/j.jshs.2016.01.013; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; White SC, 2005, ARCH PHYS MED REHAB, V86, P1958, DOI 10.1016/j.apmr.2005.04.010; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zbilut J.P., 2005, RECURRENCE QUANTIFIC, P26	100	4	4	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 11	2020	729								134975	10.1016/j.neulet.2020.134975			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LR2RT	WOS:000535543600010	32298725				2022-02-06	
J	Lingam, I; Avdic-Belltheus, A; Meehan, C; Martinello, K; Ragab, S; Peebles, D; Barkhuizen, M; Tann, CJ; Tachtsidis, I; Wolfs, TGAM; Hagberg, H; Klein, N; Fleiss, B; Gressens, P; Golay, X; Kramer, BW; Robertson, NJ				Lingam, Ingran; Avdic-Belltheus, Adnan; Meehan, Christopher; Martinello, Kathryn; Ragab, Sara; Peebles, Donald; Barkhuizen, Melinda; Tann, Cally J.; Tachtsidis, Ilias; Wolfs, Tim G. A. M.; Hagberg, Henrik; Klein, Nigel; Fleiss, Bobbi; Gressens, Pierre; Golay, Xavier; Kramer, Boris W.; Robertson, Nicola J.			Serial blood cytokine and chemokine mRNA and microRNA over 48 h are insult specific in a piglet model of inflammation-sensitized hypoxia-ischaemia	PEDIATRIC RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; CEREBROSPINAL-FLUID; CLINICAL-TRIAL; PROTEIN-LEVELS; BIOMARKERS; INFANTS; SERUM; ASSOCIATION; PREDICTORS	Background Exposure to inflammation exacerbates injury in neonatal encephalopathy (NE). We hypothesized that brain biomarker mRNA, cytokine mRNA and microRNA differentiate inflammation (E. coliLPS), hypoxia (Hypoxia), and inflammation-sensitized hypoxia (LPS+Hypoxia) in an NE piglet model. Methods Sixteen piglets were randomized: (i) LPS 2 mu g/kg bolus; 1 mu g/kg infusion (LPS;n = 5), (ii) Saline with hypoxia (Hypoxia;n = 6), (iii) LPS commencing 4 h pre-hypoxia (LPS+Hypoxia;n = 5). Total RNA was acquired at baseline, 4 h after LPS and 1, 3, 6, 12, 24, 48 h post-insult (animals euthanized at 48 h). Quantitative PCR was performed for cytokines (IL1A,IL6,CXCL8,IL10,TNFA) and brain biomarkers (ENO2,UCHL1,S100B,GFAP,CRP,BDNF,MAPT). MicroRNA was detected using GeneChip (Affymetrix) microarrays. Fold changes from baseline were compared between groups and correlated with cell death (TUNEL) at 48 h. Results Within 6 h post-insult, we observed increasedIL1A,CXCL8,CCL2andENO2mRNA in LPS+Hypoxia and LPS compared to Hypoxia.IL10mRNA differentiated all groups. Four microRNAs differentiated LPS+Hypoxia and Hypoxia: hsa-miR-23a, 27a, 31-5p, 193-5p. Cell death correlated withTNFA(R = 0.69;p < 0.01) at 1-3 h andENO2(R = -0.69;p = 0.01) at 48 h. Conclusions mRNA and miRNA differentiated hypoxia from inflammation-sensitized hypoxia within 6 h in a piglet model. This information may inform human studies to enable triage for tailored neuroprotection in NE. Impact Early stratification of infants with neonatal encephalopathy is key to providing tailored neuroprotection. , , , and mRNA are promising biomarkers of inflammation-sensitized hypoxia. mRNA levels differentiated all three pathological states; fold changes from baseline was the highest in LPS+Hypoxia animals, followed by LPS and Hypoxia at 6 h. miR-23, -27, -31-5p and -193-5p were significantly upregulated within 6 h of a hypoxia insult. Functional analysis highlighted the diverse roles of miRNA in cellular processes.	[Lingam, Ingran; Avdic-Belltheus, Adnan; Meehan, Christopher; Martinello, Kathryn; Ragab, Sara; Tann, Cally J.; Robertson, Nicola J.] UCL, Inst Womens Hlth, Neonatol, London, England; [Martinello, Kathryn] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Peebles, Donald; Kramer, Boris W.] UCL, Inst Womens Hlth, Maternal Fetal Med, London, England; [Barkhuizen, Melinda; Wolfs, Tim G. A. M.] Univ Maastricht, Dept Pediat, Maastricht, Netherlands; [Tann, Cally J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Maternal Adolescent Reprod & Child Hlth MARCH Ctr, London, England; [Tachtsidis, Ilias] UCL, Med Phys & Biomed Engn, London, England; [Hagberg, Henrik] Gothenburg Univ, Sahlgrenska Acad, Ctr Perinatal Med & Hlth, Dept Clin Sci, Gothenburg, Sweden; [Klein, Nigel] UCL, Inst Child Hlth, Paediat Infect Dis & Immunol, London, England; [Fleiss, Bobbi; Gressens, Pierre] Kings Coll London, Ctr Developing Brain, London, England; [Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, PROTECT, F-75019 Paris, France; [Golay, Xavier] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England		Robertson, NJ (corresponding author), UCL, Inst Womens Hlth, Neonatol, London, England.	n.robertson@ucl.ac.uk	Kramer, Boris/AAO-3183-2021; Golay, Xavier/AAJ-8094-2021; Fleiss, Bobbi/F-9899-2011; Tann, Cally/ABE-3184-2020	Golay, Xavier/0000-0002-6447-4446; Fleiss, Bobbi/0000-0001-7828-673X; Tann, Cally/0000-0003-0131-4952; Wolfs, Tim/0000-0003-4417-4144; Klein, Nigel/0000-0003-3925-9258; Tachtsidis, Ilias/0000-0002-8125-0313	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/M006743/1]; UK Department of Health's National Institute for Health Research Biomedical Research Center's funding schemeNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M006743/1] Funding Source: UKRI	We thank Debbie Kraus (statistical analysis), David Chambers and Geoff Scopes (UK Bioinformatics) for their support in this study. This study was funded by the Medical Research Council (MR/M006743/1). This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Center's funding scheme.	Alshweki A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008453; BLENNOW M, 1995, PEDIATR RES, V37, P260, DOI 10.1203/00006450-199503000-00002; Camps C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-28; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Celtik C, 2004, BRAIN DEV-JPN, V26, P398, DOI 10.1016/j.braindev.2003.12.007; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chiesa C, 2003, EUR J CLIN INVEST, V33, P352, DOI 10.1046/j.1365-2362.2003.01136.x; Cinar Mehmet Ulas, 2012, BMC Res Notes, V5, P107, DOI 10.1186/1756-0500-5-107; DERKX B, 1995, J INFECT DIS, V171, P229, DOI 10.1093/infdis/171.1.229; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Eklind S, 2001, EUR J NEUROSCI, V13, P1101, DOI 10.1046/j.0953-816x.2001.01474.x; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Garberg HT, 2017, NEONATOLOGY, V111, P133, DOI 10.1159/000449032; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Imam S S, 2009, Pak J Biol Sci, V12, P1498, DOI 10.3923/pjbs.2009.1498.1504; Impey LWM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.011; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jenkins DD, 2013, PEDIATR CRIT CARE ME, V14, P786, DOI 10.1097/PCC.0b013e3182975cc9; Jenkins DD, 2012, J CEREBR BLOOD F MET, V32, P1888, DOI 10.1038/jcbfm.2012.83; Kaneko T, 2012, BRAIN RES, V1466, P128, DOI 10.1016/j.brainres.2012.05.001; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Looney AM, 2015, J PEDIATR-US, V167, P269, DOI 10.1016/j.jpeds.2015.04.060; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Martinello KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46488-y; Massaro AN, 2013, PEDIATR CRIT CARE ME, V14, P310, DOI 10.1097/PCC.0b013e3182720642; Meng ZY, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.116.005052; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; Nelson Karin B., 2000, Current Opinion in Neurology, V13, P133, DOI 10.1097/00019052-200004000-00004; O'Hare FM, 2017, ACTA PAEDIATR, V106, P561, DOI 10.1111/apa.13745; O'Sullivan MP, 2019, JAMA NEUROL, V76, P333, DOI 10.1001/jamaneurol.2018.4182; Orrock JE, 2016, PEDIATR RES, V79, P742, DOI 10.1038/pr.2015.280; Osredkar D, 2014, RESUSCITATION, V85, P567, DOI 10.1016/j.resuscitation.2013.12.006; Pilotte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028446; Qiu J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/350419; Ramaswamy V, 2009, PEDIATR NEUROL, V40, P215, DOI 10.1016/j.pediatrneurol.2008.09.026; Risso FM, 2013, ACTA PAEDIATR, V102, pE467, DOI 10.1111/apa.12343; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Rocha-Ferreira E, 2017, J NEUROINFLAMMATION, V14; Scherrer N, 2017, J STROKE, V19, P323, DOI 10.5853/jos.2017.00423; Tann CJ, 2018, ARCH DIS CHILD-FETAL, V103, pF250, DOI 10.1136/archdischild-2017-312744; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Vasiljevic B, 2011, PEDIATR INT, V53, P454, DOI 10.1111/j.1442-200X.2010.03290.x; Wang D, 2015, MOL MED REP, V11, P1759, DOI 10.3892/mmr.2014.2905; Wang JY, 2014, ASIAN AUSTRAL J ANIM, V27, P471, DOI 10.5713/ajas.2013.13471; Whitehead CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078487; Yang YY, 2013, J NEUROPATHOL EXP NE, V20, P77; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	52	4	4	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	FEB	2021	89	3					464	475		10.1038/s41390-020-0986-3		JUN 2020	12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	QZ5IU	WOS:000544196000001	32521540	Green Submitted			2022-02-06	
J	Wilde, EA; Goodrich-Hunsaker, NJ; Ware, AL; Taylor, BA; Biekman, BD; Hunter, JV; Newman-Norlund, R; Scarneo, S; Casa, DJ; Levin, HS				Wilde, Elisabeth A.; Goodrich-Hunsaker, Naomi J.; Ware, Ashley L.; Taylor, Brian A.; Biekman, Brian D.; Hunter, Jill, V; Newman-Norlund, Roger; Scarneo, Samantha; Casa, Douglas J.; Levin, Harvey S.			Diffusion Tensor Imaging Indicators of White Matter Injury Are Correlated with a Multimodal Electroencephalography-Based Biomarker in Slow Recovering, Concussed Collegiate Athletes	JOURNAL OF NEUROTRAUMA			English	Article						brain function index; diffusion tensor imaging; electroencephalography; magnetic resonance imaging; mild traumatic brain injury; sport-related concussion	TRAUMATIC BRAIN-INJURY; COMMON DATA ELEMENTS; NEUROIMAGING FINDINGS; HEAD IMPACTS; HIGH-SCHOOL; IMPAIRMENT; INTEGRITY; EXPOSURE; METRICS	There are no validated, objective diagnostic or prognostic biomarkers for sports-related concussion (SRC), which hinders evidence-based treatment for concussed athletes. While quantitative electrophysiology (EEG) and diffusion tensor imaging (DTI) are promising technologies for providing objective biomarkers for concussion, the degree to which they are related has not been systematically investigated in concussed athletes. This study examined whether diffusion metrics differentiated concussed athletes with prolonged recovery (n = 18) from non-conccused athletes (n = 13) and whether observed diffusion alterations related to EEG. Collegiate athletes (N = 31) completed EEG, neurocognitive, and magnetic resonance imaging. White matter diffusivity differed between the groups in multiple white matter tracts, including the corpus callosum, cingulum bundle, thalamic radiations, and inferior fronto-occipital, inferior longitudinal, and uncinate fasciculi, but not after correction for multiple comparisons. The enhanced Brain Function Index (eBFI), a measure that combines EEG and neurocognitive data, significantly correlated with altered diffusion in the concussed athletes. These preliminary findings suggest that the absolute deviation of diffusion metrics in concussed versus non-concussed athletes may have clinically utility. Results also suggested that the eBFI may be sensitive to early changes from sports-related concussion.	[Wilde, Elisabeth A.] George E Wahlen VA Med Ctr, Salt Lake City, UT USA; [Wilde, Elisabeth A.; Goodrich-Hunsaker, Naomi J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Wilde, Elisabeth A.; Ware, Ashley L.; Biekman, Brian D.; Hunter, Jill, V; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill, V] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Goodrich-Hunsaker, Naomi J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Ware, Ashley L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Ware, Ashley L.; Biekman, Brian D.] Univ Houston, Dept Psychol, Houston, TX USA; [Ware, Ashley L.; Biekman, Brian D.] Univ Houston, Texas Inst Measurement Evaluat & Stat, Houston, TX USA; [Taylor, Brian A.] Virginia Commonwealth Univ, Coll Engn, Biomed Engn, Richmond, VA USA; [Taylor, Brian A.] Virginia Commonwealth Univ, C Kenneth & Dianne Wright Ctr Clin & Translat Res, Richmond, VA USA; [Hunter, Jill, V] Texas Childrens Hosp, EB Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Newman-Norlund, Roger] Univ South Carolina, Dept Psychol, Sch Arts & Sci, Columbia, SC 29208 USA; [Scarneo, Samantha; Casa, Douglas J.] Univ Connecticut, Korey Stringer Inst, Dept Kinesiol, Storrs, CT USA; [Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA		Wilde, EA (corresponding author), Univ Utah, Sch Med, TBI & Concuss Ctr, 729 Arapeen Rd, Salt Lake City, UT 84108 USA.	Elisabeth.wilde@hsc.utah.edu			U.S. Navy (Naval Health Research Center) [W911QY-14-C-0098]	The clinical study was funded, in part, by a contract to BrainScope Company Inc. from the U.S. Navy (Naval Health Research Center), contract #W911QY-14-C-0098.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blumenthal JD, 2002, NEUROIMAGE, V16, P89, DOI 10.1006/nimg.2002.1076; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Brooks JL, 2017, PSYCHOPHYSIOLOGY, V54, P100, DOI 10.1111/psyp.12682; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US, pGA; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebel C, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3778; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Tamnes CK, 2018, DEV COGN NEUROS-NETH, V33, P161, DOI 10.1016/j.dcn.2017.12.002; TEASDALE G, 1974, LANCET, V2, P81; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vertes PE, 2015, J CHILD PSYCHOL PSYC, V56, P299, DOI 10.1111/jcpp.12365; Wang C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00571; Ware AL, 2020, BRAIN IMAGING BEHAV, V14, P772, DOI 10.1007/s11682-018-0018-7; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilde EA, 2018, BRAIN INJURY, V32, P1266, DOI 10.1080/02699052.2018.1494855; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	48	4	4	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2093	2101		10.1089/neu.2018.6365		JUN 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000541769200001	31931657				2022-02-06	
J	Li, HP; Lin, YN; Cheng, ZH; Qu, W; Zhang, L; Li, QY				Li, Hong Peng; Lin, Ying Ni; Cheng, Zhi Hui; Qu, Wei; Zhang, Liu; Li, Qing Yun			Intracranial-to-central venous pressure gap predicts the responsiveness of intracranial pressure to PEEP in patients with traumatic brain injury: a prospective cohort study	BMC NEUROLOGY			English	Article						Positive end-expiratory pressure; Intracranial pressure; Central venous pressure; Mechanical ventilation; Traumatic brain injury; P(IC)Gap	END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; MECHANICAL VENTILATION; RECRUITMENT MANEUVER; ARTERIAL; POSITION	Background Mechanical ventilation (MV) with positive end-expiratory pressure (PEEP) is commonly applied in patients with severe traumatic brain injury (sTBI). However, the individual responsiveness of intracranial pressure (ICP) to PEEP varies. Thus, identifying an indicator detecting ICP responsiveness to PEEP is of great significance. As central venous pressure (CVP) could act as an intermediary to transduce pressure from PEEP to ICP, we developed a new indicator, P(IC)Gap, representing the gap between baseline ICP and baseline CVP. The aim of the current study was to explore the relationship between P(IC)Gap and ICP responsiveness to PEEP. Methods A total of 112 patients with sTBI undergoing MV were enrolled in this prospective cohort study. ICP, CVP, cerebral perfusion pressure (CPP), static compliance of the respiratory system (Cst), and end-tidal carbon dioxide pressure (PetCO(2)) were recorded at the initial (3 cmH(2)O) and adjusted (15 cmH(2)O) levels of PEEP. P(IC)Gap was assessed as baseline ICP - baseline CVP (when PEEP = 3 cmH(2)O). The patients were classified into the ICP responder and non-responder groups based on whether ICP increment with PEEP adjusted from 3 cmH(2)O to 15 cmH(2)O was greater than 20% of baseline ICP. The above parameters were compared between the two groups, and prediction of ICP responsiveness to PEEP adjustment was evaluated by receiver operating characteristic (ROC) curve analysis. Results Compared with the non-responder group, the responder group had lower P(IC)Gap (1.63 +/- 1.33 versus 6.56 +/- 2.46 mmHg; p < 0.001), lower baseline ICP, and higher baseline CVP. ROC curve analysis suggested that P(IC)Gap was a stronger predictive indicator of ICP responsiveness to PEEP (AUC = 0.957, 95%CI 0.918-0.996; p < 0.001) compared with baseline ICP and baseline CVP, with favorable sensitivity (95.24, 95%CI 86.91-98.70%) and specificity (87.6, 95%CI 75.76-94.27%), at a cut off value of 2.5 mmHg. Conclusion The impact of PEEP on ICP depends on the gap between baseline ICP and baseline CVP, i.e. P(IC)Gap. In addition, P(IC)Gap is a potential predictor of ICP responsiveness to PEEP adjustment in patients with sTBI.	[Li, Hong Peng; Lin, Ying Ni; Zhang, Liu; Li, Qing Yun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Resp & Crit Care Med, Shanghai 200025, Peoples R China; [Li, Hong Peng; Lin, Ying Ni; Zhang, Liu; Li, Qing Yun] Shanghai Jiao Tong Univ, Inst Resp Med, Sch Med, Shanghai 200025, Peoples R China; [Li, Hong Peng; Cheng, Zhi Hui; Qu, Wei] Shanghai Univ Med & Hlth Sci, Affiliated Zhoupu Hosp, Dept Emergency & Crit Care Med, Shanghai 201318, Peoples R China		Li, QY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Resp & Crit Care Med, Shanghai 200025, Peoples R China.; Li, QY (corresponding author), Shanghai Jiao Tong Univ, Inst Resp Med, Sch Med, Shanghai 200025, Peoples R China.	liqingyun68@hotmail.com			Shanghai University of Medicine & Health Sciences [HMSF-17-22-041]; Key Research Program of Shanghai Science and Technology Commission [18140903600]; Shanghai Key Discipline for Respiratory Disease [2017ZZ02014]	The present study was supported in part by the seed fund program of Shanghai University of Medicine & Health Sciences (grant number HMSF-17-22-041), the Key Research Program of Shanghai Science and Technology Commission (grant number 18140903600), and Shanghai Key Discipline for Respiratory Disease (grant number 2017ZZ02014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APUZZO MLJ, 1977, J NEUROSURG, V46, P227, DOI 10.3171/jns.1977.46.2.0227; Boone MD, 2017, NEUROCRIT CARE, V26, P174, DOI 10.1007/s12028-016-0328-9; Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Cao Feng, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P341; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1132-2; Chiumello D, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0113-0; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; De Rosa S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196980; Flexman AM, 2017, CAN J ANESTH, V64, P626, DOI 10.1007/s12630-017-0863-7; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Kongstad L, 1999, ACTA ANAESTH SCAND, V43, P501, DOI 10.1034/j.1399-6576.1999.430503.x; Koutsoukou Antonia, 2016, World J Crit Care Med, V5, P65, DOI 10.5492/wjccm.v5.i1.65; Lee JS, 2005, ACTA ANAESTH SCAND, V49, P759, DOI 10.1111/j.1399-6576.2005.00698.x; Lim CM, 2001, CRIT CARE MED, V29, P1255, DOI 10.1097/00003246-200106000-00037; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Protti A, 2013, CRIT CARE MED, V41, P1046, DOI 10.1097/CCM.0b013e31827417a6; Robba C, 2016, BRIT J ANAESTH, V117, P783, DOI 10.1093/bja/aew356; Robba C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2662-8; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; ROPPER AH, 1982, NEUROLOGY, V32, P1288, DOI 10.1212/WNL.32.11.1288; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; SHOJAEE M, 2017, EMERGENCY, V5; Tejerina E, 2017, J CRIT CARE, V38, P341, DOI 10.1016/j.jcrc.2016.11.010; Yang Zi-jian, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P588	31	4	4	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUN 8	2020	20	1							234	10.1186/s12883-020-01764-7			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY9HM	WOS:000540838800001	32513142	gold, Green Submitted, Green Published			2022-02-06	
J	Previti, S; Vivancoe, M; Remand, E; Beaulieu, S; Longpre, JM; Ballet, S; Sarret, P; Cavelier, F				Previti, Santo; Vivancoe, Melanie; Remand, Emmanuelle; Beaulieu, Sabrina; Longpre, Jean-Michel; Ballet, Steven; Sarret, Philippe; Cavelier, Florine			Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NTS1-Induced Protective Hypothermia	FRONTIERS IN CHEMISTRY			English	Article						NTS1; reduced peptide bonds; unnatural amino acids; proteolytic stability; hypothermia	PHARMACOLOGICALLY INDUCED HYPOTHERMIA; BOND PSEUDOPEPTIDE ANALOGS; BRAIN SYNAPTIC-MEMBRANES; PEPTIDE-BOND; IN-VIVO; ISCHEMIC-STROKE; HIGHLY POTENT; RECEPTOR; STABILITY; BINDING	Therapeutic hypothermia represents a brain-protective strategy for multiple emergency situations, such as stroke or traumatic injury. Neurotensin (NT), which exerts its effects through activation of two G protein-coupled receptors, namely NTS1 and NTS2, induces a strong and long-lasting decrease in core body temperature after its central administration. Growing evidence demonstrates that NTS1 is the receptor subtype mediating the hypothermic action of NT. As such, potent NTS1 agonists designed on the basis of the minimal C-terminal NT(8-13) bioactive fragment have been shown to produce mild hypothermia and exert neuroprotective effects under various clinically relevant conditions. The high susceptibility of NT(8-13) to protease degradation (half-life <2 min) represents, however, a serious limitation for its use in pharmacological therapy. In light of this, we report here a structure-activity relationship study in which pairs of NT(8-13) analogs have been developed, based on the incorporation of a reduced Lys(8)-Lys(9)bond. To further stabilize the peptide bonds, a panel of backbone modifications was also inserted along the peptide sequence, including Sip(10), D-Trp(11), Dmt(11), Tle(12), and TMSAla(13). Our results revealed that the combination of appropriate chemical modifications leads to compounds exhibiting improved resistance to proteolytic cleavages (>24 h;16). Among them, the NT(8-13) analogs harboring the reduced amine bond combined with the unnatural amino acids TMSAla(13)(4) and Sip(10)(6) or the di-substitution Lys(11)- TMSAla(13)(12), D-Trp(11)-TMSAla(13)(14), and Dmt(11)-Tle(12)(16) produced sustained hypothermic effects (-3 degrees C for at least 1 h). Importantly, we observed that hypothermia was mainly driven by the increased stability of the NT(8-13) derivatives, instead of the high binding-affinity at NTS1. Altogether, these results reveal the importance of the reduced amine bond in optimizing the metabolic properties of the NT(8-13) peptide and support the development of stable NTS1 agonists as first drug candidate in neuroprotective hypothermia.	[Previti, Santo; Remand, Emmanuelle; Cavelier, Florine] Univ Montpellier, IBMM, UMR 5247, CNRS,ENSCM, Montpellier, France; [Previti, Santo; Ballet, Steven] Vrije Univ Brussel, Res Grp Organ Chem, Dept Bioengn Sci, Brussels, Belgium; [Previti, Santo; Ballet, Steven] Vrije Univ Brussel, Res Grp Organ Chem, Dept Chem, Brussels, Belgium; [Vivancoe, Melanie; Beaulieu, Sabrina; Longpre, Jean-Michel; Sarret, Philippe] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol Physiol, Inst Pharmacol Sherbrooke, Sherbrooke, PQ, Canada		Cavelier, F (corresponding author), Univ Montpellier, IBMM, UMR 5247, CNRS,ENSCM, Montpellier, France.; Sarret, P (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol Physiol, Inst Pharmacol Sherbrooke, Sherbrooke, PQ, Canada.	philippe.sarret@USherbrooke.ca; fiorine.cavelier@umontpellier.fr			Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [FDN-148413]; France Life Imaging from the French program Investissements d'AvenirFrench National Research Agency (ANR) [ANR-11-INBS-0006 - SP.]; Institut de Pharmacologie de Sherbrooke (IPS); Centre d' Excellence en Neurosciences de l' Universite de Sherbrooke (CNS); Canada Research Chair in Neurophysiopharmacology of Chronic Pain	This work was supported by the Canadian Institute of Health Research (CIHR) (FDN-148413) awarded to PS and by France Life Imaging (Grant No. ANR-11-INBS-0006 - SP.) from the French program Investissements d'Avenir to FC and MV was supported by a research fellowship from the Institut de Pharmacologie de Sherbrooke (IPS) and Centre d' Excellence en Neurosciences de l' Universite de Sherbrooke (CNS). PS holds a Canada Research Chair in Neurophysiopharmacology of Chronic Pain.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; BISSETTE G, 1982, ANN NY ACAD SCI, V400, P268, DOI 10.1111/j.1749-6632.1982.tb31575.x; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Boules M, 2010, BRAIN RES, V1308, P35, DOI 10.1016/j.brainres.2009.10.050; Calbo S, 1999, J IMMUNOL, V162, P4657; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Cavelier F, 2002, J AM CHEM SOC, V124, P2917, DOI 10.1021/ja017440q; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1985, J NEUROCHEM, V45, P1509, DOI 10.1111/j.1471-4159.1985.tb07220.x; CHECLER F, 1984, J NEUROCHEM, V43, P1295, DOI 10.1111/j.1471-4159.1984.tb05386.x; Chen F, 2014, PROG NEUROBIOL, V115, P246, DOI 10.1016/j.pneurobio.2013.12.007; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; COY DH, 1988, J BIOL CHEM, V263, P5056; CUSACK B, 1995, J BIOL CHEM, V270, P18359, DOI 10.1074/jbc.270.31.18359; Dobner PR, 2006, PEPTIDES, V27, P2405, DOI 10.1016/j.peptides.2006.04.025; DOULUT S, 1992, PEPTIDE RES, V5, P30; DUBUC I, 1988, EUR J PHARMACOL, V151, P117, DOI 10.1016/0014-2999(88)90699-1; Dubuc I, 1999, J NEUROSCI, V19, P503, DOI 10.1523/JNEUROSCI.19-01-00503.1999; Einsiedel J, 2011, J MED CHEM, V54, P2915, DOI 10.1021/jm200006c; Eiselt E, 2019, ACS CHEM NEUROSCI, V10, P4535, DOI 10.1021/acschemneuro.9b00390; Fanelli R, 2017, J MED CHEM, V60, P3303, DOI 10.1021/acs.jmedchem.6b01848; Fanelli R, 2015, J MED CHEM, V58, P7785, DOI 10.1021/acs.jmedchem.5b00841; Fantegrossi WE, 2005, PHARMACOL BIOCHEM BE, V80, P341, DOI 10.1016/j.pbb.2004.12.005; Feifel D, 2010, NEUROPHARMACOLOGY, V58, P195, DOI 10.1016/j.neuropharm.2009.07.001; Feng YP, 2015, CURR PHARM DESIGN, V21, P840; GRANIER C, 1982, EUR J BIOCHEM, V124, P117, DOI 10.1111/j.1432-1033.1982.tb05913.x; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hadden MK, 2005, NEUROPHARMACOLOGY, V49, P1149, DOI 10.1016/j.neuropharm.2005.06.010; Held C, 2013, CHEMMEDCHEM, V8, P75, DOI 10.1002/cmdc.201200376; HENRY JA, 1993, BIOORG MED CHEM LETT, V3, P949, DOI 10.1016/S0960-894X(00)80698-8; Huber C, 2019, BRAIN CIRC, V5, P195, DOI 10.4103/bc.bc_25_19; JOLICOEUR FB, 1984, NEUROPEPTIDES, V4, P467, DOI 10.1016/0143-4179(84)90090-8; KALIVAS PW, 1985, BRAIN RES, V326, P219, DOI 10.1016/0006-8993(85)90031-9; Katz LM, 2001, ACAD EMERG MED, V8, P1115, DOI 10.1111/j.1553-2712.2001.tb01126.x; Krumm BE, 2016, SCI REP-UK, V6, DOI 10.1038/srep38564; Kurisu K, 2019, CURR MED CHEM, V26, P5430, DOI 10.2174/0929867326666190506124836; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Liu KY, 2016, NEUROL RES, V38, P478, DOI 10.1080/01616412.2016.1187826; LUGRIN D, 1991, EUR J PHARMACOL, V205, P191, DOI 10.1016/0014-2999(91)90819-C; Magafa V, 2019, AMINO ACIDS, V51, P1009, DOI 10.1007/s00726-019-02741-2; Marschutz MK, 2002, PEPTIDES, V23, P1727, DOI 10.1016/S0196-9781(02)00148-1; Martin C., 2015, TOPICS HETEROCYCLIC, V48, P27, DOI DOI 10.1007/7081_2015_177; MARTIN GE, 1980, PEPTIDES, V1, P333, DOI 10.1016/0196-9781(80)90011-X; Mechanic JA, 2009, EUR NEUROPSYCHOPHARM, V19, P466, DOI 10.1016/j.euroneuro.2009.01.004; NEMEROFF CB, 1977, BRAIN RES, V128, P485, DOI 10.1016/0006-8993(77)90173-1; Orwig KS, 2009, J MED CHEM, V52, P1803, DOI 10.1021/jm801072v; Pettibone DJ, 2002, J PHARMACOL EXP THER, V300, P305, DOI 10.1124/jpet.300.1.305; Remaury A, 2002, BRAIN RES, V953, P63, DOI 10.1016/S0006-8993(02)03271-7; Remond E, 2016, CHEM REV, V116, P11654, DOI 10.1021/acs.chemrev.6b00122; Rene A, 2013, AMINO ACIDS, V45, P301, DOI 10.1007/s00726-013-1492-2; Richard F, 2001, MOL PHARMACOL, V60, P1392, DOI 10.1124/mol.60.6.1392; Richelson E., 2008, Peptide Analogs That are Potent and Selective for Human Neurotensin Receptor Subtype 2, Patent No. 2008137720; Sarret P., 2018, REFERENCE MODULE NEU, P1; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; STPIERRE S, 1981, J MED CHEM, V24, P370, DOI 10.1021/jm00136a004; SU CM, 1991, HORM METAB RES, V23, P15, DOI 10.1055/s-2007-1003601; Sun YJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00586; Tyler-McMahon BM, 2000, EUR J PHARMACOL, V390, P107, DOI 10.1016/S0014-2999(99)00877-8; UHL GR, 1977, BRAIN RES, V130, P299, DOI 10.1016/0006-8993(77)90277-3; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Vivet B, 2000, EUR J ORG CHEM, V2000, P807; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Werner HM, 2016, CHEMBIOCHEM, V17, P712, DOI 10.1002/cbic.201500312; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; WUSTROW DJ, 1995, BIOORG MED CHEM LETT, V5, P997, DOI 10.1016/0960-894X(95)00155-M; Xue TF, 2017, J PHARMACOL SCI, V135, P105, DOI 10.1016/j.jphs.2017.10.004; Zhao YY, 2020, EXP NEUROL, V325, DOI 10.1016/j.expneurol.2019.113133; Zhong WW, 2020, AGING DIS, V11, P1, DOI 10.14336/AD.2019.0507	71	4	4	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2646			FRONT CHEM	Front. Chem.	JUN 5	2020	8								406	10.3389/fchem.2020.00406			15	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	MC1DA	WOS:000543035600001	32582624	Green Published, gold			2022-02-06	
J	Chen, SH; Sun, JM; Fang, WK				Chen, Shih-Han; Sun, Jui-Ming; Fang, Wen-Kuei			The impact of time from injury to surgery in functional recovery of traumatic acute subdural hematoma	BMC NEUROLOGY			English	Article						Time from injury to surgery; Traumatic acute subdural hematoma; Surgical outcomes of TASDH; ROC curve	GLASGOW COMA SCALE; BRAIN-INJURY; RISK-FACTORS; MORTALITY; MORBIDITY; ADULTS; AGE	BackgroundThe time from injury to surgery (TIS) is critical in the functional recovery of individuals with traumatic acute subdural hematoma (TASDH). However, only few studies have confirmed such notion.MethodsThe data of TASDH patients who were surgically treated in Chia-Yi Christian Hospital between January 2008 and December 2015 were collected. The significance of variables, including age, sex, traumatic mechanism, coma scale, midline shift on brain computed tomography (CT) scan, and TIS, in functional recovery was assessed using the student's t-test, Mann-Whitney U test, chi-square test, univariate and multivariate models, and receiver operating characteristic (ROC) curve.ResultsA total of 37 patients achieved functional recovery (outcome scale score of 4 or 5) and 33 patients had poor recovery (outcome scale score of 1-3) after at least 1year of follow-up. No significant difference was observed in terms of age, sex, coma scale score, traumatic mechanism, or midline shift on brain CT scan between the functional and poor recovery groups. TIS was found to be significantly shorter in the functional recovery group than in the poor recovery group (145.527.0 vs. 181.9 +/- 54.5min, P-value=0.002). TIS was a significant factor for functional outcomes in the univariate and multivariate regression models. The analysis of TIS with the ROC curve between these two groups showed that the threshold time for functional recovery in comatose patients and those with TASDH who were surgically treated was 2h and 57.5min.Conclusions p id=Par TIS is an important factor l for the functional recovery of comatose TASDH patients who underwent surgery.	[Chen, Shih-Han; Sun, Jui-Ming; Fang, Wen-Kuei] Chia Yi Christian Hosp, Ditmanson Med Fdn, Neurosurg Dept, 539 Zhongxiao Rd, Chiayi 60002, Taiwan		Chen, SH (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Neurosurg Dept, 539 Zhongxiao Rd, Chiayi 60002, Taiwan.	shihan1963@gmail.com		Chen, Shih-Han/0000-0002-7584-9346			DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mathai KI, 2010, INDIAN J NEUROTRAUM, V7, P9, DOI 10.1016/S0973-0508(10)80004-8; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	20	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUN 4	2020	20	1								10.1186/s12883-020-01810-4			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY1YF	WOS:000540316600001	32498710	gold, Green Published			2022-02-06	
J	Muftuler, LT; Meier, TB; Keith, M; Budde, MD; Huber, DL; McCrea, MA				Muftuler, L. Tugan; Meier, Timothy B.; Keith, Monica; Budde, Matthew D.; Huber, Daniel L.; McCrea, Michael A.			Serial Diffusion Kurtosis Magnetic Resonance Imaging Study during Acute, Subacute, and Recovery Periods after Sport-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion management; concussion symptoms; diffusion tensor imaging; DKI; mild traumatic brain injury; SRC	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; WHITE-MATTER DEVELOPMENT; POSTURAL STABILITY; TENSOR; ADOLESCENTS; DISTORTIONS; CHILDHOOD; CHILDREN	Sport-related concussion (SRC) is common in contact sports, but there remains a lack of reliable, unbiased biomarkers of brain injury and recovery. Although the symptoms of SRC generally resolve over a period of days to weeks, the lack of a biomarker impairs detection and return-to-play decisions. To this date, the pathophysiological recovery profile and relationships between brain changes and symptoms remained unclear. In the current study, diffusion kurtosis imaging (DKI) was used to monitor the effects of SRC on the brain and the trajectory of recovery in concussed American football players (n = 96) at <48 h, and 8, 15, and 45 days post-injury, who were compared with a matched group of uninjured players (n = 82). The concussed group reported significantly higher symptoms within 48 h after injury than controls, which resolved by the 8-day follow-up. The concussed group also demonstrated poorer performance on balance testing at <48 h and 8 days than controls. There were no significant differences between the groups in the Standardized Assessment of Concussion (SAC), a cognitive screening measure. DKI data were acquired with 3 mm isotropic resolution, and analyzed using tract-based spatial statistics (TBSS). Additionally, voxel- and region of interest-based analyses were also conducted. At <48 h, the concussed group showed significantly higher axial kurtosis than the control group. These differences increased in extent and magnitude at 8 days, then receded at 15 days, and returned to the normal levels by 45 days. Kurtosis fractional anisotropy (FA) exhibited a delayed response, with a consistent increase by days 15 and 45. The results indicate that changes detected in the acute period appear to be prolonged compared with clinical recovery, but additional brain changes not observable acutely appear to progress. Although further studies are needed to understand the pathological features of DKI changes after SRC, these findings highlight a potential disparity between clinical symptoms and pathophysiological recovery after SRC.	[Muftuler, L. Tugan; Meier, Timothy B.; Budde, Matthew D.; Huber, Daniel L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Keith, Monica] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Muftuler, L. Tugan; Meier, Timothy B.; Budde, Matthew D.; Huber, Daniel L.; McCrea, Michael A.] Med Coll Wisconsin, Ctr Neurotrauma Res, Milwaukee, WI 53226 USA		Muftuler, LT (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	lmuftuler@mcw.edu	Muftuler, L. Tugan/AAG-7539-2021		Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-141-0561]; National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR001436]	This work was supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through Award No. W81XWH-141-0561. The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), award number UL1TR001436. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense or the NIH.	Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Borja MJ, 2018, NEUROIMAG CLIN N AM, V28, P117, DOI 10.1016/j.nic.2017.09.009; Budde MD, 2018, J MAGN RESON, V292, P137, DOI 10.1016/j.jmr.2018.04.016; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2000, STANDARDIZED ASSESSM; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Muftuler LT, 2012, BRAIN RES, V1466, P33, DOI 10.1016/j.brainres.2012.05.035; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tax CMW, 2015, MAGN RESON MED, V73, P794, DOI 10.1002/mrm.25165; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	64	4	4	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2081	2092		10.1089/neu.2020.6993		JUN 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000538187100001	32253977	Green Published			2022-02-06	
J	Farnese, ML; Girardi, G; Fida, R; Bivona, U; Bartolo, M; De Tanti, A; Intiso, D; Scarponi, F; Antonucci, G				Farnese, Maria Luisa; Girardi, Giovanna; Fida, Roberta; Bivona, Umberto; Bartolo, Michelangelo; De Tanti, Antonio; Intiso, Domenico; Scarponi, Federico; Antonucci, Gabriella			Caregivers' engagement during in-hospital care of sABI's patients: Evaluation of informal co-production from the health providers' perspective	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article						acquired brain injury; co-production; health professionals; informal care	TRAUMATIC BRAIN-INJURY; CO-CREATION; REHABILITATION; DESTRUCTION; EXPERIENCES; CONSUMER; SERVICE; STROKE; NEEDS	One of the challenges of providing healthcare services is to enhance its value (for patients, staff and the service) by integrating the informal caregivers into the care process, both concretely managing their patient's health conditions and treatment (co-executing) and participating in the whole healthcare process (co-planning). This study aims at exploring the co-production contribution to the healthcare process, analysing whether and how it is related to higher caregivers' satisfaction with service care and reduced staff burnout, in the eyes of the staff. It also investigated two possible factors supporting caregivers in their role of co-producers, namely relationship among staff and informal caregivers related to knowledge sharing (i.e. an ability determinant supporting co-production) and related to role social conflict (i.e. a willingness determinant reducing co-production). Results of a structural equation model on a sample of 119 healthcare providers employed by neurorehabilitation centers in Italy with severe acquired brain injury confirmed that knowledge sharing positively related with caregivers' co-executing and co-planning. Also, social role conflict was negatively related with co-executing but positively with co-planning. Furthermore, co-planning resulted in being unrelated to both outcomes, whereas co-executing was associated with caregivers' satisfaction, as measured by staff perceptions. Overall, our data provided initial empirical evidence supporting the ability of the determinant's contribution in allowing informal caregivers to assume an active role in both co-production domains. Furthermore, as expected, the role of conflict willingness determinant was found to be a hindering factor for co-executing but, conversely, a trigger for co-planning. This result should be considered more carefully in future studies.	[Farnese, Maria Luisa; Girardi, Giovanna; Antonucci, Gabriella] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Fida, Roberta] Univ East Anglia, Norwich Business Sch, Norwich, Norfolk, England; [Bivona, Umberto; Antonucci, Gabriella] IRCCS Fdn S Lucia, Rome, Italy; [Bartolo, Michelangelo] HABILITA, Neurorehabil Unit, Dept Rehabil, Bergamo, Italy; [De Tanti, Antonio] Ctr Cardinal Ferrari, Ist S Stefano Riabilitaz, Fontanellato, PR, Italy; [Intiso, Domenico] IRCCS Casa Sollievo Sofferenza, UOC Med Fis & Riabilitat, San Giovanni Rotondo, FG, Italy; [Scarponi, Federico] Osped San Giovanni Battista Torino, Foligno, PG, Italy		Farnese, ML (corresponding author), Sapienza Univ Rome, Dept Psychol, Rome, Italy.	marialuisa.farnese@uniroma1.it	Girardi, Giovanna/ABC-9408-2020; GIRARDI, Giovanna/AAQ-8679-2020; Intiso, Domenico/H-2414-2016; FARNESE, Maria Luisa/U-9268-2018	GIRARDI, Giovanna/0000-0002-5384-6347; Intiso, Domenico/0000-0002-6564-5956; FARNESE, Maria Luisa/0000-0001-7493-9772			Aiken LH, 2000, NURS RES, V49, P146, DOI 10.1097/00006199-200005000-00006; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Bollen K. A., 1989, STRUCTURAL EQUATIONS, DOI 10.1002/9781118619179; Bunderson JS, 2002, ACAD MANAGE J, V45, P875, DOI 10.2307/3069319; Coffman DL, 2005, MULTIVAR BEHAV RES, V40, P235, DOI 10.1207/s15327906mbr4002_4; D'Ippolito M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2824081; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dormann C, 2004, J OCCUP HEALTH PSYCH, V9, P61, DOI 10.1037/1076-8998.9.1.61; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Etgar M, 2008, J ACAD MARKET SCI, V36, P97, DOI 10.1007/s11747-007-0061-1; Farnese ML, 2020, CURR PSYCHOL, DOI 10.1007/s12144-020-00639-x; Farnese ML, 2019, LEADERSHIP ORG DEV J, V40, P17, DOI 10.1108/LODJ-04-2018-0152; Gilardi S, 2016, COPRODUCTION PUBLIC, P77; Haley WE, 2019, REHABIL NURS, V44, P302, DOI 10.1097/rnj.0000000000000100; Harman H.H., 1976, MODERN FACTOR ANAL; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hobfoll S.E., 2010, OXFORD HDB STRESS HL, P128; Humphreys A, 2008, SOCIOL COMPASS, V2, P963, DOI 10.1111/j.1751-9020.2008.00112.x; IBM Corp, 2016, IBM SPSS STAT WIND V; Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; LAITINEN P, 1993, J ADV NURS, V18, P1480, DOI 10.1046/j.1365-2648.1993.18091480.x; Laver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-397; Lee YY, 2010, SOC SCI MED, V71, P1811, DOI 10.1016/j.socscimed.2010.08.008; Maslach C., 1996, MBI MASLACH BURNOUT; Merz M.Y., 2013, J BUSINESS BEHAV SCI, V25, P152; Needham I, 2005, J ADV NURS, V49, P283, DOI 10.1111/j.1365-2648.2004.03286.x; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Owens J, 2012, HEALTH CARE ANAL, V20, P268, DOI 10.1007/s10728-011-0186-8; Palumbo R, 2018, POLICY SOC, V37, P368, DOI 10.1080/14494035.2018.1411872; Payne AF, 2008, J ACAD MARKET SCI, V36, P83, DOI 10.1007/s11747-007-0070-0; Pindus DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192533; Ple L, 2010, J SERV MARK, V24, P430, DOI 10.1108/08876041011072546; Prahalad CK, 2004, J INTERACT MARK, V18, P5, DOI 10.1002/dir.20015; Rand S, 2019, HEALTH SOC CARE COMM, V27, P151, DOI 10.1111/hsc.12634; Ranjan KR, 2016, J ACAD MARKET SCI, V44, P290, DOI 10.1007/s11747-014-0397-2; Realpe AX, 2015, PATIENT EDUC COUNS, V98, P1608, DOI 10.1016/j.pec.2015.07.005; Sapountzi-Krepia D, 2006, DISABIL REHABIL, V28, P3, DOI 10.1080/09638280500165070; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; SCHNEIDER B, 1985, J APPL PSYCHOL, V70, P423, DOI 10.1037/0021-9010.70.3.423; Sebern M, 2009, EUR J CARDIOVASC NUR, V8, P97, DOI 10.1016/j.ejcnurse.2008.07.004; Smith AM, 2013, EUR J MARKETING, V47, P1889, DOI 10.1108/EJM-08-2011-0420; Spann A, 2020, HEALTH SOC CARE COMM, V28, P699, DOI 10.1111/hsc.12912; Taricco M, 2006, Eura Medicophys, V42, P73; Teunissen GJ, 2015, HEALTH CARE ANAL, V23, P288, DOI 10.1007/s10728-013-0254-3; Toffler A., 1980, 3 WAVE; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; Vargo, 2006, MARKETING THEORY, V6, P281, DOI DOI 10.1177/1470593106066781; Verschuere B, 2012, VOLUNTAS, V23, P1083, DOI 10.1007/s11266-012-9307-8; Visser-Meily A, 2005, CEREBROVASC DIS, V20, P443, DOI 10.1159/000088983; Wood BL, 2012, PARADIGMS IN THEORY CONSTRUCTION, P169, DOI 10.1007/978-1-4614-0914-4_9; Zampolini M, 2013, EUR J PHYS REHAB MED, V49, P365; ZEITHAML VA, 2000, SERVICE MARKETING IN	58	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community	NOV	2020	28	6					2086	2094		10.1111/hsc.13019		JUN 2020	9	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	NW2AM	WOS:000536814900001	32483930	Green Published			2022-02-06	
J	Arango-Lasprilla, JC; Zeldovich, M; Olabarrieta-Landa, L; Forslund, MV; Nunez-Fernandez, S; von Steinbuechel, N; Howe, EI; Roe, C; Andelic, N				Arango-Lasprilla, Juan Carlos; Zeldovich, Marina; Olabarrieta-Landa, Laiene; Forslund, Marit Vindal; Nunez-Fernandez, Silvia; von Steinbuechel, Nicole; Howe, Emilie Isager; Roe, Cecilie; Andelic, Nada		Ctr TBI Participants Investigators	Early Predictors of Employment Status One Year Post Injury in Individuals with Traumatic Brain Injury in Europe	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; prospective studies; multicenter studies; rehabilitation; outcome assessment; employment	WORKING-AGE INDIVIDUALS; RETURN-TO-WORK; PROGNOSTIC-FACTORS; CENTER-TBI; OUTCOMES; DISABILITY; STABILITY; MODERATE; EPIDEMIOLOGY; TRAJECTORIES	Sustaining a traumatic brain injury (TBI) often affects the individual's ability to work, reducing employment rates post-injury across all severities of TBI. The objective of this multi-country study was to assess the most relevant early predictors of employment status in individuals after TBI at one-year post-injury in European countries. Using a prospective longitudinal non-randomized observational cohort (The Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) project), data was collected between December 2014-2019 from 63 trauma centers in 18 European countries. The 1015 individuals who took part in this study were potential labor market participants, admitted to a hospital and enrolled within 24 h of injury with a clinical TBI diagnosis and indication for a computed tomography (CT) scan, and followed up at one year. Results from a binomial logistic regression showed that older age, status of part-time employment or unemployment at time of injury, premorbid psychiatric problems, and higher injury severity (as measured with higher Injury severity score (ISS), lower Glasgow Coma Scale (GCS), and longer length of stay (LOS) in hospital) were associated with higher unemployment probability at one-year after injury. The study strengthens evidence for age, employment at time of injury, premorbid psychiatric problems, ISS, GCS, and LOS as important predictors for employment status one-year post-TBI across Europe.	[Arango-Lasprilla, Juan Carlos; Nunez-Fernandez, Silvia] Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain; [Arango-Lasprilla, Juan Carlos] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [Arango-Lasprilla, Juan Carlos] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa 48940, Spain; [Zeldovich, Marina; von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [Olabarrieta-Landa, Laiene] Univ Publ Navarra, Dept Ciencias Salud, Pamplona 31006, Spain; [Forslund, Marit Vindal; Howe, Emilie Isager; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Howe, Emilie Isager; Roe, Cecilie] Univ Oslo, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [Roe, Cecilie; Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Inst Hlth & Soc, N-0318 Oslo, Norway		Arango-Lasprilla, JC (corresponding author), Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain.; Arango-Lasprilla, JC (corresponding author), Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain.; Arango-Lasprilla, JC (corresponding author), Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa 48940, Spain.; Zeldovich, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany.	jcalasprilla@gmail.com; marina.zeldovich@med.uni-goettingen.de; laieneolabarrieta@gmail.com; mavfor@ous-hf.no; silay60@gmail.com; nvsteinbuechel@med.uni-goettingen.de; e.i.howe@medisin.uio.no; cecilie.roe@medisin.uio.no; nandelic@online.no	Landa, Laiene Olabarrieta/V-6207-2017; Posti, Jussi P./Y-2908-2019	Landa, Laiene Olabarrieta/0000-0002-8305-8720; Posti, Jussi P./0000-0002-5925-5193; Nunez- Fernandez, Silvia/0000-0001-6602-5786	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); One Mind (USA); Integra Life Sciences Corporation (USA); Neurotrauma Sciences (USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained fromthe Hannelore Kohl Stiftung (Germany), fromOne Mind (USA), fromIntegra Life Sciences Corporation (USA) and from Neurotrauma Sciences (USA).	Alves DE, 2020, OCCUP ENVIRON MED, V77, P122, DOI 10.1136/oemed-2019-106102; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; European Commission, 2010, EUR DIS STRAT 2010 2; Faul M, 2010, TRAUMATIC BRAIN INJU; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hart T, 2019, REHABIL PSYCHOL, V64, P435, DOI 10.1037/rep0000290; Heymas M., PSFMI PREDICTION MOD; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Konle-Seidl R., 2017, RETENTION RE INTEGRA; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Melo F., 2013, ENCY SYSTEMBIOL, P38; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Oliva AC, 2008, REV ESP SALUD PUBLIC, V82, P273, DOI [10.1590/S1135-57272008000300004, 10.1590/s1135-57272008000300004]; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez-Romero C, 2017, GAC SANIT, V31, P108, DOI 10.1016/j.gaceta.2016.10.007; R Development Core Team, 2012, R LANG ENV STAT COMP; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Reme SE, 2019, SCAND J WORK ENV HEA, V45, P33, DOI 10.5271/sjweh.3753; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubin D., 1987, MULTIPLE IMPUTATION; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; TEASDALE G, 1974, LANCET, V2, P81; van Buuren S, 2011, J STAT SOFTW, V45, P1; Van Gyes G., 2013, IMPACT CRISIS WORKIN; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Watkin C, 2020, BRAIN INJURY, V34, P68, DOI 10.1080/02699052.2019.1681512; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	67	4	4	2	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2020	9	6							2007	10.3390/jcm9062007			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MT1LX	WOS:000554730900001	32604823	Green Published, gold			2022-02-06	
J	Benaroya, H				Benaroya, Haym			Brain energetics, mitochondria, and traumatic brain injury	REVIEWS IN THE NEUROSCIENCES			English	Article						astrocytes; ATP; glia; synapses	DIFFUSE AXONAL INJURY; ENERGY-METABOLISM; ELECTRICAL-ACTIVITY; IN-VITRO; GLIAL-CELLS; ASTROCYTES; MODEL; DYNAMICS; NEURONS; GLUCOSE	We review current thinking about, and draw connections between, brain energetics and metabolism, and between mitochondria and traumatic brain injury. Energy is fundamental to proper brain function. Its creation in a useful form for neurons and glia, and consistently in response to the brain's high energy needs, is critical for physiological pathways. Dysfunction in the mechanisms of energy production is at the center of neurological and neuropsychiatric pathologies. We examine the connections between energetics and mitochondria - the organelle responsible for almost all the energy production in the cell - and how secondary pathologies in traumatic brain injury result from energetic dysfunction. This paper interweaves these topics, a necessity since they are closely coupled, and identifies where there exist a lack of understanding and of data. In addition to summarizing current thinking in these disciplines, our goal is to suggest a framework for the mathematical modeling of mechanisms and pathways based on optimal energetic decisions.	[Benaroya, Haym] Rutgers State Univ, Dept Mech & Aerosp Engn, 98 Brett Rd, Piscataway, NJ 08854 USA		Benaroya, H (corresponding author), Rutgers State Univ, Dept Mech & Aerosp Engn, 98 Brett Rd, Piscataway, NJ 08854 USA.	benaroya@soe.rutgers.edu		Benaroya, Haym/0000-0002-2239-2469			Adiele RC, 2019, MITOCHONDRION, V44, P7, DOI 10.1016/j.mito.2017.12.005; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Al-Sarraj S, 2016, DIAGNOSTIC HISTOPATH, V22, P318, DOI [10.1016/j.mpdhp.2016.08.005, DOI 10.1016/J.MPDHP.2016.08.005]; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Allen NJ, 2017, NEURON, V96, P697, DOI 10.1016/j.neuron.2017.09.056; [Anonymous], 2018, S ROCK U NEW YORK 25; Ashrafi G, 2017, CURR OPIN NEUROBIOL, V45, P156, DOI 10.1016/j.conb.2017.03.007; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Aubert A, 2005, J CEREBR BLOOD F MET, V25, P1476, DOI 10.1038/sj.jcbfm.9600144; Aubert A, 2002, NEUROIMAGE, V17, P1162, DOI 10.1006/nimg.2002.1224; Aubert A, 2001, ACTA BIOTHEOR, V49, P301, DOI 10.1023/A:1014286728421; Aubert A, 2002, ACTA BIOTHEOR, V50, P281, DOI 10.1023/A:1022620818701; Aubert A, 2007, GLIA, V55, P1272, DOI 10.1002/glia.20360; Aubert A, 2007, P NATL ACAD SCI USA, V104, P4188, DOI 10.1073/pnas.0605864104; Barres BA, 2003, GLIA, V43, P4, DOI 10.1002/glia.10252; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Barros L.F., 2010, FRONT NEUROENERG, V2, P1; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Bartnik-Olson B.L., 2013, FRONT NEUROENERG, V5, P1; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Buhlman L.M, 2016, MITOCHONDRIAL MECH D; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burda JE, 2017, CELL RES, V27, P726, DOI 10.1038/cr.2017.37; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Calvetti D., 2019, ENCY COMPUT NEUROS B; Calvetti D, 2016, J MATH BIOL, V73, P1823, DOI 10.1007/s00285-016-1011-7; Calvetti D, 2015, REND LINCEI-SCI FIS, V26, P193, DOI 10.1007/s12210-015-0422-5; Calvetti D, 2015, J THEOR BIOL, V376, P48, DOI 10.1016/j.jtbi.2015.03.037; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Castora FJ, 2019, PROG NEURO-PSYCHOPH, V92, P83, DOI 10.1016/j.pnpbp.2018.12.015; Chan F, 2019, BRAIN, V142, P391, DOI 10.1093/brain/awy320; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184832; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloutier M, 2009, J COMPUT NEUROSCI, V27, P391, DOI 10.1007/s10827-009-0152-8; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Correia S.C., 2018, MITOCHONDRIAL BIOL E, P213; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; DICKEL G, 1989, J CHEM SOC FARAD T 1, V85, P1463, DOI 10.1039/f19898501463; Dienel GA, 2017, NEUROSCI LETT, V637, P18, DOI 10.1016/j.neulet.2015.02.052; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; DiNuzzo M, 2017, CURR OPIN NEUROBIOL, V47, P65, DOI 10.1016/j.conb.2017.09.010; Diogo CV, 2018, BIOCHEM BIOPH RES CO, V500, P87, DOI 10.1016/j.bbrc.2017.04.124; Dossi E, 2018, BRAIN RES BULL, V136, P139, DOI 10.1016/j.brainresbull.2017.02.001; Drapaca CS, 2015, FRONT CELL NEUROSCI, V9, P1; Eisenberg B, 2011, CHEM PHYS LETT, V511, P1, DOI 10.1016/j.cplett.2011.05.037; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elfawy HA, 2019, LIFE SCI, V218, P165, DOI 10.1016/j.lfs.2018.12.029; Engl E, 2015, J PHYSIOL-LONDON, V593, P3417, DOI 10.1113/jphysiol.2014.282517; Escartin C, 2013, FRONT NEUROENERGETIC, V5, P1; Escartin C, 2006, J NEUROCHEM, V99, P393, DOI 10.1111/j.1471-4159.2006.04083.x; Feng Q., 2018, J CELL SCI, V131, P1; Gibbons A, 1998, SCIENCE, V280, P1345, DOI 10.1126/science.280.5368.1345; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gobel B, 2010, J THEOR BIOL, V264, P1214, DOI 10.1016/j.jtbi.2010.02.033; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hitze Britta, 2010, Front Neuroenergetics, V2, P7, DOI 10.3389/fnene.2010.00007; Hoitzing H, 2015, BIOESSAYS, V37, P687, DOI 10.1002/bies.201400188; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Jha MK, 2018, EXP NEUROL, V309, P23, DOI 10.1016/j.expneurol.2018.07.009; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; JOLIVET R, 2009, FRONT NEUROENERGETIC, V1, P1; Joshi AU, 2018, PHARMACOL RES, V138, P2, DOI 10.1016/j.phrs.2018.08.010; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kembro JM, 2013, BIOPHYS J, V104, P332, DOI 10.1016/j.bpj.2012.11.3808; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Koslik HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092887; Kurt B., 2013, DIS MOL MED, V1, P11; Lackner LL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-35; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Laughlin SB, 2004, BRAIN ENERGETICS NEU, P111; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lemonde H., 2014, CHILD HLTH, V25, P133; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Magistretti PJ, 2016, NEUROSCIENCE IN THE 21ST CENTURY: FROM BASIC TO CLINICAL, 2ND EDITION, P1879, DOI 10.1007/978-1-4939-3474-4_56; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1174, DOI 10.1152/ajpcell.1998.274.4.C1174; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1158, DOI 10.1152/ajpcell.1998.274.4.C1158; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Martinac B, 2014, BBA-BIOMEMBRANES, V1838, P682, DOI 10.1016/j.bbamem.2013.07.015; Maurya V, 2006, Med J Armed Forces India, V62, P277, DOI 10.1016/S0377-1237(06)80021-3; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moeendarbary E, 2014, WIRES SYST BIOL MED, V6, P371, DOI 10.1002/wsbm.1275; Mohammadipour A, 2017, J BIOMECH, V65, P61, DOI 10.1016/j.jbiomech.2017.09.029; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001; Nortley R, 2017, CURR OPIN NEUROBIOL, V47, P80, DOI 10.1016/j.conb.2017.09.012; Oschmann F, 2018, BRAIN RES BULL, V136, P76, DOI 10.1016/j.brainresbull.2017.01.027; Pagliuso A, 2018, CELL MOL LIFE SCI, V75, P355, DOI 10.1007/s00018-017-2603-0; Panchal K, 2019, MITOCHONDRION, V47, P151, DOI 10.1016/j.mito.2018.11.002; Peebles P, 2018, J PROF NURS, V34, P488, DOI 10.1016/j.profnurs.2018.01.002; Peppiatt C, 2004, NATURE, V431, P137, DOI 10.1038/431137a; Petit JM, 2016, NEUROSCIENCE, V323, P135, DOI 10.1016/j.neuroscience.2015.12.007; Petridou NI, 2017, NAT CELL BIOL, V19, P581, DOI 10.1038/ncb3524; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Prebil Mateja, 2011, Archives of Physiology and Biochemistry, V117, P64, DOI 10.3109/13813455.2010.539616; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Robinson MB, 2016, NEUROCHEM INT, V98, P56, DOI 10.1016/j.neuint.2016.03.014; Rossi MJ, 2019, CURR OPIN NEUROBIOL, V57, P149, DOI 10.1016/j.conb.2019.02.001; Roth B.J., 2016, ARXIV161108287; Saa A, 2013, B MATH BIOL, V75, P1636, DOI 10.1007/s11538-013-9862-1; SCEMES E, 2004, ADV MOL CEL, V31, P165; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sedlackova L, 2019, BBA-MOL CELL RES, V1866, P575, DOI 10.1016/j.bbamcr.2018.12.012; Shaham S, 2005, CURR TOP DEV BIOL, V69, P39, DOI 10.1016/S0070-2153(05)69003-5; Sheeran FL, 2017, ADV EXP MED BIOL, V982, P65, DOI 10.1007/978-3-319-55330-6_4; Siedler D., 2014, FRONT CELL NEUROSCI, V8, P1; Simcox E. M., 2016, MITOCHONDRIAL DYSFUN, P3; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Somersalo E, 2012, ANN BIOMED ENG, V40, P2328, DOI 10.1007/s10439-012-0643-z; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stogsdill JA, 2017, CURR OPIN NEUROBIOL, V42, P1, DOI 10.1016/j.conb.2016.09.016; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tang BL, 2018, BRAIN RES BULL, V137, P225, DOI 10.1016/j.brainresbull.2017.12.010; Turner DA, 2011, J NEUROPATH EXP NEUR, V70, P167, DOI 10.1097/NEN.0b013e31820e1152; Tzameli I, 2012, TRENDS ENDOCRIN MET, V23, P417, DOI 10.1016/j.tem.2012.07.008; Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088; Valabregue R, 2003, J CEREBR BLOOD F MET, V23, P536, DOI 10.1097/01.WCB.0000055178.31872.38; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vanhauwaert R, 2019, CURR OPIN NEUROBIOL, V57, P87, DOI 10.1016/j.conb.2019.01.015; Vatov L, 2006, B MATH BIOL, V68, P275, DOI 10.1007/s11538-005-9008-1; Venkateswaran N., 2012, FRONT NEUROENERG, V4, P1; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Vinogradskaya I.S., 2014, MOSC BIOL B, V69, P57; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Watson W.D., 2014, FRONT NEUROENERG, V5, P1; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yan CK, 2012, ADV INTEL SOFT COMPU, V145, P395; Yang XF, 2011, MED HYPOTHESES, V77, P60, DOI 10.1016/j.mehy.2011.03.023; ZAMPONI N, 2018, SCI REP, V8, P1; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zick M., 2011, MITOCHONDRIA CELLULA, P87	178	4	4	1	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	JUN	2020	31	4					363	390		10.1515/revneuro-2019-0086			28	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LV0CH	WOS:000538111900002	32004148	Green Submitted			2022-02-06	
J	Grangeon, L; O'Connor, E; Chan, CK; Akijian, L; Ngoc, TMP; Matharu, MS				Grangeon, Lou; O'Connor, Emer; Chan, Chun-Kong; Akijian, Layan; Pham Ngoc, Thanh Mai; Matharu, Manjit Singh			New insights in post-traumatic headache with cluster headache phenotype: a cohort study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; MIGRAINE; PAIN; MECHANISMS	Objectives To define the characteristics of post-traumatic headache with cluster headache phenotype (PTH-CH) and to compare these characteristics with primary CH. Methods A retrospective study was conducted of patients seen between 2007 and 2017 in a headache centre and diagnosed with PTH-CH that developed within 7 days of head trauma. A control cohort included 553 patients with primary CH without any history of trauma who attended the headache clinic during the same period. Data including demographics, attack characteristics and response to treatments were recorded. Results Twenty-six patients with PTH-CH were identified. Multivariate analysis revealed significant associations between PTH-CH and family history of CH (OR 3.32, 95%CI 1.31 to 8.63), chronic form (OR 3.29, 95%CI 1.70 to 6.49), parietal (OR 14.82, 95%CI 6.32 to 37.39) or temporal (OR 2.04, 95%CI 1.10 to 3.84) location of pain, and presence of prominent cranial autonomic features during attacks (miosis OR 11.24, 95%CI 3.21 to 41.34; eyelid oedema OR 5.79, 95%CI 2.57 to 13.82; rhinorrhoea OR 2.65, 95%CI 1.26 to 5.86; facial sweating OR 2.53, 95%CI 1.33 to 4.93). Patients with PTH-CH were at a higher risk of being intractable to acute (OR 12.34, 95%CI 2.51 to 64.73) and preventive (OR 16.98, 95%CI 6.88 to 45.52) treatments and of suffering from associated chronic migraine (OR 10.35, 95%CI 3.96 to 28.82). Conclusion This largest series of PTH-CH defines it as a unique entity with specific evolutive profile. Patients with PTH-CH are more likely to suffer from the chronic variant, have marked autonomic features, be intractable to treatment and have associated chronic migraine compared with primary CH.	[Grangeon, Lou; Chan, Chun-Kong; Akijian, Layan; Matharu, Manjit Singh] UCL Queen Sq Inst Neurol, Headache & Facial Pain Grp, London WC1N 3BG, England; [Grangeon, Lou] Univ Hosp Ctr Rouen, Dept Neurol, Rouen, Normandie, France; [O'Connor, Emer] UCL Queen Sq Inst Neurol, Dept Mol Neurosci, London, England; [Pham Ngoc, Thanh Mai] Paris Sud Univ, CNRS, Math Inst Orsay, Orsay, Ile De France, France; [Pham Ngoc, Thanh Mai] Paris Saclay Univ, Orsay, Ile De France, France; [Matharu, Manjit Singh] Natl Hosp Neurol & Neurosurg, Headache & Facial Pain Grp, London, England		Matharu, MS (corresponding author), UCL Queen Sq Inst Neurol, Headache & Facial Pain Grp, London WC1N 3BG, England.	m.matharu@uclmail.net	Matharu, Manjit/AAY-3064-2021; Lang, Steven/AAE-8102-2021	Matharu, Manjit/0000-0002-4960-2294; Lang, Steven/0000-0003-1669-9146			Almoznino G, 2017, SLEEP MED REV, V33, P39, DOI 10.1016/j.smrv.2016.04.005; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Burstein R, 2001, PAIN, V89, P107, DOI 10.1016/S0304-3959(00)00478-4; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Goadsby PJ, 2006, CEPHALALGIA, V26, P1168, DOI 10.1111/j.1468-2982.2006.01173.x; Holland PR, 2009, CURR PAIN HEADACHE R, V13, P147, DOI 10.1007/s11916-009-0025-x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lambru Giorgio, 2012, Ann Indian Acad Neurol, V15, pS51; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Lambru G, 2010, CEPHALALGIA, V30, P1502, DOI 10.1177/0333102409359710; Lambru G, 2009, HEADACHE, V49, P1059, DOI 10.1111/j.1526-4610.2009.01456.x; LANCE JW, 1971, J NEUROL SCI, V13, P401, DOI 10.1016/0022-510X(71)90003-7; Leone M, 2009, LANCET NEUROL, V8, P755, DOI 10.1016/S1474-4422(09)70133-4; Lunardon N, 2014, R J, V6, P79; Manzoni Gian Camillo, 2006, Curr Pain Headache Rep, V10, P130, DOI 10.1007/s11916-006-0024-0; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; May A, 2001, Curr Pain Headache Rep, V5, P60, DOI 10.1007/s11916-001-0011-4; May A, 2000, NEUROLOGY, V55, P1328, DOI 10.1212/WNL.55.9.1328; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; May A, 2016, NAT REV NEUROL, V12, P455, DOI 10.1038/nrneurol.2016.93; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mitsikostas DD, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-79; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Putzki N, 2005, CEPHALALGIA, V25, P395, DOI 10.1111/j.1468-2982.2004.00860.x; ROGADO AZ, 1979, HEADACHE, V19, P58, DOI 10.1111/j.1526-4610.1979.hed1902058.x; Roper LS, 2017, J PAIN RES, V10, P1991, DOI 10.2147/JPR.S129808; Saab CY, 2012, TRENDS NEUROSCI, V35, P629, DOI 10.1016/j.tins.2012.06.002; Schurks M, 2006, HEADACHE, V46, P1246, DOI 10.1111/j.1526-4610.2006.00534.x; Sheftell FD, 2007, NEUROL SCI, V28, pS203, DOI 10.1007/s10072-007-0777-1; Soros P, 2001, NEUROSCI LETT, V298, P195, DOI 10.1016/S0304-3940(00)01752-3; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; TURKEWITZ LJ, 1992, HEADACHE, V32, P504, DOI 10.1111/j.1526-4610.1992.hed3210504.x; Yang FC, 2015, J NEUROL NEUROSUR PS, V86, P437, DOI 10.1136/jnnp-2014-308122; Yilmaz T, EMERG MED J EMJ	40	4	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2020	91	6					572	579		10.1136/jnnp-2019-322725			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	LW3RG	WOS:000539061900005	32381638	Green Published, hybrid			2022-02-06	
J	Guo, K; Yao, XY; Wu, WJ; Yu, ZY; Li, ZZ; Ma, ZL; Liu, DX				Guo, Kai; Yao, Xinyu; Wu, Weijing; Yu, Ziyi; Li, Zhenzhong; Ma, Zenglu; Liu, Dengxiang			HIF-1 alpha/SDF-1/CXCR4 axis reduces neuronal apoptosis via enhancing the bone marrow-derived mesenchymal stromal cell migration in rats with traumatic brain injury	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						Traumatic brain injury; Bone marrow-derived mesenchymalstromal cells; Neuronal apoptosis; Stromal cell-derived factor-1; Hypoxia-inducible factor-1alpha; Chemotaxis cytokine receptor-4	STEM-CELLS; SDF-1/CXCR4 AXIS; HIF-1-ALPHA EXPRESSION; HEMATOPOIETIC STEM; CXCL12; CXCR4; SDF-1; TRANSPLANTATION; PROLIFERATION; PROGNOSIS	Mesenchymal stromal injection is a promising therapy for traumatic brain injury (TBI). The aim of this study was to explore the effects of the HIF-1 alpha/SDF-1/CXCR4 axis on neuron repair in TBI rats through improving the bone marrow-derived mesenchymalstromal cells (BMSCs) migration. TBI rat models were established. The rats were treated with exogenous SDF-1, and then the neuronal apoptosis in TBI rats was measured. BMSCs from rats were collected, and the roles of NF-kappa B p65 expression in nuclei, overexpression of SDF-1 and HIF-1 alpha, as well as downregulation of CXCR4 in BMSC migration were identified. HIF-1 alpha- and SDF-1- treated BMSCs were transplanted into TBI rats, after which the neuronal apoptosis and activity of the HIF-1 alpha/SDF-1/CXCR4 axis were detected. Consequently, we found SDF-1 elevated the HIF-1 alpha/SDF-1/CXCR4 activity and presented protective roles in TBI rat hippocampal neurons with reduced neuronal apoptosis. SDF-1 promoted BMSC migration in vitro, and co-effects of SDF-1 and HIF-1 alpha showed strong promotion, while CXCR4 inhibition suppressed BMSC migration. BMSC transplantation activated the HIF-1 alpha/SDF-1/CXCR4 axis and reduced neuronal apoptosis in TBI rats. To conclude, our study demonstrated that the HIF-1 alpha/SDF-1/CXCR4 axis could enhance BMSC migration and alleviate neuronal damage and apoptosis in TBI rats. This study provided novel options for TBI therapy.	[Guo, Kai; Wu, Weijing; Li, Zhenzhong; Ma, Zenglu] Xingtai Peoples Hosp, Dept Neurosurg, Xingtai 054031, Hebei, Peoples R China; [Yao, Xinyu] Xingtai Peoples Hosp, Dept Anesthesia, Xingtai 054031, Hebei, Peoples R China; [Yu, Ziyi] Tangshan Worker Hosp, Dept Intens Care Unit, Tangshan 063000, Hebei, Peoples R China; [Liu, Dengxiang] Xingtai Peoples Hosp, Dept Radiotherapy, 16 Hongxing St, Xingtai 054031, Hebei, Peoples R China		Liu, DX (corresponding author), Xingtai Peoples Hosp, Dept Radiotherapy, 16 Hongxing St, Xingtai 054031, Hebei, Peoples R China.	Liudengx0709@163.com			Hebei Province Key Research and Development Plan [182777151]	This study was supported by Hebei Province Key Research and Development Plan (No. 182777151).	Adamiak M, 2015, ONCOTARGET, V6, P18819, DOI 10.18632/oncotarget.4710; Adelita T, 2017, STEM CELL RES, V22, P61, DOI 10.1016/j.scr.2017.05.013; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Christie Brian R, 2019, Curr Protoc Neurosci, V89, pe80, DOI 10.1002/cpns.80; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; Deng QJ, 2018, CELL MOL NEUROBIOL, V38, P467, DOI 10.1007/s10571-017-0490-4; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063628; Ghazale H, 2018, BEHAV BRAIN RES, V340, P1, DOI 10.1016/j.bbr.2017.11.007; Gong J, 2014, MOL MED REP, V9, P1575, DOI 10.3892/mmr.2014.2053; Han XG, 2018, J GENE MED, V20, DOI 10.1002/jgm.3062; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Khan M, 2018, BEHAV BRAIN RES, V340, P63, DOI 10.1016/j.bbr.2016.10.037; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li J, 2015, INT J MOL MED, V36, P1205, DOI 10.3892/ijmm.2015.2344; Li L, 2007, BRAIN RES, V1180, P133, DOI 10.1016/j.brainres.2007.08.059; Lin YP, 2017, AGING DIS, V8, P115, DOI 10.14336/AD.2016.0610; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Ma JH, 2015, NEUROL RES, V37, P50, DOI 10.1179/1743132814Y.0000000399; Mendt M, 2015, CYTOKINE, V76, P214, DOI 10.1016/j.cyto.2015.05.004; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Qi C, 2017, CELL MOL BIOL, V63, P12, DOI 10.14715/cmb/2017.63.7.2; Qin D, 2017, ONCOTARGET, V8, P98823, DOI 10.18632/oncotarget.22006; Sang XG, 2017, ANN CLIN BIOCHEM, V54, P584, DOI 10.1177/0004563216673087; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shi XD, 2018, CELL TISSUE RES, V372, P67, DOI 10.1007/s00441-017-2716-7; Stroncek DF, 2014, TISSUE ENG PART B-RE, V20, P200, DOI [10.1089/ten.TEB.2013.0529, 10.1089/ten.teb.2013.0529]; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Tang D, 2018, CELL PHYSIOL BIOCHEM, V46, P2460, DOI 10.1159/000489652; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Wang GD, 2017, ONCOTARGET, V8, P11629, DOI 10.18632/oncotarget.14619; Yao RM, 2017, BIORESOURCE TECHNOL, V244, P1188, DOI 10.1016/j.biortech.2017.08.078; Ye ZZ, 2013, CHINESE SCI BULL, V58, P3519, DOI 10.1007/s11434-013-5936-6; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Yu Q, 2015, BIOCHEM BIOPH RES CO, V464, P447, DOI 10.1016/j.bbrc.2015.06.135; Zamproni LN, 2017, INT J PHARMACEUT, V519, P323, DOI 10.1016/j.ijpharm.2017.01.036; Zatroch KK, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0982-y; Zhang S, 2009, CHIN J TRAUMATOL, V12, P263, DOI 10.3760/cma.j.issn.1008-1275.2009.05.002; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Zhou Y, 2018, CHIN J NAT MEDICINES, V16, P801, DOI 10.1016/S1875-5364(18)30122-5; Zhu C, 2017, BRAIN RES, V1657, P223, DOI 10.1016/j.brainres.2016.06.011	46	4	5	1	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	JUN	2020	114								104416	10.1016/j.yexmp.2020.104416			11	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	LO4VD	WOS:000533626500014	32165091				2022-02-06	
J	Howell, DR; Mayer, AR; Master, CL; Leddy, J; Zemek, R; Meier, TB; Yeates, KO; Arbogast, KB; Mannix, R; Meehan, WP				Howell, David R.; Mayer, Andrew R.; Master, Christina L.; Leddy, John; Zemek, Roger; Meier, Timothy B.; Yeates, Keith Owen; Arbogast, Kristy B.; Mannix, Rebekah; Meehan, William P., III			Prognosis for Persistent Post Concussion Symptoms using a Multifaceted Objective Gait and Balance Assessment Approach	GAIT & POSTURE			English	Article							DUAL-TASK GAIT; SINGLE-TASK; SPORT; STATEMENT; RECOVERY; INJURY; RISK		[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Mayer, Andrew R.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Leddy, John] SUNY Buffalo, UBMD Orthopaed & Sports Med, Buffalo, NY USA; [Zemek, Roger] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mannix, Rebekah] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Mannix, Rebekah] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA		Howell, DR (corresponding author), Univ Colorado, Childrens Hosp Colorado, Dept Orthoped, ATC Sports Med Ctr,Sch Med, 13123 E 16th Ave, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu	Yeates, Keith/AAJ-4223-2020	Howell, David/0000-0002-2955-0191	Eastern Athletic Trainers Association, Inc.	This study was partially funded by a research grant from the Eastern Athletic Trainers Association, Inc.	[Anonymous], 2020, J CONCUSSION, V79, P53, DOI [10.1177/2059700218804917, DOI 10.1177/2059700218804917]; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D.R., 2019, J NEUROSURGERY; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Ranganathan P., 2017, CLIN RES, V8, P148, DOI DOI 10.4103/picr.PICR_87_17; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Stuart S, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102557; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	30	4	4	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JUN	2020	79						53	59		10.1016/j.gaitpost.2020.04.013			7	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	LZ1JK	WOS:000540985700010	32361125				2022-02-06	
J	Imaduddin, SM; Fanelli, A; Vonberg, FW; Tasker, RC; Heldt, T				Imaduddin, Syed M.; Fanelli, Andrea; Vonberg, Frederick W.; Tasker, Robert C.; Heldt, Thomas			Pseudo-Bayesian Model-Based Noninvasive Intracranial Pressure Estimation and Tracking	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Estimation; Microsoft Windows; Biomedical measurement; Biological system modeling; Data models; Blood; Extraterrestrial measurements; Bayesian estimation; model-based signal processing; intracranial pressure; brain injury	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER; ICP; MANAGEMENT; GUIDELINES	Objective: A noninvasive intracranial pressure (ICP) estimation method is proposed that incorporates a model-based approach within a probabilistic framework to mitigate the effects of data and modeling uncertainties. Methods: A first-order model of the cerebral vasculature relates measured arterial blood pressure (ABP) and cerebral blood flow velocity (CBFV) to ICP. The model is driven by the ABP waveform and is solved for a range of mean ICP values to predict the CBFV waveform. The resulting errors between measured and predicted CBFV are transformed into likelihoods for each candidate ICP in two steps. First, a baseline ICP estimate is established over five data windows of 20 beats by combining the likelihoods with a prior distribution of the ICP to yield an a posteriori distribution whose median is taken as the baseline ICP estimate. A single-state model of cerebral autoregulatory dynamics is then employed in subsequent data windows to track changes in the baseline by combining ICP estimates obtained with a uniform prior belief and model-predicted ICP. For each data window, the estimated model parameters are also used to determine the ICP pulse pressure. Results: On a dataset of thirteen pediatric patients with a variety of pathological conditions requiring invasive ICP monitoring, the method yielded for mean ICP estimation a bias (mean error) of 0.6 mmHg and a root-mean-squared error of 3.7 mmHg. Conclusion: These performance characteristics are well within the acceptable range for clinical decision making. Significance: The method proposed here constitutes a significant step towards robust, continuous, patient-specific noninvasive ICP determination.	[Imaduddin, Syed M.; Heldt, Thomas] MIT, Inst Med Engn & Sci, Res Lab Elect, Cambridge, MA 02139 USA; [Imaduddin, Syed M.; Heldt, Thomas] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Fanelli, Andrea] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Fanelli, Andrea] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Vonberg, Frederick W.; Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA		Heldt, T (corresponding author), MIT, Inst Med Engn & Sci, Res Lab Elect, Cambridge, MA 02139 USA.; Heldt, T (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	thomas@mit.edu		Fanelli, Andrea/0000-0001-9876-9050; Tasker, Robert/0000-0003-3647-8113	National Institutes for Neurological Disorders and Stroke of the United States National Institutes of Health [R21 NS084264]; Maxim Integrated Products; Philips Healthcare; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology under the Grass Instruments Fellowship	This work was supported in part by the National Institutes for Neurological Disorders and Stroke of the United States National Institutes of Health under Grant R21 NS084264 and in part by Maxim Integrated Products and Philips Healthcare through funding to MIT's Medical Electronic Device Realization Center. The work of S. M. Imaduddin was supported by the Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology under the Grass Instruments Fellowship.	Avery RA, 2010, NEW ENGL J MED, V363, P891, DOI 10.1056/NEJMc1004957; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Daley ML, 2005, ACT NEUR S, V95, P327; De Simone R, 2014, J NEUROL, V261, P1365, DOI 10.1007/s00415-014-7355-2; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Evensen KB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23142-7; Fanelli A, 2019, J NEUROSURG-PEDIATR, V24, P509, DOI 10.3171/2019.5.PEDS19178; Filippidis AS, 2011, J NEUROSURG, V115, P1031, DOI 10.3171/2011.6.JNS101504; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Ganslandt O, 2018, J NEUROSURG, V128, P1653, DOI 10.3171/2016.11.JNS152268; GILLAND O, 1974, J NEUROSURG, V40, P587, DOI 10.3171/jns.1974.40.5.0587; GILLAND O, 1969, NEW ENGL J MED, V280, P904; HANLO PW, 1995, ULTRASOUND MED BIOL, V21, P613, DOI 10.1016/0301-5629(94)00147-6; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; Hu X, 2007, IEEE T BIO-MED ENG, V54, P597, DOI 10.1109/TBME.2006.890130; Hu X, 2006, BIOMED SIGNAL PROCES, V1, P64, DOI 10.1016/j.bspc.2006.05.003; Imaduddin S. M., 2018, THESIS; Kashif FM, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P369, DOI 10.1109/CIC.2008.4749055; Kashif FM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003249; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Levinsky A, 2016, MED ENG PHYS, V38, P477, DOI 10.1016/j.medengphy.2016.02.009; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Ljung L., 1999, SYSTEM IDENTIFICATIO, V2nd; Morgalla MH, 1997, ACTA NEUROCHIR, V139, P569, DOI 10.1007/BF02751002; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Ninness B, 2010, AUTOMATICA, V46, P40, DOI 10.1016/j.automatica.2009.10.015; Noraky J, 2016, ACTA NEUROCHIR SUPPL, V122, P65, DOI 10.1007/978-3-319-22533-3_13; O'Horo JC, 2014, CRIT CARE MED, V42, P1334, DOI 10.1097/CCM.0000000000000166; Oppenheim A. V., 2002, DISCRETE TIME SIGNAL; PETERKA V, 1981, AUTOMATICA, V17, P41, DOI 10.1016/0005-1098(81)90083-2; Ragauskas A, 2005, ACT NEUR S, V95, P357; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Speyer JL, 2008, ADV DES CONTROL, P1; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Wang JX, 2019, ANN BIOMED ENG, V47, P714, DOI 10.1007/s10439-018-02191-z; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Xu P, 2010, IEEE T INF TECHNOL B, V14, P971, DOI 10.1109/TITB.2009.2027317; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256	45	4	4	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JUN	2020	67	6					1604	1615		10.1109/TBME.2019.2940929			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	LT8CU	WOS:000537293200009	31535978	Green Published, Bronze			2022-02-06	
J	Li, FF; Lu, LY; Chen, HY; Wang, P; Zhang, H; Chen, YC; Yin, XD				Li, Fengfang; Lu, Liyan; Chen, Huiyou; Wang, Peng; Zhang, Hong; Chen, Yu-Chen; Yin, Xindao			Neuroanatomical and functional alterations of insula in mild traumatic brain injury patients at the acute stage	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Gray matter volume; Functional connectivity; Cognitive function; MRI	MONTREAL COGNITIVE ASSESSMENT; UNCOMPLICATED MILD; COMPLICATED MILD; CONNECTIVITY; NETWORKS; ABNORMALITIES; MODERATE; INDIVIDUALS; DEFICITS; VOLUME	Cognitive impairment is a major cause of disability and decline in quality of life in mild traumatic brain injury (mTBI) survivors, but the underlying pathophysiology is still poorly understood. The insula has extensive connections to other cortex and is believed to responsible for integrating external and internal processes and controlling cognitive functions. To explore this hypothesis, we investigated early alterations in the gray matter volume (GMV) and brain functional connectivity (FC) of insula in mTBI patients within 7 days after injury and any possible correlations with cognitive function. A total of 58 mTBI patients at the acute stage and 32 matched healthy controls were recruited and underwentT1-weighted magnetic resonance imaging (MRI)andresting-state functional MRI scans within 7 days of injury. FC was characterized using seed-based region of interest analysis method. The patients' cognitive function was evaluated with Montreal Cognitive Assessment (MoCA) score. The resulting of GMV and FC of insula were correlated with cognitive alterations. We found that the GMV was significantly reduced only in the right insula in mTBI patients and no significant GMV increase was observed in either hemisphere. mTBI patients demonstrated decreased FC in the right parahippocampal gyrus and increased FC in the right supramargianl gyrus. In addition, compared to the healthy controls, the mTBI patients in the acute stage presented a decline in the visuospatial/executive (p = 0.013) and attention (p = 0.038) subcategories. In the mTBI group, the changes in GMV in the right insula were positively correlated with poor attention performance (r = 0.316, p = 0.016). Our data demonstrated alterations of the GMV and resting-stateFC of the right insula in mTBI patients at the acute stage. These early changes in GMV and resting-state FC perhaps serve as a potential biomarker for improving the understanding of cognitive decline for mTBI in the acute setting.	[Li, Fengfang; Lu, Liyan; Chen, Huiyou; Wang, Peng; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China; [Zhang, Hong] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Radiol, Nanjing, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China.	chenyuchen1989@126.com; y.163yy@163.com		Chen, Yu-Chen/0000-0002-8539-7224	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870563] Funding Source: Medline; Nanjing Medical University grant [2017NJMU123] Funding Source: Medline; Six Talent Peaks Project in Jiangsu Province [YY-079] Funding Source: Medline; Youth Medical Talents of Jiangsu Province [QNRC2016062] Funding Source: Medline; Jiangsu Provincial Special Program of Medical Science [BE2017614] Funding Source: Medline		Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Livny A, 2017, J NEUROTRAUM, V34, P1466, DOI 10.1089/neu.2016.4598; Lu LY, 2014, NEUROL INDIA, V62, P487, DOI 10.4103/0028-3886.144434; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Piras F, 2015, CORTEX, V62, P89, DOI 10.1016/j.cortex.2013.01.016; RIGG JL, 2011, PHYS MED REHABILITAT, V3, P380; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tops M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00330; Tu Y, 2016, CLIN NEUROPHYSIOL, V127, P1470, DOI 10.1016/j.clinph.2015.07.036; Uddin LQ, 2014, J COGNITIVE NEUROSCI, V26, P16, DOI 10.1162/jocn_a_00462; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	52	4	5	2	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2020	14	3					907	916		10.1007/s11682-019-00053-3			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LV2EP	WOS:000538253100022	30734204				2022-02-06	
J	McGeown, JP; Kara, S; Fulcher, M; Crosswell, H; Borotkanics, R; Hume, PA; Quarrie, KL; Theadom, A				McGeown, Joshua P.; Kara, Stephen; Fulcher, Mark; Crosswell, Hannah; Borotkanics, Robert; Hume, Patria A.; Quarrie, Kenneth L.; Theadom, Alice			Predicting Sport-related mTBI Symptom Resolution Trajectory Using Initial Clinical Assessment Findings: A Retrospective Cohort Study	SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; MOTOR SCREENING VOMS; POSTURAL CONTROL; SEX-DIFFERENCES; CONCUSSION; RECOVERY; EXERCISE; RELIABILITY	Objectives To identify which aspects of initial clinical assessment for sport-related mild traumatic brain injury (SR-mTBI) predict whether an athlete achieves symptom resolution within 14 days of the injury. Research Design Retrospective cohort study using prospectively collected data. Methods Clinical assessment data were collected from 568 patients diagnosed with SR-mTBI at a single medical clinic between February 2017 and December 2018. Demographic data, medical history, SCAT-5 testing, and physician notes were included in the data set. Data were processed and analysed to identify a shortlist of predictor variables to develop a logistic regression model to discriminate between SR-mTBI symptom resolution that occurred in <= 14-days or > 14-days. The data were randomly divided into model development and validation subsamples. The top 15 models were analysed to determine the predictor variables to be included in the final logistic regression model. The final model was then applied to the validation subsample. Results Half of the athlete participants in this study experienced > 14-day symptom resolution. The final logistic regression model included sex, symptom reporting at initial assessment and presentation with a physiological predominant symptom cluster. The model accounted for 0.90 and 0.85 of the area under the curve and predicted recovery trajectory with 81% and 76% accuracy for the training and validation subsamples, respectively. Conclusions Being female, reporting a higher Positive Symptom Total at initial assessment, and being less likely to have a physiological predominant symptom cluster at initial assessment predicted > 14 versus <= 14-day SR-mTBI symptom resolution with a high level of accuracy.	[McGeown, Joshua P.; Borotkanics, Robert; Hume, Patria A.; Quarrie, Kenneth L.] Auckland Univ Technol, Sports Performance Res Inst New Zealand SPRINZ, Fac Hlth & Environm Sci, Private Bag 92006, Auckland 1142, New Zealand; [Kara, Stephen; Fulcher, Mark; Crosswell, Hannah] Axis Sports Med Clin, Auckland, New Zealand; [Hume, Patria A.; Theadom, Alice] Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci NISAN, Auckland, New Zealand; [Quarrie, Kenneth L.] New Zealand Rugby, 100 Molesworth St, Wellington, New Zealand		McGeown, JP (corresponding author), Auckland Univ Technol, Sports Performance Res Inst New Zealand SPRINZ, Fac Hlth & Environm Sci, Private Bag 92006, Auckland 1142, New Zealand.	josh.mcgeown@aut.ac.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; McGeown, Joshua/0000-0003-0225-4488			[Anonymous], 2016, OXFORD DICT SPORTS S; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Costello DM, 2018, J CLIN NEUROSCI, V56, P1, DOI 10.1016/j.jocn.2018.07.002; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Doherty C, 2017, HUM MOVEMENT SCI, V52, P160, DOI 10.1016/j.humov.2017.02.005; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Reid D, 2018, 4 SPRINZ AUCKL U TEC; Rice DA, 2018, BRIT J ANAESTH, V121, P804, DOI 10.1016/j.bja.2018.05.070; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Solomito MJ, 2019, BRAIN INJURY, V33, P105, DOI 10.1080/02699052.2018.1542507; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tommerdahl, 2018, J PHYSIOTHER RES, V2, P13; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	46	4	4	0	5	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	JUN	2020	50	6					1191	1202		10.1007/s40279-019-01240-4			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	LP3XV	WOS:000534253000009	31845203				2022-02-06	
J	Selvakumar, GP; Ahmed, ME; Iyer, SS; Thangavel, R; Kempuraj, D; Raikwar, SP; Bazley, K; Wu, K; Khan, A; Kukulka, K; Bussinger, B; Zaheer, S; Burton, C; James, D; Zaheer, A				Selvakumar, Govindhasamy Pushpavathi; Ahmed, Mohammad Ejaz; Iyer, Shankar S.; Thangavel, Ramasamy; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Bazley, Kieran; Wu, Kristopher; Khan, Asher; Kukulka, Klaudia; Bussinger, Bret; Zaheer, Smita; Burton, Casey; James, Donald; Zaheer, Asgar			Absence of Glia Maturation Factor Protects from Axonal Injury and Motor Behavioral Impairments after Traumatic Brain Injury	EXPERIMENTAL NEUROBIOLOGY			English	Article						Traumatic brain injury; Neuroinflammation; Glia maturation factor; Parkinson's disease; Motor behavior	NF-KAPPA-B; FLUID-PERCUSSION INJURY; FACTOR-DEPENDENT ACTIVATION; COLONY-STIMULATING FACTOR; C-TERMINAL HYDROLASE; NERVE GROWTH-FACTOR; DOPAMINERGIC-NEURONS; COGNITIVE DEFICITS; MOUSE MODEL; OXIDATIVE STRESS	Traumatic brain injury (TBI) causes disability and death, accelerating the progression towards Alzheimer's disease and Parkinson's disease (PD). TBI causes serious motor and cognitive impairments. as seen in PD that arise during the period of the initial insult However, this has been understudied relative to TBI induced neuroinflammation, motor and cognitive decline that progress towards PD. Neuronal ubiquitin-C-terminal hydrolase-L1 (UCHL1) is a thiol protease that breaks down ubiquitinated proteins and its level represents the severity of TBI. Previously, vie demonstrated the molecular action of glia maturation factor (GMF); a proinflammatory protein in mediating neuroinflanunation and neuronal loss. Here. we show that the weight drop method induced TBI neuropathology using behavioral tests, western blotting, and immunofluorescence techniques on sections from wild type (WT) and GMF-deficient (GMF-KO) mice. Results reveal a significant improvement in substantia nigral tyrosine hydroxyiase and dopamine transporter expression with motor behavioral performance in GMF-KO mice following TBI. In addition, a significant reduction in neuroinflanunation was manifested, as shown by activation of nuclear factor-kB, reduced levels of inducible nitric oxide synthase, and cyclooxygenase-2 expressions. Likewise, neurotrophins including brain-derived neurotrophic factor and glial-derived neurotrophic factor were significantly improved in GMF-KO mice than WT 72 h post-TBI. Consistently we found that TBI enhances GFAP and UCHL-1 expression and reduces the number of dopaminergic TH-positive neurons in WT compared to GMF-KO mice 72 h post-TBI. Interestingly, we observed a reduction of TH-positive tanycytes in the median eminence of WT than GMF-KO mice. Overall, we found that absence of GMF significantly reversed these neuropathological events and improved behavioral outcome. This study provides evidence that PD-associated pathology progression can be initiated upon induction of TBI.	[Selvakumar, Govindhasamy Pushpavathi; Ahmed, Mohammad Ejaz; Iyer, Shankar S.; Thangavel, Ramasamy; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Zaheer, Asgar] Harry S Truman Mem Vet Hosp, Columbia, MO 65211 USA; [Selvakumar, Govindhasamy Pushpavathi; Ahmed, Mohammad Ejaz; Iyer, Shankar S.; Thangavel, Ramasamy; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Bazley, Kieran; Wu, Kristopher; Khan, Asher; Kukulka, Klaudia; Bussinger, Bret; Zaheer, Smita; Zaheer, Asgar] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA; [Selvakumar, Govindhasamy Pushpavathi; Ahmed, Mohammad Ejaz; Iyer, Shankar S.; Thangavel, Ramasamy; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Bazley, Kieran; Wu, Kristopher; Khan, Asher; Kukulka, Klaudia; Bussinger, Bret; Zaheer, Smita; Zaheer, Asgar] Univ Missouri, Ctr Translat Neurosci, Sch Med, Columbia, MO 65211 USA; [Burton, Casey; James, Donald] Phelps Hlth, Rolla, MO 65401 USA		Zaheer, A (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65211 USA.; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA.; Zaheer, A (corresponding author), Univ Missouri, Ctr Translat Neurosci, Sch Med, Columbia, MO 65211 USA.	zaheera@health.missouri.edu	Raikwar, Sudhanshu/AAT-5128-2021	Khan, Asher/0000-0001-6314-240X; Raikwar, Sudhanshu/0000-0001-8549-8570	Leonard Wood Institute; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; VA Research Career Scientist Award	Research was sponsored by the Leonard Wood Institute in cooperation with the U.S. Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Leonard Wood Institute, the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation heron. The authors express their gratitude for the Acute Effects of Neurotrauma Consortium in assisting and coordinating the conduct of this project at Fort Leonard Wood. Dr Zaheer (AZ) is the recipient of the VA Research Career Scientist Award.	Aartsma-Rus Annemieke, 2014, J Vis Exp, DOI 10.3791/51303; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ahmed ME, 2019, MOL NEUROBIOL, V56, P6964, DOI 10.1007/s12035-019-1544-z; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; Bales James W, 2010, Open Drug Discov J, V2, P119; Baquet ZC, 2005, J NEUROSCI, V25, P6251, DOI 10.1523/JNEUROSCI.4601-04.2005; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buckley MJ, 2005, Q J EXP PSYCHOL-B, V58, P246, DOI 10.1080/02724990444000186; Burke RE, 1998, J NEUROCHEM, V71, P517; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chen MH, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7371403; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dresselhaus EC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01043; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grandoso L, 2007, INT J PHARMACEUT, V343, P69, DOI 10.1016/j.ijpharm.2007.05.027; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; GUNDERSEN HJG, 1992, ACTA NEUROL SCAND, V85, P8, DOI 10.1111/j.1600-0404.1992.tb05032.x; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Johr J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228474; KAPLAN R, 1991, J NEUROCHEM, V57, P483, DOI 10.1111/j.1471-4159.1991.tb03777.x; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Khan MM, 2015, NEUROCHEM RES, V40, P980, DOI 10.1007/s11064-015-1553-x; Khan MM, 2014, J MOL NEUROSCI, V53, P590, DOI 10.1007/s12031-013-0225-z; Khan MM, 2013, NEUROCHEM INT, V62, P379, DOI 10.1016/j.neuint.2013.01.029; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIM R, 1988, DEV BRAIN RES, V40, P277, DOI 10.1016/0165-3806(88)90140-X; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; Lim R, 2004, BRAIN RES, V1024, P225, DOI 10.1016/j.brainres.2004.08.003; Lim R, 2006, HDB NEUROCHEMISTRY M, P203; Liu H, 2019, P NATL ACAD SCI USA, V116, P4643, DOI 10.1073/pnas.1821282116; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Machado DG, 2007, PROG NEURO-PSYCHOPH, V31, P421, DOI 10.1016/j.pnpbp.2006.11.004; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Przedborski Serge, 2007, Handb Clin Neurol, V83, P535, DOI 10.1016/S0072-9752(07)83026-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Selvakumar GP, 2014, BRAIN RES, V1585, P23, DOI 10.1016/j.brainres.2014.03.010; Selvakumar GP, 2020, BRAIN BEHAV IMMUN, V87, P429, DOI 10.1016/j.bbi.2020.01.013; Selvakumar GP, 2019, MOL NEUROBIOL, V56, P3865, DOI 10.1007/s12035-018-1340-1; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Snow WM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00118; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stahl K, 2011, BRAIN RES, V1378, P105, DOI 10.1016/j.brainres.2010.12.090; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; von Bohlen und Halbach O, 2005, FASEB J, V19, P1740, DOI 10.1096/fj.05-3845fje; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wong C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.28; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zaheer A, 1997, J BIOL CHEM, V272, P5183, DOI 10.1074/jbc.272.8.5183; ZAHEER A, 1993, J NEUROCHEM, V60, P914, DOI 10.1111/j.1471-4159.1993.tb03237.x; Zaheer A, 2007, J NEUROCHEM, V101, P364, DOI 10.1111/j.1471-4159.2006.04385.x; Zaheer A, 2006, NEUROCHEM RES, V31, P579, DOI 10.1007/s11064-006-9049-3; Zhang HS, 2018, INT J MOL MED, V41, P3203, DOI 10.3892/ijmm.2018.3567; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	121	4	4	2	3	KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE	SEOUL	EXPERIMENTAL NEUROBIOLOGY,  SEOUL NATL UNIV, RM 410, BLDG 152-1, SEOUL, 151-742, SOUTH KOREA	1226-2560	2093-8144		EXP NEUROBIOL	Exp. Neurobiol.	JUN	2020	29	3					230	248		10.5607/en20017			19	Medicine, Research & Experimental; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Neurosciences & Neurology	MI6AX	WOS:000547489300005	32565489	Green Published, gold			2022-02-06	
J	Zeldovich, M; Wu, YJ; Gorbunova, A; Mikolic, A; Polinder, S; Plass, AM; Covic, A; Asendorf, T; Andelic, N; Voormolen, DC; von Steinbuchel, N				Zeldovich, Marina; Wu, Yi-Jhen; Gorbunova, Anastasia; Mikolic, Ana; Polinder, Suzanne; Plass, Anne Marie; Covic, Amra; Asendorf, Thomas; Andelic, Nada; Voormolen, Daphne C.; von Steinbuechel, Nicole		CTR-TBI 7 Participants Investigato	Influence of Sociodemographic, Premorbid, and Injury-Related Factors on Post-Concussion Symptoms after Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						RPQ; post-concussion symptoms; traumatic brain injury; negative binomial model; zero-inflated negative binomial model	MILD HEAD-INJURY; POSTCONCUSSION SYNDROME; RISK-FACTORS; CENTER-TBI; RECOVERY; FATIGUE; AGE; QUESTIONNAIRE; EPIDEMIOLOGY; PREVALENCE	Background: Post-concussion symptoms (PCS) are often reported as consequences of mild and moderate traumatic brain injury (TBI), but these symptoms are not well documented in severe TBI. There is a lack of agreement as to which factors and covariates affect the occurrence, frequency, and intensity of PCS among TBI severity groups. The present study therefore aims to examine the association between sociodemographic, premorbid, and injury-related factors and PCS. Methods: A total of 1391 individuals (65% male) from the CENTER-TBI study were included in the analyses. The occurrence, frequency (number of PCS), and intensity (severity) of PCS were assessed using the Rivermead Post-concussion Symptoms Questionnaire (RPQ) at six months after TBI. To examine the association between selected factors (age, sex, living situation, employment status, educational background, injury and TBI severity, and premorbid problems) and PCS, a zero-inflated negative binomial model (ZINB) for occurrence and frequency of PCS and a standard negative binomial regression (NB) for intensity were applied. Results: Of the total sample, 72% of individuals after TBI reported suffering from some form of PCS, with fatigue being the most frequent among all TBI severity groups, followed by forgetfulness, and poor concentration. Different factors contributed to the probability of occurrence, frequency, and intensity of PCS. While the occurrence of PCS seemed to be independent of the age and sex of the individuals, both the frequency and intensity of PCS are associated with them. Both injury and TBI severity influence the occurrence and frequency of PCS, but are associated less with its intensity (except "acute" symptoms such as nausea, vomiting, and headaches). Analyses focusing on the mTBI subgroup only yielded results comparable to those of the total sample. Discussion: In line with previous studies, the results support a multifactorial etiology of PCS and show the importance of differentiating between their occurrence, frequency, and intensity to better provide appropriate treatment for individual subgroups with different symptoms (e.g., multiple PCS or more intense PCS). Although PCS often occur in mild to moderate TBI, individuals after severe TBI also suffer from PCS or post-concussion-like symptoms that require appropriate treatment. The chosen statistical approaches (i.e., ZINB and NB models) permit an ameliorated differentiation between outcomes (occurrence, frequency, and intensity of PCS) and should be used more widely in TBI research.	[Zeldovich, Marina; Wu, Yi-Jhen; Gorbunova, Anastasia; Plass, Anne Marie; Covic, Amra; von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [Mikolic, Ana; Polinder, Suzanne; Voormolen, Daphne C.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, NL-3000 Rotterdam, Netherlands; [Asendorf, Thomas] Univ Med Ctr Gottingen, Dept Med Stat, D-37073 Gottingen, Germany; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0450 Oslo, Norway; [Andelic, Nada] Res Ctr Habilitat & Rehabil Models, Fac Med, Inst Hlth & Soc, N-0373 Oslo, Norway		Zeldovich, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany.	marina.zeldovich@med.uni-goettingen.de; yi-jhen.wu@med.uni-goettingen.de; anastasia.gorbunova@med.uni-goettingen.de; a.mikolic@erasmusmc.nl; s.polinder@erasmusmc.nl; annemarie.plass@med.uni-goettingen.de; amra.covic@med.uni-goettingen.de; thomas.asendorf@med.uni-goettingen.de; nandelic@online.no; d.voormolen@erasmusmc.nl; nvsteinbuechel@med.uni-goettingen.de	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Plass, Anne Marie/0000-0002-7801-9655	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany). The funders did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acquadro C., 2012, LINGUISTIC VALIDATIO; American Psychiatric Association, 1994, AM PSYCH ASS DIAGN S, V4th; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Barefoot JC, 2001, PSYCHOL AGING, V16, P342, DOI 10.1037/0882-7974.16.2.342; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Casson RJ, 2014, CLIN EXP OPHTHALMOL, V42, P590, DOI 10.1111/ceo.12358; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gennarelli TA, 2008, ASS ADV AUTOMOTIVE M; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hinde J, 1998, COMPUT STAT DATA AN, V27, P151, DOI 10.1016/S0167-9473(98)00007-3; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Jackman S., 2017, R PACKAGE VERSION, V1, P2; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kleiber C, 2016, AM STAT, V70, P296, DOI 10.1080/00031305.2016.1173590; La Fountaine MF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00691; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; R Core Team, 2019, R LANG ENV STAT COMP; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Stanworth RD, 2008, CLIN INTERV AGING, V3, P25; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; TEASDALE G, 1974, LANCET, V2, P81; Tukey J.W., 1972, STAT PAPERS HONOR GW, P293; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wang Z, 2015, BIOMETRICAL J, V57, P867, DOI 10.1002/bimj.201400143; WHO, 2004, ICD 10 INT STAT CLAS, V2; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zeileis A, 2018, COUNTREG COUNT DATA; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	70	4	4	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2020	9	6							1931	10.3390/jcm9061931			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ML4IC	WOS:000549430700001	32575667	Green Published, gold			2022-02-06	
J	Zhang, BL; Gao, YL; Li, QF; Sun, DD; Dong, XL; Li, XT; Xin, WQ; Zhang, JN				Zhang, Baoliang; Gao, Yalong; Li, Qifeng; Sun, Dongdong; Dong, Xinlong; Li, Xiaotian; Xin, Wenqiang; Zhang, Jianning			Effects of Brain -Derived Mitochondria on the Function of Neuron and Vascular Endothelial Cell After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article							PLASTICITY; PATHWAY; MODEL		[Zhang, Baoliang] Tianjin Med Univ Gen Hosp, Dept Gen Med, Airport Hosp, Tianjin, Peoples R China; [Zhang, Baoliang] Tianjin Med Univ Gen Hosp, Dept Med Cosmetol, Airport Hosp, Tianjin, Peoples R China; [Gao, Yalong; Li, Qifeng; Dong, Xinlong; Li, Xiaotian; Xin, Wenqiang; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Airport Hosp, Tianjin, Peoples R China; [Gao, Yalong; Li, Qifeng; Dong, Xinlong; Li, Xiaotian; Xin, Wenqiang; Zhang, Jianning] Minist Educ China, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin, Peoples R China; [Gao, Yalong; Li, Qifeng; Dong, Xinlong; Li, Xiaotian; Xin, Wenqiang; Zhang, Jianning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Sun, Dongdong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Airport Hosp, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Minist Educ China, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Tianjin Neurol Inst, Tianjin, Peoples R China.	jianningzhang@hotmail.com		Xin, Wenqiang/0000-0003-0231-6474			Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chien L, 2018, BBA-MOL BASIS DIS, V1864, P3001, DOI 10.1016/j.bbadis.2018.06.012; CLAYTON GH, 1994, J COMP NEUROL, V347, P470, DOI 10.1002/cne.903470312; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269; Colangelo AM, 2019, NEURAL REGEN RES, V14, P201, DOI 10.4103/1673-5374.244775; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gollihue JL, 2017, MITOCHONDRION, V35, P70, DOI 10.1016/j.mito.2017.05.007; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; He Y, 2016, J THEOR BIOL, V403, P159, DOI 10.1016/j.jtbi.2016.05.015; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Nguyen H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072127; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kostyuk Vladimir A, 2009, Front Biosci (Elite Ed), V1, P179; Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rebbeck CA, 2011, SCIENCE, V331, P303, DOI 10.1126/science.1197696; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Wang Y, 2019, PROG NEURO-PSYCHOPH, V93, P240, DOI 10.1016/j.pnpbp.2019.04.010; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007	42	4	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2020	138						E1	E9		10.1016/j.wneu.2019.11.172			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY7SV	WOS:000540728900001	31816451				2022-02-06	
J	Lietke, S; Zausinger, S; Patzig, M; Holtmanspotter, M; Kunz, M				Lietke, Stefanie; Zausinger, Stefan; Patzig, Maximilian; Holtmanspoetter, Markus; Kunz, Mathias			CT-Based Classification of Acute Cerebral Edema: Association with Intracranial Pressure and Outcome	JOURNAL OF NEUROIMAGING			English	Article						acute cerebral lesions; cerebral edema; computed tomography; intracranial pressure; outcome	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ARTERY INFARCTION; PROGNOSTIC VALUE; MANAGEMENT; DIFFUSION; VOLUME; PATHOPHYSIOLOGY	BACKGROUND AND PURPOSE Brain edema after acute cerebral lesions may lead to raised intracranial pressure (ICP) and worsen outcome. Notwithstanding, no CT-based scoring system to quantify edema formation exists. This retrospective correlative analysis aimed to establish a valid and definite CT score quantifying brain edema after common acute cerebral lesions. METHODS A total of 169 CT investigations in 60 patients were analyzed: traumatic brain injury (TBI; n = 47), subarachnoid hemorrhage (SAH; n = 70), intracerebral hemorrhage (ICH; n = 42), and ischemic stroke (n = 10). Edema formation was classified as 0: no edema, 1: focal edema confined to 1 lobe, 2: unilateral edema > 1 lobe, 3: bilateral edema, 4: global edema with disappearance of sulcal relief, and 5: global edema with basal cisterns effacement. ICP and Glasgow Outcome Score (GOS) were correlated to edema formation. RESULTS Median ICP values were 12.0, 14.0, 14.9, 18.2, and 25.9 mm Hg in grades 1-5, respectively. Edema grading significantly correlated with ICP (r = .51; P < .0001) in focal and global cerebral edema, particularly in patients with TBI, SAH, and ICH (r = .5, P r = .5; P r = .6, P < .0001, respectively). At discharge, 23.7% of patients achieved a GOS of 5 or 4, 65.0% reached a GOS of 3 or 2, and 11.9% died (GOS 1). CT-score of cerebral edema in all patients correlated with outcome (r = -.3, P = .046). CONCLUSION The proposed CT-based grading of extent of cerebral edema significantly correlated with ICP and outcome in TBI, SAH, and ICH patients and might be helpful for standardized description of CT-images and as parameter for clinical studies, for example, measuring effects of antiedematous therapies.	[Lietke, Stefanie; Zausinger, Stefan; Kunz, Mathias] Ludwigs Maximilians Univ, Dept Neurosurg, Munich, Germany; [Patzig, Maximilian; Holtmanspoetter, Markus] Ludwig Maximilians Univ Munchen, Inst Neuroradiol, Munich, Germany; [Holtmanspoetter, Markus] Paracelsus Med Univ, Nuremberg Hosp, Neuroradiol, Nurnberg, Germany		Lietke, S (corresponding author), Hosp Univ Munich, Dept Neurosurg, Campus Grosshadern,Marchioninistr 15, D-83177 Munich, Germany.	stefanie.lietke@med.uni-muenchen.de		Kunz MD, Mathias/0000-0003-1641-450X; Quach, Stefanie/0000-0003-2914-3649			Baethmann A, 1997, ZBL NEUROCHIR, V58, P20; Broocks G, 2018, STROKE, V49, P1906, DOI 10.1161/STROKEAHA.118.020507; Broocks G, 2018, INVEST RADIOL, V53, P472, DOI 10.1097/RLI.0000000000000475; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Choi HA, 2016, NEUROCRIT CARE, V25, P64, DOI 10.1007/s12028-015-0229-3; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Firlik AD, 1998, J NEUROSURG, V89, P243, DOI 10.3171/jns.1998.89.2.0243; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; GROEGER U, 1989, ACTA NEUROCHIR, V101, P134, DOI 10.1007/BF01410529; Gupta M, 2014, J NEUROSCI RURAL PRA, V5, P48, DOI 10.4103/0976-3147.127873; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Lampl Y, 2005, CEREBROVASC DIS, V20, P433, DOI 10.1159/000088981; Lampl Y, 2006, BRAIN RES, V1113, P194, DOI 10.1016/j.brainres.2006.07.030; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Ma L, 2011, NEUROL RES, V33, P494, DOI 10.1179/016164111X13007856084124; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Mocco J, 2007, Neurosurg Focus, V22, pE7; Mohammed MF, 2018, INVEST RADIOL, V53, P63, DOI 10.1097/RLI.0000000000000413; Na DG, 2005, RADIOLOGY, V235, P992, DOI 10.1148/radiol.2353040571; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rowland MJ, 2017, J CEREB BLOOD FLOW M, V39, P285; Rudkin S, 2018, EMERG RADIOL, V25, P659, DOI 10.1007/s10140-018-1623-x; Sheth KN, 2018, STROKE, V49, P1457, DOI 10.1161/STROKEAHA.117.020365; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Weimer JM, 2017, AM J NEURORADIOL, V38, P928, DOI 10.3174/ajnr.A5181; Wu J, 2010, ACTA NEUROCHIR SUPPL, V106, P147, DOI 10.1007/978-3-211-98811-4_26; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	48	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	SEP	2020	30	5					640	647		10.1111/jon.12736		MAY 2020	8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	NU0EO	WOS:000535715600001	32462690				2022-02-06	
J	Rietdijk, R; Power, E; Attard, M; Togher, L				Rietdijk, Rachael; Power, Emma; Attard, Michelle; Togher, Leanne			Acceptability of telehealth-delivered rehabilitation: Experiences and perspectives of people with traumatic brain injury and their carers	JOURNAL OF TELEMEDICINE AND TELECARE			English	Article; Early Access						Acceptability; telerehabilitation; traumatic brain injury	COMMUNICATION PARTNERS; TELEREHABILITATION; EFFICACY	Introduction Communication skills training for people with traumatic brain injury (TBI) and their carers is recommended best practice. Delivery via telehealth could improve access to this training. This paper focuses on the acceptability of telehealth delivery of communication skills training. Methods A mixed-methods investigation of acceptability of telehealth to people with TBI and their carers was incorporated into a clinical trial. Thirty-six people with TBI (23 metropolitan and 13 regional) and their carers were recruited. Metropolitan participants were randomly allocated to telehealth or in-person intervention at a 1:3 ratio. Regional participants were allocated to telehealth. Telehealth and in-person participants were compared on retention, time to complete the programme, home practice completion and therapeutic alliance ratings. Participants completed semi-structured interviews regarding their views on telehealth, which were analysed using thematic analysis. Results There were no significant differences between telehealth and in-person participants in retention rate, time to complete the programme, degree of home practice completion or therapeutic alliance ratings. Three themes were identified: 'telehealth delivery opens a window for access to rehabilitation in the context of my daily life', 'in-person delivery offers rehabilitation based on natural human interaction' and 'weighing telehealth against in-person delivery'. Discussion Participants found telehealth delivery acceptable, as indicated by the similarity between groups in the quantitative process measures, and as reported in interviews. Some reported a preference for in-person delivery if there had been a choice of delivery mode. Participants described characteristics of the two delivery modes which were relevant to their attitudes towards telehealth.	[Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Ultimo, NSW, Australia; [Rietdijk, Rachael; Power, Emma; Attard, Michelle; Togher, Leanne] Univ Sydney, Fac Med & Hlth, POB 170, Lidcombe, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Fac Med & Hlth, POB 170, Lidcombe, NSW, Australia.	rachael.rietdijk@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406	Australian Postgraduate AwardAustralian Government	The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was supported by a grant from icare NSW and an Australian Postgraduate Award.	Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cahill J, 2012, PSYCHOTHER RES, V22, P241, DOI 10.1080/10503307.2011.643253; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; Crotty M., 1998, FDN SOCIAL RES MEANI; Crotty M, 2014, J TELEMED TELECARE, V20, P370, DOI 10.1177/1357633X14552382; Hines M, 2015, J TELEMED TELECARE, V21, P469, DOI 10.1177/1357633X15604555; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Kocsis BJ, 2018, TELEMED E-HEALTH, V24, P329, DOI 10.1089/tmj.2017.0088; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McGrath N, 2008, J HEAD TRAUMA REHAB, V23, P388, DOI 10.1097/01.HTR.0000341434.74875.c8; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponterotto JG, 2007, PERCEPT MOTOR SKILL, V105, P997, DOI 10.2466/PMS.105.3.997-1014; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rietdijk R, 2019, TBICONNECT CLINICIAN; Rietdijk R, 2020, BRAIN IMPAIR, V21, P110, DOI 10.1017/BrImp.2019.9; Rietdijk R, 2020, J SPEECH LANG HEAR R, V63, P615, DOI 10.1044/2019_JSLHR-19-00076; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Shek AC, 2021, NEUROPSYCHOL REHABIL, V31, P432, DOI 10.1080/09602011.2019.1701501; Shulver W, 2017, HEALTH EXPECT, V20, P120, DOI 10.1111/hex.12443; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L., 2010, TBI EXPRESS SOCIAL C; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Vaezipour A, 2019, J HEAD TRAUMA REHAB, V34, pE67, DOI 10.1097/HTR.0000000000000462; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067	33	4	4	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1357-633X	1758-1109		J TELEMED TELECARE	J. Telemed. Telecare											1357633X20923824	10.1177/1357633X20923824		MAY 2020	13	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	LS7DC	WOS:000536539900001	32460583				2022-02-06	
J	Wearne, T; Anderson, V; Catroppa, C; Morgan, A; Ponsford, J; Tate, R; Ownsworth, T; Togher, L; Fleming, J; Douglas, J; Docking, K; Sigmundsdottir, L; Francis, H; Honan, C; McDonald, S				Wearne, Travis; Anderson, Vicki; Catroppa, Cathy; Morgan, Angela; Ponsford, Jennie; Tate, Robyn; Ownsworth, Tamara; Togher, Leanne; Fleming, Jennifer; Douglas, Jacinta; Docking, Kimberley; Sigmundsdottir, Linda; Francis, Heather; Honan, Cynthia; McDonald, Skye			Psychosocial functioning following moderate-to-severe pediatric traumatic brain injury: recommended outcome instruments for research and remediation studies	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Pediatric; Psychosocial; Outcome assessment; Outcome instuments; Remediation; Research; Recommendations	QUALITY-OF-LIFE; SOCIAL COMPETENCE; YOUNG-CHILDREN; ADOLESCENTS; RECOVERY; VALIDATION; CHALLENGES; YOUTH	Psychosocial functioning is compromised following pediatric traumatic brain injury (TBI), with the past few decades witnessing a proliferation of research examining the effect of childhood brain insult on a range of psychosocial outcomes. This paper describes the systematic recommendation of outcome instruments to address psychosocial functioning following pediatric TBI. A total of 65 instruments across 11 psychosocial areas (i.e., Global Outcome, Communication, Social Cognition, Behavioural and Executive Function, Other Neuropsychological Functioning, Psychological Status, TBI-related Symptoms, Activities and Participation, Support and Relationships, Sense of Self, and Health-Related Quality of Life) were reviewed using various assessment methods, including working groups, literature searches, comparisons with selection guidelines, and international expert opinion. Each measure was reviewed for its usefulness across early recovery, intervention, and outcome related studies. 34 instruments were recommended and classified according to the World Health Organization's International Classification of Functioning, Disability and Health taxonomy and categorised by psychosocial area. This compilation provides a common framework to guide the activities of clinicians and researchers in psychosocial rehabilitation. It is anticipated that these will foster a multidisciplinary approach to psychosocial dysfunction to enhance the evaluation, prediction, and improvement of functional outcomes for those with pediatric TBI.	[Wearne, Travis; Francis, Heather; Honan, Cynthia; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Wearne, Travis; Anderson, Vicki; Catroppa, Cathy; Morgan, Angela; Ponsford, Jennie; Tate, Robyn; Ownsworth, Tamara; Togher, Leanne; Fleming, Jennifer; Douglas, Jacinta; Docking, Kimberley; Sigmundsdottir, Linda; Francis, Heather; Honan, Cynthia; McDonald, Skye] Moving Ahead Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [Anderson, Vicki; Catroppa, Cathy; Morgan, Angela] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Catroppa, Cathy; Morgan, Angela] Univ Melbourne, Dept Psychol Sci & Paediat, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Parkville, Vic, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Tate, Robyn; Sigmundsdottir, Linda] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Med Sch, Northern Clin Sch, Sydney, NSW, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Togher, Leanne; Docking, Kimberley] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Fleming, Jennifer] Univ Queensland, Fac Hlth & Behav Sci, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Douglas, Jacinta] La Trobe Univ, Sch Allied Hlth, Dept Community & Clin Allied Hlth, Melbourne, Vic, Australia; [Francis, Heather] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Honan, Cynthia] Univ Tasmania, Sch Med, Dept Psychol, Launceston, Tas, Australia		McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Togher, Leanne/AAC-7083-2019; Catroppa, Cathy/AAX-9458-2021; Ownsworth, Tamara/ABB-6961-2021; Morgan, Angela/J-5235-2017; Ponsford, Jennie/H-8341-2014	Catroppa, Cathy/0000-0002-9750-0436; Ownsworth, Tamara/0000-0003-1835-7094; Anderson, Vicki/0000-0001-5233-3147; Morgan, Angela/0000-0003-1147-7405; Fleming, Jennifer/0000-0002-5603-2410; Docking, Kimberley/0000-0001-9996-7235; Francis, Heather/0000-0002-7223-7782; Wearne, Travis/0000-0002-7565-9163; Douglas, Jacinta/0000-0003-0940-6624; Ponsford, Jennie/0000-0003-0430-125X	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia	The Moving Ahead Centre for Research Excellence is funded by the National Health and Medical Research Council (NHMRC) for the period 2012-2017.	Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; [Anonymous], 2013, US ICF PRACT MAN US; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bonner MJ, 2006, J PEDIATR PSYCHOL, V31, P310, DOI 10.1093/jpepsy/jsj034; Bowers L., 2008, SOCIAL LANGUAGE DEV; Bowers Linda, 2004, WORD TEST 2 ELEMENTA; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Carrow-Woolfolkd E., 2011, ORAL WRITTEN LANGUAG; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Conoley JC, 1996, J LEARN DISABIL-US, V29, P662, DOI 10.1177/002221949602900610; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Edelbrock C, 1991, BURLINGTON VT, V7, P371; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gresham F., 2008, SOCIAL SKILLS IMPROV; Haley S, 1992, PEDIAT EVALUATION DI; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Kemp, 1998, NEPSY DEV NEUROPSYCH; Knafl K, 2011, J PEDIATR PSYCHOL, V36, P494, DOI 10.1093/jpepsy/jsp034; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lang M., 1983, CHILDRENS DEPRESSION; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; Muscara F, 2010, BRAIN IMPAIR, V11, P162, DOI 10.1375/brim.11.2.162; Nelson N. W., 2015, TEST INTEGRATED LANG; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Reynolds CR, 2002, COMPREHENSIVE TRAIL, P408; Rosenberg M., 1965, SOC ADOLESCENT SELF; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Soo C, 2016, DEV NEUROREHABIL, V19, P356, DOI 10.3109/17518423.2014.1000504; Soo C, 2008, DEV NEUROREHABIL, V11, P204, DOI 10.1080/17518420802259498; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thompson EJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016633; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wechsler D., 2014, WECHSLER INTELLIGENC; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Wiig EH, 2013, CLIN EVALUATION LANG, V5th; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2007, INT CLASS FUNCT DIS; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T	66	4	4	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 27	2020	30	5					973	987		10.1080/09602011.2018.1531768			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LK7GF	WOS:000531029900010	30296904				2022-02-06	
J	Parry, J; Hwang, J; Stahel, CF; Henderson, C; Nadeau, J; Stacey, S; Beauchamp, K; Moore, EE; Stahel, PF				Parry, Joshua; Hwang, Jiho; Stahel, Cedric F.; Henderson, Corey; Nadeau, Jason; Stacey, Stephen; Beauchamp, Kathryn; Moore, Ernest E.; Stahel, Philip F.			Soluble terminal complement activation fragment sC5b-9: a new serum biomarker for traumatic brain injury?	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Neuroinflammation; Complement activation; Membrane attack complex; sC5b-9; Biomarker	CLOSED-HEAD INJURY; ALTERNATIVE PATHWAY; EXPRESSION; C5A; INHIBITION; RECEPTOR; SYSTEM; TNF; C3	Purpose Terminal complement pathway activation after traumatic brain injury (TBI) leads to formation of the membrane attack complex (MAC/C5b-9) which induces neuronal cell death and host-mediated secondary brain injury. Serum levels of soluble MAC (sC5b-9) have not been previously determined in patients with isolated TBI. Methods A prospective observational cohort study was performed during a 5-year time-period on adult patients with isolated TBI admitted to an academic level I trauma center in the United States. Controls consisted of patients with femur shaft fractures with or without TBI to mitigate the effect of systemic complement activation by peripheral trauma. Healthy volunteers served as internal controls. The sC5b-9 serum concentrations were measured on the day of admission by enzyme-linked immunosorbent assay (ELISA) and compared between the study cohorts. Univariate analysis was performed to determine independent predictive variables of major complications during hospital admission. Results Serum sC5b-9 levels were significantly elevated in patients with isolated TBI (n = 42), compared to patients with isolated femoral shaft fractures (n = 36) or combined TBI and femoral shaft fractures (n = 30; p < 0.05). There was no significant difference in serum sC5b-9 levels between the femur group and the combined injury group, compared to the healthy volunteers (n = 21). Univariate analysis revealed serum sC5b-9 levels as an independent predictor of major postinjury complications after isolated TBI (p < 0.01). Conclusion The soluble terminal complement complex sC5b-9 represents a potential novel serum biomarker specific for isolated head injuries, since peripheral trauma did not appear to affect the serum sC5b-9 levels.	[Parry, Joshua; Hwang, Jiho; Stahel, Cedric F.; Henderson, Corey; Nadeau, Jason; Stacey, Stephen; Stahel, Philip F.] Denver Hlth Med Ctr, Dept Orthopaed, Denver, CO 80204 USA; [Parry, Joshua; Hwang, Jiho; Stahel, Cedric F.; Henderson, Corey; Nadeau, Jason; Stacey, Stephen; Beauchamp, Kathryn; Moore, Ernest E.; Stahel, Philip F.] Univ Colorado, Sch Med, Denver, CO 80204 USA; [Henderson, Corey; Stahel, Philip F.] Rocky Vista Univ, Coll Osteopath Med, Parker, CO 80134 USA; [Beauchamp, Kathryn; Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO 80204 USA		Stahel, PF (corresponding author), Denver Hlth Med Ctr, Dept Orthopaed, Denver, CO 80204 USA.; Stahel, PF (corresponding author), Univ Colorado, Sch Med, Denver, CO 80204 USA.; Stahel, PF (corresponding author), Rocky Vista Univ, Coll Osteopath Med, Parker, CO 80134 USA.	Philip.Stahel@gmail.com			Stryker Corporation, Kalamazoo, MI (USA)	This study was supported by a peer-reviewed industrial grant to the senior author (P.F.S.) by Stryker Corporation, Kalamazoo, MI (USA).	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Barnum SR, 2017, TRENDS PHARMACOL SCI, V38, P503, DOI 10.1016/j.tips.2017.03.009; Barnum SR, 2017, PHARMACOL THERAPEUT, V172, P63, DOI 10.1016/j.pharmthera.2016.11.014; Barrett CD, 2019, J TRAUMA ACUTE CARE, V86, P101, DOI 10.1097/TA.0000000000002092; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Chakraborty S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02050; Edwards P, 2005, LANCET, V365, P1957; Flierl MA, 2010, J ORTHOP TRAUMA, V24, P107, DOI 10.1097/BOT.0b013e3181b6bdfc; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harhausen D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-15; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Levi M, 2019, RES PRACT THROMB HAE, V3, P38, DOI 10.1002/rth2.12175; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0229-2; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Roselli F, 2018, J NEUROTRAUM, V35, P226, DOI 10.1089/neu.2017.5168; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Stahel PF, 1997, AM J PATHOL, V151, P897; Stahel PF, 1997, J IMMUNOL, V159, P861; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Stahel PF, 2016, LANCET, V388, P102, DOI 10.1016/S0140-6736(16)30522-0; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Weber B, 2020, SHOCK, V54, P761, DOI 10.1097/SHK.0000000000001536; Wong EKS, 2015, TRANSL RES, V165, P306, DOI 10.1016/j.trsl.2014.10.010	40	4	4	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1491	1497		10.1007/s00068-020-01407-z		MAY 2020	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000535444700002	32451568				2022-02-06	
J	Gallagher, MJ; Hogg, FRA; Kearney, S; Kopp, MA; Blex, C; Serdani, L; Sherwood, O; Schwab, JM; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Gallagher, Mathew J.; Hogg, Florence R. A.; Kearney, Siobhan; Kopp, Marcel A.; Blex, Christian; Serdani, Leonarda; Sherwood, Oliver; Schwab, Jan M.; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Effects of local hypothermia-rewarming on physiology, metabolism and inflammation of acutely injured human spinal cord	SCIENTIFIC REPORTS			English	Article							INTRASPINAL PRESSURE; SYSTEMIC HYPOTHERMIA; BRAIN-INJURY; PERFUSION-PRESSURE; POSTTRAUMATIC HYPOTHERMIA; MICRODIALYSIS; CONTUSION; PROFILE	In five patients with acute, severe thoracic traumatic spinal cord injuries (TSCIs), American spinal injuries association Impairment Scale (AIS) grades A-C, we induced cord hypothermia (33 degrees C) then rewarming (37 degrees C). A pressure probe and a microdialysis catheter were placed intradurally at the injury site to monitor intraspinal pressure (ISP), spinal cord perfusion pressure (SCPP), tissue metabolism and inflammation. Cord hypothermia-rewarming, applied to awake patients, did not cause discomfort or neurological deterioration. Cooling did not affect cord physiology (ISP, SCPP), but markedly altered cord metabolism (increased glucose, lactate, lactate/pyruvate ratio (LPR), glutamate; decreased glycerol) and markedly reduced cord inflammation (reduced IL1 beta, IL8, MCP, MIP1 alpha, MIP1 beta). Compared with pre-cooling baseline, rewarming was associated with significantly worse cord physiology (increased ICP, decreased SCPP), cord metabolism (increased lactate, LPR; decreased glucose, glycerol) and cord inflammation (increased IL1 beta, IL8, IL4, IL10, MCP, MIP1 alpha). The study was terminated because three patients developed delayed wound infections. At 18-months, two patients improved and three stayed the same. We conclude that, after TSCI, hypothermia is potentially beneficial by reducing cord inflammation, though after rewarming these benefits are lost due to increases in cord swelling, ischemia and inflammation. We thus urge caution when using hypothermia-rewarming therapeutically in TSCI.	[Gallagher, Mathew J.; Hogg, Florence R. A.; Kearney, Siobhan; Sherwood, Oliver; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, Mol & Clin Sci Inst, London, England; [Kopp, Marcel A.; Blex, Christian; Serdani, Leonarda; Schwab, Jan M.] Charite Univ Med Berlin, Clin & Expt Spinal Cord Injury Res Neuroparaplegi, Charitepl 1, D-10117 Berlin, Germany; [Kopp, Marcel A.] QUEST Ctr Transforming Biomed Res, Berlin Inst Hlth, Berlin, Germany; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Belford Ctr Spinal Cord Injury, Dept Neurol,Neurol Inst, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Neurol Inst, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Neurol Inst, Columbus, OH 43210 USA; [Zoumprouli, Argyro] St George Hosp, Neuroanaesthesia & Neurointens Care Unit, London, England		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, Mol & Clin Sci Inst, London, England.	ssaadoun@sgul.ac.uk	Kopp, Marcel/AAX-3960-2020	Kopp, Marcel/0000-0001-6832-9599; Serdani, Leonarda/0000-0003-0194-046X; Schwab, Jan/0000-0001-6784-4919	Wings for Life Spinal Cord Research Foundation; Era-Net-NEURON Program of the European Union (SILENCE) [01EW170A]; NIDILRRUnited States Department of Health & Human Services [90SI5020]; W.E. Hunt & C.M. Curtis Endowment; Neurosciences Research Foundation (Fletcher Fund); Royal College of Surgeons of England	This work was supported by the Wings for Life Spinal Cord Research Foundation, the Era-Net-NEURON Program of the European Union (SILENCE Grant #01EW170A), NIDILRR (Grant #90SI5020), and the W.E. Hunt & C.M. Curtis Endowment and the Neurosciences Research Foundation (Fletcher Fund). We thank the neurosurgeons at St. George's, King's College and Royal Sussex Hospitals as well as the spinal orthopaedic surgeons at St. George's Hospital who helped us recruit patients. The neuroanaesthetic, neurointensive care and operating theatre staff at St. George's Hospital helped with patient management and data collection. F.R.A.H. holds a research fellowship from the Royal College of Surgeons of England.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bricolo A, 1976, Surg Neurol, V6, P101; Cappuccino Andrew, 2017, Am J Orthop (Belle Mead NJ), V46, pE79; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Dididze M, 2013, SPINAL CORD, V51, P395, DOI 10.1038/sc.2012.161; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hansebout RR, 2014, J NEUROSURG-SPINE, V20, P550, DOI 10.3171/2014.2.SPINE13318; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hogg FRA, 2020, J NEUROTRAUM, V37, P1156, DOI 10.1089/neu.2019.6789; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mizuma A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00467; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Zhu L, 2018, ADV EXP MED BIOL, V1097, P295, DOI 10.1007/978-3-319-96445-4_16	34	4	4	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 15	2020	10	1							8125	10.1038/s41598-020-64944-y			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND9JE	WOS:000562215900013	32415143	gold, Green Published, Green Accepted			2022-02-06	
J	Seno, S; Wang, J; Cao, SY; Saraswati, M; Park, S; Simoni, J; Ma, L; Soltys, B; Hsia, CJC; Koehler, RC; Robertson, CL				Seno, Soichiro; Wang, Jun; Cao, Suyi; Saraswati, Manda; Park, Sharon; Simoni, Jan; Ma, Li; Soltys, Bohdan; Hsia, Carleton J. C.; Koehler, Raymond C.; Robertson, Courtney L.			Resuscitation with macromolecular superoxide dismutase/catalase mimetic polynitroxylated PEGylated hemoglobin offers neuroprotection in guinea pigs after traumatic brain injury combined with hemorrhage shock	BMC NEUROSCIENCE			English	Article						Carbon monoxide; Controlled cortical impact; Guinea pig; Hemoglobin-based oxygen carrier; Hippocampus; Neuroprotection	BLOOD; TRANSFUSION; OXYGENATION	Background Polynitroxylated PEGylated hemoglobin (PNPH, aka SanFlow) possesses superoxide dismutase/catalase mimetic activities that may directly protect the brain from oxidative stress. Stabilization of PNPH with bound carbon monoxide prevents methemoglobin formation during storage and permits it to serve as a carbon monoxide donor. We determined whether small volume transfusion of hyperoncotic PNPH is neuroprotective in a polytrauma model of traumatic brain injury (TBI) plus hemorrhagic shock. Guinea pigs were used because, like humans, they do not synthesize their own ascorbic acid, which is important in reducing methemoglobin. Results TBI was produced by controlled cortical impact and was followed by 20 mL/kg hemorrhage to a mean arterial pressure (MAP) of 40 mmHg. At 90 min, animals were resuscitated with 20 mL/kg lactated Ringer's solution or 10 mL/kg PNPH. Resuscitation with PNPH significantly augmented the early recovery of MAP after hemorrhagic shock by 10-18 mmHg; whole blood methemoglobin was only 1% higher and carboxyhemoglobin was 2% higher. At 9 days of recovery, unbiased stereology analysis revealed that, compared to animals resuscitated with lactated Ringer's solution, those treated with PNPH had significantly more viable neurons in the hippocampus CA1 + 2 region (59 +/- 10% versus 87 +/- 18% of sham and naive mean value) and in the dentate gyrus (70 +/- 21% versus 96 +/- 24%; n = 12 per group). Conclusion PNPH may serve as a small-volume resuscitation fluid for polytrauma involving TBI and hemorrhagic shock. The neuroprotection afforded by PNPH seen in other species was sustained in a species without endogenous ascorbic acid synthesis, thereby supporting potential translatability for human use.	[Seno, Soichiro; Wang, Jun; Cao, Suyi; Saraswati, Manda; Park, Sharon; Koehler, Raymond C.; Robertson, Courtney L.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 600 North Wolfe St,Blalock 1404, Baltimore, MD 21287 USA; [Seno, Soichiro] Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan; [Simoni, Jan; Soltys, Bohdan; Hsia, Carleton J. C.] AntiRad Therapeut, Sioux Falls, SD USA; [Ma, Li] Georgia Southern Univ, Dept Phys, Statesboro, GA USA		Koehler, RC (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 600 North Wolfe St,Blalock 1404, Baltimore, MD 21287 USA.	rkoehler@jhmi.edu		Koehler, Raymond/0000-0002-5890-9992	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-17-C-0223]	This work is supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-17-C-0223. The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision, unless so designated by other documentation.	Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Brockman EC, 2017, J NEUROTRAUM, V34, P1337, DOI 10.1089/neu.2016.4656; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Buehler PW, 2007, J PHARMACOL EXP THER, V323, P49, DOI 10.1124/jpet.107.126409; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Cao SY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006505; Conover CD, 1999, ARTIF ORGANS, V23, P1088, DOI 10.1111/j.1525-1594.1999.06429.x; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Forrester JD, 2019, DISASTER MED PUBLIC, V13, P1074, DOI 10.1017/dmp.2019.42; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142, DOI 10.1042/BST0351142; Okayama N, 1999, FREE RADICAL RES, V31, P53, DOI 10.1080/10715769900300591; Saetzler RK, 1999, FREE RADICAL BIO MED, V27, P1, DOI 10.1016/S0891-5849(99)00037-4; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Stoyanovsky DA, 2010, BIOCHEM BIOPH RES CO, V399, P139, DOI 10.1016/j.bbrc.2010.07.030; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Young MA, 2005, CRIT CARE MED, V33, P1794, DOI 10.1097/01.CCM.0000172648.55309.13; Zhang J, 2012, J APPL PHYSIOL, V113, P1709, DOI 10.1152/japplphysiol.01079.2012	21	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	MAY 13	2020	21	1							22	10.1186/s12868-020-00571-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LS2IR	WOS:000536213600001	32404052	Green Published, gold			2022-02-06	
J	Zeng, XJ; Li, P; Ning, YL; Zhao, Y; Peng, Y; Yang, N; Xu, YW; Chen, JF; Zhou, YG				Zeng, Xu-Jia; Li, Ping; Ning, Ya-Lei; Zhao, Yan; Peng, Yan; Yang, Nan; Xu, Ya-Wei; Chen, Jiang-Fan; Zhou, Yuan-Guo			A(2A)R inhibition in alleviating spatial recognition memory impairment after TBI is associated with improvement in autophagic flux in RSC	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						lysosomal biogenesis; manganese-enhanced magnetic resonance imaging; neuronal apoptosis; retrosplenial cortex; transcription factor EB	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ADENOSINE A(2A); RECEPTOR; CELLS; MODEL; NEUROINFLAMMATION; INACTIVATION; COGNITION; PATHWAY	Spatial recognition memory impairment is an important complication after traumatic brain injury (TBI). We previously found that spatial recognition memory impairment can be alleviated in adenosine A(2A) receptor knockout (A(2A)R KO) mice after TBI, but the mechanism remains unclear. In the current study, we used manganese-enhanced magnetic resonance imaging and the Y-maze test to determine whether the electrical activity of neurons in the retrosplenial cortex (RSC) was reduced and spatial recognition memory was impaired in wild-type (WT) mice after moderate TBI. Furthermore, spatial recognition memory was damaged by optogenetically inhibiting the electrical activity of RSC neurons in WT mice. Additionally, the electrical activity of RSC neurons was significantly increased and spatial recognition memory impairment was reduced in A(2A)R KO mice after moderate TBI. Specific inhibition of A(2A)R in the ipsilateral RSC alleviated the impairment in spatial recognition memory in WT mice. In addition, A(2A)R KO improved autophagic flux in the ipsilateral RSC after injury. In primary cultured neurons, activation of A(2A)R reduced lysosomal-associated membrane protein 1 and cathepsin D (CTSD) levels, increased phosphorylated protein kinase A and phosphorylated extracellular signal-regulated kinase 2 levels, reduced transcription factor EB (TFEB) nuclear localization and impaired autophagic flux. These results suggest that the impairment of spatial recognition memory after TBI may be associated with impaired autophagic flux in the RSC and that A(2A)R activation may reduce lysosomal biogenesis through the PKA/ERK2/TFEB pathway to impair autophagic flux.	[Zeng, Xu-Jia; Li, Ping; Ning, Ya-Lei; Zhao, Yan; Peng, Yan; Yang, Nan; Xu, Ya-Wei; Zhou, Yuan-Guo] Army Med Univ, Daping Hosp, Dept Occupat Dis, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol & Pharmacol, Boston, MA 02118 USA		Zhou, YG (corresponding author), 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	ygzhou@tmmu.edu.cn		Li, Ping/0000-0002-4926-3835	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771176]; Cutting-Edge Research Plan of Chongqing [cstc2014jcyjA10072]	National Natural Science Foundation of China, Grant/Award Number: 81771176; Cutting-Edge Research Plan of Chongqing, Grant/Award Number: cstc2014jcyjA10072	Bassani TB, 2017, BEHAV BRAIN RES, V335, P41, DOI 10.1016/j.bbr.2017.08.014; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2014, INT REV NEUROBIOL, V119, P257, DOI 10.1016/B978-0-12-801022-8.00012-X; Chen Y, 2017, CLIN EXP PHARM PHYSL; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Diaz-Cabiale Z, 2002, NEUROSCI LETT, V324, P154, DOI 10.1016/S0304-3940(02)00179-9; Freitag MT, 2015, J NEUROIMAGING, V25, P582, DOI 10.1111/jon.12202; Fu Y, 2017, INT J DEV NEUROSCI, V60, P8, DOI 10.1016/j.ijdevneu.2017.03.010; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Hu QH, 2016, SCI REP-UK, V6, DOI 10.1038/srep18959; Jiang S, 2017, NEUROREPORT, V28, P386, DOI 10.1097/WNR.0000000000000760; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knight R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00135; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Ma MX, 2007, NEUROSCIENCE, V147, P1059, DOI 10.1016/j.neuroscience.2007.05.020; Martirosyan NL, 2010, NEUROSURGERY, V66, P131, DOI 10.1227/01.NEU.0000361997.08116.96; Miller AMP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00586; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Okada K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13158; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shao L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9917; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Simoes AP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-204; Stieltjes B, 2006, MAGN RESON MED, V55, P1124, DOI 10.1002/mrm.20888; Todd TP, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/414173; Torvinen M, 2005, MOL PHARMACOL, V67, P400, DOI 10.1124/mol.104.003376; Vann SD, 2011, CURR OPIN NEUROBIOL, V21, P440, DOI 10.1016/j.conb.2011.02.002; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Xia Q, 2016, EMBO J, V35, P121, DOI 10.15252/embj.201591998; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4	39	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	JUN	2020	24	12					7000	7014		10.1111/jcmm.15361		MAY 2020	15	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	LY6PW	WOS:000531528300001	32394486	gold, Green Published			2022-02-06	
J	Baker, VB; Sowers, CB; Hack, NK				Baker, Virginia B.; Sowers, Christopher B.; Hack, Nawaz K.			Lost productivity associated with headache and depression: a quality improvement project identifying a patient population at risk	JOURNAL OF HEADACHE AND PAIN			English	Article						Migraine; PHQ-9; Multi-disciplinary; Productivity; Mild traumatic brain injury (mTBI)	TRAUMATIC BRAIN-INJURY; UNITED-STATES; AFGHANISTAN WARS; HEALTH-CARE; MIGRAINE; PREVALENCE; BURDEN; COMORBIDITY; EPIDEMIOLOGY; STATISTICS	Objective This quality improvement project was implemented in order to highlight the association between headache, mTBI and depression on lost productivity and resource utilization. Background Mood disorders, environment and traumatic brain injury are common in patients with headache, and have been shown to influence clinical course, treatment response and outcome. Although widely recognized, the association of these factors on clinical outcomes, resource utilization and productivity is not well understood. Methods All patients presenting to a military referral center for migraines are assessed for presence of traumatic brain injury, Headache Impact Score (HIT-6) and Patient Depression Questionnaire (PHQ-9). Based on screening, patients are offered referral to mental health and a multidisciplinary headache education course. Results 237 patients were seen for headache or migraine. 180 patients had severely disabling headaches. These patients accounted for 146 emergency room visits over the course of one year. Of headache patients, 65% met criteria for depression and 15% of patients had severe depression. Only 37% of these patients carried a formal diagnosis of depression and 38% had been seen by mental health. Lost productivity and duty limitations were significantly associated with severity of depression. In service members screening positively for mild, moderate or severe depression, duty restrictions had been placed on 8.3%, 32.5% and 53.8%, respectively. Only 3.8% of patients who did not screen for depression had similar duty limitations. A history of mTBI strongly correlated with comorbid depression. Lost productivity and duty limitations were not impacted by other headache characteristics or HIT-6 scores. Conclusions This quality improvement project identified a practice gap for treatment of comorbid depression in patients presenting to Neurology for headache. Depression strongly correlated with productivity loss, highlighting a possible target for the economic burden of headache.	[Baker, Virginia B.; Hack, Nawaz K.] Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Sowers, Christopher B.] Naval Med Ctr San Diego, Dept Anesthesiol, San Diego, CA USA		Baker, VB (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Rockville Pike, Bethesda, MD 20889 USA.	Ginni.baker11@gmail.com					Amoozegar F, 2017, INT REV PSYCHIATR, V29, P504, DOI 10.1080/09540261.2017.1326882; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P12; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bonafede M, 2018, HEADACHE, V58, P700, DOI 10.1111/head.13275; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Burton WN, 2002, J OCCUP ENVIRON MED, V44, P523, DOI 10.1097/00043764-200206000-00013; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Dahlman C, 2007, COST MILITARY PERSON; Diener HC, 2011, CEPHALALGIA, V31, P1039, DOI 10.1177/0333102411409075; Fraser F, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0624-x; Guillem E, 1999, ENCEPHALE, V25, P436; Hazard E, 2009, VALUE HEALTH, V12, P55, DOI 10.1111/j.1524-4733.2008.00404.x; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lafata JE, 2004, J GEN INTERN MED, V19, P1005, DOI 10.1111/j.1525-1497.2004.30021.x; Lanteri-Minet M, 2013, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-013-0385-0; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Louter MA, 2015, J PSYCHOSOM RES, V79, P458, DOI 10.1016/j.jpsychores.2015.09.014; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Maurer DM, 2018, AM FAM PHYSICIAN, V98, P508; May A, 2016, NAT REV NEUROL, V12, P455, DOI 10.1038/nrneurol.2016.93; Minen MT, 2014, HEADACHE, V54, P1611, DOI 10.1111/head.12461; Minen MT, 2016, J NEUROL NEUROSUR PS, V87, P741, DOI 10.1136/jnnp-2015-312233; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pompili M, 2013, INDIAN J PSYCHIAT, V55, P256, DOI 10.4103/0019-5545.117145; Pompili M, 2012, PSYCHIAT RES, V200, P389, DOI 10.1016/j.psychres.2012.05.010; Porter JK, 2019, PHARMACOECON-OPEN, V3, P411, DOI 10.1007/s41669-018-0105-0; Peres MFP, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0742-1; Rendas-Baum R., 2014, HEALTH QUAL LIFE OUT, V12, P117, DOI [10.1186/s12955-014-0117-0, DOI 10.1186/s12955-014-0117-0, DOI 10.1186/S12955-014-0117-0]; Shala N, 2018, NEUROL NEUROCHIR POL, V52, P490, DOI 10.1016/j.pjnns.2018.03.003; SILBERSTEIN SD, 1995, CEPHALALGIA, V15, P358, DOI 10.1046/j.1468-2982.1995.1505358.x; Silberstein SD, 1998, CEPHALALGIA, V18, P50, DOI 10.1177/0333102498018S2113; Skopp Nancy A, 2012, MSMR, V19, P7; Smitherman TA, 2013, HEADACHE, V53, P427, DOI 10.1111/head.12074; Stokes M, 2011, HEADACHE, V51, P1058, DOI 10.1111/j.1526-4610.2011.01945.x; Wallasch TM, 2012, HEADACHE, V52, P1094, DOI 10.1111/j.1526-4610.2012.02189.x; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890; Yang YH, 2016, CEPHALALGIA, V36, P679, DOI 10.1177/0333102416638520; Ziegler DK, 1993, ARCH NEUROL-CHICAGO, V50, P449, DOI [10.1001/archneur.1993.00540050005002, DOI 10.1001/ARCHNEUR.1993.00540050005002]	39	4	4	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	MAY 11	2020	21	1							50	10.1186/s10194-020-01107-4			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP5CR	WOS:000534335700002	32393164	Green Published, gold			2022-02-06	
J	Cheung, A; Streijger, F; So, K; Okon, EB; Manouchehri, N; Shortt, K; Kim, KT; Keung, MSM; Chan, RM; Fong, A; Sun, J; Griesdale, DE; Sehkon, MS; Kwon, BK				Cheung, Amanda; Streijger, Femke; So, Kitty; Okon, Elena B.; Manouchehri, Neda; Shortt, Katelyn; Kim, Kyoung-Tae; Keung, Martin Sheung Man; Chan, Ryan M.; Fong, Allan; Sun, Jenny; Griesdale, Donald E.; Sehkon, Mypinder S.; Kwon, Brian K.			Relationship between Early Vasopressor Administration and Spinal Cord Hemorrhage in a Porcine Model of Acute Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						hemodynamics; MAP; pressure; spinal cord injury; vasopressor support	MEAN ARTERIAL-PRESSURE; BLOOD-FLOW; NONINVASIVE MEASUREMENT; SECONDARY INJURY; OXIDATIVE STRESS; BRAIN-INJURY; PERFUSION; METABOLISM; RAT; ACTIVATION	Current practice guidelines for acute spinal cord injury (SCI) recommend augmenting mean arterial blood pressure (MAP) for the first 7 days post-injury. After SCI, the cord may be compressed by the bone/ligaments of the spinal column, limiting regional spinal cord blood flow. Following surgical decompression, blood flow may be restored, and can potentially promote a "reperfusion" injury. The effects of MAP augmentation on the injured cord during the compressed and decompressed conditions have not been previously characterized. Here, we used our porcine model of SCI to examine the impact of MAP augmentation on blood flow, oxygenation, hydrostatic pressure, metabolism, and intraparenchymal (IP) hemorrhage within the compressed and then subsequently decompressed spinal cord. Yucatan mini-pigs underwent a T10 contusion injury followed by 2 h of sustained compression. MAP augmentation of similar to 20 mm Hg was achieved with norepinephrine (NE). Animals received MAP augmentation either during the period of cord compression (CP), after decompression (DCP), or during both periods (CP-DCP). Probes to monitor spinal cord blood flow (SCBF), oxygenation, pressure, and metabolic responses were inserted into the cord parenchyma adjacent to the injury site to measure these responses. The cord was harvested for histological evaluation. MAP augmentation increased SCBF and oxygenation in all groups. In the CP-DCP group, spinal cord pressure steadily increased and histological analysis showed significantly increased hemorrhage in the spinal cord at and near the injury site. MAP augmentation with vasopressors may improve blood flow and reduce ischemia in the injured cord but may also induce undesirable increases in IP pressure and hemorrhage.	[Cheung, Amanda; Streijger, Femke; So, Kitty; Okon, Elena B.; Manouchehri, Neda; Shortt, Katelyn; Kim, Kyoung-Tae; Keung, Martin Sheung Man; Chan, Ryan M.; Fong, Allan; Sun, Jenny; Kwon, Brian K.] Univ British Columbia, Dept Orthoped, Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Kwon, Brian K.] Univ British Columbia, Dept Orthoped, Vancouver Spine Surg Inst, Vancouver, BC, Canada; [Kim, Kyoung-Tae] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Neurosurg, Daegu, South Korea; [Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Anesthesiol, Vancouver, BC, Canada; [Sehkon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada		Kwon, BK (corresponding author), Univ British Columbia, Dept Orthoped, Blusson Spinal Cord Ctr, Vancouver Gen Hosp, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca		Cheung, Amanda/0000-0002-5571-6386; Fong, Allan/0000-0003-2738-4991; Sun, Jenny/0000-0003-4169-1226	US Department of Defense, Spinal Cord Injury Research Program (SCIRP)United States Department of Defense [SC130007]; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 133513]	This study was funded by the US Department of Defense, Spinal Cord Injury Research Program (SCIRP), SC130007, and the Canadian Institutes for Health Research (CIHR), MOP 133513.	ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; Augustine G., 2001, NEUROSCIENCE; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; Burlacu A, 2001, CELL TISSUE RES, V306, P409, DOI 10.1007/s004410100424; Caliaperumal J, 2012, EXP NEUROL, V237, P363, DOI 10.1016/j.expneurol.2012.07.001; Cao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12643; Caplan L.R., 1994, INTRACEREBRAL HEMORR, P99; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Catapano JS, 2016, WORLD NEUROSURG, V96, P72, DOI 10.1016/j.wneu.2016.08.053; Cohen JA, 2010, TOP SPINAL CORD INJ, V15, P96, DOI [10.1310/sci1503-96, DOI 10.1310/SCI1503-96]; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Crielaard BJ, 2017, NAT REV DRUG DISCOV, V16, P400, DOI 10.1038/nrd.2016.248; Dakson A, 2017, SPINAL CORD, V55, P1033, DOI 10.1038/sc.2017.52; Didion SP, 2003, STROKE, V34, P2038, DOI 10.1161/01.STR.0000081225.46324.AA; Didion SP, 2002, AM J PHYSIOL-HEART C, V283, pH1569, DOI 10.1152/ajpheart.00079.2002; DYSTE GN, 1989, NEUROSURGERY, V24, P228, DOI 10.1227/00006123-198902000-00012; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; FELDMAN RA, 1971, J NEUROSURG, V34, P618, DOI 10.3171/jns.1971.34.5.0618; Fernandez-Rodriguez OM, 2006, TRANSPL P, V38, P2603, DOI 10.1016/j.transproceed.2006.08.047; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstein EZ, 2017, EXP NEUROL, V298, P42, DOI 10.1016/j.expneurol.2017.08.015; Goodrich JA, 2001, COMPARATIVE MED, V51, P13; Griepp EB, 2012, ANN CARDIOTHORAC SUR, V1, P350, DOI 10.3978/j.issn.2225-319X.2012.09.03; Griffiths JR, 1999, BRIT J RADIOL, V72, P627, DOI 10.1259/bjr.72.859.10624317; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Ishizaki M, 1999, EUR J VASC ENDOVASC, V18, P17, DOI 10.1053/ejvs.1999.0845; Kepler CK, 2015, SPINAL CORD, V53, P763, DOI 10.1038/sc.2015.76; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kubota K, 2012, SPINE, V37, P1448, DOI 10.1097/BRS.0b013e31824ffda5; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; LOCKE GE, 1971, J NEUROSURG, V34, P614, DOI 10.3171/jns.1971.34.5.0614; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin Niels D, 2015, J Emerg Trauma Shock, V8, P94, DOI 10.4103/0974-2700.155507; Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f; MICHEELS J, 1984, RESUSCITATION, V12, P31, DOI 10.1016/0300-9572(84)90056-X; Moon SH, 2012, J ACUPUNCT MERIDIAN, V5, P226, DOI 10.1016/j.jams.2012.07.006; Myrie SB, 2012, COMPARATIVE MED, V62, P282; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Okon EB, 2013, J NEUROTRAUM, V30, P1564, DOI 10.1089/neu.2013.2956; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Poeggel S, 2015, SENSORS-BASEL, V15, P17115, DOI 10.3390/s150717115; RAWE SE, 1978, J NEUROSURG, V48, P1002, DOI 10.3171/jns.1978.48.6.1002; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; Roriz P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050903; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Schomberg DT, 2017, J NEUROTRAUM, V34, P541, DOI 10.1089/neu.2016.4567; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Squair JW, 2017, NEUROLOGY, V89, P1660, DOI 10.1212/WNL.0000000000004519; Strauch JT, 2007, ANN THORAC SURG, V83, P2130, DOI 10.1016/j.athoracsur.2007.01.060; Streijger F, 2017, J NEUROTRAUM, V34, P3336, DOI 10.1089/neu.2017.5034; Streijger F, 2018, J NEUROTRAUM, V35, P1345, DOI 10.1089/neu.2017.5285; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Wakisaka Y, 2008, J CEREBR BLOOD F MET, V28, P1175, DOI 10.1038/jcbfm.2008.7; WALLACE MC, 1987, NEUROSURGERY, V20, P710; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; WOLF A, 1991, J NEUROSURG, V75, P883, DOI 10.3171/jns.1991.75.6.0883	66	4	4	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 1	2020	37	15					1696	1707		10.1089/neu.2019.6781		MAY 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MT3XG	WOS:000532330000001	32233727				2022-02-06	
J	Niziolek, GM; Boudreau, RM; Baker, J; Friend, LA; Makley, AT; Edwards, MJ; Gulbins, E; Goodman, MD				Niziolek, Grace M.; Boudreau, Ryan M.; Baker, Jennifer; Friend, Lou Ann; Makley, Amy T.; Edwards, Michael J.; Gulbins, Erich; Goodman, Michael D.			Acid Sphingomyelinase Inhibition Mitigates Histopathological and Behavioral Changes in a Murine Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						acid sphingomyelinase; depression; phosphorylated tau aggregation; traumatic brain injury	HEAD-INJURY; MICROGLIAL ACTIVATION; COGNITIVE DEFICITS; CERAMIDE SYSTEM; MILD; DEPRESSION; NEUROBIOLOGY; ESTROGEN; DISEASE; MOUSE	Traumatic brain injury (TBI) can lead to the development of chronic traumatic encephalopathy as a result of neuronal phosphorylated tau (p-tau) protein aggregation and neuroinflammation. Acid sphingomyelinase (Asm) may also contribute to post-TBI neurodegenerative disorders. We hypothesized that Asm inhibition would ameliorate p-tau aggregation, neuroinflammation, and behavioral changes after TBI in a murine model. TBI was generated using a weight-drop method. Asm inhibition in wild-type mice was achieved with a single injection of amitriptyline 1 h after TBI. Genetic Asm ablation was achieved using Asm-deficient mice (Asm(-/-)). Thirty days after TBI, mice underwent behavioral testing with the forced swim test for symptoms of depression or were euthanized for neurohistological analysis. Neuroinflammation was quantified using the microglial markers, ionized calcium-binding adaptor molecule 1 and transmembrane protein 119. Compared to sham mice, TBI mice demonstrated increased hippocampal p-tau. Mice that received amitriptyline after TBI demonstrated decreased p-tau compared to mice that received a saline control. Further, post-TBI Asm(-/-) mice demonstrated lower levels of p-tau compared to wild-type mice. Though a decrease in neuroinflammation was observed at 1 month post-TBI, no change was demonstrated with mice treated with amitriptyline. Similarly, TBI mice were more likely to show depression compared to mice that received amitriptyline after TBI. Utilizing a weight-drop method to induce moderate TBI, we have shown that genetic deficiency or pharmacological inhibition of Asm prevented hippocampal p-tau aggregation 1 month after injury as well as decreased symptoms of depression. These findings highlight an opportunity to potentially reduce the long-term consequences of TBI.	[Niziolek, Grace M.; Boudreau, Ryan M.; Baker, Jennifer; Friend, Lou Ann; Makley, Amy T.; Edwards, Michael J.; Gulbins, Erich; Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Sect Gen Surg, Med Sci Bldg,SRU Room 1577, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu			NIH/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [ROI GM124156-O1A1]	Funding was received from NIH/NIGMS ROI GM124156-O1A1.	Albayram O, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0124-4; Barbacci DC, 2017, ACS CHEM NEUROSCI, V8, P2266, DOI 10.1021/acschemneuro.7b00189; Bellucci A, 2011, NEURODEGENER DIS, V8, P221, DOI 10.1159/000322228; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BODNOFF SR, 1988, PSYCHOPHARMACOLOGY, V95, P298; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Brodowicz J, 2018, NEUROTOX RES, V33, P474, DOI 10.1007/s12640-017-9798-6; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; CRAWLEY J, 1980, PHARMACOL BIOCHEM BE, V13, P167, DOI 10.1016/0091-3057(80)90067-2; Deb S, 1999, AM J PSYCHIAT, V156, P374; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Gerhard A, 2006, MOVEMENT DISORD, V21, P89, DOI 10.1002/mds.20668; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Johnson BL, 2016, SHOCK, V46, P541, DOI 10.1097/SHK.0000000000000648; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kornhuber J, 2008, J MED CHEM, V51, P219, DOI 10.1021/jm070524a; Kornhuber J, 2014, TRENDS PHARMACOL SCI, V35, P293, DOI 10.1016/j.tips.2014.04.003; Kulesskaya N, 2014, PHYSIOL BEHAV, V133, P30, DOI 10.1016/j.physbeh.2014.05.006; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Peng HM, 2015, J MOL MED, V93, P675, DOI 10.1007/s00109-014-1246-y; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Postler E, 2000, J NEUROIMMUNOL, V104, P85, DOI 10.1016/S0165-5728(99)00222-2; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yankelevitch-Yahav R., 2015, JOVE-J VIS EXP, V97, DOI [10.3791/52587, DOI 10.3791/52587]; Young JW, 2015, J PSYCHOPHARMACOL, V29, P178, DOI 10.1177/0269881114555252	54	4	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1902	1909		10.1089/neu.2019.6436		MAY 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000530736100001	32138594	Green Published			2022-02-06	
J	Awan, N; DiSanto, D; Juengst, SB; Kumar, RG; Bertisch, H; Niemeier, J; Fann, JR; Sperry, J; Wagner, AK				Awan, Nabil; DiSanto, Dominic; Juengst, Shannon B.; Kumar, Raj G.; Bertisch, Hilary; Niemeier, Janet; Fann, Jesse R.; Sperry, Jason; Wagner, Amy K.			Interrelationships Between Post-TBI Employment and Substance Abuse: A Cross-lagged Structural Equation Modeling Analysis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Employment; Rehabilitation; Substance-related disorders	TRAUMATIC BRAIN-INJURY; WORKING-AGE INDIVIDUALS; RETURN-TO-WORK; UNITED-STATES; PSYCHIATRIC-DISORDERS; DEIDENTIFIED DATA; DISABILITY; PREDICTION; UNEMPLOYMENT; ASSOCIATIONS	Objective: To describe the interrelationship of postinjury employment and substance abuse (SA) among individuals with traumatic brain injury. Design: Structural equation model (SEM) and logistic regression analytic approach using a merged database of the National Trauma Data Bank (NTDB) and Traumatic Brain Injury Model Systems (TBIMS) National Database, with acute care and rehabilitation hospitalization data and 1, 2, and 5 year follow-up data. Setting: United States Level I/II trauma centers and inpatient rehabilitation centers with telephone follow-up. Participants: Individuals in the TBIMS National Database successfully matched to their NTDB data, aged 18-59 years, with trauma severity, age, sex, employment, and SA data at 1, 2, and/or 5 years postinjury (N=2890). Interventions: Not applicable. Main Outcome Measure: Employment status (employed/unemployed) and SA (present/absent) at year 1, year 2, and year 5 postinjury. Results: SEM analysis showed older age at injury predicted lower likelihood of employment at all time points postinjury (beta(YR1)= -0.016; beta(YR2)=-0.006; beta(YR5)=-0.016; all P<.001), while higher injury severity score (ISS) predicted lower likelihood of employment (beta=-0.008; P=.027) and SA (beta=-0.007; P=.050) at year 1. Male sex predicted higher likelihood of SA at each follow-up (beta(YR1)=0.227; beta(YR2)=0.184; beta(YR5)=0.161; all P<.100). Despite associations of preinjury unemployment with higher preinjury SA, postinjury employment at year 1 predicted SA at year 2 (beta=0.118; P=.028). Employment and SA during the previous follow-up period predicted subsequent employment and SA, respectively. Conclusions: Employment and SA have unique longitudinal interrelationships and are additionally influenced by age, sex, and ISS. The present work suggests the need for more research on causal, confounding, and mediating factors and appropriate screening and intervention tools that minimize SA and facilitate successful employment (C) 2019 by the American Congress of Rehabilitation Medicine	[Awan, Nabil; DiSanto, Dominic; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Awan, Nabil] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15213 USA; [Awan, Nabil] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Kumar, Raj G.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, Brain Injury Res Ctr, New York, NY 10029 USA; [Bertisch, Hilary] NYU Rusk Rehabil, Dept Psychol, New York, NY USA; [Niemeier, Janet] UAB Spain Rehabil Ctr, Dept Phys Med & Rehabil, Birmingham, AL USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Sperry, Jason] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		DiSanto, Dominic/0000-0002-8815-2169	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [TL1 TR0001858, R21 HD 089075-01]; NIH Center for Large Data Research and Data Sharing in Rehabilitation [NIH P2C HD065702]; NIDILRRUnited States Department of Health & Human Services [90DP0031, 90DP0041, 90DPTB0013-01-00, 90DP0044-01, 90DPTB0011-01-00, 90DP0037, 90AR5025]; VA Central Office VATBI Model System Program of Research, Subcontract from General Dynamics Health Solutions [W91YTZ-13-C-0015]; Defense and Veterans Brain Injury Center, US Department of Veterans Affairs Health Services Research and Development Center of Innovation [1 I50 HX001233-01]	Supported by the National Institutes of Health (NIH; grant nos. TL1 TR0001858, R21 HD 089075-01) and the NIH Center for Large Data Research and Data Sharing in Rehabilitation (NIH P2C HD065702). The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) supported the collection of original data for this manuscript. The contents of this manuscript were developed under NIDILRR (grant nos. 90DP0031, 90DP0041, 90DPTB0013-01-00, 90DP0044-01, 90DPTB0011-01-00, 90DP0037) and with postdoctoral fellow support by NIDILRR (grant no. 90AR5025). Additional support was received from VA Central Office VATBI Model System Program of Research, Subcontract from General Dynamics Health Solutions (grant no. W91YTZ-13-C-0015), and the Defense and Veterans Brain Injury Center, US Department of Veterans Affairs Health Services Research and Development Center of Innovation (grant no. 1 I50 HX001233-01).	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner J, 2012, J HEAD TRAUMA REHAB, V27, P317, DOI 10.1097/HTR.0b013e3182686330; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Failla MD, 2016, J HEAD TRAUMA REHAB, V31, pE62, DOI 10.1097/HTR.0000000000000214; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; KARPUR A, GUIDE TRAUMATIC BRAI; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kesinger MR, 2017, AM J PHYS MED REHAB, V96, P17, DOI 10.1097/PHM.0000000000000513; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kumar RG, 2018, AM J PHYS MED REHAB, V97, P236, DOI 10.1097/PHM.0000000000000838; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; O'Neil ME, 2013, TABLE A 1 CLASSIFICA; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Parks Jennifer K, 2010, Proc (Bayl Univ Med Cent), V23, P355; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sherba RT, 2018, J SUBST ABUSE TREAT, V87, P70, DOI 10.1016/j.jsat.2018.01.015; Sherer M, 1999, BRAIN INJURY, V13, P973; Siegal HA, 1996, J SUBST ABUSE TREAT, V13, P93, DOI 10.1016/0740-5472(96)00029-3; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Substance Abuse and Mental Health Services Administration, 2015, NSDUH SER H; Substance Abuse and Mental Health Services Administration, ALC TOB OTH DRUGS; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Department of Health and Human Services and U.S. Department of Agriculture US-DHHS,, 2015, 2015 2020 DIET GUID, V8th; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857	61	4	4	2	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2020	101	5					797	806		10.1016/j.apmr.2019.10.189			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MC0ZD	WOS:000543025400007	31821796	Green Accepted			2022-02-06	
J	Chen, BY; Ghezzi, C; Villegas, B; Quon, A; Radu, CG; Witte, ON; Clark, PM				Chen, Bao Ying; Ghezzi, Chiara; Villegas, Brendon; Quon, Andrew; Radu, Caius G.; Witte, Owen N.; Clark, Peter M.			F-18-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis	JOURNAL OF NUCLEAR MEDICINE			English	Article						PET imaging; autoimmune disease; leukocytes; brain	POSITRON-EMISSION-TOMOGRAPHY; DEOXYCYTIDINE KINASE; NEUROINFLAMMATION; LYMPHOCYTES; FINGOLIMOD; ACTIVATION; EFFICACY; CELLS; PROBE	Brain-infiltrating leukocytes contribute to multiple sclerosis (MS) and autoimmune encephalomyelitis and likely play a role in traumatic brain injury, seizure, and stroke. Brain-infiltrating leukocytes are also primary targets for MS disease-modifying therapies. However, no method exists for noninvasively visualizing these cells in a living organism. 1-(2'deoxy-2'-18F-fluoroarabinofuranosyl) cytosine (F-18-FAC) is a PET radiotracer that measures deoxyribonucleoside salvage and accumulates preferentially in immune cells. We hypothesized that F-18-FAC PET could noninvasively image brain-infiltrating leukocytes. Methods: Healthy mice were imaged with F-18-FAC PET to quantify if this radiotracer crosses the blood brain barrier (BBB). Experimental autoimmune encephalomyelitis (EAE) is a mouse disease model with brain-infiltrating leukocytes. To determine whether F-18-FAC accumulates in brain-infiltrating leukocytes, EAE mice were analyzed with F-18-FAC PET, digital autoradiography, and immunohistochemistry, and deoxyribonucleoside salvage activity in brain-infiltrating leukocytes was analyzed ex vivo. Fingolimod-treated EAE mice were imaged with F-18-FAC PET to assess if this approach can monitor the effect of an immunomodulatory drug on brain-infiltrating leukocytes. PET scans of individuals injected with 2-chloro-2'-deoxy-2'-F-18-fluoro-9-13-q-arabinofuranosyl-adenine (F-18-CFA), a PET radiotracer that measures deoxyribonucleoside salvage in humans, were analyzed to evaluate whether F-18-CFA crosses the human BBB. Results: F-18-FAC accumulates in the healthy mouse brain at levels similar to F-18-FAC in the blood (2.54 +/- 0.2 and 3.04 +/- 0.3 percentage injected dose per gram, respectively) indicating that F-18-FAC crosses the BBB. EAE mice accumulate F-18-FAC in the brain at 180% of the levels of control mice. Brain F-18-FAC accumulation localizes to periventricular regions with significant leukocyte infiltration, and deoxyribonucleoside salvage activity is present at similar levels in brain infiltrating T and innate immune cells. These data suggest that F-18-FAC accumulates in brain-infiltrating leukocytes in this model. Fingolimodtreated EAE mice accumulate F-18-FAC in the brain at 37% lower levels than control-treated EAE mice, demonstrating that F-18-FAC PET can monitor therapeutic interventions in this mouse model. F-18-CFA accumulates in the human brain at 15% of blood levels (0.08 +/- 0.01 and 0.54 0.07 SUV, respectively), indicating that F-18-CFA does not cross the BBB in humans. Conclusion: F-18-FAC PET can visualize brain-infiltrating leukocytes in a mouse MS model and can monitor the response of these cells to an immunomodulatory drug. Translating this strategy into humans will require exploring additional radiotracers.	[Chen, Bao Ying; Ghezzi, Chiara; Quon, Andrew; Radu, Caius G.; Witte, Owen N.; Clark, Peter M.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Chen, Bao Ying; Ghezzi, Chiara; Clark, Peter M.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Villegas, Brendon] Univ Calif Los Angeles, Dept Pulm & Crit Care Med, Los Angeles, CA USA; [Quon, Andrew; Radu, Caius G.] Univ Calif Los Angeles, Ahmanson Translat Imaging Div, Los Angeles, CA USA; [Witte, Owen N.; Clark, Peter M.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Witte, Owen N.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA		Clark, PM (corresponding author), Crump Inst, Box 951770,4333 CNSI, Los Angeles, CA 90095 USA.	pclark@mednet.ucla.edu	Radu, Caius/D-3936-2013	Radu, Caius/0000-0002-9338-5397	UCLA Eugene Cota Robles Fellowship; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AI119916, R01NS112287]; Parker Institute for Cancer Immunotherapy [20163828]; Broad Stem Cell Research Center at UCLA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS112287] Funding Source: NIH RePORTER	This work was supported by the UCLA Eugene Cota Robles Fellowship (to Bao Ying Chen), NIH grant R21AI119916 (to Peter Clark), NIH grant R01NS112287 (to Peter Clark), Parker Institute for Cancer Immunotherapy grant 20163828 (to Owen Witte), and the Broad Stem Cell Research Center at UCLA. Owen Witte and Caius Radu are inventors on a patent held by the University of California Regents that discloses <SUP>18</SUP>F-FAC. No other potential conflict of interest relevant to this article was reported.	Airas L, 2015, J NUCL MED, V56, P305, DOI 10.2967/jnumed.114.149955; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Barrio MJ, 2017, J NUCL MED, V58, P374, DOI 10.2967/jnumed.116.182394; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Cansev M, 2006, BRAIN RES REV, V52, P389, DOI 10.1016/j.brainresrev.2006.05.001; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Engvall C, 2008, J NEUROSURG ANESTH, V20, P41, DOI 10.1097/ANA.0b013e31815d4c70; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Gerwien H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8020; Gronberg NV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-115; James ML, 2017, J NUCL MED, V58, P1845, DOI 10.2967/jnumed.117.189597; Kim W, 2016, P NATL ACAD SCI USA, V113, P4027, DOI 10.1073/pnas.1524212113; LAFRANCECOREY RG, 2011, JOVE-J VIS EXP, V52, P2747, DOI DOI 10.3791/2747; Laurent C, 2017, BRAIN, V140, P184, DOI 10.1093/brain/aww270; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; Murphy JM, 2013, J MED CHEM, V56, P6696, DOI 10.1021/jm400457y; Nair-Gill E, 2010, J CLIN INVEST, V120, P2005, DOI 10.1172/JCI41250; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; Radu CG, 2007, P NATL ACAD SCI USA, V104, P1937, DOI 10.1073/pnas.0610544104; Salas JR, 2018, J NUCL MED, V59, P1616, DOI 10.2967/jnumed.118.210328; Salas JR, 2018, J NUCL MED, V59, P1308, DOI 10.2967/jnumed.117.206961; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Schwarzenberg J, 2011, EUR J NUCL MED MOL I, V38, P711, DOI 10.1007/s00259-010-1666-z; Shu CJ, 2010, J NUCL MED, V51, P1092, DOI 10.2967/jnumed.109.073361; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Unterrainer M, 2018, EUR J NUCL MED MOL I, V45, P1423, DOI 10.1007/s00259-018-3974-7; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046	41	4	4	0	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	MAY 1	2020	61	5					757	763		10.2967/jnumed.119.229351			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	LK4MV	WOS:000530836100028	31653711	Bronze, Green Published, Green Submitted			2022-02-06	
J	Cucinotta, FA; Cacao, E				Cucinotta, Francis A.; Cacao, Eliedonna			Predictions of cognitive detriments from galactic cosmic ray exposures to astronauts on exploration missions	LIFE SCIENCES IN SPACE RESEARCH			English	Article						Space radiation; Novel object recognition; Cognitive detriments; Galactic cosmic rays; Track structure models; Voyager I measurements	ENERGY-SPECTRA; MOUSE MODEL; OBJECT RECOGNITION; CHARGE COMPOSITION; MEMORY DEFICITS; 20 CGY; RADIATION; DISEASE; IMPAIRMENT; RATS	For the first-time we report on predictions on cognitive detriments from galactic cosmic ray (GCR) exposures on long-duration space missions outside the protection of the Earth's magnetosphere and solid body shielding. Estimates are based on a relative risk (RR) model of the fluence response for proton and heavy ion in rodent studies using the widely used novel object recognition (NOR) test, which estimates detriments in recognition or object memory. Our recent meta-analysis showed that linear and linear-quadratic dose response models were not accurate, while exponential increasing fluence response models based on particle track structure provided good descriptions of rodent data for doses up to 1 Gy. Using detailed models of the GCR environment and particle transport in shielding and tissue, we predict the excess relative risk (ERR) for NOR detriments for several longterm space mission scenarios. Predictions suggest ERR < 0.15 for most space mission scenarios with ERR<0.1 for 1-year lunar surface missions, and about ERR similar to 0.1 for a 1000 day Mars mission for average solar cycle conditions. We discuss possible implications of these ERR levels of cognitive performance detriments relative to other neurological challenges such as rodent models of Alzheimer's disease (AD), Parkinson's disease (PD) and traumatic brain injury (TBI). Comparisons suggest a small but potentially clinically significant risk for possible space mission scenarios.	[Cucinotta, Francis A.; Cacao, Eliedonna] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Box 453037, Las Vegas, NV 89195 USA		Cucinotta, FA (corresponding author), Univ Nevada, Dept Hlth Phys & Diagnost Sci, Box 453037, Las Vegas, NV 89195 USA.	francis.cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020				Adriani O, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/91; Alp M, 2019, RADIAT RES, V189, P312; Alp M, 2017, LIFE SCI SPACE RES, V13, P27, DOI 10.1016/j.lssr.2017.03.004; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Ave M, 2008, ASTROPHYS J, V678, P262, DOI 10.1086/529424; BADHWAR GD, 1994, RADIAT RES, V138, P201, DOI 10.2307/3578590; Boezio M, 2003, ASTROPART PHYS, V19, P583, DOI 10.1016/S0927-6505(02)00267-0; Britten RA, 2014, RADIAT RES, V182, P292, DOI 10.1667/RR3766.1; Cacao E, 2019, RADIAT RES, V192, P463, DOI 10.1667/RR15419.1; Cacao E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153998; Capurro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056870; Chao OYH, 2013, EXP NEUROL, V247, P373, DOI 10.1016/j.expneurol.2013.01.003; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 1998, RADIAT ENVIRON BIOPH, V37, P259, DOI 10.1007/s004110050127; Cucinotta FA, 1999, RADIAT ENVIRON BIOPH, V38, P81, DOI 10.1007/s004110050142; Cucinotta FA, 2019, INT J RADIAT BIOL, V95, P985, DOI 10.1080/09553002.2019.1623427; Cucinotta FA, 2019, RADIAT PROT DOSIM, V183, P69, DOI 10.1093/rpd/ncy265; Cucinotta FA, 2017, LIFE SCI SPACE RES, V13, P1, DOI 10.1016/j.lssr.2017.01.005; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cummings AC, 2016, ASTROPHYS J, V831, DOI [10.3847/0004-637X/831/1/18, 10.3847/0004-637x/831/1/18]; D'Agostino G, 2012, NEUROPSYCHOPHARMACOL, V37, P1784, DOI 10.1038/npp.2012.25; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dos Santos ACD, 2013, J NEUROSCI RES, V91, P1508, DOI 10.1002/jnr.23258; ENGELMANN JJ, 1990, ASTRON ASTROPHYS, V233, P96; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fernandes VS, 2012, BEHAV BRAIN RES, V231, P154, DOI 10.1016/j.bbr.2012.03.008; George JS, 2009, ASTROPHYS J, V698, P1666, DOI 10.1088/0004-637X/698/2/1666; GLEESON LJ, 1968, ASTROPHYS J, V154, P1011, DOI 10.1086/149822; Goes ATR, 2014, NEUROSCIENCE, V256, P61, DOI 10.1016/j.neuroscience.2013.09.042; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; Haino S, 2004, NUCL INSTRUM METH A, V518, P167, DOI 10.1016/j.nima.2003.10.051; He PP, 2013, HORM BEHAV, V64, P1, DOI 10.1016/j.yhbeh.2013.04.009; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Ho SC, 2014, BEHAV BRAIN RES, V268, P177, DOI 10.1016/j.bbr.2014.04.022; Ho YJ, 2011, BEHAV BRAIN RES, V219, P280, DOI 10.1016/j.bbr.2011.01.028; KATZ R, 1994, RADIAT RES, V140, P356, DOI 10.2307/3579113; Kim M.Y., 2015, FRONT RADIAT ONCOL, DOI [10.3389/ fonc.2015.00122, DOI 10.3389/FONC.2015.00122, 10.3389/fonc.2015.00122]; LEZNIAK JA, 1978, ASTROPHYS J, V223, P676, DOI 10.1086/156301; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Lonart G, 2012, RADIAT RES, V178, P289, DOI 10.1667/RR2862.1; Luques L, 2007, EXP NEUROL, V206, P209, DOI 10.1016/j.expneurol.2007.04.007; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; MINAGAWA G, 1981, ASTROPHYS J, V248, P847, DOI 10.1086/159210; NAS National Academy of Sciences, 1973, HZE PART MANN SPAC F; NCRP, 1989, 98 NCPR MD; NCRP, 2006, 153 NCRP; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raber J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00179; Raber J, 2016, RADIAT RES, V185, P20, DOI 10.1667/RR14222.1; Rabin BM, 2007, RADIAT ENVIRON BIOPH, V46, P173, DOI 10.1007/s00411-006-0071-2; Rabin BM, 2011, ADV SPACE RES, V48, P370, DOI 10.1016/j.asr.2011.03.008; Santos JR, 2013, BEHAV BRAIN RES, V253, P68, DOI 10.1016/j.bbr.2013.06.031; Scali C, 1997, EUR J PHARMACOL, V325, P173, DOI 10.1016/S0014-2999(97)00128-3; Sipos E, 2007, NEUROSCIENCE, V147, P28, DOI 10.1016/j.neuroscience.2007.04.011; Sivakumaran MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30030-7; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Weil RS, 2016, BRAIN, V139, P2827, DOI 10.1093/brain/aww175; Wiedenbeck M.E., 2005, P 29 INT COSM RAY C; Wilson J.W., 1995, TP19953495 NASA; Wyrobek AJ, 2016, ENVIRON MOL MUTAGEN, V57, P331, DOI 10.1002/em.22018; Yabuki Y, 2014, NEUROSCIENCE, V259, P126, DOI 10.1016/j.neuroscience.2013.11.051; YOUNG JS, 1981, ASTROPHYS J, V246, P1014, DOI 10.1086/158997; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034	67	4	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2214-5524	2214-5532		LIFE SCI SPACE RES	Life Sci. Space Res.	MAY	2020	25						129	135		10.1016/j.lssr.2019.10.004			7	Astronomy & Astrophysics; Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Astronomy & Astrophysics; Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	LO4QC	WOS:000533613300013	32414486				2022-02-06	
J	Giordano, KR; Denman, CR; Dollish, HK; Fernandez, F; Lifshitz, J; Akhter, M; Rowe, RK				Giordano, Katherine R.; Denman, Charlotte R.; Dollish, Hannah K.; Fernandez, Fabian; Lifshitz, Jonathan; Akhter, Murtaza; Rowe, Rachel K.			Intracerebral hemorrhage in the mouse altered sleep-wake patterns and activated microglia	EXPERIMENTAL NEUROLOGY			English	Article						Intracerebral hemorrhage; Stroke; Inflammation; Circadian biology; Microglia; Cytokines; Neurological disorders; Preclinieal; Mouse	TRAUMATIC BRAIN-INJURY; DAYTIME SLEEPINESS; BASAL GANGLIA; STROKE; CYTOKINES; INFLAMMATION; MECHANISMS; RISK; ADULTS; EDEMA	Sleep-wake disturbances are both a risk factor and reported morbidity for intracerebral hemorrhage (ICH). ICH begins with a ruptured blood vessel and blood leakage into the parenchyma. In response to initial damage, pathophysiological processes ensue that both exacerbate and repair damage. Inflammation is a hallmark process of ICH, which includes microglia activation and increased cytokine signaling. Due to the dual role of cytokines as inflammatory signaling proteins and sleep regulatory substances (SRSs), we hypothesized that ICH would activate microglia, increase SRSs, and alter sleep-wake patterns following an experimental model of ICH in the mouse. Male mice were randomized to receive an injection of collagenase (ICH; n = 8) or saline (sham; n = 11) in the striatum of the right hemisphere. Sleep-wake activity was recorded for 6 full days after ICH via noninvasive sleep cages. Blood and tissue were collected at 7 days after ICH to quantify pro-inflammatory cytokines/SRSs (IL-beta, TNF-alpha, IL-6) and microglia deramification by skeleton analysis. There was an overall injury effect on sleep in mice subjected to ICH at the transition from dark (wake) to light (sleep) at 2, 3, 4, 5, and 6 days after ICH compared with shams. Further analysis confirmed that ICH mice had significantly earlier wake offsets at the dark/light transition and more robust circadian patterns of wake behavior than saline control mice. Spatiotemporal skeleton analysis indicated an increase in microglial cell number with a decrease in endpoints per cell (decreased ramification) for the ipsilateral ICH perihematomal region compared with saline control. There were no changes to plasma cytokine levels at 7 days after ICH when comparing each condition. This is the first known study to show changes in sleep-wake patterns after experimental ICH. Elucidation of mechanisms that link sleep, inflammation, and ICH offers new pharmacological opportunities and rehabilitative strategies to improve recovery in stroke patients.	[Giordano, Katherine R.; Lifshitz, Jonathan; Akhter, Murtaza; Rowe, Rachel K.] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ USA; [Giordano, Katherine R.; Denman, Charlotte R.; Lifshitz, Jonathan; Akhter, Murtaza; Rowe, Rachel K.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Denman, Charlotte R.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Dollish, Hannah K.; Fernandez, Fabian] Univ Arizona, BIO5 Inst, Evelyn F McKnight Brain Inst, Dept Psychol, Tucson, AZ USA; [Dollish, Hannah K.; Fernandez, Fabian] Univ Arizona, BIO5 Inst, Evelyn F McKnight Brain Inst, Dept Neurol, Tucson, AZ USA; [Lifshitz, Jonathan; Rowe, Rachel K.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [Akhter, Murtaza] Univ Arizona, Dept Emergency Med, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Akhter, Murtaza] Maricopa Integrated Hlth Syst, Phoenix, AZ USA		Rowe, RK (corresponding author), Univ Arizona, Coll Med Phoenix, Translat Neurotrauma Res Program, ABC 1 Bldg,425 N 5th St, Phoenix, AZ 85004 USA.	kgiordano@email.arizona.edu; charlotte.denman@oist.jp; hannahdollish@email.arizona.edu; fabianf@email.arizona.edu; jlifshitz@email.arizona.edu; rkro222@email.arizona.edu		Rowe, Rachel/0000-0002-9034-3159; Giordano, Katherine/0000-0002-0925-3579; Fernandez, Fabian-Xose/0000-0002-4288-5383	Phoenix Children's Hospital Mission Support Funds; University of Arizona College of Medicine Phoenix Deans' Fund; Velux Stiftung	The authors would like to acknowledge Alexis Hatch and Pranati Guduru for technical assistance. Research reported in this manuscript was supported by Phoenix Children's Hospital Mission Support Funds and University of Arizona College of Medicine Phoenix Deans' Fund. FF acknowledges support from the Velux Stiftung. JL is a member of the University of Arizona BI05 Institute.	An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bakken LN, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/936298; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Baumann CR, 2006, SLEEP, V29, P1339, DOI 10.1093/sleep/29.10.1339; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Camilo MR, 2012, CLINICS, V67, P1357, DOI 10.6061/clinics/2012(12)02; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chokroverty S, 2010, INDIAN J MED RES, V131, P126; COUNSELL C, 1995, CEREBROVASC DIS, V5, P26, DOI 10.1159/000107814; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Duss SB, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0879-6; Flores AE, 2007, IEEE T BIO-MED ENG, V54, P225, DOI 10.1109/TBME.2006.886938; Gao Z, 2008, ACTA NEUROCHIR SUPPL, V105, P51; Gemma C, 1997, AM J PHYSIOL-REG I, V272, pR601, DOI 10.1152/ajpregu.1997.272.2.R601; Gottlieb E, 2019, SLEEP MED REV, V45, P54, DOI 10.1016/j.smrv.2019.03.003; Hermann DM, 2016, NEUROLOGY, V87, P1407, DOI 10.1212/WNL.0000000000003037; Hogan D, 2003, J NEUROIMMUNOL, V137, P59, DOI 10.1016/S0165-5728(03)00038-9; Huang YL, 2014, NEUROLOGY, V82, P1153, DOI 10.1212/WNL.0000000000000268; Ikram MK, 2012, STROKE, V43, P1681, DOI 10.1161/STROKEAHA.112.654632; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lackland DT, 2016, EXPERT REV CARDIOVAS, V14, P609, DOI 10.1586/14779072.2016.1143359; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Liew HK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-13; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lively S, 2012, TRANSL STROKE RES, V3, pS132, DOI 10.1007/s12975-012-0151-3; Ma XC, 2016, INT CONF CONTR AUTO, P17, DOI 10.1109/ICCAIS.2016.7822428; Manfredini R, 1996, ANN NY ACAD SCI, V783, P141, DOI 10.1111/j.1749-6632.1996.tb26713.x; Mang GM, 2014, SLEEP, V37, P1383, DOI 10.5665/sleep.3936; Maple AM, 2018, J BIOL RHYTHM, V33, P662, DOI 10.1177/0748730418803802; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Matsushita H, 2014, J NEUROSCI RES, V92, P1024, DOI 10.1002/jnr.23379; McKee Z, 2019, CLEV CLIN J MED, V86, P407, DOI 10.3949/ccjm.86a.18033; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Meng He, 2008, J Circadian Rhythms, V6, P9, DOI 10.1186/1740-3391-6-9; Mensen A, 2019, J NEUROSCI METH, V313, P37, DOI 10.1016/j.jneumeth.2018.12.011; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; OPP MR, 1991, AM J PHYSIOL, V260, pR52, DOI 10.1152/ajpregu.1991.260.1.R52; Pinho J, 2019, J NEUROL SCI, V398, P54, DOI 10.1016/j.jns.2019.01.013; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rowe RK, 2019, J NEUROTRAUM, V36, P1318, DOI 10.1089/neu.2018.5980; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schuiling WJ, 2005, STROKE, V36, P578, DOI 10.1161/01.STR.0000154862.33213.73; Takahashi S, 1999, AM J PHYSIOL-REG I, V276, pR1132, DOI 10.1152/ajpregu.1999.276.4.R1132; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang XM, 2016, EUR REV MED PHARMACO, V20, P2868; Wasserman JK, 2007, EXP NEUROL, V207, P227, DOI 10.1016/j.expneurol.2007.06.025; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zafar Azra, 2008, J Pak Med Assoc, V58, P356; Zhang YR, 2011, ARCH INTERN MED, V171, P1811, DOI 10.1001/archinternmed.2011.443; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	73	4	4	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2020	327								113242	10.1016/j.expneurol.2020.113242			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX8RA	WOS:000522140800019	32057796				2022-02-06	
J	Gottsche, J; Fritzsche, F; Kammler, G; Sauvigny, T; Westphal, M; Regelsberger, J				Goettsche, Jennifer; Fritzsche, Friederike; Kammler, Gertrud; Sauvigny, Thomas; Westphal, Manfred; Regelsberger, Jan			A Comparison between Pediatric and Adult Patients after Cranioplasty: Aseptic Bone Resorption Causes Earlier Revision in Children	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						cranioplasty; children; adolescents; bone resorption; risk factors	SINGLE-CENTER EXPERIENCE; DECOMPRESSIVE CRANIECTOMY; FLAP RESORPTION; RISK-FACTORS; INFECTION; COMPLICATIONS; OUTCOMES	Background and Study Aims/Objective Cranioplasty, a common neurosurgical intervention following decompressive craniectomy (DC), is associated with high complication rates. Bone flap resorption in particular leads to a considerable number of patients requiring further surgery. The aim of this study was to investigate the frequency and time of occurrence of complications following cranioplastic procedures in children and adults. Material and Methods Data of children and adults who underwent cranioplasty between July 2010 and March 2018 were analyzed retrospectively. Clinical data, complications, and risk factors regarding aseptic bone resorption (ABR) were evaluated including patient age, occurrence of shunt-dependent hydrocephalus, and number of fragments in autologous bone flaps. Results Severe traumatic brain injury (TBI) was the leading cause for DC among children (66.7%), associated with a significantly higher number of fragments ( p = 0.002). In the adult population, the most common cause was malignant infarction (55.9%) followed by TBI (24.6%). Pediatric patients in our institution received autologous bone flaps less frequently than adult patients (61.1% and 83.1%, respectively). Young age and a higher number of fragments in autologous bone flaps were associated with the occurrence of ABR. Children and adolescents showed significantly higher rates of aseptic bone necrosis ( p = 0.007) and revision cranioplasty ( p = 0.036). Kaplan-Meier estimates were used to further analyze bone flap resorption in children and adults, showing that revision surgery due to ABR was performed earlier in children ( p = 0.001, log-rank test). Conclusion Pediatric patients demand specific care when cranioplasty is performed following DC. We identified age as an independent risk factor. The higher number of fragments appears to be a correlation due to the higher number of TBIs in children. Our data indicate that young age is the most important risk factor for the development of ABR as a frequent and early complication with a shorter revision-free time interval in children. Consequently, the uncritical use of cryopreserved autologous bone flaps should be questioned in this population.	[Goettsche, Jennifer; Fritzsche, Friederike; Kammler, Gertrud; Sauvigny, Thomas; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Neurosurg, Martinistr 52, D-20246 Hamburg, Germany		Gottsche, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	j.goettsche@uke.de					Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Daou B, 2016, WORLD NEUROSURG, V92, P89, DOI 10.1016/j.wneu.2016.04.115; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Erdogan E, 2003, NEUROL INDIA, V51, P479; Fu KJ, 2016, J CRANIOFAC SURG, V27, P593, DOI 10.1097/SCS.0000000000002491; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Kim Jin Seong, 2015, Korean J Neurotrauma, V11, P100, DOI 10.13004/kjnt.2015.11.2.100; Kim Sung Hoon, 2017, Korean J Neurotrauma, V13, P15, DOI 10.13004/kjnt.2017.13.1.15; Korhonen TK, 2019, ACTA NEUROCHIR, V161, P473, DOI 10.1007/s00701-018-03791-3; Korhonen TK, 2019, J NEUROSURG, V130, P312, DOI 10.3171/2017.8.JNS171857; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lee S. H., 2014, J NEUROTRAUM, V10, P10, DOI [1410.13004/kjnt.2014.10.1.1027169026, DOI 10.13004/kjnt.2014.10.1.10]; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Mracek J, 2015, ACTA NEUROCHIR, V157, P501, DOI 10.1007/s00701-014-2333-0; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shibahashi K, 2017, WORLD NEUROSURG, V101, P20, DOI 10.1016/j.wneu.2017.01.106; Stel VS, 2011, NEPHRON CLIN PRACT, V119, pC83, DOI 10.1159/000324758; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Waqas M, 2017, PEDIATR NEUROSURG, V52, P77, DOI 10.1159/000452808; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]	28	4	4	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAY	2020	81	3					227	232		10.1055/s-0039-1698391			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LF9KZ	WOS:000527733000006	31777050				2022-02-06	
J	Goodenough, CJ; Moffitt, JK; Wainwright, DJ; Cantor, AD; Nguyen, PD; Teichgraeber, JF; Greives, MR				Goodenough, Christopher J.; Moffitt, Joseph K.; Wainwright, D'Arcy J.; Cantor, Andrew D.; Nguyen, Phuong D.; Teichgraeber, John F.; Greives, Matthew R.			Cervical Spine Injuries in Pediatric Maxillofacial Trauma: An Under-Recognized Problem	JOURNAL OF CRANIOFACIAL SURGERY			English	Article; Proceedings Paper	18th International Congress of the International-Society-of-Craniofacial-Surgery (ISCFS)	SEP 16-19, 2019	Paris, FRANCE	Int Soc Craniofacial Surg		Pediatric trauma; cervical spine injury; facial fracture	FACIAL FRACTURES; PATTERNS	Pediatric cervical spine injuries (CSI) are uncommon events, but can be devastating injuries. Facial fractures have been associated with injuries to the cervical spine in children, but may be deemed isolated facial fractures and bypass the standard trauma pathway. The objective of this study is to describe the mechanisms, associated injuries and outcomes of pediatric cervical spine injuries in patients with known maxillofacial trauma at a level 1 trauma center. An analysis was performed of all patients under the age of 18 with maxillofacial trauma admissions to a single level 1 trauma center, from 2006 to 2015. Patients were stratified based on the presence or absence of a cervical spine injury. Data was abstracted to include demographic, mechanism and clinical outcomes data. There were 1274 patients who were admitted with maxillofacial trauma during the study period. Of these, 72 (5.7%) experienced a cervical spine injury. Factors associated with cervical spine injuries include older age and penetrating mechanism. Cervical spine injuries were associated with concomitant traumatic brain injuries and skull fractures. Patients with spine injuries were more like to experience a longer length of stay and death. On multivariate analysis, only increased age predicted CSI. Our database demonstrated a 5.7% incidence of pediatric cervical spine injuries in patients with maxillofacial trauma. This incidence is higher than previously published reports of smaller cohorts. Clinicians must take care to stabilize the cervical spine in any patient with facial fractures, especially during work up and diagnostic maneuvers performed before spinal injuries are ruled out.	[Greives, Matthew R.] Univ Texas Hlth Sci Ctr Houston, Div Pediat Plast Surg, Dept Pediat Surg, McGovern Sch Med, 6431 Fannin St,MSB 5-281, Houston, TX 77030 USA; Childrens Mem Hermann Hosp, Houston, TX USA		Greives, MR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Pediat Plast Surg, Dept Pediat Surg, McGovern Sch Med, 6431 Fannin St,MSB 5-281, Houston, TX 77030 USA.	Matthew.R.Greives@uth.tmc.edu					Bayouth L, 2019, J PEDIATR SURG, V54, P160, DOI 10.1016/j.jpedsurg.2018.10.003; BERTOLAMI CN, 1982, ORAL SURG ORAL MED O, V53, P122, DOI 10.1016/0030-4220(82)90274-2; Clayton JL, 2012, INJURY, V43, P431, DOI 10.1016/j.injury.2011.06.022; DAVIDSON JSD, 1989, J TRAUMA, V29, P1276, DOI 10.1097/00005373-198909000-00016; Elahi MM, 2008, PLAST RECONSTR SURG, V121, P201, DOI 10.1097/01.prs.0000293763.82790.aa; Gentile Michael A, 2013, Atlas Oral Maxillofac Surg Clin North Am, V21, P69, DOI 10.1016/j.cxom.2012.12.010; Grunwaldt L, 2011, PLAST RECONSTR SURG, V128, P1263, DOI 10.1097/PRS.0b013e318230c8cf; Hackl W, 2001, ORAL SURG ORAL MED O, V92, P370, DOI 10.1067/moe.2001.116894; Halsey JN, 2016, J CRANIOFAC SURG, V27, P109, DOI 10.1097/SCS.0000000000002284; HAUG RH, 1991, J ORAL MAXIL SURG, V49, P725, DOI 10.1016/S0278-2391(10)80236-8; Hoppe IC, 2014, J CRANIO MAXILL SURG, V42, P1408, DOI 10.1016/j.jcms.2014.04.002; Hoppe IC, 2014, J CRANIOFAC SURG, V25, P1825, DOI 10.1097/SCS.0000000000001055; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P559, DOI 10.1016/j.joms.2008.07.010; LEWIS VL, 1985, J TRAUMA, V25, P90, DOI 10.1097/00005373-198501000-00014; Miller Matthew L, 2008, Ann Adv Automot Med, V52, P101; Mithani SK, 2009, PLAST RECONSTR SURG, V123, P1293, DOI 10.1097/PRS.0b013e31819e26f2; Mukherjee S, 2015, ANN ROY COLL SURG, V97, P66, DOI 10.1308/003588414X14055925059633; Roccia F, 2007, J CRANIOFAC SURG, V18, P1259, DOI 10.1097/scs.0b013e31814e0581; Rosati SF, 2015, J TRAUMA ACUTE CARE, V78, P1117, DOI 10.1097/TA.0000000000000643; Slaar A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011686.pub2	20	4	4	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2020	31	3					775	777		10.1097/SCS.0000000000006111			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	NE3UT	WOS:000562524800081	31895850				2022-02-06	
J	Haslerig, SJ; Vue, R; Grummert, SE				Haslerig, Siduri J.; Vue, Rican; Grummert, Sara E.			Invincible bodies: American sport media's racialization of Black and white college football players	INTERNATIONAL REVIEW FOR THE SOCIOLOGY OF SPORT			English	Article						American football; Black college athletes; injury; physicality; race; racialization; sport media	TRAUMATIC BRAIN-INJURY; RACIAL BIAS; CONCUSSION; RACE; PAIN; DEHUMANIZATION; MASCULINITY; PERCEPTIONS; MANAGEMENT; VIOLENCE	As the most watched college sport broadcast of all time, the US Entertainment and Sports Programming Network (ESPN)'s College GameDay (CGD) is one source of socialization that primes US audiences to make certain associations. Through disaggregated analysis of regular- and post-season CGD pre-game and game-of-the-week broadcasts during the 2016 football season, the authors examine the coverage of players' physicality and injuries, contrasting the portrayals of Black and white American football players. The paper documents prominent narratives that promoted Black players as relatively invulnerable, while making the case that these narratives serve to prime audiences to ascribe inhuman abilities to Black people and thereby reinforce white supremacist ideology.	[Haslerig, Siduri J.] Univ Oklahoma, Norman, OK 73019 USA; [Vue, Rican] Oregon State Univ, Corvallis, OR 97331 USA; [Grummert, Sara E.] Univ Calif Riverside, Riverside, CA 92521 USA		Haslerig, SJ (corresponding author), Univ Oklahoma, Educ Leadership & Policy Studies, 230C Collings Hall,820 Van Vleet Oval, Norman, OK 73019 USA.	haslerig@ou.edu	haslerig, s/T-9823-2019	haslerig, s/0000-0001-6627-2621			Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; ALEXANDER E, 1994, PUBLIC CULTURE, V7, P77, DOI 10.1215/08992363-7-1-77; Alexander M., 2012, NEW JIM CROW MASS IN; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Azzarito L, 2008, INT REV SOCIOL SPORT, V43, P347, DOI 10.1177/1012690208099871; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Billings, 2011, SPORTS MEDIA TRANSFO, P162; Birrell S., 1989, Sociology of Sport Journal, V6, P212; BROUSSARD P, 2013, J GENDER RACE JUSTIC, V16, P373; Carragee KM, 2004, J COMMUN, V54, P214, DOI 10.1093/joc/54.2.214; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cummins RG, 2013, MASS COMMUN SOC, V16, P787, DOI 10.1080/15205436.2013.779719; *DED, 2016, VERS 7 0 23 WEB APPL; Ferber AL, 2007, J SPORT SOC ISSUES, V31, P11, DOI 10.1177/0193723506296829; Fries-Britt S, 2007, J COLL STUDENT DEV, V48, P509, DOI 10.1353/csd.2007.0048; Goff PA, 2008, J PERS SOC PSYCHOL, V94, P292, DOI 10.1037/0022-3514.94.2.292; Goff PA, 2014, J PERS SOC PSYCHOL, V106, P526, DOI 10.1037/a0035663; Goyal MK, 2015, JAMA PEDIATR, V169, P996, DOI 10.1001/jamapediatrics.2015.1915; Grano DA, 2010, SOUTH COMMUN J, V75, P255, DOI 10.1080/10417940903336850; Guba E. G., 1994, HDB QUALITATIVE RES, V2, P163; Hall S, 2006, POLIT CULT MOD AM, P167; HARRIS CI, 1993, HARVARD LAW REV, V106, P1707, DOI 10.2307/1341787; Hartmann D, 2000, SOCIOL SPORT J, V17, P229, DOI 10.1123/ssj.17.3.229; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Hughey MW, 2015, ANN AM ACAD POLIT SS, V661, P182, DOI 10.1177/0002716215588067; Hunter DW, 1996, J AFRICAN AM MEN, V2, P23; Kellner D., 1995, MEDIA CULTURE CULTUR; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; KING DW, 2008, AFRICAN AM CULTURE P; Leonard DJ, 2009, STUD SYMB INTERACT, V33, P165, DOI 10.1108/S0163-2396(2009)0000033013; Leonard DJ, 2004, J SPORT SOC ISSUES, V28, P284, DOI 10.1177/0193723504267546; LEONARD DJ, 2017, PLAYING WHITE PRIVIL; Light CE, 2017, STAND YOUR GROUND HI; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Marcus N., 2016, DUKE J CONSTITUTIONA, V12, P53; Markovitz Jonathan, 2004, LEGACIES LYNCHING RA; Maschi T., 2015, CONTENT ANAL; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer J, 2018, INT REV SOCIOL SPORT, V53, P49, DOI 10.1177/1012690216640525; McCombs M, 1997, JOURNALISM MASS COMM, V74, P703, DOI 10.1177/107769909707400404; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morgan M., 2002, MEDIA EFFECTS ADV TH, V2nd, P43; MOY P, 2016, INT ENCY COMMUNICATI, P00001; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; ORIARD M, 2009, BOWLED BIG TIME COLL; PIKE ECJ, 2005, INT REV SOCIOL SPORT, V40, P201, DOI DOI 10.1177/1012690205057199; Rada JA, 2005, J BROADCAST ELECTRON, V49, P65, DOI 10.1207/s15506878jobem4901_5; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Trawalter S, 2015, SOC PERSONAL PSYCHOL, V9, P146, DOI 10.1111/spc3.12161; Van Sterkenburg J, 2010, MEDIA CULT SOC, V32, P819, DOI 10.1177/0163443710373955; Wallsten K, 2017, POLIT RES QUART, V70, P209, DOI 10.1177/1065912916685186; Walzer AS, 2011, J SOC PSYCHOL, V151, P527, DOI 10.1080/00224545.2010.503250; Waytz A, 2015, SOC PSYCHOL PERS SCI, V6, P352, DOI 10.1177/1948550614553642; White MH, 2016, SOC PSYCHOL-GERMANY, V47, P187, DOI 10.1027/1864-9335/a000272; Wilson JP, 2017, J PERS SOC PSYCHOL, V113, P59, DOI 10.1037/pspi0000092; Woodward JR, 2004, SOCIOL SPORT J, V21, P356, DOI 10.1123/ssj.21.4.356; Young K, 2015, INT REV SOCIOL SPORT, V50, P640, DOI 10.1177/1012690214547373; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	73	4	4	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1012-6902	1461-7218		INT REV SOCIOL SPORT	Int. Rev. Sociol. Sport	MAY	2020	55	3					272	290		10.1177/1012690218809317			19	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	LD9XJ	WOS:000526378300002					2022-02-06	
J	Henry, MK; Feudtner, C; Fortin, K; Lindberg, DM; Anderst, JD; Berger, RP; Wood, JN				Henry, M. Katherine; Feudtner, Chris; Fortin, Kristine; Lindberg, Daniel M.; Anderst, James D.; Berger, Rachel P.; Wood, Joanne N.			Occult head injuries in infants evaluated for physical abuse	CHILD ABUSE & NEGLECT			English	Article						Traumatic brain injury; Child abuse	AGE-RELATED INCIDENCE; COMPUTED-TOMOGRAPHY; CHILDREN; TRIGGER; RISK	Background:Abusive head injuries in infants may be occult but clinically or forensically important. Data conflict regarding yield of neuroimaging in detecting occult head injuries in infants evaluated for physical abuse, with prior studies identifying yields of 4.3-37.3 %. Objectives: (1) To quantify yield of computed tomography or magnetic resonance imaging in identification of occult head injuries in infants with concerns for physical abuse and (2) to evaluate risk factors for occult head injuries. Participants and Setting: We conducted a retrospective, stratified, random systematic sample of 529 infants < 12 months evaluated for physical abuse at 4 urban children's hospitals in the United States from 2008-2012. Infants with signs or symptoms suggesting head injury or skull fracture on plain radiography (N = 359), and infants without neuroimaging (N = 1) were excluded. Methods: Sampling weights were applied to calculate proportions of infants with occult head injuries. We evaluated for associations between hypothesized risk factors (age < 6 months, rib or extremity fracture, facial bruising) and occult head injury using chi-square tests. Results: Of 169 neurologically normal infants evaluated for abuse, occult head injury was identified in 6.5 % (95 % CI: 2.6, 15.8). Infants < 6 months were at higher risk (9.7 %; 95 % CI: 3.6, 23.3) than infants 6-12 months (1.0 %; 95 % CI: 1.3, 20.2). Rib fracture, extremity fracture and facial bruising were not associated with occult head injury. Conclusions: Occult head injuries were less frequent than previously reported in some studies, but were identified in 1 in 10 infants < 6 months. Clinicians should have a low threshold to obtain neuroimaging in young infants with concern for abuse.	[Henry, M. Katherine; Feudtner, Chris; Fortin, Kristine; Wood, Joanne N.] Childrens Hosp Philadelphia, Div Gen Pediat, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Henry, M. Katherine; Feudtner, Chris; Wood, Joanne N.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, 2716 South St, Philadelphia, PA 19146 USA; [Henry, M. Katherine; Feudtner, Chris; Fortin, Kristine; Wood, Joanne N.] Univ Penn, Dept Pediat, Perelman Sch Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Henry, M. Katherine] Univ Penn, Dept Radiol, Perelman Sch Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Lindberg, Daniel M.] Univ Colorado, Dept Emergency Med, Sch Med, 12401 E 17th Ave, Aurora, CO 80238 USA; [Lindberg, Daniel M.] Univ Colorado, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Sch Med, 12401 E 17th Ave, Aurora, CO 80238 USA; [Anderst, James D.] Univ Missouri, Dept Pediat, Div Child Advers & Resilience, Sch Med, 2401 Gillham Rd, Kansas City, MO 64108 USA; [Anderst, James D.] Childrens Mercy Hosp, 2401 Gillham Rd, Kansas City, MO 64108 USA; [Berger, Rachel P.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Dept Pediat, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Wood, Joanne N.] Childrens Hosp Philadelphia, PolicyLab, 2716 South St, Philadelphia, PA 19146 USA		Henry, MK (corresponding author), Childrens Hosp Philadelphia, Roberts Ctr Pediat Res, 2716 South St,10th Floor, Philadelphia, PA 19146 USA.	henrym2@email.chop.edu		Wood, Joanne/0000-0001-6431-8024	National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) Career Development Award [1K23HD071967-04]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32HS024194]; NIH/NICHD Career Development Award [K23HD083559]	This study was supported by National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) Career Development Award1K23HD071967-04 (Dr. Wood). A portion of investigator time was supported by the Agency for Healthcare Research and Quality F32HS024194(Dr. Henry), and NIH/NICHD Career Development AwardK23HD083559 (Dr. Lindberg).	Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Berger RP, 2020, PEDIATR RADIOL, V50, P75, DOI 10.1007/s00247-019-04506-1; Boehnke M, 2018, PEDIATR RADIOL, V48, P1123, DOI 10.1007/s00247-018-4128-6; Char D, 2016, CONGENIT HEART DIS, V11, P221, DOI 10.1111/chd.12352; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Fingarson A, 2019, J EMERG MED, V57, P195, DOI 10.1016/j.jemermed.2019.03.041; Fisher BT, 2012, PHARMACOEPIDEM DR S, P244, DOI DOI 10.1002/9781119959946.CH16; Henry MK, 2021, PEDIATR EMERG CARE, V37, pE1, DOI 10.1097/PEC.0000000000001455; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Klevens J, 2010, CHILD ABUSE NEGLECT, V34, P262, DOI 10.1016/j.chiabu.2009.07.005; Lane WG, 2007, CLIN ORTHOP RELAT R, P219, DOI 10.1097/BLO.0b013e31805c0849; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Letson MM, 2016, CHILD ABUSE NEGLECT, V60, P36, DOI 10.1016/j.chiabu.2016.09.001; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Ramgopal S, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1919-3; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Shaikh H, 2019, PEDIATR EMERG CARE, V35, P596, DOI 10.1097/PEC.0000000000001187; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Tien I, 2002, PEDIATRICS, V110, P1226, DOI 10.1542/peds.110.6.1226; Williams J, 2005, CLIN PEDIATR, V44, P343, DOI 10.1177/000992280504400410; Wilson PM, 2014, J PEDIATR-US, V164, P1274, DOI 10.1016/j.jpeds.2013.12.041; Wood JN, 2019, ACAD PEDIATR, V19, P428, DOI 10.1016/j.acap.2018.08.007; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	28	4	4	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	MAY	2020	103								104431	10.1016/j.chiabu.2020.104431			8	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	LK7YL	WOS:000531077400011	32143091	Green Accepted			2022-02-06	
J	Jiang, WB; Fu, JH; Chen, F; Zhan, QJ; Wang, YY; Wei, M; Xiao, B				Jiang, Wenbin; Fu, Jinhua; Chen, Fang; Zhan, Qijia; Wang, Yanyan; Wei, Min; Xiao, Bo			Basal ganglia infarction after mild head trauma in pediatric patients with basal ganglia calcification	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Cerebral infarction; Basal ganglia; Vascular calcification; Craniocerebral trauma	LENTICULOSTRIATE VASCULOPATHY; CEREBRAL INFARCTION; RISK-FACTORS; STROKE; INJURY; CHILDHOOD; FEATURES; CHILDREN; INFANTS	Objectives: Incidence rate of basal ganglia infarction (BGI) after mild head trauma was reported higher in children with basal ganglia calcification (BGC). We would like to review patients with BGC showed in head CT scan to see the incidence rate of stroke in these patients and the correlation of variables in these cases. Patients and methods: CT imaging data of cases with diagnosis of mild traumatic brain injury (mTBI) in a large tertiary pediatric center between Mar. 2014 and Mar. 2019 was retrospectively reviewed. Cases with findings of punctate calcification in the region of basal ganglion in CT scan were included. Correlation of variables of these cases (age, side and volume of basal ganglion calcification) with the diagnosis of BGI was the focus of this study. Results: 37 patients (26 males, 9 females, median age: 3.88 +/- 3.54) were included in this study. 17 cases (45.9 %) were diagnosed of BGI and were admitted into the department of neurosurgery. Altogether 63 sides of BGC were categorized into two groups based on whether BGI happened and ROC curve was drawn. ROC curve showed when the cut-off point was 6.55 mm(3), the sensitivity was 88.9 % and the specificity was 87.5 %; the area under curve was 0.849 (p< 0.01). All the cases were divided into two groups according to whether basal ganglia infarction occurred or not. Mann-Whitney U test showed significant difference between these two groups in age (p=0.01). ROC curve of how age affect BGI after mTBI were drawn. The cut-off point was 3.25 years, and the sensitivity was 65.0 % and the specificity was 88.2 %; the area under curve was 0.746 (p=0.01). All patients received conservative treatment and recovered. Conclusion: Incidence rate is higher in children with BGC after mild head injury than that of other children. Larger BGC volume indicates higher risk of developing infarction after minor head injury. Older children with BGC are less-likely getting BGI after mTBI.	[Jiang, Wenbin; Zhan, Qijia; Wang, Yanyan; Wei, Min; Xiao, Bo] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Neurosurg, Shanghai 200062, Peoples R China; [Fu, Jinhua] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Radiol, Shanghai 200062, Peoples R China; [Chen, Fang] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 1, Dept Urol, Shanghai 200233, Peoples R China		Xiao, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Neurosurg, Shanghai 200062, Peoples R China.	xiao977@hotmail.com		jiang, wenbin/0000-0001-6434-533X			DALESSANDRO G, 1992, STROKE, V23, P1712, DOI 10.1161/01.STR.23.12.1712; DHARKER SR, 1993, NEUROSURGERY, V33, P863; Fidan E, 2018, PEDIATR EMERG CARE, V34, pE233, DOI 10.1097/PEC.0000000000001229; Fujimura M, 2004, CHILD NERV SYST, V20, P430, DOI 10.1007/s00381-003-0884-0; Ganesan V, 2000, DEV MED CHILD NEUROL, V42, P455, DOI 10.1017/S0012162200000852; Goraya JS, 2018, J CHILD NEUROL, V33, P146, DOI 10.1177/0883073817750501; Ishihara C, 2009, PEDIATR INT, V51, P829, DOI 10.1111/j.1442-200X.2009.02924.x; Ivanov I, 2012, J CLIN ULTRASOUND, V40, P607, DOI 10.1002/jcu.21922; Izumi T, 2013, EUR SPINE J, V22, P2569, DOI 10.1007/s00586-013-2989-9; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Landi A, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-2; Lingappa L, 2014, DEV MED CHILD NEUROL, V56, P78, DOI 10.1111/dmcn.12275; MAKI Y, 1980, CHILD BRAIN, V7, P113; Mallick AA, 2014, LANCET NEUROL, V13, P35, DOI 10.1016/S1474-4422(13)70290-4; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; TEELE RL, 1988, RADIOLOGY, V169, P423, DOI 10.1148/radiology.169.2.2845473; UMANSKY F, 1985, J NEUROSURG, V62, P261, DOI 10.3171/jns.1985.62.2.0261; WANG HS, 1995, AM J NEURORADIOL, V16, P97; Williams A N, 2000, Eur J Paediatr Neurol, V4, P103, DOI 10.1053/ejpn.2000.0276; Yamada M, 2013, GERIATR GERONTOL INT, V13, P706, DOI 10.1111/ggi.12004; Yang FH, 2013, PEDIATR NEUROL, V48, P220, DOI 10.1016/j.pediatrneurol.2012.12.008	23	4	5	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2020	192								105706	10.1016/j.clineuro.2020.105706			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LG6IG	WOS:000528201700002	32058199				2022-02-06	
J	Kreitzer, N; Bakas, T; Kurowski, B; Lindsell, CJ; Ferioli, S; Foreman, B; Ngwenya, LB; Thomas, S; Keegan, S; Adeoye, O				Kreitzer, Natalie; Bakas, Tamilyn; Kurowski, Brad; Lindsell, Christopher J.; Ferioli, Simona; Foreman, Brandon; Ngwenya, Laura B.; Thomas, Stephanie; Keegan, Sara; Adeoye, Opeolu			The Experience of Caregivers Following a Moderate to Severe Traumatic Brain Injury Requiring ICU Admission	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute brain injuries; caregiver; caregiver burnout; family caregivers; spouse caregivers; traumatic brain injury	QUALITY-OF-LIFE; FAMILY CAREGIVERS; UNITED-STATES; INPATIENT REHABILITATION; DECISION-MAKING; SERVICE NEEDS; SUPPORT NEEDS; HEALTH; COMMUNICATION; SATISFACTION	Objectives: Survivors of moderate and severe traumatic brain injury (TBI) require substantial care, much of which is ultimately provided by friends and family. We sought to describe the unmet needs of informal caregivers. Design: Qualitative, semistructured interviews with informal caregivers of moderate and severe TBI survivors were conducted 72 hours, 1 month, 3 months, and 6 months after injury. Setting: Intensive care unit of a level 1 trauma center. Participants: Informal caregivers were friends or family who planned to provide care for the patient. Patients were 18 years or older with a moderate to severe TBI, and not expected to imminently die of their injuries. Measurements and Main Results: Eighteen patient-caregiver dyads were enrolled. Fifty-three interviews with caregivers were completed and analyzed over the course of 6 months. Three themes were identified in the qualitative analysis: caregiver burden, caregiver health-related quality of life, and caregiver needs for information and support. Conclusions: This study provides new information about the experience of informal caregivers during the 6 months after their friend or family member survived a moderate to severe TBI. Interventions to promote caregiving may be a substantial opportunity to improve patient-centered outcomes following TBI.	[Kreitzer, Natalie; Thomas, Stephanie; Keegan, Sara; Adeoye, Opeolu] Collaborat Res Acute Neurol Injury, Dept Emergency Med, Cincinnati, OH USA; [Kreitzer, Natalie; Adeoye, Opeolu] Collaborat Res Acute Neurol Injury, Div Neurocrit Care, Cincinnati, OH USA; [Ferioli, Simona; Foreman, Brandon; Ngwenya, Laura B.] Collaborat Res Acute Neurol Injury, Dept Neurol, Cincinnati, OH USA; [Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Bakas, Tamilyn] Univ Cincinnati, Coll Nursing, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Childrens Hosp, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Lindsell, Christopher J.] Vanderbilt Univ, Med Ctr, Nashville, TN USA		Kreitzer, N (corresponding author), Univ Cincinnati, Dept Emergency Med, Med Sci Bldg,Room 1654,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	kreitzne@ucmail.uc.edu	Bakas, Tamilyn/ABC-5664-2020	Ngwenya, Laura/0000-0001-7103-971X	University of Cincinnati Gardner Neuroscience Institute (UCGNI); College of Medicine grant	Dr Kreitzer has received honorarium from Emergency Medicine Cardiac Research and Education Group International (EM-CREG), and serves on the Portola Speaker Bureau. This work was funded by a University of Cincinnati Gardner Neuroscience Institute (UCGNI) and College of Medicine grant.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Bakas Tamilyn, 2002, J Neurosci Nurs, V34, P242; Bakas T, 2009, J NURS SCHOLARSHIP, V41, P368, DOI 10.1111/j.1547-5069.2009.01282.x; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Broodryk M, 2015, AFR J DISABIL, V4, DOI 10.4102/ajod.v4i1.165; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Campbell C H, 1988, Rehabil Nurs, V13, P320; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Czerwonka AI, 2015, J CRIT CARE, V30, P242, DOI 10.1016/j.jcrc.2014.10.017; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Engli M, 1993, J Neurosci Nurs, V25, P78; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Houghton C, 2015, NURSE RES, V22, P8, DOI 10.7748/nr.22.5.8.e1307; Huffines M, 2013, CRIT CARE NURSE, V33, P56, DOI 10.4037/ccn2013354; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Moore M, 2017, BRAIN INJURY, V31, P1876, DOI 10.1080/02699052.2017.1346291; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Niemeier JP, 2019, ARCH PHYS MED REHAB, V100, pS65, DOI 10.1016/j.apmr.2018.07.422; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Reader TW, 2007, BRIT J ANAESTH, V98, P347, DOI 10.1093/bja/ael372; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski MJ, 2010, RES NURS HEALTH, V33, P1, DOI 10.1002/nur.20365; Shaw DJ, 2014, CRIT CARE MED, V42, P265, DOI 10.1097/CCM.0b013e3182a26ea5; Sinnakaruppan I, 2005, BRAIN INJURY, V19, P283, DOI 10.1080/02699050400003924; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Welch JL, 2014, CLIN NURS RES, V23, P644, DOI 10.1177/1054773813495407; Whitaker-Brown CD, 2017, HEART LUNG, V46, P79, DOI 10.1016/j.hrtlng.2016.11.003; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	51	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E299	E309		10.1097/HTR.0000000000000525			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200013	31479080				2022-02-06	
J	Kumar, RG; Ornstein, KA; Bollens-Lund, E; Watson, EM; Ankuda, CK; Kelley, AS; Dams-O'Connor, K				Kumar, Raj G.; Ornstein, Katherine A.; Bollens-Lund, Evan; Watson, Eric M.; Ankuda, Claire K.; Kelley, Amy S.; Dams-O'Connor, Kristen			Lifetime history of traumatic brain injury is associated with increased loneliness in adults: A US nationally representative study	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						loneliness; older adults; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; OLDER-ADULTS; RISK-FACTORS; HEALTH-CARE; OUTCOMES; REHABILITATION; EPIDEMIOLOGY; METAANALYSIS; PREVALENCE; DEPRESSION	Background/Objectives An estimated 55 million individuals worldwide live with chronic disability associated with traumatic brain injury (TBI), which may include cognitive, behavioral, and social impairments. Reduced participation in social activities is common after TBI; however, few studies have evaluated loneliness among survivors of TBI. The current study aimed to evaluate the association between history of TBI and loneliness and to identify mediators of this association. Methods/Design Retrospective cohort study. Nationally representative sample of N = 724 adults over age 50 years (Health and Retirement Study). Loneliness was evaluated using the 11-item Revised University of California Los Angeles (R-UCLA) Loneliness Scale (range 11-33). Lifetime history of TBI evaluated retrospectively using the Ohio State University TBI Identification Method. We included the following covariates: age, sex, race, and education; and mediators: depressive symptoms, number of comorbidities, chronic pain, difficulty with activities of daily living, and social network index. Results History of TBI was associated with a 1.28-point (95% CI, 0.46-2.11; P < .05; Cohen's D = 0.284) increase in R-UCLA Loneliness Scale scores after covariate adjustment. Individuals with more recent injuries (within 10 years) and multiple lifetime TBIs reported the highest loneliness scores. In the structural equation model, depressive symptoms partially mediated the relationship between TBI and loneliness. All models were adjusted for US population sampling weights. Conclusions History of TBI was associated with greater loneliness compared with individuals without TBI in a representative sample of US adults. Managing depressive symptoms and medical consequences of TBI may be a target to ameliorate reporting of loneliness in this population.	[Kumar, Raj G.; Watson, Eric M.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Ornstein, Katherine A.; Bollens-Lund, Evan; Ankuda, Claire K.; Kelley, Amy S.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY 10029 USA		Dams-O'Connor, K (corresponding author), One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	kristen.dams-oconnor@mountsinai.org	Ankuda, Claire/AAB-5902-2021	Dams-O'Connor, Kristen/0000-0002-2506-0216; Ankuda, Claire/0000-0003-1371-8524; Watson, Eric/0000-0003-2072-9213			ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], SAS 9 4; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bernard, 2006, CONT ISSUES COMMUN S, V33, P42, DOI [10.1044/cicsd_33_S_42, DOI 10.1044/cicsd_33_S_42]; Boekhout JM, 2019, J AGING PHYS ACTIV, V27, P787, DOI 10.1123/japa.2018-0325; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cacioppo JT, 2018, LANCET, V391, P426, DOI 10.1016/S0140-6736(18)30142-9; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cefalu CA, 2011, CLIN GERIATR MED, V27, P491, DOI 10.1016/j.cger.2011.07.001; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Clarke P, 2008, GUIDE CONTENT HRS PS, P6; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Donovan NJ, 2017, INT J GERIATR PSYCH, V32, P564, DOI 10.1002/gps.4495; Emerson K, 2018, J AGING HEALTH, V30, P1450, DOI 10.1177/0898264317721348; Emerson KG, 2016, J AM GERIATR SOC, V64, P886, DOI 10.1111/jgs.14053; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Gerst-Emerson K, 2015, AM J PUBLIC HEALTH, V105, P1013, DOI 10.2105/AJPH.2014.302427; Hakulinen C, 2018, HEART, V104, P1536, DOI 10.1136/heartjnl-2017-312663; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Harrison-Felix C, 2018, ARCH PHYS MED REHAB, V99, P2131, DOI 10.1016/j.apmr.2018.05.030; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heeringa SG, 1995, TECH DESCR HLTH RETI, P1; High Jr WM, 2005, REHABILITATION TRAUM; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kulinski K, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00004; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lee J, 2017, AM J GERIAT PSYCHIAT, V25, P1173, DOI 10.1016/j.jagp.2017.06.004; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Oberski D, 2014, J STAT SOFTW, V57, P1; Ong AD, 2016, GERONTOLOGY, V62, P443, DOI 10.1159/000441651; Perissinotto C, 2019, J AM GERIATR SOC, V67, P657, DOI 10.1111/jgs.15746; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; R Development Core Team, 2012, R LANG ENV STAT COMP; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rigon A, 2019, J INT NEUROPSYCH SOC, V25, P285, DOI 10.1017/S1355617718001108; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Steptoe A, 2004, PSYCHONEUROENDOCRINO, V29, P593, DOI 10.1016/S0306-4530(03)00086-6; Stravynski A, 2001, SUICIDE LIFE-THREAT, V31, P32, DOI 10.1521/suli.31.1.32.21312; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tsaousides T, 2017, J HEAD TRAUMA REHAB, V32, P354, DOI 10.1097/HTR.0000000000000345; Yang KM, 2011, AGEING SOC, V31, P1368, DOI 10.1017/S0144686X1000139X	60	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	MAY	2020	35	5					553	563		10.1002/gps.5271			11	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	KZ9WH	WOS:000523609000013	31994215				2022-02-06	
J	Leahy, R; Farrington, S; Whyte, E; O'Connor, S				Leahy, Roisin; Farrington, Shane; Whyte, Enda; O'Connor, Siobhan			Concussion reporting, knowledge and attitudes in Irish amateur gaelic games athletes	PHYSICAL THERAPY IN SPORT			English	Article						Head injury; Concussion reporting; Health education; Ireland	HIGH-SCHOOL; RECURRENT CONCUSSION; FOOTBALL PLAYERS; BEHAVIORS; HISTORY; INJURY; SPORT; RATES; RISK	Objectives: To examine self-reported concussion history, knowledge and attitudes towards concussion reporting and education in Irish adult Gaelic games players. Design: Cross-sectional survey. Setting: Data were collected using an online survey instrument. Participants: Two hundred and sixteen adult Gaelic games athletes (106 male, 110 female). Main outcome measures: Self-reported concussion history for the previous season, reporting history for participants' most recent concussion, concussion knowledge, willingness to report future concussions in a variety of situations and desire for further concussion education. Results: Seventy-three percent of participants suspected they had sustained a concussion in the past. Most (72.2%) informed someone of their most recent concussion, although two-thirds continued to play during their most recent concussion. Participants had a good overall understanding of concussion, although concussion knowledge score was not associated with safer behaviour following participants' most recent concussion. While most agreed that concussion is a serious injury (95.8%), 46.8% would not report a concussion during important games. Conclusions: The high proportion of participants playing following concussion and their reluctance to report concussions during important games is concerning. Interventions aimed at improving attitudes towards concussion reporting among athletes and other stakeholders are required to improve concussion management in amateur Gaelic games athletes. (C) 2019 Elsevier Ltd. All rights reserved.	[Leahy, Roisin; Farrington, Shane; Whyte, Enda; O'Connor, Siobhan] Dublin City Univ, Sch Hlth & Human Performance, XB30, Dublin 9, Ireland		Leahy, R (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, XB30, Dublin 9, Ireland.	roisin.leahy6@mail.dcu.ie	O'Connor, Siobhan/Q-8568-2018	O'Connor, Siobhan/0000-0002-2001-0746; Leahy, Roisin/0000-0002-9902-5683	Health Research Board Summer Student Scholarships [SS-2017-113]	This work was supported by the Health Research Board Summer Student Scholarships (Grant ID: SS-2017-113). The Health Research Board did not have any role in the design of the study, collection, analysis and interpretation of data, writing the manuscript or the decision to submit for publication.	[Anonymous], 2014, ENGLAND PROFESSIONAL; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Blake C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005059; Buckley CS, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2017-000315; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen J., 2013, STAT POWER ANAL BEHA; Conway F. N., 2018, CLIN J SPORT MED, V1, DOI [10.1097/JSM, DOI 10.1097/JSM]; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; LaBrie JW, 2010, ADDICT BEHAV, V35, P1094, DOI 10.1016/j.addbeh.2010.08.003; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Murphy JC, 2012, BRIT J SPORT MED, V46, P138, DOI 10.1136/bjsm.2010.072132; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; O'Connor S, 2020, CLIN J SPORT MED, V30, P578, DOI 10.1097/JSM.0000000000000658; OConnor S., 2018, CLIN J SPORT MED, V1, DOI [10.1097/JSM, DOI 10.1097/JSM]; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sullivan L, 2016, INT J ADOLESC MED HL, V29, DOI [10.1515/ijamh-2015-0084., DOI 10.1515/IJAMH-2015-0084]; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	39	4	4	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAY	2020	43						236	243		10.1016/j.ptsp.2019.06.004			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LK8AH	WOS:000531082200032	31213341				2022-02-06	
J	Morrow, EL; Duff, MC				Morrow, Emily L.; Duff, Melissa C.			Sleep Supports Memory and Learning: Implications for Clinical Practice in Speech-Language Pathology	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; WAKE DISTURBANCES; DEPENDENT IMPROVEMENT; DECLARATIVE MEMORY; BEHAVIOR DISORDER; SCHOOL; IMPACT; CHILDREN; ADULTS; INCREASES	Purpose: This tutorial aims to draw attention to the interactions among memory, sleep, and therapy potential and to increase awareness and knowledge in the field of speech-language pathology of the potential impact of sleep as a mediating or moderating factor in promoting therapeutic outcome. Method: We highlight key findings from the literature on the cognitive neuroscience of memory, the neurophysiology of sleep, how sleep supports memory, and how sleep disruption affects memory and learning abilities in populations commonly served in speech-language pathology. Results: Research increasingly points to the critical importance of sleep quality and quantity to memory and learning, and sleep disruption is linked to deficits in functional cognition that may limit our clients' ability to benefit from speech pathology interventions. Conclusions: As a field dedicated to promoting memory, learning, and relearning through our interventions, any systemic factors that affect these abilities demand our attention. Although speech-language pathologists do not treat sleep disturbance, we play a critical role in recognizing the signs and symptoms of sleep disturbance and making appropriate referrals, as undiagnosed and untreated sleep disturbance can have serious impacts on success in therapeutic contexts. By considering how related factors affect memory and learning, we have the opportunity to take a whole client approach to maximizing our clients' therapy potential and functional progress.	[Morrow, Emily L.; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA		Morrow, EL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA.	emily.l.morrow@vanderbilt.edu		Morrow, Emily/0000-0003-4629-2283			[Anonymous], 2019, NATL HLTH SLEEP AWAR; Antony J.W., 2017, HIPPOCAMPUS CELLS SY, P245; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Batterink LJ, 2017, BRAIN LANG, V167, P83, DOI 10.1016/j.bandl.2015.09.003; Brawn TP, 2013, PSYCHOL SCI, V24, P439, DOI 10.1177/0956797612457391; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Carter M, 2009, ARCH DIS CHILD, V94, P308, DOI 10.1136/adc.2008.146845; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cohen, 2001, CONDITIONING CONSCIO; Cohen N. J., 2003, COGNITIVE NEUROSCIEN, P323; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cousins JN, 2019, PROG BRAIN RES, V246, P27, DOI 10.1016/bs.pbr.2019.01.007; Covington NV, 2018, J COGNITIVE NEUROSCI, V30, P680, DOI 10.1162/jocn_a_01228; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Dumay N, 2007, PSYCHOL SCI, V18, P35, DOI 10.1111/j.1467-9280.2007.01845.x; Dunster GP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau6200; Earle FS, 2018, NEUROSCI LETT, V666, P58, DOI 10.1016/j.neulet.2017.12.030; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Eliasson Arne, 2002, Sleep Breath, V6, P45, DOI 10.1007/s11325-002-0045-9; EMPSON JAC, 1970, NATURE, V227, P287, DOI 10.1038/227287a0; Epstein R, 1998, SLEEP, V21, P250, DOI 10.1093/sleep/21.3.250; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gais S, 2002, J NEUROSCI, V22, P6830; Gaskell MG, 2019, COGNITION, V182, P109, DOI 10.1016/j.cognition.2018.09.007; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Hermann DM, 2008, STROKE, V39, P62, DOI 10.1161/STROKEAHA.107.494955; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huffington A., 2017, SLEEP REVOLUTION TRA; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Kumar S, 2002, MOVEMENT DISORD, V17, P775, DOI 10.1002/mds.10167; Landsness EC, 2009, SLEEP, V32, P1273; Levanon A, 1999, J PEDIATR-US, V134, P755, DOI 10.1016/S0022-3476(99)70293-3; Liu XC, 2006, CHILD PSYCHIAT HUM D, V37, P179, DOI 10.1007/s10578-006-0028-3; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1371, DOI 10.1044/2019_AJSLP-18-0295; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mayo Clinic, 2019, SLEEP DIS SYMPT CAUS; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; McGregor Karla K, 2015, EBP Briefs, V10, P1; McGregor KK, 2014, J SPEECH LANG HEAR R, V57, P1842, DOI 10.1044/2014_JSLHR-L-13-0273; McGregor KK, 2013, J SPEECH LANG HEAR R, V56, P1845, DOI 10.1044/1092-4388(2013/12-0233); Molle M, 2011, PROG BRAIN RES, V193, P93, DOI 10.1016/B978-0-444-53839-0.00007-7; Murray ME, 2013, NEUROLOGY, V81, P1681, DOI 10.1212/01.wnl.0000435299.57153.f0; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Neighmond P., 2018, NATL PUBLIC RADIO; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prince TM, 2013, LEARN MEMORY, V20, P558, DOI 10.1101/lm.031674.113; Quach J, 2009, PEDIATRICS, V123, P1287, DOI 10.1542/peds.2008-1860; Reber PJ, 1996, BEHAV NEUROSCI, V110, P861, DOI 10.1037/0735-7044.110.5.861; Rubin RD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070082; Sadeh A, 2000, DEV PSYCHOL, V36, P291, DOI 10.1037/0012-1649.36.3.291; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schabus M, 2008, BRAIN RES, V1191, P127, DOI 10.1016/j.brainres.2007.10.106; Schreck KA, 2004, RES DEV DISABIL, V25, P57, DOI 10.1016/j.ridd.2003.04.007; SMITH C, 1991, BEHAV NEUROSCI, V105, P282, DOI 10.1037/0735-7044.105.2.282; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P241, DOI 10.1146/annurev.ne.05.030182.001325; STERN RA, 1991, AM J PSYCHIAT, V148, P351; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Suzuki K, 2017, J GEN FAM MED, V18, P61, DOI 10.1002/jgf2.27; Tall AR, 2019, NATURE, V566, P329, DOI 10.1038/d41586-019-00393-6; Tamaki M, 2008, SLEEP, V31, P204, DOI 10.1093/sleep/31.2.204; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Trockel MT, 2000, J AM COLL HEALTH, V49, P125, DOI 10.1080/07448480009596294; Turner RS, 2000, NEUROLOGY, V55, P1730, DOI 10.1212/WNL.55.11.1730; Ullman MT, 2018, SECOND LANG RES, V34, P39, DOI 10.1177/0267658316675195; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wei YN, 2016, J NEUROSCI, V36, P4231, DOI 10.1523/JNEUROSCI.3648-15.2016; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; Wiseman-Hakes C, 2019, ASN NEURO, V11, DOI 10.1177/1759091418822405; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Wiseman-Hakes C, 2011, BRAIN INJURY, V25, P1256, DOI 10.3109/02699052.2011.608215; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851	85	4	4	0	8	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2020	29	2					577	585		10.1044/2019_AJSLP-19-00125			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MM5FZ	WOS:000550183600001	32202919				2022-02-06	
J	Mudri, M; Williams, A; Priestap, F; Davidson, J; Merritt, N				Mudri, Martina; Williams, Andrew; Priestap, Fran; Davidson, Jacob; Merritt, Neil			Comparison of drugs used for intubation of pediatric trauma patients	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	51st Annual Meeting of the Canadian-Association-of-Pediatric-Surgeons (CAPS)	SEP 19-21, 2019	Quebec, CANADA	Canadian Assoc Pediat Surg		Rapid sequence intubation (RSI); Propofol; Trauma; Pediatric; Traumatic brain injury (TBI)	RAPID-SEQUENCE INTUBATION; PROCEDURAL SEDATION; TRACHEAL INTUBATION; ENDOTRACHEAL INTUBATION; EMERGENCY-DEPARTMENT; PROPOFOL SEDATION; INDUCTION; MANAGEMENT; KETAMINE	Purpose: Rapid sequence intubation (RSI) drugs, such as propofol, affect clinical outcomes, but this has not been examined in the pediatric population. This descriptive study compares the outcomes associated with intubation drugs used in pediatric traumatic brain injury (TBI) patients. Methods: A retrospective chart review and descriptive analysis of intubated TBI patients, ages 0-17, admitted to Children's Hospital London Health Sciences Centre (LHSC) from January 2006-December 2016 was performed. Results: Out of 259 patients intubated, complete data was available for 107 cases. Average injury severity score was 28; 46 were intubated at LHSC, 55 at primary care site, and 6 on scene. Intubation attempts were recorded in 87 of 107 paper charts. First-pass intubation success rate was 88.5%. Propofol (n = 21), midazolam (n = 31), etomidate (n = 13), and ketamine (n = 7) were the most commonly used intubation drugs. Paralytics were used in 50% of patients. Following use of propofol, Pediatric Adjusted Shock Index was increased as a result of worsening hypotension. Mean total hospital length of staywas 21 days with 7.5 days in ICU. Survival was 87%. Conclusion: Great variability exists in the use of induction agents and paralytics for RSI. Propofol was commonly used and is potentially associated with poorer clinical outcomes. Type of Study: Retrospective. (c) 2020 Elsevier Inc. All rights reserved.	[Mudri, Martina; Williams, Andrew] Western Univ, Schulich Sch Med & Dent, Div Gen Surg, London, ON, Canada; [Priestap, Fran] Western Univ, Schulich Sch Med & Dent, Div Crit Care, Dept Med, London, ON, Canada; [Davidson, Jacob; Merritt, Neil] Western Univ, Schulich Sch Med & Dent, Div Paediat Gen Surg, Childrens Hosp,London Hlth Sci Ctr, London, ON, Canada		Merritt, N (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Rm B1-188,800 Commissioners Rd East, London, ON N6C 2V3, Canada.	Neil.Merritt@lhsc.on.ca					Abdel-Latif ME, 2007, PEDIATRICS, V120, P933, DOI 10.1542/peds.2007-2352; Andolfatto G, 2012, ANN EMERG MED, V59, P504, DOI 10.1016/j.annemergmed.2012.01.017; Aouad MT, 2012, PEDIATR ANESTH, V22, P616, DOI 10.1111/j.1460-9592.2012.03845.x; Bano S, 2012, PEDIATR EMERG CARE, V28, P1129, DOI 10.1097/PEC.0b013e3182713316; David H, 2011, ANN EMERG MED, V57, P435, DOI 10.1016/j.annemergmed.2010.11.025; Dietrich SK, 2018, AM SURGEON, V84, P1504; Gerardi MJ, 1996, ANN EMERG MED, V28, P55, DOI 10.1016/S0196-0644(96)70140-3; Jasiak KD, 2012, PEDIATR EMERG CARE, V28, P440, DOI 10.1097/PEC.0b013e3182531a9b; Long E, 2014, PEDIATR ANESTH, V24, P1204, DOI 10.1111/pan.12490; Mallory MD, 2011, ANN EMERG MED, V57, P462, DOI 10.1016/j.annemergmed.2011.03.008; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; McFadyen J Grant, 2012, Int J Crit Illn Inj Sci, V2, P121, DOI 10.4103/2229-5151.100888; Mort Thomas C, 2007, J Intensive Care Med, V22, P157, DOI 10.1177/0885066607299525; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; Shah A, 2011, ANN EMERG MED, V57, P425, DOI 10.1016/j.annemergmed.2010.08.032; Shaikh SI, 2010, INDIAN J ANAESTH, V54, P29, DOI 10.4103/0019-5049.60493; Sivilotti MLA, 1998, ANN EMERG MED, V31, P313, DOI 10.1016/S0196-0644(98)70341-5; Skokan EG, 2001, CLIN PEDIATR, V40, P663, DOI 10.1177/000992280104001204; Stollings JL, 2014, ANN PHARMACOTHER, V48, P62, DOI 10.1177/1060028013510488; Zuckerbraun NS, 2006, ACAD EMERG MED, V13, P602, DOI 10.1197/j.aem.2005.12.026	21	4	4	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2020	55	5					926	929		10.1016/j.jpedsurg.2020.01.041			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	LS6JH	WOS:000536487400030	32067810				2022-02-06	
J	Sribnick, EA; Hensley, J; Moore-Clingenpeel, M; Muszynski, JA; Thakkar, RK; Hall, MW				Sribnick, Eric A.; Hensley, Josey; Moore-Clingenpeel, Melissa; Muszynski, Jennifer A.; Thakkar, Rajan K.; Hall, Mark W.			Nosocomial Infection Following Severe Traumatic Injury in Children	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						critical care; cross infection; indwelling catheters; multiple trauma; pediatrics; traumatic brain injuries	SERIOUS CONCOMITANT INJURIES; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE UNITS; BRAIN-INJURY; RISK-FACTORS; HEAD TRAUMA; SURVEILLANCE; SEPSIS; PNEUMONIA; INTERVAL	Objectives: Nosocomial infection is a common source of morbidity in critically injured children including those with traumatic brain injury. Risk factors for nosocomial infection in this population, however, are poorly understood. We hypothesized that critically ill pediatric trauma patients with traumatic brain injury would demonstrate higher rates of nosocomial infection than those without traumatic brain injury. Design: Retrospective case-control study. Setting: PICU, single institution. Patients: Patients under 18 years old who were admitted to the PICU for at least 48 hours following a traumatic injury were included. Patients were admitted between September 2008 and December 2015. Patients with the following injury types were excluded: thermal injury, drowning, hanging/strangulation, acute hypoxic ischemic encephalopathy, or nonaccidental trauma. Data collected included demographics, injury information, hospital and PICU length of stay, vital signs, laboratory data, insertion and removal dates for invasive devices, surgeries performed, transfusions of blood products, and microbiology culture results. Initial Pediatric Risk of Mortality III and Pediatric Logistic Organ Dysfunction-2 scores were determined. Patients were classified as having: 1) an isolated traumatic brain injury, 2) a traumatic injury without traumatic brain injury, or 3) polytrauma with traumatic brain injury. Interventions: None. Measurements and Main Results: Two hundred three patients were included in the analyses, and 27 patients developed a nosocomial infection. Patients with polytrauma with traumatic brain injury demonstrated a significantly higher infection rate (30%) than patients with isolated traumatic brain injury (6%) or traumatic injury without traumatic brain injury (9%) (p < 0.001). This increased rate of nosocomial infection was noted on univariate analysis, on multivariable analysis, and after adjusting for other risk factors. Conclusions: In this single-center, retrospective analysis of critically ill pediatric trauma patients, nosocomial infections were more frequently observed in patients admitted following polytrauma with traumatic brain injury than in patients with isolated traumatic brain injury or trauma without traumatic brain injury.	[Sribnick, Eric A.] Nationwide Childrens Hosp, Dept Surg, Div Neurosurg, Columbus, OH 43205 USA; [Sribnick, Eric A.] Ohio State Univ, Coll Med, Dept Neurosurg, Columbus, OH 43210 USA; [Sribnick, Eric A.; Hensley, Josey; Moore-Clingenpeel, Melissa; Muszynski, Jennifer A.; Thakkar, Rajan K.; Hall, Mark W.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH 43205 USA; [Muszynski, Jennifer A.; Hall, Mark W.] Nationwide Childrens Hosp, Dept Pediat, Div Crit Care Med, Columbus, OH USA; [Thakkar, Rajan K.] Nationwide Childrens Hosp, Dept Surg, Div Pediat Surg, Columbus, OH USA		Sribnick, EA (corresponding author), Nationwide Childrens Hosp, Dept Surg, Div Neurosurg, Columbus, OH 43205 USA.; Sribnick, EA (corresponding author), Ohio State Univ, Coll Med, Dept Neurosurg, Columbus, OH 43210 USA.; Sribnick, EA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH 43205 USA.	eric.sribnick@nationwidechil-drens.org			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Bristol Myers SquibbBristol-Myers Squibb; La Jolla Pharmaceuticals	Dr. Muszynski's institution received funding from the National Institutes of Health (NIH), and she received support for article research from the NIH. Dr. Hall received funding from Bristol Myers Squibb and La Jolla Pharmaceuticals. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abulhasan YB, 2018, AM J INFECT CONTROL, V46, P656, DOI 10.1016/j.ajic.2017.12.001; Abulhasan YB, 2018, WORLD NEUROSURG, V115, pE393, DOI 10.1016/j.wneu.2018.04.061; Ak O, 2011, MED SCI MONITOR, V17, pPH29, DOI 10.12659/MSM.881750; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Almizraq RJ, 2018, BLOOD ADV, V2, P2296, DOI 10.1182/bloodadvances.2018021931; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Carcillo JA, 2012, PEDIATR CRIT CARE ME, V13, P165, DOI 10.1097/PCC.0b013e31823896ae; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Cheron A, 2010, CRIT CARE, V14, DOI 10.1186/cc9331; Condotta SA, 2015, J IMMUNOL, V195, P116, DOI 10.4049/jimmunol.1402473; Cutler Gretchen J, 2017, Hosp Pediatr, V7, P164, DOI 10.1542/hpeds.2016-0072; Devine RA, 2018, INT J BURNS TRAUMA, V8, P6; Ditschkowski M, 1999, ANN SURG, V229, P246, DOI 10.1097/00000658-199902000-00013; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Khan Inam Danish, 2017, Med J Armed Forces India, V73, P222, DOI 10.1016/j.mjafi.2016.10.008; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Leteurtre S, 2013, CRIT CARE MED, V41, P1761, DOI 10.1097/CCM.0b013e31828a2bbd; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morillo-Garcia A, 2015, GAC SANIT, V29, P282, DOI 10.1016/j.gaceta.2015.02.008; Muszynski JA, 2014, SHOCK, V42, P313, DOI 10.1097/SHK.0000000000000217; Muszynski JA, 2013, PEDIATR CRIT CARE ME, V14, P533, DOI 10.1097/PCC.0b013e31828a897f; Nakos G, 2002, CRIT CARE MED, V30, P1488, DOI 10.1097/00003246-200207000-00015; POLK HC, 1986, ANN SURG, V204, P282; Pollack MM, 2013, PEDIATR CRIT CARE ME, V14, P448, DOI 10.1097/PCC.0b013e31828a7270; Saliba P, 2018, J HOSP INFECT, V99, P48, DOI 10.1016/j.jhin.2017.11.002; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shibahashi K, 2018, WORLD NEUROSURG, V110, pE1078, DOI 10.1016/j.wneu.2017.12.002; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Spec A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1182-z; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Wang LC, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3772-2; Worth LJ, 2018, J HOSP INFECT, V99, P55, DOI 10.1016/j.jhin.2017.11.021; Wunderink Richard G, 2005, Proc Am Thorac Soc, V2, P440, DOI 10.1513/pats.2005080-83JS; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	43	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2020	21	5					443	450		10.1097/PCC.0000000000002238			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	LO1WG	WOS:000533417600019	32106190				2022-02-06	
J	Tsolinas, RE; Burke, JF; DiGiorgio, AM; Thomas, LH; Duong-Fernandez, X; Harris, MH; Yue, JK; Winkler, EA; Suen, CG; Pascual, LU; Ferguson, AR; Huie, JR; Pan, JZ; Hemmerle, DD; Singh, V; Torres-Espin, A; Omondi, C; Kyritsis, N; Haefeli, J; Weinstein, PR; Neto, CAD; Kuo, YH; Taggard, D; Talbott, JF; Whetstone, WD; Manley, GT; Bresnahan, JC; Beattie, MS; Dhall, SS				Tsolinas, Rachel E.; Burke, John F.; DiGiorgio, Anthony M.; Thomas, Leigh H.; Duong-Fernandez, Xuan; Harris, Mark H.; Yue, John K.; Winkler, Ethan A.; Suen, Catherine G.; Pascual, Lisa U.; Ferguson, Adam R.; Huie, J. Russell; Pan, Jonathan Z.; Hemmerle, Debra D.; Singh, Vineeta; Torres-Espin, Abel; Omondi, Cleopa; Kyritsis, Nikos; Haefeli, Jenny; Weinstein, Philip R.; Neto, Carlos A. de Almeida; Kuo, Yu-Hung; Taggard, Derek; Talbott, Jason F.; Whetstone, William D.; Manley, Geoffrey T.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Dhall, Sanjay S.			Transforming Research and Clinical Knowledge in Spinal Cord Injury (TRACK-SCI): an overview of initial enrollment and demographics	NEUROSURGICAL FOCUS			English	Article						SCI; spine trauma; data registries	BRAIN; CLASSIFICATION; RECOVERY; REVISION; OUTCOMES; SYSTEM; TUMORS	OBJECTIVE Traumatic spinal cord injury (SCI) is a dreaded condition that can lead to paralysis and severe disability. With few treatment options available for patients who have suffered from SCI, it is important to develop prospective databases to standardize data collection in order to develop new therapeutic approaches and guidelines. Here, the authors present an overview of their multicenter, prospective, observational patient registry, Transforming Research and Clinical Knowledge in SCI (TRACK-SCI). METHODS Data were collected using the National Institute of Neurological Disorders and Stroke (NINDS) common data elements (CDEs). Highly granular clinical information, in addition to standardized imaging, biospecimen, and followup data, were included in the registry. Surgical approaches were determined by the surgeon treating each patient; however, they were carefully documented and compared within and across study sites. Follow-up visits were scheduled for 6 and 12 months after injury. RESULTS One hundred sixty patients were enrolled in the TRACK-SCI study. In this overview, basic clinical, imaging, neurological severity, and follow-up data on these patients are presented. Overall, 78.8% of the patients were determined to be surgical candidates and underwent spinal decompression and/or stabilization. Follow-up rates to date at 6 and 12 months are 45% and 36.3%, respectively. Overall resources required for clinical research coordination are also discussed. CONCLUSIONS The authors established the feasibility of SCI CDE implementation in a multicenter, prospective observational study. Through the application of standardized SCI CDEs and expansion of future multicenter collaborations, they hope to advance SCI research and improve treatment.	[Tsolinas, Rachel E.; Burke, John F.; DiGiorgio, Anthony M.; Thomas, Leigh H.; Duong-Fernandez, Xuan; Harris, Mark H.; Yue, John K.; Winkler, Ethan A.; Suen, Catherine G.; Ferguson, Adam R.; Huie, J. Russell; Pan, Jonathan Z.; Hemmerle, Debra D.; Singh, Vineeta; Torres-Espin, Abel; Omondi, Cleopa; Kyritsis, Nikos; Haefeli, Jenny; Neto, Carlos A. de Almeida; Talbott, Jason F.; Manley, Geoffrey T.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Dhall, Sanjay S.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Burke, John F.; DiGiorgio, Anthony M.; Thomas, Leigh H.; Duong-Fernandez, Xuan; Harris, Mark H.; Yue, John K.; Winkler, Ethan A.; Suen, Catherine G.; Ferguson, Adam R.; Huie, J. Russell; Hemmerle, Debra D.; Torres-Espin, Abel; Omondi, Cleopa; Kyritsis, Nikos; Haefeli, Jenny; Weinstein, Philip R.; Neto, Carlos A. de Almeida; Manley, Geoffrey T.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Dhall, Sanjay S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Pascual, Lisa U.] Univ Calif San Francisco, Dept Orthoped Surg, San Francisco, CA USA; [Pan, Jonathan Z.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA USA; [Singh, Vineeta] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Whetstone, William D.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA USA; [Thomas, Leigh H.; Duong-Fernandez, Xuan; Harris, Mark H.; Ferguson, Adam R.; Huie, J. Russell; Hemmerle, Debra D.; Singh, Vineeta; Omondi, Cleopa; Kyritsis, Nikos; Weinstein, Philip R.; Neto, Carlos A. de Almeida; Bresnahan, Jacqueline C.; Beattie, Michael S.] Weill Inst Neurosci, San Francisco, CA USA; [Pascual, Lisa U.] Zuckerberg San Francisco Gen Hosp, Orthopaed Surg & Orthoped Trauma Inst, San Francisco, CA USA; [Ferguson, Adam R.] San Francisco Vet Affairs Healthcare Syst, San Francisco, CA USA; [Weinstein, Philip R.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Talbott, Jason F.] Zuckerberg San Francisco Gen Hosp, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Kuo, Yu-Hung; Taggard, Derek] Univ Calif San Francisco, Dept Neurol Surg, Fresno, CA USA		Burke, JF (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	john.burke@ucsf.edu	Torres, Abel/ABD-1354-2020; Kyritsis, Nikos/AAD-5187-2021	Torres, Abel/0000-0002-9787-8738; Kyritsis, Nikos/0000-0001-7801-5796; Burke, John/0000-0002-6190-5116; Harris, Mark/0000-0002-1598-225X; Ferguson, Adam/0000-0001-7102-1608; Thomas, Leigh/0000-0002-7593-0240	Department of DefenseUnited States Department of Defense [W81XWH-13-1-0297, W81XWH-16-1-0497]; Craig H. Neilsen grant Center of Excellence in Spinal Cord Injury: TRACK-SCI; Wings for Life [WFL-US-07-18]	The current work was supported by Department of Defense grant nos. W81XWH-13-1-0297 (Effects of Early Acute Care on Autonomic Outcomes in SCI: Bedside to Bench and Back) and W81XWH-16-1-0497 (Early Critical Care Decisions and Outcomes after SCI: TRACK-SCI), the Craig H. Neilsen grant Center of Excellence in Spinal Cord Injury: TRACK-SCI, and the Wings for Life grant no. WFL-US-07-18 (Discovering Blood RNA Biomarkers for Diagnosis of SCI Severity and/or Prognosis of Neurological Recovery).	Baldi I, 2018, NEUROCHIRURGIE, V64, P5, DOI 10.1016/j.neuchi.2014.05.006; Biering-Sorensen F, 2006, SPINAL CORD, V44, P530, DOI 10.1038/sj.sc.3101930; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; Biering-Sorensen F, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030029; Burke JF, 2019, NEUROSURGERY, V85, P199, DOI 10.1093/neuros/nyy537; Catapano JS, 2016, WORLD NEUROSURG, V96, P72, DOI 10.1016/j.wneu.2016.08.053; Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; Dhall SS, 2018, NEUROSURGERY, V82, P870, DOI 10.1093/neuros/nyx320; DiGiorgio A, 2018, J NEUROSURG, V128, P54; DiGiorgio AM, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17437; Fehlings MG, 2016, SPINAL CORD, V54, P8, DOI 10.1038/sc.2015.95; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Huie JR, 2018, NEUROLOGY, V90; Jung KW, 2015, CANCER RES TREAT, V47, P166, DOI 10.4143/crt.2014.017; Kim T, 2019, J NEUROSURG, V130, P1965, DOI 10.3171/2018.1.JNS172766; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767; National Spinal Cord Injury Statistical Center, 2016, SPIN CORD INJ FACTS; Noonan V, 2002, WORKING INT SPINAL C; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov189; Parker SL, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15355; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Readdy WJ, 2015, J NEUROSURG-SPINE, V23, P574, DOI 10.3171/2015.2.SPINE14746; Reinhold M, 2013, EUR SPINE J, V22, P2184, DOI 10.1007/s00586-013-2738-0; Sebastian AS, 2016, CLIN SPINE SURG, V29, P427, DOI 10.1097/BSD.0000000000000464; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Yue JK, 2019, NEUROSURGERY S1, V66; Yue JK, 2020, WORLD NEUROSURG, V133, pE391, DOI 10.1016/j.wneu.2019.09.044; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	35	4	4	20	21	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2020	48	5							E6	10.3171/2020.2.FOCUS191030			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX0XY	WOS:000575443400002	32357323	gold			2022-02-06	
J	Weber, AE; Trasolini, NA; Bolia, IK; Rosario, S; Prodromo, JP; Hill, C; Romano, R; Liu, CY; Tibone, JE; Gamradt, SC				Weber, Alexander E.; Trasolini, Nicholas A.; Bolia, Ioanna K.; Rosario, Santano; Prodromo, John P.; Hill, Catherine; Romano, Russ; Liu, Charles Y.; Tibone, James E.; Gamradt, Seth C.			Epidemiologic Assessment of Concussions in an NCAA Division I Women's Soccer Team	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; head injury; risk factors; epidemiology; soccer	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; SPORTS; RECOVERY; TRENDS; BALL	Background: Among collegiate sports, ice hockey and wrestling have been reported to have the highest rates of concussion injury. Recent literature has shown that among all sports, female soccer players had the highest rate of concussion injury at the high school level. Sport-specific analysis will increase our knowledge of epidemiologic characteristics of this serious injury in young soccer players, where "heading" is commonly involved during participation. Hypothesis: Heading during soccer will be associated with increased frequency of concussion injury in collegiate female players compared with other mechanisms of injury, and concussion injury mechanism and rates will differ by setting of injury (practice or match) and player position. Study Design: Descriptive epidemiologic study. Methods: This was a retrospective review and epidemiologic analysis of all concussions documented from a single National Collegiate Athletic Association (NCAA) Division I female collegiate soccer team between 2004 and 2017. A total of 381 participants were reviewed, and concussion injury mechanism, setting (practice or match), player position, and number of games and practices missed due to injury were analyzed. Results: Overall, 25 concussions in 22 players from the 2004 to 2017 seasons were identified, for an annual rate of 1.79 concussions per year. Collisions (36%) followed by headers (20%) were the most common mechanisms. Forwards sustained the most concussions (32%). Injuries were more common in games (56%) than practice (40%). Of note, the most common cause of concussion during practice was headers (40%). Of the concussions documented, 20 (91%) were the player's first concussion. On average, each concussion resulted in a player missing 3.96 games and 12.46 practices. Conclusion: Our results demonstrate that concussion rates in female NCAA soccer players vary by position and occur with different frequencies and mechanisms in practice and games. Interventions for concussion avoidance should aim to limit exposure to high-risk activity, including player-to-player contact in games and headers in practice. Although gameplay and collisions can be unpredictable and difficult to control, practice settings can be modified in an attempt to decrease risk.	[Weber, Alexander E.; Trasolini, Nicholas A.; Bolia, Ioanna K.; Rosario, Santano; Prodromo, John P.; Hill, Catherine; Romano, Russ; Liu, Charles Y.; Tibone, James E.; Gamradt, Seth C.] Keck Med USC, USC Epstein Family Ctr Sports Med, 1520 San Pablo St 2000, Los Angeles, CA 90033 USA; [Rosario, Santano] Univ Calif Los Angeles, Los Angeles, CA USA; [Prodromo, John P.] Drexel Univ, Dept Orthopaed Surg, Coll Med, Philadelphia, PA 19104 USA; [Liu, Charles Y.] USC Neurorestorat Ctr, Dept Neurol Surg, Los Angeles, CA USA		Weber, AE (corresponding author), Keck Med USC, USC Epstein Family Ctr Sports Med, 1520 San Pablo St 2000, Los Angeles, CA 90033 USA.	weber.ae@gmail.com					Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Brown G, NCAA STUDENT ATHLETE; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Fraser MA, 2017, J ATHL TRAINING, V52, P698, DOI 10.4085/1062-6050-52.3.10; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kunz M, 2007, FIFA MAGAZINE; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris B, WHY IS US SO GOOD WO; Mueller F., 1996, CATASTROPHIC INJURIE; Mueller FO, 2011, 29 ANN REPORT 1982 S; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	22	4	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAY	2020	8	5							2325967120921746	10.1177/2325967120921746			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	LS0CU	WOS:000536062400001	32478117	gold, Green Published			2022-02-06	
J	Riemann, L; Zweckberger, K; Unterberg, A; El Damaty, A; Younsi, A				Riemann, Lennart; Zweckberger, Klaus; Unterberg, Andreas; El Damaty, Ahmed; Younsi, Alexander		Collaborative European NeuroTrauma	Injury Causes and Severity in Pediatric Traumatic Brain Injury Patients Admitted to the Ward or Intensive Care Unit: A Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study	FRONTIERS IN NEUROLOGY			English	Article						pediatric TBI; children; traumatic brain injury; injury characteristics; CT imaging; outcome	PREHOSPITAL INTUBATION; PROGNOSTIC VALUE; BLOOD-PRESSURE; HEAD-INJURY; OUTCOMES; CHILDREN; EPIDEMIOLOGY; HYPOTENSION; MULTICENTER; DISCHARGE	Background: Traumatic brain injury (TBI) is the leading cause of death and disability in children. It includes a range of different pathologies that differ considerably from adult TBI. Analyzing and understanding injury patterns of pediatric TBI is essential to establishing new preventive efforts as well as to improve clinical management. Methods: The multi-center, prospectively collected CENTER-TBI core and registry databases were screened and patients were included when younger than 18 years at enrollment and admitted to the regular ward (admission stratum) or intensive care unit (ICU stratum) following TBI. Patient demographics, injury causes, clinical findings, brain CT imaging details, and outcome (GOSE at 6 months follow-up) were retrieved and analyzed. Injury characteristics were compared between patients admitted to the regular ward and ICU and multivariate analysis of factors predicting an unfavorable outcome (GOSE 1-4) was performed. Results from the core study were compared to the registry dataset which includes larger patient numbers but no follow-up data. Results: Two hundred and twenty seven patients in the core dataset and 687 patients in the registry dataset were included in this study. In the core dataset, road-traffic incidents were the most common cause of injury overall and in the ICU stratum, while incidental falls were most common in the admission stratum. Brain injury was considered serious to severe in the majority of patients and concurrent injuries in other body parts were very common. Intracranial abnormalities were detected in 60% of initial brain CTs. Intra- and extracranial surgical interventions were performed in one-fifth of patients. The overall mortality rate was 3% and the rate of unfavorable outcome 10%, with those numbers being considerably higher among ICU patients. GCS and the occurrence of secondary insults could be identified as independent predictors for an unfavorable outcome. Injury characteristics from the core study could be confirmed in the registry dataset. Conclusion: Our study displays the most common injury causes and characteristics of pediatric TBI patients that are treated in the regular ward or ICU in Europe. Road-traffic incidents were especially common in ICU patients, indicating that preventive efforts could be effective in decreasing the incidence of severe TBI in children.	[Riemann, Lennart; Zweckberger, Klaus; Unterberg, Andreas; El Damaty, Ahmed; Younsi, Alexander; Collaborative European NeuroTrauma] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany		Younsi, A (corresponding author), Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany.	alexander.younsi@med.uni-heidelberg.de	Damaty, Ahmed El/AAU-7315-2020; Younsi, Alexander/AAW-7869-2020; Posti, Jussi P./Y-2908-2019	Damaty, Ahmed El/0000-0003-0146-8943; Younsi, Alexander/0000-0002-8218-9243; Posti, Jussi P./0000-0002-5925-5193	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).	Alali AS, 2020, J NEUROSURG, V132, P537, DOI 10.3171/2018.10.JNS18964; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; [Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P198, DOI 10.4103/0974-2700.82206; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; de Franca SA, 2020, CRIT CARE MED, V48, pE325, DOI 10.1097/CCM.0000000000004239; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hoffmann M, 2017, J NEUROSURG ANESTH, V29, P161, DOI 10.1097/ANA.0000000000000275; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Purcell LN, 2020, WORLD NEUROSURG, V137, pE597, DOI 10.1016/j.wneu.2020.02.062; R Core Team, 2018, STATS PACK LANG ENV; Robba C, 2020, INTENS CARE MED, V46, P983, DOI 10.1007/s00134-020-05935-5; Robertson Brian D, 2013, J Inj Violence Res, V5, P51, DOI 10.5249/jivr.v5i1.205; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Sarioglu FC, 2018, EUR J TRAUMA EMERG S, V44, P351, DOI 10.1007/s00068-017-0838-y; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y; Wani AA, 2017, J PEDIATR NEUROSCI, V12, P332, DOI 10.4103/jpn.JPN_80_17	33	4	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 30	2020	11								345	10.3389/fneur.2020.00345			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LS1KQ	WOS:000536151000001	32425879	gold, Green Published			2022-02-06	
J	Matheson, FI; McIsaac, KE; Fung, K; Stewart, LA; Wilton, G; Keown, LA; Nathens, AB; Colantonio, A; Moineddin, R				Matheson, Flora, I; McIsaac, Kathryn E.; Fung, Kinwah; Stewart, Lynn A.; Wilton, Geoff; Keown, Leslie A.; Nathens, Avery B.; Colantonio, Angela; Moineddin, Rahim			Association between traumatic brain injury and prison charges: a population-based cohort study	BRAIN INJURY			English	Article						Serious charges; prison; longitudinal; data linkage; sex differences	SUBSTANCE-ABUSE; NEIGHBORHOOD FACTORS; OFFENDER POPULATION; ADMINISTRATIVE DATA; CRIMINAL BEHAVIOR; HEAD-INJURY; PREVALENCE; INCARCERATION; MISCONDUCT; SEQUELAE	Background: Traumatic Brain Injury (TBI) is a serious hidden health issue disproportionately affecting people who experience incarceration. Objective: We examined the association between TBI and serious disciplinary charges among men and women sentenced by the courts to terms of two or more years. Methods: The study originated in Ontario, Canada and used linked administrative health and correctional data. The cohort included adults experiencing their first federal sentence between 1998 and 2011 (N = 12,038). We examined disciplinary charges incurred 2 years post-sentence commencement. TBI was defined using the International Classification of Diseases (ICD-9 and ICD-10) diagnostic codes. Robust Poisson regression was conducted to assess the association between TBI and disciplinary charges. Findings: The prevalence of TBI for the full sample was 13.2%. One-third of adults with a recent TBI had a serious disciplinary charge. The unadjusted risk of incurring a serious charge for those with a history of TBI was 39% higher than those with no history of TBI (CI: 1.29-1.49). The adjusted risk was 1.14 (CI: 1.06-1.22). Conclusions: TBI is a serious health concern that makes it difficult for incarcerants to adjust to prison. Additional support/resources are needed to support those with histories of TBI.	[Matheson, Flora, I] St Michaels Hosp, MAP Ctr Urban Hlth Solut, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Matheson, Flora, I] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Matheson, Flora, I; Fung, Kinwah; Colantonio, Angela; Moineddin, Rahim] ICES, Toronto, ON, Canada; [Matheson, Flora, I] Univ Toronto, Ctr Criminol & Sociolegal Studies, Toronto, ON, Canada; [McIsaac, Kathryn E.] Nova Scotia Hlth Author, Res & Innovat, Halifax, NS, Canada; [Stewart, Lynn A.; Wilton, Geoff; Keown, Leslie A.] Correct Serv Canada, Res Branch, Ottawa, ON, Canada; [Nathens, Avery B.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Nathens, Avery B.] Sunnybrook Res Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada		Matheson, FI (corresponding author), St Michaels Hosp, MAP Ctr Urban Hlth Solut, 30 Bond St, Toronto, ON M5B 1W8, Canada.	Flora.Matheson@UnityHealth.TO			ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario; Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC) [890-2011-0027]; MAP Center for Urban Health Solutions; St. Michael's Hospital; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario	The study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). This study was also funded by the Social Sciences and Humanities Research Council of Canada [no. 890-2011-0027]. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. The study was also supported by MAP Center for Urban Health Solutions, St. Michael's Hospital, and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario.	Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; Andrews DA, 2006, CRIME DELINQUENCY, V52, P7, DOI 10.1177/0011128705281756; [Anonymous], 2014, Prescrire Int, V23, P154; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Barrington WE, 2014, HEALTH PLACE, V27, P120, DOI 10.1016/j.healthplace.2014.02.001; Bodkin C, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2018.304855; Bonta J., 2007, 20070 PUBL SAF, V6, P1; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Ciszak MC, 1996, CATHOL U LAW REV, V45, P1101; Cochran JC, 2014, JUSTICE Q, V31, P1044, DOI 10.1080/07418825.2012.736526; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Corrections APADo, 2015, TRAUM BRAIN INJ PROJ; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Dennison CR, 2019, CRIME DELINQUENCY, V65, P215, DOI 10.1177/0011128717753115; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Drapela LA, 2019, JUSTICE Q, V36, P1023, DOI 10.1080/07418825.2018.1481221; Durand E, 2014, ANN PHYS REHABIL MED, V57, pe66, DOI [10.1016/j.rehab.2014.03.239, DOI 10.1016/J.REHAB.2014.03.239]; Durand E, 2014, ANN PHYS REHABIL MED, V57, pe70, DOI [10.1016/j.rehab.2014.03.253, DOI 10.1016/J.REHAB.2014.03.253]; Durand E, 2014, ANN PHYS REHABIL MED, V57, pe71, DOI [10.1016/j.rehab.2014.03.254, DOI 10.1016/J.REHAB.2014.03.254]; Durand E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.535; FLANAGAN TJ, 1982, J RES CRIME DELINQ, V19, P216, DOI 10.1177/002242788201900206; Foundation TDT, 2016, BRAIN INJ LINKW SERV; Gaes GG, 2002, PRISON J, V82, P359, DOI 10.1177/003288550208200304; Glorney E, 2018, BRAIN INJURY LINKWOR; Greenberg GA, 2008, PSYCHIAT SERV, V59, P170, DOI 10.1176/ps.2008.59.2.170; Greenberg Greg A, 2008, Crim Behav Ment Health, V18, P88, DOI 10.1002/cbm.685; Greve KW, 2001, BRAIN INJURY, V15, P255; Justice VDo, 2011, CORR RES PAP SER; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kim H, 2010, BRAIN INJURY, V24, P200; Kouyoumdjian FG, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3660-2; Kouyoumdjian FG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201592; Lane KS, 2017, J FORENSIC SCI, V62, P545, DOI 10.1111/1556-4029.13289; LIGHT SC, 1990, FED PROBAT, V54, P63; Linton SL, 2017, SOC SCI MED, V185, P81, DOI 10.1016/j.socscimed.2017.04.055; Marr A., 2004, CENTRAL NERVOUS SYST; Matheson FI, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006032; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McIsaac KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161173; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Merbitz C., 1995, J OFFENDER REHABILIT, V22, P11, DOI DOI 10.1300/J076V22N03_02; Metraux S., 2004, CRIMINOL PUBLIC POL, V3, P139, DOI [10.1111/j.1745-9133.2004.tb00031.x, DOI 10.1111/J.1745-9133.2004.TB00031.X]; Metraux S, 2007, NAT S HOM RES; Metraux S, 2006, CRIME DELINQUENCY, V52, P504, DOI 10.1177/0011128705283565; MN-DOC, 2015, TBI MINN CORR FAC SY; Nagele D, 2018, J OFFENDER REHABIL, V57, P562, DOI 10.1080/10509674.2018.1549178; Network NPH, 2016, BRAIN INJ OFF; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Palijan TZ, 2010, PSYCHIAT DANUB, V22, P253; Petersen MR, 2007, BIOMETRICAL J, V49, P328, DOI 10.1002/bimj.200610319; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Sariaslan A, 2013, INT J EPIDEMIOL, V42, P1057, DOI 10.1093/ije/dyt066; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Steiner B, 2014, J CRIM JUST, V42, P462, DOI 10.1016/j.jcrimjus.2014.08.001; To MJ, 2016, CAN J PUBLIC HEALTH, V107, pE550, DOI [10.17269/cjph.107.5607, 10.17269/CJPH.107.5607]; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Trulson CR, 2011, CRIME DELINQUENCY, V57, P709, DOI 10.1177/0011128709340224; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wiseman-Hakes C, 2019, TRAUMATIC BRAIN INJU; Wright EM., 2007, J CONTEMP CRIM JUST, V23, P310, DOI [10.1177/1043986207309595, DOI 10.1177/1043986207309595]	81	4	4	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					757	765		10.1080/02699052.2020.1753114		APR 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000531922200001	32324431				2022-02-06	
J	Abou-El-Hassan, H; Bsat, S; Sukhon, F; Assaf, EJ; Mondello, S; Kobeissy, F; Wang, KKW; Weiner, HL; Omeis, I				Abou-El-Hassan, Hadi; Bsat, Shadi; Sukhon, Fares; Assaf, Edwyn Jeremy; Mondello, Stefania; Kobeissy, Firas; Wang, Kevin K. W.; Weiner, Howard L.; Omeis, Ibrahim			Protein Degradome of Spinal Cord Injury: Biomarkers and Potential Therapeutic Targets	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Degradomics; Protease; Breakdown; Biomarkers	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; TISSUE-PLASMINOGEN ACTIVATOR; ADHESION MOLECULE L1; MATRIX METALLOPROTEINASES; BARRIER DISRUPTION; PROMOTES RECOVERY; INFLAMMATORY RESPONSE; EXTRACELLULAR-MATRIX; BSCB DISRUPTION/HEMORRHAGE	Degradomics is a proteomics sub-discipline whose goal is to identify and characterize protease-substrate repertoires. With the aim of deciphering and characterizing key signature breakdown products, degradomics emerged to define encryptic biomarker neoproteins specific to certain disease processes. Remarkable improvements in structural and analytical experimental methodologies as evident in research investigating cellular behavior in neuroscience and cancer have allowed the identification of specific degradomes, increasing our knowledge about proteases and their regulators and substrates along with their implications in health and disease. A physiologic balance between protein synthesis and degradation is sought with the activation of proteolytic enzymes such as calpains, caspases, cathepsins, and matrix metalloproteinases. Proteolysis is essential for development, growth, and regeneration; however, inappropriate and uncontrolled activation of the proteolytic system renders the diseased tissue susceptible to further neurotoxic processes. In this article, we aim to review the protease-substrate repertoires as well as emerging therapeutic interventions in spinal cord injury at the degradomic level. Several protease substrates and their breakdown products, essential for the neuronal structural integrity and functional capacity, have been characterized in neurotrauma including cytoskeletal proteins, neuronal extracellular matrix glycoproteins, cell junction proteins, and ion channels. Therefore, targeting exaggerated protease activity provides a potentially effective therapeutic approach in the management of protease-mediated neurotoxicity in reducing the extent of damage secondary to spinal cord injury.	[Abou-El-Hassan, Hadi; Weiner, Howard L.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bsat, Shadi; Omeis, Ibrahim] Amer Univ Beirut, Fac Med, Dept Surg, Div Neurosurg,Med Ctr, Beirut, Lebanon; [Sukhon, Fares; Assaf, Edwyn Jeremy] Amer Univ Beirut, Fac Med, Med Ctr, Beirut, Lebanon; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Omeis, Ibrahim] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Omeis, I (corresponding author), Amer Univ Beirut, Fac Med, Dept Surg, Div Neurosurg,Med Ctr, Beirut, Lebanon.	io04@aub.edu.lb	Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944	Lebanese National Council for Scientific Research (CNRS)Centre National de la Recherche Scientifique (CNRS) [103486]	This work was financially supported by a grant from the Lebanese National Council for Scientific Research (CNRS), grant award number: 103486.	Abou-Abbass H, 2016, ELECTROPHORESIS, V37, P1562, DOI 10.1002/elps.201500583; Abou-Abbass H, 2016, ELECTROPHORESIS, V37, P1549, DOI 10.1002/elps.201500585; Abou-El-Hassan H, 2017, MED HYPOTHESES, V108, P69, DOI 10.1016/j.mehy.2017.08.008; Abou-El-Hassan H, 2017, METHODS MOL BIOL, V1598, P65, DOI 10.1007/978-1-4939-6952-4_4; Abou-El-Hassan H, 2017, EXP BIOL MED, V242, P397, DOI 10.1177/1535370216675772; Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; Ahmed MM, 2014, ANN NEUROSCI, V21, P97, DOI 10.5214/ans.0972.7531.210305; Ahn M, 2015, ACTA HISTOCHEM, V117, P56, DOI 10.1016/j.acthis.2014.11.001; Alawieh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135024; Anik I, 2011, J SPINAL CORD MED, V34, P257, DOI 10.1179/107902611X12972448729648; Arevalo-Martin A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02365; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bai LJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00350; Bai LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42288; BANAYSCHWARTZ M, 1987, NEUROCHEM RES, V12, P361, DOI 10.1007/BF00993246; Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; Benton RL, 2000, NEUROSCI LETT, V291, P1, DOI 10.1016/S0304-3940(00)01362-8; Bock P, 2013, BRAIN PATHOL, V23, P82, DOI 10.1111/j.1750-3639.2012.00617.x; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Brocard C, 2016, NAT MED, V22, P404, DOI 10.1038/nm.4061; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Burda JE, 2013, GLIA, V61, P1456, DOI 10.1002/glia.22534; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cai XJ, 2018, BRAIN RES BULL, V143, P171, DOI 10.1016/j.brainresbull.2018.08.005; Calderon-Vallejo D, 2012, NEUROSCI LETT, V515, P187, DOI 10.1016/j.neulet.2012.03.052; Caprelli MT, 2018, J NEUROTRAUM, V35, P1929, DOI 10.1089/neu.2017.5495; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Carwardine D, 2016, J NEUROL SCI, V367, P311, DOI 10.1016/j.jns.2016.06.011; Chakrabarti M, 2014, NEUROSCIENCE, V256, P322, DOI 10.1016/j.neuroscience.2013.10.027; Chamney C, 2013, EXP PHYSIOL, V98, P796, DOI 10.1113/expphysiol.2012.069658; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen AS, 2013, NEUROCHEM RES, V38, P2247, DOI 10.1007/s11064-013-1132-y; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Chen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033177; Chen XL, 2017, CELL MOL NEUROBIOL, V37, P487, DOI 10.1007/s10571-016-0384-x; Cheng Q, 2016, CLIN EXP PHARMACOL P, V43, P930, DOI 10.1111/1440-1681.12606; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Colak A, 2009, NEUROCIRUGIA, V20, P245; Colon JM, 2018, EXP NEUROL, V299, P109, DOI 10.1016/j.expneurol.2017.10.006; da Silva BF, 2016, MOL CELL PROTEOMICS, V15, P1424, DOI 10.1074/mcp.M115.052175; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; David WS, 2017, NEW ENGL J MED, V376, P2471, DOI 10.1056/NEJMcpc1701762; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Demircan K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/693746; Deng WP, 2014, SPINE J, V14, P2488, DOI 10.1016/j.spinee.2014.04.024; Devaux S, 2017, MOL CELL PROTEOMICS, V16, P1394, DOI 10.1074/mcp.M116.064881; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Duan HQ, 2018, CNS NEUROSCI THER, V24, P429, DOI 10.1111/cns.12801; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Durham-Lee JC, 2012, NEUROSCIENCE, V202, P454, DOI 10.1016/j.neuroscience.2011.09.058; El-Assaad A, 2017, METHODS MOL BIOL, V1598, P329, DOI 10.1007/978-1-4939-6952-4_17; Ellis RC, 2005, EXP NEUROL, V193, P19, DOI 10.1016/j.expneurol.2004.11.034; Ellis RC, 2004, J NEUROCHEM, V88, P689, DOI 10.1046/j.1471-4159.2003.02197.x; Esposito E, 2008, J PINEAL RES, V45, P149, DOI 10.1111/j.1600-079X.2008.00569.x; Fu Qi, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P92; Gao K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/260161; Gao LS, 2018, BIOFACTORS, V44, P369, DOI 10.1002/biof.1433; Garraway SM, 2014, PAIN, V155, P2344, DOI 10.1016/j.pain.2014.08.034; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghasemlou N, 2010, BRAIN, V133, P126, DOI 10.1093/brain/awp304; Gill LC, 2014, RESP PHYSIOL NEUROBI, V192, P66, DOI 10.1016/j.resp.2013.12.006; Gogel S, 2010, DEV NEUROBIOL, V70, P456, DOI 10.1002/dneu.20789; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Graham ZA, 2016, SPINAL CORD, V54, P502, DOI 10.1038/sc.2015.183; Grant RA, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0334-1; Grulova I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13702; Guo J, 2014, INT J MOL MED, V34, P74, DOI 10.3892/ijmm.2014.1751; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; HALL ED, 1993, RES P ARNMD, V71, P81; Hansen CN, 2013, J NEUROSCI, V33, P13101, DOI 10.1523/JNEUROSCI.1576-13.2013; Hashimoto M, 2005, ACTA NEUROPATHOL, V109, P165, DOI 10.1007/s00401-004-0926-z; Hegde AN, 2007, TRENDS NEUROSCI, V30, P587, DOI 10.1016/j.tins.2007.08.005; Hergenroeder GW, 2016, NEUROREPORT, V27, P90, DOI 10.1097/WNR.0000000000000502; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Hu LY, 2010, NEUROSCIENCE, V169, P1046, DOI 10.1016/j.neuroscience.2010.05.046; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jiang XJ, 2017, NEUROCHEM RES, V42, P3245, DOI 10.1007/s11064-017-2361-2; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kataria H, 2016, MOL NEUROBIOL, V53, P4461, DOI 10.1007/s12035-015-9352-6; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; Koehn Liam M, 2016, F1000Res, V5, P1822, DOI 10.12688/f1000research.9094.2; Kumar H, 2018, MOL NEUROBIOL, V55, P2577, DOI 10.1007/s12035-017-0509-3; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lee JY, 2018, J NEUROTRAUM, V35, P508, DOI 10.1089/neu.2017.5235; Lee JY, 2016, NEUROPHARMACOLOGY, V109, P78, DOI 10.1016/j.neuropharm.2016.05.018; Lee JY, 2015, ENDOCRINOLOGY, V156, P1838, DOI 10.1210/en.2014-1832; Lee JY, 2014, BBA-MOL BASIS DIS, V1842, P2403, DOI 10.1016/j.bbadis.2014.09.006; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee JY, 2014, AM J PATHOL, V184, P2985, DOI 10.1016/j.ajpath.2014.07.016; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Lemarchant S, 2014, NEUROBIOL DIS, V66, P28, DOI 10.1016/j.nbd.2014.02.005; Lenz G, 2000, BRIT J PHARMACOL, V129, P927, DOI 10.1038/sj.bjp.0703138; Leonard AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098364; Levine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096408; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Li Z, 2018, MOL MED REP, V17, P2957, DOI 10.3892/mmr.2017.8249; Liabeuf S, 2017, J NEUROTRAUM, V34, P3397, DOI 10.1089/neu.2017.5152; Light M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-122; Liu CX, 2013, MOL MED REP, V7, P1431, DOI 10.3892/mmr.2013.1383; Liu D, 2015, NEUROSCIENCE, V285, P81, DOI 10.1016/j.neuroscience.2014.10.063; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Liu WM, 2011, J NEUROSCI RES, V89, P791, DOI 10.1002/jnr.22602; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Lutz D, 2016, MOL NEUROBIOL, V53, P3360, DOI 10.1007/s12035-015-9277-0; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Ma L, 2017, NEUROSCI LETT, V644, P55, DOI 10.1016/j.neulet.2017.02.038; Ma LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095098; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McKinley W, 2007, J SPINAL CORD MED, V30, P215, DOI 10.1080/10790268.2007.11753929; Mckinley William O, 2002, J Spinal Cord Med, V25, P28; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Moghieb A, 2016, MOL CELL PROTEOMICS, V15, P2379, DOI 10.1074/mcp.M116.058115; Moon C, 2008, J VET MED SCI, V70, P937, DOI 10.1292/jvms.70.937; Muresanu DF, 2015, MOL NEUROBIOL, V52, P837, DOI 10.1007/s12035-015-9298-8; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Myeku N, 2012, NEUROSCI LETT, V527, P126, DOI 10.1016/j.neulet.2012.08.051; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nasser M, 2016, CNS NEUROL DISORD-DR, V15, P1030, DOI 10.2174/1871527315666160815093525; Nazari-Robati M, 2016, INT J BIOL MACROMOL, V91, P812, DOI 10.1016/j.ijbiomac.2016.06.030; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nesic O, 2010, NEUROSCIENCE, V168, P1019, DOI 10.1016/j.neuroscience.2010.01.037; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Noble LJ, 2002, J NEUROSCI, V22, P7526; Nokkari A, 2018, PROG NEUROBIOL, V165, P26, DOI 10.1016/j.pneurobio.2018.01.003; Oliveira KM, 2014, INT J CLIN EXP PATHO, V7, P3524; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519; Paterniti I, 2010, J NEUROCHEM, V112, P611, DOI 10.1111/j.1471-4159.2009.06471.x; Pei JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0870-1; Petrovic A, 2019, EUR J NEUROSCI, V49, P215, DOI 10.1111/ejn.14218; Plantier V, 2017, M S-MED SCI, V33, P629, DOI 10.1051/medsci/20173306020; Poormasjedi-Meibod MS, 2019, J NEUROTRAUM, V36, P950, DOI 10.1089/neu.2017.5624; Porasuphatana S, 2003, COMP BIOCHEM PHYS C, V134, P281, DOI 10.1016/S1532-0456(02)00271-5; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Quanico J, 2017, METHODS MOL BIOL, V1598, P269, DOI 10.1007/978-1-4939-6952-4_13; Radulovic M, 2015, NEUROBIOL DIS, V83, P75, DOI 10.1016/j.nbd.2015.08.021; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Ray SK, 2011, NEUROTHERAPEUTICS, V8, P180, DOI 10.1007/s13311-011-0037-1; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Rodrigues L, 2018, MOL NEUROBIOL, V55, P6436, DOI 10.1007/s12035-017-0858-y; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Roerig A, 2013, VET J, V197, P253, DOI 10.1016/j.tvjl.2013.02.005; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; Ropper AE, 2017, NEW ENGL J MED, V376, P1358, DOI 10.1056/NEJMra1516539; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Sahu S, 2019, FASEB J, V33, P2252, DOI 10.1096/fj.201800852RR; Sakurai M, 2006, J CELL SCI, V119, P162, DOI 10.1242/jcs.02716; Sanchez-Brualla I, 2018, NEUROSCIENCE, V387, P48, DOI 10.1016/j.neuroscience.2017.08.033; Sarkis GA, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0736-z; Saunders NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099080; Savickas S, 2018, BIOL CHEM, V399, P47, DOI 10.1515/hsz-2017-0187; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Seeds N, 2011, CELL MOL NEUROBIOL, V31, P961, DOI 10.1007/s10571-011-9701-6; Sharma HS, 2015, MOL NEUROBIOL, V52, P882, DOI 10.1007/s12035-015-9297-9; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P295, DOI 10.1007/978-3-211-98811-4_55; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Snyder EY, 2012, NEW ENGL J MED, V366, P1940, DOI 10.1056/NEJMcibr1200138; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Squair JW, 2018, J NEUROTRAUM, V35, P424, DOI 10.1089/neu.2017.4984; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Takeuchi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3740; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tauchi R, 2012, NEUROSCI LETT, V517, P1, DOI 10.1016/j.neulet.2012.03.002; Terayama R, 2007, NEUROSCIENCE, V148, P175, DOI 10.1016/j.neuroscience.2007.05.037; Tica J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051461; Tran AP, 2018, J NEUROSCI, V38, pS399, DOI 10.1523/JNEUROSCI.3214-17.2018; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Trivedi A, 2016, EXP NEUROL, V284, P50, DOI 10.1016/j.expneurol.2016.07.018; Tsai MC, 2008, SURG NEUROL, V70, P19, DOI 10.1016/j.surneu.2007.09.033; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Vangansewinkel T, 2016, FASEB J, V30, P2040, DOI 10.1096/fj.201500114R; Veeravalli KK, 2012, J NEUROTRAUM, V29, P2251, DOI 10.1089/neu.2012.2460; Veeravalli KK, 2009, NEUROBIOL DIS, V36, P200, DOI 10.1016/j.nbd.2009.07.012; Veillon L, 2018, ACS CHEM NEUROSCI, V9, P51, DOI 10.1021/acschemneuro.7b00271; Wang C, 2016, BIOCHEM BIOPH RES CO, V477, P534, DOI 10.1016/j.bbrc.2016.05.148; Wang P, 2018, CNS NEUROSCI THER, V24, P1185, DOI 10.1111/cns.12856; Wei HX, 2012, NEUROCHEM RES, V37, P2758, DOI 10.1007/s11064-012-0869-z; Wei ZJ, 2015, MOL MED REP, V12, P63, DOI 10.3892/mmr.2015.3395; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Xu JC, 2011, J NEUROTRAUM, V28, P1921, DOI 10.1089/neu.2011.1783; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yang ZH, 2018, MOL NEUROBIOL, V55, P2174, DOI 10.1007/s12035-017-0424-7; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yoon H, 2017, GLIA, V65, P2070, DOI 10.1002/glia.23215; Yoon H, 2013, J NEUROCHEM, V127, P283, DOI 10.1111/jnc.12293; Yousefifard M, 2019, J NEUROCHEM, V149, P317, DOI 10.1111/jnc.14637; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhang D, 2017, J CELL MOL MED, V21, P3322, DOI 10.1111/jcmm.13235; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zhang YH, 2015, MOL NEUROBIOL, V52, P522, DOI 10.1007/s12035-014-8840-4; Zheng BB, 2017, INT J BIOL SCI, V13, P1520, DOI 10.7150/ijbs.21107; Zheng BB, 2016, J CELL MOL MED, V20, P1062, DOI 10.1111/jcmm.12761; Zhong ZQ, 2017, NEURAL REGEN RES, V12, P969, DOI 10.4103/1673-5374.208592; Zhou Y, 2014, CELL MOL NEUROBIOL, V34, P1151, DOI 10.1007/s10571-014-0090-5; Zhu B, 2013, SPINAL CORD, V51, P610, DOI 10.1038/sc.2013.24; Zhu YL, 2012, NEUROSCIENCE, V200, P186, DOI 10.1016/j.neuroscience.2011.10.037; Zou J, 2011, NEUROCHEM INT, V58, P404, DOI 10.1016/j.neuint.2010.12.018	230	4	4	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2020	57	6					2702	2726		10.1007/s12035-020-01916-3		APR 2020	25	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8SJ	WOS:000528329900001	32328876				2022-02-06	
J	Baker, JG; Willer, BS; Dwyer, MG; Leddy, JJ				Baker, John G.; Willer, Barry S.; Dwyer, Michael G.; Leddy, John J.			A preliminary investigation of cognitive intolerance and neuroimaging among adolescents returning to school after concussion	BRAIN INJURY			English	Article						Concussion; cognitive intolerance; neuroimaging; neuropsychology; return to learn	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; AXONAL INJURY; RECOVERY; SPORTS; EXERCISE; CHILDREN; TIME; RELIABILITY; ACTIVATION	Primary objective To introduce the concept of cognitive intolerance. A test is proposed to measure this concept and pilot data are presented to support this measure and future research to develop this concept into a construct. Research design: Three-group comparison to protect larger study blinding. Methods and procedures: Two groups of student athletes (n = 13, n = 13) between 13 and 17 (mean 15.1 +/- 1.1 years; 58% male) who sustained a sport-related concussion within 10 days and one group (n = 13) of age-matched healthy controls were recruited for a comparison of correlations between self and observer ratings of cognitive difficulties and DTI fractional anisotropy (FA) using tract-based spatial statistics (TBSS) analysis at two time points. Main outcomes and results: Significant negative only associations (higher cognitive difficulty and lower FA) with DTI FA were found in white matter tracts. These included the anterior corpus callosum, frontal-parietal longitudinal fasciculi, and cortical-subcortical pathways at only the second time point. Several working memory networks would likely involve connections using the above-identified white matter tracts. Conclusions: Cognitive intolerance can be defined as symptom exacerbation from prolonged cognitive activity. Cognitive intolerance could be measured by the n-back working memory task and time to symptom exacerbation.	[Baker, John G.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept UBMD Orthoped & Sports Med & Nucl Med, Buffalo, NY 14214 USA; [Willer, Barry S.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14214 USA; [Dwyer, Michael G.] Univ Buffalo, Buffalo Neuroimaging Anal Ctr, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY 14214 USA; [Leddy, John J.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Orthopaed & Sports Med, Buffalo, NY 14214 USA		Baker, JG (corresponding author), Univ Buffalo, Dept Nucl Med, 105 Parker Hall, Buffalo, NY 14214 USA.	Ph.D.jgbaker@buffalo.edu		Dwyer, Michael/0000-0003-4684-4658; Willer, Barry/0000-0002-9586-8448	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health [under grant number 1R01NS094444] and the National Center for Advancing Translational Sciences of the National Institutes of Health under [grant number UL1TR001412 to the University at Buffalo].	Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYS, V60; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hu YZ, 2013, J NEUROSCI, V33, P18566, DOI 10.1523/JNEUROSCI.1973-13.2013; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kearney-Ramos TE, 2014, J INT NEUROPSYCH SOC, V20, P736, DOI 10.1017/S135561771400054X; Kirov II, 2018, NEUROIMAG CLIN N AM, V28, P91, DOI 10.1016/j.nic.2017.09.007; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makki Ali Y, 2016, Glob Pediatr Health, V3, p2333794X16630493, DOI 10.1177/2333794X16630493; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Sady MD, 2019, J HEAD TRAUMA REHAB, V34, pE35, DOI 10.1097/HTR.0000000000000424; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorek G, 2018, BRAIN INJURY, V32, P770, DOI 10.1080/02699052.2018.1450993; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xiong K, 2014, BRAIN RES, V1591; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	57	4	4	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					820	829		10.1080/02699052.2020.1749932		APR 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000538607100001	32324445	Green Accepted			2022-02-06	
J	Roby, PR; Chandran, A; Barczak-Scarboro, NE; DeLellis, SM; Ford, CB; Healy, ML; Means, GE; Kane, SF; Lynch, JH; Mihalik, JP				Roby, Patricia R.; Chandran, Avinash; Barczak-Scarboro, Nikki E.; DeLellis, Stephen M.; Ford, Cassie B.; Healy, Marshall L.; Means, Gary E.; Kane, Shawn F.; Lynch, James H.; Mihalik, Jason P.			Cerebrovascular Reactivity in Special Operations Forces Combat Soldiers	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Military; Mild traumatic brain injury; Cerebrovascular function; Neurophysiology; Blast injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; TRANSCRANIAL DOPPLER; SPORT CONCUSSION; VASOREACTIVITY; MILITARY; HISTORY; IMPACT; AGE	The purpose of this study was to investigate how concussion history affects cerebrovascular reactivity (CVR) in Special Operations Forces (SOF) combat soldiers. We studied 104 SOF soldiers [age = 33.5 +/- 4.3 years; height = 179.7 +/- 6.3 cm; 59 (56.7%) with self-reported concussion history]. We employed transcranial Doppler (TCD) ultrasound to measure middle cerebral artery (MCA) velocity. Baseline TCD data were collected for 2 min. Changes in MCA velocity were measured in response to five breath-holding trials and five hyperventilation trials. Cerebrovascular reactivity was quantified by the breath-holding index (BHI), vasomotor reactivity reserve (VMRr), and percent change in overall response curves. Independent t tests were employed to assess group differences in BHI, and VMRr values. We employed mixed effects models with quadratic mean structures to assess group differences in percent change MCA velocity response curves. There were no significant group differences in BHI (t(102) = 0.04, p = 0.97) or VMRr (t(102) = -0.33, p = 0.75). There were no group differences in relative MCA velocity response curves during the breath-holding task (F-1,F-5092 = 0.19, p = 0.66) or during the hyperventilation task (F-1,F-5092 = 0.41, p = 0.52) between SOF soldiers with and without a self-reported concussion history. If CVR deficits exist immediately post-concussion, our study suggests that these deficits recover over time in this population. While long-term neurophysiological effects of blast-related injury are currently unknown, assessing CVR response may provide further insight into cerebrovascular function and overall physiological health following blast exposure.	[Roby, Patricia R.; Chandran, Avinash; Barczak-Scarboro, Nikki E.; Ford, Cassie B.; Kane, Shawn F.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Ctr,Campus Box 87, Chapel Hill, NC 27599 USA; [Roby, Patricia R.; Barczak-Scarboro, Nikki E.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Sch Med, Chapel Hill, NC 27599 USA; [DeLellis, Stephen M.] Def Med Strategies LLC, Fayetteville, NC USA; [Healy, Marshall L.; Means, Gary E.; Lynch, James H.] US Army Special Operat Command, Ft Bragg, NC USA; [Kane, Shawn F.] Univ North Carolina Chapel Hill, Dept Family Med, Chapel Hill, NC USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Ford, Cassie B.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA		Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Ctr,Campus Box 87, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Roby, Patricia/0000-0003-0166-4274; Barczak-Scarboro, Nikki/0000-0003-4877-6732; kane, Shawn/0000-0002-9110-5224	United States Army Special Operations Command (USASOC); Preservation of the Force and Family Program at US Special Operations Command; Henry M. Jackson Foundation; Uniformed Services University	This project was funded with contract grant support from the United States Army Special Operations Command (USASOC) to the University of North Carolina at Chapel Hill (Chapel Hill, NC, USA). This work was also supported by funding secured by the Preservation of the Force and Family Program at US Special Operations Command and executed as a subaward issued to the University of North Carolina by the Henry M. Jackson Foundation under a cooperative agreement with the Uniformed Services University. Co-authors DeLellis, Healy, Kane, Lynch, and Means were employed by USASOC for part or all of the study period. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. We would like to thank the research team at the Matthew Gfeller SportRelated Traumatic Brain Injury Research Center for assistance with data collection. We would also like to thank LTC Kane Morgan, SFC Zac Prengler, SGM John Sims, MSG Daniel Carver, and SGM Lance Doody for assistance with the study.	Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Champagne AA, 2019, BRAIN INJURY, V33, P1479, DOI 10.1080/02699052.2019.1644375; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Claassen JAHR, 2007, J APPL PHYSIOL, V102, P870, DOI 10.1152/japplphysiol.00906.2006; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Coverdale NS, 2017, J CEREBR BLOOD F MET, V37, P344, DOI 10.1177/0271678X15626156; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murray CK, 2005, MIL MED, V170, P501, DOI 10.7205/MILMED.170.6.501; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Purkayastha S, 2019, J NEUROTRAUM, V36, P2385, DOI 10.1089/neu.2018.5861; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Settakis G, 2002, J NEUROIMAGING, V12, P252, DOI 10.1177/10528402012003007; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Staszewski J, 2019, J ULTRAS MED, V38, P975, DOI 10.1002/jum.14782; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011	37	4	4	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUN	2020	48	6					1651	1660		10.1007/s10439-020-02514-z		APR 2020	10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	LW4EV	WOS:000528318200001	32328806				2022-02-06	
J	Lu, LY; Li, FF; Chen, HY; Wang, P; Zhang, H; Chen, YC; Yin, XD				Lu, Liyan; Li, Fengfang; Chen, Huiyou; Wang, Peng; Zhang, Hong; Chen, Yu-Chen; Yin, Xindao			Functional connectivity dysfunction of insular subdivisions in cognitive impairment after acute mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Cognitive impairment; Functional magnetic resonance imaging; Insula subdivision	POSTTRAUMATIC-STRESS; NETWORKS	Purpose This study aimed to investigate the early functional connectivity alterations between insula subdivisions and other cortical regions in patients with acute mild traumatic brain injury (mTBI) and subsequently to explore the relationship between functional connectivity changes of insula subdivisions with other cortical regions and cognitive function. Methods Fifty-three mTBI patients and 37 age-, gender- and education level- matched healthy controls were included in this study. All participants obtained resting state functional magnetic resonance imaging (rs-fMRI) and clinical and neuropsychological evaluations (Montreal cognitive assessment, MoCA) at the acute stage. Functional connectivity alterations of insula subdivisions and correlations with MoCA were further explored by seed-voxel functional connectivity. Results Compared with healthy controls, patients with acute mTBI showed significantly decreased functional connectivity between the L-vAI and the left middle temporal gyrus and right superior frontal gyrus and significantly decreased functional connectivity between the R-vAI and the right middle frontal gyrus and right hippocampus. While significantly decreased functional connectivity were observed between the L-dAI and the right superior frontal gyrus. In addition, significantly increased functional connectivity was observed between the R-PI and the left inferior frontal gyrus. Furthermore, the mTBI group demonstrated positive correlations between performances in orientation and insula and middle temporal gyrus and superior frontal gyrus and middle frontal gyrus functional connectivities. ion scores for mTBI patients positively correlated with functional connectivity between insula and middle frontal gyrus. Conclusions The present study demonstrated functional connectivity dysfunction of insula subdivisions and correlations between these alterations and cognitive performance, which provide a novel insight into the neurophysiological mechanism of cognitive impairment in patients with mTBI at the acute stage.	[Lu, Liyan; Li, Fengfang; Chen, Huiyou; Wang, Peng; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China; [Zhang, Hong] Nanjing Med Univ, Dept Radiol, Affiliated Jiangning Hosp, Nanjing, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China.	chenyuchen1989@126.com; y.163yy@163.com			Jiangsu Provincial Special Program of Medical Science [BE2017614]; Youth Medical Talents of Jiangsu Province [QNRC2016062]; 14th "Six Talent Peaks" Project of Jiangsu Province [YY-079]; Nanjing Medical University [2017NJMU123]	This work was supported by Jiangsu Provincial Special Program of Medical Science (No.BE2017614), Youth Medical Talents of Jiangsu Province (No. QNRC2016062), 14th "Six Talent Peaks" Project of Jiangsu Province (No.YY-079), and Nanjing Medical University grant (No. 2017NJMU123).	Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Chand GB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00367; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Iaria G, 2008, HUM BRAIN MAPP, V29, P363, DOI 10.1002/hbm.20393; Li FF, 2020, BRAIN IMAGING BEHAV, V14, P907, DOI 10.1007/s11682-019-00053-3; Lu LY, 2019, EUR J RADIOL, V114, P69, DOI 10.1016/j.ejrad.2019.03.002; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Peng XL, 2018, J AFFECT DISORDERS, V227, P280, DOI 10.1016/j.jad.2017.11.018; Sampedro F, 2020, BRAIN IMAGING BEHAV, V14, P321, DOI 10.1007/s11682-018-0022-y; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tops M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00330; Uddin LQ, 2014, J COGNITIVE NEUROSCI, V26, P16, DOI 10.1162/jocn_a_00462; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Wang JF, 2019, NEUROPSYCH DIS TREAT, V15, P1355, DOI 10.2147/NDT.S194803; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Zhang W, 2014, EUR J RADIOL, V83, P1907, DOI 10.1016/j.ejrad.2014.07.003; Zuo MM, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01177	27	4	4	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2020	14	3					941	948		10.1007/s11682-020-00288-5		APR 2020	8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LV2EP	WOS:000526466900001	32304021	hybrid, Green Published			2022-02-06	
J	Lysenko-Martin, MR; Hutton, CP; Sparks, T; Snowden, T; Christie, BR				Lysenko-Martin, Melanie R.; Hutton, Craig P.; Sparks, Taya; Snowden, Taylor; Christie, Brian R.			Multiple Object Tracking Scores Predict Post-Concussion Status Years after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; concussion; machine learning; motion perception; traumatic brain injury	MEMORY CHANGES; CRITERIA	The diagnosis of concussion remains challenging, particularly in cases where several months have passed between a traumatic brain injury (TBI) and clinical assessment. Tracking multiple moving objects in three-dimensional (3D) space engages many of the same cognitive processes that are affected by concussion, a form of mild TBI (mTBI), suggesting that tests of 3D multiple object tracking (3D-MOT) may be sensitive to post-concussion syndrome (PCS) after a brain injury has occurred. To test this, we evaluated 3D-MOT performance (using NeuroTracker(TM)) against Sports Concussion Assessment Tool results for cognition, balance, and symptom severity in a large sample (N = 457) of male and female participants between the ages of 6 and 73 years. 3D-MOT performance in subjects under age 13 was not impaired by a history of concussion, but was positively associated with cognition and balance. 3D-MOT performance in those 13 and older was negatively associated with concussion symptom severity and positively associated with cognition and balance. 3D-MOT was selectively impaired in subjects with probable PCS (pPCS), defined using the 95th percentile of symptom severity for subjects with no history of concussion. A decision tree predicted concussion status with 95.2% overall test accuracy (91.1% sensitivity, 97.8% specificity), using concussion history, age, and 3D-MOT score. Persons with a history of concussion in the past 37 days were predicted to have pPCS if they were >= 35 years of age, or if they were <35 years of age but achieved scores below 1.2 on the 3D-MOT. These results demonstrate the potential of 3D-MOT for pPCS diagnosis and highlight the increased vulnerability to concussion symptoms that comes with age.	[Lysenko-Martin, Melanie R.; Hutton, Craig P.; Sparks, Taya; Snowden, Taylor; Christie, Brian R.] Univ Victoria, Div Med Sci, Med Sci Bldg,Room 218, Victoria, BC V8P 5C2, Canada		Christie, BR (corresponding author), Univ Victoria, Div Med Sci, Med Sci Bldg,Room 218, Victoria, BC V8P 5C2, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [FRN 127050]	Funding provided by Canadian Institutes for Health Research (FRN 127050) to BRC.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Asken B.M., CLIN NEUROPSYCHOL, DOI [10.1093/arclin/acz007], DOI 10.1093/ARCLIN/ACZ007]]; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Beauchamp P., 2011, CIRCUIT E J; Beltz AM, 2016, ASSESSMENT, V23, P447, DOI 10.1177/1073191116648209; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chermann JF, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000384; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; Corbin-Berrigan LA, 2018, NEUROREPORT, V29, P559, DOI 10.1097/WNR.0000000000000988; Craik FIM, 2008, CAN J PSYCHIAT, V53, P343, DOI 10.1177/070674370805300601; CRAIK FIM, 1994, CURR DIR PSYCHOL SCI, V3, P155, DOI 10.1111/1467-8721.ep10770653; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; DELIA JG, 1977, COMMUN MONOGR, V44, P326, DOI 10.1080/03637757709390144; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Foundation, 2011, INTRO RECURSIVE PART; Fox J., 2018, R COMPANION APPL REG; Fox John, 2008, APPL REGRESSION ANAL; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hastie J., 2009, ELEMENTS STAT LEARNI, VSecond, DOI DOI 10.1007/978-0-387-84858-7; HOLM S, 1979, SCAND J STAT, V6, P65; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; James G., 2017, SPRINGER TEXTS STAT, DOI [DOI 10.1007/978-1-4614-7138-7_8, 10.1007/978-1-4614-7138-7]; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kherad-Pajouh S, 2010, COMPUT STAT DATA AN, V54, P1881, DOI 10.1016/j.csda.2010.02.015; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kuhn M., 2019, CARET CLASSIFICATION; Kuhn M., 2014, MACHINE LEARNING; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Microsoft Canada Inc, 2010, MICR POW 2010, pCanada; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; R Core Team, 2018, STATS PACK LANG ENV; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Siu CR, 2018, EYE BRAIN, V10, P25, DOI 10.2147/EB.S130893; TEASDALE G, 1974, LANCET, V2, P81; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Tullo D, 2018, INTELLIGENCE, V69, P158, DOI 10.1016/j.intell.2018.06.001; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4, DOI 10.1007/978-3-319-24277-4_9]	52	4	4	5	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2020	37	16					1777	1787		10.1089/neu.2019.6842		APR 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	MW0CL	WOS:000526659000001	31950862				2022-02-06	
J	Wooldridge, G; Hansmann, A; Aziz, O; O'Brien, N				Wooldridge, Gavin; Hansmann, Andreas; Aziz, Omer; O'Brien, Nicole			Survey of resources available to implement severe pediatric traumatic brain injury management guidelines in low and middle-income countries	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; TBI; Pediatric; LMIC; Guidelines	FOUNDATION GUIDELINES; OUTCOMES; EPIDEMIOLOGY; CARE	Purpose Traumatic brain injury (TBI) is a leading cause of death and disability worldwide, with a disproportionately high burden in low-middle income countries. Guideline implementation has been associated with mortality reduction in high-income countries (HIC), but it is not known if hospitals in low and middle-income countries possess the resources to implement the pre-hospital TBI guidelines and the guidelines for the management of severe pediatric traumatic brain injury. Method An anonymous online survey was undertaken by a range of health care professionals currently managing children with severe TBI in low to middle-income countries. A variety of international and national pediatric, intensive care, and neurological societies assisted in the survey distribution. Thirty-eight questions were included to evaluate patient care and the provider's perceptions of their resources available to implement the pre-hospital specific TBI and current pediatric severe TBI guidelines. Results Two hundred and forty-seven hospitals were represented from 68 countries. Fifty percent of LMIC hospitals that responded had the resources to implement 13 of 15 guidelines for the pediatric component of pre-hospital management for TBI and all baseline care recommendations. First tier therapies including the intracranial pressure (ICP) and cerebral perfusion pathways (CPP), however, demonstrated low capacity for uptake with 21.5% and 38.5% of surveyed hospitals possessing sufficient resources to follow the recommended pathways. Conclusion Pediatric TBI ICP/CPP management guidelines require numerous resources not widely sourced in LMIC. The creation of international guidelines that outline recommendations of care for LMIC may benefit patient care and outcomes in these settings.	[Wooldridge, Gavin; O'Brien, Nicole] Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Hansmann, Andreas] Natl Pediat Hosp, Phnom Penh, Cambodia; [Aziz, Omer] Bristol Royal Hosp Children, Bristol, Avon, England; [O'Brien, Nicole] Nationwide Childrens Hosp, Columbus, OH USA		Wooldridge, G (corresponding author), Queen Elizabeth Cent Hosp, Blantyre, Malawi.	gfwooldridge@gmail.com					Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Appenteng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201550; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bradshaw CJ, 2018, WORLD J SURG, V42, P1885, DOI 10.1007/s00268-017-4396-6; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dewan MC, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18272; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fink EL, 2018, PEDIATR CRIT CARE ME, V19, P649, DOI 10.1097/PCC.0000000000001554; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Organization WH, 2018, GLOBAL STATUS REPORT; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Punchak M, 2018, WORLD NEUROSURG, V114, pE396, DOI 10.1016/j.wneu.2018.02.191; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Reilly PL, 2019, J CLIN NEUROSCI, V61, P201, DOI 10.1016/j.jocn.2018.10.030; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Vaca SD, 2019, J NEUROSURG-PEDIATR, V23, P125, DOI 10.3171/2018.7.PEDS17601; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; Vavilala MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189296; Vavilala MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166478; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; von Saint Andre-von Arnim AO, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5030034; World Health Organization UN Office on Drugs and Crime UN Development Programme, GLOB STAT REP VIOL P	33	4	4	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2020	36	11					2647	2655		10.1007/s00381-020-04603-9		APR 2020	9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	OG4CD	WOS:000557894500001	32300872				2022-02-06	
J	Piscitelli, F; Guida, F; Luongo, L; Iannotti, FA; Boccella, S; Verde, R; Lauritano, A; Imperatore, R; Smoum, R; Cristino, L; Lichtman, AH; Parker, LA; Mechoulam, R; Maione, S; Di Marzo, V				Piscitelli, Fabiana; Guida, Francesca; Luongo, Livio; Iannotti, Fabio Arturo; Boccella, Serena; Verde, Roberta; Lauritano, Anna; Imperatore, Roberta; Smoum, Reem; Cristino, Luigia; Lichtman, Aron H.; Parker, Linda A.; Mechoulam, Raphael; Maione, Sabatino; Di Marzo, Vincenzo			Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						mTBI; endocannabinoids; N-oleoylglycine; neuroprotection; N-acylethanolamines; behavior	IMPROVES FUNCTIONAL RECOVERY; ENDOCANNABINOIDS; PAIN; 2-ARACHIDONOYLGLYCEROL; SERINE; 2-AG; EXPRESSION; PROMOTES; SURVIVAL; BEHAVIOR	Traumatic brain injury (TBI) is one of the main causes of death in young people for which currently no efficacious treatment exists. Recently, we have reported that mice with mild-TBI with a specific injury in the insula showed elevated levels of a little investigated N-acyl amino acid, N-oleoylglycine (OlGly). N-acyl amino acids have recently experienced an increased interest because of their important biological activities. They belong to the endocannabinoidome family of lipids with structural similarities with the endocannabinoids (eCBs). The aim of this study was to test the neuroprotective and antihyperalgesic actions of OlGly in a model of mouse mild-TBI (mTBI) and its effect on levels of eCBs and N-acylethanolamines at the end of treatment. Following mTBI, mice were administered a daily injection of OlGly (10-50-100 mg/kg i.p.) for 14 days. Treatment with OlGly normalized motor impairment and behavior in the light/dark box test, ameliorated TBI-induced thermal hyperalgesia and mechanical allodynia, and normalized aggressiveness and depression. Moreover, levels of eCBs and some N-acylethanolamines underwent significant changes 60 days after TBI, especially in the prefrontal cortex and hypothalamus, and OlGly reversed some of these changes. In conclusion, our findings reveal that OlGly ameliorates the behavioral alterations associated with mTBI in mice, while concomitantly modulating eCB and eCB-like mediator tone.	[Piscitelli, Fabiana; Iannotti, Fabio Arturo; Verde, Roberta; Lauritano, Anna; Cristino, Luigia; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, I-80078 Naples, Italy; [Guida, Francesca; Luongo, Livio; Boccella, Serena; Maione, Sabatino] Univ Campania L Vanvitelli, Dept Expt Med, Pharmacol Div, I-80138 Naples, Italy; [Imperatore, Roberta] Univ Sannio, Dept Sci & Technol, I-82100 Benevento, Italy; [Smoum, Reem; Mechoulam, Raphael] Hebrew Univ Jerusalem, Med Fac, Inst Drug Res, IL-91120 Jerusalem, Israel; [Lichtman, Aron H.] Virginia Commonwealth Univ, Med Coll, Dept Pharmacol & Toxicol, Virginia Campus, Richmond, VA 23298 USA; [Parker, Linda A.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; [Parker, Linda A.] Univ Guelph, Collaborat Neurosci Grad Program, Guelph, ON N1G 2W1, Canada; [Di Marzo, Vincenzo] Univers & Laval, Canada Excellence Res Chair Microbiome Endocannab, Quebec City, PQ G1V 0A6, Canada		Piscitelli, F (corresponding author), CNR, Inst Biomol Chem, I-80078 Naples, Italy.	fpiscitelli@icb.cnr.it	Cristino, Luigia/AAE-3934-2020; Piscitelli, Fabiana/A-7100-2014; iannotti, fabio a/K-5704-2016	Cristino, Luigia/0000-0002-0182-4699; iannotti, fabio a/0000-0003-4480-8370; Lauritano, Anna/0000-0001-6788-5999; Piscitelli, Fabiana/0000-0001-9343-4622; IMPERATORE, Roberta/0000-0003-3609-2771; Maione, Sabatino/0000-0003-3850-6704			Baggelaar MP, 2018, PROG LIPID RES, V71, P1, DOI 10.1016/j.plipres.2018.05.002; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Cristino L., 2020, NAT REV NEUROL, V16, P29; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; Di Marzo V, 2018, NAT REV DRUG DISCOV, V17, P623, DOI 10.1038/nrd.2018.115; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Donvito G, 2019, NEUROPHARMACOLOGY, V148, P320, DOI 10.1016/j.neuropharm.2018.03.020; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Guida F, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-60; Guidali C, 2011, INT J NEUROPSYCHOPH, V14, P17, DOI 10.1017/S1461145710000209; Hansen HS, 2002, PHARMACOL THERAPEUT, V95, P119, DOI 10.1016/S0163-7258(02)00251-6; Huang WJ, 2016, MOL MED REP, V14, P2899, DOI 10.3892/mmr.2016.5585; Iannotti F. A., 2018, ENDOCANNABINOIDOME, P1, DOI [10.1002/9780470015902.a0028301, DOI 10.1002/9780470015902.A0028301]; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Iannotti FA, 2010, J PHARMACOL EXP THER, V332, P811, DOI 10.1124/jpet.109.162800; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kim HY, 2018, MOL ASPECTS MED, V64, P34, DOI 10.1016/j.mam.2018.03.004; Kim HY, 2013, PROSTAG LEUKOTR ESS, V88, P121, DOI 10.1016/j.plefa.2012.08.002; Llorente-Berzal A, 2015, PSYCHOPHARMACOLOGY, V232, P2811, DOI 10.1007/s00213-015-3917-y; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Luongo L, 2014, EUR J NEUROSCI, V39, P401, DOI 10.1111/ejn.12440; Manduca A, 2015, EUR NEUROPSYCHOPHARM, V25, P1362, DOI 10.1016/j.euroneuro.2015.04.005; Mann Aniv, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P209, DOI 10.1515/jbcpp-2015-0092; Mann A, 2015, J NEUROIMMUNE PHARM, V10, P356, DOI 10.1007/s11481-015-9595-z; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Smoum R, 2010, P NATL ACAD SCI USA, V107, P17710, DOI 10.1073/pnas.0912479107; Sonti S, 2018, CHEM PHYS LIPIDS, V210, P90, DOI 10.1016/j.chemphyslip.2017.11.002; Sticht MA, 2016, NEUROPHARMACOLOGY, V102, P92, DOI 10.1016/j.neuropharm.2015.10.039; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Wei D, 2017, TRENDS NEUROSCI, V40, P385, DOI 10.1016/j.tins.2017.04.005; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zamberletti E, 2017, J LIPID RES, V58, P301, DOI 10.1194/jlr.M068387; Zhuang LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-263	48	4	4	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	APR 15	2020	11	8					1117	1128		10.1021/acschemneuro.9b00633			12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	LD8UH	WOS:000526302200002	32017529				2022-02-06	
J	Chiaretti, A; Eftimiadi, G; Buonsenso, D; Rendeli, C; Staccioli, S; Conti, G				Chiaretti, Antonio; Eftimiadi, Gemma; Buonsenso, Danilo; Rendeli, Claudia; Staccioli, Susanna; Conti, Giorgio			Intranasal nerve growth factor administration improves neurological outcome after GBS meningitis	CHILDS NERVOUS SYSTEM			English	Article						Brain injury; Group B Streptococcus; Human-recombinant nerve growth factor; Intranasal administration; Meningitis; Neurotrophins	OPTIC GLIOMAS	Nerve growth factor (NGF) is a neurotrophin that promotes neural recovery and plasticity after experimental brain injury, supporting neuronal growth, differentiation, and survival of brain cells. Only a few studies reported NGF administration in pediatric patients with impaired brain functions after traumatic injuries, ischemic or infectious diseases, such as meningitis. We described the beneficial therapeutic effects of human-recombinant nerve growth factor (hr-NGF) treatment in an infant with persistent unresponsive wakefulness syndrome (UWS), due to late-onset group B Streptococcus meningitis. The infant received five monthly cycles of intranasal hr-NGF (0.1 mg/kg, 3 times daily for 7 consecutive days) through a mucosal atomizer device (MAD). NGF administration improved functional [positron emission tomography/computed tomography (PET/CT), single-photon emission/computed tomography (SPECT/CT), and magnetic resonance imaging (MRI)] assessments, electrophysiological [Electroencephalogram (EEG)] studies, as well as main cognitive processes and clinical and neurological functions. After hr-NGF treatment, significant improvements in facial mimicry, attention, motor reactions, oral motility, and feeding capacity were observed. She also recovered some hypothalamic functions and her cough reflex was restored. No side effects were reported during and after the treatment. For the first time ever, hr-NGF has been successfully utilized in an infant with UWS and severe neurologic outcome due to a bacterial meningitis. Although further studies are needed for better understanding the neuroprotective role of this neurotrophin, intranasal hr-NGF administration appears to be a promising and save rescuing strategy treatment in infants with severe neurological impairment after brain damage.	[Chiaretti, Antonio; Eftimiadi, Gemma; Buonsenso, Danilo; Conti, Giorgio] Univ Cattolica Sacro Cuore, Inst Pediat, Largo Francesco Vito 1, I-00168 Rome, RM, Italy; [Chiaretti, Antonio; Buonsenso, Danilo; Rendeli, Claudia] Fdn Policlin Univ A Gemelli IRCCS, Dept Woman & Child Hlth & Publ Hlth, Rome, Italy; [Staccioli, Susanna] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, Neurorehabil Unit, Via Torre Palidoro, I-00050 Fiumicino, RM, Italy; [Conti, Giorgio] Fdn Policlin Univ Agostino Gemelli IRCC, Dept Emergency, Pediat Intens Care Unit, Anesthesia & Intens Care, Rome, Italy		Chiaretti, A (corresponding author), Univ Cattolica Sacro Cuore, Inst Pediat, Largo Francesco Vito 1, I-00168 Rome, RM, Italy.; Chiaretti, A (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Dept Woman & Child Hlth & Publ Hlth, Rome, Italy.	antonio.chiaretti@unicatt.it	Conti, Giorgio/AAB-9546-2022	Conti, Giorgio/0000-0002-8566-9365; Buonsenso, Danilo/0000-0001-8567-2639; Eftimiadi, Gemma/0000-0001-7124-1213			Chan V, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0631-2; Chiaretti A, 2008, NEUROL RES, V30, P223, DOI 10.1179/016164107X247948; Chiaretti A, 2017, BRAIN INJURY, V31, P1538, DOI 10.1080/02699052.2017.1376760; Choi Seo Yeol, 2018, Korean J Pediatr, V61, P245, DOI 10.3345/kjp.2018.61.8.245; Colangelo AM, 2019, NEURAL REGEN RES, V14, P201, DOI 10.4103/1673-5374.244775; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Falsini B, 2016, BRAIN, V139, P404, DOI 10.1093/brain/awv366; Falsini B, 2011, NEUROREHAB NEURAL RE, V25, P512, DOI 10.1177/1545968310397201; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Herold R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215393; Hsu MH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00903; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; Manni L, 2013, GROWTH FACTORS, V31, P115, DOI 10.3109/08977194.2013.804073; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Phadke RV, 2017, J NEUROSCI RURAL PRA, V8, P158, DOI 10.4103/0976-3147.193528; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Skaper SD, 2017, IMMUNOLOGY, V151, P1, DOI 10.1111/imm.12717; Yikilmaz A, 2008, PEDIATR RADIOL, V38, P129, DOI 10.1007/s00247-007-0538-6	18	4	4	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2020	36	9					2083	2088		10.1007/s00381-020-04590-x		APR 2020	6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	ND6DD	WOS:000557839500001	32274529				2022-02-06	
J	Lange, RT; Lippa, SM; Bailie, JM; Wright, M; Driscoll, A; Sullivan, J; Gartner, R; Ramin, D; Robinson, G; Eshera, Y; Gillow, K; French, LM; Brickell, TA				Lange, Rael T.; Lippa, Sara M.; Bailie, Jason M.; Wright, Megan; Driscoll, Angela; Sullivan, Jamie; Gartner, Rachel; Ramin, Daniel; Robinson, Gabrielle; Eshera, Yasmine; Gillow, Kelly; French, Louis M.; Brickell, Tracey A.			Longitudinal trajectories and risk factors for persistent postconcussion symptom reporting following uncomplicated mild traumatic brain injury in US Military service members	CLINICAL NEUROPSYCHOLOGIST			English	Article						Longitudinal symptom reporting; postconcussion symptoms; military; uncomplicated mild traumatic brain injury; long-term outcome	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; CLINICAL UTILITY; VALIDITY-10 SCALE; BLAST EXPOSURE; TBI; EXAGGERATION; PERFORMANCE; DEPLOYMENT; SEVERITY	Objective: The purpose of this study was to examine individual postconcussion symptom [PCSx] trajectories following mild traumatic brain injury (MTBI), and to examine risk factors for persistent PCSx reporting. Method: Participants were 138 U.S. military service members and veterans (SMVs) prospectively enrolled in the Defense and Veterans Brain Injury Center, 15-Year Longitudinal TBI study. Participants were classified into three groups: uncomplicated MTBI (n = 54), injured controls (IC, n = 26), and non-injured controls (NIC, n = 58). Participants completed the Neurobehavioral Symptom Inventory, PTSD Checklist, and Traumatic Brain Injury Quality of Life at baseline (<8 months post-injury) and at follow-up (2-4 years post-injury). Results: The prevalence of those who met DSM-IV-TR symptom criteria for Postconcussional Disorder (PCD) was high in all three groups (e.g., 44.8-63.0%) and did not significantly change from baseline to follow-up (all ps>.05). However, there was substantial variability in individual symptom trajectories over time. The majority of participants had symptom trajectories classified as either 'persistent' (similar to 32-55%) or 'asymptomatic' (similar to 30-36%), with a substantial minority classified as 'improved' (similar to 7-12%) or 'developed' (similar to 7-19%). Factors associated with 'persistent' PCD trajectories included cognitive complaints, PTSD, depression, anxiety, pain, and headaches at baseline; but not the presence/absence of MTBI. Factors associated with 'developed' PCD trajectories included PTSD and the number of lifetime exposures to blast. Conclusions: Reporting of 'new' PCSx over time was common in individuals with and without MTBI. It would be erroneous to assume uncritically that PCSx reported many years post-injury reflect only persistent symptomatology, or can be solely attributable to the direct consequences of a brain injury.	[Lange, Rael T.; Lippa, Sara M.; Wright, Megan; Driscoll, Angela; Sullivan, Jamie; Gartner, Rachel; Ramin, Daniel; Robinson, Gabrielle; Eshera, Yasmine; Gillow, Kelly; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lange, Rael T.; Lippa, Sara M.; Wright, Megan; Driscoll, Angela; Sullivan, Jamie; Gartner, Rachel; Ramin, Daniel; Robinson, Gabrielle; Eshera, Yasmine; Gillow, Kelly; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, Def & Vet Brain Injury Ctr, Oceanside, CA USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rlange@dvbic.org		french, louis/0000-0002-9451-0604			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Defense and Veterans Brain Injury Center D, 2012, DOD NUMB TRAUM BRAIN; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange R, 2019, ARCH CLIN NEUROPSYCH, V34, P1003, DOI 10.1093/arclin/acz034.140; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2019, J CLIN EXP NEUROPSYC, V41, P497, DOI 10.1080/13803395.2019.1585518; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; McCrae M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Polimanti R, 2017, J NEUROTRAUM, V34, P781, DOI 10.1089/neu.2016.4550; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2017, J TRAUMA STRESS, V30, P318, DOI 10.1002/jts.22184; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251	61	4	4	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1134	1155		10.1080/13854046.2020.1746832		APR 2020	22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000526501400001	32284000				2022-02-06	
J	Hendry, K; Ownsworth, T; Waters, AM; Jackson, M; Lloyd, O				Hendry, Kathryn; Ownsworth, Tamara; Waters, Allison M.; Jackson, Megan; Lloyd, Owen			Investigation of children and adolescents' mood and self-concept after acquired brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Acquired brain injury; mental health; mood; self-concept; child	BEHAVIORAL OUTCOMES; ADJUSTMENT PROBLEMS; CHILDHOOD; LESIONS; SYMPTOMS; PARTICIPATION; INTERVENTIONS; DEPRESSION; DISORDERS; ESTEEM	Few studies have examined the self-reported mental health of children with an acquired brain injury (ABI). The current study aimed to: 1) identify levels of child-reported depressive and anxiety symptoms and poor self-concept, 2) investigate demographic and injury-related factors associated with children's mood and self-concept, and 3) examine associations between children's self-reported mental health and parents' reports of children's emotional and behavioral functioning in children specifically with traumatic brain injury (TBI). 122 children (66% male) aged 8-16 years with ABI of mixed etiology were consecutively recruited through an outpatient rehabilitation clinic. Children were administered the Beck Youth Inventories - Second Edition, and parents completed the Adaptive Behavior Assessment System and the Child Behavior Checklist (CBCL). Relative to the norms, 16.4% of children scored in the clinical range for the depression and anxiety scales, and 24.6% reported clinically low self-concept. Children with lower functional status had greater anxiety symptoms. Older children (13-16 years) reported significantly higher depressive and anxiety symptoms and lower self-concept than younger children (8-12 years). A significant interaction between age and sex indicated that older girls reported greater depressive and anxiety symptoms than younger girls whereas no age-based differences were found for boys. Parent-reported total emotional and behavioral problems were positively associated with children's self-reported depressive and anxiety symptoms and were negatively correlated with self-concept. These findings indicate that adolescents, particularly girls, may be at heightened risk of poor mental health following ABI. Further research investigating the reasons for these demographic differences may inform developmentally sensitive interventions.	[Hendry, Kathryn; Ownsworth, Tamara; Waters, Allison M.; Lloyd, Owen] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Hendry, Kathryn; Ownsworth, Tamara; Waters, Allison M.; Lloyd, Owen] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Jackson, Megan] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Jackson, Megan; Lloyd, Owen] Queensland Childrens Hosp, Queensland Paediat Rehabil Serv, Childrens Hlth Queensland, Brisbane, Qld, Australia; [Jackson, Megan; Lloyd, Owen] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Messines Ridge Rd, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094; Waters, Allison/0000-0003-2453-793X	Queensland Pediatric Rehabilitation Service (QPRS) at the Queensland Children's Hospital	The authors thank all staff from the Queensland Pediatric Rehabilitation Service (QPRS) at the Queensland Children's Hospital for supporting the study and the families who so generously participated in this study.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2017, DEV NEUROPSYCHOLOGY; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Australian Institute of Health and Welfare (AIHW, 2007, DIS SER; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bell H, 2018, PSYCHO-ONCOLOGY, V27, P2317, DOI 10.1002/pon.4850; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Butler Richard J, 2005, Child Adolesc Ment Health, V10, P190, DOI 10.1111/j.1475-3588.2005.00368.x; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; DAMON W, 1982, CHILD DEV, V53, P841, DOI 10.1111/j.1467-8624.1982.tb01347.x; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Dockett S, 2009, J EARLY CHILD RES, V7, P283, DOI 10.1177/1476718X09336971; Dray J, 2017, J AM ACAD CHILD PSY, V56, P813, DOI 10.1016/j.jaac.2017.07.780; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Friefeld SJ, 2011, J CHILD NEUROL, V26, P1186, DOI 10.1177/0883073811408609; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Ghandour RM, 2019, J PEDIATR-US, V206, P256, DOI 10.1016/j.jpeds.2018.09.021; Gomes A, 2014, DEV NEUROPSYCHOL, V39, P9, DOI 10.1080/87565641.2013.827197; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Harrison P.L., 2015, ABAS 3 ADAPTIVE BEHA; Harter S., 2012, CONSTRUCTION SELF DE, V2nd ed.; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; Jolly J. B., 2005, BECK YOUTH INVENTORI; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Lawrence D, 2016, AUST NZ J PSYCHIAT, V50, P876, DOI 10.1177/0004867415617836; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lloyd O., 2019, ASSBI NZRA IN TRANST; Lloyd O, 2018, CHILD NEUROPSYCHOL, V24, P702, DOI 10.1080/09297049.2017.1332173; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Marsh HW, 2003, J EDUC PSYCHOL, V95, P687, DOI 10.1037/0022-0663.95.4.687; Mason J, 2011, CHILD INDIC RES, V4, P185, DOI 10.1007/s12187-011-9108-4; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; O'Dea J. A., 1999, ADOLESCENCE, V34, P136; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Pastore V, 2018, BRAIN INJURY, V32, P1011, DOI 10.1080/02699052.2018.1469041; Pastore V, 2015, BRAIN INJURY, V29, P937, DOI 10.3109/02699052.2015.1008045; Pastore V, 2014, J CHILD NEUROL, V29, P1664, DOI 10.1177/0883073813513329; Pastore V, 2013, BRAIN INJURY, V27, P677, DOI 10.3109/02699052.2013.775482; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSENBERG FR, 1975, SEX ROLES, V1, P147, DOI 10.1007/BF00288008; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Tabachnick B.G., 2013, USING MULTIVARIATE S; Thabrew H., 2017, GLOBAL PEDIAT HLTH, V4; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wakefield CE, 2010, J PEDIATR PSYCHOL, V35, P262, DOI 10.1093/jpepsy/jsp056; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zyrianova Y, 2016, BRAIN INJURY, V30, P1, DOI 10.3109/02699052.2015.1075590	63	4	4	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	NOV 16	2020	26	8					1005	1025		10.1080/09297049.2020.1750577		APR 2020	21	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NX2KF	WOS:000526478200001	32253978	Green Accepted			2022-02-06	
J	Li, HT; Pan, YT; Wu, HJ; Yu, SN; Wang, JX; Zheng, J; Wang, C; Li, JG; Jiang, JY				Li, Huiting; Pan, Yitong; Wu, Hongjuan; Yu, Shuna; Wang, Jianxin; Zheng, Jie; Wang, Can; Li, Jianguo; Jiang, Jiying			Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats	PEERJ			English	Article						Hepatic ischemia-reperfusion injury; H2O2; N-acetyl-L-tryptophan; Mitophagy	TRAUMATIC BRAIN-INJURY; HEPATIC ISCHEMIA; SUBSTANCE-P; AUTOPHAGY	In order to investigate the mechnism of hepatoprotective of N-acetyl-L-tryptophan (L-NAT) against ischemia-reperfusion (I/R) injury, the effects of L-NAT were investigated in hepatic ischemia-reperfusion injury (HIRI) models both in vitro and in vivo, which were made by BRL cells and Sprague-Dawley (SD) rats, respectively. The cell viability of hepatocyte was assessed by cell counting kit-8 (CCK-8) staining. The activation of autophagy was detected by electron microscopy (EM), quantitative real-time PCR (qRT-PCR), Western blotting and immunofluorescence. The activation of mitophagy was determined by the change of autophagy related protein, change of mitochondrial structure and function, co-location of autophagy protein and MitoTracker. Results showed that the morphological structures of hepatocytes were changed significantly after HIRI, and the cell viability of hydrogen peroxide (H2O2)-induced BRL cells was decreased. Autophagy markers Beclin1, microtubule associated protein 1 light chain 3-II (LC3-II) and autophagy related protein-7 (ATG-7) were highly expressed and the expression of SQSTM1 (P62) was decreased after HIRI, which suggested that autophagy of hepatocytes was activated after I/R. The reduction of ATP, mitochondrial DNA (mtDNA) and the mitochondrial transmembrane potential (Delta Psi m) after H2O2-induced revealed that function of mitochondrial had also undergone significant changes. The increased expression of autophagy protein, destructure of mitochondria and mitochondrial dysfunction, the increased co-location of Beclin1 and MitoTracker induced by H2O2 implied the excessive mitophagy. The expression of the autophagy protein was increased by 3-Methyladenine (3-MA), providing another piece of evidence. Importantly, all changes were restored by L-NAT pretreament. In conclusion, the present findings demonstrate that excessive mitophagy involved in the process of HIRI and L-NAT may protect hepatocytes against HIRI by inhibiting activation of mitophagy and improving the structure and function of mitochondria.	[Li, Huiting; Pan, Yitong; Yu, Shuna; Wang, Jianxin; Wang, Can; Li, Jianguo; Jiang, Jiying] Weifang Med Univ, Dept Anat, Weifang, Peoples R China; [Wu, Hongjuan] Weifang Med Univ, Morphol Lab, Weifang, Peoples R China; [Zheng, Jie] Weifang Med Univ, Dept Pathol, Weifang, Peoples R China		Li, JG; Jiang, JY (corresponding author), Weifang Med Univ, Dept Anat, Weifang, Peoples R China.	ljg7111@wfmc.edu.cn; jiangjy@wfmc.edu.cn			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81760567, 81802474]; Key R&D Program of Shandong Province [GG201809200094]; Natural Science Foundation of Shandong Province, ChinaNatural Science Foundation of Shandong Province [ZR2018MC012, ZR2014HL020, ZR2014HL021]; Project Funding for the Development of Medical and Health Science and Technology in Shandong Province [2014WS0464]; Neurologic Disorders and Regenerative Repair Lab "13th five-year plan'' Key Lab of Shandong Higher Education	The study was supported by the National Science Foundation of China (Grant No. 81760567; 81802474), the Key R&D Program of Shandong Province (GG201809200094), the Natural Science Foundation of Shandong Province, China (ZR2018MC012; ZR2014HL020; ZR2014HL021) and the Project Funding for the Development of Medical and Health Science and Technology in Shandong Province (2014WS0464) and the Neurologic Disorders and Regenerative Repair Lab "13th five-year plan'' Key Lab of Shandong Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadoro G, 2014, NEUROBIOL DIS, V62, P489, DOI 10.1016/j.nbd.2013.10.018; Bhogal RH, 2018, LIVER TRANSPLANT, V24, P1437, DOI 10.1002/lt.25313; Codogno P, 2013, J HEPATOL, V59, P389, DOI 10.1016/j.jhep.2013.02.031; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Hou J, 2019, DNA CELL BIOL, V38, P895, DOI 10.1089/dna.2019.4767; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jiang JY, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/310504; Kalimeris K, 2016, J SURG RES, V206, P263, DOI 10.1016/j.jss.2016.08.049; Lan R, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/4147502; Lee SC, 2016, AM J TRANSPLANT, V16, P2042, DOI 10.1111/ajt.13729; Li FZ, 2018, CELL PHYSIOL BIOCHEM, V48, P1492, DOI 10.1159/000492259; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Li N, 2018, EXP CELL RES, V369, P27, DOI 10.1016/j.yexcr.2018.04.025; Li Q, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00865; Li W, 2015, NEUROBIOL DIS, V80, P93, DOI 10.1016/j.nbd.2015.05.002; Li Y, 2018, AGING-US, V10, P1902, DOI 10.18632/aging.101511; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Ling LU, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.12; Ning XJ, 2018, MOL MED REP, V18, P5663, DOI 10.3892/mmr.2018.9606; Park SW, 2009, KIDNEY INT, V76, P739, DOI 10.1038/ki.2009.255; Rao ZQ, 2017, ANESTH ANALG, V125, P1355, DOI 10.1213/ANE.0000000000002385; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; Sirianni AC, 2015, J NEUROCHEM, V134, P956, DOI 10.1111/jnc.13190; Sun XL, 2019, J CELL BIOCHEM, V120, P4255, DOI 10.1002/jcb.27711; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034138, 10.1371/journal.pone.0042630]; Turner R. J., 2005, J CEREB BLOOD FLOW M, V25, pS32, DOI DOI 10.1038/SJ.JCBFM.9591524.0032; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Wang JX, 2019, PHARM BIOL, V57, P385, DOI 10.1080/13880209.2019.1617750; Wu XW, 2018, BRAIN RES, V1698, P89, DOI 10.1016/j.brainres.2018.06.028; Yang MJ, 2019, BBA-MOL BASIS DIS, V1865, P2293, DOI 10.1016/j.bbadis.2019.05.007; Zhao YM, 2019, J CELL BIOCHEM, V120, P14960, DOI 10.1002/jcb.28758	34	4	4	5	7	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	APR 9	2020	8								e8665	10.7717/peerj.8665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LC1IE	WOS:000525081400001	32296597	Green Published, gold			2022-02-06	
J	Paleo, BJ; Madalena, KM; Mital, R; McElhanon, KE; Kwiatkowski, TA; Rose, AL; Lerch, JK; Weisleder, N				Paleo, Brian J.; Madalena, Kathryn M.; Mital, Rohan; McElhanon, Kevin E.; Kwiatkowski, Thomas A.; Rose, Aubrey L.; Lerch, Jessica K.; Weisleder, Noah			Enhancing membrane repair increases regeneration in a sciatic injury model	PLOS ONE			English	Article							HUMAN MG53 PROTEIN; GIRDLE MUSCULAR-DYSTROPHY; DYSFERLIN; MECHANISM; ISCHEMIA; CARDIOPROTECTION	Various injuries to the neural tissues can cause irreversible damage to multiple functions of the nervous system ranging from motor control to cognitive function. The limited treatment options available for patients have led to extensive interest in studying the mechanisms of neuronal regeneration and recovery from injury. Since many neurons are terminally differentiated, by increasing cell survival following injury it may be possible to minimize the impact of these injuries and provide translational potential for treatment of neuronal diseases. While several cell types are known to survive injury through plasma membrane repair mechanisms, there has been little investigation of membrane repair in neurons and even fewer efforts to target membrane repair as a therapy in neurons. Studies from our laboratory group and others demonstrated that mitsugumin 53 (MG53), a muscle-enriched tripartite motif (TRIM) family protein also known as TRIM72, is an essential component of the cell membrane repair machinery in skeletal muscle. Interestingly, recombinant human MG53 (rhMG53) can be applied exogenously to increase membrane repair capacity both in vitro and in vivo. Increasing the membrane repair capacity of neurons could potentially minimize the death of these cells and affect the progression of various neuronal diseases. In this study we assess the therapeutic potential of rhMG53 to increase membrane repair in cultured neurons and in an in vivo mouse model of neurotrauma. We found that a robust repair response exists in various neuronal cells and that rhMG53 can increase neuronal membrane repair both in vitro and in vivo. These findings provide direct evidence of conserved membrane repair responses in neurons and that these repair mechanisms can be targeted as a potential therapeutic approach for neuronal injury.	[Paleo, Brian J.; McElhanon, Kevin E.; Kwiatkowski, Thomas A.; Rose, Aubrey L.; Weisleder, Noah] Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Madalena, Kathryn M.; Mital, Rohan; Lerch, Jessica K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA		Weisleder, N (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	noah.weisleder@osumc.edu		Mital, Rohan/0000-0002-5190-2958	Medical Research Grant from the National Football League; National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056504]; National Cancer Institute, Bethesda, MDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA016058]; Ohio State University Ross Heart Hospital TriFit Challenge	This work was supported by a Medical Research Grant from the National Football League and by the National Institute on Aging of the National Institutes of Health under Award Number R01AG056504 (NW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Images presented in this report were generated using the instruments and services at the Campus Microscopy and Imaging Facility, The Ohio State University. This facility is supported in part by grant P30 CA016058, National Cancer Institute, Bethesda, MD. This project was also supported by The Ohio State University Ross Heart Hospital TriFit Challenge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; [Anonymous], 1993, J NEUROSCIENCE OFFIC, V13; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; B TM M MM, 1980, NEUROSCIENCE LETT, V17; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bittner GD, 2016, NEURAL REGEN RES, V11, P1033, DOI 10.4103/1673-5374.187019; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Castro-Gomes T, 2014, TRENDS BIOCHEM SCI, V39, P307, DOI 10.1016/j.tibs.2014.06.001; Castro-Gomes T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152583; Chase TH, 2009, AM J PATHOL, V175, P2299, DOI 10.2353/ajpath.2009.080930; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Cooper ST, 2015, NEUROSCIENTIST, V21, P653, DOI 10.1177/1073858414558336; Corona BT, 2014, MUSCLE NERVE, V49, P919, DOI 10.1002/mus.24160; Demonbreun AR, 2016, J CELL BIOL, V213, P705, DOI 10.1083/jcb.201512022; Detrait E, 2000, J NEUROBIOL, V44, P382, DOI 10.1002/1097-4695(20000915)44:4<382::AID-NEU2>3.0.CO;2-Q; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; GUAN FX, 2019, BIOL PSYCHIAT, V95, DOI DOI 10.1016/J.PNPBP.2019.109684; Gushchina LV, 2017, MOL THER, V25, P2360, DOI 10.1016/j.ymthe.2017.06.025; Hendricks BK, 2014, NEUROSCI BULL, V30, P627, DOI 10.1007/s12264-013-1446-4; Houang EM, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.42; Jaiswal JK, 2007, TRAFFIC, V8, P77, DOI 10.1111/j.1600-0854.2006.00505.x; Jaiswal JK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4795; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Kim SC, 2014, AM J PHYSIOL-LUNG C, V307, pL449, DOI 10.1152/ajplung.00172.2014; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; Lee JJA, 2018, JOVE-J VIS EXP, DOI 10.3791/56999; Lemckert FA, 2016, CARDIOVASC RES, V110, P178, DOI 10.1093/cvr/cvw017; Lerch JK, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0246-17.2017; Li HC, 2015, J BIOL CHEM, V290, P24592, DOI 10.1074/jbc.M115.680074; Liu JX, 2015, J MOL CELL CARDIOL, V80, P10, DOI 10.1016/j.yjmcc.2014.12.010; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Mina EW, 2009, J MOL BIOL, V391, P577, DOI 10.1016/j.jmb.2009.06.024; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; Nagre N, 2018, AM J RESP CELL MOL B; PARSEGIAN VA, 1984, CIBA F SYMP, V103, P9; Quattrocelli M, 2017, AM J PATHOL, V187, P2520, DOI 10.1016/j.ajpath.2017.07.017; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Sreetama SC, 2018, MOL THER, V26, P2231, DOI 10.1016/j.ymthe.2018.07.021; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; Torii T, 2019, ADV EXP MED BIOL, V1190, P3, DOI 10.1007/978-981-32-9636-7_1; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; van der Kooi AJ, 2007, NEUROLOGY, V68, P2125, DOI 10.1212/01.wnl.0000264853.40735.3b; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Wenzel K, 2007, J MOL MED, V85, P1203, DOI 10.1007/s00109-007-0253-7; Wu HK, 2019, CIRCULATION, V139, P901, DOI 10.1161/CIRCULATIONAHA.118.037216; Xie WR, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0008-17.2017; Yao WF, 2017, J CELL MOL MED, V21, P2503, DOI 10.1111/jcmm.13171; Yao YG, 2016, ONCOTARGET, V7, P22474, DOI 10.18632/oncotarget.7965; Yoo S, 2003, J NEUROSCI RES, V74, P541, DOI 10.1002/jnr.10771; Zhu H, 2015, MUSCLE NERVE, V52, P852, DOI 10.1002/mus.24619; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	64	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2020	15	4							e0231194	10.1371/journal.pone.0231194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8WI	WOS:000535977000059	32271817	Green Published, gold, Green Submitted			2022-02-06	
J	Salmon, DM; Mcgowan, J; Sullivan, SJ; Murphy, I; Walters, S; Whatman, C; Keung, S; Clacy, A; Romanchuk, J				Salmon, Danielle M.; Mcgowan, Jody; Sullivan, S. John; Murphy, Ian; Walters, Simon; Whatman, Chris; Keung, Sierra; Clacy, Amanda; Romanchuk, Janelle			What they know and who they are telling: Concussion knowledge and disclosure behaviour in New Zealand adolescent rugby union players	JOURNAL OF SPORTS SCIENCES			English	Article						Ethnicity; high school; concussion; rugby union; socioeconomic status; reporting behaviours	SPORT-RELATED CONCUSSION; INJURY; EDUCATION; PARTICIPATION; ATTITUDES; CALGARY; RETURN	The purpose of this study was to survey high school rugby players from a range of ethnic, geographic and socioeconomic backgrounds in New Zealand (NZ) to gain an understanding of concussion knowledge, awareness of NZ Rugby's (NZR) guidelines and attitudes towards reporting behaviours. Male and female high school rugby players (n= 416) from across NZ were surveyed. The findings indicated that 69% of players had sustained a suspected concussion, and 31% had received a medical diagnosis of concussion. 63% of players indicated they were aware of NZR's guidelines. Maori and Pasifika players were less likely to be aware of the guidelines compared to NZ European, Adjusted OR 0.5, p = 0.03. Guideline awareness was significantly higher for those from high decile schools when compared to low (Unadjusted OR 1.63, p = 0.04); however, when ethnicity and school locations were controlled for this became non-significant (Adjusted OR= 1.3, p=0.37). The coach was the key individual for the provision of concussion information and disclosure of symptoms for players. The findings of this study will inform the development and delivery of NZR's community concussion initiative and how these examined factors influence a high school player's concussion knowledge and reporting behaviour.	[Salmon, Danielle M.; Mcgowan, Jody; Murphy, Ian; Romanchuk, Janelle] New Zealand Rugby, Hlth Safety & Welf, POB 2172, Wellington 6140, New Zealand; [Sullivan, S. John] Univ Otago, Ctr Hlth Act & Rehabil Res, Sch Physiotherapy, Dunedin, New Zealand; [Walters, Simon; Whatman, Chris; Keung, Sierra] Auckland Univ Technol, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Clacy, Amanda] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Australia		Salmon, DM (corresponding author), New Zealand Rugby, Hlth Safety & Welf, POB 2172, Wellington 6140, New Zealand.	Danielle.salmon@nzrugby.co.nz		Romanchuk, Janelle/0000-0002-8442-9589	Accidental Compensation Corporation	Funding for this project was provided by The Accidental Compensation Corporation through the RugbySmart program.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Clacy A, 2019, APPL ERGON, V80, P256, DOI 10.1016/j.apergo.2017.06.010; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Gianotti S, 2007, J SCI MED SPORT, V10, P436, DOI 10.1016/j.jsams.2006.10.006; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hodge K, 2011, J CLIN SPORT PSYCHOL, V5, P350, DOI 10.1123/jcsp.5.4.350; Hunt C, 2018, CAN J NEUROL SCI, V45, P283, DOI 10.1017/cjn.2017.299; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kraak W J, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30i1a4404; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Malpas K., 2016, SPORT NZ INJURY PART; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Salmon D., 2019, BRIT J SPORT MED, V54, P298, DOI [10.1136/bjsports-2019-100950s, DOI 10.1136/BJSPORTS-2019-100950S]; Salmon D, 2020, BRIT J SPORT MED, V54, P300, DOI 10.1136/bjsports-2019-100949; Schaaf Matani, 2006, JUNCTURES, V7, P41; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Viljoen C T, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1942; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Zealand HRCoN, 2014, PAC HLTH RES GUID NZ	38	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	JUL 17	2020	38	14					1585	1594		10.1080/02640414.2020.1749409		APR 2020	10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	MY5EF	WOS:000526484400001	32264762				2022-02-06	
J	Campolettano, ET; Gellner, RA; Sproule, DW; Begonia, MT; Rowson, S				Campolettano, Eamon T.; Gellner, Ryan A.; Sproule, David W.; Begonia, Mark T.; Rowson, Steven			Quantifying Youth Football Helmet Performance: Assessing Linear and Rotational Head Acceleration	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Concussion; Injury risk; Impact	NATIONAL OPERATING COMMITTEE; PROFESSIONAL FOOTBALL; IMPACT EXPOSURE; BIOMECHANICAL PERFORMANCE; RECURRENT CONCUSSION; HYBRID III; STANDARDS; CIRCUMFERENCE; CHILDREN; ADULT	Youth football helmet testing standards have served to largely eliminate catastrophic head injury from the sport. These standards, though, do not presently consider concussion and do not offer consumers the capacity to differentiate the impact performance of youth football helmets. This study adapted the previously developed Summation of Tests for the Analysis of Risk (STAR) equation for youth football helmet assessment. This adaptation made use of a youth-specific testing surrogate, on-field data collected from youth football players, and a concussion risk function developed for youth athletes. Each helmet is subjected to 48 laboratory impacts across 12 impact conditions. Peak linear head acceleration and peak rotational head acceleration values from each laboratory impact are aggregated into a single STAR value that combines player exposure and risk of concussion. This single value can provide consumers with valuable information regarding the relative performance of youth football helmets.	[Campolettano, Eamon T.; Gellner, Ryan A.; Sproule, David W.; Begonia, Mark T.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA		Campolettano, ET (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	eamonc@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; Institute for Critical Technology and Applied Science at Virginia Tech	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS094410. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. The authors also appreciate the support of the Institute for Critical Technology and Applied Science at Virginia Tech.	Beusenberg MC., 2000, P INT RES C BIOM IMP; Bland C, 2019, UNDER DISCUSS, P1; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cobb B. R, 2015, LAB FIELD STUDIES SP; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Culver C. C., 1972, P 16 STAPP CAR CRASH, P720959; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma S. M, 2013, EFFECTIVENESS HELMET; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P303, DOI 10.1597/1545-1569(1992)029<0303:AGSOTH>2.3.CO;2; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Graham R., 2014, SPORTS RELATED CONCU, P309; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Huelke DF, 1998, P ANN C ASS, P93; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jarrett K., 2002, INJ BIOMECH RES, P77; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kuczmarski RJ, 2000, CDC GROWTH CHARTS; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mertz H., 1989, SIZE WEIGHT BIOMECHA; Mertz H. J, 1996, HEAD INJURY RISK ASS; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Newman J.A., 1986, P INT IRCOBI C ZUR S; NOCSAE, 2017, STAND PERF SPEC NEWL; Olvey S. E, 2006, RECOMMENDED STANDARD; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Refakis C. A, 2017, CLIN SPINE SURG; ROCHE AF, 1987, PEDIATRICS, V79, P706; Rowson, 2018, VARSITY FOOTBALL HEL; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, J NEUROSURG, V119, P805, DOI 10.3171/2013.3.JNS121735; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; SAE J211, J211 SAE; Sproule DW, 2017, P I MECH ENG P-J SPO, V231, P317, DOI 10.1177/1754337117703019; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Tyson A, 2018, ADULT FOOTBALL STAR; Urban J. E, 2013, ANN BIOMED ENG; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Yoganandan N, 2014, J BIOMECH, V47, P1749, DOI 10.1016/j.jbiomech.2014.03.010; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	56	4	4	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUN	2020	48	6					1640	1650		10.1007/s10439-020-02505-0		APR 2020	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	LW4EV	WOS:000524619100001	32266597	Green Accepted			2022-02-06	
J	Reyes, J; Mitra, B; McIntosh, A; Clifton, P; Makdissi, M; Nguyen, JVK; Harcourt, P; Howard, TS; Cameron, PA; Rosenfeld, JV; Willmott, C				Reyes, Jonathan; Mitra, Biswadev; McIntosh, Andrew; Clifton, Patrick; Makdissi, Michael; Nguyen, Jack V. K.; Harcourt, Peter; Howard, Teresa S.; Cameron, Peter A.; Rosenfeld, Jeffrey V.; Willmott, Catherine			An Investigation of Factors Associated With Head Impact Exposure in Professional Male and Female Australian Football Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						nonhelmeted accelerometer; professional athletes; head impact biomechanics; wearable accelerometers; sports-related concussion; sports injury	VIDEO ANALYSIS; CONCUSSION; INJURY; RUGBY; PROFILE; HOCKEY; ACCELERATIONS; SURVEILLANCE; BIOMECHANICS; MECHANISMS	Background: Exposure to head acceleration events (HAEs) has been associated with player sex, player position, and player experience in North American football, ice hockey, and lacrosse. Little is known of these factors in professional Australian football. Video analysis allows HAE verification and characterization of important determinants of injury. Purpose: To characterize verified HAEs in the nonhelmeted contact sport of professional Australian football and investigate the association of sex, player position, and player experience with HAE frequency and magnitude. Study Design: Descriptive epidemiology study. Methods: Professional Australian football players wore a nonhelmeted accelerometer for 1 match, with data collected across 14 matches. HAEs with peak linear accelerations (PLAs) >= 30g were verified with match video. Verified HAEs were summarized by frequency and median PLA and compared between the sexes, player position, and player experience. Characterization of match-related situations of verified HAEs was conducted, and the head impact rate per skill execution was calculated. Results: 92 male and 118 female players were recruited during the 2017 season. Male players sustained more HAEs (median, 1; IQR, 0-2) than female players (median, 0; IQR, 0-1; P = .007) during a match. The maximum PLAs incurred during a match were significantly higher in male players (median, 61.8g; IQR, 40.5-87.1) compared with female players (median, 44.5g; IQR, 33.6-74.8; P = .032). Neither player position nor experience was associated with HAE frequency. Of all verified HAEs, 52% (n = 110) occurred when neither team had possession of the football, and 46% (n = 98) were caused by contact from another player attempting to gain possession of the football. A subset of HAEs (n = 12; 5.7%) resulted in players seeking medical aid and/or being removed from the match (median PLA, 58.8g; IQR, 34.0-89.0), with 2 (male) players diagnosed with concussion after direct head impacts and associated PLAs of 62g and 75g, respectively. In the setting of catching (marking) the football, female players exhibited twice the head impact rate (16 per 100 marking contests) than male players (8 per 100 marking contests). Conclusion: Playing situations in which players have limited control of the football are a common cause of impacts. Male players sustained a greater exposure to HAEs compared with female players. Female players, however, sustained higher exposure to HAEs than male players during certain skill executions, possibly reflecting differences in skill development. These findings can therefore inform match and skill development in the emerging professional women's competition of Australian football.	[Reyes, Jonathan; Nguyen, Jack V. K.; Willmott, Catherine] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton Campus, Melbourne, Vic, Australia; [Mitra, Biswadev; Howard, Teresa S.; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [McIntosh, Andrew] Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia; [McIntosh, Andrew] Edith Cowan Univ, Sch Engn, Joondalup, Australia; [McIntosh, Andrew] Edith Cowan Univ, Australian Collaborat Res Injury Sport & Its Prev, Joondalup, Australia; [Clifton, Patrick; Harcourt, Peter] Australian Football League, Melbourne, Vic, Australia; [Makdissi, Michael] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Makdissi, Michael] Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia; [Howard, Teresa S.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Willmott, Catherine] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Willmott, C (corresponding author), Monash Psychol Ctr, Turner Inst Brain & Mental Hlth, Ground Floor,Bldg 1,270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@monash.edu	Mitra, Biswadev/AAC-3724-2019	Mitra, Biswadev/0000-0002-0508-2450; makdissi, michael/0000-0003-0334-7133; Reyes, Jonathan/0000-0002-6087-3159; Nguyen, Jack/0000-0002-6698-1935	National Health and Medical Research Council grant (Canberra, Australia) [APP1133923]; Alfred Trauma Service (ATS); Australian Football League (AFL); AFL	This study was supported by a National Health and Medical Research Council grant (Canberra, Australia) (APP1133923, 2016), the Alfred Trauma Service (ATS), and the Australian Football League (AFL). The X2 Biosystems X-Patch devices were purchased on a commercial basis, and no author has any financial interest in the product or distributor of the product. The ATS worked with the investigator team to provide oversight of the project and stakeholder management. The Turner Institute for Brain and Mental Health also provided in-kind support across the course of this study, including research accounting support, high-level stakeholder engagement, attendance at investigator meetings as required, and a research assistant. The AFL provided direct funding to cover the costs of research assistant salaries as well as in-kind support in the form of AFL staff time to educate investigators in relation to current AFL concussion management processes, attend investigator meetings, assist with access to participating clubs, and assist in manuscript preparation. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Australian Football League, 2019, LAWS AUSTR FOOTB; Australian Football League, 2016, OFF AFL LEV 1 COACH; Australian Football League, 2017, 26 ANN AFL INJ SURV; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Black GM, 2018, SCI MED FOOTBALL, V3, P138; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Chahla J, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118791754; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dawson B, 2004, J SCI MED SPORT, V7, P278, DOI 10.1016/S1440-2440(04)80023-9; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Ekegren CL, 2015, CLIN J SPORT MED, V25, P162, DOI 10.1097/JSM.0000000000000108; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gellner RA, 2019, J NEUROSURG-PEDIATR, V24, P47, DOI 10.3171/2019.2.PEDS18176; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; McIntosh AS, 2019, J SCI MED SPORT, V22, P784, DOI 10.1016/j.jsams.2019.02.004; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Vijayakumar V, 2006, MECH SYSTEMS J, V115, P155; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Willmott C, 2018, J SCI MED SPORT, V21, P442, DOI 10.1016/j.jsams.2017.09.591; Wisbey B, 2010, J SCI MED SPORT, V13, P531, DOI 10.1016/j.jsams.2009.09.002; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	53	4	4	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2020	48	6					1485	1495	0363546520912416	10.1177/0363546520912416		APR 2020	11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	LM7BR	WOS:000527124100001	32255667				2022-02-06	
J	July, J; Pranata, R				July, Julius; Pranata, Raymond			Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials	BMC NEUROLOGY			English	Article						Brain trauma; Coagulopathy; Thromboembolism; Tranexamic acid; Traumatic brain injury; Vascular occlusive events	SHOCK	Background This systematic review and meta-analysis aimed to synthesize the latest evidence on the efficacy and safety of tranexamic acid (TXA) on traumatic brain injury (TBI). Methods We performed a systematic literature search on topics that compared intravenous TXA to placebo in patients with TBI up until January 2020 from several electronic databases. Results There were 30.522 patients from 7 studies. Meta-analysis showed that TXA was associated with reduced mortality (RR 0.92 [0.88, 0.97], p = 0.002; I-2: 0%) and hemorrhagic expansion (RR 0.79 [0.64, 0.97], p = 0.03; I-2: 0%). Both TXA and control group has a similar need for neurosurgical intervention (p = 0.87) and unfavourable Glasgow Outcome Scale (GOS) (p = 0.59). The rate for vascular occlusive events (p = 0.09), and its deep vein thrombosis subgroup (p = 0.23), pulmonary embolism subgroup (p = 1), stroke subgroup (p = 0.38), and myocardial infarction subgroup (p = 0.15) were similar in both groups. Subgroup analysis on RCTs with low risk of bias showed that TXA was associated with reduced mortality and hemorrhagic expansion. TXA was associated with reduced vascular occlusive events (RR 0.85 [0.73, 0.99], p = 0.04; I-2: 4%). GRADE was performed for the RCT with low risk of bias subgroup, it showed a high certainty of evidence for lower mortality, less hemorrhage expansion, and similar need for neurosurgical intervention in TXA group compared to placebo group. Conclusion TXA was associated with reduced mortality and hemorrhagic expansion but similar need for neurosurgical intervention and unfavorable GOS. Vascular occlusive events were slightly lower in TXA group on subgroup analysis of RCTs with low risk of bias.	[July, Julius] Pelita Harapan Univ, Siloam Hosp, Med Fac, Neurosci Ctr,Dept Neurosurg, Lippo Village, Tangerang, Indonesia; [Pranata, Raymond] Univ Pelita Harapan, Fac Med, Tangerang, Indonesia		July, J (corresponding author), Pelita Harapan Univ, Siloam Hosp, Med Fac, Neurosci Ctr,Dept Neurosurg, Lippo Village, Tangerang, Indonesia.	juliusjuly@yahoo.com	Pranata, Raymond/M-7898-2018	Pranata, Raymond/0000-0003-3998-6551; July, Julius/0000-0002-1106-0864			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Behravesh Sasan, 2017, Thrombosis, V2017, P3039713, DOI 10.1155/2017/3039713; Chakroun-Walha O, 2019, EUR J TRAUMA EMERG S, V45, P719, DOI 10.1007/s00068-018-0974-z; Chan DYC, 2019, WORLD NEUROSURG, V125, pE665, DOI 10.1016/j.wneu.2019.01.145; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diebel LN, 2017, J TRAUMA ACUTE CARE, V82, P1080, DOI 10.1097/TA.0000000000001445; Draxler DF, 2019, J THROMB HAEMOST, V17, P2174, DOI 10.1111/jth.14603; Draxler DF, 2019, J NEUROTRAUM, V36, P3297, DOI 10.1089/neu.2018.6030; Ebrahimi P, 2019, REV RECENT CLIN TRIA, V14, P286, DOI 10.2174/1574887114666190620112829; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Gall L, 2016, LANCET, V387, P46; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lier H, 2019, ANESTH ANALG, V129, P1574, DOI 10.1213/ANE.0000000000004389; May S, 2019, PREHOSPITAL TRANEXAM; Mousavinejad M, 2020, REV RECENT CLIN TRIA, V15, P70, DOI 10.2174/1574887114666191118111826; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Reed MR, 2015, BJA EDUC, V15, P32, DOI 10.1093/bjaceaccp/mku009; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Teng Y, 2018, EXP ANIM TOKYO, V67, P313, DOI 10.1538/expanim.17-0143; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Yu XB, 2020, J THROMB THROMBOLYS, V50, P243, DOI 10.1007/s11239-019-02034-1; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	28	4	4	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	APR 6	2020	20	1							119	10.1186/s12883-020-01694-4			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LC4CQ	WOS:000525272700005	32252661	Green Published, gold, Green Submitted			2022-02-06	
J	Maekawa, T; Uchida, T; Nakata-Horiuchi, Y; Kobayashi, H; Kawauchi, S; Kinoshita, M; Saitoh, D; Sato, S				Maekawa, Takaaki; Uchida, Takahiro; Nakata-Horiuchi, Yuka; Kobayashi, Hiroaki; Kawauchi, Satoko; Kinoshita, Manabu; Saitoh, Daizoh; Sato, Shunichi			Oral ascorbic acid 2-glucoside prevents coordination disorder induced via laser-induced shock waves in rat brain	PLOS ONE			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GENE-TRANSFER; INJURY; EXPOSURE; INFLAMMATION; APOPTOSIS; SYSTEM; CELLS; MICE	Oxidative stress is considered to be involved in the pathogenesis of primary blast-related traumatic brain injury (bTBI). We evaluated the effects of ascorbic acid 2-glucoside (AA2G), a well-known antioxidant, to control oxidative stress in rat brain exposed to laser-induced shock waves (LISWs). The design consisted of a controlled animal study using male 10-week-old Sprague-Dawley rats. The study was conducted at the University research laboratory. Low-impulse (54 Pa.s) LISWs were transcranially applied to rat brain. Rats were randomized to control group (anesthesia and head shaving, n = 10), LISW group (anesthesia, head shaving and LISW application, n = 10) or LISW + post AA2G group (AA2G administration after LISW application, n = 10) in the first study. In another study, rats were randomized to control group (n = 10), LISW group (n = 10) or LISW + pre and post AA2G group (AA2G administration before and after LISW application, n = 10). The measured outcomes were as follows: (i) motor function assessed by accelerating rotarod test; (ii) levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), an oxidative stress marker; (iii) ascorbic acid in each group of rats. Ascorbic acid levels were significantly decreased and 8-OHdG levels were significantly increased in the cerebellum of the LISW group. Motor coordination disorder was also observed in the group. Prophylactic AA2G administration significantly increased the ascorbic acid levels, reduced oxidative stress and mitigated the motor dysfunction. In contrast, the effects of therapeutic AA2G administration alone were limited. The results suggest that the prophylactic administration of ascorbic acid can reduce shock wave-related oxidative stress and prevented motor dysfunction in rats.	[Maekawa, Takaaki; Uchida, Takahiro; Nakata-Horiuchi, Yuka; Kobayashi, Hiroaki] Japan Ground Self Def Force, Test & Evaluat Command, Mil Med Res Unit, Setagaya Ku, Tokyo, Japan; [Maekawa, Takaaki] Natl Def Med Coll, Dept Internal Med, Div Hematol, Tokorozawa, Saitama, Japan; [Uchida, Takahiro] Tokyo Med Univ, Dept Nephrol, Hachi Med Ctr, Hachioji, Tokyo, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Div Bioinformat & Therapeut Syst, Res Inst, Tokorozawa, Saitama, Japan; [Kinoshita, Manabu] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Div Traumatol, Res Inst, Tokorozawa, Saitama, Japan		Maekawa, T (corresponding author), Japan Ground Self Def Force, Test & Evaluat Command, Mil Med Res Unit, Setagaya Ku, Tokyo, Japan.; Maekawa, T (corresponding author), Natl Def Med Coll, Dept Internal Med, Div Hematol, Tokorozawa, Saitama, Japan.	tmaekawa-ndmc@umin.ac.jp		Maekawa, Takaaki/0000-0002-8611-0862			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Alley M., 2009, THESIS, DOI [10.1089/neu.1994.11.187, DOI 10.1089/NEU.1994.11.187]; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Brown SL, 2010, RADIAT RES, V173, P462, DOI 10.1667/RR1716.1; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Chen X, 2018, BIOMED PHARMACOTHER, V97, P75, DOI 10.1016/j.biopha.2017.10.030; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; de Lanerolle NC, 2015, SEMIN NEUROL, V35, P12, DOI 10.1055/s-0035-1544240; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Gu M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2075463; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ito Y, 2013, INT J MOL SCI, V14, P19618, DOI 10.3390/ijms141019618; Jenkins TG, 2011, FERTIL STERIL, V95, P2001, DOI 10.1016/j.fertnstert.2011.02.023; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Koyama S, 1998, MUTAT RES-FUND MOL M, V421, P45, DOI 10.1016/S0027-5107(98)00153-5; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee S, 2020, ANTIOXID REDOX SIGN, V32, P35, DOI 10.1089/ars.2019.7743; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lindley TE, 2009, AM J PHYSIOL-REG I, V296, pR1, DOI 10.1152/ajpregu.00078.2008; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mathew D, 2007, J RADIAT RES, V48, P369, DOI 10.1269/jrr.07007; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Moretti M, 2017, CNS NEUROSCI THER, V23, P921, DOI 10.1111/cns.12767; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117020; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Satoh Y, 2018, J NEUROPATH EXP NEUR, V77, P827, DOI 10.1093/jnen/nly060; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sorice A, 2014, MINI-REV MED CHEM, V14, P444, DOI 10.2174/1389557514666140428112602; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Toyokuni S, 1997, LAB INVEST, V76, P365; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yamamoto T, 2010, J RADIAT RES, V51, P145, DOI 10.1269/jrr.09078; Zhang JY, 2017, MED GAS RES, V7, P113, DOI 10.4103/2045-9912.208517	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230774	10.1371/journal.pone.0230774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	WOS:000535945000042	32240226	gold, Green Published			2022-02-06	
J	Choi, YI; Kim, YJ; Chung, JW; Kim, KO; Kim, H; Park, RW; Park, DK				Choi, Youn, I; Kim, Yoon Jae; Chung, Jun-Won; Kim, Kyoung Oh; Kim, Hakki; Park, Rae Woong; Park, Dong Kyun			Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study	JMIR MEDICAL INFORMATICS			English	Article						ulcerative colitis; Crohn's disease; early-onset; late-onset; common data model	TRAUMATIC BRAIN-INJURY; CROHNS-DISEASE; DATA ELEMENTS; ULCERATIVE-COLITIS; RISK-FACTORS; GUIDELINES; MANAGEMENT; NATIONWIDE; DIAGNOSIS; TUBERCULOSIS	Background: The Observational Health Data Sciences and Informatics (OHDSI) network is an international collaboration established to apply open-source data analytics to a large network of health databases, including the Korean common data model (K-CDM) network. Objective: The aim of this study is to analyze the effect that age at diagnosis has on the prognosis of inflammatory bowel disease (IBD) in Korea using a CDM network database. Methods: We retrospectively analyzed the K-CDM network database from 2005 to 2015. We transformed the electronic medical record into the CDM version 5.0 used in OHD SI. A worsened IBD prognosis was defined as the initiation of therapy with biologic agents, including infliximab and adalimumab To evaluate the effect that age at diagnosis had on the prognosis of IBD, we divided the patients into an early-onset (EO) IBD group (age at diagnosis <40 years) and a late-onset (LO) IBD group (age at diagnosis >= 40 years) with the cutoff value of age at diagnosis as 40 years, which was calculated using the Youden index method. We then used the logrank test and Cox proportional hazards model to analyze the effect that age at diagnosis (EO group vs LO group) had on the prognosis in patients with IBD. Results: A total of 3480 patients were enrolled. There was 2017 patients with ulcerative colitis (UC) and 1463 with Crohn's disease (CD). The median follow up period was 109.5 weeks. The EO UC group was statistically significant and showed less event-five survival (ie, experiences of biologic agents) than the LO UC group (P<.001). In CD, the EO CD group showed less event-five survival (ie, experiences of biologic agents) than the LO CD group. In the Cox proportional hazard analysis, the odds ratio (OR) of the EO UC group on experiences of biologic agents compared with the LO UC group was 2.3 (95% CI 1.3-3.8, P=.002). The OR of the EO CD group on experiences of biologic agents compared with the LO CD group was 5.4 (95% CI 1.9-14.9, P=.001). Conclusions: The EO IBD group showed a worse prognosis than the LO IBD group in Korean patients with IBD. In addition, this study successfully verified the CDM model in gastrointestinal research.	[Choi, Youn, I; Kim, Yoon Jae; Chung, Jun-Won; Kim, Kyoung Oh; Park, Dong Kyun] Gachon Univ, Coll Internal Med, Gil Med Ctr, Dept Gastroenterol, 21,Namdong Daero 774 Beon Gil, Incheon 405760, South Korea; [Kim, Hakki] Gachon Univ, Hlth IT Res Ctr, Gil Med Ctr, Incheon, South Korea; [Park, Rae Woong] Ajou Med Ctr, Suwon, South Korea		Kim, YJ (corresponding author), Gachon Univ, Coll Internal Med, Gil Med Ctr, Dept Gastroenterol, 21,Namdong Daero 774 Beon Gil, Incheon 405760, South Korea.; Kim, YJ (corresponding author), Gachon Univ, Coll Internal Med, Gil Med Ctr, Dept Gastroenterol, 21,Namdong Daero 774 Beon Gil, Incheon 21565, South Korea.	Yoonmed@gachon.ac.kr	Chung, Jun-Won/AAX-4365-2021; Kim, Yoon Jae/G-6633-2015; Park, Rae Woong/K-8097-2013	Chung, Jun-Won/0000-0002-0869-7661; Kim, Yoon Jae/0000-0001-8477-6823; Kim, Kyoung Oh/0000-0002-5365-2550; Choi, Youn I/0000-0001-6561-6752; Park, Rae Woong/0000-0003-4989-3287	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03034546]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3201]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03034546), and supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C3201).	Amre DK, 2006, AM J GASTROENTEROL, V101, P1005, DOI 10.1111/j.1572-0241.2006.00526.x; Ananthakrishnan AN, 2009, INFLAMM BOWEL DIS, V15, P182, DOI 10.1002/ibd.20628; Baars JE, 2012, J GASTROENTEROL, V47, P1308, DOI 10.1007/s00535-012-0603-2; Baek SJ, 2018, ANN COLOPROCTOL, V34, P299, DOI 10.3393/ac.2018.07.21; Belenkaya R, 2019, STUD HEALTH TECHNOL, V264, P1831, DOI 10.3233/SHTI190670; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Carbonnel F, 2019, J MED INTERNET RES, V21, DOI 10.2196/13606; Choi CH, 2017, INTEST RES, V15, P7, DOI 10.5217/ir.2017.15.1.7; Cohen MZ, 2015, NURS OUTLOOK, V63, P181, DOI 10.1016/j.outlook.2014.11.006; Dulai PS, 2018, GASTROENTEROLOGY, V155, P687, DOI 10.1053/j.gastro.2018.05.039; Everhov AH, 2018, GASTROENTEROLOGY, V154, P518, DOI 10.1053/j.gastro.2017.10.034; Fiske A, 2019, J MED INTERNET RES, V21, DOI 10.2196/11672; Gower-Rousseau C, 2009, AM J GASTROENTEROL, V104, P2080, DOI 10.1038/ajg.2009.177; Hong SJ, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e132; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Hripcsak G, 2016, P NATL ACAD SCI USA, V113, P7329, DOI 10.1073/pnas.1510502113; Huang X, 2015, WORLD J GASTROENTERO, V21, P3650, DOI 10.3748/wjg.v21.i12.3650; Israeli E, 2014, CLIN GASTROENTEROL H, V12, P72, DOI 10.1016/j.cgh.2013.06.027; Jiang Guoqian, 2015, AMIA Annu Symp Proc, V2015, P659; Jung Y, 2016, AM J GASTROENTEROL, V111, P1156, DOI 10.1038/ajg.2016.212; Kamm MA, 2017, LANCET, V390, P2741, DOI 10.1016/S0140-6736(17)32669-7; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Katapally TR, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/14056; Khan NH, 2014, ALIMENT PHARM THER, V40, P374, DOI 10.1111/apt.12834; Kim ES, 2010, GUT LIVER, V4, P1, DOI 10.5009/gnl.2010.4.1.1; Kim HH, 2019, J MED INTERNET RES, V21, DOI 10.2196/14126; Kim M, 2019, JMIR MED INF, V7, DOI 10.2196/14083; Klement E, 2008, AM J GASTROENTEROL, V103, P1775, DOI 10.1111/j.1572-0241.2008.01905.x; Lamb CA, 2019, GUT, V68, pS1, DOI 10.1136/gutjnl-2019-318484; Lee J, 2020, GUT LIVER, V14, P89, DOI 10.5009/gnl19023; Lee JW, 2015, INTEST RES, V13, P213, DOI 10.5217/ir.2015.13.3.213; Lichtenstein GR, 2018, AM J GASTROENTEROL, V113, P481, DOI 10.1038/ajg.2018.27; Salgado VCL, 2017, WORLD J GASTROENTERO, V23, P5549, DOI 10.3748/wjg.v23.i30.5549; Malaty HM, 2016, DIGEST DIS SCI, V61, P861, DOI 10.1007/s10620-015-3930-3; Martins AL, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0822-y; Mavragani A, 2019, JMIR PUBLIC HLTH SUR, V5, P59, DOI 10.2196/13439; Mavragani A, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9366; McPadden J, 2019, J MED INTERNET RES, V21, DOI 10.2196/13043; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Olen O, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3951; Panaccio MP, 2015, CLIN EPIDEMIOL, V7, P77, DOI 10.2147/CLEP.S64936; Park JJ, 2017, INTEST RES, V15, P38, DOI 10.5217/ir.2017.15.1.38; Rubin DT, 2019, AM J GASTROENTEROL, V114, P384, DOI 10.14309/ajg.0000000000000152; Sheehan J, 2016, CLIN TRIALS, V13, P671, DOI 10.1177/1740774516653238; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Tobore I, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/11966; Wu PY, 2017, IEEE T BIO-MED ENG, V64, P263, DOI 10.1109/TBME.2016.2573285; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zheng XC, 2019, J MED INTERNET RES, V21, DOI 10.2196/13583; Zhou XF, 2013, DRUG SAFETY, V36, P119, DOI 10.1007/s40264-012-0009-3; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	53	4	4	1	1	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA		2291-9694		JMIR MED INF	JMIR Med. Inf.	APR	2020	8	4							e15124	10.2196/15124			12	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	LK8CX	WOS:000531089000006	32293578	Green Published, gold			2022-02-06	
J	Krishnamoorthy, V; Chaikittisilpa, N; Lee, JM; Mackensen, GB; Gibbons, EF; Laskowitz, D; Hernandez, A; Velazquez, E; Lele, AV; Vavilala, MS				Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Lee, James; Mackensen, G. Burkhard; Gibbons, Edward F.; Laskowitz, Daniel; Hernandez, Adrian; Velazquez, Eric; Lele, Abhijit V.; Vavilala, Monica S.			Speckle Tracking Analysis of Left Ventricular Systolic Function Following Traumatic Brain Injury: A Pilot Prospective Observational Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; stress cardiomyopathy; echocardiography; trauma	OF-ECHOCARDIOGRAPHYS GUIDELINES; STANDARDS COMMITTEE; DYSFUNCTION; RECOMMENDATIONS; ASSOCIATION; MANAGEMENT	Background: Systolic dysfunction and reduction in left ventricular ejection fraction (LVEF) has been documented after traumatic brain injury (TBI). Speckle tracking is an emerging technology for myocardial strain assessment which has been utilized to identify subclinical myocardial dysfunction, and is most commonly reported as global longitudinal strain (GLS). We examined myocardial strain and regional strain patterns following moderate-severe TBI. Materials and Methods: We conducted a prospective cohort study of moderate-severe TBI patients (Glasgow Coma Scale <= 12) and age/sex-matched controls. Transthoracic echocardiography was performed within the first day and 1 week following TBI. Myocardial function was assessed using both GLS and LVEF, and impaired systolic function was defined as GLS >-16% or LVEF <= 50%. Regional strain patterns and individual strain trajectories were examined. Results: Thirty subjects were included, 15 patients with TBI and 15 age/sex-matched controls. Among patients with adequate echocardiographic windows, systolic dysfunction was observed in 2 (17%) patients using LVEF and 5 (38%) patients using GLS within the first day after TBI. Mean GLS was impaired in patients with TBI compared with controls (-16.4 +/- 3.8% vs. -20.7 +/- 1.8%, P=0.001). Regional myocardial examination revealed impaired strain primarily in the basal and mid-ventricular segments. There was no improvement in GLS from day 1 to day 7 (P=0.81). Conclusions: Myocardial strain abnormalities are common and persist for at least 1 week following moderate-severe TBI. Speckle tracking may be useful for the early diagnosis and monitoring of systolic dysfunction following TBI.	[Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Laskowitz, Daniel] Duke Univ, Dept Neurol, Durham, NC USA; [Hernandez, Adrian] Duke Univ, Dept Internal Med, Div Cardiol, Durham, NC USA; [Mackensen, G. Burkhard; Lele, Abhijit V.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Gibbons, Edward F.] Univ Washington, Dept Cardiol, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Gibbons, Edward F.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Lee, James] Henry Ford Hlth Syst, Dept Internal Med, Div Cardiol, Detroit, MI USA; [Velazquez, Eric] Yale Univ, Dept Internal Med, Div Cardiol, New Haven, CT USA		Krishnamoorthy, V (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	vijay.krishnamoorthy@duke.edu	Mackensen, G. Burkhard/AAJ-3951-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [L30 NS084420]	Supported by NIH L30 NS084420.	Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cinotti R, 2016, INTENS CARE MED, V42, P173, DOI 10.1007/s00134-015-4106-5; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leung DY, 2010, HEART LUNG CIRC, V19, P161, DOI 10.1016/j.hlc.2009.11.006; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Ng PY, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1327-0; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Sanfilippo F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1451-x; TEASDALE G, 1974, LANCET, V2, P81; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	24	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2020	32	2					156	161		10.1097/ANA.0000000000000578			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	LB4DU	WOS:000524587000008	30676403	Green Accepted			2022-02-06	
J	Lanka, P; Rangaprakash, D; Gotoor, SSR; Dretsch, MN; Katz, JS; Denney, TS; Deshpande, G				Lanka, Pradyumna; Rangaprakash, D.; Gotoor, Sai Sheshan Roy; Dretsch, Michael N.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			MALINI (Machine Learning in NeuroImaging): A MATLAB toolbox for aiding clinical diagnostics using resting-state fMRI data	DATA IN BRIEF			English	Article; Data Paper						Resting-state functional MRI; Supervised machine learning; Diagnostic classification; Functional connectivity; Autism; ADHD; Alzheimer's disease; PTSD	FUNCTIONAL MRI; BRAIN NETWORKS; CONNECTIVITY; SOLDIERS; CLASSIFICATION	Resting-state functional Magnetic Resonance Imaging (rs-fMRI) has been extensively used for diagnostic classification because it does not require task compliance and is easier to pool data from multiple imaging sites, thereby increasing the sample size. A MATLAB-based toolbox called Machine Learning in NeuroImaging (MALINI) for feature extraction and disease classification is presented. The MALINI toolbox extracts functional and effective connectivity features from preprocessed rs-fMRI data and performs classification between healthy and disease groups using any of 18 popular and widely used machine learning algorithms that are based on diverse principles. A consensus classifier combining the power of multiple classifiers is also presented. The utility of the toolbox is illustrated by accompanying data consisting of resting-state functional connectivity features from healthy controls and subjects with various brain-based disorders: autism spectrum disorder from autism brain imaging data exchange (ABIDE), Alzheimer's disease and mild cognitive impairment from Alzheimer's disease neuroimaging initiative (ADNI), attention deficit hyperactivity disorder from ADHD-200, and post-traumatic stress disorder and post-concussion syndrome acquired in-house. Results of classification performed on the above datasets can be obtained from the main article titled "Supervised machine learning for diagnostic classification from large-scale neuroimaging datasets" [1]. The data was divided into homogeneous and heterogeneous splits, such that 80% could be used for training, model building and cross-validation, while the remaining 20% of the data could be used as a hold-out independent test data for replication of the classification performance, to ensure the robustness of the classifiers to population variance in image acquisition site and age of the sample. (c) 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Lanka, Pradyumna; Rangaprakash, D.; Gotoor, Sai Sheshan Roy; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, Auburn, AL 36849 USA; [Lanka, Pradyumna] Univ Calif Merced, Dept Psychol Sci, Merced, CA USA; [Rangaprakash, D.] Harvard Med Sch, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02115 USA; [Rangaprakash, D.] MIT, Div Hlth Sci & Technol, Boston, MA USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] US Army, Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis Mcchord, WA USA; [Dretsch, Michael N.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Alabama Adv Imaging Consortium, Birmingham, AL USA; [Deshpande, Gopikrishna] Auburn Univ, Ctr Hlth Ecol & Equ Res, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Ctr Neurosci, Auburn, AL 36849 USA; [Deshpande, Gopikrishna] Natl Inst Mental & Neurosci, Dept Psychiat, Bangalore, Karnataka, India; [Deshpande, Gopikrishna] Capital Normal Univ, Sch Psychol, Beijing, Peoples R China; [Deshpande, Gopikrishna] Capital Normal Univ, Key Lab Learning & Cognit, Beijing, Peoples R China		Deshpande, G (corresponding author), Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, Auburn, AL 36849 USA.	gopi@auburn.edu		Rangaprakash, D/0000-0001-9553-1354	U.S. Army Medical Research and Materiel Command (MRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [00007218]	For the functional connectivity data included with this article, we would like to acknowledge the contributions of International Neuroimaging DataeSharing Initiative (INDI), the organizers of the International ADHD-200 competition and Neurobureau for providing us with access to the ADHD neuroimaging data. We also used data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (adni. loni.usc.edu) database. As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.We would also like to acknowledge the researchers and agencies that contributed to the ABIDE database. Finally, the authors acknowledge financial support for PTSD/PCS data acquisition from the U.S. Army Medical Research and Materiel Command (MRMC) (Grant #00007218). The views, opinions, and/or findings from PTSD/PCS data contained in this article are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. The authors thank the personnel at the TBI clinic and behavioral health clinic, Fort Benning, GA, USA and the US Army Aeromedical Research Laboratory, Fort Rucker, AL, USA, and most of all, the Soldiers who participated in the study. The authors thank Julie Rodiek and Wayne Duggan for facilitating PTSD data acquisition.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Deshpande G, 2012, BRAIN CONNECT, V2, P235, DOI 10.1089/brain.2012.0091; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Huang G, 2015, NEURAL NETWORKS, V61, P32, DOI 10.1016/j.neunet.2014.10.001; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; Jin CF, 2017, HUM BRAIN MAPP, V38, P4479, DOI 10.1002/hbm.23676; Lanka P, 2020, BRAIN IMAGING BEHAV, V14, P2378, DOI 10.1007/s11682-019-00191-8; Libero LE, 2015, CORTEX, V66, P46, DOI 10.1016/j.cortex.2015.02.008; Palaniyappan L, 2019, SCHIZOPHR RES, V214, P24, DOI 10.1016/j.schres.2018.01.006; Rangaprakash D, 2018, DATA BRIEF, V17, P1175, DOI 10.1016/j.dib.2018.01.003; Rangaprakash D, 2018, MAGN RESON MED, V80, P1697, DOI 10.1002/mrm.27146; Rangaprakash D, 2018, HUM BRAIN MAPP, V39, P264, DOI 10.1002/hbm.23841; Rangaprakash D, 2017, NEUROIMAGE-CLIN, V16, P409, DOI 10.1016/j.nicl.2017.07.016; Rangaprakash D, 2017, DATA BRIEF, V14, P558, DOI 10.1016/j.dib.2017.07.072; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Syed MA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00459; Thayananthan A, 2006, LECT NOTES COMPUT SC, V3953, P124; Uddin LQ, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.164; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yousef M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-144; Zhao SN, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00211; Zhao XY, 2019, DATA BRIEF, V22, P570, DOI 10.1016/j.dib.2018.01.080	33	4	4	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-3409			DATA BRIEF	Data Brief	APR	2020	29								105213	10.1016/j.dib.2020.105213			9	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	LI3IE	WOS:000529377400018	32090157	Green Published, gold			2022-02-06	
J	Liu, X; Yang, LF; Cai, WR; Gao, LL; Li, YP				Liu, Xin; Yang, Longfei; Cai, Wenrui; Gao, Linlin; Li, Yaping			Clinical features and visual prognostic indicators after vitrectomy for Terson syndrome	EYE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; VITREOUS HEMORRHAGE; MEMBRANE	Purpose To determine clinical characteristics and identify factors associated with better visual outcomes in patients who had vitrectomy for vitreous haemorrhage (VH) associated with Terson syndrome (TS). Methods The records of 48 patients (54 corresponding eyes) who underwent vitrectomy for VH associated with TS from January 2008 to December 2017 were retrospectively reviewed. The main outcome measure was the final postoperative visual acuity. Results At the last visit, 34 eyes (63.0%) achieved a BCVA of 0.3 or better. Eyes associated with traumatic brain injury had a better visual outcome than those with primary intracerebral haemorrhage (P = 0.042). In the primary intracerebral haemorrhage group, patients with hypertension-induced intracranial haemorrhage (IH) showed poorer final visual acuities than the ruptured intracranial aneurysm group (P = 0.023). In the delayed vitrectomy group, epiretinal membrane and peripheral retina changes were more common (P < 0.05). However, the difference in final visual acuity between the early and delayed vitrectomy groups was not significant (P = 0.69). Conclusion Most of the patients obtained visual recovery after vitrectomy for TS. VH associated with ruptured intracranial aneurysm or traumatic brain injury or eyes without retinal haemorrhage are predictive of better prognosis. Although the timing of vitrectomy was not related to the final postoperative visual outcome, early vitrectomy by three months seems to suggest less epiretinal membrane formation, retinal tears, and retinal detachments.	[Liu, Xin; Cai, Wenrui; Gao, Linlin; Li, Yaping] Jilin Univ, Ctr Eye, Hosp 2, 218 Ziqiang St, Changchun 130000, Jilin, Peoples R China; [Yang, Longfei] Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Hosp 2, 218 Ziqiang St, Changchun 130000, Jilin, Peoples R China		Li, YP (corresponding author), Jilin Univ, Ctr Eye, Hosp 2, 218 Ziqiang St, Changchun 130000, Jilin, Peoples R China.	li_yp2002@163.com	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670	Natural Science Foundation of Jilin Province (Natural Science Foundation of Jilin Province of China) [20180520118JH, 20170414048GH] Funding Source: Medline		Augsten R, 2000, EUR J OPHTHALMOL, V10, P293, DOI 10.1177/112067210001000404; Czorlich P, 2015, NEUROSURG REV, V38, P129, DOI 10.1007/s10143-014-0564-4; Daus W, 1992, Ophthalmologe, V89, P77; Fountas KN, 2008, J NEUROSURG, V109, P439, DOI 10.3171/JNS/2008/109/9/0439; GARFINKLE AM, 1992, J NEUROSURG, V76, P766, DOI 10.3171/jns.1992.76.5.0766; Garweg JG, 2009, ACTA OPHTHALMOL, V87, P222, DOI 10.1111/j.1755-3768.2008.01200.x; Gnanaraj L, 2000, RETINA-J RET VIT DIS, V20, P374, DOI 10.1097/00006982-200007000-00009; He Tao, 2011, Zhonghua Yan Ke Za Zhi, V47, P1096; Hoving EW, 2009, J NEUROSURG, V110, P858, DOI 10.3171/2008.6.17610; Joswig H, 2016, ACTA NEUROCHIR, V158, P1027, DOI 10.1007/s00701-016-2766-8; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Mao XB, 2017, EXP THER MED, V14, P1193, DOI 10.3892/etm.2017.4592; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; Moisseiev E, 2013, EYE, V27, P65, DOI 10.1038/eye.2012.226; Muslubas IS, 2018, GRAEF ARCH CLIN EXP, V256, P503, DOI 10.1007/s00417-017-3887-3; Nacef Leila, 2004, Tunis Med, V82, P461; Narayanan R, 2017, OPHTHALMOLOGY, V124, P118, DOI 10.1016/j.ophtha.2016.09.009; Ness T, 2005, GRAEF ARCH CLIN EXP, V243, P859, DOI 10.1007/s00417-005-1131-z; Ogawa T, 2001, OPHTHALMOLOGY, V108, P1654, DOI 10.1016/S0161-6420(01)00673-X; Ritland JS, 2002, ACTA OPHTHALMOL SCAN, V80, P172, DOI 10.1034/j.1600-0420.2002.800210.x; ROUX FX, 1991, NEUROCHIRURGIE, V37, P106; Sakamoto M, 2010, JPN J OPHTHALMOL, V54, P135, DOI 10.1007/s10384-009-0783-3; SCHULTZ PN, 1991, OPHTHALMOLOGY, V98, P1814; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Sharma T, 2002, OPHTHALMIC SURG LAS, V33, P195; SHAW HE, 1975, AM J OPHTHALMOL, V80, P207, DOI 10.1016/0002-9394(75)90134-8; Srinivasan S, 2006, EYE, V20, P1099, DOI 10.1038/sj.eye.6702134; Stienen MN, 2012, CLIN NEUROL NEUROSUR, V114, P535, DOI 10.1016/j.clineuro.2011.10.034; Terson A, 1900, CLIN OPHTHALMOL, V6, P312; VELIKAY M, 1994, OPHTHALMOLOGY, V101, P35; Yokoi M, 1997, JPN J OPHTHALMOL, V41, P168, DOI 10.1016/S0021-5155(97)00025-7	31	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-222X	1476-5454		EYE	Eye	APR	2020	34	4					650	656		10.1038/s41433-019-0547-3			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	KW9RR	WOS:000521521300009	31455901	Green Published, Bronze			2022-02-06	
J	Lohse, KR; Shen, JC; Kozlowski, AJ				Lohse, Keith R.; Shen, Jincheng; Kozlowski, Allan J.			Modeling Longitudinal Outcomes: A Contrast of Two Methods	JOURNAL OF MOTOR LEARNING AND DEVELOPMENT			English	Article						motor development; motor learning; rehabilitation	TRAUMATIC BRAIN-INJURY; GROWTH; PERFORMANCE; PSYCHOLOGY	Background: Repeated measures analysis of variance (ANOVA) is frequently used to model longitudinal data but does not appropriately account for within-person correlations over time, does not explicitly model time, and cannot flexibly handle missing data. In contrast, mixed-effects regression addresses these limitations. In this commentary, we compare these two methods using openly available tools. Methods: We emulated a real developmental study of elite skiers, tracking national rankings from 2011 to 2018. We constructed unconditional models of time (establishing the "pattern" of change) and conditional models of time (identifying factors that affect change over time), and contrasted these models against comparable repeated measures ANOVAs. Results: Mixed-effects regression allowed for linear and non-linear modeling of the skiers' longitudinal trajectories despite missing data. Missing data is still a concern in mixed-effects regression models, but in the present dataset missingness could be accounted for by skiers' ages, satisfying the missing at random assumption. Discussion: Although ANOVA and mixed-effects regression are both suitable for time-series data, their applications differ. ANOVA will be most parsimonious when the research question focuses on group-level mean differences at arbitrary time points. However, mixed-effects regression is more suitable where time is inherently important to the outcome, and where individual differences are of interest.	[Lohse, Keith R.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA; [Lohse, Keith R.] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84112 USA; [Shen, Jincheng] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Kozlowski, Allan J.] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Kozlowski, Allan J.] Mary Free Bed Rehabil Hosp, John F Butzer Ctr Res & Innovat, Grand Rapids, MI USA		Lohse, KR (corresponding author), Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.; Lohse, KR (corresponding author), Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84112 USA.	rehabinformatics@gmail.com					Angell R.M., 2018, J MOTOR LEARN DEV, V6, P315, DOI [10.1123/jmld.2017-0026, DOI 10.1123/JMLD.2017-0026]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brysbaert Marc, 2018, J Cogn, V1, P9, DOI 10.5334/joc.10; Cantin N, 2014, HUM MOVEMENT SCI, V34, P217, DOI 10.1016/j.humov.2014.02.006; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dixon PC, 2019, HUM MOVEMENT SCI, V66, P504, DOI 10.1016/j.humov.2019.06.002; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; Fawver B, 2020, PSYCHOL SPORT EXERC, V47, DOI 10.1016/j.psychsport.2019.101616; Garcia TP, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0723-4; GREEN BF, 1960, PSYCHOMETRIKA, V25, P127, DOI 10.1007/BF02288577; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hendry DT, 2018, J SPORT SCI, V36, P2009, DOI 10.1080/02640414.2018.1432236; Hill A, 2007, DATA ANAL USING REGR; Hodges NJ, 2004, J EXP PSYCHOL-APPL, V10, P219, DOI 10.1037/1076-898X.10.4.219; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Long J. D., 2012, LONGITUDINAL DATA AN; McClelland GH, 2015, J CONSUM PSYCHOL, V25, P679, DOI 10.1016/j.jcps.2015.05.006; Mirman D, 2014, GROWTH CURVE ANAL VI, P109; Molenberghs G, 2001, STAT MODEL, V1, P235, DOI 10.1177/1471082X0100100402; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; R Core Team, 2019, R LANG ENV STAT COMP; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Westfall J, 2014, J EXP PSYCHOL GEN, V143, P2020, DOI 10.1037/xge0000014; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	30	4	4	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2325-3193	2325-3215		J MOTOR LEARN DEV	J. Motor Learn. Dev.	APR	2020	8	1			1		145	165		10.1123/jmld.2019-0007			21	Psychology, Developmental; Psychology, Experimental; Sport Sciences	Emerging Sources Citation Index (ESCI)	Psychology; Sport Sciences	SV9CI	WOS:000664114500009		Green Submitted			2022-02-06	
J	Morissette, MP; Cordingley, DM; Ellis, MJ; Leiter, JRS				Morissette, Marc P.; Cordingley, Dean M.; Ellis, Michael J.; Leiter, Jeff R. S.			Evaluation of Early Submaximal Exercise Tolerance in Adolescents with Symptomatic Sport-related Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						SPORT-RELATED CONCUSSION; EXERCISE INTOLERANCE; EXERCISE PHYSIOLOGY	CEREBRAL-BLOOD-FLOW; HEART-RATE-VARIABILITY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; MEDICINE; ZURICH	Purpose This study aimed to compare cardiorespiratory response to a graded aerobic exercise challenge between adolescents with symptomatic sport-related concussion (SSRC) and healthy control subjects. Methods A quasiexperimental nonrandomized study at a multidisciplinary pediatric concussion program was conducted. Thirty-four adolescents with SSRC (19 males and 15 females) and 40 healthy control subjects (13 males and 27 females) completed the Buffalo Concussion Treadmill Testing (BCTT) until either symptom exacerbation or volitional fatigue. Main outcome measures included heart rate (HR), oxygen consumption ((V) over dotO(2)), carbon dioxide production ((V) over dotCO(2)), and minute ventilation ((V) over dot(E)) at rest and at test termination, and change from rest in variables (Delta HR, Delta(V) over dotO(2), Delta(V) over dotCO(2), and Delta(V) over dot(E)) during the first five stages of the BCTT. Main outcomes were analyzed using three-way mixed-model ANOVA, with group status (control vs SSRC) and sex (male vs female) as between-subject factors, and time (BCTT stage) as the within-subject factor. Results No group differences in resting HR, systolic and diastolic blood pressure, Delta(V) over dotO(2), (V) over dotCO(2), and (V) over dot(E) were observed. During the first five stages of the BCTT, no group differences in Delta(V) over dotO(2), (V) over dotCO(2), and (V) over dot(E) were observed; however, SSRC patients demonstrated higher RPE (P < 0.0005) compared with control subjects. No sex-based differences were observed among SSRC patients on measures collected at rest and during early stages of BCTT. Conclusions Although SSRC patients exhibited higher RPE during a graded aerobic exercise challenge, no differences in cardiorespiratory response were observed compared with control subjects exercising at equivalent workloads. Further work is needed to elucidate the physiological mechanisms underlying exercise intolerance after SSRC.	[Morissette, Marc P.; Cordingley, Dean M.] Pan Am Clin Fdn, Winnipeg, MB, Canada; [Morissette, Marc P.] Univ Manitoba, Appl Hlth Sci, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Dept Surg & Pediat, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Am Concuss Program, Winnipeg, MB, Canada; [Leiter, Jeff R. S.] Univ Manitoba, Fac Kinesiol & Recreat Management, Winnipeg, MB, Canada		Morissette, MP (corresponding author), 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mmorissette2@panamclinic.com		Morissette, Marc/0000-0002-5342-8938	Pan Am Clinic Foundation; Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR)	The authors acknowledge the Pan Am Clinic Foundation for their financial support of this project, theWinnipeg Regional Health Authority, and Drs. Todd Duhamel, Jason Peeler, and Robert Tate for their assistance with various aspects of this project. M. P. Morissette was supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship.	Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ellis MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01115; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P4; Imhoff S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13131; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lee DK, 2016, KOREAN J ANESTHESIOL, V69, P555, DOI 10.4097/kjae.2016.69.6.555; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Wright AD, 2018, ACTA NEUROCHIR SUPPL, V126, P303, DOI 10.1007/978-3-319-65798-1_59; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	36	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	APR	2020	52	4					820	826		10.1249/MSS.0000000000002198			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LE0GP	WOS:000526403500006	31688644				2022-02-06	
J	Rego, ICQ; Vilarinho, SMM; Rodrigues, CKF; Correia, PVDR; Junqueira, JLC; Oliveira, LB				Rego, Isabel Cristina Quaresma; Vilarinho, Silvia Marques Martins; Rodrigues, Claudia Karolyne Freitas; Correia, Paula Vitoria de Almeida Ramos; Junqueira, Jose Luiz Cintra; Oliveira, Luciana Butini			Oral and cranio-maxillofacial trauma in children and adolescents in an emergency setting at a Brazilian hospital	DENTAL TRAUMATOLOGY			English	Article						adolescents; children; dental trauma; epidemiology; maxillofacial injuries	PEDIATRIC FACIAL FRACTURES; DENTAL INJURIES; TREATMENT PLANS; EPIDEMIOLOGY; NORTHEAST; PATTERNS; OUTCOMES; VIOLENCE; AGE	Background/Aims Very few studies have been performed to evaluate cranio-maxillofacial trauma diagnosed in hospitals in children and adolescents. The aim of this study was to perform an analysis of oral and cranio-maxillofacial trauma in the aforementioned population. Materials and Methods A hospital-based retrospective study, which reviewed 1438 patient records, was conducted at the "Teresina Emergency Hospital", Brazil. Data regarding demographics, day of the week on which trauma occurred, type of injury, etiology, anatomic trauma site, time of hospital admission, and associated comorbidities (or injuries) were collected. Results There were 1092 (75.9%) males and 346 (24.1%) females. The largest group was adolescents aged between 13 and 18 years (956, 66.5%). The majority lived in urban areas (69%). Trauma occurred most frequently during the week. The most prevalent etiology was road traffic accidents involving motorcycles (771, 53.6%) causing facial and skull fractures (598, 41%). The most prevalent soft tissue lesions were facial abrasions (49%), followed by injuries to the cheek (16.7%). Comorbidities associated with craniofacial trauma were present in 82%, with complications from traumatic brain injuries being the most prevalent (65.6%) Dental trauma was recorded in only 81 cases (5.6%). Conclusion Male adolescents living in urban areas were most affected by craniofacial trauma. The most common cause was road traffic accidents involving motorcycles, resulting in facial and skull fractures. Complications from traumatic brain injuries were the most common associated injuries.	[Rego, Isabel Cristina Quaresma; Vilarinho, Silvia Marques Martins; Rodrigues, Claudia Karolyne Freitas; Correia, Paula Vitoria de Almeida Ramos] Uninovafapi, Sch Dent, Teresina, Brazil; [Rego, Isabel Cristina Quaresma; Junqueira, Jose Luiz Cintra; Oliveira, Luciana Butini] Fac Sao Leopoldo Mand, Sch Dent, Campinas, Brazil		Oliveira, LB (corresponding author), Fac Sao Leopoldo Mand, Jose Rocha Junqueira,13, BR-13045755 Campinas, SP, Brazil.	lubutini@uol.com.br	Junqueira, Jose Luiz Cintra/AAR-8797-2020				Abosadegh MM, 2017, DENT TRAUMATOL, V33, P369, DOI 10.1111/edt.12349; Almahdi Hatim M, 2016, BMC Res Notes, V9, P120, DOI 10.1186/s13104-016-1934-5; Boffano P, 2015, OR SURG OR MED OR PA, V119, P499, DOI 10.1016/j.oooo.2014.12.012; Borges TS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172235; Braun TL, 2017, SEMIN PLAST SURG, V31, P118, DOI 10.1055/s-0037-1601380; Bregagnolo Livia Aguiar, 2013, Braz. Dent. J., V24, P397, DOI 10.1590/0103-6440201302227; Cavalcanti Alessandro Leite, 2014, ScientificWorldJournal, V2014, P632720, DOI 10.1155/2014/632720; Cavalcanti AL, 2010, DENT TRAUMATOL, V26, P149, DOI 10.1111/j.1600-9657.2009.00859.x; Chandra SR, 2017, FACIAL PLAST SURG CL, V25, P581, DOI 10.1016/j.fsc.2017.06.009; Choi SC, 2010, DENT TRAUMATOL, V26, P70, DOI 10.1111/j.1600-9657.2009.00840.x; Collao-Gonzalez C, 2014, MED ORAL PATOL ORAL, V19, pE99, DOI 10.4317/medoral.19035; Silva CJD, 2014, CIENC SAUDE COLETIVA, V19, P127, DOI 10.1590/1413-81232014191.2059; El-Menyar A, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0159-9; FARIAS Laís Gonzaga de, 2015, RGO, Rev. Gaúch. Odontol., V63, P19, DOI 10.1590/1981-863720150001000032952; Ferreira P, 2015, BRIT J ORAL MAX SURG, V53, P251, DOI 10.1016/j.bjoms.2014.12.002; Ferreira PC, 2015, J CRANIO MAXILL SURG, V43, P437, DOI 10.1016/j.jcms.2015.01.008; Hashim H, 2011, DENT TRAUMATOL, V27, P19, DOI 10.1111/j.1600-9657.2010.00958.x; Hoppe IC, 2015, J CRANIOFAC SURG, V26, P1446, DOI 10.1097/SCS.0000000000001822; Hoppe IC, 2014, J CRANIO MAXILL SURG, V42, P1408, DOI 10.1016/j.jcms.2014.04.002; Hoppe IC, 2014, J CRANIOFAC SURG, V25, P400, DOI 10.1097/SCS.0000000000000657; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Jung T K, 2015, N Z Dent J, V111, P76; Kim SH, 2012, ARCH PLAST SURG-APS, V39, P606, DOI 10.5999/aps.2012.39.6.606; Kundal Vijay Kumar, 2017, J Indian Assoc Pediatr Surg, V22, P33, DOI 10.4103/0971-9261.194618; da Fonseca RCL, 2019, DENT TRAUMATOL, V35, P171, DOI 10.1111/edt.12469; Lima M, 2015, J DENT APP, V2, P282; Marano AA, 2016, CRANIOMAX TRAUM REC, V9, P35, DOI 10.1055/s-0035-1558453; Miller AF, 2018, PEDIATR EMERG CARE, V34, P21, DOI 10.1097/PEC.0000000000001306; Mosaddad SA, 2018, DENT TRAUMATOL, V34, P347, DOI 10.1111/edt.12428; Munante-Cardenas JL, 2011, J CRANIOFAC SURG, V22, P1251, DOI 10.1097/SCS.0b013e31821c696c; Barbosa K, 2017, ORAL MAXILLOFAC SURG, V21, P131, DOI 10.1007/s10006-017-0610-9; NORONHA CKC, 2011, REV PAN AMAZ SAUDE, V2, P11; Osunde OD, 2013, NIGER J CLIN PRACT, V16, P149, DOI 10.4103/1119-3077.110126; Freitas JPP, 2007, CAD SAUDE PUBLICA, V23, P3055, DOI 10.1590/S0102-311X2007001200028; Ramdas S, 2014, ANN TROP MED PUBLIC, V7, P100, DOI 10.4103/1755-6783.146388; Razak NA, 2017, DENT TRAUMATOL, V33, P400, DOI 10.1111/edt.12355; Ribeiro ALR., 2016, J ORAL MAXIL SURG, V74, P2480; Rocchi G, 2007, J TRAUMA, V62, P404, DOI 10.1097/01.ta.0000197627.05242.a4; Samieirad S, 2017, MED ORAL PATOL ORAL, V22, pE616, DOI 10.4317/medoral.21809; Samieirad S, 2015, MED ORAL PATOL ORAL, V20, pE729, DOI 10.4317/medoral.20652; Soleimani T, 2015, J CRANIO MAXILL SURG, V43, P1979, DOI 10.1016/j.jcms.2015.10.008; Verma S, 2016, J DENT MED SCI, V15, P80; Wong FK, 2016, J CRANIOFAC SURG, V27, P128, DOI 10.1097/SCS.0000000000002185; Yunus SSM, 2015, AM J EMERG MED, V33, P1253, DOI 10.1016/j.ajem.2015.05.009; Zaror C, 2018, COMMUNITY DENT ORAL, V46, P88, DOI 10.1111/cdoe.12333; Zhang QB, 2013, OR SURG OR MED OR PA, V115, P436, DOI 10.1016/j.oooo.2012.04.026; Zhou HH, 2013, INT J PEDIATR OTORHI, V77, P494, DOI 10.1016/j.ijporl.2012.12.017	47	4	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2020	36	2					167	173		10.1111/edt.12515			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KS3BP	WOS:000518184800010	31541558				2022-02-06	
J	Ren, LH; Wang, DD; Liu, X; Yu, HL; Jiang, CY; Hu, YZ				Ren, Lihai; Wang, Dangdang; Liu, Xi; Yu, Huili; Jiang, Chengyue; Hu, Yuanzhi			Influence of Skull Fracture on Traumatic Brain Injury Risk Induced by Blunt Impact	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						blunt impact; head finite element model; skull fracture; traumatic brain injury	HEAD-INJURIES	This study is aimed at investigating the influence of skull fractures on traumatic brain injury induced by blunt impact via numerous studies of head-ground impacts. First, finite element (FE) damage modeling was implemented in the skull of the Total HUman Model for Safety (THUMS), and the skull fracture prediction performance was validated against a head-ground impact experiment. Then, the original head model of the THUMS was assigned as the control model without skull element damage modeling. Eighteen (18) head-ground impact models were established using these two FE head models, with three head impact locations (frontal, parietal, and occipital regions) and three impact velocities (25, 35, and 45 km/h). The predicted maximum principal strain and cumulative strain damage measure of the brain tissue were employed to evaluate the effect of skull fracture on the cerebral contusion and diffuse brain injury risks, respectively. Simulation results showed that the skull fracture could reduce the risk of diffuse brain injury risk under medium and high velocities significantly, while it could increase the risk of brain contusion under high-impact velocity.	[Ren, Lihai; Liu, Xi; Hu, Yuanzhi] China Automot Engn Reasearch Inst Co Ltd, State Key Lab Vehicle NVH & Safety Technol, Chongqing 401122, Peoples R China; [Ren, Lihai; Liu, Xi; Hu, Yuanzhi] Chongqing ChangAn Automobile Co Ltd, Chongqing 401122, Peoples R China; [Ren, Lihai; Wang, Dangdang; Liu, Xi; Jiang, Chengyue; Hu, Yuanzhi] Chongqing Univ Technol, Key Lab Adv Mfg Technol Automobile Parts, Minist Educ, Chongqing 400054, Peoples R China; [Yu, Huili] ChangAn Automobile Co Ltd, Chongqing 400023, Peoples R China		Liu, X (corresponding author), China Automot Engn Reasearch Inst Co Ltd, State Key Lab Vehicle NVH & Safety Technol, Chongqing 401122, Peoples R China.; Liu, X (corresponding author), Chongqing ChangAn Automobile Co Ltd, Chongqing 401122, Peoples R China.; Liu, X (corresponding author), Chongqing Univ Technol, Key Lab Adv Mfg Technol Automobile Parts, Minist Educ, Chongqing 400054, Peoples R China.	lihai.ren@cqut.edu.cn; wangdangdang@2018.cqut.edu.cn; liuxi@cqut.edu.cn; yuhl@changan.com.cn; jiangchengyue@cqut.edu.cn; yuanzhihu@cqut.edu.cn	Wang, Dangdang/AAE-4553-2021		Scientific and Technological Research Program of Chongqing Municipal Commission [KJQN201801107]; Graduate Student Innovation Program of Chongqing University of Technology [ycx20192014]; State Key Laboratory of Vehicle NVH and Safety Technology Open Foundation [NVHSKL-201908]	This research was funded by the Scientific and Technological Research Program of Chongqing Municipal Commission (Grant No. KJQN201801107), Graduate Student Innovation Program of Chongqing University of Technology (Grant No. ycx20192014), and State Key Laboratory of Vehicle NVH and Safety Technology Open Foundation (Grant No. NVHSKL-201908).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmad S, 2018, PAK J MED SCI, V34, P130, DOI 10.12669/pjms.341.13184; Antona-Makoshi J, 2018, ACCIDENT ANAL PREV, V117, P98, DOI 10.1016/j.aap.2018.04.009; Carson HJ, 2009, J FORENSIC LEG MED, V16, P115, DOI 10.1016/j.jflm.2008.08.013; Cheng Y., 2008, THESIS; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Frida A., 2016, THESIS; Grunert J., 2007, APSP32010R APROSYS T, P14; Highway Planning and Design Institute of the Ministry of Transport, 1997, SPEC DES HIGHW ASPH; Huang J, 2018, ACCIDENT ANAL PREV, V119, P91, DOI 10.1016/j.aap.2018.07.012; Jacome-Sosa MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-60; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Li ZP, 2010, J BIOMECH, V43, P228, DOI 10.1016/j.jbiomech.2009.08.040; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Ren LH, 2020, INT J COMP METH-SING, V17, DOI 10.1142/S0219876219500294; Ren LH, 2015, INT J CRASHWORTHINES, V20, P602, DOI 10.1080/13588265.2015.1073132; Sahoo D, 2016, J MECH BEHAV BIOMED, V57, P24, DOI 10.1016/j.jmbbm.2015.11.014; Sahoo D, 2013, J MECH BEHAV BIOMED, V28, P340, DOI 10.1016/j.jmbbm.2013.08.010; Shang S, 2018, ACCIDENT ANAL PREV, V110, P9, DOI 10.1016/j.aap.2017.10.011; Simms CK, 2006, INT J CRASHWORTHINES, V11, P345, DOI 10.1533/ijcr.2005.0109; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; The Ministry of Public Security of the People's Republic of China, 2018, ANN REP ROAD TRAFF A; Toyota Central R&D Laboratories, 2011, TOYOT MOT CORP DOC T, P26; Van Lierde C, 2003, J Appl Biomater Biomech, V1, P194; Wang F, 2020, TRAFFIC INJ PREV, V21, P102, DOI 10.1080/15389588.2019.1680837; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Watanabe R., 2012, ACCID RECONSTR J, V22, P11; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Wood RL, 1981, APPL CONDITIONING TH, P81; World Health Organization, GLOB STAT REP ROAD S; Xu J, 2016, ACCIDENT ANAL PREV, V89, P128, DOI 10.1016/j.aap.2016.01.013; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012; Yu C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020492	40	4	4	3	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2020	17	7							2392	10.3390/ijerph17072392			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	LK3LI	WOS:000530763300224	32244585	Green Published, gold			2022-02-06	
J	Shankar, JJS; Green, R; Virani, K; Wong, H; Eddy, K; Vandorpe, R				Shankar, Jai Jai Shiva; Green, Rob; Virani, Karim; Wong, Helen; Eddy, Katie; Vandorpe, Robert			Admission Perfusion CT for Classifying Early In-Hospital Mortality of Patients With Severe Traumatic Brain Injury: A Pilot Study	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						brain; brainstem death; perfusion CT; pilot study; traumatic brain injury; unenhanced CT	DEATH; EXTRAVASATION	OBJECTIVE. The purposes of this study were to assess the feasibility and safety of perfusion CT of patients with severe traumatic brain injury (TBI) at hospital admission and to examine whether early in-hospital mortality could be characterized with perfusion CT (PCT). The hypothesis was that PCT can be used to characterize brain death, when present, in patients with severe TBI at hospital admission. SUBJECTS AND METHODS. In this prospective cohort pilot study, PCT was performed on patients with severe TBI at first imaging workup at hospital admission. PCT images were processed at the end of the study and assessed for features of brain death. The PCT features were then compared with the clinical outcome of in-hospital mortality. RESULTS. A total of 19 patients (13 men [68.4%]; six women [31.6%]; mean age, 36.4 years; median, 275 years) had a mean hospital stay longer than 1 month. No complications of PCI" were found In the first 48 hours after admission, four patients (21%) died. Admission PCT changes suggesting brainstem death were sensitive (75%) and specific (100%) and had high positive (100%) and negative (93.75%) predictive value for correct classification early in-hospital mortality. CONCLUSION. Admission PCI' of patients with severe TBI was feasible and safe. Admission PCT findings helped in correctly classifying early in-hospital mortality in the first 48 hours of hospital admission.	[Shankar, Jai Jai Shiva; Virani, Karim; Wong, Helen; Eddy, Katie; Vandorpe, Robert] Dalhousie Univ, Dept Diagnost Radiol, Halifax, NS, Canada; [Shankar, Jai Jai Shiva] Univ Manitoba, Rady Fac Hlth Sci, Neuroradiol Sect, Dept Diagnost Imaging, Rm 807K JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P5, Canada; [Green, Rob] Dalhousie Univ, Dept Crit Care, Halifax, NS, Canada; [Green, Rob] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada		Shankar, JJS (corresponding author), Dalhousie Univ, Dept Diagnost Radiol, Halifax, NS, Canada.; Shankar, JJS (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Neuroradiol Sect, Dept Diagnost Imaging, Rm 807K JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P5, Canada.	shivajai1@gmail.com		Shankar, Jai/0000-0002-3707-9723	Nova Scotia Health Research Foundation; Nova Scotia Health Authority Research Foundation; Radiology Research Foundation; Dalhousie University	Supported by a Nova Scotia Health Research Foundation grant, Nova Scotia Health Authority Research Foundation grant, and the Radiology Research Foundation, Dalhousie University.	Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Campbell BCV, 2019, LANCET NEUROL, V18, P46, DOI 10.1016/S1474-4422(18)30314-4; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; Emergency Health Services Nova Scotia Trauma Program, 2014, TRAUM REG REP INJ NO; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Government of Canada, 2014, MAPP CONN UND NEUR C; Hoffmann O, 2015, EUR NEUROL, V74, P11, DOI 10.1159/000431089; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kramer AH, 2014, NEUROCRIT CARE, V21, P539, DOI 10.1007/s12028-014-9997-4; MacDonald D, 2018, J NEUROIMAGING, V28, P374, DOI 10.1111/jon.12516; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; National Scientific Advisory Committee, 2004, ID PRIOR RES CAP DEV; Pavel D, 2006, BRAIN COGNITION, V60, P211; Shankar JJS, 2013, AM J NEURORADIOL, V34, P1175, DOI 10.3174/ajnr.A3376; Shankar JJS, 2018, AM J CARDIOL, V121, P874, DOI 10.1016/j.amjcard.2017.12.027; Shankar JJS, 2016, CAN J NEUROL SCI, V43, P93, DOI 10.1017/cjn.2015.349; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Taylor T, 2014, COCHRANE DB SYST REV, V3; TEASDALE G, 1974, LANCET, V2, P81; Wang CL, 2007, RADIOLOGY, V243, P80, DOI 10.1148/radiol.2431060554; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311	27	4	4	0	0	AMER ROENTGEN RAY SOC	LEESBURG	44211 SLATESTONE CT, LEESBURG, VA USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	APR	2020	214	4					872	876		10.2214/AJR.19.21599			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	KX0ST	WOS:000521594700028	31990213				2022-02-06	
J	Thompson, HJ; Rivara, FP; Wang, J				Thompson, Hilaire J.; Rivara, Frederick P.; Wang, Jin			Effect of Age on Longitudinal Changes in Symptoms, Function, and Outcome in the First Year After Mild-Moderate Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						aged; brain injuries; nursing; outcomes assessment	QUALITY-OF-LIFE; HEALTH SURVEY; RELIABILITY; ADVERSITY; SCALES	OBJECTIVE: The aim of this study was to describe and compare the recovery and disability trajectory at 1 year post injury for younger and older adults with traumatic brain injury (TBI). METHODS: This was a prospective longitudinal cohort study. Individuals 21 years and older with mild to moderate TBI were recruited from the emergency department (n = 33). We measured symptoms, function (Glasgow Outcome Scale-Extended, Functional Status Examination), and health-related quality of life (HRQOL) at 1 week and 1, 3, 6, and 12 months post injury. RESULTS: Whereas the total number of symptoms does not differ between younger and older adults after TBI, the specific constellation of symptoms experienced does. Older adults are more likely to experience physical symptoms such as fatigue, balance, and coordination problems as well as complain of being bothered by noise. Younger adults, in contrast, endorse more psychological symptoms such as anxiety. Functioning as measured by the Glasgow Outcome Scale-Extended and Functional Status Examination was lower in older adults at 1 year post injury. Physical HRQOL was consistently poorer in the year post injury among older adults compared with younger adults after TBI. Mental HRQOL, in contrast, was higher in older adults post TBI at 1 year. CONCLUSIONS: During the first year post TBI, older adults report different symptom clusters than do younger adults post TBI. To foster improved recovery and HRQOL in the older adult post TBI, nursing management strategies should focus on balance, coordination, and energy conservation.	[Thompson, Hilaire J.] Sch Nursing, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Thompson, Hilaire J.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Training Core, Seattle, WA 98122 USA; [Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Pediat Hlth Outcomes Res, Seattle, WA 98195 USA; [Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, Methods Core, Seattle, WA 98195 USA		Thompson, HJ (corresponding author), Sch Nursing, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA.; Thompson, HJ (corresponding author), Harborview Injury Prevent & Res Ctr, Training Core, Seattle, WA 98122 USA.	hilairet@uw.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [KL2RR025015]; Fagin Fellowship [06-202]	This study was supported by the National Institutes of Health KL2RR025015 and a John A. Hartford Foundation ClaireM. Fagin Fellowship 06-202, both to H.J.T.	Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Burns ER., 2015, CDC COMPENDIUM EFFEC; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gijzel SMW, 2019, J AM GERIATR SOC, V67, P2650, DOI 10.1111/jgs.16149; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hildon Z, 2010, GERONTOLOGIST, V50, P36, DOI 10.1093/geront/gnp067; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Rapport LJ, 2020, DISABIL REHABIL, V42, P2049, DOI 10.1080/09638288.2018.1552327; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Seery MD, 2010, J PERS SOC PSYCHOL, V99, P1025, DOI 10.1037/a0021344; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	4	4	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2020	52	2					46	52		10.1097/JNN.0000000000000498			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	LE4PN	WOS:000526701800003	32032276	Green Accepted			2022-02-06	
J	Zhao, JJ; Liu, ZW; Wang, B; Huang, TQ; Guo, D; Zhao, YL; Song, JN				Zhao, Jun-Jie; Liu, Zun-Wei; Wang, Bo; Huang, Ting-Qin; Guo, Dan; Zhao, Yong-Lin; Song, Jin-Ning			Inhibiting endogenous tissue plasminogen activator enhanced neuronal apoptosis and axonal injury after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						apoptosis; astrocytes; axonal injury; inflammation; microglia; nerve regeneration; neural regeneration; neuronal injury; neurons; neuroserpin; tissue plasminogen activator; traumatic brain injury	MICROGLIAL ACTIVATION; PATTERNS; DEFICITS; BARRIER; PROTEIN; STROKE	Tissue plasminogen activator is usually used for the treatment of acute ischemic stroke, but the role of endogenous tissue plasminogen activator in traumatic brain injury has been rarely reported. A rat model of traumatic brain injury was established by weight-drop method. The tissue plasminogen activator inhibitor neuroserpin (5 mu L, 0.25 mg/mL) was injected into the lateral ventricle. Neurological function was assessed by neurological severity score. Neuronal and axonal injuries were assessed by hematoxylin-eosin staining and Bielschowsky silver staining. Protein level of endogenous tissue plasminogen activator was analyzed by western blot assay. Apoptotic marker cleaved caspase-3, neuronal marker neurofilament light chain, astrocyte marker glial fibrillary acidic protein and microglial marker Iba-1 were analyzed by immunohistochemical staining. Apoptotic cell types were detected by immunofluorescence double labeling. Apoptotic cells in the damaged cortex were detected by terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP-biotin nick-end labeling staining. Degenerating neurons in the damaged cortex were detected by Fluoro-Jade B staining. Expression of tissue plasminogen activator was increased at 6 hours, and peaked at 3 days after traumatic brain injury. Neuronal apoptosis and axonal injury were detected after traumatic brain injury. Moreover, neuroserpin enhanced neuronal apoptosis, neuronal injury and axonal injury, and activated microglia and astrocytes. Neuroserpin further deteriorated neurobehavioral function in rats with traumatic brain injury. Our findings confirm that inhibition of endogenous tissue plasminogen activator aggravates neuronal apoptosis and axonal injury after traumatic brain injury, and activates microglia and astrocytes. This study was approved by the Biomedical Ethics Committee of Animal Experiments of Shaanxi Province of China in June 2015.	[Zhao, Jun-Jie; Wang, Bo; Song, Jin-Ning] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Liu, Zun-Wei] Xi An Jiao Tong Univ, Inst Organ Transplantat, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Liu, Zun-Wei] Xi An Jiao Tong Univ, Nephropathy Hosp, Dept Renal Transplantat, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Huang, Ting-Qin] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Guo, Dan] Xian Med Univ, Dept Sci & Technol, Xian, Shaanxi, Peoples R China; [Zhao, Yong-Lin] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	jinningsong@126.com					Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Bertrand T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.296; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Fan X, 2017, TRANSL STROKE RES, V8, P549, DOI 10.1007/s12975-017-0542-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Huang TQ, 2018, NEUROREPORT, V29, P661, DOI [10.1097/WNR.0000000000001015, 10.1097/wnr.0000000000001015]; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Lee HY, 2007, J NEUROCHEM, V101, P1236, DOI 10.1111/j.1471-4159.2007.04417.x; Lee RHC, 2018, NEURAL REGEN RES, V13, P373, DOI 10.4103/1673-5374.228711; Liot G, 2006, J NEUROCHEM, V98, P1458, DOI 10.1111/j.1471-4159.2006.03982.x; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Nagai K, 2017, J NEUROL SCI, V382, P101, DOI 10.1016/j.jns.2017.09.042; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Qin J, 2015, ZHONGGUO ZUZHI GONGC, V19, P7292; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reumann R, 2017, LEARN MEMORY, V24, P650, DOI 10.1101/lm.045864.117; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Saber H, 2019, STROKE, V50, P683, DOI 10.1161/STROKEAHA.118.023967; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sherchan P, 2016, NEUROBIOL DIS, V85, P164, DOI 10.1016/j.nbd.2015.11.003; Siao CJ, 2002, J NEUROSCI, V22, P3352; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Simon F, 2019, NEURAL REGEN RES, V14, P1309, DOI 10.4103/1673-5374.253507; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; The Ministry of Science and Technology of the People's Republic of China, 1988, REG ADM AFF EXP AN 1; Vivien D, 2012, NAT REV NEUROL, V8, P538, DOI 10.1038/nrneurol.2012.192; Wang T, 2019, ZHONGGUO ZUZHI GONGC, V23, P3998; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012; Wu L, 2021, J NEUROTRAUM, V38, P1450, DOI 10.1089/neu.2017.5607; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhao YL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4706915	47	4	6	3	36	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2020	15	4					667	675		10.4103/1673-5374.266914			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	JW7OL	WOS:000503237500012	31638090	gold, Green Published			2022-02-06	
J	Gao, J; Su, G; Liu, JF; Zhang, JJ; Zhou, JP; Liu, XY; Tian, Y; Zhang, ZC				Gao, Juan; Su, Gang; Liu, Jifei; Zhang, Jiajia; Zhou, Juanping; Liu, Xiaoyan; Tian, Ye; Zhang, Zhenchang			Mechanisms of Inhibition of Excessive Microglial Activation by Melatonin	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Melatonin; Microglia; Inflammation; Oxidative stress; Apoptosis	TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAY; OXIDATIVE STRESS; INFLAMMATORY CYTOKINES; BV2 MICROGLIA; PROTECTS; CELLS; MAPK; RATS; NEUROINFLAMMATION	As the innate immune cells that permanently reside in the central nervous system (CNS), microglia play an increasingly important role in maintaining brain function. Normally, microglia act as resting phenotype, which can be activated by various types of stimuli and release a variety of inflammatory mediators. Melatonin is an endogenous rhythmic hormone secreted principally by the pineal gland. Increasing evidence suggests that melatonin can detoxify reactive oxygen species (ROS) and prevent microglia from over-activation. This review summarizes the mechanisms of melatonin in inhibiting excessive activation of microglia and demonstrates the feasibility of melatonin in the treatment of diseases related to microglial over-activation.	[Gao, Juan; Liu, Jifei; Zhang, Jiajia; Zhou, Juanping; Liu, Xiaoyan; Tian, Ye; Zhang, Zhenchang] Lanzhou Univ, Dept Neurol, Hosp 2, Lanzhou 730030, Gansu, Peoples R China; [Su, Gang] Lanzhou Univ, Sch Basic Med Sci, Inst Genet, Lanzhou 730000, Gansu, Peoples R China		Zhang, ZC (corresponding author), Lanzhou Univ, Dept Neurol, Hosp 2, Lanzhou 730030, Gansu, Peoples R China.	tougao13893647595@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31870335]; Health Industry Planning Project of Gansu Provincial Health and Family Planning Commission [GSWSKY 2016-17]; Science and Technology Major Special Collaboration Project of Gansu Provincial Key Laboratory of Gene Function [BA2016036]; "Cuiying Technology Innovation" Planning Project of Lanzhou University Second Hospital [CY2017-MS19]; Cuiying Graduate Supervisor Applicant Training Program Of Lanzhou University Second Hospital [201802]; Key Laboratory of Biotherapy and Regenerative Medicine, Gansu Province [zdsyskfkt201703]	This work was supported by the National Natural Science Foundation of China (31870335); the Health Industry Planning Project of Gansu Provincial Health and Family Planning Commission (GSWSKY 2016-17); the Science and Technology Major Special Collaboration Project of Gansu Provincial Key Laboratory of Gene Function (BA2016036); the "Cuiying Technology Innovation" Planning Project of Lanzhou University Second Hospital (CY2017-MS19); Cuiying Graduate Supervisor Applicant Training Program Of Lanzhou University Second Hospital (201802); and the Key Laboratory of Biotherapy and Regenerative Medicine, Gansu Province (zdsyskfkt201703).	Ali T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1157-x; Amati AL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1434872; Ano Y, 2020, CURR ALZHEIMER RES, V17, P52, DOI 10.2174/1567205017666200212160343; Arioz BI, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01511; Biber K, 2002, CURR OPIN PHARMACOL, V2, P63, DOI 10.1016/S1471-4892(01)00122-9; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cao Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186764; Carrascal L, 2018, CURR PHARM DESIGN, V24, P1563, DOI 10.2174/1381612824666180426112832; Chaturantabut S, 2019, GASTROENTEROLOGY, V156, P1788, DOI 10.1053/j.gastro.2019.01.010; Cheng JB, 2017, CELL DEATH DIFFER, V24, P276, DOI 10.1038/cdd.2016.121; Chiang RPY, 2013, J PINEAL RES, V54, P232, DOI 10.1111/jpi.12029; Cianciulli A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010137; Ciechanowska A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151911; Cosin-Roger J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00213-3; Dai JP, 2018, INT IMMUNOPHARMACOL, V54, P177, DOI 10.1016/j.intimp.2017.11.009; De Simone R, 2015, J NEUROCHEM, V135, P147, DOI 10.1111/jnc.13244; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; do Amaral FG, 2018, ARCH ENDOCRIN METAB, V62, P472, DOI 10.20945/2359-3997000000066; Rubio APD, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12439; Dong L, 2016, CNS NEUROSCI THER, V22, P661, DOI 10.1111/cns.12557; Du Y, 2017, J CEREBR BLOOD F MET, V37, P1425, DOI 10.1177/0271678X16656199; Han CJ, 2019, ACTA PHARMACOL SIN, V40, P1292, DOI 10.1038/s41401-019-0225-9; Han DX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0236-8; Hassan S, 2020, J ETHNOPHARMACOL, V254, DOI 10.1016/j.jep.2020.112710; Hattori Yorito, 2016, Nihon Rinsho, V74, P589; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hong Y, 2010, J PINEAL RES, V49, P201, DOI 10.1111/j.1600-079X.2010.00786.x; Hopp SC, 2021, J NEUROSCI RES, V99, P141, DOI 10.1002/jnr.24585; Hou LY, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101134; Hu L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212138; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu YY, 2017, ONCOTARGET, V8, P31638, DOI 10.18632/oncotarget.15780; Jang MH, 2005, NEUROSCI LETT, V380, P26, DOI 10.1016/j.neulet.2005.01.003; Kata D, 2017, BRAIN RES BULL, V132, P61, DOI 10.1016/j.brainresbull.2017.05.009; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lam JS, 2014, METHODS MOL BIOL, V1149, P375, DOI 10.1007/978-1-4939-0473-0_31; Lawrimore CJ, 2017, ALCOHOL CLIN EXP RES, V41, P939, DOI 10.1111/acer.13368; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lim JL, 2014, ARCH TOXICOL, V88, P1773, DOI 10.1007/s00204-014-1338-z; Lin CC, 2017, NEUROUROL URODYNAM, V36, P1988, DOI 10.1002/nau.23234; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu CH, 2016, HISTOCHEM CELL BIOL, V146, P599, DOI 10.1007/s00418-016-1470-3; Lu JN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01360; Lu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178098; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Mohebiany AN, 2020, CELL REP, V30, P1585, DOI 10.1016/j.celrep.2019.12.097; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Okorji UP, 2016, MOL NEUROBIOL, V53, P6426, DOI 10.1007/s12035-015-9543-1; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Park BK, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/7585896; Park E, 2017, NEUROCHEM RES, V42, P656, DOI 10.1007/s11064-016-2122-7; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; Peruzzotti-Jametti L, 2018, TRENDS MOL MED, V24, P838, DOI 10.1016/j.molmed.2018.07.007; Qin C, 2017, STROKE, V48, P3336, DOI 10.1161/STROKEAHA.117.018505; Radogna F, 2006, ANN NY ACAD SCI, V1090, P226, DOI 10.1196/annals.1378.025; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Reiter RJ, 2017, CELL MOL LIFE SCI, V74, P3863, DOI 10.1007/s00018-017-2609-7; Sarra GM, 2005, OPHTHAL RES, V37, P72, DOI 10.1159/000084248; Shah SA, 2017, CNS NEUROSCI THER, V23, P33, DOI 10.1111/cns.12588; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Singh J, 2006, BRAIN RES BULL, V69, P37, DOI 10.1016/j.brainresbull.2005.10.011; Sinha B, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12443; Slusarczyk J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071965; Soni D, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0056-3; Tocharus J, 2010, J PINEAL RES, V48, P347, DOI 10.1111/j.1600-079X.2010.00761.x; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Tvrdik P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112366; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wang CG, 2018, J CELL MOL MED, V22, P1148, DOI 10.1111/jcmm.13368; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wang Z, 2013, PHARMACOL RES, V76, P84, DOI 10.1016/j.phrs.2013.07.008; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Waseem M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180953; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Wu UI, 2011, J PINEAL RES, V50, P159, DOI 10.1111/j.1600-079X.2010.00825.x; Xue JF, 2017, BIOMED PHARMACOTHER, V89, P1252, DOI 10.1016/j.biopha.2017.01.130; Yan AJ, 2017, MOL MED REP, V16, P2491, DOI 10.3892/mmr.2017.6884; Yan L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/895975; Yao K, 2020, INFLAMMOPHARMACOLOGY, V28, P95, DOI 10.1007/s10787-019-00613-5; Yao LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166010; Zhang Y, 2019, J NEUROSCI RES, V97, P733, DOI 10.1002/jnr.24409; Zhou JF, 2008, J PINEAL RES, V45, P157, DOI 10.1111/j.1600-079X.2008.00570.x	86	4	4	2	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	AUG	2020	70	8					1229	1236		10.1007/s12031-020-01531-w		MAR 2020	8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MJ2FR	WOS:000522027800001	32222896				2022-02-06	
J	Kudryashev, JA; Waggoner, LE; Leng, HT; Mininni, NH; Kwon, EJ				Kudryashev, Julia A.; Waggoner, Lauren E.; Leng, Hope T.; Mininni, Nicholas H.; Kwon, Ester J.			An Activity-Based Nanosensor for Traumatic Brain Injury	ACS SENSORS			English	Article						traumatic brain injury; activity-based nanosensor; nanomedicine; calpain-1; protease activity	CORTICAL IMPACT; MU-CALPAIN; SPECTRIN; RAT; PERMEABILITY; EXPRESSION; MOLECULES; BARRIER; FLUID	Currently, traumatic brain injury (TBI) is detected by medical imaging; however, medical imaging requires expensive capital equipment, is time- and resource-intensive, and is poor at predicting patient prognosis. To date, direct measurement of elevated protease activity has yet to be utilized to detect TBI. In this work, we engineered an activity-based nanosensor for TBI (TBI-ABN) that responds to increased protease activity initiated after brain injury. We establish that a calcium-sensitive protease, calpain-1, is active in the injured brain hours within injury. We then optimize the molecular weight of a nanoscale polymeric carrier to infiltrate into the injured brain tissue with minimal renal filtration. A calpain-1 substrate that generates a fluorescent signal upon cleavage was attached to this nanoscale polymeric carrier to generate an engineered TBI-ABN. When applied intravenously to a mouse model of TBI, our engineered sensor is observed to locally activate in the injured brain tissue. This TBI-ABN is the first demonstration of a sensor that responds to protease activity to detect TBI.	[Kudryashev, Julia A.; Leng, Hope T.; Mininni, Nicholas H.; Kwon, Ester J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Waggoner, Lauren E.] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA		Kwon, EJ (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	ejkwon@ucsd.edu		Waggoner, Lauren/0000-0001-8641-0577; Kwon, Ester/0000-0002-6335-9681; Kudryashev, Julia/0000-0003-3022-0058	National Science Foundation (NSF) Graduate Research Fellowship ProgramNational Science Foundation (NSF) [DGE-1650112]	J.A.K. is supported by the National Science Foundation (NSF) Graduate Research Fellowship Program under Grant No. DGE-1650112. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Boyd BJ, 2015, J DRUG TARGET, V23, P847, DOI 10.3109/1061186X.2015.1034280; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dudani JS, 2018, P NATL ACAD SCI USA, V115, P8954, DOI 10.1073/pnas.1805337115; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Kwon EJ, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0054; Kwon EJ, 2016, ACS NANO, V10, P7926, DOI 10.1021/acsnano.6b03858; Kwong GA, 2015, P NATL ACAD SCI USA, V112, P12627, DOI 10.1073/pnas.1506925112; Kwong GA, 2013, NAT BIOTECHNOL, V31, P63, DOI 10.1038/nbt.2464; Levesque S, 2010, BRAIN, V133, P808, DOI 10.1093/brain/awp333; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Mitala CM, 2008, J NEUROSCI METH, V174, P177, DOI 10.1016/j.jneumeth.2008.06.034; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Price L., 2016, TRANSLATIONAL RES TR, P85; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Stockholm D, 2005, J MOL BIOL, V346, P215, DOI 10.1016/j.jmb.2004.11.039; Thorek DLJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2335; Urano Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002823; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Whitley MJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0293; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	42	4	4	3	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2379-3694			ACS SENSORS	ACS Sens.	MAR 27	2020	5	3					686	692		10.1021/acssensors.9b01812			7	Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics	LD9XC	WOS:000526377600010	32100994	Green Submitted, Green Accepted			2022-02-06	
J	Li, MF; Reisman, J; Morris-Eppolito, B; Qian, SX; Kazis, LE; Wolozin, B; Goldstein, LE; Xia, WM				Li, Mingfei; Reisman, Joel; Morris-Eppolito, Benjamin; Qian, Shirley X.; Kazis, Lewis E.; Wolozin, Benjamin; Goldstein, Lee E.; Xia, Weiming			Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer's disease after traumatic brain injury	ALZHEIMERS RESEARCH & THERAPY			English	Article						Alzheimer's disease; Traumatic brain injury; Statins; Angiotensin-converting enzyme inhibitors; Treatment; Prevention	HEAD-INJURY; RISK-FACTOR; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; PRECISION MEDICINE; ADULT CHANGES; IN-VITRO; DEMENTIA; CHOLESTEROL; PREVALENCE	Background Pathological analysis of brain tissue from animals and humans with a history of traumatic brain injury (TBI) suggests that TBI could be one of the risk factors facilitating onset of dementia with possible Alzheimer's disease (AD), but medications to prevent or delay AD onset are not yet available. Methods This study explores four medication classes (angiotensin-converting enzyme inhibitors (ACEI), beta blockers, metformin, and statins) approved by the Food and Drug Administration (FDA) for other indications and evaluates their influence when used in combination on the risk of possible AD development for patients with a history of TBI. We identified patients with history of TBI from an existing Department of Veterans Affairs (VA) national database. Among 1,660,151 veterans who used VA services between the ages of 50 to 89 years old, we analyzed 733,920 patients, including 15,450 patients with a history of TBI and 718,470 non-TBI patients. The TBI patients were followed for up to 18.5 years, with an average of 7.7 +/- 4.7 years, and onset of dementia with possible AD was recorded based on International Statistical Classification of Diseases (ICD) 9 or 10 codes. The effect of TBI on possible AD development was evaluated by multivariable logistic regression models adjusted by age, gender, race, and other comorbidities. The association of ACEI, beta blockers, metformin, statins, and combinations of these agents over time from the first occurrence of TBI to possible AD onset was assessed using Cox proportional hazard models adjusted for demographics and comorbidities. Results Veterans with at least two TBI occurrences by claims data were 25% (odds ratio (OR) = 1.25, 95% confidence intervals (CI) (1.13, 1.37)) more likely to develop dementia with possible AD, compared to those with no record of TBI. In multivariable logistic regression models (propensity score weighted or adjusted), veterans taking a combination of ACEI and statins had reduced risk in developing possible AD after suffering TBI, and use of this medication class combination was associated with a longer period between TBI occurring and dementia with possible AD onset, compared to patients who took statins alone or did not take any of the four target drugs after TBI. Conclusions The combination of ACEI and statins significantly lowered the risk of development of dementia with possible AD in a national cohort of people with a history of TBI, thus supporting a clinical approach to lowering the risk of dementia with possible AD.	[Li, Mingfei; Reisman, Joel; Qian, Shirley X.; Kazis, Lewis E.] Edith Nourse Rogers Mem Hosp, Ctr Healthcare Org & Implementat, Bedford, MA USA; [Li, Mingfei] Bentley Univ, Dept Math Sci, Waltham, MA USA; [Morris-Eppolito, Benjamin; Xia, Weiming] Edith Nourse Rogers Mem Vet Hosp, Geriatr Res Educ Clin Ctr, Bedford, MA 01730 USA; [Qian, Shirley X.; Kazis, Lewis E.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Wolozin, Benjamin; Xia, Weiming] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Elect Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Comp Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Photon Ctr, Boston, MA USA; [Goldstein, Lee E.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA		Xia, WM (corresponding author), Edith Nourse Rogers Mem Vet Hosp, Geriatr Res Educ Clin Ctr, Bedford, MA 01730 USA.; Xia, WM (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	weiming.xia@va.gov			Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [I21BX002215, I21BX003807, IO1 BX003527]; National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG063913]; Cure Alzheimer's Fund	This study was supported by the award I21BX002215, I21BX003807 and IO1 BX003527 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (WX), R01AG063913 from National Institute on Aging, NIH (WX, LEG), and the Cure Alzheimer's Fund (WX).	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexopoulos P, 2018, J NEURAL TRANSM, V125, P193, DOI 10.1007/s00702-017-1810-z; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BARNES NM, 1991, EUR J PHARMACOL, V200, P289, DOI 10.1016/0014-2999(91)90584-D; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Burke SL, 2018, AGING MENT HEALTH, V22, P1577, DOI 10.1080/13607863.2017.1387760; Chantrill LA, 2015, CLIN CANCER RES, V21, P2029, DOI 10.1158/1078-0432.CCR-15-0426; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; COX DR, 1972, J R STAT SOC B, V34, P187; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Farr SA, 2019, J ALZHEIMERS DIS, V68, P1699, DOI 10.3233/JAD-181240; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hampel H, 2016, J Prev Alzheimers Dis, V3, P243, DOI 10.14283/jpad.2016.112; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li NC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5465; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Miners JS, 2008, NEUROPATH APPL NEURO, V34, P181, DOI 10.1111/j.1365-2990.2007.00885.x; Miners S, 2009, AM J TRANSL RES, V1, P163; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Rabinovici Gil D, 2017, Alzheimers Dement (N Y), V3, P83, DOI 10.1016/j.trci.2016.09.002; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; SantaCruz KS, 2011, J NEUROPATH EXP NEUR, V70, P832, DOI 10.1097/NEN.0b013e31822e8ae9; Scheen AJ, 2016, DIABETES RES CLIN PR, V117, P12, DOI 10.1016/j.diabres.2016.04.033; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Singh B, 2013, J RENIN-ANGIO-ALDO S, V14, P124, DOI 10.1177/1470320312459977; Sonnen JA, 2009, J ALZHEIMERS DIS, V18, P703, DOI 10.3233/JAD-2009-1180; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weinstein G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212293; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193	70	4	4	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1758-9193		ALZHEIMERS RES THER	Alzheimers Res. Ther.	MAR 27	2020	12	1							33	10.1186/s13195-020-00589-3			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY1TB	WOS:000522353200001	32220235	Green Published, gold			2022-02-06	
J	Todorov, H; Searle-White, E; Gerber, S				Todorov, Hristo; Searle-White, Emily; Gerber, Susanne			Applying univariate vs. multivariate statistics to investigate therapeutic efficacy in (pre)clinical trials: A Monte Carlo simulation study on the example of a controlled preclinical neurotrauma trial	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; ANIMAL-MODELS; EXPERIMENTAL STROKE; ISCHEMIC-STROKE; PLASTICITY; PATHOPHYSIOLOGY; INFLAMMATION; METAANALYSIS; DISCOVERY	Background Small sample sizes combined with multiple correlated endpoints pose a major challenge in the statistical analysis of preclinical neurotrauma studies. The standard approach of applying univariate tests on individual response variables has the advantage of simplicity of interpretation, but it fails to account for the covariance/correlation in the data. In contrast, multivariate statistical techniques might more adequately capture the multi-dimensional pathophysiological pattern of neurotrauma and therefore provide increased sensitivity to detect treatment effects. Results We systematically evaluated the performance of univariate ANOVA, Welch's ANOVA and linear mixed effects models versus the multivariate techniques, ANOVA on principal component scores and MANOVA tests by manipulating factors such as sample and effect size, normality and homogeneity of variance in computer simulations. Linear mixed effects models demonstrated the highest power when variance between groups was equal or variance ratio was 1:2. In contrast, Welch's ANOVA outperformed the remaining methods with extreme variance heterogeneity. However, power only reached acceptable levels of 80% in the case of large simulated effect sizes and at least 20 measurements per group or moderate effects with at least 40 replicates per group. In addition, we evaluated the capacity of the ordination techniques, principal component analysis (PCA), redundancy analysis (RDA), linear discriminant analysis (LDA), and partial least squares discriminant analysis (PLS-DA) to capture patterns of treatment effects without formal hypothesis testing. While LDA suffered from a high false positive rate due to multicollinearity, PCA, RDA, and PLS-DA were robust and PLS-DA outperformed PCA and RDA in capturing a true treatment effect pattern. Conclusions Multivariate tests do not provide an appreciable increase in power compared to univariate techniques to detect group differences in preclinical studies. However, PLS-DA seems to be a useful ordination technique to explore treatment effect patterns without formal hypothesis testing.	[Todorov, Hristo; Gerber, Susanne] Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, Fac Biol, Mainz, Germany; [Todorov, Hristo] Fresenius Kabi Deutschland GmbH, Oberursel, Germany; [Searle-White, Emily] Johannes Gutenberg Univ Mainz, Inst Math, Mainz, Germany		Gerber, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, Fac Biol, Mainz, Germany.	sugerber@uni-mainz.de	Gerber, Susanne/I-6352-2018	Gerber, Susanne/0000-0001-9513-0729	Fresenius Kabi Deutschland GmbH [CRC 1193]; Center for Computational Sciences in Mainz (CSM)	The work of HT was funded by Fresenius Kabi Deutschland GmbH. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The work of SG was partly supported by the CRC 1193. ESW was supported by Center for Computational Sciences in Mainz (CSM). The funder provided support in the form of salaries for author HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of all authors are articulated in the `author contributions' section.	Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Batchelor PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072659; Bath PMW, 2009, BRIT J PHARMACOL, V157, P1157, DOI 10.1111/j.1476-5381.2009.00196.x; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Blanca MJ, 2018, BEHAV RES METHODS, V50, P937, DOI 10.3758/s13428-017-0918-2; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Cohen J., 2013, STAT POWER ANAL BEHA; Couillard-Despres S, 2017, NEUROLOGICAL ASPECTS; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Everitt JI, 2015, TOXICOL PATHOL, V43, P70, DOI 10.1177/0192623314555162; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Finch W. H., 2007, MULTIPLE LINEAR REGR, V33, P12; Fitts DA, 2011, J AM ASSOC LAB ANIM, V50, P445; Frizzell JP, 2005, AACN ADV CRIT CARE, V16, P421, DOI 10.1097/00044067-200510000-00002; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Hotelling H, 1951, P 2 BERK S MATH STAT; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim YH, 2017, CLIN ORTHOP SURG, V9, P1, DOI 10.4055/cios.2017.9.1.1; Kropf S., 1997, DRUG INF J, V31, P433; Laajala TD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30723; Laban KG, 2015, J CEREBR BLOOD F MET, V35, P1085, DOI 10.1038/jcbfm.2015.89; Lee J., 2015, SURGERY, V33, P238, DOI [10.1016/j.mpsur.2015.04.003, DOI 10.1016/J.MPSUR.2015.04.003]; Liu XZ, 1997, J NEUROSCI, V17, P5395; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maysami S, 2016, J CEREBR BLOOD F MET, V36, P596, DOI 10.1177/0271678X15606714; McCann SK, 2016, TRANSL STROKE RES, V7, P395, DOI 10.1007/s12975-016-0489-z; McCann SK, 2014, STROKE, V45, P3055, DOI 10.1161/STROKEAHA.114.006304; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; Muhlhausler BS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001481; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nielson JL, 2015, BRAIN RES, V1619, P124, DOI 10.1016/j.brainres.2014.10.048; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; OLSON CL, 1979, PSYCHOL BULL, V86, P1350, DOI 10.1037/0033-2909.86.6.1350; Pedder H, 2014, STROKE, V45, P563, DOI 10.1161/STROKEAHA.113.003128; PILLAI KCS, 1955, ANN MATH STAT, V26, P117, DOI 10.1214/aoms/1177728599; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; R Core Team, 2017, R LANG ENV STAT COMP; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; ROY SN, 1953, ANN MATH STAT, V24, P220, DOI 10.1214/aoms/1177729029; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th; Todorov H., 2018, GENOM, V4, pE100041, DOI [10.18547/gcb.2018.vol4.iss2.e100041, DOI 10.18547/GCB.2018.VOL4.ISS2.E100041]; van Luijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089981; Warne R. T., 2014, PRACT ASSESS RES EVA, V19; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wilks SS, 1932, BIOMETRIKA, V24, P471	59	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230798	10.1371/journal.pone.0230798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	WOS:000535934200062	32214370	Green Published, gold, Green Submitted			2022-02-06	
J	Folweiler, KA; Sandsmark, DK; Diaz-Arrastia, R; Cohen, AS; Masino, AJ				Folweiler, Kaitlin A.; Sandsmark, Danielle K.; Diaz-Arrastia, Ramon; Cohen, Akiva S.; Masino, Aaron J.			Unsupervised Machine Learning Reveals Novel Traumatic Brain Injury Patient Phenotypes with Distinct Acute Injury Profiles and Long-Term Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; GCS; machine learning; TBI; unsupervised clustering	COMMON DATA ELEMENTS; CLINICAL-TRIALS; HEAD-INJURY	The heterogeneity of traumatic brain injury (TBI) remains a core challenge for the success of interventional clinical trials. Data-driven approaches for patient stratification may help to identify TBI patient phenotypes during the acute injury period as well as facilitate targeted trial patient enrollment and analysis of treatment efficacy. In this study, we implemented an unsupervised machine learning approach to identify TBI subpopulations at injury baseline using data from 1213 TBI patients who participated in the Citicoline Brain Injury Treatment Trial (COBRIT) Trial. A wrapper framework utilizing generalized low-rank models automatically selected relevant clinical features that were subsequently used to cluster patients using a partitioning around medoids clustering algorithm. Using this approach, we identified three patient phenotypes with unique clinical injury profiles based on a subset of acute injury features. Phenotype-specific differences in long-term functional outcome trajectories were respectively observed at 3 and 6 months after injury. In comparison, when patients were grouped by baseline Glasgow Coma Scale (GCS), no differences in baseline clinical feature profiles or long-term outcomes were observed. To test phenotype reproducibility in an external validation data set, we used a K-nearest neighbors algorithm to classify subjects in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot data set into corresponding phenotypes, then measured the Gower's dissimilarities between TRACK-TBI and COBRIT subjects in each phenotype. No significant differences were found between trial subjects within two phenotypes, suggesting that these phenotypes may be generalizable within a broad range of TBI severity. Further, Extended Glasgow Outcome Scale (GOS-E) outcomes in the TRACK-TBI data set similarly demonstrated phenotype-specific differences in long-term outcomes. Our results suggest that unsupervised machine learning is a promising and effective approach for discovery of novel injury subpopulations over the conventional GCS-based method, and may improve patient selection in future TBI clinical trials.	[Folweiler, Kaitlin A.; Cohen, Akiva S.; Masino, Aaron J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Folweiler, Kaitlin A.; Masino, Aaron J.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Sandsmark, Danielle K.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cohen, Akiva S.; Masino, Aaron J.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Folweiler, KA (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Abramson Res Ctr, Room 814-1,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	kfolw@pennmedicine.upenn.edu			Department of Anesthesiology and Critical Care at the Children's Hospital of Philadelphia; Children's Hospital of Philadelphia Research Institute; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 HD059288]	This project was funded by the Department of Anesthesiology and Critical Care at the Children's Hospital of Philadelphia and the Children's Hospital of Philadelphia Research Institute (A.J.M) as well as by National Institutes of Health (NIH) R37 HD059288 (A.S.C).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Gamberger D, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0183-0; Gardner RC, 2019, J NEUROTRAUM, V36, P2521, DOI 10.1089/neu.2018.6167; Gareth J., 2000, INTRO STAT LEARNING; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jaccard P, 1912, NEW PHYTOL, V11, P37, DOI [DOI 10.1111/J.1469-8137.1912.TB05611.X, 10.1111/j.1469-8137.1912.tb05611.x]; Kuhn M., 2018, CARET CLASSIFICATION; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maechler M., 2015, CLUSTER CLUSTER ANAL; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Rosenbaum PR, 2005, J ROY STAT SOC B, V67, P515, DOI 10.1111/j.1467-9868.2005.00513.x; Rousseeuw, 2009, FINDING GROUPS DATA; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schuler A, 2016, BIOCOMPUT-PAC SYM, P144; Shen HP, 2008, J MULTIVARIATE ANAL, V99, P1015, DOI 10.1016/j.jmva.2007.06.007; Shi J., 2016, ONCOTARGET, V7, P52; Si B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00606; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thompson HJ, 2015, ANNU REV NURS RES-SE, V33, P1, DOI 10.1891/0739-6686.33.1; Udell M, 2016, FOUND TRENDS MACH LE, V9, P2, DOI 10.1561/2200000055; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Visscher RMS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214525; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	44	4	4	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1431	1444		10.1089/neu.2019.6705		MAR 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525033700001	32008422	Green Published			2022-02-06	
J	Harfmann, EJ; deRoon-Cassini, TA; McCrea, MA; Nader, AM; Nelson, LD				Harfmann, Elisabeth J.; deRoon-Cassini, Terri A.; McCrea, Michael A.; Nader, Amy M.; Nelson, Lindsay D.			Comparison of Four Quality of Life Inventories for Patients with Traumatic Brain Injuries and Orthopedic Injuries	JOURNAL OF NEUROTRAUMA			English	Article						health-related quality of life; orthopedic injury; outcome measurement; traumatic brain injury	OUTCOME MEASURES; HEAD-INJURY; QOLIBRI; RECOMMENDATIONS; SCALE; QUESTIONNAIRE; VALIDATION; VALIDITY	The value of assessing health-related quality of life (HRQoL) in traumatic brain injury (TBI) patients has been increasingly recognized in recent years. Yet, research examining generic and TBI-specific quality of life (QOL) methodologies within this population has been limited, rendering decisions to use one alternative over another difficult and based largely on conceptual grounds. The current study compared widely used generic QoL/HRQOL measures (Satisfaction With Life Scale, 36-item Short Form Survey) and newer population-specific HRQoL measures (Quality of Life after Brain Injury [QOLIBRI], Trauma-Quality of Life [TQoL]) among 77 TBI and 23 orthopedically injured trauma control patients. The QOLIBRI Cognition and Physical Problems subscales were the only HRQoL scores across the four instruments administered that differentiated between patient groups: participants with TBI reported being significantly less satisfied with their cognitive abilities and more bothered by physical problems. Analyses of the unique population-specific QOLIBRI content revealed that 12.2-31.5% of TBI patients endorsed dissatisfaction and 28.8-51.4% endorsed being bothered by items unique to the QOLIBRI. Endorsement rates for unique TQoL items ranged from 1.4-75.7%. Overall, the QOLIBRI and TQoL appear to capture important information pertinent to patients with TBI and trauma. Inclusion of these disease-specific HRQoL measures is recommended over the use of only generic measures among TBI populations.	[Harfmann, Elisabeth J.; McCrea, Michael A.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Harfmann, Elisabeth J.] Carl T Hayden VA Med Ctr, Phoenix, AZ USA; [deRoon-Cassini, Terri A.] Med Coll Wisconsin, Dept Surg, Div Trauma & Acute Care Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [McCrea, Michael A.; Nader, Amy M.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Nelson, LD (corresponding author), Med Coll Wisconsin, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu			Medical College of Wisconsin Center for Advancing Population Science (CAPS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS110856]; MCW Clinical and Translational Science Institute (National Institutes of Health grant)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR001436]	The study was funded by the Medical College of Wisconsin Center for Advancing Population Science (CAPS) and NIH grant R01NS110856. The REDCap database used for the study was supported by theMCW Clinical and Translational Science Institute (National Institutes of Health grant UL1TR001436).	Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; Bown D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211684; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Bush JW., 1982, HEALTH PSYCHOL, V1, P61, DOI [10.1037/0278-6133.1.1.61, DOI 10.1037/0278-6133.1.1.61]; Castano-Leon AM, 2018, EVAL HEALTH PROF, V41, P456, DOI 10.1177/0163278717702696; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gennarelli TA., 2008, ABBREVIATED INJURY S; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Groswasser Z, 2018, BRAIN INJURY, V32, P879, DOI 10.1080/02699052.2018.1466196; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Gunning A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0375-z; HAVLICEK LL, 1976, PERCEPT MOTOR SKILL, V43, P1319, DOI 10.2466/pms.1976.43.3f.1319; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kendall M., 1999, KENDALLS ADV THEOR A; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krueger RF, 2012, PSYCHOL MED, V42, P1879, DOI 10.1017/S0033291711002674; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin YN, 2016, J NEUROTRAUM, V33, P1363, DOI 10.1089/neu.2015.4094; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Nelson LD, 2020, J NEUROTRAUM, V37, P675, DOI 10.1089/neu.2019.6719; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rosenberg Graeme M, 2018, Trauma Surg Acute Care Open, V3, pe000202, DOI 10.1136/tsaco-2018-000202; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wanner JP, 2015, J TRAUMA ACUTE CARE, V79, P275, DOI 10.1097/TA.0000000000000749; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; WINTER V, 2005, ACTA NEUROPSYCHOL, V3, P36	53	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1408	1417		10.1089/neu.2019.6746		MAR 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525035700001	32000584	Green Published			2022-02-06	
J	Nielson, JL; Cooper, SR; Seabury, SA; Luciani, D; Fabio, A; Temkin, NR; Ferguson, AR				Nielson, Jessica L.; Cooper, Shelly R.; Seabury, Seth A.; Luciani, Davide; Fabio, Anthony; Temkin, Nancy R.; Ferguson, Adam R.		TRACK-TBI Investigators	Statistical Guidelines for Handling Missing Data in Traumatic Brain Injury Clinical Research	JOURNAL OF NEUROTRAUMA			English	Article						assessment tools; missing data; statistical guidelines; TBI	MULTIPLE IMPUTATION; FOLLOW-UP; PREVENTION; THERAPY	Missing data is a persistent and unavoidable problem in even the most carefully designed traumatic brain injury (TBI) clinical research. Missing data patterns may result from participant dropout, non-compliance, technical issues, or even death. This review describes the types of missing data that are common in TBI research, and assesses the strengths and weaknesses of the statistical approaches used to draw conclusions and make clinical decisions from these data. We review recent innovations in missing values analysis (MVA), a relatively new branch of statistics, as applied to clinical TBI data. Our discussion focuses on studies from the International Traumatic Brain Injury Research (InTBIR) initiative project: Transforming Research and Clinical Knowledge in TBI (TRACK-TBI), Collaborative Research on Acute TBI in Intensive Care Medicine in Europe (CREACTIVE), and Approaches and Decisions in Acute Pediatric TBI Trial (ADAPT). In addition, using data from the TRACK-TBI pilot study (n = 586) and the completed clinical trial assessing valproate (VPA) for the treatment of post-traumatic epilepsy (n = 379) we present real-world examples of typical missing data patterns and the application of statistical techniques to mitigate the impact of missing data in order to draw sound conclusions from ongoing clinical studies.	[Nielson, Jessica L.] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN USA; [Nielson, Jessica L.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA; [Cooper, Shelly R.] Washington Univ, Dept Psychol & Brain Sci, Cognit Control & Psychopathol Lab, St Louis, MO 63110 USA; [Seabury, Seth A.] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90007 USA; [Luciani, Davide] IRCCS Mario Negri Inst Pharmacol Res, Unit Clin Knowledge Engn, Lab Clin Epidemiol, Milan, Italy; [Fabio, Anthony] Univ Pittsburgh, Epidemiol Data Ctr, Pittsburgh, PA USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Ferguson, Adam R.] UCSF, BASIC, Weill Inst Neurosci, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ferguson, Adam R.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA USA		Ferguson, AR (corresponding author), UCSF, Brain & Spinal Injury Ctr, Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101 Box 0899, San Francisco, CA 94143 USA.	adam.ferguson@ucsf.edu	Luciani, Davide/ABF-7639-2020; Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Hemphill, Claude/0000-0003-4019-7525; Ferguson, Adam/0000-0001-7102-1608	Department of Defense (DoD)United States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069409, NS069409-02S1, NS106899, NS088475, MH116156]; CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR002494]	This work was supported by: Department of Defense (DoD) grants W81XWH-13-1-0441 (G.T.M.), W81XWH-14-2-0176 (N.R.T.), National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grants NS069409 (G.T.M.), NS069409-02S1 (G.T.M.), NS106899 (A.R.F.), NS088475 (A.R.F.), MH116156 (J.L.N.), and CTSA UL1 TR002494.	Alonso A, 2006, EUR J EPIDEMIOL, V21, P351, DOI 10.1007/s10654-006-9008-y; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Buuren Sv., 2012, FLEXIBLE IMPUTATION; Childs C, 2011, BRAIN INJURY, V25, P1163, DOI 10.3109/02699052.2011.607791; Crameri A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01042; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Feng Mengling, 2012, Acta Neurochir Suppl, V114, P51, DOI 10.1007/978-3-7091-0956-4_10; Gardner RC, 2019, J NEUROTRAUM, V36, P2521, DOI 10.1089/neu.2018.6167; Goldstein H, 2014, J R STAT SOC A STAT, V177, P553, DOI 10.1111/rssa.12022; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mansournia MA, 2016, BMJ-BRIT MED J, V352, P1189; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Rubin DB., 1987, MULTIPLE IMPUTATION, P202, DOI DOI 10.1002/9780470316696; Steyerberg E.W., 2019, CLIN PREDICTION MODE, P157; Steyerberg EW, 2019, CLIN PREDICTION MODE, DOI DOI 10.1007/978-3-030-16399-0_7; Strycker L.A., 2006, QUANTITATIVE METHODO; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thabane L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-92; van Buuren S, 2011, J STAT SOFTW, V45, P1; Van Ness PH, 2007, J CLIN EPIDEMIOL, V60, P1239, DOI 10.1016/j.jclinepi.2007.03.006; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zelnick LR, 2014, J NEUROTRAUM, V31, P1029, DOI 10.1089/neu.2013.3122	29	4	4	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2530	2537		10.1089/neu.2019.6702		MAR 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000525031000001	32008424				2022-02-06	
J	Rahman, MS; Yang, JB; Luan, Y; Qiu, ZG; Zhang, JS; Lu, HX; Chen, XL; Liu, Y				Rahman, Md Saidur; Yang, Jianbo; Luan, Yan; Qiu, Zhengguo; Zhang, Jianshui; Lu, Haixia; Chen, Xinlin; Liu, Yong			Attenuation of Acute Intracerebral Hemorrhage-Induced Microglial Activation and Neuronal Death Mediated by the Blockade of Metabotropic Glutamate Receptor 5 In Vivo	NEUROCHEMICAL RESEARCH			English	Article						Intracerebral hemorrhage; Metabotropic glutamate receptor 5; Microglial activation; MTEP; Neuroprotection	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; FRAGILE-X; NEUROPROTECTIVE ACTIVITY; AGONIST CHPG; RAT MODEL; MGLUR5; POLARIZATION; ANTAGONISTS; NEUROINFLAMMATION	The activation of microglia in response to intracerebral hemorrhagic stroke is one of the principal components of the progression of this disease. It results in the formation of pro-inflammatory cytokines that lead to neuronal death, a structural deterioration that, in turn interferes with functional recovery. Metabotropic glutamate receptor 5 (mGluR5) is highly expressed in reactive microglia and is involved in the pathological processes of brain disorders, but its role in intracerebral hemorrhage (ICH) remains unknown. We hypothesized that mGluR5 regulates microglial activation and ICH maintenance. In this study, collagenase-induced ICH mice received a single intraperitoneal injection of the mGluR5 antagonist-, MTEP, or vehicle 2 h after injury. We found that acute ICH upregulated mGluR5 and microglial activation. mGluR5 was highly localized in reactive microglia in the peri-hematomal cortex and striatum on days 3 and 7 post-ICH. The MTEP-mediated pharmacological inhibition of mGluR5 in vivo resulted in the substantial attenuation of acute microglial activation and IL-6, and TNF-alpha release. We also showed that the blockade of mGluR5 markedly reduced cell apoptosis, and neurodegeneration and markedly elevated neuroprotection. Furthermore, the MTEP-mediated inhibition of mGluR5 significantly reduced the lesion volume and improved functional recovery. Taken together, our results demonstrate that ICH injury enhances mGluR5 expression in the acute and subacute stages and that mGluR5 is highly localized in reactive microglia. The blockade of mGluR5 reduces ICH-induced acute microglial activation, provides neuroprotection and promotes neurofunctional recovery after ICH. The inhibition of mGluR5 may be a relevant therapeutic target for intracerebral hemorrhagic stroke.	[Rahman, Md Saidur; Luan, Yan; Zhang, Jianshui; Lu, Haixia; Chen, Xinlin; Liu, Yong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Inst Neurobiol, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Rahman, Md Saidur] Patuakhali Sci & Technol Univ, Dept Anat & Histol, Dhaka, Bangladesh; [Yang, Jianbo] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurol, Xian, Peoples R China; [Qiu, Zhengguo] Xian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Xian 710038, Shaanxi, Peoples R China		Chen, XL; Liu, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Inst Neurobiol, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	chenxl@mail.xjtu.edu.cn; liuy5599@mail.xjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371348]	This work supported by the Grant from the National Natural Science Foundation of China (Approval No. 81371348). We want to thank Junzhou Zhao, Shengfeng Ji, and Yingfei Liu for their excellent support during the experiment.	Abd-Elrahman KS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0456-1; Abushik PA, 2014, J NEUROCHEM, V129, P264, DOI 10.1111/jnc.12615; Anderson JJ, 2002, J PHARMACOL EXP THER, V303, P1044, DOI 10.1124/jpet.102.040618; Arif M, 2014, P NATL ACAD SCI USA, V111, P1144, DOI 10.1073/pnas.1322614111; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Bonifacino T, 2017, NEUROPHARMACOLOGY, V123, P433, DOI 10.1016/j.neuropharm.2017.06.020; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Bruno V, 2000, NEUROPHARMACOLOGY, V39, P2223, DOI 10.1016/S0028-3908(00)00079-4; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Cosford NDP, 2003, J MED CHEM, V46, P204, DOI 10.1021/jm025570j; Cosford NDP, 2003, BIOORG MED CHEM LETT, V13, P351, DOI 10.1016/S0960-894X(02)00997-6; Domin H, 2006, PHARMACOL REP, V58, P846; Drouin-Ouellet J, 2011, GLIA, V59, P188, DOI 10.1002/glia.21086; Ehara A, 2009, ACTA HISTOCHEM CYTOC, V42, P171, DOI 10.1267/ahc.09018; Hsieh MH, 2012, PHARMACOL BIOCHEM BE, V102, P64, DOI 10.1016/j.pbb.2012.03.022; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hu X, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3215391; Huang YX, 2018, ASN NEURO, V10, DOI 10.1177/1759091418811021; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lan X, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-98; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Li HL, 2013, ASN NEURO, V5, DOI 10.1042/AN20130002; Liu F, 2014, NEUROSCIENCE, V281, P24, DOI 10.1016/j.neuroscience.2014.09.034; Liu Q, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1398-3; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Makarewicz D, 2006, NEUROCHEM INT, V48, P485, DOI 10.1016/j.neuint.2005.12.022; Malter JS, 2010, CURR ALZHEIMER RES, V7, P200, DOI 10.2174/156720510791050957; Manno Edward M, 2012, Continuum (Minneap Minn), V18, P598, DOI 10.1212/01.CON.0000415430.99394.3e; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Mudo G, 2007, BRAIN RES, V1149, P1, DOI 10.1016/j.brainres.2007.02.041; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Overk CR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-18; Paquet M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-9; Parmentier-Batteur S, 2014, NEUROPHARMACOLOGY, V82, P161, DOI 10.1016/j.neuropharm.2012.12.003; Prabhakaran S, 2012, STROKE, V43, P2258, DOI 10.1161/STROKEAHA.112.655910; Rao AM, 2000, NEUROSCI LETT, V293, P1, DOI 10.1016/S0304-3940(00)01483-X; Ribeiro FM, 2014, HUM MOL GENET, V23, P2030, DOI 10.1093/hmg/ddt598; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Ribeiro FM, 2010, J NEUROSCI, V30, P316, DOI 10.1523/JNEUROSCI.4974-09.2010; Riek-Burchardt M, 2007, NEUROSCI RES, V57, P499, DOI 10.1016/j.neures.2006.12.006; Righy C, 2016, CURR NEUROPHARMACOL, V14, P392, DOI 10.2174/1570159X14666151230110058; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Takagi N, 2012, NEUROSCI LETT, V530, P91, DOI 10.1016/j.neulet.2012.09.035; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Wagner KR, 2007, STROKE, V38, P753, DOI 10.1161/01.STR.0000255033.02904.db; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Wu CH, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1005-4; Xu X, 2012, NEUROSCIENCE, V202, P474, DOI 10.1016/j.neuroscience.2011.12.008; Zhang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26295; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhang ZY, 2015, NEUROCHEM RES, V40, P1121, DOI 10.1007/s11064-015-1572-7; Zhao L, 2011, NEUROSCIENCE, V192, P185, DOI 10.1016/j.neuroscience.2011.06.044; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551	66	4	4	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2020	45	5					1230	1243		10.1007/s11064-020-03006-1		MAR 2020	14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LE0KF	WOS:000518304300001	32140955				2022-02-06	
J	Si, LL; Wang, HF; Wang, LY				Si, Lili; Wang, Haifeng; Wang, Leyuan			Suppression of miR-193a alleviates neuroinflammation and improves neurological function recovery after traumatic brain injury (TBI) in mice	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury (TBI); miR-193a; Neuroinflammation; microglial activation; NLRP3	NLRP3 INFLAMMASOME; ACTIVATION; MODELS; DAMAGE	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in the world, and is tightly associated with microglia-regulated neuroinflammation. However, the activation profile of microglia during the pathophysiological responses is still not fully understood. Micro-RNAs (miRs), as noncoding RNAs, are involved in the progression of TBI. In this study, we attempted to explore the effects of miR-193a on TBI using the in vivo and in vitro studies. Following experimental TBI in mice, we found that miR-193a expression was significantly up-regulated in ipsilateral cortical tissues and in the microglia/ macrophages isolated from the ipsilateral cortical tissues, which was accompanied with markedly enhanced expression of pro-inflammatory factors. We then found that miR-193a hairpin inhibitor (antagomir) markedly reduced lesion volume, brain water contents and neuron death in TBI mice induced by the controlled cortical impact (CCI). In addition, cognitive dysfunction in TBI mice was markedly improved after miR-193a antagomir injection. Of note, CCI-induced activation of microglia was repressed by miR-193a inhibition, along with significantly reduced expression of neuroinflammatory markers, which were associated with the blockage of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. The anti-neuroinflammation effects of miR-193a suppression were verified in lipopolysaccharide (LPS)-incubated microglial cells transfected with miR-193a inhibitor. In contrast, LPS-induced activation of microglial cells and the expression of pro-inflammatory factors was markedly further accelerated by the transfection of miR-193a mimic. Taken together, TBI resulted in a robust neuroinflammatory response that was closely associated with the up-regulated miR-193a expression mainly in microglia/macrophages; however, miR-193a suppression significantly alleviated post-traumatic neuroinflammation and cognitive dysfunction. Therefore, miR-193a might be a promising therapeutic target for the treatment of TBI-associated neuroinflammation. (C) 2019 Published by Elsevier Inc.	[Si, Lili] Guangrao Cty Peoples Hosp, Dept Neurol, Dongying 257300, Shandong, Peoples R China; [Wang, Haifeng] Tongji Univ, Tongji Hosp, Sch Med, Dept Geriatr, Shanghai 200065, Peoples R China; [Wang, Leyuan] Changle Peoples Hosp, Dept Neurol, Jinan 262400, Shandong, Peoples R China		Wang, LY (corresponding author), Changle Peoples Hosp, Dept Neurol, Jinan 262400, Shandong, Peoples R China.	sti-chow121@foxmail.com					Alfonso-Loeches S, 2016, NEUROCHEM RES, V41, P193, DOI 10.1007/s11064-015-1760-5; Alghetaa H, 2018, J CELL MOL MED, V22, P2644, DOI 10.1111/jcmm.13542; Barnhart CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124521; Basrai HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153418; Biagioni F, 2019, NEUROBIOL DIS, V121, P76, DOI 10.1016/j.nbd.2018.09.019; Caneus J, 2018, MOL BIOL CELL, V29, P575, DOI 10.1091/mbc.E17-01-0031; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Dai X, 2015, J BIOL CHEM, V290, P16099, DOI 10.1074/jbc.M115.659318; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Gao X, 2015, J INT TRANSL MED, V3, P1; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; LEMASTER E, 2017, FASEB J S1, V31; Li TS, 2019, BIOCHEM PHARMACOL, V166, P139, DOI 10.1016/j.bcp.2019.05.016; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mei M, 2019, NEUROPHARMACOLOGY, V160, DOI 10.1016/j.neuropharm.2019.107758; Osmand AP, 2016, J HUNTINGTONS DIS, V5, P343, DOI 10.3233/JHD-160217; Qiao Y, 2019, NEUROL RES, V41, P536, DOI 10.1080/01616412.2019.1580461; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Samaeekia R, 2017, CLIN CANCER RES, V23, P1091, DOI 10.1158/1078-0432.CCR-16-0943; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	33	4	4	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAR 5	2020	523	2					527	534		10.1016/j.bbrc.2019.11.095			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	LB6IN	WOS:000524737600038	31924304				2022-02-06	
J	Holmes, A; Chen, ZX; Yahng, L; Fletcher, D; Kawata, K				Holmes, Acacia; Chen, Zhongxue; Yahng, Lilian; Fletcher, David; Kawata, Keisuke			Return to Learn: Academic Effects of Concussion in High School and College Student-Athletes	FRONTIERS IN PEDIATRICS			English	Article						mild traumatic brain injury; sport-related concussion; sports injury; brain injury; high school	MILD HEAD-INJURY; NEUROCOGNITIVE PERFORMANCE; SYMPTOMS; RECOMMENDATIONS; CLASSROOM; CHILDREN	While awareness and understanding of concussion have improved drastically, post-concussion management in academic settings is still at its infancy. The aim of the study was to examine to what extent concussion influences academic performance and to whether there would be a difference in concussion effects on academic performance between high school and college students. This cross-sectional survey study included students, who were between 14 and 24 years old and sustained a sport-related concussion within the previous year. The study used a modified chain-referral sampling method, by distributing a questionnaire link to 3,000 randomly stratified athletic trainers, who worked in high school or college settings. These athletic trainers were then asked to forward the questionnaire link to students in their team, who have sustained a concussion within the previous year. The questionnaire recorded responses regarding demographics (age, sex, race/ethnicity, number of previous concussions); 22 concussion-related symptoms in a binary scale (presence/absence); perception of difficulties in math, reading, writing, computer use, and attention in a 5-point Likert scale; and asymptomatic duration of academic engagement in a 7-point Likert scale. There were 130 respondents with a history of concussion in the past year (n = 59 high school, n = 71 college). While recovering from concussion, significantly more college students (84.5%) reported "difficulty concentrating" than high school students (68.6%: p = 0.049). High -school students experienced more difficulty with math than college students (p = 0.002), whereas college students experienced more difficulty with reading (p = 0.013) and computer use (p = 0.026) than high school students. Asymptomatic duration of cognitive activity was influenced by age (p = 0.0004), where younger students were less tolerant in performing academic tasks after a concussion than older students. Our data indicate that concussions can induce negative symptoms in the academic setting regardless of age. The post-concussion difficulties in academic performance may be a grade-dependent manner, where concussions triggered difficulty in math among high school students and in reading and computer use among college students. It is clear that there is a need for guidelines and accommodations to support students with concussion in academic settings, and the guideline should reflect the age-dependent response to concussions.	[Holmes, Acacia; Kawata, Keisuke] Indiana Univ, Sch Publ Hlth Bloomington, Dept Kinesiol, Bloomington, IN 47405 USA; [Chen, Zhongxue] Indiana Univ, Sch Publ Hlth Bloomington, Dept Epidemiol & Biostat, Bloomington, IN USA; [Yahng, Lilian] Indiana Univ, Ctr Survey Res, Bloomington, IN USA; [Fletcher, David] Indiana Univ, Hlth Ctr, Bloomington, IN USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN USA		Kawata, K (corresponding author), Indiana Univ, Sch Publ Hlth Bloomington, Dept Kinesiol, Bloomington, IN 47405 USA.	kkawata@indiana.edu			Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health [ISCBIRF 0019939]; Indiana University OVPR Center for Survey Research Methodology Development Award	This work was partly supported by the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (to KK: ISCBIRF 0019939) and Indiana University OVPR Center for Survey Research Methodology Development Award (to KK).	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bevilacqua Zachary W, 2019, Concussion, V4, pCNC63, DOI 10.2217/cnc-2019-0004; Boy F, 2011, BIOL PSYCHIAT, V70, P866, DOI 10.1016/j.biopsych.2011.05.030; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364	27	4	4	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	MAR 4	2020	8								57	10.3389/fped.2020.00057			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	LC1UP	WOS:000525114500001	32195210	gold, Green Published			2022-02-06	
J	Appavu, B; Foldes, S; Temkit, M; Jacobson, A; Burrows, BT; Brown, D; Boerwinkle, V; Marku, I; Adelson, PD				Appavu, Brian; Foldes, Stephen; Temkit, M'hamed; Jacobson, Austin; Burrows, Brian T.; Brown, Danni; Boerwinkle, Varina; Marku, Iris; Adelson, P. David			Intracranial Electroencephalography in Pediatric Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						electroencephalography; multimodal neuromonitoring; neurocritical care; traumatic brain injury	EEG	Objectives: Electroencephalography is used in neurocritical care for detection of seizures and assessment of cortical function. Due to limited resolution from scalp electroencephalography, important abnormalities may not be readily detectable. We aimed to identify whether intracranial electroencephalography allows for improved methods of monitoring cortical function in children with severe traumatic brain injury. Design: This is a retrospective cohort study from a prospectively collected clinical database. We investigated the occurrence rate of epileptiform abnormalities detected on intracranial electroencephalography when compared with scalp electroencephalography. We also investigated the strength of association of quantitative electroencephalographic parameters and cerebral perfusion pressure between both intracranial and scalp electroencephalography. Setting: This is a single-institution study performed in the Phoenix Children's Hospital PICU. Patients: Eleven children with severe traumatic brain injury requiring invasive neuromonitoring underwent implantation of a six-contact intracranial electrode as well as continuous surface electroencephalography. Interventions: None. Measurements and Main Results: Visual detection of epileptiform abnormalities was performed by pediatric epileptologists. Association of intracranial and scalp electroencephalography total power, alpha percentage, and alpha-delta power ratio to cerebral perfusion pressure was performed using univariate dynamic structural equations modeling. Demographic data were assessed by retrospective analysis. Intracranial and scalp electroencephalography was performed in 11 children. Three of 11 children had observed epileptiform abnormalities on intracranial electroencephalography. Two patients had epileptiform abnormalities identified exclusively on intracranial electroencephalography, and one patient had seizures initiating on intracranial electroencephalography before arising on scalp electroencephalography. Identification of epileptiform abnormalities was associated with subsequent identification of stroke or malignant cerebral edema. We observed statistically significant positive associations between intracranial alpha-delta power ratio to cerebral perfusion pressure in nine of 11 patients with increased strength of association on intracranial compared with scalp recordings. Conclusions: These findings suggest that intracranial electroencephalography may be useful for detection of secondary insult development in children with traumatic brain injury.	[Appavu, Brian; Foldes, Stephen; Temkit, M'hamed; Jacobson, Austin; Burrows, Brian T.; Brown, Danni; Boerwinkle, Varina; Marku, Iris; Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosci, Phoenix, AZ 85016 USA; [Appavu, Brian; Boerwinkle, Varina; Adelson, P. David] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA		Appavu, B (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosci, Phoenix, AZ 85016 USA.; Appavu, B (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.	bappavu@phoenixchild-rens.com	Boerwinkle, Varina/AAS-8002-2020; Appavu, Brian L/AAE-7180-2021; Boerwinkle, Varina/AAS-8638-2020	Boerwinkle, Varina/0000-0002-1429-2994; Foldes, Stephen/0000-0002-2061-3790	Moberg ICU Solutions; Integra Codman Franchise	Supported, in part, by a research grant from Moberg ICU Solutions and a grant from the Integra Codman Franchise for program development.	Appavu B, 2019, J NEUROSURG-PEDIATR, V23, P661, DOI 10.3171/2019.2.PEDS18384; Appavu B, 2018, NEUROCRIT CARE, V29, P9, DOI 10.1007/s12028-017-0424-5; Asparouhov T, 2018, STRUCT EQU MODELING, V25, P359, DOI 10.1080/10705511.2017.1406803; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Foreman B, 2018, J CEREBR BLOOD F MET, V38, P506, DOI 10.1177/0271678X17700433; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Gilks WR, 1996, MARKOV CHAIN CARLO P; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Kahane P, 2003, EPILEPTIC DISORD, V5, P205; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kothare SV, 1998, NEUROLOGY, V51, P1723, DOI 10.1212/WNL.51.6.1723; Li LM, 1997, ANN NEUROL, V41, P662, DOI 10.1002/ana.410410516; Newey CR, 2017, NEUROHOSPITALIST, V7, P179, DOI 10.1177/1941874417708938; PILLAY PK, 1992, BRIT J NEUROSURG, V6, P47, DOI 10.3109/02688699209002901; Rathakrishnan R, 2011, NEUROCRIT CARE, V14, P152, DOI 10.1007/s12028-010-9495-2; Schneider Anita L, 2005, Am J Electroneurodiagnostic Technol, V45, P102; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Ulbert I, 2004, EXP NEUROL, V187, P310, DOI 10.1016/j.expneurol.2003.12.003; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Witsch J, 2017, JAMA NEUROL, V74, P299, DOI 10.1001/jamaneurol.2016.5325	22	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2020	21	3					240	247		10.1097/PCC.0000000000002136			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	LH8CB	WOS:000529009700006	31569184				2022-02-06	
J	Calero-Martinez, SA; Matula, C; Peraud, A; Biroli, F; Fernandez-Alen, J; Bierschneider, M; Cunningham, M; Hawryluk, GWJ; Babu, M; Bullock, MR; Rubiano, AM				Calero-Martinez, Sergio A.; Matula, Christian; Peraud, Aurelia; Biroli, Francesco; Fernandez-Alen, Jose; Bierschneider, Michael; Cunningham, Michael; Hawryluk, Gregory W. J.; Babu, Maya; Bullock, M. Ross; Rubiano, Andres M.			Development and assessment of competency-based neurotrauma course curriculum for international neurosurgery residents and neurosurgeons	NEUROSURGICAL FOCUS			English	Article						neurotrauma; education; competence-based; course; curriculum; international	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; SIMULATION; EDUCATION; SURGERY	OBJECTIVE Traumatic brain injuries (TBIs) are a significant disease burden worldwide. It is imperative to improve neurosurgeons' training during and after their medical residency with appropriate neurotrauma competencies. Unfortunately, the development of these competencies during neurosurgeons' careers and in daily practice is very heterogeneous. This article aimed to describe the development and evaluation of a competency-based international course curriculum designed to address a broad spectrum of needs for taking care of patients with neurotrauma with basic and advanced interventions in different scenarios around the world. METHODS A committee of 5 academic neurosurgeons was involved in the task of building this course curriculum. The process started with the identification of the problems to be addressed and the subsequent performance needed. After this, competencies were defined. In the final phase, educational activities were designed to achieve the intended learning outcomes. In the end, the entire process resulted in competency and outcomes-based education strategy, including a definition of all learning activities and learning outcomes (curriculum), that can be integrated with a faculty development process, including training. Further development was completed by 4 additional academic neurosurgeons supported by a curriculum developer specialist and a project manager. After the development of the course curriculum, template programs were developed with core and optional content defined for implementation and evaluation. RESULTS The content of the course curriculum is divided into essentials and advanced concepts and interventions in neurotrauma care. A mixed sample of 1583 neurosurgeons and neurosurgery residents attending 36 continuing medical education activities in 30 different cities around the world evaluated the course. The average satisfaction was 97%. The average usefulness score was 4.2, according to the Likert scale. CONCLUSIONS An international competency-based course curriculum is an option for creating a well-accepted neurotrauma educational process designed to address a broad spectrum of needs that a neurotrauma practitioner faces during the basic and advanced care of patients in different regions of the world. This process may also be applied to other areas of the neurosurgical knowledge spectrum. Moreover, this process allows worldwide standardization of knowledge requirements and competencies, such that training may be better benchmarked between countries regardless of their income level.	[Calero-Martinez, Sergio A.; Rubiano, Andres M.] Meditech Fdn, Cali, Colombia; [Calero-Martinez, Sergio A.] Clemenshosp Munster, Munster, Germany; [Matula, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Peraud, Aurelia] Univ Hosp Ulm, Ulm, Germany; [Biroli, Francesco] Fdn Ric Osped Maggiore, Bergamo, Italy; [Fernandez-Alen, Jose] Hosp 12 Octubre, Madrid, Spain; [Bierschneider, Michael] BG Unfallklin Murnau, Murnau, Germany; [Cunningham, Michael] AO Fdn, AO Educ Inst, Dubendorf, Switzerland; [Hawryluk, Gregory W. J.] Univ Manitoba, Winnipeg, MB, Canada; [Babu, Maya] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bullock, M. Ross] Univ Miami, Coral Gables, FL 33124 USA; [Rubiano, Andres M.] Univ El Bosque, Bogota, Colombia; [Rubiano, Andres M.] Global Neuro Fdn, Davos, Switzerland		Rubiano, AM (corresponding author), Meditech Fdn, Santiago De Cali, Colombia.	andresrubiano@aol.com	ALEN, JOSE A FERNANDEZ/G-4990-2018; RUBIANO, ANDRES M/K-6704-2012	ALEN, JOSE A FERNANDEZ/0000-0002-3321-983X; RUBIANO, ANDRES M/0000-0001-8931-3254; Calero Martinez, Sergio Alexander/0000-0003-2515-368X	AO Foundation	The AO Foundation supported the initiation of this curricular development process. Global Neuro supports the final part of the curricular development process. Dr. Calero-Martinez claims no conflict of interest; the rest of the authors are active members of the Global Neuro Curriculum Committee.	Anderson GA, 2018, J SURG EDUC, V75, P1317, DOI 10.1016/j.jsurg.2018.02.014; Androulakis J, 2002, ARCH HELLEN MED, V19, P333; Asthagiri A, 2014, NEUROSURGERY, V75, pN7; Bouillon B, 2004, UNFALLCHIRURG, V107, P844, DOI 10.1007/s00113-004-0847-2; Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042; Crow ML, 2015, J ED SOCIAL POLICY, V2, P13; Davis J, 2008, MED TEACH, V30, P302, DOI 10.1080/01421590701784349; Deptula P, 2013, J SURG EDUC, V70, P408, DOI 10.1016/j.jsurg.2012.11.007; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dewan MC, 2019, J NEUROSURG, V130, P1098, DOI 10.3171/2017.10.JNS17347; Doyle-Scharff M, 2005, J CONTIN EDUC HEALTH, V25, P297; Fontes Ricardo B V, 2014, J Surg Educ, V71, pe83, DOI 10.1016/j.jsurg.2014.06.016; Gasco J, 2014, MALAYS J MED SCI, V21, P1; Gelinas-Phaneuf N, 2013, NEUROSURGERY, V73, P30, DOI 10.1227/NEU.0000000000000115; Green JS, 2005, AO PRINCIPLES TEACHI; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Konakondla S, 2017, ADV MED EDUC PRACT, V8, P465, DOI 10.2147/AMEP.S113565; Larouche J, 2016, SPINE, V41, P530, DOI 10.1097/BRS.0000000000001251; Lobato RD, 2016, NEUROCIRUGIA, V27, P75, DOI 10.1016/j.neucir.2016.02.001; Moore DE, 2009, J CONTIN EDUC HEALTH, V29, P1, DOI 10.1002/chp.20001; Oliveira Louise Makarem, 2019, Asian J Neurosurg, V14, P364, DOI 10.4103/ajns.AJNS_269_18; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roberts L, 2018, J SURG EDUC, V75, P1180, DOI 10.1016/j.jsurg.2018.02.005; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosseau G, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18295; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Shaye DA, 2018, WORLD J SURG, V42, P3514, DOI 10.1007/s00268-018-4690-y; Steiger HJ, 2001, ACTA NEUROCHIR WIEN, V143, P100; Suri A, 2016, NEUROL INDIA, V64, P387, DOI 10.4103/0028-3886.181556; Ten Cate O., 2017, GMS J MED ED, V34, pDoc69; World Health Organization, INJ VIOL FACTS	34	4	4	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAR	2020	48	3							E13	10.3171/2019.12.FOCUS19850			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS6BA	WOS:000518391000013	32114549	gold			2022-02-06	
J	Camara-Costa, H; Francillette, L; Opatowski, M; Toure, H; Brugel, D; Laurent-Vannier, A; Meyer, P; Dellatolas, G; Watier, L; Chevignard, M				Camara-Costa, Hugo; Francillette, Leila; Opatowski, Marion; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Meyer, Philippe; Dellatolas, Georges; Watier, Laurence; Chevignard, Mathilde			Self- and Parent-Reported Fatigue 7 Years After Severe Childhood Traumatic Brain Injury: Results of the Traumatisme Grave de l'Enfant Prospective Longitudinal Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; health-related quality of life; multidimensional fatigue; prospective cohort study; severe traumatic brain injury	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; MULTIDIMENSIONAL FATIGUE; SLEEP DISTURBANCE; CHILDREN; MODERATE; MODEL; PARTICIPATION; DEPRESSION; VALIDITY	Objective: To investigate presence of and factors associated with self- and parent-reported fatigue 7 years after severe childhood traumatic brain injury (TBI) in the prospective longitudinal study TGE (Traumatisme Grave de l'Enfant-severe childhood trauma). Methods: Self-reports and/or parent reports on the Multidimensional Fatigue Scale were collected for 38 participants (aged 7-22 years) 7 years after severe childhood TBI, and 33 controls matched for age, gender, and parental educational level. The data collected included sociodemographic characteristics, age at injury and injury severity scores, overall disability (Glasgow Outcome Scale Extended), intellectual outcome (Wechsler scales), and questionnaires assessing executive functions, health-related quality of life, behavior, and participation. Results: Fatigue levels were significantly worse in the TBI than in the control group, especially for cognitive fatigue. Correlations of reported fatigue with age at injury, gender, TBI severity, and intellectual ability were moderate and often not significant. Fatigue was significantly associated with overall level of disability (Glasgow Outcome Scale Extended) and with all questionnaires completed by the same informant. Conclusion: High levels of fatigue were reported by 30% to 50% of patients 7 years after a severe childhood TBI. Reported fatigue explained more than 60% of the variance of reported health-related quality of life by the same informant (patient or parent).	[Camara-Costa, Hugo; Dellatolas, Georges] Univ Paris Saclay, Univ Paris SUD, INSERM, UVSQ,CESP, Paris, France; [Camara-Costa, Hugo; Francillette, Leila; Dellatolas, Georges; Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed, LIB, Paris, France; [Opatowski, Marion; Watier, Laurence] Univ Paris Saclay, Inst Pasteur, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, INSERM,UVSQ, Paris, France; [Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France; [Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Meyer, Philippe] Hop Necker Enfants Malad, Paediat Anesthesiol Dept, Paris, France; [Meyer, Philippe] Fac Med Rene Descartes Paris 5, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, Grp Rech Clin Handicap Cognitif & Readaptat HanCR, Paris, France		Camara-Costa, H (corresponding author), INSERM, Ctr Rech Epidemiol & Sante Populat, U1018, 97 Blvd Port Royal, F-75014 Paris, France.	hugocamaracosta@gmail.com	Meyer, Philippe/ABE-4242-2020; Dellatolas, Georges/AAW-1377-2021; WATIER, Laurence/K-8213-2013	Meyer, Philippe/0000-0002-3829-6631; WATIER, Laurence/0000-0002-4057-1102; Camara-Costa, Hugo/0000-0002-3739-7190	Departement de la Recherche Clinique et du Developpement, AP-HP (Paris) [PHRC 2003, AOM 03018]; French Ministry of Health's general direction of health and direction of research, studies, assessment and statistics; national fund for health insurance of salaried workers; national fund for health insurance of independent workers; national fund for solidarity and autonomy; national institute for prevention and education for health; French Speaking Society of Research in Children with Disabilities (SFERHE); French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC); French Speaking Society of Physical Medicine and Rehabilitation (SOFMER)	The initial data collection for the initiation of the cohort study was funded by the Departement de la Recherche Clinique et du Developpement, AP-HP (Paris, No. PHRC 2003; AOM 03018). The 7-year follow-up study was funded by a co-funding by the French Ministry of Health's general direction of health and direction of research, studies, assessment and statistics, by the national fund for health insurance of salaried workers, the national fund for health insurance of independent workers, by the national fund for solidarity and autonomy and by the national institute for prevention and education for health, in the call for research projects launched by the IReSP in 2011. In depth analyses and manuscript preparation were also funded by two grant( s) awarded toHugo Camara-Costa: one grant from the French Speaking Society of Research in Children with Disabilities (SFERHE, www.sferhe.org) and one joint grant from the French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC) and the French Speaking Society of Physical Medicine and Rehabilitation (SOFMER, www.sofmer.com).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bayley MT, 2018, J HEAD TRAUMA REHAB, V33, P296, DOI 10.1097/HTR.0000000000000428; Beaulieu-Bonneau Simon, 2017, Neuropsychol Rehabil, V27, P983, DOI 10.1080/09602011.2016.1162176; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Camara-Costa H, 2017, NEURO-ONCOL PRACT, V4, P161, DOI 10.1093/nop/npw028; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Chiou KS, 2016, J HEAD TRAUMA REHAB, V31, pE60, DOI 10.1097/HTR.0000000000000161; Clark AL, 2018, J HEAD TRAUMA REHAB, V33, P382, DOI 10.1097/HTR.0000000000000377; Coutinho V, 2017, APPL NEUROPSYCH-CHIL, V6, P255, DOI 10.1080/21622965.2016.1146141; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gioia GA, 2014, BRIEF INVENTAIRE EVA; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Krasny-Pacini A, 2015, DISABIL REHABIL, V37, P2092, DOI 10.3109/09638288.2014.998783; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Masel BE, 2017, NEUROPSYCHOL REHABIL, V27, P1071, DOI 10.1080/09602011.2015.1125374; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Norup A, 2019, NEUROPSYCHOL REHABIL, V29, P1113, DOI 10.1080/09602011.2017.1371045; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Roth RM, 2015, BRIEF INVENTAIRE EVA; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Touzet C, 2017, BRAIN INJURY, V31, P1625, DOI 10.1080/02699052.2017.1344300; van Markus-Doornbosch F, 2016, BRAIN INJURY, V30, P1533, DOI 10.1080/02699052.2016.1197968; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 2011, ECHELLE INTELLIGENCE, V4th ed.; Wilkinson J, 2018, NEUROPSYCHOL REV, V28, P73, DOI 10.1007/s11065-018-9370-z; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242	57	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		104	116		10.1097/HTR.0000000000000502			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500007	31246880				2022-02-06	
J	Cohen, PE; Sufrinko, A; Elbin, RJ; Collins, MW; Sinnott, AM; Kontos, AP				Cohen, Paul E.; Sufrinko, Alicia; Elbin, Robert J.; Collins, Michael W.; Sinnott, Aaron M.; Kontos, Anthony P.			Do Initial Symptom Factor Scores Predict Subsequent Impairment Following Concussion?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; recovery; neurocognitive; vestibular	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; BASE-LINE; RECOVERY; RELIABILITY; MANAGEMENT; RESOLUTION; MIGRAINE; CHILDREN; VALIDITY	Objective: Symptom factors present during the first week following concussion may predict subsequent concussion outcomes and recovery duration. We hypothesized that a high loading on cognitive-fatigue-migraine and somatic factors would be predictive of neurocognitive impairment following concussion. We also hypothesized that the affective factor would be related to vestibular symptoms and impairment. Design: Prospective repeated measures. Setting: Concussion specialty clinic. Participants: Athletes aged 13 to 20 years diagnosed with a concussion within the past 7 days. Independent Variable: Symptom factors at the initial visit 1 to 7 days after injury. Main Outcome Measure: Symptom factor score, neurocognitive testing, and vestibular/ocular motor assessment at the second visit (2-4 weeks after injury). Results: The somatic symptom factor from the initial visit was significant (P< 0.05) in all vestibular/ocular screening components (P< 0.05) but not neurocognitive test performance (P> 0.05) at the second visit. The cognitive-migraine-fatigue and affective symptom factors predicted symptom burden at the second visit (P< 0.001) but did not predict recovery time (P= 0.200). Conclusions: The somatic symptom factor during the first week after injury predicted symptom provocation during vestibular/ocular screening at 2 to 4 weeks after injury. Specifically, higher scores on somatic symptom factor at the initial visit predicted worse symptom reporting for all vestibular/ocular screening components at the second visit. Patients with higher scores on the cognitive-migraine-fatigue and affective symptom factors at the initial visit predicted total symptom burden at the second visit.	[Cohen, Paul E.; Sufrinko, Alicia; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Elbin, Robert J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Sinnott, Aaron M.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Warrior Human Performance Res Ctr, Neuromuscular Res Lab,Dept Sports Med & Nutr, Pittsburgh, PA USA		Kontos, AP (corresponding author), UPMC Rooney Sports Complex,3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Sinnott, Aaron/0000-0002-8887-759X	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01 DC012332] Funding Source: Medline		Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bandelow B, 2014, DTSCH ARZTEBL INT, V111, P473, DOI 10.3238/arztebl.2014.0473; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Furman JM, 2001, J ANXIETY DISORD, V15, P9, DOI 10.1016/S0887-6185(00)00040-2; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Womble Melissa N, 2016, Am J Orthop (Belle Mead NJ), V45, P352	38	4	4	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S61	S68		10.1097/JSM.0000000000000581			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700008	32132479	Green Accepted			2022-02-06	
J	Collins, JM; Woodhouse, A; Bye, N; Vickers, JC; King, AE; Ziebell, JM				Collins, Jessica M.; Woodhouse, Adele; Bye, Nicole; Vickers, James C.; King, Anna E.; Ziebell, Jenna M.			Pathological Links between Traumatic Brain Injury and Dementia: Australian Pre-Clinical Research	JOURNAL OF NEUROTRAUMA			English	Article						AD; CTE; microglia; plaques; Tau; traumatic brain injury dementia	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DYSTROPHIC NEURITES; SODIUM SELENATE; BETA ACCUMULATION; TAU PATHOLOGY; NEUROFIBRILLARY TANGLES; HYPERPHOSPHORYLATED TAU	Traumatic brain injury (TBI) can cause persistent cognitive changes and ongoing neurodegeneration in the brain. Accumulating epidemiological and pathological evidence implicates TBI in the development of Alzheimer's disease, the most common cause of dementia. Further, the TBI-induced form of dementia, called chronic traumatic encephalopathy, shares many pathological hallmarks present in multiple different diseases which cause dementia. The inflammatory and neuritic responses to TBI and dementia overlap, indicating that they may share common pathological mechanisms and that TBI may ultimately cause a pathological cascade culminating in the development of dementia. This review explores Australian pre-clinical research investigating the pathological links between TBI and dementia.	[Collins, Jessica M.; Woodhouse, Adele; Vickers, James C.; King, Anna E.; Ziebell, Jenna M.] Univ Tasmania, Coll Hlth & Med, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia; [Bye, Nicole] Univ Tasmania, Coll Hlth & Med, Sch Pharm, Hobart, Tas, Australia; [Vickers, James C.] Univ Tasmania, Coll Hlth & Med, Sch Med, Hobart, Tas, Australia		Ziebell, JM (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Private Bag 143, Hobart, Tas 7001, Australia.	jenna.ziebell@utas.edu.au	; Vickers, James/J-7464-2014	Collins, Jessica/0000-0002-1938-2470; Vickers, James/0000-0001-5671-4879	NHMRC Boosting Dementia Research Leadership FellowshipNational Health and Medical Research Council of Australia [APP1136913]	A.E.K. is supported by an NHMRC Boosting Dementia Research Leadership Fellowship (APP1136913).	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adlard PA, 2002, ACTA NEUROPATHOL, V103, P377, DOI 10.1007/s00401-001-0476-6; Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arulsamy A, 2019, BEHAV BRAIN RES, V365, P66, DOI 10.1016/j.bbr.2019.02.045; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENZING WC, 1995, EXP NEUROL, V132, P162, DOI 10.1016/0014-4886(95)90021-7; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cardoso BR, 2019, NEUROTHERAPEUTICS, V16, P192, DOI 10.1007/s13311-018-0662-z; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Collins JM, 2019, J NEUROTRAUM, V36, P1876, DOI 10.1089/neu.2018.5982; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; Collins-Praino L., 2018, J NEUROINFLAMM, V2, P1; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; DeWitt DA, 1996, EXP NEUROL, V142, P103, DOI 10.1006/exnr.1996.0182; DICKSON DW, 1988, AM J PATHOL, V132, P86; Dickson TC, 1999, EXP NEUROL, V156, P100, DOI 10.1006/exnr.1998.7010; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Dong Y, 2018, ANN NEUROL, V83, P387, DOI 10.1002/ana.25159; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hassiotis S, 2018, EUR J NEUROSCI, V47, P1043, DOI 10.1111/ejn.13913; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Knowles RB, 1999, J NEUROPATH EXP NEUR, V58, P1090, DOI 10.1097/00005072-199910000-00007; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Malpas CB, 2016, J ALZHEIMERS DIS, V54, P223, DOI 10.3233/JAD-160544; MASLIAH E, 1992, BRAIN RES, V574, P312, DOI 10.1016/0006-8993(92)90831-S; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; MASLIAH E, 1993, BRAIN RES, V617, P258, DOI 10.1016/0006-8993(93)91093-8; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Mitew S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00030; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plummer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190449; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Saunders HL, 1998, ALZHEIMERS REP, V1, P111; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P714, DOI 10.1097/00005072-199807000-00008; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Song GL, 2014, J ALZHEIMERS DIS, V41, P85, DOI 10.3233/JAD-131805; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Stuart KE, 2019, NEUROSCIENCE, V408, P282, DOI 10.1016/j.neuroscience.2019.04.015; Su JH, 1996, BRAIN RES, V739, P79, DOI 10.1016/S0006-8993(96)00811-6; Su JH, 1998, ACTA NEUROPATHOL, V96, P463, DOI 10.1007/s004010050920; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thal DR, 1997, ACTA NEUROPATHOL, V94, P255, DOI 10.1007/s004010050701; Thal DR, 1998, NEUROBIOL AGING, V19, P517, DOI 10.1016/S0197-4580(98)00090-6; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tomidokoro Y, 2001, J PATHOL, V194, P500, DOI 10.1002/path.897; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; TROJANOWSKI JQ, 1994, AM J PATHOL, V144, P449; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vickers JC, 2016, BRAIN RES BULL, V126, P324, DOI 10.1016/j.brainresbull.2016.07.012; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Woodhouse A, 2005, NEUROTOX RES, V7, P5, DOI 10.1007/BF03033772; Woodhouse A, 2009, NEUROBIOL AGING, V30, P864, DOI 10.1016/j.neurobiolaging.2007.09.003; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	145	4	4	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					782	791		10.1089/neu.2019.6906			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200008	32046575				2022-02-06	
J	Eonta, SE; Kamimori, GH; Wang, KKW; Carr, W; LaValle, CR; Egnoto, MJ; Tate, CM				Eonta, Stephanie E.; Kamimori, Gary H.; Wang, Kevin K. W.; Carr, Walter; LaValle, Christina R.; Egnoto, Michael J.; Tate, Charmaine M.			Case Study of a Breacher: Investigation of Neurotrauma Biomarker Levels, Self-reported Symptoms, and Functional MRI Analysis Before and After Exposure to Measured Low-Level Blast	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE-L1; INTRACRANIAL LESIONS; MILD	We report a case study on a single military member who received moderate blast overpressure (OP) exposure during routine breacher training. We extend previous research on blast exposure during training, which lacked sufficient data to assess symptom profiles and OP exposure. The present work was conducted because a subjective symptom profile similar to that seen in sports concussion has been reported by military personnel exposed to blast. Data collection for this study was carried out under a research protocol approved by the relevant Human Subjects Review Committees on one subject, who received the highest OP exposure during training. The volunteer was a 20-year-old male with no prior history of traumatic brain injury (TBI) or blast exposure. The volunteer was part of a breacher training team that completed a 2-week explosive entry course. The course included 3 classroom days and 9 days of practical training, held in the morning, afternoon, and evening sessions. Blast exposure occurred on five of the nine practical training days, with multiple exposures over the course of each day. Assessments of serum, self-reported symptoms, magnetic resonance imaging, and blast characterization were conducted. Results indicated changes in glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 postblast exposure but did not manifest changes in spectrin-derived breakdown product 150 or magnetic resonance imaging. No additional symptoms were reported by the subject. Objective markers of mild TBI remain elusive, but support for serum biomarkers as an early detection mechanism is promising. Additionally, this case study demonstrated an association between OP and high level of neurotrauma biomarker in an individual.	[Eonta, Stephanie E.; Kamimori, Gary H.; Carr, Walter] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarker Res, 1149 South Newell Dr, Gainesville, FL 32611 USA; [LaValle, Christina R.; Egnoto, Michael J.] Geneva Fdn, 917 Pacific Ave, Tacoma, WA 98402 USA; [Tate, Charmaine M.] New Zealand Def Force, 143 Porchester Rd, Auckland 2110, New Zealand		Eonta, SE (corresponding author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.				Congressionally Directed Medical Research Program (CDMRP)United States Department of Defense [W81XWH-09-2-0055]; RAD III of the US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC)	This work was funded by Grant from the Congressionally Directed Medical Research Program (CDMRP Award Number: W81XWH-09-2-0055) and RAD III of the US Army Medical Research and Materiel Command (USAMRMC).	Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Stone JR, 2013, J NEUROTRAUM, V30, pA120; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683	13	4	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					E513	E517		10.1093/milmed/usz185			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR7HU	WOS:000535866100030	31429467	hybrid			2022-02-06	
J	Hossack, MR; Reid, MW; Aden, JK; Gibbons, T; Noe, JC; Willis, AM				Hossack, Michael R.; Reid, Matthew W.; Aden, James K.; Gibbons, Thomas; Noe, Jody C.; Willis, Adam M.			Adverse Childhood Experience, Genes, and PTSD Risk in Soldiers: A Methylation Study	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-RECEPTOR; SKA2 METHYLATION; DNA METHYLATION; BRAIN; SUSCEPTIBILITY; GENOTYPE; PREDICTS; EVENTS	Introduction Epigenetics can serve as a marker of susceptibility to many known psychiatric diseases. DNA methylation patterns of multiple genes have been studied in both civilian populations and military personnel with post-traumatic stress disorder (PTSD). Many of these genes serve various functions that span the hypothalamic-pituitary-adrenal axis, immune system, and central nervous system (CNS) growth factors and neurotransmission. It is thought that the methylation levels of such genes may be able to identify individuals who are at higher risk of developing PTSD. Our study seeks to establish whether previously reported PTSD genes possess a particular methylation pattern that is predictive of PTSD in active duty military members with combat exposure. Materials and Methods This is an institutional review board (IRB)-approved, cross-sectional, case control, gene-environment interaction study. About 170 active military members with and without PTSD were recruited. Patients with a history of structural brain damage, traumatic brain injury (TBI) resulting in loss of consciousness, predeployment diagnosis of PTSD or anxiety disorder, and predeployment prescription of an antidepressant or psychoactive medication were excluded. Validated measures of childhood trauma and adversity (adverse childhood experience [ACE] score), PTSD symptoms (PTSD check-list military version [PCL-M]), and combat exposure scales (CES) were measured via validated questionnaires for all subjects. After extracting DNA from peripheral blood provided by the 170 subjects, we determined methylation percentages, via pyrosequencing assays, for nine target areas within the following seven genes: BDNF, NR3C1, MAN2C1, TLR8, SLC6A4, IL-18, and SKA2. These genes are commonly reported in the literature as being highly correlated with PTSD and early-life traumatic experiences. Methylation levels were measured as a percentage at specific sites within the previously mentioned genes. Data were examined with SPSS v 22.0 Statistics and JMP v13.1 software using a general linear model for methylationxtrauma (CES scores) split by diagnosis of PTSD or not, methylation versus childhood trauma (ACE scores), and methylation versus PTSD severity (PCL-M score). Two-wayANOVAwas performed to control for antidepressant use. A two-tailed Student t-test was performed for PTSD analyses and was correlated with PTSD diagnosis, demographic information as well as ACE score, PCL-M score, and CES scores. Results Differentially methylated sites that were highly associated with PTSD diagnosis were found in three of seven candidate genes: BDNF, NR3C1, and MAN2C1. When compared to controls, patients with PTSD diagnosis had significantly lower levels of methylation, even after controlling for antidepressant use. PCL-M, ACE, and CES scores were significantly associated with PTSD diagnosis. Conclusion Our study suggests that methylation of key genes involved in synaptic plasticity and the hypothalamic-pituitary-adrenal axis is associated with lower levels of methylation in military PTSD subjects exposed to combat when compared to their non-PTSD counterparts. Strengths of this study include controlling for antidepressant use and excluding TBI patients. Similar studies in an active duty population of this size are scarce. What is not clear is whether methylation changes are driving PTSD symptomology or whether they are merely a marker of disease. Future areas of research include prospective studies that measure methylation pre- and postcombat exposure in the same individual.	[Hossack, Michael R.; Willis, Adam M.] San Antonio Mil Med Ctr, Dept Neurol, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Reid, Matthew W.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Aden, James K.] Brooke Army Med Ctr, Grad Med Educ, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA; [Gibbons, Thomas] Lab Serv Branch Clin Invest & Res Support, 1255 Wilford Hall Loop,BLDG 4430, Lackland AFB, TX 78236 USA; [Noe, Jody C.] 59 MDW SGVUL, Div Clin Res, 2200 Bergquist Dr,BLDG 4430, Lackland AFB, TX 78236 USA; [Willis, Adam M.] Univ Texas SouthWestern, Dept Neurol & Neurotherapeut, 5303 Harry Hinds Blvd, Dallas, TX 75390 USA; [Willis, Adam M.] Michigan State Univ, Dept Mech Engn, 428 S Shaw Lane,Room 2555,Engn Bldg, E Lansing, MI 48824 USA		Hossack, MR (corresponding author), San Antonio Mil Med Ctr, Dept Neurol, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.				Air Force Medical Support Agency-Intramural Research Development Test Evaluation [FY14-15]; Clinical Research Division, 59th Medical Wing, Science and Technology Division, Lackland AFB	Air Force Medical Support Agency-Intramural Research Development Test & Evaluation FY14-15 Funds and Clinical Research Division, 59th Medical Wing, Science and Technology Division, Lackland AFB.	Alink LRA, 2012, DEV PSYCHOL, V48, P224, DOI 10.1037/a0024892; Bakermans-Kranenburg MJ, 2011, DEV PSYCHOPATHOL, V23, P39, DOI 10.1017/S0954579410000635; Berger W, 2010, PROG NEURO-PSYCHOPH, V34, P1279, DOI 10.1016/j.pnpbp.2010.07.008; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boks MP, 2016, NEUROPSYCHOPHARMACOL, V41, P1350, DOI 10.1038/npp.2015.286; Boks MP, 2012, EPIGENETICS-US, V7, P20, DOI 10.4161/epi.7.1.18688; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Delahanty DL, 2013, CNS SPECTRUMS, V18, P103, DOI 10.1017/S1092852913000096; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Duman EA, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0017-x; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825; Kuan PF, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.130; LeardMann CA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-437; Ma Y, 2007, CELL CYCLE, V6, P2859, DOI 10.4161/cc.6.23.5018; Maddox Stephanie A, 2013, Front Psychiatry, V4, P62, DOI 10.3389/fpsyt.2013.00062; Malan-Muller S, 2014, GENES BRAIN BEHAV, V13, P52, DOI 10.1111/gbb.12102; Martin C, 2018, BIOL RES NURS, V20, P352, DOI 10.1177/1099800418758951; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morey RA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-76; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Rusiecki Jennifer A, 2013, Front Psychiatry, V4, P56, DOI 10.3389/fpsyt.2013.00056; Sadeh N, 2016, MOL PSYCHIATR, V21, P357, DOI 10.1038/mp.2015.134; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Tang YL, 2010, PROG NEURO-PSYCHOPH, V34, P1396, DOI 10.1016/j.pnpbp.2010.07.002; Tyrka AR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.112; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153	38	4	4	2	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					377	384		10.1093/milmed/usz292			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	LR7HU	WOS:000535866100046	32976583	hybrid			2022-02-06	
J	Kochar, A; Borland, ML; Phillips, N; Dalton, S; Cheek, JA; Furyk, J; Neutze, J; Lyttle, MD; Hearps, S; Dalziel, S; Bressan, S; Oakley, E; Babl, FE				Kochar, Amit; Borland, Meredith L.; Phillips, Natalie; Dalton, Sarah; Cheek, John Alexander; Furyk, Jeremy; Neutze, Jocelyn; Lyttle, Mark D.; Hearps, Stephen; Dalziel, Stuart; Bressan, Silvia; Oakley, Ed; Babl, Franz E.			Association of clinically important traumatic brain injury and Glasgow Coma Scale scores in children with head injury	EMERGENCY MEDICINE JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; DECISION RULES; CHALICE; EPIDEMIOLOGY; PREDICTION; ACCURACY; PECARN; CATCH	Objective Head injury (HI) is a common presentation to emergency departments (EDs). The risk of clinically important traumatic brain injury (ciTBI) is low. We describe the relationship between Glasgow Coma Scale (GCS) scores at presentation and risk of ciTBI. Methods Planned secondary analysis of a prospective observational study of children<18 years who presented with HIs of any severity at 10 Australian/New Zealand centres. We reviewed all cases of ciTBI, with ORs (Odds Ratio) and their 95% CIs (Confidence Interval) calculated for risk of ciTBI based on GCS score. We used receiver operating characteristic (ROC) curves to determine the ability of total GCS score to discriminate ciTBI, mortality and need for neurosurgery. Results Of 20 137 evaluable patients with HI, 280 (1.3%) sustained a ciTBI. 82 (29.3%) patients underwent neurosurgery and 13 (4.6%) died. The odds of ciTBI increased steadily with falling GCS. Compared with GCS 15, odds of ciTBI was 17.5 (95% CI 12.4 to 24.6) times higher for GCS 14, and 484.5 (95% CI 289.8 to 809.7) times higher for GCS 3. The area under the ROC curve for the association between GCS and ciTBI was 0.79 (95% CI 0.77 to 0.82), for GCS and mortality 0.91 (95% CI 0.82 to 0.99) and for GCS and neurosurgery 0.88 (95% CI 0.83 to 0.92). Conclusions Outside clinical decision rules, decreasing levels of GCS are an important indicator for increasing risk of ciTBI, neurosurgery and death. The level of GCS should drive clinician decision-making in terms of urgency of neurosurgical consultation and possible transfer to a higher level of care.	[Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Kochar, Amit; Borland, Meredith L.; Phillips, Natalie; Dalton, Sarah; Cheek, John Alexander; Furyk, Jeremy; Neutze, Jocelyn; Dalziel, Stuart; Oakley, Ed; Babl, Franz E.] Paediat Res Emergency Dept Int Collaborat, PREDICT, Melbourne, Vic, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat & Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Phillips, Natalie] Queensland Childrens Hosp, Emergency Dept, South Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Child Hlth Res Ctr, Fac Med, South Brisbane, Qld, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Dept Emergency, Sydney, NSW, Australia; [Cheek, John Alexander; Lyttle, Mark D.; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp Melbourne, Emergency Dept, Parkville, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Furyk, Jeremy] Univ Hosp Geelong, Emergency Dept, Geelong, Vic, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Hearps, Stephen] Murdoch Childrens Res Inst, Emergency Res, Parkville, Vic, Australia; [Dalziel, Stuart] Starship Childrens Hosp, Childrens Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Bressan, Silvia] Univ Padua, Dept Womens & Childs Hlth, Padua, Italy		Kochar, A (corresponding author), Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia.; Kochar, A (corresponding author), Paediat Res Emergency Dept Int Collaborat, PREDICT, Melbourne, Vic, Australia.	amit.kochar@sa.gov.au		Furyk, Jeremy/0000-0002-9503-0928; Lyttle, Mark/0000-0002-8634-7210; Hearps, Stephen/0000-0003-2984-1172	National Health and Medical Research Council, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727]; National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine) Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140),Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia, a Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; and an NHMRC Practitioner Fellowship, Canberra, Australia. SRD's time was part funded by the Health Research Council of New Zealand (HRC13/556).	[Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Bossuyt PM, 2003, ACAD RADIOL, V10, P664, DOI 10.1016/S1076-6332(03)80086-7; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; NICE guidelines, HEAD INJ ASS EARL MA; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Reiley DG, 2003, ACAD EMERG MED, V10, P492; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Wing R, 2013, EMERG MED CLIN N AM, V31, P653, DOI 10.1016/j.emc.2013.05.007; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	33	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	MAR	2020	37	3					127	+		10.1136/emermed-2018-208154			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LJ2ZR	WOS:000530038300004	32051126				2022-02-06	
J	Kulesza, B; Litak, J; Grochowski, C; Nogalski, A; Rola, R				Kulesza, Bartlomiej; Litak, Jakub; Grochowski, Cezary; Nogalski, Adam; Rola, Radoslaw			The Initial Factors with Strong Predictive Value in Relation to Six-Month Outcome among Patients Operated due to Extra-Axial Hematomas	DIAGNOSTICS			English	Article						traumatic brain injury; epidural hematoma; subdural hematoma; factors; outcome	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; COMPUTERIZED-TOMOGRAPHY SCAN; PROGNOSTIC VALUE; SURGICAL-MANAGEMENT; HEAD-INJURY; MORTALITY; ALCOHOL; MODERATE; CT	Introduction: Traumatic brain injuries (TBI) are a real social problem, with an upward trend worldwide. The most frequent consequence of a traumatic brain injury is extra-axial hemorrhage, i.e., an acute subdural (SDH) and epidural hematoma (EDH). Most of the factors affecting the prognosis have been analyzed on a wide group of traumatic brain injuries. Nonetheless, there are few studies analyzing factors influencing the prognosis regarding patients undergoing surgery due to acute subdural and epidural hematoma. The aim of this study was to identify the factors which have the strongest prognostic value in relation to the 6-month outcome of the patients undergoing surgery for SDH and EDH. Patients and methods: The study included a group of 128 patients with isolated craniocerebral injuries. Twenty eight patients were operated upon due to EDH, and a group of 100 patients were operated upon due to SDH. The following factors from the groups were analyzed: demographic data, physiological factors, laboratory factors, computed tomography scan characteristics, and time between the trauma and the surgery. All of these factors were correlated in a multivariate analysis with the six-month outcome in the Glasgow outcome scale. Results: The factors with the strongest prognostic value are GCS score, respiration rate, saturation, glycaemia and systolic blood pressure. Conclusion: Initial GCS score, respiratory rate, saturation, glycaemia and systolic blood pressure were the factors with the strongest prognostic value.	[Kulesza, Bartlomiej; Litak, Jakub; Rola, Radoslaw] Med Univ Lublin, Dept Neurosurg & Pediat Neurosurg, Jaczewskiego 8, PL-20954 Lublin, Poland; [Litak, Jakub] Med Univ Lublin, Dept Immunol, Chodzki 4a, PL-20093 Lublin, Poland; [Grochowski, Cezary] Med Univ Lublin, Dept Anat, Jaczewskiego 4, PL-20090 Lublin, Poland; [Grochowski, Cezary] Med Univ Lublin, Dept Anat, Lab Virtual Man, Jaczewskiego 4, PL-20090 Lublin, Poland; [Nogalski, Adam] Med Univ Lublin, Dept Trauma Surg & Emergency Med, Stasz 16, PL-20090 Lublin, Poland		Litak, J (corresponding author), Med Univ Lublin, Dept Neurosurg & Pediat Neurosurg, Jaczewskiego 8, PL-20954 Lublin, Poland.; Litak, J (corresponding author), Med Univ Lublin, Dept Immunol, Chodzki 4a, PL-20093 Lublin, Poland.	kuleszabartek88@gmail.com; jakub.litak@gmail.com; cezary.grochowski@o2.pl; chirurgiaurazowalublin@tlen.pl; rola.radoslaw@gmail.com	Litak, Jakub/AAY-8496-2020; Grochowski, Cezary/AAF-1165-2021; Kulesza, Bartlomiej/AAY-3156-2020; Rola, Radoslaw/AAQ-5587-2021	Grochowski, Cezary/0000-0002-2938-885X; Kulesza, Bartlomiej/0000-0002-9973-9571; Rola, Radoslaw/0000-0003-0613-6593; Litak, Jakub/0000-0001-7954-9263; Nogalski, Adam/0000-0003-0720-4690			Balik V, 2011, CENT EUR NEUROSURG, V72, P169, DOI 10.1055/s-0031-1286261; Bernier RA, 2016, BRAIN INJURY, V30, P414, DOI 10.3109/02699052.2015.1127998; Cely CM, 2004, CHEST, V126, P879, DOI 10.1378/chest.126.3.879; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0; Gurkanlar D, 2009, TURK NEUROSURG, V19, P211; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jeong Young Ha, 2016, Korean J Neurotrauma, V12, P47, DOI 10.13004/kjnt.2016.12.2.47; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Kalayci M, 2013, J PAK MED ASSOC, V63, P38; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Krishna G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020588; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ndoumbe A., 2016, OPEN J MOD NEUROSURG, V6, P89, DOI [10.4236/ojmn.2016.63016, DOI 10.4236/OJMN.2016.63016]; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Rejeb I, 2015, J ACUTE DIS, V4, P68, DOI 10.1016/S2221-6189(14)60087-1; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sergides IG, 2006, BRIT J NEUROSURG, V20, P301, DOI 10.1080/02688690600999976; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wood RL, 1981, APPL CONDITIONING TH, P81; Yurt I, 1996, TURKISH NEUROSURG, V6, P63; Zuhroidah I., 2018, NURSE HLTH J KEPERAW, V7, P148	45	4	4	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	MAR	2020	10	3							174	10.3390/diagnostics10030174			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA9XR	WOS:000524293700024	32209970	Green Published, gold			2022-02-06	
J	Ponsford, J; Lee, NK; Wong, D; McKay, A; Haines, K; Downing, M; Alway, Y; Furtado, C; O'Donnell, ML				Ponsford, Jennie; Lee, Nicole K.; Wong, Dana; McKay, Adam; Haines, Kerrie; Downing, Marina; Alway, Yvette; Furtado, Christina; O'Donnell, Meaghan L.			Factors Associated With Response to Adapted Cognitive Behavioral Therapy for Anxiety and Depression Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; cognitive behavioral therapy; depression; traumatic brain injury	WORKING ALLIANCE; PANIC DISORDER; STRESS SCALES; REHABILITATION; PSYCHOTHERAPY; PREDICTORS; VARIABLES; EFFICACY; CBT	Background: Given the high frequency and significance of anxiety and depression following traumatic brain injury (TBI), there is a need to evaluate the efficacy of psychological interventions and to understand factors influencing response to such interventions. The present study investigated factors associated with positive response to cognitive behavioral therapy adapted for cognitive impairments (CBT-ABI) for individuals with anxiety and depression following TBI, including demographic and injury-related factors, pretreatment levels of anxiety and depression, working alliance, and change expectancy as predictors. Methods: Participants were 45 individuals enrolled in an active treatment condition within a randomized controlled trial, examining the efficacy of a 9-session CBT-ABI program for anxiety and depression following TBI. These participants completed all CBT sessions. Results: Mixed-effects regressions controlling for baseline anxiety and depression indicated that for anxiety, older age at injury, as well as higher level of baseline anxiety, was associated with greater symptom reduction. For depression, longer time since injury and higher expectancy for change, as well as higher baseline level of depression, were significantly associated with a greater reduction in depression symptoms. Conclusions: This study paves the way for more detailed studies of the therapeutic processes involved in alleviating anxiety and depression following TBI.	[Ponsford, Jennie; Wong, Dana; McKay, Adam; Haines, Kerrie; Downing, Marina; Alway, Yvette; Furtado, Christina] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic 3800, Australia; [Lee, Nicole K.] Curtin Univ, Natl Drug Res Inst, Bentley, WA, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia; [O'Donnell, Meaghan L.] Univ Melbourne, Phoenix Australia, Carlton, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632; Wong, Dana/0000-0001-9619-1929; O'Donnell, Meaghan/0000-0003-4349-0022			Aharonovich E, 2008, DRUG ALCOHOL DEPEN, V95, P279, DOI 10.1016/j.drugalcdep.2008.01.009; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Baldwin SA, 2007, J CONSULT CLIN PSYCH, V75, P842, DOI 10.1037/0022-006X.75.6.842; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Brabban A, 2009, SCHIZOPHRENIA BULL, V35, P859, DOI 10.1093/schbul/sbp065; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Coughlin A, 2007, MEMORY INFORM PROCES; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dow MGT, 2007, PSYCHOL MED, V37, P1493, DOI 10.1017/S0033291707000670; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Feeley M, 1999, J CONSULT CLIN PSYCH, V67, P578, DOI 10.1037/0022-006X.67.4.578; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Greenberg RP, 2006, CLIN PSYCHOL REV, V26, P657, DOI 10.1016/j.cpr.2005.03.002; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Lorenzo-Luaces L, 2014, J CONSULT CLIN PSYCH, V82, P368, DOI 10.1037/a0035994; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Pais C, 2017, NEUROPSYCHOL REHABIL, P1; Pinsoff, 1986, PSYCHOTHERAPEUTIC PR, P529; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Tracey T.J., 1989, J CONSULT CLIN PSYCH, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207, 10.1037/1040-3590.1.3.207.]; Westra HA, 2007, J CONSULT CLIN PSYCH, V75, P363, DOI 10.1037/0022-006X.75.3.363; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wong D, 2018, COGNITIVE BEHAV THER; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		117	126		10.1097/HTR.0000000000000510			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500009	31365437				2022-02-06	
J	Pretz, C; Kowalski, RG; Cuthbert, JP; Whiteneck, GG; Miller, AC; Ketchum, JM; Dams-O'Connor, K				Pretz, Christopher; Kowalski, Robert G.; Cuthbert, Jeffrey P.; Whiteneck, Gale G.; Miller, A. Cate; Ketchum, Jessica M.; Dams-O'Connor, Kristen			Return to Productivity Projections for Individuals With Moderate to Severe TBI Following Inpatient Rehabilitation: A NIDILRR TBIMS and CDC Interagency Collaboration	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						education; employment; longitudinal data analysis; outcomes; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SYSTEMS NATIONAL DATABASE; WORKING-AGE INDIVIDUALS; UNITED-STATES; EMPLOYMENT; OUTCOMES; DISABILITY; PREDICTORS; INSTITUTE; LIFE	Objective: Return to work and school following traumatic brain injury (TBI) is an outcome of central importance both to TBI survivors and to society. The current study estimates the probability of returning to productivity over 5 years following moderate to severe brain injury. Design: A secondary longitudinal analysis using random effects modeling, that is, individual growth curve analysis based on a sample of 2542 population-weighted individuals from a multicenter cohort study. Setting: Acute inpatient rehabilitation facilities. Participants: Individuals 16 years and older with a primary diagnosis of TBI who were engaged in school or work at the time of injury. Main Outcome Measures: Participation in productive activity, defined as employment or school, as reported during follow-up telephone interviews at 1, 2, and 5 years postinjury. Results: Baseline variables, age of injury, race, level of education and occupational category at the time of injury, disability rating at hospital discharge, substance abuse status, and rehabilitation length of stay, are significantly associated with probability of return to productivity. Individual-level productivity trajectories generally indicate that the probability of returning to productivity increases over time. Conclusions: Results of this study highlight the importance of preinjury occupational status and level of education in returning to productive activity following moderate to severe TBI.	[Pretz, Christopher; Whiteneck, Gale G.; Ketchum, Jessica M.] Craig Hosp, Denver, CO USA; [Pretz, Christopher; Kowalski, Robert G.; Whiteneck, Gale G.; Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Stat & Data, Englewood, CO USA; [Cuthbert, Jeffrey P.] Swedish Ridge Med Ctr, Englewood, CO USA; [Miller, A. Cate] NIDILRR, Adm Community Living, Washington, DC USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.; Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	Kristen.Dams-OConnor@mountsinai.org			US Department of Health and Human Services (HHS); Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; NIDRR [90DP0013, 90DP0084]; NIDILRRUnited States Department of Health & Human Services [90DP0038, 90DP0009]; National Institutes of Health, National Institute of Child Health and Development (NIH/NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01 HD074651]	This research was supported by an interagency agreement between the US Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and the US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR), with supplemental funding to the NIDRR-funded Traumatic Brain Injury Model Systems National Data and Statistical Center (grant nos. 90DP0013 and 90DP0084). In 2014, NIDRR was moved from the US Department of Education to the Administration for Community Living of HHS and was renamed the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). The TBIModel SystemsNational Database is supported by NIDILRR and created and maintained by the TBI Model System Centers program. This project was additionally supported by grants from NIDILRR (90DP0038, 90DP0009) and the National Institutes of Health, National Institute of Child Health and Development (NIH/NICHD, grant no. K01 HD074651).	Butler LN, 2016, J VOCAT REHABIL, V44, P295, DOI 10.3233/JVR-160804; Colton, 2005, ENCY BIOSTATISTICS; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dahm J, 2015, BRAIN INJURY, V29, P1539, DOI 10.3109/02699052.2015.1075141; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kalton G., 2003, J OFF STAT, V19, P81; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Pretz CR, 2015, ARCH PHYS MED REHAB, V96, P746, DOI 10.1016/j.apmr.2014.09.025; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Pretz CR, 2015, JOINT STAT M AUG 12; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; US Department of Labor, 2006, EMPL PERS OCC SEX AG; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wagner M., 2004, TRANSITION PLANNING; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Willmott C, 2015, BRAIN INJURY, V29, P929, DOI 10.3109/02699052.2015.1022882	49	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		140	151		10.1097/HTR.0000000000000506			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500013	31365435				2022-02-06	
J	Register-Mihalik, JK; Kay, MC; Kerr, ZY; Peck, KY; Houston, MN; Gildner, P; Svoboda, SJ; Marshall, SW; Cameron, KL				Register-Mihalik, Johna K.; Kay, Melissa C.; Kerr, Zachary Y.; Peck, Karen Y.; Houston, Megan N.; Gildner, Paula; Svoboda, Steven J.; Marshall, Stephen W.; Cameron, Kenneth L.			Influence of Concussion Education Exposure on Concussion-Related Educational Targets and Self-Reported Concussion Disclosure among First-Year Service Academy Cadets	MILITARY MEDICINE			English	Article							FOR-DISEASE-CONTROL; ICE HOCKEY; COLLEGIATE; COMMUNICATION; KNOWLEDGE; HEADS; NORMS	Introduction Concussion disclosure is often essential for military personnel to receive appropriate care following concussive injury. Concussion-related education and training may play a role in improving disclosure and recognition among peers, allowing for more timely concussion identification and treatment. The objectives of this study were to: (1) describe concussion education exposure among first-year service academy cadets and (2) examine the association between exposure to concussion education sources (multiple vs. only one) and concussion-related knowledge, attitudes, perceived social norms, intention to disclose symptoms, and disclosure behaviors. Materials and Methods First-year service academy cadets completed a cross-sectional survey to assess perceptions of concussion disclosure during preseason concussion baseline testing sessions. Associations between key cadet characteristics and exposure to multiple concussion education sources were examined using odds ratios and 95% confidence intervals. Linear regression was used to model the continuous measures of concussion-related knowledge, attitudes, and perceived social norms. Logbinomial regression was used to model the categorical outcomes of high perceived control over concussion disclosure (higher vs. lower), intention to disclose (higher vs. lower), and disclosure of all possible concussive events at the time of injury (yes vs. no). The primary predictor for all models was exposure to multiple sources of concussion education (video, coach, medical professional, or other) vs. exposure to only one educational source. All models were adjusted for gender, high school contact sport participation, and previous concussion history. Results Of the 972 first-year cadets (85% response; age = 18.4 +/- 0.9 years; 21.7% female, 29.0% NCAA student-athlete), 695 (71.5%) reported receiving some type of previous concussion education and 229 (23.6%) reported a previous concussion history (206/229 reported the actual number they experienced). Of those reporting previous concussion-related education (n = 695), 542 (78.0%) watched a video, 514 (74.0%) talked with a coach about concussion, 433 (62.3%) talked with a medical professional, and 61 (8.8%) reported other sources of education ranging from anatomy teachers to brochures. Overall, 527 (75.8%) reported receiving more than one source of concussion education. Having played a contact sport in high school and having a history of concussion were associated with having multiple concussion education exposures. Being female was associated with lower odds of multiple exposures. Exposure to multiple sources of concussion education was not associated with knowledge, attitudes, perceived norms, or higher intention to disclose concussion symptoms. However, among those with a concussion history, exposure to multiple sources of concussion education was associated with a nearly 40% higher prevalence of disclosing all concussions at the time of injury compared to only one source of educational exposure (67.1% vs. 48.3%; prevalence ratio = 1.4; 95% confidence interval: 0.9, 2.1). Thus, although multiple sources of education may not influence intermediate variables of knowledge, attitudes, perceived norms and intentions, exposure to multiple sources of concussion education may influence actual decision-making around concussion disclosure among first-year service academy cadets. Conclusions These data suggest disparities in concussion education exposure that can be addressed in first-year cadets. Additionally, findings support the importance and use of multiple sources of concussion education in improving cadet's concussion-related decision-making.	[Register-Mihalik, Johna K.; Kay, Melissa C.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, CB 8700, Chapel Hill, NC 27599 USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.; Gildner, Paula; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, CB 7505, Chapel Hill, NC 27599 USA; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, 118 Coll Dr,5122, Hattiesburg, MS 39406 USA; [Peck, Karen Y.; Houston, Megan N.; Svoboda, Steven J.; Cameron, Kenneth L.] US Mil Acad, Keller Army Hosp, 990 Washington Rd, West Point, NY 10996 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, CB 7400, Chapel Hill, NC 27599 USA; [Cameron, Kenneth L.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, CB 8700, Chapel Hill, NC 27599 USA.; Register-Mihalik, JK (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, CB 7505, Chapel Hill, NC 27599 USA.				NCAA-DoD Mind Matters Challenge Research Grant	This study was funded in part by a NCAA-DoD Mind Matters Challenge Research Grant.	Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Piana LE, 2019, PHYSICIAN SPORTSMED, V3, P1; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Rawlins MLW, 2020, MIL MED, V185, pE269, DOI 10.1093/milmed/usz162; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; Wilkerson GB, 2018, J ATHL TRAINING, V53, P320, DOI 10.4085/1062-6050-8-17	18	4	4	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					E403	E409		10.1093/milmed/usz414			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR7HU	WOS:000535866100015	31789379	Bronze			2022-02-06	
J	Shepherd-Banigan, M; Sperber, N; McKenna, K; Pogoda, TK; Van Houtven, CH				Shepherd-Banigan, Megan; Sperber, Nina; McKenna, Kevin; Pogoda, Terri K.; Van Houtven, Courtney H.			Leveraging institutional support for family caregivers to meet the health and vocational needs of persons with disabilities	NURSING OUTLOOK			English	Article						Family caregivers; Health system; Persons with disabilities; Qualitative research; Social support; US Department of Veterans; Affairs; Vocational assistance services	TRAUMATIC BRAIN-INJURY; VETERANS; REINTEGRATION; EMPLOYMENT; SERVICES; WORK; CARE	Background: Family caregivers might enhance veteran engagement in health and nonhealth services (i.e., vocational/educational assistance). Purpose: To describe how veterans with disabilities perceive their recovery needs, identify types of social support from caregivers that help veterans engage in Veterans Affairs (VA) health and nonhealth services, and explore participant views of VA institutional support for caregivers to help veterans engage in these services. Methods: Joint in-depth qualitative interviews with U.S. veterans and family caregivers (n = 26). Findings: Caregivers performed social support functions that helped veterans engage in health and vocational/educational services and institutional support from VA enhanced caregivers' capacity. Discussion: Caregivers are well positioned to align health and nonhealth services with patient needs to enhance recovery. Staffing a point person for caregivers within the health system is key to help families develop a coordinated plan of treatment and services to improve patient success across health and nonhealth domains. Nurses are well suited to perform this role.	[Shepherd-Banigan, Megan; Sperber, Nina; Van Houtven, Courtney H.] Durham VA Hlth Care Syst, Ctr Innovat Accelerate Discovery & Practice Trans, Durham, NC 27705 USA; [Shepherd-Banigan, Megan; Sperber, Nina; McKenna, Kevin; Van Houtven, Courtney H.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Van Houtven, Courtney H.] Duke Univ, Duke Margolis Ctr Hlth Policy, Durham, NC USA		Shepherd-Banigan, M (corresponding author), Durham VA Hlth Care Syst, 508 Fulton St, Durham, NC 27705 USA.	mes86@duke.edu		McKenna, Kevin/0000-0003-3983-1306; Van Houtven, Courtney/0000-0002-0783-1611	Robert Wood Johnson Foundation through the Systems for Action National Coordinating Center [74941]; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) at the Durham VA Health Care System [CIN 13-410]; Department of Veterans Affairs, Caregiver Support Program, and Quality Enhancement Research InitiativeUS Department of Veterans Affairs [PEC 14-272]	Support for this publication was provided by the Robert Wood Johnson Foundation through the Systems for Action National Coordinating Center, ID 74941. Additional support comes from the Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT; CIN 13-410) at the Durham VA Health Care System and the Department of Veterans Affairs, Caregiver Support Program, and Quality Enhancement Research Initiative (PEC 14-272). We would like to acknowledge the efforts of Karen Stechuchak who compiled the recruitment list and Emilie Travis who recruited all participants.	Abraham KM, 2014, J REHABIL RES DEV, V51, P401, DOI 10.1682/JRRD.2013.05.0114; Administration VH, 2016, WHOL HLTH LIF COMP P; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Davis LL, 2018, JAMA PSYCHIAT, V75, P316, DOI 10.1001/jamapsychiatry.2017.4472; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; Fischer EP, 2015, PSYCHOL SERV, V12, P187, DOI 10.1037/ser0000033; Gaudet T, 2019, J ALTERN COMPLEM MED, V25, pS7, DOI 10.1089/acm.2018.29061.gau; Grant Marcia, 2012, Semin Oncol Nurs, V28, P279, DOI 10.1016/j.soncn.2012.09.011; Guest G., 2012, APPL THEMATIC ANAL; Holder K. A., 2018, VET WHO HAVE SERVED; Holmes RD, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-138; Kukla M, 2016, PSYCHIAT SERV, V67, P412, DOI 10.1176/appi.ps.201500108; Kukla M, 2015, J REHABIL RES DEV, V52, P477, DOI 10.1682/JRRD.2014.11.0289; Kukla M, 2012, J NERV MENT DIS, V200, P214, DOI 10.1097/NMD.0b013e318247cb29; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Polak L, 2016, QUAL HEALTH RES, V26, P1638, DOI 10.1177/1049732315580103; Resnik L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-145; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Sayer NA, 2008, J TRAUMA STRESS, V21, P40, DOI 10.1002/jts.20309; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Simmons Leigh Ann, 2016, Fed Pract, V33, P27; Sperber NR, 2019, HEALTH AFFAIR, V38, P957, DOI 10.1377/hlthaff.2019.00012; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Van Houtven CH, 2019, MED CARE RES REV, V76, P89, DOI 10.1177/1077558717697015; Van Houtven CH, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-77; Wills TA, 1991, REV PERSONALITY SOCI; Wills TA., 1985, SOCIAL SUPPORT HLTH, P61; Wyse J. J., 2018, PSYCHOL SERVICES; Zenzano T, 2011, AM J PREV MED, V40, P261, DOI 10.1016/j.amepre.2010.10.023	31	4	4	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0029-6554	1528-3968		NURS OUTLOOK	Nurs. Outlook	MAR-APR	2020	68	2					184	193		10.1016/j.outlook.2019.08.006			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	LD5ZH	WOS:000526108400010	31570147	Green Accepted			2022-02-06	
J	Zhao, JJ; Wang, T; Lv, QM; Zhou, N				Zhao, Junjing; Wang, Tao; Lv, Qiming; Zhou, Nan			Expression of heat shock protein 70 and Annexin A1 in serum of patients with acutely severe traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						severe traumatic brain injury; heat shock protein 70; Annexin A1; diagnostic value	HEAT-SHOCK PROTEINS; CEREBRAL-ISCHEMIA; HSP70; STRESS; PROTECTS; CELLS	Trends of early expression levels of heat shock protein 70 (Hsp70) and Annexin A1 (ANXA1) in serum of patients with acutely severe traumatic brain injury and the effects on clinical prognosis were investigated. Eighty-four patients with severe traumatic brain injury admitted to Binzhou Center Hospital from June 2014 to July 2017 were selected as the experimental group. Glasgow coma scale and acute physiology and chronic health evaluation II (APACHE II) score were obtained after admission. A further 75 healthy subjects were selected as the control group. Serum expression of Hsp70 and ANXA1 in the two groups was detected by enzyme-linked immunosorbent assay on the 1st, 2nd, 3rd and 4th day after admission. The receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of Hsp70 and ANXA1 for the death of patients with acutely severe traumatic brain injury. Compared with the control group, expression of Hsp70 in the experimental group was significantly increased on the 1st, 2nd, 3rd and 4th day after admission (P<0.05), while expression of ANXA1 was significantly decreased (P<0.05). Expression levels of serum Hsp70 in the experimental group reached the peak on the 3rd day after admission, and the difference was statistically significant compared with the 1st, 2nd and 4th day (P<0.05). Expression of ANXA1 was the lowest on the 3rd day, and the difference was statistically significant compared with the 1st, 2nd and 4th day (P<0.05). The ROC curve analysis showed that the area under the curve of serum Hsp70 and ANXA1 was, respectively, 0.721 (95% CI: 0.611-0.829) and 0.684 (95% CI: 0.569-0.799). In conclusion, Hsp70 and ANXA1 may be involved in the occurrence and progression of acutely severe traumatic brain injury. The detection of serum Hsp70 and ANXA1 has certain diagnostic value for the death of patients with acutely severe traumatic brain injury.	[Zhao, Junjing] Binzhou Ctr Hosp, Dept Neurosurg, Binzhou 251700, Shandong, Peoples R China; [Wang, Tao; Lv, Qiming] Liaocheng Third Peoples Hosp, Dept Neurosurg, Liaocheng 252000, Shandong, Peoples R China; [Zhou, Nan] Jinan Cent Hosp, Dept Hlth Care, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China		Zhou, N (corresponding author), Jinan Cent Hosp, Dept Hlth Care, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.	zrjh99@163.com					Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Bidmon-Fliegenschnee B, 2015, PEDIATR RES, V78, P358, DOI 10.1038/pr.2015.112; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Capraz IY, 2015, SEIZURE-EUR J EPILEP, V29, P63, DOI 10.1016/j.seizure.2015.03.015; Chen Feixiang, 2018, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V30, P57, DOI 10.3760/cma.j.issn.2095-4352.2018.01.011; Cheng CY, 2019, AM J CHINESE MED, V47, P39, DOI 10.1142/S0192415X19500034; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; Deane CAS, 2018, NEUROCHEM RES, V43, P340, DOI 10.1007/s11064-017-2429-z; Godinjak Amina, 2016, Acta Med Acad, V45, P97, DOI 10.5644/ama2006-124.165; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Kim J, 2016, NEUROPSYCH DIS TREAT, V12, P1887, DOI 10.2147/NDT.S110400; Luo ZZ, 2014, J NEUROIMMUNOL, V276, P24, DOI 10.1016/j.jneuroim.2014.07.013; Memarian N, 2015, COMPUT BIOL MED, V64, P67, DOI 10.1016/j.compbiomed.2015.06.008; Miova B, 2015, J CELL BIOCHEM, V116, P2365, DOI 10.1002/jcb.25187; Ren BQ, 2016, CELL STRESS CHAPERON, V21, P677, DOI 10.1007/s12192-016-0694-4; Sen A, 2018, BRAIN, V141, P1592, DOI 10.1093/brain/awy022; Sun ZX, 2015, EXP THER MED, V10, P1896, DOI 10.3892/etm.2015.2753; Wang T, 2018, J STROKE CEREBROVASC, V27, P2829, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.018; Wang Z, 2017, J CEREBR BLOOD F MET, V37, P2509, DOI 10.1177/0271678X16669513; Xia M, 2017, CELL MOL NEUROBIOL, V37, P1105, DOI 10.1007/s10571-016-0444-2; Xiong Jie, 1998, Yaoxue Xuebao, V33, P401; Xu GT, 2015, BIOL TRACE ELEM RES, V164, P192, DOI 10.1007/s12011-014-0225-z; Yan J, 2017, FISH SHELLFISH IMMUN, V66, P103, DOI 10.1016/j.fsi.2017.05.023; Yurinskaya MM, 2016, DOKL BIOCHEM BIOPHYS, V469, P239, DOI 10.1134/S1607672916040025; Zhang Y, 2016, ANTIOXID REDOX SIGN, V24, P991, DOI 10.1089/ars.2015.6505; Zhou Yi, 2015, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V31, P136; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	28	4	4	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAR	2020	19	3					1896	1902		10.3892/etm.2019.8357			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KU5CC	WOS:000519726400036	32104246	gold, Green Published			2022-02-06	
J	Nebie, O; Barro, L; Wu, YW; Knutson, F; Buee, L; Devos, D; Peng, CW; Blum, D; Burnouf, T				Nebie, Ouada; Barro, Lassina; Wu, Yu-Wen; Knutson, Folke; Buee, Luc; Devos, David; Peng, Chih-Wei; Blum, David; Burnouf, Thierry			Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro	PLATELETS			English	Article						HPL; human platelet lysates; neurorestoration; neurotrophins	TRAUMATIC BRAIN-INJURY; GROWTH-FACTORS; RICH PLASMA; REGENERATIVE MEDICINE; NEURITE OUTGROWTH; CELL-LINE; MODEL; INFLAMMATION; BIOMATERIALS; DERIVATIVES	The neurorestorative efficacy of human platelet lysates in neurodegenerative disorders is still under investigation. Platelets prepared from standard and pathogen reduced platelet concentrates were pelletized, washed, concentrated, and subjected to freeze-thawing. The lysate was heated to 56 degrees C for 30 min and characterized. Toxicity was evaluated using SH-SY5Y neuroblastoma, BV-2 microglial, and EA-hy926 endothelial cells. Inflammatory activity was tested by examining tumor necrosis factor (TNF) and cyclooxygenase (COX)-2 expressions by BV-2 microglia with or without stimulation by lipopolysaccharides (LPS). The capacity to stimulate wound healing was evaluated by a scratch assay, and the capacity to differentiate SH-SY5Y into neurons was also examined. Platelet lysates contained a range of neurotrophins. They were not toxic to SH-SY5Y, EA-hy926, or BV-2 cells, did not induce the expression of TNF or COX-2 inflammatory markers by BV-2 microglia, and decreased inflammation after LPS stimulation. They stimulated the wound closure in the scratch assay and induced SH-SY5Y differentiation as revealed by the increased length of neurites as well as beta 3-tubulin and neurofilament staining. These data confirm the therapeutic potential of platelet lysates in the treatment of disorders of the central nervous system and support further evaluation as novel neurorestorative biotherapy in preclinical models.	[Nebie, Ouada; Wu, Yu-Wen; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Xing St, Taipei 11031, Taiwan; [Barro, Lassina; Peng, Chih-Wei; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan; [Knutson, Folke] Uppsala Univ, Clin Immunol & Transfus Med IGP, Uppsala, Sweden; [Buee, Luc; Devos, David; Blum, David] Univ Lille, CHU Lille, INSERM, U1172,Lille Neurosci & Cognit, Lille, France; [Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Int PhD Program Cell Therapy & Regenerat Med, Taipei, Taiwan; [Burnouf, Thierry] Taipei Med Univ, PhD Program Mind Brain & Consciousness, Taipei, Taiwan		Burnouf, T (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Xing St, Taipei 11031, Taiwan.; Blum, D (corresponding author), Univ Lille, Univ Hosp Lille, Aubert Res Ctr, UMR S 1172,Inserm, 1 Pl De Verdun, F-59037 Lille, France.	david.blum@inserm.fr; thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019; BUEE, Luc/B-3126-2010; Devos, David/E-4059-2013	Burnouf, Thierry/0000-0002-0507-9243; BUEE, Luc/0000-0002-6261-4230; Devos, David/0000-0002-2417-799X; Blum, David/0000-0001-5691-431X; BARRO, Lassina/0000-0002-2202-9731; Wu, Yu-Wen/0000-0001-7636-0393; Nebie, OUADA/0000-0002-6802-4215	Ministry of Science and Technology (MOST) of TaiwanMinistry of Science and Technology, Taiwan [108-2314-B-038-009]; Taipei Medical University (TMU) Higher Education Sprout Project MoE [DP2-108-21121-01-N-09-01]; MOST; French Association of Taiwan-Campus France [109-2927-I-038-504]	This study was supported in part by grant 108-2314-B-038-009 from the Ministry of Science and Technology (MOST) of Taiwan and Taipei Medical University (TMU) Higher Education Sprout Project MoE (DP2-108-21121-01-N-09-01 to T. Burnouf's laboratory). The cooperation between T. Burnouf's laboratory of TMU and Inserm UMR-S1172 (Dr. David Blum) was supported by a bilateral Orchid research project (MOST and French Association of Taiwan-Campus France; 109-2927-I-038-504). The funding bodies played no role in the design of the study, collection, analysis, interpretation of the data, or in writing the manuscript.	Alsousou J, 2013, PLATELETS, V24, P173, DOI 10.3109/09537104.2012.684730; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Anitua E, 2015, J CONTROL RELEASE, V203, P170, DOI 10.1016/j.jconrel.2015.02.030; Anitua E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073118; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P5377, DOI 10.1007/s12035-017-0771-4; Barsotti MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084753; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Burnouf T, 2016, BIOMATERIALS, V76, P371, DOI 10.1016/j.biomaterials.2015.10.065; Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001; Chahla J, 2019, ARTHROSCOPY, V35, P118, DOI 10.1016/j.arthro.2018.07.036; Chen NF, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00252; Chou ML, 2017, BIOMATERIALS, V142, P77, DOI 10.1016/j.biomaterials.2017.07.018; Chung JY, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0140-z; D'asta F, 2018, PLATELETS, V29, P9, DOI 10.1080/09537104.2017.1317731; De Pascale MR, 2015, TRANSFUS MED REV, V29, P52, DOI 10.1016/j.tmrv.2014.11.001; Dessels C, 2019, PLATELETS, V30, P356, DOI 10.1080/09537104.2018.1445840; Dukhinova M, 2018, BRAIN BEHAV IMMUN, V74, P7, DOI 10.1016/j.bbi.2018.09.009; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Gouel F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00835; Gouel F, 2017, J TISSUE ENG REGEN M, V11, P3236, DOI 10.1002/term.2222; Harrison P, 2018, J THROMB HAEMOST, V16, P1895, DOI 10.1111/jth.14223; Hayon Y, 2013, THROMB HAEMOSTASIS, V110, P323, DOI 10.1160/TH12-11-0875; Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Leiter O, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101695; Leiter O, 2019, STEM CELL REP, V12, P667, DOI 10.1016/j.stemcr.2019.02.009; Li Y, 2019, J DIABETES, V11, P359, DOI 10.1111/1753-0407.12850; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Miglio G, 2009, NEUROSCI LETT, V454, P134, DOI 10.1016/j.neulet.2009.03.014; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nebie O, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0579-9; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Santos SCND, 2018, TISSUE ENG PART B-RE, V24, P454, DOI [10.1089/ten.teb.2018.0008, 10.1089/ten.TEB.2018.0008]; Nurden AT, 2018, FRONT BIOSCI-LANDMRK, V23, P726, DOI 10.2741/4613; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Park BK, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/7585896; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; Renn TY, 2015, VOX SANG, V109, P138, DOI 10.1111/vox.12264; Rutter S, 2019, TRANSFUSION, V59, P1628, DOI 10.1111/trf.15241; Schallmoser K, 2020, TRENDS BIOTECHNOL, V38, P13, DOI 10.1016/j.tibtech.2019.06.002; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Strandberg G, 2017, TRANSFUSION, V57, P1058, DOI 10.1111/trf.13998; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zhu J, 2018, AM J TRANSL RES, V10, P966; ZUCKERMAN SH, 1989, J IMMUNOL, V143, P1223	51	4	4	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0953-7104	1369-1635		PLATELETS	Platelets	FEB 17	2021	32	2					226	237		10.1080/09537104.2020.1732324		FEB 2020	12	Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology	QV2NS	WOS:000517371500001	32106742				2022-02-06	
J	Edwards, KA; Motamedi, V; Osier, ND; Kim, HS; Yun, SJ; Cho, YE; Lai, C; Dell, KC; Carr, W; Walker, P; Ahlers, S; LoPresti, M; Yarnell, A; Tschiffley, A; Gill, JM				Edwards, Katie A.; Motamedi, Vida; Osier, Nicole D.; Kim, Hyung-Suk; Yun, Sijung; Cho, Young-Eun; Lai, Chen; Dell, Kristine C.; Carr, Walter; Walker, Peter; Ahlers, Stephen; LoPresti, Matthew; Yarnell, Angela; Tschiffley, Anna; Gill, Jessica M.			A Moderate Blast Exposure Results in Dysregulated Gene Network Activity Related to Cell Death, Survival, Structure, and Metabolism	FRONTIERS IN NEUROLOGY			English	Article						blast; overpressure; gene expression; RNA-sequencing; NanoString	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; FALSE DISCOVERY RATE; CARBOXY-TERMINAL HYDROLASE; LOW-LEVEL BLAST; SIGNALING PATHWAY; NEURONAL DEATH; EXPRESSION; UBIQUITIN; MILD	Blast exposure is common in military personnel during training and combat operations, yet biological mechanisms related to cell survival and function that coordinate recovery remain poorly understood. This study explored how moderate blast exposure influences gene expression; specifically, gene-network changes following moderate blast exposure. On day 1 (baseline) of a 10-day military training program, blood samples were drawn, and health and demographic information collected. Helmets equipped with bilateral sensors worn throughout training measured overpressure in pounds per square inch (psi). On day 7, some participants experienced moderate blast exposure (peak pressure >= 5 psi). On day 10, 3 days post-exposure, blood was collected and compared to baseline with RNA-sequencing to establish gene expression changes. Based on dysregulation data from RNA-sequencing, followed by top gene networks identified with Ingenuity Pathway Analysis, a subset of genes was validated (NanoString). Five gene networks were dysregulated; specifically, two highly significant networks: (1) Cell Death and Survival (score: 42), including 70 genes, with 50 downregulated and (2) Cell Structure, Function, and Metabolism (score: 41), including 69 genes, with 41 downregulated. Genes related to ubiquitination, including neuronal development and repair: UPF1, RNA Helicase and ATPase (UPF1) was upregulated while UPF3 Regulator of Nonsense Transcripts Homolog B (UPF3B) was downregulated. Genes related to inflammation were upregulated, including AKT serine/threonine kinase 1 (AKT1), a gene coordinating cellular recovery following TBIs. Moderate blast exposure induced significant gene expression changes including gene networks involved in (1) cell death and survival and (2) cellular development and function. The present findings may have implications for understanding blast exposure pathology and subsequent recovery efforts.	[Edwards, Katie A.; Kim, Hyung-Suk; Yun, Sijung; Lai, Chen; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Edwards, Katie A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Motamedi, Vida] Wake Forest Univ, Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Osier, Nicole D.] Univ Texas Austin, Sch Nursing, Austin, TX 78712 USA; [Osier, Nicole D.] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Cho, Young-Eun] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA; [Dell, Kristine C.; Carr, Walter; LoPresti, Matthew; Yarnell, Angela] Walter Reed Army Inst Res, Silver Spring, MD USA; [Walker, Peter; Ahlers, Stephen; Tschiffley, Anna] Naval Med Res Ctr, Silver Spring, MD USA; [Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, CNRM Co Director Biomarkers Core, Bethesda, MD 20814 USA		Edwards, KA (corresponding author), NINR, NIH, Bethesda, MD 20892 USA.; Edwards, KA (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	katie.edwards@nih.gov		Edwards, Katie/0000-0002-7682-8598	National Institute of Nursing Research Intramural Program; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Navy Bureau of Medicine (NMRC) [2011.0002]; US Navy Bureau of Medicine (WRAIR) [1796]	This work was supported by the National Institute of Nursing Research Intramural Program, the US Army Medical Research and Materiel Command, and the US Navy Bureau of Medicine (NMRC#2011.0002; WRAIR#1796). While producing this article, KE was supported as a Jonas Nurse Leader Scholar.	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bailey Zachary S, 2015, Biomed Sci Instrum, V51, P423; Barichello T, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/371465; Benjamini Y, 2001, ANN STAT, V29, P1165; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cho YE, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00168; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leroy E, 1998, DNA Res, V5, P397, DOI 10.1093/dnares/5.6.397; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Li YS, 2019, MIL MED, V184, P265, DOI 10.1093/milmed/usy330; Lian S, 2015, TOXICOLOGY, V338, P104, DOI 10.1016/j.tox.2015.10.008; Livingston WS, 2017, J NEUROTRAUM, V34, P853, DOI 10.1089/neu.2016.4479; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Struebing FL, 2018, J NEUROTRAUM, V35, P118, DOI 10.1089/neu.2017.5104; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tenielien T, 2008, INVISIBLE WOUNDS WAR, DOI [10.1037/e527612010-001, DOI 10.1037/E527612010-001]; Toman E, 2016, J ROY ARMY MED CORPS, V162, P103, DOI 10.1136/jramc-2015-000517; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Vogl AM, 2015, NAT NEUROSCI, V18, P239, DOI 10.1038/nn.3912; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435; Yan FX, 2017, BIOCHEM BIOPH RES CO, V482, P632, DOI 10.1016/j.bbrc.2016.11.084; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zawada AM, 2016, EPIGENETICS-US, V11, P259, DOI 10.1080/15592294.2016.1158363; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583	67	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 26	2020	11								91	10.3389/fneur.2020.00091			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB3TX	WOS:000524560800001	32174881	Green Published, gold			2022-02-06	
J	Matthews, CR				Matthews, Christopher R.			'The fog soon clears': Bodily negotiations, embodied understandings, competent body action and 'brain injuries' in boxing	INTERNATIONAL REVIEW FOR THE SOCIOLOGY OF SPORT			English	Article						boxing; brain injury; concussion; embodiment; sport; violence; CTE	CHRONIC TRAUMATIC ENCEPHALOPATHY; ATHLETES EXPERIENCES; CONCUSSION; SPORT; RUGBY; MANAGEMENT; CLINICIAN; CULTURE; GENDER; FEMALE	Boxing is 'all about bodies'; beautiful bodies, broken bodies and, sometimes, brain-damaged bodies. And while a lot of research has explored the physiological side of 'punch drunk' syndrome, far less work has attempted to consider how boxers experience brain injuries. Perhaps surprisingly, considering the sports historical and symbolic ties to concussion and degenerative brain diseases, contemporary socio-cultural explorations of the sport tend to be largely devoid of theoretically nuanced discussions of such phenomena. Within this paper, as a means of partly addressing this issue, I examine the 'bodily negotiations' that were part of personal understandings of 'brain injuries'. By considering the manner that such embodied knowhow is shaped by risky notions about the body, I demonstrate how culturally specific competent bodily actions are developed. Such an analysis provides insights into the ways that boxers might symbolically neutralise, pragmatically manage or 'fight through' what they considered to be relatively 'run of the mill' neurological disruption. This helps to demonstrate how their embodied engagement provides the basis by which 'outsider' knowledge, including that provided by medical personnel, might be largely excluded and otherwise diminished.	[Matthews, Christopher R.] Nottingham Trent Univ, Nottingham, England		Matthews, CR (corresponding author), Nottingham Trent Univ, Nottingham, England.	dr.christopher.r.matthews@gmail.com					Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 2017, CLIN SPORTS MED, V17, P37; Caron JG, 2017, J LOSS TRAUMA, V22, P501, DOI 10.1080/15325024.2017.1335150; Channon A, 2020, J SCI MED SPORT, V23, P237, DOI 10.1016/j.jsams.2019.10.014; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M, 1949, C VINCENT; CROSSLEY N, 1995, BODY SOC, V1, P43, DOI [DOI 10.1177/1357034X95001001004, 10.1177/1357034x95001001004]; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Gaetz M, 2017, MED HYPOTHESES, V102, P130, DOI 10.1016/j.mehy.2017.03.023; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Heiskanen B, 2012, URBAN GEOGRAPHY BOXI; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Joki E, 1941, MED ASPECTS BOXING; Jump D, 2017, J YOUTH STUD, V20, P1093, DOI 10.1080/13676261.2017.1307331; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lakoff G, 1991, PHILOS FLESH EMBODIE; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Listen K, 2019, RES SOCIOLOGY SPORT, V12, P89; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Malcolm D, 2002, SOCIOL SPORT J, V19, P149, DOI 10.1123/ssj.19.2.149; Malcolm D., 2019, CONCUSSION CRISIS SP; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matthews C. R., 2019, BUSINESS CULTURE SPO, V2, P113; Matthews C. R, 2015, RES EMBODIED SPORT E; Matthews CR, 2020, ROUT INT HANDB, P373; Matthews CR, 2020, QUAL RES SPORT EXERC, V12, P631, DOI 10.1080/2159676X.2019.1664623; Matthews CR, 2019, ROUTL RES SPORT CULT, P102; Matthews CR, 2017, SPORT SOC, V20, P751, DOI 10.1080/17430437.2016.1179735; Matthews CR, 2016, SYMB INTERACT, V39, P557, DOI 10.1002/SYMB.265; Matthews CR, 2016, GENDER SOC, V30, P312, DOI 10.1177/0891243215620557; Matthews CR, 2014, MEN MASC, V17, P99, DOI 10.1177/1097184X14526699; Matthews CR., 2019, ATHLETE LEARNING ELI, P59; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Mennesson C., 2000, International Review for the Sociology of Sport, V35, P21, DOI 10.1177/101269000035001002; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Merleau-Ponty M, 1964, SIGNS; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Paradis E, 2012, BODY SOC, V18, P82, DOI 10.1177/1357034X12440829; Parviainen J, 2002, DANCE RES J, V31, P11; Polanyi M., 1966, TACIT DIMENSION; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1988, LANCET, V2, P1456; Roderick M, 2005, ETHICS SPORT, P17; Ryle G, 1984, CONCEPT MIND; Sabo, 2000, MASCULINITIES GENDER, P96; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sheard K. G., 1998, International Journal of the History of Sport, V15, P74, DOI 10.1080/09523369808714043; Sugden J., 1996, BOXING SOC INT ANAL; Valovich McLeod TC, 2017, ORTHOP J SPORTS MED, V5, P1; van Ingen C, 2011, SOCIOL SPORT J, V28, P171, DOI 10.1123/ssj.28.2.171; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Wacquant LoicJ.D., 2004, BODY SOUL NOTEBOOKS; Woodward K., 2007, BOXING MASCULINITY I; Woodward K, 2008, ETHNOGRAPHY, V9, P536, DOI 10.1177/1466138108096991; Wright EJ, 2020, INT REV SOCIOL SPORT, V55, P437, DOI 10.1177/1012690218815139; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; Young K, 2012, SPORTS VIOLENCE SOC; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; [No title captured]	73	4	4	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1012-6902	1461-7218		INT REV SOCIOL SPORT	Int. Rev. Sociol. Sport	AUG	2021	56	5					719	738	1012690220907026	10.1177/1012690220907026		FEB 2020	20	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	SU8HH	WOS:000516686100001		hybrid, Green Accepted			2022-02-06	
J	Kjell, J; Gotz, M				Kjell, Jacob; Goetz, Magdalena			Filling the Gaps - A Call for Comprehensive Analysis of Extracellular Matrix of the Glial Scar in Region- and Injury-Specific Contexts	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						brain injury; extracellular matrix; proteomics; glial scar; monocytes; macrophages	SPINAL-CORD-INJURY; INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; BRAIN; MACROPHAGES; IDENTIFICATION; PATHOLOGY; ACCURATE; STROKE	Central nervous system (CNS) injury results in chronic scar formation that interferes with function and inhibits repair. Extracellular matrix (ECM) is prominent in the scar and potently regulates cell behavior. However, comprehensive information about the ECM proteome is largely lacking, and region- as well as injury-specific differences are often not taken into account. These aspects are the focus of our perspective on injury and scar formation. To highlight the importance of such comprehensive proteome analysis we include data obtained with novel analysis tools of the ECM composition in the scar and show the contribution of monocytes to the ECM composition after traumatic brain injury (TBI). Monocyte invasion was reduced using the CCR2-/- mouse line and step-wise de-cellularization and proteomics allowed determining monocyte-dependent ECM composition and architecture of the glial scar. We find significant reduction in the ECM proteins Tgm1, Itih (1,2, and 3), and Ftl in the absence of monocyte invasion. We also describe the scar ECM comprising zones with distinctive composition and show a subacute signature upon comparison to proteome obtained at earlier times after TBI. These results are discussed in light of injury-, region- and time-specific regulation of scar formation highlighting the urgent need to differentiate injury conditions and CNS-regions using comprehensive ECM analysis.	[Kjell, Jacob; Goetz, Magdalena] Ludwig Maximilian Univ Munich, Div Physiol Genom, Biomed Ctr, Munich, Germany; [Kjell, Jacob; Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany; [Kjell, Jacob] Karolinska Inst, Dept Clin Neurosci, Solna, Sweden; [Kjell, Jacob] Karolinska Univ Hosp, Dept Neurol, Solna, Sweden; [Kjell, Jacob] Karolinska Univ Hosp, Dept Neurosurg, Solna, Sweden; [Goetz, Magdalena] Univ Munich, SYNERGY, Excellence Cluster Syst Neurol, Munich, Germany		Kjell, J; Gotz, M (corresponding author), Ludwig Maximilian Univ Munich, Div Physiol Genom, Biomed Ctr, Munich, Germany.; Kjell, J; Gotz, M (corresponding author), Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany.; Kjell, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Solna, Sweden.; Kjell, J (corresponding author), Karolinska Univ Hosp, Dept Neurol, Solna, Sweden.; Kjell, J (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, Solna, Sweden.; Gotz, M (corresponding author), Univ Munich, SYNERGY, Excellence Cluster Syst Neurol, Munich, Germany.	jacob.kjell@ki.se; magdalena.goetz@helmholtz-muenchen.de		Kjell, Jacob/0000-0002-8335-0780	German Research CouncilGerman Research Foundation (DFG) [SFB870, SPP1751, SPP1738]; EU (Eranet) [S-700982-5008-001]; ERC (aERC ChroNeuroRepair) [340793]; Swedish Society for Medical Research (SSMF)	We gratefully acknowledge funding from the German Research Council to MG (SFB870, SPP1751, SPP1738), the EU (Eranet S-700982-5008-001), the ERC (aERC ChroNeuroRepair, 340793, to MG), and the Swedish Society for Medical Research (SSMF) postdoctoral grant to JK.	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; Barkers RA, 2018, NATURE, V557, P329, DOI 10.1038/s41586-018-0087-1; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Conrad M, 2019, NAT CHEM BIOL, V15, P1137, DOI 10.1038/s41589-019-0408-1; Coscia F, 2018, CELL, V175, P159, DOI 10.1016/j.cell.2018.08.065; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Eckert MA, 2019, NATURE, V569, P723, DOI 10.1038/s41586-019-1173-8; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Gascon S, 2016, CELL STEM CELL, V18, P396, DOI 10.1016/j.stem.2015.12.003; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Kizil C, 2015, EMBO REP, V16, P416, DOI 10.15252/embr.201439702; Kjell J, 2020, CELL STEM CELL, V26, P277, DOI 10.1016/j.stem.2020.01.002; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lahiri S, 2016, PROTEOMICS, V16, P437, DOI 10.1002/pmic.201500345; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Mattugini N, 2018, GLIA, V66, P1644, DOI 10.1002/glia.23329; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Quanico J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34518-0; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Roll L, 2019, SEMIN CELL DEV BIOL, V89, P118, DOI 10.1016/j.semcdb.2018.09.012; Roll L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00219; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schiller HB, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156123; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tica J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051461; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Wierer M, 2018, MOL CELL PROTEOMICS, V17, P321, DOI 10.1074/mcp.RA117.000315	55	4	4	3	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	FEB 20	2020	14								32	10.3389/fncel.2020.00032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB5EL	WOS:000524657800001	32153367	gold, Green Published			2022-02-06	
J	Song, JY; Wang, XG; Zhang, ZY; Che, L; Fan, B; Li, GY				Song, Jing-Yao; Wang, Xue-Guang; Zhang, Zi-Yuan; Che, Lin; Fan, Bin; Li, Guang-Yu			Endoplasmic reticulum stress and the protein degradation system in ophthalmic diseases	PEERJ			English	Article						ER stress; Autophagy; UPS; Ophthalmic disease; Ocular	UBIQUITIN-PROTEASOME SYSTEM; AUTOPHAGIC CELL-DEATH; QUALITY-CONTROL PROTEINS; TRAUMATIC BRAIN-INJURY; ER-STRESS; MISFOLDED PROTEINS; APOPTOSIS; DEGENERATION; PATHWAY; ATF6	Objective. Endoplasmic reticulum (ER) stress is involved in the pathogenesis of various ophthalmic diseases, and ER stress-mediated degradation systems play an important role in maintaining ER homeostasis during ER stress. The purpose of this review is to explore the potential relationship between them and to find their equilibrium sites. Design. This review illustrates the important role of reasonable regulation of the protein degradation system in ER stress-mediated ophthalmic diseases. There were 128 articles chosen for review in this study, and the keywords used for article research are ER stress, autophagy, UPS, ophthalmic disease, and ocular. Data sources. The data are from Web of Science, PubMed, with no language restrictions from inception until 2019 Jul. Results. The ubiquitin proteasome system (UPS) and autophagy are important degradation systems in ER stress. They can restore ER homeostasis, but if ER stress cannot be relieved in time, cell death may occur. However, they are not independent of each other, and the relationship between them is complementary. Therefore, we propose that ER stability can be achieved by adjusting the balance between them. Conclusion. The degradation system of ER stress, UPS and autophagy are interrelated. Because an imbalance between the UPS and autophagy can cause cell death, regulating that balance may suppress ER stress and protect cells against pathological stress damage.	[Song, Jing-Yao; Zhang, Zi-Yuan; Che, Lin; Fan, Bin; Li, Guang-Yu] Second Hosp Jilin Univ, Dept Ophthalmol, Changchun, Peoples R China; [Wang, Xue-Guang] Third Peoples Hosp Jinan, Dept Traumat Orthoped, Jinan, Peoples R China		Li, GY (corresponding author), Second Hosp Jilin Univ, Dept Ophthalmol, Changchun, Peoples R China.	liguangyu@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81570864]; Natural Science Foundation of Jilin Province [20160101004JC, 20160414045GH, 2016J041]	The study was funded by the National Natural Science Foundation of China (No. 81570864) and the Natural Science Foundation of Jilin Province (No. 20160101004JC; No. 20160414045GH; No. 2016J041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Allen Dylan, 2018, J Mol Signal, V13, P1, DOI 10.5334/1750-2187-13-1; Amato R, 2018, PHARMACOL RES, V128, P167, DOI 10.1016/j.phrs.2017.09.022; Angele MK, 1999, J TRAUMA, V46, P34, DOI 10.1097/00005373-199901000-00006; Ansar M, 2015, HUM GENET, V134, P941, DOI 10.1007/s00439-015-1571-4; Athanasiou Dimitra, 2017, Hum Mol Genet, V26, P4896, DOI 10.1093/hmg/ddx370; Bachar-Wikstrom E, 2013, AUTOPHAGY, V9, P626, DOI 10.4161/auto.23642; Bao Y, 2018, AUTOPHAGY, V14, P1562, DOI 10.1080/15548627.2018.1462426; Bejarano Eloy, 2010, Proc Am Thorac Soc, V7, P29, DOI 10.1513/pats.200909-102JS; Boya P, 2016, PROG RETIN EYE RES, V55, P206, DOI 10.1016/j.preteyeres.2016.08.001; Chandrika BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140025; Chen C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00658; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Choi SI, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12426; Christen V, 2012, CHEMOSPHERE, V87, P423, DOI 10.1016/j.chemosphere.2011.12.046; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Cohen-Kaplan V, 2017, AUTOPHAGY, V13, P759, DOI 10.1080/15548627.2016.1278327; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Darom A, 2010, MOL BIOL CELL, V21, P1788, DOI 10.1091/mbc.E09-09-0774; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dibas A, 2008, MOL VIS, V14, P1770; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; Doh SH, 2010, BRAIN RES, V1308, P158, DOI 10.1016/j.brainres.2009.10.025; El Khouri E, 2013, J BIOL CHEM, V288, P31177, DOI 10.1074/jbc.M113.470500; Elmasry K, 2018, DIABETOLOGIA, V61, P1220, DOI 10.1007/s00125-018-4560-z; Franziska W, 2018, J BIOL CHEM, V293, P18270, DOI [10.1074/jbc.RA118.002121, DOI 10.1074/JBC.RA118.002121]; Fregno Ilaria, 2018, F1000Res, V7, P454, DOI 10.12688/f1000research.13968.1; Fu DX, 2016, DIABETOLOGIA, V59, P2251, DOI 10.1007/s00125-016-4058-5; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glickman MH, 2000, SEMIN CELL DEV BIOL, V11, P149, DOI 10.1006/scdb.2000.0161; Golestaneh N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.453; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guo FJ, 2014, CELL SIGNAL, V26, P332, DOI 10.1016/j.cellsig.2013.11.018; Ha YJ, 2018, INVEST OPHTH VIS SCI, V59, P4670, DOI 10.1167/iovs.18-24427; Hayat B, 2019, EXP EYE RES, V181, P197, DOI 10.1016/j.exer.2019.02.004; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang HB, 2014, MOL MED REP, V9, P1737, DOI 10.3892/mmr.2014.1987; Jiang TX, 2018, BIOL REV, V93, P1765, DOI 10.1111/brv.12419; Karnati R, 2016, EXP EYE RES, V144, P4, DOI 10.1016/j.exer.2015.08.015; Kimura K, 2010, INVEST OPHTH VIS SCI, V51, P1943, DOI 10.1167/iovs.09-3573; Kleesattel D, 2015, INVEST OPHTH VIS SCI, V56, P8215, DOI 10.1167/iovs.15-17885; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kroeger H, 2019, FEBS J, V286, P399, DOI 10.1111/febs.14522; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lee JH, 2019, AUTOPHAGY, V15, P726, DOI 10.1080/15548627.2019.1569917; Lenin R, 2018, J CELL BIOCHEM, V119, P8460, DOI 10.1002/jcb.27072; Lenox AR, 2015, NEUROSCI LETT, V609, P30, DOI 10.1016/j.neulet.2015.10.019; Li FH, 2017, ONCOTARGET, V8, P43799, DOI 10.18632/oncotarget.16460; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Li WM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01609-x; Li X, 2016, AUTOPHAGY, V12, P1521, DOI 10.1080/15548627.2016.1191722; Libby RT, 2010, ADV EXP MED BIOL, V664, P403, DOI 10.1007/978-1-4419-1399-9_46; Lin WJ, 2014, AUTOPHAGY, V10, P1692, DOI 10.4161/auto.36076; Lindholm D, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00048; Liu CW, 2013, TRENDS BIOCHEM SCI, V38, P103, DOI 10.1016/j.tibs.2012.11.009; Liu CC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0373-6; Liu HR, 2017, J MOL MED, V95, P553, DOI 10.1007/s00109-016-1502-4; Liu K, 2015, P NATL ACAD SCI USA, V112, P1071, DOI 10.1073/pnas.1404059112; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Lorincz P, 2016, EXP EYE RES, V144, P90, DOI 10.1016/j.exer.2015.06.013; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mallinger A, 2012, BIOCHEM BIOPH RES CO, V418, P44, DOI 10.1016/j.bbrc.2011.12.109; McLaughlin T, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0250-z; Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733; Milan E, 2015, AUTOPHAGY, V11, P1161, DOI 10.1080/15548627.2015.1052928; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nam T, 2017, MOL CELLS, V40, P897, DOI 10.14348/molcells.2017.0226; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ojino K, 2015, J NEUROSCI RES, V93, P1675, DOI 10.1002/jnr.23630; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Periyasamy P, 2017, PROG RETIN EYE RES, V60, P1, DOI 10.1016/j.preteyeres.2017.08.003; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qiu YY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1780-1; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rossi S, 2015, MEDIAT INFLAMM; Rousseau A, 2018, NAT REV MOL CELL BIO, V19, P697, DOI 10.1038/s41580-018-0040-z; Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi Xiang, 2013, Zhonghua Yan Ke Za Zhi, V49, P956; Shruthi K, 2016, J NUTR BIOCHEM, V33, P73, DOI 10.1016/j.jnutbio.2016.03.008; Storniolo A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0002-9; Tang BZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091482; Tang B, 2015, AUTOPHAGY, V11, P344, DOI 10.1080/15548627.2015.1023682; TATIANA L, 2018, CELL DEATH DIS, V9, DOI DOI 10.18254/S0002250-4-1; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vegliante R, 2018, VITAM HORM, V108, P273, DOI 10.1016/bs.vh.2018.01.006; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wafa BC, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI [10.1093/nar/gkt563, DOI 10.1093/NAR/GKT563]; Wakabayashi S, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303010; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang XJ, 2015, INVEST OPHTH VIS SCI, V56, P5816, DOI 10.1167/iovs.15-17294; Yao JY, 2018, AUTOPHAGY, V14, P1226, DOI 10.1080/15548627.2018.1463121; Zattas D, 2015, CRIT REV BIOCHEM MOL, V50, P1, DOI 10.3109/10409238.2014.959889; Zhang JL, 2015, INT J MOL SCI, V16, P1644, DOI 10.3390/ijms16011644; Zhang TZ, 2014, BIOCHEM BIOPH RES CO, V450, P966, DOI 10.1016/j.bbrc.2014.06.082; Zhang YM, 2015, ENDOCR J, V62, P673, DOI 10.1507/endocrj.EJ15-0030; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616; Zhou YF, 2016, BBA-MOL BASIS DIS, V1862, P1433, DOI 10.1016/j.bbadis.2016.05.003; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	123	4	4	0	2	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	FEB 20	2020	8								e8638	10.7717/peerj.8638			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN2OL	WOS:000514681600007	32117642	Green Published, gold			2022-02-06	
J	Chen, JH; Li, MC; Chen, L; Chen, WL; Zhang, CL; Feng, Y; Wang, YH; Chen, QX				Chen, Junhui; Li, Mingchang; Chen, Lei; Chen, Weiliang; Zhang, Chunlei; Feng, Yi; Wang, Yuhai; Chen, Qianxue			The Effect of Controlled Decompression for Severe Traumatic Brain Injury: A Randomized, Controlled Trial	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; controlled decompression; ICP; RCT; intraoperative brain swelling; delayed hematoma	POSTTRAUMATIC CEREBRAL INFARCTION; SEVERE HEAD-INJURY; EPIDURAL HEMATOMA; RISK-FACTORS; CRANIECTOMY; HEMICRANIECTOMY; CT	Background: Experimental evidence has indicated the benefits of intraoperative controlled decompression for the treatment of severe traumatic brain injury (sTBI). Intraoperative rapid decompression (conventional decompression) for the treatment of sTBI may result in intra- and post-operative complications. Controlled decompression may reduce these complications. Previous clinical trials in China have not yielded conclusive results regarding controlled decompression for sTBI. Therefore, we explored whether controlled decompression treatment decreases the rates of complications and improves the outcomes of patients with sTBI. Methods: We performed this randomized, controlled trial at our hospital. Patients with sTBI aged 18-75 years old were randomly (1:1) divided into controlled decompression surgery (n = 124) or rapid decompression surgery groups (n = 124). The primary outcome measures were the Extended Glasgow Outcome Scale (GOS-E) score at 6 months and 30-days all-cause mortality. The secondary outcomes were the incidences of intraoperative brain swelling, post-traumatic cerebral infarction, and delayed hematoma. Results: Compared with the rapid decompression group, the controlled decompression group had reduced 30-days all-cause mortality (18.6 vs. 30.8%, P = 0.035) and improved the 6-months GOS-E scores, and the difference was significant. In addition, the patients in the controlled decompression group had a lower intraoperative brain swelling rate (13.3 vs. 24.3%, P = 0.036), a lower delayed hematoma rate (17.7 vs. 29.0%, P = 0.048) and a relatively lower post-traumatic cerebral infarction rate (15.0 vs. 22.4%, P = 0.127) than those in the rapid decompression group. Conclusions: Our data suggest that controlled decompression surgery significantly improves sTBI outcomes and decreases the rates of sTBI-related complications. However, this was a single-hospital study, and well-designed multicenter randomized controlled trials are needed to evaluate the effects of controlled decompression surgery for the management of patients with sTBI.	[Chen, Junhui; Li, Mingchang; Chen, Qianxue] Wuhan Univ, Dept Neurosurg, Renmin Hosp, Wuhan, Peoples R China; [Chen, Junhui; Chen, Lei; Chen, Weiliang; Zhang, Chunlei; Feng, Yi; Wang, Yuhai] Anhui Med Univ, Wuxi Clin Coll, Hosp Joint Logist Support Force PLA 904, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China		Chen, QX (corresponding author), Wuhan Univ, Dept Neurosurg, Renmin Hosp, Wuhan, Peoples R China.; Wang, YH (corresponding author), Anhui Med Univ, Wuxi Clin Coll, Hosp Joint Logist Support Force PLA 904, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China.	wangyuhai1516@163.com; chenqx666@whu.edu.cn	Chen, Junhui/AAS-1669-2021; Junhui, Chen/AAU-4572-2021	Junhui, Chen/0000-0002-9410-9722; Chen, Qianxue/0000-0002-9413-1030	Wuxi Key Disciplines Fund Major Project [ZDXK005]; Nanjing Military Area Research Fund Major Project [15DX003]; Wuxi Foundation for the Development of Science and Technology [WX18IIAN041]	We were grateful for the financial support from the Wuxi Key Disciplines Fund Major Project (ZDXK005), the Nanjing Military Area Research Fund Major Project (15DX003), and the Wuxi Foundation for the Development of Science and Technology (WX18IIAN041).	Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Chen JH, 2018, WORLD NEUROSURG, V113, pE690, DOI 10.1016/j.wneu.2018.02.122; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gong JB, 2016, J CRANIOFAC SURG, V27, pE159, DOI 10.1097/SCS.0000000000002404; Ham HY, 2011, J KOREAN NEUROSURG S, V50, P370, DOI 10.3340/jkns.2011.50.4.370; Huang X, 2010, INT J MED SCI, V7, P385; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; MIRVIS SE, 1990, AM J NEURORADIOL, V11, P355; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Sauvigny T, 2018, J NEUROSURG, V128, P819, DOI 10.3171/2016.11.JNS162263; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Su TM, 2018, TURK NEUROSURG, V28, P582, DOI 10.5137/1019-5149.JTN.20761-17.1; Su TM, 2016, WORLD NEUROSURG, V89, P223, DOI 10.1016/j.wneu.2016.02.020; Talbott JF, 2014, AM J NEURORADIOL, V35, P1930, DOI 10.3174/ajnr.A4001; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wang YH, 2014, TURK NEUROSURG, V24, P214, DOI 10.5137/1019-5149.JTN.8135-13.1; [徐勤义 Xu Qinyi], 2012, [中华神经外科杂志, Chinese Journal of Neurosurgery], V28, P123; Zhao YD, 2001, WORLD J SURG, V25, P1202; Zuccoli G, 2017, PEDIATR NEUROL, V72, P31, DOI 10.1016/j.pediatrneurol.2017.04.003	29	4	7	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 18	2020	11								107	10.3389/fneur.2020.00107			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KS9GM	WOS:000518616200001	32132972	Green Published, gold			2022-02-06	
J	Eyolfson, E; Malik, H; Mychasiuk, R				Eyolfson, Eric; Malik, Haris; Mychasiuk, Richelle			Sexually Dimorphic Behavioral and Genetic Outcomes Associated With Administration of TA65 (A Telomerase Activator) Following Repetitive Traumatic Brain Injury: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						telomere; concussion; prefrontal cortex; hippocampus; therapeutic	REVERSE-TRANSCRIPTASE; CONCUSSION SYMPTOMS; OXIDATIVE STRESS; SEX-DIFFERENCES; DNA-DAMAGE; LENGTH; TEP1; TERT; DISTINCT; SINGLE	Children and adolescents have the highest rates of traumatic brain injury (TBI), with mild TBI (mTBI) accounting for most of these injuries. This demographic also often suffers from post-injury symptomologies that may persist for months. Telomere length (TL) has previously been used as a marker for outcomes following repetitive mild TBI (RmTBI) and it may be possible that telomere elongation can reduce post-traumatic behavioral impairments. Telomerase activator-65 (TA-65) is a telomerase small-molecule activator purified from the root of Chinese herbs that has been anecdotally reported to have anti-aging and life-extending potential. We hypothesized that RmTBI would shorten TL but administration of TA-65 would reverse RmTBI-induced telomere shortening and behavioral deficits. Male and female Sprague-Dawley rats were orally administered TA-65 or a placebo substance for 30 consecutive days [postnatal day (P) 25-55]. Following the injury protocol (mTBIs on P33, 36, and 40), rats went through a behavioral test battery designed to examine symptomologies commonly associated with mTBI (balance and motor coordination, exploratory behavior, short-term working memory, and anxiety- and depressive-like behaviors). TL in ear and brain tissue (prefrontal cortex and hippocampus) and relative expression of TERT and Tep1 via qPCR were assessed 15 days following the last injury. We observed a heterogenous response between males and females, with TA65 administration resulting in increased mRNA expression of TERT and Tep1 in female rats that experienced RmTBI, which was accompanied by some functional recovery on motor behavior and footslips in the beam walk task and depressive-like behavior in the forced swim task.	[Eyolfson, Eric; Malik, Haris; Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia		Mychasiuk, R (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada.; Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.	Richelle.mychasiuk@monash.edu		Eyolfson, Eric/0000-0002-2201-5444	Alberta Children's Hospital Research Institute; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT153051]; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC) [1304881]	The authors would like to thank the Alberta Children's Hospital Research Institute, Canadian Institute of Health Research (PJT153051), and Natural Sciences and Engineering Research Council (1304881) for their financial contributions.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x; Bhattacharyya S, 2010, J CELL BIOCHEM, V109, P7, DOI 10.1002/jcb.22388; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fu WM, 2002, EXP NEUROL, V178, P294, DOI 10.1006/exnr.2002.8030; Gelain DP, 2009, FRONT BIOSCI-LANDMRK, V14, P4457, DOI 10.2741/3541; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; HYMAN C, 1994, J NEUROSCI, V14, P335; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Kronenberg G, 2017, EUR ARCH PSY CLIN N, V267, P473, DOI 10.1007/s00406-016-0750-1; Kyo S, 1999, CANCER RES, V59, P5917; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; Mattson MP, 2001, J NEUROSCI RES, V63, P1; Metz GA., 2005, BEHAV LAB RAT HDB TE; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salberg S, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112225; Salberg S, 2018, J NEUROTRAUM, V35, P1895, DOI 10.1089/neu.2018.5744; Salvador L, 2016, REJUV RES, V19, P478, DOI 10.1089/rej.2015.1793; Schallert T, 2002, DISENTANGLING MULTIP, P201; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Tabor J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00481; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Vina J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Wang ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31101-5; Whittemore K, 2019, AGING-US, V11, P2916, DOI 10.18632/aging.101982; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamakawa GR, 2019, NEUROSCIENCE, V413, P264, DOI 10.1016/j.neuroscience.2019.06.022; Yan LF, 2014, GENE, V534, P139, DOI 10.1016/j.gene.2013.11.008; Yankelevitch-Yahav R., 2015, JOVE-J VIS EXP, V97, DOI [10.3791/52587, DOI 10.3791/52587]; Yao PJ, 2016, TRENDS NEUROSCI, V39, P840, DOI 10.1016/j.tins.2016.10.001; Yu YJ, 2018, EXP THER MED, V16, P2175, DOI 10.3892/etm.2018.6501; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zilles K., 1985, CORTEX RAT STEREOTAX, DOI [10.1007/978-3-642-70573-1, DOI 10.1007/978-3-642-70573-1]	61	4	4	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 18	2020	11								98	10.3389/fneur.2020.00098			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KS9FX	WOS:000518614700001	32132968	Green Published, gold			2022-02-06	
J	Wang, MW; Luo, L				Wang, Mengwei; Luo, Le			An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						GSK2795039; Traumatic brain injury; NOX2 inhibitor; Neurological deficits; Apoptosis	OXIDATIVE DAMAGE; RAT MODEL; APOCYNIN; ACTIVATION; DIPHENYLENEIODONIUM; ACID	Traumatic brain injury (TBI) has become a leading cause of death and disability all over the world. Pharmacological suppression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) can inhibit oxidative stress which is implicated in the pathology of TBI. GSK2795039 was reported to target NOX2 to inhibit O2 and ROS production. The present study aimed to investigate the effect of GSK2795039 on NOX2 activity and neurological deficits in a TBI mouse model. TBI mouse model was established by a weight-drop to mouse skull. GSK2795039 at a dose of 100 mg/kg was administrated to mice 30 min before TBI. NOX2 expression and activity were detected by Western blot and biochemical method. Neurological damage and apoptosis were detected by behavioral test and terminal deoxynucleotidyl transferase dUTP nick end labeling staining. GSK2795039 significantly inhibited NOX2 expression and activity in the TBI mouse model. It also attenuated TBI-induced neurological deficits, apoptosis, and neurological recovery. The results indicate that GSK2795039 can be used as a potential drug for TBI treatment.	[Wang, Mengwei] China Med Univ, Dept Emergency, Affiliated Hosp 4, 4 Chongshan East Rd, Shenyang 110032, Liaoning, Peoples R China; [Luo, Le] Shanghai Zhuole Biotechnol Ctr, 2066 Wangyuan Rd, Shanghai 201499, Peoples R China		Wang, MW (corresponding author), China Med Univ, Dept Emergency, Affiliated Hosp 4, 4 Chongshan East Rd, Shenyang 110032, Liaoning, Peoples R China.	wmwtougao@163.com					Ano Y, 2010, NEUROSCI LETT, V469, P39, DOI 10.1016/j.neulet.2009.11.040; Armitage ME, 2009, J MOL MED, V87, P1071, DOI 10.1007/s00109-009-0544-2; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Bernard K, 2014, ANTIOXID REDOX SIGN, V20, P2838, DOI 10.1089/ars.2013.5608; Cairns B, 2012, CURR DRUG TARGETS, V13, P199, DOI 10.2174/138945012799201676; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Cruz-Alvarez S, 2017, NEUROSCIENCE, V350, P65, DOI 10.1016/j.neuroscience.2017.03.011; De Silva TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028393; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Glennon-Alty L, 2018, FREE RADICAL BIO MED, V125, P25, DOI 10.1016/j.freeradbiomed.2018.03.049; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Hoffmann MH, 2018, FREE RADICAL BIO MED, V125, P62, DOI 10.1016/j.freeradbiomed.2018.03.016; Hwang TL, 2003, MOL PHARMACOL, V64, P1419, DOI 10.1124/mol.64.6.1419; Ji ZH, 2017, ANESTH ANALG, V125, P653, DOI 10.1213/ANE.0000000000002186; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kulbe JR, 2018, J NEUROTRAUM, V35, P1280, DOI 10.1089/neu.2017.5353; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Ma MR, 2012, J NEUROTRAUM, V29, P445, DOI 10.1089/neu.2011.2060; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mora-Pale M, 2012, FREE RADICAL BIO MED, V52, P962, DOI 10.1016/j.freeradbiomed.2011.12.015; Nagel S, 2007, BRAIN RES, V1132, P210, DOI 10.1016/j.brainres.2006.11.023; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Okamura T, 2018, PHYTOMEDICINE, V38, P84, DOI 10.1016/j.phymed.2017.05.006; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Petronio MS, 2013, MOLECULES, V18, P2821, DOI 10.3390/molecules18032821; Qin YY, 2017, FREE RADICAL BIO MED, V104, P333, DOI 10.1016/j.freeradbiomed.2017.01.034; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shah FA, 2018, NEUROCHEM RES, V43, P1608, DOI 10.1007/s11064-018-2576-x; Shen H, 2011, BRAIN RES, V1368, P248, DOI 10.1016/j.brainres.2010.10.014; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Ximenes VF, 2007, ARCH BIOCHEM BIOPHYS, V457, P134, DOI 10.1016/j.abb.2006.11.010; Yauger YJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1430-7; Zhang HM, 2018, DRUG DES DEV THER, V12, P3847, DOI 10.2147/DDDT.S174037; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	49	4	4	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2020	45	5					1097	1106		10.1007/s11064-020-02987-3		FEB 2020	10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LE0KF	WOS:000516293600001	32072445				2022-02-06	
J	Shore, J; Janssen, I				Shore, Joshua; Janssen, Ian			Adolescents' engagement in multiple risk behaviours is associated with concussion	INJURY EPIDEMIOLOGY			English	Article						Multiple risk behaviours; Concussion; Injury; Epidemiology; Adolescent	INJURIES; CHILDREN	BackgroundThe objective of this study was to investigate the relationship between engagement in multiple risk behaviours (MRB) and concussion amongst youth.MethodsThis was a cross-sectional study that used survey data collected from 3059 students in grades 6-10 (approximate ages 11-15years) from Ontario, Canada. Students reported whether or not they had a medically diagnosed concussion within the previous 12months and the frequency that they participated in several risky behaviours including fighting, bullying, smoking, drinking alcohol, using illicit drugs, drinking caffeinated beverages, not using protective equipment, and having unsafe sex. Responses to the risky behavior items were used to create a MRB score. The association between MRB and concussion was explored using logistic regression that controlled for several confounding variables.ResultsApproximately 10.7% of students reported that they had a medically diagnosed concussion within the past year. A dose-response relationship was found between MRB and concussion among students in grades 9-10, while in grades 6-8 students only those in the highest MRB quartile had an increased likelihood of concussion. The relative odds for concussion in the highest versus the lowest MRB quartile were 4.67 (95% confidence interval: 2.33, 9.35) in grades 9-10 students and 2.94 (95% confidence interval, 1.90, 4.56) in grades 6-8 students.ConclusionsEngagement in MRB may be an important etiologic component of adolescent concussion. Future studies should address whether behavioural interventions designed to decrease engagement in MRB reduce the risk of concussion and other injuries.	[Shore, Joshua; Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, 28 Div St, Kingston, ON K7L 3N6, Canada; [Janssen, Ian] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada		Janssen, I (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, 28 Div St, Kingston, ON K7L 3N6, Canada.; Janssen, I (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	ian.janssen@queensu.ca	Janssen, Ian/B-7700-2009	Janssen, Ian/0000-0003-2159-3012	Public Health Agency of Canada; Canada Research Chair awardNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs	The Canadian HBSC was funded by the Public Health Agency of Canada. IJ was funded by a Canada Research Chair award.	Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Buckley L, 2017, J PUBLIC HEALTH-UK, V39, P52, DOI 10.1093/pubmed/fdw009; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dryfoos JG, 1991, ADOLESCENTS RISK PRE; Freeman J., 2016, HLTH BEHAV SCH AGED HLTH BEHAV SCH AGED; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Koven R, 2005, PREV MED, V41, P240, DOI 10.1016/j.ypmed.2004.11.009; Kwong JL, 2018, INT J PUBLIC HEALTH, V63, P137, DOI 10.1007/s00038-017-1046-6; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Pickett W, 2002, SOC SCI MED, V55, P1055, DOI 10.1016/S0277-9536(01)00224-6; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zuckerman M., 1979, OPTIMAL LEVEL AROUSA	19	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	FEB 17	2020	7	1							6	10.1186/s40621-020-0233-8			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5HJ	WOS:000669357600001		Green Published, gold			2022-02-06	
J	Barretto, TA; Park, K; Maghen, L; Park, E; Kenigsberg, S; Gallagher, D; Liu, E; Gauthier-Fisher, A; Librach, C; Baker, A				Barretto, Tanya A.; Park, Katya; Maghen, Leila; Park, Eugene; Kenigsberg, Shlomit; Gallagher, Denis; Liu, Elaine; Gauthier-Fisher, Andree; Librach, Clifford; Baker, Andrew			Axon Degeneration Is Rescued with Human Umbilical Cord Perivascular Cells: A Potential Candidate for Neuroprotection After Traumatic Brain Injury	STEM CELLS AND DEVELOPMENT			English	Article						human umbilical cord perivascular cells (HUCPVCs); sympathetic cervical ganglia (SCGs); cortical neurons; oxygen glucose deprivation (OGD); nerve growth factor (NGF); traumatic brain injury (TBI)	MESENCHYMAL STEM-CELLS; NEUROFILAMENT COMPACTION; DIFFERENTIATION; TRANSPORT; GROWTH; MECHANISMS; THERAPIES; RECOVERY; RECEPTOR; SURVIVAL	Traumatic brain injury (TBI) leads to delayed secondary injury events consisting of cellular and molecular cascades that exacerbate the initial injury. Human umbilical cord perivascular cells (HUCPVCs) secrete neurotrophic and prosurvival factors. In this study, we examined the effects of HUCPVC in sympathetic axon and cortical axon survival models and sought to determine whether HUCPVC provide axonal survival cues. We then examined the effects of the HUCPVC in an in vivo fluid percussion injury model of TBI. Our data indicate that HUCPVCs express neurotrophic and neural survival factors. They also express and secrete relevant growth and survival proteins when cultured alone, or in the presence of injured axons. Coculture experiments indicate that HUCPVCs interact preferentially with axons when cocultured with sympathetic neurons and reduce axonal degeneration. Nerve growth factor withdrawal in axonal compartments resulted in 66 +/- 3% axon degeneration, whereas HUCPVC coculture rescued axon degeneration to 35 +/- 3%. Inhibition of Akt (LY294002) resulted in a significant increase in degeneration compared with HUCPVC cocultures (48 +/- 7% degeneration). Under normoxic conditions, control cultures showed 39 +/- 5% degeneration. Oxygen glucose deprivation (OGD) resulted in 58 +/- 3% degeneration and OGD HUCPVC cocultures reduced degeneration to 34 +/- 5% (p < 0.05). In an in vivo model of TBI, immunohistochemical analysis of NF200 showed improved axon morphology in HUCPVC-treated animals compared with injured animals. These data presented in this study indicate an important role for perivascular cells in protecting axons from injury and a potential cell-based therapy to treat secondary injury after TBI.	[Barretto, Tanya A.; Baker, Andrew] St Michaels Hosp, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Barretto, Tanya A.; Park, Eugene; Liu, Elaine; Baker, Andrew] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Park, Katya; Maghen, Leila; Kenigsberg, Shlomit; Gallagher, Denis; Gauthier-Fisher, Andree; Librach, Clifford] CReATe Fertil Ctr, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Librach, Clifford] Sunnybrook Hlth Sci Ctr, Dept Obstet, Div Reprod Endocrinol & Infertil, Toronto, ON, Canada; [Librach, Clifford] Sunnybrook Hlth Sci Ctr, Dept Gynecol, Div Reprod Endocrinol & Infertil, Toronto, ON, Canada; [Librach, Clifford] Womens Coll Hosp, Toronto, ON, Canada; [Baker, Andrew] St Michaels Hosp, Dept Crit Care, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada		Barretto, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	tanya.barretto@mail.utoronto.ca		Librach, Clifford/0000-0002-9699-4059			Arboleda G, 2010, NEUROTOXICOLOGY, V31, P687, DOI 10.1016/j.neuro.2010.08.001; Badner A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1243-0; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Edstrorn A, 2003, J NEUROSCI RES, V74, P726, DOI 10.1002/jnr.10686; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Gallagher D, 2019, BIOL PSYCHIAT, V86, P712, DOI 10.1016/j.biopsych.2019.07.015; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Goswami M, 2001, DEV BIOL, V236, P259, DOI 10.1006/dbio.2001.0338; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Hong SH, 2013, STEM CELLS DEV, V22, P2425, DOI 10.1089/scd.2012.0552; Huang HT, 2017, NEUROCHEM RES, V42, P3515, DOI 10.1007/s11064-017-2399-1; Ikonomovic MD, 2019, NEUROPHARMACOLOGY, V145, P160, DOI 10.1016/j.neuropharm.2018.06.021; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Keeler AB, 2017, MOL CELL NEUROSCI, V82, P66, DOI 10.1016/j.mcn.2017.04.011; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Khotskaya YB, 2017, PHARMACOL THERAPEUT, V173, P58, DOI 10.1016/j.pharmthera.2017.02.006; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lin YC, 2011, STROKE, V42, P2045, DOI 10.1161/STROKEAHA.110.603621; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; MA Y, 1992, J CELL BIOL, V117, P135, DOI 10.1083/jcb.117.1.135; Maghen L, 2016, REPRODUCTION; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; MARONEZI V, 2019, REV INST GEOL, V40, P17, DOI DOI 10.33958/revig.v40i2.645; McGuckin CP, 2013, ARCH BIOCHEM BIOPHYS, V534, P88, DOI 10.1016/j.abb.2013.02.005; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Rao MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044320; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17; Scott-Solomon E, 2018, MOL CELL NEUROSCI, V91, P25, DOI 10.1016/j.mcn.2018.03.013; Seule M, 2015, FACIAL PLAST SURG, V31, P325, DOI 10.1055/s-0035-1562884; Shlush E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0491-8; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vawda R, 2019, STEM CELL TRANSL MED, V8, P639, DOI 10.1002/sctm.18-0192; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Yabe JT, 2003, CELL MOTIL CYTOSKEL, V56, P193, DOI 10.1002/cm.10137; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yuan A, 2017, COLD SPRING HARB PER, V9; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	64	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	FEB 15	2020	29	4					198	211		10.1089/scd.2019.0135			14	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	KL0GC	WOS:000513110300004	31701812	Bronze			2022-02-06	
J	Mantey, DS; Omega-Njemnobi, O; Barroso, CS; Kelder, SH				Mantey, Dale S.; Omega-Njemnobi, Onyinye; Barroso, Cristina S.; Kelder, Steven H.			Self-reported history of concussions is associated with risk factors for suicide completion among high school students	JOURNAL OF AFFECTIVE DISORDERS			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH OUTCOMES; ADOLESCENT SUICIDE; PREVALENCE; YOUTH; VICTIMIZATION; PREVENTION; DEPRESSION; BEHAVIORS	Background: Suicide is the third leading cause of death among adolescents. While research has found concussions to be a risk factor for suicide in adults, this relationship is not well studied in nationally representative samples of youth. This study examines the relationship between self-reported history of sports-related concussion and five risk factors for suicide completion. Methods: Data were obtained from the 2017 Youth Risk Behavior Surveillance Survey (n= 13,353). Multivariate logistic regression models assessed the relationship between self-reported, sports-related concussion and five risk factors for suicide completion. Analyses controlled for sex, race/ethnicity, grade, bullying victimization, and sexual orientation. Subsample analyses were conducted stratified by sex. Interaction models examined biological sex as a possible effect modifier. Results: Overall, 15.0% of high school students reported a sports-related concussion in the past 12-months. Self-reported, sports-related concussion was significantly associated with greater odds of feeling sad/hopeless (Adj OR: 1.20; 95% CI:1.02-1.42), suicidal ideations (Adj OR: 1.25; 95% CI:1.02-1.55), suicide attempt (Adj OR: 1.60; 95% CI:1.31-1.96), and suicide attempt treated by a doctor/nurse (Adj OR: 2.35; 95% CI:1.68-3.29), adjusting for covariates. Stratified analyses demonstrated differences by sex, however, no direct evidence of effect modification was observed in interaction models. Limitations: Data are cross-sectional, prohibiting causal inferences. Measures were assessed via self-report. No pre-concussion measures of mental health. Conclusion: Self-reported sports-related concussion was associated with risk factors for suicide completion. No direct evidence of effect modification was observed but stratified analyses suggest biological sex may impact the observed relationship.	[Mantey, Dale S.; Omega-Njemnobi, Onyinye; Kelder, Steven H.] Univ Texas Austin, Sch Publ Hlth, 1616 Guadalupe,Suite 6-300, Austin, TX 78701 USA; [Barroso, Cristina S.] Univ Tennessee, Coll Educ Hlth & Human Sci, Dept Publ Hlth, Knoxville, TN 37996 USA		Mantey, DS (corresponding author), Univ Texas Austin, Sch Publ Hlth, 1616 Guadalupe,Suite 6-300, Austin, TX 78701 USA.	dale.s.mantey@uth.tmc.edu		Barroso, Cristina/0000-0002-4354-9058			Aranmolate R., 2017, JSM SCHIZOPHRENIA, V2, P1011; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bilsen J, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00540; Borowsky IW, 2001, PEDIATRICS, V107, P485, DOI 10.1542/peds.107.3.485; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Case KR, 2016, J SCHOOL HEALTH, V86, P832, DOI 10.1111/josh.12437; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; Corraini P, 2017, CLIN EPIDEMIOL, V9, P331, DOI 10.2147/CLEP.S129728; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Gordon KE, 2018, BRAIN INJURY, V32, P41, DOI 10.1080/02699052.2017.1403046; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hinduja S, 2010, ARCH SUICIDE RES, V14, P206, DOI 10.1080/13811118.2010.494133; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kim S, 2018, J YOUTH ADOLESCENCE, V47, P661, DOI 10.1007/s10964-017-0678-4; Klomek AB, 2011, SUICIDE LIFE-THREAT, V41, P501, DOI 10.1111/j.1943-278X.2011.00046.x; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall Alexandra, 2016, Yale Journal of Biology and Medicine, V89, P205; McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Minino Arialdi, 2010, NCHS Data Brief, P1; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Olivier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058777; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; Storch EA, 2005, CLIN PEDIATR, V44, P29, DOI 10.1177/000992280504400103; Tokunaga RS, 2010, COMPUT HUM BEHAV, V26, P277, DOI 10.1016/j.chb.2009.11.014; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Wang J, 2009, J ADOLESCENT HEALTH, V45, P368, DOI 10.1016/j.jadohealth.2009.03.021; Wangnoo T., 2018, J NEUROTRAUMA JA; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3	42	4	4	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 15	2020	263						684	691		10.1016/j.jad.2019.11.047			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	KE9MP	WOS:000508874400087	31740108				2022-02-06	
J	Soriano, S; Moffet, B; Wicker, E; Villapol, S				Soriano, Sirena; Moffet, Bridget; Wicker, Evan; Villapol, Sonia			Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Neuroinflammation; Brain trauma; Acute phase response; Microglia; Neutrophil accumulation	ALZHEIMERS-DISEASE; SYSTEMIC INFLAMMATION; PROTEIN; CELLS; NEUROINFLAMMATION; CONSEQUENCES; ACTIVATION; DEPOSITION; MICROGLIA; CYTOKINES	Serum amyloid A (SAA) is an acute phase protein upregulated in the liver after traumatic brain injury (TBI). So far, it has not been investigated whether SAA expression also occurs in the brain in response to TBI. For this, we performed a moderate controlled cortical impact injury in adult male and female mice and analyzed brain, blood, and liver samples at 6 h, 1, 3, and 10 days post-injury (dpi). We measured the levels of SAA in serum, brain and liver by western blot. We also used immunohistochemical techniques combined with in situ hybridization to determine SAA mRNA and protein expression in the brain. Our results revealed higher levels of SAA in the bloodstream in males compared to females at 6 h post-TBI. Liver and serum SAA protein showed a peak of expression at 1 dpi followed by a decrease at 3 to 10 dpi in both sexes. Both SAA mRNA and protein expression colocalize with astrocytes and macrophages/microglia in the cortex, corpus callosum, thalamus, and hippocampus after TBI. For the first time, here we show that SAA is expressed in the brain in response to TBI. Collectively, SAA expression was higher in males compared to females, and in association with the sex-dependent neuroinflammatory response after brain injury. We suggest that SAA could be a crucial protein associated to the acute neuroinflammation following TBI, not only for its hepatic upregulation but also for its expression in the injured brain.	[Soriano, Sirena; Villapol, Sonia] Houston Methodist Res Inst, Dept Neurosurg, 6670 Bertner Ave, Houston, TX 77030 USA; [Moffet, Bridget] Georgetown Univ, MS Biochem & Mol Biol Program, Washington, DC USA; [Wicker, Evan] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA; [Villapol, Sonia] Weill Cornell Med Coll, Dept Neurosci Neurol Surg, New York, NY 10065 USA		Villapol, S (corresponding author), Houston Methodist Res Inst, Dept Neurosurg, 6670 Bertner Ave, Houston, TX 77030 USA.; Villapol, S (corresponding author), Weill Cornell Med Coll, Dept Neurosci Neurol Surg, New York, NY 10065 USA.	svillapol@houstonmethodist.org		Villapol, Sonia/0000-0002-6174-4113; Soriano, Sirena/0000-0001-9967-7262	National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS095038]; Houston Methodist Research Institute	This work was supported by R03NS095038 (SV) grant from the National Institute for Neurological Disorders and Stroke (NINDS), and funds from Houston Methodist Research Institute.	Anada RP, 2018, ELECTROPHORESIS, V39, P2308, DOI 10.1002/elps.201700407; Barbierato M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12529-7; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Carabias CS, 2020, J INTENSIVE CARE MED, V35, P1180, DOI 10.1177/0885066619837913; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Chen AQ, 2016, NEUROBIOL AGING, V38, P56, DOI 10.1016/j.neurobiolaging.2015.10.021; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; COGAN AM, 2019, PM&R 0930, DOI DOI 10.1002/pmrj.12237; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Dotson AL, 2015, J NEUROIMMUNOL, V278, P289, DOI 10.1016/j.jneuroim.2014.11.020; Du LL, 2017, MOL NEUROBIOL, V54, P1992, DOI 10.1007/s12035-016-9758-9; ELOVAARA I, 1986, ACTA NEUROL SCAND, V74, P245, DOI 10.1111/j.1600-0404.1986.tb07863.x; Facci L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1205-6; Fe Lanfranco M, 2017, CELLS BIOPROTOC, DOI [10.21769/BioProtoc.2608, DOI 10.21769/BIOPROTOC.2608]; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Gorevic PD, 2013, P NATL ACAD SCI USA, V110, P16291, DOI 10.1073/pnas.1315112110; Guo JT, 2002, J NEUROSCI, V22, P5900; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hughes RN, 2007, BEHAV PHARMACOL, V18, P583, DOI 10.1097/FBP.0b013e3282eff0e8; Jang WY, 2017, BRAIN RES, V1654, P55, DOI 10.1016/j.brainres.2016.09.003; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; Kisilevsky R, 1997, ANN NY ACAD SCI, V826, P117, DOI 10.1111/j.1749-6632.1997.tb48465.x; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Kuroda T, 2002, CLIN RHEUMATOL, V21, P123, DOI 10.1007/PL00011217; Kuroda T, 2017, AMYLOID, V24, P123, DOI 10.1080/13506129.2017.1338565; Lane T, 2017, AMYLOID, V24, P162, DOI 10.1080/13506129.2017.1342235; Lanfranco MF, 2018, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00137; Liang JS, 1997, NEUROSCI LETT, V225, P73, DOI 10.1016/S0304-3940(97)00196-1; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; RAMADORI G, 1985, J EXP MED, V162, P930, DOI 10.1084/jem.162.3.930; RAMADORI G, 1985, J IMMUNOL, V135, P3645; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Sandberg K, 2015, FASEB J, V29, P1646, DOI 10.1096/fj.14-269548; Santos-Galindo Maria, 2011, Biol Sex Differ, V2, P7, DOI 10.1186/2042-6410-2-7; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Sundelof J, 2009, J ALZHEIMERS DIS, V18, P79, DOI 10.3233/JAD-2009-1126; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Uhlar CM, 1999, SCAND J IMMUNOL, V49, P399; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wicker E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5967816; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10201-8; Yu Y, 2014, J ALZHEIMERS DIS, V38, P133, DOI 10.3233/JAD-130818; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	64	4	4	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2020	40	7					1199	1211		10.1007/s10571-020-00808-3		FEB 2020	13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NA4SR	WOS:000516130800002	32060858	Green Accepted			2022-02-06	
J	Frueh, BC; Madan, A; Fowler, JC; Stomberg, S; Bradshaw, M; Kelly, K; Weinstein, B; Luttrell, M; Danner, SG; Beidel, DC				Frueh, B. Christopher; Madan, Alok; Fowler, J. Christopher; Stomberg, Sasha; Bradshaw, Major; Kelly, Karen; Weinstein, Benjamin; Luttrell, Morgan; Danner, Summer G.; Beidel, Deborah C.			"Operator syndrome": A unique constellation of medical and behavioral health-care needs of military special operation forces	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						veterans; military; special forces; traumatic brain injury; posttraumatic stress disorder; endocrine; sleep; pain; suicide	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SLEEP DISTURBANCES; SEXUAL DYSFUNCTION; VETERANS; PREVALENCE; AFGHANISTAN; MECHANISMS; IRAQ	Objective U.S. military special operation forces represent the most elite units of the U.S. Armed Forces. Their selection is highly competitive, and over the course of their service careers, they experience intensive operational training and combat deployment cycles. Yet, little is known about the health-care needs of this unique population. Method Professional consultations with over 50 special operation forces operators (and many spouses or girlfriends) over the past 6 years created a naturalistic, observational base of knowledge that allowed our team to identify a unique pattern of interrelated medical and behavioral health-care needs. Results We identified a consistent pattern of health-care difficulties within the special operation forces community that we and other special operation forces health-care providers have termed "Operator Syndrome." This includes interrelated health and functional impairments including traumatic brain injury effects; endocrine dysfunction; sleep disturbance; obstructive sleep apnea; chronic joint/back pain, orthopedic problems, and headaches; substance abuse; depression and suicide; anger; worry, rumination, and stress reactivity; marital, family, and community dysfunction; problems with sexual health and intimacy; being "on guard" or hypervigilant; memory, concentration, and cognitive impairments; vestibular and vision impairments; challenges of the transition from military to civilian life; and common existential issues. Conclusions "Operator Syndrome" may be understood as the natural consequences of an extraordinarily high allostatic load; the accumulation of physiological, neural, and neuroendocrine responses resulting from the prolonged chronic stress; and physical demands of a career with the military special forces. Clinical research and comprehensive, intensive immersion programs are needed to meet the unique needs of this community.	[Frueh, B. Christopher] Univ Hawaii, Dept Psychol, Hilo, HI 96720 USA; [Frueh, B. Christopher; Madan, Alok; Fowler, J. Christopher; Bradshaw, Major; Weinstein, Benjamin; Danner, Summer G.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Trauma & Resilience Ctr, Houston, TX 77030 USA; [Frueh, B. Christopher; Madan, Alok; Fowler, J. Christopher; Bradshaw, Major; Weinstein, Benjamin] Houston Methodist Hosp, Dept Behav Hlth, Houston, TX 77030 USA; [Stomberg, Sasha] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Kelly, Karen] Naval Hlth Res Ctr, Dept Warfighter Performance, San Diego, CA USA; [Luttrell, Morgan] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, 1941 East Rd, Houston, TX 77054 USA; [Beidel, Deborah C.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA		Frueh, BC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, 1941 East Rd, Houston, TX 77054 USA.	frueh@hawaii.edu					Ambrosi E, 2017, ACTA PSYCHIAT SCAND, V136, P129, DOI 10.1111/acps.12724; Avallone KM, 2019, MIL MED, V184, pE118, DOI 10.1093/milmed/usy225; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Bartone PT, 2008, INT J SELECT ASSESS, V16, P78, DOI 10.1111/j.1468-2389.2008.00412.x; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Beal S. A., 2010, ROLES PERSEVERANCE C; Beidel DC, 2017, J ANXIETY DISORD, V50, P23, DOI 10.1016/j.janxdis.2017.05.001; Beidel DC, 2011, J ANXIETY DISORD, V25, P224, DOI 10.1016/j.janxdis.2010.09.006; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Breyer BN, 2014, J SEX MED, V11, P75, DOI 10.1111/jsm.12201; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Clapp JD, 2013, J CLIN PSYCHIAT, V74, P492, DOI 10.4088/JCP.12m07842; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fowler JC, 2019, PSYCHOTHERAPY, V56, P91, DOI 10.1037/pst0000174; Fowler JC, 2015, J PSYCHIATR RES, V68, P114, DOI 10.1016/j.jpsychires.2015.06.018; Hohl A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00029; Hosain GMM, 2013, J SEX MED, V10, P516, DOI 10.1111/j.1743-6109.2012.02978.x; Howlett JR, 2016, TRANSLATIONAL RES TR; Jensen AE, 2019, STEROIDS, V152, DOI 10.1016/j.steroids.2019.108504; Larson EB, 2018, NEUROREHABILITATION, V43, P297, DOI 10.3233/NRE-182534; Lester P., 2013, MIL BEHAV HLTH, V1, P31, DOI [10.1080/21635781.2012.721062, DOI 10.1080/21635781.2012.721062]; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Madan A, 2015, PRIM CARE COMPANION, V17; Madan A, 2017, J NEUROPSYCH CLIN N, V29, P275, DOI 10.1176/appi.neuropsych.16090174; Madan A, 2016, PSYCHOSOM MED, V78, P271, DOI 10.1097/PSY.0000000000000298; Mantua J, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/7940832; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Orzel-Gryglewska J, 2010, INT J OCCUP MED ENV, V23, P95, DOI 10.2478/v10001-010-0004-9; OSS Assessment Staff, 1948, ASS MAN SEL PERS OFF; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Satcher D, 2012, INT J SEX HEALTH, V24, P6, DOI 10.1080/19317611.2011.645949; Sayers SL, 2011, COGN BEHAV PRACT, V18, P108, DOI 10.1016/j.cbpra.2010.03.002; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Turchik JA, 2012, INT J SEX HEALTH, V24, P45, DOI 10.1080/19317611.2011.639592; VandeVord PJ, 2016, J NEUROTRAUM, V33, P82, DOI 10.1089/neu.2014.3786; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yoon SJ, 2019, J PROTEOME RES, V18, P3295, DOI 10.1021/acs.jproteome.9b00234	55	4	4	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2174	1541-3527		INT J PSYCHIAT MED	Int. J. Psychiatr. Med.	JUL	2020	55	4					281	295	0091217420906659	10.1177/0091217420906659		FEB 2020	15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	LT1ZR	WOS:000513398900001	32052666				2022-02-06	
J	Gourdeau, J; Fingold, A; Colantonio, A; Mansfield, E; Stergiou-Kita, M				Gourdeau, Jenna; Fingold, Alissa; Colantonio, Angela; Mansfield, Elizabeth; Stergiou-Kita, Mary			Workplace accommodations following work-related mild traumatic brain injury: what works?	DISABILITY AND REHABILITATION			English	Article						Brain injuries; traumatic; return to work; workers&#8217; compensation; rehabilitation; vocational; workplace accommodations	RETURN; PEOPLE; EPIDEMIOLOGY; PERCEPTIONS; SYMPTOMS	Background: Individuals who have experienced a work-related mild traumatic brain injury face a variety of challenges when returning to work. Research has demonstrated that the implementation of workplace accommodations can reduce the incidence of workplace disability. Few studies investigate work-related mild traumatic brain injury from injured workers' perspectives, and none examine workplace accommodations in detail. Purpose: This study explores the types of accommodations that individuals receive, and the factors that influence how they are provided and to whom. Materials and methods: This study is a qualitative secondary data analysis of 12 telephone interviews. ATLAS.ti software was used to facilitate coding and thematic analysis was used to analyze the data. Results: This study makes explicit various accommodations identified as being useful or required by individuals on return to work. Participants identified a gradual return to work, and modified duties, among other accommodations. Components of the workplace social and structural environment, and the occupational context influenced how accommodations were provided and to whom. Conclusions: Obtaining appropriate support is of great importance to injured employees, their employers, insurers, and healthcare providers. Stakeholders should be aware of how to successfully identify and access appropriate workplace accommodations to support injured workers on return to work.	[Gourdeau, Jenna; Fingold, Alissa; Colantonio, Angela; Mansfield, Elizabeth; Stergiou-Kita, Mary] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela; Stergiou-Kita, Mary] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela; Stergiou-Kita, Mary] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Mansfield, Elizabeth] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada; [Stergiou-Kita, Mary] Inst Work & Hlth, Toronto, ON, Canada		Gourdeau, J (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	jennagourdeau@gmail.com			CIHRCanadian Institutes of Health Research (CIHR) [OGW-123786, CGW-126580] Funding Source: Medline		Beardwood BA, 2005, QUAL HEALTH RES, V15, P30, DOI 10.1177/1049732304268716; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Calsafern K, 2002, BCS MENTAL HLTH REFO; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Government of Canada, 2016, CAN HUM RIGHTS ACT; Government of Canada, 2011, DUT ACC GEN PROC MAN; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lundqvist A, 2012, BRAIN INJURY, V26, P1574, DOI 10.3109/02699052.2012.698363; MacDonald-Wilson KL, 2002, COMMUNITY MENT HLT J, V38, P35, DOI 10.1023/A:1013955830779; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; McDowell C, 2015, J OCCUP REHABIL, V25, P197, DOI 10.1007/s10926-014-9512-y; Moon NW, 2012, J DISABIL POLICY STU, V23, P94, DOI 10.1177/1044207311425383; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Solovieva TI, 2013, J WORKPLACE BEHAV HE, V28, P192, DOI 10.1080/15555240.2013.808079; Solovieva TI, 2011, DISABIL HEALTH J, V4, P39, DOI 10.1016/j.dhjo.2010.03.001; Stergiou-Kita M, 2014, J OCCUP REHABIL, V24, P173, DOI 10.1007/s10926-013-9463-8; Stergiou-Kita M, 2012, J OCCUP REHABIL, V22, P166, DOI 10.1007/s10926-011-9332-2; TARASUK V, 1995, QUAL HEALTH RES, V5, P204, DOI 10.1177/104973239500500205; Varekamp I, 2010, OCCUP MED-OXFORD, V60, P287, DOI 10.1093/occmed/kqq078; Williams Michael, 2006, Work, V27, P355; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	27	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 13	2020	42	4					552	561		10.1080/09638288.2018.1503733			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	OM4SB	WOS:000586015500010	30451033				2022-02-06	
J	Paramita, P; Sethu, SN; Subhapradha, N; Ragavan, V; Ilangovan, R; Balakrishnan, A; Srinivasan, N; Murugesan, R; Moorthi, A				Paramita, Pragyan; Sethu, Sai Nivethitha; Subhapradha, Namasivayam; Ragavan, Vijayashree; Ilangovan, Ramachandran; Balakrishnan, Anandan; Srinivasan, Narasimhan; Murugesan, Ramachandran; Moorthi, Ambigapathi			Neuro-protective effects of nano-formulated hesperetin in a traumatic brain injury model of Danio rerio	DRUG AND CHEMICAL TOXICOLOGY			English	Article; Early Access						Traumatic brain injury; nano-hesperetin; zebrafish; neural regeneration	ORAL BIOAVAILABILITY; DIFFERENTIATION; NANOCRYSTALS; ANTIOXIDANT; EXPRESSION; CELLS	Understanding the mechanism behind neuronal regeneration is critical for treating ischemic stroke and traumatic brain injury. The presence of neural stem cells in and around the sub-ventricular zone of human and also in zebrafish is evidenced. In this current study, the neuro-protective potential of nano-formulated hesperetin on injury-induced neurogenesis in zebrafish was assessed. Nanoformulation of hesperetin was prepared by anti-solvent precipitation technique using sodium dodecyl sulfate (SDS) as the stabilizing agent. The synthesized particles were characterized using SEM, DLS, XRD and FT-IR. Anti-oxidant capacity of nano hesperetin (nHST) in in vitro followed by in vivo studies in a traumatic brain injury (TBI) model of adult zebrafish (Danio rerio), catalase activity, histological analysis and gene expression studies for the genes Sox2, Nestin, Fabp7a and HuC were carried out. The synthesized particles were found to be in nanoscale and SDS had successfully integrated with hesperetin. Moreover, nHST had a significantly higher anti-oxidant capacity in vitro. Catalase levels in nHST treated group were significantly restored compared to other groups. Histological studies supported reduced tissue damage on oral administration of nano-hesperetin as compared to other groups. Gene expression studies showed that nano-hesperetin at a concentration of 10 mu M when administered orally induced proliferation of neural stem cells without inducing cell death.	[Paramita, Pragyan; Sethu, Sai Nivethitha; Subhapradha, Namasivayam; Srinivasan, Narasimhan; Murugesan, Ramachandran; Moorthi, Ambigapathi] Chettinad Hlth City, Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Chennai, Tamil Nadu, India; [Ragavan, Vijayashree] Chettinad Hlth City, Chettinad Acad Res & Educ, Chettinad Hosp & Res Inst, Dept Pathol, Chennai, Tamil Nadu, India; [Ilangovan, Ramachandran] Univ Madras, Dr A Lakshmanasamy Mudaliar Post Grad Inst Basic, Dept Endocrinol, Chennai, Tamil Nadu, India; [Balakrishnan, Anandan] Univ Madras, Dr A Lakshmanasamy Mudaliar Post Grad Inst Basic, Dept Genet, Chennai, Tamil Nadu, India		Moorthi, A (corresponding author), Chettinad Hlth City, Chettinad Acad Res & Educ, Chennai 603103, Tamil Nadu, India.	moorthiibms@gmail.com	Balakrishnan, Anandan/ABC-2559-2020; Paramita, Pragyan/AAA-6320-2022	Balakrishnan, Anandan/0000-0003-4747-3799; Ambigapathi, Moorthi/0000-0002-2360-9535	DST-SERB, Govt. of India [PDF/2016/003715]; Chettinad Academy of Research and Education	Dr. N. Subhapradha is grateful to DST-SERB, Govt. of India, for the financial support in the form of grant [NPDF (PDF/2016/003715)]. We would like to express our sincere heartfelt gratitude and thanks to Chettinad Academy of Research and Education for the financial support in the form of CARE-JRF and Post Graduate (PG) research funding.	Aranganathan S, 2009, FOOD CHEM TOXICOL, V47, P2594, DOI 10.1016/j.fct.2009.07.019; Brand Michael, 2002, P7; Dang M, 2016, DIS MODEL MECH, V9, P811, DOI 10.1242/dmm.024166; Eladl MA, 2017, INT J NEPHROL RENOV, V10, P61, DOI 10.2147/IJNRD.S121473; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fathi M, 2013, J FUNCT FOODS, V5, P1382, DOI 10.1016/j.jff.2013.05.006; Gurushankar K, 2014, ADV NAT SCI-NANOSCI, V5, DOI 10.1088/2043-6262/5/1/015006; Hu J, 2011, INT J PHARMACEUT, V404, P198, DOI 10.1016/j.ijpharm.2010.10.055; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Junyaprasert VB, 2015, ASIAN J PHARM SCI, V10, P13, DOI 10.1016/j.ajps.2014.08.005; Kakran M., 2015, PHARM ANAL ACTA, V6, DOI [10.4172/2153-2435.1000326, DOI 10.4172/2153-2435.1000326]; Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389; Kodydkova J, 2014, FOLIA BIOL-PRAGUE, V60, P153; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Matthews M, 2002, LAB ANIMAL, V31, P34; Moorthi A, 2013, INT J BIOL MACROMOL, V56, P181, DOI 10.1016/j.ijbiomac.2013.02.017; Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Saravanan S, 2015, J BIOMED NANOTECHNOL, V11, P1124, DOI 10.1166/jbn.2015.2057; Shete G, 2015, MOL PHARMACEUT, V12, P1158, DOI 10.1021/mp5008647; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Tse WKF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-637; Waddington R.J., 2016, TISSUE ENG REGENERAT; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305	26	4	4	2	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0148-0545	1525-6014		DRUG CHEM TOXICOL	Drug Chem. Toxicol.												10.1080/01480545.2020.1722690		FEB 2020	8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy; Toxicology	KL9PP	WOS:000513748600001	32050810				2022-02-06	
J	Malekahmadi, M; Moghaddam, OM; Islam, SMS; Tanha, K; Nematy, M; Pahlavani, N; Firouzi, S; Zali, MR; Norouzy, A				Malekahmadi, Mahsa; Moghaddam, Omid Moradi; Islam, Sheikh Mohammed Shariful; Tanha, Kiarash; Nematy, Mohsen; Pahlavani, Naseh; Firouzi, Safieh; Zali, Mohammad Reza; Norouzy, Abdolreza			Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol	TRIALS			English	Article						Traumatic brain injury; Critical care; Pycnogenol; Inflammation; Nutrition support; French maritime pine bark extract	IMMUNONUTRITION; NEUROPROTECTION; EPIDEMIOLOGY; DEFICITS; PLASMA; EDEMA	Background Traumatic brain injury (TBI) is one of the major health and socioeconomic problems in the world. Immune-enhancing enteral formula has been proven to significantly reduce infection rate in TBI patients. One of the ingredients that can be used in immunonutrition formulas to reduce inflammation and oxidative stress is pycnogenol. Objective The objective of this work is to survey the effect of pycnogenol on the clinical, nutritional, and inflammatory status of TBI patients. Methods This is a double-blind, randomized controlled trial. Block randomization will be used. An intervention group will receive pycnogenol supplementation of 150 mg for 10 days and a control group will receive a placebo for the same duration. Inflammatory status (IL-6, IL- 1 beta, C-reactive protein) and oxidative stress status (malondialdehyde, total antioxidant capacity), at the baseline, at the 5th day, and at the end of the study (10th day) will be measured. Clinical and nutritional status will be assessed three times during the intervention. The Sequential Organ Failure Assessment (SOFA) questionnaire for assessment of organ failure will be filled out every other day. The mortality rate will be calculated within 28 days of the start of the intervention. Weight, body mass index, and body composition will be measured. All analyses will be conducted by an initially assigned study arm in an intention-to-treat analysis. Discussion We expect that supplementation of 150 mg pycnogenol for 10 days will improve clinical and nutritional status and reduce the inflammation and oxidative stress of the TBI patients.	[Malekahmadi, Mahsa; Pahlavani, Naseh; Firouzi, Safieh] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran; [Malekahmadi, Mahsa; Nematy, Mohsen; Pahlavani, Naseh; Firouzi, Safieh; Norouzy, Abdolreza] Mashhad Univ Med Sci, Fac Med, Nutr Dept, Bahonar St, Mashhad, Razavi Khorasan, Iran; [Moghaddam, Omid Moradi] Iran Univ Med Sci, Trauma & Injury Res Ctr, Crit Care Dept, Rasoul E Akram Complex Hosp, Tehran, Iran; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Sch Exercise & Nutr Sci, IPAN, Melbourne, Vic, Australia; [Tanha, Kiarash] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran; [Nematy, Mohsen] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Razavi Khorasan, Iran; [Zali, Mohammad Reza; Norouzy, Abdolreza] Behbood Res Ctr Gastroenterol & Liver Dis, Tehran, Iran		Norouzy, A (corresponding author), Mashhad Univ Med Sci, Fac Med, Nutr Dept, Bahonar St, Mashhad, Razavi Khorasan, Iran.; Norouzy, A (corresponding author), Behbood Res Ctr Gastroenterol & Liver Dis, Tehran, Iran.	norouzya@mums.ac.ir	moghaddam, omid moradi/AAF-3672-2021; zali, mohammadreza/AAD-4452-2022; Pahlavani, Naseh/Y-5149-2019; Islam, Mohammed Shariful/B-1219-2011; malekahmadi, mahsa/ABD-2352-2020; Norouzy, Abdolreza/AAX-1160-2020; Tanha, Kiarash/AAO-4389-2021; Tanha, Kiarash/AAI-5279-2021	Pahlavani, Naseh/0000-0001-7960-7267; Islam, Mohammed Shariful/0000-0001-7926-9368; Tanha, Kiarash/0000-0002-2820-5409; Norouzy, Abdolreza/0000-0001-6740-5502	Mashhad University of Medical Sciences; Trauma and Injury Research Center of Iran University of Medical Sciences	The trial is funded by the Mashhad University of Medical Sciences, and the Trauma and Injury Research Center of Iran University of Medical Sciences and was peer reviewed as part of the funding application process. These centers support all stages of study (the design of the study and collection, analysis, and interpretation of data and in writing the manuscript).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Cesarone MR, 2010, J CARDIOVASC PHARM T, V15, P41, DOI 10.1177/1074248409356063; Cesarone MR, 2005, CLIN APPL THROMB-HEM, V11, P289, DOI 10.1177/107602960501100307; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Enseleit F, 2012, EUR HEART J, V33, P1589, DOI 10.1093/eurheartj/ehr482; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gulati OP, 2015, PHYTOTHER RES, V29, P949, DOI 10.1002/ptr.5341; Gulati OP, 2014, PHYTOTHER RES, V28, P348, DOI 10.1002/ptr.5019; Hadi A, 2019, PHYTOTHER RES, V33, P276, DOI 10.1002/ptr.6234; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Ishrat T, 2009, BEHAV PHARMACOL, V20, P567, DOI 10.1097/FBP.0b013e32832c7125; Khorana Jiraporn, 2009, Journal of the Medical Association of Thailand, V92, P188; Kim H, 2019, BIOMED PHARMACOTHER, V109, P1718, DOI 10.1016/j.biopha.2018.11.015; Lilly CM, 2011, JAMA-J AM MED ASSOC, V305, P2175, DOI 10.1001/jama.2011.697; Lipman PD, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2267-y; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luzzi R, 2017, MINERVA GINECOL, V69, P29, DOI 10.23736/S0026-4784.16.03913-7; Malekahmadi M, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104472; McGuire MF, 2019, PERSP TRANS CELL BIO, V4, P221, DOI 10.1016/B978-0-12-813832-8.00012-1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Muballe KD, 2019, J NEUROSURG, V131, P1648, DOI 10.3171/2018.4.JNS172185; Naghibi T, 2017, J CLIN DIAGN RES, V11, pPC6, DOI 10.7860/JCDR/2017/19132.9198; Oliff H., 2009, SCI CLIN MONOGRAPH P; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng QL, 2002, MOL BRAIN RES, V104, P55, DOI 10.1016/S0169-328X(02)00263-2; Peterik A, 2009, CRIT CARE, V13, DOI 10.1186/cc7899; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rai VRH, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0369-4; Rohdewald PJ, 2018, J MED FOOD, V21, P1, DOI 10.1089/jmf.2017.0015; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sahebkar A, 2014, J CARDIOVASC PHARM T, V19, P244, DOI 10.1177/1074248413511691; Schafer A, 2006, BIOMED PHARMACOTHER, V60, P5, DOI 10.1016/j.biopha.2005.08.006; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Strand K, 2010, CRIT CARE, V14, DOI 10.1186/cc9279; TEASDALE G, 1974, LANCET, V2, P81; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Vaughan LE, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1384-1; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AL, 2018, PHYS MANAGEMENT NEUR; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zhang Z, 2018, IRAN J PUBLIC HEALTH, V47, P779	49	4	4	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	FEB 11	2020	21	1							162	10.1186/s13063-019-4008-x			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KM7VP	WOS:000514348700002	32046747	Green Submitted, Green Published, gold			2022-02-06	
J	Ditch, KL; Flahive, JM; West, AM; Osgood, ML; Muehlschlegel, S				Ditch, Kristen L.; Flahive, Julie M.; West, Ashley M.; Osgood, Marcy L.; Muehlschlegel, Susanne			Hyperchloremia, not Concomitant Hypernatremia, Independently Predicts Early Mortality in Critically Ill Moderate-Severe Traumatic Brain Injury Patients	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Hyperchloremia; Hypernatremia; Neurocritical care; Mortality	ACUTE KIDNEY INJURY; INTENSIVE-CARE-UNIT; LACTATED RINGERS; CLINICAL-OUTCOMES; GLYCEMIC CONTROL; NORMAL SALINE; INFUSION; IMPACT; CHLORIDE; RESUSCITATION	Background Hypernatremia has been associated with mortality in neurocritically ill patients, with and without traumatic brain injury (TBI). These studies, however, lack concomitant adjustment for hyperchloremia as a physiologically co-occurring finding despite the associations with hyperchloremia and worse outcomes after trauma, sepsis, and intracerebral hemorrhage. The objective of our study was to examine the association of concomitant hypernatremia and hyperchloremia with in-hospital mortality in moderate-severe TBI (msTBI) patients. Methods We retrospectively analyzed prospectively collected data from the OPTIMISM-study and included all msTBI patients consecutively enrolled between 11/2009 and 1/2017. Time-weighted average (TWA) sodium and chloride values were calculated for all patients to examine the unadjusted mortality rates associated with the burden of hypernatremia and hyperchloremia over the entire duration of the intensive care unit stay. Multivariable logistic regression modeling predicting in-hospital mortality adjusted for validated confounders of msTBI mortality was applied to evaluate the concomitant effects of hypernatremia and hyperchloremia. Internal bootstrap validation was performed. Results Of the 458 patients included for analysis, 202 (44%) died during the index hospitalization. Fifty-five patients (12%) were excluded due to missing data. Unadjusted mortality rates were nearly linearly increasing for both TWA sodium and TWA chloride, and were highest for patients with a TWA sodium > 160 mmol/L (100% mortality) and TWA chloride > 125 mmol/L (94% mortality). When evaluated separately in the multivariable analysis, TWA sodium (per 10 mmol/L change: adjusted OR 4.0 [95% CI 2.1-7.5]) and TWA chloride (per 10 mmol/L change: adjusted OR 3.9 [95% CI 2.2-7.1]) independently predicted in-hospital mortality. When evaluated in combination, TWA chloride remained independently associated with in-hospital mortality (per 10 mmol/L change: adjusted OR 2.9 [95% CI 1.1-7.8]), while this association was no longer observed with TWA sodium values (per 10 mmol/L change: adjusted OR 1.5 [95% CI 0.51-4.4]). Conclusions When concomitantly adjusting for the burden of hyperchloremia and hypernatremia, only hyperchloremia was independently associated with in-hospital mortality in our msTBI cohort. Pending validation, our findings may provide the rationale for future studies with targeted interventions to reduce hyperchloremia and improve outcomes in msTBI patients.	[Ditch, Kristen L.] UMass Mem Med Ctr, Dept Clin Pharm, 55 Lake Ave North, Worcester, MA 01655 USA; [Flahive, Julie M.] UMass Med Sch, Dept Populat & Quantitat Hlth Sci, Worcester, MA USA; [West, Ashley M.] Yale New Haven Med Ctr, Dept Clin Pharm, 20 York St, New Haven, CT 06504 USA; [Osgood, Marcy L.; Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Neurol, Worcester, MA USA; [Osgood, Marcy L.; Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Anesthesia Crit Care, Worcester, MA USA; [Osgood, Marcy L.; Muehlschlegel, Susanne] Univ Massachusetts, Dept Surg, Med Sch, Worcester, MA USA		Ditch, KL (corresponding author), UMass Mem Med Ctr, Dept Clin Pharm, 55 Lake Ave North, Worcester, MA 01655 USA.	Kristen.ditch@gmail.com			NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR000161]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [HR001117S0032-WASH-FP-031]; UMass Memorial Medical Group PACEPrize 2018	This study was supported by: NIH/NICHD 5K23HD080971 (PI: Muehlschlegel) and NIH UL1TR000161 (CTSA; PI: Luzuriaga). Dr. Muehlschlegel is supported by grants NIH/NICHD 5K23HD080971 (PI); UMass Memorial Medical Group PACEPrize 2018 (co-PI); DARPA HR001117S0032-WASH-FP-031 (consultant).	Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; [Anonymous], SAS MACRO BOOTSTRAPP; Austin PC, 2017, STAT METHODS MED RES, V26, P796, DOI 10.1177/0962280214558972; Badawi O, 2009, AM J MED QUAL, V24, P310, DOI 10.1177/1062860609336366; Berry W.D, 1985, QUANTITATIVE APPL SO; Boniatti MM, 2011, J CRIT CARE, V26, P175, DOI 10.1016/j.jcrc.2010.04.013; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Darmon M, 2013, CRIT CARE, V17, DOI 10.1186/cc11937; de Vasconcellos K, 2018, J CRIT CARE, V45, P45, DOI 10.1016/j.jcrc.2018.01.019; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Gonen M., 2007, ANAL RECEIVER OPERAT; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Groenwold RHH, 2014, CAN MED ASSOC J, V186, P1153, DOI 10.1503/cmaj.131353; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kim MY, 2014, J NEUROSURG, V120, P1340, DOI 10.3171/2013.12.JNS13888; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Lee JY, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0311-7; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Mukaka M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1473-3; National Research Council, 2010, PREV TREATM MISS DAT; Neyra JA, 2015, CRIT CARE MED, V43, P1938, DOI 10.1097/CCM.0000000000001161; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Riha HM, 2017, CRIT CARE MED, V45, pE947, DOI 10.1097/CCM.0000000000002522; Sadan O, 2017, CRIT CARE MED, V45, P1382, DOI 10.1097/CCM.0000000000002497; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suetrong B, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1499-7; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; Tsipotis E, 2018, AM J MED, V131, P72, DOI 10.1016/j.amjmed.2017.08.011; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085029; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	46	4	4	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					533	541		10.1007/s12028-020-00928-0		FEB 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000516145800002	32043263				2022-02-06	
J	Anderson, MN; Lempke, LB; Bell, DH; Lynall, RC; Schmidt, JD				Anderson, M. N.; Lempke, L. B.; Bell, D. H.; Lynall, R. C.; Schmidt, J. D.			The ability of CNS vital signs to detect coached sandbagging performance during concussion baseline testing: a randomized control trial	BRAIN INJURY			English	Article						Psychometric; mild-traumatic brain injury; neurocognitive testing	IMMEDIATE POST-CONCUSSION; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; ATHLETIC TRAINERS; IMPACT; MANAGEMENT; RELIABILITY; BEHAVIORS; STATEMENT; VALIDITY	Objective: Despite widespread use of baseline neurocognitive testing in concussion management, suboptimal performance due to sandbagging still readily occurs without detection. The purpose of this study is to determine CNS Vital Signs validity indicator accuracy in detecting coached sandbagging compared to controls. Method: We compared rates of invalidity and domain composite scores for neurocognitive test performance between two groups of twenty-five college-aged students (age = 20.8 +/- 1.1 years, range 18-25, 48% female) completing CNS Vital Signs instructed to either 1) give their best effort (control) or, 2) give suboptimal performance (sandbag). The sandbagging group was given standardized instructions on how to sandbag without detection. All participants rated their effort after completing on a Visual Analog Scale (0-100 mm). Results: Built in invalidity indicators successfully identified 68.0% of sandbaggers, while only 12% in the control group presented with invalid scores. Participants in the sandbagging group on average reported significantly lower effort (sandbag: 51.0 +/- 21.0, control: 86.0 +/- 12.0, p < .001) Conclusions: Built-in CNS Vital Signs validity indicators have an overall high accuracy in identifying those attempting to purposefully sandbag and are comparable to other computerized neurocognitive tests. Given that 32% of intentional sandbaggers went undetected, clinicians should consider additional safeguards to detect these individuals at baseline.	[Anderson, M. N.; Lempke, L. B.; Bell, D. H.; Lynall, R. C.; Schmidt, J. D.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Anderson, MN (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA.	Melissa.Anderson@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Bailey CM, 2006, J INT NEUROPSYCHOL S, V12; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P422, DOI 10.1093/arclin/acu029; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; CNS Vital Signs LLC, 2017, FREQ ASK QUEST; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz K. M, 2015, KINESIOLOGY REV, V4, P156, DOI DOI 10.1123/kr.2015-0010; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hill BD, 2015, APPL NEUROPSYCH-ADUL, V22, P233, DOI 10.1080/23279095.2014.910215; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Rabinowitz AR, 2016, J CLIN EXP NEUROPSYC, V38, P599, DOI 10.1080/13803395.2015.1123224; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	32	4	4	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					369	374		10.1080/02699052.2020.1724332		FEB 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000513089000001	32026729				2022-02-06	
J	Hamilton, JA; Perrin, PB; Campbell, TA; Danish, SJ; Goldstein, AL				Hamilton, Janette A.; Perrin, Paul B.; Campbell, Thomas A.; Danish, Steven J.; Goldstein, Alissa L.			Predicting emergence from a disorder of consciousness using the Coma Recovery Scale-Revised	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Emerging consciousness; Traumatic brain injury; Acquired brain injury; Disorders of consciousness; Coma Recovery Scale	BRAIN-INJURY; VETERANS; RECOMMENDATIONS; REHABILITATION; OUTCOMES; COMBAT; SCORE; CARE	This study explored the utility of the Coma Recovery Scale-Revised (CRS-R) in predicting emergence from a disorder of consciousness, using a sample of veterans who were treated at one of the five Veterans Affairs (VA) polytrauma rehabilitation centre sites in an Emerging Consciousness programme. Participants (N = 70) included both combat and non-combat active duty military personnel and veterans who sustained either a severe traumatic brain injury, or anoxic brain injury and were considered to have a disorder of consciousness at the time of admission. Patient information was retrospectively collected from electronic medical records from one of the VA polytrauma rehabilitation centre sites. Receiver Operator Characteristic models were utilised to explore "cut-off scores" for predicting emergence using the CRS-R. Results showed that week-three scores on the CRS-R were more accurate in determining whether a veteran would emerge from a disorder of consciousness. Limitations, including a limited sample size are explored, along with implications and recommendations for future research and clinical practice.	[Hamilton, Janette A.; Campbell, Thomas A.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA 23249 USA; [Perrin, Paul B.; Danish, Steven J.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Goldstein, Alissa L.] Radford Univ, Dept Psychol, Radford, VA 24142 USA		Hamilton, JA (corresponding author), Hunter Holmes McGuire VA Med Ctr, Richmond, VA 23249 USA.	hamiltonja@vcu.edu	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Day K. V., 2017, NEUROPSYCHOL REHABIL, V150, P1; Defense and Veterans Brain Injury Center, 2017, DOD NUMB TRAUM BRAIN; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; McNamee S, 2012, J HEAD TRAUMA REHAB, V27, P244, DOI 10.1097/HTR.0b013e31825e12c8; Meyers L. S., 2013, APPL MULTIVARIATE ST; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Streiner DL, 2007, CAN J PSYCHIAT, V52, P121, DOI 10.1177/070674370705200210; Tabachnick B.G., 2013, USING MULTIVARIATE S	22	4	5	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2020	30	2					266	280		10.1080/09602011.2018.1461656			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	KQ4EM	WOS:000516877900007	29661098				2022-02-06	
J	Ceniccola, GD; Okamura, AB; Neta, JDS; Lima, FC; de Deus, ACS; de Oliveira, JA; dos Santos, SSM; de Sousa, RB; de Brito-Ashurst, I				Ceniccola, Guilherme Duprat; Okamura, Aline Bassetto; Sepulveda Neta, Jeane da Silva; Lima, Fernanda Cintra; Santos de Deus, Andressa Cristina; de Oliveira, Jessica Amarante; Martins dos Santos, Sabrina Souza; de Sousa, Rildo Batista; de Brito-Ashurst, Ione			Association Between AND-ASPEN Malnutrition Criteria and Hospital Mortality in Critically Ill Trauma Patients: A Prospective Cohort Study	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						intensive care; malnutrition; nutrition assessment; trauma	SUBJECTIVE GLOBAL ASSESSMENT; ENTERAL NUTRITION; AMERICAN SOCIETY; ENERGY DEFICIT; BRAIN-INJURY; ACADEMY	Background Malnutrition is prevalent in trauma victims because of intense muscle wasting triggered by traumatic events and is a mortality risk. The Academy of Nutrition and Dietetics-American Society for Parenteral and Enteral Nutrition (AND-ASPEN) tool has the potential to diagnose malnutrition in this population. This study aims to evaluate this criterion as a malnutrition diagnostic tool and as a hospital mortality predictor in critically ill trauma patients. Methods We performed an observational prospective cohort study from April 2015 to February 2017 in a Brazilian hospital. Patients were >18 years old, remained in the intensive care unit (ICU) >48 hours, and had completed data regarding the recommended clinical characteristics (RCCs) for malnutrition. The main exposure of interest was malnutrition assessed by a specialist dietitian using AND-ASPEN. The primary outcome was all causes of mortality during hospital stay. Secondary outcome was the RCCs assessment, to predict malnutrition and hospital mortality. Results Included were 414 trauma patients. Malnutrition prevalence was 26.8% at ICU admission. The main analysis showed that malnutrition increases mortality chances 1.96 times (95% CI, 1.13-3.30; P = .015). Secondary analysis showed that all 5 RCCs were significantly associated with malnutrition. The only RCC associated with mortality was energy intake (odds ratio 1.5; 95% CI, 1.1-2.0; P = .008). Conclusions AND-ASPEN criterion is a feasible and accurate method to recognize malnutrition and predict hospital mortality when applied by trained dietitians for the critical care trauma population. Further studies are needed considering patient subgroups such as obese and elderly.	[Ceniccola, Guilherme Duprat; Okamura, Aline Bassetto; Lima, Fernanda Cintra; Santos de Deus, Andressa Cristina; de Oliveira, Jessica Amarante; Martins dos Santos, Sabrina Souza; de Sousa, Rildo Batista] Hosp Base Dist Fed, Terapia Intens, Brasilia, DF, Brazil; [Okamura, Aline Bassetto] Ctr Univ Brasilia, Brasilia, DF, Brazil; [Sepulveda Neta, Jeane da Silva] Hosp Sirio Libanes, Brasilia, DF, Brazil; [Lima, Fernanda Cintra; de Oliveira, Jessica Amarante] Fundacao Ensino & Pesquisa Ciencias Saude, Brasilia, DF, Brazil; [de Brito-Ashurst, Ione] Royal Marsden NHS Fdn Trust, London, England		Ceniccola, GD (corresponding author), Hosp Base Dist Fed, Dept Nutr, MHS Q 101, BR-7033000 Brasilia, DF, Brazil.	gui_duprat1@hotmail.com		Amarante de Oliveira, Jessica/0000-0002-1604-6471			[Anonymous], 2015, SAUD BRAS AN SIT SAU; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Bector S, 2016, J INTENSIVE CARE MED, V31, P485, DOI 10.1177/0885066615596325; Andrade SSCD, 2017, EPIDEMIOL SERV SAUDE, V26, P31, DOI [10.5123/S1679-49742017000100004, 10.5123/s1679-49742017000100004]; Ceniccola GD, 2018, J CRIT CARE, V44, P398, DOI 10.1016/j.jcrc.2017.12.013; Ceniccola GD, 2019, NUTRITION, V62, P25, DOI 10.1016/j.nut.2018.11.028; Chapple LAS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1177-1; CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Faisy C, 2009, BRIT J NUTR, V101, P1079, DOI 10.1017/S0007114508055669; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Fontes D, 2014, CLIN NUTR, V33, P291, DOI 10.1016/j.clnu.2013.05.004; Gaudencio TG, 2013, REV NEUROCIENC, V21, P427; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Gunawan B, 2017, EJKI, V5, P161, DOI [10.23886/ejki.5.8148.Abstract, DOI 10.23886/EJKI.5.8148.ABSTRACT, 10.23886/ejki.5.8148, DOI 10.23886/EJKI.5.8148]; Hudson L, 2018, JPEN-PARENTER ENTER, V42, P892, DOI 10.1002/jpen.1021; Jensen GL, 2019, JPEN-PARENTER ENTER, V43, P32, DOI [10.1002/jpen.1440, 10.1016/j.clnu.2018.08.002]; Kakeshita Idalina Shiraishi, 2009, Psic.: Teor. e Pesq., V25, P263, DOI 10.1590/S0102-37722009000200015; Kane SP, 2018, CLIN CALCULATORS; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Lee C, 2018, JPEN-PARENTER ENTER, V42, P1263, DOI 10.1002/jpen.1175; Malone A, 2013, NUTR CLIN PRACT, V28, P639, DOI 10.1177/0884533613508435; Mogensen KM, 2019, NUTR CLIN PRACT, V34, P657, DOI 10.1002/ncp.10310; Mogensen KM, 2015, CRIT CARE MED, V43, P2605, DOI 10.1097/CCM.0000000000001306; Mueller C, 2011, JPEN-PARENTER ENTER, V35, P16, DOI 10.1177/0148607110389335; OPAS B, 2012, TRAUMAS MATAM MAIS Q; Pasqualli L, 1999, INSTRUMENTOS PSICOLO; Puthucheary Z, 2010, J PHYSIOL-LONDON, V588, P4641, DOI 10.1113/jphysiol.2010.197632; Santos C, 2007, AVALIACAO NUTR ASPEC, P289; Sauer AC, 2019, JPEN-PARENTER ENTER, V43, P918, DOI 10.1002/jpen.1499; Sharma K, 2019, NUTR CLIN PRACT, V34, P12, DOI 10.1002/ncp.10232; Sigueira-Paese MC, 2016, NUTR HOSP, V33, P522, DOI 10.20960/nh.253; Correia MITD, 2018, NUTR CLIN PRACT, V33, P62, DOI 10.1177/0884533617719669; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; World Health Organization, 1998, WHO TECHN REP SER; World Health Organization, 2013, GLOB STAT REP ROAD S	37	4	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	SEP	2020	44	7					1347	1354		10.1002/jpen.1795		FEB 2020	8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	NP1HX	WOS:000511261200001	32026492				2022-02-06	
J	Parent, M; Chitturi, J; Santhakumar, V; Hyder, F; Sanganahalli, BG; Kannurpatti, SS				Parent, Maxime; Chitturi, Jyothsna; Santhakumar, Vijayalakshmi; Hyder, Fahmeed; Sanganahalli, Basavaraju G.; Kannurpatti, Sridhar S.			Kaempferol Treatment after Traumatic Brain Injury during Early Development Mitigates Brain Parenchymal Microstructure and Neural Functional Connectivity Deterioration at Adolescence	JOURNAL OF NEUROTRAUMA			English	Article						adolescence; connectivity; DTI; fMRI; Kaempferol; traumatic brain injury	GLUCOSE-METABOLISM; WHITE-MATTER; MITOCHONDRIA; ACTIVATION; UNIPORTER; EXCITABILITY; MATURATION; INCREASES; HUMANS; TIME	Targeting mitochondrial ion homeostasis using Kaempferol, a mitochondrial Ca2+ uniporter channel activator, improves energy metabolism and behavior soon after a traumatic brain injury (TBI) in developing rats. Because of broad TBI pathophysiology and brain mitochondrial heterogeneity, Kaempferol-mediated early-stage behavioral and brain metabolic benefits may accrue from diverse sources within the brain. We hypothesized that Kaempferol influences TBI outcome by differentially impacting the neural, vascular, and synaptic/axonal compartments. After TBI at early development (P31), functional magnetic resonance imaging and diffusion tensor imaging (DTI) were applied to determine imaging outcomes at adolescence (2 months post-injury). Vehicle and Kaempferol treatments were made at 1, 24, and 48 h post-TBI, and their effects were assessed at adolescence. A significant increase in neural connectivity was observed after Kaempferol treatment as assessed by the spatial extent and strength of the somatosensory cortical and hippocampal resting-state functional connectivity (RSFC) networks. However, no significant RSFC changes were observed in the thalamus. DTI measures of fractional anisotropy (FA) and apparent diffusion coefficient, representing synaptic/axonal and microstructural integrity, showed significant improvements after Kaempferol treatment, with highest changes in the frontal and parietal cortices and hippocampus. Kaempferol treatment also increased corpus callosal FA, indicating measurable improvement in the interhemispheric structural connectivity. TBI prognosis was significantly altered at adolescence by early Kaempferol treatment, with improved neural connectivity, neurovascular coupling, and parenchymal microstructure in select brain regions. However, Kaempferol failed to improve vasomotive function across the whole brain, as measured by cerebrovascular reactivity. The differential effects of Kaempferol treatment on various brain functional compartments support diverse cellular-level mitochondrial functional outcomes in vivo.	[Parent, Maxime; Hyder, Fahmeed; Sanganahalli, Basavaraju G.] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA; [Santhakumar, Vijayalakshmi] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Med Sci Bldg, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Univ Calif Riverside, Dept Mol Cell & Syst Neurosci, Riverside, CA 92521 USA; [Hyder, Fahmeed] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Chitturi, Jyothsna; Kannurpatti, Sridhar S.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Radiol, Newark, NJ USA		Kannurpatti, SS (corresponding author), RUTGERS New Jersey Med Sch, Dept Radiol, ADMC 5 Room 575,30 Bergen St, Newark, NJ 07103 USA.	kannursr@njms.rutgers.edu	Chitturi, Jyothsna/AAR-3986-2020	Santhakumar, Vijayalakshmi/0000-0001-6278-4187	New Jersey Commission for Brain Injury research [CBIR15IRG010]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS097750, R01 MH067528, P30 NS052519]	Funding from the New Jersey Commission for Brain Injury research (CBIR15IRG010; to S.K.), NIH R01 NS097750 (to V.S.), NIH R01 MH067528 (to F.H.), and NIH P30 NS052519 (to F.H.) are acknowledged.	Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Casey P, 2006, CRIT CARE MED, V34, pA17, DOI 10.1097/00003246-200612002-00067; CHIRON C, 1992, J NUCL MED, V33, P696; Chitturi J, 2019, J NEUROTRAUM, V36, P1264, DOI 10.1089/neu.2018.6100; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Dubinsky JM, 2009, EXP NEUROL, V218, P293, DOI 10.1016/j.expneurol.2009.05.020; DuPont MS, 2004, EUR J CLIN NUTR, V58, P947, DOI 10.1038/sj.ejcn.1601916; Fiandaca MS, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0521-2; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hayakawa K, 2018, STEM CELLS, V36, P1404, DOI 10.1002/stem.2856; Hayakawa K, 2018, JAMA NEUROL, V75, P119, DOI 10.1001/jamaneurol.2017.3475; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Kaneko G, 2017, BIOL PSYCHIAT, V81, P503, DOI 10.1016/j.biopsych.2016.05.019; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1567, DOI 10.1016/j.neuroimage.2007.09.040; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2015, NMR BIOMED, V28, P1579, DOI 10.1002/nbm.3421; Kannurpatti SS, 2002, MAGN RESON MED, V47, P864, DOI 10.1002/mrm.10131; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Liu RN, 2006, BIOMED CHROMATOGR, V20, P1178, DOI 10.1002/bmc.675; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Parent M, 2019, J NEUROTRAUM, V36, P601, DOI 10.1089/neu.2018.5741; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prins ML, 2017, CHILD NERV SYST, V33, P1711, DOI 10.1007/s00381-017-3518-7; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Shih TY, 2013, AAPS J, V15, P753, DOI 10.1208/s12248-013-9490-6; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Vay L, 2007, J PHYSIOL-LONDON, V580, P39, DOI 10.1113/jphysiol.2006.126391; Winter JD, 2011, PEDIATR RES, V69, P418, DOI 10.1203/PDR.0b013e3182110f7e; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	50	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					966	974		10.1089/neu.2019.6486		FEB 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000512334500001	31830867	Green Published, Green Submitted			2022-02-06	
J	Alam, HB; Vercruysse, G; Martin, M; Brown, CVR; Brasel, K; Moore, EE; Sava, J; Ciesla, D; Inaba, K				Alam, Hasan B.; Vercruysse, Gary; Martin, Matthew; Brown, Carlos V. R.; Brasel, Karen; Moore, Ernest E.; Sava, Jack; Ciesla, David; Inaba, Kenji			Western Trauma Association critical decisions in trauma: Management of intracranial hypertension in patients with severe traumatic brain injuries	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc			DECOMPRESSIVE CRANIECTOMY; PRESSURE; DEXMEDETOMIDINE; GUIDELINES; SEDATION; THERAPY; VISITS; TRIAL		[Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI USA; [Vercruysse, Gary] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Martin, Matthew] Scripps Mercy Hosp, Dept Surg, San Diego, CA USA; [Brown, Carlos V. R.] Univ Texas Austin, Dept Surg, Dell Med Sch, Austin, TX 78712 USA; [Brasel, Karen] OHSU, Dept Surg, Portland, OR USA; [Moore, Ernest E.] Univ Colorado, Dept Surg, Denver, CO 80202 USA; [Sava, Jack] Washington Hosp Ctr, Dept Surg, Washington, DC 20010 USA; [Ciesla, David] Univ S Florida, Dept Surg, Tampa, FL 33620 USA; [Inaba, Kenji] Univ Southern Calif, Dept Surg, Los Angeles, CA 90007 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu					Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; American College of Surgeons Trauma Quality Improvement Program, ACS TQIP BEST PRACT; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bothwell SW, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0129-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Chen H, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010904, DOI 10.1002/14651858.CD010904]; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Humble SS, 2016, BRAIN INJURY, V30, P1266, DOI 10.1080/02699052.2016.1187289; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Kolias AG, 2018, CURR TRAUMA REP, V4, P326, DOI 10.1007/s40719-018-0147-x; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; McCafferty RR, 2018, MIL MED, V183, P67, DOI 10.1093/milmed/usy071; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Shaefi Shahzad, 2016, Surg Neurol Int, V7, P103, DOI 10.4103/2152-7806.194816; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Xie Q, 2017, WORLD NEUROSURG, V100, P118, DOI 10.1016/j.wneu.2016.12.097; Yoon S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00365	32	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2020	88	2					345	351		10.1097/TA.0000000000002555			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	KJ3LI	WOS:000511958800046	31999657				2022-02-06	
J	Argyropoulou, MI; Alexiou, GA; Xydis, VG; Adamsbaum, C; Chateil, JF; Rossi, A; Girard, N; Vazquez, E; Astrakas, LG				Argyropoulou, Maria, I; Alexiou, George A.; Xydis, Vassileios G.; Adamsbaum, Catherine; Chateil, Jean-Francois; Rossi, Andrea; Girard, Nadine; Vazquez, Elida; Astrakas, Loukas G.			Pediatric minor head injury imaging practices: results from an ESPR survey	NEURORADIOLOGY			English	Article						Minor head injury; CT; Children; Survey	DOSE REDUCTION; CT; CHILDREN; EXPOSURE; RULES	Purpose Computed tomography (CT) for minor head injury exposes a large number of children to ionizing radiation, with an associated increased lifetime risk of malignancy. To study imaging practices for children with minor head injury and the level of awareness of radiologists of the current clinical decision rules for minor traumatic brain injury (TBI). Methods A questionnaire consisting of 17 questions was distributed electronically to 472 ESPR members. The questionnaire covered demographic information, employment status, years of experience and the current practice setting of the participants, the number of CTs performed for pediatric head trauma, awareness of clinical decision rules and use of shielding, pediatric CT protocol and MRI. Results The response rate was 18.4%. The majority of participants was aged over 50 years and was full-time consultants. Regarding decision rules, 73.8% of respondents cited the NICE head injury guidelines, and 79% reported that the decision to perform CT was agreed between specialists. Shielding was used by 58.3% and 67.4% applied a specific pediatric protocol. MRI was not used for pediatric head trauma by 70.6% of respondents, although always available in 68.6% of cases. The reported obstacles to MRI use were machine availability (42.7%), the long acquisition time (39%) and patients' intolerance (18.3%), and less frequently the cost and the need for sedation. Conclusion There is room for decreasing the use of CT for pediatric minor TBI. The use of shielding and application of pediatric CT protocols constitute areas for improvement.	[Argyropoulou, Maria, I; Xydis, Vassileios G.] Univ Ioannina, Med Sch, Dept Radiol, Ioannina, Greece; [Alexiou, George A.] Univ Ioannina, Med Sch, Dept Neurosurg, Ioannina 45500, Greece; [Adamsbaum, Catherine] Paris Sud Univ, Bicetre Hosp, Fac Med, Paris, France; [Adamsbaum, Catherine] Paris Sud Univ, Bicetre Hosp, AP HP, Pediat Radiol Dept, Paris, France; [Chateil, Jean-Francois] Univ Bordeaux, CRMSB, UMR 5536, F-33076 Bordeaux, France; [Rossi, Andrea] IRCCS Ist Giannina Gaslini, Neuroradiol Unit, Genoa, Italy; [Girard, Nadine] Aix Marseille Univ, Timone Hosp, AP HM, UMR CNRS 7339, Marseille, France; [Vazquez, Elida] Hosp Univ Vall dHebron, Dept Pediat Radiol, Barcelona, Spain; [Astrakas, Loukas G.] Univ Ioannina, Med Sch, Dept Med Phys, Ioannina, Greece		Alexiou, GA (corresponding author), Univ Ioannina, Med Sch, Dept Neurosurg, Ioannina 45500, Greece.	alexiougr@gmail.com	Xydis, Vasileios/AAO-4450-2021; Vazquez, Elida/F-8362-2016; Alexiou, George A/B-3995-2012	Alexiou, George A/0000-0003-0257-4481; Xydis, Vasileios/0000-0002-1475-9021; Astrakas, Loukas/0000-0002-4890-4805			Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Brisse HJ, 2009, J RADIOL, V90, P207, DOI 10.1016/S0221-0363(09)72471-0; Celier D, 2020, EUR RADIOL, V30, P1156, DOI 10.1007/s00330-019-06405-3; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Curtis Jessica Ryann, 2010, Radiol Technol, V81, P428; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Granata C, 2015, PEDIATR RADIOL, V45, P695, DOI 10.1007/s00247-014-3201-z; Graves JM, 2014, J AM COLL RADIOL, V11, P161, DOI 10.1016/j.jacr.2013.07.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McCollough CH, 2011, J AM COLL RADIOL, V8, P878, DOI 10.1016/j.jacr.2011.09.001; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Raissaki M, 2010, PEDIATR RADIOL, V40, P1748, DOI 10.1007/s00247-010-1715-6; Rogers AJ, 2013, PEDIATRICS, V132, pE356, DOI 10.1542/peds.2013-0299; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Smith AB, 2008, RADIOLOGY, V247, P499, DOI 10.1148/radiol.2472071054; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Yakoumakis E, 2009, HEALTH PHYS, V97, P595, DOI 10.1097/01.HP.0000363840.78169.1b	23	4	4	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	FEB	2020	62	2					251	255		10.1007/s00234-019-02326-6			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	KL1WP	WOS:000513221400018	31828360				2022-02-06	
J	Cai, ZH; Xia, Y; Huang, XY				Cai, Zhihua; Xia, Yun; Huang, Xingyuan			ANALYSES OF PEDESTRIAN'S HEAD-TO-WINDSHIELD IMPACT BIOMECHANICAL RESPONSES AND HEAD INJURIES USING A HEAD FINITE ELEMENT MODEL	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Finite element head model; head injuries; windshield; head-to-windshield impact; contact force	LID-DRIVEN CAVITY; REALISTIC MODEL; SIMULATION; FRONT; FLOW; CONCUSSION; DEPOSITION; BEHAVIOR	Head injuries in the vehicle crashes or pedestrian accidents can usually cause death or permanent disabilities, and head injuries resulting from the impact of car windshields remain a major problem. Anatomically, more realistic head models are required to more accurately document and evaluate the head-to-windshield impact responses and head injuries. The current study developed a head finite element model and carried out various simulations to investigate the head-to-windshield impact biomechanical responses and assess the head injuries. First, a 50th percentile three-dimensional finite element head model was developed and validated by using previously published cadaver experimental data. Then, the biomechanical responses were predicted under a head-to-windshield impact at different impact velocities (10, 12, and 15 m/s) and different inclination angles of the windshield (35 degrees, 40 degrees, and 45 degrees). Finally, head injuries were investigated through examining various injury parameters. The results indicated that the contact force, the acceleration, the intracranial pressure, the deformation of the skull, and the negative pressure rose when the impact velocity and the inclination angles increased. Thus, the vehicle impact velocity and the inclination angle of the windshield greatly affect the severity of the resulting injuries on pedestrians' heads, with the severity increasing with the impact velocity and windshield inclination angle.	[Cai, Zhihua; Xia, Yun; Huang, Xingyuan] Hunan Univ Sci & Technol, Sch Electromech Engn, Xiangtan 411201, Peoples R China		Cai, ZH (corresponding author), Hunan Univ Sci & Technol, Sch Electromech Engn, Xiangtan 411201, Peoples R China.	caizhihua003@163.com			National Key Research and Development Program of China [2016YFC0802800]; China Postdoctoral Science Foundation Funded ProjectChina Postdoctoral Science Foundation [2016M592421]; Educational Commission of Hunan Province of China [18A188, 17A068]	We acknowledge the support from the National Key Research and Development Program of China (2016YFC0802800), China Postdoctoral Science Foundation Funded Project (2016M592421), the Educational Commission of Hunan Province of China (17A068), and the Educational Commission of Hunan Province of China (18A188).	Bezi S, 2018, INT J HEAT MASS TRAN, V124, P841, DOI 10.1016/j.ijheatmasstransfer.2018.03.109; Cai Z, 2013, P FISITA 2012 WORLD, V197, P375; Cai Z, COMPUT METHODS BIOME, V18, P974; Cai ZH, 2019, COMPUT METHOD BIOMEC, V22, P169, DOI 10.1080/10255842.2018.1541983; Cai ZH, 2016, J VIBROENG, V18, P539; Carter EL, 2008, INT J CRASHWORTHINES, V13, P629, DOI 10.1080/13588260802411457; Committee EEVs, 1998, 17 EEVC COMM EECS TN, P6; Crocetta G, 2015, ACCIDENT ANAL PREV, V79, P56, DOI 10.1016/j.aap.2015.03.009; DAWSON SL, 1980, HUM PATHOL, V11, P155, DOI 10.1016/S0046-8177(80)80136-5; Dixit P., 2016, ARCH COMPUT METHODS, V24, P1; Fildes B, 2004, PEDESTRIAN IMPACT PR; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Hammami F, 2018, INT J NUMER METHOD H, V28, P943, DOI 10.1108/HFF-09-2016-0361; Hammami F, 2017, COMPUT FLUIDS, V156, P317, DOI 10.1016/j.compfluid.2017.07.017; Janssen EG, 1996, P INT TECHN C ENH SA, P1212; Jhorgan T, 2003, INT J CRASHWORTHINES, V8, P14; Li GB, 2018, ACCIDENT ANAL PREV, V115, P143, DOI 10.1016/j.aap.2018.03.014; Li GB, 2017, ACCIDENT ANAL PREV, V101, P11, DOI 10.1016/j.aap.2017.01.012; Liu BH, 2016, INT J IMPACT ENG, V90, P26, DOI 10.1016/j.ijimpeng.2015.11.010; LIU HC, 1979, ACTA NEUROCHIR, V47, P105, DOI 10.1007/BF01404667; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mo FH, 2012, ACCIDENT ANAL PREV, V46, P18, DOI 10.1016/j.aap.2011.12.003; Otte D., 1999, P INT C BIOM IMP, P329; Peng Y, 2011, INFANTS INT FORUM AU; Peng Y, 2013, INT J IMPACT ENG, V57, P27, DOI 10.1016/j.ijimpeng.2013.01.010; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Rahimi-Gorji M, 2015, J MOL LIQ, V209, P121, DOI 10.1016/j.molliq.2015.05.031; Rahimi-Gorji M, 2016, COMPUT BIOL MED, V74, P1, DOI 10.1016/j.compbiomed.2016.04.017; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Shence W, 2018, APPL BIONICS BIOMECH, V2018, P1; Souayeh B, 2019, J MOL LIQ, V284, P163, DOI 10.1016/j.molliq.2019.03.151; Timmel M, 2007, INT J IMPACT ENG, V34, P1465, DOI 10.1016/j.ijimpeng.2006.07.008; Xu J, 2010, COMP MATER SCI, V48; Yang J., 2011, CHINESE J AUTOMOTIVE, V1, P81	35	4	4	0	7	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	FEB	2020	20	1							1950063	10.1142/S0219519419500635			15	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	KW4KT	WOS:000521135600002					2022-02-06	
J	Camara-Costa, H; Opatowski, M; Francillette, L; Toure, H; Brugel, D; Laurent-Vannier, A; Meyer, P; Watier, L; Dellatolas, G; Chevignard, M				Camara-Costa, Hugo; Opatowski, Marion; Francillette, Leila; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Meyer, Philippe; Watier, Laurence; Dellatolas, Georges; Chevignard, Mathilde			Self- and parent-reported Quality of Life 7 years after severe childhood traumatic brain injury in the Traumatisme Grave de l'Enfant cohort: associations with objective and subjective factors and outcomes	QUALITY OF LIFE RESEARCH			English	Article						Severe traumatic brain injury; Child; Adolescent; Health-related Quality of Life; Prospective cohort study	POPULATION HEALTH MEASURE; EXECUTIVE FUNCTION; CHILDREN; ADOLESCENTS; RELIABILITY; SCALE; PREDICTORS; PEDSQL(TM); VALIDITY; FATIGUE	Purpose To investigate self- and parent-reported Health-Related Quality-of-Life (HRQoL) and their associations after severe childhood traumatic brain injury (TBI) in the Traumatisme Grave de l'Enfant (TGE) cohort. Methods Self- (n = 34) and/or parent-reports (n = 25) of HRQoL were collected for 38 participants (age 7-22 years) 7 years after severe childhood TBI. The collected data included sociodemographic characteristics, injury severity indices, and overall disability and functional outcome at 3-months, 1- and 2-years post-injury. At 7-years post-injury, data were collected in the TBI group and in a control group (n = 33): overall disability (Glasgow Outcome Scale Extended), intellectual ability (IQ), and questionnaires assessing HRQoL (Pediatric Quality of Life Inventory), executive functions (Behavior Rating Inventory of Executive Functions), behavior (Child Behavior Checklist), fatigue (Multidimensional Fatigue Scale) and participation (Child and Adolescent Scale of Participation). Results Parent- and self-reports of HRQoL were significantly lower in the TBI group than in the control group. Parent-rated HRQoL was not associated with objectively assessed factors, whereas self-reported HRQoL was associated with gender (worse in females) and initial functional outcome. All questionnaire scores completed by the same informant (self or parent) were strongly inter-correlated. Conclusions Reported HRQoL 7-years after severe childhood TBI is low compared to controls, weakly or not-related to objective factors, such as injury severity indices, clinically assessed functional outcomes, or IQ, but strongly related to reports by the same informant of executive deficits, behavior problems, fatigue, and participation.	[Camara-Costa, Hugo; Dellatolas, Georges] Univ Paris SUD, Univ Paris Saclay, UVSQ, CESP,INSERM, 97 Blvd Port Royal, F-75014 Paris, France; [Camara-Costa, Hugo; Chevignard, Mathilde] Sorbonne Univ, LIB, Paris, France; [Opatowski, Marion] Univ Paris Saclay, UVSQ, INSERM, Inst Pasteur,Biostat Biomath Pharmacoepidemiol &, Paris, France; [Francillette, Leila; Watier, Laurence] Sorbonne Univ, Paris, France; [Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Neurol Injury, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Brugel, Dominique; Chevignard, Mathilde] Sorbonne Univ, HaMCRe, GRC 24, Paris, France; [Meyer, Philippe] Hop Necker Enfants Malad, Paediat Anesthesiol Dept, Paris, France; [Meyer, Philippe] Fac Med Rene Descartes, Paris 5, France		Camara-Costa, H (corresponding author), Univ Paris SUD, Univ Paris Saclay, UVSQ, CESP,INSERM, 97 Blvd Port Royal, F-75014 Paris, France.; Camara-Costa, H (corresponding author), Sorbonne Univ, LIB, Paris, France.	hugocamaracosta@gmail.com	Dellatolas, Georges/AAW-1377-2021; Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Camara-Costa, Hugo/0000-0002-3739-7190	Departement de la Recherche Clinique et du Developpement [AOM 03018, PHRC 2003] Funding Source: Medline		Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Camara-Costa H, 2019, DISABILITY REHABILIT; Camara-Costa H, 2017, NEURO-ONCOL PRACT, V4, P161, DOI 10.1093/nop/npw028; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coutinho V, 2017, APPL NEUROPSYCH-CHIL, V6, P255, DOI 10.1080/21622965.2016.1146141; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gioia G.A., 2014, BRIEF BEHAV RATING I; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Ilmer EC, 2016, EUR J PAEDIATR NEURO, V20, P131, DOI 10.1016/j.ejpn.2015.09.003; Kennedy C, 2014, INT J RADIAT ONCOL, V88, P292, DOI 10.1016/j.ijrobp.2013.09.046; Krasny-Pacini A, 2017, DEV NEUROREHABIL, V20, P456, DOI 10.1080/17518423.2016.1265605; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Norman GR, 2003, QUAL LIFE RES, V12, P239, DOI 10.1023/A:1023211129926; Patteau G, 2014, REANIMATION, V23, P507, DOI 10.1007/s13546-014-0920-y; Pieper P, 2015, J PEDIATR HEALTH CAR, V29, P343, DOI 10.1016/j.pedhc.2015.01.008; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Roth RM, 2015, BRIEF A BEHAV RATING; Ryan NP, 2019, ANN PHYS REHABILITAT; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Tessier S, 2009, EUR REV APPL PSYCHOL, V59, P291, DOI 10.1016/j.erap.2009.06.001; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2006, QUAL LIFE RES, V15, P203, DOI 10.1007/s11136-005-1388-z; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Waters E, 2009, DEV MED CHILD NEUROL, V51, P660, DOI 10.1111/j.1469-8749.2009.03324.x; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 2011, ECHELLE INTELLIGENCE, V4th ed.; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	60	4	4	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	FEB	2020	29	2					515	528		10.1007/s11136-019-02305-7			14	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	KI7NF	WOS:000511535800019	31549364				2022-02-06	
J	Li, ZH; Xu, FF; Li, YQ; Wang, RF; Zhang, ZG; Qu, Y				Li, Zhihong; Xu, Feifei; Li, Yuqian; Wang, Runfeng; Zhang, Zhiguo; Qu, Yan			Assessment of intracranial pressure monitoring in patients with moderate traumatic brain injury: A retrospective cohort study	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Moderate traumatic brain injury; Intracranial pressure; Glasgow outcome scale; Ventricular drainage catheter; Intraparenchymal catheter	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; TALK; MORTALITY; DIE; CLASSIFICATION; EPIDEMIOLOGY; IMPACT; SCORE; COMA	Objectives: intracranial pressure (ICP) monitoring has now been a standard technique for the treatment of severe traumatic brain injury (sTBI), while the effect of ICP monitoring for moderate traumatic brain injury (mTBI) is not clear. Moreover, evidence comparing the two types of ICP monitoring: ventricular drainage (VD) catheter and intraparenchymal (IP) catheter is scarce. Patients and methods: 91 patients with mTBI were reviewed retrospectively. They were divided into VD, IP and Non-ICP group. Baseline parameters were recorded. The clinical outcome was reflected by Glasgow Outcome Scale (GOS) and mortality at discharge and six months after injury. The rate of surgical decompression, refractory intracranial hypertension, neuroworsening, dose of mannitol and cranial CT were recorded. Meningitis and intracranial hematoma, two major complications of ICP monitoring, were also collected. Results: the three groups showed no significant difference in GOS at discharge and six months after injury. The mortality was similar among the three groups at six months after injury, while the Non-ICP group had the highest mortality at discharge. The Non-ICP group was administered the most mannitol while the VD group was administered the least. The Non-ICP group also received the most cranial CT scans among the three groups. Incidence of meningitis and intracranial hematoma were not significantly different among the VD and IP group. Conclusion: use of ICP monitoring could hardly improve the functional outcome of mTBI, but may possibly reduce the in-hospital mortality. By using ICP monitoring, the dose of mannitol and cranial CT scan for mTBI patients may be decreased.	[Li, Zhihong; Li, Yuqian; Wang, Runfeng; Zhang, Zhiguo; Qu, Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurery, Xian 710039, Shaanxi, Peoples R China; [Xu, Feifei] Fourth Mil Med Univ, Dept Foreign Languages, Xian 710032, Shaanxi, Peoples R China		Zhang, ZG; Qu, Y (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurery, Xian 710039, Shaanxi, Peoples R China.	zhiguofmmu@163.com; yanqu0123@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701310]	This study was supported by National Natural Science Foundation of China (No: 81701310), which approved the design and conduct of this study.	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Aiolfi A, 2018, J NEUROSURG, V128, P828, DOI 10.3171/2016.11.JNS162198; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Aziz S.A., 2018, J NEUROSURG, P1; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Candanedo C, 2019, NEUROCRIT CARE, V30, P340, DOI 10.1007/s12028-018-0612-y; COLOHAN ART, 1992, J NEUROTRAUM, V9, pS259; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Haider MN, 2018, BRAIN INJURY, V32, P809, DOI 10.1080/02699052.2018.1469045; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; HICKMAN KM, 1990, HEART LUNG, V19, P84; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Kourbeti IS, 2015, J NEUROSURG, V122, P1113, DOI 10.3171/2014.8.JNS132557; Lazaridis C, 2016, NEUROSURG CLIN N AM, V27, P509, DOI 10.1016/j.nec.2016.05.010; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marklund N, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00540; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; REILLY PL, 1975, LANCET, V2, P375; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Reithmeier T, 2018, ANASTH INTENSIV NOTF, V53, P682, DOI 10.1055/s-0043-118971; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; Ronning P, 2019, J NEUROSURG, V131, P1896, DOI 10.3171/2018.7.JNS18270; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Tunkel AR, 2017, CLIN INFECT DIS, V64, pE34, DOI 10.1093/cid/ciw861; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Volovici V, 2019, J NEUROTRAUM, V36, P988, DOI 10.1089/neu.2018.6086; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	36	4	5	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	FEB	2020	189								105538	10.1016/j.clineuro.2019.105538			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KO0BC	WOS:000515210000020	31846845				2022-02-06	
J	Ohbe, H; Jo, T; Matsui, H; Fushimi, K; Yasunaga, H				Ohbe, Hiroyuki; Jo, Taisuke; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Early enteral nutrition in patients with severe traumatic brain injury: a propensity score-matched analysis using a nationwide inpatient database in Japan	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						enteral nutrition; traumatic brain injury; retrospective study; propensity score; health care-associated pneumonia	ADJUSTMENT; GUIDELINES; MANAGEMENT; CARE	Background: Whether enteral nutrition (EN) should be administered early in severe traumatic brain injury (TBI) patients has not been fully addressed. Objective: The present study aimed to evaluate whether early EN can reduce mortality or nosocomial pneumonia among severe TBI patients. Methods: Using the Japanese Diagnosis Procedure Combination inpatient database from April 2014 to March 2017 linked with the Survey for Medical Institutions, we identified patients admitted for intracranial injury with Japan Coma Scale scores >= 30 (corresponding to Glasgow Coma Scale scores <= 8) at admission. We designated patients who started EN within 2 d of admission as the early EN group, and those who started EN at 3-5 d after admission as the delayed EN group. The primary outcome was in-hospital mortality. The secondary outcome was nosocomial pneumonia. Propensity score-matched analyses were performed to compare the outcomes between the 2 groups. Results: We identified 3080 eligible patients during the 36-mo study period, comprising 1100 (36%) in the early EN group and 1980 (64%) in the delayed EN group. After propensity score matching, there was no significant difference in in-hospital mortality (difference: -0.3%; 95% CI: -3.7%, 3.1%) between the 2 groups. The proportion of nosocomial pneumonia was significantly lower in the early EN group than in the delayed EN group (difference:-3.2%; 95% CI: -5.9%, -0.4%). Conclusions: Early EN may not reduce mortality, but may reduce nosocomial pneumonia in patients with severe TBI.	[Ohbe, Hiroyuki; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Jo, Taisuke] Univ Tokyo, Grad Sch Med, Dept Hlth Serv Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan		Ohbe, H (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.	hohbey@gmail.com	Ohbe, Hiroyuki/ABB-6008-2021	Ohbe, Hiroyuki/0000-0001-8544-2569; Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, JapanMinistry of Health, Labour and Welfare, Japan [19AA2007, H30-Policy-Designated-004]; Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17H04141]	Supported by Ministry of Health, Labour and Welfare, Japan, grants 19AA2007 (to HY) and H30-Policy-Designated-004 (to HY) andMinistry of Education, Culture, Sports, Science and Technology, Japan, grant 17H04141 (to HY).	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Alpers DH, 2002, CURR OPIN CLIN NUTR, V5, P679, DOI 10.1097/00075197-200211000-00011; APELGREN KN, 1982, CRIT CARE MED, V10, P305, DOI 10.1097/00003246-198205000-00003; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Blaser AR, 2017, INTENS CARE MED, V43, P380, DOI 10.1007/s00134-016-4665-0; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chapple LAS, 2017, CRIT CARE RESUSC, V19, P29; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; DeWitt RC, 1999, INFECT DIS CLIN N AM, V13, P465, DOI 10.1016/S0891-5520(05)70086-6; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fushimi K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-50; GIANOTTI L, 1994, CRIT CARE MED, V22, P265, DOI 10.1097/00003246-199402000-00018; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Leuven E., 2003, PSMATCH2 STATA MODUL; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Miglioretti DL, 2007, AM J EPIDEMIOL, V165, P453, DOI 10.1093/aje/kwk020; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Ministry of Health Labour and Welfare Japan, 2017, ANN REP FUNCT MED I; Ministry of Health Labour and Welfare Japan, 2010, JANIS JAP NOS INF SU; Mourik MSM, 2015, BMJ OPEN, V5; Park C, 1998, COMPUT STAT DATA AN, V27, P229, DOI 10.1016/S0167-9473(98)00004-8; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Wada T, 2017, INJURY PREV, V23, P263, DOI 10.1136/injuryprev-2016-042106; Windsor ACJ, 1998, GUT, V42, P431, DOI 10.1136/gut.42.3.431; Yamana H, 2016, J EPIDEMIOL, V26, P530, DOI 10.2188/jea.JE20150286; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	35	4	4	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	FEB	2020	111	2					378	384		10.1093/ajcn/nqz290			7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	KS6PR	WOS:000518429700020	31751450				2022-02-06	
J	Rotbaum, Y; Parvari, G; Eichen, Y; Rittel, D				Rotbaum, Yonatan; Parvari, Galit; Eichen, Yoav; Rittel, Daniel			Linear and Nonlinear Shock Attenuation of Aqueous Methylcellulose Solutions	INTERNATIONAL JOURNAL OF IMPACT ENGINEERING			English	Article						Aqueous methylcellulose; Thermoreversible gelation; Energy absorption; Attenuation coefficient; Dynamic loading	TRAUMATIC BRAIN-INJURY; COEFFICIENT SLOPE; ENERGY-ABSORPTION; BALLISTIC IMPACT; ULTRASOUND; BLAST; ELASTOMERS; FOAM; RELAXATION; PROTECTION	Aqueous methylcellulose solutions are fascinating inverse-freezing materials, known to reversibly form gels upon heating. Recently, these materials have been found to undergo this endothermic solidification upon impact. The impact-induced solidification was shown to occur in the microseconds' timescale, setting the path for examining their functionality for shock absorption purposes. This present work focuses on characterizing the ability of methylcellulose solutions to mitigate impact forces, and on quantifying their attenuation coefficients for weak ultrasonic pulses as well as violent impacts. Ultrasonic attenuation measurements at temperatures higher than the gelation temperature (solid gel), reveal unique behavior which is attributed to the thermogelation mechanism. Impact experiments on 2 cm thick solutions have shown unexpectedly strong force and impulse mitigation, along with a high attenuation coefficient that grows exponentially with frequency. This attenuation performance was even further improved by increasing the concentration of gel-forming material. Reducing the thickness of the sample to 1 cm does not apparently reduce the force and impulse mitigation characteristics from those measured for 2 cm thickness, which is a distinct "anomaly" of materials used for wave mitigation. These observations imply that in the materials investigated herein, the main mechanism of shockwave attenuation is the sol -> gel phase-transition, in contrast to shockwave passage through the viscous material bulk. Thus, the common normalization of the attenuation coefficient to the thickness of the medium is not valid for these materials.	[Rotbaum, Yonatan; Rittel, Daniel] Technion, Fac Mech Engn, IL-3200008 Haifa, Israel; [Parvari, Galit; Eichen, Yoav] Technion, Schulich Fac Chem, IL-3200008 Haifa, Israel		Rotbaum, Y (corresponding author), Technion, Fac Mech Engn, IL-3200008 Haifa, Israel.	y.rotbaum@gmail.com			Technion Security Science and Technology Center [2024374]; Israel Innovation Authority, Nofar Program for RD [62155]	This research was supported by the Technion Security Science and Technology Center, Grant 2024374, and by the Israel Innovation Authority, Nofar Program for R&D, case number 62155.	Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006; Alghamdi AAA, 2001, THIN WALL STRUCT, V39, P189, DOI 10.1016/S0263-8231(00)00048-3; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Arvidson SA, 2013, MACROMOLECULES, V46, P300, DOI 10.1021/ma3019359; BLITZ J, 1971, ULTRASONICS METHODS; Bodvik R, 2010, COLLOID SURFACE A, V354, P162, DOI 10.1016/j.colsurfa.2009.09.040; Brown E, 2010, NAT MATER, V9, P220, DOI [10.1038/NMAT2627, 10.1038/nmat2627]; Chatterjee T, 2012, BIOMACROMOLECULES, V13, P3355, DOI 10.1021/bm301123a; CHEN CH, 2007, ULTRASONIC ADV METHO; Chen WNW, 2011, MECH ENG SER, P1, DOI 10.1007/978-1-4419-7982-7; Cui L, 2009, MAT SCI ENG A-STRUCT, V507, P215, DOI 10.1016/j.msea.2008.12.011; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Desbrieres J, 1998, CARBOHYD POLYM, V37, P145, DOI 10.1016/S0144-8617(98)00023-X; Doengi F., 1998, ESA B, V93, P2; DUNN F, 1986, J ACOUST SOC AM, V80, P1248, DOI 10.1121/1.393818; Enelund M, 1999, INT J SOLIDS STRUCT, V36, P2417, DOI 10.1016/S0020-7683(98)00111-5; Fancey KS, 2005, J MATER SCI, V40, P4827, DOI 10.1007/s10853-005-2020-x; Farrer AI, 2015, J THER ULTRASOUND, V3, DOI 10.1186/s40349-015-0030-y; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GOULD PL, 1994, INTRO LINEAR ELASTIC; Guo A, 2000, J APPL POLYM SCI, V77, P467, DOI 10.1002/(SICI)1097-4628(20000711)77:2<467::AID-APP25>3.0.CO;2-F; Hahn SL., 1996, HILBERT TRANSFORMS S; Hayda R, 2004, CLIN ORTHOP RELAT R, P97, DOI 10.1097/01.blo.0000128295.28666.ee; He P, 2000, J ACOUST SOC AM, V107, P801, DOI 10.1121/1.428263; Hernandez-Jimenez A, 2002, POLYM TEST, V21, P325, DOI 10.1016/S0142-9418(01)00092-7; Hibbler R, 1992, ENG MECH STATICS DYN; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Jones KD, 2010, J COUNS DEV, V88, P372, DOI 10.1002/j.1556-6678.2010.tb00036.x; KAK AC, 1978, IEEE T BIO-MED ENG, V25, P321, DOI 10.1109/TBME.1978.326259; Kolsky H., 1949, INVESTIGATION MECH P, P676; KUC R, 1979, IEEE T SON ULTRASON, V26, P353, DOI 10.1109/T-SU.1979.31116; KUC R, 1982, ULTRASOUND MED BIOL, V8, P403, DOI 10.1016/S0301-5629(82)80008-2; Kwon J, 2010, J BIOMECH, V43, P420, DOI 10.1016/j.jbiomech.2009.10.008; Lee YS, 2003, J MATER SCI, V38, P2825, DOI 10.1023/A:1024424200221; Levy D, 2018, INT J IMPACT ENG, V122, P182, DOI 10.1016/j.ijimpeng.2018.07.014; Li L, 2002, LANGMUIR, V18, P7291, DOI 10.1021/la020029b; Lott JR, 2013, BIOMACROMOLECULES, V14, P2484, DOI 10.1021/bm400694r; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marsden JE., 1994, MATH FDN ELASTICITY; McAllister JW, 2015, ACS MACRO LETT, V4, P538, DOI 10.1021/acsmacrolett.5b00150; Mukai T., 1999, SCR MAT, V40; Ozdemir Z, 2016, INT J IMPACT ENG, V89, P49, DOI 10.1016/j.ijimpeng.2015.10.007; PARKINSON WW, 1971, NUCL ENG DES, V17, P247, DOI 10.1016/0029-5493(71)90026-4; Parvari G, 2018, CHEM COMMUN, V54, P12578, DOI 10.1039/c8cc06378h; Patel TR, 2008, MACROMOL BIOSCI, V8, P1108, DOI 10.1002/mabi.200800064; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Rahimzadeh T, 2015, J MECH PHYS SOLIDS, V85, P98, DOI 10.1016/j.jmps.2015.09.009; Ramirez BJ, 2018, MECH MATER, V127, P39, DOI 10.1016/j.mechmat.2018.08.011; Richler D, 2014, EXP MECH, V54, P805, DOI 10.1007/s11340-014-9848-4; Rijensky O, 2016, INT J IMPACT ENG, V98, P1, DOI 10.1016/j.ijimpeng.2016.07.006; Ritter T, 2000, IEEE T ULTRASON FERR, V47, P792, DOI 10.1109/58.852060; Roberts JC, 2005, J TRAUMA, V58, P1241, DOI 10.1097/01.TA.0000169805.81214.DC; Roland CM, 2010, COMPOS STRUCT, V92, P1059, DOI 10.1016/j.compstruct.2009.09.057; Rose J. L., 2004, ULTRASONIC WAVES SOL; Rotbaum Y, 2019, MAT SCI ENG C-MATER, V96, P176, DOI 10.1016/j.msec.2018.11.019; Rotbaum Y, 2019, MECH MATER, V132, P57, DOI 10.1016/j.mechmat.2019.02.013; Rotbaum Y, 2017, MACROMOLECULES, V50, P4817, DOI 10.1021/acs.macromol.7b00270; Salisbury CP, 2009, EXP MECH, V49, P829, DOI 10.1007/s11340-008-9207-4; Sanborn B, 2017, LAT AM J SOLIDS STRU, V14, P560, DOI 10.1590/1679-78253268; Santosa SP, 2000, INT J IMPACT ENG, V24, P509, DOI 10.1016/S0734-743X(99)00036-6; SARKAR N, 1979, J APPL POLYM SCI, V24, P1073, DOI 10.1002/app.1979.070240420; Schupper N, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046107; Shepherd CJ, 2009, AIP CONF PROC, V1195, P1399; SNYDER WE, 1978, IEEE T INSTRUM MEAS, V27, P94, DOI 10.1109/TIM.1978.4314628; Swain MV, 2014, J MECH BEHAV BIOMED, V29, P385, DOI 10.1016/j.jmbbm.2013.09.024; Tasdemirci A, 2012, INT J IMPACT ENG, V44, P1, DOI 10.1016/j.ijimpeng.2011.12.005; Verbitsky O, 1998, J APPL BIOMECH, V14, P300, DOI 10.1123/jab.14.3.300; VERHOEF WA, 1985, IEEE T BIO-MED ENG, V32, P521, DOI 10.1109/TBME.1985.325569; Wackerlig J, 2016, ANAL CHEM, V88, P250, DOI 10.1021/acs.analchem.5b03804; Wagner N., United States Patent, Patent No. [US72268782007, 722687820075]; Yu HJ, 2007, MAT SCI ENG A-STRUCT, V454, P542, DOI 10.1016/j.msea.2006.11.091	71	4	4	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0734-743X	1879-3509		INT J IMPACT ENG	Int. J. Impact Eng.	FEB	2020	136								103392	10.1016/j.ijimpeng.2019.103392			9	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	JW2KP	WOS:000502886900006					2022-02-06	
J	Stockwell, DW; Blalock, R; Podell, K; Marco, RAW				Stockwell, David W.; Blalock, Richard; Podell, Kenneth; Marco, Rex A. W.			At-Risk Tackling Techniques in American Football	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						tackling techniques; head-up tackle technique; "head across the bow" technique; pathomechanics of cervical spine injury	NECK INJURY REGISTRY; TRAUMATIC BRAIN; HIGH-SCHOOL; FATALITIES; HEAD	Background: In American football, fewer fatalities and severe injuries have been seen annually since 1976, after data from 1971 through 1975 were retrospectively reviewed to better understand the mechanisms involved in catastrophic cervical spine injury and rules were enacted to prohibit certain types of aggressive tackling. The National Football Head and Neck Injury Registry was established in 1975. Purpose: To assess (1) tackling techniques that coaches were teaching at 3 levels-youth level (YL; 4th to 5th grades), middle school (MS; 6th to 8th grades), and high school (HS; 9th to 12th grades); (2) tackling techniques used during games; and (3) the successful tackle rates of these techniques. Study Design: Descriptive epidemiology study. Methods: Surveys were distributed via email to 500 coaches of YL, MS, and HS football teams in Texas. Coaches provided video recordings of football games, and all tackle attempts were graded by a single reviewer who watched game videos; 1000 consecutive tackles were observed for each group. Survey data included how coaches instructed their players to tackle, the types of tackles, the number of tackles versus missed tackles, the head position, and the initial contact. Data were analyzed with the chi-square test. A subset of 100 consecutive tackles at each level of play was reviewed by 2 blinded reviewers to assess intra- and interrater reliabilities. Results: In all groups, coaches responded that they preferred to teach the at-risk "head across the bow" tackling technique (83% YL, 81% MS, 75% HS). Coaches stated that they instructed players to "keep your head up," as currently recommended, 89% in YL, 100% in MS, and 81% in HS. During games, players used head-up, inside-shoulder tackles more successfully across all groups (97.5% YL, 99.5% MS, 98.8% HS). While intra- and interrater reliabilities were in the good range, these scores were lower in the youth group. Conclusion: Our study supports the effectiveness of tackling with the head up and making the initial contact with the inside shoulder. Lower reliability ratings for the youth group were likely due to lower video quality and the lack of players' tackling experience.	[Stockwell, David W.; Blalock, Richard; Podell, Kenneth; Marco, Rex A. W.] Univ Texas Houston, Houston, TX USA; [Stockwell, David W.] Indiana Univ, Sch Med, Dept Neurol Surg, 355 W 16th St,Suite 5100, Indianapolis, IN 46202 USA; [Blalock, Richard] Murray Calloway Cty Hosp, Murray, KY USA; [Podell, Kenneth] Houston Methodist Hosp, Houston Methodist Concuss Ctr, Houston, TX 77030 USA; [Podell, Kenneth; Marco, Rex A. W.] Weill Cornell Med Coll, Houston, TX USA; [Podell, Kenneth; Marco, Rex A. W.] Inst Acad Med Houston Methodist, Houston, TX USA		Stockwell, DW (corresponding author), Indiana Univ, Sch Med, Dept Neurol Surg, 355 W 16th St,Suite 5100, Indianapolis, IN 46202 USA.	dwstockw@iu.edu			Houston Methodist Concussion Center via Swanson family	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was funded in part by the Houston Methodist Concussion Center via support from the Swanson family. D.W.S. has received hospitality payments from Globus Medical and Medtronic. R.B. has received educational support from Arthrex, Gentleman Orthopedic Solutions, and Smith & Nephew and hospitality payments from Stryker. R.A.W.M. has received consulting fees from Aesculap, DePuy/Medical Device Business Solutions, Globus Medical, Nuvasive, and Stryker and speaking fees from Globus Medical. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	[Anonymous], 2000, SEE WHAT YOU HIT VID; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Heck J F, 1996, J Athl Train, V31, P31; HECK J F, 1992, Journal of Athletic Training, V27, P120; Heck JF, 2004, J ATHL TRAINING, V39, P101; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Schneider R C, 1964, Clin Neurosurg, V12, P226; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; TORG JS, 1987, CLIN SPORT MED, V6, P61; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; USA_Football, HEADS FOOTB	14	4	4	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	FEB	2020	8	2							2325967120902714	10.1177/2325967120902714			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	KQ8GX	WOS:000517160200001	32128317	gold, Green Published			2022-02-06	
J	Tang, ZJ; Yang, K; Zhong, M; Yang, RJ; Zhang, JS; Jiang, QH; Liu, HY				Tang, Zhiji; Yang, Kun; Zhong, Ming; Yang, Ruijin; Zhang, Jinshi; Jiang, Qiuhua; Liu, Hongyi			Predictors of 30-Day Mortality in Traumatic Brain-Injured Patients after Primary Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Mortality; Predictors; Primary decompressive craniectomy; Traumatic brain injury	PROGRESSIVE HEMORRHAGIC INJURY; CHINESE MILITARY HOSPITALS; ASSOCIATION; EPIDEMIOLOGY; COAGULATION; HYPOTENSION; CRANIOTOMY; INPATIENTS; CHILDREN; OUTCOMES	OBJECTIVE: Primary decompressive craniectomy (DC) is an important therapeutic technique for severe head-injured patients with space-occupying lesions in emergency situations, hut these patients are still at high risk for unfavorable outcomes. This study aimed to investigate the predictors of 30-day mortality in adult patients undergoing primary DC after traumatic brain injury (TBI). METHODS: All adult patients (>= 18 years of age) who underwent primary DC from January 2012 to March 2019 were included. Demographic, clinical, surgical, and laboratory variables were collected for analysis. Early mortality was defined as 30-day mortality after DC. First, a univariate analysis (P < 0.05) was used to compare survivors and nonsurvivors. Multivariate logistic regression analysis was used to identify the predictors of 30-day mortality for patients who underwent primary DC. RESULTS: A total of 387 patients were enrolled in the study. The 30-day mortality was 31.52% (122/387). The median age at presentation was 49 years (interquartile range, 38-60), and 316 (81.65%) patients were male. In the multivariate logistic regression analysis, the factors associated with 30-day mortality included age (odds ratio [OK 1.068; 95% confidence interval [CI], 1.040-1.096; P < 0.001), bilateral unreactive pupils (OR, 12.734; 95% CI, 4.129-39.270; P < 0.001), subdural hemorrhage (OR, 3.468; 95% CI, 1.305-9.218; P < 0.013), completely effaced basal cistern (OR, 3.52; 95% CI, 1.568-7.901; P = 0.002), intraoperative hypotension (OR, 11.532; 95% CI, 4.222-31.499; P < 0.001), preoperative activated partial thromboplastin time (OR, 6.905; 95% CI, 2.055-23.202; P = 0.002), and Injury Severity Score (OR, 1.081; 95% CI, 1.031-1.133; P = 0.002). CONCLUSIONS: In patients undergoing primary DC after traumatic brain injury, the predictors of 30-day mortality include age, bilateral unreactive pupils, subdural hemorrhage, completely effaced basal cistern, intraoperative hypotension, preoperative activated partial thromboplastin time, and Injury Severity Score.	[Tang, Zhiji; Yang, Ruijin; Zhang, Jinshi; Jiang, Qiuhua] Ganzhou Peoples Hosp, Dept Neurosurg, Ganzhou, Jiangxi, Peoples R China; [Tang, Zhiji; Yang, Kun; Liu, Hongyi] Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Zhong, Ming] Huichang Cty Peoples Hosp, Dept Neurosurg, Ganzhou, Jiangxi, Peoples R China		Jiang, QH (corresponding author), Ganzhou Peoples Hosp, Dept Neurosurg, Ganzhou, Jiangxi, Peoples R China.	jiangqh1968@126.com			Science & Technology Program of Health Commission of Jiangxi Province [20197373]	This study was funded by the Science & Technology Program of Health Commission of Jiangxi Province (number 20197373).	Ahmed N, 2017, J NEUROL SURG PART A, V78, P453, DOI 10.1055/s-0036-1593978; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jamous M, 2010, EUR J TRAUMA EMERG S, V36, P465, DOI 10.1007/s00068-010-0002-4; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Li YM, 2017, J CLIN NEUROSCI, V44, P107, DOI 10.1016/j.jocn.2017.05.026; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; Manuel Vinas-Rios Juan, 2015, Asian J Neurosurg, V10, P190, DOI 10.4103/1793-5482.161171; Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820; Mhanna MJ, 2015, J NEUROSURG-PEDIATR, V16, P508, DOI 10.3171/2014.10.PEDS14117; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Mohindra S, 2008, SURG NEUROL, V69, P474, DOI 10.1016/j.surneu.2007.02.031; Nakae Ryuta, 2017, Surg Neurol Int, V8, P214, DOI 10.4103/sni.sni_56_17; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Nambiar M, 2015, CRIT CARE RESUSC, V17, P67; Nardi G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0817-9; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Strnad M, 2016, WIEN KLIN WOCHENSCHR, V129, P1; Tang ZJ, 2018, WORLD NEUROSURG, V119, pE389, DOI 10.1016/j.wneu.2018.07.173; Tapper Julius, 2017, Surg Neurol Int, V8, P141, DOI 10.4103/sni.sni_453_16; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Watts Hannah F, 2012, J Emerg Trauma Shock, V5, P131, DOI 10.4103/0974-2700.96481; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yang CJ, 2011, J TRAUMA, V71, pE132, DOI 10.1097/TA.0b013e31820ea36b; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang K, 2016, BRIT J NEUROSURG, V30, P251, DOI 10.3109/02688697.2016.1139052; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	47	4	4	3	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2020	134						E298	E305		10.1016/j.wneu.2019.10.053			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK6VS	WOS:000512878200036	31629151				2022-02-06	
J	Williams, CN; Hartman, ME; McEvoy, CT; Hall, TA; Lim, MM; Shea, SA; Luther, M; Guilliams, KP; Guerriero, RM; Bosworth, CC; Piantino, JA				Williams, Cydni N.; Hartman, Mary E.; McEvoy, Cindy T.; Hall, Trevor A.; Lim, Miranda M.; Shea, Steven A.; Luther, Madison; Guilliams, Kristin P.; Guerriero, Rejean M.; Bosworth, Christopher C.; Piantino, Juan A.			Sleep-Wake Disturbances After Acquired Brain Injury in Children Surviving Critical Care	PEDIATRIC NEUROLOGY			English	Article						Pediatric; Sleep; Sleep-wake disorders; Critical care outcomes; Brain injury; Trauma	QUALITY-OF-LIFE; OUTCOMES; SCALE; UNIT; DISORDERS; CHILDHOOD; MELATONIN; MODERATE; SDSC	Background: Sleep-wake disturbances are underevaluated among children with acquired brain injury surviving critical care. We aimed to quantify severity, phenotypes, and risk factors for sleep-wake disturbances. Methods: We performed a prospective cohort study of 78 children aged >= 3 years with acquired brain injury within three months of critical care hospitalization. Diagnoses included traumatic brain injury (n = 40), stroke (n = 11), infectious or inflammatory disease (n = 10), hypoxic-ischemic injury (n = 9), and other (n = 8). Sleep Disturbances Scale for Children standardized T scores measured sleep-wake disturbances. Overall sleep-wake disturbances were dichotomized as any total or subscale T score >= 60. Any T score >= 70 defined severe sleep-wake disturbances. Subscale T scores >= 60 identified sleep wake disturbance phenotypes. Results: Sleep-wake disturbances were identified in 44 (56%) children and were classified as severe in 36 (46%). Sleep-wake disturbances affected >= 33% of patients within each diagnosis and were not associated with severity of illness measures. The most common phenotype was disturbance in initiation and maintenance of sleep (47%), although 68% had multiple concurrent sleep-wake disturbance phenotypes. One third of all patients had preadmission chronic conditions, and this increased risk for sleep-wake disturbances overall (43% vs 21%, P = 0.04) and in the traumatic brain injury subgroup (52% vs 5%, P = 0.001). Conclusions: Over half of children surviving critical care with acquired brain injury have sleep-wake disturbances. Most of these children have severe sleep-wake disturbances independent of severity of illness measures. Many sleep-wake disturbances phenotypes were identified, but most children had disturbance in initiation and maintenance of sleep. Our study underscores the importance of evaluating sleep-wake disturbances after acquired brain injury. (C) 2019 Elsevier Inc. All rights reserved.	[Williams, Cydni N.; Hall, Trevor A.; Luther, Madison; Piantino, Juan A.] Oregon Hlth & Sci Univ, Pediat Crit Care & Neurotrauma Recovery Program, Portland, OR 97201 USA; [Williams, Cydni N.] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Hartman, Mary E.; Guilliams, Kristin P.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Crit Care Med,Dept Pediat, St Louis, MO 63110 USA; [McEvoy, Cindy T.] Oregon Hlth & Sci Univ, Dept Pediat, Div Neonatol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Hall, Trevor A.] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Psychol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Lim, Miranda M.; Shea, Steven A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Lim, Miranda M.] VA Portland Hlth Care Syst, Portland, OR USA; [Guilliams, Kristin P.; Guerriero, Rejean M.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Pediat & Dev Neurol,Dept Neurol, St Louis, MO 63110 USA; [Bosworth, Christopher C.] Washington Univ, St Louis Childrens Hosp, Sch Med, Dept Psychol, St Louis, MO 63110 USA; [Piantino, Juan A.] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Neurol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA		Williams, CN (corresponding author), Oregon Hlth & Sci Univ, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA.	willicyd@ohsu.edu		Williams, Cydni/0000-0002-2049-7662; Shea, Steven/0000-0003-1949-0954	Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1RR024140]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL105447, K12HL133115]; Office of Dietary SupplementUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01H L129060, UG30D023288]; VA Portland Health Care SystemUS Department of Veterans Affairs; VA Career Development Award [IK2 BX002712]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HL125893, R01-HL125893-03S1, R01-HL142064, ROl HL140577]; Oregon Institute of Occupational Health Sciences via funds from the Division of Consumer and Business Services of the State of Oregon [ORS 656.630]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS099472]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL125893, R01HL105447, K12HL133115, R01HL140577, R01HL142064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS099472] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2BX002712] Funding Source: NIH RePORTER	This research was made possible with support from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Funding: C.N.W. is supported by the Agency for Healthcare Research and Quality, grant number K12HS022981. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. C.T.M. is supported by the National Heart, Lung and Blood Institute, R01 HL105447 with cofunding from the Office of Dietary Supplement, R01H L129060 and UG30D023288. M.M.L. is supported with resources and the use of facilities at the VA Portland Health Care System and VA Career Development Award #IK2 BX002712. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. S.A.S. is supported by the National Institutes of Health, grant numbers R01-HL125893, R01-HL125893-03S1, R01-HL142064, and ROl HL140577, as well as the Oregon Institute of Occupational Health Sciences via funds from the Division of Consumer and Business Services of the State of Oregon (ORS 656.630). K.P.G. is supported by the National Institute of Neurological Disorders and Stroke, grant number K23NS099472. J.A.P. is supported by the National Heart, Lung and Blood Institute, grant number K12HL133115.	Abdelgadir IS, 2018, ARCH DIS CHILD, V103, P1155, DOI 10.1136/archdischild-2017-314181; Als LC, 2015, PEDIATR CRIT CARE ME, V16, pE141, DOI 10.1097/PCC.0000000000000424; Archbold KH, 2002, J PEDIATR-US, V140, P97, DOI 10.1067/mpd.2002.119990; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Chang CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181430; Colville G, 2008, AM J RESP CRIT CARE, V177, P976, DOI 10.1164/rccm.200706-857OC; Colville GA, 2019, PEDIATR CRIT CARE ME, V20, pE98, DOI 10.1097/PCC.0000000000001794; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Delahaye J, 2014, RES AUTISM SPECT DIS, V8, P292, DOI 10.1016/j.rasd.2013.12.015; Dodd JN, 2018, PEDIATR NEUROL, V89, P58, DOI 10.1016/j.pediatrneurol.2018.09.007; Ekinci O, 2017, INT J PSYCHIAT MED, V52, P72, DOI 10.1177/0091217417703288; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Galland Barbara C, 2012, Sleep Med Rev, V16, P561, DOI 10.1016/j.smrv.2012.01.007; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Herrup Elizabeth A, 2017, World J Crit Care Med, V6, P124, DOI 10.5492/wjccm.v6.i2.124; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Keegan LJ, 2014, DEV NEUROREHABIL, V17, P355, DOI 10.3109/17518423.2012.741147; Kocevska D, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw022; Kudchadkar SR, 2014, SLEEP MED REV, V18, P103, DOI 10.1016/j.smrv.2013.02.002; Marseglia L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051053; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Ophoff D, 2018, EUR J PEDIATR, V177, P641, DOI 10.1007/s00431-018-3116-z; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Owens JA, 2009, PEDIATR PULM, V44, P417, DOI 10.1002/ppul.20981; Patel AK, 2017, PEDIATR CLIN N AM, V64, P1117, DOI 10.1016/j.pcl.2017.06.009; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Rennick JE, 2009, J CHILD HEALTH CARE, V13, P128, DOI 10.1177/1367493509102472; Ringli M, 2011, PROG BRAIN RES, V193, P63, DOI 10.1016/B978-0-444-53839-0.00005-3; Romeo DM, 2013, EUR J PAEDIATR NEURO, V17, P374, DOI 10.1016/j.ejpn.2012.12.009; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schmidt H, 2006, J NEUROL NEUROSUR PS, V77, P554, DOI 10.1136/jnnp.2005.071142; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Tan X, 2019, SLEEP MED, V59, P42, DOI 10.1016/j.sleep.2018.08.007; Uchiyama M, 2015, SLEEP MED CLIN, V10, P495, DOI 10.1016/j.jsmc.2015.07.006; van Markus-Doornbosch F, 2016, BRAIN INJURY, V30, P1533, DOI 10.1080/02699052.2016.1197968; Volk C, 2015, ARCH ITAL BIOL, V153; Wainwright MS, 2014, SEMIN PEDIATR NEUROL, V21, P248, DOI 10.1016/j.spen.2014.10.006; Watson RS, 2018, J PEDIATR-US, V198, P16, DOI 10.1016/j.jpeds.2017.12.084; Williams CN, 2018, PEDIATR NEUROL, V89, P31, DOI 10.1016/j.pediatrneurol.2018.07.013; Williams CN, 2018, NAT SCI SLEEP, V10, P225, DOI 10.2147/NSS.S174608; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083	51	4	4	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	FEB	2020	103						43	51		10.1016/j.pediatrneurol.2019.08.010			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	KI3GT	WOS:000511237900008	31735567	Green Accepted			2022-02-06	
J	Panwar, J; Hsu, CCT; Tator, CH; Mikulis, D				Panwar, Jyoti; Hsu, Charlie Chia-Tsong; Tator, Charles H.; Mikulis, David			Magnetic Resonance Imaging Criteria for Post-Concussion Syndrome: A Study of 127 Post-Concussion Syndrome Patients	JOURNAL OF NEUROTRAUMA			English	Article						hemorrhages; MRI; neuroimaging criteria; PCS; WMH	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CEREBRAL MICROHEMORRHAGES; POSTCONCUSSION SYNDROME; PREDICTING OUTCOMES; UNITED-STATES; MILD; ABNORMALITIES; MICROBLEEDS; PREVALENCE	The purpose of this study was to assess the frequency of structural lesions on conventional magnetic resonance imaging (MRI) of the brain in a large prospective cohort of post-concussion syndrome (PCS) patients. Conventional 3T MRI was used to evaluate 127 prospectively enrolled PCS patients and 29 controls for non-specific white matter hyperintensities (WMH) and traumatic structural lesions, including encephalomalacia, atrophy, microhemorrhage, subarachnoid hemorrhage, and cortical siderosis. All PCS patients had a clinical diagnosis of one or more concussions based on the Concussion in Sport Group (CISG) consensus statements. Patients with recognized intracranial hemorrhage on prior head computed tomography (CT) and MRI were excluded. The differences between the PCS and control groups were analyzed. Four patients in the PCS group (3.1%) had positive findings, which included microhemorrhages in two patients and encephalomalacia in another two patients. None of these lesions was present in the control group, but there was no statistical difference between the two groups (p = 0.5 for microhemorrhage and p = 0.5 for encephalomalacia). In the PCS group, 28 patients (22%) had WMH (15.7% had 1-10 lesions and 6.3% had >10 lesions), and these results did not differ from the age-matched control (20.6%, all with 1-10 lesions; p = 0.9) The location of the WMH showed no significant difference in the number of juxtacortical WMH between the PCS and control groups (p = 0.5). Structural lesions were rare in PCS in this study, and the presence of such findings suggests a more severe form of traumatic brain injury. Our data support the role for MRI in the diagnosis of PCS by exclusion of atrophy, encephalomalacia, and all forms of intracranial hemorrhage. The presence of WMH irrespective of number is not an exclusion. This is the first description of the MRI criteria for PCS.	[Panwar, Jyoti] Christian Med Coll & Hosp, Dept Radiol, Vellore, Tamil Nadu, India; [Hsu, Charlie Chia-Tsong] Gold Coast Univ Hosp, Dept Med Imaging, Southport, Qld, Australia; [Tator, Charles H.] Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Mikulis, David] Univ Toronto, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada		Mikulis, D (corresponding author), Toronto Western Hosp, Dept Med Imaging, 399 Bathurst St, Toronto, ON, Canada.	david.mikulis@uhn.ca	Hsu, Charlie Chia-Tsong/H-7146-2019	Hsu, Charlie Chia-Tsong/0000-0003-0803-593X	Ontario Brain Institute, Canada; Canadian Concussion Centre, Toronto Western Hospital	This study was funded by the Ontario Brain Institute, Canada, and the Canadian Concussion Centre, Toronto Western Hospital.	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bergman DA, 1999, PEDIATRICS, V104, P1407; Bigler E.D, 2015, BRAIN NEUROTRAUMA MO, P433; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Department of Defense, 2007, TRAUM BRAIN INJ DEF; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Lindemer ER, 2017, NEUROIMAGE-CLIN, V14, P156, DOI 10.1016/j.nicl.2017.01.022; Liu GB, 2015, ACTA RADIOL, V56, P1256, DOI 10.1177/0284185114552883; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Powell JW, 2001, J ATHL TRAINING, V36, P307; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Vernooij MW, 2008, RADIOLOGY, V248, P272, DOI 10.1148/radiol.2481071158	51	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1190	1196		10.1089/neu.2019.6809		JAN 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000510742400001	31822164				2022-02-06	
J	Tadepalli, SA; Bali, ZK; Bruszt, N; Nagy, LV; Amrein, K; Fazekas, B; Buki, A; Czeiter, E; Hernadi, I				Tadepalli, Sai Ambika; Bali, Zsolt Kristof; Bruszt, Nora; Nagy, Lili Veronika; Amrein, Krisztina; Fazekas, Balint; Buki, Andras; Czeiter, Endre; Hernadi, Istvan			Long-term cognitive impairment without diffuse axonal injury following repetitive mild traumatic brain injury in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Chronic traumatic encephalopathy; Novel object recognition; Water maze; Memory; Glial fibrillary acidic protein; Amyloid precursor protein	MOUSE MODEL; TAU; S100B; GFAP; PROTEIN; IMPACT; CONSEQUENCES; BIOMARKERS; TRANSPORT	Repetitive mild traumatic brain injuries (TBI) impair cognitive abilities and increase risk of neurodegenerative disorders in humans. We developed two repetitive mild TBI models in rats with different time intervals between successive weight-drop injuries. Rats were subjected to repetitive Sham (no injury), single mild (mTBI), repetitive mild (rmTBI - 5 hits, 24 h apart), rapid repetitive mild (rapTBI - 5 hits, 5 min apart) or a single severe (sTBI) TBI. Cognitive performance was assessed 2 and 8 weeks after TBI in the novel object recognition test (NOR), and 6-7 weeks after TBI in the water maze (MWM). Acute immunohistochemical markers were evaluated 24 h after TBI, and blood biomarkers were measured with ELISA 8 weeks after TBI. In the NOR, both rmTBI and rapTBI showed poor performance at 2 weeks post-injury. At 8 weeks post-injury, the rmTBI group still performed worse than the Sham and mTBI groups, while the rapTBI group recovered. In the MWM, the rapTBI group performed worse than the Sham and mTBI groups. Acute APP and RMO-14 immunohistochemistry showed axonal injury at the pontomedullary junction in the sTBI, but not in other groups. ELISA showed increased serum GFAP levels 8 weeks after sTBI, while no differences were found between the injury groups in the levels of phosphorylated-tau and S100 beta. Results suggest that the rmTBI protocol is the most suitable model for testing cognitive impairment after mild repetitive head injuries and that the prolonged cognitive impairment after repetitive mild TBI originates from different structural and molecular mechanisms compared to similar impairments after single sTBI.	[Tadepalli, Sai Ambika; Nagy, Lili Veronika; Hernadi, Istvan] Univ Pecs, Fac Sci, Dept Expt Zool & Neurobiol, Ifjusag Utja 6, H-7624 Pecs, Hungary; [Tadepalli, Sai Ambika; Bali, Zsolt Kristof; Bruszt, Nora; Nagy, Lili Veronika; Hernadi, Istvan] Univ Pecs, Szentagothai Res Ctr, Translat Neurosci Res Grp, Ifjusag Utja 20, H-7624 Pecs, Hungary; [Tadepalli, Sai Ambika; Bali, Zsolt Kristof; Bruszt, Nora; Nagy, Lili Veronika; Amrein, Krisztina; Fazekas, Balint; Buki, Andras; Czeiter, Endre; Hernadi, Istvan] Univ Pecs, Ctr Neurosci, Szentagothai Res Ctr, Ifjusag Utja 20, H-7624 Pecs, Hungary; [Bali, Zsolt Kristof; Hernadi, Istvan] Univ Pecs, Grastyan Translat Res Ctr, Ifjusag Utja 6, H-7624 Pecs, Hungary; [Bruszt, Nora; Hernadi, Istvan] Univ Pecs, Med Sch, Inst Physiol, Szigeti Ut 12, H-7624 Pecs, Hungary; [Amrein, Krisztina; Fazekas, Balint; Buki, Andras; Czeiter, Endre] Univ Pecs, Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary; [Amrein, Krisztina; Fazekas, Balint; Buki, Andras; Czeiter, Endre] Univ Pecs, Szentagothai Res Ctr, Neurotrauma Res Grp, Ifjusag Utja 20, H-7624 Pecs, Hungary; [Czeiter, Endre] MTA PTE Clin Neurosci MR Res Grp, Ret U 2, H-7623 Pecs, Hungary		Bali, ZK (corresponding author), Univ Pecs, Szentagothai Res Ctr, Translat Neurosci Res Grp, Ifjusag Utja 20, H-7624 Pecs, Hungary.	bali.zsolt.k@gmail.com	Bali, Zsolt Kristof/L-1653-2014	Bali, Zsolt Kristof/0000-0003-0712-0788; Hernadi, Istvan/0000-0001-7882-4817; Czeiter, Endre/0000-0002-9578-6944	Hungarian National Brain Research Programme of the National Research, Development and Innovation Office of the Hungarian Government [2017-1.2.1-NKP-2017-00002]; National Research, Development and Innovation Fund of the Hungarian Government [K 129247]; Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary [20765-3/2018/FEKUTSTRAT, EFOP-3.6.2.-16-2017-00008]; Hungarian Economic Development and Innovation Operational Programme [GINOP-2.3.2-15-2016-00048, GINOP-2.3.3-15-2016-00032]	This research was funded by Hungarian National Brain Research Programme of the National Research, Development and Innovation Office of the Hungarian Government (grant no. `2017-1.2.1-NKP-2017-00002'), by the National Research, Development and Innovation Fund of the Hungarian Government (grant no. `K 129247'), by the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary `The role of neuro-inflammation in neurodegeneration: from molecules to clinics' (grant no. `20765-3/2018/FEKUTSTRAT' and `EFOP-3.6.2.-16-2017-00008'), and the Hungarian Economic Development and Innovation Operational Programme (grant no. `GINOP-2.3.2-15-2016-00048' and `GINOP-2.3.3-15-2016-00032'). The funders had no role in the design of the study, in the collection, analyses or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baron DA, 2013, CLINICAL SPORTS PSYCHIATRY: AN INTERNATIONAL PERSPECTIVE, P89; Bey T, 2009, WEST J EMERG MED, V10, P6; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Brooks DM, 2017, EXP NEUROL, V297, P62, DOI 10.1016/j.expneurol.2017.07.015; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Selassie A.W., 2008, J HEAD TRAUMA REHAB, V2003, P123; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Webster K.M., 2015, J NEUROINFLAMM, V12, P1	49	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 27	2020	378								112268	10.1016/j.bbr.2019.112268			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	LD5HB	WOS:000526059200041	31580914	Green Submitted, hybrid			2022-02-06	
J	Bedard, M; Steffener, J; Taler, V				Bedard, Marc; Steffener, Jason; Taler, Vanessa			Long-term cognitive impairment following single mild traumatic brain injury with loss of consciousness: Findings from the Canadian Longitudinal Study on Aging	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; loss of consciousness; cognitive impairment; executive functions; CLSA	METAANALYSES; SEQUELAE; SCORES	Objective: We examined the extent to which loss of consciousness (LOC) following mild traumatic brain injury (mTBI) may be associated with impairments in executive functions and declarative memory more than a year after brain injury. Method: Analyses were run on 548 participants who had self-reported LOC of <1 min, 441 with LOC of 1-20 min, and 13,609 no brain injury comparison participants, taken from the Canadian Longitudinal Study on Aging (CLSA), a nationwide study on health and aging. Results: Those that had mTBI with LOC of 1-20 min were more likely than no head injury comparisons to be impaired on measures of executive functioning and declarative memory. Impairments were evident when examining for single- and two-test impairment rates on measures of executive functioning and declarative memory. Conclusions: A subset of people that had reported a single mTBI with LOC more than 12 months ago may experience impairments in executive functioning and declarative memory, particularly those who spent more time unconscious.	[Bedard, Marc; Taler, Vanessa] Bruyere Res Inst, Ottawa, ON, Canada; [Bedard, Marc; Steffener, Jason; Taler, Vanessa] Univ Ottawa, Sch Psychol, 136 Jean Jacques Lussier,Vanier Hall, Ottawa, ON K1N 6N5, Canada; [Steffener, Jason] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada		Taler, V (corresponding author), Univ Ottawa, Sch Psychol, 136 Jean Jacques Lussier,Vanier Hall, Ottawa, ON K1N 6N5, Canada.	vtaler@uottawa.ca			Government of Canada through the Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [LSA 9447]; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR	Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: [LSA 9447] and the Canada Foundation for Innovation.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Bedard M, 2018, CLIN NEUROPSYCHOL, V32, P1002, DOI 10.1080/13854046.2017.1404644; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Godbolt A. K., 2014, ARCH PHYS MED REHAB, V95, P245; Huizenga HM, 2016, J CLIN EXP NEUROPSYC, V38, P611, DOI 10.1080/13803395.2015.1132299; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rickards TA, 2018, APPL NEUROPSYCH-ADUL, V25, P219, DOI 10.1080/23279095.2017.1278602; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Teng E.L., 1994, MENTAL ALTERNATION T; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z	30	4	4	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 20	2020	42	4					344	351		10.1080/13803395.2020.1714552		JAN 2020	8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	LE0UN	WOS:000509430800001	31984839				2022-02-06	
J	da Silva, PGC; Hsu, K; Benton, JL; Beltz, BS; Allodi, S				Chaves da Silva, Paula Grazielle; Hsu, Kelly; Benton, Jeanne L.; Beltz, Barbara S.; Allodi, Silvana			A Balancing Act: The Immune System Supports Neurodegeneration and Neurogenesis	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Neurogenic niche; Immune response; Nitric oxide synthase; Hemocytes; Vasculature; Crayfish	CENTRAL-NERVOUS-SYSTEM; ANTERIOR PROLIFERATION CENTER; CRAYFISH PROCAMBARUS-CLARKII; TRAUMATIC BRAIN-INJURY; FRESH-WATER CRAYFISH; ADULT NEUROGENESIS; NITRIC-OXIDE; SPINY LOBSTER; PANULIRUS-ARGUS; ANTENNULAR PROJECTIONS	Decapod crustaceans, like mammals, retain the ability to make new neurons throughout life. In mammals, immune cells are closely associated with stem cells that generate adult-born neurons. In crayfish, evidence suggests that immune cells (hemocytes) originating in the immune system travel to neurogenic regions and transform into neural progenitor cells. This nontraditional immune activity takes place continuously under normal physiological conditions, but little is known under pathological conditions (neurodegeneration). In this study, the immune system and its relationship with neurogenesis were investigated during neurodegeneration (unilateral antennular ablation) in adult crayfish. Our experiments show that after ablation (1) Proliferating cells decrease in neurogenic areas of the adult crayfish brain; (2) The immune response, but not neurogenesis, is ablation-side dependent; (3) Inducible nitric oxide synthase (iNOS) plays a crucial role in the neurogenic niche containing neural progenitors during the immune response; (4) Brain areas targeted by antennular projections respond acutely (15 min) to the lesion, increasing the number of local immune cells; (5) Immune cells are recruited to the area surrounding the ipsilateral neurogenic niche; and (6) The vasculature in the niche responds acutely by dilation and possibly also neovascularization. We conclude that immune cells are important in both neurodegeneration and neurogenesis by contributing in physiological conditions to the maintenance of the number of neural precursor cells in the neurogenic niche (neurogenesis), and in pathological conditions (neurodegeneration) by coordinating NO release and vascular responses associated with the neurogenic niche. Our data suggest that neural damage and recovery participate in a balance between these competing immune cell roles.	[Chaves da Silva, Paula Grazielle; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21949902 Rio De Janeiro, RJ, Brazil; [Chaves da Silva, Paula Grazielle; Hsu, Kelly; Benton, Jeanne L.; Beltz, Barbara S.] Wellesley Coll, Wellesley, MA 02481 USA		Allodi, S (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21949902 Rio De Janeiro, RJ, Brazil.	p.chaves@biof.ufrj.br; sallodi@biof.ufrj.br	Allodi, Silvana/G-1781-2012; S, Allodi/AAR-7968-2020	Allodi, Silvana/0000-0002-3053-3866; Beltz, Barbara/0000-0001-5335-015X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [8698-11-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [304648/2014-0]; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ) [E26/202.762/2017]; U.S. National Science FoundationNational Science Foundation (NSF) [IOS-1121345, IOS-1656103]	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil), Grant number 8698-11-2 (to P. Chaves da Silva), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil), Grant number 304648/2014-0 (to S. Allodi), Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil), Grant number E26/202.762/2017 (to S. Allodi), and U.S. National Science Foundation, Grant numbers IOS-1121345 and IOS-1656103 (to B. Beltz). We are grateful to the Rudolf Barth Electron Microscopy Platform of the Oswaldo Cruz Institute/Fiocruz for the electron microscopy facilities.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ARBAS EA, 1988, J COMP PHYSIOL A, V164, P231, DOI 10.1007/BF00603953; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beltz BS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00662; Beltz BS, 2003, ARTHROPOD STRUCT DEV, V32, P39, DOI 10.1016/S1467-8039(03)00038-0; Benton JL, 2007, DEV DYNAM, V236, P3047, DOI 10.1002/dvdy.21340; Benton JL, 2014, DEV CELL, V30, P322, DOI 10.1016/j.devcel.2014.06.016; Benton JL, 2013, INT J DEV NEUROSCI, V31, P657, DOI 10.1016/j.ijdevneu.2012.11.010; Benton JL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-53; BLAUSTEIN DN, 1988, J CRUSTACEAN BIOL, V8, P493, DOI 10.2307/1548686; Brenneis G, 2020, J COMP NEUROL, V528, P1459, DOI 10.1002/cne.24820; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cardenas A, 2005, BRAIN RES REV, V50, P1, DOI 10.1016/j.brainresrev.2005.03.006; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Carreira BP, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/895659; Cayre M, 1996, J COMP NEUROL, V371, P300, DOI 10.1002/(SICI)1096-9861(19960722)371:2<300::AID-CNE9>3.0.CO;2-6; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; da Silva PGC, 2015, ISJ-INVERT SURVIV J, V12, P142; da Silva PGC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080896; da Silva PGC, 2013, STEM CELLS DEV, V22, P1027, DOI 10.1089/scd.2012.0583; da Silva PGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039267; Chaves-Da-Silva PG, 2010, CELL TISSUE RES, V342, P179, DOI 10.1007/s00441-010-1045-x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Harry GJ, 2008, NEUROIMMUNE PHARM, P445, DOI [10.1007/978-0-387-72573-4_32, DOI 10.1007/978-0-387-72573-4_32]; Harzsch S, 2018, PROG NEUROBIOL, V161, P23, DOI 10.1016/j.pneurobio.2017.11.005; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Horgusluoglu E, 2017, AM J MED GENET B, V174, P93, DOI 10.1002/ajmg.b.32429; HOWES EA, 1987, TISSUE CELL, V19, P877, DOI 10.1016/0040-8166(87)90026-7; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jin X, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00066; JOHANSSON KUI, 1994, BRAIN RES, V649, P36, DOI 10.1016/0006-8993(94)91046-4; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; Leiter O, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1681590; Lin XH, 2011, BLOOD, V117, P6417, DOI 10.1182/blood-2010-11-320614; Lind M, 2017, BIOMED PHARMACOTHER, V93, P370, DOI 10.1016/j.biopha.2017.06.036; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; MELLON D, 1990, J COMP NEUROL, V296, P253, DOI 10.1002/cne.902960205; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Noonin C, 2012, STEM CELLS DEV, V21, P3173, DOI 10.1089/scd.2012.0077; Novas A, 2004, INT J BIOCHEM CELL B, V36, P390, DOI 10.1016/S1357-2725(03)00212-7; Palumbo A, 2005, COMP BIOCHEM PHYS A, V142, P241, DOI 10.1016/j.cbpb.2005.05.043; Pathania M, 2010, NEUROPHARMACOLOGY, V58, P865, DOI 10.1016/j.neuropharm.2010.01.010; PERSSON M, 1987, J FISH DIS, V10, P471, DOI 10.1111/j.1365-2761.1987.tb01098.x; Price L., 2016, BLOOD BRAIN BARRIER; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; SANDEMAN DC, 1976, BRAIN RES, V115, P492, DOI 10.1016/0006-8993(76)90365-6; Sandeman R, 1998, J NEUROSCI, V18, P6195; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schmidt M, 1996, J COMP PHYSIOL A, V178, P579, DOI 10.1007/BF00227374; SCHMIDT M, 1992, J COMP NEUROL, V318, P277, DOI 10.1002/cne.903180305; SCHMIDT M, 1992, J COMP NEUROL, V318, P291, DOI 10.1002/cne.903180306; Schmidt M, 1996, J COMP PHYSIOL A, V178, P605, DOI 10.1007/BF00227375; Schmidt M, 2007, CHEM SENSES, V32, P365, DOI 10.1093/chemse/bjm008; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Smith LK, 2018, CELL TISSUE RES, V371, P105, DOI 10.1007/s00441-017-2715-8; SMITH PJS, 1984, J NEUROSCI, V4, P2698; SMITH PJS, 1987, J EXP BIOL, V132, P59; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; SODERHALL K, 1986, CELL TISSUE RES, V245, P43; Stoecklein VM, 2012, J LEUKOCYTE BIOL, V92, P539, DOI 10.1189/jlb.0212072; Sullivan JM, 2007, J MOL HISTOL, V38, P527, DOI 10.1007/s10735-007-9112-7; Sullivan JM, 2007, J COMP NEUROL, V500, P574, DOI 10.1002/cne.21187; Sullivan JM, 2005, J COMP NEUROL, V481, P118, DOI 10.1002/cne.20346; Sullivan JM, 2001, J COMP NEUROL, V441, P9, DOI 10.1002/cne.1394; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tota B, 2005, COMP BIOCHEM PHYS A, V142, P99, DOI 10.1016/j.cbpa.2005.08.026; Tuchina O, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00094; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; YOSHINO M, 1983, CELL TISSUE RES, V230, P37; Zhang Y, 2009, DEV NEUROBIOL, V69, P415, DOI 10.1002/dneu.20717; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	79	4	4	3	10	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2020	40	6					967	989		10.1007/s10571-020-00787-5		JAN 2020	23	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MD8EN	WOS:000509145900001	31980992				2022-02-06	
J	Ortiz, JB; Sukhina, A; Balkan, B; Harootunian, G; Adelson, PD; Lewis, KS; Oatman, O; Subbian, V; Rowe, RK; Lifshitz, J				Ortiz, J. Bryce; Sukhina, Alona; Balkan, Baran; Harootunian, Gevork; Adelson, P. David; Lewis, Kara S.; Oatman, Oliver; Subbian, Vignesh; Rowe, Rachel K.; Lifshitz, Jonathan			Epidemiology of Pediatric Traumatic Brain Injury and Hypothalamic-Pituitary Disorders in Arizona	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; pediatrics; endocrine dysfunction; concussion; adolescence; hypopituitarism; puberty; head injury	GROWTH-HORMONE DEFICIENCY; LONG-TERM; HYPOPITUITARISM; DYSFUNCTION; PREVALENCE; CHILDREN; SURVIVORS; ABNORMALITIES; ADOLESCENTS; PREDICTORS	Traumatic brain injury (TBI) in children can result in long-lasting social, cognitive, and neurological impairments. In adults, TBI can lead to endocrinopathies (endocrine system disorders), but this is infrequently reported in children. Untreated endocrinopathies can elevate risks of subsequent health issues, such that early detection in pediatric TBI survivors can initiate clinical interventions. To understand the risk of endocrinopathies following pediatric TBI, we identified patients who had experienced a TBI and subsequently developed a new-onset hypothalamic regulated endocrinopathy (n = 498). We hypothesized that pediatric patients who were diagnosed with a TBI were at higher risk of being diagnosed with a central endocrinopathy than those without a prior diagnosis of TBI. In our epidemiological assessment, we identified pediatric patients enrolled in the Arizona Health Care Cost Containment System (AHCCCS) from 2008 to 2014 who were diagnosed with one of 330 TBI International Classification of Diseases (ICD)-9 codes and subsequently diagnosed with one of 14 central endocrinopathy ICD-9 codes. Additionally, the ICD-9 code data from over 600,000 Arizona pediatric patients afforded an estimate of the incidence, prevalence, relative risk, odds ratio, and number needed to harm, regarding the development of a central endocrinopathy after sustaining a TBI in Arizona Medicaid pediatric patients. Children with a TBI diagnosis had 3.22 times the risk of a subsequent central endocrine diagnosis compared with the general population (+/- 0.28). Pediatric AHCCCS patients with a central endocrine diagnosis had 3.2-fold higher odds of a history of a TBI diagnosis than those without an endocrine diagnosis (+/- 0.29). Furthermore, the number of patients with a TBI diagnosis for one patient to receive a diagnosis of a central endocrine diagnosis was 151.2 (+/- 6.12). Female subjects were more likely to present with a central endocrine diagnosis after a TBI diagnosis compared to male subjects (64.1 vs. 35.9%). These results are the first state-wide epidemiological study conducted to determine the risk of developing a hypothalamic-pituitary disorder after a TBI in the pediatric population. Our results contribute to a body of knowledge demonstrating a TBI etiology for idiopathic endocrine disorders, and thus advise physicians with regard to TBI follow-up care that includes preventive screening for endocrine disorders.	[Ortiz, J. Bryce; Sukhina, Alona; Adelson, P. David; Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Translat Neurotrauma Res Program, Phoenix, AZ 85004 USA; [Ortiz, J. Bryce; Sukhina, Alona; Adelson, P. David; Lewis, Kara S.; Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Balkan, Baran; Subbian, Vignesh] Univ Arizona, Coll Engn, Tucson, AZ USA; [Harootunian, Gevork] Arizona State Univ, Ctr Hlth Informat & Res, Tempe, AZ USA; [Oatman, Oliver] Phoenix Childrens Hosp, Endocrinol, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA		Lifshitz, J (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Translat Neurotrauma Res Program, Phoenix, AZ 85004 USA.; Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA.; Lifshitz, J (corresponding author), Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA.	jlifshitz@email.arizona.edu		Subbian, Vignesh/0000-0001-9974-8382; Rowe, Rachel/0000-0002-9034-3159	Phoenix Children's Hospital Mission Support Funds; Center for Health Information Research (CHIR) through Arizona State University; Science Foundation Arizona Bisgrove Fellowship; National Science FoundationNational Science Foundation (NSF) [1838745]	Research reported in this manuscript was supported, in part, by Phoenix Children's Hospital Mission Support Funds. AS was awarded a Valley Research Partnership grant to pursue these studies to extract data from the Center for Health Information Research (CHIR) through Arizona State University. RR was supported by a Science Foundation Arizona Bisgrove Fellowship during these studies. BB and VS were supported, in part, by the National Science Foundation under grant #1838745.	Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Auble BA, 2014, J NEUROTRAUM, V31, P321, DOI 10.1089/neu.2013.2916; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Caglar AS, 2019, J NEUROTRAUM, V36, P1195, DOI 10.1089/neu.2018.5751; Casano-Sancho P, 2013, CLIN ENDOCRINOL, V79, P853, DOI 10.1111/cen.12237; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cernak I, 1999, BRAIN INJURY, V13, P1005; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; DANIEL PM, 1959, LANCET, V2, P927; Eberhardt J, 2018, DIS COLON RECTUM, V61, P1128, DOI 10.1097/DCR.0000000000001190; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Emelifeonwu JA, 2020, J NEUROTRAUM, V37, P217, DOI 10.1089/neu.2018.6349; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; King MS, 2002, J AM BOARD FAM PRACT, V14, P184; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Salomon-Estebanez MA, 2014, J ENDOCRINOL INVEST, V37, P143, DOI 10.1007/s40618-013-0020-2; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Sundaram NK, 2013, ENDOCRIN METAB CLIN, V42, P565, DOI 10.1016/j.ecl.2013.05.003; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987	53	4	5	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 22	2020	10								1410	10.3389/fneur.2019.01410			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KI5BV	WOS:000511365700001	32038466	Green Published, gold			2022-02-06	
J	Juengst, SB; Terhorst, L; Wagner, AK				Juengst, Shannon B.; Terhorst, Lauren; Wagner, Amy K.			Factor structure of the Behavioral Assessment Screening Tool (BAST) in traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; measurement; psychometrics; behavior; emotions	DEPRESSION; FATIGUE; SYMPTOMS; ADULTS	Objective: Establish the factor structure of the Behavioral Assessment Screening Tool (BAST), a self-reported emotional/behavioral symptom measure for adults with traumatic brain injury (TBI). Setting: Community. Participants: Community-dwelling adults with moderate-severe TBI (n = 162; n = 110). Design: Assessment development (cohort study). Main measures: Behavioral Assessment Screening Tool. Results: The original BAST included 61 items (55 primary, six secondary), an Environmental Context checklist including recent major life events, and three open-ended questions about other relevant factors. Two rounds of pilot testing and exploratory factor analysis of the BAST (n = 162; n = 110) reduced the total items to 37 primary items and six secondary coping items. The final BAST had a five-factor solution with communalities ranging from 0.323 to 0.771. Internal consistency reliabilities ranged from acceptable to excellent for all factors (Cronbach's alpha = 0.76-0.90). The items related to coping, given only to those endorsing stress, had a two-factor solution with communalities ranging from 0.224 to 0.605, but demonstrated acceptable to poor internal consistency (Cronbach's alpha = 0.46-0.68). Participants rated ease of use and overall satisfaction with completing the scale as high, with mean scores of 6.42 and 6.22 out of 7, respectively. Conclusions: The BAST, a measure of behavioral and emotional symptoms after TBI, has a multidimensional factor structure with evidence of good internal consistency reliability. Future work will evaluate the convergent, discriminant, and discriminative validity of the BAST and employ item response theory analyses to further develop a short version for mobile health assessment.	[Juengst, Shannon B.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Juengst, Shannon B.] Univ Texas Southwestern, Dept Rehabil Counseling, Dallas, TX USA; [Terhorst, Lauren] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA USA; [Terhorst, Lauren] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat, Pittsburgh, PA USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd C56-202, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X			Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bureau UC, 2017, ED ATTAINMENT US; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Mallery P., 2005, SPSS WINDOWS STEP BY; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schmelkin L.P., 1991, MEASUREMENT DESIGN A; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Stevens J.P, 2009, APPL MULTIVARIATE ST; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Zhao N., 2009, MINIMUM SAMPLE SIZE	23	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JAN 16	2020	42	2					255	260		10.1080/09638288.2018.1496487			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	KC6BK	WOS:000507260500012	30451025				2022-02-06	
J	Hurwitz, M; Lucas, S; Bell, KR; Temkin, N; Dikmen, S; Hoffman, J				Hurwitz, Max; Lucas, Sylvia; Bell, Kathleen R.; Temkin, Nancy; Dikmen, Sureyya; Hoffman, Jeanne			Use of Amitriptyline in the Treatment of Headache After Traumatic Brain Injury: Lessons Learned From a Clinical Trial	HEADACHE			English	Article						posttraumatic headache; amitriptyline; chronic headache; headache prophylaxis; mild traumatic brain injury; headache prevention	SCHEDULED TELEPHONE INTERVENTION; MIGRAINE PROPHYLAXIS; FOLLOW-UP; RECOMMENDATIONS; PREVALENCE; ADHERENCE; SYMPTOMS; PATTERNS; MODERATE; IMPACT	Objectives The primary outcome of this study was to assess the efficacy and safety of preventive treatment with amitriptyline on headache frequency and severity after mild traumatic brain injury (mTBI). Background Despite the fact that headache is the most common and persistent physical symptom after TBI, there has been little research on the longitudinal course or pharmacologic treatment of this disorder. Of those who have headache after injury, about 60% continue to complain of headache at 3 months post injury, with higher levels of disability than those without headache. There have been no prospective, randomized, controlled trials of a pharmacologic agent for headache after TBI. Additionally, a brain-injured population may be more susceptible to side effects of medication. Design This is a single-center phase II trial of amitriptyline to prevent persistent headache after an mTBI. Medication dose was gradually increased from 10 to 50 mg daily. Results Fifty participants were enrolled and 33 who completed the 90-day assessment were included in the final analysis. In order to detect a possible cognitive impact of the study drug, 24 participants were randomly assigned to start amitriptyline immediately after study enrollment and 26 were assigned to start 30 days after enrollment. Forty-nine percent (18/37) of those assigned to take medication took none throughout the study period, with less compliance in younger participants with mean ages of 32.7 in those who did not take any medication, 33.4 who were less than 80% compliant, and 42.3 who were compliant (P = .013). Compliance in keeping a daily headache diary was low, with 29/50 participants (58%) meeting daily entry completion, and only 10 participants maintaining 100% diary completion. No differences were found between those who started medication immediately vs at day 30 in headache frequency or severity. Conclusions While headache is the most common symptom following mTBI, current evidence does not support a specific treatment. No differences were noted in headache frequency compared to our prior study. However, the current sample had significantly lower headache severity (15% vs 36% with pain rating of 6 or above, P = .015) compared to our prior study. Our current study was not able to determine whether there is any benefit for the use of amitriptyline as a headache preventive because of difficulty with study recruitment and compliance. The challenges with recruitment and retention in the mTBI population were instructive, and future research in this area will need to identify strategies to improve recruitment, diary compliance, and medication adherence in this population.	[Hurwitz, Max; Lucas, Sylvia; Dikmen, Sureyya; Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Lucas, Sylvia; Temkin, Nancy; Dikmen, Sureyya] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Lucas, Sylvia] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bell, Kathleen R.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Med, Seattle, WA 98195 USA		Hoffman, J (corresponding author), Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.	jeanneh@u.washington.edu			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133G120055/90IF0025] Funding Source: Medline		Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Costa E, 2015, PATIENT PREFER ADHER, V9, DOI 10.2147/PPA.S87551; COUCH JR, 1979, ARCH NEUROL-CHICAGO, V36, P695, DOI 10.1001/archneur.1979.00500470065013; Crandall M, 2014, BRAIN INJURY, V28, P1359, DOI 10.3109/02699052.2014.919533; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; GOMERSALL JD, 1973, J NEUROL NEUROSUR PS, V36, P684, DOI 10.1136/jnnp.36.4.684; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hepp Z, 2014, J MANAGE CARE PHARM, V20, P22, DOI 10.18553/jmcp.2014.20.1.22; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Jackson JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5222; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marcus DA, 2003, HEADACHE, V43, P117, DOI 10.1046/j.1526-4610.2003.03028.x; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Raina KD, 2016, J HEAD TRAUMA REHAB, V31, pE41, DOI 10.1097/HTR.0000000000000196; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Seng EK, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0498-8; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Strauss E, 1990, COMPENDIUM NEUROPSYC, P776; TEASDALE G, 1974, LANCET, V2, P81; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Castells ET, 2008, MED ORAL PATOL ORAL, V13, pE567; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Wallenstein S, 1997, STAT MED, V16, P1329, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1329::AID-SIM567>3.0.CO;2-I; Wechsler D, 2008, WECHSLER ADULT INTEL, V4; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	36	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	APR	2020	60	4					713	723		10.1111/head.13748		JAN 2020	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX0IN	WOS:000506834500001	31943197				2022-02-06	
J	Schmidt, M; Fisher, AP; Sensenbaugh, J; Ling, B; Rietta, C; Babcock, L; Kurowski, BG; Wade, SL				Schmidt, Matthew; Fisher, Allison P.; Sensenbaugh, Joshua; Ling, Brandt; Rietta, Carmen; Babcock, Lynn; Kurowski, Brad G.; Wade, Shari L.			User Experience (re)Design and Evaluation of a Self-Guided, Mobile Health App for Adolescents with Mild Traumatic Brain Injury	JOURNAL OF FORMATIVE DESIGN IN LEARNING			English	Article						Concussion; mTBI; Adolescent; mHealth; Recovery; Rehabilitation	SPORTS-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; RANDOMIZED-TRIAL; INTERVENTION; SYMPTOMS; CHILDREN; OUTCOMES; BEHAVIOR; YOUTH; RISK	Mild traumatic brain injury (mTBI) is a significant cause of morbidity for adolescents. Currently, there is a lack of evidence-based interventions to address common sequelae of mTBI. To address this gap, we designed a program to promote recovery for adolescents following mTBI. Preliminary testing of the Self-Monitoring Activity Regulation and Relaxation Treatment (SMART) program demonstrated good usability but indicated a need for modifications to the program. The SMART application was redesigned with the addition of more interactive and gamified components. Content was also reframed to specifically target and engage adolescents with mTBI. We describe the usability evaluation of the updated SMART application. Children aged 11-18 years diagnosed with mTBI who were 1 to 6 months post mTBI were recruited to participate in a 1-2-h usability session in which they thought aloud and responded to targeted usability-related questions during their interaction with SMART. After completing the session, participants rated their usability experience using the System Usability Scale (SUS) and rated the overall user-friendliness of the program. Participants' responses during the session were qualitatively coded and analyzed. Six adolescents participated in a usability session (average age = 13.7 years). On the SUS, participants rated the program as highly usable (M= 85.6, SD = 3.24). They also had overwhelmingly positive feedback regarding the content, design, and structure of the program. Overall, findings suggest that the redesigned SMART program was usable, acceptable, and relevant to adolescents with mTBI. Based on adolescents' feedback, additional modifications were made before the program undergoes efficacy testing.	[Schmidt, Matthew] Univ Florida, Gainesville, FL 32611 USA; [Fisher, Allison P.; Babcock, Lynn; Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Sensenbaugh, Joshua; Ling, Brandt] Wright State Univ, Dayton, OH 45435 USA; [Rietta, Carmen] Univ Cincinnati, Cincinnati, OH USA		Schmidt, M (corresponding author), Univ Florida, Gainesville, FL 32611 USA.	matthew.schmidt@coe.ufl.edu; allison.fisher@cchmc.org; sensenbaugh.2@wright.edu; ling.16@wright.edu; rienacn@ucmail.uc.edu; lynnbabcock@cchmc.org; Brad.Kinowski@cchmc.org; shari.wade@cchmc.org		Schmidt, Matthew/0000-0002-8110-4367	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD087844]	This work was funded by the National Institute of Child Health and Human Development [R21HD087844].	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anderson M, 2018, TEENS SOCIAL MEDIA T; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bangor A., 2009, DETERMINING WHAT IND, V4; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Barnum C., 2003, C HUM FACT COMP SYST, V5, P698; Bath E, 2018, J AM ACAD CHILD PSY, V57, P903, DOI 10.1016/j.jaac.2018.08.012; Brooke J., 1986, SUS QUICK DIRTY USAB; Bull S, 2016, AM J PUBLIC HEALTH, V106, pS117, DOI 10.2105/AJPH.2016.303363; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Deterding S., 2011, ACM 2011 PRESENTED 1, P9, DOI DOI 10.1145/2181037.2181040; Dexheimer JW, 2017, INT J MED INFORM, V97, P163, DOI 10.1016/j.ijmedinf.2016.10.007; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e20; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; International Organization for Standardization, 2011, SYST SOFTW ENG SYST; Johnson Daniel, 2016, Internet Interv, V6, P89, DOI 10.1016/j.invent.2016.10.002; Johnson WL, 1998, PRESENCE-TELEOP VIRT, V7, P523, DOI 10.1162/105474698565929; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lenhart A., 2015, TEENS SOCIAL MEDIA T; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Nezu AM, 2006, PROBLEM SOLVING THER; Nielsen J., 2000, WHY YOU ONLY NEED TE; Nielsen J., 1995, PAP ESSAYS, V54, P1; Nowacki R, 2017, EUR J PAEDIATR NEURO, V21, P382, DOI 10.1016/j.ejpn.2016.10.009; O'Brien KHM, 2019, J TECHNOL HUMAN SERV, V37, P255, DOI 10.1080/15228835.2018.1561347; Oh H, 2005, J MED INTERNET RES, V7; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schwartz LA, 2019, CLIN PRACT PEDIAT PS, V7, P31, DOI 10.1037/cpp0000272; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; WHO-World Health Organization, 2011, MHEALTH NEW HORIZONS; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; World Health Organization, 2011, 2 GLOB SURV EHEALTH; World Health Organization, 2010, TEL OPP DEV MEMB STA; Worthen-Chaudhari L, 2017, BRAIN INJURY, V31, P1279, DOI 10.1080/02699052.2017.1332388; Ybarra ML, 2019, J ADOLESCENT HEALTH, V65, P417, DOI 10.1016/j.jadohealth.2019.04.025; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang NH, 2019, J NEUROTRAUM, V36, P1147, DOI 10.1089/neu.2018.5885	57	4	4	2	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND		2509-8039		J FORMATIVE DES LEAR	J. Formative Des. Learn.	DEC	2020	4	2					51	64		10.1007/s41686-019-00038-x		JAN 2020	14	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	PD4CQ	WOS:000548479000001	33860150	Green Accepted			2022-02-06	
J	Curley, JM; Ciceri, DP; Culp, WC				Curley, Jonathan M.; Ciceri, David P.; Culp, William C., Jr.			Sugammadex Administration to Facilitate Timely Neurologic Examination in the Traumatic Brain Injury Patient	NEUROCRITICAL CARE			English	Article							STAGE RENAL-FAILURE; ROCURONIUM; PHARMACOKINETICS		[Curley, Jonathan M.] Texas A&M Univ, Coll Med, Dept Anesthesiol, Baylor Scott & White Med Ctr Temple, 2401 S 31st St,MS-20-D304, Temple, TX 76508 USA; [Ciceri, David P.] Texas A&M Univ, Div Cardiac Anesthesiol & Crit Care, Dept Anesthesiol, Baylor Scott & White Med Ctr Temple,Coll Med, 2401 S 31st St,MS-20-D304, Temple, TX 76508 USA; [Culp, William C., Jr.] Texas A&M Univ, Div Cardiothorac Anesthesiol, Dept Anesthesiol, Baylor Scott & White Med Ctr Temple,Coll Med, 2401 S 31st St,MS-20-D304, Temple, TX 76508 USA		Curley, JM (corresponding author), Texas A&M Univ, Coll Med, Dept Anesthesiol, Baylor Scott & White Med Ctr Temple, 2401 S 31st St,MS-20-D304, Temple, TX 76508 USA.	Jonathan.Curley@BSWHealth.org		Curley, Jonathan/0000-0003-1778-4705			Adams DR, 2020, ANAESTHESIA, V75, P348, DOI 10.1111/anae.14914; [Anonymous], 2019, LEX DRUGS; [Anonymous], 2019, LEX DRUGS; Bullock R, 2006, NEUROSURGERY, V58, pS2, DOI DOI 10.1227/01.NEU.0000210364.29290.C9; Bullock R, 2006, NEUROSURGERY, V58, pS2, DOI DOI 10.1227/01.NEU.0000210365.36914.E3; Bullock R, 2006, NEUROSURGERY, V58, pS2; Caldwell JE, 1986, BRIT J ANAESTH, V58, P382; Cammu G, 2012, BRIT J ANAESTH, V109, P382, DOI 10.1093/bja/aes207; COOPER RA, 1993, BRIT J ANAESTH, V71, P222, DOI 10.1093/bja/71.2.222; Hristovska AM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012763; KirkegaardNielsen H, 1996, CAN J ANAESTH, V43, P932, DOI 10.1007/BF03011807; Lobaz S, 2013, BMJ CASE REP; Martin ACM, 2009, ACTA ANAESTH SCAND, V53, P957, DOI 10.1111/j.1399-6576.2009.01977.x; Olivieri L, 2005, CAN J ANAESTH, V52, P88, DOI 10.1007/BF03018587; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; Robertson EN, 2005, EUR J ANAESTH, V22, P4, DOI 10.1017/S0265021505000025; Staals LM, 2008, BRIT J ANAESTH, V101, P492, DOI 10.1093/bja/aen216; Staals LM, 2010, BRIT J ANAESTH, V104, P31, DOI 10.1093/bja/aep340	18	4	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2020	32	3					880	882		10.1007/s12028-019-00901-6		JAN 2020	3	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LV6MP	WOS:000505361100001	31898175				2022-02-06	
J	Li, ZG; Ji, C; Li, DP; Luo, RT; Wang, GL; Jiang, JZ				Li, Zhigang; Ji, Cheng; Li, Dapeng; Luo, Rutao; Wang, Guangliang; Jiang, Jinzhong			A comprehensive study on the mechanical properties of different regions of 8-week-old pediatric porcine brain under tension, shear, and compression at various strain rates	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury (TBI); Pediatric porcine brain; Mechanical properties; Region; Strain rate; Stress state	HEAD IMPACT; TISSUE; BEHAVIOR; INJURY; VALIDATION; CHILD; STEM	Young porcine brain is often used as a surrogate for studying the mechanical factors affecting traumatic brain injury in children. However, the mechanical properties of pediatric brain tissue derived from humans and piglets are very scarce, and this seriously detracts from the biofidelity of the developed finite element (FE) models of the pediatric head/brain. The present study addresses this issue by subjecting the cerebrum (white matter and gray matter), cerebellum, and brainstem specimens derived from 8-week-old piglets to tension and shear testing at strain rates of 0.01, 1, and 50/s. The experimental data are combined with the corresponding data derived from a previous study under compression to obtain comprehensive stress-strain curves of the pediatric porcine cerebrum, cerebellum, and brainstem tissue specimens. In general, the average stress level of the white matter is somewhat higher than that of the gray matter under the tension, shear and compression conditions, however, this difference does not reach a significant level. The stiffness of the cerebellum and the cerebrum does not differ significantly under tension and shear conditions, but the stiffness of the cerebellum is greater than that of the cerebrum under compression. The brainstem has significantly higher stiffness than the cerebrum and the cerebellum under all loading modes. In addition, the mechanical properties of brain tissue exhibit significant strain-rate dependences. With increasing strain rate from 0.01/s to 50/s, the average stress at a strain of 0.5 for all of the brain tissue increased by about 2.2 times under tension, about 2.4 times under shearing and about 2.2 times under compression. The variations in the stress as a function of the strain rate for brain tissue specimens were well characterized by exponential functions at strains of 0.25 and 0.5 under all three loading modes. The results of this study are useful for developing biofidelic FE models of the pediatric brain. (C) 2019 Elsevier Ltd. All rights reserved.	[Li, Zhigang; Ji, Cheng; Wang, Guangliang] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing 100044, Peoples R China; [Li, Dapeng; Luo, Rutao] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurosurg, Beijing 100045, Peoples R China; [Jiang, Jinzhong] Cangzhou Hosp Integrated Tradit & Western Med Heb, Cangzhou 061001, Hebei, Peoples R China		Li, ZG (corresponding author), Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing 100044, Peoples R China.	zgli@bjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51505024]; Ministry of Industry and Information Technology for Civil Aircraft; Aeronautical Science Foundation of China	This study was supported by the National Natural Science Foundation of China (Grant No. 51505024), Funding of Ministry of Industry and Information Technology for Civil Aircraft, and the Aeronautical Science Foundation of China. The authors would thank Xiaoming Wang from TA Instruments for his assistance in compression testing.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bilston LE, 2001, BIORHEOLOGY, V38, P335; CDC, 2006, CHILD PASS SAF FACT; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Fan H., 2014, P WSU 75 ANN S INJ B; Franklyn Melanie, 2007, Critical Reviews in Biomedical Engineering, V35, P197; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Li K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123506; Li ZG, 2019, J MECH BEHAV BIOMED, V89, P122, DOI 10.1016/j.jmbbm.2018.09.010; Li ZG, 2016, J MECH BEHAV BIOMED, V60, P557, DOI 10.1016/j.jmbbm.2016.03.021; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Nicolle S., 2004, SAE TECHNICAL PAPER; Prange M., 2000, SAE TECHNICAL PAPER; Prange M.T., 2002, THESIS; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; [阮世捷 Ruan Shijie], 2012, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V31, P502; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Takhounts EG, 2003, SAE TECHNICAL PAPER; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Zhang W, 2016, J APPL MECH-T ASME, V83, DOI 10.1115/1.4033890; Zhao H, 2016, MED SCI MONIT BASIC, V22, P6, DOI 10.12659/MSMBR.896368	40	4	4	3	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 2	2020	98								109380	10.1016/j.jbiomech.2019.109380			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KG0DV	WOS:000509612800004	31630775				2022-02-06	
J	Vlagsma, TT; Duits, AA; Dijkstra, HT; van Laar, T; Spikman, JM				Vlagsma, Thialda T.; Duits, Annelien A.; Dijkstra, Hilde T.; van Laar, Teus; Spikman, Jacoba M.			Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Parkinson&#8217; s disease; Neuropsychological rehabilitation; Executive impairments; Strategy training	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; REHABILITATION; MANAGEMENT; COGNITION; IMPAIRMENT; VALIDATION	In this multicentre randomised controlled trial (RCT), 43 patients with Parkinson's disease (PD) were randomly allocated to either the experimental condition receiving cognitive rehabilitation including strategy training (ReSET; Strategic Executive Treatment, n = 24) or to the control condition receiving computerised repetitive practice training for attention (Cogniplus, n = 16). We expected that strategy training (ReSET) would be more effective than cognitive training (Cogniplus) in improving patients' everyday life executive functioning. Neuropsychological assessment was administered at baseline, at 2 weeks and 3-5 months post-treatment. Primary outcome measure was the Role Resumption List (RRL). Secondary outcome measures were treatment goal attainment (TGA), Dysexecutive Questionnaire (DEX), Parkinson's Disease Questionnaire (PDQ-39), Zarit Burden Interview (ZBI) and neuropsychological tests. No effects of treatment were found on the primary outcome measure and on neuropsychological tests, except for one test of attention. At 2 weeks and 3-5 months post-treatment, PD patients in both the ReSET and Cogniplus group reported a significant improvement in everyday life executive functioning, as measured with TGA and the DEX-self, with an advantage for ReSET only shortly after treatment. Given these results and that PD patients were able to adhere to these treatments despite their motor symptoms and fatigue (i.e., the drop-out rate was small), we conclude that both strategy training and cognitive training for impairments in EF might be beneficial and feasible for PD patients.	[Vlagsma, Thialda T.; Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands; [Duits, Annelien A.] Maastricht Univ, Dept Psychiat & Psychol, Med Ctr, Maastricht, Netherlands; [Dijkstra, Hilde T.] Med Ctr Nij Smellinghe, Dept Med Psychol, Drachten, Netherlands; [van Laar, Teus; Spikman, Jacoba M.] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Vlagsma, TT (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	t.t.vlagsma@rug.nl	van Laar, Teus/AAO-3906-2021	Spikman, Jacoba/0000-0002-6477-0763; van Laar, Teus/0000-0001-5088-480X			Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1996, DYSEXECUTIVE QUESTIO; Calleo J, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/512892, 10.1155/2012/907513]; Cerasa A, 2014, NEUROL SCI, V35, P1173, DOI 10.1007/s10072-014-1666-z; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Deelman B. G., 1980, NEUROPSYCHOLOGIE NED, P253; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; Elgh E, 2009, EUR J NEUROL, V16, P1278, DOI 10.1111/j.1468-1331.2009.02707.x; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Klepac N, 2008, EUR J NEUROL, V15, P128, DOI 10.1111/j.1468-1331.2007.02011.x; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Kudlicka A, 2014, INT J GERIATR PSYCH, V29, P68, DOI 10.1002/gps.3970; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; Kuijer RG, 2003, PSYCHOL HEALTH, V18, P313, DOI 10.1080/0887044031000146815; Lawson RA, 2014, PARKINSONISM RELAT D, V20, P1071, DOI 10.1016/j.parkreldis.2014.07.004; Leung IHK, 2015, NEUROLOGY, V85, P1843, DOI 10.1212/WNL.0000000000002145; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LUTEIJN F, 1983, GRONINGER INTELLIGEN; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Mohlman Jan, 2010, Clin Case Stud, V9, P74; Mohlman J, 2011, J GERIATR PSYCH NEUR, V24, P91, DOI 10.1177/0891988711402350; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Pena J, 2014, NEUROLOGY, V83, P2167, DOI 10.1212/WNL.0000000000001043; Petrelli A, 2014, PARKINSONISM RELAT D, V20, P1196, DOI 10.1016/j.parkreldis.2014.08.023; Paris AP, 2011, MOVEMENT DISORD, V26, P1251, DOI 10.1002/mds.23688; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter Iris, 2012, J Aging Res, V2012, P373294, DOI 10.1155/2012/373294; Robertson I. H., 1994, MANUAL TEST EVERYDAY; Vasconcellos LFR, 2015, J CLIN EXP NEUROPSYC, V37, P988, DOI 10.1080/13803395.2015.1073227; Rosqvist K, 2017, ACTA NEUROL SCAND, V136, P64, DOI 10.1111/ane.12695; Sammer G, 2006, J NEUROL SCI, V248, P115, DOI 10.1016/j.jns.2006.05.028; Schuhfried G, 2007, COGNIPLUS; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Thombs BD, 2017, RHEUMATOL INT, V37, P281, DOI 10.1007/s00296-016-3602-4; Verbaan D, 2011, MOVEMENT DISORD, V26, P1881, DOI 10.1002/mds.23750; Vlagsma T. T., 2015, NEUROPSYCHOL REHABIL, V26, P1; Vlagsma TT, 2016, J CLIN EXP NEUROPSYC, V38, P844, DOI 10.1080/13803395.2016.1167840; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; Zarit S. H., 1985, MEMORY BEHAV PROBLEM; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann R, 2014, NEUROLOGY, V82, P1219, DOI 10.1212/WNL.0000000000000287; 2017, STAT SOC BEHAV SCI, P1, DOI DOI 10.1080/09638288.2017.1288275	46	4	4	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2020	30	1					67	84		10.1080/09602011.2018.1452761			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OP0HF	WOS:000587755700005	29566588	hybrid, Green Published			2022-02-06	
J	Wu, XG; Wang, CL; Wang, JB; Zhu, MJ; Yao, YS; Liu, JC				Wu, Xiaogang; Wang, Chunlin; Wang, Jinbiao; Zhu, Meijie; Yao, Yinsheng; Liu, Jiachuan			Hypoxia preconditioning protects neuronal cells against traumatic brain injury through stimulation of glucose transport mediated by HIF-1 alpha/GLUTs signaling pathway in rat	NEUROSURGICAL REVIEW			English	Article						Traumatic brain injury; Hypoxic preconditioning; Glucose transporter-1(GLUT1); Glucose transporter-3(GLUT3); Hypoxia-inducible factor-1 alpha(HIF-1 alpha)	HIF-1 TARGET GENES; EXPERIMENTAL-MODEL; EXPRESSION; GLUT3; METABOLISM; ISCHEMIA; PATHOPHYSIOLOGY; NEUROPROTECTION; TOLERANCE; RESPONSES	Hypoxia preconditioning (HPC), a well-established preconditioning model, has been shown to protect the brain against severe hypoxia or ischemia caused by traumatic brain injury (TBI), but the mechanism has not been well elucidated. Anaerobic glycolysis is the major way for neurons to produce energy under cerebral ischemia and hypoxia after TBI, and it requires large amounts of glucose. We hypothesized that glucose transport, as a rate-limiting step of glucose metabolism, may play key roles in the neuroprotective effects of HPC on cerebral cortex tissue against TBI. The aim of this study was to investigate the effect of HPC on glucose transport activity of rat cerebral cortex tissue after TBI through examining the gene expression of two major glucose transporters (GLUT1 and GLUT3) and their upstream target gene hypoxia-inducible factor-1 alpha (HIF-1 alpha). Sprague-Dawley rats were treated with HPC (50.47 kPa, 3 h/d, 3d). Twenty-four hours after the last treatment, the rats were injured using the Feeney free falling model. Cortex tissues of injured rats were removed at 1 h, 4 h, 8 h, 12 h, 1 day, 3 days, 7 d, and 14 days post-injury for histological analysis. Compared with TBI alone, HPC before TBI resulted in the expression of HIF-1 alpha, GLUT1, and GLUT3 to increase at 1 h; they were markedly increased at 4 h, 8 h, 12 h, 1 day, and 3 days and decreased thereafter (p < 0.05). HPC before TBI could improve neuronal survival in rats by examining NeuN staining and observing reduced apoptosis by examining TUNEL staining. The result showed that HPC before TBI could increase the expression of GLUT1 and GLUT3. And through double immunofluorescence staining for GLUT3 and NeuN, the results strongly suggest that HPC improved glucose transport activity of neurons in rats with TBI. In summary, our results further support that HPC can improve hypoxia tolerance and attenuate neuronal loss of cerebral cortex in rats after TBI. The mechanism is mainly related to the increase of glucose transport activity through inducing GLUT1 and GLUT3 expression through upregulating HIF-1 alpha expression.	[Wu, Xiaogang; Wang, Chunlin; Wang, Jinbiao; Zhu, Meijie; Yao, Yinsheng; Liu, Jiachuan] 901 Hosp Chinese Peoples Liberat Army Logist Supp, Dept Neurosurg, Hefei, Anhui, Peoples R China		Liu, JC (corresponding author), 901 Hosp Chinese Peoples Liberat Army Logist Supp, Dept Neurosurg, Hefei, Anhui, Peoples R China.	wxg18909696645@126.com			Military Medical Science and Technology "Twelfth Five-Year Plan" Scientific Research Project [CWS11J26]	This study is supported by the Military Medical Science and Technology "Twelfth Five-Year Plan" Scientific Research Project, Award Number CWS11J26. Grant recipient is Jiachuan Liu.	Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; Elson DA, 2000, CANCER RES, V60, P6189; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Galle AA, 2013, BRAIN RES, V1498, P1, DOI 10.1016/j.brainres.2012.12.026; Giacoppo S, 2017, FASEB J, V31, P5592, DOI 10.1096/fj.201700524R; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Hu XL, 2002, ACTA NEUROPATHOL, V104, P462, DOI 10.1007/s00401-002-0579-8; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Lu N, 2018, J MOL NEUROSCI, V66, P238, DOI 10.1007/s12031-018-1162-7; MAHER F, 1995, J NEUROSCI RES, V42, P459, DOI 10.1002/jnr.490420404; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; NAGAMATSU S, 1992, J BIOL CHEM, V267, P467; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Sadlecki P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/616850; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Thamotharan S, 2013, AM J PHYSIOL-ENDOC M, V304, pE583, DOI 10.1152/ajpendo.00513.2012; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Wu ZJ, 2019, METALLOMICS, V11, P429, DOI 10.1039/c8mt00280k; Xu SNA, 2012, NEURAL REGEN RES, V7, P1318, DOI 10.3969/j.issn.1673-5374.2012.17.006; Yamaki T, 2018, JOVE-J VIS EXP, DOI 10.3791/58641; Yong-Ming Z, 2012, AFR HEALTH SCI, V12, P552, DOI 10.4314/ahs.v12i4.24; Yu J, 2012, BRAIN RES, V1430, P18, DOI 10.1016/j.brainres.2011.10.046; Yu S, 2008, BRAIN RES, V1211, P22, DOI 10.1016/j.brainres.2005.04.029; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231	39	4	6	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	FEB	2021	44	1					411	422		10.1007/s10143-019-01228-8		JAN 2020	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QB1MO	WOS:000505331300003	31897883	Green Published, hybrid			2022-02-06	
J	Adams, RS; Campbell-Sills, L; Stein, MB; Sun, XY; Larson, MJ; Kessler, RC; Ursano, RJ; Jain, S; Corrigan, JD				Adams, Rachel Sayko; Campbell-Sills, Laura; Stein, Murray B.; Sun, Xiaoying; Larson, Mary Jo; Kessler, Ronald C.; Ursano, Robert J.; Jain, Sonia; Corrigan, John D.			The Association of Lifetime and Deployment-Acquired Traumatic Brain Injury With Postdeployment Binge and Heavy Drinking	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						binge drinking; heavy drinking; military; postdeployment; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TBI IDENTIFICATION METHOD; POST-CONCUSSIVE SYMPTOMS; DUTY MILITARY PERSONNEL; ASSESS RISK; MULTIPLE CONCUSSIONS; ARMY; RESILIENCE; INTERVIEW; SOLDIERS	Objective: To investigate associations of lifetime traumatic brain injury (LT-TBI) prior to an index deployment, and/or deployment-acquired TBI (DA-TBI), with postdeployment binge and heavy drinking. Setting: Soldiers from 3 Brigade Combat Teams deployed to Afghanistan in 2012. Participants: A total of 4645 soldiers who participated in the Army STARRS Pre/Post Deployment Study and completed 4 assessments: T0 (1-2 months predeployment), T1 (upon return to United States), T2 (3 months postdeployment), and T3 (9 months postdeployment). Design: Prospective, longitudinal study controlling for baseline binge drinking. Main Measures: Self-reported past month binge drinking (5+ alcoholic beverages on the same day) and past month heavy drinking (binge drinking at least weekly) at T2 and T3. Results: In total, 34.3% screened positive for LT-TBI, and 19.2% screened positive for DA-TBI. At T2 only, LT-TBI, but not DA-TBI, was associated with increased odds of binge drinking (adjusted odds ratio [AOR] = 1.39, 95% confidence interval [CI]: 1.20-1.60, P < .001) and heavy drinking (AOR = 1.28, 95% CI: 1.09-1.49, P = .007). Among the subgroup with LT-TBI, also having DA-TBI was associated with increased risk of heavy drinking at T3 (AOR = 1.42, 95% CI: 1.03-1.95, P = .047). Conclusion: Routine screening for LT-TBI may help target efforts to prevent alcohol misuse among military members.	[Adams, Rachel Sayko; Larson, Mary Jo] Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy & Management, 415 South St,MS 035, Waltham, MA 02453 USA; [Adams, Rachel Sayko] VHA Rocky Mountain Mental Illness Res Educ & Clin, Aurora, CO USA; [Campbell-Sills, Laura; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.; Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Adams, RS (corresponding author), Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy & Management, 415 South St,MS 035, Waltham, MA 02453 USA.	radams@brandeis.edu	Ursano, Robert/ABE-6533-2020; Adams, Rachel/AAH-4653-2020		Department of the Army; US Department of Health & Human Services, National Institutes of Health, and National Institute of Mental Health (NIH/NIMH) [U01MH087981]; Department of Defense (USUHS)United States Department of Defense [HU0001-15-2-0004]; National Center for Complementary and Integrative Health (NCCIH) [R01 AT008404]	Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement number U01MH087981 with the US Department of Health & Human Services, National Institutes of Health, and National Institute of Mental Health (NIH/NIMH). Subsequently, STARRS-LS was sponsored and funded by the Department of Defense (USUHS grant number HU0001-15-2-0004). Drs Adams and Larson were supported in part by the National Center for Complementary and Integrative Health (NCCIH; R01 AT008404). Contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health & Human Services, NIMH, NCCIH, NIH, the Veterans Administration, the Department of the Army, or the Department of Defense.	Adams RS, 2017, J NEUROTRAUM, V34, P1457, DOI 10.1089/neu.2016.4693; Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; [Anonymous], 2016, R LANG ENV STAT COMP; Assistant Secretary of Defense, 2015, TRAUM BRAIN INJ UPD; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Boggs JM, 2018, PSYCHIAT SERV, V69, P677, DOI 10.1176/appi.ps.201700237; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Campbell-Sills L, 2018, PSYCHOL MED, V48, P1624, DOI 10.1017/S0033291717003105; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Center for Behavioral Health Statistics and Quality, 2017, 2016 NAT SURV DRUG U; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1315; Department of Defense, 2012, DOD POL GUID MAN MIL, P11; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2013, INT J METH PSYCH RES, V22, P303, DOI 10.1002/mpr.1398; Kessler RC, 2013, INT J METH PSYCH RES, V22, P288, DOI 10.1002/mpr.1399; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000284; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Walker DD, 2017, J CONSULT CLIN PSYCH, V85, P99, DOI 10.1037/ccp0000148; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yumul JN, 2016, PM&R, V8, P1097, DOI 10.1016/j.pmrj.2016.05.005	54	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		27	36		10.1097/HTR.0000000000000508			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300006	31365436	Green Accepted			2022-02-06	
J	Arena, JD; Johnson, VE; Lee, EB; Gibbons, GS; Smith, DH; Trojanowski, JQ; Stewart, W				Arena, John D.; Johnson, Victoria E.; Lee, Edward B.; Gibbons, Garrett S.; Smith, Douglas H.; Trojanowski, John Q.; Stewart, William			Astroglial tau pathology alone preferentially concentrates at sulcal depths in chronic traumatic encephalopathy neuropathologic change	BRAIN COMMUNICATIONS			English	Article						chronic traumatic encephalopathy; Alzheimer's disease; tau; ageing-related tau astrogliopathy; traumatic brain injury	BETA-AMYLOID PROTEIN; NEURODEGENERATIVE DISEASES; QUANTITATIVE DIFFERENCES; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; BRAIN-INJURY; DISRUPTION; DEMENTIA; TAUOPATHIES; CONSEQUENCE	Current diagnostic criteria for the neuropathological evaluation of the traumatic brain injury-associated neurodegeneration, chronic traumatic encephalopathy, define the pathognomonic lesion as hyperphosphorylated tau-immunoreactive neuronal and astroglial profiles in a patchy cortical distribution, clustered around small vessels and showing preferential localization to the depths of sulci. However, despite adoption into diagnostic criteria, there has been no formal assessment of the cortical distribution of the specific cellular components defining chronic traumatic encephalopathy neuropathologic change. To address this, we performed comprehensive mapping of hyperphosphorylated tau-immunoreactive neurofibrillary tangles and thorn-shaped astrocytes contributing to chronic traumatic encephalopathy neuropathologic change. From the Glasgow Traumatic Brain Injury Archive and the University of Pennsylvania Center for Neurodegenerative Disease Research Brain Bank, material was selected from patients with known chronic traumatic encephalopathy neuropathologic change, either following exposure to repetitive mild (athletes n=17; non-athletes n=1) or to single moderate or severe traumatic brain injury (n=4), together with material from patients with previously confirmed Alzheimer's disease neuropathologic changes (n=6) and no known exposure to traumatic brain injury. Representative sections were stained for hyperphosphorylated or Alzheimer's disease conformation-selective tau, after which stereotypical neurofibrillary tangles and thorn-shaped astrocytes were identified and mapped. Thorn-shaped astrocytes in chronic traumatic encephalopathy neuropathologic change were preferentially distributed towards sulcal depths [sulcal depth to gyral crest ratio of thorn-shaped astrocytes 12.84 +/- 15.47 (mean +/- standard deviation)], with this pathology more evident in material from patients with a history of survival from non-sport injury than those exposed to sport-associated traumatic brain injury (P=0.009). In contrast, neurofibrillary tangles in chronic traumatic encephalopathy neuropathologic change showed a more uniform distribution across the cortex in sections stained for either hyperphosphorylated (sulcal depth to gyral crest ratio of neurofibrillary tangles 1.40 +/- 0.74) or Alzheimer's disease conformation tau (sulcal depth to gyral crest ratio 1.64 +/- 1.05), which was comparable to that seen in material from patients with known Alzheimer's disease neuropathologic changes (P=0.82 and P=0.91, respectively). Our data demonstrate that in chronic traumatic encephalopathy neuropathologic change the astroglial component alone shows preferential distribution to the depths of cortical sulci. In contrast, the neuronal pathology of chronic traumatic encephalopathy neuropathologic change is distributed more uniformly from gyral crest to sulcal depth and echoes that of Alzheimer's disease. These observations provide new insight into the neuropathological features of chronic traumatic encephalopathy that distinguish it from other tau pathologies and suggest that current diagnostic criteria should perhaps be reviewed and refined.	[Arena, John D.; Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lee, Edward B.; Gibbons, Garrett S.; Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lee, Edward B.] Univ Penn, Translat Neuropathol Res Lab, Philadelphia, PA 19104 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland		Stewart, W (corresponding author), Queen Elizabeth Univ Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.; Trojanowski, JQ (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Perelman Sch Med,HUP, Maloney 3rd Floor,36th & Spruce St, Philadelphia, PA 19104 USA.	trojanow@upenn.edu; william.stewart@glasgow.ac.uk	Lee, Edward/AAU-8436-2021	Arena, John/0000-0002-4322-4472; Stewart, William/0000-0003-2199-2582	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS115322, R01NS092398, R01NS094003, R01NS038104]; National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG010124, AG017586, AG054991, AG09215, AG17586]; National Health Service Research Scotland [TL1TR001880]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32AG053036]; Football Association; Professional Footballers Association; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701018, MR/N004272/1, G1100578] Funding Source: UKRI	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers U54NS115322, R01NS092398, R01NS094003 and R01NS038104; National Institute on Aging of the National Institutes of Health grants AG010124, AG017586, AG054991, AG09215 and AG17586; National Health Service Research Scotland; Clinical and Translational Science Awards training grant TL1TR001880; National Institutes of Health award F32AG053036 and by The Football Association and the Professional Footballers Association.	Arena JD, 2020, BRAIN, V143, P1572, DOI 10.1093/brain/awaa071; Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; ARMSTRONG RA, 1994, DEMENTIA, V5, P1, DOI 10.1159/000106686; Armstrong RA, 2019, NEUROL SCI, V40, P529, DOI 10.1007/s10072-018-3686-6; Armstrong RA, 2017, J NEURAL TRANSM, V124, P185, DOI 10.1007/s00702-016-1635-1; CLINTON J, 1993, NEUROPATH APPL NEURO, V19, P277, DOI 10.1111/j.1365-2990.1993.tb00438.x; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M, 1949, PUNCH DRUNK SYNDROME; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; GENTLEMAN SM, 1992, NEUROSCI LETT, V136, P27, DOI 10.1016/0304-3940(92)90639-O; Gibbons GS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0687-5; Gibbons GS, 2018, J NEUROPATH EXP NEUR, V77, P216, DOI 10.1093/jnen/nly010; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Ikeda K, 1998, NEUROBIOL AGING, V19, pS85, DOI 10.1016/S0197-4580(98)00034-7; Ikeda K, 1996, NEUROPATHOLOGY, V16, P71, DOI 10.1111/j.1440-1789.1996.tb00158.x; IKEDA K, 1995, ACTA NEUROPATHOL, V90, P620; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kovacs GG, 2018, NEUROPATH APPL NEURO, V44, P491, DOI 10.1111/nan.12427; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Kovacs GG, 2017, BRAIN PATHOL, V27, P675, DOI 10.1111/bpa.12536; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lee EB, 2018, ACTA NEUROPATHOL, V135, P643, DOI 10.1007/s00401-018-1827-x; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Liu AKL, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0330-7; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, BULLETIN, V35, P297; Montine TJ, 2016, ALZHEIMERS DEMENT, V12, P164, DOI 10.1016/j.jalz.2015.07.492; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Robinson JL, 2018, ACTA NEUROPATHOL, V136, P377, DOI 10.1007/s00401-018-1872-5; Shimizu H, 2008, ACTA NEUROPATHOL, V115, P185, DOI 10.1007/s00401-007-0321-7; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Toledo JB, 2014, ALZHEIMERS DEMENT, V10, P477, DOI 10.1016/j.jalz.2013.06.003; Tribett T, 2019, J FORENSIC SCI, V64, P1248, DOI 10.1111/1556-4029.14001; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193	60	4	4	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							210	10.1093/braincomms/fcaa210			13	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800143	33426528	Green Published, gold, Green Accepted			2022-02-06	
J	Bartsch, A; Dama, R; Alberts, J; Samorezov, S; Benzel, E; Miele, V; Shah, A; Humm, J; McCrea, M; Stemper, B				Bartsch, Adam; Dama, Rajiv; Alberts, Jay; Samorezov, Sergey; Benzel, Edward; Miele, Vincent; Shah, Alok; Humm, John; McCrea, Michael; Stemper, Brian			Measuring Blunt Force Head Impacts in Athletes	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				SEVERITY	Introduction Although concussion continues to be a major source of acute and chronic injuries, concussion injury mechanisms and risk functions are ill-defined. This lack of definition has hindered efforts to develop standardized concussion monitoring, safety testing, and protective countermeasures. To overcome this knowledge gap, we have developed, tested, and deployed a head impact monitoring mouthguard (IMM) system. Materials and Methods The IMM system was first calibrated in 731 laboratory tests. Versus reference, Laboratory IMM data fit a linear model, with results close to the ideal linear model of form y = x + 0, R-2 = 1. Next, during on-field play involving n = 54 amateur American athletes in football and boxing, there were tens of thousands of events collected by the IMM. A total of 890 true-positive head impacts were confirmed using a combination of signal processing and National Institute of Neurological Disorders and Stroke/National Institutes of Health Common Data Elements methods. Results The median and 99th percentile of peak scalar linear acceleration and peak angular acceleration were 20 and 50 g and 1,700 and 4,600 rad/s(2), respectively. No athletes were diagnosed with concussion. Conclusions While these data are useful for preliminary human tolerance limits, a larger population must be used to quantify real-world dose response as a function of impact magnitude, direction, location, and accumulation. This work is ongoing.	[Bartsch, Adam; Dama, Rajiv] Prevent Biometr, 4530 W 77th St,Suite 300, Edina, MN 55435 USA; [Alberts, Jay; Samorezov, Sergey; Benzel, Edward] Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44190 USA; [Miele, Vincent] Univ Pittsburgh, Med Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Shah, Alok; Humm, John; McCrea, Michael; Stemper, Brian] Med Coll Wisconsin, Zablocki VA Ctr, 500 W Natl Ave, Milwaukee, WI 53295 USA		Bartsch, A (corresponding author), Prevent Biometr, 4530 W 77th St,Suite 300, Edina, MN 55435 USA.		Stemper, Brian/AAX-7611-2020		Cleveland Clinic Innovations [595339680101, 597042420101]; Cleveland Clinic Neurological Institute, Cleveland Clinic Stanley Zielony Spinal Surgery Research and Education Fund, Cleveland Clinic Research Program Committee [2012-1034]; National Football League Charities [2010-01]; Ohio Department of Development 3rd Frontier TECH [09-024]; Rawlings Performance Institute at Cleveland Clinic, Orthopaedic Research and Education Foundation Grant PCRGSC [1]; Murata Manufacturing Company, Ltd.; Federal Aviation Administration [13-P-022]; NIH NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000055, 1UL1RR031973-01]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Defense Health Program under the DOD BAA Award [W81XWH-14-1-0561]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R41HD079158-01A1, 2R44NS0761 02-02A1]	Cleveland Clinic Innovations Grants 595339680101 and 597042420101, Cleveland Clinic Neurological Institute, Cleveland Clinic Stanley Zielony Spinal Surgery Research and Education Fund, Cleveland Clinic Research Program Committee Grant #2012-1034, National Football League Charities Grant 2010-01, Ohio Department of Development 3rd Frontier TECH Grant 09-024, Rawlings Performance Institute at Cleveland Clinic, Orthopaedic Research and Education Foundation Grant PCRGSC #1, Murata Manufacturing Company, Ltd, National Institutes of Health SBIR Grant #1R43NS076102-01A1, Federal Aviation Administration Grant #13-P-022 BIODYNAMICS, National Institutes of Health STTR Grant #R41HD079158-01A1, NIH NCATS Grants 8UL1TR000055 and 1UL1RR031973-01, National Institutes of Health SBIR Grant #2R44NS0761 02-02A1, USAMRMC Award No. W81XWH-12-1-0004, and by the Defense Health Program under the DOD BAA Award No. W81XWH-14-1-0561.	Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Gay KE, 2018, NEUROLOGY, V91, pS3; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hedin D. S., 2016, IEEE MED BIOL; Institute of Medicine and National Research Council Committee on Sports Related Concussion in Youth, 2014, SPORTS RELATED CONCU; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Meaney DF, 2014, J BIOMECH ENG; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004	14	4	4	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			190	196		10.1093/milmed/usz334			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600029	32074346	Green Published, Bronze			2022-02-06	
J	Ben-Moshe, H; Luz, I; Liraz, O; Boehm-Cagan, A; Salomon-Zimri, S; Michaelson, D				Ben-Moshe, Hila; Luz, Ishai; Liraz, Ori; Boehm-Cagan, Anat; Salomon-Zimri, Shiran; Michaelson, Daniel			ApoE4 Exacerbates Hippocampal Pathology Following Acute Brain Penetration Injury in Female Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Brain injury; apoE4; Inflammation; Neurodegeneration; Vascular	APOLIPOPROTEIN-E-GENOTYPE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; TARGETED REPLACEMENT; VASCULAR PATHOLOGY; GLIAL ACTIVATION; FOCAL ISCHEMIA; DEMENTIA RISK; MOUSE MODEL; E GENE	The e4 allele of apolipoprotein E (apoE4) is the most prevalent genetic risk factor for Alzheimer's disease. ApoE4 is also associated with poor recovery and functional outcome following traumatic brain injury. This study examined the effects of the apoE genotype on brain pathology following acute injury, induced by penetration of a needle through the cortex and hippocampus, at 3 and 14 days following the injury in female apoE3 and apoE4 alpha-synuclein-deficient targeted replacement (TR) mice. The results obtained revealed a marked inflammatory, synaptic and vascular response following the needle penetration injury (NPI). These results were found to be affected by the apoE genotype such that the inflammatory response, as measured utilizing the astrocytic marker GFAP and the microglial marker iba1, was faster and more prolonged in the apoE4 than in the apoE3 mice. The synaptic changes following the injury included a transient increase in synaptophysin levels in the apoE3 and not in the apoE4 mice, which was associated with a subsequent decrease in glutamatergic synapses, as measured utilizing VGluT1, in apoE4 and not in the apoE3 mice. Unlike these effects, measurements of the vasculature utilizing collagen IV as a marker revealed a significant increase which was similar in both apoE3 and apoE4 mice. Taken together, these results show that following acute brain injury, there is an apoE4-specific inflammatory and neuronal response to the injury. The NPI model provides a useful tool for studying the mechanism underlying the effects of apoE4 following acute brain injury and for the development of a corresponding anti-apoE4-targeted treatment.	[Ben-Moshe, Hila; Luz, Ishai; Liraz, Ori; Boehm-Cagan, Anat; Salomon-Zimri, Shiran; Michaelson, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel		Michaelson, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	dmichael@post.tau.ac.il		Luz, Ishai/0000-0003-2060-7742	Israel Science FoundationIsrael Science Foundation [794/17] Funding Source: Medline; Harold and Eleanore Foonberg Foundation [un-numbered grant] Funding Source: Medline; Sagol Foundation [un-numbered grant] Funding Source: Medline		Arendt T, 1997, J NEUROSCI, V17, P516; Arvanitakis Z, 2011, ANN NEUROL, V69, P320, DOI 10.1002/ana.22112; Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X; Bar Roni, 2018, Alzheimers Dement (Amst), V10, P1, DOI 10.1016/j.dadm.2017.08.003; Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Belinson H, 2009, J NEURAL TRANSM, V116, P1427, DOI 10.1007/s00702-009-0218-9; Burns MP, 2003, MOL BRAIN RES, V110, P119, DOI 10.1016/S0169-328X(02)00647-2; Busche MA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0429; Cook M, 2015, AGE AGEING, V44, P695, DOI 10.1093/ageing/afv061; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; de Bont N, 1999, J LIPID RES, V40, P680; Dhungana H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-102; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Funakubo Asanuma Yu, 2012, Nihon Rinsho Meneki Gakkai Kaishi, V35, P470; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Haas A, 2012, NEURODEGENER DIS, V10, P41, DOI 10.1159/000334902; Hartig W, 1997, BRAIN RES, V751, P315, DOI 10.1016/S0006-8993(96)01423-0; Hartman RE, 2002, J NEUROSCI, V22, P10083; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Kim SK, 2017, GLIA, V65, P1719, DOI 10.1002/glia.23169; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lin AL, 2017, J CEREBR BLOOD F MET, V37, P217, DOI 10.1177/0271678X15621575; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Liu L, 2016, MOL NEUROBIOL, V53, P4529, DOI 10.1007/s12035-015-9386-9; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Maezawa I, 2006, FASEB J, V20, P797, DOI 10.1096/fj.05-5423fje; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mori T, 2004, J CEREBR BLOOD F MET, V24, P646, DOI 10.1097/01.WCB.0000120787.53851.A4; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Ophir G, 2005, NEUROBIOL DIS, V20, P709, DOI 10.1016/j.nbd.2005.05.002; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Rodriguez GA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-111; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P938; Roselaar SE, 1998, J LIPID RES, V39, P1740; Roses AD, 1997, NEUROBIOL DIS, V4, P170, DOI 10.1006/nbdi.1997.0161; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Saffarpour S, 2017, PHYSIOL BEHAV, V175, P97, DOI 10.1016/j.physbeh.2017.03.025; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sweeney SE, 2004, INT J BIOCHEM CELL B, V36, P372, DOI 10.1016/S1357-2725(03)00259-0; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Teter B, 2004, J MOL NEUROSCI, V23, P167, DOI 10.1385/JMN:23:3:167; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; Van Dooren T, 2006, AM J PATHOL, V168, P245, DOI 10.2353/ajpath.2006.050752; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Yip AG, 2005, NEUROLOGY, V65, P259, DOI 10.1212/01.wnl.0000168863.49053.4d; Zhang HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046666; Zhang XM, 2012, EXP NEUROL, V233, P323, DOI 10.1016/j.expneurol.2011.10.024; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	71	4	4	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2020	70	1					32	44		10.1007/s12031-019-01397-7			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KJ4TL	WOS:000512051500006	31489583				2022-02-06	
J	Berryman, A; Rasavage, K; Politzer, T; Gerber, D				Berryman, Amy; Rasavage, Karen; Politzer, Tom; Gerber, Don			Oculomotor Treatment in Traumatic Brain Injury Rehabilitation: A Randomized Controlled Pilot Trial	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							VISUAL PERCEPTUAL DYSFUNCTION; HIERARCHICAL MODEL	Importance: Vision impairments are common after traumatic brain injury (TBI). Little evidence exists to assist clinicians with effective interventions for impaired oculomotor skills in people with TBI. Objective: To pilot a randomized controlled trial (RCT) of oculomotor treatment in TBI rehabilitation. Design: An impairment-based oculomotor protocol was compared with an activity-based standard of care in a two-group RCT. Participants were masked to assignment. Setting: Inpatient rehabilitation. Participants: For 1 yr, 138 people with TBI, ages 18-65 yr, were screened. Twenty-six were eligible; 6 declined. Inclusion criteria: oculomotor impairment. Exclusion criteria: inpatient stay <6 wk, blind, no functional arm use, unable to follow a three-step command, attention <30 min, or in another clinical trial. Intervention: Participants were randomized into an experimental group (n = 10) receiving the Six Eye Exercises protocol or a control group (n = 10) receiving a standard-of-care protocol for 30 min/day, 5 days/wk, for 4 wk. Oculomotor and related functional impairments were measured at baseline and posttreatment. Outcomes and Measures: Measures were chosen before the start. Primary outcome measure: Craig Hospital Eye Evaluation Rating Scale for oculomotor status. Secondary measures for functional status: King-Devick Test, Delis-Kaplan Executive Function System Trail Making Test: Condition 1 Visual Scanning, Modified Nelson-Denny Reading Test, and Subjective Vision Symptom Scale. Results: Sixteen participants finished. Fatigue was the primary reason for withdrawal. No other negative effects were noted. Selected outcome measures captured positive improvements in both groups. Conclusions and Relevance: Study findings suggest conducting an appropriately powered RCT to evaluate efficacy of oculomotor treatment in this population. What This Article Adds: Oculomotor dysfunction seems to improve during inpatient TBI rehabilitation with remedial treatment. Best practice in occupational therapy has not yet been established. An appropriately powered RCT could positively contribute to the evidence available to clinicians.	[Berryman, Amy; Rasavage, Karen; Politzer, Tom; Gerber, Don] Craig Hosp, Englewood, CO 80113 USA		Berryman, A (corresponding author), Craig Hosp, Englewood, CO 80113 USA.	aberryman@craighospital.org			Colorado Neurological Institute (CNI)	We thank the Colorado Neurological Institute (CNI) for its generous grant to make this pilot study financially possible. In addition to financial support, CNI also shared its statistician, Larry Snell, who provided us clear direction, expert statistical abilities, and enthusiastic participation in this project. The authors have no individual conflicts of interest to disclose.	BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Berger S, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020875; Brown J. I., 1993, THE NELSON DENNY REA; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dodick D, 2017, J CHILD NEUROL, V32, P104, DOI 10.1177/0883073816668704; Heick JD, 2016, ATHLETIC TRAINING SP, V8, P222, DOI DOI 10.3928/19425864-20160509-01; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P3; Lieberman S, 1983, J Am Optom Assoc, V54, P631; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Politzer T, 2017, PM&R, V9, P477, DOI 10.1016/j.pmrj.2016.08.032; Powell JM, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P351, DOI 10.1201/b10524-11; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Riggs RV, 2007, AM J PHYS MED REHAB, V86, P853, DOI 10.1097/PHM.0b013e318151f907; RUDNER LM, 1991, REV TESTS APPROVED S; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55; Zoltan B., 2007, VISION PERCEPTION CO, P48	23	4	4	0	21	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2020	74	1							7401185050	10.5014/ajot.2020.026880			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	KK8KH	WOS:000512984700007	32078510	Green Published			2022-02-06	
J	Billeri, L; Filoni, S; Russo, EF; Portaro, S; Militi, D; Calabro, RS; Naro, A				Billeri, Luana; Filoni, Serena; Russo, Emanuele Francesco; Portaro, Simona; Militi, David; Calabro, Rocco Salvatore; Naro, Antonino			Toward Improving Diagnostic Strategies in Chronic Disorders of Consciousness: An Overview on the (Re-)Emergent Role of Neurophysiology	BRAIN SCIENCES			English	Article						disorder of consciousness (DoC); unresponsive wakefulness syndrome (UWS); minimally conscious state (MCS); functional Locked-In Syndrome (fLIS); resting state; passive paradigms; neurophysiology	UNRESPONSIVE WAKEFULNESS SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION; LASER-EVOKED-POTENTIALS; CORTICAL EFFECTIVE CONNECTIVITY; GAMMA-BAND OSCILLATIONS; TRAUMATIC BRAIN-INJURY; LOCKED-IN SYNDROME; RESTING-STATE EEG; VEGETATIVE STATE; PROLONGED DISORDERS	The differential diagnosis of patients with Disorder of Consciousness (DoC), in particular in the chronic phase, is significantly difficult. Actually, about 40% of patients with unresponsive wakefulness syndrome (UWS) and the minimally conscious state (MCS) are misdiagnosed. Indeed, only advanced paraclinical approaches, including advanced EEG analyses, can allow achieving a more reliable diagnosis, that is, discovering residual traces of awareness in patients with UWS (namely, functional Locked-In Syndrome (fLIS)). These approaches aim at capturing the residual brain network models, at rest or that may be activated in response to relevant stimuli, which may be appropriate for awareness to emerge (despite their insufficiency to generate purposeful motor behaviors). For this, different brain network models have been studied in patients with DoC by using sensory stimuli (i.e., passive tasks), probing response to commands (i.e., active tasks), and during resting-state. Since it can be difficult for patients with DoC to perform even simple active tasks, this scoping review aims at summarizing the current, innovative neurophysiological examination methods in resting state/passive modality to differentiate and prognosticate patients with DoC. We conclude that the electrophysiologically-based diagnostic procedures represent an important resource for diagnosis, prognosis, and, therefore, management of patients with DoC, using advance passive and resting state paradigm analyses for the patients who lie in the "greyzones" between MCS, UWS, and fLIS.	[Billeri, Luana; Portaro, Simona; Calabro, Rocco Salvatore; Naro, Antonino] IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy; [Filoni, Serena; Russo, Emanuele Francesco] Padre Pio Fdn & Rehabil Ctr, I-71013 Foggia, Italy; [Militi, David] Stomatodent Ctr, I-98100 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy.; Filoni, S (corresponding author), Padre Pio Fdn & Rehabil Ctr, I-71013 Foggia, Italy.	luana.billeri@irccsme.it; serena.diba@gmail.com; uo.tecnologica@fondazionepadrepio-onlus.it; simona.portaro@irccsme.it; david.militi@alice.it; salbro77@tiscali.it; g.naro11@alice.it	Calabro, Rocco S/K-7520-2016; Russo, Emanuele Francesco/AAV-2974-2021	calabro, rocco salvatore/0000-0002-8566-3166; Billeri, Luana/0000-0002-0462-6364			Arico I, 2016, BRAIN INJURY, V30, P159, DOI 10.3109/02699052.2015.1089595; Arnaldi D, 2016, CLIN NEUROPHYSIOL, V127, P1445, DOI 10.1016/j.clinph.2015.10.042; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bai Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00471; Bai Y, 2017, NEUROIMAGE-CLIN, V15, P702, DOI 10.1016/j.nicl.2017.01.025; Bai Y, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00473; Bareham CA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00676; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bodien YG, 2017, SEMIN NEUROL, V37, P485, DOI 10.1055/s-0037-1607310; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bonfiglio L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093252; Bonfiglio L, 2013, HUM BRAIN MAPP, V34, P2178, DOI 10.1002/hbm.22056; Bruno MA, 2010, COGN NEUROSCI-UK, V1, P193, DOI 10.1080/17588928.2010.485677; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cacciola A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030306; Calabro RS, 2018, CLIN NEUROPHYSIOL, V129, P1049, DOI 10.1016/j.clinph.2018.01.067; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cheliout-Heraut F, 2001, NEUROPHYSIOL CLIN, V31, P283, DOI 10.1016/S0987-7053(01)00270-2; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Coleman MR, 2005, J NEUROL NEUROSUR PS, V76, P432, DOI 10.1136/jnnp.2004.045930; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; Cologan V, 2010, SLEEP MED REV, V14, P97, DOI 10.1016/j.smrv.2009.04.003; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; DANZE F, 1989, Neurosurgical Review, V12, P477, DOI 10.1007/BF01790694; de Biase S, 2014, SLEEP MED, V15, P393, DOI 10.1016/j.sleep.2013.09.026; De Salvo S, 2015, BRAIN INJURY, V29, P1467, DOI 10.3109/02699052.2015.1071430; de Tommaso M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00017; de Tommaso M, 2013, BRAIN INJURY, V27, P962, DOI 10.3109/02699052.2013.775507; Demertzi A., 2012, I KNOW WHAT YOU ARE, P7; Demertzi A., 2015, NEUROLOGY CONSCIOUSN; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Demertzi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00538; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Dolce Giuliano, 2015, ScientificWorldJournal, V2015, P463829, DOI 10.1155/2015/463829; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Fingelkurts Alexander A, 2013, Suppl Clin Neurophysiol, V62, P81; Fingelkurts AA, 2012, CONSCIOUS COGN, V21, P149, DOI 10.1016/j.concog.2011.10.004; Fingelkurts AA, 2013, CLIN EEG NEUROSCI, V44, P209, DOI 10.1177/1550059412474929; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Formisano R, 2011, BRAIN INJURY, V25, P638, DOI 10.3109/02699052.2011.572948; Formisano R, 2013, BRAIN INJURY, V27, P1332, DOI 10.3109/02699052.2013.809555; Formisano R, 2011, FUNCT NEUROL, V26, P15; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Gilutz Y, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00087; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Grossberg S., 2003, FILLING IN PERCEPTUA, P123; He FP, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5036184; Heine L., 2015, CLIN NEUROPHYSIOL, P149; Heine L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00295; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; Huang G, 2013, IEEE ENG MED BIO, P4207, DOI 10.1109/EMBC.2013.6610473; Hughes J R, 1978, Ann N Y Acad Sci, V315, P121, DOI 10.1111/j.1749-6632.1978.tb50335.x; HUMPHREYS GW, 1994, COGNITIVE NEUROPSYCH, V11, P207, DOI 10.1080/02643299408251974; Iannetti GD, 2005, NEUROSCIENCE, V131, P199, DOI 10.1016/j.neuroscience.2004.10.035; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; Khanmohammadi S, 2018, CLIN NEUROPHYSIOL, V129, P2296, DOI 10.1016/j.clinph.2018.08.004; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2013, RESTOR NEUROL NEUROS, V31, P25, DOI 10.3233/RNN-120249; Lancioni GE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00025; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Leo A, 2016, EXP BRAIN RES, V234, P2189, DOI 10.1007/s00221-016-4622-8; Leon-Carrion J, 2012, BRAIN RES, V1476, P22, DOI 10.1016/j.brainres.2012.03.055; Liberati G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00865; Malinowska U, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-109; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; Marinazzo D, 2014, CLIN EEG NEUROSCI, V45, P33, DOI 10.1177/1550059413510703; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Miller A, 2004, BRIT J ANAESTH, V92, P8, DOI 10.1093/bja/aeh003; Monti MM, 2013, HUM BRAIN MAPP, V34, P1245, DOI 10.1002/hbm.21507; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Naro A, 2016, NEUROSCIENCE, V317, P141, DOI 10.1016/j.neuroscience.2016.01.009; Naro A, 2018, INT J NEURAL SYST, V28, DOI 10.1142/S0129065717500599; Naro A, 2018, CORTEX, V103, P316, DOI 10.1016/j.cortex.2018.03.029; Naro A, 2017, NEUROREHABILITATION, V41, P735, DOI 10.3233/NRE-172160; Naro A, 2017, CEREBELLUM, V16, P859, DOI 10.1007/s12311-017-0859-4; Naro A, 2017, NEUROSCIENCE, V349, P165, DOI 10.1016/j.neuroscience.2017.02.053; Naro A, 2016, J NEUROL SCI, V368, P178, DOI 10.1016/j.jns.2016.07.016; Naro A, 2016, BRAIN RES, V1646, P262, DOI 10.1016/j.brainres.2016.06.012; Naro A, 2016, BRAIN TOPOGR, V29, P623, DOI 10.1007/s10548-016-0489-z; Naro A, 2016, CLIN NEUROPHYSIOL, V127, P1845, DOI 10.1016/j.clinph.2015.12.010; Naro A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144713; Naro A, 2015, J PAIN, V16, P1022, DOI 10.1016/j.jpain.2015.06.014; Naro A, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/391349; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P447, DOI 10.3233/RNN-150525; Naro A, 2015, NEUROREHAB NEURAL RE, V29, P603, DOI 10.1177/1545968314562114; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Oksenberg A, 2001, SLEEP, V24, P703, DOI 10.1093/sleep/24.6.703; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2002, NEUROCASE, V8, P394, DOI 10.1076/neur.8.4.394.16184; Pavlov YG, 2017, J SLEEP RES, V26, P629, DOI 10.1111/jsr.12524; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Pisani LR, 2015, CONSCIOUS COGN, V38, P1, DOI 10.1016/j.concog.2015.09.012; Pistoia F, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6040047; Pollonini L, 2010, BRAIN TOPOGR, V23, P221, DOI 10.1007/s10548-010-0139-9; Ragazzoni A, 2017, CLIN NEUROPHYSIOL, V128, P1629, DOI 10.1016/j.clinph.2017.06.037; Ragazzoni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057069; Raichle ME, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P81; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Rosanova M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06871-1; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2005, NEUROPSYCHOL REHABIL, V15, P381, DOI 10.1080/09602010443000524; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schorr B, 2016, J NEUROL, V263, P937, DOI 10.1007/s00415-016-8084-5; Sebastiano DR, 2018, CLIN NEUROPHYSIOL, V129, P687, DOI 10.1016/j.clinph.2017.12.012; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song M, 2018, NEUROSCI BULL, V34, P592, DOI 10.1007/s12264-018-0243-5; Stefan S, 2018, BRAIN TOPOGR, V31, P848, DOI 10.1007/s10548-018-0643-x; Storm JF, 2017, J NEUROSCI, V37, P10882, DOI 10.1523/JNEUROSCI.1838-17.2017; Thul A, 2016, CLIN NEUROPHYSIOL, V127, P1419, DOI 10.1016/j.clinph.2015.07.039; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Varotto G, 2014, CLIN NEUROPHYSIOL, V125, P63, DOI 10.1016/j.clinph.2013.06.016; Vithoulkas G, 2014, J Med Life, V7, P104; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P1956, DOI 10.1016/j.clinph.2011.03.018; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Xie Y, 2015, BRAIN STIMUL, V8, P674, DOI 10.1016/j.brs.2015.01.406; Zhang Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00620; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	159	4	5	3	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2020	10	1							42	10.3390/brainsci10010042			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KL0NW	WOS:000513130500027	31936844	Green Published, gold			2022-02-06	
J	Blackwell, C; Cary, K; Holst, K; Mandle, K; Dryg, L; Clemens, S; Lemke, JH; Castro, S; Hendricks, E; Kelly, R				Blackwell, Cherie; Cary, Kathy; Holst, Kami; Mandle, Kristen; Dryg, Lori; Clemens, Susan; Lemke, Jon H.; Castro, Sarah; Hendricks, Emma; Kelly, Ryan			Dynavision Normative Data for Healthy Adults: Reaction Test Program	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							TEST-RETEST RELIABILITY; REACTION-TIME; DRIVING ABILITY; SKILLS; REHABILITATION; PSYCHOMOTOR; AGE	Importance: Previous research has calculated normative data for the Dynavision D2 Visuomotor Training (D2) System among healthy athletes to understand concussion management, but to date no studies have identified the norms for healthy adults over a large age range (18-80 yr) for physical response speed. Objective: To provide normative data for the D2 for physical response speed in adults ages 18-80 yr. Design: Cross-sectional, descriptive study to obtain normative data on physical response speed using the D2 for adults in age categories 18-40,41-60, and 61-80 yr. Setting: Genesis Physical Therapy and Wellness Center, a Midwestern outpatient hospital-based therapy center. Participants: Three hundred adults, stratified into three different age categories. Normal standards with quartiles were identified for each age and sex category. Outcomes and Measures: Multiple regression model of the inverse response times. Results: The results showed a significant difference in physical response speed between men and women and between the different age groups. Women in all age categories were slower than men. Physical response speed increased with age in both sexes, but each had significantly different age and sex main effects (p < .0005). Conclusions and Relevance: Occupational therapy practitioners can use the normative standards identified in this study in their assessment of clients with visual and cognitive deficits after a brain injury, stroke, or other neurologic pathology. What This Article Adds: This study's results can be added to the battery of other common evaluation measures that occupational therapists use to evaluate visual and cognitive deficits after neurological impairments.	[Blackwell, Cherie; Cary, Kathy; Holst, Kami; Mandle, Kristen; Dryg, Lori; Clemens, Susan; Lemke, Jon H.; Hendricks, Emma] Genesis Phys Therapy & Wellness Ctr, Bettendorf, IA 52722 USA; [Castro, Sarah] Unity Point Hlth Trinity, Rock Isl, IL USA; [Castro, Sarah] Genesis Hlth Syst, Davenport, IA USA; [Hendricks, Emma] Univ Iowa, Clin Mental Hlth Counseling, Iowa City, IA USA; [Kelly, Ryan] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Kelly, Ryan] Genesis Med Ctr, Bettendorf, IA USA		Blackwell, C (corresponding author), Genesis Phys Therapy & Wellness Ctr, Bettendorf, IA 52722 USA.	blackwellc@genesishealth.com		Blackwell, Cherie/0000-0003-0630-5123	Genesis Research program	We acknowledge the Genesis Research program for their assistance and financial support, including Gina Gore, Yvonne Bonick, and staff. The preliminary findings were presented at the 2018 AOTA Conference & Expo.	[Anonymous], ACS DEM HOUS EST; Berger S, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020875; Bigsby K, 2014, INT J SPORTS PHYS TH, V9, P436; Clark JF, 2017, CLIN J SPORT MED, V27, P457, DOI 10.1097/JSM.0000000000000381; Crotty M, 2009, ARCH PHYS MED REHAB, V90, P2096, DOI 10.1016/j.apmr.2009.08.143; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Klavora P, 1998, PERCEPT MOTOR SKILL, V86, P23, DOI 10.2466/pms.1998.86.1.23; KLAVORA P, 1994, PERCEPT MOTOR SKILL, V79, P448, DOI 10.2466/pms.1994.79.1.448; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; Klavora P, 2000, ARCH PHYS MED REHAB, V81, P701, DOI 10.1016/S0003-9993(00)90096-0; KLAVORA P, 1995, AM J OCCUP THER, V49, P534, DOI 10.5014/ajot.49.6.534; Moscoso Del Prado Martin F, 2009, THERMODYNAMICS HUMAN; U.S. Census Bureau, ED ATT SURV 2013 201; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wells AJ, 2013, NUTR RES, V33, P464, DOI 10.1016/j.nutres.2013.03.009	18	4	4	2	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2020	74	1							7401185060	10.5014/ajot.2020.036251			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	KK8KH	WOS:000512984700008	32078511	Green Published			2022-02-06	
J	Brahmajothi, MV; Abou-Donia, MB				Brahmajothi, Mulugu, V; Abou-Donia, Mohamed B.			PTSD Susceptibility and Challenges: Pathophysiological Consequences of Behavioral Symptoms	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				POSTTRAUMATIC-STRESS-DISORDER; NEUROTROPHIC FACTOR; BRAIN; VETERANS; METAANALYSIS; MIGRATION; PROTEINS; BDNF	Introduction Posttraumatic stress disorder (PTSD) can develop during the aftermath of traumatic events. Although many are impacted by several stressors, nearly 3.6% suffer from PTSD in the United States with higher incidence reported in military service personnel. Any injury to the blood-brain barrier can ignite an array of biological signaling molecules in the immune-privileged brain parenchyma, which can disrupt the synaptic neural network, resulting in altered behavior. Materials and Methods In this preliminary study, we compared 20 PTSD veterans with age-matched healthy veterans to identify plasma levels of brain-specific protein markers using enzyme-linked immunosorbent assay/immunofluorometric sandwich assay for neurotrophic factors and neuropoietic cytokines, and catalytic activity of matrix metalloproteinase (MMP) by zymography. Results We observed an increased level of glial fibrillary acidic protein, tumor necrosis factor-alpha, interleukin 6, and MMP2 and MMP9 but decreased level of brain-derived neurotrophic factor, nerve growth factor-beta, and negligible difference in astroglial marker S100 calcium-binding protein B compared to controls. Conclusion Identification of neural biomarkers is essential to understand the subclinical symptoms for the diagnosis PTSD, which may not be visible by magnetic resonance imaging (MRI/fMRI) and may take years to clinically manifest.	[Brahmajothi, Mulugu, V; Abou-Donia, Mohamed B.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, POB 3813,308 Res Dr, Durham, NC 27710 USA		Brahmajothi, MV (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, POB 3813,308 Res Dr, Durham, NC 27710 USA.				DODUnited States Department of Defense [W81XWH-15-1-0641, W81XWH-18-1-0454]	DOD Contract No. W81XWH-15-1-0641 and W81XWH-18-1-0454.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Back SE, 2018, CONTEMP CLIN TRIALS, V73, P8, DOI 10.1016/j.cct.2018.08.009; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chaldakov GN, 2004, PROG BRAIN RES, V146, P279, DOI 10.1016/S0079-6123(03)46018-4; Clausen AN, 2017, DEPRESS ANXIETY, V34, P427, DOI 10.1002/da.22613; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hauck S, 2010, PROG NEURO-PSYCHOPH, V34, P459, DOI 10.1016/j.pnpbp.2010.01.010; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Jacob L, 2018, J AFFECT DISORDERS, V232, P385, DOI 10.1016/j.jad.2018.02.063; Jin H, 2009, J CLIN PSYCHOPHARM, V29, P210, DOI 10.1097/JCP.0b013e3181a45ed0; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Loew Benjamin, 2014, Traumatology (Tallahass Fla), V20, P150; Lovalekar M, 2018, J SCI MED SPORT, V21, P1125, DOI 10.1016/j.jsams.2018.05.028; Martindale SL, 2017, REHABIL PSYCHOL, V62, P563, DOI 10.1037/rep0000159; Misaki M, 2018, NEUROIMAGE-CLIN, V20, P543, DOI 10.1016/j.nicl.2018.08.025; Najavits LM, 2018, SUBST USE MISUSE, V53, P1788, DOI 10.1080/10826084.2018.1432653; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nindl BC, 2018, J SCI MED SPORT, V21, P1116, DOI 10.1016/j.jsams.2018.05.005; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Rau HK, 2018, CLIN NEUROPSYCHOL, V32, P1319, DOI 10.1080/13854046.2017.1381277; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Smith MA, 1996, BEHAV BRAIN RES, V78, P25, DOI 10.1016/0166-4328(95)00220-0; Umholtz M, 2016, J CLIN ANESTH, V34, P3, DOI 10.1016/j.jclinane.2016.02.047; Wekerle H, 2006, CURR TOP MICROBIOL, V305, P25, DOI 10.1007/3-540-29714-6_2	33	4	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			279	285		10.1093/milmed/usz321			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600040	32074333	Bronze			2022-02-06	
J	Byun, JH; Park, MH; Jeong, BY				Byun, Jong Han; Park, Myoung Hwan; Jeong, Byung Yong			Effects of age and violations on occupational accidents among motorcyclists performing food delivery	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Motorcycle crash; occupational accident; food delivery; teenage worker; violation	HELMET-USE; INJURIES; CRASHES; SEVERITY; BEHAVIOR; ERRORS; RATES; ROADS	BACKGROUND: Risk factors for motorcycle injuries are associated with rider-related factors and crash-related factors. OBJECTIVE: This study investigates the effects of age and violations on occupational accidents among motorcyclists performing food delivery. METHODS: This study analyzed 1,317 injured couriers regarding rider-related factors and crash-related factors according to rider's age or violations. RESULTS: Among injured riders, 67.4% were temporary workers, 76.1% worked in small companies with <5 employees, 58.7% in the nighttime, and 51.5% had a work experience of <1 month. However, among the injured teens, 93.5% were temporary workers, 87.0% in companies with <5 employees, 79.5% in nighttime, and 61.4% with work experience of <1 month. The proportion of novice with <1 month, of the temporary worker, of 'head/face/neck' injury, or of the 'concussion/hemorrhage' type of injury all decreased with age. However, the proportion of `fracture,' rider alone,' or 'death or disability' accidents increased with age. Furthermore, the violation rate was high in teens (17.4%), at night (15.4%), or in type of 'crash with a car' (26.2%). The violation rate decreased with age. CONCLUSIONS: The results are expected to be useful for injury prevention policies and guidelines in the food delivery industries.	[Byun, Jong Han] OSH Training Inst, Kosha, South Korea; [Park, Myoung Hwan; Jeong, Byung Yong] Hansung Univ, Dept Ind & Management Engn, 116 Samseongyoro 16Gil, Seoul 02876, South Korea		Jeong, BY (corresponding author), Hansung Univ, Dept Ind & Management Engn, 116 Samseongyoro 16Gil, Seoul 02876, South Korea.	byjeong@hansung.ac.kr	Jeong, Byung Yong/Q-6377-2018	Jeong, Byung Yong/0000-0001-6837-1324	Hansung University	This research was financially supported by Hansung University.	BAKER CC, 1987, BRIT J IND MED, V44, P206; Ballesteros MF, 2002, ACCIDENT ANAL PREV, V34, P279, DOI 10.1016/S0001-4575(01)00023-9; BLOCKEY PN, 1995, ERGONOMICS, V38, P1759, DOI 10.1080/00140139508925225; BRADDOCK M, 1992, ANN EMERG MED, V21, P273, DOI 10.1016/S0196-0644(05)80887-X; Byun Jong Han, 2017, [Journal of the ergonomics society of Korea, 대한인간공학회지], V36, P157, DOI 10.5143/JESK.2017.36.2.157; Chung Y, 2014, ACCIDENT ANAL PREV, V62, P79, DOI 10.1016/j.aap.2013.08.024; Clarke DD, 2007, ACCIDENT ANAL PREV, V39, P974, DOI 10.1016/j.aap.2007.01.002; de Rome L, 2016, INJURY, V47, P2025, DOI 10.1016/j.injury.2016.03.033; Houston DJ, 2008, ACCIDENT ANAL PREV, V40, P200, DOI 10.1016/j.aap.2007.05.005; Jeong BY, 2017, INT J OCCUP SAF ERGO, V23, P76, DOI 10.1080/10803548.2016.1199500; 김정남, 2016, [Journal of the ergonomics society of Korea, 대한인간공학회지], V35, P465, DOI 10.5143/JESK.2016.35.5.465; Jeong Byung Yong, 2016, [Journal of the ergonomics society of Korea, 대한인간공학회지], V35, P135, DOI 10.5143/JESK.2016.35.3.135; Kim JS, 2018, WORK, V60, P587, DOI 10.3233/WOR-182766; Lee S, 2016, SAF HEALTH WORK-KR, V7, P38, DOI 10.1016/j.shaw.2015.11.005; Li LP, 2008, ACCIDENT ANAL PREV, V40, P1937, DOI 10.1016/j.aap.2008.06.019; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Mullin B, 2000, Inj Prev, V6, P32, DOI 10.1136/ip.6.1.32; NICHOLSON AS, 1985, ERGONOMICS, V28, P31, DOI 10.1080/00140138508963109; PEDEN M, WORLD REPORT ROAD TR; PEEK C, 1994, J TRAUMA, V37, P358; RABBITT P, 1991, ERGONOMICS, V34, P775, DOI 10.1080/00140139108967350; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rodrigues EMS, 2014, INT J INJ CONTROL SA, V21, P170, DOI 10.1080/17457300.2013.792289; ROSS DJ, 1983, INJURY, V15, P75, DOI 10.1016/0020-1383(83)90030-X; Shin DS, 2018, IND ENG MANAG SYST, V17, P302, DOI 10.7232/iems.2018.17.2.302; Statistics Korea, 2007, KOR STAND CLASS OCC; Williams AF, 2006, J SAFETY RES, V37, P123, DOI 10.1016/j.jsr.2006.01.001; Woratanarat P, 2013, ACCIDENT ANAL PREV, V58, P115, DOI 10.1016/j.aap.2013.05.001	30	4	4	12	22	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2020	65	1					53	61		10.3233/WOR-193057			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KF7IF	WOS:000509412200005	31868711				2022-02-06	
J	Carlozzi, NE; Kisala, PA; Boulton, AJ; Roth, E; Kratz, AL; Sherer, M; Sander, AM; Heinemann, AW; Chiaravalloti, ND; Bushnik, T; Tulsky, DS				Carlozzi, Noelle E.; Kisala, Pamela A.; Boulton, Aaron J.; Roth, Elliot; Kratz, Anna L.; Sherer, Mark; Sander, Angelle M.; Heinemann, Allen W.; Chiaravalloti, Nancy D.; Bushnik, Tamara; Tulsky, David S.			Measuring Pain in TBI: Development of the TBI-QOL Pain Interference Item Bank and Short Form	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuriestraumatic; Outcome assessment (health care); Pain; Quality of life; Rehabilitation; Surveys and questionnaires	QUALITY-OF-LIFE; RESPONSE THEORY; NATURAL-HISTORY; NEURO-QOL; BACK-PAIN; OUTCOMES; PROMIS; FIT; CALIBRATION; VALIDATION	Objective: To develop a pain interference item bank, computer adaptive test (CAT), and short form for use by individuals with traumatic brain injury (TBI). Design: Cross-sectional survey study. Setting: Five TBI Model Systems rehabilitation hospitals. Participants: Individuals with TBI (N=590). Interventions: Not applicable. Outcome Measures: Traumatic Brain Injury-Quality of Life (TBI-QOL) Pain Interference item bank. Results: Confirmatory factor analysis provided evidence of a single underlying trait (chi(2) [740]=3254.030; P<.001; Comparative Fix Index=0.988; Tucker-Lewis Index=0.980; Root Mean Square Error of Approximation=0.076) and a graded response model (GRM) supported item fit of 40 Pain Interference items. Items did not exhibit differential item functioning or local item dependence. GRM calibration data were used to inform the selection of a 10-item static short form and to program a TBI-QOL Pain Interference CAT. Comparative analyses indicated excellent comparability and reliability across test administration formats. Conclusion: The 40-item TBI-QOL Pain Interference item bank demonstrated strong psychometric properties. End users can administer this measure as either a 10-item short form or CAT. (C) 2019 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Kratz, Anna L.] Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Kisala, Pamela A.; Boulton, Aaron J.; Tulsky, David S.] Univ Delaware, Coll Hlth Sci, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Roth, Elliot; Heinemann, Allen W.] Shirley Ryan AbilityLab, Chicago, IL USA; [Roth, Elliot; Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Sherer, Mark; Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Chiaravalloti, Nancy D.] Kessler Fdn, E Hanover, NJ USA; [Bushnik, Tamara] NYU Langone, Rusk Rehabil, New York, NY USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA		Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Chiaravalloti, Nancy/0000-0003-2943-7567; Tulsky, David/0000-0002-4335-4509; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01AR057929]; NIDILRRUnited States Department of Health & Human Services [H133A120100]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant nos. H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038) and the National Institutes of Health (U01AR057929). Additional support for the preparation of this manuscript was provided by NIDILRR (grant no. H133A120100).	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Becker J, 2007, PAIN MED, V8, pS129, DOI 10.1111/j.1526-4637.2007.00377.x; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bode RK, 2003, ARCHPHYSMEDREHABIL, V84, P52; Brown M.W., 1993, SOCIOL METHOD RES, P136; Carlozzi N, 2015, QUAL LIFE RES, V24, P66; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Faul M, 2010, TRAUMATIC BRAIN INJU; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Kisala PA, 2019, HEALTH PSYCHOL, V38, P435, DOI 10.1037/hea0000685; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Muthen B. O., 1998, M PLUS USERS GUIDE; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Northwestern University, NIH TOOLB PROMIS IPA; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; POLLARD CA, 1984, PERCEPT MOTOR SKILL, V59, P974, DOI 10.2466/pms.1984.59.3.974; PROMIS, PROMIS INSTR DEV PSY; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rutherford C, 2016, QUAL LIFE RES, V25, P559, DOI 10.1007/s11136-015-1110-8; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Steiger J. H., 1980, ANN M PSYCH SOC MAY; STOCKING ML, 1983, APPL PSYCH MEAS, V7, P201, DOI 10.1177/014662168300700208; Sullivan MD, 2016, PAIN, V157, P65, DOI 10.1097/j.pain.0000000000000336; THISSEN D, 1995, APPL PSYCH MEAS, V19, P39, DOI 10.1177/014662169501900105; Tourangeau R., 1984, COGNITIVE ASPECTS SU, DOI [10.17226/930., DOI 10.17226/930]; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P298, DOI 10.1097/HTR.0000000000000532; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Ware JE, 2003, ARCH PHYS MED REHAB, V84, pS43, DOI 10.1053/apmr.2003.50246; Willis GB, 1999, M AM STAT ASS AUG 8	47	4	4	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					11	19		10.1016/j.apmr.2019.07.019			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300002	31562878				2022-02-06	
J	Casper, ST; O'Donnell, K				Casper, Stephen T.; O'Donnell, Kelly			The punch-drunk boxer and the battered wife: Gender and brain injury research	SOCIAL SCIENCE & MEDICINE			English	Article						Traumatic brain injury; Chronic traumatic encephalopathy; Intimate partner violence; Emerging disease; Gender and biomedicine; Battered women; Boxing; Brain damage; Construction of disease	HEAD-INJURY; VIOLENCE; TRAUMA; CONCUSSION; OUTCOMES; HISTORY; SCIENCE; PLACE; WOMEN	This essay uses gender as a category of historical and sociological analysis to situate two populations-boxers and victims of domestic violence-in context and explain the temporal and ontological discrepancies between them as potential brain injury patients. In boxing, the question of brain injury and its sequelae were analyzed from 1928 on, often on profoundly somatic grounds. With domestic violence, in contrast, the question of brain injury and its sequelae appear to have been first examined only after 1990. Symptoms prior to that period were often cast as functional in specific psychiatric and psychological nomenclatures. We examine this chronological and epistemological disconnection between forms of violence that appear otherwise highly similar even if existing in profoundly different spaces.	[Casper, Stephen T.] Clarkson Univ, Potsdam, NY 13699 USA; [O'Donnell, Kelly] Thomas Jefferson Univ, Coll Humanities & Sci, Philadelphia, PA 19107 USA		Casper, ST (corresponding author), Clarkson Univ, Potsdam, NY 13699 USA.	scasper@clarkson.edu		O'Donnell, Kelly/0000-0002-7055-870X; Casper, Stephen/0000-0003-2915-8592			Aleck Elizabeth, 1987, DOMESTIC TYRANNY; [Anonymous], 2015, QUEENS SQUAR; [Anonymous], 1938, NATIONS BUS, V26, P7; [Anonymous], 1895, NY TIMES, P13; [Anonymous], 2019, J AGGRESSION MALTREA, V28; [Anonymous], 1879, PUNCH LONDON CH 1213, P265; [Anonymous], 1951, CHANGING TIMES   APR, V6, P45; [Anonymous], AM J PSYCHIAT, V60, P373; Arnold G, 2013, VIOLENCE AGAINST WOM, V19, P557, DOI 10.1177/1077801213490508; Aronowitz R.A., 1992, FRAMING DIS STUDIES, P155; Bachynski K., 2019, NO GAME BOYS PLAY HI; Bachynski KE, 2019, J HIST MED ALL SCI, V74, P167, DOI 10.1093/jhmas/jry042; Beizer Janet., 1994, VENTRILOQUIZED BODIE; BENEDICT J, 1998, PROS CONS CRIMINALS; Berg Marc, 1998, DIFFERENCES MED UNRA; Brody Jane E., 1983, NY TIMES, pC11; Brooks Rachelle, 1997, FEMINISTS NEGOTIATE, P65; BROWNE A, 1993, AM PSYCHOL, V48, P1077, DOI 10.1037/0003-066X.48.10.1077; Bruetsch WL, 1935, J NERV MENT DIS, V81, P531, DOI 10.1097/00005053-193505000-00004; Carney M, 2007, AGGRESS VIOLENT BEH, V12, P108, DOI 10.1016/j.avb.2006.05.002; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; Carter Neil, 2012, MED SPORT BODY HIST, P185; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Casper ST, 2018, CAN MED ASSOC J, V190, pE140, DOI 10.1503/cmaj.171204; Casper Stephen T., 2014, NEUROLOGISTS HIST ME, P74; CDC National Center for Injury Prevention and Control, TRAUM BRAIN INJ PRIS; Cooter R., 2000, WAR MED MODERNITY; COURVILLE CB, 1953, COMMOTIO CEREBRI CER; Creighton Robert E., 1933, AM SPEECH, V8, P34; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Crone Rosalind, 2016, VIOLENT VICTORIANS P; Dagi T. F., 1997, HIST NEUROSURGERY IT, P289; Daniels C. R., 1997, FEMINISTS NEGOTIATE; Duncanson JG, 1903, BRIT MED J, V1903, P782, DOI 10.1136/bmj.1.2205.782; ELLIOTT H, 1953, CAN MED ASSOC J, V68, P475; Fagan J., 1996, CRIMINALIZATION DOME; Fine C., 2010, DELUSIONS GENDER OUR; Funder Anna, 1993, TRANSNATL L CONT PRO, V3, P417; GAYFORD JJ, 1975, MED SCI LAW, V15, P237, DOI 10.1177/002580247501500404; GAYFORD JJ, 1975, BRIT MED J, V1, P194, DOI 10.1136/bmj.1.5951.194; GAYFORD JJ, 1977, INT J ENVIRON STUD, V10, P283; GAYFORD JJ, 1979, MED SCI LAW, V19, P19, DOI 10.1177/002580247901900104; Geller J.L., 1995, WOMEN ASYLUM VOICES; Gelles Richard J., 1989, J INTERPERS VIOLENCE, V4, P408; Gelles Richard J., 1974, VIOLENT HOME STUDY P; Gillett G, 2018, CAMB Q HEALTHC ETHIC, V27, P710, DOI 10.1017/S0963180118000191; Gordon Linda, 2002, HEROES THEIR OWN LIV; Gowing Laura, 2005, DOMESTIC DANGERS WOM; Graham J. W., 1975, 8 9 OUT 50 YEARS BOX, P56; Gregory H, 2020, SOC SCI MED, V244, DOI 10.1016/j.socscimed.2019.112598; Grenfell Julian, 2003, BRIEF HIST 1 WORLD W, P69; GRONWALL D, 1975, LANCET, V2, P995; Gurdjian ES., 1973, HEAD INJURY ANTIQUIT; Gurdjian ES, 1958, HEAD INJURIES MECH D; Hack Tuke D., 1892, DICT PSYCHOL MED GIV, V2, P1306; Hasday JE, 2000, CALIF LAW REV, V88, P1373, DOI 10.2307/3481263; Helfer R E, 1968, Adv Pediatr, V15, P9; Henne K, 2020, CRIME MEDIA CULT, V16, P395, DOI 10.1177/1741659019879888; Hirshbein Laura D., 2014, AM MELANCHOLY CONSTR, P127; Howard Samuel A., 1976, JURISMPRUDENCE CORPU, P64; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jacquet Catherine, 2015, CIRCULATING NOW 1015; Johnson MP, 2000, J MARRIAGE FAM, V62, P948, DOI 10.1111/j.1741-3737.2000.00948.x; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KANTOR GK, 1987, SOC PROBL, V34, P213, DOI 10.1525/sp.1987.34.3.03a00010; Katz JD, 2010, GENDER MED, V7, P19, DOI 10.1016/j.genm.2010.01.003; Kawako Laura E, TRAUMA VIOLENCE ABUS, V12, P115; KERBER LK, 1988, J AM HIST, V75, P9, DOI 10.2307/1889653; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Levin H.S., 1989, MILD HEAD INJURY; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LUNDBERG GD, 1986, JAMA-J AM MED ASSOC, V255, P2483, DOI 10.1001/jama.255.18.2483; MARTIN DL, 1995, CANADIAN J WOMEN LAW, V8, P3; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Micale MS, 2001, TRAUMATIC PASTS HIST; Mickle W.J., 1892, TRAUMATIC FACTOR MEN, V15, P76; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Monahan K., 1999, HLTH SOCIAL WORK, V24, P270; Musselman Elizabeth Green, 2012, NERVOUS CONDITIONS S; Oppenheim J., 1991, SHATTERED NERVES DOC; Oudshoorn N, 2008, SOCIOL HEALTH ILL, V30, P272, DOI 10.1111/j.1467-9566.2007.01032.x; Palladino P., 2006, THEORY EVENT, V9, DOI [10.1353/tae.2006.0028, DOI 10.1353/TAE.2006.0028]; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Pizzey E., 1979, SCREAM QUIETLY NEIGH; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Proctor R., 2008, AGNOTOLOGY MAKING UN; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Rosen G., 2004, POSTTRAUMATIC STRESS, P127; Ross R, 2019, SOC HIST MED, V32, P565, DOI 10.1093/shm/hkx118; Ross R, 2018, MED HIST, V62, P449, DOI 10.1017/mdh.2018.42; Rutherford A, 2017, HIST HUM SCI, V30, P100, DOI 10.1177/0952695117722715; Schmitt Michael N., 2018, HARVARD NATL SECURIT, V9, P75; Schneider RC., 1973, HEAD NECK INJURIES F; Schneider Richard, 1973, HEAD NECK INJURIES F, P140; SCOTT JW, 1986, AM HIST REV, V91, P1053, DOI 10.2307/1864376; SCOTT PD, 1974, BRIT J PSYCHIAT, V125, P433, DOI 10.1192/bjp.125.5.433; Shephard B., 2003, WAR NERVES SOLDIERS; Showalter Elaine, 1987, FEMALE MALADY WOMEN; Smith L. L., 1876, AUSTR J, P461; Smith L. L., 1894, JAMA-J AM MED ASSOC, P243; Smith L. L., 1885, NY TIMES, P5; Smith Red, 1976, NY TIMES, P3; Smith Red, 1974, NY TIMES, P51; Snedaker Katherine Price, 2019, E COMMUNICATION; Snyder Rachel Louise, 2015, NEW YORKER; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; Strauss I., 1934, ARCH NEUROLOGY PSYCH, V31, P947; Streible D, 2008, FIGHT PICTURES: A HISTORY OF BOXING AND EARLY CINEMA, P1; TJADEN P, 2000, VIOLENCE WOMEN, V0006; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera Eve M, J WOMENS HLTH, V27, P735; Valera Eve M., 2019, 1R01NS11269401 NIH; Valera Eve Marie, 1999, THESIS; Veech ML, 1947, MICH LAW REV, V45, P537, DOI 10.2307/1283494; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Walker L., 1985, VICTIMOLOGY INT J, V10, P281; Webster Mike, 2014, LEAGUE DENIAL NFL CO, P151; Wechsler I. S., 1949, INJURIES BRAIN SPINA, P426; Winterstein CE, 1937, LANCET, V230, P719; Woods AH, 1911, J AMER MED ASSOC, V56, P1876; [No title captured]	121	4	4	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	JAN	2020	245								112688	10.1016/j.socscimed.2019.112688			9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	KH9JS	WOS:000510965500027	31830739	hybrid, Green Published			2022-02-06	
J	Chockalingam, S; Cohen, T				Chockalingam, S.; Cohen, T.			Shear shock shock evolution in incompressible soft solids	JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS			English	Article						Transverse waves; Nonlinear shear waves; Shear shocks; Soft solids; Traumatic brain injury	FINITE-AMPLITUDE; HYPERELASTIC MODELS; WAVES; PROPAGATION; DEFORMATION; ELASTICITY; BEAMS	Nonlinear evolution of shear waves into shocks in incompressible elastic materials is investigated using the framework of large deformation elastodynamics, for a family of loadings and commonly used hyperelastic material models. Closed form expressions for the shock formation distance are derived and used to construct non-dimensional phase maps that determine regimes in which a shock can be realized. These maps reveal the sensitivity of shock evolution to the amplitude, shape, and ramp time of the loading, and to the elastic material parameters. In light of a recent study (Espindola et al., 2017), which hypothesizes that shear shock formation could play a significant role in Traumatic Brain Injury (TBI), application to brain tissue is considered and it is shown that the size matters in TBI research. Namely, for realistic loadings, smaller brains are less susceptible to formation of shear shocks. Furthermore, given the observed sensitivity to the imparted waveform and the constitutive properties, it is suggested that the non-dimensional maps can guide the design of protective structures by determining the combination of loading parameters, material dimensions, and elastic properties that can avoid shock formation. (C) 2019 Elsevier Ltd. All rights reserved.	[Chockalingam, S.] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Cohen, T.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cohen, T.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA		Cohen, T (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Cohen, T (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	talco@mit.edu		Senthilnathan, Chockalingam/0000-0003-2173-4700			Aboudi J., 1973, International Journal of Solids and Structures, V9, P363, DOI 10.1016/0020-7683(73)90086-3; Aboudi J., 1974, International Journal of Solids and Structures, V10, P293, DOI 10.1016/0020-7683(74)90078-X; Bland D.R., 1965, Journal of the Institute of Mathematics and Its Applications, V1, P56; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; CARROLL MM, 1977, Q J MECH APPL MATH, V30, P223, DOI 10.1093/qjmam/30.2.223; CARROLL MM, 1979, J APPL MECH-T ASME, V46, P867, DOI 10.1115/1.3424669; CARROLL MM, 1977, J ELASTICITY, V7, P411, DOI 10.1007/BF00041731; CARROLL MM, 1974, Z ANGEW MATH PHYS, V25, P83, DOI 10.1007/BF01602111; Carroll MM., 1967, ACTA MECH, V3, P167; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; CHU BT, 1964, J MECH PHYS SOLIDS, V12, P45, DOI 10.1016/0022-5096(64)90006-7; CHU BT, 1967, J MECH PHYS SOLIDS, V15, P1, DOI 10.1016/0022-5096(67)90002-6; COLLINS WD, 1966, Q J MECH APPL MATH, V19, P259, DOI 10.1093/qjmam/19.3.259; COLLINS WD, 1967, Q J MECH APPL MATH, V20, P429, DOI 10.1093/qjmam/20.4.429; DAVISON L, 1966, J MECH PHYS SOLIDS, V14, P249, DOI 10.1016/0022-5096(66)90022-6; Destrade M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016620; Destrade M, 2012, INT J NONLIN MECH, V47, P210, DOI 10.1016/j.ijnonlinmec.2011.05.008; Destrade M, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2019.0061; Destrade M, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2016.0811; Espindola D, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.044024; Fung Y., 1993, BIOMECHANICS; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Hamilton M.F., 1998, NONLINEAR ACOUSTICS, V237; Hamilton MF, 2004, J ACOUST SOC AM, V116, P41, DOI 10.1121/1.1736652; Horgan CO, 2015, INT J NONLIN MECH, V68, P9, DOI 10.1016/j.ijnonlinmec.2014.05.010; Horgan CO, 2012, RUBBER CHEM TECHNOL, V85, P108, DOI 10.5254/1.3672433; Horgan CO, 2011, P ROY SOC A-MATH PHY, V467, P760, DOI 10.1098/rspa.2010.0288; LEEBAPTY IP, 1987, PHILOS T R SOC A, V323, P173, DOI 10.1098/rsta.1987.0081; MARCHAND A, 1988, J MECH PHYS SOLIDS, V36, P251, DOI 10.1016/0022-5096(88)90012-9; Mercier S, 1998, J MECH PHYS SOLIDS, V46, P1463, DOI 10.1016/S0022-5096(97)00069-0; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Ogden RW, 2004, COMPUT MECH, V34, P484, DOI 10.1007/s00466-004-0593-y; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pucci E, 2002, RUBBER CHEM TECHNOL, V75, P839, DOI 10.5254/1.3547687; Pucci E, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2018.0891; RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024; Saccomandi G, 2019, INT J NONLIN MECH, V109, P9, DOI 10.1016/j.ijnonlinmec.2018.09.008; Saccomandi G, 2014, J MATH PHYS, V55, DOI 10.1063/1.4891602; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533; ZABOLOTSKAYA EA, 1986, SOV PHYS ACOUST+, V32, P296; Ziv R, 2019, MECH MATER, V135, P67, DOI 10.1016/j.mechmat.2019.05.002	45	4	4	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-5096	1873-4782		J MECH PHYS SOLIDS	J. Mech. Phys. Solids	JAN	2020	134								103746	10.1016/j.jmps.2019.103746			29	Materials Science, Multidisciplinary; Mechanics; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics; Physics	JW2LA	WOS:000502888000010		Green Submitted			2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Neurometabolites and sport-related concussion: From acute injury to one year after medical clearance	NEUROIMAGE-CLINICAL			English	Article						Concussion; Brain injury; Neurometabolite; SVS; DTI; BOLD fMRI	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; QUANTIFICATION PRECISION; TEMPORAL WINDOW; MOTOR NETWORK; WHITE-MATTER; GLIOSIS; CORTEX; VULNERABILITY; SPECTROSCOPY	Sport-related concussion is associated with acute disturbances in neurometabolic function, with effects that may last weeks to months after injury. However, is presently unknown whether these disturbances resolve at medical clearance to return to play (RTP) or continue to evolve over longer time intervals. Moreover, little is known about how these neurometabolic changes correlate with other measures of brain physiology. In this study, these gaps were addressed by evaluating ninety-nine (99) university-level athletes, including 33 with sport-related concussion and 66 without recent injury, using multi-parameter magnetic resonance imaging (MRI), which included single-voxel spectroscopy (SVS), diffusion tensor imaging (DTI) and resting-state functional MRI (fMRI). The concussed athletes were scanned at the acute phase of injury (27/33 imaged), medical clearance to RTP (25/33 imaged), one month post-RTP (25/33 imaged) and one year post-RTP (13/33 imaged). We measured longitudinal changes in N-acetyl aspartate (NAA) and myo-inositol (Ins), over the course of concussion recovery. Concussed athletes showed no significant abnormalities or longitudinal change in NAA values, whereas Ins was significantly elevated at RTP and one month later. Interestingly, Ins response was attenuated by a prior history of concussion. Subsequent analyses identified significant associations between Ins values, DTI measures of white matter microstructure and fMRI measures of functional connectivity. These associations varied over the course of concussion recovery, suggesting that elevated Ins values at RTP and beyond reflect distinct changes in brain physiology, compared to acute injury. These findings provide novel information about neurometabolic recovery after a sport-related concussion, with evidence of disturbances that persist beyond medical clearance to RTP.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), 209 Victoria St, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342 - 401,065, RN294001-367,456]; Canadian Institute for Military and Veterans Health Research (CIMVHR) [W7714-145,967]; Siemens Healthineers Canada	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant numbers RN356342 - 401,065, RN294001-367,456]; the Canadian Institute for Military and Veterans Health Research (CIMVHR) [grant number W7714-145,967]; and Siemens Healthineers Canada.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bartha R, 2000, MAGNET RESON MED, V44, P185; Bluml S, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P197, DOI 10.1007/0-387-32565-4_9; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brooks WM, 1999, MAGNET RESON MED, V41, P193, DOI 10.1002/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.3.CO;2-G; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Churchill N.W., 2019, NEUROLOGY; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Geurts JJG, 2004, J MAGN RESON IMAGING, V20, P366, DOI 10.1002/jmri.20138; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jung YH, 2019, NEUROREPORT, V30, P108, DOI 10.1097/WNR.0000000000001168; Karl A, 2010, NEUROSCI BIOBEHAV R, V34, P7, DOI 10.1016/j.neubiorev.2009.06.008; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; LIEN YHH, 1990, J CLIN INVEST, V85, P1427, DOI 10.1172/JCI114587; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Moriguchi S, 2019, MOL PSYCHIATR, V24, P952, DOI 10.1038/s41380-018-0252-9; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Pantano P, 2002, BRAIN, V125, P1607, DOI 10.1093/brain/awf164; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Saini S, 2004, J NEUROL NEUROSUR PS, V75, P840, DOI 10.1136/jnnp.2003.016782; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Tarlochan F., 2013, INT, V2, P17; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wadden KP, 2015, BEHAV BRAIN RES, V286, P136, DOI 10.1016/j.bbr.2015.02.054; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Witcher KG, 2017, JAMA NEUROL, V74, P23, DOI 10.1001/jamaneurol.2016.4539	49	4	4	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	27								102258	10.1016/j.nicl.2020.102258			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ND4DF	WOS:000561851600020	32388345	gold, Green Published			2022-02-06	
J	Escolas, SM; Luton, M; Ferdosi, H; Chavez, BD; Engel, SD				Escolas, Sandra M.; Luton, Margie; Ferdosi, Hamid; Chavez, Bianca D.; Engel, Scot D.			Traumatic Brain Injuries: Unreported and Untreated in an Army Population	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				HEAD-INJURY; PARKINSON DISEASE; RISK; PREVALENCE	Introduction In 2008, it was reported that 19.5% of service members previously deployed experienced a mild traumatic brain injury (mTBI). Fifty-seven percent of those did not seek medical care. It was suggested that concerns with seeking care involved confidentiality and career issues. Objective: This study addressed mTBI history, medical treatment history, and stigmas associated with mTBI/concussion. Materials and Methods An anonymous questionnaire was developed. Data collection occurred throughout March 2018 in conjunction with Brain Injury Awareness Month activities. Results All 5,174 volunteers were Army; 86% male; 87% were between 18 and 34 years old; 89% had <14 years in the military; 35% had a combat deployment; and 10% reported having one or more mTBIs in their military careers. Of the Soldiers who reported a concussion, 52% sought medical care. Of those not seeking care, 64% reported they did not think the injury required care, followed by 18% fearing negative impact on their career. Twenty-eight percent who experienced an mTBI versus 11% who have not reported that there is a stigma associated with an mTBI. Conclusions Soldiers sometimes failed to report their suspected concussions and did not seek medical care. Educational efforts may increase reporting of and medical screening for potentially concussive events. Future research to determine the ramifications of unreported and untreated mTBIs/concussions is recommended.	[Escolas, Sandra M.; Luton, Margie; Ferdosi, Hamid; Chavez, Bianca D.; Engel, Scot D.] Def & Vet Brain Injury Ctr, 1335 East West Highway,Ste 6-100, Silver Spring, MD 20910 USA; [Escolas, Sandra M.; Luton, Margie; Ferdosi, Hamid; Chavez, Bianca D.] Gen Dynam Informat Technol, 3211 Jermantown Rd, Fairfax, VA 22030 USA; [Escolas, Sandra M.; Luton, Margie; Engel, Scot D.] Ft Hood Intrepid Spirit Ctr, Bldg 36029 58th St, Ft Hood, TX 76544 USA; [Chavez, Bianca D.] Traumat Brain Injury Clin, Bldg 2496,Ricker Rd, Ft Bliss, TX 79916 USA		Escolas, SM (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway,Ste 6-100, Silver Spring, MD 20910 USA.; Escolas, SM (corresponding author), Gen Dynam Informat Technol, 3211 Jermantown Rd, Fairfax, VA 22030 USA.; Escolas, SM (corresponding author), Ft Hood Intrepid Spirit Ctr, Bldg 36029 58th St, Ft Hood, TX 76544 USA.				Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This study was supported internally through the Defense and Veterans Brain Injury Center.	[Anonymous], 2011, 24211 HQDA EXORD; [Anonymous], 2013, 16513 HQDA EXORD; [Anonymous], 2010, 0933 DTM; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Center for Military Health Policy Research, 2008, INV WOUNDS MENT HLTH; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Chuck Y, 2008, MILD TRAUMATIC BRAIN; Defense and Veterans Brain Injury Center, HEADS CONC WALL CARD; Defense and Veterans Brain Injury Center, TBI BAS; Defense and Veterans Brain Injury Center, DOD WORLDW NUM TBI; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gottlieb S, 2000, BRIT MED J, V321, P1100; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kenborg L, 2015, NEUROLOGY, V84, P1098, DOI 10.1212/WNL.0000000000001362; Kenney K, 2018, JAMA NEUROL, V75, P1043, DOI 10.1001/jamaneurol.2018.0347; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Redelmeier DA, 2019, JAMA NEUROL, V76, P140, DOI 10.1001/jamaneurol.2018.3445; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; U.S. Department of Defense, BRAIN INJ AW MONTH 2; United States Department of Defense Instruction (DODI) 6490.11, 2012, 649011 DODI; United States Department of the Army, 2017, ARM TRAIN LEAD DEV T; United States Marine Corps, 2012, 29412 MARADMINS US M; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02	33	4	4	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			154	160		10.1093/milmed/usz259			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600024	32074303	Bronze			2022-02-06	
J	Gagner, C; Degeilh, F; Bernier, A; Beauchamp, MH				Gagner, Charlotte; Degeilh, Fanny; Bernier, Annie; Beauchamp, Miriam H.			Persistent Changes in Child Behavior After Early Mild Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						behaviors; concussions; growth curve modeling; longitudinal research; preschool period; traumatic brain injury	NEUROCOGNITIVE OUTCOMES; HEAD-INJURY; PREDICTORS; SYMPTOMS; TBI	Objective To document longitudinal changes in internalizing and externalizing behavioral symptoms after mild traumatic brain injury (mTBI) sustained in early childhood (i.e., between 18 and 60 months of age). Methods Participants (N = 226) were recruited to one of three groups: children with mTBI, typically developing children and orthopedic injured children. The Child Behavior Checklist was used to document the presence of internalizing and externalizing behaviors at 6, 18, and 30 months postinjury. Linear mixed-model analyses were used to examine group effects on the trajectory of internalizing and externalizing behavioral manifestations over 30 months postinjury. Results Children who sustain mTBI during the preschool period have higher rates of internalizing and externalizing behavioral symptoms at the initial assessment time point and these symptoms persist up to 30 months postinjury. Moreover, results indicate that for up to 18 months postinjury, significantly more children with mTBI present behavioral difficulties that may require some form of clinical attention (i.e., scores in the borderline or clinical range), than do their orthopedically injured and noninjured peers. Conclusions Sustaining mTBI early in life may lead to long-lasting behavioral changes in young children (i.e., at least 30 months). These changes are likely the product of a complex interplay between neurological and non-neurological factors, both contributing to generating and maintaining behavioral difficulties.	[Gagner, Charlotte; Degeilh, Fanny; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Gagner, Charlotte; Degeilh, Fanny; Beauchamp, Miriam H.] St Justine Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Degeilh, Fanny/AAA-7445-2019	Degeilh, Fanny/0000-0002-5802-4975	Canadian Health Research Fund [MOP111036]	This work was supported by the Canadian Health Research Fund (grant number MOP111036).	Abidin R., 1990, PARENTING STRESS IND; Achenbach T. M., 2000, MANUAL ASEBA PRESCHO, V30; Achenbach TM, 2001, ASEBA SCH AGE FORMS; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Duhig AM, 2000, CLIN PSYCHOL-SCI PR, V7, P435, DOI 10.1093/clipsy/7.4.435; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hoffman L, 2015, MULTIVAR APPL SER, P1; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Kaldoja ML, 2015, J CHILD NEUROL, V30, P860, DOI 10.1177/0883073814544705; Keenan H. T., 2018, J NEUROTRAUM, V36, P282; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Mirman D., 2016, GROWTH CURVE ANAL VI; Salomonsson B, 2010, INFANT MENT HEALTH J, V31, P412, DOI 10.1002/imhj.20263; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	40	4	4	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JAN-FEB	2020	45	1					50	60		10.1093/jpepsy/jsz071			11	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	LW0BU	WOS:000538812700006	31584662	Bronze			2022-02-06	
J	Harch, PG; Andrews, SR; Rowe, CJ; Lischka, JR; Townsend, MH; Yu, QZ; Mercante, DE				Harch, Paul G.; Andrews, Susan R.; Rowe, Cara J.; Lischka, Johannes R.; Townsend, Mark H.; Yu, Qingzhao; Mercante, Donald E.			Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial	MEDICAL GAS RESEARCH			English	Article						chronic brain injury; hyperbaric oxygen therapy; neurobehavioral symptom inventory; neuropsychological testing; neurorehabilitation; persistent postconcussion syndrome; post-traumatic stress disorder; randomized controlled trial; symptoms; traumatic brain injury	POST-CONCUSSION SYNDROME; NEUROBEHAVIORAL SYMPTOM INVENTORY; MILITARY SERVICE MEMBERS; GENE-EXPRESSION; UNITED-STATES; PHASE-I; DESIGN; PTSD; RECOMMENDATIONS; METABOLISM	Persistent postconcussion syndrome (PPCS) after mild traumatic brain injury (mTBI) is a significant public health and military problem for which there is limited treatment evidence. The aim of this study was to determine whether forty 150 kPa hyperbaric oxygen therapies (HBOTs) can improve symptoms and cognitive function in subjects with the PPCS of mTBI, using a randomized controlled crossover design with 2-month follow-up. Sixty-three civilian and military subjects with mTBI/PPCS were randomized to either 40 HBOTs at 150 kPa/60 minutes, once daily, 5 days per week in 8 weeks or an equivalent no-treatment control period. The Control Group was then crossed over to HBOT. Subjects underwent symptom, neuropsychological, and psychological testing, before and after treatment or control with retesting 2 months after the 40th HBOT. Fifty subjects completed the protocol with primary outcome testing. HBOT subjects experienced significant improvements in Neurobehavioral Symptom Inventory, Memory Index, Automated Neuropsychological Assessment Metrics, Hamilton Depression Scale, Hamilton Anxiety Scale, Post-Traumatic Stress Disorder Checklist, Pittsburgh Sleep Quality Index, and Quality Of Life after Brain Injury compared to the Control Group. After crossing over to HBOT the Control Group experienced near-identical significant improvements. Further improvements were experienced by both groups during the 2-month follow-up period. These data indicate that 40 HBOTs at 150 kPa/60 minutes demonstrated statistically significant improvements in postconcussion and Post-Traumatic Stress Disorder symptoms, memory, cognitive functions, depression, anxiety, sleep, and quality of life in civilian and military subjects with mTBI/PPCS compared to controls. Improvements persisted at least 2 months after the 40th HBOT. The study was registered on ClinicalTrials.gov (NCT02089594) on March 18, 2014 and with the U.S. Food and Drug Administration under Investigational New Drug #113823. The Institutional Review Boards of the United States Army Medical Research and Materiel Command Office of Research Protections Human Research Protection Office and the Louisiana State University School of Medicine (approval No. 7381) approved the study on May 13, 2014 and December 20, 2013, respectively.	[Harch, Paul G.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Emergency & Hyperbar Med, New Orleans, LA 70803 USA; [Andrews, Susan R.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Med & Psychiat, New Orleans, LA USA; [Rowe, Cara J.] Tulane Univ, Sch Med, CaTS Clin Translat Unit, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Lischka, Johannes R.] Family Phys Ctr, Marrero, LA USA; [Townsend, Mark H.] Louisiana State Univ, Hlth Sci Ctr, Dept Psychiat, Ochsner Psychiat Residency Training Program, New Orleans, LA USA; [Yu, Qingzhao; Mercante, Donald E.] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA		Harch, PG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Emergency & Hyperbar Med, New Orleans, LA 70803 USA.	pharch@lsuhsc.edu			U.S. Army Medical Research and Materiel Command Fort DetrickU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-1-0962]; Joe W. and Dorothy Dorsett Brown Foundation	This study was supported by U.S. Army Medical Research and Materiel Command Fort Detrick, No. W81XWH-10-1-0962, and Joe W. and Dorothy Dorsett Brown Foundation.	Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brismar K, 1997, Wound Repair Regen, V5, P147; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, V45; Chen Y, 2009, NEUROCHEM RES, V34, P1047, DOI 10.1007/s11064-008-9873-8; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Ferdosi H, 2019, AM J EPIDEMIOL, V188, P77, DOI 10.1093/aje/kwy199; Figueroa XA, 2016, NEUROLOGY, V87, P1400, DOI 10.1212/WNL.0000000000003146; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; Golden C, STROOP COLOR WORD TE; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2017, MED GAS RES, V7, P156, DOI 10.4103/2045-9912.215745; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; Harch PG, 2010, WOUND CARE HYPERBARI, V1, P26; Harch PG, 1996, TXB HYPERBARIC MED, P480; Harch PG, 2017, TXB HYPERBARIC MED, V20, P269; Harch PG, 2009, TXB HYPERBARIC MED, P505; Harch PG, 2004, TXB HYPERBARIC MED, P223; Harch PG, 2009, TXB HYPERBARIC MED, P235; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; Harch PG, 2002, P 2 INT S HYP OX CER, P31; HARCH PG, 1999, TXB HYPERBARIC MED, P319; Heaton R. K., 2004, REVISED COMPREHENSIV; Hedlund J. L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOLBACH KH, 1977, J NEUROL, V217, P17, DOI 10.1007/BF00316313; Hu Q, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0033-3; JACKSON M, 2009, TXB HYPERBARIC MED, P449; Jain KK, 2017, TXB HYPERBARIC MED, P609; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall AC, 2013, UNDERSEA HYPERBAR M, V40, P115; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lesak M, 2004, NEUROPSYCHOLOGICAL A, V776, P365; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P520; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; MANSON PN, 1980, SURG FORUM, V31, P564; Marois P, 2015, JAMA INTERN MED, V175, P1239, DOI 10.1001/jamainternmed.2015.1032; MARX RE, 1990, AM J SURG, V160, P519, DOI 10.1016/S0002-9610(05)81019-0; Marx RE, 1988, PROBLEM WOUNDS ROLE, P65; Mathieu D, 2017, DIVING HYPERB MED, V47, P24, DOI 10.28920/dhm47.1.24-32; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mitchell SJ, 2014, DIVING HYPERB MED, V44, P228; Mozayeni BR, 2019, MED GAS RES, V9, P1, DOI 10.4103/2045-9912.254636; Mychaskiw G, 2013, UNDERSEA HYPERBAR M, V40, P371; Mychaskiw G, 2013, J NEUROTRAUM, V30, P1681, DOI 10.1089/neu.2012.2805; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Oh S, 2008, CELL STRESS CHAPERON, V13, P447, DOI 10.1007/s12192-008-0041-5; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scorza K, 2013, HYPERBARIC OXYGEN EF; Shytle RD, 2019, CELL TRANSPLANT, V28, P885, DOI 10.1177/0963689719853232; Siddiqui A, 1997, PLAST RECONSTR SURG, V99, P148, DOI 10.1097/00006534-199701000-00023; Sivan AB., 1992, BENTON VISUAL RETENT; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Ueng SWN, 1998, J TRAUMA, V44, P676, DOI 10.1097/00005373-199804000-00020; UHL E, 1994, PLAST RECONSTR SURG, V93, P835, DOI 10.1097/00006534-199404000-00028; Undersea and Hyperbaric Medical Society Hyperbaric Oxygen Committee, 2014, HYP OX THER IND HYP; Vincent AS, 2018, APPL NEUROPSYCH-ADUL, V25, P366, DOI 10.1080/23279095.2017.1314967; Walker JM, 2018, SLEEP MED, V51, P66, DOI 10.1016/j.sleep.2018.06.006; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; WechslerD, 2001, WECHSLER TEST ADULT; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wortzel HS, 2012, J NEUROTRAUM, V29, P2421, DOI 10.1089/neu.2012.2426; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Zogg CK, 2018, EPIDEMIOLOGY, V29, P885, DOI [10.1097/EDE.0000000000000900, 10.1097/ede.0000000000000900]; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791; [No title captured]	107	4	4	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JAN-MAR	2020	10	1					8	20		10.4103/2045-9912.279978			13	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	LC0QG	WOS:000525034700002	32189664	Green Published			2022-02-06	
J	Jones, KF; Pryor, J; Care-Unger, C; Simpson, GK				Jones, Kate Fiona; Pryor, Julie; Care-Unger, Candice; Simpson, Grahame Kenneth			Rehabilitation health professionals' perceptions of spirituality and spiritual care: The results of an online survey	NEUROREHABILITATION			English	Article						Spirituality; spinal cord injury; traumatic brain injury; rehabilitation; health professionals	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PALLIATIVE CARE; ADJUSTMENT; PREVALENCE; RESILIENCE; RELIGION; BELIEFS	BACKGROUND: Spirituality has been positively associated with key adjustment indicators for individuals affected by traumatic brain injury or spinal cord injury. OBJECTIVE: To explore the perceptions of health professionals working in rehabilitation in relation to spirituality and spiritual care practice. METHODS: An observational study. An adapted version of the Royal College of Nursing Spirituality Survey was emailed to specialty networks of rehabilitation health professionals across Australia. RESULTS: The majority of the 125 participants were female (92.8%), from a nursing (67.2%) background, and selected 'Christian' as their religious affiliation (68.8%). A range of spiritual needs for rehabilitation clients were identified, including a source of hope and strength. Although 84% agreed that spirituality was a fundamental aspect of healthcare, 85% agreed that staff did not receive enough education or training. Thematic analysis identified three key ways participants felt their workplaces could better address spirituality: increasing staff knowledge and skills in providing spiritual care, incorporating spirituality into rehabilitation processes, and providing patients with access to spiritual resources. CONCLUSIONS: Spirituality is considered to play an important role after traumatic injury, but most staff do not feel well equipped to provide spiritual care. Training in spiritual care for rehabilitation professionals is warranted.	[Jones, Kate Fiona; Pryor, Julie; Care-Unger, Candice] Royal Rehab, Sydney, NSW, Australia; [Pryor, Julie] Univ Sydney, Susan Wakil Sch Nursing & Midwifery, Sydney, NSW, Australia; [Simpson, Grahame Kenneth] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Simpson, Grahame Kenneth] Griffith Univ, Sch Human Serv & Social Work, Brisbane, Qld, Australia; [Jones, Kate Fiona] Griffith Univ, Menzies Hlth Inst, Gold Coast, Qld, Australia		Pryor, J (corresponding author), Royal Rehab, POB 6, Ryde 1680, Australia.	Julie.pryor@royalrehab.com.au	Jones, Kate/AAV-7641-2021	Simpson, Grahame/0000-0001-8156-9060; Pryor, Julie/0000-0003-4907-8530; Jones, Kate/0000-0002-5964-3479	Royal Rehab; Australasian Rehabilitation Nurses' Association, and Community of Christ	The authors would like to thank all the health professionals who participated in this study, and Royal Rehab, the Australasian Rehabilitation Nurses' Association, and Community of Christ for their support.	Agyemang A, 2017, ARCH PHYS MED REHAB, V98, pe81, DOI [10.1016/j.apmr.2016.12.016, DOI 10.1016/J.APMR.2016.12.016]; Austin PD, 2016, J STUDY SPIRITUAL, V6, P20, DOI 10.1080/20440243.2016.1158453; Australian Bureau of Statistics, 2017, REL AUSTR 2016 CENS; Best M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5090077; Best M, 2016, SUPPORT CARE CANCER, V24, P3295, DOI 10.1007/s00520-016-3135-0; Best M, 2016, PALLIATIVE MED, V30, P327, DOI 10.1177/0269216315600912; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Canda E.R, 2009, SPIRITUAL DIVERSITY; Chan RCK, 2000, DISABIL REHABIL, V22, P764, DOI 10.1080/09638280050200269; Davis DE, 2015, J COUNS PSYCHOL, V62, P503, DOI 10.1037/cou0000082; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper P, 2012, J NURS MANAGE, V20, P970, DOI 10.1111/jonm.12005; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gallison BS, 2013, J HOLIST NURS, V31, P95, DOI 10.1177/0898010112464121; Hilbers J, 2010, AUST HEALTH REV, V34, P3, DOI 10.1071/AH09655; Hodge DR, 2015, J NURS MANAGE, V23, P27, DOI 10.1111/jonm.12078; Hodge DR, 2013, SOC WORK, V58, P223, DOI 10.1093/sw/swt019; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Jones K, 2016, DISABIL REHABIL, V38, P921, DOI 10.3109/09638288.2015.1066884; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Jones KF, 2019, CLIN REHABIL, V33, P1503, DOI 10.1177/0269215519845034; Jones KF, 2018, REHABIL PSYCHOL, V63, P521, DOI 10.1037/rep0000229; Jones Kate Fiona, 2018, Spinal Cord Ser Cases, V4, P54, DOI 10.1038/s41394-018-0078-3; Kaldor P., 2010, SPIRIT MATTERS MAKIN; Kirshblum S., 2009, SPINAL CORD INJURIES, P1, DOI DOI 10.1016/B978-032300699-6.10001-2; Kociszewski C, 2004, HEART LUNG, V33, P401, DOI 10.1016/j.hrtlng.2004.06.004; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; McSherry W, 2002, J ADV NURS, V38, P479, DOI 10.1046/j.1365-2648.2002.02209.x; McSherry W, 2002, INT J NURS STUD, V39, P723, DOI 10.1016/S0020-7489(02)00014-7; McSherry W., 1997, DESCRIPTIVE SURVEY N; McSherry W., 2010, RCN SPIRITUALITY SUR; Meaningful Ageing Australia, 2016, NAT GUID SPIR CAR AG; Meredith P, 2012, J RELIG HEALTH, V51, P879, DOI 10.1007/s10943-010-9399-7; Millar LA., 2010, J PHYS THERAPY ED, V24; NHS Education for Scotland, 2009, SPIR CAR MATT; Oxhandler HK, 2015, SOC WORK, V60, P228, DOI 10.1093/sw/swv018; Pierce LL, 2008, WESTERN J NURS RES, V30, P606, DOI 10.1177/0193945907310560; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Puchalski C, 2009, J PALLIAT MED, V12, P885, DOI 10.1089/jpm.2009.0142; Ross L, 2014, NURS EDUC TODAY, V34, P697, DOI 10.1016/j.nedt.2013.09.014; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schonherr MC, 2005, SPINAL CORD, V43, P241, DOI 10.1038/sj.sc.3101683; Simpson G. K., NEUROREHABILITATION; Swift Chris, 2007, Br J Nurs, V16, P1279; TAYLOR EJ, 1994, CANCER NURS, V17, P479; Tirgari B, 2013, HOLIST NURS PRACT, V27, P199, DOI 10.1097/HNP.0b013e318294e774	48	4	4	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	1					17	30		10.3233/NRE-192857			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NT8RU	WOS:000573205100003	32039867				2022-02-06	
J	Khan, AD; Elseth, AJ; Brosius, JA; Moskowitz, E; Liebscher, SC; Anstadt, MJ; Dunn, JA; McVicker, JH; Schroeppel, T; Gonzalez, RP				Khan, Abid D.; Elseth, Anna J.; Brosius, Jacqueline A.; Moskowitz, Eliza; Liebscher, Sean C.; Anstadt, Michael J.; Dunn, Julie A.; McVicker, John H.; Schroeppel, Thomas; Gonzalez, Richard P.			Multicenter assessment of the Brain Injury Guidelines and a proposal of guideline modifications	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						brain injuries; traumatic; head injuries; closed; practice guideline	DECOMPRESSIVE CRANIECTOMY; COMPUTED-TOMOGRAPHY; HEAD-INJURY; INTRACRANIAL HEMORRHAGE; MILD; MANAGEMENT; CARE	BackgroundThe Brain Injury Guidelines provide an algorithm fortreating patients with traumatic brain injury (TBI) and intracranial hemorrhage(ICH) that does not mandate hospital admission, repeat head CT, orneurosurgical consult for all patients. The purposes of this study are toreview the guidelines' safety, to assess resource utilization, and to proposeguideline modifications that improve patient safety and widespreadreproducibility.MethodsA multi-institutional review of TBI patients was conducted. Patients with ICH on CT were classified as BIG 1, 2, or 3 based on the guidelines. BIG 3 patients were excluded. Variables collected included demographics, Injury Severity Score (ISS), hospital length of stay (LOS), intensive care unit LOS, number of head CTs, type of injury, progression of injury, and neurosurgical interventions performed.Results269 patients met inclusion criteria. 98 were classifiedas BIG 1 and 171 as BIG 2. The median length of stay (LOS) was 2 (2,4)days and the ICU LOS was 1 (0,2) days. Most patients had a neurosurgeryconsultation (95.9%) and all patients included had a repeat head CT. 370repeat head CT scans were performed, representing 1.38 repeat scans perpatient. 11.2% of BIG 1 and 11.1% of BIG 2 patients demonstratedworsening on repeat head CT. Patients who progressed exhibited a higherISS (14 vs. 10, p=0.040), and had a longer length of stay (4 vs. 2 days;p=0.015). After adjusting for other variables, the presence of epiduralhematoma (EDH) and intraparenchymal hematoma were independent predictors ofprogression. Two BIG 2 patients with EDH had clinical deteriorationrequiring intervention.DiscussionThe Brain Injury Guidelines may improve resourceallocation if utilized, but alterations are required to ensure patientsafety. The modified Brain Injury Guidelines refine the originalguidelines to enhance reproducibility and patient safety while continuing toprovide improved resource utilization in TBI management.	[Khan, Abid D.; Elseth, Anna J.; Moskowitz, Eliza; Schroeppel, Thomas] UCHlth Mem Hosp Cent, Dept Trauma & Acute Care Surg, Colorado Springs, CO 80909 USA; [Brosius, Jacqueline A.; Liebscher, Sean C.; Anstadt, Michael J.; Gonzalez, Richard P.] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Maywood, IL USA; [Dunn, Julie A.] Med Ctr Rockies, Dept Trauma & Acute Care Surg, Loveland, CO USA; [McVicker, John H.] UCHlth Mem Hosp Cent, Dept Neurosurg, Colorado Springs, CO USA		Khan, AD (corresponding author), UCHlth Mem Hosp Cent, Dept Trauma & Acute Care Surg, Colorado Springs, CO 80909 USA.	adkhan@gmail.com		Khan, Abid/0000-0002-1533-4578; Elseth, Anna/0000-0002-2344-7468			Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Centers for Disease Control and Prevention, INJURY PREVENTION CO; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper SW, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000313; DMV.org, DRIV INFL DRIV INT DRIV INFL DRIV INT; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Khan AD, 2017, AM SURGEON, V83, P836; Lewis Paul R, 2017, J Trauma Acute Care Surg, V82, P776, DOI 10.1097/TA.0000000000001388; Roberts DJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000229; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e	28	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2020	5	1							e000483	10.1136/tsaco-2020-000483			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	TI1OW	WOS:000672553900057	32537518	Green Published, gold			2022-02-06	
J	Killien, EY; Huijsmans, RLN; Ticknor, IL; Smith, LS; Vavilala, MS; Rivara, FP; Watson, RS				Killien, Elizabeth Y.; Huijsmans, Roel L. N.; Ticknor, Iesha L.; Smith, Lincoln S.; Vavilala, Monica S.; Rivara, Frederick P.; Watson, R. Scott			Acute Respiratory Distress Syndrome Following Pediatric Trauma: Application of Pediatric Acute Lung Injury Consensus Conference Criteria	CRITICAL CARE MEDICINE			English	Article						acute respiratory distress syndrome; child; hospital mortality; intensive care units; outcome assessment; trauma centers	DEFINITION; OUTCOMES; CHILDREN	Objectives: To assess the incidence, severity, and outcomes of pediatric acute respiratory distress syndrome following trauma using Pediatric Acute Lung Injury Consensus Conference criteria. Design: Retrospective cohort study. Setting: Level 1 pediatric trauma center. Patients: Trauma patients less than or equal to 17 years admitted to the ICU from 2009 to 2017. Interventions: None. Measurements and Main Results: We queried electronic health records to identify patients meeting pediatric acute respiratory distress syndrome oxygenation criteria for greater than or equal to 6 hours and determined whether patients met complete pediatric acute respiratory distress syndrome criteria via chart review. We estimated associations between pediatric acute respiratory distress syndrome and outcome using generalized linear Poisson regression adjusted for age, injury mechanism, Injury Severity Score, and serious brain and chest injuries. Of 2,470 critically injured children, 103 (4.2%) met pediatric acute respiratory distress syndrome criteria. Mortality was 34.0% among pediatric acute respiratory distress syndrome patients versus 1.7% among patients without pediatric acute respiratory distress syndrome (adjusted relative risk, 3.7; 95% CI, 2.0-6.9). Mortality was 50.0% for severe pediatric acute respiratory distress syndrome at onset, 33.3% for moderate, and 30.5% for mild. Cause of death was neurologic in 60.0% and multiple organ failure in 34.3% of pediatric acute respiratory distress syndrome nonsurvivors versus neurologic in 85.4% of nonsurvivors without pediatric acute respiratory distress syndrome (p = 0.001). Among survivors, 77.1% of pediatric acute respiratory distress syndrome patients had functional disability at discharge versus 30.7% of patients without pediatric acute respiratory distress syndrome patients (p < 0.001), and only 17.5% of pediatric acute respiratory distress syndrome patients discharged home without ongoing care versus 86.4% of patients without pediatric acute respiratory distress syndrome (adjusted relative risk, 1.5; 1.1-2.1). Conclusions: Incidence and mortality associated with pediatric acute respiratory distress syndrome following traumatic injury are substantially higher than previously recognized, and pediatric acute respiratory distress syndrome development is associated with high risk of poor outcome even after adjustment for underlying injury type and severity.	[Killien, Elizabeth Y.; Huijsmans, Roel L. N.; Ticknor, Iesha L.; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Killien, Elizabeth Y.; Smith, Lincoln S.; Watson, R. Scott] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Huijsmans, Roel L. N.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Ticknor, Iesha L.] Univ Washington, Seattle, WA 98195 USA; [Smith, Lincoln S.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Watson, R. Scott] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Div Gen Pediat, Seattle, WA 98195 USA		Killien, EY (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.; Killien, EY (corresponding author), Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA.	elizabeth.killien@seattlechildrens.org	/AAD-2116-2020	Huijsmans, Roel/0000-0002-8136-2796	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 T32 HD057822-08]	Supported, in part, by National Institute of Child Health and Human Development grant 5 T32 HD057822-08.	Aitken ME, 1999, ARCH PHYS MED REHAB, V80, P889, DOI 10.1016/S0003-9993(99)90079-5; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; De Luca D, 2013, INTENS CARE MED, V39, P2083, DOI 10.1007/s00134-013-3110-x; de Roulet A, 2019, J PEDIATR SURG, V54, P1405, DOI 10.1016/j.jpedsurg.2018.07.005; Dowell JC, 2018, CRIT CARE MED, V46, P1811, DOI [10.1097/CCM.0000000000003371, 10.1097/ccm.0000000000003371]; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Gupta S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00093; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Keim G, 2018, CRIT CARE MED, V46, P1731, DOI 10.1097/CCM.0000000000003341; Khemani RG, 2019, LANCET RESP MED, V7, P115, DOI 10.1016/S2213-2600(18)30344-8; Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432; Killien EY, 2019, CRIT CARE MED, V47, pE112, DOI 10.1097/CCM.0000000000003525; Killien EY, 2018, CRIT CARE MED, V46, pE1088, DOI 10.1097/CCM.0000000000003379; Kneyber MCJ, 2008, INTENS CARE MED, V34, P751, DOI 10.1007/s00134-008-1029-4; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Parvathaneni K, 2017, PEDIATR CRIT CARE ME, V18, P17, DOI 10.1097/PCC.0000000000000945; Quasney MW, 2015, PEDIATR CRIT CARE ME, V16, pS118, DOI 10.1097/PCC.0000000000000438; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schoell SL, 2018, TRAFFIC INJ PREV, V19, P280, DOI 10.1080/15389588.2017.1409894; Schouten LRA, 2016, CRIT CARE MED, V44, P819, DOI [10.1097/CCM.0000000000001388, 10.1097/CCM.0000000000002008]; Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Villar J, 2018, CRIT CARE MED, V46, P892, DOI 10.1097/CCM.0000000000003022; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Yehya N, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00051; Yehya N, 2015, CRIT CARE MED, V43, P937, DOI 10.1097/CCM.0000000000000867; Zimmerman JJ, 2009, PEDIATRICS, V124, P87, DOI 10.1542/peds.2007-2462	27	4	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2020	48	1					E26	E33		10.1097/CCM.0000000000004075			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JW0SY	WOS:000502770900008	31634233	Green Accepted			2022-02-06	
J	LaRovere, KL; Tasker, RC; Wainwright, M; Reuter-Rice, K; Appavu, B; Miles, D; Lidsky, K; Vittner, P; Gundersen, D; O'Brien, NF; Schober, M; Robertson, C; Kurz, J; Pineda, J; Wainwright, M; Bell, M				LaRovere, Kerri L.; Tasker, Robert C.; Wainwright, Mark; Reuter-Rice, Karin; Appavu, Brian; Miles, Darryl; Lidsky, Karen; Vittner, Patrick; Gundersen, Daniel; O'Brien, Nicole F.; Schober, Michelle; Robertson, Courtney; Kurz, Jonathan; Pineda, Jose; Wainwright, Mark; Bell, Mike		PNCRG	Transcranial Doppler Ultrasound During Critical Illness in Children: Survey of Practices in Pediatric Neurocritical Care Centers*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						critical care; Doppler ultrasonography; transcranial; intensive care units; pediatric; nervous system diseases; pediatrics	EXTRACORPOREAL MEMBRANE-OXYGENATION; BLOOD-FLOW VELOCITY; CEREBRAL AUTOREGULATION; VASOSPASM; INJURY; ILL; SONOGRAPHY; STROKE; STAGE	Objectives: The scope of transcranial Doppler ultrasound in the practice of pediatric neurocritical care is unknown. We have surveyed pediatric neurocritical care centers on their use of transcranial Doppler and analyzed clinical management practices. Design: Electronic-mail recruitment with survey of expert centers using web-based questionnaire. Setting: Survey of 43 hospitals (31 United States, 12 international) belonging to the Pediatric Neurocritical Care Research Group. Patients: None. Interventions: None. Measurements and Main Results: A 67% (29/43) hospital-response rate. Of these centers, 27 reported using transcranial Doppler in the PICU; two hospitals opted out due to lack of transcranial Doppler availability/use. The most common diagnoses for using transcranial Doppler in clinical care were intracranial/subarachnoid hemorrhage (20 hospitals), arterial ischemic stroke (14 hospitals), and traumatic brain injury (10 hospitals). Clinical studies were carried out and interpreted by credentialed individuals in 93% (25/27) and 78% (21/27) of the centers, respectively. A written protocol for performance of transcranial Doppler in the PICU was available in 30% (8/27 hospitals); of these, two of eight hospitals routinely performed correlation studies to validate results. In 74% of the centers (20/27), transcranial Doppler results were used to guide clinical care: that is, when to obtain a neuroimaging study (18 hospitals); how to manipulate cerebral perfusion pressure with fluids/vasopressors (13 hospitals); and whether to perform a surgical intervention (six hospitals). Research studies were also commonly performed for a range of diagnoses. Conclusions: At least 27 pediatric neurocritical care centers use transcranial Doppler during clinical care. In the majority of centers, studies are performed and interpreted by credentialed personnel, and findings are used to guide clinical management. Further studies are needed to standardize these practices.	[LaRovere, Kerri L.; Tasker, Robert C.; Vittner, Patrick] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [LaRovere, Kerri L.; Tasker, Robert C.; Vittner, Patrick; Gundersen, Daniel] Boston Childrens Hosp, Boston, MA 02115 USA; [Tasker, Robert C.] Harvard Med Sch, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [Wainwright, Mark] Univ Washington, Sch Med, Dept Neurol, Div Pediat Neurol, Seattle, WA USA; [Wainwright, Mark] Seattle Childrens Hosp, Seattle, WA USA; [Reuter-Rice, Karin] Duke Univ, Dept Pediat, Sch Nursing, Div Crit Care Med, Durham, NC 27706 USA; [Appavu, Brian] Univ Arizona, Coll Med, Dept Neurosci, Phoenix, AZ USA; [Appavu, Brian] Phoenix Childrens Hosp, Phoenix, AZ USA; [Miles, Darryl] UT Southwestern Med Ctr, Dept Pediat, Div Crit Care Med, Dallas, TX USA; [Lidsky, Karen] Univ Florida, Dept Pediat Crit Care, Div Crit Care Med, Jacksonville, FL USA; [Lidsky, Karen] Wolfson Childrens Hosp, Jacksonville, FL USA; [Gundersen, Daniel] Harvard Med Sch, Ctr Populat Sci Survey & Data Management Core, Boston, MA 02115 USA; [O'Brien, Nicole F.] Ohio State Univ, Dept Pediat, Div Crit Care Med, Columbus, OH 43210 USA; [O'Brien, Nicole F.] Nationwide Childrens Hosp, Columbus, OH USA		LaRovere, KL (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; LaRovere, KL (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	kerri.larovere@childrens.harvard.edu	Gundersen, Daniel A/G-9332-2018; Appavu, Brian L/AAE-7180-2021	Gundersen, Daniel A/0000-0003-2543-9231; Reuter-Rice, Karin/0000-0003-1501-8994	American Heart AssociationAmerican Heart Association; Moberg ICU Solutions	Dr. Appavu's institution received funding from American Heart Association and Moberg ICU Solutions. The remaining authors have disclosed that they do not have any potential conflicts of interest.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abecasis F, 2018, CHILD NERV SYST, V34, P1465, DOI 10.1007/s00381-018-3877-8; Bell MJ, 2012, NEUROCRIT CARE, V17, P468, DOI 10.1007/s12028-012-9731-z; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Bonow RH, 2017, CRIT CARE MED, V45, pE1011, DOI 10.1097/CCM.0000000000002549; Cheatham SL, 2018, PEDIATR CARDIOL, V39, P837, DOI 10.1007/s00246-018-1836-5; Chen KS, 2003, J ULTRAS MED, V22, P1061, DOI 10.7863/jum.2003.22.10.1061; Cook MR, 2018, J TRAUMA ACUTE CARE, V84, P50, DOI 10.1097/TA.0000000000001631; Ducharme-Crevier L, 2016, PEDIATR NEUROL, V65, P52, DOI 10.1016/j.pediatrneurol.2016.08.027; Figaji AA, 2010, CHILD NERV SYST, V26, P431, DOI 10.1007/s00381-009-1036-y; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heffren J, 2015, PEDIATR NEUROL, V52, P356, DOI 10.1016/j.pediatrneurol.2014.11.003; LaRovere KL, 2018, PEDIATR CRIT CARE ME, V19, P1039, DOI 10.1097/PCC.0000000000001708; LaRovere KL, 2016, J NEUROTRAUM, V33, P2105, DOI 10.1089/neu.2015.4344; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; LaRovere KL, 2015, CURR OPIN PEDIATR, V27, P712, DOI 10.1097/MOP.0000000000000282; Lau VI, 2017, CRIT ULTRASOUND J, V9, DOI 10.1186/s13089-017-0077-9; Leliefeld PH, 2009, ULTRASOUND MED BIOL, V35, P1601, DOI 10.1016/j.ultrasmedbio.2009.04.024; Lin JJ, 2015, RESUSCITATION, V89, P182, DOI 10.1016/j.resuscitation.2015.01.029; Lovett ME, 2018, RESUSCITATION, V126, P191, DOI 10.1016/j.resuscitation.2018.02.005; Ma L, 2014, PEDIATR CRIT CARE ME, V15, P742, DOI 10.1097/PCC.0000000000000197; O'Brien NF, 2019, PEDIATR CRIT CARE ME, V20, P178, DOI 10.1097/PCC.0000000000001778; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2013, PEDIATR CRIT CARE ME, V14, pE126, DOI 10.1097/PCC.0b013e3182712d62; O'Brien NF, 2018, J PEDIATR-US, V203, P116, DOI 10.1016/j.jpeds.2018.07.075; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Peeples ES, 2016, PEDIATR RES, V79, P333, DOI 10.1038/pr.2015.227; Reuter-Rice K, 2018, BIOL RES NURS, V20, P566, DOI 10.1177/1099800418785982; Reuter-Rice Karin, 2017, J Radiol Nurs, V36, P3, DOI 10.1016/j.jradnu.2016.11.003; Rilinger JF, 2017, J STROKE CEREBROVASC, V26, P2336, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.022; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2149, DOI 10.1007/s00701-018-3687-5; Zieleskiewicz L, 2015, INTENS CARE MED, V41, P1638, DOI 10.1007/s00134-015-3952-5; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002	37	4	4	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2020	21	1					67	74		10.1097/PCC.0000000000002118			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	KF8YN	WOS:000509523000017	31568242				2022-02-06	
J	Lokhandwala, A; Hanna, K; Gries, L; Zeeshan, M; Ditillo, M; Tang, A; Hamidi, M; Joseph, B				Lokhandwala, Adil; Hanna, Kamil; Gries, Lynn; Zeeshan, Muhammad; Ditillo, Michael; Tang, Andrew; Hamidi, Mohammad; Joseph, Bellal			Preinjury Statins Are Associated With Improved Survival in Patients With Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Owen Wangensteen Scientific Forum / 104th Annual Clinical Congress of the American-College-of-Surgeons (ACS)	OCT 21-25, 2018	Boston, MA	Amer Coll Surg		Traumatic brain injury; Statins; Neuroinflammation	REDUCTASE INHIBITORS; SIMVASTATIN; ATORVASTATIN; PATHOPHYSIOLOGY	Background: Statins have been shown to improve outcomes in traumatic brain injury (TBI) in animal models. The aim of our study was to determine the effect of preinjury statins on outcomes in TBI patients. Methods: We performed a 4-y (2014-2017) review of our TBI database and included all patients aged >18 y with severe isolated TBI. Patients were stratified into those who were on statins and those who were not and were matched (1:2 ratio) using propensity score matching. The primary outcome was in-hospital mortality. The secondary outcomes were skilled nursing facility disposition, Glasgow Outcome Scale-extended score, and hospital and intensive care unit length of stay (LOS). Results: We identified 1359 patients, of which 270 were matched (statin: 90, no-statin: 180). Mean age was 55 +/- 8y, median Glasgow Coma Scale was 10 (8-12), and median head-abbreviated injury scale was 3 (3-5). Matched groups were similar in age, mechanism of injury, Glasgow Coma Scale, Injury Severity Score, neurosurgical intervention, type and size of intracranial hemorrhage, and preinjury anticoagulant or antiplatelet use. The overall in-hospital mortality rate was 18%. Patients who received statins had lower rates of in-hospital mortality (11% versus 21%, P = 0.01), skilled nursing facility disposition (19% versus 28%; P = 0.04), and a higher median Glasgow Outcome Scale-extended (11 [9-13] versus 9 [8-10]; P = 0.04). No differences were found between the two groups in terms of hospital LOS (6 [4-9] versus 5 [3-8]; P = 0.34) and intensive care unit LOS (3 [3-6] versus 4 [3-5]; P = 0.09). Conclusions: Preinjury statin use in isolated traumatic brain injury patients is associated with improved outcomes. This finding warrants further investigations to evaluate the potential beneficial role of statins as a therapeutic drug in a TBI. (C) 2019 Elsevier Inc. All rights reserved.	[Lokhandwala, Adil; Hanna, Kamil; Gries, Lynn; Zeeshan, Muhammad; Ditillo, Michael; Tang, Andrew; Hamidi, Mohammad; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411 POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Ditillo, Michael/AAI-6259-2020				Blake Gavin J, 2000, Curr Control Trials Cardiovasc Med, V1, P161, DOI 10.1186/CVM-1-3-161; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jasinska M, 2007, PHARMACOL REP, V59, P483; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Naghibi T, 2016, TURK J MED SCI, V46, P1, DOI 10.3906/sag-1404-125; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Robertson CS, 2017, J NEUROTRAUM, V34, P1394, DOI 10.1089/neu.2016.4717; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whyte J, 2019, J NEUROTRAUM, V36, P118, DOI 10.1089/neu.2017.5545; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Zacco A, 2003, J NEUROSCI, V23, P11104	21	4	4	2	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2020	245						367	372		10.1016/j.jss.2019.07.081			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	JT4CK	WOS:000500939000048	31425877				2022-02-06	
J	McGeary, C; Nabity, P; Reed, D; Cobos, B; Eapen, B; Pugh, MJ; Jaramillo, C; Potter, J; Houle, T; Young-McCaughan, S; Peterson, A; McGeary, D				McGeary, Cindy; Nabity, Paul; Reed, David; Cobos, Briana; Eapen, Blessen; Pugh, Mary Jo; Jaramillo, Carlos; Potter, Jennifer; Houle, Timothy; Young-McCaughan, Stacey; Peterson, Alan; McGeary, Don			A test of the fear avoidance model to predict chronic pain outcomes in a polytrauma sample	NEUROREHABILITATION			English	Article						Polytrauma; chronic pain; fear avoidance; prediction	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ALLOSTATIC LOAD; SYMPTOMS; VETERANS	BACKGROUND: Chronic musculoskeletal pain is a complex problem, particularly for individuals with head injury and comorbid psychiatric conditions. The Fear Avoidance Model offers one of the strongest opportunities to conceptualize comorbid traumatic injury and pain, but this model is largely untested. OBJECTIVE: This study tests the Fear Avoidance Model of chronic pain using a sample from a study of polytrauma patients in a large Department of Veterans Affairs facility who participated in a federally-funded study of interdisciplinary chronic pain management. METHODS: The present study comprises a secondary analysis of 93 veterans with chronic pain, head injury, posttraumatic stress symptoms and a history of persistent opioid use. Standardized measures of Fear Avoidance Model risk factors (e.g., pain catastrophizing, fear avoidance beliefs, anxiety, depression) were examined as cross-sectional predictors of pain-related disability. RESULTS: Secondary data analysis revealed that Fear Avoidance Model factors accounted for almost 40% of the variance in pain-related disability, with pain catastrophizing and depression demonstrating the strongest relationships with disability. A summary variable combining all four factors revealed a 6% increase in disability for each factor that was clinically significant for the sample patients. CONCLUSIONS: This study represents the first attempt to examine a complex, theoretical model of pain in a comorbid pain and TBI sample. Findings revealed a strong relationship between this model and pain-related disability that outperforms pain intensity ratings. This model could be used to guide better treatment for comorbid pain and TBI.	[McGeary, Cindy; Nabity, Paul; Reed, David; Cobos, Briana; Potter, Jennifer; Young-McCaughan, Stacey; Peterson, Alan; McGeary, Don] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Eapen, Blessen] Univ Calif Los Angeles, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Pugh, Mary Jo] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Jaramillo, Carlos; McGeary, Don] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Houle, Timothy] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA		McGeary, D (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	mcgeary@uthscsa.edu	Houle, Timothy T/I-7649-2019	Reed, II, David/0000-0003-0109-5999	National Center for Complementary and Integrative Health (NCCIH) [R01 AT008422-01]	Some of thework for this studywas funded through the National Center for Complementary and Integrative Health (NCCIH) award R01 AT008422-01.	Beckie TM, 2016, WOMEN HEALTH ISS, V26, P555, DOI 10.1016/j.whi.2016.05.008; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Borsook D, 2018, PAIN, V159, P2421, DOI 10.1097/j.pain.0000000000001401; Carlozzi NE, 2020, ARCH PHYS MED REHAB, V101, P11, DOI 10.1016/j.apmr.2019.07.019; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Dindo L, 2020, CONTEMP CLIN TRIALS, V90, DOI 10.1016/j.cct.2020.105954; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Gedin F, 2019, J BODYW MOV THER, V23, P241, DOI 10.1016/j.jbmt.2018.02.012; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Guerrero AVS, 2018, CLIN J PAIN, V34, P838, DOI 10.1097/AJP.0000000000000601; Hoffman JM, 2019, CONTEMP CLIN TRIALS, V76, P112, DOI 10.1016/j.cct.2018.12.004; IOM, 2009, GULF WAR HLTH, V7; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Li Y, 2018, MIDWIFERY, V62, P205, DOI 10.1016/j.midw.2018.04.002; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Saggar M, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0384-19.2019; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Song K., 2020, J PAIN; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thompson D. P., 2019, PHYSIOTHERAPY; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wang HL, 2016, NURS EDUC TODAY, V47, P2, DOI 10.1016/j.nedt.2016.06.017; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551	32	4	4	1	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	1					35	43		10.3233/NRE-203084			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NE7EM	WOS:000562764300004	32675428				2022-02-06	
J	Menatti, ARR; Melinder, MRD; Warren, SL				Menatti, Andrew R. R.; Melinder, Meredith R. D.; Warren, Stacie L.			Limited Prediction of Performance Validity Using Embedded Validity Scales of the Neurobehavioral Symptom Inventory in an mTBI Veteran Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; concussion; head injury; malingering; mental health; performance validity; rehabilitation neuropsychology; symptom validity; TBI	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGY; VALIDATION	Objective: To test embedded symptom validity scales of the Neurobehavioral Symptom Inventory (NSI) as predictors of performance validity. Setting: A Veterans Affairs Level II TBI/Polytrauma outpatient care unit in the Midwestern United States. Participants: Veterans with a history of mild traumatic brain injury undergoing neuropsychological assessment as part of their routine care within the TBI/Polytrauma clinic. Design: Retrospective analysis of the existing clinical data. Main Measures: The NSI, the b Test, Test of Memory Malingering, Reliable Digit Span, California Verbal Learning Test-II Forced Choice. Results: Embedded NSI validity scales were positively correlated with number of performance validity test failures. Participants identified as invalid responders scored higher on embedded NSI validity scales than participants identified as valid responders. Using receiver operating characteristic analysis, the embedded NSI validity scales showed poor sensitivity and specificity for invalid responding using previously published cutoff scores. Only 1 scale differentiated valid from invalid responders better than chance. Conclusion: The embedded NSI validity scales' usefulness in predicting invalid neuropsychological performance validity was limited in this sample. Continued measurement of both symptom and performance validity in clinical settings involving traumatic brain injury treatment is recommended, as the present results support the existing research suggesting symptom validity tests and performance validity tests tap into related but ultimately distinct constructs.	[Menatti, Andrew R. R.; Melinder, Meredith R. D.; Warren, Stacie L.] VA St Louis Healthcare Syst, TBI Polytrauma Clin, 1 Jefferson Barracks Dr,116A-JB, St Louis, MO 63125 USA; [Warren, Stacie L.] Palo Alto Univ, Dept Psychol, Palo Alto, CA USA		Melinder, MRD (corresponding author), VA St Louis Healthcare Syst, TBI Polytrauma Clin, 1 Jefferson Barracks Dr,116A-JB, St Louis, MO 63125 USA.	Meredith.Melinder@va.gov		Warren, Stacie/0000-0002-6096-5950			Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCrea M., 2014, CLIN NEUROPSYCHOLOGY, P208; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth; Yeates KO, 2017, J INT NEUROPSYCH SOC, V23, P806, DOI 10.1017/S1355617717000686; [No title captured]	26	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		E36	E42		10.1097/HTR.0000000000000467			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300007	30829816				2022-02-06	
J	Meng, SY; Cernicchi, A; Kleiven, S; Halldin, P				Meng, Shiyang; Cernicchi, Alessandro; Kleiven, Svein; Halldin, Peter			High-speed helmeted head impacts in motorcycling: A computational study	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Finite element method; High-speed impact; Traumatic brain injury; Motorcycle; Helmet; Sliding and rolling; Tissue strain	CERVICAL-SPINE; INJURY; RESPONSES	The motorcyclist is exposed to the risk of falling and impacting ground head-first at a wide range of travelling speeds - from a speed limit of less than 50 km/h on the urban road to the race circuit where speed can reach well above 200 km/h. However, motorcycle helmets today are tested at a single and much lower impact speed, i.e. 30 km/h. There is a knowledge gap in understanding the dynamics and head impact responses at high travelling speeds due to the limitation of existing laboratory rigs. This study used a finite element head model coupled with a motorcycle helmet model to simulate head-first falls at travelling speed (or tangential velocity at impact) from 0 to 216 km/h. The effect of different falling heights (1.6 m and 0.25 m) and coefficient of frictions (0.20 and 0.45) between the helmet outer shell and ground were also examined. The simulation results were analysed together with the analytical model to better comprehend rolling and/or sliding phenomena that are often observed in helmet oblique impacts. Three types of helmet-to-ground interactions are found when the helmet impacts ground from low to high tangential velocities: (1) helmet rolling without slipping; (2) a combination of sliding and rolling; and (3) continuous sliding. The tangential impulse transmitted to the head-helmet system, peak angular head kinematics and brain strain increase almost linearly with the tangential velocity when the helmet rolls but plateaus when the helmet slides. The critical tangential velocity at which the motion transit from the rolling regime to the sliding regime depends on both the falling height and friction coefficient. Typically, for a fall height of 1.63 m and a friction coefficient of 0.45, the rolling/sliding transition occurs at a tangential velocity of 10.8 m/s (38.9 km/h). Low sliding resistance in helmet design, i.e. by the means of a lower friction coefficient between the helmet outer shell and ground, has shown a higher reduction of brain tissue strain in the sliding regime than in the rolling regime. This study uncovers the underlying dynamics of rolling and sliding phenomena in high-speed oblique impacts, which largely affect head impact biomechanics. Besides, the study highlights the importance of testing helmets at speeds covering both the rolling and sliding regime since potential designs for improved head protection at high-speed impacts can be more distinguishable in the sliding regime than in the rolling regime.	[Meng, Shiyang; Kleiven, Svein; Halldin, Peter] KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, S-14152 Huddinge, Sweden; [Meng, Shiyang; Halldin, Peter] MIPS AB, Kalltorpsvagen 2, S-18371 Taby, Sweden; [Cernicchi, Alessandro] Dainese SpA, Via Louvigny 35, I-36060 Colceresa, VI, Italy		Meng, SY (corresponding author), KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, S-14152 Huddinge, Sweden.	shiyangm@kth.se			European Union Horizon 2020 Research and Innovation Programme under the Marie Skodowska-Curie Grant [642662]	This work was partially supported by the European Union Horizon 2020 Research and Innovation Programme under the Marie Skodowska-Curie Grant Agreement No.642662.	Aare Magnus, 2003, Inj Control Saf Promot, V10, P131, DOI 10.1076/icsp.10.3.131.14556; Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Aldman B., 1978, IRCOBI INT RES COMM, P129; Aldman B., 1978, P IRCOBI, P118; Bedolla J, 2016, AM J EMERG MED, V34, P1872, DOI 10.1016/j.ajem.2016.07.005; Bonugli E., 2017, REPLICATING REAL WOR; Bourdet N., 2016, P INT IRCOBI C BIOM, P503; Chinn B., 2001, DIRECTORATE GEN ENER; Cossalter V., 2007, 20 INT TECHN C ENH S; Cross R, 2002, AM J PHYS, V70, P1093, DOI 10.1119/1.1507792; D'Artibale E, 2018, J SPORT SCI, V36, P1061, DOI 10.1080/02640414.2017.1355064; Dunford A., 2013, FRICTION TEXTURE AGG; Ebrahimi I, 2015, TRAFFIC INJ PREV, V16, P404, DOI 10.1080/15389588.2014.937804; Evans TA, 2018, JAMA SURG, V153, P183, DOI 10.1001/jamasurg.2017.3163; Fahlstedt M., 2016, P 2016 IRCOBI C INT, P459; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Feist F., 2016, INT RES COUNC BIOM I, P14; Feist F, 2016, INT RES COUNC BIOM I; FIM, 2017, FIM RAC HOM PROGR HE; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Fredriksson R., 2015, P C IRCOBI; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Gibson T., 2007, HELMET PROTECTION BA; GLAISTER DH, 1986, INJURY, V17, P376, DOI 10.1016/0020-1383(86)90074-4; Halldin, 2018, EFFECT IMPACT VELOCI; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Henry JJ, 2000, EVALUATION PAVEMENT; Holbourn AHS, 1943, LANCET, V2, P438; Horner C H, 1986, Br J Sports Med, V20, P157; Hurt H. H., 1981, MOTORCYCLE ACCIDENT; Kerrigan JR, 2014, TRAFFIC INJ PREV, V15, pS265; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leu M. C., 1978, TRANSPORT RES REC, P7; Lloyd J.D., 2016, J FORENSIC BIOMECH, V7, P125, DOI [10.4172/2090-2697.1000125, DOI 10.4172/2090-2697.1000125]; MAIDS A., 2004, 12 ACEM; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Meng S., 2018, INT J CRASHWORTHINES, P1; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Nightingale R.W., 1991, SAE T, P2040; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; Nightingale RW, 1997, SAE T, V106, P3968; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Otte D., 1991, SAE TECHNICAL PAPER; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Piantini S., 2016, IRCOBI C; Roseveare A., 2016, IRCOBI C P; Shushan B., 2013, INTRO TRIBOLOGY; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; World Health Organization, 2015, GLOB STAT REP ROAD S; YOGANANDAN N, 1989, Journal of Biomechanical Engineering, V111, P250; Zasa M, 2016, SPORTS ORTHOP TRAUMA, V32, P289; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293	59	4	4	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2020	134								105297	10.1016/j.aap.2019.105297			11	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	JU4MO	WOS:000501651900007	31683233				2022-02-06	
J	Mousavinejad, M; Mozafari, J; Ilkhchi, RB; Hanafi, MG; Ebrahimi, P				Mousavinejad, Maryam; Mozafari, Javad; Ilkhchi, Reza Bahrami; Hanafi, Mohammad Ghasem; Ebrahimi, Pouya			Intravenous Tranexamic Acid for Brain Contusion with Intraparenchymal Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial	REVIEWS ON RECENT CLINICAL TRIALS			English	Article						Cerebral hemorrhage; emergency medicine; intraparenchymal hemorrhage; tranexamic acid; trauma; linical trial study	INJURY; EPIDEMIOLOGY	Introduction: Controlling of secondary traumatic brain injuries (TBI) is necessary due to its salient effect on the improvement of patients with TBI and the final outcomes within early hours of trauma onset. This study aims to investigate the effect of intravenous tranexamic acid (TAX) administration on decreased hemorrhage during surgery. Methods: This double-blind, randomized, and placebo-controlled trial was conducted on patients referring to the emergency department (ED) with IPH due to brain contusion within 8 h of injury onset. The patients were evaluated by receiving TXA and 0.9% normal saline as a placebo. The following evaluation and estimations were performed: intracranial hemorrhage volume after surgery using brain CT-scan; hemoglobin (Hb) volume before, immediately after, and six hours after surgery; and the severity of TBI based on Glasgow Coma Score (GCS). Results: 40 patients with 55.02 +/- 18.64 years old diagnosed with a contusion and intraparenchymal hemorrhage. Although the (Mean +/- SD) hemorrhage during surgery in patients receiving TXA (784.21 +/- 304.162) was lower than the placebo group (805.26 +/- 300.876), no significant difference was observed between two groups (P =0.83). The (Mean +/- SD) Hb volume reduction immediately during surgery (0.07 +/- 0.001 and 0.23 +/- 0.02) and six hours after surgery (0.04 +/- 0.008 and 0.12 +/- 0.006) was also lower in TXA group but had no significant difference (P = 0.89 and P = 0.97, respectively). Conclusion: Using TXA may reduce the hemorrhage in patients with TBI, but this effect, as in this study, was not statistically significant and it is suggested that a clinical trial with a larger population is employed for further investigation.	[Mousavinejad, Maryam; Ebrahimi, Pouya] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran; [Mozafari, Javad] Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran; [Ilkhchi, Reza Bahrami] Ahvaz Jundishapur Univ Med Sci, Dept Neurosurg, Ahvaz, Iran; [Hanafi, Mohammad Ghasem] Ahvaz Jundishapur Univ Med Sci, Dept Radiol, Ahvaz, Iran		Mozafari, J (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran.	mozafari.taha@yahoo.com	Mozafari, Javad/N-4394-2017	Mozafari, Javad/0000-0002-8903-7138; bahrami ilkhchi, reza/0000-0003-0736-0853; Hanafi, Mohamad ghasem/0000-0003-1533-5244	Ahvaz Jundishapur University of Medical Sciences, Iran [GP94164]	Ahvaz Jundishapur University of Medical Sciences, Iran funded this study (Grant. No GP94164).	Abosadegh MM, 2017, DENT TRAUMATOL, V33, P369, DOI 10.1111/edt.12349; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; BELL WN, 1954, NATURE, V174, P880, DOI 10.1038/174880a0; Benaissa A, 2016, AM J NEURORADIOL, V37, P475, DOI 10.3174/ajnr.A4561; Beno S, 2014, CRIT CARE, V18, DOI 10.1186/cc13965; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; D'Agostino E, 2018, WORLD NEUROSURG, V120, pE274, DOI 10.1016/j.wneu.2018.08.050; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; HAAR FL, 1975, AM J DIS CHILD, V129, P1197, DOI 10.1001/archpedi.1975.02120470047013; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harvey V, 2014, ANN EMERG MED, V63, P460, DOI 10.1016/j.annemergmed.2013.08.028; Hunt BJ, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12910; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Majima Nozomi, 2013, Masui, V62, P410; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Medcalf RL, 2017, J THROMB HAEMOST, V15, P2089, DOI 10.1111/jth.13849; Miller JB, 2014, CLIN NEUROPSYCHOL, V28, P575, DOI 10.1080/13854046.2014.907445; Peden M., 2004, WORLD REPORT ROAD TR; Perper M, 2017, AM J CLIN DERMATOL, V18, P373, DOI 10.1007/s40257-017-0263-3; Reilly P, 2005, HEAD INJURY; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vogel M S, 1992, J Am Optom Assoc, V63, P537; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	30	4	4	1	4	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-8871	1876-1038		REV RECENT CLIN TRIA	Rev. Recent Clin. Trials		2020	15	1					70	75		10.2174/1574887114666191118111826			6	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	KN4MA	WOS:000514811600009	31744452				2022-02-06	
J	Payen, JF; Richard, M; Francony, G; Audibert, G; Barbier, EL; Bruder, N; Dahyot-Fizelier, C; Geeraerts, T; Gergele, L; Puybasset, L; Vigue, B; Skaare, K; Bosson, JL; Bouzat, P				Payen, Jean-Francois; Richard, Marion; Francony, Gilles; Audibert, Gerard; Barbier, Emmanuel L.; Bruder, Nicolas; Dahyot-Fizelier, Claire; Geeraerts, Thomas; Gergele, Laurent; Puybasset, Louis; Vigue, Bernard; Skaare, Kristina; Bosson, Jean Luc; Bouzat, Pierre			Comparison of strategies for monitoring and treating patients at the early phase of severe traumatic brain injury: the multicentre randomised controlled OXY-TC trial study protocol	BMJ OPEN			English	Article						adult intensive & critical care; trauma management; Neurosurgery	INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; PRESSURE; MANAGEMENT; TENSION; HYPOXIA; ADULT; TBI	Introduction Intracranial hypertension is considered as an independent risk factor of mortality and neurological disabilities after severe traumatic brain injury (TBI). However, clinical studies have demonstrated that episodes of brain ischaemia/hypoxia are common despite normalisation of intracranial pressure (ICP). This study assesses the impact on neurological outcome of guiding therapeutic strategies based on the monitoring of both brain tissue oxygenation pressure (PbtO(2)) and ICP during the first 5 days following severe TBI. Methods and analysis Multicentre, open-labelled, randomised controlled superiority trial with two parallel groups in 300 patients with severe TBI. Intracerebral monitoring must be in place within the first 16 hours post-trauma. Patients are randomly assigned to the ICP group or to the ICP + PbtO(2)group. The ICP group is managed according to the international guidelines to maintain ICP <= 20 mm Hg. The ICP + PbtO(2)group is managed to maintain PbtO(2)>= 20 mm Hg in addition to the conventional optimisation of ICP. The primary outcome measure is the neurological status at 6 months as assessed using the extended Glasgow Outcome Scale. Secondary outcome measures include quality-of-life assessment, mortality rate, therapeutic intensity and incidence of critical events during the first 5 days. Analysis will be performed according to the intention-to-treat principle and full statistical analysis plan developed prior to database freeze. Ethics and dissemination This study has been approved by the Institutional Review Board of Sud-Est V (14-CHUG-48) and from the National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament et des produits de sante) (141 435B-31). Results will be presented at scientific meetings and published in peer-reviewed publications. The study was registered with ClinTrials NCT02754063 on 28 April 2016 (pre-results).	[Payen, Jean-Francois; Richard, Marion; Francony, Gilles; Barbier, Emmanuel L.] Univ Grenoble Alpes, Ctr Hosp Univ Grenoble Alpes, Grenoble Inst Neurosci, Dept Anaesthesia & Intens Care,INSERM,U121, Grenoble, France; [Audibert, Gerard] Lorraine Univ, Nancy Univ Hosp, Dept Anaesthesia & Intens Care, Nancy, France; [Bruder, Nicolas] Aix Marseille Univ, AP HM, Dept Anaesthesiol & Intens Care, Marseille, France; [Dahyot-Fizelier, Claire] Univ Poitiers Hosp, Dept Anaesthesia & Intens Care, Poitiers, France; [Dahyot-Fizelier, Claire] Poitiers Hosp, Pharmacol Antimicrobial Agents, INSERM, U1070, Poitiers, France; [Geeraerts, Thomas] Toulouse Univ Hosp, Dept Anaesthesia & Intens Care, Toulouse, France; [Geeraerts, Thomas] Toulouse 3 Paul Sabatier Univ, Toulouse, France; [Gergele, Laurent] Hop Prive Loire, Dept Intens Care, Ramsay Sante, St Etienne, France; [Puybasset, Louis] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Anaesthesia & Crit Care,GRC 29,DMU DREAM, Paris, France; [Vigue, Bernard] Ctr Hosp Univ Bicetre, AP HP, Dept Anaesthesia & Intens Care, Le Kremlin Bicetre, France; [Skaare, Kristina] Univ Grenoble Alpes, Dept Publ Hlth, CHU Grenoble Alpes, Grenoble, France; [Bosson, Jean Luc] Ctr Hosp Univ Grenoble Alpes, TIMC IMAG, Grenoble, France; [Bouzat, Pierre] Ctr Hosp Univ Grenoble, Grenoble, France		Payen, JF (corresponding author), Univ Grenoble Alpes, Ctr Hosp Univ Grenoble Alpes, Grenoble Inst Neurosci, Dept Anaesthesia & Intens Care,INSERM,U121, Grenoble, France.	jfpayen@univ-grenoble-alpes.fr	Barbier, Emmanuel/E-6302-2011	Barbier, Emmanuel/0000-0002-4952-1240; payen, jean-francois/0000-0001-8400-3839; GERGELE, Laurent/0000-0002-7283-6793	French National Program for Clinical Research [RCB 2014-A01674-43]; Integra Lifesciences [38RC14.039]	This study is supported by a grant from the French National Program for Clinical Research (RCB 2014-A01674-43) and by an unrestricted grant from Integra Lifesciences (38RC14.039).	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Green JA, 2013, NEUROCRIT CARE, V18, P20, DOI 10.1007/s12028-012-9797-7; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	31	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	8							e040550	10.1136/bmjopen-2020-040550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NH0DY	WOS:000564351500062	32820002	gold, Green Published			2022-02-06	
J	Rakhra, S; Martin, EL; Fitzgerald, M; Udy, A				Rakhra, Sandeep; Martin, Emma-Leah; Fitzgerald, Mark; Udy, Andrew			The ATLANTIC study: Anti-Xa level assessment in trauma intensive care	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Intensive care; Venous thromboembolism prophylaxis; Haematology; Low-molecular weight heparin; Anti-Xa	AUGMENTED RENAL CLEARANCE; VENOUS THROMBOEMBOLISM; 1602 EPISODES; ENOXAPARIN; ASSOCIATION; RISK	Objective: To quantify the pharmacodynamic (PD) activity of daily subcutaneous (SC) enoxaparin as venous thromboembolism (VTE) prophylaxis in high-risk trauma patients admitted to the intensive care unit (ICU). Methods: This was a prospective observational PD study conducted in the ICU of a state-wide major trauma referral centre. The study cohort included adult patients admitted to the ICU with a high risk of VTE, as defined by at least one of the following: age > 40 years, prior VTE, spinal cord injury (SCI), traumatic brain injury (TBI), major venous injury, pelvic fractures, spinal fractures requiring treatment, severe lower limb injuries, and major surgery >2 h in duration. Standard prophylactic enoxaparin dosing was 40 mg SC daily, unless amended by the treating clinician. Plasma anti-Xa activity was measured approximately 60 min before dosing (trough activity), and at 3-5 h after dosing (peak activity). Target peak and trough activity were defined as >0.2 IU/mL and >0.1 IU/mL respectively. Clinical data including the development of VTE and haemorrhagic complications were collected. Results: Twenty-five patients were enrolled. Median [IQR] age, weight, and plasma creatinine were 59 years [36,70], 85 kg [76.5,93.5] and 70 mu mol/L [60.5,109] respectively. Median APACHE III and Injury Severity Score were 54 [42.5,66.5] and 27 [17,34] respectively. Thirteen patients suffered a TBI, in 12 cases surgery extended beyond two hours, and five patients had spinal fractures requiring treatment. Twenty-two patients received enoxaparin 40 mg SC daily, two 60 mg, and one 20 mg. Median peak and trough anti-Xa activity was <= 0.21 IU/mL [0.125,0.25] and 0.01 IU/mL [0,0.05] respectively. Twelve (12/25; 48%) patients had low peak activity <0.2 IU/mL. Twenty-one (21/23; 91%) patients had low trough activity (<= 0.1 IU/mL) and in six (6/23; 26%) cases, these were undetectable. Eight (8/25; 32%) patients had documented VTE of whom seven had low trough activity. There were no major haemorrhagic complications. Conclusions: In a cohort of high risk critically ill trauma patients receiving daily SC enoxaparin as VTE chemoprophylaxis, measured peak and trough plasma anti-Xa activity was inadequate in a significant proportion. On this basis, further systematic investigation concerning dose optimisation in this patient population appears warranted. (C) 2019 Elsevier Ltd. All rights reserved.	[Rakhra, Sandeep; Martin, Emma-Leah; Udy, Andrew] Alfred Hlth, Dept Hyperbar & Intens Care Med, Melbourne, Vic, Australia; [Fitzgerald, Mark] Alfred Hlth, Trauma Serv, Melbourne, Vic, Australia; [Fitzgerald, Mark] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Udy, Andrew] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia		Rakhra, S (corresponding author), Alfred Hlth, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	sandeeprakhra@gmail.com			National Trauma Research Institute (NTRI); Alfred Research Trust	This project received funding from the National Trauma Research Institute (NTRI) and the Alfred Research Trust (Small Project Grant). There are no conflicts of interest.	Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304; Costantini TW, 2013, J TRAUMA ACUTE CARE, V74, P128, DOI 10.1097/TA.0b013e3182788fa7; El Naeem HEMA, 2017, EGYPT J ANAESTH, V33, P113, DOI 10.1016/j.egja.2016.11.001; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Karcutskie CA, 2018, JAMA SURG, V153, P144, DOI 10.1001/jamasurg.2017.3787; Karcutskie CA, 2017, J TRAUMA ACUTE CARE, V83, P1102, DOI 10.1097/TA.0000000000001663; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Ko A, 2016, JAMA SURG, V151, P1006, DOI 10.1001/jamasurg.2016.1662; Kopelman TR, 2017, INJURY, V48, P1088, DOI 10.1016/j.injury.2016.10.039; Lang TA, 2015, INT J NURS STUD, V52, P5, DOI 10.1016/j.ijnurstu.2014.09.006; Lu JP, 2009, J AM COLL SURGEONS, V209, P589, DOI 10.1016/j.jamcollsurg.2009.08.001; Malinoski D, 2010, J TRAUMA, V68, P874, DOI 10.1097/TA.0b013e3181d32271; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Queensland DoH, 2016, GUID ANT PROPHUS LOW; Robinson S, 2013, CRIT CARE, V17, DOI 10.1186/cc12684; Robinson S, 2010, CRIT CARE, V14, DOI 10.1186/cc8924; Selby R, 2009, THROMB RES, V124, P281, DOI 10.1016/j.thromres.2008.10.002; Shackford SR, 2004, ANN SURG, V240, P496; Singer GA, 2016, J TRAUMA ACUTE CARE, V81, P1101, DOI 10.1097/TA.0000000000001193; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Surgeons RACo, PREV VEN THROMB; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029	24	4	4	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2020	51	1					10	14		10.1016/j.injury.2019.10.066			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	JY8UQ	WOS:000504683800003	31679829				2022-02-06	
J	Rice, S; Iaccarino, MA; Bhatnagar, S; Robidoux, G; Zafonte, R; Kotler, DH				Rice, Sarah; Iaccarino, Mary Alexis; Bhatnagar, Saurabha; Robidoux, Greg; Zafonte, Ross; Kotler, Dana H.			Reporting of Concussion-Like Symptoms After Cycling Crashes: A Survey of Competitive and Recreational Cyclists	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; traumatic brain injuries; head injuries; bicycling	TRAUMATIC BRAIN-INJURY; HELMET USE; BICYCLE INJURIES; HEAD-INJURY; PROGRAM; SCAT3	Context: Cycling crashes are common among recreational and competitive riders and may result in head and bodily trauma. Information is limited regarding the signs and symptoms of head injury (HI) after cycling crashes, medical treatment, and recovery. Objectives: To evaluate concussion-like symptom reporting after cycling crashes with or without HI in recreational and competitive cyclists and to assess crash characteristics and follow-up medical care. Design: Cross-sectional study. Setting: Voluntary online survey. Patients or Other Participants: A convenience sample of 780 cyclists residing in the United States: 528 males, 249 females, 2 gender queer/nonbinary, and 1 transgender female. Main Outcome Measure(s): Survey-based, self-reported signs and symptoms of HI, including the third edition of the Sport Concussion Assessment Tool (SCAT3) symptom checklist, loss of consciousness, posttraumatic amnesia, and helmet damage. Results: Of the participants, 403 reported crashes in the previous 2 years. Cyclists who self-reported no significant injury after their crash were excluded, leaving 77 HI reporters (HI group) and 260 trauma controls (TC group). The HI group more frequently reported experiencing 17 of the 22 symptoms on the SCAT3 symptom checklist. The HI group described a 4-fold higher incidence of loss of consciousness (HI = 13/77 [16.9%] versus TC =11/2600 [4.2%]) and memory loss immediately after the crash (HI = 44/77 [57.1%] versus TC = 37/260 [14.2%]). The HI group reported major, noncosmetic helmet damage 2.5 times more frequently than the TC group (HI = 49/77 [63.6%] versus TC = 67/260 [25.8%]). Conclusions: The findings suggest that a standardized concussion assessment is needed for cyclists who experience major trauma.	[Rice, Sarah] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Iaccarino, Mary Alexis; Bhatnagar, Saurabha; Zafonte, Ross; Kotler, Dana H.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iaccarino, Mary Alexis; Bhatnagar, Saurabha; Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Iaccarino, Mary Alexis; Bhatnagar, Saurabha; Robidoux, Greg; Zafonte, Ross; Kotler, Dana H.] Spaulding Rehabil Hosp, Boston, MA USA; [Bhatnagar, Saurabha] US Dept Vet Affairs, Washington, DC USA; [Kotler, Dana H.] Newton Wellesley Hosp, 159 Wells Ave, Newton, MA 02459 USA		Kotler, DH (corresponding author), Newton Wellesley Hosp, 159 Wells Ave, Newton, MA 02459 USA.	dkotler@partners.org					Abramson AK, 2012, MED CYCL C AUG 24 26; [Anonymous], WE RID AN BIC AM CIT; Basch CH, 2014, J COMMUN HEALTH, V39, P956, DOI 10.1007/s10900-014-9836-8; Bin Zahid A, 2018, APPL NEUROPSYCH-ADUL, V25, P110, DOI 10.1080/23279095.2016.1248765; Brassil HE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0200-y; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; Dreier F, 2019, VELONEWS; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gorman M, 2017, APPL NEUROPSYCH-CHIL, V6, P364, DOI 10.1080/21622965.2016.1210011; Greve MW, 2012, CLIN J SPORT MED, V22, P81, DOI 10.1097/JSM.0b013e318243bf32; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Iaccarino M, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0211; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kantrowitz DE, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118767077; Mather V., 2016, NY TIMES; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meyers AC, 2018, J SCI CYCL, V6, P27; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Reynolds CCO, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-47; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Thomas RE, 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000095; Union Cycliste Internationale, RUL REG 13; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	30	4	4	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2020	55	1					11	16		10.4085/1062-6050-91-19			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	KC9BJ	WOS:000507465600003	31855078	Green Published, gold			2022-02-06	
J	Schatz, P; Corcoran, M; Kontos, AP; Elbin, RJ				Schatz, Philip; Corcoran, Mary; Kontos, Anthony P.; Elbin, R. J.			Youth Soccer Parents' Perceptions of Long-Term Effects of Concussion	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; KNOWLEDGE; SPORT; TRENDS	Increased focus on sports-related concussion (SRC) in football in the media, and mandatory concussion education for parents of youth sport athletes, may result in parental concern that youth athletes will experience longterm effects from concussion. We sought to identify beliefs about long-term effects of concussion in parents of youth soccer athletes. Four hundred and eleven parents from soccer leagues in three states completed a survey assessing parents' perceptions and knowledge of long-term effects of SRC. Nearly all youth soccer parents surveyed (96.5%) believe there are longterm effects from SRCs, 76% reported concern their child would sustain a concussion, and 71% had talked with their child about concussion symptoms/reporting. Parents ranked tackle football as having the highest risk for concussion, followed by soccer, ice hockey, cheerleading, and lacrosse. Parents of children that had previously sustained a concussion were 8.3x more likely to be concerned their child would sustain a concussion, and parents with a personal history of concussion were 2x more likely to consider not allowing their child to participate in youth sports. There are wide-spread beliefs among youth soccer parents regarding long-term effects of SRCs, and concerns their children will sustain concussions while participating in youth sports.	[Schatz, Philip; Corcoran, Mary] St Josephs Univ, Dept Psychol, 222 Post Hall, Philadelphia, PA 19131 USA; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA		Schatz, P (corresponding author), St Josephs Univ, Dept Psychol, 222 Post Hall, Philadelphia, PA 19131 USA.	pschatz@sju.edu					[Anonymous], 2017, NFHS ANN REP, P2; [Anonymous], 2019, 2019 PHYS ACT COUNC, P1; Asken BM, 2018, J ORTHOP SPORT PHYS, V48, P672, DOI 10.2519/jospt.2018.0612; Boufous S, 2004, AUST NZ J PUBL HEAL, V28, P482, DOI 10.1111/j.1467-842X.2004.tb00032.x; Brett BL, 2019, J ALZHEIMERS DIS, V68, P591, DOI 10.3233/JAD-181058; Brutlag R., 2018, CALIFORNIA INTERSCHO, P1; Butcher J., 2002, J SPORT BEHAV, V25, P19; CDC, 2019, HEADS FACT SHEET PAR; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Daugherty J, 2018, BRAIN INJURY, V32, P1773, DOI 10.1080/02699052.2018.1530801; Emanuel D, 2017, CNN; Inst. A, 2018, STAT PLAY 2018 TREND; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; King B., 2017, SPORTS BUSINESS J, V20; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Langhorst P., 2016, YOUTH SPORTS PARTICI; Lee A., 2015, HLTH SPORT; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Murray Mark., 2018, NBC NEWS; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; SIFA, 2018, 2018 SPORTS FITN LEI; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Taranto E, 2018, J NATL MED ASSOC, V110, P635, DOI 10.1016/j.jnma.2018.10.001; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Ward J., 2017, NY TIMES; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	36	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2020	45	3					110	117		10.1080/87565641.2020.1766464			8	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	MD5WV	WOS:000544044200002	32419513				2022-02-06	
J	Suzuki, K; Nagai, S; Iwai, K; Furukawa, T; Mukai, N; Miyakawa, S; Takemura, M				Suzuki, Keita; Nagai, Satoshi; Iwai, Koichi; Furukawa, Takuo; Mukai, Naoki; Miyakawa, Shumpei; Takemura, Masahiro			Characteristics and factors of concussion events for tacklers in collegiate rugby union	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						community rugby; concussion; etiology; inciting event; tackle		The purpose of this study was to determine the factors related to the occurrence of concussion in rugby tacklers. Match video records showing tackles leading to concussion were used to identify injury-inciting events. Additionally, noninjury tackles by concussed tacklers (prior to concussion) and position-matched tacklers from the same matches were used as a control cohort. All tackles were coded according to the tackling characteristics. The odds ratio (OR) was reported by logistic regression. The results demonstrated that a side step of the ball-carrier reduced the risk of concussion for tacklers (OR = 0.13 [95% CI, 0.03-0.58]; P = .008). Conversely, the tackler's head/neck contacting the ball-carrier (OR = 18.62 [95% CI, 4.59-75.49]; P < .001) and not remaining bound to the ball-carrier since making initial contact (OR = 4.38 [95% CI, 1.69-11.34]; P = .002) were identified as risk factors for the concussion of tacklers. These results suggest that avoidance movements of the ball-carrier prior to tackling reduced the risk of concussion and that incorrect tackling techniques contributed to an increased occurrence of concussion. Furthermore, the probability of concussion for tacklers increased when their head was in front or to one side of the ball-carrier, and the direction of the tackle also affected the risk of concussion, especially from the side. Therefore, it is important to emphasize the tackler's head position in conjunction with the direction of tackle.	[Suzuki, Keita] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, Ibaraki, Japan; [Suzuki, Keita; Iwai, Koichi] Ibaraki Prefectural Univ Hlth Sci, Ctr Humanities & Sci, Ibaraki, Japan; [Nagai, Satoshi] Tsukuba Int Univ, Fac Hlth Sci, Dept Phys Therapy, Ibaraki, Japan; [Furukawa, Takuo; Mukai, Naoki; Miyakawa, Shumpei; Takemura, Masahiro] Univ Tsukuba, Fac Hlth & Sport Sci, 1-1-1,Tennodai, Tsukuba, Ibaraki 3058577, Japan		Takemura, M (corresponding author), Univ Tsukuba, Fac Hlth & Sport Sci, 1-1-1,Tennodai, Tsukuba, Ibaraki 3058577, Japan.	takemura.masahiro.gw@u.tsukuba.ac.jp	Suzuki, Keita/E-8919-2019	Suzuki, Keita/0000-0003-1762-2116	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [16H00722] Funding Source: Medline		[Anonymous], 2014, WORLD RUGBY CONCUSSI; Burger N, 2017, AM J SPORT MED, V45, P278, DOI 10.1177/0363546516677548; Cross MJ., 2017, BR J SPORTS MED, V1; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Sobue S, 2018, BRIT J SPORT MED, V52, P353, DOI 10.1136/bjsports-2017-098135; Sterne, 2003, ESSENTIAL MED STAT; Suzuki K., 2019, J PHYS FIT SPORTS ME, V8, P79, DOI [10.7600/jpfsm.8.79, DOI 10.7600/JPFSM.8.79]; Suzuki K, 2020, SCAND J MED SCI SPOR, V30, P185, DOI 10.1111/sms.13553; Tierney GJ., 2018, J SPORT SCI, V3, P1; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wheeler KW, 2011, INT J SPORTS SCI COA, V6, P419, DOI 10.1260/1747-9541.6.3.419	24	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JAN	2020	30	1					185	192		10.1111/sms.13553			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PX7GZ	WOS:000611522400020	31494968				2022-02-06	
J	Tarallo, L; Porcellini, G; Merolla, G; Pellegrini, A; Giorgini, A; Catani, F				Tarallo, Luigi; Porcellini, Giuseppe; Merolla, Giovanni; Pellegrini, Andrea; Giorgini, Andrea; Catani, Fabio			Isolated displaced type II partial articular radial head fracture: correlation of preoperative imaging with intraoperative findings of lateral ulnar collateral ligament tear	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						LUCL lesion; radial head fracture; unknown dislocation	ROTATORY INSTABILITY; COMPUTED-TOMOGRAPHY; ELBOW; INJURIES; COMPLEX; RECONSTRUCTION; EPIDEMIOLOGY; CONTRACTURE; ANATOMY; PATTERN	Background: The aim of this study was to determine the lateral ulnar collateral ligament (LUCL) injury associated with isolated radial head fracture (RHF) and the relationship of the ligament injury with the displacement of the fragment-loss of contact-in unstable displaced partial articular RHF in individuals without any history of ulnohumeral dislocation. Methods: We retrospectively identified 131 consecutive patients who underwent open reduction and internal fixation of isolated closed Mason type II RHF performed at our institution. We identified 3 subsets by the pattern of RHF and the position of the unstable fragment (anterior or posterior) relative to the capitulum humeri: displaced stable (group I), displaced anterior unstable (group II), and displaced posterior unstable (group III). Standard radiographs were obtained preoperatively and postoperatively. The pattern of lateral collateral ligament avulsion and its distribution were inferred from intraoperative records. Results: Preoperative radiographs of the 131 patients showed 101 nonseparated fractures (77%, group I) and 30 unstable fractures (23%). Anterior displacement of the fragment was found in 18 elbows (14%, group II) and posterior displacement in 12 (9%, group III). LUCL avulsion was found in 18 of 30 unstable RHFs (60%) and in 1 of 60 stable RHFs (1.6%). Conclusion: RHF is a complex fracture often associated with soft tissue lesions. It is important to determine which structures need to be repaired to avoid complications that could lead to elbow instability. The RHF pattern and classification as stable or unstable can help the surgeon in the identification and treatment of LUCL lesions. (C) 2019 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.	[Tarallo, Luigi; Porcellini, Giuseppe; Pellegrini, Andrea; Giorgini, Andrea; Catani, Fabio] Univ Modena & Reggio Emilia, Orthopaed & Trauma Unit, Largo Pozzo 71, I-41100 Modena, Italy; [Merolla, Giovanni] AUSL Romagna, Cervesi Hosp, Shoulder & Elbow Unit, Cattolica, Italy		Tarallo, L (corresponding author), Univ Modena & Reggio Emilia, Orthopaed & Trauma Unit, Largo Pozzo 71, I-41100 Modena, Italy.	ltarallo@unimore.it		Tarallo, Luigi/0000-0002-7999-8154			Acar K, 2016, J EMERG MED, V50, P444, DOI 10.1016/j.jemermed.2015.03.009; Batlle JA, 2019, INSIGHTS IMAGING, V10, DOI 10.1186/s13244-019-0725-7; Beingessner DM, 2005, J ORTHOP RES, V23, P210, DOI 10.1016/j.orthres.2004.06.001; BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Capo JT, 2015, J ORTHOP TRAUMATOL, V16, P125, DOI 10.1007/s10195-014-0331-x; Cohen MS, 1997, J BONE JOINT SURG AM, V79A, P225, DOI 10.2106/00004623-199702000-00010; Damodar D, 2018, J ORTHOP, V15, P817, DOI 10.1016/j.jor.2018.08.023; DiPaola M, 2008, HAND CLIN, V24, P39, DOI 10.1016/j.hcl.2007.11.010; Duckworth AD, 2012, J HAND SURG-AM, V37A, P112, DOI 10.1016/j.jhsa.2011.09.034; Duggan JP, 2011, J SHOULDER ELB SURG, V20, P226, DOI 10.1016/j.jse.2010.09.011; El Ibrahimi Abdelhalim, 2010, J Emerg Trauma Shock, V3, P422, DOI 10.4103/0974-2700.70767; FRANKLIN PD, 1988, J COMPUT ASSIST TOMO, V12, P817, DOI 10.1097/00004728-198809010-00019; Haapamaki VV, 2004, ACTA RADIOL, V45, P65, DOI 10.1080/02841850410003310; HUSBAND JB, 1990, J BONE JOINT SURG AM, V72A, P1353, DOI 10.2106/00004623-199072090-00012; Itamura J, 2005, J SHOULDER ELB SURG, V14, P421, DOI 10.1016/j.jse.2004.11.003; Kaas L, 2011, J SHOULDER ELB SURG, V20, P1282, DOI 10.1016/j.jse.2011.06.011; Kaas L, 2010, J SHOULDER ELB SURG, V19, P520, DOI 10.1016/j.jse.2009.10.015; Kodde IF, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0603-5; Luokkala T, 2019, J SHOULDER ELB SURG, V28, P341, DOI 10.1016/j.jse.2018.08.010; Mansat P, 1998, J BONE JOINT SURG AM, V80A, P1603, DOI 10.2106/00004623-199811000-00006; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; McKee MD, 2003, J SHOULDER ELB SURG, V12, P391, DOI 10.1016/S1058-2746(03)00027-2; McLean J, 2018, J ORTHOP TRAUMA, V32, pE469, DOI 10.1097/BOT.0000000000001313; MORREY BF, 1991, CLIN ORTHOP RELAT R, P187; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; ODRISCOLL SW, 1992, CLIN ORTHOP RELAT R, P186; Rethnam Ulfin, 2007, J Med Case Rep, V1, P38, DOI 10.1186/1752-1947-1-38; Rineer CA, 2010, J SHOULDER ELB SURG, V19, P21, DOI 10.1016/j.jse.2009.05.015; Ring D, 2004, HAND CLIN, V20, P415, DOI 10.1016/j.hcl.2004.06.001; Rohrbough JT, 2002, AM J SPORT MED, V30, P541, DOI 10.1177/03635465020300041401; Takigawa N, 2005, J HAND SURG-BRIT EUR, V30B, P143, DOI 10.1016/j.jhsb.2004.09.016	31	4	4	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JAN	2020	29	1					132	138		10.1016/j.jse.2019.07.006			7	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	JU7DP	WOS:000501833400022	31521526				2022-02-06	
J	Tsushima, WT; Tsushima, VG; Murata, NM				Tsushima, William T.; Tsushima, Vincent G.; Murata, Nathan M.			ImPACT Normative Data of Ethnically Diverse Adolescent Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						neuropsychological; ethnic minority; age; sex; concussion	SPORT-RELATED CONCUSSION; NEUROCOGNITIVE TEST BATTERY; NEUROPSYCHOLOGICAL ASSESSMENT; CLINICAL UTILITY; HIGH-SCHOOL; TESTS; PLAY; PERFORMANCE; EDUCATION; VALIDITY	Objective: The aim of this research was to develop preliminary norms for the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) administered to a large sample of adolescent athletes from diverse ethnic backgrounds. Design: A retrospective records review. Setting: Middle and high school athletic departments. Participants: A total of 5741 male and female adolescent athletes in Hawaii, aged 13 to 18 years, in grades 9 to 12 were included in the study. Independent Variables: Age, sex, ethnicity, and sport. Main Outcome Measures: ImPACT Composite scores (Verbal Memory, Visual Memory, Visual Motor Speed, Reaction Time, and Impulse Control) and Total Symptom score from baseline testing. Results: The results indicated statistically significant differences between age and sex groups, as well as between ethnic and sport groups. Conclusions: The findings support the continued use of stratified norms for age and sex for ethnically diverse adolescent athletes. Comparisons of ethnic and sport groups deserve further investigation. When baseline scores are not available for postconcussion comparison, present observations tentatively support the cautious use of standard ImPACT norms with ethnically diverse athletes.	[Tsushima, William T.] Straub Med Ctr, Dept Psychiat & Psychol, Honolulu, HI USA; [Tsushima, Vincent G.] Hawaii Pacific Univ, Dept Psychol, Honolulu, HI USA; [Murata, Nathan M.] Univ Hawaii Manoa, Dept Kinesiol & Rehabil Sci, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Med Ctr, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; American Psychiatric Association, 2013, DIAGN STAT MAN, Vfifth; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Echemendia RJ, 2004, APPL NEUROPSYCHOL, V11, P4, DOI 10.1207/s15324826an1101_2; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovell M.R., 2011, IMPACT TECHNICAL MAN, V2013; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mckay CD, 2014, ARCH CLIN NEUROPSYCH, V29, P141, DOI 10.1093/arclin/act116; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Page P, 2014, INT J SPORTS PHYS TH, V9, P726; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Tsushima William T, 2014, Hawaii J Med Public Health, V73, P208; Tsushima William T, 2008, Hawaii Med J, V67, P93; Wong TM, 2000, CRIT ISS NE, P3; Yang LL, 2012, CLIN NEUROPSYCHOL, V26, P641, DOI 10.1080/13854046.2012.666266	40	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2020	30	1					52	59		10.1097/JSM.0000000000000567			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	LB0WS	WOS:000524358800018	31855913				2022-02-06	
J	Turtzo, LC; Jikaria, N; Cota, MR; Williford, JP; Uche, V; Davis, T; MacLaren, J; Moses, AD; Parikh, G; Castro, MA; Pham, DL; Butman, JA; Latour, LL				Turtzo, Lisa Christine; Jikaria, Neekita; Cota, Martin R.; Williford, Joshua P.; Uche, Victoria; Davis, Tara; MacLaren, Judy; Moses, Anita D.; Parikh, Gunjan; Castro, Marcelo A.; Pham, Dzung L.; Butman, John A.; Latour, Lawrence L.			Meningeal blood-brain barrier disruption in acute traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; neuroimaging; MRI; blood-brain barrier; blood-cerebrospinal fluid barrier	FLUID; GADOLINIUM; MARKER; ENCEPHALOPATHY; UTILITY; SYSTEM; SCALE	The meninges serve as a functional barrier surrounding the brain, critical to the immune response, and can be compromised following head trauma. Meningeal enhancement can be detected on contrast-enhanced MRI in patients presenting with acute traumatic brain injury, even when head CT is negative. Following head trauma, gadolinium-based contrast appears to extravasate from the vasculature, enhancing the dura within minutes, and later permeates the subarachnoid space. The aims of this study were to characterize the initial kinetics of the uptake of contrast agent after injury and the delayed redistribution of contrast enhancement in the subarachnoid space in hyperacute patients. Neuroimaging was obtained prospectively in two large ongoing observational studies of patients aged 18years or older presenting to the emergency department with suspected acute head injury. Dynamic contrast-enhanced MRI studies in a cohort of consecutively enrolling patients with mild traumatic brain injury (n=36) determined that the kinetic half-life of dural-related meningeal enhancement was 1.30.6min (95% enhancement within 6min). The extravasation of contrast into the subarachnoid space was investigated in a cohort of CT negative mild traumatic brain injury patients initially imaged within 6h of injury (hyperacute) who subsequently underwent a delayed MRI, with no additional contrast administration, several hours after the initial MRI. Of the 32 patients with delayed post-contrast imaging, 18 (56%) had conspicuous expansion of the contrast enhancement into the subarachnoid space, predominantly along the falx and superior sagittal sinus. Patients negative for traumatic meningeal enhancement on initial hyperacute MRI continued to have no evidence of meningeal enhancement on the delayed MRI. These studies demonstrate that (i) the initial enhancement of the traumatically injured meninges occurs within minutes of contrast injection, suggesting highly permeable meningeal vasculature, and that (ii) contrast in the meninges redistributes within the subarachnoid space over the period of hours, suggesting a compromise in the blood-brain and/or blood-cerebrospinal barriers. Data from the parent study indicate that up to one in two patients with mild traumatic brain injury have traumatic brain injury on acute (<48h) MRI, with a higher prevalence seen in patients with moderate or severe traumatic brain injury. The current study's findings of traumatic meningeal enhancement and the subsequent delayed extravasation of contrast into the subarachnoid spaces indicate that a substantial percentage of patients with even mild traumatic brain injury may have a transient disruption in barriers separating the vasculature from the brain.	[Turtzo, Lisa Christine; Latour, Lawrence L.] NINDS, Acute Cerebrovasc Diagnost Unit, NIH, Bethesda, MD 20892 USA; [Jikaria, Neekita; Cota, Martin R.; Uche, Victoria; Moses, Anita D.; Castro, Marcelo A.; Pham, Dzung L.; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Williford, Joshua P.; Davis, Tara; MacLaren, Judy] Johns Hopkins Suburban Hosp, Bethesda, MD 20814 USA; [Parikh, Gunjan] Univ Maryland, R Adams Shock Trauma Ctr, Sch Med, Baltimore, MD 21201 USA; [Parikh, Gunjan] Univ Maryland, Div Neurocrit Care & Emergency Neurol, Sch Med, Baltimore, MD 21201 USA; [Pham, Dzung L.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Butman, John A.] NIH, Radiol & Imaging Sci, Clin Ctr, Bethesda, MD 20892 USA		Latour, LL (corresponding author), NINDS, NIH, 10 Ctr Dr,Bldg 10,Rm B1D733, Bethesda, MD 20892 USA.	latourl@ninds.nih.gov		Davis, Tara/0000-0002-6293-3602; Castro, Marcelo/0000-0003-3450-0989	United States Department of Defense through the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Intramural Research programme of the National Institutes of Health, United States Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Support for this work was provided by the United States Department of Defense through the Center for Neuroscience and Regenerative Medicine and the Intramural Research programme of the National Institutes of Health, United States Department of Health and Human Services.	Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Absinta M, 2017, NEUROLOGY, V88, P1439, DOI 10.1212/WNL.0000000000003820; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Barr TL, 2010, STROKE, V41, pE123, DOI 10.1161/STROKEAHA.109.570515; Bozzao A, 2003, EUR RADIOL, V13, P592, DOI 10.1007/s00330-002-1546-4; Castro MA, 2016, PROC SPIE, V9788, DOI 10.1117/12.2216902; Davis TS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234881; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Goo HW, 2003, PEDIATR RADIOL, V33, P843, DOI 10.1007/s00247-003-1057-8; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kidwell CS, 2011, NEUROLOGY, V77, P1725, DOI 10.1212/WNL.0b013e318236ef46; Kidwell CS, 2008, CEREBROVASC DIS, V25, P338, DOI 10.1159/000118379; Kim SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102229; Kohrmann M, 2012, STROKE, V43, P259, DOI 10.1161/STROKEAHA.111.632356; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meng Y, 2019, ANN NEUROL, V86, P975, DOI 10.1002/ana.25604; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Ringstad G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121537; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Stuckey SL, 2007, AM J ROENTGENOL, V189, P913, DOI 10.2214/AJR.07.2424; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121	43	4	4	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							143	10.1093/braincomms/fcaa143			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800083	33829156	Green Published, gold			2022-02-06	
J	Vasilevskaya, A; Taghdiri, F; Burke, C; Tarazi, A; Naeimi, SA; Khodadadi, M; Goswami, R; Sato, C; Grinberg, M; Moreno, D; Wennberg, R; Mikulis, D; Green, R; Colella, B; Davis, KD; Rusjan, P; Houle, S; Tator, C; Rogaeva, E; Tartaglia, MC				Vasilevskaya, Anna; Taghdiri, Foad; Burke, Charles; Tarazi, Apameh; Naeimi, Seyed Ali; Khodadadi, Mozghan; Goswami, Ruma; Sato, Christine; Grinberg, Mark; Moreno, Danielle; Wennberg, Richard; Mikulis, David; Green, Robin; Colella, Brenda; Davis, Karen D.; Rusjan, Pablo; Houle, Sylvain; Tator, Charles; Rogaeva, Ekaterina; Tartaglia, Maria C.			Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes	NEUROIMAGE-CLINICAL			English	Article						Concussion; Apoe4; Positron emission tomography; Tau; Chronic traumatic encephalopathy	CHRONIC TRAUMATIC ENCEPHALOPATHY; POSITRON-EMISSION-TOMOGRAPHY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; A-BETA; PATHOLOGY; ASSOCIATION; CONCUSSION; HAPLOTYPE; DIAGNOSIS	Background: Genetic polymorphisms like apolipoprotein E (APOE) and microtubule-associated protein tau (MAPT) genes increase the risk of neurodegeneration. Methods: 38 former players (age 52.63 +/- 14.02) of contact sports underwent neuroimaging, biofluid collection, and comprehensive neuropsychological assessment. The [F-18]AV-1451 tracer signal was compared in the cortical grey matter between APOE4 allele carriers and non-carriers as well as carriers of MAPT H1H1 vs non-H1H1. Participants were then divided into the high (N = 13) and low (N = 13) groups based on cortical PET tau standard uptake value ratios (SUVRs) for comparison. Findings: Cortical grey matter PET tau SUVR values were significantly higher in APOE4 carriers compared to non-carriers (p = 0.020). In contrast, there was no significant difference in SUVR between MAPT H1H1 vs non-H1H1 carrier genes (p = 1.00). There was a significantly higher APOE4 allele frequency in the high cortical grey matter PET tau group, comparing to low cortical grey matter PET tau group (p = 0.048). No significant difference in neuropsychological function was found between APOE4 allele carriers and non-carriers. Interpretation: There is an association between higher cortical grey matter tau burden as seen with [F-18]AV-1451 PET tracer SUVR, and the APOE4 allele in former professional and semi-professional players at high risk of concussions. APOE4 allele may be a risk factor for tau accumulation in former contact sports athletes at high risk of neurodegeneration.	[Vasilevskaya, Anna; Taghdiri, Foad; Burke, Charles; Sato, Christine; Grinberg, Mark; Moreno, Danielle; Rogaeva, Ekaterina; Tartaglia, Maria C.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 0S8, Canada; [Vasilevskaya, Anna; Taghdiri, Foad; Burke, Charles; Mikulis, David; Green, Robin; Davis, Karen D.; Tator, Charles; Tartaglia, Maria C.] Univ Toronto, Inst Med Sci, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Vasilevskaya, Anna; Burke, Charles; Tarazi, Apameh; Wennberg, Richard; Tartaglia, Maria C.] Univ Hlth Network, Toronto Western Hosp, Div Neurol, 399 Bathurst St, Bathurst, ON M5T 2S8, Canada; [Vasilevskaya, Anna; Taghdiri, Foad; Burke, Charles; Tarazi, Apameh; Naeimi, Seyed Ali; Khodadadi, Mozghan; Goswami, Ruma; Wennberg, Richard; Mikulis, David; Green, Robin; Colella, Brenda; Davis, Karen D.; Tator, Charles; Tartaglia, Maria C.] Univ Hlth Network, Toronto Western Hosp, Canadian Concuss Ctr, Krembil Neurosci Ctr, 399 Bathurst St, Bathurst, ON M5T 2S8, Canada; [Burke, Charles] Western Univ, Sch Med & Dent, Windsor, ON, Canada; [Mikulis, David] Univ Hlth Network, Joint Dept Med Imaging, Div Neuroradiol, 399 Bathurst St, Bathurst, ON M5T 2S8, Canada; [Green, Robin; Colella, Brenda] Univ Toronto, Dept Rehabil Sci, 500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Davis, Karen D.] Univ Toronto, Dept Surg, 149 Coll St, Toronto, ON M5T 1P5, Canada; [Rusjan, Pablo; Houle, Sylvain] Campbell Res Inst, Ctr Addict & Mental Hlth, Res Imaging Ctr, 250 Coll St, Toronto, ON M5T 1R8, Canada; [Tator, Charles] Univ Hlth Network, Toronto Western Hosp, Krembil Brain Inst, Div Neurosurg, 399 Bathurst St, Bathurst, ON M5T 2S8, Canada; [Rogaeva, Ekaterina] Univ Toronto, Dept Med, Div Neurol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada		Tartaglia, MC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	carmela.tartaglia@uhn.ca		Rusjan, Pablo/0000-0003-0075-2918	Toronto General and Western Hospital Foundations; Weston Brain Institute; Canadian Consortium on Neurodegeneration in ageing; Krembil Research Institute	Toronto General and Western Hospital Foundations; Weston Brain Institute; Canadian Consortium on Neurodegeneration in ageing; Krembil Research Institute. There was no role of the funders in this study.	Adalbert R, 2007, TRENDS MOL MED, V13, P135, DOI 10.1016/j.molmed.2007.02.004; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004; Blue EE, 2019, ALZHEIMERS DEMENT, V15, P1524, DOI 10.1016/j.jalz.2019.07.016; Cao J., 2017, SCI REP, V7; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Cho H, 2016, NEUROLOGY, V87, P375, DOI 10.1212/WNL.0000000000002892; Choi JY, 2018, J NUCL MED, V59, P117, DOI 10.2967/jnumed.117.195248; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; ETO M, 1986, CLIN GENET, V30, P422; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Goldstein LE, 2012, SCI TRANSL MED, V4; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Heaton RK, 1992, COMPREHENSIVE NORMS; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; HUANG DY, 1995, NEUROSCI LETT, V192, P209, DOI 10.1016/0304-3940(95)11649-H; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jovalekic A, 2016, EJNMMI RADIOPHARM CH, V1, DOI 10.1186/s41181-016-0015-3; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lemoine L, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0325-z; Lesman-Segev OH, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102025; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maddalena A, 2003, ARCH NEUROL-CHICAGO, V60, P1202, DOI 10.1001/archneur.60.9.1202; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Marquie M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0808-1; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merritt V.C., 2019, ARCH CLIN NEUROPSYCH, DOI [10.1093/arclin/acy082/5231884, DOI 10.1093/ARCLIN/ACY082/5231884]; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh J, 1937, US NAVAL MED B, V35, P303; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Morey, 1991, PERSONALITY ASSESSME; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571, DOI 10.1038/jcbfm.1992.81; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Paglini G., TAU PROTEIN FUNCTION, V7; Pastor P, 2004, ANN NEUROL, V56, P249, DOI 10.1002/ana.20178; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Rajabli F, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007791; Rajan KB, 2019, J ALZHEIMERS DIS, V72, P45, DOI 10.3233/JAD-190538; Rajan KB, 2019, J AM GERIATR SOC, V67, P734, DOI 10.1111/jgs.15727; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schmidt M., 1996, REY AUDITORY VERBAL; Seet WT, 2004, CLIN CHIM ACTA, V340, P201, DOI 10.1016/j.cccn.2003.11.001; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Van Giau V, 2015, NEUROPSYCH DIS TREAT, V11, P1723, DOI 10.2147/NDT.S84266; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR, V3rd edn; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Yu L., 2017, PLOS ONE, V12; Zhang CC, 2017, ONCOTARGET, V8, P44994, DOI 10.18632/oncotarget.16690; Zhang CC, 2016, MOL NEUROBIOL, V53, P4893, DOI 10.1007/s12035-015-9415-8; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	93	4	4	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	26								102212	10.1016/j.nicl.2020.102212			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LN7YO	WOS:000533149400030	32097865	Green Published, gold			2022-02-06	
J	Wang, JQ; Ma, CY; Zhu, J; Rao, GF; Li, HJ				Wang, Jinqiao; Ma, Chunyan; Zhu, Jing; Rao, Gaofeng; Li, Hongjuan			Effect of 3-Aminobenzamide on the Ultrastructure of Astrocytes and Microvessels After Focal Cerebral Ischemia in Rats	DOSE-RESPONSE			English	Article						BBB; ultrastructure; 3-aminobenzamide; middle cerebral artery occlusion	BLOOD-BRAIN-BARRIER; PROTECTS; PERMEABILITY; INHIBITION; MEMBRANE; STRESS; INJURY; STROKE	The disruption of blood-brain barrier (BBB) is a critical event in the formation of brain edema during early phases of ischemic brain injury. Poly(ADP-ribose) polymerase (PARP) activation, which contributes to BBB damage, has been reported in ischemia-reperfusion and traumatic brain injury. Here, we investigated the effect of 3-aminobenzamide (3-AB), a PARP-1 inhibitor, on the ultrastructure of BBB. Male Sprague Dawley rats were suffered from 90 minutes of middle cerebral artery occlusion, followed by 4.5 hours or 22.5 hours of reperfusion (R). The vehicle or 3-AB (10 mg/kg) was administered intraperitoneally (ip) 60 minutes after lacking of blood. Tissue Evans Blue (EB) levels, ultrastructures of astrocytes and microvessels, and areas of perivascular edema were examined in penumbra and core, at I 1.5 hours /R 4.5 hours and I 1.5 hours /R 22.5 hours, respectively. The severity of ultrastructural changes was graded with a scoring system in each group. We showed that 3-AB treatment significantly decreased tissue EB levels and ultrastructural scores, attenuated damages in astrocytes and microvessels, and reduced areas of perivascular edema. In conclusion, PARP inhibition may provide a novel therapeutic approach to ischemic brain injury.	[Wang, Jinqiao; Ma, Chunyan; Rao, Gaofeng; Li, Hongjuan] Wenzhou Med Univ, Peoples Hosp Wenling 1, Dept Rehabil Med, Wenling, Zhejiang, Peoples R China; [Zhu, Jing] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA		Zhu, J (corresponding author), Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA.	syusejing@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601965]; Zhejiang Medical Technology Program [2018KY918]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the grant from the National Natural Science Foundation of China (No. 81601965) and Zhejiang Medical Technology Program (No. 2018KY918).	Ashwal S, 1999, PEDIATR RES, V46, P390, DOI 10.1203/00006450-199910000-00006; Fresta CG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0280-z; Garbuzova-Davis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063553; Gero D, 2014, MOL MED, V20, P313, DOI 10.2119/molmed.2014.00102; Hazer DB, 2010, CLIN HEMORHEOL MICRO, V46, P1, DOI 10.3233/CH-2010-1328; Kang C, 2016, CURR DRUG METAB, V17, P745, DOI 10.2174/1389200217666160728152939; Kangwantas K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0495-9; Kristiansen RG, 2010, SCAND J GASTROENTERO, V45, P935, DOI 10.3109/00365521003675047; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Lattanzi S, 2017, ONCOTARGET, V8, P57489, DOI 10.18632/oncotarget.15423; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Li H, 2018, CURR NEUROPHARMACOL, V16, P758, DOI 10.2174/1570159X15666171030142108; Pan S, 2018, DOSE-RESPONSE, V16, DOI 10.1177/1559325818789841; Rom S, 2015, J CEREBR BLOOD F MET, V35, P28, DOI 10.1038/jcbfm.2014.167; Sun M, 2012, TRANSL RES, V160, P223, DOI 10.1016/j.trsl.2012.02.007; Tan F, 2015, EXP THER MED, V9, P1757, DOI 10.3892/etm.2015.2365; Wang JP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1226-1; Wu XL, 2014, J MOL NEUROSCI, V53, P1, DOI 10.1007/s12031-013-0175-5; Yang ZG, 2019, THERANOSTICS, V9, P6269, DOI 10.7150/thno.37139; Yin DP, 2018, BRAIN RES, V1698, P1, DOI 10.1016/j.brainres.2018.05.040; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Zangari R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0481-2; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	23	4	4	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1559-3258			DOSE-RESPONSE	Dose-Response	JAN	2020	18	1							1559325819901242	10.1177/1559325819901242			8	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	KF0BA	WOS:000508913100001	32030092	Green Published, gold			2022-02-06	
J	Williamson, DR; Cherifa, SI; Frenette, AJ; Mitjans, MS; Charbonney, E; Cataford, G; Williams, V; Palacios, JL; Burry, L; Mehta, S; Arbour, C; Bernard, F				Williamson, David R.; Cherifa, Sofia Ihsenne; Frenette, Anne Julie; Mitjans, Mar Saavedra; Charbonney, Emmanuel; Cataford, Gabrielle; Williams, Virginie; Palacios, Julia Lainer; Burry, Lisa; Mehta, Sangeeta; Arbour, Caroline; Bernard, Francis		Canadian Critical Care Trials Grp	Agitation, confusion, and aggression in critically ill traumatic brain injury-a pilot cohort study (ACACIA-PILOT)	PILOT AND FEASIBILITY STUDIES			English	Article						Traumatic brain injury; Agitation; Confusion; Aggressiveness; Feasibility; Intensive care	HEAD-INJURY; REHABILITATION; CLASSIFICATION; RELIABILITY; SEVERITY; SCALE; PREDICTION; BEHAVIOR; OUTCOMES; MILD	BackgroundAgitated behaviors are problematic in intensive care unit (ICU) patients recovering from traumatic brain injury (TBI) as they create substantial risks and challenges for healthcare providers. To date, there have been no studies evaluating their epidemiology and impact in the ICU. Prior to planning a multicenter study, assessment of recruitment, feasibility, and pilot study procedures is needed. In this pilot study, we aimed to evaluate the feasibility of conducting a large multicenter prospective cohort study.MethodsThis feasibility study recruited adult patients admitted to the ICU with TBI and an abnormal cerebral CT scan. In all patients, we documented Richmond Agitation Sedation Score (RASS) and agitated behaviors every 8-h nursing shift using a dedicated tool documenting 14 behaviors. Our feasibility objectives were to obtain consent from at least 2 patients per month; completion of screening logs for agitated behaviors by bedside nurses for more than 90% of 8-h shifts; completion of data collection in an average of 6 h or less; and obtain 6-month follow-up for surviving patients. The main clinical outcome was the incidence of agitation and individual agitated behaviors.ResultsIn total, 47 eligible patients were approached for inclusion and 30 (64% consent rate) were recruited over a 10-month period (3 patients/month). In total, 794 out of 827 (96%) possible 8-h periods of agitated behavior logs were completed by bedside nurses, with a median of 24 observations (IQR 28.0) per patient. During the ICU stay, 17 of 30 patients developed agitation (56.7%; 95% CI 0.37-0.75) defined as RASS >= 2 during at least one observation period and for a median of 4 days (IQR 5.5). At 6 months post-TBI, among the 24 available patients, an unfavorable score (GOS-E < 5 including death) was reported in 12 patients (50%). In the 14 patients who were alive and available at 6 months, the median QOLIBRI score was 74.5 (IQR 18.5).ConclusionsThis study demonstrates the feasibility of conducting a larger cohort study to evaluate the epidemiology and impact of agitated behaviors in critically ill TBI patients. This study also shows that agitated behaviors are frequent and are associated with adverse events.	[Williamson, David R.; Cherifa, Sofia Ihsenne; Frenette, Anne Julie; Mitjans, Mar Saavedra; Cataford, Gabrielle] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Williamson, David R.; Cherifa, Sofia Ihsenne; Frenette, Anne Julie; Mitjans, Mar Saavedra; Charbonney, Emmanuel; Cataford, Gabrielle; Williams, Virginie; Palacios, Julia Lainer; Arbour, Caroline; Bernard, Francis] Ctr Integre Univ Sante & Serv Sociaux Nord De Iil, Res Ctr, Montreal, PQ, Canada; [Williamson, David R.; Frenette, Anne Julie] Ctr Integre Univ Sante & Serv Sociaux Nord De Iil, Hop Sacre Coeur Montreal, Pharm Dept, Montreal, PQ, Canada; [Charbonney, Emmanuel; Bernard, Francis] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Charbonney, Emmanuel; Bernard, Francis] Ctr Integre Univ Sante & Serv Sociaux Nord De Iil, Hop Sacre Coeur Montreal, Crit Care, Montreal, PQ, Canada; [Burry, Lisa] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Burry, Lisa] Mt Sinai Hosp, Pharm Dept, Toronto, ON, Canada; [Mehta, Sangeeta] Univ Toronto, Dept Med, Sinai Hlth Syst, Toronto, ON, Canada; [Mehta, Sangeeta] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Arbour, Caroline] Univ Montreal, Fac Sci Infirmieres, Montreal, PQ, Canada		Williamson, DR (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.; Williamson, DR (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Nord De Iil, Res Ctr, Montreal, PQ, Canada.; Williamson, DR (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Nord De Iil, Hop Sacre Coeur Montreal, Pharm Dept, Montreal, PQ, Canada.	david.Williamso@umontreal.ca		Williamson, David/0000-0003-3360-4831	Fonds de Rercherche du Quebec-Sante (FRQS) research grant; Fonds de Recherche du Quebec-Sante (FRQ-S) clinical scientist career grant; Fundacion Alfonso Martin Escudero research scholarships in universities or centers abroad; Fonds de Recherche du Quebec-Sante (FRQ-S) scientist career grant	This research is supported by a Fonds de Rercherche du Quebec-Sante (FRQS) research grant. D.R.W and C.A are supported by a Fonds de Recherche du Quebec-Sante (FRQ-S) clinical scientist career grant. MSM is supported by a Fundacion Alfonso Martin Escudero research scholarships in universities or centers abroad. C.A is supported by a Fonds de Recherche du Quebec-Sante (FRQ-S) scientist career grant.	Almeida Thiago Miranda Lopes de, 2016, Rev Bras Ter Intensiva, V28, P413, DOI 10.5935/0103-507X.20160074; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Billingham SAM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-104; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Burk RS, 2014, AM J CRIT CARE, V23, P414, DOI 10.4037/ajcc2014714; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; DeBoussard CN, 2017, CLIN REHABIL, V31, P555, DOI 10.1177/0269215516652184; Frenette AJ, 2016, INTENS CARE MED, V42, P122, DOI 10.1007/s00134-015-3964-1; Haidet KK, 2009, RES NURS HEALTH, V32, P465, DOI 10.1002/nur.20334; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Larsen LK, 2019, ACTA ANAESTH SCAND, V63, P352, DOI 10.1111/aas.13270; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Pandharipande PP, 2017, INTENS CARE MED, V43, P1329, DOI 10.1007/s00134-017-4860-7; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Reznik ME, 2017, NEUROCRIT CARE, V26, P428, DOI 10.1007/s12028-016-0331-1; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Stockwell T, 2012, DRUG ALCOHOL REV, V31, P126, DOI 10.1111/j.1465-3362.2011.00342.x; TEASDALE G, 1974, LANCET, V2, P81; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; van der Naalt J, 2000, BRAIN INJURY, V14, P781; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Williamson D., 2019, NEUROCRIT CARE, V31, pS29; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604; Wolffbrandt MM, 2013, REHABIL NURS, V38, P133, DOI 10.1002/rnj.82	34	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2055-5784		PILOT FEASIBILITY ST	Pilot Feasibility Stud.		2020	6	1							193	10.1186/s40814-020-00736-5			10	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	XN0XQ	WOS:000729238200192	33308318	gold, Green Published			2022-02-06	
J	Witkin, JM; Li, GG; Golani, LK; Xiong, WH; Smith, JL; Ping, XJ; Rashid, F; Jahan, R; Cerne, R; Cook, JM; Jin, XM				Witkin, Jeffrey M.; Li, Guanguan; Golani, Lalit K.; Xiong, Wenhui; Smith, Jodi L.; Ping, Xingjie; Rashid, Farjana; Jahan, Rajwana; Cerne, Rok; Cook, James M.; Jin, Xiaoming			The Positive Allosteric Modulator of alpha 2/3-Containing GABA(A) Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							GAMMA-AMINOBUTYRIC-ACID; PHOTOSENSITIVE EPILEPSY; HIPPOCAMPAL SCLEROSIS; ANTIEPILEPTIC DRUGS; SEIZURE; MICE; BENZODIAZEPINES; ANTICONVULSANT; CARBAMAZEPINE; LAMOTRIGINE	The imidizodiazepine, 5-(8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f] imidazo[1,5-a][1,4]diazepin-3-yl)oxazole (KRM-II-81), is selective for alpha 2/3-containing GABA(A) receptors. KRM-II-81 dampens seizure activity in rodent models with enhanced efficacy and reduced motor-impairment compared with diazepam. In the present study, KRM-II-81 was studied in assays designed to detect antiepileptics with improved chances of impacting pharmaco-resistant epilepsies. The potential for reducing neural hyperactivity weeks after traumatic brain injury was also studied. KRM-II-81 suppressed convulsions in corneal-kindled mice. Mice with kainate-induced mesial temporal lobe seizures exhibited spontaneous recurrent hippocampal paroxysmal discharges that were significantly reduced by KRM-II-81 (15 mg/kg, orally). KRM-II-81 also decreased convulsions in rats undergoing amygdala kindling in the presence of lamotrigine (lamotrigine-insensitive model) (ED50 = 19 mg/kg, i.p.). KRM-II-81 reduced focal and generalized seizures in a kainate-induced chronic epilepsy model in rats (20 mg/kg, i.p., three times per day). In mice with damage to the left cerebral cortex by controlledcortical impact, enduring neuronal hyperactivity was dampened by KRM-II-81 (10 mg/kg, i.p.) as observed through in vivo two-photon imaging of layer II/III pyramidal neurons in GCaMP6-expressing transgenic mice. No notable side effects emerged up to doses of 300 mg/kg KRM-II-81. Molecular modeling studies were conducted: docking in the binding site of the alpha 1 beta 3 gamma 2L GABA(A) receptor showed that replacing the C8 chlorine atom of alprazolam with the acetylene of KRM-II-81 led to loss of the key interaction with alpha 1His102, providing a structural rationale for its low affinity for alpha 1-containing GABA(A) receptors compared with benzodiazepines such as alprazolam. Overall, these findings predict that KRM-II-81 has improved therapeutic potential for epilepsy and post-traumatic epilepsy. SIGNIFICANCE STATEMENT We describe the effects of a relatively new orally bioavailable small molecule in rodent models of pharmaco-resistant epilepsy and traumatic brain injury. KRM-II-81 is more potent and generally more efficacious than standard-of-care antiepileptics. In silico docking experiments begin to describe the structural basis for the relative lack of motor impairment induced by KRM-II-81. KRM-II-81 has unique structural and anticonvulsant effects, predicting its potential as an improved antiepileptic drug and novel therapy for posttraumatic epilepsy.	[Xiong, Wenhui; Ping, Xingjie; Cerne, Rok; Jin, Xiaoming] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Witkin, Jeffrey M.; Li, Guanguan; Golani, Lalit K.; Rashid, Farjana; Jahan, Rajwana; Cook, James M.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA; [Xiong, Wenhui; Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Smith, Jodi L.] St Vincents Hosp, Lab Antiepilept Drug Discovery, Indianapolis, IN USA		Witkin, JM (corresponding author), Witkin Consulting, 1616 Cool Creek Dr, Carmel, IN 46033 USA.; Jin, XM (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.	witkinconsult@gmail.com; xijin@iupui.edu	Jin, Xiaoming/AAH-3555-2020; ping, xingjie/AAW-4597-2020; Golani, Lalit Kumar/AAG-3082-2019	Golani, Lalit Kumar/0000-0002-6233-7747; Jahan, Rajwana/0000-0002-7092-0780	Henry and Nellie Pence family through a Pence Foundation Grant; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH-096463, NS-076517]; National Science Foundation, Division of ChemistryNational Science Foundation (NSF) [CHE-1625735]; University of Wisconsin-Milwaukee's Shimadzu Laboratory for Advanced and Applied Analytical Chemistry; University of Wisconsin-Milwaukee Research Foundation; Milwaukee Institute of Drug Discovery	This work was supported by the Henry and Nellie Pence family for supporting this work through a Pence Foundation Grant (awarded to J.L.S.); the National Institutes of Health [Grants MH-096463 and NS-076517]; the National Science Foundation, Division of Chemistry [Grant CHE-1625735]; the University of Wisconsin-Milwaukee's Shimadzu Laboratory for Advanced and Applied Analytical Chemistry; the Milwaukee Institute of Drug Discovery; and the University of Wisconsin-Milwaukee Research Foundation.	Atack JR, 2011, CURR TOP MED CHEM, V11, P1176; Ator NA, 2010, J PHARMACOL EXP THER, V332, P4, DOI 10.1124/jpet.109.158303; Banerjee J, 2014, ANN INDIAN ACAD NEUR, V17, pS134, DOI 10.4103/0972-2327.128688; Barker-Haliski ML, 2017, NEUROCHEM RES, V42, P1904, DOI 10.1007/s11064-017-2227-7; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; DeGiorgio CM, 2019, ACTA NEUROL SCAND, V139, P220, DOI 10.1111/ane.13049; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Duveau V, 2019, CNS NEUROSCI THER, V25, P255, DOI 10.1111/cns.13046; French JA, 2014, NEUROTHERAPEUTICS, V11, P412, DOI 10.1007/s13311-013-0243-0; Gitto R., 2010, BURGERS MED CHEM DRU; Grabenstatter HL, 2019, EPILEPSIA, V60, P636, DOI 10.1111/epi.14680; Gurrell R, 2019, NEUROLOGY, V92, pE1786, DOI 10.1212/WNL.0000000000007271; Hammond RS, 2017, EPILEPSY RES, V134, P16, DOI 10.1016/j.eplepsyres.2017.05.001; Huang Q, 1998, J MED CHEM, V41, P4130, DOI 10.1021/jm980317y; Huang Q, 2000, J MED CHEM, V43, P71, DOI 10.1021/jm990341r; Hwang JK, 2019, J KOREAN NEUROSURG S, V62, P336, DOI 10.3340/jkns.2019.0031; Kim TH, 2016, CELL REP, V17, P3385, DOI 10.1016/j.celrep.2016.12.004; Leclercq K, 2014, EPILEPSY RES, V108, P675, DOI 10.1016/j.eplepsyres.2014.02.013; Li GG, 2018, SYNTHESIS-STUTTGART, V50, P4124, DOI 10.1055/s-0037-1610211; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Metcalf CS, 2019, EPILEPSIA OPEN, V4, P452, DOI 10.1002/epi4.12354; Metcalf CS, 2017, EPILEPSIA, V58, P1073, DOI 10.1111/epi.13764; Middendorp SJ, 2014, ACS CHEM BIOL, V9, P1846, DOI 10.1021/cb500186a; Moerke MJ, 2019, BEHAV PHARMACOL, V30, P452, DOI 10.1097/FBP.0000000000000464; Nickolls SA, 2018, BRIT J PHARMACOL, V175, P708, DOI 10.1111/bph.14119; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Ping XJ, 2014, J NEUROTRAUM, V31, P1172, DOI 10.1089/neu.2013.3147; Poe MM, 2016, J MED CHEM, V59, P10800, DOI 10.1021/acs.jmedchem.6b01332; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ralvenius WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7803; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Rivas FM, 2009, J MED CHEM, V52, P1795, DOI 10.1021/jm801652d; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sadr SS, 2018, ARCH MED SCI, V14, P717, DOI 10.5114/aoms.2016.60377; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Simonato M, 2014, LANCET NEUROL, V13, P949, DOI 10.1016/S1474-4422(14)70076-6; Sinha S, 2011, NEUROSCIENCES, V16, P3; Srivastava AK, 2013, EPILEPSIA, V54, P1186, DOI 10.1111/epi.12234; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Trenite DGAKN, 1996, EPILEPSY RES, V25, P225, DOI 10.1016/S0920-1211(96)00031-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wat R, 2019, WORLD NEUROSURG, V122, P433, DOI 10.1016/j.wneu.2018.11.076; West PJ, 2018, EPILEPSIA, V59, P2035, DOI 10.1111/epi.14563; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Wilcox KS, 2013, EPILEPSIA, V54, P24, DOI 10.1111/epi.12296; Witkin JM, 2019, PHARMACOL BIOCHEM BE, V180, P22, DOI 10.1016/j.pbb.2019.02.013; Witkin JM, 2018, NEUROPHARMACOLOGY, V137, P332, DOI 10.1016/j.neuropharm.2018.05.006; Witkin JM, 2017, PHARMACOL BIOCHEM BE, V157, P35, DOI 10.1016/j.pbb.2017.04.009; Witkin JM, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146356; Xiong WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12972-6; Yuen ESM, 2014, SEIZURE-EUR J EPILEP, V23, P490, DOI 10.1016/j.seizure.2014.03.011; Zuiker RGJA, 2016, J PSYCHOPHARMACOL, V30, P253, DOI 10.1177/0269881115620435	64	4	4	0	6	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	JAN 1	2020	372	1					83	94		10.1124/jpet.119.260968			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KD5ZV	WOS:000507945200009	31694876	Green Published, Bronze			2022-02-06	
J	Xue, YF; Ding, JH; Liu, YL; Pan, YC; Zhao, PL; Ren, ZW; Xu, J; Ye, LL; Xu, Y				Xue, Yuanfeng; Ding, Junhong; Liu, Yulong; Pan, Yuchun; Zhao, Penglai; Ren, Zhiwen; Xu, Jian; Ye, Liangliang; Xu, Ying			Preparation and Evaluation of Recombinant Human Erythropoietin Loaded Tween 80-Albumin Nanoparticle for Traumatic Brain Injury Treatment	INTERNATIONAL JOURNAL OF NANOMEDICINE			English	Article						traumatic brain injury; rh-erythropoietin; Tween 80 modified albumin nanoparticle; electrostatic spray technology	DELIVERY; EDEMA; AQUAPORIN-4; MODEL; IMPROVES; NEUROPROTECTION; BIOAVAILABILITY; RESPONSES; RECOVERY; BARRIER	Objective: Traumatic brain injury (TBI) is a serious health problem with few available treatment options. Rh-erythropoietin (rh-EPO) is a potential therapeutic drug for TBI, but it cannot cross the blood-brain barrier (BBB) directly. In this regard, a novel strategy to deliver rh-EPO for enhanced TBI treatment is via the development of Tween 80 modified albumin nanoparticles using electrostatic spray technology. Methods: The rh-EPO loaded Tween 80 modified albumin nanoparticles (rh-EPO-Tw-ABNPs) were prepared by electrostatic spray technology, while the process parameters were optimized via a single factor design. Investigation of physicochemical properties, bioactivity and stability of rh-EPO-Tw-ABNPs was carried out. The in vitro release and biocompatibility with nerve cells were also analyzed. The in vivo brain targeting efficiency, brain edema relieving effect and the expression of aquaporin 4 (AQP4) and glial fibrillary acidic protein (GFAP) in the brain were evaluated in TBI model rats. Results: The particle size of optimal rh-EPO-Tw-ABNPs was about 438 +/- 45 nm, with a zeta potential of -25.42 +/- 0.8 my. The average drug loading ratio of rh-EPO-Tw-ABNPs was 21.3 +/- 3.7 IU/mg with a relative bioactivity of 91.6 +/- 4.1%. The in vitro release of rh-EPO from the nanoparticles was rather slow, while neither the blank Tw-ABNPs nor rh-EPO-Tw-ABNPs exhibited toxicity on the microglia cells. Furthermore, in vivo experiments indicated that the rh-EPO-Tw-ABNPs could enhance the distribution of EPO in the brain and relieve brain edema more effectively. Moreover, compared with an rh-EPO injection, the rh-EPO-Tw-ABNPs could increase the AQP4 level but reduced GFAP expression in the brain with more efficiency. Conclusion: The rh-EPO-Tw-ABNPs could enhance the transport of rh-EPO into the brain with superior therapeutic effect for TBI.	[Xue, Yuanfeng; Ding, Junhong; Pan, Yuchun; Ren, Zhiwen; Xu, Jian; Ye, Liangliang] Southeast Univ, Zhongda Hosp, Nanjing Lishui Peoples Hosp, Dept Neurosurg,Lishui Branch, Nanjing 211200, Peoples R China; [Liu, Yulong; Xu, Ying] Jiangsu Univ, Coll Pharm, Zhenjiang 212013, Jiangsu, Peoples R China; [Zhao, Penglai] Nanjing Med Univ, Brain Hosp, Dept Neurosurg, Nanjing 210029, Peoples R China		Xue, YF (corresponding author), Southeast Univ, Zhongda Hosp, Nanjing Lishui Peoples Hosp, Dept Neurosurg,Lishui Branch, Nanjing 211200, Peoples R China.; Xu, Y (corresponding author), Jiangsu Univ, Coll Pharm, Zhenjiang 212013, Jiangsu, Peoples R China.	672455219@qq.com; ingyx@sina.com.cn			Nanjing Medical Science and Technology Development Fund Project [YKK17230]; Nanjing Young Health Talents Training Project [QRX 17084]; Jiangsu University Clinical Medical Science and Technology Development Project [JLY20180213, JLY20180216]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M610309, 2019T120403]	This work supported by Nanjing Medical Science and Technology Development Fund Project (YKK17230), Nanjing Young Health Talents Training Project (QRX 17084), Jiangsu University Clinical Medical Science and Technology Development Project (JLY20180213, JLY20180216) and the China Postdoctoral Science Foundation (2017M610309, 2019T120403).	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44; Alyautdin RN, 1997, PHARMACEUT RES, V14, P325, DOI 10.1023/A:1012098005098; Alyautdin RN, 1998, J MICROENCAPSUL, V15, P67, DOI 10.3109/02652049809006836; Antonov YA, 2015, FOOD HYDROCOLLOID, V43, P243, DOI 10.1016/j.foodhyd.2014.05.029; Arya N, 2009, J BIOMED MATER RES B, V88B, P17, DOI 10.1002/jbm.b.31085; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Blixt J, 2018, J NEUROTRAUM, V35, P671, DOI 10.1089/neu.2017.5015; Bock N, 2012, PROG POLYM SCI, V37, P1510, DOI 10.1016/j.progpolymsci.2012.03.002; Boda SK, 2018, J AEROSOL SCI, V125, P164, DOI 10.1016/j.jaerosci.2018.04.002; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Carson KR, 2005, BEST PRACT RES CL HA, V18, P467, DOI 10.1016/j.beha.2005.01.015; Chen H, 2012, STROKE, V43, P884, DOI 10.1161/STROKEAHA.111.637090; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Grasso G, 2007, DRUG NEWS PERSPECT, V20, P315, DOI 10.1358/dnp.2007.20.5.1120219; Gulyaev AE, 1999, PHARM RES-DORDR, V16, P1564, DOI 10.1023/A:1018983904537; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Huang J, 2013, BRAIN RES, V1539, P61, DOI 10.1016/j.brainres.2013.09.022; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Jaworek A, 2007, POWDER TECHNOL, V176, P18, DOI 10.1016/j.powtec.2007.01.035; Juul S, 2012, J MATERN-FETAL NEO M, V25, P97, DOI 10.3109/14767058.2012.715467; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; Kwon EJ, 2016, ACS NANO, V10, P7926, DOI 10.1021/acsnano.6b03858; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; Lei F, 2013, PUBLIC ADMINISTRATION IN THE TIME OF REGIONAL CHANGE (ICPM 2013), P127; Li XB, 2009, NANOMED-NANOTECHNOL, V5, P473, DOI 10.1016/j.nano.2009.01.013; Liu HF, 2018, INT J NANOMED, V13, P8379, DOI 10.2147/IJN.S181002; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matabola KP, 2013, J MATER SCI, V48, P5475, DOI 10.1007/s10853-013-7341-6; Mehta P., 2016, DRUG DISCOV TODAY, V22; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Moghadam H., 2009, IRANIAN J CHEM ENG, V6, P88; Nath SD, 2013, INT J PHARMACEUT, V443, P87, DOI 10.1016/j.ijpharm.2012.12.037; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Parhizkar M, 2017, MATER DESIGN, V126, P73, DOI 10.1016/j.matdes.2017.04.029; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pohland M, 2017, INT J NANOMED, V12, P1577, DOI 10.2147/IJN.S127206; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Sun WQ, 2004, BIOMATERIALS, V25, P3065, DOI 10.1016/j.biomaterials.2003.09.087; Varshosaz J, 2018, EUR J PHARM SCI, V112, P195, DOI 10.1016/j.ejps.2017.11.026; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Wilson B, 2008, EUR J PHARM BIOPHARM, V70, P75, DOI 10.1016/j.ejpb.2008.03.009; Yacoby I, 2007, ANTIMICROB AGENTS CH, V51, P2156, DOI 10.1128/AAC.00163-07; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491; Zhang WJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3153326; Zhou ZW, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.827; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	55	4	4	1	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2013			INT J NANOMED	Int. J. Nanomed.		2020	15						8495	8506		10.2147/IJN.S264025			12	Nanoscience & Nanotechnology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Pharmacology & Pharmacy	OJ1EJ	WOS:000583710100001	33154639	gold, Green Published			2022-02-06	
J	Zhao, L; Chen, XS; Zhou, SJ; Lin, ZQ; Yu, X; Huang, Y				Zhao, Lei; Chen, Xiaosheng; Zhou, Shengjun; Lin, Zhiqing; Yu, Xi; Huang, Yi			DNA methylation of AHCY may increase the risk of ischemic stroke	BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Ischemic stroke; DNA methylation; S-adenosylhomocysteine hydrolase; sex; age	L-HOMOCYSTEINE HYDROLASE; EPIGENETIC MECHANISMS; GENOME-WIDE; ASSOCIATION; POLYMORPHISMS; MORTALITY; VARIANTS; SUBTYPES; DISEASE	Genetic factors play an important role in the pathogenesis of ischemic stroke. Of these, epigenetic modifications provide a new direction for the study of ischemic stroke pathogenesis. This study aimed to determine the correlation between DNA methylation of the gene encoding S-adenosylhomocysteine hydrolase (AHCY) and the risk of ischemic stroke in 64 ischemic stroke patients and 138 patients with traumatic brain injury (control group). The methylation level of AHCY was analyzed using quantitative methylation-specific polymerase chain reaction. Statistically significant differences in AHCY methylation levels were observed between the case group [medians (interquartile range): 0.13% (0.09%, 0.27%)] and the control group [0.06% (0.00%, 0.17%), p < 0.0001], and these associations remained significant in both male (p = 0.003) and female (p = 0.0005) subjects. A subgroup analysis by age revealed a considerably higher percentage of methylated AHCY in the case group than the control group in all age groups (age < 60 years, p = 0.007; age = 60 years, p < 0.0001). A receiver operating characteristic (ROC) curve analysis revealed a trend toward a role for AHCY methylation as an indicator of risk in all ischemic patients [area under the curve (AUC) = 0.70, p = 0.0001], male patients (AUC = 0.67, p = 0.004), and female patients (AUC = 0.75, p = 0.0002). Our study confirmed a significant association between the AHCY DNA methylation level and the risk of ischemic stroke, suggesting that this gene methylation pattern may be a potential diagnostic marker of ischemic stroke.	[Zhao, Lei; Chen, Xiaosheng; Zhou, Shengjun; Lin, Zhiqing; Huang, Yi] Ningbo First Hosp, Dept Neurosurg, 59 Liuting St, Ningbo 315010, Zhejiang, Peoples R China; [Zhao, Lei; Chen, Xiaosheng; Zhou, Shengjun; Lin, Zhiqing; Huang, Yi] Zhejiang Univ, Ningbo Hosp, Sch Med, Ningbo, Peoples R China; [Yu, Xi] Lihuili Hosp, Key Lab, Ningbo Med Ctr, 111 Jiangnan Rd, Ningbo 315040, Zhejiang, Peoples R China		Huang, Y (corresponding author), Ningbo First Hosp, Dept Neurosurg, 59 Liuting St, Ningbo 315010, Zhejiang, Peoples R China.; Yu, X (corresponding author), Lihuili Hosp, Key Lab, Ningbo Med Ctr, 111 Jiangnan Rd, Ningbo 315040, Zhejiang, Peoples R China.	yuxizhenhao@163.com; huangy102@gmail.com		Huang, Yi/0000-0003-3598-9747	Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LQ17H090002]; Medicine and Health Science and Technology Projects of Zhejiang Province [2018KY665, 2018KY674, 2017KY586, 2017KY588, 2017KY610]; Ningbo Health Branding Subject Fund [PPXK2018-04]	This study was supported by grants from the Zhejiang Provincial Natural Science Foundation of China (LQ17H090002), the Medicine and Health Science and Technology Projects of Zhejiang Province (2018KY665, 2018KY674, 2017KY586, 2017KY588, 2017KY610), and the Ningbo Health Branding Subject Fund (PPXK2018-04).	Baric I, 2009, J INHERIT METAB DIS, V32, P459, DOI 10.1007/s10545-009-1146-4; Cardoso AL, 2018, AGEING RES REV, V47, P214, DOI 10.1016/j.arr.2018.07.004; Chen ZH, 2017, NEUROEPIDEMIOLOGY, V48, P95, DOI 10.1159/000477494; Demyanenko S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122882; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Fu YF, 2006, J PHARMACOL EXP THER, V316, P1229, DOI 10.1124/jpet.105.093369; Giusti B, 2008, J MED GENET, V45, P721, DOI 10.1136/jmg.2008.057851; Giusti B, 2010, THROMB HAEMOSTASIS, V104, P231, DOI 10.1160/TH09-11-0748; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Haghdoost-Yazdi H, 2014, PHARMACOL BIOCHEM BE, V124, P297, DOI 10.1016/j.pbb.2014.06.020; Hu HC, 2019, PATHOL ONCOL RES, V25, P567, DOI 10.1007/s12253-018-0505-6; Jakubowski JL, 2017, J PARKINSON DIS, V7, P1, DOI 10.3233/JPD-160914; Ji HH, 2019, GENE, V689, P84, DOI 10.1016/j.gene.2018.11.088; Kassis H, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030089; Li S, 2019, CURR NEUROVASC RES, V16, P494, DOI 10.2174/1567202616666191029112334; Li X, 2018, CHIN J PRACT NERV DI, V21, P1424; Markus HS, 2011, HUM MOL GENET, V20, pR124, DOI 10.1093/hmg/ddr345; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Novak EM, 2016, MED HYPOTHESES, V97, P22, DOI 10.1016/j.mehy.2016.10.008; Schweizer S, 2013, J CEREBR BLOOD F MET, V33, P1335, DOI 10.1038/jcbfm.2013.93; Shen Y, 2019, STROKE, V50; Shen ZS, 2016, ONCOL LETT, V12, P2999, DOI 10.3892/ol.2016.5018; Singhal A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02264; Soriano-Tarraga C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22579-0; Soriano-Tarraga C, 2017, NEUROLOGY, V89, P830, DOI 10.1212/WNL.0000000000004261; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Thon N, 2017, J NEUROL, V264, P350, DOI 10.1007/s00415-016-8355-1; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wang LY, 2017, NEUROLOGY, V89, P758, DOI 10.1212/WNL.0000000000004278; Wang ZP, 2016, NEUROSCI LETT, V621, P47, DOI 10.1016/j.neulet.2016.04.016; Wezyk M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6918797; Xiao JH, 2019, CURR NEUROVASC RES, V16, P115, DOI 10.2174/1567202616666190412154407; Ye ZS, 2017, J STROKE CEREBROVASC, V26, P618, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.016; Zhang Ying-dong, 2005, Chinese Medical Sciences Journal, V20, P247; Zhong XD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00589; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221; Zhou SJ, 2017, DNA CELL BIOL, V36, P436, DOI 10.1089/dna.2016.3499; Zhu Y, 2019, NEUROL RES, V41, P1090, DOI 10.1080/01616412.2019.1673286; Zhuang JH, 2017, ARTERIOSCL THROM VAS, V37, P84, DOI 10.1161/ATVBAHA.116.307923	40	4	4	5	7	ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO	CEKALUSA	UNIV SARAJEVO, MEDICAL FAC, CEKALUSA, SARAJEVO 90, BOSNIA & HERCEG	1512-8601	1840-4812		BOSNIAN J BASIC MED	Bosnian J. Basic Med. Sci.		2020	20	4					471	476		10.17305/bjbms.2020.4535			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	NT9KN	WOS:000573258600008	32020847	Green Published, gold			2022-02-06	
J	Makley, MJ; Gerber, D; Newman, JK; Philippus, A; Monden, KR; Biggs, J; Spier, E; Tarwater, P; Weintraub, A				Makley, Michael J.; Gerber, Don; Newman, Jody K.; Philippus, Angie; Monden, Kimberley R.; Biggs, Jennifer; Spier, Eric; Tarwater, Patrick; Weintraub, Alan			Optimized Sleep After Brain Injury (OSABI): A Pilot Study of a Sleep Hygiene Intervention for Individuals With Moderate to Severe Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						sleep disorders; traumatic brain injury (TBI); actigraphy; sleep hygiene; rehabilitation; circadian disorders; sleep; wake cycle disorders	WAKE DISTURBANCES; DISORDERS; MEMORY; REHABILITATION; ORIENTATION; PREVALENCE; COGNITION; RECOVERY; IMPACT; SCALE	Background. Disrupted sleep is common after traumatic brain injury (TBI) particularly in the inpatient rehabilitation setting where it may affect participation in therapy and outcomes. Treatment of sleep disruption in this setting is varied and largely unexamined. Objective. To study the feasibility of instituting a sleep hygiene intervention on a rehabilitation unit. Methods. Twenty-two individuals admitted to a brain injury unit were enrolled and allocated, using minimization, to either a sleep hygiene protocol (SHP) or standard of care (SOC). All participants wore actigraphs, underwent serial cognitive testing, and had light monitors placed in their hospital rooms for 4 weeks. Additionally, participants in the SHP received 30 minutes of blue-light therapy each morning, had restricted caffeine intake after noon, and were limited to 30-minute naps during the day. SHP participants had their lights out time set according to preinjury sleep time preference. Both groups were treated with the same restricted formulary of centrally acting medications. Results. Of 258 patients screened, 27 met all study inclusion criteria of whom 22 were enrolled. Nine participants in each group who had at least 21 days of treatment were retained for analysis. The protocol was rated favorably by participants, families, and staff. Actigraph sleep metrics improved in both groups during the 4-week intervention; however, only in the SHP was the change significant. Conclusions. Sleep hygiene is a feasible, nonpharmacologic intervention to treat disrupted sleep in a TBI inpatient rehabilitation setting. A larger study is warranted to examine treatment efficacy. Identifier: NCT02838082.	[Makley, Michael J.; Gerber, Don; Newman, Jody K.; Philippus, Angie; Monden, Kimberley R.; Biggs, Jennifer; Spier, Eric; Weintraub, Alan] Craig Hosp, Englewood, CO USA; [Makley, Michael J.; Spier, Eric; Weintraub, Alan] CNS Med Grp, Englewood, CO USA; [Makley, Michael J.; Monden, Kimberley R.; Spier, Eric; Weintraub, Alan] Univ Colorado, Sch Med, Aurora, CO USA; [Tarwater, Patrick] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA		Makley, MJ (corresponding author), Craig Hosp, CNS Med Grp, 3425 South Clarkson St, Englewood, CO 80113 USA.	mmakley@craighospital.org	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452; Philippus, Angela/0000-0001-7427-8660	Craig Hospital Foundation; MINDSOURCE-Brain Injury Network [NCT02838082]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Craig Hospital Foundation and MINDSOURCE-Brain Injury Network, formerly the Colorado Brain Injury Trust Program, under grant number NCT02838082	Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Ancoli-Israel S, 2015, BEHAV SLEEP MED, V13, pS4, DOI 10.1080/15402002.2015.1046356; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Bogner J, INTRO AGITATED BEHAV; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; Draganich C, 2019, BRAIN INJURY, V33, P1194, DOI 10.1080/02699052.2019.1631484; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Hermann DM, 2016, NEUROLOGY, V87, P1407, DOI 10.1212/WNL.0000000000003037; Higgins PA, 2007, RES NURS HEALTH, V30, P120, DOI 10.1002/nur.20167; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Mackey M., 2012, FISCAL TIMES; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2018, NEUROREHABILITATION, V43, P277, DOI 10.3233/NRE-182537; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Monden KR, 2017, BRAIN INJ PROFESSION, V14; Morin C. M., 2011, PRINCIPLES PRACTICE, P866, DOI [DOI 10.1016/B978-1-4160-6645-3.00079-7, 10.1016/b978-1-4160-6645-3.00079-7]; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Richards KC, 2005, J AM GERIATR SOC, V53, P1510, DOI 10.1111/j.1532-5415.2005.53460.x; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Walker M., 2017, WHY WE SLEEP UNLOCKI; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Werner JK, 2017, SEMIN NEUROL, V37, P419, DOI 10.1055/s-0037-1604487; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Wright J., 2000, INTRO DISABILITY RAT	53	4	4	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	FEB	2020	34	2					111	121	1545968319895478	10.1177/1545968319895478		DEC 2019	11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KJ9XO	WOS:000507007600001	31884895				2022-02-06	
J	Rauwenhoff, J; Peeters, F; Bol, Y; Van Heugten, C				Rauwenhoff, Johanne; Peeters, Frenk; Bol, Yvonne; Van Heugten, Caroline			The BrainACT study: acceptance and commitment therapy for depressive and anxiety symptoms following acquired brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Acquired brain injury; Acceptance and commitment therapy; Depression; Anxiety; Protocol; RCT	COGNITIVE-BEHAVIORAL THERAPY; PSYCHOLOGICAL FLEXIBILITY; PSYCHOMETRIC-PROPERTIES; POSTSTROKE DEPRESSION; MAJOR DEPRESSION; HOSPITAL ANXIETY; STROKE PATIENTS; QUESTIONNAIRE; PSYCHOTHERAPY; EFFICACY	Background Following an acquired brain injury, individuals frequently experience anxiety and/or depressive symptoms. However, current treatments for these symptoms are not very effective. A promising treatment is acceptance and commitment therapy (ACT), which is a third-wave behavioural therapy. The primary goal of this therapy is not to reduce symptoms, but to improve psychological flexibility and general well-being, which may be accompanied by a reduction in symptom severity. The aim of this study is to investigate the effectiveness of an adapted ACT intervention (BrainACT) in people with acquired brain injury who experience anxiety and/or depressive symptoms. Methods The study is a multicenter, randomized, controlled, two-arm parallel trial. In total, 94 patients who survive a stroke or traumatic brain injury will be randomized into an ACT or control (i.e. psycho-education and relaxation) intervention. The primary outcome measures are the Hospital Anxiety and Depression Scale and the Depression Anxiety Stress Scale. Outcomes will be assessed by trained assessors, blinded to treatment condition, pre-treatment, during treatment, post-treatment, and at 7 and 12 months. Discussion This study will contribute to the existing knowledge on how to treat psychological distress following acquired brain injury. If effective, BrainACT could be implemented in clinical practice and potentially help a large number of patients with acquired brain injury.	[Rauwenhoff, Johanne; Van Heugten, Caroline] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands; [Rauwenhoff, Johanne; Van Heugten, Caroline] Limburg Brain Injury Ctr, POB 616, NL-6200 MD Maastricht, Netherlands; [Peeters, Frenk] Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol Sci, POB 5800, NL-6202 AZ Maastricht, Netherlands; [Bol, Yvonne] Zuyderland Med Ctr, Dept Clin & Med Psychol, POB 5500, NL-6130 MB Sittard, Netherlands; [Van Heugten, Caroline] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands		Van Heugten, C (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands.; Van Heugten, C (corresponding author), Limburg Brain Injury Ctr, POB 616, NL-6200 MD Maastricht, Netherlands.; Van Heugten, C (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands.	caroline.vanheugten@maastrichtuniversity.nl		Rauwenhoff, Johanne/0000-0002-0064-6560; Peeters, F/0000-0002-6167-8582	ZonMWNetherlands Organization for Health Research and Development	The study is funded by ZonMW. The funder had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.	A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Ayis SA, 2018, J AFFECT DISORDERS, V228, P33, DOI 10.1016/j.jad.2017.11.037; Baars-Elsinga A, 2013, NEDERLANDS TIJDSCHRI, V1, P29; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Broomfield NM, 2011, CLIN PSYCHOL PSYCHOT, V18, P202, DOI 10.1002/cpp.711; Capaldi VF, 2010, PSYCHOL RES BEHAV MA, V3, P109, DOI 10.2147/PRBM.S10035; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Corp I, 2017, IBM SPSS STAT WIND V; Crowley D, 2018, AGING MENT HEALTH, V22, P1321, DOI 10.1080/13607863.2017.1348478; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fledderus M, 2013, BEHAV RES THER, V51, P142, DOI 10.1016/j.brat.2012.11.007; Gillanders DT, 2014, BEHAV THER, V45, P83, DOI 10.1016/j.beth.2013.09.001; Graham CD, 2015, CLIN CASE STUD, V14, P83, DOI 10.1177/1534650114539386; Hayes SC, 2004, BEHAV THER, V35, P639, DOI 10.1016/S0005-7894(04)80013-3; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 2004, PRACTICAL GUIDE ACCE; Jacobson E, 1938, J ABNORM PSYCHOL, V75, P18; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jansen G, 2014, TIME ACT BASISBOEK P; Janssen B., 2015, EQ 5D 5L USER GUIDE; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kneebone I, 2014, DISABIL REHABIL, V36, P771, DOI 10.3109/09638288.2013.808275; Kootker JA, 2017, ARCH PHYS MED REHAB, V98, P687, DOI 10.1016/j.apmr.2016.10.013; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE47, DOI 10.1097/HTR.0000000000000439; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Luoma J.B., 2007, LEARNING ACT ACCEPTA; Majumdar S, 2019, BRIT J CLIN PSYCHOL, V58, P70, DOI 10.1111/bjc.12198; McCracken LM, 2014, CLIN J PAIN, V30, P894, DOI 10.1097/AJP.0000000000000047; Ost LG, 2014, BEHAV RES THER, V61, P105, DOI 10.1016/j.brat.2014.07.018; Pais C, 2019, NEUROPSYCHOL REHABIL, V29, P625, DOI 10.1080/09602011.2017.1313745; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Powers MB, 2009, PSYCHOTHER PSYCHOSOM, V78, P73, DOI 10.1159/000190790; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Schultz JH, 1989, UBUNGSHEFT AUTOGENE; Smith J, 2009, CLIN REHABIL, V23, P195, DOI 10.1177/0269215508092820; Swain J, 2013, CLIN PSYCHOL REV, V33, P965, DOI 10.1016/j.cpr.2013.07.002; Thorn JC, 2013, APPL HEALTH ECON HEA, V11, P155, DOI 10.1007/s40258-013-0022-4; Townend E, 2010, CLIN REHABIL, V24, P555, DOI 10.1177/0269215509358934; van Mierlo ML, 2015, ARCH PHYS MED REHAB, V96, P1064, DOI 10.1016/j.apmr.2015.01.022; Waldron B, 2013, NEUROPSYCHOL REHABIL, V23, P64, DOI 10.1080/09602011.2012.724196; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Wicksell RK, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2010.05.001; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706; Wilz G, 2007, BRAIN INJURY, V21, P39, DOI 10.1080/02699050601121996	53	4	4	1	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	DEC 27	2019	20	1							773	10.1186/s13063-019-3952-9			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	JY9CV	WOS:000504705100016	31881916	gold, Green Published			2022-02-06	
J	Barloese, MCJ; Beske, RP; Petersen, AS; Haddock, B; Lund, N; Jensen, RH				Barloese, Mads C. J.; Beske, Rasmus P.; Petersen, Anja S.; Haddock, Bryan; Lund, Nunu; Jensen, Rigmor H.			Episodic and Chronic Cluster Headache: Differences in Family History, Traumatic Head Injury, and Chronorisk	HEADACHE			English	Article						cluster headache; biological rhythm disorders; traumatic brain injuries	SLEEP; CONNECTION; MIGRAINE	Objective and Background The diagnostic criteria of episodic and chronic cluster headache (cCH) were recently modified, yet pathophysiological differences between the two are still unclear. The aim of this cross-sectional study is to identify and characterize other differences between episodic and cCH. Methods Data from a retrospective, questionnaire- and interview-based study were analyzed with a focus on associated factors including traumatic head injury (THI), familial history, and change of phenotype. Attack patterns were analyzed using Gaussian and spectral modeling. Results 400 patients and 200 controls participated. A positive family history was more prevalent in chronic than episodic cluster headache (eCH) (34/146 (23%) vs 33/253 (13%), respectively, P = .008). A history of THI was more common in patients than controls (173/400 (43%) vs 51/200 (26%), respectively, P < .0001) and in chronic compared to eCH (77/146 (53%) vs 96/253 (37%), respectively, P = .004). Patients with a positive family history had a unique diurnal attack pattern with twice the risk of nocturnal attacks as patients who did not report family history. Patients reporting phenotype change had a chronobiological fingerprint similar to the phenotype they had experienced a transition into. A higher attack frequency in chronic patients was the only difference in symptom manifestation across all analyzed subgroups of patients. Conclusions cCH is associated with a positive family history and THI. In familial CH, a peak in nocturnal chronorisk may implicate genes involved in diurnal-, sleep- and homeostatic regulation. The stereotypical nature of the CH attacks themselves is confirmed and differences between subgroups should be sought in other characteristics.	[Barloese, Mads C. J.] Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct & Diagnost Imaging, Copenhagen, Denmark; [Barloese, Mads C. J.; Beske, Rasmus P.; Petersen, Anja S.; Lund, Nunu; Jensen, Rigmor H.] Rigshosp Glostrup, Danish Headache Ctr, Dept Neurol, Glostrup, Denmark; [Haddock, Bryan] Rigshosp Glostrup, Dept Clin Physiol Nucl Med & PET, Glostrup, Denmark		Barloese, MCJ (corresponding author), Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct & Diagnost Imaging, Copenhagen, Denmark.	mads.christian.johannes.barloese@regionh.dk		Barloese, Mads/0000-0003-1046-2586	Tryg Foundation	This study was in part funded by a grant from the Tryg Foundation.	Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Barloese M, 2015, CEPHALALGIA, V35, P969, DOI 10.1177/0333102414564892; Barloese M, 2014, CEPHALALGIA, V34, P813, DOI 10.1177/0333102414537726; Barloese M, 2012, CEPHALALGIA, V32, P481, DOI 10.1177/0333102412441090; Barloese MCJ, 2015, EUR J NEUROL, V22, P656, DOI 10.1111/ene.12623; Barloese M, 2018, CEPHALALGIA, V38, P2058, DOI 10.1177/0333102418769955; Blau JN, 2004, HEADACHE, V44, P1013, DOI 10.1111/j.1526-4610.2004.04196.x; Fourier C, 2019, HEADACHE, V59, P410, DOI 10.1111/head.13462; Fourier C, 2018, CEPHALALGIA, V38, P496, DOI 10.1177/0333102417698709; Frederiksen HH, 2020, CEPHALALGIA, V40, P49, DOI 10.1177/0333102419863030; Gobel H, 1998, NEUROLOGY, V51, P908, DOI 10.1212/WNL.51.3.908; Jensen RM, 2007, CEPHALALGIA, V27, P535, DOI 10.1111/j.1468-2982.2007.01330.x; KUDROW L, 1981, HEADACHE, V21, P1, DOI 10.1111/j.1526-4610.1981.hed2101001.x; KUDROW L, 1994, HEADACHE, V34, P400, DOI 10.1111/j.1526-4610.1994.hed3407400.x; Lambru G, 2010, CEPHALALGIA, V30, P1502, DOI 10.1177/0333102409359710; Lambru G, 2009, HEADACHE, V49, P1059, DOI 10.1111/j.1526-4610.2009.01456.x; Leone M, 2001, NEUROLOGY, V56, P1233, DOI 10.1212/WNL.56.9.1233; Lund N, 2019, CEPHALALGIA, V39, P254, DOI 10.1177/0333102418784751; Lund N, 2017, NEUROLOGY, V88, P1069, DOI 10.1212/WNL.0000000000003715; Manzoni GC, 1999, CEPHALALGIA, V19, P88, DOI 10.1046/j.1468-2982.1999.019002088.x; MANZONI GC, 1991, CEPHALALGIA, V11, P169, DOI 10.1046/j.1468-2982.1991.1104169.x; Moon H-S, 2019, CEPHALALGIA, V11; Petersen AS, 2019, HEADACHE, V59, P1198, DOI 10.1111/head.13603; Rozen TD, 2012, HEADACHE, V52, P99, DOI 10.1111/j.1526-4610.2011.02028.x; Russell MB, 2004, LANCET NEUROL, V3, P279; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjostrand C, 2010, HEADACHE, V50, P374, DOI 10.1111/j.1526-4610.2009.01426.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x	28	4	5	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAR	2020	60	3					515	525		10.1111/head.13730		DEC 2019	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KQ3YL	WOS:000504241700001	31868233				2022-02-06	
J	Vogel, EW; Panzer, MB; Morales, FN; Varghese, N; Bass, CR; Meaney, DF; Morrison, B				Vogel, Edward W., III; Panzer, Matthew B.; Morales, Fatima N.; Varghese, Nevin; Bass, Cameron R.; Meaney, David F.; Morrison, Barclay, III			Direct Observation of Low Strain, High Rate Deformation of Cultured Brain Tissue During Primary Blast	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; In vitro studies; Military injury	FINITE-ELEMENT MODEL; IN-VITRO; MECHANICAL STRETCH; AXONAL DAMAGE; INJURY; VULNERABILITY; DISRUPTION; HEAD	The Veterans Health Administration determined that over 250,000 U.S. service members were diagnosed with a traumatic brain injury (TBI) between 2008 and 2018, of which a great proportion were due to blast exposure. Although the penetrating (secondary) and inertia-driven (tertiary) phases of blast-induced TBI (bTBI) have been studied thoroughly and are known to be injurious, primary blast brain injury has been less studied. We investigated the biomechanics of primary bTBI in our previously developed in vitro shock tube model with a fluid-filled sample receiver. Using stereoscopic, high-speed cameras and digital image correlation (DIC), we mapped the deformation of organotypic hippocampal slice cultures (OHSCs) following a range of blast exposures to characterize the induced strains. As blast exposure increased, tissue strain increased, although the levels remained relatively low (maximum < 9%), with strains rates between 25 and 85 s(-1). Both strain magnitude and rate were highly correlated with the in-air blast impulse and in-fluid peak pressure parameters. Comparing biomechanical parameters to previously reported blast-induced electrophysiological dysfunction, a threshold for deficits in long-term potentiation (LTP) was observed for strains between 3.7 and 6.7% and strain rates between 25 and 33 s(-1). This is the first study to experimentally determine primary blast-induced strain and strain rates in hippocampal tissue.	[Vogel, Edward W., III; Morales, Fatima N.; Varghese, Nevin; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA; [Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Dept Mech & Aerosp Engn, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Bass, Cameron R.] Duke Univ, Dept Biomed Engn, 136 Hudson Hall, Durham, NC 27708 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	Multidisciplinary University Research Initiative from the Army Research Office [W911NF-10-1-0526]; Defense University Research Instrumentation Program (DURIP) grant from the Office of Naval Research [N00014-14-1-0750]; National Defense Science & Engineering Graduate Fellowship from the Department of Defense [EWV-2012]	This work was supported in part by a Multidisciplinary University Research Initiative from the Army Research Office (W911NF-10-1-0526), a Defense University Research Instrumentation Program (DURIP) grant from the Office of Naval Research (N00014-14-1-0750), and by a National Defense Science & Engineering Graduate Fellowship from the Department of Defense (EWV-2012).	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Defense and Veterans Brain Injury Center (DVBIC), 2018, DEP DEF NUMB TRAUM B; Effgen GB, 2017, J NEUROTRAUM, V34, P914, DOI 10.1089/neu.2016.4477; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P1033, DOI 10.1007/s10237-015-0652-6; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Khosla D, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00147; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Takhounts EG, 2008, STAPP CAR C, V52, P1; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	41	4	4	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	APR	2020	48	4					1196	1206		10.1007/s10439-019-02437-4		DEC 2019	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KW4ZG	WOS:000503670500001	31863230				2022-02-06	
J	Okidi, R; Ogwang, DM; Okello, TR; Ezati, D; Kyegombe, W; Nyeko, D; Scolding, NJ				Okidi, R.; Ogwang, D. M.; Okello, T. R.; Ezati, D.; Kyegombe, W.; Nyeko, D.; Scolding, N. J.			Factors affecting mortality after traumatic brain injury in a resource-poor setting	BJS OPEN			English	Article							PROGNOSTIC VALUE; EPIDEMIOLOGY	Background Traumatic brain injury (TBI) is a major cause of long-term disability and economic loss to society. The aim of this study was to assess the factors affecting mortality after TBI in a resource-poor setting. Methods Chart review was performed for randomly selected patients who presented with TBI between 2013 and 2017 at St Mary's Hospital, Lacor, northern Uganda. Data collected included demographic details, time from injury to presentation, and vital signs on arrival. In-hospital management and mortality were recorded. Severe head injury was defined as a Glasgow Coma Scale score below 9. Results A total of 194 patient charts were reviewed. Median age at time of injury was 27 (i.q.r. 2-68) years. The majority of patients were male (M : F ratio 4 center dot 9 : 1). Some 30 center dot 9 per cent of patients had severe head injury, and an associated skull fracture was observed in 8 center dot 8 per cent. Treatment was mainly conservative in 94 center dot 8 per cent of patients; three patients (1 center dot 5 per cent) had burr-holes, four (2 center dot 1 per cent) had a craniotomy, and three (1 center dot 5 per cent) had skull fracture elevation. The mortality rate was 33 center dot 0 per cent; 46 (72 per cent) of the 64 patients who died had severe head injury. Of the ten surgically treated patients, seven died, including all three patients who had a burr-hole. In multivariable analysis, factors associated with mortality were mean arterial pressure (P = 0 center dot 012), referral status (P = 0 center dot 001), respiratory distress (P = 0 center dot 040), severe head injury (P = 0 center dot 011) and pupil reactivity (P = 0 center dot 011). Conclusion TBI in a resource-poor setting remains a major challenge and affects mainly young males. Decisions concerning surgical intervention are compromised by the lack of both CT and intracranial pressure monitoring, with consequent poor outcomes.	[Okidi, R.; Ogwang, D. M.; Ezati, D.; Kyegombe, W.; Nyeko, D.] St Marys Hosp, Dept Surg, Lacor, Gulu, Uganda; [Okidi, R.; Ogwang, D. M.; Scolding, N. J.] Gulu Univ, Fac Med, Gulu, Uganda; [Okello, T. R.] Lira Univ, Fac Med, Dept Surg, Lira, Uganda; [Scolding, N. J.] Univ Bristol, Inst Clin Neurosci, Bristol, Avon, England		Okidi, R (corresponding author), St Marys Hosp, Dept Surg, Lacor, Gulu, Uganda.	ronnieokidi@gmail.com	Okidi, Ronald/AAM-9258-2020	Okidi, Ronald/0000-0002-0573-3866; Scolding, Neil/0000-0001-9177-1043	LHIREC	The authors give special thanks to the Records Department staff at StMary's Hospital, Lacor, for their support in retrieving patients' charts, and to all staff from the Department of Surgery. They also thank the hospital's LHIREC for positively supporting this review project.	Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Dunser MW, 2017, ANAESTHESIA, V72, P181, DOI 10.1111/anae.13710; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kalyan SR, 2007, S AFR J PHYSIOTHER, V63, pa141; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	16	4	4	0	1	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	2474-9842			BJS OPEN	BJS Open	APR	2020	4	2					320	325		10.1002/bjs5.50243		DEC 2019	6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KX6NK	WOS:000503750600001	32207576	hybrid, Green Published			2022-02-06	
J	Yamagata, B; Ueda, R; Tasato, K; Aoki, Y; Hotta, S; Hirano, J; Takamiya, A; Nakaaki, S; Tabuchi, H; Mimura, M				Yamagata, Bun; Ueda, Ryo; Tasato, Kumiko; Aoki, Yuta; Hotta, Shogo; Hirano, Jinichi; Takamiya, Akihiro; Nakaaki, Shutaro; Tabuchi, Hajime; Mimura, Masaru			Widespread White Matter Aberrations Are Associated with Phonemic Verbal Fluency Impairment in Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; neuroimaging; tract-based spatial statistics (TBSS); traumatic brain injury; verbal fluency task	CORPUS-CALLOSUM; AXONAL INJURY; DIFFUSION; MICROSTRUCTURE; PERFORMANCE; INTEGRITY; DISORDER; VERSION; MODEL	Microstructural white matter (WM) disruption and resulting abnormal structural connectivity form a potential underlying pathology in traumatic brain injury (TBI). Herein, to determine the potential mechanism of cognitive deterioration in TBI, we examined the association of damage to specific WM tracts with cognitive function in TBI patients. We recruited 18 individuals with mild-to-moderate/severe TBI in the chronic phase and 17 age-matched controls. We determined the pattern of WM aberrations in TBI using tract-based spatial statistics (TBSS) and then examined the relationship between cognitive impairment and WM damage using the threshold-free cluster enhancement correction in TBSS. TBSS analysis showed that TBI patients exhibited WM aberrations in a wide range of brain regions. In the majority of these regions, lower fractional anisotropy (FA) largely overlapped with increased radial diffusivity, but not with axial diffusivity. Further, voxel-wise correction in TBSS demonstrated that higher FA values were associated with better performance in the phonemic verbal fluency task (VFT) in widespread WM regions, but not with the semantic VFT. Despite variation in the magnitude and location of brain injury between individual cases, chronic TBI patients exhibited widespread WM aberrations. We confirmed the findings of previous studies that WM integrity is lower across the spectrum of TBI severity in chronic subjects compared to controls. Further, phonemic VFT may be a more sensitive cognitive measure of executive dysfunction associated with WM aberrations in TBI compared with semantic VFT.	[Yamagata, Bun; Tasato, Kumiko; Hotta, Shogo; Hirano, Jinichi; Takamiya, Akihiro; Tabuchi, Hajime; Mimura, Masaru] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan; [Ueda, Ryo] Tokyo Metropolitan Univ, Grad Sch Hlth Sci, Dept Radiol Sci, Tokyo, Japan; [Ueda, Ryo] Keio Univ Hosp, Off Radiat Technol, Tokyo, Japan; [Aoki, Yuta] Showa Univ, Med Inst Dev Disabil Res, Tokyo, Japan; [Nakaaki, Shutaro] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan		Yamagata, B (corresponding author), Keio Univ, Dept Neuropsychiat, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yamagata@a6.keio.jp	Takamiya, Akihiro/AAE-8592-2021	Takamiya, Akihiro/0000-0003-2985-6673; aoki, yuta/0000-0001-5617-4948	General Insurance Association of Japan	This work was partially supported by The General Insurance Association of Japan (to B.Y.).	Aoki Y, 2018, J CHILD PSYCHOL PSYC, V59, P193, DOI 10.1111/jcpp.12778; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Barnea-Goraly N, 2010, ARCH GEN PSYCHIAT, V67, P1052, DOI 10.1001/archgenpsychiatry.2010.123; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bloemen OJN, 2010, AUTISM RES, V3, P203, DOI 10.1002/aur.146; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Cralidis A, 2014, BRAIN INJURY, V28, P456, DOI 10.3109/02699052.2014.896945; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hirata-Mogi S, 2016, PSYCHIAT CLIN NEUROS, V70, P362, DOI 10.1111/pcn.12400; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li L, 2016, CHINESE MED J-PEKING, V129, P1091, DOI 10.4103/0366-6999.180518; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027	43	4	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					975	981		10.1089/neu.2019.6751		DEC 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000504860800001	31631743				2022-02-06	
J	Rauen, K; Pop, V; Trabold, R; Badaut, J; Plesnila, N				Rauen, Katrin; Pop, Viorela; Trabold, Raimund; Badaut, Jerome; Plesnila, Nikolaus			Vasopressin V-1a Receptors Regulate Cerebral Aquaporin 1 after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						arginine vasopressin; brain edema; cerebral aquaporin; traumatic brain injury; vasopressin V-1a receptor knockout mouse	CONTROLLED CORTICAL IMPACT; ARGININE-VASOPRESSIN; V1A RECEPTOR; CATECHOLAMINERGIC NEURONS; ANTAGONIST SR49059; CONTUSION VOLUME; ARTERY OCCLUSION; EDEMA FORMATION; V-2 RECEPTORS; BLOOD-VOLUME	Brain edema formation contributes to secondary brain damage and unfavorable outcome after traumatic brain injury (TBI). Aquaporins (AQP), highly selective water channels, are involved in the formation of post-trauma brain edema; however, their regulation is largely unknown. Because vasopressin receptors are involved in AQP-mediated water transport in the kidney and inhibition of V-1a receptors reduces post-trauma brain edema formation, we hypothesize that cerebral AQPs may be regulated by V-1a receptors. Cerebral Aqp1 and Aqp4 messenger ribonucleic acid (mRNA) and AQP1 and AQP4 protein levels were quantified in wild-type and V-1a receptor knockout (V-1a(-/-)) mice before and 15 min, 1, 3, 6, 12, or 24 h after experimental TBI by controlled cortical impact. In non-traumatized mice, we found AQP1 and AQP4 expression in cortical neurons and astrocytes, respectively. Experimental TBI had no effect on Aqp4 mRNA or AQP4 protein expression, but increased Aqp1 mRNA (p < 0.05) and AQP1 protein expression (p < 0.05) in both hemispheres. The Aqp1 mRNA and AQP1 protein regulation was blunted in V-1a receptor knockout mice. The V-1a receptors regulate cerebral AQP1 expression after experimental TBI, thereby unraveling the molecular mechanism by which these receptors may mediate brain edema formation after TBI.	[Rauen, Katrin; Trabold, Raimund; Plesnila, Nikolaus] Univ Munich, Dept Neurosurg, Lab Expt Neurosurg, Med Ctr, Munich, Germany; [Rauen, Katrin; Trabold, Raimund; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Surg Res, Munich, Germany; [Rauen, Katrin; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Munich, Germany; [Rauen, Katrin] Univ Zurich, Dept Geriatr Psychiat, Univ Hosp Psychiat Zurich, Zurich, Switzerland; [Rauen, Katrin] Univ Zurich, Inst Regenerat Med, Zurich, Switzerland; [Pop, Viorela; Badaut, Jerome] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA; [Badaut, Jerome] Univ Bordeaux, Aquitaine Inst Cognit & Integrat Neurosci, Bordeaux, France; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany		Plesnila, N (corresponding author), Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de		Rauen, Katrin/0000-0003-4555-6697	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD061946]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3100A0-122166]; ERA-NET NEURON/BMBF CnsAflame [01EW1502B]	JB was supported by the National Institutes of Health (NIH) grant R01HD061946 and by the Swiss National Science Foundation grant 3100A0-122166. NP was supported by ERA-NET NEURON/BMBF CnsAflame (Funding #01EW1502B).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alonso G, 2008, ENDOCRINOLOGY, V149, P4279, DOI 10.1210/en.2008-0387; Anthony TL, 2000, MOL PHARMACOL, V57, P576, DOI 10.1124/mol.57.3.576; Armbrecht M., 2008, PHOTOMETRIE LEITFADE, P12; Badaut J, 2008, BRAIN RES, V1188, P17, DOI 10.1016/j.brainres.2007.10.087; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Campbell EM, 2012, MOL PHARMACOL, V81, P97, DOI 10.1124/mol.111.073692; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Clement T, 2018, J NEUROSCI RES; Delporte C, 2014, BBA-GEN SUBJECTS, V1840, P1524, DOI 10.1016/j.bbagen.2013.08.007; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Han ZQ, 2000, BIOCHEM BIOPH RES CO, V273, P328, DOI 10.1006/bbrc.2000.2944; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; Hunt MR, 2010, MICROBIOLOGY IMMUNOL; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; King ZA, 2018, DRUG DES DEV THER, V12, P2539, DOI 10.2147/DDDT.S150043; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marmarou A, 2005, ACT NEUR S, V95, P277; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Oshio K, 2003, ACT NEUR S, V86, P525; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Patil RV, 1997, BIOCHEM BIOPH RES CO, V238, P392, DOI 10.1006/bbrc.1997.7310; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Rauen K., 2014, THESIS; Rauen K, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P353, DOI 10.1016/B978-0-12-803196-4.00019-9; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2011, J CEREBR BLOOD F MET, V31, P47, DOI 10.1038/jcbfm.2010.188; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; SZOT P, 1994, MOL BRAIN RES, V24, P1, DOI 10.1016/0169-328X(94)90111-2; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Xu Miao, 2007, Chin J Traumatol, V10, P90; Yool AJ, 2007, NEUROSCIENTIST, V13, P470, DOI 10.1177/1073858407303081; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang W, 2007, J BIOL CHEM, V282, P20933, DOI 10.1074/jbc.M703858200; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	71	4	4	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					665	674		10.1089/neu.2019.6653		DEC 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000501203900001	31547764	Green Published			2022-02-06	
J	Bhatti, F; Naiman, M; Tsarev, A; Kulstad, E				Bhatti, Faraaz; Naiman, Melissa; Tsarev, Alexander; Kulstad, Erik			Esophageal Temperature Management in Patients Suffering from Traumatic Brain Injury	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						temperature mechanisms; traumatic brain injury; brain trauma; cooling strategies; hyperthermia; targeted temperature management; esophageal temperature; heat transfer device	HEAT-TRANSFER DEVICE; COOLING DEVICE; THERAPEUTIC HYPOTHERMIA; FEVER CONTROL; THROMBOSIS; NORMOTHERMIA	Traumatic brain injury (TBI) is a leading cause of death in the United States, and represents 2.5 million Emergency Department attendances, admissions into hospital, and deaths. A range of temperature modulating devices have been used to proactively cool TBI patients; however, there are currently no uniform targeted temperature management (TTM) guidelines in this patient population. Esophageal temperature management (ETM) is a relatively new TTM modality and the purpose of this study is to determine whether ETM is effective in controlling core temperature in TBI cases. This prospective interventional trial was a single-site study that enrolled 12 patients who received a TTM protocol using ETM. Eleven out of 12 patients reached target temperature during the first 10 hours of treatment. A total of 480 temperature measurements were recorded; 85% of the total measurements were within +/- 1 degrees C of target temperature (408 measurements) and 75% were within +/- 0.5 degrees C of target temperature (360 measurements). The average time to target was 5.83 +/- 5.01 hours (range 1-20), with an average cooling rate of 0.58 degrees C/h (range 0.15-1.5 degrees C/h). This prospective interventional trial supports that ETM is a feasible TTM modality for severe TBI cases. The esophageal heat transfer device used in this study demonstrated comparable or superior performance to other commercially available TTM modalities, and the low adverse event rate may offer advantages over more invasive methods with reported higher complication rates.	[Bhatti, Faraaz] Bradford Teaching Hosp NHS Fdn Trust, Dept Emergency Med, Bradford BD9 6RJ, W Yorkshire, England; [Naiman, Melissa] Univ Illinois, Collaborat Adv Design Res & Evaluat, Chicago, IL USA; [Tsarev, Alexander] Hlth Minist Ukraine, Dnipropetrovsk Med Acad, Dept Anesthesiol, Dnepropetrovsk, Ukraine; [Kulstad, Erik] Univ Texas Dallas, Southwestern Med Ctr, Dept Emergency Med, Dallas, TX USA		Bhatti, F (corresponding author), Bradford Teaching Hosp NHS Fdn Trust, Dept Emergency Med, Bradford BD9 6RJ, W Yorkshire, England.	faraaz.bhatti@nhs.net	Tsarev, Alexander V./AAX-8797-2021	Tsarev, Alexander V./0000-0002-2611-604X	Attune Medical	Original study funded by Advanced Cooling Therapy, Inc., now Attune Medical. E.K. is an equity holder of Attune Medical. M.N. is an employee of Attune Medical. All other authors have no related disclosures.	Abou El Fadl MH, 2017, NEUROL CLIN, V35, P641, DOI 10.1016/j.ncl.2017.06.003; [Anonymous], 2015, CDC REP C TRAUM BRAI; Aujla Gurpreet Singh, 2017, Ther Hypothermia Temp Manag, V7, P147, DOI 10.1089/ther.2016.0031; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gierman Joshua L, 2013, Proc (Bayl Univ Med Cent), V26, P100; Gillon Stuart, 2015, J Intensive Care Soc, V16, P71, DOI 10.1177/1751143714551251; Goury A, 2017, RESUSCITATION, V121, P54, DOI 10.1016/j.resuscitation.2017.09.021; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hegazy AF, 2017, HEART LUNG, V46, P143, DOI 10.1016/j.hrtlng.2017.03.001; Hegazy AF, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0133-6; Khan I, 2018, THER HYPOTHERMIA TEM, V8, P53, DOI 10.1089/ther.2017.0033; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lau E, 2010, RESUSCITATION, V81, P1457, DOI 10.1016/j.resuscitation.2010.06.013; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markota A, 2017, J EMERG MED, V52, pE27, DOI 10.1016/j.jemermed.2016.07.086; Markota A, 2016, AM J EMERG MED, V34, P741, DOI 10.1016/j.ajem.2016.01.028; Maze R, 2014, RESUSCITATION, V85, P1354, DOI 10.1016/j.resuscitation.2014.05.029; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Prunet Bertrand, 2009, Cases J, V2, P8857, DOI 10.1186/1757-1626-0002-0000008857; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Reccius A, 2015, NEUROCRIT CARE, V23, P72, DOI 10.1007/s12028-014-0069-6; Simosa HF, 2007, AM SURGEON, V73, P461; Wang X, 2018, THER HYPOTHERMIA TEM, V8, P117, DOI 10.1089/ther.2017.0059; WILLIAMS D, 2016, CASE REP ANESTHESIOL, V2016, P6	31	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	DEC	2019	9	4					238	242		10.1089/ther.2018.0034			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KM2CD	WOS:000513927800004	30657435	Green Published, hybrid			2022-02-06	
J	Chong, AJ; Lim, SW; Lee, YL; Chio, CC; Chang, CH; Kuo, JR; Wang, CC				Chong, Arng Jack; Lim, Sher-Wei; Lee, Yao-lin; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung; Wang, Che-Chuan			The Neuroprotective Effects of Simvastatin on High Cholesterol Following Traumatic Brain Injury in Rats	WORLD NEUROSURGERY			English	Article						Apoptosis, tumor necrosis factor-alpha; Cholesterol; Fluid percussion injury; Simvastatin; Tumor necrosis factor-alpha receptor	STATINS; CNS; NEUROINFLAMMATION; DEGENERATION; DEPRESSION; PROTEIN	BACKGROUND: High cholesterol has been correlated with a greater risk of cerebrovascular diseases. Whether pre-existing high cholesterol exacerbates traumatic brain injury (TBI), and whether treatment with the cholesterol-lowering agent simvastatin has neuroprotective effects, especially anti-neuroinflammatory effects, after TBI are not well investigated. METHODS: Five-week-old male Sprague-Dawley rats were fed a high-fat diet for 8 weeks to induce hypercholesterolemia. Anesthetized male Sprague-Dawley rats were divided into 5 groups, including the sham-operated control, TBI control, and TBI with simvastatin treatment (4 mg/kg, 10 mg/kg, or 20 mg/kg) groups. Simvastatin was intraperitoneally injected at 0, 24, and 48 hours after TBI. Motor function was measured using an inclined plane. Neuronal apoptosis (maker Neu-N, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling), tumor necrosis factor-alpha expression in microglia (marker OX42) and astrocytes (marker glial fibrillary acidic protein), and Tumor necrosis factor-alpha receptor (TNFR) 1 and TNFR2 expression in neurons in the ischemic cortex were investigated using an immunofluorescence assay. All of the parameters were measured on the third day after TBI. RESULTS: TBI significantly increased the serum levels of cholesterol. The TBI-induced motor deficit was significantly attenuated by 4, 10, and 20 mg/kg simvastatin therapy on the third day after TBI. TBI-induced neuronal TNFR1 activation and apoptosis, as well as tumor necrosis factor-alpha expression in astrocytes in the ischemic cortex, were significantly attenuated by simvastatin, particularly when 20 mg/kg was administered. Simultaneously, the serum cholesterol remained high despite simvastatin treatment. CONCLUSIONS: The neuroprotection effects of simvastatin on the pre-existing hypercholesterolemia during TBI in rats may be related to its anti-neuroinflammatory effects but not to its cholesterol-lowing effects.	[Chong, Arng Jack; Lim, Sher-Wei; Lee, Yao-lin; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Gen Educ, Tainan, Taiwan; [Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	kuojinnrung@gmail.com		Lee, Yaolin/0000-0001-7443-1514			Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Cucchiara B, 2001, J NEUROL SCI, V187, P81, DOI 10.1016/S0022-510X(01)00529-9; DEMEDIUK P, 1988, Journal of Neurotrauma, V5, P105, DOI 10.1089/neu.1988.5.105; Diaz-Castro L, 2011, ACTAS ESP PSIQUIATRI, V39, P115; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Farr S, 2016, CURR OPIN LIPIDOL, V27, P1, DOI 10.1097/MOL.0000000000000254; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Herz J, 2014, NEUROBIOL DIS, V62, P456, DOI 10.1016/j.nbd.2013.10.022; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Krisanova N, 2012, BBA-MOL BASIS DIS, V1822, P1553, DOI 10.1016/j.bbadis.2012.06.005; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; MAURO VF, 1993, CLIN PHARMACOKINET, V24, P195, DOI 10.2165/00003088-199324030-00002; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Omotoso AT., 2013, ASIAN J NAT APPL SCI, V2, P82; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	29	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2019	132						E99	E108		10.1016/j.wneu.2019.08.250			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JN5VR	WOS:000496966300014	31518751				2022-02-06	
J	Wright, JN; Feyma, TJ; Ishak, GE; Abeshaus, S; Metz, JB; Brown, ECB; Friedman, SD; Browd, SR; Feldman, KW				Wright, Jason N.; Feyma, Timothy J.; Ishak, Gisele E.; Abeshaus, Sergey; Metz, James B.; Brown, Emily C. B.; Friedman, Seth D.; Browd, Samuel R.; Feldman, Kenneth W.			Subdural hemorrhage rebleeding in abused children: frequency, associations and clinical presentation	PEDIATRIC RADIOLOGY			English	Article						Abusive head trauma; Child abuse; Computed tomography; Infants; Magnetic resonance imaging; Subdural hemorrhage; Subdural rebleeding	ABUSIVE HEAD TRAUMA; HEMATOMAS	Background Limited documentation exists about how frequently radiologically visible rebleeding occurs with abusive subdural hemorrhages (SDH). Likewise, little is known about rebleeding predispositions and associated symptoms. Objective To describe the frequency of subdural rebleeding after abusive head trauma (AHT), its predispositions and clinical presentation. Materials and methods We evaluated children with SDHs from AHT who were reimaged within a year of their initial hospitalization, retrospectively reviewing clinical details and imaging. We used the available CT and MR images. We then performed simple descriptive and comparative statistics. Results Fifty-four of 85 reimaged children (63.5%) with AHT-SDH rebled. No child had new trauma, radiologic evidence of new parenchymal injury or acute neurologic symptoms from rebleeding. From the initial presentation, macrocephaly was associated with subsequent rebleeding. Greater subdural depth, macrocephaly, ventriculomegaly and brain atrophy at follow-up were associated with rebleeding. No other radiologic findings at initial presentation or follow-up predicted rebleeding risk, although pre-existing brain atrophy at initial admission and initial chronic SDHs barely missed significance. Impact injuries, retinal hemorrhages and clinical indices of initial injury severity were not associated with rebleeding. All rebleeding occurred within chronic SDHs; no new bridging vein rupture was identified. The mean time until rebleeding was recognized was 12 weeks; no child had rebleeding after 49 weeks. Conclusion Subdural rebleeding is common and occurs in children who have brain atrophy, ventriculomegaly, macrocephaly and deep SDHs at rebleed. It usually occurs in the early months post-injury. All children with rebleeds were neurologically asymptomatic and lacked histories or clinical or radiologic findings of new trauma. Bleeds did not occur outside of chronic SDHs. We estimate the maximum predicted frequency of non-traumatic SDH rebleeding accompanied by acute neurological symptoms in children with a prior abusive SDH is 3.5%.	[Wright, Jason N.; Ishak, Gisele E.; Friedman, Seth D.] Seattle Childrens Hosp, Harborview Med Ctr, Dept Radiol, Seattle, WA USA; [Wright, Jason N.; Ishak, Gisele E.; Brown, Emily C. B.; Friedman, Seth D.; Browd, Samuel R.; Feldman, Kenneth W.] Univ Washington, Seattle, WA 98195 USA; [Feyma, Timothy J.] Gillette Childrens Specialty Hlth Care, Dept Neurol, St Paul, MN USA; [Abeshaus, Sergey] Rambam Hlth Care Campus, Dept Neurosurg, Haifa, Israel; [Metz, James B.] Univ Vermont, Sch Med, Dept Pediat, Burlington, VT USA; [Brown, Emily C. B.; Feldman, Kenneth W.] Seattle Childrens Hosp, Harborview Med Ctr, Dept Pediat, Childrens Protect Program, M-S SB 250,4800 Sand Point Way NE, Seattle, WA 98105 USA; [Browd, Samuel R.] Seattle Childrens Hosp, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA USA		Feldman, KW (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Feldman, KW (corresponding author), Seattle Childrens Hosp, Harborview Med Ctr, Dept Pediat, Childrens Protect Program, M-S SB 250,4800 Sand Point Way NE, Seattle, WA 98105 USA.	kfeldman@uw.edu		Feldman, Kenneth/0000-0002-9020-5223	Matty Eappen Foundation	The Matty Eappen Foundation provided partial funding for the parent epidemiology study that provided some of the AHT subjects, but the foundation had no role in the current study design or execution, or the development of this manuscript.	Adamsbaum C, 2014, PEDIATR RADIOL, V44, P578, DOI 10.1007/s00247-014-3171-1; [Anonymous], 2013, AANS NEUROSURG, V22; [Anonymous], 2019, TOOLS CALC; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Feldman KW, 2015, J NEUROSURG-PEDIATR, V16, P177, DOI 10.3171/2014.12.PEDS14607; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Hymel Kent P, 2002, Child Maltreat, V7, P329, DOI 10.1177/107755902237263; ITO H, 1987, J NEUROSURG, V66, P862, DOI 10.3171/jns.1987.66.6.0862; Lee KS, 2004, BRAIN INJURY, V18, P351, DOI 10.1080/02699050310001645801; NOMURA S, 1994, J NEUROSURG, V81, P910, DOI 10.3171/jns.1994.81.6.0910; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Sieswerda-Hoogendoorn T, 2014, EUR J RADIOL, V83, P1257, DOI 10.1016/j.ejrad.2014.03.015; Stoodley M, 2000, NEUROSURG CLIN N AM, V11, P425, DOI 10.1016/S1042-3680(18)30104-9; Tysiak EWN, 2012, EUR J PAEDIATR NEURO, V16, P736, DOI 10.1016/j.ejpn.2012.02.006; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512	18	4	4	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	DEC	2019	49	13					1762	1772		10.1007/s00247-019-04483-5			11	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	JO0KJ	WOS:000497275900009	31745619				2022-02-06	
J	Zhu, J; Ling, JY; Ding, N				Zhu, Jie; Ling, Jiyang; Ding, Ning			Association between Diffusion Tensor Imaging Findings and Cognitive Outcomes Following Mild Traumatic Brain Injury: A PRISMA-Compliant Meta-Analysis	ACS CHEMICAL NEUROSCIENCE			English	Article						Diffusion tensor imaging; mild traumatic brain injury; meta-analysis	WHITE-MATTER; IMPAIRMENT; INTEGRITY; NEUROPSYCHOLOGY; DYSFUNCTION; FATIGUE; ADULTS; DAMAGE	Previous diffusion tensor imaging (DTI) research in mild traumatic brain injury (mTBI) patients only concentrated on a limited number of brain regions and a specific cognitive function. Thus, the study aimed to explore the association between DTI findings and cognitive function following mTBI using a meta-analysis. We conducted a search for articles exploring the associations between DTI findings and cognitive outcomes following mTBI published in English in databases (PubMed, Web of Science, EMBASE, Medline, and Google Scholar) before October 2019. The correlations were computed to explore associations between DTI findings and specific cognitive function. Finally, 9 studies (including 293 mTBI patients) were included in the meta-analysis. The study showed that higher fractional anisotropy (FA) values in the longitudinal fasciculus (LF), sagittal stratum (SS), cerebellum, and internal capsule (IC) were associated with better general cognitive function. However, the study showed that higher FA values in the cerebellar peduncles (CP) were associated with worse general cognitive function. Additionally, the present study showed that higher FA values in the mesencephalon, anterior corona radiata (ACR), forceps major (FM), uncinate fasciculus (UF), cingulum, and genu of corpus callosum (gCC) were related to better memory. Higher FA values in the ACR were associated with worse attention, processing speed, and working memory. The study indicated that higher mean diffusivity (MD)/apparent diffusion coefficient (ADC) values in the external capsule (EC) were associated with worse memory. Additionally, higher MD/ADC values in the UF were associated with worse attention, processing speed, and working memory. The present study showed that better white matter integrity (higher FA, lower MD/ADC) might be associated with better cognitive function following mTBI.	[Zhu, Jie; Ling, Jiyang; Ding, Ning] Capital Med Univ, Beijing Tongren Hosp, Dept Emergency Med, 1 Dongjiaominxiang St, Beijing 100730, Peoples R China		Ding, N (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Emergency Med, 1 Dongjiaominxiang St, Beijing 100730, Peoples R China.	NingDing201801@hotmail.com					Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030	29	4	4	0	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	DEC	2019	10	12					4864	4869		10.1021/acschemneuro.9b00584			11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	JX7NW	WOS:000503918400011	31746583				2022-02-06	
J	Dunn, LK; Taylor, DG; Smith, SJ; Skojec, AJ; Wang, TR; Chung, J; Hanak, MF; Lacomis, CD; Palmer, JD; Ruminski, C; Fang, SH; Tsang, S; Spangler, SN; Durieux, ME; Naik, BI				Dunn, Lauren K.; Taylor, Davis G.; Smith, Samantha J.; Skojec, Alexander J.; Wang, Tony R.; Chung, Joyce; Hanak, Mark F.; Lacomis, Christopher D.; Palmer, Justin D.; Ruminski, Caroline; Fang, Shenghao; Tsang, Siny; Spangler, Sarah N.; Durieux, Marcel E.; Naik, Bhiken, I			Persistent post-discharge opioid prescribing after traumatic brain injury requiring intensive care unit admission: A cross-sectional study with longitudinal outcome	PLOS ONE			English	Article							PRESSURE	Traumatic brain injury (TBI) is associated with increased risk for psychological and substance use disorders. The study aim is to determine incidence and risk factors for persistent opioid prescription after hospitalization for TBI. Electronic medical records of patients age. 18 admitted to a neuroscience intensive care unit between January 2013 and February 2017 for an intracranial injury were retrospectively reviewed. Primary outcome was opioid use through 12 months post-hospital discharge. A total of 298 patients with complete data were included in the analysis. The prevalence of opioid use among preadmission opioid users was 48 (87%), 36 (69%) and 22 (56%) at 1, 6 and 12-months post-discharge, respectively. In the opioid naive group, 69 (41%), 24 (23%) and 17 (19%) were prescribed opioids at 1, 6 and 12 months, respectively. Preadmission opioid use (OR 324.8, 95% CI 23.116907.5, p = 0.0004) and higher opioid requirements during hospitalization (OR 4.5, 95% CI 1.8-16.3, p = 0.006) were independently associated with an increased risk of being prescribed opioids 12 months post-discharge. These factors may be used to identify and target at-risk patients for intervention.	[Dunn, Lauren K.; Smith, Samantha J.; Skojec, Alexander J.; Chung, Joyce; Hanak, Mark F.; Lacomis, Christopher D.; Palmer, Justin D.; Ruminski, Caroline; Fang, Shenghao; Spangler, Sarah N.; Durieux, Marcel E.; Naik, Bhiken, I] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Taylor, Davis G.; Wang, Tony R.; Durieux, Marcel E.; Naik, Bhiken, I] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA; [Tsang, Siny] Washington State Univ, Nutr & Exercise Physiol, Spokane, WA USA		Dunn, LK (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA.	lak3r@virginia.edu		Tsang, Siny/0000-0001-5076-5587; Skojec, Alexander/0000-0002-9400-9916			Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Brummett CM, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.0504; Camps AS, 2000, CRIT CARE MED, V28, P3612, DOI 10.1097/00003246-200011000-00009; Colton K, 2016, J INTENSIVE CARE MED, V31, P263, DOI 10.1177/0885066614555692; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259; Dunn LK, 2018, ANESTH ANALG; Harbaugh CM, 2018, JAMA-J AM MED ASSOC, V320, P504, DOI 10.1001/jama.2018.9023; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Portenoy R, 2017, CANC PAIN MANAGEMENT; Shehabi Y, 2019, NEW ENGL J MED, V380, P2506, DOI 10.1056/NEJMoa1904710; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sun YX, 2012, DIS COLON RECTUM, V55, P1183, DOI 10.1097/DCR.0b013e318259bcd8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Team RDC, 2015, R LANG ENV STAT COMP; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Wang HT, 2018, CRIT CARE MED, V46, P1934, DOI 10.1097/CCM.0000000000003401; Wiener J, 2019, BRAIN INJURY, V33, P559, DOI 10.1080/02699052.2019.1574328; Zhao HY, 2019, J CRIT CARE, V54, P136, DOI 10.1016/j.jcrc.2019.08.022	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225787	10.1371/journal.pone.0225787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	WOS:000533896400063	31774864	Green Published, gold			2022-02-06	
J	Hejrati, N; Guzman, R; Soleman, J				Hejrati, Nader; Guzman, Raphael; Soleman, Jehuda			Acute cerebellar edema after traumatic brain injury in a child. a case report	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatric neurosurgery; Bifrontal craniectomy; Cerebellar edema; Posttraumatic hydrocephalus	SINUS THROMBOSIS; HEAD; TRIAL	Traumatic brain injuries (TBI) are a major cause of morbidity and mortality in children. Malignant cerebral edema is described to occur more often in children than in adults. Its infratentorial analogous, a malignant cerebellar edema, has not been reported yet. A 10-year-old boy fell from a height of 3 m where he sustained a TBI. Approximately 36 h after trauma, a significant drop in Glasgow Coma Scale (GCS) occurred accompanied by bilateral fixed and dilated pupils. A computed tomography (CT) scan revealed an underlying acute cerebellar edema without evidence of a sinus vein thrombosis or cerebellar contusions. Immediate suboccipital decompressive surgery and insertion of an external ventricular drain (EVD) were performed. Early postoperative CT imaging showed increasing, space-occupying frontal contusions and perilesional edema, which is why an additional bifrontal craniectomy was performed. A posttraumatic hydrocephalus occurring on the 27th day after trauma was treated with a ventricular-peritoneal shunt. On follow-up, 6 months after trauma, he showed a GCS of 15 with no evident neurological findings. This case report is the first to describe and discuss an acute cerebellar edema occurring after TBI. Its acute complications of brainstem compression and obstructive hydrocephalus are effectively treated by immediate suboccipital decompression and EVD insertion.	[Hejrati, Nader; Guzman, Raphael; Soleman, Jehuda] Univ Hosp Basel, Dept Neurosurg, Spitalstr 21, CH-4031 Basel, Switzerland; [Guzman, Raphael; Soleman, Jehuda] Univ Childrens Hosp Basel, Div Pediat Neurosurg, Spitalstr 33, CH-4056 Basel, Switzerland; [Guzman, Raphael; Soleman, Jehuda] Univ Basel, Fac Med, Basel, Switzerland		Hejrati, N (corresponding author), Univ Hosp Basel, Dept Neurosurg, Spitalstr 21, CH-4031 Basel, Switzerland.	nader.hejrati@bluewin.ch	Soleman, Jehuda/D-8083-2017	Soleman, Jehuda/0000-0003-1900-9286; Hejrati, Nader/0000-0001-8583-9849; Guzman, Raphael/0000-0001-9620-0581			BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TSAI FY, 1995, AM J NEURORADIOL, V16, P1021; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Wilcher J, 2016, PEDIATR EMERG CARE, V32, P872, DOI 10.1097/PEC.0000000000000344	10	4	4	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2020	36	4					847	851		10.1007/s00381-019-04418-3		NOV 2019	5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	KU4FE	WOS:000498742000001	31758241				2022-02-06	
J	Choi, DH; Song, KJ; Shin, SD; Ro, YS; Hong, KJ; Park, JH				Choi, Dong Hyun; Song, Kyoung Jun; Shin, Sang Do; Ro, Young Sun; Hong, Ki Jeong; Park, Jeong Ho			Epidemiology and Outcomes of Sports-Related Traumatic Brain Injury in Children	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Traumatic Brain Injury; Sports; Children	STATES HIGH-SCHOOL; UNITED-STATES; EMERGENCY-DEPARTMENT; HEAD; CONCUSSIONS; TRENDS	Background: Traumatic brain injury (TBI) is one of the leading causes of pediatric disability that results in many emergency department visits. The risk of TBI is high while playing sports. The aim of this study was to examine the demographics and clinical characteristics of sports-related TBI. Methods: We performed a multicenter observational study using the Emergency Department-Based Injury In-Depth Surveillance database in Korea. Patients aged 5 to 18 years old, who sustained unintentional, sports-related head injuries between January 2011 and December 2016 were included. The type of sports was the main variable of interest, and it was classified into 6 categories. The primary outcome was TBI, and the secondary outcome was intracranial injury and hospital admission. A multivariable logistic regression analysis was performed to calculate the adjusted odds ratios (aORs) with 95% confidence intervals for the outcomes by sports type. Results: Of the 1,537,617 injured patients, 10,717 (0.7%) patients were included in the study. Most of the patients were male (87.5%), and the most prevalent sports type was field sports (51.2%). The proportion of TBI, intracranial injury, and admission were 15.7%, 1.2%, and 3.5%, respectively. The aORs of TBI, intracranial injury, and admission in bicycle and street sports compared to field sports were 1.77 (1.37-2.28), 4.99 (2.62-9.50), and 2.27 (1.42-3.61) respectively. Conclusion: This is the first nationwide epidemiologic study of pediatric sports-related TBI in Korea. The ratios of TBI, intracranial injury and admission were highest in bicycle and street sports. Prevention strategies for pediatric sports-related TBI can be developed according to sports types.	[Choi, Dong Hyun; Shin, Sang Do; Hong, Ki Jeong; Park, Jeong Ho] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul Natl Univ Hosp, Seoul, South Korea; [Song, Kyoung Jun] Seoul Natl Univ, Dept Emergency Med, Seoul Metropolitan Govt, Boramae Med Ctr, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea; [Ro, Young Sun] Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea		Song, KJ (corresponding author), Seoul Natl Univ, Dept Emergency Med, Seoul Metropolitan Govt, Boramae Med Ctr, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea.	skciva@gmail.com		Hong, Ki Jeong/0000-0003-3334-817X; Park, Jeong Ho/0000-0001-6330-9820; Song, Kyoung Jun/0000-0002-0027-6352; Choi, Dong Hyun/0000-0001-6036-1404			Bandte A, 2018, WORLD NEUROSURG, V111, pE434, DOI 10.1016/j.wneu.2017.12.094; Centers for Disease Control and Prevention, 2011, INJ PREV CONTR FY 20; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Harrison JE, 2012, BRAIN INJURY, V26, P996, DOI 10.3109/02699052.2012.660515; ICECI Coordination and Maintenance Group, 2004, INT CLASS EXT CAUS I; Jeong HW, 2017, J KOREAN NEUROSURG S, V60, P710, DOI 10.3340/jkns.2016.1010.001; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Kwak BH, 2015, J KOREAN MED SCI, V30, P1881, DOI 10.3346/jkms.2015.30.12.1881; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Park GJ, 2018, INJURY, V49, P1097, DOI 10.1016/j.injury.2018.04.001; Park YJ, 2016, AM J EMERG MED, V34, P515, DOI 10.1016/j.ajem.2015.12.024; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schrieff-Elson LE, 2017, CHILD NERV SYST, V33, P1775, DOI 10.1007/s00381-017-3527-6; Seo DE, 2019, AM J EMERG MED, V37, P1709, DOI 10.1016/j.ajem.2018.12.022; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tator CH, 2008, CATASTROPHIC INJURIE; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	26	4	4	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	NOV 18	2019	34	44							e290	10.3346/jkms.2019.34.e290			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JO6JW	WOS:000497684900004	31726495	Green Published, gold			2022-02-06	
J	Petkus, V; Preiksaitis, A; Chaleckas, E; Chomskis, R; Zubaviciute, E; Vosylius, S; Rocka, S; Rastenyte, D; Aries, MJ; Ragauskas, A; Neumann, JO				Petkus, Vytautas; Preiksaitis, Aidanas; Chaleckas, Edvinas; Chomskis, Romanas; Zubaviciute, Erika; Vosylius, Saulius; Rocka, Saulius; Rastenyte, Daiva; Aries, Marcel J.; Ragauskas, Arminas; Neumann, Jan-Oliver			Optimal Cerebral Perfusion Pressure: Targeted Treatment for Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular autoregulation; critical care; optimal cerebral perfusion pressure; pressure reactivity index; traumatic brain injury	AUTOREGULATION; REACTIVITY; OUTCOMES; INDEX	Identification of individual therapy targets is critical for traumatic brain injury (TBI) patients. Clinical outcomes depend on cerebrovascular autoregulation (CA) impairment. Here, we compare the effectiveness of optimal cerebral perfusion pressure (CPPopt)-targeted therapy in younger (<45 years of age) and elderly (>= 45 years of age) TBI patients. Single-center multi-modal invasive arterial blood pressure(t), intracranial pressure (ICP)(t), cerebral perfusion pressure CPP(t), and CPPopt(t) monitoring (n = 81) was performed. ICM+ software was used for continuous CPPopt(t) status assessment by identification of pressure reactivity index (PRx). The most significant prognostic factors were age, Glasgow Coma Scale, serum glucose, and duration of longest CA ompairment event (LCAI) when PRx(t) >0.5 within 24 h after admission. The modeled accuracies for favorable and unfavorable outcome prediction were 86.5% and 90.9%, respectively. Age above 45 years and averaged ICP during all monitoring time above 21.3 mm Hg was associated with unfavorable outcome of an individual patient. Averaged CPP values close to CPPopt were associated with a better outcome in younger patients. Averaged Delta CPPopt <-5.0 mm Hg, averaged PRx >0.36, and LCAI >100 min were significantly associated with mortality for the younger patients. The critical values of averaged PRx >0.26 and LCAI >61 min were significantly associated with mortality for the elderly group. Autoregulation-guided treatment was important for individual TBI management, especially in younger patients. Further randomized multi-center studies are needed to prove final benefit.	[Petkus, Vytautas; Preiksaitis, Aidanas; Chaleckas, Edvinas; Chomskis, Romanas; Ragauskas, Arminas] Kaunas Univ Technol, Hlth Telemat Sci Inst, Barsauskas Str 59,Off A555, LT-51423 Kaunas, Lithuania; [Preiksaitis, Aidanas; Rastenyte, Daiva] Lithuanian Univ Hlth Sci, Dept Neurol, Med Acad, Kaunas, Lithuania; [Preiksaitis, Aidanas; Zubaviciute, Erika; Vosylius, Saulius; Rocka, Saulius] Vilnius Univ, Clin Neurol & Neurosurg, Fac Med, Vilnius, Lithuania; [Preiksaitis, Aidanas; Vosylius, Saulius; Rocka, Saulius] Republ Vilnius Univ Hosp, Dept Neurosurg, Vilnius, Lithuania; [Aries, Marcel J.] Univ Maastricht, Dept Intens Care, Med Ctr, Maastricht, Netherlands; [Neumann, Jan-Oliver] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany		Petkus, V (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Inst, Barsauskas Str 59,Off A555, LT-51423 Kaunas, Lithuania.	vytautas.petkus@ktu.lt			Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-087/2015]; European Commission FP7-HEALTHEuropean Commission [602150]	This research was supported by the Research Council of Lithuania (grant no.: MIP-087/2015) and European Commission FP7HEALTH (grant no.: 602150).	Aries MJ, 2014, J NEUROTRAUM, V31, pA62; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHILLON JM, 2002, CEREBRAL BLOOD FLOW, P395; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kramer AH, 2019, NEUROCRIT CARE, V30, P51, DOI 10.1007/s12028-018-0570-4; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Mannino C, 2018, J NEUROSCI RES, V96, P696, DOI 10.1002/jnr.24097; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Petkus V, 2017, J CRIT CARE, V41, P49, DOI 10.1016/j.jcrc.2017.04.029; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Rosenblatt K, 2020, J INTENSIVE CARE MED, V35, P1453, DOI 10.1177/0885066619828293; Schmidt B, 2016, J CLIN MONIT COMPUT, V30, P367, DOI 10.1007/s10877-015-9726-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2	28	4	4	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					389	396		10.1089/neu.2019.6551		NOV 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000496152900001	31583962				2022-02-06	
J	Mollayeva, T; Bordignon, C; Ishtiaq, M; Colquhoun, H; D'Souza, A; Archambault, P; Lewko, J; Quilico, E; Colantonio, A				Mollayeva, Tatyana; Bordignon, Caterina; Ishtiaq, Maryam; Colquhoun, Heather; D'Souza, Andrea; Archambault, Patrick; Lewko, John; Quilico, Enrico; Colantonio, Angela			Knowledge of sex and gender and related information needs in patients with traumatic brain injury: in-depth interview study	DISABILITY AND REHABILITATION			English	Article						MeSH-compliant keywords; sex; gender and health; knowledge framework; clinical decision; patient clinician partnership	HEALTH-CARE; QUALITATIVE RESEARCH; SOCIAL DETERMINANTS; REHABILITATION; COMPETENCE; CAREGIVERS; EDUCATION	Aim: This research aimed to gain an understanding of biological sex and social gender phenomena experienced by patients with traumatic brain injury in recovery, and to understand the educational needs of this group. Methods: We conducted semi-structured interviews of 40 adult patients (22 men, 18 women) of different ages, education levels, and ethnicities, with diagnoses of mild and moderate-severe traumatic brain injury at the acute and chronic stages post-injury. Results: Applying classic content analysis with inductive coding, three overarching themes that limited patients' knowledge and subsequent efforts to obtain information on the topic emerged: (1) the complexity of sex and gender subject matters, (2) patients' dependence on others, and (3) uncertainty about the course of recovery. The first diminished the patient's desire to seek further information. Dependence on others and trust that others were in a better position to use the information, compelled patients to redirect the need for education to clinicians, significant others, and the public on the unique post-injury experiences of men and women. Uncertainty about what to expect in the acute phases, and a feeling of identity loss in the chronic phases, established patients' desire to seek out only the information they believed to be necessary for them to carry on with life. Conclusions: In developing recommendations for patient education, variations in patients' knowledge and desire for information, and the reasons behind these variations, should be considered. Improving injury prognosis requires taking into account the gendered context of injury and recovery from it.	[Mollayeva, Tatyana; Bordignon, Caterina; Ishtiaq, Maryam; D'Souza, Andrea; Quilico, Enrico; Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehabil Res Inst, 550 Univ Ave,Rm 11-183, Toronto, ON M5G 2A2, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Bordignon, Caterina; Ishtiaq, Maryam] Univ Toronto Mississauga, Biol Dept, Mississauga, ON, Canada; [Colquhoun, Heather; D'Souza, Andrea; Quilico, Enrico; Colantonio, Angela] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Archambault, Patrick] Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Archambault, Patrick] Univ Laval, Ctr Rech Soins & Serv Premi Ere Ligne, CERSSPL UL, Quebec City, PQ, Canada; [Lewko, John] Laurentian Univ, Sch Rural & Northern Hlth, Sudbury, ON, Canada; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Archambault, Patrick] Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Ste Marie, ON, Canada; [Archambault, Patrick] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada		Mollayeva, T (corresponding author), Univ Hlth Network, KITE Toronto Rehabil Res Inst, 550 Univ Ave,Rm 11-183, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Mollayeva, Tatyana/0000-0002-2787-1848	Canadian Institutes for Health Research - Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	This work was supported by a research grant from the Canadian Institutes for Health Research - Institute for Gender and Health (#CGW-126580).	Ahlgren C, 2016, DISABIL REHABIL, V38, P2255, DOI 10.3109/09638288.2015.1127435; Ahlsen B, 2014, DISABIL REHABIL, V36, P359, DOI 10.3109/09638288.2013.793750; Bernard H.R., 2010, ANAL QUALITATIVE DAT; Bourgois P, 2017, ACAD MED, V92, P299, DOI 10.1097/ACM.0000000000001294; Brain Injury Association of America, BRAIN INJ; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Chase RP, 2015, SOC SCI MED, V147, P309, DOI 10.1016/j.socscimed.2015.11.015; COHEN NJ, 1985, ANN NY ACAD SCI, V444, P54, DOI 10.1111/j.1749-6632.1985.tb37579.x; Cole PL, 2014, SOC WORK, V59, P261, DOI 10.1093/sw/swu015; Cresswell J, 2007, QUALITATIVE INQUIRY; D'Cruz K, 2016, SCAND J OCCUP THER, V23, P30, DOI 10.3109/11038128.2015.1057521; Equator Network, ENH QUAL TRANSP HLTH; Finset A, 2008, PATIENT EDUC COUNS, V73, P1, DOI 10.1016/j.pec.2008.08.004; Gray JAM, 2006, CAN MED ASSOC J, V175, P129; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Grob R, 2019, JAMA-J AM MED ASSOC, V321, P1347, DOI 10.1001/jama.2019.1500; Guest G., 2012, APPL THEMATIC ANAL; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hansen H, 2017, ACAD MED, V92, P279, DOI 10.1097/ACM.0000000000001542; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Lorber J., 1994, PARADOXES GENDER; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mollayeva T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024674; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Nisker J, 2019, CAN MED ASSOC J, V191, pE454, DOI 10.1503/cmaj.71861; Northern Brain Injury Association, BRAIN INJ STAT; Patel KCR, 2010, CLIN MED, V10, P130, DOI 10.7861/clinmedicine.10-2-130; Pletzer B, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00240; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Sahyouni R, 2017, NEUROSURGERY, V81, P787, DOI 10.1093/neuros/nyx095; Shetty T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00836; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Winter L, 2016, DISABIL REHABIL, V38, P1280, DOI 10.3109/09638288.2015.1077531; World Health Organization, GEND EQ HUM RIGHTS; Zeiler KJ, 2017, CAN J NEUROL SCI, V44, P525, DOI 10.1017/cjn.2017.49	44	4	4	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 19	2021	43	13					1872	1882		10.1080/09638288.2019.1683235		NOV 2019	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	SY0WN	WOS:000495198200001	31702962				2022-02-06	
J	Evers, KS; Huhn, EA; Fouzas, S; Barro, C; Kuhle, J; Fisch, U; Bernasconi, L; Lapaire, O; Wellmann, S				Evers, Katrina Suzanne; Huhn, Evelyn Annegret; Fouzas, Sotirios; Barro, Christian; Kuhle, Jens; Fisch, Urs; Bernasconi, Luca; Lapaire, Olav; Wellmann, Sven			Impact of parturition on maternal cardiovascular and neuronal integrity in a high risk cohort - a prospective cohort study	BMC PREGNANCY AND CHILDBIRTH			English	Article						Parturition; Brain; Delivery; Pregnancy; Birth; Surrogate marker	NATRIURETIC-PEPTIDE; NEUROFILAMENT LIGHT; GROWTH-FACTOR; PREGNANCY; SERUM; COPEPTIN; WOMEN; BIOMARKERS; PRECURSOR; DELIVERY	Background To better understand the profound multisystem changes in maternal physiology triggered by parturition, in particular in the underexplored neuronal system, by deploying a panel of pre- vs post-delivery maternal serum biomarkers, most notably the neuronal cytoskeleton constituent neurofilament light chain (NfL). This promising fluid biomarker is not only increasingly applied to investigate disease progression in numerous brain diseases, particularly in proteopathies, but also in detection of traumatic brain injury or monitoring neuroaxonal injury after ischemic stroke. Methods The study was nested within a prospective cohort study of pregnant women at risk of developing preeclampsia at the University Hospital of Basel. Paired ante- and postpartum levels of progesterone, soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin (CT-proAVP), and NfL were measured in 56 women with complete clinical data. Results Placental delivery significantly decreased all placental markers: progesterone 4.5-fold, PlGF 2.2-fold, and sFlt-1 1.7-fold. Copeptin and MR-proANP increased slightly (1.4- and 1.2-fold, respectively). Unexpectedly, NfL levels (median [interquartile range]) increased significantly post-partum: 49.4 (34.7-77.8) vs 27.7 (16.7-31.4) pg/ml (p < 0.0001). Antepartum NfL was the sole independent predictor of NfL peri-partum change; mode of delivery, duration of labor, clinical characteristics and other biomarkers were all unrelated. Antepartum NfL levels were themselves independently predicted only by maternal age. Conclusions Parturition per se increases maternal serum NfL levels, suggesting a possible impact of parturition on maternal neuronal integrity.	[Evers, Katrina Suzanne; Wellmann, Sven] Univ Childrens Hosp Basel UKBB, Div Neonatol, Spitalstr 33, CH-4056 Basel, Switzerland; [Huhn, Evelyn Annegret; Lapaire, Olav] Univ Hosp Basel, Div Obstet & Gynecol, Basel, Switzerland; [Fouzas, Sotirios] Univ Hosp Patras, Paediat Resp Unit, Patras, Greece; [Fouzas, Sotirios] Univ Hosp Patras, Dept Neonatol, Patras, Greece; [Barro, Christian; Kuhle, Jens; Fisch, Urs] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland; [Barro, Christian; Kuhle, Jens; Fisch, Urs] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed & Clin Res, Basel, Switzerland; [Bernasconi, Luca] Kantonsspital Aarau, Inst Lab Med, Aarau, Switzerland; [Wellmann, Sven] Univ Regensburg, Univ Childrens Hosp Regensburg KUNO, Div Neonatol, Regensburg, Germany		Evers, KS (corresponding author), Univ Childrens Hosp Basel UKBB, Div Neonatol, Spitalstr 33, CH-4056 Basel, Switzerland.	katrina.evers@ukbb.ch	Barro, Christian/AAO-3567-2021; Huhn, Evelyn/AAG-7095-2020; Fouzas, Sotirios/Q-3043-2016; Evers, Katrina/ABF-4388-2020	Barro, Christian/0000-0002-7795-7383; Huhn, Evelyn/0000-0001-5382-1353; Fouzas, Sotirios/0000-0001-7617-9076; Fisch, Urs/0000-0003-1557-9062; Evers, Katrina/0000-0002-0572-8709	Gottfried und Julia Bangerter-RhynerStiftung, Bern, Switzerland; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [160221, 169848]	This work was supported by the Gottfried und Julia Bangerter-RhynerStiftung, Bern, Switzerland and the Swiss National Science Foundation (Grant numbers: 160221 and 169848). The funders had no involvement in the study design, data collection and analysis, interpretation of data and preparation of the manuscript.	Begue C, 2019, HEART; BELLMANN O, 1976, KLIN PADIATR, V188, P385; Bergman L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196025; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Davidovski FS, 2019, BIOMARK MED; Depoorter A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00984; Disanto G, 2017, ANN NEUROL; DONG DLY, 1993, J BIOL CHEM, V268, P16679; Evered L, 2018, JAMA NEUROL, V75, P542, DOI 10.1001/jamaneurol.2017.4913; Evers KS, 2018, HYPERTENSION, V71, P1178, DOI 10.1161/HYPERTENSIONAHA.117.10314; Evers KS, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00075; Evers KS, 2018, HYPERTENSION; Foda AA, 2012, EUR J OBSTET GYN R B, V165, P215, DOI 10.1016/j.ejogrb.2012.08.012; Gegenhuber A, 2006, CLIN CHEM, V52, P827, DOI 10.1373/clinchem.2005.065441; Haase EB, 1997, CELL TISSUE RES, V288, P293, DOI 10.1007/s004410050815; Halaas NB, 2018, DEMENT GERIATR COGN, V46, P346, DOI 10.1159/000494754; Hoekzema E, 2017, NAT NEUROSCI, V20, P287, DOI 10.1038/nn.4458; Huhn EA, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00325; Ivanov R, 2000, CRIT CARE MED, V28, P615, DOI 10.1097/00003246-200003000-00002; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; Khaleghi M, 2009, AM J CARDIOL, V103, P1255, DOI 10.1016/j.amjcard.2009.01.012; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kinsley CH, 2008, J NEUROENDOCRINOL, V20, P515, DOI 10.1111/j.1365-2826.2008.01667.x; Korzeniewski SJ, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.015; Leuner B, 2010, TRENDS NEUROSCI, V33, P465, DOI 10.1016/j.tins.2010.07.003; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; LEWIS PR, 1987, J ENDOCRINOL, V115, P177, DOI 10.1677/joe.0.1150177; Mckie PM, 2016, J AM COLL CARDIOL, V68, P2437, DOI 10.1016/j.jacc.2016.10.001; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Nanno H, 1998, MOL HUM REPROD, V4, P609, DOI 10.1093/molehr/4.6.609; Oatridge A, 2002, AM J NEURORADIOL, V23, P19; Pouta AM, 1996, BRIT J OBSTET GYNAEC, V103, P988, DOI 10.1111/j.1471-0528.1996.tb09548.x; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Romero R, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.02.037; Saleh L, 2017, J HYPERTENS, V35, pE176, DOI 10.1097/01.hjh.0000523479.40609.fa; Schreurs MPH, 2012, FASEB J, V26, P355, DOI 10.1096/fj.11-191916; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; Schulte-Herbruggen O, 2007, J REPROD IMMUNOL, V74, P170, DOI 10.1016/j.jri.2006.10.003; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sugulle M, 2012, HYPERTENSION, V59, P395, DOI 10.1161/HYPERTENSIONAHA.111.185264; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Tiedt S, 2018, NEUROLOGY, V91, pE1338, DOI 10.1212/WNL.0000000000006282; Wellmann S, 2014, FETAL DIAGN THER, V36, P202, DOI 10.1159/000361016; WILLIS DM, 1986, AM J PHYSIOL, V250, pR459, DOI 10.1152/ajpregu.1986.250.3.R459; Yoshida A, 2019, J MED INVESTIG, V66, P75, DOI 10.2152/jmi.66.75; Yu L, 2018, ECHOCARDIOGR-J CARD, V35, P459, DOI 10.1111/echo.13817	47	4	4	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2393		BMC PREGNANCY CHILDB	BMC Pregnancy Childbirth	NOV 5	2019	19	1							403	10.1186/s12884-019-2570-6			8	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	JK2BF	WOS:000494651200001	31690271	Green Published, gold			2022-02-06	
J	Onida, A; Di Vita, A; Bianchini, F; Rivera, D; Morlett-Paredes, A; Guariglia, C; Arango-Lasprilla, JC				Onida, Alessandra; Di Vita, Antonella; Bianchini, Filippo; Rivera, Diego; Morlett-Paredes, Alejandra; Guariglia, Cecilia; Carlos Arango-Lasprilla, Juan			Neuropsychology as a profession in Italy	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Clinical neuropsychology; diagnosis; Italy; rehabilitation; practice; training	TEST NORMATIVE DATA; FOLLOW-UP SURVEY; CLINICAL NEUROPSYCHOLOGY; UNITED-STATES; SALARY SURVEY; AMERICAN; REHABILITATION; BELIEFS; INCOMES	The purpose of this study was to analyze the characteristics of individuals working in the field of neuropsychology in Italy, as part of a larger study examining the practice of neuropsychology across various countries. They were asked about their background, professional training, current work situation, types of assessment, preferred diagnostic procedures, as well as the rehabilitation techniques, their targeted populations, teaching responsibilities, and research activities. A total of 154 professionals completed an online survey from April 28, 2016 through June 30, 2016. The majority of participants were women, with a mean age of 42.6?years. Participants reported working for the National Health System, in private practice, or in private rehabilitation facilities. Overall, they reported being very satisfied with their work. Those who identified themselves as neuropsychologists primarily assessed individuals with dementia, stroke, movement disorders, and traumatic brain injury. While the majority of participants declared no problems with the instruments they used, others reported complaints, including but not limited to the financial cost of current neuropsychological tests and the lack of psychometric support. The main perceived obstacles were the lack of willingness to collaborate among professionals, the scarcity of academic training programs, and the lack of clinical training opportunities.	[Onida, Alessandra] ASSL Nuoro, ATS, UOC Neurol & Stroke Unit, Nuoro, Italy; [Di Vita, Antonella; Bianchini, Filippo; Guariglia, Cecilia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Di Vita, Antonella; Bianchini, Filippo; Guariglia, Cecilia] IRCCS Santa Lucia Fdn, Rome, Italy; [Rivera, Diego; Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp, BioCruces Hlth Res Inst, Baracaldo, Spain; [Morlett-Paredes, Alejandra] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Carlos Arango-Lasprilla, Juan] Ikerbasque, Basque Fdn Sci, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Cruces Univ Hosp, Ikerbasque, Basque Fdn Sci, BioCruces Hlth Res Inst,Grp Psicol & Salud, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com	DI VITA, ANTONELLA/I-8584-2018; Arango-Lasprilla, Juan Carlos/AAB-5407-2019; Rivera, Diego/U-8872-2017	DI VITA, ANTONELLA/0000-0003-2345-4809; Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Rivera, Diego/0000-0001-7477-1893; guariglia, cecilia/0000-0001-7474-6030			[Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; [Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1; [Anonymous], 2015, G U SERIE GEN; Arango-Lasprilla JC, 2015, NEUROREHABILITATION, V37, P699, DOI 10.3233/NRE-151286; Arango-Lasprilla JC, 2015, NEUROREHABILITATION, V37, P625, DOI 10.3233/NRE-151282; Arango-Lasprilla J. C. O., 2015, NEUROPSICOLOGIA COLO, P21; BASSO A, 1979, ARCH NEUROL-CHICAGO, V36, P190, DOI 10.1001/archneur.1979.00500400044005; BASSO A, 1975, REV NEUROL, V131, P607; Bianchi A, 2008, ESAME NEUROPSICOLOGI; Bianchi A, 2008, NEUROL SCI, V29, P209, DOI 10.1007/s10072-008-0970-x; Bianchi L., 1895, BRAIN, V18, P497, DOI [10.1016/s0140-6736(01)24735-7, DOI 10.1093/BRAIN/18.4.497]; Block C, 2017, ARCH CLIN NEUROPSYCH, V32, P369, DOI 10.1093/arclin/acx002; Boller F, 2015, FUNCT NEUROL, V30, P5; Arango-Lasprilla JC, 2017, APPL NEUROPSYCH-ADUL, V24, P318, DOI 10.1080/23279095.2016.1185423; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; Denes G, 1998, BRAIN LANG, V62, P29, DOI 10.1006/brln.1997.1867; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Egeland J, 2017, PROF PSYCHOL-RES PR, V48, P227, DOI 10.1037/pro0000119; Egeland J, 2016, CLIN NEUROPSYCHOL, V30, P1479, DOI 10.1080/13854046.2016.1237675; Fonseca-Aguilar Paola, 2015, Psicol. caribe, V32, P344, DOI 10.14482/psdc.32.3.7896; Ghidoni E., 2011, KIT NEUROPSICOLOGO I; IBM Corp, 2016, IBM SPSS STAT WINDOW; Istituto Nazionale di Statistica, 2017, 2642017 I NAZ STAT, P5; Legge & marzo, 2017, GAZZ UFF SER GEN; Fernandez AL, 2016, CLIN NEUROPSYCHOL, V30, P1154, DOI 10.1080/13854046.2016.1197313; MARHABA S, 1981, LINEAMENTI PSICOLOGI; Norup A, 2017, CLIN NEUROPSYCHOL, V31, P20, DOI 10.1080/13854046.2017.1291857; Olabarrieta-Landa L, 2015, NEUROREHABILITATION, V37, P515, DOI 10.3233/NRE-151279; Olabarrieta-Landa L, 2015, NEUROREHABILITATION, V37, P501, DOI 10.3233/NRE-151278; Olabarrieta-Landa L, 2016, CLIN NEUROPSYCHOL, V30, P1335, DOI 10.1080/13854046.2016.1183049; Panyavin IS, 2015, ARCH CLIN NEUROPSYCH, V30, P413, DOI 10.1093/arclin/acv026; Ponsford J, 2016, CLIN NEUROPSYCHOL, V30, P1179, DOI 10.1080/13854046.2016.1195015; Rivera D, 2017, NEUROREHABILITATION, V41, P581, DOI 10.3233/NRE-172275; Rivera D, 2015, NEUROREHABILITATION, V37, P677, DOI 10.3233/NRE-151285; Rivera D, 2015, NEUROREHABILITATION, V37, P591, DOI 10.3233/NRE-151281; Sorbonne Joint Declaration, 1998, JOINT DECL HARM ARCH; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 1996, CLIN NEUROPSYCHOL, V10, P202, DOI 10.1080/13854049608406681; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P479, DOI 10.1076/clin.14.4.479.7201; SWEET JJ, 1990, CLIN NEUROPSYCHOL, V4, P101, DOI DOI 10.1080/13854049008401504; Truter S, 2018, APPL NEUROPSYCH-ADUL, V25, P344, DOI 10.1080/23279095.2017.1301453; Vallar G., 2012, RIABILITAZIONE NEURO; Vallar G, 2015, NEUROL SCI, V36, P361, DOI 10.1007/s10072-014-2044-6; Vicari S., 2002, DISTURBI SVILUPPO; [No title captured]	47	4	4	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2019	26	6					543	557		10.1080/23279095.2018.1466782			15	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9ER	WOS:000488884700005	30183355				2022-02-06	
J	Breeze, J; Bowley, DM; Combes, JG; Baden, J; Rickard, RF; DuBose, J; Powers, DB				Breeze, John; Bowley, Douglas M.; Combes, James G.; Baden, James; Rickard, Rory F.; DuBose, Joseph; Powers, David B.			Facial injury management undertaken a US and UK medical treatment facilities during the Iraq and Afghanistan conflicts: a retrospective cohort study	BMJ OPEN			English	Article							MANDIBULAR FRACTURES; BATTLE INJURIES; NECK INJURIES; TRAUMA; FREEDOM; GUNSHOT; WOUNDS; HEAD; FACE; OPERATIONS	Objectives To perform the first direct comparison of the facial injuries sustained and treatment performed at USA and UK deployed medical treatment facilities (MTFs) in support of the military campaigns in Iraq and Afghanistan. Setting The US and UK Joint Theatre Trauma Registries were scrutinised for all patients with facial injuries presenting alive to a UK or US deployed MTF between 1 March 2003 and 31 October 2011. Participants US and UK military personnel, local police, local military and civilians. Primary and secondary outcome measures An adjusted multiple logistic regression model was performed using tracheostomy as the primary dependent outcome variable and treatment in a US MTF, US or UK military, mandible fracture and treatment of mandible fracture as independent secondary variables. Results Facial injuries were identified in 16944 casualties, with the most common being those to skin/muscle (64%), bone fractures (36%), inner/middle ear (28%) and intraoral damage (11%). Facial injuries were equally likely to undergo surgery in US MTF as UK MTF (OR: 1.06, 95% CI 0.4603 to 1.142, p=0.6656); however, variations were seen in injury type treated. In US MTF, 692/1452 (48%) of mandible fractures were treated by either open or closed reduction compared with 0/167 (0%) in UK MTF (chi(2) :113.6; p <= 0.0001). US military casualties who had treatment of their mandible fracture (open reduction and internal fixation or mandibulo-maxillary fixation) were less likely to have had a tracheostomy than those who did not undergo stabilisation of the fractured mandible (OR: 0.61, 95% CI 0.44 to 0.86; p=0.0066). Conclusions The capability to surgically treat mandible fractures by open or closed reduction should be considered as an integral component of deployed coalition surgical care in the future.	[Breeze, John; Bowley, Douglas M.; Baden, James; Rickard, Rory F.] Royal Ctr Def Med, Birmingham, W Midlands, England; [Breeze, John; Bowley, Douglas M.; Baden, James] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Combes, James G.] Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England; [DuBose, Joseph] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Powers, David B.] Duke Univ, Med Ctr, Durham, NC USA		Breeze, J (corresponding author), Royal Ctr Def Med, Birmingham, W Midlands, England.; Breeze, J (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	johno.breeze@gmail.com		Breeze, John/0000-0002-2352-1365			[Anonymous], 1916, TIMES; Biernoff S, 2011, SOC HIST MED, V24, P666, DOI 10.1093/shm/hkq095; Blanch RJ, 2011, EYE, V25, P218, DOI 10.1038/eye.2010.190; Breeze J, 2015, BRIT J ORAL MAX SURG, V53, P3, DOI 10.1016/j.bjoms.2014.04.017; Breeze J, 2011, BRIT J ORAL MAX SURG, V49, P607, DOI 10.1016/j.bjoms.2010.10.006; Breeze J, 2011, BRIT J ORAL MAX SURG, V49, P464, DOI 10.1016/j.bjoms.2010.08.002; Breeze J, 2011, INT J ORAL MAX SURG, V40, P483, DOI 10.1016/j.ijom.2011.01.005; Breeze J, 2010, BRIT J ORAL MAX SURG, V48, P613, DOI 10.1016/j.bjoms.2009.10.013; Breeze J, 2010, J R Army Med Corps, V156, P137; Breeze J, 2010, J R Army Med Corps, V156, P125; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P183, DOI 10.1136/jramc-2018-000971; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P133, DOI 10.1136/jramc-2017-000881; Breeze J, 2011, J TRAUMA, V71, P108, DOI 10.1097/TA.0b013e318203304a; Brennan J, 2006, OTOLARYNG HEAD NECK, V134, P100, DOI 10.1016/j.otohns.2005.10.008; Brennan J., 2013, LARYNGOSCOPE, V64; Bricknell M, 2014, J ROY ARMY MED CORPS, V160, P64, DOI 10.1136/jramc-2013-000228; Brisebois R, 2011, CAN J SURG, V54, pS20, DOI 10.1503/cjs.024811; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; Chan RK, 2012, J TRAUMA ACUTE CARE, V73, pS453, DOI 10.1097/TA.0b013e3182754868; Faulkner JA, 2009, J CRANIOFAC SURG, V20, P62, DOI 10.1097/SCS.0b013e3181945a7a; Feldt BA, 2013, OTOLARYNG HEAD NECK, V148, P403, DOI 10.1177/0194599812472874; Gibbons AJ, 2011, INT J ORAL MAX SURG, V40, P103, DOI 10.1016/j.ijom.2010.08.001; Gibbons A J, 2010, J R Army Med Corps, V156, P113; Girotto JA, 2001, PLAST RECONSTR SURG, V108, P312, DOI 10.1097/00006534-200108000-00005; GRUSS JS, 1991, PLAST RECONSTR SURG, V87, P436, DOI 10.1097/00006534-199103000-00008; Keller MW, 2015, MIL MED, V180, P315, DOI 10.7205/MILMED-D-14-00345; Kittle CP, 2012, J CRANIOFAC SURG, V23, P1587, DOI 10.1097/SCS.0b013e318256514a; Lew TA, 2010, J ORAL MAXIL SURG, V68, P3, DOI 10.1016/j.joms.2009.06.006; Lopez MA, 2007, ARCH FACIAL PLAST S, V9, P400, DOI 10.1001/archfaci.9.6.400; Maitland L, 2016, PLAST RECONSTR SURG, V137, p717E, DOI 10.1097/PRS.0000000000002020; Ministry of Defence, 2015, MIN DEF ALL JOINT B; Motamedi MHK, 2003, J ORAL MAXIL SURG, V61, P1390, DOI 10.1016/j.joms.2003.07.001; Peled M, 2012, CRANIOMAX TRAUM REC, V5, P31, DOI 10.1055/s-0031-1293518; Powers D B, 2010, J R Army Med Corps, V156, P117; Vayvada H, 2005, J CRANIOFAC SURG, V16, P794, DOI 10.1097/01.scs.0000180014.06352.65; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Wordsworth M, 2017, INJURY, V48, P70, DOI 10.1016/j.injury.2016.08.009; Worst Loss Of All, 1918, MANCHESTER EVENING C; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zachar MR, 2013, J ORAL MAXIL SURG, V71, P734, DOI 10.1016/j.joms.2012.10.030	40	4	4	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	NOV	2019	9	11							e033557	10.1136/bmjopen-2019-033557			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KK5IG	WOS:000512774800379	31772107	Green Published, gold			2022-02-06	
J	Bryan, CJ; Bryan, AO				Bryan, Craig J.; Bryan, AnnaBelle O.			Financial Strain, Suicidal Thoughts, and Suicidal Behavior Among US Military Personnel in the National Guard	CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION			English	Article						suicide; military; financial strain; credit problems; economics	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SERVICE MEMBERS; ARMY; PREVALENCE; RESILIENCE; VALIDITY; HEALTH	Background: Although financial strain is an identified risk factor for suicide among US military personnel, research is limited regarding the specific dimensions of financial strain that confer the greatest risk. Aims: The present study examined the associations among multiple indicators of financial strain, suicide ideation, and suicide attempts in a sample of US National Guard personnel, a high-risk subgroup of the US military. Method: National Guard personnel from Utah and Idaho (n = 997) completed an anonymous online self-report survey. Weighted univariate and multivariate logistic regression was used to test hypothesized associations. Results: Lifetime history of suicide ideation was significantly more common among participants reporting recent income decrease, credit problems, and difficulty making ends meet, even when adjusting for other covariates. Lifetime history of suicide attempt was significantly associated with recent foreclosure or loan default, credit problems, and difficulty making ends meet, but only in univariate analyses. Recent credit problems were the only financial strain indicator that significantly predicted a history of suicide attempt among participants with a history of suicide ideation. Limitations:The present study includes self-report methodology and cross-sectional design. Conclusion: Although multiple indicators of financial strain are associated with increased risk for suicidal thinking among National Guard military personnel, credit problems had the strongest association with suicide attempts.	[Bryan, Craig J.; Bryan, AnnaBelle O.] Natl Ctr Vet Studies, 260 S Cent Campus Dr,Suite 3525, Salt Lake City, UT 84112 USA; [Bryan, Craig J.; Bryan, AnnaBelle O.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA		Bryan, CJ (corresponding author), Natl Ctr Vet Studies, 260 S Cent Campus Dr,Suite 3525, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu					APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Black SA, 2011, MIL PSYCHOL, V23, P433, DOI 10.1080/08995605.2011.590409; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Bryan CJ, 2015, SUICIDE LIFE-THREAT, V45, P633, DOI 10.1111/sltb.12163; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Department of Defense, 2016, DODSER DEP DEF SUIC; Griffith J, 2012, MIL PSYCHOL, V24, P568, DOI 10.1080/08995605.2012.736324; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Hyman J, 2012, AM J PUBLIC HEALTH, V102, pS138, DOI 10.2105/AJPH.2011.300484; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; National Center for Veterans Studies, 2016, MENT HLTH NEEDS UT N; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; O'Connor RC, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0268; Pew Research Center, 2016, AM SHRINK MIDDL CLAS; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Richardson T, 2013, CLIN PSYCHOL REV, V33, P1148, DOI 10.1016/j.cpr.2013.08.009; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Weathers F.W., 2013, PTSD CHECKLIST DSM 5	21	4	4	0	2	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	MERKELSTR 3, D-37085 GOTTINGEN, GERMANY	0227-5910	2151-2396		CRISIS	Crisis	NOV	2019	40	6					437	445		10.1027/0227-5910/a000592			9	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	JT2IX	WOS:000500820600009	31030554				2022-02-06	
J	Cancelliere, C; Mohammed, RJ				Cancelliere, Carol; Mohammed, Riaz J.			Brain Drain: Psychosocial Factors Influence Recovery Following Mild Traumatic Brain Injury-3 Recommendations for Clinicians Assessing Psychosocial Factors	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						brain concussion; postconcussion syndrome; psychology; recovery of function	POST-CONCUSSION SYMPTOMS; SPORT-RELATED CONCUSSION; FLEXION-ROTATION TEST; CERVICAL-SPINE; CERVICOGENIC DIZZINESS; MANUAL THERAPY; MUSCULOSKELETAL DYSFUNCTION; WHIPLASH INJURY; NECK PAIN; RELIABILITY	SYNOPSIS: Mild traumatic brain injury is a major global public health concern. While most people recover within days to months, 1 in 5 people with mild traumatic brain injury report persistent, disabling symptoms that interfere with participation in work, school, and sport. People with injuries to regions other than the head may report similar symptoms. The biopsychosocial model of health explains this phenomenon in terms of factors associated with recovery that are not biomedical. Important psychosocial factors include poor recovery expectations and pretraumatic and posttraumatic psychological symptoms. Recent clinical practice guidelines recommend that clinicians examine all relevant biopsychosocial factors that may contribute to persistent postconcussive symptoms and consider them when helping their patients make health-management decisions. However, because clinical training continues to prioritize biomedical symptoms, clinicians may not feel confident in the psychosocial domain. Our objective is to provide 3 recommendations for clinicians to assess psychosocial factors in patients after concussion, and to argue a case for clinicians to improve their skills in assessing psychosocial factors.	[Cancelliere, Carol] Ontario Tech Univ, Fac Hlth Sci, Oshawa, ON, Canada; [Cancelliere, Carol] Ontario Tech Univ, Ctr Disabil Prevent & Rehabil, Oshawa, ON, Canada; [Cancelliere, Carol; Mohammed, Riaz J.] Canadian Mem Chiropract Coll, Toronto, ON, Canada		Cancelliere, C (corresponding author), Univ Ontario Inst Technol, Fac Hlth Sci, Oshawa, ON L1G 0C5, Canada.	carolina.cancelliere@uoit.ca		Mohammed, Riaz/0000-0002-5033-0169			Beeckmans K, 2017, ACTA NEUROL BELG, V117, P493, DOI 10.1007/s13760-017-0745-3; Bogduk N, 2000, CLIN BIOMECH, V15, P633, DOI 10.1016/S0268-0033(00)00034-6; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Carey TS, 2003, SPINE, V28, P1631, DOI 10.1097/00007632-200308010-00001; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hall T, 2004, MANUAL THER, V9, P197, DOI 10.1016/j.math.2004.04.004; Hall T, 2010, MANUAL THER, V15, P542, DOI 10.1016/j.math.2010.06.002; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Jung FC, 2017, J ORTHOP SPORT PHYS, V47, P874, DOI 10.2519/jospt.2017.7425; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Karlberg M, 1996, ARCH PHYS MED REHAB, V77, P874, DOI 10.1016/S0003-9993(96)90273-7; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kooistra B, 2009, J BONE JOINT SURG AM, V91A, P21, DOI 10.2106/JBJS.H.01573; Korthals-de Bos IBC, 2003, BRIT MED J, V326, P911; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ogince M, 2007, MANUAL THER, V12, P256, DOI 10.1016/j.math.2006.06.016; Olson HM, 2016, J CHIROPR MED, V15, P208, DOI 10.1016/j.jcm.2016.04.006; Reid SA, 2008, MANUAL THER, V13, P357, DOI 10.1016/j.math.2007.03.006; Reid SA, 2015, MANUAL THER, V20, P148, DOI 10.1016/j.math.2014.08.003; Reid SA, 2014, ARCH PHYS MED REHAB, V95, P1603, DOI 10.1016/j.apmr.2014.04.009; Rubio-Ochoa J, 2016, MANUAL THER, V21, P35, DOI 10.1016/j.math.2015.09.008; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zito G, 2006, MANUAL THER, V11, P118, DOI 10.1016/j.math.2005.04.007	50	4	4	1	1	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					842	+		10.2519/jospt.2019.8849			15	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100009	31154953	Bronze			2022-02-06	
J	Carey, C; Saxe, J; White, FA; Naugle, KM				Carey, Christopher; Saxe, Jonathan; White, Fletcher A.; Naugle, Kelly M.			An Exploratory Study of Endogenous Pain Modulatory Function in Patients Following Mild Traumatic Brain Injury	PAIN MEDICINE			English	Article						Conditioned Pain Modulation; Post-traumatic Headache; Brain Injury; Temporal Summation of Pain	POSTTRAUMATIC HEADACHE; CENTRAL SENSITIZATION; DEPRESSION; PREVALENCE; MECHANISMS; SYMPTOMS; ANXIETY; IMPACT	Background. Recent animal research suggests that mild traumatic brain injury (mTBI) facilitates abnormal endogenous modulation of pain, potentially underlying the increased risk for persistent headaches following injury. However, no human studies have directly assessed the functioning of endogenous facilitory and inhibitory systems in the early stages after an mTBI. Objective. The purpose of this exploratory study was to examine trigeminal sensitization and endogenous pain inhibitory capacity in mTBI patients in the acute stage of injury compared with matched controls. We also examined whether post-traumatic headache pain intensity within the mTBI sample was related to sensitization and pain inhibitory capacity. Methods. Twenty-four mTBI patients recruited from emergency departments and 21 age-, race-, and sex-matched controls completed one experimental session. During this session, participants completed quantitative sensory tests measuring trigeminal sensitization (pressure pain thresholds and temporal summation of pain in the head) and endogenous pain inhibition (conditioned pain modulation). Participants also completed validated questionnaires measuring headache pain, depression, anxiety, and pain catastrophizing. Results. The results revealed that the mTBI group exhibited significantly decreased pressure pain thresholds of the head and decreased pain inhibition on the conditioned pain modulation test compared with the control group. Furthermore, correlational analysis showed that the measures of trigeminal sensitization and depression were significantly associated with headache pain intensity within the mTBI group. Conclusions. In conclusion, mTBI patients may be at risk for maladaptive changes to the functioning of endogenous pain modulatory systems following head injury that could increase risk for post-traumatic headaches.	[Carey, Christopher; Naugle, Kelly M.] Indiana Univ Purdue Univ, Sch Hlth & Human Sci, Dept Kinesiol, 901 W New York St, Indianapolis, IN 46202 USA; [Saxe, Jonathan] St Vincent Indianapolis Hosp, Trauma Dept, Indianapolis, IN USA; [White, Fletcher A.] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [White, Fletcher A.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA		Naugle, KM (corresponding author), Indiana Univ Purdue Univ, Sch Hlth & Human Sci, Dept Kinesiol, 901 W New York St, Indianapolis, IN 46202 USA.	kmnaugle@iupui.edu	Naugle, Kelly/AAQ-1628-2021; White, Fletcher/F-3203-2015	White, Fletcher/0000-0002-8408-9262	Indiana State Department of Health's Indiana Spinal Cord and Brain Injury Fund Research Grant Program; St. Vincent Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102415] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002209] Funding Source: NIH RePORTER	This research was funded by the Indiana State Department of Health's Indiana Spinal Cord and Brain Injury Fund Research Grant Program (KMN and FAW) and the St. Vincent Foundation (FAW).	Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chaput G, 2016, PAIN RES MANAG, V2016, P1; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Filatova E, 2008, J HEADACHE PAIN, V9, P295, DOI 10.1007/s10194-008-0061-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Laglois JA, 2006, TRAUMATIC BRAIN INJU; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Maruish M., 2004, USE PSYCHOL TESTING, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nahman-Averbuch H, 2013, HEADACHE, V53, P1104, DOI 10.1111/head.12117; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; PACKARD RC, 1993, HEADACHE, V33, P133, DOI 10.1111/j.1526-4610.1993.hed3303133.x; Sahbaie P, 2018, J PAIN, V19, P1392, DOI 10.1016/j.jpain.2018.06.004; Scott W, 2014, CLIN J PAIN, V30, P183, DOI 10.1097/AJP.0b013e31828eee6c; Spielberger CD, 1970, STAI MANUAL FO STATE; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Vaccarino AL, 2008, J AFFECT DISORDERS, V110, P270, DOI 10.1016/j.jad.2008.01.009; Vaccarino AL, 2009, PSYCHOSOM MED, V71, P159, DOI 10.1097/PSY.0b013e3181906572; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarnitsky D, 2015, EUR J PAIN, V19, P805, DOI 10.1002/ejp.605; Yarnitsky D, 2015, PAIN, V156, pS24, DOI 10.1097/01.j.pain.0000460343.46847.58; Yarnitsky D, 2015, ANESTHESIOLOGY, V122, P734, DOI 10.1097/ALN.0000000000000594; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Zeilig G, 2012, BRAIN, V135, P418, DOI 10.1093/brain/awr270; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	41	4	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	NOV	2019	20	11					2198	2207		10.1093/pm/pnz058			10	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	JY3KB	WOS:000504316200013	30938813	Bronze, Green Published			2022-02-06	
J	des Roches, AD; Lardy, R; Capdeville, J; Mounier, L; Veissier, I				des Roches, Alice de Boyer; Lardy, Romain; Capdeville, Jacques; Mounier, Luc; Veissier, Isabelle			Do International Commission of Agricultural and Biosystems Engineering (CIGR) dimension recommendations for loose housing of cows improve animal welfare?	JOURNAL OF DAIRY SCIENCE			English	Article						dairy cow; loose housing; cow welfare; equipment dimensions	RISK-FACTORS; DAIRY-COWS; HYGIENE SCORES; SKIN-LESIONS; FREE STALLS; MILK-YIELD; LAMENESS; PREVALENCE; CATTLE; FARM	Design of cubicles and self-locking barriers can affect cow skin alterations, lameness, and dirtiness. We investigated whether the International Commission of Agricultural and Biosystems Engineering (CIGR, Gainesville, FL)-recommended cattle housing design and dimensions actually improve cow welfare. We recorded individual cow body dimensions and assessed skin alterations, dirtiness, and lameness on 3,841 cows from 131 loose housing dairy farms (76 farms with cubicles and 55 straw-yard systems). We recorded the dimensions of cubicles (e.g., width, length, and so on) and of the self-locking barrier (e.g., top rail height and so on) for each farm. We then compared whether these dimensions would match with the individual cow body dimensions and whether compliance was associated with the occurrence of skin alterations, lameness, and dirtiness. Most cows (69.2%) had at least one skin alteration, on the tarsus (41.2%); neck, shoulder, or back (28.2%); hindquarters (22.0%); carpus (21.2%); and flank, side, or udder (11.6%). Lameness prevalence reached 17.9%. Most cows (83.1%) were scored dirty in at least one body region, mainly on the lower hind legs including hocks (81.4%), hindquarters (41.8%), and udder (21.0%). Cubicle recommendations were mostly met for cubicle resting length (75.9% of cubicles) and neck rail distance (NRD, 60.7%) but less so for overall cubicle length (CL, 38.8%), cubicle width (CW, 30.9%), neck rail height (NRH, 22.5%), head space (HS, 15.8%), partition zone for controlling lying position (ii zone, 15.7%), head and lunging space (HLS, 10.6%), partition head zone (i zone, 9.4%), and partition zone for pelvis freedom (iii zone, 6.0%). Compliance with design recommendations was associated with fewer skin alterations on neck (recommendation met for CW, CL, HS, and NRD and i zone), hindquarters (CW, CL, NRD), tarsus (CW, i and ii zones), and carpus (CW, HS, i and ii zones); less lameness (CW, NRIL i zone); and less dirtiness on the hindquarters (CW, HLS, NRD), lower hind legs (iii zone), and udder (CW, CL, HLS, NRD). Compliance with recommended i zone and ii zone design was associated with less injury and lameness but more dirtiness, whereas the opposite was true for the iii zone. Self-locking barrier recommendations were mostly met for bottom rail height (68.2%), separation wall width (SWW, 68.3%), and top rail height (TRH, 56.9%) and less often met for separation wall height (36.3%) and height difference between feeding floor and walking alley (26.5%). Risk for skin alterations on carpus and neck only decreased when SWW and TRH met recommendations. In conclusion, compliance with CIGR recommendations for some cubicle dimensions and neck rail position was associated with lower risk for cow welfare. However, the CIGR recommendations on cubicle partitions and self-locking barriers still leave welfare at risk and so need to be refined through further research with close observation of cow lying and feeding behavior.	[des Roches, Alice de Boyer; Lardy, Romain; Mounier, Luc; Veissier, Isabelle] Univ Clermont Auvergne, INRA, VetAgro Sup, UMR Herbivores, F-63122 St Genes Champanelle, France; [Capdeville, Jacques] Antenne Toulouse Castanet Tolosan, Inst Elevage, F-31321 Castanet Tolosan, France		des Roches, AD (corresponding author), Univ Clermont Auvergne, INRA, VetAgro Sup, UMR Herbivores, F-63122 St Genes Champanelle, France.	alice.deboyerdesroches@vetagro-sup.fr		Veissier, Isabelle/0000-0002-8497-5395; Lardy, Romain/0000-0003-1338-8553; de Boyer des Roches, Alice/0000-0002-6903-7456	Danone Research (Paris, France)Danone Nutricia; pole Enseignement Sciences Technologiques et d'Innovation dans les domaines du Vivant et de l'Environnement (ESTIVE); French government [Initiative D'EXcellence-Initiative Science-Innovation-Territoires-Economie (IDEX-ISITE) initiative] [16-IDEX-0001]; French government [Clermont-Auvergne Projet (CAP), Clermont-Ferrand, France] [20-25]	This work received financial support from Danone Research (Paris, France), pole Enseignement Sciences Technologiques et d'Innovation dans les domaines du Vivant et de l'Environnement (ESTIVE), and the French government [Initiative D'EXcellence-Initiative Science-Innovation-Territoires-Economie (IDEX-ISITE) initiative 16-IDEX-0001, Clermont-Auvergne Projet (CAP) 20-25, Clermont-Ferrand, France]. We thank the "Groupements de Defense Sanitaire" for providing lists of eligible farms and all the farmers who willingly cooperated in this survey. We are also particularly grateful to Eric Delval (INRA, Clermont-Ferrand, France), Christophe Mallet (INRA), Maud Coignard of Nantes-Atlantic National College of Veterinary Medicine, Food Science and Engineering (ONIRIS, Nantes, France), and Remi Debauchez of the Institut superieur d'agriculture Rhone-Alpes (ISARA, Lyon, France) for their help with data collection; Jean-Yves Audiart (ONIRIS), Didier Billon (ONIRIS), and Eric Delval (INRA) for their help with data entry; and Jos Noordhuizen, Raphael Guatteo (ONIRIS), Nathalie Bareille (ONIRIS), and Claire Agabriel (VetAgro Sup, Clermont-Ferrand, France) for their valuable advice on survey design. The authors thank Metaform Langues for their editorial support and English reviewing.	Akaike H., 1973, P 2 INT S INF THEOR, V1973, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2009, WELF QUAL ASS PROT C; Botner A, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2554; Bouffard V, 2017, J DAIRY SCI, V100, P2935, DOI 10.3168/jds.2016-11842; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; CIGR, 1994, 14 CIGR ADAS BRIDG D; CIGR (International Commission of Agricultural and Biosystems En-gineering), 2014, 14 CIGR SECT 2 WORK; Cook NB, 2003, J AM VET MED ASSOC, V223, P1324, DOI 10.2460/javma.2003.223.1324; Dairy Farmers of Canada and National Farm Animal Care Council, 2009, COD PRACT CAR HANDL; de Boyer des Roches A., 2013, BEHAV 2013, P180; des Roches AD, 2014, ANIM WELFARE, V23, P467, DOI 10.7120/09627286.23.4.467; des Roches AD, 2016, J DAIRY SCI, V99, P5573, DOI 10.3168/jds.2015-10633; Dippel S, 2009, PREV VET MED, V90, P102, DOI 10.1016/j.prevetmed.2009.03.014; Espejo LA, 2006, J DAIRY SCI, V89, P3052, DOI 10.3168/jds.S0022-0302(06)72579-6; European Food Safety Authority, 2009, EFSA J, V7, p1143r, DOI [10.2903/j.efsa.2009.1143r, DOI 10.2903/J.EFSA.2009.1143R]; Fregonesi JA, 2009, J DAIRY SCI, V92, P1979, DOI 10.3168/jds.2008-1604; Fregonesi JA, 2002, LIVEST PROD SCI, V78, P245, DOI 10.1016/S0301-6226(02)00097-0; Heyerhoff JCZ, 2014, J DAIRY SCI, V97, P173, DOI 10.3168/jds.2012-6367; Huxley JN, 2004, VET REC, V155, P237, DOI 10.1136/vr.155.8.237; Kielland C, 2010, J DAIRY SCI, V93, P3979, DOI 10.3168/jds.2009-2909; Kielland C, 2009, J DAIRY SCI, V92, P5487, DOI 10.3168/jds.2009-2293; Main DCJ, 2003, VET REC, V153, P227, DOI 10.1136/vr.153.8.227; Potterton SL, 2011, J DAIRY SCI, V94, P2952, DOI 10.3168/jds.2010-4084; Prunier A, 2013, ANIMAL, V7, P998, DOI 10.1017/S1751731112002406; R Core Team, 2018, STATS PACK LANG ENV; Reneau JK, 2005, JAVMA-J AM VET MED A, V227, P1297, DOI 10.2460/javma.2005.227.1297; Ruud LE, 2010, J DAIRY SCI, V93, P5216, DOI 10.3168/jds.2010-3321; Ruud LE, 2010, J DAIRY SCI, V93, P1578, DOI 10.3168/jds.2009-2752; Schreiner DA, 2003, J DAIRY SCI, V86, P3460, DOI 10.3168/jds.S0022-0302(03)73950-2; Sogstad AM, 2005, ACTA VET SCAND, V46, P203, DOI 10.1186/1751-0147-46-203; Solano L, 2015, J DAIRY SCI, V98, P6978, DOI 10.3168/jds.2015-9652; Veissier I, 2004, J ANIM SCI, V82, P3321; Weary DM, 2000, J DAIRY SCI, V83, P697, DOI 10.3168/jds.S0022-0302(00)74931-9; Westin R, 2016, J DAIRY SCI, V99, P3732, DOI 10.3168/jds.2015-10414; Whay HR, 2003, VET REC, V153, P197, DOI 10.1136/vr.153.7.197; Zurbrigg K, 2005, CAN VET J, V46, P902	36	4	4	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	NOV	2019	102	11					10235	10249		10.3168/jds.2018-16154			15	Agriculture, Dairy & Animal Science; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Food Science & Technology	JC4YS	WOS:000489285000055	31447147	Bronze			2022-02-06	
J	Harris, MB; Rafeedie, S; McArthur, D; Babikian, T; Snyder, A; Polster, D; Giza, CC				Harris, Madison B.; Rafeedie, Samia; McArthur, David; Babikian, Talin; Snyder, Aliyah; Polster, Douglas; Giza, Christopher C.			Addition of Occupational Therapy to an Interdisciplinary Concussion Clinic Improves Identification of Functional Impairments	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; neurology; occupational therapy; pediatrics; quality of life; therapy		Background: Concussions, or mild traumatic brain injuries, are prevalent among youth and young adults. These injuries may disrupt a person's daily activities (occupations) including school, physical activity, work, and socialization. Rehabilitation professionals, such as occupational therapists (OTs), are experts in providing individualized intervention to address these temporary life changes during recovery. Objective: This article aims to identify the benefit of having an occupational therapy practitioner on an interdisciplinary treatment team when providing intervention to patients with concussion. Setting: Concussion clinic at an academic institution. Participants: Participants ages 12 to 24 years with a reported history of mild traumatic brain injury or concussion were evaluated by a physician, or by a physician and OT, in an initial evaluation appointment. Design: A single researcher (OT) with training in concussion qualitatively compared reported impacted occupational domains as defined in the Occupational Therapy Practice Framework, using both a retrospective and a prospective cohort. The prospective group differed from the retrospective group in that an OT was present, and participated in the initial evaluation. Results: The domains of performance patterns (P=.007) and performance skills (P <= .001) were identified significantly more often when an occupational therapy practitioner participated in the initial evaluation. Conclusions: Rehabilitation professionals, such as OTs, play an important role in identifying impacted domains after a concussion, which can help optimize patient care.	[Harris, Madison B.; McArthur, David; Babikian, Talin; Snyder, Aliyah; Polster, Douglas; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Harris, Madison B.; McArthur, David; Babikian, Talin; Snyder, Aliyah; Polster, Douglas; Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA USA; [Rafeedie, Samia] Univ Southern Calif, Mrs TH Chan Div Occupat Sci & Occupat Therapy, Los Angeles, CA USA		Harris, MB (corresponding author), Univ Calif Los Angeles, UCLA Neurosurg, 300 Stein Plaza,554Q Wasserman Bldg, Los Angeles, CA 90095 USA.	mbharris@mednet.ucla.edu	Snyder, Aliyah/AAT-6250-2020		NCAA; US Department of DefenseUnited States Department of Defense; UCLA Steve Tisch BrainSPORT program; NIHNINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS27544]; UCLA Brain Injury Research Center; Easton Clinic for Brain Health; NINDS Neural Analytics SBIR grant [NS092209 2016-2018]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544] Funding Source: NIH RePORTER	Dr Giza does not believe any of these disclosures represent a direct conflict of interest with the current work; however, in an effort for full transparency, he always elects to disclose all potential conflict of interests. Grants/research support: NCAA, US Department of Defense, UCLA Steve Tisch BrainSPORT program, NIHNINDS(R01 NS27544), UCLA Brain Injury Research Center, Easton Clinic for Brain Health, NINDS Neural Analytics SBIR grant (NS092209 2016-2018). Consultant: NBA, NFL-Neurological Care Program, NHLPA. Advisory panel: Highmark Interactive (2018-2019), MLS, NBA, USSF, NCAA Concussion Committee (end 3/2018). Medico-legal: One or two cases annually. Stock shareholder: Highmark Interactive stock options (2018). Other: Book royalties-Blackwell/Wiley Publishing: Prioritized Neurological Differential Diagnosis.	American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; [Anonymous], 2017, Am J Occup Ther, V71, p7103420010p1, DOI 10.5014/ajot.2017.713002; Brayton-Chung A, 2016, AM J OCCUP THER, V21, P8; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, 2017, WHAT IS CONC; CLARK FA, 1991, AM J OCCUP THER, V45, P300, DOI 10.5014/ajot.45.4.300; Clark F, 2010, AM J OCCUP THER, V64, P848, DOI 10.5014/ajot.2010.64602; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; R Core Team, 2018, STATS PACK LANG ENV; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Sahai-Srivastava S, 2017, HEADACHE, V57, P1482, DOI 10.1111/head.13118; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Yerxa E. J., 1993, OCCUPATIONAL SCI, V1, P3, DOI [10.1080/14427591.1993.9686373, DOI 10.1080/14427591.1993.9686373]	16	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					425	432		10.1097/HTR.0000000000000544			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200014	31688379				2022-02-06	
J	Harriss, AB; Abbott, K; Kimpinski, K; Holmes, JD; Johnson, AM; Walton, DM; Dickey, JP				Harriss, Alexandra B.; Abbott, Kolten; Kimpinski, Kurt; Holmes, Jeffrey D.; Johnson, Andrew M.; Walton, David M.; Dickey, James P.			An Evaluation of Heart Rate Variability in Female Youth Soccer Players Following Soccer Heading: A Pilot Study	SPORTS			English	Article						concussion; subconcussion; autonomic nervous system; adolescents; head impacts	CONCUSSION; FREQUENCY; EXPOSURE; INJURY; SPORT	Most head impacts in soccer occur from purposeful heading; however, the link between heading and neurological impairment is unknown. Previous work suggests concussion may result in an uncoupling between the autonomic nervous system and cardiovascular system. Accordingly, heart rate variability (HRV) may be a sensitive measure to provide meaningful information regarding repetitive heading in soccer. The purpose of this pilot study assesses the feasibility of measuring HRV to evaluate autonomic function following soccer heading. Sixteen youth female participants underwent heart rate monitoring during a heading and footing condition. Participants completed a five minute resting supine trial at the start and end of each testing session. Standard 450 g soccer balls were projected at 6 m/s towards participants. Participants performed five headers, for the header condition, and five footers for the footer condition. The HRV for resting supine trials, pre- and post-header and footer conditions were assessed for both time and frequency domains. HRV effect sizes were small when comparing conditions, except absolute low frequency (d = 0.61) and standard deviation of the normal-normal (NN) intervals (d = 0.63). Participant retention and adherence were high, without adverse events. Findings suggest HRV is a feasible measure for evaluating the effects of heading on autonomic function.	[Harriss, Alexandra B.; Abbott, Kolten; Dickey, James P.] Univ Western Ontario, Sch Kinesiol, London, ON N6A 3K7, Canada; [Harriss, Alexandra B.; Walton, David M.] Univ Western Ontario, Sch Phys Therapy, London, ON N6A 3K7, Canada; [Kimpinski, Kurt] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 3K7, Canada; [Holmes, Jeffrey D.] Univ Western Ontario, Sch Occupat Therapy, London, ON N6A 3K7, Canada; [Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON N6A 3K7, Canada		Dickey, JP (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON N6A 3K7, Canada.	aharri73@uwo.ca; kolten.abbott@gmail.com; kkimpin@uwo.ca; jholme@uwo.ca; ajohnson@uwo.ca; dwalton5@uwo.ca; jdickey@uwo.ca	Johnson, Andrew M/B-2048-2012; Dickey, James P/K-6776-2013; Walton, David M/C-9902-2015	Dickey, James P/0000-0002-4101-835X; Walton, David M/0000-0001-9155-3337; Johnson, Andrew M./0000-0002-7269-3016	Ontario Women's Health Scholars Award	This research was funded by The Ontario Women's Health Scholars Award.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Muise DP, 2016, INT J ATHL THER TRAI, V21, P36, DOI 10.1123/ijatt.2016-0005; Paniccia M, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000355; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Stuart S, 2017, J SPORT HEALTH SCI, V6, P299, DOI 10.1016/j.jshs.2017.03.009; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024	26	4	5	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4663		SPORTS	Sports	NOV	2019	7	11							229	10.3390/sports7110229			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	JS0QY	WOS:000500020700002	31689916	Green Published, gold			2022-02-06	
J	Li, HX; He, L; Zhang, CC; Eisinger, R; Pan, YX; Wang, T; Sun, BM; Wu, YW; Li, DY				Li, Hong-Xia; He, Lu; Zhang, Chen-Cheng; Eisinger, Robert; Pan, Yi-Xin; Wang, Tao; Sun, Bo-Min; Wu, Yi-Wen; Li, Dian-You			Deep brain stimulation in post-traumatic dystonia: A case series study	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						deep brain stimulation; globus pallidus internus; post-traumatic dystonia; subthalamic nucleus; ventral intermediate nucleus	TERM-FOLLOW-UP; PALLIDUS INTERNUS STIMULATION; SUBTHALAMIC NUCLEUS; HEMIDYSTONIA; SECONDARY; INJURY	Aims Deep brain stimulation (DBS) has been proposed as an effective treatment for drug-intolerant isolated dystonia, but whether it is also efficacious for posttraumatic dystonia (PTD) is unknown. Reports are few in number and have reached controversial conclusions regarding the efficacy of DBS for PTD treatment. Here, we report a case series of five PTD patients with improved clinical benefit following DBS treatment. Methods Five patients with disabling PTD underwent DBS therapy. The clinical outcomes were assessed with the Burke-Fahn-Marsden dystonia rating scale (BFMDRS) at baseline and the last follow-up visit (at more than 12 months). Results Patients 1 and 3 received unilateral globus pallidus internus (GPi) DBS for contralateral dystonia. The subthalamic nucleus (STN) was chosen as target for patients 2 and 4, due to a lesion located in the globus pallidus. Patient 5 had an electrode in the ventral intermediate nucleus (VIM) for treating predominant tremor of left upper extremity, with unexpected improvement of focal hand dystonia. The scores of BFMDRS movement exhibited favorable improvement in all five patients at the last follow-up, ranging from 52.4% to 78.6%. Conclusions Deep brain stimulation may be an effective and safe treatment for medically refractory PTD, but this needs to be confirmed by further studies.	[Li, Hong-Xia; He, Lu; Wu, Yi-Wen] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China; [Li, Hong-Xia; He, Lu; Wu, Yi-Wen] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Inst Neurol, Shanghai, Peoples R China; [Zhang, Chen-Cheng; Pan, Yi-Xin; Wang, Tao; Sun, Bo-Min; Li, Dian-You] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Funct Neurosurg, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China; [Eisinger, Robert] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Wu, Yi-Wen] Chinese Acad Sci, SIBS, Inst Hlth Sci, Lab Neurodegenerat Dis, Shanghai, Peoples R China; [Wu, Yi-Wen] Chinese Acad Sci, SIBS, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Wu, Yi-Wen] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China		Wu, YW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China.; Wu, YW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Inst Neurol, Shanghai, Peoples R China.; Li, DY (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Funct Neurosurg, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	wyw11380@rjh.com.cn; ldy11483@rjh.com.cn	Zhang, ChenCheng/AAK-6096-2020; Eisinger, Robert/AAW-4533-2021; Pan, Yi/AAJ-2341-2021	Zhang, ChenCheng/0000-0003-4472-4134; Eisinger, Robert/0000-0003-3191-2355; Li, Dian-you/0000-0003-4212-4231; Wu, Yiwen/0000-0001-6059-7054			Albanese A, 2014, MOVEMENT DISORD, V29, P578, DOI [10.1002/mds.25840, 10.1002/mds.25861]; Carvalho KS, 2014, J CLIN NEUROSCI, V21, P153, DOI 10.1016/j.jocn.2013.02.009; Chang JW, 2002, J NEUROL NEUROSUR PS, V73, P588, DOI 10.1136/jnnp.73.5.588; Dec M, 2014, PARKINSONISM RELAT D, V20, P131, DOI 10.1016/j.parkreldis.2013.09.015; Deng ZD, 2017, PARKINSONISM RELAT D, V41, P58, DOI 10.1016/j.parkreldis.2017.05.010; Deng ZD, 2018, PARKINSONISM RELAT D, V55, P103, DOI 10.1016/j.parkreldis.2018.05.024; Fonoff ET, 2012, MOVEMENT DISORD, V27, P1559, DOI 10.1002/mds.25127; Frei K, 2017, J NEUROL SCI, V379, P183, DOI 10.1016/j.jns.2017.05.040; Gruber D, 2009, NEUROLOGY, V73, P53, DOI 10.1212/WNL.0b013e3181aaea01; JABBARI B, 1992, MOVEMENT DISORD, V7, P78, DOI 10.1002/mds.870070116; Jahanshahi M, 2011, MOVEMENT DISORD, V26, pS68, DOI 10.1002/mds.23511; Kang DW, 2010, NEUROMODULATION, V13, P261, DOI 10.1111/j.1525-1403.2010.00306.x; Kim JP, 2012, ACTA NEUROCHIR, V154, P823, DOI 10.1007/s00701-012-1306-4; Krauss JK, 1996, NEUROLOGY, V47, P1488, DOI 10.1212/WNL.47.6.1488; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Kwon CS, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.05.014; Lin SZ, 2020, J NEUROSURG, V132, P721, DOI 10.3171/2018.12.JNS181927; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; Margolesky J, 2017, BRAIN STIMUL, V10, P870, DOI 10.1016/j.brs.2017.04.123; Rojas-Medina LM, 2016, STEREOT FUNCT NEUROS, V94, P379, DOI 10.1159/000448078; Martinez Jairo Alberto Espinoza, 2013, Acta Neurochir Suppl, V117, P61, DOI 10.1007/978-3-7091-1482-7_10; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; Parent M, 2004, PARKINSONISM RELAT D, V10, P203, DOI 10.1016/j.parkreldis.2004.02.007; Patel A, 2018, TREMOR OTHER HYPERK, V8, DOI 10.7916/D8P85VBQ; Ren J, 2014, MOVEMENT DISORD, V29, pS96; SELLAL F, 1993, MOVEMENT DISORD, V8, P515, DOI 10.1002/mds.870080418; Slow EJ, 2015, J NEUROL NEUROSUR PS, V86, P1046, DOI 10.1136/jnnp-2014-308943; Zhang JG, 2006, CHINESE MED J-PEKING, V119, P2069, DOI 10.1097/00029330-200612020-00008	29	4	4	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	NOV	2019	25	11					1262	1269		10.1111/cns.13145			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	JK2HY	WOS:000494669300007	31033189	Green Published, gold			2022-02-06	
J	Liang, Y; Tong, F; Zhang, L; Zhu, LL; Li, WH; Huang, WS; Zhao, SQ; He, GL; Zhou, YW				Liang, Yue; Tong, Fang; Zhang, Lin; Zhu, Longlong; Li, Wenhe; Huang, Weisheng; Zhao, Shuquan; He, Guanglong; Zhou, Yiwu			iTRAQ-based proteomic analysis discovers potential biomarkers of diffuse axonal injury in rats	BRAIN RESEARCH BULLETIN			English	Article						Diffuse axonal injury; iTRAQ; Proteomics; Biomarkers; Rat	INTERMEDIATE-FILAMENT PROTEIN; TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; CORPUS-CALLOSUM; CEREBROSPINAL-FLUID; BETA-APP; PERIPHERIN; ACTIVATION; EXPRESSION; CALSENILIN	Diffuse axonal injury (DAI) is one of the most common and severe pathological consequences of traumatic brain injury (TBI). The molecular mechanism of DAI is highly complicated and still elusive, yet a clear understanding is crucial for the diagnosis, treatment, and prognosis of DAL In our study, we used rats to establish a DAI model and applied isobaric tags for relative and absolute quantitation (iTRAQ) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis to identify differentially expressed proteins (DEPs) in the corpus callosum. As a result, a total of 514 proteins showed differential expression between the injury groups and the control. Among these DEPs, 14 common DEPs were present at all seven time points postinjury (1, 3, 6, 12, 24, 48, and 72 h). Next, bioinformatic analysis was performed to elucidate the pathogenesis of DAI, which was found to possibly involve calcium ion-regulatory proteins (e.g., calsenilin and ryanodine receptor 2), cytoskeleton organization (e.g., peripherin, NFL, NFM, and NFH), apoptotic processes (e.g., calsenilin and protein kinase C delta type), and inflammatory response proteins (e.g., complement C3 and C-reactive protein). Moreover, peripherin and calsenilin were successfully confirmed by western blotting to be significantly upregulated during DAI, and immunohistochemical (IHC) analysis revealed that their expression increased and could be observed in axons after injury, thus indicating their potential as DAI biomarkers. Our experiments not only provide insight into the molecular mechanisms of axonal injury in rats during DAI but also give clinicians and pathologists important reference data for the diagnosis of DAI. Our findings may expand the list of DAI biomarkers and improve the postmortem diagnostic rate of DAI.	[Liang, Yue; Tong, Fang; Zhang, Lin; Zhu, Longlong; Huang, Weisheng; Zhao, Shuquan; Zhou, Yiwu] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China; [Li, Wenhe] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Pathol, Wuhan 430030, Hubei, Peoples R China; [He, Guanglong] Minist Publ Secur Peoples Republ China, Inst Forens Sci, 17 Nanli Mulidi, Beijing 100038, Peoples R China		Zhou, YW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.; He, GL (corresponding author), Minist Publ Secur Peoples Republ China, Inst Forens Sci, 17 Nanli Mulidi, Beijing 100038, Peoples R China.	yueyueashin@126.com; fytongfang@gmail.com; lyre2008@126.com; yuexiashuangzhuo@126.com; 18707165089@163.com; weishenghehe@163.com; fyzsq123@126.com; guanglong_he@163.com; zhouyiwu@outlook.com	Tong, Fang/AAR-5228-2020		National Key Research and Development Program of China [2018YFC0807203]; Fundamental Research Funds for the Central Universities, HUSTFundamental Research Funds for the Central Universities [2016JCTD117]	This work was supported by National Key Research and Development Program of China (No. 2018YFC0807203) and the Fundamental Research Funds for the Central Universities, HUST (No. 2016JCTD117).	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Beaulieu JM, 2002, BRAIN RES, V946, P153, DOI 10.1016/S0006-8993(02)02830-5; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2000, J NEUROSCI, V20, P2825; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cengiz P, 2008, PEDIATR CRIT CARE ME, V9, P524, DOI 10.1097/PCC.0b013e3181849dc9; CHADAN S, 1994, J NEUROSCI RES, V39, P127; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Datta A, 2013, J PROTEOMICS, V91, P556, DOI 10.1016/j.jprot.2013.08.017; Dolinak D, 2000, NEUROPATH APPL NEURO, V26, P448, DOI 10.1046/j.1365-2990.2000.00273.x; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; ESCURAT M, 1990, J NEUROSCI, V10, P764; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Hammond PI, 2003, MOL BRAIN RES, V111, P104, DOI 10.1016/S0169-328X(02)00693-9; Hol EM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a021642; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jin JK, 2005, NEUROREPORT, V16, P451, DOI 10.1097/00001756-200504040-00007; Jo DG, 2005, NEUROSCI LETT, V378, P59, DOI 10.1016/j.neulet.2004.12.078; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaasinen SK, 2002, EXP NEUROL, V176, P203, DOI 10.1006/exnr.2002.7919; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Kobek M, 2014, Arch Med Sadowej Kryminol, V64, P268; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kupina NC, 2002, J CEREBR BLOOD F MET, V22, P1212, DOI 10.1097/01.wbc.0000037994.34930.bc; Lam H, 2010, J PROTEOME RES, V9, P605, DOI 10.1021/pr900947u; Larrode P, 2018, MOL NEUROBIOL, V55, P1, DOI 10.1007/s12035-017-0713-1; Lepinoux-Chambaud C, 2013, HISTOCHEM CELL BIOL, V140, P13, DOI 10.1007/s00418-013-1101-1; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Muth T, 2010, PROTEOMICS, V10, P1223, DOI 10.1002/pmic.200900374; OBLINGER MM, 1989, J NEUROSCI, V9, P3766; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Pang H., 2016, MEDIAT INFLAMM, V2016; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; PARYSEK LM, 1991, J NEUROSCI RES, V30, P80, DOI 10.1002/jnr.490300110; Paxinos G., 2006, RAT BRAIN STEREOTAXI, V3; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Ren T, 2016, ONCOTARGETS THER, V9, P5883, DOI 10.2147/OTT.S111103; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schwacke JH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-342; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Suankratay C, 1998, CLIN EXP IMMUNOL, V113, P353; Szalai AJ, 2000, J IMMUNOL, V165, P1030, DOI 10.4049/jimmunol.165.2.1030; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; TROY CM, 1990, BRAIN RES, V529, P232, DOI 10.1016/0006-8993(90)90832-V; TROY CM, 1990, NEUROSCIENCE, V36, P217, DOI 10.1016/0306-4522(90)90364-A; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; Ubukata S, 2016, J NEUROPSYCH CLIN N, V28, P97, DOI 10.1176/appi.neuropsych.15070159; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Wallerstedt E, 2010, DIABETOLOGIA, V53, P946, DOI 10.1007/s00125-010-1668-1; Winkler T, 2003, ACTA NEUROCHIR SUPPL, V86, P425; WONG J, 1990, J NEUROSCI RES, V27, P332, DOI 10.1002/jnr.490270312; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	88	4	4	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	NOV	2019	153						289	304		10.1016/j.brainresbull.2019.09.004			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JP5UU	WOS:000498330200032	31539556				2022-02-06	
J	Lundine, JP; Barron, HD				Lundine, Jennifer P.; Barron, Heath D.			Microstructural and Fluency Characteristics of Narrative and Expository Discourse in Adolescents With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							CHILDREN; MEMORY; RECOVERY; COHESION; TERM	Purpose: The purpose of this exploratory study was to identify specific microstructural and fluency differences in expository and narrative summaries produced by students with a traumatic brain injury (TBI) compared to students with typical development (TD). Method: Method: Five adolescents with TBI and 5 matched peers with TD verbally summarized 1 narrative and 2 expository (compare-contrast, cause-effect) lectures, creating 30 summaries. Researchers transcribed summaries and used paired t tests to analyze between-group differences in microstructural measures (productivity, lexical diversity, syntactic complexity), mazing behaviors, and pausing patterns. Results: Youth with TBI produced significantly fewer utterances than teens with TD in both expository contexts, whereas youth with TD produced a significantly greater mean length of C-unit than teens with TBI in the narrative summary only. Youth with TBI produced significantly fewer filled pauses per utterance than did youth with TD during the cause-effect summary only and significantly more pauses per utterance and within-clause pauses per utterance during the compare-contrast summary. Where findings were statistically significant, effect sizes were large. There were no statistically significant between-group differences in mazing or pausing behaviors during narrative summary production. Conclusions: This study is the 1st to compare microstructural and fluency characteristics in teens with TBI and those without when producing verbal summaries of a narrative and 2 types of expository passages. Findings from this study reinforce the need to expand research focusing on expository discourse tasks and identify variables that may be prone to disruption following TBI. Future work is needed to confirm whether identified differences correspond to true discourse difficulties.	[Lundine, Jennifer P.; Barron, Heath D.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH 43205 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH 43205 USA		Lundine, JP (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA.; Lundine, JP (corresponding author), Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH 43205 USA.; Lundine, JP (corresponding author), Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH 43205 USA.	lundine.4@osu.edu	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	Alumni Grant for Graduate Research and Scholarship; Ohio State UniversityOhio State University	This research was supported in part by the Alumni Grant for Graduate Research and Scholarship and a laboratory start-up seed grant from The Ohio State University to the first author. The authors are grateful for the assistance of Allison Gonzalez and Oliva Crawford, who helped code transcripts for this research.	Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P133, DOI 10.1111/mono.12039; Best RM, 2008, READ PSYCHOL, V29, P137, DOI 10.1080/02702710801963951; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Boersma Paul., 2018, PRAAT DOING PHONETIC; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cohen J., 2013, STAT POWER ANAL BEHA; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gillam RB, 1999, TOP LANG DISORD, V20, P33, DOI 10.1097/00011363-199911000-00005; Glang A, 2008, NEUROREHABILITATION, V23, P477; Goldman Eisler F, 1968, PSYCHOLINGUISTICS EX; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hunt K. W., 1965, 3 NAT COUNC TEACH EN; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kircher TTJ, 2004, NEUROIMAGE, V21, P84, DOI 10.1016/j.neuroimage.2003.09.041; KIRSNER K, 2002, P 9 AUSTR INT C SPEE; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Loban Walter, 1976, LANGUAGE DEV KINDERG; Lundine JP, 2018, LANG SPEECH HEAR SER, V49, P551, DOI 10.1044/2018_LSHSS-17-0105; Lundine JP, 2018, AM J SPEECH-LANG PAT, V27, P247, DOI 10.1044/2017_AJSLP-16-0131; Miller J. F., 2010, SYSTEMATIC ANAL LANG; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Navarro-Ruiz MI, 2001, CLIN LINGUIST PHONET, V15, P63, DOI 10.3109/02699200109167632; Peach RK, 2016, NEUROPSYCHOLOGIA, V80, P157, DOI 10.1016/j.neuropsychologia.2015.11.015; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Ward-Lonergan J. M., 2010, EXPOSITORY DISCOURSE, P155; Weintraub S, 2013, MONOGR SOC RES CHILD, V78, P1, DOI 10.1111/mono.12031; Wiig EH, 2013, CLIN EVALUATION LANG, V5th; Wolfe MBW, 2005, J EXP PSYCHOL LEARN, V31, P359, DOI 10.1037/0278-7393.31.2.359; Wolfe MBW, 2007, BRIT J EDUC PSYCHOL, V77, P541, DOI 10.1348/000709906X143902; Wolfe MBW, 2010, BRIT J EDUC PSYCHOL, V80, P341, DOI 10.1348/000709910X485700; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	49	4	4	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2019	28	4					1638	1648		10.1044/2019_AJSLP-19-0012			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JP0ML	WOS:000497966200018	31525074				2022-02-06	
J	Mazwi, NL; Izzy, S; Tan, CO; Martinez, S; Glenn, MB; Giacino, JT; Wu, O; Zafonte, R; Edlow, BL				Mazwi, Nicole L.; Izzy, Saef; Tan, Can Ozan; Martinez, Sergi; Glenn, Mel B.; Giacino, Joseph T.; Wu, Ona; Zafonte, Ross; Edlow, Brian L.			Traumatic Microbleeds in the Hippocampus and Corpus Callosum Predict Duration of Posttraumatic Amnesia	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						posttraumatic amnesia; traumatic axonal injury; traumatic brain injury; traumatic microbleeds	DIFFUSE AXONAL INJURY; BRAIN-INJURY; HEAD-INJURY; GALVESTON ORIENTATION; SCALE; CLASSIFICATION; CONSCIOUSNESS; ABNORMALITIES; DISCONNECTION; INDIVIDUALS	Objective: Radiologic predictors of posttraumatic amnesia (PTA) duration are lacking. We hypothesized that the number and distribution of traumatic microbleeds (TMBs) detected by gradient recalled echo (GRE) magnetic resonance imaging (MRI) predicts PTA duration. Setting: Academic, tertiary medical center. Participants: Adults with traumatic brain injury (TBI). Design: We identified 65 TBI patients with acute GRE MRI. PTA duration was determined with the Galveston Orientation and Amnesia Test, Orientation Log, or chart review. TMBs were identified within memory regions (hippocampus, corpus callosum, fornix, thalamus, and temporal lobe) and control regions (internal capsule and global). Regression tree analysis was performed to identify radiologic predictors of PTA duration, controlling for clinical PTA predictors. Main Measures: TMB distribution, PTA duration. Results: Sixteen patients (25%) had complicated mild, 4 (6%) had moderate, and 45 (69%) had severe TBI. Median PTA duration was 43 days (range, 0-240 days). In univariate analysis, PTA duration correlated with TMBs in the corpus callosum (R = 0.29, P = .02) and admission Glasgow Coma Scale (GCS) score (R = -0.34, P = .01). In multivariate regression analysis, admission GCS score was the only significant contributor to PTA duration. However, in regression tree analysis, hippocampal TMBs, callosal TMBs, age, and admission GCS score explained 26% of PTA duration variance and distinguished a subgroup with prolonged PTA. Conclusions: Hippocampal and callosal TMBs are potential radiologic predictors of PTA duration.	[Mazwi, Nicole L.; Zafonte, Ross] Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Izzy, Saef; Martinez, Sergi; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Tan, Can Ozan; Wu, Ona] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Wu, Ona; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02115 USA; [Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Boston, MA 02115 USA; [Mazwi, Nicole L.; Tan, Can Ozan; Glenn, Mel B.; Giacino, Joseph T.; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Izzy, Saef; Martinez, Sergi] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Charlestown, MA USA		Mazwi, NL (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	nmazwi@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021; Tan, Can Ozan/E-2598-2016	Giacino, Joseph/0000-0002-7916-9698; Tan, Can Ozan/0000-0001-9673-9907; Wu, Ona/0000-0002-5509-9461	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743, K23NS094538]; American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, US Department Health and Human Services [H133A120085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R25NS065743] Funding Source: NIH RePORTER	The authors thank Steven L. Meisler and India A. Lissak for assistance with database quality assessment. This studywas supported by theNational Institute of Neurological Disorders and Stroke (R25NS065743, K23NS094538), the American Academy of Neurology/American Brain Foundation, the James S. McDonnell Foundation, and theNational Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, US Department Health and Human Services to Spaulding Rehabilitation Hospital (H133A120085).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Catani M, 2008, CORTEX, V44, P911, DOI 10.1016/j.cortex.2008.05.001; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Greer DM, 2013, J STROKE CEREBROVASC, V22, P899, DOI 10.1016/j.jstrokecerebrovasdis.2012.08.006; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Horner AJ, 2017, CURR OPIN NEUROBIOL, V43, P102, DOI 10.1016/j.conb.2017.02.004; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Martinez-Ramirez S, 2015, ALZHEIMERS DEMENT, V11, P1480, DOI 10.1016/j.jalz.2015.04.009; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	47	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					E10	E18		10.1097/HTR.0000000000000479			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200002	31033742	Green Accepted			2022-02-06	
J	Muballe, KD; Sewani-Rusike, CR; Longo-Mbenza, B; Iputo, J				Muballe, Kadhaya David; Sewani-Rusike, Constance R.; Longo-Mbenza, Benjamin; Iputo, Jehu			Predictors of recovery in moderate to severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						trauma; traumatic brain injury; oxidative stress; inflammatory changes; recovery	GLASGOW COMA SCALE; TUMOR-NECROSIS-FACTOR; SUBARACHNOID HEMORRHAGE; NERVOUS-SYSTEM; UNITED-STATES; FREE-RADICALS; CYTOKINES; INTERLEUKIN-10; INFLAMMATION; SCORE	OBJECTIVE Traumatic brain injury (TBI) is a significant cause of morbidity and mortality worldwide. Clinical outcomes in TBI are determined by the severity of injury, which is dependent on the primary and secondary brain injury processes. Whereas primary brain injury lesions are related to the site of impact, secondary brain injury results from physiological changes caused by oxidative stress and inflammatory responses that occur after the primary insult. The aim of this study was to identify important clinical and biomarker profiles that were predictive of recovery after moderate to severe TBI. A good functional outcome was defined as a Glasgow Outcome Scale (GOS) score of >= 4. METHODS This was a prospective study of patients with moderate to severe TBI managed at the Nelson Mandela Academic Hospital during the period between March 2014 and March 2016. Following admission and initial management, the patient demographic data (sex, age) and admission Glasgow Coma Scale score were recorded. Oxidative stress and inflammatory biomarkers in blood and CSF were sampled on days 1-7. On day 14, only blood was sampled for the same biomarkers. The primary outcome was the GOS score-due to its simplicity, the GOS was used to assess clinical outcomes at day 90. Because of difficulty in performing regular follow-up due to the vastness of the region, difficult terrain, and long travel distances, a 3-month follow-up period was used to avoid default. RESULTS Sixty-four patients with Glasgow Coma Scale scores of <= 12 were seen and managed. Among the 56 patients who survived, 42 showed significant recovery (GOS score >= 4) at 3 months. Important predictors of recovery included antioxidant activity in the CSF (superoxide dismutase and total antioxidant capacity). CONCLUSIONS Recovery after TBI was dependent on the resolution of oxidative stress imbalance.	[Muballe, Kadhaya David] Walter Sisulu Univ, Dept Neurosurg, Mthatha, Eastern Cape Pr, South Africa; [Sewani-Rusike, Constance R.; Iputo, Jehu] Walter Sisulu Univ, Dept Physiol, Mthatha, Eastern Cape Pr, South Africa; [Longo-Mbenza, Benjamin] Walter Sisulu Univ, Dept Publ Hlth, Mthatha, Eastern Cape Pr, South Africa		Muballe, KD (corresponding author), Walter Sisulu Univ, Mthatha, Eastern Cape Pr, South Africa.	kmuballe@yahoo.co.uk			Walter Sisulu University research office	I (K.D.M.) would like to thank the Walter Sisulu University research office for funding this study. This funding was granted to me during my Doctor of Philosophy in Health Sciences studies.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; Batinic-Haberle I, 2011, FREE RADICAL BIO MED, V51, P1035, DOI 10.1016/j.freeradbiomed.2011.04.046; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DOHERTY DE, 1988, LAB INVEST, V59, P200; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Egerod I, 2010, CRIT CARE, V14, DOI 10.1186/cc8978; FAN L, 1995, MOL BRAIN RES, V30, P125; Feng QL, 2015, EXP THER MED, V9, P1695, DOI 10.3892/etm.2015.2363; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GAETANI P, 1990, STROKE, V21, P328, DOI 10.1161/01.STR.21.2.328; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; IKEDA Y, 1989, NEUROSURGERY, V24, P679, DOI 10.1227/00006123-198905000-00004; JENNETT B, 1975, LANCET, V1, P480; Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151, DOI 10.1016/S0149-7634(96)00005-X; Koller M, 1998, LANGENBECK ARCH SURG, V383, P460, DOI 10.1007/s004230050161; KONTOS HA, 1984, CIRC RES, V55, P295, DOI 10.1161/01.RES.55.3.295; Kretzschmar M, 1998, EXP TOXICOL PATHOL, V50, P477, DOI 10.1016/S0940-2993(98)80037-7; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Lisinski TJ, 2002, J LEUKOCYTE BIOL, V72, P503; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARZATICO F, 1993, ACTA NEUROL SCAND, V87, P62; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCord J M, 1993, New Horiz, V1, P70; MCCORD JM, 1993, CLIN BIOCHEM, V26, P351, DOI 10.1016/0009-9120(93)90111-I; Meagher EA, 2000, FREE RADICAL BIO MED, V28, P1745, DOI 10.1016/S0891-5849(00)00232-X; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rosenberg Andrew L, 2002, Curr Opin Crit Care, V8, P321, DOI 10.1097/00075198-200208000-00009; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schlag G, 1996, WORLD J SURG, V20, P406, DOI 10.1007/s002689900064; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; TEASDALE G, 1974, LANCET, V2, P81; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Todo H, 1998, J CEREBR BLOOD F MET, V18, P808, DOI 10.1097/00004647-199807000-00011; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Vincent JL, 2000, CRIT CARE CLIN, V16, P353, DOI 10.1016/S0749-0704(05)70114-7; Williams TI, 2005, ANAL CHEM, V77, P3383, DOI 10.1021/ac048265+; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yin ZH, 1997, ARTHRITIS RHEUM, V40, P1788, DOI 10.1002/art.1780401010; Yin ZN, 1997, ARTHRITIS RHEUM, V40, P69, DOI 10.1002/art.1780400111; Zuccarello M, 1998, STROKE, V29, P1924, DOI 10.1161/01.STR.29.9.1924	60	4	4	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2019	131	5					1648	1657		10.3171/2018.4.JNS172185			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2EE	WOS:000493973300038	30497133	Bronze			2022-02-06	
J	Noel, L; Kuhl, E				Noel, L.; Kuhl, E.			Modeling neurodegeneration in chronic traumatic encephalopathy using gradient damage models	COMPUTATIONAL MECHANICS			English	Article						Chronic traumatic encephalopathy; Mild traumatic brain injury; Continuum damage mechanics; Gradient damage; Finite element modeling	ENHANCED DAMAGE; BRAIN-INJURY; IDENTIFICATION; BIOMECHANICS; PROPAGATION; FORMULATION; DYNAMICS; SPECTRUM	Chronic traumatic encephalopathy is a progressive neurodegenerative disorder that results from repetitive impacts to the head. Its distinguishing feature is an accumulation of abnormal tau proteins in characteristic regions within the brain. Histopathological studies reveal that tau consistently localizes at the depth of cerebral sulci; yet, the mechanistic origin of this pattern remains unclear. Here we show that a continuum damage model, enhanced with nonlocal gradients, can explain the initial distribution of abnormal tau proteins. We hypothesize that tau aggregation is associated with neuronal death, which we represent as tissue softening and stiffness degradation. Our simulations correctly identify the initial locations of tau deposition, at the depth of cerebral sulci, from where damage spreads within the cortical layer and then across the entire brain. Our computational model has the potential to provide a mechanistic explanation of the stereotypic histopathology of chronic traumatic encephalopathy and predict the cumulative effects of repeated mild traumatic brain injuries.	[Noel, L.; Kuhl, E.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA		Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X	Belgian American Educational Foundation (BAEF); University of LiegeUniversity of Liege; NSFNational Science Foundation (NSF) [CMMI 1727268]	This study was supported by a postdoctoral fellowship from the Belgian American Educational Foundation (BAEF) and a Duesberg postdoctoral fellowship from the University of Liege to Lise Noel and by the NSF Grant CMMI 1727268 Understanding Neurodegeneration across the Scales to Ellen Kuhl.	Askes H, 2011, INT J SOLIDS STRUCT, V48, P1962, DOI 10.1016/j.ijsolstr.2011.03.006; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; BAZANT ZP, 1984, J ENG MECH-ASCE, V110, P1666; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; de Rooij R, 2017, COMPUT MECH, V59, P523, DOI 10.1007/s00466-016-1359-y; de Rooij R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00144; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Garcia-Gonzalez D, 2019, J MECH PHYS SOLIDS, V125, P22, DOI 10.1016/j.jmps.2018.12.009; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Karaman E, 2011, J CRANIOFAC SURG, V22, P2374, DOI 10.1097/SCS.0b013e318231e511; Kiefer B, 2018, INT J DAMAGE MECH, V27, P253, DOI 10.1177/1056789516676306; LASRY D, 1988, INT J SOLIDS STRUCT, V24, P581, DOI 10.1016/0020-7683(88)90059-5; Lemaitre J., 1992, COURSE DAMAGE MECH; Mahnken R, 1999, EUR J MECH A-SOLID, V18, P819, DOI 10.1016/S0997-7538(99)00127-8; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Nishimoto T, 2000, JSAE REV, V21, P117, DOI 10.1016/S0389-4304(99)00079-X; Ostwald R, 2019, COMPUT MECH, V64, P847, DOI 10.1007/s00466-019-01684-5; Peerlings RHJ, 1996, INT J NUMER METH ENG, V39, P3391, DOI 10.1002/(SICI)1097-0207(19961015)39:19<3391::AID-NME7>3.0.CO;2-D; Peerlings RHJ, 2001, INT J SOLIDS STRUCT, V38, P7723, DOI 10.1016/S0020-7683(01)00087-7; RIKS E, 1979, INT J SOLIDS STRUCT, V15, P529, DOI 10.1016/0020-7683(79)90081-7; Shetty T, 2016, SPORTS HEALTH, V8, P26, DOI 10.1177/1941738115588745; SIMO JC, 1987, INT J SOLIDS STRUCT, V23, P821, DOI 10.1016/0020-7683(87)90083-7; SIMO JC, 1987, INT J SOLIDS STRUCT, V23, P841, DOI 10.1016/0020-7683(87)90084-9; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Steinmann P, 1999, INT J NUMER METH ENG, V46, P757, DOI 10.1002/(SICI)1097-0207(19991020)46:5<757::AID-NME731>3.0.CO;2-N; van den Bedem H, 2017, CURR OPIN BIOMED ENG, V1, P23, DOI 10.1016/j.cobme.2017.02.003; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Waffenschmidt T, 2014, COMPUT METHOD APPL M, V268, P801, DOI 10.1016/j.cma.2013.10.013; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V84, P88, DOI 10.1016/j.jmbbm.2018.04.009; Weickenmeier J, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.158101; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V77, P702, DOI 10.1016/j.jmbbm.2017.08.029; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	49	4	4	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-7675	1432-0924		COMPUT MECH	Comput. Mech.	NOV	2019	64	5					1375	1387		10.1007/s00466-019-01717-z			13	Mathematics, Interdisciplinary Applications; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics; Mechanics	JJ3QZ	WOS:000494077000011					2022-02-06	
J	Noje, C; Jackson, EM; Nasr, IW; Costabile, PM; Cerullo, M; Hoops, K; Rasmussen, L; Henderson, E; Ziegfeld, S; Puett, L; Robertson, CL				Noje, Corina; Jackson, Eric M.; Nasr, Isam W.; Costabile, Philomena M.; Cerullo, Marcelo; Hoops, Katherine; Rasmussen, Lindsey; Henderson, Eric; Ziegfeld, Susan; Puett, Lisa; Robertson, Courtney L.			Trauma Bay Disposition of Infants and Young Children With Mild Traumatic Brain Injury and Positive Head Imaging	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						optimal disposition; pediatric neurotrauma; traumatic brain injury	MANAGEMENT; CLASSIFICATION; ADMISSION; OUTCOMES; SCORES	Objectives: To describe the disposition of infants and young children with isolated mild traumatic brain injury and neuroimaging findings evaluated at a level 1 pediatric trauma center, and identify factors associated with their need for ICU admission. Design: Retrospective cohort. Setting: Single center. Patients: Children less than or equal to 4 years old with mild traumatic brain injury (Glasgow Coma Scale 13-15) and neuroimaging findings evaluated between January 1, 2013, and December 31, 2015. Polytrauma victims and patients requiring intubation or vasoactive infusions preadmission were excluded. Interventions: None. Measurements and Main Results: Two-hundred ten children (median age/weight/Glasgow Coma Scale: 6 mo/7.5 kg/15) met inclusion criteria. Most neuroimaging showed skull fractures with extra-axial hemorrhage/no midline shift (30%), nondisplaced skull fractures (28%), and intracranial hemorrhage without fractures/midline shift (19%). Trauma bay disposition included ICU (48%), ward (38%), intermediate care unit and home (7% each). Overall, 1% required intubation, 4.3% seizure management, and 4.3% neurosurgical procedures; 15% were diagnosed with nonaccidental trauma. None of the ward/intermediate care unit patients were transferred to ICU. Median ICU/hospital length of stay was 2 days. Most patients (99%) were discharged home without neurologic deficits. The ICU subgroup included all patients with midline shift, 62% patients with intracranial hemorrhage, and 20% patients with skull fractures. Across these imaging subtypes, the only clinical predictor of ICU admission was trauma bay Glasgow Coma Scale less than 15 (p = 0.018 for intracranial hemorrhage; p < 0.001 for skull fractures). A minority of ICU patients (18/100) required neurocritical care and/or neurosurgical interventions; risk factors included neurologic deficit, loss of consciousness/seizures, and extra-axial hemorrhage (especially epidural hematoma). Conclusions: Nearly half of our cohort was briefly monitored in the ICU (with disposition mostly explained by trauma bay imaging, rather than clinical findings); however, less than 10% required ICU-specific interventions. Although ICU could be used for close neuromonitoring to prevent further neurologic injury, additional research should explore if less conservative approaches may preserve patient safety while optimizing healthcare resource utilization.	[Noje, Corina; Hoops, Katherine; Robertson, Courtney L.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Jackson, Eric M.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Nasr, Isam W.; Ziegfeld, Susan; Puett, Lisa] Johns Hopkins Univ, Sch Med, Dept Surg, Div Pediat Surg, Baltimore, MD 21205 USA; [Costabile, Philomena M.; Puett, Lisa] Johns Hopkins Univ Hosp, Dept Nursing, Div Pediat Surg, Baltimore, MD 21287 USA; [Cerullo, Marcelo] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Rasmussen, Lindsey] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Henderson, Eric] LifeStar Response Maryland, Halethorpe, MD USA		Noje, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	cnicule1@jhmi.edu		Jackson, Eric/0000-0001-9306-9290	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075774] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM075774] Funding Source: Medline		Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; Auerbach DI, 2017, NURS OUTLOOK, V65, P116, DOI 10.1016/j.outlook.2016.07.004; Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44; Burns EC, 2019, PEDIATR EMERG CARE, V35, P161, DOI 10.1097/PEC.0000000000000950; Chandee T, 2017, PEDIATR CRIT CARE ME, V18, P1166, DOI 10.1097/PCC.0000000000001350; Cook Rebecca S, 2006, J Trauma Nurs, V13, P58; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Teke A, 2016, AM J NEURORADIOL, V37, P990, DOI 10.3174/ajnr.A4658; US Department of Health and Human Services Health Resources and Services Administration National Center for Health Workforce Analysis, 2017, NAT REG SUPPL DEM PR; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wendling-Keim DS, 2017, PEDIATR SURG INT, V33, P249, DOI 10.1007/s00383-016-4021-z; Woestman R, 1998, J Pediatr Health Care, V12, P288, DOI 10.1016/S0891-5245(98)90140-7; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	23	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	NOV	2019	20	11					1061	1068		10.1097/PCC.0000000000002033			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	JK2ZC	WOS:000494714100011	31232854	Green Accepted			2022-02-06	
J	Patel, P; Taylor, D; Park, MS				Patel, Parantap; Taylor, Davis; Park, Min S.			Characteristics of traumatic brain injury during Operation Enduring Freedom-Afghanistan: a retrospective case series	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; blast injury; military medicine; neurorehabilitation; decompressive craniectomy; comorbid injury	COMBAT CASUALTY CARE; OUTCOMES; MANAGEMENT; QUALITY	Traumatic brain injury (TBI) is a significant cause of morbidity and mortality, especially among members of the armed services. Injuries sustained in the battlefield are subject to different mechanisms than those sustained in civilian life, particularly blast and high-velocity injury. Due to the unique nature of these injuries and the challenges associated with battlefield medicine, surgical interventions play a key role in acute management of TBI. However, the burden of chronic disease posed by TBI is poorly understood and difficult to investigate, especially in the military setting. The authors report the case logs of a United States Navy neurosurgeon, detailing the acute management and outcomes of 156 patients sustaining TBI between November 2010 and May 2011 during the war in Afghanistan. By demographics, more than half of the patients treated were local nationals. By mechanism of injury, blunt trauma (40.4%) and explosive injury (37.2%) were the most common contributors to TBI. Decompressive craniectomies (24.0%) and clot evacuations (14.7%) were the procedures most commonly performed. Nearly one-quarter of patients were transferred to receive further care, yet only 3 patients were referred for rehabilitative services. Furthermore, the data suggest that patients sustaining comorbid injuries in addition to TBI may be predisposed to worse outcomes. Improvements in documentation of military patients may improve knowledge of TBI and further identify potential variables or treatments that may affect prognosis. The increased survivability from TBI also highlights the need for additional research expenditure in the field of neurorehabilitation specifically.	[Patel, Parantap; Taylor, Davis; Park, Min S.] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA		Park, MS (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA 22903 USA.	mp2tq@virginia.edu		Patel, Parantap/0000-0001-7890-290X			Albrecht JS, 2017, ARCH PHYS MED REHAB, V98, P2548, DOI 10.1016/j.apmr.2017.06.007; Baldwin G, 2015, C TRAUM BRAIN INJ US; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Butler FK, 2017, MIL MED, V182, pE1563, DOI 10.7205/MILMED-D-16-00214; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Dams-O'Connor K, 2018, BRAIN INJURY, V32, P431, DOI 10.1080/02699052.2018.1429024; DeBeer BB, 2017, J NERV MENT DIS, V205, P512, DOI 10.1097/NMD.0000000000000695; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Hasoon James, 2017, US Army Med Dep J, P102; Howard JT, 2018, J TRAUMA ACUTE CARE, V84, P11, DOI 10.1097/TA.0000000000001727; Kreitzer N, 2019, J HEAD TRAUMA REHABI; Lehman C, 2008, REHABIL NURS, V33, P192, DOI 10.1002/j.2048-7940.2008.tb00227.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Manring MM, 2009, CLIN ORTHOP RELAT R, V467, P2168, DOI 10.1007/s11999-009-0738-5; MAUGHON JS, 1970, MIL MED, V135, P8, DOI 10.1093/milmed/135.1.8; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018626; Norisue Y, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0316-6; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Oh JS, 2016, MIL MED, V181, P1069, DOI 10.7205/MILMED-D-15-00264; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pikoulis EA, 2004, WORLD J SURG, V28, P425, DOI 10.1007/s00268-003-6931-x; Pruitt BA, 2006, ANN SURG, V243, P715, DOI 10.1097/01.sla.0000220038.66466.b5; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schulz-Heik RJ, 2017, BRAIN INJURY, V31, P1287, DOI 10.1080/02699052.2017.1307449; Sharrock AE, 2019, INJURY, V50, P125, DOI 10.1016/j.injury.2018.06.037; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	34	4	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E13	10.3171/2019.8.FOCUS19493			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900013	31675708	gold			2022-02-06	
J	Rajneesh, CP; Yang, LY; Chen, SC; Hsieh, TH; Chin, HY; Peng, CW				Rajneesh, Chellappan Praveen; Yang, Ling-Yu; Chen, Shih-Ching; Hsieh, Tsung-Hsun; Chin, Hung-Yen; Peng, Chih-Wei			Cystometric Measurements in Rats with an Experimentally Induced Traumatic Brain Injury and Voiding Dysfunction: A Time-Course Study	BRAIN SCIENCES			English	Article						traumatic brain injury; cystometric measurements; time-course analysis; external urethral sphincter electromyographic activity	RAISED INTRACRANIAL-PRESSURE; MODEL; MICTURITION	Traumatic brain injuries (TBIs) are a serious public health issue worldwide with increased mortality as well as severe disabilities and injuries caused by falls and road accidents. Unfortunately, there is no approved therapy for TBIs, and bladder dysfunction is a striking symptom. Accordingly, we attempted to analyze bladder dysfunction and voiding efficiency in rats with a TBI at different time-course intervals. Time-dependent analyses were scheduled from the next day until four weeks after a TBI. Experimental animals were grouped and analyzed under the above conditions. Cystometric measurements were used for this analysis and were further elaborated as external urethral sphincter electromyographic (EUS-EMG) activity and cystometrogram (CMG) measurements. Moreover, magnetic resonance imaging (MRI) studies were conducted to investigate secondary injury progression in TBI rats, and results were compared to normal control (NC) rats. Results of EUS-EMG revealed that the burst period, active period, and silent period in TBI rats were drastically reduced compared to NC rats, but they increased later and reached a stagnant phase. Likewise, in CMG measurements, bladder function, the voided volume, and voiding efficiency decreased immediately after the TBI, and other parameters like the volume threshold, inter-contraction interval, and residual volume drastically increased. Later, those levels changed, and all observed results were compared to NC rats. MRI results revealed the prevalence of cerebral edema and the progression of secondary injury. All of the above-stated results of the experiments were extensively substantiated. Thus, these innovative findings of our study model will surely pave the way for new therapeutic interventions for TBI treatment and prominently highlight their applications in the field of neuroscience in the future.	[Rajneesh, Chellappan Praveen; Yang, Ling-Yu; Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei 11031, Taiwan; [Chen, Shih-Ching] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei 11031, Taiwan; [Chen, Shih-Ching] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei 11031, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Linkou 33305, Taiwan; [Chin, Hung-Yen] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Taipei 11031, Taiwan; [Chin, Hung-Yen] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei 11031, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Res Ctr Biomed Device, Taipei 11031, Taiwan		Peng, CW (corresponding author), Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei 11031, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Res Ctr Biomed Device, Taipei 11031, Taiwan.	pr2502@tmu.edu.tw; allison73323@gmail.com; csc@tmu.edu.tw; hsiehth@mail.cgu.edu.tw; chin671009@gmail.com; cwpeng@tmu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941	Taiwan Ministry of Science and Technology [106-2221-E-038-010-MY3, MOST103-2221-E-038-007, MOST108-2314-B-038-017]; Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan [DP2-108-21121-01-N-08-02]	This study was supported by grants from the Taiwan Ministry of Science and Technology (106-2221-E-038-010-MY3, MOST103-2221-E-038-007, MOST108-2314-B-038-017) and the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (DP2-108-21121-01-N-08-02) to C.W. Peng.	Albayram O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45234-8; BLAIVAS JG, 1982, J UROLOGY, V127, P958, DOI 10.1016/S0022-5347(17)54147-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fowler CJ, 1999, BRAIN, V122, P1213, DOI 10.1093/brain/122.7.1213; Fry CH, 2010, AUTON NEUROSCI-BASIC, V154, P3, DOI 10.1016/j.autneu.2009.10.006; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Hulens M, 2018, J PAIN RES, V11, P3129, DOI 10.2147/JPR.S186878; Jiang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059176; Kadekawa K, 2016, AM J PHYSIOL-REG I, V310, pR752, DOI 10.1152/ajpregu.00450.2015; Kadow BT, 2015, CURR BLADDER DYSFUNC, V10, P325, DOI 10.1007/s11884-015-0331-6; Kakizaki H, 1997, AM J PHYSIOL-REG I, V272, pR1647, DOI 10.1152/ajpregu.1997.272.5.R1647; Leinonen V, 2018, HAND CLINIC, V145, P25, DOI 10.1016/B978-0-12-802395-2.00004-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; McMurray G, 2006, BRIT J PHARMACOL, V147, pS62, DOI 10.1038/sj.bjp.0706630; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moody BJ, 2014, NEUROUROL URODYNAM, V33, P1159, DOI 10.1002/nau.22470; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Peng CW, 2006, NEUROUROL URODYNAM, V25, P388, DOI 10.1002/nau.20229; Rajneesh CP, 2019, INT UROL NEPHROL, V51, P41, DOI 10.1007/s11255-018-2028-1; Salk MR, 1939, AM J PHYSIOL, V126, P316; Sarma OVS, 2018, ADV INTELL SYST, V563, P197, DOI 10.1007/978-981-10-6872-0_19; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	28	4	4	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2019	9	11							325	10.3390/brainsci9110325			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3NV	WOS:000502273900036	31739594	gold, Green Published			2022-02-06	
J	Rosas-Hernandez, H; Burks, SM; Cuevas, E; Ali, SF				Rosas-Hernandez, Hector; Burks, Susan M.; Cuevas, Elvis; Ali, Syed F.			Stretch-Induced Deformation as a Model to Study Dopaminergic Dysfunction in Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Dopamine; Apoptosis; In vitro models	IN-VITRO MODEL; ALPHA-SYNUCLEIN; SH-SY5Y CELLS; APOPTOSIS; CULTURES; RELEASE; SYSTEM; DAMAGE; DEATH; RISK	Traumatic brain injury (TBI) is defined as damage to the brain that consequently disrupts normal function. Neuronal death, a hallmark of TBI, has been related to the development of neurodegenerative disorders like Parkinson's disease (PD), where loss of dopaminergic neurons and dopaminergic dysfunction are observed. To date, no in vitro model exists in which the dopaminergic damage observed in TBI is replicated. In this study, we evaluated the effects of in vitro simulated TBI on human dopaminergic neurons. To simulate TBI, neurons were subjected to 0%, 5%, 10%, 15%, 25% and 50% deformation. 24 h after injury, cell viability and apoptosis were determined by lactate dehydrogenase (LDH) release and DNA fragmentation, as well as ethidium homodimer and caspase 3/7 staining. Dopamine (DA) levels were determined by ELISA. Levels of tyrosine hydroxylase (TH) and DA transporter (DAT) were determined by western blot. Only 50% stretch increased LDH release and ethidium homodimer staining, suggesting the induction of necrosis. On the contrary, 25% and 50% stretch increased DNA fragmentation while 15%, 25% and 50% increased caspase 3/7 staining, suggesting that moderate and severe TBI promote apoptosis. Levels of intracellular DA decreased in a stretch-dependent manner with 15%, 25% and 50% stretch, which were related with a decrease in TH expression. Extracellular DA levels increased only at 50%. Levels of DAT remained unchanged regardless of treatment. These data support the use of stretch as a model to simulate TBI in vitro in human dopaminergic neurons, replicating the acute effects of TBI in the dopaminergic system.	[Rosas-Hernandez, Hector; Burks, Susan M.; Cuevas, Elvis; Ali, Syed F.] Natl Ctr Toxicol Res, Div Neurotoxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA		Rosas-Hernandez, H; Ali, SF (corresponding author), Natl Ctr Toxicol Res, Div Neurotoxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.	Hector.Rosas-Hernandez@fda.hhs.gov; Syed.Ali@fda.hhs.gov	Rosas-Hernandez, Hector/AAU-1294-2020	Rosas-Hernandez, Hector/0000-0002-2736-8302; Burks, Susan/0000-0002-4459-8126	National Center for Toxicological Research [Protocol E07584.11] Funding Source: Medline		Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Campos-Pires R, 2018, JOVE-J VIS EXP, DOI 10.3791/58400; Chen Yuan-Hao, 2018, Oncotarget, V9, P10016, DOI 10.18632/oncotarget.24245; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Chen YH, 2017, NEUROSCIENCE, V348, P180, DOI 10.1016/j.neuroscience.2017.02.001; Chen YH, 2015, CELL TRANSPLANT, V24, P2113, DOI 10.3727/096368914X683584; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dehay B, 2015, LANCET NEUROL, V14, P855, DOI 10.1016/S1474-4422(15)00006-X; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Jackson TC, 2018, EXP NEUROL, V300, P232, DOI 10.1016/j.expneurol.2017.11.013; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kumaria A, 2017, ATLA-ALTERN LAB ANIM, V45, P201, DOI 10.1177/026119291704500405; Lopez-Garcia I, 2018, BRIT J PHARMACOL, V175, P284, DOI 10.1111/bph.13642; Ma J, 2016, AM J TRANSL RES, V8, P1895; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rosas-Hernandez H, 2018, NEUROSCI LETT, V672, P123, DOI 10.1016/j.neulet.2018.02.019; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Salvador E, 2018, METHODS MOL BIOL, V1717, P219, DOI 10.1007/978-1-4939-7526-6_17; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sieg F, 1999, J NEUROTRAUM, V16, P1197, DOI 10.1089/neu.1999.16.1197; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Wang F, 2014, NEUROTOXICOLOGY, V41, P54, DOI 10.1016/j.neuro.2014.01.002; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Xu ZM, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0378-8; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	51	4	4	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2019	44	11					2546	2555		10.1007/s11064-019-02872-8			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	JH3JF	WOS:000492663200010	31529335				2022-02-06	
J	Shah, AA; Zuberi, M; Cornwell, E; Williams, M; Manicone, P; Kane, T; Sandler, A; Petrosyan, M				Shah, Adil A.; Zuberi, Maaz; Cornwell, Edward; Williams, Mallory; Manicone, Paul; Kane, Timothy; Sandler, Anthony; Petrosyan, Mikael			Gaps in access to comprehensive rehabilitation following traumatic injuries in children: A nationwide examination	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric trauma; Rehabilitation; Disparities; Home healthcare; Outcomes; Access	BRAIN-INJURY; HEALTH-CARE; INPATIENT REHABILITATION; PEDIATRIC INJURY; DISPARITIES	Introduction: Acute rehabilitation following traumatic injuries is associated with improved functional recovery. Access is often limited to patients at the time of hospital discharge. This phenomenon remains less well described in children, who may have more to benefit with rehabilitation posttrauma. This study aims to determine factors influencing access to rehabilitation among children with traumatic injuries utilizing a nationally representative sample. Methods: The Kids Inpatient Database (2000-2012) was queried for trauma patients. The outcome measure of interest was discharge with rehabilitative services [acute rehabilitation facilities or home healthcare (HHC)]. Patients that did not survive and those that did not meet hospital admission criteria were excluded. Multivariable models adjusted for age, race/ethnicity, gender, insurance-status, income, injury severity score, year, children's hospital designation, hospital-volume, teaching status, location, and geographical region. Results: A total of 811,941 records were included These were predominantly male (65.9%) with an average age of 11.6 (+/- 6.7) years. 4.2% were discharged to rehabilitation facilities, and 3.9% were discharged with HHC. African-American and Hispanic patients were less likely to be placed/have access to rehabilitation facilities (p < 0.001). Similarly, uninsured patients were less likely to receive these services postdischarge (p < 0.05). However, patients with government insurance, those in the highest income-quartile, those treated at children's hospitals, and those treated at teaching and urban hospitals were more likely to be placed/have access to rehabilitation services. Conclusion: Race/ethnicity and insurance status are associated with disparities in access to postdischarge rehabilitation in pediatric trauma patients. Moreover, treatment at designated children's, teaching and urban hospitals better-facilitates discharge planning with rehabilitative services. (C) 2019 Elsevier Inc. All rights reserved.	[Shah, Adil A.; Zuberi, Maaz; Cornwell, Edward; Williams, Mallory] Howard Univ Hosp & Coll Med, Dept Surg, Washington, DC USA; [Shah, Adil A.; Kane, Timothy; Sandler, Anthony; Petrosyan, Mikael] Childrens Natl Hlth Syst, Dept Gen & Thorac Surg, Washington, DC USA; [Manicone, Paul] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA		Petrosyan, M (corresponding author), Childrens Natl Med Ctr, Gen & Thorac Surg, Washington, DC 20010 USA.; Petrosyan, M (corresponding author), George Washington Univ, Surg & Pediat, Washington, DC 20052 USA.	MPetrosy@childrensnational.org	Williams, Mallory/ABC-2484-2020; Williams, Mallory/AAQ-2862-2021	Sandler, Anthony/0000-0001-9440-2964			Aitken ME, 1999, ARCH PHYS MED REHAB, V80, P889, DOI 10.1016/S0003-9993(99)90079-5; Centers for Medicare & Medicaid Services (CMS) HHS, 2012, Fed Regist, V77, P68209; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Forsyth R, 2015, DEV MED CHILD NEUROL, V57, P16, DOI 10.1111/dmcn.12575; Gillan JS, 2006, INJURY PREV, V12, P44, DOI 10.1136/ip.2006.012880; Hacker K, 2015, RISK MANAG HEALTHC P, V8, P175, DOI 10.2147/RMHP.S70173; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Jaffe KM, 2008, J TRAUMA, V64, P819, DOI 10.1097/TA.0b013e318165f177; Jaffe KM, 2015, ARCH PHYS MED REHAB, V96, P1371, DOI 10.1016/j.apmr.2015.04.017; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Monnat SM, 2017, RURAL SOCIOL, V82, P3, DOI 10.1111/ruso.12116; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Schultz CR, 2007, J TRAUMA, V63, P1143, DOI 10.1097/TA.0b013e31815688e3; Shope JT, 2006, INJURY PREV, V12, P9, DOI 10.1136/ip.2006.011874; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Snyder CW, 2018, J TRAUMA ACUTE CARE; Sohn H, 2017, POPUL RES POLICY REV, V36, P181, DOI 10.1007/s11113-016-9416-y; Toomey SL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3372; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Xu Jiaquan, 2018, Natl Vital Stat Rep, V67, P1; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	25	4	4	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	NOV	2019	54	11					2369	2374		10.1016/j.jpedsurg.2019.06.001			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	JQ3LQ	WOS:000498851100027	31255326				2022-02-06	
J	Shahror, RA; Wu, CC; Chiang, YH; Chen, KY				Shahror, Rami Ahmad; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun			Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 153; intranasal delivery; cell tracking; SPIO; cell labelling; in vivo imaging; traumatic brain injury	STROMAL CELLS; IN-VIVO; TRANSPLANTATION; DECREASE; STROKE	Stem cell-based therapies for brain injuries, such as traumatic brain injury (TBI), are a promising approach for clinical trials. However, technical hurdles such as invasive cell delivery and tracking with low transplantation efficiency remain challenges in translational stem-based therapy. This article describes an emerging technique for stem cell labeling and tracking based on the labeling of the mesenchymal stem cells (MSCs) with superparamagnetic iron oxide (SPIO) nanoparticles, as well as intranasal delivery of the labeled MSCs. These nanoparticles are fluorescein isothiocyanate (FITC)-embedded and safe to label the MSCs, which are subsequently delivered to the brains of TBI-induced mice by the intranasal route. They are then tracked non-invasively in vivo by real-time magnetic resonance imaging (MRI). Important advantages of this technique that combines SPIO for cell labeling and intranasal delivery include (1) non-invasive, in vivo MSC tracking after delivery for long tracking periods, (2) the possibility of multiple dosing regimens due to the non-invasive route of MSC delivery, and (3) possible applications to humans, owing to the safety of SPIO, non-invasive nature of the cell-tracking method by MRI, and route of administration.	[Shahror, Rami Ahmad; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Shahror, Rami Ahmad; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Zhunan, Taiwan; [Shahror, Rami Ahmad; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Shahror, Rami Ahmad; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, TMU Neurosci Res Ctr, Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Dept Neurosurg, Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan		Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan.; Chen, KY (corresponding author), Natl Hlth Res Inst, Zhunan, Taiwan.; Wu, CC; Chen, KY (corresponding author), Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan.; Wu, CC; Chen, KY (corresponding author), Taipei Med Univ, TMU Neurosci Res Ctr, Taipei, Taiwan.; Wu, CC (corresponding author), Taipei Med Univ, Dept Neurosurg, Taipei, Taiwan.; Wu, CC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan.	johnwu@tmu.edu.tw; kychen08@tmu.edu.tw		Shahror, Rami/0000-0001-6403-9404	Ministry of Science and Technology Grants, Taiwan [MOST 104-2923-B-038-004 -MY2, MOST 107-2314B-038-063, MOST 107-2314-B-038-042]; Taipei Medical University [TMU 105-AE1-B03, TMU 106-5400-004-400, TMU 106-5310-001-400, DP2-107-21121-01-N-05, DP2-108-21121-01-N-05-01]	This work was supported by the Ministry of Science and Technology Grants, Taiwan (MOST 104-2923-B-038-004 -MY2, MOST 107-2314B-038-063, and MOST 107-2314-B-038-042) and Taipei Medical University (TMU 105-AE1-B03, TMU 106-5400-004-400, TMU 106-5310-001-400, DP2-107-21121-01-N-05 and DP2-108-21121-01-N-05-01).	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Danielyan L, 2014, CELL TRANSPLANT, V23, pS123, DOI 10.3727/096368914X684970; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Pelled G, 2012, J ORTHOP RES, V30, P1932, DOI 10.1002/jor.22167; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Roeder E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098451; Schafer R, 2009, CYTOTHERAPY, V11, P68, DOI 10.1080/14653240802666043; Shahror RA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6422; Shahror RA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112624; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	17	4	4	4	11	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	NOV	2019		153							e60450	10.3791/60450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JS5RF	WOS:000500362600069	31814625	Bronze			2022-02-06	
J	Studenka, BE; Raikes, A				Studenka, Breanna E.; Raikes, Adam			Gender differences in nonlinear motor performance following concussion	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Average power; Concussion; Isometric motor control; Nonlinear analyses; Sample entropy; Visual-motor processing	TRAUMATIC BRAIN-INJURY; POSTURAL-CONTROL; CEREBRAL CONCUSSION; TIME SCALES; APPROXIMATE ENTROPY; FOOTBALL PLAYERS; COMPLEXITY; AGE; VARIABILITY; STABILITY	Purpose: To quantify differences in nonlinear aspects of performance on a seated visual-motor tracking task between clinically asymptomatic males and females with and without a self-reported mild traumatic brain injury history. Methods: Seventy-three individuals with a self-reported concussion history (age: 21.40 +/- 2.25 years, mean +/- SD) and 75 without completed the visual-motor tracking task (age: 21.50 +/- 2.00 years). Participants pressed an index finger against a force sensor, tracing a line across a computer screen (visual-motor tracking). The produced signal's root-mean-square error (RMSE), sample entropy (SampEn, a measure of regularity), and average power (AvP) between 0 and 12 Hz were calculated. Results: Males with a history of 0 or 1 concussion had greater RMSE (worse performance) than females with 0 (p < 0.0001) and 1 concussion (p = 0.052). Additionally, females with 2+ concussions exhibited lower SampEn than females with no history (p= 0.001) or a history of 1 concussion (p = 0.026). Finally, females with 2+ concussions had lower 8-12 Hz AvP than males with 2+ concussions (p= 0.031). Few differences were observed in the male participants. Conclusion: Females with a self-reported history of multiple concussions exhibited lower SampEn in the visual-motor tracking-task force output structure as compared to those with no reported history of concussion and their male counterparts. Lower SampEn and lower power between 8 and 12 Hz indicated persistent impairment in visual processing and feed-forward or predictive motor control systems. (C) 2019 Published by Elsevier B.V. on behalf of Shanghai University of Sport.	[Studenka, Breanna E.; Raikes, Adam] Utah State Univ, Kinesiol & Hlth Sci, Logan, UT 84322 USA		Raikes, A (corresponding author), Utah State Univ, Kinesiol & Hlth Sci, Logan, UT 84322 USA.	adam.raikes@usu.edu	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727			Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Deuschl G, 2001, MUSCLE NERVE, V24, P716, DOI 10.1002/mus.1063; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hu XG, 2011, EXP BRAIN RES, V212, P497, DOI 10.1007/s00221-011-2760-6; Kaushik T., 2006, SPORTS NEUROPSYCHOLO, P216; Kelty-Stephen DG, 2015, PSYCHOL ASSESSMENT, V27, P1379, DOI 10.1037/pas0000122; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rhea C. K., 2014, GAIT BIOMETRICS BASI, P17; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Slifkin AB, 2000, J MOTOR BEHAV, V32, P141, DOI 10.1080/00222890009601366; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sosnoff JJ, 2009, J EXP PSYCHOL HUMAN, V35, P439, DOI 10.1037/a0012731; Sosnoff JJ, 2008, J GERONTOL B-PSYCHOL, V63, pP344, DOI 10.1093/geronb/63.6.P344; Sosnoff JJ, 2005, PERCEPT PSYCHOPHYS, V67, P335, DOI 10.3758/BF03206496; Studenka BE, 2014, J EXP PSYCHOL HUMAN, V40, P1629, DOI 10.1037/a0037113; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Orden G., 2010, MIND MATTER, V8, P19; Vieluf S, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0153-7; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	46	4	4	1	3	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	NOV	2019	8	6					540	547		10.1016/j.jshs.2017.03.006			8	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	JI3GG	WOS:000493352400011	31720065	gold, Green Published			2022-02-06	
J	Tay, MRJ; Soh, YM; Plunkett, TK; Ong, PL; Huang, WP; Kong, KH				Tay, Matthew Rong Jie; Soh, Yan Ming; Plunkett, Tegan Kate; Ong, Poo Lee; Huang, Wanping; Kong, Keng He			The Validity of the Montreal Cognitive Assessment for Moderate to Severe Traumatic Brain Injury Patients A Pilot Study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Cognition; Traumatic Brain Injury; Neuropsychological; Montreal Cognitive Assessment	MENTAL-STATE-EXAMINATION; NEUROPSYCHOLOGICAL STATUS RBANS; REPEATABLE BATTERY; NATIONAL ACADEMY; CLINICAL UTILITY; SCREENING-TESTS; IMPAIRMENT; STROKE; MOCA; RELIABILITY	Objective The aim of the study was to pilot the use of Montreal Cognitive Assessment as a quick clinical screen for cognitive assessment in traumatic brain injury patients. Design The study recruited 61 participants with moderate to severe traumatic brain injury presenting to a tertiary rehabilitation center under the Brain Injury Program. A Montreal Cognitive Assessment questionnaire and neuropsychological battery (Repeatable Battery for the Assessment of Neuropsychological Status and Color Trails Test) were administered to participants who had completed inpatient rehabilitation. Results Receiver operating characteristic analysis for the Montreal Cognitive Assessment revealed an optimal balance of sensitivity and specificity at 24/25 to discriminate participants who were classified as less than 5th centile on the Total Scale Index on the Repeatable Battery for the Assessment of Neuropsychological Status. This achieved a sensitivity, specificity, PPV, and NPV of 73.9%, 86.5%, 77.3%, and 84.2%, respectively. Receiver operating characteristic analysis for the trail making subtest of the Montreal Cognitive Assessment achieved a sensitivity, specificity, PPV, and NPV of 79.4%, 74.1%, 79.4%, and 74.1% in identifying patients classified as less than 5th centile on Color Trail Test part 2. Conclusions The use of Montreal Cognitive Assessment displayed good validity in identifying patients with clinically significant impairment on a standard neuropsychological assessment battery in the study population. However, it may lack sensitivity for estimating mild levels of impairment.	[Tay, Matthew Rong Jie; Soh, Yan Ming; Plunkett, Tegan Kate; Ong, Poo Lee; Huang, Wanping; Kong, Keng He] Tan Tock Seng Hosp, Rehabil Ctr, Singapore, Singapore		Tay, MRJ (corresponding author), Tan Tock Seng Hosp, Rehabil Ctr, TTSH Rehabil Ctr Ang Mo Kio Thye Hua Kwan AMK THK, 17,Ang Mo Kio Ave 9, Singapore 569766, Singapore.		Tay, Matthew/AAM-2170-2021; Ong, Poo Lee/ABA-5568-2021	Ong, Poo Lee/0000-0002-0910-6683			[Anonymous], 2009, VA DOD CLIN PRACT GU; Blackburn DJ, 2013, AGE AGEING, V42, P113, DOI 10.1093/ageing/afs116; Chiti G, 2014, STROKE, V45, P3135, DOI 10.1161/STROKEAHA.114.004590; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; Harkness K, 2011, AM J CARDIOL, V107, P1203, DOI 10.1016/j.amjcard.2010.12.021; Hazan E, 2017, BRAIN INJURY, V31, P1501, DOI 10.1080/02699052.2017.1376763; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ng A, 2013, SINGAP MED J, V54, P616; Olson R, 2011, SUPPORT CARE CANCER, V19, P1849, DOI 10.1007/s00520-010-1028-1; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Roebuck-Spencer TM, 2017, ARCH CLIN NEUROPSYCH, V32, P491, DOI 10.1093/arclin/acx021; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007; Zhao J, 2012, METAB BRAIN DIS, V27, P17, DOI 10.1007/s11011-011-9275-5	32	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV	2019	98	11					971	975		10.1097/PHM.0000000000001227			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JK3FX	WOS:000494732100011	31136306				2022-02-06	
J	Kokorelis, C; Slomine, B; Rowe, PC; Suskauer, S				Kokorelis, Christina; Slomine, Beth; Rowe, Peter C.; Suskauer, Stacy			Screening for Orthostatic Intolerance in Symptomatic Children Presenting for Concussion Care	CLINICAL PEDIATRICS			English	Article						concussion; adolescents; POTS; orthostatic intolerance	NEURALLY-MEDIATED HYPOTENSION; POSTURAL TACHYCARDIA SYNDROME; EHLERS-DANLOS-SYNDROME; POSTCONCUSSION SYNDROME; RECOVERY; YOUTH	Following concussion, children often experience nonspecific symptoms that overlap with those of other common pediatric conditions, including orthostatic intolerance (OI). The primary goal of this study was to evaluate OI in youth presenting for clinical care for concussion and reporting symptoms frequently observed in OI. Eighty-two of 114 patients aged 10 to 22 years endorsed symptoms based on 8 screening questions, and 24 of those 82 patients met criteria for OI based on an active standing test. No screening question generated clinically useful likelihood ratios for predicting OI. The prevalence of OI in this cohort is considerably higher than estimates in the general pediatric population, suggesting a link between concussion and OI. Future work is needed to evaluate the best method of testing for OI, the natural history of OI symptoms in youth with concussion, and the response to intervention in children with both concussion and OI.	[Kokorelis, Christina; Rowe, Peter C.; Suskauer, Stacy] Johns Hopkins Univ, Baltimore, MD USA; [Kokorelis, Christina; Slomine, Beth; Suskauer, Stacy] Kennedy Krieger Inst, Baltimore, MD USA		Kokorelis, C (corresponding author), Johns Hopkins Med, 600 North Wolfe St, Baltimore, MD 21287 USA.	Kokorelis@kennedykrieger.org					Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Boris JR, 2018, CARDIOL YOUNG, V28, P668, DOI 10.1017/S1047951117002888; BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; Centers for Disease Control and Prevention, CDC PED MTBI GUID; Convertino VA, 2007, AM J MED SCI, V334, P72, DOI 10.1097/MAJ.0b013e318063c6e4; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; De Wandele I, 2014, SEMIN ARTHRITIS RHEU, V44, P353, DOI 10.1016/j.semarthrit.2014.05.013; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Johnson JN, 2010, PEDIATR NEUROL, V42, P77, DOI 10.1016/j.pediatrneurol.2009.07.002; Kanjwal K, 2010, CARDIOL J, V17, P482; Kirbis M, 2013, FUNCT NEUROL, V28, P39, DOI 10.11138/FNeur/2013.28.1.039; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113625; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Medow Marvin S, 2007, Cardiol Rev, V15, P67, DOI 10.1097/01.crd.0000233768.68421.40; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Natelson Benjamin H, 2007, Dyn Med, V6, P2, DOI 10.1186/1476-5918-6-2; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Roma M, 2018, FATIGUE, V6, P179, DOI 10.1080/21641846.2018.1512836; ROWE PC, 1995, LANCET, V345, P623, DOI 10.1016/S0140-6736(95)90525-1; Rowe PC, 1999, J PEDIATR-US, V135, P494, DOI 10.1016/S0022-3476(99)70173-3; Ruzieh Mohammed, 2018, Herzschrittmacherther Elektrophysiol, V29, P183, DOI 10.1007/s00399-018-0563-1; SCHONDORF R, 1993, NEUROLOGY, V43, P132, DOI 10.1212/WNL.43.1_Part_1.132; Shin KJ, 2016, ACTA NEUROL SCAND, V134, P108, DOI 10.1111/ane.12516; Stewart JM, 2001, J PEDIATR-US, V138, P512, DOI 10.1067/mpd.2001.112170; Stewart JM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1673; Stewart JM, 2013, PEDIATRICS, V131, P968, DOI 10.1542/peds.2012-2610; Tanaka H, 2009, PEDIATR INT, V51, P169, DOI 10.1111/j.1442-200X.2008.02783.x; Teodorovich N, 2016, WORLD J CARDIOL, V8, P277, DOI 10.4330/wjc.v8.i3.277	37	4	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JAN	2020	59	1					75	82	0009922819885656	10.1177/0009922819885656		OCT 2019	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	JP2PV	WOS:000495264800001	31672071				2022-02-06	
J	Yousefzadeh-Chabok, S; Kapourchali, FR; Ramezani, S				Yousefzadeh-Chabok, Shahrokh; Kapourchali, Fatemeh Ramezani; Ramezani, Sara			Determinants of long-term health-related quality of life in adult patients with mild traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Executive function; Post-concussion symptoms; Minor brain trauma; Neuroimaging; SF-36	EXECUTIVE DYSFUNCTION; DIAGNOSIS; PREDICTION; MANAGEMENT; DISORDER	Purpose Mild traumatic brain injury (mTBI) usually leads to the appearance of post-concussion symptoms (PCS) which may resolve after a short time. In this study, the mental and physical aspects of quality of life (QoL) were evaluated 6 months after mTBI, and the association of demographic and injury-related factors, post-injury primary executive function and PCS types with the long-term QoL status was investigated. Methods 123 eligible mTBI patients of initial sampling participated in follow-up phase of this longitudinal study. The demographic, clinical, and para-clinical data of patients were recorded. Paraclinical data comprised brain lesion volume, type and location determined by CT scan. The executive function and primary PCS were examined during the discharge using the verbal fluency task and a checklist, respectively. QoL was measured via SF-36 questionnaire. The collected data were entered into SPSS 22, and analyzed using appropriate statistical tests. Results Youngers aged between 18 and 35 years and women had a lower QoL score than others. Primary somatic and cognitive PCS together were associated with poor QoL. There was no significant difference in QoL and executive function scores between the normal and abnormal brain CT groups. However, among people with abnormal CT, those having multifocal lesions including at least an intracranial hemorrhage type such as intra parenchymal hemorrhage or extra-axial bleeding together with other intracranial lesions or skull fracture demonstrated less QoL score in SF-36. A significant correlation was discovered between the scores of the executive function and QoL in mental dimensions of SF-36. Conclusions This study emphasizes on the clinical significance of early executive function and PCS examination in mTBI population, as well as optimal management of the victims regardless of the initial brain CT findings, especially in high-risk populations.	[Yousefzadeh-Chabok, Shahrokh; Ramezani, Sara] Guilan Univ Med Sci, Neurosci Res Ctr, Sch Med, Rasht, Iran; [Yousefzadeh-Chabok, Shahrokh; Ramezani, Sara] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Kapourchali, Fatemeh Ramezani] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA		Ramezani, S (corresponding author), Guilan Univ Med Sci, Neurosci Res Ctr, Sch Med, Rasht, Iran.; Ramezani, S (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran.	s.ramezanislp@gmail.com					Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bazarian JJ, 2000, ACAD EMERG MED, V7, P504; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rahimi-Movaghar V, 2011, AM SURGEON, V77, pE112; Rengachary SS, 2005, PRINCIPLES NEUROSURG; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Shinoda J, 2017, NEUROL MED-CHIR, V57, P199, DOI 10.2176/nmc.ra.2016-0293; Silver JM, 2011, TXB TRAUMATIC BRAIN, V1, P3; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Vafaee R, 2013, WULFENIA, V20, P257; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Yousefzade-Chabok SH, 2014, HEALTH, V6, P496; Yousefzadeh-Chabok Shahrokh, 2015, Asian J Neurosurg, V10, P173, DOI 10.4103/1793-5482.161165	40	4	4	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2021	47	3			SI		839	846		10.1007/s00068-019-01252-9		OCT 2019	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SO8AZ	WOS:000494069900002	31673715				2022-02-06	
J	Gardner, AJ; Howell, DR; Iverson, GL				Gardner, Andrew J.; Howell, David R.; Iverson, Grant L.			The association between multiple prior concussions, cognitive test scores, and symptom reporting in youth rugby league players	BRAIN INJURY			English	Article						Concussion; youth; sports; rugby league	TRAUMATIC BRAIN-INJURY; PAST CONCUSSIONS; VIDEO ANALYSIS; HISTORY; PERFORMANCE; UNION	Objective: To examine the effect of prior concussion history on cognitive test performance and concussion symptom reporting among adolescent youth rugby league athletes.Participants: Participants were male elite level youth rugby league players (N = 73; Mean Age = 15.8; SD = 0.9; range = 14-18 years).Main Outcome Measure: CogSport performance based on participants group; those who reported no previous concussions (n = 30),1-2 previous concussions (n = 19), and >= 3 previous concussions (n = 29).Results: 73 participants with valid CogSport scores were included in the cognitive analyses. All participants were included in the symptom analyses. There were no differences between the groups with 0,1-2, or >= 3 previous concussions for processing speed, attention, learning, or working memory. There was atrend for those with multiple prior concussions to report more baseline preseason symptoms.Conclusions: There were no differences in scores on the CogSport test among those with ahistory of 0,1-2, or >= 3 prior concussions. Consistent with prior studies, youth with ahistory of multiple past concussions are more likely to endorse baseline preseason symptoms.	[Gardner, Andrew J.] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Hunter New England Local Hlth Dist Sport Concuss, Callaghan, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Howell, David R.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, MassGen Hosp Children Sports Concuss Program, Home Base, Boston, MA 02115 USA		Gardner, AJ (corresponding author), Univ Newcastle, Calvary Mater Hosp, Fac Hlth & Med, Ctr Stroke & Brain Injury,Sch Med & Publ Hlth, Level 5 McAuley Bldg, Waratah, NSW 2308, Australia.	Andrew.Gardner@neurogard.com.au		Gardner, Andrew/0000-0001-5031-5586; Howell, David/0000-0002-2955-0191; Iverson, Grant/0000-0001-7348-9570			Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; King D, 2013, NZ J SPORTS MED, V40, P64; King D, 2006, NZ J SPORTS MED, V34, P21; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412	34	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					224	228		10.1080/02699052.2019.1683894		OCT 2019	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000493149700001	31661635				2022-02-06	
J	Watkin, C; Phillips, J; Radford, K				Watkin, Connor; Phillips, Julie; Radford, Kathryn			What is a 'return to work' following traumatic brain injury? Analysis of work outcomes 12 months post TBI	BRAIN INJURY			English	Article						Return to work; RTW; traumatic brain injury; TBI; employment	QUALITY-OF-LIFE; VOCATIONAL-REHABILITATION; PROGNOSTIC-FACTORS; DISABILITY; TRAJECTORIES; SATISFACTION; MODERATE; AGE	Background: Literature lacks a clear description of return to work following traumatic brain injury (TBI). Aim: to describe work metrics for people with mild and moderate/severe TBI at 3, 6, and 12 months post-injury. Methods: A retrospective cross-sectional analysis of 172 TBI participants measuring work outcomes up to 12-months post-injury. Metrics described vocational status, accommodations, satisfaction, hours, time taken to return, financial status, and responsibilities. Logistic regression identified factors indicative of complete (80% of pre-injury hours) return to work. Results: 59/86 moderate/severely injured (68.6%) and 68/81 mildly injured (84%) people returned to work following TBI. Twenty-eight (16.3%) achieved a complete return by 12 months. The regression model was statistically significant X-2(4) = 51.980,p = <.0005, suggesting that those with high health-related quality of life, anxiety and functional ability were more likely to achieve complete return to work. At 12 months, 41 participants (23.8%) had workplace accommodations. One hundredfifteen (66.9%) were less content with their job and many reported reduced working hours. Discussion: This study highlights the heterogeneity of work post-TBI. Even people with 'mild' TBI fail to make a complete return to work by 12 months. Conclusions: Further longitudinal research is needed to explore the personal and economic legacy of TBI.	[Watkin, Connor; Phillips, Julie; Radford, Kathryn] Univ Nottingham, Sch Med, Nottingham, England		Watkin, C (corresponding author), Univ Nottingham, Nottingham, England.	cwatkin94@gmail.com	Radford, Kate A/F-8571-2013	Radford, Kate A/0000-0001-6246-3180	Department of HealthEuropean Commission [11/66/02] Funding Source: Medline		[Anonymous], 2017, DISCUSSION PAPER SER, V11186; Bartys S, 2017, HEALTH POLICY, V121, P903, DOI 10.1016/j.healthpol.2017.05.011; BIGOS SJ, 1992, CLIN ORTHOP RELAT R, P21; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Buck PW, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/625621; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Chen Q, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015130; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Galizzi M, 2010, IND RELAT, V49, P22, DOI 10.1111/j.1468-232X.2009.00585.x; Grant M, 2014, BRIT J OCCUP THER, V77, P457, DOI 10.4276/030802214X14098207541072; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kendall E, 2006, J VOCAT REHABIL, V25, P149; KIND P, 1999, 172 U YORK CTR HLTH; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; NHS England, 2017, NEXT STEPS NHS 5 YEA; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Oyeflaten I, 2014, J OCCUP REHABIL, V24, P199, DOI 10.1007/s10926-013-9466-5; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Radford K, 2018, HEALTH TECHNOL ASSES, V22; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Radford Kathryn A, 2015, Pilot Feasibility Stud, V1, P24; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Ruet A, 2018, ANN PHYS REHABIL MED, V61, pe38, DOI [DOI 10.1016/J.REHAB.2018.05.084, 10.1016/j.rehab.2018.05.084]; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shaw WS, 2009, J OCCUP REHABIL, V19, P64, DOI 10.1007/s10926-008-9159-7; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Waddell G, 2008, VOCATIONAL REHABILIT; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	4	4	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					68	77		10.1080/02699052.2019.1681512		OCT 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000493149800001	31661643	Green Accepted			2022-02-06	
J	Zheng, ZL; Wu, YQ; Li, ZM; Ye, LX; Lu, Q; Zhou, YJ; Yuan, Y; Jiang, T; Xie, L; Liu, YL; Chen, DQ; Ye, JM; Nimlamool, W; Zhang, HY; Xiao, J				Zheng, Zhilong; Wu, Yanqing; Li, Zhengmao; Ye, Luxia; Lu, Qi; Zhou, Yajiao; Yuan, Yuan; Jiang, Ting; Xie, Ling; Liu, Yanlong; Chen, Daqing; Ye, Junming; Nimlamool, Wutigri; Zhang, Hongyu; Xiao, Jian			Valproic acid affects neuronal fate and microglial function via enhancing autophagic flux in mice after traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						autophagic flux; inflammation; microglia; traumatic brain injury (TBI); valproic acid (VPA)	CELL-DEATH; THERAPEUTIC TARGET; BARRIER DISRUPTION; HEMORRHAGIC-SHOCK; INFLAMMATION; ACTIVATION; RECOVERY; DAMAGE; NEURODEGENERATION; POLARIZATION	In recent years, many studies have focused on autophagy, an evolutionarily conserved mechanism that relies on lysosomes to achieve cellular metabolic requirements and organelle turnover, and revealed its important role in animal models of traumatic injury. Autophagy is a double-edged sword. Appropriate levels of autophagy can promote the removal of abnormal proteins or damaged organelles, while hyperactivated autophagy can induce autophagic apoptosis. However, recent studies suggest that autophagic flux seems to be blocked after traumatic brain injury (TBI), which contributes to the apoptosis of brain cells. In this study, valproic acid (VPA), which was clinically used for epilepsy treatment, was used to treat TBI. The Morris water maze test, hematoxylin & eosin staining and Nissl staining were first conducted to confirm that VPA treatment had a therapeutic effect on mice after TBI. Western blotting, enzyme-linked immunosorbent assay and immunofluorescence staining were then performed to reveal that VPA treatment reversed TBI-induced blockade of autophagic flux, which was accompanied by a reduced inflammatory response. In addition, the variations in activation and phenotypic polarization of microglia were observed after VPA treatment. Nevertheless, the use of the autophagy inhibitor 3-methyladenine partially abolished VPA-induced neuroprotection and the regulation of microglial function after TBI, resulting in the deterioration of the central nervous system microenvironment and neurological function. Collectively, VPA treatment reversed the TBI-induced blockade of autophagic flux in the mouse brain cortex, subsequently inhibiting brain cell apoptosis and affecting microglial function to achieve the promotion of functional recovery in mice after TBI.	[Zheng, Zhilong; Li, Zhengmao; Ye, Luxia; Lu, Qi; Zhou, Yajiao; Yuan, Yuan; Jiang, Ting; Xie, Ling; Liu, Yanlong; Zhang, Hongyu; Xiao, Jian] Wenzhou Med Univ, Sch Pharmaceut Sci, Mol Pharmacol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Wu, Yanqing] Wenzhou Univ, Inst Life Sci, Wenzhou, Zhejiang, Peoples R China; [Chen, Daqing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Chen, Daqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Ye, Junming] Gangnan Med Univ, Affiliated Hosp 1, Dept Anesthesia, Ganzhou, Jiangxi, Peoples R China; [Nimlamool, Wutigri] Chiang Mai Univ, Fac Med, Dept Pharmacol, Chiang Mai, Thailand		Xiao, J (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China.	xfxj2000@126.com			Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LR18H50001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81722028, 81560375, 81760230]	This study was partially supported by a research grant from Zhejiang Provincial Natural Science Foundation (LR18H50001), National Natural Science Foundation of China (81722028, 81560375 and 81760230). The authors declare no conflict of interest.	Angelopoulou E, 2018, J NEUROCHEM, V146, P211, DOI 10.1111/jnc.14450; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chong ZZ, 2012, PROG NEUROBIOL, V99, P128, DOI 10.1016/j.pneurobio.2012.08.001; Coulter C, 2011, LANDSC EDUC, P29; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dong LH, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-53; Edwards P, 2005, LANCET, V365, P1957; Fodale V, 2012, CRIT CARE MED, V40, P2523, DOI 10.1097/CCM.0b013e318258e67e; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gyoneva S, 2014, GLIA, V62, P1345, DOI 10.1002/glia.22686; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heckmann BL, 2019, CELL, V178, P536, DOI 10.1016/j.cell.2019.05.056; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hill RL, 2019, J NEUROTRAUM, V36, P1231, DOI 10.1089/neu.2018.5946; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Islam MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051405; Ji MM, 2015, AUTOPHAGY, V11, P2160, DOI 10.1080/15548627.2015.1082024; Karunakaran I, 2019, GLIA, V67, P1859, DOI 10.1002/glia.23663; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee JY, 2014, J NEUROTRAUM, V31, P582, DOI 10.1089/neu.2013.3146; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Li Y, 2019, AUTOPHAGY, V15, P478, DOI 10.1080/15548627.2018.1522467; Li ZM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020315; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; LUDER AS, 1990, J CLIN INVEST, V86, P1574, DOI 10.1172/JCI114877; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; MACDONALD RL, 1989, EPILEPSIA, V30, pS19, DOI 10.1111/j.1528-1157.1989.tb05810.x; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Matsuzawa-Ishimoto Y, 2018, ANNU REV IMMUNOL, V36, P73, DOI 10.1146/annurev-immunol-042617-053253; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pan JR, 2017, MOL NEUROBIOL, V54, P1710, DOI 10.1007/s12035-016-9735-3; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ratliff EP, 2016, AUTOPHAGY, V12, P2256, DOI 10.1080/15548627.2016.1221565; RINK A, 1995, AM J PATHOL, V147, P1575; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shao M, 2018, INT J NANOMED, V13, P8231, DOI 10.2147/IJN.S174300; She H, 2018, AUTOPHAGY, V14, P1097, DOI 10.1080/15548627.2018.1446626; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Stavoe AKH, 2019, ANNU REV CELL DEV BI, V35, P477, DOI 10.1146/annurev-cellbio-100818-125242; Wang CG, 2018, J CELL MOL MED, V22, P1148, DOI 10.1111/jcmm.13368; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang WR, 2017, CELL PHYSIOL BIOCHEM, V41, P569, DOI 10.1159/000457878; Wang XS, 2020, GLIA, V68, P27, DOI 10.1002/glia.23697; Weitzner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52706; Wright DW, 2015, NEW ENGL J MED, V372, P1766, DOI 10.1056/NEJMc1503138; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang YB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.77	70	4	6	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2020	154	3					284	300		10.1111/jnc.14892		OCT 2019	17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MN9EU	WOS:000492672200001	31602651				2022-02-06	
J	Chauhan, V; Chauhan, A				Chauhan, Ved; Chauhan, Abha			Traumatic injury in female Drosophila melanogaster affects the development and induces behavioral abnormalities in the offspring	BEHAVIORAL AND BRAIN FUNCTIONS			English	Article						Developmental disorders; Drosophila melanogaster; Larval length; Pregnancy; Social interaction; Traumatic injury	SOCIAL-INTERACTION; WASHINGTON-STATE; ABDOMINAL-TRAUMA; MATING-BEHAVIOR; PREGNANCY; MODEL; OUTCOMES; COMMUNICATION; EXPERIENCE; CHILDREN	Traumatic injury (TI) during pregnancy increases the risk for developing neurological disorders in the infants. These disorders are a major concern for the well-being of children born after TI during pregnancy. TI during pregnancy may result in preterm labor and delivery, abruptio placentae, and/or fetomaternal hemorrhage. Drosophila melanogaster (fruit fly) is a widely used model to study brain and behavioral disorders in humans. In this study, we analyzed the effects of TI to female fruit flies on the development timing of larvae, social interaction and the behavior of offspring flies. TI to the female flies was found to affect the development of larvae and the behavior of offspring flies. There was a significant increase in the length of larvae delivered by traumatically injured maternal flies as compared to larvae from control maternal flies (without TI). The pupae formation from larvae, and the metamorphosis of pupae to the first generation of flies were faster in the TI group than the control group. Negative geotaxis and distance of the fly to its nearest neighbor are parameters of behavioral assessment in fruit flies. Negative geotaxis significantly decreased in the first generation of both male (p = 0.0021) and female (p = 0.0426) flies. The distance between the first generation of flies to its nearest neighbor was shorter in both male and female offspring flies in the TI group as compared to control group flies. These results indicate that TI to the female flies affected the development of larvae and resulted in early delivery, impaired social interaction and behavioral alterations in the offspring.	[Chauhan, Ved; Chauhan, Abha] New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA		Chauhan, V (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	ved.chauhan@opwdd.ny.gov		Chauhan, Ved/0000-0001-7132-7498	New York State Office for People with Developmental Disabilities; Autism Research Institute	This work was supported in part by funds from the New York State Office for People with Developmental Disabilities and the Autism Research Institute.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGRAN PF, 1987, ANN EMERG MED, V16, P1355, DOI 10.1016/S0196-0644(87)80418-3; Billeter JC, 2012, P ROY SOC B-BIOL SCI, V279, P2417, DOI 10.1098/rspb.2011.2676; Bolduc FV, 2010, FLY, V4, P216, DOI 10.4161/fly.4.3.12280; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Burg ED, 2013, GENES BRAIN BEHAV, V12, P338, DOI 10.1111/gbb.12025; Burns JG, 2012, P NATL ACAD SCI USA, V109, P17239, DOI 10.1073/pnas.1121265109; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Chauhan V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101108; Chauhan V, 2016, INT J DEV NEUROSCI, V51, P36, DOI 10.1016/j.ijdevneu.2016.04.010; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Coen P, 2014, NATURE, V507, P233, DOI 10.1038/nature13131; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; DROST TF, 1990, J TRAUMA, V30, P574, DOI 10.1097/00005373-199005000-00008; El Kady D, 2004, AM J OBSTET GYNECOL, V190, P1661, DOI 10.1016/j.ajog.2004.02.051; ESPOSITO TJ, 1989, J TRAUMA, V29, P1628, DOI 10.1097/00005373-198912000-00006; FILDES J, 1992, J TRAUMA, V32, P643, DOI 10.1097/00005373-199205000-00017; GOODWIN TM, 1990, AM J OBSTET GYNECOL, V162, P665, DOI 10.1016/0002-9378(90)90979-H; Hahn N, 2013, BEHAV BRAIN RES, V252, P450, DOI 10.1016/j.bbr.2013.06.020; Hill CC, 2008, SURG CLIN N AM, V88, P421, DOI 10.1016/j.suc.2007.12.006; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Kaur K, 2015, BEHAV BRAIN RES, V284, P77, DOI 10.1016/j.bbr.2015.02.001; Kohn NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081272; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kuo C, 2007, AM J OBSTET GYNECOL, V196, pe1; LAVIN JP, 1983, CLIN PERINATOL, V10, P423, DOI 10.1016/S0095-5108(18)30976-X; Luke L, 2012, AUTISM, V16, P612, DOI 10.1177/1362361311415876; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Moraes F, 2016, BIOCHEM MOL BIOL EDU, V44, P215, DOI 10.1002/bmb.20952; Novak I, 2012, PEDIATRICS, V130, pE1285, DOI 10.1542/peds.2012-0924; Novelli D, 2010, BRIT J SOC PSYCHOL, V49, P223, DOI 10.1348/014466609X449377; Pak LL, 1998, AM J OBSTET GYNECOL, V179, P1140, DOI 10.1016/S0002-9378(98)70121-8; PEARLMAN MD, 1990, AM J OBSTET GYNECOL, V162, P1502, DOI 10.1016/0002-9378(90)90913-R; PECKHAM CH, 1963, AM J OBSTET GYNECOL, V87, P609, DOI 10.1016/0002-9378(63)90055-3; Restifo LL, 2005, MENT RETARD DEV D R, V11, P286, DOI 10.1002/mrdd.20083; Ruan HY, 2008, P NATL ACAD SCI USA, V105, P7506, DOI 10.1073/pnas.0711127105; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schiff MA, 2005, AM J EPIDEMIOL, V161, P503, DOI 10.1093/aje/kwi078; Schiff MA, 2002, J TRAUMA, V53, P939, DOI 10.1097/00005373-200211000-00021; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; Schneider J, 2012, ADV GENET, V77, P59, DOI 10.1016/B978-0-12-387687-4.00003-9; SEXTON OWEN J., 1961, ANIMAL BEHAVIOUR, V9, P77, DOI 10.1016/0003-3472(61)90053-7; Shah KH, 1998, J TRAUMA, V45, P83, DOI 10.1097/00005373-199807000-00018; Shaw OEF, 2019, PHARMACOL RES, V139, P228, DOI 10.1016/j.phrs.2018.08.022; Shevell MI, 2009, DEV MED CHILD NEUROL, V51, P872, DOI 10.1111/j.1469-8749.2009.03269.x; Simon AF, 2012, GENES BRAIN BEHAV, V11, P243, DOI 10.1111/j.1601-183X.2011.00740.x; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; SOMMER R, 1959, SOCIOMETRY, V22, P247, DOI 10.2307/2785668; Tauber JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027100; Technau GM, 2007, J NEUROGENET, V21, P183, DOI 10.1080/01677060701695359; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Vexler Z S, 2001, Semin Neonatol, V6, P99, DOI 10.1053/siny.2001.0041; Wadge H, 2019, CORTEX, V115, P15, DOI 10.1016/j.cortex.2019.01.003; Weiss HB, 2001, JAMA-J AM MED ASSOC, V286, P1863, DOI 10.1001/jama.286.15.1863; Willenbrink AM, 2016, J NEUROGENET, V30, P205, DOI 10.1080/01677063.2016.1255211; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	62	4	4	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1744-9081		BEHAV BRAIN FUNCT	Behav. Brain Funct.	OCT 25	2019	15	1							11	10.1186/s12993-019-0163-1			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	JH9ZG	WOS:000493127100001	31653253	Green Published, gold			2022-02-06	
J	Carver, CM; Hastings, SD; Cook, ME; Shapiro, MS				Carver, Chase M.; Hastings, Shayne D.; Cook, Mileah E.; Shapiro, Mark S.			Functional responses of the hippocampus to hyperexcitability depend on directed, neuron-specific KCNQ2 K+ channel plasticity	HIPPOCAMPUS			English	Article						epileptogenesis; hippocampus; hyperexcitability; KCNQ channels; plasticity	EPILEPSY-ASSOCIATED KCNQ2; TEMPORAL-LOBE EPILEPSY; DENTATE GYRUS; STATUS EPILEPTICUS; SEIZURE SUSCEPTIBILITY; PILOCARPINE MODEL; ELECTRICAL-STIMULATION; RETIGABINE EZOGABINE; RECEPTOR COMPLEXES; POTASSIUM CHANNELS	M-type (KCNQ2/3) K+ channels play dominant roles in regulation of active and passive neuronal discharge properties such as resting membrane potential, spike-frequency adaptation, and hyper-excitatory states. However, plasticity of M-channel expression and function in nongenetic forms of epileptogenesis are still not well understood. Using transgenic mice with an EGFP reporter to detect expression maps of KCNQ2 mRNA, we assayed hyperexcitability-induced alterations in KCNQ2 transcription across subregions of the hippocampus. Pilocarpine and pentylenetetrazol chemoconvulsant models of seizure induction were used, and brain tissue examined 48 hr later. We observed increases in KCNQ2 mRNA in CA1 and CA3 pyramidal neurons after chemoconvulsant-induced hyperexcitability at 48 hr, but no significant change was observed in dentate gyrus (DG) granule cells. Using chromogenic in situ hybridization assays, changes to KCNQ3 transcription were not detected after hyper-excitation challenge, but the results for KCNQ2 paralleled those using the KCNQ2-mRNA reporter mice. In mice 7 days after pilocarpine challenge, levels of KCNQ2 mRNA were similar in all regions to those from control mice. In brain-slice electrophysiology recordings, CA1 pyramidal neurons demonstrated increased M-current amplitudes 48 hr after hyperexcitability; however, there were no significant changes to DG granule cell M-current amplitude. Traumatic brain injury induced significantly greater KCNQ2 expression in the hippocampal hemisphere that was ipsilateral to the trauma. In vivo, after a secondary challenge with subconvulsant dose of pentylenetetrazole, control mice were susceptible to tonic-clonic seizures, whereas mice administered the M-channel opener retigabine were protected from such seizures. This study demonstrates that increased excitatory activity promotes KCNQ2 upregulation in the hippocampus in a cell-type specific manner. Such novel ion channel expressional plasticity may serve as a compensatory mechanism after a hyperexcitable event, at least in the short term. The upregulation described could be potentially leveraged in anticonvulsant enhancement of KCNQ2 channels as therapeutic target for preventing onset of epileptogenic seizures.	[Carver, Chase M.; Hastings, Shayne D.; Cook, Mileah E.; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX USA		Shapiro, MS (corresponding author), Univ Texas San Antonio, Dept Physiol, Hlth Sci Ctr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu		Shapiro, Mark/0000-0002-9630-0600; Hastings, Shayne/0000-0002-6303-0181	Center for Scientific ReviewUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HL007446]; Morrison Trust; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS043394, R01 NS094461]	Center for Scientific Review, Grant/Award Number: T32 HL007446; Morrison Trust, Grant/Award Number: Morrison Trust Grant; National Institute of Neurological Disorders and Stroke, Grant/Award Numbers: R01 NS043394, R01 NS094461	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Alkadhi KA, 2019, MOL NEUROBIOL, V56, P6566, DOI 10.1007/s12035-019-1541-2; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arnold EC, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0036-19.2019; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bernard C., 2012, JASPERS BASIC MECH E, V4th ed.; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Bierbower SM, 2015, J NEUROSCI, V35, P2101, DOI 10.1523/JNEUROSCI.3805-14.2015; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Boscia F, 2006, NEUROPHARMACOLOGY, V51, P283, DOI 10.1016/j.neuropharm.2006.03.024; Brennan GP, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022384; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Bui AD, 2018, SCIENCE, V359, P787, DOI 10.1126/science.aan4074; Carver CM, 2019, J NEUROSCI, V39, P1566, DOI 10.1523/JNEUROSCI.1781-18.2018; Carver CM, 2014, J NEUROSCI, V34, P14181, DOI 10.1523/JNEUROSCI.0596-14.2014; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Coultrap SJ, 2005, MOL BRAIN RES, V135, P104, DOI 10.1016/j.molbrainres.2004.12.005; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Daniluk Jerzy, 2016, Drugs Real World Outcomes, V3, P155; Dao AT, 2016, MOL NEUROBIOL, V53, P6859, DOI 10.1007/s12035-015-9612-5; de Lanerolle NC, 2003, EPILEPSIA, V44, P677, DOI 10.1046/j.1528-1157.2003.32701.x; Dengler CG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42090; Dudek FE, 2012, JASPERS BASIC MECH E; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Evseev AI, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00277; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Fujita S, 2014, J NEUROSCI, V34, P16671, DOI 10.1523/JNEUROSCI.0584-14.2014; Gamper N., 2015, HDB ION CHANNELS, P275; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Golowasch J, 2009, MEMBRANE CAPACITANCE; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grabenstatter HL, 2012, EPILEPSIA, V53, P71, DOI 10.1111/epi.12036; Greene DL, 2018, EPILEPSIA, V59, P1908, DOI 10.1111/epi.14541; Greene DL, 2017, CELL MOL LIFE SCI, V74, P495, DOI 10.1007/s00018-016-2359-y; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Harvey BD, 2005, J COMP NEUROL, V488, P442, DOI 10.1002/cne.20594; Henshall D. C., 2012, JASPERS BASIC MECHAN; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Hsu JC, 1998, J CEREBR BLOOD F MET, V18, P768, DOI 10.1097/00004647-199807000-00008; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jung S, 2011, J NEUROSCI, V31, P14291, DOI 10.1523/JNEUROSCI.1148-11.2011; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; Klinger F, 2011, NEUROIMAGE, V58, P761, DOI 10.1016/j.neuroimage.2011.07.003; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; Kumar M, 2016, MOL PHARMACOL, V89, P667, DOI 10.1124/mol.115.103200; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Lavenex P, 2013, BEHAV BRAIN RES, V254, P8, DOI 10.1016/j.bbr.2013.02.007; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Lezmy J, 2017, P NATL ACAD SCI USA, V114, pE10234, DOI 10.1073/pnas.1708700114; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Lidster K, 2016, J NEUROSCI METH, V260, P2, DOI 10.1016/j.jneumeth.2015.09.007; Liu YQ, 2014, NEUROSCI BULL, V30, P985, DOI 10.1007/s12264-014-1478-4; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; Maguire Jamie, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS84, DOI 10.1016/j.psyneuen.2009.06.019; Mazarati A, 2008, EPILEPSIA, V49, P1777, DOI 10.1111/j.1528-1167.2008.01674.x; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Miceli F, 2015, J NEUROSCI, V35, P3782, DOI 10.1523/JNEUROSCI.4423-14.2015; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Niday Z, 2017, J NEUROSCI, V37, P576, DOI [10.1523/JNEUROSCI.1425-16.2017, 10.1523/JNEUROSCI.1425-16.2016]; Nieto-Gonzalez JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067318; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Poolos NP, 2012, EPILEPSIA, V53, P32, DOI 10.1111/epi.12033; Powell KL, 2008, EPILEPSIA, V49, P1686, DOI 10.1111/j.1528-1167.2008.01593.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sampath D, 2017, NEUROPHARMACOLOGY, V123, P126, DOI 10.1016/j.neuropharm.2017.06.002; Scharfman HE, 2019, EPILEPSY CURR, V19, P249, DOI 10.1177/1535759719855952; Scharfman HE, 2016, NEUROBIOL LEARN MEM, V129, P69, DOI 10.1016/j.nlm.2015.09.005; Scharfman HE, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03480.x; Schartz ND, 2016, SCI REP-UK, V6, DOI 10.1038/srep24988; Schmidt EF, 2013, COLD SPRING HARB PRO, V2013, P3; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/NMETH.1855, 10.1038/nmeth.1855]; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Sloviter RS, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01335.x; Soh H, 2018, ELIFE, V7, DOI 10.7554/eLife.38617; Soh H, 2014, J NEUROSCI, V34, P5311, DOI 10.1523/JNEUROSCI.3919-13.2014; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Sorensen Andreas T, 2017, eNeuro, V4, DOI 10.1523/ENEURO.0172-17.2017; SQUIRES RF, 1984, LIFE SCI, V35, P1439, DOI 10.1016/0024-3205(84)90159-0; Steve TA, 2014, EPILEPSY RES, V108, P1279, DOI 10.1016/j.eplepsyres.2014.07.003; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; Takano H., 2012, JASPERS BASIC MECH E; Trieu BH, 2015, J PHYSIOL-LONDON, V593, P2889, DOI 10.1113/JP270398; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Uchida T, 2017, EPILEPSIA, V58, P1430, DOI 10.1111/epi.13807; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Vezzani A, 2000, EPILEPSIA, V41, pS115, DOI 10.1111/j.1528-1157.2000.tb01569.x; Vigil FA, 2020, J CEREBR BLOOD F MET, V40, P1256, DOI 10.1177/0271678X19857818; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Y, 2014, NEUROBIOL AGING, V35, P88, DOI 10.1016/j.neurobiolaging.2013.07.007; Whitmire LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188064; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P3519, DOI 10.1152/jn.2000.83.6.3519; Yan XX, 2012, EXP NEUROL, V235, P228, DOI 10.1016/j.expneurol.2012.01.003; Zhang H, 2013, NEUROSCIENCE, V254, P70, DOI 10.1016/j.neuroscience.2013.08.064; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019	124	4	4	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	MAY	2020	30	5					435	455		10.1002/hipo.23163		OCT 2019	21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD5HI	WOS:000490648400001	31621989	Green Accepted			2022-02-06	
J	Li, Y; Li, CX; Gan, C; Zhao, K; Chen, JB; Song, JN; Lei, T				Li, Yu; Li, Chaoxi; Gan, Chao; Zhao, Kai; Chen, Jianbin; Song, Jinning; Lei, Ting			A Precise, Controllable in vitro Model for Diffuse Axonal Injury Through Uniaxial Stretch Injury	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury (TBI); diffuse axonal injury (DAI); traumatic axonal injury (TAI); stretch; in vitro model	TRAUMATIC BRAIN-INJURY; DEGENERATION; STRAIN	Regarding the determination of the biomechanical parameters in a reliable in vitro cell model for diffuse axonal injury (DAI), our study aimed to demonstrate connections between those parameters and secondary axotomy through examination of morphological alterations under a variety of traumatic conditions. An in vitro cell model for DAI was established in primary cultured mouse neurons by uniaxial mechanical stretching of non-myelinated axons under various traumatic conditions: strain (epsilon) = 5, 10, 20, and 50%; strain time (t) = 500, 100, and 20 ms; strain rate ranging between 0.1 and 25 s(-1). Axonal real strains (strain(axon)) were measured as 4.53 +/- 0.27, 9.02 +/- 0.91, 17.75 +/- 1.65, and 41.8 +/- 4.4%. Axonal real strain rates (SRaxon) ranged between 0.096 +/- 0.0054 and 20.9 +/- 2.2 s(-1). Results showed there was no obvious abnormality of axons with a lower strain condition (strain(axon) < 17.75 +/- 1.65%) during the acute phase within 30 min after injury. In contrast, acute axonal degeneration (AAD) was observed in the axons following injury with a higher strain condition (SRaxon > 17.75 +/- 1.65%). In addition, the incidence and degree of AAD were closely correlated with strain rate. Specifically, AAD occurred to all axons that were examined, when + = 50% (strainaxon = 41.8 +/- 4.4%) for 20 ms, while no spontaneous rupture was observed in those axons. Besides, the concentration of Ca2+ within the axonal process was significantly increased under such traumatic conditions. Moreover, the continuity of axon cytoskeleton was interrupted, eventually resulting in neuronal death during subacute stage following injury. In this study, we found that there is a minimum strain threshold for the occurrence of AAD in non-myelinated axons of primary cultured mouse neurons, which ranges between 9.02 +/- 0.91 and 17.75 +/- 1.65%. Basically, the severity of axonal secondary axotomy post DAI is strain rate dependent under a higher strain above the threshold. Hence, a reliable and reproducible in vitro cell model for DAI was established, when epsilon = 50% (strain(axon) = 41.8 +/- 4.4%) for 20 ms.	[Li, Yu; Li, Chaoxi; Gan, Chao; Zhao, Kai; Chen, Jianbin; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Hubei, Peoples R China; [Li, Yu; Song, Jinning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China		Lei, T (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Hubei, Peoples R China.; Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China.	jinningsong@126.com; tleitjh@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30471774]	This study was supported by the National Natural Science Foundation of China (Project 30471774).	Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Dolle JP, 2013, LAB CHIP, V13, P432, DOI 10.1039/c2lc41063j; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Xiao-Sheng H, 2004, J CLIN NEUROSCI, V11, P402, DOI 10.1016/j.jocn.2004.01.001	25	4	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 17	2019	13								1063	10.3389/fnins.2019.01063			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO4YY	WOS:000497587200001	31680808	Green Published, gold			2022-02-06	
J	Robicsek, SA; Bhattacharya, A; Rabai, F; Shukla, K; Dore, S				Robicsek, Steven A.; Bhattacharya, Ayon; Rabai, Ferenc; Shukla, Krunal; Dore, Sylvain			Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection	MOLECULAR NEUROBIOLOGY			English	Article						CD36; CD163; Ferritin; Hemopexin; Iron; LRP1	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL VASOSPASM; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; HAPTOGLOBIN PHENOTYPE PREDICTS; CONTROLLED-RELEASE POLYMER; HUMAN CEREBROSPINAL-FLUID; TOLL-LIKE RECEPTORS; NITRIC-OXIDE DONOR; HEME OXYGENASE-1; SCAVENGER RECEPTOR	Emergency visits, hospitalizations, and deaths due to traumatic brain injury (TBI) have increased significantly over the past few decades. While the primary early brain trauma is highly deleterious to the brain, the secondary injury post-TBI is postulated to significantly impact mortality. The presence of blood, particularly hemoglobin, and its breakdown products and key binding proteins and receptors modulating their clearance may contribute significantly to toxicity. Heme, hemin, and iron, for example, cause membrane lipid peroxidation, generate reactive oxygen species, and sensitize cells to noxious stimuli resulting in edema, cell death, and increased morbidity and mortality. A wide range of other mechanisms such as the immune system play pivotal roles in mediating secondary injury. Effective scavenging of all of these pro-oxidant and pro-inflammatory metabolites as well as controlling maladaptive immune responses is essential for limiting toxicity and secondary injury. Hemoglobin metabolism is mediated by key molecules such as haptoglobin, heme oxygenase, hemopexin, and ferritin. Genetic variability and dysfunction affecting these pathways (e.g., haptoglobin and heme oxygenase expression) have been implicated in the difference in susceptibility of individual patients to toxicity and may be target pathways for potential therapeutic interventions in TBI. Ongoing collaborative efforts are required to decipher the complexities of blood-related toxicity in TBI with an overarching goal of providing effective treatment options to all patients with TBI.	[Robicsek, Steven A.; Bhattacharya, Ayon; Rabai, Ferenc; Shukla, Krunal; Dore, Sylvain] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Dept Anesthesiol, 1275 Ctr Dr,Biomed Sci J493, Gainesville, FL 32610 USA; [Robicsek, Steven A.; Bhattacharya, Ayon; Rabai, Ferenc; Shukla, Krunal; Dore, Sylvain] Univ Florida, Coll Med, McKnight Brain Inst, 1275 Ctr Dr,Biomed Sci J493, Gainesville, FL 32610 USA; [Robicsek, Steven A.] Univ Florida, Coll Med, Dept Neurosurg, Neurosci, Gainesville, FL 32610 USA; [Bhattacharya, Ayon] West Bengal Univ Hlth Sci, KPC Med Coll, Dept Pharmacol, Kolkata, W Bengal, India; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Pharmaceut, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA		Robicsek, SA; Dore, S (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Dept Anesthesiol, 1275 Ctr Dr,Biomed Sci J493, Gainesville, FL 32610 USA.; Robicsek, SA; Dore, S (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, 1275 Ctr Dr,Biomed Sci J493, Gainesville, FL 32610 USA.	robicsek@ufl.edu; sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109	Brain Aneurysm Foundation; American Heart AssociationAmerican Heart Association; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS095166, NS103036, NS110008]; Department of Anesthesiology	This work was supported in part by grants from the Brain Aneurysm Foundation, the American Heart Association, and the National Institutes of Health (R21NS095166, NS103036, NS110008), and the Department of Anesthesiology.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akopov S, 1996, CEREBROVAS BRAIN MET, V8, P11; Al-Tamimi YZ, 2012, STROKE, V43, P677, DOI 10.1161/STROKEAHA.111.625731; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Andersen CBF, 2017, ANTIOXID REDOX SIGN, V26, P814, DOI 10.1089/ars.2016.6793; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Arima H, 2009, NEUROLOGY, V73, P1963, DOI 10.1212/WNL.0b013e3181c55ed3; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Askenase MH, 2016, SEMIN NEUROL, V36, P288, DOI 10.1055/s-0036-1582132; AUER L, 1978, ACTA NEUROCHIR, V42, P229, DOI 10.1007/BF01405338; Azarov I, 2008, NITRIC OXIDE-BIOL CH, V18, P296, DOI 10.1016/j.niox.2008.02.006; Babadjouni RM, 2017, J NEUROINTERV SURG, V9, P1202, DOI 10.1136/neurintsurg-2017-013197; Banerjee S, 2012, FREE RADICAL BIO MED, V53, P1317, DOI 10.1016/j.freeradbiomed.2012.07.023; Bardutzky J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-203; BENSHACHAR D, 1991, J NEUROCHEM, V57, P1609, DOI 10.1111/j.1471-4159.1991.tb06358.x; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; BLACK JA, 1968, NATURE, V218, P736, DOI 10.1038/218736a0; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Borsody M, 2006, NEUROLOGY, V66, P634, DOI 10.1212/01.wnl.0000200781.62172.1d; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brifault C, 2017, J BIOL CHEM, V292, P18699, DOI 10.1074/jbc.M117.798413; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Bulters D, 2018, NAT REV NEUROL, V14, P416, DOI 10.1038/s41582-018-0020-0; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Chakraborty Abhijit, 2012, Clin Pharmacokinet, V51, pe1, DOI 10.2165/11599820-000000000-00000; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen LF, 2011, J NEUROSURG, V114, P1159, DOI 10.3171/2010.10.JNS10861; Chen S, 2015, TRANSL STROKE RES, V6, P4, DOI 10.1007/s12975-014-0384-4; Chen-Roetling J, 2016, J NEUROCHEM, V139, P586, DOI 10.1111/jnc.13720; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Cho SH, 2012, CURR PHARM DESIGN, V18, P3721, DOI 10.2174/138161212802002760; Clark JF, 2008, ACTA NEUROCHIR SUPPL, V105, P7; CLEZARDIN P, 1993, CANCER RES, V53, P1421; Connor David E Jr, 2017, Pathophysiology, V24, P169, DOI 10.1016/j.pathophys.2017.04.003; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Costacou T, 2008, DIABETES, V57, P1702, DOI 10.2337/db08-0095; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Deuel JW, 2015, FREE RADICAL BIO MED, V89, P931, DOI 10.1016/j.freeradbiomed.2015.09.016; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dong BB, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-58; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; DUAN X, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/1203285; Dutra FF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00115; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Etminan N, 2013, STROKE, V44, P2162, DOI 10.1161/STROKEAHA.113.001790; Etzerodt A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40286; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; EWING JF, 1992, J NEUROCHEM, V58, P1140, DOI 10.1111/j.1471-4159.1992.tb09373.x; Ewing JF, 1997, BRAIN RES PROTOC, V1, P165, DOI 10.1016/S1385-299X(96)00027-X; Fang H, 2014, J IMMUNOL, V192, P5984, DOI 10.4049/jimmunol.1400054; Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1; Galea J, 2018, J NEUROSURG, V128, P515, DOI 10.3171/2016.9.JNS16615; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Garland P, 2016, STROKE, V47, P872, DOI 10.1161/STROKEAHA.115.011956; Garton T, 2016, STROKE VASC NEUROL, V1, P172, DOI 10.1136/svn-2016-000042; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Gomes JA, 2014, NEUROCRIT CARE, V21, P285, DOI 10.1007/s12028-014-9977-8; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Greenhalgh AD, 2012, DIS MODEL MECH, V5, P823, DOI 10.1242/dmm.008557; Groom R, 1997, CURR ANAESTH CRIT CA, V8, P248, DOI [10.1016/S0953-7112(97)80002-6, DOI 10.1016/S0953-7112(97)80002-6]; Guenegou A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039743; Hahl P, 2013, J NEUROCHEM, V125, P89, DOI 10.1111/jnc.12165; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; HANDA Y, 1987, J NEUROSURG, V67, P558, DOI 10.3171/jns.1987.67.4.0558; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Holfelder K, 2011, HISTOL HISTOPATHOL, V26, P1007, DOI 10.14670/HH-26.1007; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Ibrahim GM, 2012, NEUROSURGERY, V70, P102, DOI 10.1227/NEU.0b013e31822e5a8e; Ijas P, 2013, ATHEROSCLEROSIS, V230, P228, DOI 10.1016/j.atherosclerosis.2013.07.008; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; JUCKETT MB, 1995, AM J PATHOL, V147, P782; Kantor E, 2014, J NEUROSURG, V120, P386, DOI 10.3171/2013.10.JNS13219; KAY MMB, 1975, P NATL ACAD SCI USA, V72, P3521, DOI 10.1073/pnas.72.9.3521; Kearney CJ, 2015, CELL DEATH DIFFER, V22, P1313, DOI 10.1038/cdd.2014.222; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Khalaf S, 2019, J NEUROTRAUM, V36, P43, DOI 10.1089/neu.2017.5617; Kim S, 2012, MOL CELL BIOL, V32, P2698, DOI 10.1128/MCB.06743-11; King Melanie D, 2014, Int J Cell Biol, V2014, P495817, DOI 10.1155/2014/495817; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Koeppen AH, 2008, ACTA NEUROPATHOL, V116, P371, DOI 10.1007/s00401-008-0421-z; Kolb S, 2007, J PATHOL, V212, P249, DOI 10.1002/path.2190; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; KOSAKA H, 1989, FREE RADICAL BIO MED, V7, P653, DOI 10.1016/0891-5849(89)90146-9; Kramer AH, 2015, J CEREBR BLOOD F MET, V35, P1241, DOI 10.1038/jcbfm.2015.47; Kramer AH, 2011, NEUROCRIT CARE, V14, P489, DOI 10.1007/s12028-010-9429-z; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Kwon MS, 2015, INT J MOL SCI, V16, P5028, DOI 10.3390/ijms16035028; Kwon OY, 2008, J KOREAN NEUROSURG S, V43, P281, DOI 10.3340/jkns.2008.43.6.281; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Langlois MR, 1996, CLIN CHEM, V42, P1589; Leclerc JL, 2018, J CEREBR BLOOD F MET, V38, P1032, DOI 10.1177/0271678X16679170; Leclerc JL, 2015, P NATL ACAD SCI USA, V112, P1155, DOI 10.1073/pnas.1412833112; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Leonardo CC, 2011, NUTR NEUROSCI, V14, P226, DOI 10.1179/1476830511Y.0000000013; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Levy AP, 2002, J AM COLL CARDIOL, V40, P1984, DOI 10.1016/S0735-1097(02)02534-2; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liu Y, 2015, BIOL PHARM BULL, V38, P1234, DOI 10.1248/bpb.b15-00048; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lutz HU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00387; Ma B, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0490-1; Ma CX, 2009, NEUROL RES; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898, DOI 10.1152/ajpendo.1997.273.5.E898; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYBERG MR, 1990, J NEUROSURG, V72, P626, DOI 10.3171/jns.1990.72.4.0626; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Mendez NV, 2013, INT J CLIN ANESTHESI, V1; Michel-Monigadon D, 2010, CEREBROVASC DIS, V29, P564, DOI 10.1159/000306643; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Mocco J, 2006, NEUROSURGERY, V58, P305, DOI 10.1227/01.NEU.0000195009.02412.E8; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moraes L, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0970-2; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Murthy SB, 2016, NEUROSURGERY, V78, P71, DOI 10.1227/NEU.0000000000001000; Murthy SB, 2015, WORLD NEUROSURG, V83, P583, DOI 10.1016/j.wneu.2014.12.013; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; NONAKA T, 1979, Neurologia Medico-Chirurgica, V19, P53, DOI 10.2176/nmc.19.53; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ohnishi H, 2013, J STROKE CEREBROVASC, V22, P520, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.005; PANTER SS, 1985, J EXP MED, V161, P748, DOI 10.1084/jem.161.4.748; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Pluta RM, 2006, NEUROL RES, V28, P730, DOI 10.1179/016164106X152052; Pradilla G, 2004, NEUROSURGERY, V55, P1393, DOI 10.1227/01.NEU.0000143615.26102.1A; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Provencio JJ, 2010, NEUROCRIT CARE, V12, P244, DOI 10.1007/s12028-009-9308-7; Provencio JJ, 2016, BRAIN BEHAV IMMUN, V54, P233, DOI 10.1016/j.bbi.2016.02.007; Qu Y, 2007, J NEUROSURG, V106, P428, DOI 10.3171/jns.2007.106.3.428; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Regan RF, 2002, NEUROSCIENCE, V113, P985, DOI 10.1016/S0306-4522(02)00243-9; Rodriguez-Yanez M, 2012, J NEUROIMMUNOL, V247, P75, DOI 10.1016/j.jneuroim.2012.03.019; Ross J, 2007, NEUROPHARMACOLOGY, V53, P638, DOI 10.1016/j.neuropharm.2007.07.015; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sabri M, 2013, J CEREBR BLOOD F MET, V33, P1008, DOI 10.1038/jcbfm.2013.49; Saccucci P, 2004, NEUROGENETICS, V5, P245, DOI 10.1007/s10048-004-0192-1; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Sanchez DJ, 2001, NEUROSCI LETT, V303, P181, DOI 10.1016/S0304-3940(01)01748-7; Santarino IB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05687-1; Schaer CA, 2013, CELL DEATH DIFFER, V20, P1569, DOI 10.1038/cdd.2013.113; Schaer CA, 2016, AM J RESP CRIT CARE, V193, P1111, DOI 10.1164/rccm.201510-2058OC; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Schneider U, 2015, ACTA NEUROPATHOL, V130, P215, DOI 10.1007/s00401-015-1440-1; Sehba FA, 2000, J CEREBR BLOOD F MET, V20, P604, DOI 10.1097/00004647-200003000-00018; Selim M, 2011, STROKE, V42, P3067, DOI 10.1161/STROKEAHA.111.617589; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Shen HT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.58; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Siedlinski M, 2008, J MED GENET, V45, P400, DOI 10.1136/jmg.2008.058123; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Subramanian K, 2013, J IMMUNOL, V190, P5267, DOI 10.4049/jimmunol.1202648; Sun BL, 2003, CLIN HEMORHEOL MICRO, V29, P391; Sun CR, 2014, TURK NEUROSURG, V24, P737, DOI 10.5137/1019-5149.JTN.9837-13.2; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Teng WY, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/473276; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Terpstra V, 2000, BLOOD, V95, P2157, DOI 10.1182/blood.V95.6.2157; Thakkar M, 2019, MOL NEUROBIOL, V56, P5483, DOI 10.1007/s12035-018-1440-y; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; UEMURA Y, 1987, J NEUROSURG, V66, P741, DOI 10.3171/jns.1987.66.5.0741; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vachharajani TJ, 2000, AM J PHYSIOL-HEART C, V278, pH1613, DOI 10.1152/ajpheart.2000.278.5.H1613; VANNIEUWENHOVEN FA, 1995, BIOCHEM BIOPH RES CO, V207, P747, DOI 10.1006/bbrc.1995.1250; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Viegas MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048391; Vormittag R, 2005, HAEMATOLOGICA, V90, P1557; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wu BH, 2010, TRANSL STROKE RES, V1, P57, DOI 10.1007/s12975-009-0002-z; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xie WJ, 2016, NEURAL REGEN RES, V11, P1122, DOI 10.4103/1673-5374.187047; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21970; Yang P, 2016, EXP NEUROL, V283, P157, DOI 10.1016/j.expneurol.2016.06.010; Yang QW, 2011, J CEREBR BLOOD F MET, V31, P593, DOI 10.1038/jcbfm.2010.129; Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159; Yeatts SD, 2013, NEUROCRIT CARE, V19, P257, DOI 10.1007/s12028-013-9861-y; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122371; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235; Ziai WC, 2013, STROKE, V44, pS74, DOI 10.1161/STROKEAHA.111.000662	256	4	4	2	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2020	57	1			SI		159	178		10.1007/s12035-019-01766-8		OCT 2019	20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV1HZ	WOS:000490197000001	31617072				2022-02-06	
J	French, J; Huber, P; McShane, J; Holland, CL; Elbin, RJ; Kontos, AP				French, Jonathan; Huber, Patrick; McShane, Joseph; Holland, Cyndi L.; Elbin, Robert J.; Kontos, Anthony P.			Influence of Test Environment, Age, Sex, and Sport on Baseline Computerized Neurocognitive Test Performance	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; mTBI; neurocognitive testing; adolescent	TEST-RETEST RELIABILITY; CONCUSSION; IMPACT; MANAGEMENT; SYMPTOMS; SCORES	Background: Baseline computerized testing is a common component of concussion assessments, and the testing environment has been suggested to influence test performance and validity. Purpose: To compare concussion baseline computerized neurocognitive test performance and validity among adolescent athletes based on testing environment (group, individual), age group (10-12, 13-15, 16-18 years), sex (male, female), and sport type (collision/combat, contact, noncontact). Study Design: Cohort study; Level of evidence, 3. Methods: Through a concussion community outreach program, participants completed baseline computerized neurocognitive testing using Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). A total of 2845 athletes aged 10 to 18 years completed the baseline assessment. A total of 2241 (79%) athletes completed baseline testing in a group environment, and 604 (21%) completed testing in an individual environment. A random subsample of 500 athletes from each group was selected for statistical comparison. Results: No significant differences were supported in baseline computerized neurocognitive test performance between the group and individual administration environments. Test validity was statistically similar across testing environment, age group, and sex. However, patients of older age (16-18 years), female sex, and collision/combat and contact sports performed better on ImPACT. There were differences in total symptom severity scores (t = 2.19, df = 998, P = .03), with participants in the group testing environment reporting lower total symptom severity scores than those in the individual testing environment. The rates of invalid tests were low across all age groups, averaging from 4.0% in the 10- to 12-year age group to 4.8% in the 13- to 15-year age group. Conclusion: The findings indicated that concussion baseline neurocognitive test performance is similar when administered in group and individual testing environments. However, differences based on age group, sex, and sport type should be considered when interpreting baseline computerized neurocognitive test scores. The finding of higher symptom scores in older adolescents in the individual testing environment suggests that they may be less forthcoming about symptoms in a group setting.	[French, Jonathan; Huber, Patrick; McShane, Joseph; Holland, Cyndi L.; Elbin, Robert J.; Kontos, Anthony P.] Univ Pittsburgh, Pittsburgh, PA USA; [French, Jonathan; McShane, Joseph; Kontos, Anthony P.] UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [French, Jonathan; Holland, Cyndi L.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Huber, Patrick] UPMC Telehealth Program, Pittsburgh, PA USA; [Elbin, Robert J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA		Kontos, AP (corresponding author), UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu			University of Pittsburgh Medical Center; Pittsburgh Penguins Foundation	The authors thank the Pittsburgh Penguins Foundation and University of Pittsburgh Medical Center for supporting the Heads UP community outreach and baseline testing program.	Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Elbin RJ, 2013, TRANSL STROKE RES, V4, P425, DOI 10.1007/s12975-012-0237-y; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hinton-Bayre AD, 2015, BRAIN IMPAIR, V16, P80, DOI 10.1017/BrImp.2015.14; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Rogers SD, 2017, SPORTS MED, V47, P1893, DOI 10.1007/s40279-017-0686-2; Rohling M.L., 2015, VALIDITY TESTING CHI, P226; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	29	4	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2019	47	13					3263	3269	0363546519875137	10.1177/0363546519875137		OCT 2019	7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JI9IR	WOS:000491814100001	31609635				2022-02-06	
J	Khanuja, T; Unni, HN				Khanuja, Tanu; Unni, Harikrishnan Narayanan			Intracranial pressure-based validation and analysis of traumatic brain injury using a new three-dimensional finite element human head model	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Traumatic brain injury; finite element model; intracranial pressure; von Mises stress; magnetic resonance imaging; hyperviscoelastic	IMPACT; BIOMECHANICS; PREDICTION; TISSUE; SIMON	Traumatic brain injuries are life-threatening injuries that can lead to long-term incapacitation and death. Over the years, numerous finite element human head models have been developed to understand the injury mechanisms of traumatic brain injuries. Many of these models are erroneous and used ellipsoidal or spherical geometries to represent brain. This work is focused on the development of high-quality, comprehensive three-dimensional finite element human head model with accurate representation of cerebral sulci and gyri structures in order to study traumatic brain injury mechanisms. Present geometry, predicated on magnetic resonance imaging data consist of three rudimentary components, that is, skull, cerebrospinal fluid with the ventricular system, and the soft tissues comprising the cerebrum, cerebellum, and brain stem. The brain is modeled as a hyperviscoelastic material. Meshed model with 10 nodes modified tetrahedral type element (C3D10M) is validated against two cadaver-based impact experiments by comparing the intracranial pressures at different locations of the head. Our results indicate a better agreement with cadaver results, specifically for the case of frontal and parietal intracranial pressure values. Existing literature focuses mostly on intracranial pressure validation, while the effects of von Mises stress on brain injury are not analyzed in detail. In this work, a detailed interpretation of neurological damage resulting from impact injury is performed by analyzing von Mises stress and intracranial pressure distribution across numerous segments of the brain. A reasonably good correlation with experimental data signifies the robustness of the model for predicting injury mechanisms based on clinical predictions of injury tolerance criteria.	[Khanuja, Tanu] Indian Inst Technol Hyderabad, Dept Biomed Engn, Hyderabad, India; [Unni, Harikrishnan Narayanan] Indian Inst Technol Hyderabad, Dept Biomed Engn, Biomicrofluid & Biomech Lab, Hyderabad 502285, Telangana, India		Unni, HN (corresponding author), Indian Inst Technol Hyderabad, Dept Biomed Engn, Biomicrofluid & Biomech Lab, Hyderabad 502285, Telangana, India.	harikrishnan@iith.ac.in	Unni, Harikrishnan Narayanan/AAQ-7709-2020	Narayanan Unni, Harikrishnan/0000-0001-8678-7665	Ministry of Human Resource and Development (MHRD), Government of IndiaMinistry of Human Resource Development (MHRD), Government of India	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported and funded by the Ministry of Human Resource and Development (MHRD), Government of India.	Afshari J, 2017, J BRAZ SOC MECH SCI, V39, P3729, DOI 10.1007/s40430-017-0830-9; Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Antona MJ, 2016, THESIS; Anzelius A, 1943, ACTA PATH MICROBIO S, V48, P153; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Baumgartner D, 2005, EUR J COMPUT MECH, V14, P421; Boulanger P, 2001, CISM COURSES LECT, P131; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Deck C., 2009, 7 EUR LS DYNA C SALZ; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jefferson G, 1944, BRIT MED J, V1944, P1; KABO JM, 1983, J BIOMECH, V16, P313, DOI 10.1016/0021-9290(83)90015-5; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Lee Bruce, 2005, NeuroRx, V2, P372; Levadnyi I, 2018, J MED BIOL ENG, V38, P587, DOI 10.1007/s40846-017-0324-3; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Micheau ADH, ANATOMY BRAIN MRI CR; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; OGDEN RW, 1972, PROC R SOC LON SER-A, V328, P567, DOI 10.1098/rspa.1972.0096; Pearce CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114292; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prosser JD, 2011, OTOLARYNG CLIN N AM, V44, P857, DOI 10.1016/j.otc.2011.06.007; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Ruan J, 2001, Stapp Car Crash J, V45, P395; Ruan JS, 2008, J BIOMECH ENG, V116, P44; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Siswanto A, 2012, INT REV MECH ENG, V6, P1508; Suwatcharangkoon S, 2016, JAMA NEUROL, V73, P28, DOI 10.1001/jamaneurol.2015.3188; Tabish S. A., 2015, EMERGEN MED, V5, P1, DOI [10.4172/2165-7548.10000229, DOI 10.4172/2165-7548.10000229]; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, P 36 STAPP CAR CRASH; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; WAHI KK, 1977, ANN BIOMED ENG, V5, P303, DOI 10.1007/BF02367311; Ward C, 1980, P 24 STAPP CAR CRASH; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408278; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0	61	4	4	2	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JAN	2020	234	1					3	15		10.1177/0954411919881526		OCT 2019	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JX3PA	WOS:000491710600001	31630604				2022-02-06	
J	Wayment, HA; Huffman, AH				Wayment, Heidi A.; Huffman, Ann Hergatt			The Indirect Influence of Organizational Safety Climate on Football Players' Concussion Reporting Intentions	HEALTH EDUCATION & BEHAVIOR			English	Article						college; college health; health behavior; injury prevention; safety; social ecological model	EDUCATION; COACHES; MODEL; HOCKEY	Most of the health interventions designed to increase athletes' reporting of potential concussion symptoms have focused only on the individual athlete. Unfortunately, interventions targeted at athletes' knowledge and understanding of concussion risk has not reliably increased their reporting behavior, leading to increased calls for "changing the culture of concussion reporting." To date, no studies have examined the role of organizational safety climate has on concussion-symptom reporting behavior. We hypothesized that players' perception of organizational safety climate would be indirectly related to their concussion symptom reporting intentions, via the influence of safety culture on supportive social norms and self-efficacy, two well-known predictors of concussion reporting intentions. We used structural equation modeling techniques to create robust latent measures of our model variables and then examined the indirect influence of football program safety climate on football players' symptom reporting intentions. Surveys were completed by NCAA Division I football players (N = 223) before and after the 2017 football season. We tested a confirmatory factor analysis and hypothesized latent variable model with preseason data, made small adjustments to our model (adding correlated error terms), and then confirmed using postseason data. We also examined a competing, alternative model. Results support the indirect and influence of perceived safety climate on concussion reporting intentions primarily via the relationship between safety climate and social norms, and to a lesser extent between safety climate and self-efficacy. Discussion focuses on the importance of considering the addition of interventions aimed at systems-level influences to facilitate supportive social norms and athlete self-efficacy regarding concussion symptom reporting.	[Wayment, Heidi A.; Huffman, Ann Hergatt] No Arizona Univ, Flagstaff, AZ 86001 USA		Wayment, HA (corresponding author), No Arizona Univ, Psychol Sci, Box 15106, Flagstaff, AZ 86001 USA.	heidi.wayment@nau.edu		Wayment, Heidi/0000-0001-5287-5966	National Collegiate Athletic Association; U.S. Department of DefenseUnited States Department of Defense	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the National Collegiate Athletic Association and the U.S. Department of Defense on a programmatic research project investigating NCAA football programs' efforts to increase concussion reporting behavior. The sponsors of this research had no input in any aspect of study design, data collection, analysis and interpretation, writing of the report, or submitting for publication.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andreasen AlanR., 1995, MARKETING SOCIAL CHA; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bentler P. M., 1995, EQS STRUCTURAL EQUAT; Beus JM, 2018, J OCCUP HEALTH PSYCH, V23, P402, DOI 10.1037/ocp0000092; Beus JM, 2010, J APPL PSYCHOL, V95, P713, DOI 10.1037/a0019164; Beus JM, 2010, ACCIDENT ANAL PREV, V42, P1431, DOI 10.1016/j.aap.2009.06.002; Bollen K.A., 1993, TESTING STRUCTURAL E, V154; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; BRECKLER SJ, 1990, PSYCHOL BULL, V107, P260, DOI 10.1037/0033-2909.107.2.260; Casey T, 2017, J OCCUP HEALTH PSYCH, V22, P341, DOI 10.1037/ocp0000072; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Colley SK, 2013, SAFETY SCI, V51, P69, DOI 10.1016/j.ssci.2012.06.001; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; D'Lauro C., 2017, BRIT J SPORT MED, V51, pA642, DOI 10.1136/bjsports-2016-097270.166; Fogarty GJ, 2010, ACCIDENT ANAL PREV, V42, P1455, DOI 10.1016/j.aap.2009.08.008; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Johnson SE, 2005, J SAFETY RES, V36, P63, DOI 10.1016/j.jsr.2004.12.004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lee J, 2019, J OCCUP HEALTH PSYCH, V24, P66, DOI 10.1037/ocp0000113; Nahrgang JD, 2011, J APPL PSYCHOL, V96, P71, DOI 10.1037/a0021484; Neal A, 2000, SAFETY SCI, V34, P99, DOI 10.1016/S0925-7535(00)00008-4; Probst TM, 2008, J APPL PSYCHOL, V93, P1147, DOI 10.1037/0021-9010.93.5.1147; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reid AE, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P263, DOI 10.1007/978-0-387-09488-5_19; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Schneider B, 2011, APA HDB IND ORG PSYC, V1, DOI [10.1037/12169-012, DOI 10.1037/12169-012]; Seibert SE, 2004, ACAD MANAGE J, V47, P332, DOI 10.2307/20159585; To C, 2018, ACAD MANAGE J, V61, P1281, DOI 10.5465/amj.2016.0850; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wayment HA, 2020, J AM COLL HEALTH, V68, P438, DOI 10.1080/07448481.2019.1577863; Wayment HA, 2019, AM J PREV MED, V56, P323, DOI 10.1016/j.amepre.2018.10.007; Zohar D., 2003, HDB OCCUPATIONAL HLT, P123, DOI DOI 10.1037/10474-006	42	4	4	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	FEB	2020	47	1					91	100	1090198119879216	10.1177/1090198119879216		OCT 2019	10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KC4FJ	WOS:000490106700001	31603011	Bronze			2022-02-06	
J	Whyte, T; Liu, J; Chung, V; McErlane, SA; Abebe, ZA; McInnes, KA; Wellington, CL; Cripton, PA				Whyte, T.; Liu, J.; Chung, V; McErlane, S. A.; Abebe, Z. A.; McInnes, K. A.; Wellington, C. L.; Cripton, P. A.			Technique and preliminary findings for in vivo quantification of brain motion during injurious head impacts	JOURNAL OF BIOMECHANICS			English	Article						Brain motion; Mechanical properties; Head impact; Traumatic brain injury	SPINAL-CORD; DEFORMATION; FERRET; MODEL	Computational models of the human brain are widely used in the evaluation and development of helmets and other protective equipment. These models are often attempted to be validated using cadaver tissue displacements despite studies showing neural tissue degrades quickly after death. Addressing this limitation, this study aimed to develop a technique for quantifying living brain motion in vivo using a closed head impact animal model of traumatic brain injury (TBI) called CHIMERA. We implanted radiopaque markers within the brain of three adult ferrets and resealed the skull while the animals were anesthetized. We affixed additional markers to the skull to track skull kinematics. The CHIMERA device delivered controlled, repeatable head impacts to the head of the animals while the impacts were fluoroscopically stereo-visualized. We observed that 1.5 mm stainless steel fiducials (similar to 8 times the density of the brain) migrated from their implanted positions while neutral density targets remained in their implanted position post-impact. Brain motion relative to the skull was quantified in neutral density target tests and showed increasing relative motion at higher head impact severities. We observed the motion of the brain lagged behind that of the skull, similar to previous studies. This technique can be used to obtain a comprehensive dataset of in vivo brain motion to validate computational models reflecting the mechanical properties of the living brain. The technique would also allow the mechanical response of in vivo brain tissue to be compared to cadaveric preparations for investigating the fidelity of current human computational brain models. (C) 2019 Published by Elsevier Ltd.	[Whyte, T.; Chung, V; Abebe, Z. A.; McInnes, K. A.; Cripton, P. A.] Univ British Columbia, Orthopaed Injury Biomech Grp, Dept Mech Engn, Vancouver, BC, Canada; [Whyte, T.; Chung, V; Abebe, Z. A.; McInnes, K. A.; Cripton, P. A.] Univ British Columbia, Orthopaed Injury Biomech Grp, Dept Orthopaed, Vancouver, BC, Canada; [Whyte, T.; Chung, V; Abebe, Z. A.; McInnes, K. A.; Cripton, P. A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada; [Whyte, T.; Liu, J.; Abebe, Z. A.; McInnes, K. A.; Wellington, C. L.; Cripton, P. A.] ICORD, Vancouver, BC, Canada; [McErlane, S. A.] Univ British Columbia, Ctr Comparat Med, Vancouver, BC, Canada; [Wellington, C. L.] Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada		Cripton, PA (corresponding author), Univ British Columbia, Dept Mech Engn, 2054-6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada.	cripton@mech.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833; Whyte, Tom/0000-0002-3562-3844; McInnes, Kurt/0000-0001-5931-2963; Wellington, Cheryl/0000-0001-7014-039X; Chung, Vivian/0000-0002-5742-7502	Weston Brain Institute	The financial support from the Weston Brain Institute and assistance of the Centre for Comparative Medicine staff are gratefully acknowledged.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Barnette AR, 2009, PEDIATR RES, V66, P80, DOI 10.1203/PDR.0b013e3181a291d9; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Drake A.M, 2017, IRCOBI C ANTW BELG; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HUNG TK, 1981, J BIOMECH ENG-T ASME, V103, P43, DOI 10.1115/1.3138244; Hutchinson E, 2018, NAT CAP AR TBI RES S; Hutchinson EB, 2017, NEUROIMAGE, V152, P575, DOI 10.1016/j.neuroimage.2017.03.009; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lucas E, 2018, J NEUROTRAUM, V35, P2572, DOI 10.1089/neu.2017.5478; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Oakland RJ, 2006, P I MECH ENG H, V220, P489, DOI 10.1243/09544119JETM135; Valstar ER, 2005, ACTA ORTHOP, V76, P563, DOI 10.1080/17453670510041574; Westerhout J, 2011, J PHARM SCI-US, V100, P3577, DOI 10.1002/jps.22604; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293	24	4	4	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	OCT 11	2019	95								109279	10.1016/j.jbiomech.2019.07.023			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	JK5OU	WOS:000494893500024	31443944				2022-02-06	
J	Dowling, S; Hair, H; Boudreau, D; Grigat, D; Rice, C; Born, KB; VandenBerg, S				Dowling, Shawn; Hair, Heather; Boudreau, Denise; Grigat, Daniel; Rice, Christopher; Born, Karen B.; VandenBerg, Stephanie			A Patient-focused Information Design Intervention to Support the Minor Traumatic Brain Injuries (mTBI) Choosing Wisely Canada Recommendation	CUREUS			English	Article						head injury; choosing wisely; patient education; patient-centered care; minor traumatic brain injuries (mtbi)	EMERGENCY-DEPARTMENT; INSTRUCTIONS; EDUCATION; CRITERIA	Introduction The first Choosing Wisely Canada (CWC) recommendation for Emergency Medicine states: "Don't order CT head scans in adults and children who have suffered minor head injuries (unless positive for a validated head injury clinical decision rule)". In order to provide patients with information on the risks and benefits of computed tomography (CT) scans in minor traumatic brain injuries (mTBI) and to encourage discussions between patients and their doctor, we designed a patient-focused mTBI infographic for the emergency department (ED). Methods Stakeholders worked with content experts to co-design the infographic, which was posted in two emergency department (ED) waiting rooms. A survey was administered to evaluate whether the infographic influenced patient beliefs about the risks and benefits of CT scans and to gauge patient willingness to have a discussion with their doctor about the necessity of a scan. Results One hundred fifteen patients completed the survey. Prior to participating, 38% of patients thought a CT after an mTBI was always a good idea and 60% thought it was sometimes a good idea. After viewing the poster, 87% of respondents stated they better understood when a CT scan may be appropriate, 93% felt they better understood the risks of CT scans, and 76% understood that their doctor can often rule out serious illness without a CT scan. Only 19% of patients still felt that a CT was always necessary after an mTBI. Conclusions The mTBI infographic changed patient perceptions regarding the need for CT scans and increased awareness of the indications and risks of CT scans. This study demonstrates that targeted patient education materials can help support CWC recommendations.	[Dowling, Shawn] Phys Learning Program, Emergency Med, Calgary, AB, Canada; [Hair, Heather; Boudreau, Denise; Grigat, Daniel] Alberta Hlth Serv, Emergency Strateg Clin Network, Calgary, AB, Canada; [Rice, Christopher] Univ Calgary, Continuing Med Educ & Profess Dev, Calgary, AB, Canada; [Born, Karen B.] Univ Toronto, Epidemiol & Publ Hlth, Toronto, ON, Canada; [VandenBerg, Stephanie] Univ Calgary, Emergency Med, Calgary, AB, Canada		Dowling, S (corresponding author), Phys Learning Program, Emergency Med, Calgary, AB, Canada.	shawn.dowling@ahs.ca		Dowling, Shawn/0000-0002-6378-7299			[Anonymous], 2019, RAD DOSES; [Anonymous], 2015, MAYO CLIN IS USING I; [Anonymous], 2017, UNNECESSARY CARE CAN; Bass L, 2005, J INFUS MURS, V28, P15, DOI 10.1097/00129804-200501000-00002; Born KB, 2017, BMJ QUAL SAF, V26, P687, DOI 10.1136/bmjqs-2017-006595; Eisenberg MJ, 2011, CAN MED ASSOC J, V183, P430, DOI 10.1503/cmaj.100463; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Emergency Medicine, 2018, 10 THINGS PHYS PAT S; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Gozdzialski A, 2012, J EMERG NURS, V38, P293, DOI 10.1016/j.jen.2011.12.014; Hair H, 2017, CJEM, V19, pS71, DOI [10.1017/cem.2017.184, DOI 10.1017/CEM.2017.184]; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Jotterand F, 2016, MED HEALTH CARE PHIL, V19, P553, DOI 10.1007/s11019-016-9702-9; Lin MP, 2017, ACAD EMERG MED, V24, P668, DOI 10.1111/acem.13167; Maat HP, 2010, PATIENT EDUC COUNS, V80, P113, DOI 10.1016/j.pec.2009.09.030; Mansoor LE, 2003, ANN PHARMACOTHER, V37, P1003, DOI 10.1345/aph.1C449; Melnick Edward R, 2017, J Med Internet Res, V19, pe174, DOI 10.2196/jmir.7846; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Taylor DM, 2000, J ACCID EMERG MED, V17, P86	20	4	4	0	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	OCT 9	2019	11	10							e5877	10.7759/cureus.5877			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JC4VG	WOS:000489275400010	31763100	gold, Green Published			2022-02-06	
J	Dubuc, E; Gagnon-Roy, M; Couture, M; Bier, N; Giroux, S; Bottari, C				Dubuc, Erika; Gagnon-Roy, Mireille; Couture, Melanie; Bier, Nathalie; Giroux, Sylvain; Bottari, Carolina			Perceived needs and difficulties in meal preparation of people living with traumatic brain injury in a chronic phase: Supporting long-term services and interventions	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						activities of daily living; community access and participation; occupational therapy; qualitative research; traumatic brain injury	COGNITIVE REHABILITATION	Introduction Traumatic brain injury (TBI) is a chronic medical condition with life-long consequences. Meal preparation is one of the most significant activities impacted by TBI even after more than 10 years post-trauma. However, substantial gaps exist in our understanding of how exactly it is affected. This study examines the perceived needs and difficulties regarding meal preparation in individuals with severe TBI living in the community. This is done in an effort to justify long-term community-based interventions offered to the TBI population with regard to a task involving many safety issues. Methods The study used a descriptive qualitative design where five adults (28-50 years old) living with a severe TBI (9-37 years post-injury) were interviewed. Data analysis was completed using an inductive method. Results Participants living alone were all involved in meal preparation to diverse levels. Only two participants lived with a family member. Six categories of perceived needs were identified, of which two emerged as priorities: (i) Need for recipes to be compatible with cognitive abilities, knowledge and energy level to optimise motivation and (ii) Need to adapt complexity of grocery shopping to cognitive abilities and knowledge. The main difficulty expressed by participants was to manage their motivation to cook when tired, as it tends to diminish and fade when the person is exhausted. Conclusion Many situations were considered difficult for our participants, which calls for adaptation of the tasks and of their environment. Considering these unmet needs in the interventions offered will help individualise follow-up and ultimately optimise the social integration of individuals living with severe TBI.	[Dubuc, Erika; Gagnon-Roy, Mireille] Univ Montreal UdeM, Sch Rehabil, Montreal, PQ, Canada; [Dubuc, Erika; Gagnon-Roy, Mireille] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Couture, Melanie] Univ Network West Cent Montreal, Integrated Hlth & Social Serv, Ctr Res & Expertise Social Gerontol, Montreal, PQ, Canada; [Bier, Nathalie; Bottari, Carolina] UdeM, Sch Rehabil, 6363 Chemin Hudson, Montreal, PQ H2H 2N8, Canada; [Bier, Nathalie] Ctr Rech Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Bottari, Carolina] CRIR, Montreal, PQ, Canada; [Giroux, Sylvain] Univ Sherbrooke UdeS, Dept Comp Sci, DOMUS, Sherbrooke, PQ, Canada		Bottari, C (corresponding author), UdeM, Sch Rehabil, 6363 Chemin Hudson, Montreal, PQ H2H 2N8, Canada.; Bottari, C (corresponding author), CIUSSS Ctr Sud Ile de Montreal, Inst Univ Readaptat Deficience Phys Montreal, CRIR, 6363 Chemin Hudson, Montreal, PQ H2H 2N8, Canada.	carolina.bottari@umontreal.ca		Dubuc, Erika/0000-0001-8204-5090; Couture, Melanie/0000-0002-4919-573X	Fonds de la recherche du Quebec en sante (FRQS); Quebec Rehabilitation Research Network; Ministere de la Sant e et des Services sociaux; Association des etablissements de readaptation en deficience physique du Quebec; Association quebecoise des etablissements de sante et des services sociaux; Societe de l'assurance automobile du Quebec; PRogramme d'Excellence en Medecine pour l'Initiation En Recherche (PREMIER) from the School of Rehabilitation of UdeM	The research reported here was supported by an operating grant awarded to the authors by the Fonds de la recherche du Quebec en sante (FRQS), the Quebec Rehabilitation Research Network, the Ministere de la Sant e et des Services sociaux, the Association des etablissements de readaptation en deficience physique du Quebec, the Association quebecoise des etablissements de sante et des services sociaux the Societe de l'assurance automobile du Quebec and by the PRogramme d'Excellence en Medecine pour l'Initiation En Recherche (PREMIER) from the School of Rehabilitation of UdeM. NB is also supported by a salary ward from the FRQS. Parts of the results were presented at the 41st Annual Brain Impairment Conference presented by the Australasian Society for the Study of Brain Impairment (ASSBI), May 3-5, 2018, South Australia.	Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Balcazar F. E., 1998, CANADIAN J REHABILIT, V12, P105; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Boucher N., 2006, MILIEU VIE STIMULANT; Boyd H, 2017, STUD HEALTH TECHNOL, V242, P27, DOI 10.3233/978-1-61499-798-6-27; Brain Injury Australia, 2017, BRAIN INJURY AUSTR; Cannuscio CC, 2002, AM J PUBLIC HEALTH, V92, P1305, DOI 10.2105/AJPH.92.8.1305; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; De Loor P., 2016, 2 IET INT C TECHN AC; Dutil E., 2005, PROFIL AVQ; DUTIL E, 1996, REV QUEBECOISE ERGOT, V5, P112; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Giroux S., 2015, 2015 AAAI SPRING S S; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Gubrium JF, 1994, QUALITATIVE METHODS; Haji FA, 2016, MED EDUC, V50, P955, DOI 10.1111/medu.13086; Haskins E.C., 2012, COGNITIVE REHABILITA; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Levasseur M, 2016, DISABIL REHABIL-ASSI, V11, P636, DOI 10.3109/17483107.2015.1029536; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Miles M.B., 2013, QUALITATIVE DATA ANA; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Zilberstein S, 1996, AI MAG, V17, P73	35	4	4	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	DEC	2019	66	6					720	730		10.1111/1440-1630.12611		OCT 2019	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	KA3DQ	WOS:000489441300001	31591729	Green Submitted			2022-02-06	
J	Smith, WS; Keenan, KJ; Lovoi, PA				Smith, Wade S.; Keenan, Kevin J.; Lovoi, Paul A.			A Unique Signature of Cardiac-Induced Cranial Forces During Acute Large Vessel Stroke and Development of a Predictive Model	NEUROCRITICAL CARE			English	Article						Cranial accelerometry; Headpulse; Large vessel stroke		BackgroundCranial accelerometry is used to detect cerebral vasospasm and concussion. We explored this technique in a cohort of code stroke patients to see whether a signature could be identified to aid in the diagnosis of large vessel occlusion (LVO) stroke.MethodsA military-grade three-axis accelerometer was affixed to a headset. Accelerometer and electrocardiogram (ECG) outputs were digitized at 1.6 kHz. We call the resulting digitized signals the "headpulse." Three-minute recordings were performed immediately after computed tomography (CT) angiography (CTA) and/or immediately before and after attempted mechanical thrombectomy in patents with suspected stroke. The resulting waveforms were inspected by eye and then subjected to supervised machine learning (MATLAB Classification Learner R2018a) to train a model using fivefold cross-validation.ResultsOf 42 code stroke subjects with recordings, 19 (45%) had LVO and 23 (55%) had normal CTAs. In patients without LVO, ECG-triggered waveforms followed a self-similar time course revealing that the headpulse is highly coupled to the cardiac contraction. However, in most patients with LVO, headpulses showed little cardiac contraction correlation. We term this abnormality "chaos" and parameterized it with 156 measures of trace-by-trace variation from the ECG-signal-averaged mean for machine learning model training. Selecting the best model, using biometric data only, we properly classified 15/19 LVOs and 20/23 non-LVO patients, with receiver operating characteristic curve area=0.79, sensitivity of 73%, and specificity of 87%, P<0.0001. Headpulse waveforms following thrombectomy showed return of cardiac contraction correlation.ConclusionsHeadpulse recordings performed on patients with suspected acute stroke significantly identify those with LVO. The lack of temporal correlation of the headpulse with cardiac contraction and resolution to normal may reflect changes in cerebral blood flow and may provide a useful technique to triage stroke patients for thrombectomy using a noninvasive device.	[Smith, Wade S.; Keenan, Kevin J.; Lovoi, Paul A.] Univ Calif San Francisco, UCSF Dept Neurol, 505 Parnassus Ave,Room M-830, San Francisco, CA 94143 USA		Smith, WS (corresponding author), Univ Calif San Francisco, UCSF Dept Neurol, 505 Parnassus Ave,Room M-830, San Francisco, CA 94143 USA.	wade.smith@ucsf.edu	Keenan, Kevin/ABH-1397-2020	Keenan, Kevin/0000-0002-5643-9878	UCSF Department of Neurology sources; NIH StrokeNet FellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U24NS107229]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U24NS107229] Funding Source: NIH RePORTER	Funding was provided by internal UCSF Department of Neurology sources. Dr. Keenan was supported by NIH StrokeNet Fellowship: U24NS107229	AMES A, 1968, AM J PATHOL, V52, P437; Auerbach PS, 2015, CLIN J SPORT MED, V25, P126, DOI 10.1097/JSM.0000000000000117; Giovangrandi L, 2011, IEEE ENG MED BIO, P4279, DOI 10.1109/IEMBS.2011.6091062; Gordon J W, 1877, J Anat Physiol, V11, P533; Smith WS, 2015, NEUROCRIT CARE, V23, P364, DOI 10.1007/s12028-015-0118-9	5	4	4	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2020	33	1					58	63		10.1007/s12028-019-00845-x		OCT 2019	6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MX1ZO	WOS:000544052200001	31591693				2022-02-06	
J	Narad, ME; Treble-Barna, A; Zang, HY; Zhang, NH; Smith, J; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Narad, Megan E.; Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Smith, Julia; Yeates, Keith O.; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			Parenting Behaviors after Moderate - Severe Traumatic Injury in Early Childhood	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Parenting behavior; parenting behavior over time; Pediatric traumatic brain injury	BRAIN-INJURY; EXECUTIVE DYSFUNCTION; WARM RESPONSIVENESS; ATTENTION PROBLEMS; FAMILY ADAPTATION; INITIAL YEAR; OUTCOMES; CAREGIVER; CHILDREN; PATTERNS	Purpose: Examine the impact of traumatic brain injury (TBI) on parenting behavior over time. Method: Included 206 children (3-7 years old) with moderate to severe TBI or orthopedic injury, using a prospective longitudinal cohort study design. Assessments completed at baseline, 6-months, 12-months, 18-months, 3.5 years, and 6.8 years after injury. Dependent variables included authoritative, permissive, and authoritarian parenting. Results: Injury characteristics had limited impact on parenting behaviors over time. Levels of authoritative parenting remained stable over time; however, levels of warmth and involvement declined over time for those with TBI. Levels of permissive and authoritarian parenting declined for all participants by 3.5 years post injury. SES and stressors impacted parenting behaviors. Conclusions: While there was limited effect of TBI on parenting behavior over time, it remains unclear how individuals respond to these parenting behaviors years after injury. Clinicians should monitor family and parenting behaviors to foster an environment to promote positive recovery.	[Narad, Megan E.; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave MLC 3015, Cincinnati, OH 45229 USA; [Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Zang, Huaiyu] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Smith, Julia] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp Res Inst, Biobehav Hlth Ctr, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Stancin, Terry] Metrohlth Med Ctr, Div Pediat Psychol, Dept Pediat, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave MLC 3015, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020; Zang, Huaiyu/AAY-6603-2021	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32 HD088011, R01 HD042729] Funding Source: Medline		Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT, DOI 10.1037/t28248-000; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; Baumrind D., 1991, ENCY ADOLESCENCE, P746; Berk EL, 1998, DEV LIFESPAN; Bradley RH, 2001, CHILD DEV, V72, P1868, DOI 10.1111/1467-8624.t01-1-00383; Chapieski L, 2005, EPILEPSY BEHAV, V7, P246, DOI 10.1016/j.yebeh.2005.05.002; Clark TT, 2015, HEALTH PSYCHOL, V34, P697, DOI 10.1037/hea0000150; Cole M, 2005, CULTURE AND HUMAN DEVELOPMENT: THE IMPORTANCE OF CROSS-CULTURAL RESEARCH FOR THE SOCIAL SCIENCES, P50; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Glascoe FP, 2010, PEDIATRICS, V125, P313, DOI 10.1542/peds.2008-3129; Glasgow KL, 1997, CHILD DEV, V68, P507, DOI 10.2307/1131675; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hoff E., 2019, HDB PARENTING BIOL E, P231; Joseph M. V., 2008, GLOBAL ACAD SOC J SO, V1, P16; King TZ, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI [10.1017/S1355617711001792, DOI 10.1017/S1355617711001792]; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.1111/j.1467-8624.1991.tb01588.x; Luyckx K, 2011, J CLIN CHILD ADOLESC, V40, P468, DOI 10.1080/15374416.2011.563470; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; PAIKOFF RL, 1991, PSYCHOL BULL, V110, P47, DOI 10.1037/0033-2909.110.1.47; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Russell A, 1998, AUST J PSYCHOL, V50, P89, DOI 10.1080/00049539808257539; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Whaley SE, 1999, J CONSULT CLIN PSYCH, V67, P826, DOI 10.1037/0022-006X.67.6.826; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zhou Q, 2002, CHILD DEV, V73, P893, DOI 10.1111/1467-8624.00446	51	4	4	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	OCT 3	2019	22	7					437	444		10.1080/17518423.2018.1518350			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	IT5XO	WOS:000482942200001	30235048	Green Accepted			2022-02-06	
J	Chong, CD; Wang, LJ; Wang, K; Traub, S; Li, J				Chong, Catherine D.; Wang, Lujia; Wang, Kun; Traub, Stephen; Li, Jing			Homotopic region connectivity during concussion recovery: A longitudinal fMRI study	PLOS ONE			English	Article							INTERHEMISPHERIC FUNCTIONAL CONNECTIVITY; TRAUMATIC BRAIN-INJURY; NETWORK; CHARACTERIZE; RELIABILITY; MIGRAINEURS; RESPONSES; SYMPTOMS; VALIDITY; CORTEX	Objectives To (i) investigate alterations in homotopic functional connectivity (hfc) in concussed patients relative to healthy controls (HC) and to (ii) interrogate whether hfc in concussed patients normalized during the recovery process. The relationship between symptom recovery and change in hfc was assessed using post-hoc analyses. Methods This study included 15 concussed patients (mean age = 39.1, SD = 10.1; sex: 13 females, 2 males) and 15 HC (mean age = 39.1, SD = 11.7; sex: 13 females, 2 males). Hfc patterns were interrogated using resting-state magnetic resonance imaging (rs-MRI) for 29 a priori selected pain-processing regions. Concussed patients underwent imaging at two timepoints; at 1-month post-concussion (mean time following concussion: 28 days, SD = 9.5) and again at 5-months post-concussion (mean time following concussion: 121 days, SD = 13). At both time-points, symptoms associated with concussion were assessed using the Sports Concussion Assessment Tool (SCAT-3). Results Concussed patients had significantly weaker hfc in the following six regions 1-month post-concussion compared to HC: middle cingulate, posterior insula, middle occipital, spinal trigeminal nucleus, precentral and the pulvinar. There were no regions of significantly stronger hfc in concussed patients relative to HC. Longitudinally, patients showed significant symptom recovery 5-months post-concussion and had significant strengthening of hfc patterns in seven homotopic ROIs: middle cingulate, posterior insula, middle occipital, secondary somatosensory area, spinal trigeminal nucleus, precentral, and the pulvinar. Post-hoc analyses indicated a significant negative correlation between somatosensory functional connectivity strengthening and symptom severity. Conclusion At 1-month post-concussion, patients had significantly weaker hfc in a number of pain-processing regions relative to HC. However, over a period of 5-months, region-pair connectivity showed significant recovery and normalization. Those patients with more successful symptom recovery at 5-months post-concussion had more functional somatosensory strengthening, suggesting an association between functional strengthening and post-concussion symptom recovery.	[Chong, Catherine D.; Traub, Stephen] Mayo Clin Arizona, Phoenix, AZ 85054 USA; [Wang, Lujia; Wang, Kun; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA		Chong, CD (corresponding author), Mayo Clin Arizona, Phoenix, AZ 85054 USA.	Chong.Catherine@mayo.edu		Wang, Lujia/0000-0002-0475-004X; chong, catherine/0000-0002-9035-8748	Mayo Clinic and Arizona State University Alliance for Health Care Collaborative Research Seed Grant Program	CC and JL received funding to support this study from the Mayo Clinic and Arizona State University Alliance for Health Care Collaborative Research Seed Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LW, KW, and ST received no specific funding for this work.	[Anonymous], 2013, Br J Sports Med, V47, P259; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chong CD, 2016, CEPHALALGIA, DOI 10.1177/0333102416652091; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Heine J, 2018, J NEUROL NEUROSUR PS, V89, P1191, DOI 10.1136/jnnp-2017-317780; Hu LS, 2017, NEURO-ONCOLOGY, V19, P128, DOI 10.1093/neuonc/now135; Huang S, 2012, IIE TRANS, V44, P915, DOI 10.1080/0740817X.2011.649390; Ikpotokin O, 2013, INT J SCI ENG RES, V4, P1695; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lang X, 2016, CHINESE MED J-PEKING, V129, P2422, DOI 10.4103/0366-6999.191758; Maleki N, 2015, PAIN, V156, P1232, DOI 10.1097/j.pain.0000000000000159; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Munivenkatappa A, 2013, J PEDIATR NEUROSCI, V8, P183, DOI 10.4103/1817-1745.123659; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Qi RF, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00141; Robinson GK, BLUP IS GOOD THING E; Shen K, 2015, P NATL ACAD SCI USA, V112, P6473, DOI 10.1073/pnas.1503436112; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Tang CZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152875; Timmermann L, 2001, J NEUROPHYSIOL, V86, P1499, DOI 10.1152/jn.2001.86.3.1499; Torquati K, 2002, NEUROREPORT, V13, P813, DOI 10.1097/00001756-200205070-00016; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wei PX, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00366; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Youssef AM, 2017, HUM BRAIN MAPP, V38, P4078, DOI 10.1002/hbm.23649; Zhang JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17069-8; Zhou FQ, 2018, NEUROPSYCH DIS TREAT, V14, P1229, DOI 10.2147/NDT.S162325; Zhu YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27477	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0221892	10.1371/journal.pone.0221892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	WOS:000532388000005	31577811	gold, Green Published			2022-02-06	
J	Jordan, MC; Brems, AC; Heintel, T; Jansen, H; Hoelscher-Doht, S; Meffert, RH				Jordan, Martin C.; Brems, Anna-Christina; Heintel, Timo; Jansen, Hendrik; Hoelscher-Doht, Stefanie; Meffert, Rainer H.			The Anterior Subcutaneous Pelvic Ring Fixator No Biomechanical Advantages Compared with External Fixation	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							INTERNAL FIXATOR; FRACTURE; INFIX; COMPLICATIONS; DISRUPTIONS; REDUCTION; INJURIES; PROVIDE; SCREWS	Background: Subcutaneous fixation of the anterior pelvic ring is an emerging surgical technique for trauma patients. The aim of this study was to biomechanically evaluate 2 internal fixation devices for stabilizing a disrupted pelvic ring and compare them with traditional external fixation. Methods: Thirty-six synthetic pelvises with a simulated unstable ring fracture (anteroposterior compression type III) were divided into 3 groups. Group A underwent fixation with a supra-acetabular external fixator; group B, with an internal fixator using the USS II polyaxial system; and group C, with an internal fixator using the Click'X polyaxial system. Biomechanical testing included measurement of peak-to-peak displacement at 300, 400, and 500 N; total displacement; plastic deformation; stiffness; and fracture-line displacement. Results: Statistical analysis of all measured parameters revealed no significant differences among the groups. However, vertical displacement of the preshaped connecting rod within the screw heads occurred as a result of inadequate stability of the internal fixation at the rod-screw interface. Conclusions: Although internal fixator devices are placed close to the bone and should therefore maintain greater stiffness, our data did not support the hypothesis of superior stability. Special attention is required when using a curved connecting rod as the rod is easily displaced, placing relevant anatomical structures at risk. These devices require further refinement to avoid potential patient injury.	[Jordan, Martin C.; Brems, Anna-Christina; Heintel, Timo; Jansen, Hendrik; Hoelscher-Doht, Stefanie; Meffert, Rainer H.] Univ Hosp Wurzburg, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Wurzburg, Germany		Jordan, MC (corresponding author), Univ Hosp Wurzburg, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Wurzburg, Germany.	Jordan_M@ukw.de	Holscher-Doht, Stefanie/AAJ-3428-2020				Alton TB, 2014, CLIN ORTHOP RELAT R, V472, P2338, DOI 10.1007/s11999-014-3693-8; Apivatthakakul T, 2016, INJURY, V47, P2077, DOI 10.1016/j.injury.2016.08.006; Burkhardt M, 2005, UNFALLCHIRURG, V108, P812, DOI 10.1007/s00113-005-0997-x; Dahill M, 2017, BONE JOINT J, V99B, P1232, DOI 10.1302/0301-620X.99B9.BJJ-2016-1025.R2; Damm P, 2017, J BIOMECH, V51, P128, DOI 10.1016/j.jbiomech.2016.11.060; Eagan M, 2015, INJURY, V46, P996, DOI 10.1016/j.injury.2015.01.040; Fang C, 2017, INT ORTHOP, V41, P1785, DOI 10.1007/s00264-017-3415-4; Gardner MJ, 2012, J ORTHOP TRAUMA, V26, P314, DOI 10.1097/BOT.0b013e318220bb22; Hesse D, 2015, J ORTHOP TRAUMA, V29, P138, DOI 10.1097/BOT.0000000000000193; Hiesterman TG, 2012, CLIN ORTHOP RELAT R, V470, P2116, DOI 10.1007/s11999-012-2341-4; Hoskins W, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0468-9; Kuttner M, 2009, UNFALLCHIRURG, V112, P661, DOI 10.1007/s00113-009-1623-0; McDonald C, 2017, ORTHOPEDICS, V40, pE959, DOI 10.3928/01477447-20170918-02; Mcdonald E, 2015, EUR J TRAUMA EMERG S, V41, P665, DOI 10.1007/s00068-014-0482-8; Moazzam C, 2012, J ORTHOP TRAUMA, V26, P263, DOI 10.1097/BOT.0b013e31823e6b82; Muller FJ, 2013, INT ORTHOP, V37, P2239, DOI 10.1007/s00264-013-2032-0; Nuber S, 2019, UNFALLCHIRURG; Ochenjele G, 2018, J ORTHOP TRAUMA, V32, pE245, DOI 10.1097/BOT.0000000000001170; Osterhoff G, 2017, INJURY, V48, P2162, DOI 10.1016/j.injury.2017.08.047; Osterhoff G, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-111; Papathanasopoulos A, 2010, INJURY, V41, P1220, DOI 10.1016/j.injury.2010.10.001; POHLEMANN T, 1994, CLIN ORTHOP RELAT R, P69; Reichel LM, 2018, INJURY, V49, P309, DOI 10.1016/j.injury.2017.12.009; Shetty Ajoy Prasad, 2017, J Clin Orthop Trauma, V8, P241, DOI 10.1016/j.jcot.2017.05.009; Smith A, 2017, J ORTHOP SURG, V25, P1; Stuby FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184000; Vaidya R, 2013, CLIN ANAT, V26, P392, DOI 10.1002/ca.22149; Vaidya R, 2018, J ORTHOP TRAUMA, V32, pS24, DOI 10.1097/BOT.0000000000001248; Vaidya R, 2017, J ORTHOP TRAUMA, V31, P252, DOI 10.1097/BOT.0000000000000781; Vaidya R, 2012, CLIN ORTHOP RELAT R, V470, P2124, DOI 10.1007/s11999-011-2233-z; Vaidya R, 2012, J ORTHOP TRAUMA, V26, P1, DOI 10.1097/BOT.0b013e318233b8a7; Verbeek DO, 2018, J BONE JOINT SURG AM, V100, P1704, DOI 10.2106/JBJS.17.01289; Vigdorchik JM, 2013, INT ORTHOP, V37, P1341, DOI 10.1007/s00264-013-1890-9; Vigdorchik JM, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-31; Wu Xiao-Tian, 2017, Zhongguo Gu Shang, V30, P208, DOI 10.3969/j.issn.1003-0034.2017.03.004; Yinger K, 2003, J ORTHOP TRAUMA, V17, P481, DOI 10.1097/00005131-200308000-00002; YOUNG JWR, 1986, RADIOLOGY, V160, P445, DOI 10.1148/radiology.160.2.3726125; Yu BS, 2010, EUR SPINE J, V19, P1121, DOI 10.1007/s00586-010-1343-8	38	4	4	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	OCT 2	2019	101	19					1724	1731		10.2106/JBJS.18.01363			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	KG0ZI	WOS:000509670500007	31577677				2022-02-06	
J	Bogner, J; Hade, EM; Peng, J; Beaulieu, CL; Horn, SD; Corrigan, JD; Hammond, FM; Dijkers, MP; Montgomery, E; Gilchrist, K; Giuffrida, C; Lash, A; Timpson, M				Bogner, Jennifer; Hade, Erinn M.; Peng, Juan; Beaulieu, Cynthia L.; Horn, Susan D.; Corrigan, John D.; Hammond, Flora M.; Dijkers, Marcel P.; Montgomery, Erin; Gilchrist, Kamie; Giuffrida, Clare; Lash, Aubrey; Timpson, Misti			Family Involvement in Traumatic Brain Injury LO!) Inpatient Rehabilitation: A Propensity Score Analysis of Effects on Outcomes During the First Year After Discharge	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	4th Federal Interagency Conference on Traumatic Brain Injury (TBI)	JUN 11-13, 2018	Washington, DC				PARTICIPATION ASSESSMENT; SATISFACTION; DISABILITY; PREDICTORS; VALIDITY; IMPACT	Objective: To evaluate the effect of family attendance at inpatient rehabilitation therapy sessions on traumatic brain injury (TBI) patient outcomes at discharge and up to 9 months postdischarge. Design: Propensity score methods are applied to the TBI Practice-Based Evidence database, a database consisting of multisite, prospective, longitudinal, and observational data. Setting: Nine inpatient rehabilitation centers in the United States. Participants: Patients (N=1835) admitted for first inpatient rehabilitation after an index TBI. Intervention: Family attendance during therapy sessions. Main Outcome Measures: Participation Assessment for Recombined Tools-Objective-17 (Total scores and subdomain scores of Productivity, Out and About, and Social Relations), Functional Independence Measure, Satisfaction with Life Scale, and Patient Health Questionnaire-9. Results: Participants whose families were in attendance for at least 10% of the treatment time were more out and about in their communities at 3 and 9 months postdischarge than participants whose families attended treatment less than 10% of the time. Although findings varied by propensity score method, improved functional independence in the cognitive area at 9 months was also associated with increased family attendance. Conclusions: Family involvement during inpatient rehabilitation may improve community participation and cognitive functioning up to 9 months after discharge. Rehabilitation teams should engage patients' families in the rehabilitation process to maximize outcomes. (C) 2019 by the American Congress of Rehabilitation Medicine	[Bogner, Jennifer; Hade, Erinn M.; Peng, Juan; Beaulieu, Cynthia L.; Corrigan, John D.; Montgomery, Erin] Ohio State Univ, Coll Med, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Horn, Susan D.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Dijkers, Marcel P.] Wayne State Univ, Detroit, MI USA; [Gilchrist, Kamie] Intermt Med Ctr, Murray, UT USA; [Giuffrida, Clare] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Lash, Aubrey] Cleveland VA Med Ctr, Cleveland, OH USA; [Timpson, Misti] Rocky Mt Univ Hlth Profess, Provo, UT USA		Bogner, J (corresponding author), Ohio State Univ, Coll Med, 480 Med Ctr Dr, Columbus, OH 43210 USA.	bogner.1@osu.edu		Corrigan, John/0000-0002-7591-5622	Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CER-1403-13476]; National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]	Supported by the Patient-Centered Outcomes Research Institute (PCORI) (award no. CER-1403-13476). The statements presented in this work are solely the responsibility of the author(s) and do not necessarily represent the views of PCORI, its Board of Governors, or Methodology Committee. Funding for the databases used in this study came front the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96; Bogner J, 2019, ARCH PHYS MED REHAB, V100, P1810, DOI 10.1016/j.apmr.2018.12.037; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher A, 2019, DISABIL REHABIL, V41, P854, DOI 10.1080/09638288.2017.1407966; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leung J, 2018, BRAIN INJURY, V32, P915, DOI 10.1080/02699052.2018.1469046; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; McElroy E, 2014, AAP ANN M 2014 AAP A; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Riley GA, 2015, BRAIN INJURY, V29, P804, DOI 10.3109/02699052.2015.1004754; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	36	4	4	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1801	1809		10.1016/j.apmr.2019.04.008			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000001	31077646	Green Submitted			2022-02-06	
J	Bogner, J; Dijkers, M; Hade, EM; Beaulieu, C; Montgomery, E; Giuffrida, C; Timpson, M; Peng, J; Gilchrist, K; Lash, A; Hammond, FM; Horn, SD; Corrigan, JD				Bogner, Jennifer; Dijkers, Marcel; Hade, Erinn M.; Beaulieu, Cynthia; Montgomery, Erin; Giuffrida, Clare; Timpson, Misti; Peng, Juan; Gilchrist, Kamie; Lash, Aubrey; Hammond, Flora M.; Horn, Susan D.; Corrigan, John D.			Contextualized Treatment in Traumatic Brain Injury Inpatient Rehabilitation: Effects on Outcomes During the First Year After Discharge	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; PARTICIPATION ASSESSMENT; CHILDREN; VALIDITY; MODEL	Objective: To evaluate the effect of providing a greater percentage of therapy as contextualized treatment on acute traumatic brain injury (TBI) rehabilitation outcomes. Design: Propensity score methods are applied to the TBI Practice-Based Evidence (TBI-PBE) database, a database consisting of multi-site, prospective, longitudinal observational data. Setting: Acute inpatient rehabilitation. Participants: Patients enrolled in the TBI-PBE study (N=1843), aged 14 years or older, who sustained a severe, moderate, or complicated mild TBI, received their first inpatient rehabilitation facility admission in the US, and consented to follow-up 3 and 9 months post discharge from inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Participation Assessment with Recombined Tools-Objective (PART-O)-17, FIM Motor and Cognitive scores, Satisfaction with Life Scale, and Patient Health Questionnaire-9. Results: Increasing the percentage of contextualized treatment during inpatient TBI rehabilitation leads to better outcomes, specifically in regard to community participation. Conclusions: Increasing the proportion of treatment provided in the context of real-life activities appears to have a beneficial effect on outcome. Although the effect sizes are small, the results are consistent with other studies supporting functional-based interventions effecting better outcomes. Furthermore, any positive findings, regardless of size or strength, are endorsed as important by consumers (survivors of TBI). While the findings do not imply that decontextualized treatment should not be used, when the therapy goal can be addressed with either approach, the findings suggest that better outcomes may result if the contextualized approach is used. (C) 2019 by the American Congress of Rehabilitation Medicine	[Bogner, Jennifer; Hade, Erinn M.; Montgomery, Erin; Peng, Juan; Corrigan, John D.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Dijkers, Marcel] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Dijkers, Marcel] Wayne State Univ, Detroit, MI USA; [Beaulieu, Cynthia] Brooks Rehabil Hosp, Jacksonville, FL USA; [Giuffrida, Clare] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Timpson, Misti] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Gilchrist, Kamie] Intermt Med Ctr, Murray, UT USA; [Lash, Aubrey] Cleveland VA Med Ctr, Cleveland, OH USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Horn, Susan D.] Univ Utah, Sch Med, Salt Lake City, UT USA		Bogner, J (corresponding author), 480 Med Ctr Dr, Columbus, OH 43210 USA.	bogner.1@osu.edu			Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1403-13476]; National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability, Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]	Supported by Patient-Centered Outcomes Research Institute (award no. CER-1403-13476). The statements presented in this work are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors or Methodology Committee. Funding for the databases used in this study came from the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability, Independent Living and Rehabilitation Research (grant H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bode RK, 2004, STROKE, V35, P2537, DOI 10.1161/01.STR.0000145200.02380.a3; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Gillam SL, 2012, LANG SPEECH HEAR SER, V43, P276, DOI 10.1044/0161-1461(2011/11-0022); GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Institute of Medicine, 2011, COGN REH THER TRAUM; Koole H, 2015, LANG SPEECH HEAR SER, V46, P352, DOI 10.1044/2015_LSHSS-14-0109; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Naimi AI, 2014, EPIDEMIOLOGY, V25, P292, DOI 10.1097/EDE.0000000000000053; O'Neill B, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000358; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Trevena-Peters J, 2018, NEUROPSYCHOL REHABIL, P1; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	28	4	4	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1810	1817		10.1016/j.apmr.2018.12.037			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000002	30716280	Green Submitted			2022-02-06	
J	Bryant, BR; Narapareddy, BR; Bray, MJC; Richey, LN; Krieg, A; Shan, G; Peters, ME; Bernick, CB				Bryant, Barry R.; Narapareddy, Bharat R.; Bray, Michael J. C.; Richey, Lisa N.; Krieg, Akshay; Shan, Guogen; Peters, Matthew E.; Bernick, Charles B.			The effect of age of first exposure to competitive fighting on cognitive and other neuropsychiatric symptoms and brain volume	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Neuropsychiatry; CTE; TBI; depression; impulsivity; fighters	CHRONIC TRAUMATIC ENCEPHALOPATHY; EDUCATION; VALIDITY; INJURY; SPORTS	It has long been established that fighting sports such as boxing and mixed martial arts can lead to head injury. Prior work from this group on the Professional Fighters Brain Health Study found that exposure to repetitive head impacts is associated with lower brain volumes and decreased processing speed in fighters. Current and previously licensed professional fighters were recruited, divided into active and retired cohorts, and matched with a control group that had no prior experience in sports with likely head trauma. This study examined the relationship between age of first exposure (AFE) to fighting sports and brain structure (MRI regional volume), cognitive performance (CNS Vital Signs, iComet C3), and clinical neuropsychiatric symptoms (PHQ-9, Barratt Impulsiveness Scale). Brain MRI data showed significant correlations between earlier AFE and smaller bilateral hippocampal and posterior corpus callosum volumes for both retired and active fighters. Earlier AFE in active fighters was correlated with decreased processing speed and decreased psychomotor speed. Retired fighters showed a correlation between earlier AFE and higher measures of depression and impulsivity. Overall, the results help to inform clinicians, governing bodies, parents, and athletes of the risks associated with beginning to compete in fighting sports at a young age.	[Bryant, Barry R.; Narapareddy, Bharat R.; Bray, Michael J. C.; Richey, Lisa N.; Krieg, Akshay; Peters, Matthew E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Shan, Guogen] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Bernick, Charles B.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 West Bonneville Ave, Las Vegas, NV 89106 USA		Bernick, CB (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 West Bonneville Ave, Las Vegas, NV 89106 USA.	Bernicc@ccf.org	Bray, Michael Johnathan Charles/AAL-8925-2020	Bray, Michael Johnathan Charles/0000-0003-4650-1313; Bryant, Barry/0000-0002-3627-7824; Krieg, Akshay/0000-0002-8281-5582; Richey, Lisa/0000-0001-8050-1240	Lincy Foundation; UFC; Bellator/Spike TV; Haymon Boxing; Top Rank Promotions; UCLA Dream Fund	The PFBHS receives funding from the Lincy Foundation, UFC, Bellator/Spike TV, Haymon Boxing, Top Rank Promotions, and the UCLA Dream Fund.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; [Anonymous], 2018, SAS 2018 VERSION 9 4; [Anonymous], 2013, FREESURFER VERSION 5; Banks SJ, 2014, ARCH CLIN NEUROPSYCH, V29, P54, DOI 10.1093/arclin/act079; Bedendo A, 2015, REV BRAS PSIQUIATR, V37, P99, DOI 10.1590/1516-4446-2014-1389; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Borges A, 2017, INT J SPORTS PHYS TH, V12, P381; Deng-Bryant Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00699; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Kim GE, 2020, J GERONTOL A-BIOL, V75, P1502, DOI 10.1093/gerona/glz183; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee BG, 2018, J NEUROTRAUM, V35, P2015, DOI 10.1089/neu.2017.5558; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mu J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00217; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	28	4	4	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		89	95		10.1080/09540261.2019.1665501		OCT 2019	7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000489450200001	31587599				2022-02-06	
J	Chapman, S; Beschin, N; Cosentino, S; Elkind, MSV; Della Sala, S; Cocchini, G				Chapman, Silvia; Beschin, Nicoletta; Cosentino, Stephanie; Elkind, Mitchell S., V; Della Sala, Sergio; Cocchini, Gianna			Anosognosia for Prospective and Retrospective Memory Deficits: Assessment and Theoretical Considerations	NEUROPSYCHOLOGY			English	Article						anosognosia; memory; assessment; acquired brain injury; unawareness	TRAUMATIC BRAIN-INJURY; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; NORMATIVE DATA; QUESTIONNAIRE PRMQ; LATENT STRUCTURE; AWARENESS; DEMENTIA; IMPAIRMENT; REHABILITATION	Objective: Patients who suffer from memory loss after an Acquired Brain Injury (ABI) may also suffer from anosognosia, or unawareness of their memory loss. How we define and measure anosognosia can have critical implications for its study and clinical assessment. Commonly used measures often lack standardization and reliability checks for responses. Moreover, these methods rely heavily on cognitive abilities (e.g., language abilities) that are often affected after brain injury. The aim of this study is to elucidate how to best conceptualize and detect anosognosia for memory loss by introducing a new method of assessment, the Visual-Analogue Test for Anosognosia for memory impairment (VATAmem). Method: A total of 51 patients (M = 61 years, M = 13 years of education) with memory difficulties after ABI were recruited from outpatient clinics. A total of 73 informants were also recruited (M = 51 years old, M = 13 years of education). Both patients and informants evaluated the severity of patients' everyday memory mistakes on the VATAmem, for prospective and retrospective memory deficits by using visual analogue scales, vignettes, and check questions to ensure reliability. Results and Conclusion: A total of 30% of the patients were deemed unaware of their memory deficits. Patients were less aware of their prospective (29%) than their retrospective memory difficulties (18%). The new method of assessment provided by the VATAmem reduced possible false positives and enhanced reliability. We conclude that careful consideration of methodology is a key step to interpreting anosognosia findings within a theoretical framework.	[Chapman, Silvia; Cocchini, Gianna] Goldsmiths Univ London, Dept Psychol, London SE14 6NW, England; [Chapman, Silvia; Cosentino, Stephanie] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Gertrude H Sergievsky Ctr, Cognit Neurosci Sect, New York, NY 10027 USA; [Chapman, Silvia; Cosentino, Stephanie; Elkind, Mitchell S., V] Columbia Univ, Vagelos Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA; [Beschin, Nicoletta] Gallarate Hosp, Rehabil Dept, Gallarate, Italy; [Elkind, Mitchell S., V] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Della Sala, Sergio] Univ Edinburgh, Human Cognit Neurosci Psychol, Edinburgh, Midlothian, Scotland		Cocchini, G (corresponding author), Goldsmiths Univ London, Dept Psychol, London SE14 6NW, England.	g.cocchini@gold.ac.uk	CHAPMAN, SILVIA/AAU-4316-2020	CHAPMAN, SILVIA/0000-0002-4508-4557; Cocchini, Gianna/0000-0002-4789-9661			Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Ansell EL, 2006, NEUROPSYCHOLOGIA, V44, P1095, DOI 10.1016/j.neuropsychologia.2005.10.019; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; Clare L, 2002, NEUROPSYCHOL REHABIL, V12, P341, DOI 10.1080/09602010244000129; Clare L, 2012, AGING MENT HEALTH, V16, P566, DOI 10.1080/13607863.2011.652594; Cocchini G, 2002, NEUROPSYCHOLOGIA, V40, P2030, DOI 10.1016/S0028-3932(02)00054-4; Cocchini G., 2010, STUDY ANOSOGNOSIA, P123; Cocchini G, 2012, ACTA NEUROPSYCHOL, V10, P419, DOI 10.5604/17307503.1023693; Cocchini G, 2010, CLIN NEUROPSYCHOL, V24, P1379, DOI 10.1080/13854046.2010.524167; Corsi P. M., 1972, THESIS MCGILL U MONT; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; Cosentino S, 2007, CORTEX, V43, P1004, DOI 10.1016/S0010-9452(08)70697-X; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Cubelli R, 2017, CORTEX, V92, P320, DOI 10.1016/j.cortex.2017.03.021; Della Sala S, 1999, NEUROPSYCHOLOGIA, V37, P1189, DOI 10.1016/S0028-3932(98)00159-6; Della Sala S, 2009, CLIN NEUROPSYCHOL, V23, P406, DOI 10.1080/13854040802251393; Einstein G.O., 2008, LEARNING MEMORY COMP, P867; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotopoulou A, 2014, J NEUROPSYCHOL, V8, P1, DOI 10.1111/jnp.12010; Gainotti G, 2018, CONSCIOUS COGN, V58, P44, DOI 10.1016/j.concog.2017.10.010; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; Humphreys GW, 2012, BCOS BRAIN BEHAV ANA; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; LOPEZ OL, 1994, EUR NEUROL, V34, P277, DOI 10.1159/000117056; Mantyla T, 2003, MEM COGNITION, V31, P15, DOI 10.3758/BF03196078; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; Marsh RL, 2006, PSYCHOL LEARN MOTIV, V46, P115, DOI 10.1016/S0079-7421(06)46004-7; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MICHON A, 1994, J NEUROL NEUROSUR PS, V57, P805, DOI 10.1136/jnnp.57.7.805; Mograbi DC, 2018, CORTEX, V103, P385, DOI 10.1016/j.cortex.2018.04.001; Mograbi DC, 2009, CONSCIOUS COGN, V18, P989, DOI 10.1016/j.concog.2009.07.005; Nyenhuis DL, 1997, CLIN NEUROPSYCHOL, V11, P407, DOI 10.1080/13854049708400470; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Prigatano, 2010, STUDY ANOSOGNOSIA, P229; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRIGATANO GP, 1991, AWARENESS DEFICITS B; Randolph C., 2012, REPEATABLE BATTERY A; REED BR, 1993, J CLIN EXP NEUROPSYC, V15, P231, DOI 10.1080/01688639308402560; Reitan R, 1985, HALSTEAD REITAN NEUR; Rosen HJ, 2014, NEUROPSYCHOLOGY, V28, P436, DOI 10.1037/neu0000012; Rosen HJ, 2011, NEUROCASE, V17, P231, DOI 10.1080/13554794.2010.522588; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Starkstein SE, 1996, J NEUROL NEUROSUR PS, V61, P485, DOI 10.1136/jnnp.61.5.485; Starkstein SE, 2012, HAND CLINIC, V106, P53, DOI 10.1016/B978-0-444-52002-9.00004-8; Turnbull O. H., 2002, NEUROPSYCHANALYSIS, V4, P69, DOI 10.1080/15294145.2002.10773381; Underwood AG, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00668; Vogel A, 2005, INT J GERIATR PSYCH, V20, P238, DOI 10.1002/gps.1272; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Weinstein E.A., 1991, AWARENESS DEFICIT BR, P240; Wilkins A. J., 1978, PRACTICAL ASPECTS ME, P27; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; Wilson BA, 2003, RIVERMEAD BEHAV MEMO	64	4	6	1	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2019	33	7					1020	1031		10.1037/neu0000568			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JA7EA	WOS:000488003100011	31219295	Green Accepted, Green Submitted			2022-02-06	
J	Emami, P; Czorlich, P; Fritzsche, FS; Westphal, M; Rueger, JM; Lefering, R; Hoffmann, M				Emami, Pedram; Czorlich, Patrick; Fritzsche, Friederike S.; Westphal, Manfred; Rueger, Johannes M.; Lefering, Rolf; Hoffmann, Michael		DGU	Observed versus expected mortality in pediatric patients intubated in the field with Glasgow Coma Scale scores < 9	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Glasgow Coma Scale; Intubation; Pediatric; Prehospital; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; PREHOSPITAL INTUBATION; AIRWAY MANAGEMENT; VENTILATION; OUTCOMES; INTERVENTIONS	Purpose A Glasgow Coma Scale (GCS) score of 8 or less in patients suffering from severe traumatic brain injury (TBI) represents a decision-making marker in terms of intubation. This study evaluated the impact of prehospital intubation on the mortality of these TBI cases among different age groups. Methods This study included the data from patients predominantly suffering from severe TBI [Abbreviated Injury Scale (AIS) of the head >= 3, GCS score < 9, Injury Severity Score (ISS) > 9] who were registered in TraumaRegister DGU from 2002 to 2013. An age-related analysis of five subgroups was performed (1-6, 7-15, 16-55, 56-79, and >= 80 years old). The observed and expected mortality were matched according to the Revised Injury Severity Classification, version II. Results A total of 21,242 patients were included. More often, the intubated patients were severely injured when compared to the non-intubated patients (median ISS 29, IQR 22-41 vs. 24, IQR 16-29, respectively), with an associated higher mortality (42.2% vs. 30.0%, respectively). When compared to the calculated expected mortality, the observed mortality was significantly higher among the intubated patients within the youngest subgroup (42.2% vs. 33.4%, respectively; p = 0.03). Conclusions The observed mortality in the intubated children 1-6 years old suffering from severe TBI seemed to be higher than expected. Whether or not a GCS score of 8 or less is the only reliable criterion for intubation in this age group should be investigated in further trials.	[Emami, Pedram; Czorlich, Patrick; Fritzsche, Friederike S.; Westphal, Manfred] Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany; [Rueger, Johannes M.; Hoffmann, Michael] Univ Med Ctr Hamburg Eppendorf UKE, Dept Trauma Hand & Reconstruct Surg, Martinistr 52, D-20246 Hamburg, Germany; [Lefering, Rolf] Witten Herdecke Univ, Inst Res Operat Med IFOM, Ostmerheimerstr 200, D-51109 Cologne, Germany		Emami, P (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	p.emami@uke.de	Czorlich, Patrick/H-8934-2019				Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bieler D, 2017, INJURY, V48, P32, DOI 10.1016/j.injury.2016.08.015; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, CAN MED ASSOC J, V178, P1171, DOI 10.1503/cmaj.080234; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Haltmeier T, 2017, EUR J TRAUMA EMERG S, V43, P731, DOI 10.1007/s00068-016-0718-x; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Hoffmann M, 2017, J NEUROSURG ANESTH, V29, P161, DOI 10.1097/ANA.0000000000000275; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; Maegele M, 2015, CHIN J TRAUMATOL, V18, P125, DOI 10.1016/j.cjtee.2015.07.005; POINTER JE, 1989, AM J EMERG MED, V7, P364, DOI 10.1016/0735-6757(89)90039-9; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Sokol KK, 2015, J TRAUMA ACUTE CARE, V79, P983, DOI 10.1097/TA.0000000000000706; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	25	4	4	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2019	45	5					769	776		10.1007/s00068-018-01065-2			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JD5FT	WOS:000490009600002	30631886				2022-02-06	
J	Gil-Pages, M; Sanchez-Carrion, R; Tormos, JM; Ensenat-Cantallops, A; Garcia-Molina, A				Gil-Pages, Macarena; Sanchez-Carrion, Rocio; Tormos, Jose M.; Ensenat-Cantallops, Antonia; Garcia-Molina, Alberto			A Positive Relationship between Cognitive Reserve and Cognitive Function after Stroke: Dynamic Proxies Correlate Better than Static Proxies	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Daily living; Self-assessment; Prognosis; Cognition; Neuropsychological tests	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; NORMATIVE DATA; EDUCATION; OCCUPATION; LIFE; PARTICIPATION; IMPAIRMENT; PATHOLOGY; DEMENTIA	Objectives: How brain damage after stroke is related to specific clinical manifestation and recovery is incompletely understood. We studied cognitive reserve (CR) in stroke patients by two types of measurements: (i) objectively verifiable static proxies (i.e., education, occupational attainment), and (ii) subjective, dynamic proxies based on patient testimony in response to a questionnaire. We hypothesized that one or both of these types of CR measurements might correlate positively with patient cognitive performance during the post-acute and chronic phases of recovery. Method: Thirty-four stroke patients underwent neuropsychological assessment at 2, 6 and 24 months after stroke onset. In chronic stage at 24+ months, self-rating assessments of cognitive performance in daily life and social integration were obtained. CR before and after stroke was estimated using static proxies and dynamic proxies were obtained using the Cognitive Reserve Scale (CRS-Pre-stroke, CRS-Post-stroke). Results: CRS-Pre-stroke and CRS-Post-stroke showed significant mean differences. Dynamic proxies showed positive correlation with self-assessment of attention, metacognition, and functional ability in chronic stage. In contrast, significant correlations between static proxies and cognitive recovery were not found. Conclusions: Dynamic proxies of CR were positively correlated with patients' perception of their functional abilities in daily life. To best guide cognitive prognosis and treatment, we propose that dynamic proxies of CR should be included in neuropsychological assessments of patients with brain damage.	[Gil-Pages, Macarena; Sanchez-Carrion, Rocio; Tormos, Jose M.; Ensenat-Cantallops, Antonia; Garcia-Molina, Alberto] Univ Autonoma Barcelona, Inst Guttmann, Inst Univ Neurorehabil, Barcelona, Spain; [Gil-Pages, Macarena; Sanchez-Carrion, Rocio; Tormos, Jose M.; Ensenat-Cantallops, Antonia; Garcia-Molina, Alberto] Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain; [Gil-Pages, Macarena; Sanchez-Carrion, Rocio; Tormos, Jose M.; Ensenat-Cantallops, Antonia; Garcia-Molina, Alberto] Fdn Inst Invest Ciencies Salut Germans Tria & Puj, Barcelona, Spain; [Gil-Pages, Macarena] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Bellaterra, Cerdanyola Del, Spain		Gil-Pages, M (corresponding author), Cami Can Ruti S-N, Barcelona 08916, Spain.	macarenagil@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289	BIOCAT La Fundacio BioRegio de Catalunya [COM15-1-0004]; Fundacio Bancaria "la Caixa" - Obra Social "la Caixa" [LCF/PR/PR16/11110004]	This work was supported by BIOCAT La Fundacio BioRegio de Catalunya - Registry Number: COM15-1-0004 and Fundacio Bancaria "la Caixa" - Obra Social "la Caixa" Project number: LCF/PR/PR16/11110004.	Adam S, 2013, CLIN INTERV AGING, V8, P377, DOI 10.2147/CIA.S39921; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; [Anonymous], 2000, JAMA, V284, P3043; [Anonymous], 2018, EFFECT SIZES; Baldivia Beatriz, 2008, Dement. neuropsychol., V2, P173, DOI 10.1590/S1980-57642009DN20300003; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Berggren R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01138; Bouffioulx E, 2010, J REHABIL MED, V42, P944, DOI 10.2340/16501977-0635; Cott CA, 2007, DISABIL REHABIL, V29, P1566, DOI 10.1080/09638280701618588; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Dalemans RJP, 2010, DISABIL REHABIL, V32, P1678, DOI 10.3109/09638281003649938; Dijkers M., 2000, COMMUNITY INTEGRATIO; Donaghy M., 2009, BRAINS DIS NERVOUS S; Eaceaeceuropaeu, 2013, ORG ED SYST ITS STRU; Elkins JS, 2006, NEUROLOGY, V67, P435, DOI 10.1212/01.wnl.0000228246.89109.98; Elsner B., 2013, CLINICAL NEUROPHYSIO, V124, pe113; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Finkel D, 2009, PSYCHOL AGING, V24, P563, DOI 10.1037/a0015511; Fortuny L., 1999, MANUAL DE NORMAS Y P; Garibotto V, 2008, NEUROLOGY, V71, P1342, DOI 10.1212/01.wnl.0000327670.62378.c0; Helmer C, 2001, J NEUROL NEUROSUR PS, V71, P303, DOI 10.1136/jnnp.71.3.303; Hindle JV, 2014, PARKINSONISM RELAT D, V20, P1, DOI 10.1016/j.parkreldis.2013.08.010; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Jellema S, 2017, CLIN REHABIL, V31, P936, DOI 10.1177/0269215516671013; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kessels RPC, 2017, J INT NEUROPSYCH SOC, V23, P223, DOI 10.1017/S1355617716001016; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lee H, 2015, YONSEI MED J, V56, P1694, DOI 10.3349/ymj.2015.56.6.1694; Lenehan ME, 2015, PSYCHOGERIATRICS, V15, P154, DOI 10.1111/psyg.12083; Leon I, 2011, REV NEUROLOGIA, V52, P653, DOI 10.33588/rn.5211.2010704; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Malek-Ahmadi Michael, 2017, J Alzheimers Dis Parkinsonism, V7, DOI 10.4172/2161-0460.1000390; Moyano A., 2010, REV HOSP CLIN U CHIL, V21, P348; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Ojala-Oksala J, 2012, STROKE, V43, P2931, DOI 10.1161/STROKEAHA.112.667618; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; R Development CORE TEAM, 2012, R LANG ENV STAT COMP; Rosseel Y., 2018, LAVAAN R PACKAGE STR; Roth RM, 2005, BRIEF A BEHAV RATING; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Sanchez JL, 2002, NEUROPSY NEUROPSY BE, V15, P207, DOI 10.1097/01.WNN.0000028813.69344.13; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schooler C, 1999, PSYCHOL AGING, V14, P483, DOI 10.1037/0882-7974.14.3.483; Schooler C, 2004, AM J SOCIOL, V110, P161, DOI 10.1086/385430; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stern Y, 2017, BRAIN IMAGING BEHAV, V11, P410, DOI 10.1007/s11682-016-9566-x; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Teasell R., 2016, STROKE REHABILITATIO; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Uniarova RM, 2017, CORTEX, V97, P327, DOI 10.1016/j.cortex.2016.12.006; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Verberne DPJ, 2018, NEUROREHAB NEURAL RE, V32, P821, DOI 10.1177/1545968318796341; Verghese J, 2009, J GERIATR PSYCH NEUR, V22, P110, DOI 10.1177/0891988709332938; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zieren N, 2013, NEUROBIOL AGING, V34, P400, DOI 10.1016/j.neurobiolaging.2012.04.019; 2014, REG ANESTH PAIN MED, V9	74	4	4	1	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2019	25	9					910	921	PII S1355617719000638	10.1017/S1355617719000638			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	JB3VM	WOS:000488484800002	31317861				2022-02-06	
J	Hafner, M				Hafner, Miha			Judging homicide defendants by their brains: an empirical study on the use of neuroscience in homicide trials in Slovenia	JOURNAL OF LAW AND THE BIOSCIENCES			English	Article						criminal law; double-edged sword of neuroscience; empirical study; homicide; neuroscience; Slovenia	DOUBLE-EDGED-SWORD; SEDUCTIVE ALLURE; LAW; NEUROIMAGES; RESPONSIBILITY; COURTROOM; IMAGES	This paper presents a study that analyses all available homicide trials in Slovenia between 1991 and 2015 for neuro-evidence. Almost every fifth case discusses neuroscience. The most prevalent type of neuro-evidence is neuro-psychological testing, less common are structural neuroimaging and electroencephalography, while we discovered no use of functional neuroimaging. The two largest categories of neurological conditions suffered by defendants are traumatic brain injury and brain damage due to long-term alcohol and drug abuse. When presented, neuro-evidence affected courts' decisions in 85% of trials (15% of all tried homicide cases) and had an impact on the criminal sentence or another outcome of the trial in 79% of cases. By far most often neuro-evidence affects decisions regarding criminal capacity, ie insanity and (substantially) diminished capacity, which, in turn, strongly reflects in criminal sanctions. Neuroscience information is typically used to mitigate or even reduce the sentence, but never as an aggravating circumstance. It is also frequently utilized to support decisions about medical security measures (compulsory psychiatric treatment). This study further suggests that the double-edged sword of neuroscience is an elusive concept and that the mechanism by which neuroscience affects courts' decisions in civil-law systems is different from the one in common-law jurisdictions.	[Hafner, Miha] Univ Ljubljana, Fac Law, Poljanski Nasip 2, Ljubljana 1000, Slovenia; [Hafner, Miha] Fac Law Ljubljana, Inst Criminol, Poljanski Nasip 2, Ljubljana 1000, Slovenia		Hafner, M (corresponding author), Univ Ljubljana, Fac Law, Poljanski Nasip 2, Ljubljana 1000, Slovenia.; Hafner, M (corresponding author), Fac Law Ljubljana, Inst Criminol, Poljanski Nasip 2, Ljubljana 1000, Slovenia.	miha.hafner@pf.uni-lj.si		Hafner, Miha/0000-0001-5108-154X	Slovenian Research AgencySlovenian Research Agency - Slovenia [J5-8242]	I am grateful to Mojca M. Plesnicar for her invaluable support throughout the research and her comments on the first draft of this paper. I would also like to thank the coders of the cases, Barbara Bajda, Spela Bozic, Nika Cotic, Jaka Kukavica, Vida Marceta, Sasa Petrovic, Katja Simoncic, and Ana Slavec, for their diligent work and contribution to this study. The author acknowledges that the presented study was part of the research project Shifting Boundaries in Criminology and Crime Policy (No. J5-8242) and was financially supported by the Slovenian Research Agency.	Aharoni E, 2008, ANN NY ACAD SCI, V1124, P145, DOI 10.1196/annals.1440.007; Ambrz M., 2012, PODJETJE DELO, V38, P1596; Aspinwall LG, 2012, SCIENCE, V337, P846, DOI 10.1126/science.1219569; Baker DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074449; Barth AS, 2007, AM J LAW MED, V33, P501, DOI 10.1177/009885880703300214; Bear M., 2016, NEUROSCIENCE EXPLORI; Brodeur JP, 2007, CRIME JUSTICE, V36, P49, DOI 10.1086/592806; Catley P, 2015, J LAW BIOSCI, V2, P510, DOI 10.1093/jlb/lsv025; Chandler JA, 2015, J LAW BIOSCI, V2, P550, DOI 10.1093/jlb/lsv026; Choe SY, 2014, UCLA LAW REV, V61, P1502; de Kogel CH, 2015, J LAW BIOSCI, V2, P580, DOI 10.1093/jlb/lsv024; DENNO DW, 2015, BC L REV, V56, P493; Douglas T., 2018, TREATMENT CRIME PHIL; Dunkel Frieder, 2013, ZBORNIK ALENKO SELIH, P61; Faigman David L., 2013, PRIMER CRIMINAL LAW, P89; Farah MJ, 2013, PERSPECT PSYCHOL SCI, V8, P88, DOI 10.1177/1745691612469035; Farahany NA, 2009, IMPACT BEHAV SCI CRI, P183; Farahany NA, 2015, J LAW BIOSCI, V2, P485, DOI 10.1093/jlb/lsv059; Farahany NA, 2012, U PENN LAW REV, V160, P1239; Farahany NA, 2012, STANFORD LAW REV, V64, P351; Farisco M, 2014, NEUROETHICS-NETH, V7, P243, DOI 10.1007/s12152-013-9187-7; Feigenson egNeal, 2009, LAW MIND BRAIN, P23; Fuss J, 2016, J PSYCHIATR NEUROSCI, V41, P363, DOI 10.1503/jpn.160147; Fuss J, 2015, J MED GENET, V52, P730, DOI 10.1136/jmedgenet-2015-103284; Gaudet LM, 2010, JURIMETRICS, V51, P293; Gaudet Lyn M., 2016, DRAKE L REV, V64, P577; Ginther M, 2016, J LAW BIOSCI, V3, P324, DOI 10.1093/jlb/lsw030; Gorkic Primoz, 2013, PROSECUTOR EUROPEAN, V1, p[652, 678]; Grasso A, 2017, POLIT RES QUART, V70, P394, DOI 10.1177/1065912917695189; Greely H. T., 2013, PRIMER CRIMINAL LAW; GREELY HT, 2008, NEUROSCIENCE CRIMINA, V56, P1103; Greene E, 2012, BEHAV SCI LAW, V30, P280, DOI 10.1002/bsl.1993; Greene J, 2004, PHILOS T R SOC B, V359, P1775, DOI 10.1098/rstb.2004.1546; Gurley JR, 2008, BEHAV SCI LAW, V26, P85, DOI 10.1002/bsl.797; Hafner Miha, 2014, ZB ZNAN RAZPRAV, VLXXIV, P31; Hafner Miha, 2018, POMEN UPORABA IZSLED; Hook CJ, 2013, J COGNITIVE NEUROSCI, V25, P1397, DOI 10.1162/jocn_a_00407; Hopkins EJ, 2016, COGNITION, V155, P67, DOI 10.1016/j.cognition.2016.06.011; Keehner M, 2011, PSYCHON B REV, V18, P422, DOI 10.3758/s13423-010-0048-7; Klaming L, 2012, INT NEUROLAW A COMP, P227; Kuersten Andreas., 2016, G WASH L REV ARGUEND, V84, P178; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Miller G., 2013, WIRED; MILLER GREG, 2009, FMRI EVIDENCE USED M; Morse SJ, 2013, PRIMER CRIMINAL LAW, P150; Morse Stephen J., 2013, NEUROSCIENCE LEGAL R, P27; Patterson D., 2013, MINDS BRAINS LAW CON; Petrovec D, 2011, PRISON J, V91, P425, DOI 10.1177/0032885511424392; Petrovec Dragan, 2014, REIMAGINING IMPRISON, P71; Plesnicar MM, 2013, EUR J CRIMINOL, V10, P462, DOI 10.1177/1477370812469858; PLESNICAR MOJCA M., 2018, SHADES SANITY THEIR; Rendell JA, 2010, BEHAV SCI LAW, V28, P411, DOI 10.1002/bsl.913; Rhodes RE, 2014, J EXP PSYCHOL LEARN, V40, P1432, DOI 10.1037/a0036844; Roskies AL, 2013, TRENDS COGN SCI, V17, P99, DOI 10.1016/j.tics.2013.01.008; Roskies Adina L., 2013, PRIMER CRIMINAL LAW, P37; Saks MJ, 2014, J EMPIR LEGAL STUD, V11, P105, DOI 10.1111/jels.12036; Salecl Renata, 2014, BELGRADE J MEDIA COM, V3, P91; Salecl Renata, 2015, MOZGANI ZATOZNI KLOP; Schweitzer NJ, 2011, PSYCHOL PUBLIC POL L, V17, P357, DOI 10.1037/a0023581; Shats K, 2016, CAMB Q HEALTHC ETHIC, V25, P712, DOI 10.1017/S0963180116000438; Shaw E, 2015, HDB NEUROETHICS, P1381; Shen Francis, 2017, ARIZ STATE L J, V48, P1046; Shen FX, 2016, J LAW BIOSCI, V3, P343, DOI 10.1093/jlb/lsw029; Shen FX, 2013, HARVARD J LAW PUBL P, V36, P653; SHEN FX, 2017, ARIZONA STATE LAW J, V48, P1043; SLOVENIJA REPUBLIKA, 2015, MINSTRSTVO PRAVOSODJ; Spranger T, 2012, INT NEUROLAW A COMP; Stubbs Katjas Sugman, 2008, CRIMINAL PROCEDURE E, p[483, 494]; SUGMAN KATJA G., 2004, SLOVENIA CRIMINAL JU, P44; Tabacchi ME, 2016, PSYCHOL REP, V118, P793, DOI 10.1177/0033294116649000; The MacArthur Foundation Research Net-work on Law and Neuroscience, CUM TOT LAW NEUR PUB; Tonry M, 2007, CRIME JUSTICE, V36, P1; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Weisberg DS, 2015, JUDGM DECIS MAK, V10, P429; Woodruff William A., 2014, N C J L TECH, V16, P105; Zullo S, 2016, CAMB Q HEALTHC ETHIC, V25, P700, DOI 10.1017/S0963180116000426	76	4	4	1	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2053-9711			J LAW BIOSCI	J. Law Biosci.	OCT	2019	6	1					226	254		10.1093/jlb/lsz006			29	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	JP3UM	WOS:000498192600007	31666969	Green Published, gold			2022-02-06	
J	Harris, DA; Sorte, DE; Lam, SK; Carlson, AP				Harris, Dominic A.; Sorte, Danielle E.; Lam, Sandi K.; Carlson, Andrew P.			Blunt cerebrovascular injury in pediatric trauma: a national database study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						blunt cerebrovascular injury; pediatric trauma; national database	UNIQUE FEATURES; BRAIN-INJURY; RISK-FACTORS; CHILDREN; COMPLICATIONS; ASSOCIATION; POPULATION; GUIDELINES; MECHANISMS; PATTERNS	OBJECTIVE The incidence of blunt cerebrovascular injury (BCVI) has not been well characterized in the pediatric population. The goal of this study was to describe the incidence, patient characteristics, and risk factors for pediatric patients with cerebrovascular injuries. METHODS The authors collected data from the Kids' Inpatient Database (KID), a nationally representative database of pediatric admissions, for years 2000, 2003, 2006, 2009, and 2012. RESULTS Among an estimated 646,549 admissions for blunt trauma, 2150 were associated with BCVI, an overall incidence of 0.33%. The incidence of BCVI nearly doubled from 0.24% in 2000 to 0.49% in 2012. Patients 4 to 13 years of age were less likely to have BCVI than those in the youngest (0-3 years) and oldest age groups comprising adolescents (14-17 years) and young adults (18-20 years). BCVIs were associated with cervical (adjusted OR [aOR] 4.6, 95% CI 3.8 5.5), skull base (aOR 3.0, 95% CI 2.5-3.6), clavicular (aOR 1.4, 95% CI 1.1-1.8), and facial (aOR 1.2, 95% CI 1.01.5) fractures, as well as intracranial hemorrhage (aOR 2.7, 95% CI 2.2-3.2) and traumatic brain injury (aOR 2.0, 95% CI 1.7-2.3). Mechanism of injury was also independently associated with BCVI: motor vehicle collision (aOR 1.7, 95% CI 1.3-2.2) and struck pedestrian (aOR 1.4, 95% CI 1.0-1.9). Among pediatric patients with BCVI, 37.4% had cerebral ischemic infarction with an in-hospital mortality of 12.7%, and patients with stroke had 20% mortality. CONCLUSIONS The incidence of pediatric BCVI is increasing, likely due to increased use of screening, but remains lower than that in the adult population. Risk factors include the presence of cervical, facial, clavicular, and skull base fractures, similar to that of the adult population. Diagnosed BCVI is associated with a relatively high incidence of stroke with increased morbidity and mortality. The use of adult screening criteria is likely reasonable given the similarity in the risk factors identified in this study. Further studies are needed to investigate the role of treatment with antiplatelet agents or anticoagulation.	[Harris, Dominic A.; Sorte, Danielle E.; Carlson, Andrew P.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA; [Lam, Sandi K.] Baylor Coll Med, Texas Childrens Hosp, Div Pediat Neurosurg, Houston, TX 77030 USA		Carlson, AP (corresponding author), Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.	andrewcarlson@salud.unm.edu	Carlson, Andrew P/B-4369-2012	Carlson, Andrew P/0000-0003-2189-3699; Lam, Sandi/0000-0003-3294-6637			Azarakhsh N, 2013, J TRAUMA ACUTE CARE, V75, P1006, DOI 10.1097/TA.0b013e31829d3526; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P1120, DOI 10.1097/TA.0b013e318246c516; Cook MR, 2018, J TRAUMA ACUTE CARE, V84, P50, DOI 10.1097/TA.0000000000001631; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; Fenton SJ, 2017, SEMIN PEDIATR SURG, V26, P2, DOI 10.1053/j.sempedsurg.2017.01.003; Foreman PM, 2017, J NEUROSURG, V127, P32, DOI 10.3171/2016.7.JNS16849; Foreman PM, 2017, CEREBROVASC DIS EXTR, V7, P72, DOI 10.1159/000455391; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; Grabowski G, 2016, GLOB SPINE J, V6, P679, DOI 10.1055/s-0036-1579552; Harrigan MR, 2014, J NEUROTRAUM, V31, P1056, DOI 10.1089/neu.2013.3309; Harrigan MR, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-11; Healthcare Cost and Utilization Project, 2012, INTR HCUP KIDS INP D; Jones TS, 2012, AM J SURG, V204, P7, DOI 10.1016/j.amjsurg.2011.07.015; Kopelman TR, 2011, J TRAUMA, V71, P559, DOI 10.1097/TA.0b013e318226eadd; Lew SM, 1999, PEDIATR NEUROSURG, V30, P239, DOI 10.1159/000028804; Mohseni S, 2011, J PEDIATR SURG, V46, P1771, DOI 10.1016/j.jpedsurg.2011.03.007; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Ravindra VM, 2017, J NEUROTRAUM, V34, P391, DOI 10.1089/neu.2016.4415; Ravindra VM, 2015, J NEUROSURG-PEDIATR, V15, P599, DOI 10.3171/2014.11.PEDS14397; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146	25	4	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2019	24	4					451	460		10.3171/2019.5.PEDS18765			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JD9CK	WOS:000490281600013	31323625				2022-02-06	
J	Jang, SH; Kim, OL; Kim, SH; Lee, HD				Jang, Sung Ho; Kim, Oh Lyong; Kim, Seong Ho; Lee, Han Do			Differences in corpus callosum injury between cerebral concussion and diffuse axonal injury	MEDICINE			English	Article						cerebral concussion; corpus callosum; diffuse axonal injury; diffusion tensor tractography; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TENSOR TRACTOGRAPHY; IMAGING FINDINGS; HEAD-INJURY; MILD; PERFORMANCE; MODERATE	Background: We investigated differences in corpus callosum (CC) injuries between patients with concussion and those with diffuse axonal injury (DAI) by using diffusion tensor tractography (DTT). Methods: Twenty-nine patients with concussion, 21 patients with DAI, and 25 control subjects were recruited. We reconstructed the whole CC and 5 regions of the CC after applying Hofer classification (I, II, III, IV, and V). The whole CC and each region of the CC were analyzed to measure DTT parameters (fractional anisotropy [FA], apparent diffusion coefficient [ADC], and fiber number [FN]). Results: In the whole CC, significant differences were observed in all DTT parameters between the concussion and control groups and the DAI and control groups (P<.05). Among the 5 regions of the CC, significant differences were observed in FA and ADC between the concussion and control groups and the DAI and control groups (P<.05). Significant differences in FN were observed in CC regions I and II (connected with the prefrontal lobe and secondary motor area) between the concussion and control groups, in CC regions I, II, III, and IV (connected with the frontoparietal lobes) between the DAI and control groups, and in CC regions III, IV (connected with the motor-sensory cortex) between the concussion and DAI groups (P<.05). Conclusion: It was observed that both concussion and DAI patients showed diffuse neural injuries in the whole CC and all 5 regions of the CC. Neural FN results revealed that concussion patients appeared to be specifically injured in the anterior part of the CC connected with the frontal lobe, whereas DAI patients were injured in more diffuse regions connected with whole frontoparietal lobes.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Gyongsan, South Korea; [Kim, Oh Lyong; Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Gyongsan, South Korea; [Lee, Han Do] Ulsan Coll Univ, Coll Rehabil Sci, Dept Phys Therapy, Bongsuro 101, Ulsan 44022, South Korea		Lee, HD (corresponding author), Ulsan Coll Univ, Coll Rehabil Sci, Dept Phys Therapy, Bongsuro 101, Ulsan 44022, South Korea.	lhd890221@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gennarelli TA, 1993, HEAD INJURY, P137; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hong SS, 2011, PSYCHIAT RES-NEUROIM, V194, P333, DOI 10.1016/j.pscychresns.2011.03.009; Jang S.H., 2018, TRAUMATIC BRAIN INJU; Jang SH, 2017, J HEAD TRAUMA REHAB, V32, pE44, DOI 10.1097/HTR.0000000000000300; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kavita SRT, 2015, ARCH NEUROSCI, V2; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kim DG, 2009, NEUROREHABILITATION, V25, P117, DOI 10.3233/NRE-2009-0506; Kim DS, 2015, J KOREAN NEUROSURG S, V58, P131, DOI 10.3340/jkns.2015.58.2.131; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Ljungqvist J, 2017, BRAIN INJURY, V31, P344, DOI 10.1080/02699052.2016.1256500; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051	36	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT	2019	98	41							e17467	10.1097/MD.0000000000017467			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JF4IA	WOS:000491349800032	31593106	gold, Green Published			2022-02-06	
J	Lee, HF; Lin, JS; Chang, CF				Lee, Hung-Fu; Lin, Jhih Syuan; Chang, Che-Feng			Acute Kahweol Treatment Attenuates Traumatic Brain Injury Neuroinflammation and Functional Deficits	NUTRIENTS			English	Article						coffee; coffee diterpene kahweol; traumatic brain injury; neuroinflammation; leukocyte infiltration; innate immunity	CONTROLLED CORTICAL IMPACT; ANIMAL-MODELS; HEAD-INJURY; IN-VITRO; COFFEE; DAMAGE; RECOVERY; CELL; PHOSPHORYLATION; NEUROPROTECTION	Traumatic brain injury (TBI) affects millions worldwide with devastating long-term effects on health and cognition. Emerging data suggest that targeting the immune response may offer promising strategies to alleviate TBI outcomes; kahweol, an anti-inflammatory diterpene that remains in unfiltered coffee, has been shown to be beneficial in neuronal recovery. Here, we examined whether kahweol could alleviate brain trauma-induced injury in a mouse model of TBI and its underlying mechanisms. TBI was induced by controlled cortical impact (CCI) and various doses of kahweol were intraperitoneally administered following injury. Contusion volume, brain edema, neurobehavioral deficits, and protein expression and activity were evaluated in both short-term and long-term recovery. We found that kahweol treatments significantly reduced secondary brain injury and improved neurobehavioral outcomes in TBI mice. These changes were accompanied by the attenuation of proinflammatory cytokine secretion, decreased microglia/macrophage activation, and reduction of neutrophil and leukocyte infiltration. In addition, continuous kahweol treatment further improved short-term TBI outcomes compared to single-dosage. Collectively, our data showed that kahweol protects against TBI by reducing immune responses and may serve as a potential therapeutic intervention for TBI patients.	[Lee, Hung-Fu; Lin, Jhih Syuan] Cheng Hsin Gen Hosp, Dept Neurosurg, Taipei 11220, Taiwan; [Lin, Jhih Syuan; Chang, Che-Feng] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10051, Taiwan		Chang, CF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10051, Taiwan.	ufae0073@ms7.hinet.net; xup5@cycu.org.tw; chefengchang@ntu.edu.tw		Chang, Che-Feng/0000-0002-3211-1739	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 107-2320-B-002-063-MY2]	This research was supported by the Ministry of Science and Technology of Taiwan (MOST 107-2320-B-002-063-MY2) to C.-F.C.	Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006; Camandola S, 2019, NEUROCHEM RES, V44, P214, DOI 10.1007/s11064-018-2492-0; Cardenas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023407; Chang CF, 2018, J CLIN INVEST, V128, P607, DOI 10.1172/JCI95612; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2018, MOL NEUROBIOL, V55, P7079, DOI 10.1007/s12035-018-0897-z; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Deiters U, 1999, INFECT IMMUN, V67, P3390, DOI 10.1128/IAI.67.7.3390-3398.1999; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Furstenau CR, 2019, TOXICOL IN VITRO, V61, DOI 10.1016/j.tiv.2019.104601; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Hung TH, 2017, ONCOTARGET, V8, P103236, DOI 10.18632/oncotarget.21139; Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Iwamoto H, 2019, PROSTATE, V79, DOI 10.1002/pros.23753; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kelso ML, 2011, PROG MOL BIOL TRANSL, V98, P85, DOI 10.1016/B978-0-12-385506-0.00003-X; Kim HG, 2009, TOXICOL LETT, V187, P28, DOI 10.1016/j.toxlet.2009.01.022; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Min KJ, 2017, ONCOTARGET, V8, P83195, DOI 10.18632/oncotarget.20541; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Islam MT, 2018, CURR DRUG METAB, V19, P544, DOI 10.2174/1389200219666180302154551; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Oh SH, 2018, FOOD CHEM TOXICOL, V121, P326, DOI 10.1016/j.fct.2018.09.008; Park GH, 2017, BIOMOL THER, V25, P337, DOI 10.4062/biomolther.2016.114; Park GH, 2016, FOOD CHEM TOXICOL, V95, P142, DOI 10.1016/j.fct.2016.07.008; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Seo HY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070863; Seo HY, 2017, ONCOTARGET, V8, P87086, DOI 10.18632/oncotarget.19756; Shen T, 2010, BIOL PHARM BULL, V33, P1159, DOI 10.1248/bpb.33.1159; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Su WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15916-2; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	60	4	4	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	OCT	2019	11	10							2301	10.3390/nu11102301			15	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	JP4HG	WOS:000498227300042	31569604	Green Published, gold			2022-02-06	
J	Mackinnon, AL; Jackson, K; Kuznik, K; Turner, A; Hill, J; Davies, MAM; Jones, ME; Delmestri, A; Sanchez-Santos, MT; Newton, J				Mackinnon, Anna-Louise; Jackson, Kate; Kuznik, Kerry; Turner, Alison; Hill, Jerry; Davies, Madeleine A. M.; Jones, Mary Elizabeth; Delmestri, Antonella; Sanchez-Santos, Maria T.; Newton, Julia			Increased Risk of Musculoskeletal Disorders and Mental Health Problems in Retired Professional Jockeys: A Cross-Sectional Study	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						osteoarthritis; osteoporosis; anxiety; depression; athlete; chronic disease	BODY-MASS INDEX; WEIGHT; SPORT; AGE; PREVALENCE; OSTEOARTHRITIS; COMORBIDITY; CONCUSSION; DEPRESSION; HEIGHT	To examine the prevalence of chronic disease and mental health problems in retired professional, male jockeys compared to an age-matched reference population. A cross-sectional study comparing data from a cohort of retired professional jockeys with an age-matched general population sample. Male participants (age range: 50-89 years old) were used to compare health outcomes of self-reported physician-diagnosed conditions: heart disease, stroke, diabetes, hypertension, osteoporosis, osteoarthritis, depression and anxiety between study populations. Conditional logistic regression models were used to estimate associations between study groups and health outcome. In total, 810 participants (135 retired professional male jockeys and 675 participants from the reference population) were included, with an average age of 64.7 +/- 9.9 years old. Increased odds of having osteoporosis (OR=6.5, 95%CI 2.1-20.5), osteoarthritis (OR=7.5, 95%CI 4.6-12.2), anxiety (OR=2.8, 95%CI 1.3-5.9) and depression (OR=2.6, 95%CI 1.3-5.7) were seen in the retired professional jockeys. No differences were found for the remaining health outcomes. Retired professional jockeys had increased odds of musculoskeletal disease and mental health problems compared to the general population. Understanding the prevalence of chronic disease and mental health problems in retired professional jockeys will help inform screening and intervention strategies for jockeys.	[Mackinnon, Anna-Louise; Jackson, Kate; Kuznik, Kerry; Turner, Alison; Delmestri, Antonella; Sanchez-Santos, Maria T.; Newton, Julia] Univ Oxford, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Kuznik, Kerry; Hill, Jerry] British Horseracing Author Ltd, Med, London, England; [Davies, Madeleine A. M.; Delmestri, Antonella; Sanchez-Santos, Maria T.; Newton, Julia] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Davies, Madeleine A. M.] Univ Bath, Dept Hlth, Bath, Avon, England; [Jones, Mary Elizabeth] UCL, Inst Epidemiol & Hlth Care, Dept Primary Care & Populat Hlth, London, England		Mackinnon, AL (corresponding author), Univ Oxford, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford OX3 7LD, England.	almackinnon@icloud.com		Jones, Mary Elizabeth/0000-0001-6225-2164; Davies, Madeleine/0000-0002-6047-7340; Delmestri, Antonella/0000-0003-0388-3403	British Horseracing Authority; Professional Jockeys Association; Injured Jockey Fund; Jockeys Education and Training Scheme; Racing Foundation [HFR00920]; Arthritis Research UK Centre for Sport, Exercise and OsteoarthritisVersus Arthritis [21595]	This research was supported by the British Horseracing Authority, the Professional Jockeys Association, Injured Jockey Fund and the Jockeys Education and Training Scheme. Funding This study was funded by the Racing Foundation (grant number HFR00920) and the Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis. (Grant reference 21595). The Racing Foundation was represented on the steering group for this research but not directly involved in the research or preparation of the paper. Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis had no involvement in the research other than financial.	Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Caulfield MJ, 2008, J SPORT SCI, V26, P877, DOI 10.1080/02640410701837349; Cosh S, 2013, AUST J PSYCHOL, V65, P89, DOI 10.1111/j.1742-9536.2012.00060.x; Cullen S, 2015, INT J SPORTS MED, V36, P968, DOI 10.1055/s-0035-1548889; Cullen S, 2016, J SCI MED SPORT, V19, P283, DOI 10.1016/j.jsams.2015.05.001; Dahl AK, 2010, AGE AGEING, V39, P445, DOI 10.1093/ageing/afq038; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Dolan E, 2012, J BONE MINER METAB, V30, P164, DOI 10.1007/s00774-011-0297-1; Dolan E, 2011, J SPORT SCI, V29, P791, DOI 10.1080/02640414.2011.560173; Fernandes GS, 2018, BRIT J SPORT MED, V52, P678, DOI 10.1136/bjsports-2017-097503; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gouttebarge V, 2015, RHEUMATOL INT, V35, P405, DOI 10.1007/s00296-014-3093-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harriss DJ, 2017, INT J SPORTS MED, V38, P1126, DOI 10.1055/s-0043-124001; Jackson KA, 2017, OSTEOPOROSIS INT, V28, P2675, DOI 10.1007/s00198-017-4086-0; Jones ME, 2018, J SCI MED SPORT, V21, P558, DOI 10.1016/j.jsams.2017.10.013; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; KUJALA UM, 1994, BRIT MED J, V308, P231, DOI 10.1136/bmj.308.6923.231; Losty C, 2019, J HUM SPORT EXERC, V14, P147, DOI 10.14198/jhse.2019.141.12; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Molloy MG, 2011, BRIT J SPORT MED, V45, P275, DOI 10.1136/bjsm.2011.083956; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; O'Connor S, 2017, J ATHL TRAINING, V52, P1140, DOI 10.4085/1062-6050-52.12.17; Palazzo C, 2016, ANN PHYS REHABIL MED, V59, P134, DOI 10.1016/j.rehab.2016.01.006; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Rosenbaum S, 2011, BRIT J SPORT MED, V45, P1079, DOI 10.1136/bjsports-2011-090466; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wilson G, 2014, SPORTS MED, V44, P785, DOI 10.1007/s40279-014-0169-7	35	4	4	3	6	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	OCT	2019	40	11					732	738		10.1055/a-0902-8601			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JA6PG	WOS:000487963700007	31390657	Green Submitted, hybrid			2022-02-06	
J	Shibahashi, K; Nishimura, S; Sugiyama, K; Hoda, H; Hamabe, Y; Fujita, H				Shibahashi, Keita; Nishimura, Shigeko; Sugiyama, Kazuhiro; Hoda, Hidenori; Hamabe, Yuichi; Fujita, Hiroshi			Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						coagulopathy; cryoprecipitate; mortality; transfusion; traumatic brain injury	LARGE ANIMAL-MODEL; HEMORRHAGIC-SHOCK; COAGULOPATHY; FIBRINOGEN; PLASMA; MECHANISMS; ACID	Acute coagulopathy is common after traumatic brain injury (TBI), particularly in severe cases of acute subdural hemorrhage (ASDH). Although acute coagulopathy is associated with poor outcomes, the optimal treatment strategy remains unknown. Here, we report the initial results of an empirical cryoprecipitate transfusion strategy that we developed as an early intervention for acute coagulopathy after TBI. We performed chart reviews of adult patients (aged >= 18 years) who received early cryoprecipitate transfusion after admission to our institution with a diagnosis of severe TBI (Glasgow Coma Scale <= 8) and ASDH from March 2013 to December 2016. We compared the outcomes of these patients with those who were treated before the implementation of the cryoprecipitate transfusion strategy (January 2011-February 2013). During the study period, 33 patients received early cryoprecipitate transfusion and no acute transfusion-related adverse event was reported. The rate of coagulopathy development within 24 h after admission was lower in these patients (23%) than in the controls (49%), but the difference was not significant (P = 0.062). The in-hospital mortality rate was 36% in patients receiving early cryoprecipitate transfusion and 52% in controls. After adjusting for confounding factors, the in-hospital mortality rate was significantly lower in the intervention period [adjusted odds ratio: 0.25, 95% confidence interval (CI): 0.08-0.78, P = 0.017]. In summary, we analyzed initial results of a cryoprecipitate transfusion strategy in patients with severe isolated TBI and ASDH. No acute transfusion-related adverse event was observed, and early transfusion of the in-house-produced cryoprecipitate may have reduced rates of coagulopathy development and in-hospital mortality.	[Shibahashi, Keita; Sugiyama, Kazuhiro; Hoda, Hidenori; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan; [Nishimura, Shigeko; Fujita, Hiroshi] Tokyo Metropolitan Bokutoh Hosp, Dept Transfus Med, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064			BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Callum JL, 2009, TRANSFUS MED REV, V23, P177, DOI 10.1016/j.tmrv.2009.03.001; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Collins PW, 2014, BRIT J ANAESTH, V113, P585, DOI 10.1093/bja/aeu086; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Cushing MM, 2017, TRANSFUSION, V57, P2502, DOI 10.1111/trf.14259; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Holcomb JB, 2013, J TRAUMA ACUTE CARE, V75, pS31, DOI 10.1097/TA.0b013e31828fa3ed; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mori, 2016, JAPANESE J TRANSF CE, V62, P664; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Robillard P, 2004, TRANSFUS APHER SCI, V31, P111, DOI 10.1016/j.transci.2004.07.005; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	30	4	4	1	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	OCT	2019	59	10					371	378		10.2176/nmc.oa.2019-0062			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JE6CN	WOS:000490778700002	31281170	gold, Green Published			2022-02-06	
J	Van Essen, TA; Volovici, V; Cnossen, MC; Kolias, A; Ceyisakar, I; Nieboer, D; Peppel, LD; Heijenbrok-Kal, M; Ribbers, G; Menon, D; Hutchinson, P; Depreitere, B; de Ruiter, GCW; Lingsma, HF; Steyerberg, EW; Maas, AI; Peul, WC				Van Essen, Thomas A.; Volovici, Victor; Cnossen, Maryse C.; Kolias, Angelos; Ceyisakar, Iris; Nieboer, Daan; Peppel, Lianne D.; Heijenbrok-Kal, Majanka; Ribbers, Gerard; Menon, David; Hutchinson, Peter; Depreitere, Bart; de Ruiter, Godard C. W.; Lingsma, Hester F.; Steyerberg, Ewout W.; Maas, Andrew I.; Peul, Wilco C.			Comparative effectiveness of surgery in traumatic acute subdural and intracerebral haematoma: study protocol for a prospective observational study within CENTER-TBI and Net-QuRe	BMJ OPEN			English	Article							BRAIN-INJURY; SURGICAL-MANAGEMENT; EPIDEMIOLOGY; RELIABILITY; HEMORRHAGE; EVACUATION; GUIDELINES; REDUCTION; COMATOSE; SCALE	Introduction Controversy exists about the optimal treatment for patients with a traumatic acute subdural haematoma (ASDH) and an intracerebral haematoma/contusion (t-ICH). Treatment varies largely between different regions. The effect of this practice variation on patient outcome is unknown. Here, we present the protocol for a prospective multicentre observational study aimed at comparing the effectiveness of different treatment strategies in patients with ASDH and/or t-ICH. Specifically, the aims are to compare (1) an acute surgical approach to an expectant approach and (2) craniotomy to decompressive craniectomy when evacuating the haematoma. Methods and analysis Patients presenting to the emergency room with an ASDH and/or an t-ICH are eligible for inclusion. Standardised prospective data on patient and injury characteristics, treatment and outcome will be collected on 1000 ASDH and 750 t-ICH patients in 60-70 centres within two multicentre prospective observational cohort studies: the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) and Neurotraumatology Quality Registry (Net-QuRe). The interventions of interest are acute surgery, defined as surgery directly after the first CT at presentation versus late or no surgery and craniotomy versus decompressive craniectomy. The primary outcome measure is the Glasgow Outcome Score-Extended at 6 months. Secondary outcome measures include in-hospital mortality, quality of life and neuropsychological tests. In the primary analysis, the effect of treatment preference (eg, proportion of patients in which the intervention under study is preferred) per hospital will be analysed with random effects ordinal regression models, adjusted for casemix and stratified by study. Such a hospital-level approach reduces confounding by the indication. Sensitivity analyses will include propensity score matching, with treatment defined on patient level. This study is designed to determine the best acute management strategy for ASDH and t-ICH by exploiting the existing between-hospital variability in surgical management. Ethics and dissemination Ethics approval was obtained in all participating countries. Results of surgical management of ASDH and t-ICH/contusion will separately be submitted for publication in a peer-reviewed journal.	[Van Essen, Thomas A.; de Ruiter, Godard C. W.; Steyerberg, Ewout W.; Peul, Wilco C.] Leiden Univ, Med Ctr, Haaglanden Med Ctr, Univ Neurosurg Ctr Holland, Leiden, Netherlands; [Van Essen, Thomas A.; de Ruiter, Godard C. W.; Steyerberg, Ewout W.; Peul, Wilco C.] Haga Teaching Hosp, Leiden, Netherlands; [Van Essen, Thomas A.; de Ruiter, Godard C. W.; Steyerberg, Ewout W.; Peul, Wilco C.] Leiden Univ, Med Ctr, Univ Neurosurg Ctr Holland, Haaglanden Med Ctr, The Hague, Netherlands; [Van Essen, Thomas A.; de Ruiter, Godard C. W.; Steyerberg, Ewout W.; Peul, Wilco C.] Haga Teaching Hosp, The Hague, Netherlands; [Van Essen, Thomas A.; Volovici, Victor; Cnossen, Maryse C.; Ceyisakar, Iris; Nieboer, Daan; Lingsma, Hester F.; Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, ErasmusMC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands; [Volovici, Victor] Univ Med Ctr Rotterdam, ErasmusMC, Dept Neurosurg, Rotterdam, Netherlands; [Kolias, Angelos; Hutchinson, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Kolias, Angelos; Hutchinson, Peter] Addenbrookes Hosp, Cambridge, England; [Kolias, Angelos; Hutchinson, Peter] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Peppel, Lianne D.; Heijenbrok-Kal, Majanka; Ribbers, Gerard] Univ Med Ctr Rotterdam, ErasmusMC, Rijndam Rehabil, Rotterdam, Netherlands; [Peppel, Lianne D.; Heijenbrok-Kal, Majanka; Ribbers, Gerard] Univ Med Ctr Rotterdam, ErasmusMC, Dept Rehabil Med, Rotterdam, Netherlands; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Depreitere, Bart] Univ Hosp KU Leuven, Dept Neurosurg, Leuven, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Steyerberg, Ewout W.] Haaglanden Med Ctr, Leiden, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, The Hague, Netherlands; [Steyerberg, Ewout W.] Haaglanden Med Ctr, The Hague, Netherlands; [Maas, Andrew I.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I.] Univ Antwerp, Edegem, Belgium		Van Essen, TA (corresponding author), Leiden Univ, Med Ctr, Haaglanden Med Ctr, Univ Neurosurg Ctr Holland, Leiden, Netherlands.; Van Essen, TA (corresponding author), Haga Teaching Hosp, Leiden, Netherlands.; Van Essen, TA (corresponding author), Leiden Univ, Med Ctr, Univ Neurosurg Ctr Holland, Haaglanden Med Ctr, The Hague, Netherlands.; Van Essen, TA (corresponding author), Haga Teaching Hosp, The Hague, Netherlands.; Van Essen, TA (corresponding author), Univ Med Ctr Rotterdam, ErasmusMC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands.	t.a.vanessen@erasmusmc.nl	de Ruiter, Godard/ABC-4074-2020; Maas, Andrew IR/C-5584-2013; Volovici, Victor/AAZ-8901-2020	Maas, Andrew IR/0000-0003-1612-1264; Volovici, Victor/0000-0002-5798-5360; Kolias, Angelos/0000-0003-3992-0587; Van Essen, Thomas/0000-0003-4657-5283; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Hersenstichting Nederland (the Dutch Brain Foundation) [ps2014.06]; European Union seventh Framework ProgramEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); NeuroTrauma Sciences (USA); NIHR Global Health Research Group on Neurotrauma [16/137/105]; NIHRNational Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Royal College of Surgeons of England; Clinical Lectureship, School of Clinical Medicine, University of Cambridge	The project described in this study protocol is funded by the Hersenstichting Nederland (the Dutch Brain Foundation, grant number ps2014.06) for Net-QuRe and the European Union seventh Framework Program (grant 602150) for CENTER-TBI. Additional support for CENTER-TBI was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), from Integra LifeSciences Corporation (USA) and from NeuroTrauma Sciences (USA). Authors PH and AK are supported by the NIHR Global Health Research Group on Neurotrauma, which was commissioned by the National Institute for Health Research (NIHR) using UK aid from the UK Government (project 16/137/105). PH is supported by a Research Professorship from the NIHR, the NIHR Cambridge Biomedical Research Centre and the Royal College of Surgeons of England. AK is supported by the Royal College of Surgeons of England and a Clinical Lectureship, School of Clinical Medicine, University of Cambridge.	Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Davies NM, 2013, EPIDEMIOLOGY, V24, P363, DOI 10.1097/EDE.0b013e31828abafb; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Eurosafe, 2013, INJ EUR UN SUMM INJ; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Federatie Medisch Specialisten, CHOOS WIS NETH CAMP; Gernsback JE, 2018, WORLD NEUROSURG, V120, pE414, DOI 10.1016/j.wneu.2018.08.095; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gregson BA, 2019, STROKE, V50, P1108, DOI 10.1161/STROKEAHA.118.022694; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kolias AG, 2018, CURR TRAUMA REP, V4, P326, DOI 10.1007/s40719-018-0147-x; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas A, 2014, CTR TBI COLL EUR NEU; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Stein SC, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.2.FOCUS1232; Tallon JM, 2008, CAN J SURG, V51, P339; Van Essen TA, 2018, J NEUROTRAUM; van Essen TA, 2019, J NEUROTRAUM, V36, P1184, DOI 10.1089/neu.2018.5869; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910	45	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	OCT	2019	9	10							e033513	10.1136/bmjopen-2019-033513			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KK6XG	WOS:000512882200301	31619435	Green Published, gold			2022-02-06	
J	Whaley, CC; Young, MM; Gaynor, BG				Whaley, Calvin C.; Young, Michael M.; Gaynor, Brandon G.			Very High Blood Alcohol Concentration and Fatal Hemorrhage in Acute Subdural Hematoma	WORLD NEUROSURGERY			English	Article						Alcohol; Coagulopathy; Subdural hematoma; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SERUM ETHANOL LEVELS; TIME-COURSE; COAGULOPATHY; INTOXICATION; COAGULATION; PREDICTOR; SURVIVAL	INTRODUCTION: Alcohol intoxication is often present concurrently with traumatic brain injury (TBI). Recent studies have looked at the effect alcohol has on TBI and on coagulopathy. Typically, cases reviewed in the current literature report only on the effects of modest alcohol intoxication. CASE DESCRIPTION: A 43-year-old male presented to the trauma center after a fall, with rapidly deteriorating mental status. Computed tomography of the head demonstrated a 1.9-cm acute subdural hematoma. Of note, classical coagulation studies were normal, hut blood ethanol level was high, 436 mg/dL. Post-operatively, the patient suffered an intracerebral hemorrhage requiring emergent return to the operating room, where a large volume of unclotted blood and clinical coagulopathy was encountered. DISCUSSION: We review the literature pertaining to coagulopathy in the context of TBI and ethanol intoxication. This case is a cautionary tale of a phenomenon of unmeasured coagulopathy in the face of severe alcohol intoxication manifested by intraoperative coagulopathy with new postoperative hemorrhage. Although routine preoperative testing indicated normal clotting function, a thromboelastogram demonstrated delayed clot formation. The protective effects of alcohol are well described; however, we believe that there is a population of patients with severe acute intoxication who have coagulopathy that may go undetected by routine preoperative screening. CONCLUSIONS: Caution should be exercised when taking care of patients with very high levels of alcohol because physiologic derangements may be unpredictable. Additional research is needed for patients with very high levels of alcohol intoxication and the effect it may have on coagulation.	[Whaley, Calvin C.; Young, Michael M.; Gaynor, Brandon G.] Advocate Christ Med Ctr, Sect Neurosurg, Oak Lawn, IL 60453 USA		Whaley, CC (corresponding author), Advocate Christ Med Ctr, Sect Neurosurg, Oak Lawn, IL 60453 USA.	calvinwhaley@gmail.com		Young, Michael/0000-0002-9771-0572			[Anonymous], 2015, C TRAUM BRAIN INJ US; Berry C, 2010, AM SURGEON, V76, P1067; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Centers for Disease Control and Prevention, 2016, EARL REL SEL EST BAS; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P865, DOI 10.1097/TA.0000000000000357; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P403, DOI 10.1097/TA.0000000000000504; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Martin G, 2018, NEUROCRIT CARE, V28, P330, DOI 10.1007/s12028-017-0485-5; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Rao AJ, 2018, WORLD NEUROSURG, V112, pE216, DOI 10.1016/j.wneu.2018.01.025; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Shrestha Ajit, 2017, Asian J Neurosurg, V12, P648, DOI 10.4103/ajns.AJNS_192_14; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738	23	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2019	130						454	458		10.1016/j.wneu.2019.06.124			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JB0MH	WOS:000488248200221	31252079				2022-02-06	
J	Yamagami, K; Kurogi, R; Kurogi, A; Nishimura, K; Onozuka, D; Ren, N; Kada, A; Nishimura, A; Arimura, K; Ido, K; Mizoguchi, M; Sakamoto, T; Kayama, T; Suzuki, M; Arai, H; Hagihara, A; Iihara, K				Yamagami, Keitaro; Kurogi, Ryota; Kurogi, Ai; Nishimura, Kunihiro; Onozuka, Daisuke; Ren, Nice; Kada, Akiko; Nishimura, Ataru; Arimura, Koichi; Ido, Keisuke; Mizoguchi, Masahiro; Sakamoto, Tetsuya; Kayama, Takamasa; Suzuki, Michiyasu; Arai, Hajime; Hagihara, Akihito; Iihara, Koji		J-ASPECT Study Collaborators	The Influence of Age on the Outcomes of Traumatic Brain Injury: Findings from a Japanese Nationwide Survey (J-ASPECT Study-Traumatic Brain Injury)	WORLD NEUROSURGERY			English	Article						Aging; Hospital mortality; Prognosis; Subdural hematoma; Traumatic brain injury	CLINICAL-VARIABLES; HOSPITAL VOLUME; IMPACT; GENDER; COMA; CARE	BACKGROUND: The epidemiology of patients with traumatic brain injury (TBI) has changed dramatically over recent decades as a result of rapid advances in aging societies. We assessed the influence of age on outcomes of patients with TBI and sought to identify prognostic factors for in-hospital mortality of TBI among elderly patients. METHODS: Using a nationwide database, we analyzed data from 5651 patients with TBI. Univariate analysis was conducted to compare patient demographics, neurologic status on admission, radiologic findings, systemic complication rates, length of hospital stay, in-hospital mortality, and home discharge rates between elderly and nonelderly groups. Multivariable analysis was conducted to determine prognostic factors for in-hospital mortality among elderly patients. RESULTS: Overall in-hospital mortality was significantly higher in elderly patients (12.8% vs. 19.3%; P < 0.001). Inhospital mortality of elderly patients with mild TBI increased significantly at >7 days after admission, whereas that of elderly patients with moderate or severe TBI was significantly higher immediately after admission. Age (odds ratio [OR], 1.62; P = 0.024), male sex (OR, 1.30; P = 0.004), Japan Coma Scale score on admission (OR, 5.95, P < 0.001), and incidence of acute subdural hematoma (OR, 1.89; P < 0.001) were associated with in-hospital mortality in elderly patients with TBI. CONCLUSIONS: Elderly patients with TBI showed significantly higher in-hospital mortality. Delayed increases in in-hospital mortality were observed among elderly patients with mild TBI. Level of consciousness on admission was the strongest predictor of in-hospital mortality among elderly patients.	[Yamagami, Keitaro; Kurogi, Ryota; Kurogi, Ai; Ren, Nice; Nishimura, Ataru; Arimura, Koichi; Ido, Keisuke; Mizoguchi, Masahiro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Fukuoka, Japan; [Nishimura, Kunihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med, Suita, Osaka, Japan; [Onozuka, Daisuke; Hagihara, Akihito] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Commun, Fukuoka, Fukuoka, Japan; [Kada, Akiko] Natl Hosp Org Nagoya Med Ctr, Dept Clin Res Management, Nagoya, Aichi, Japan; [Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Kayama, Takamasa] Yamagata Univ, Fac Med, Dept Adv Canc Sci, Yamagata, Japan; [Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi, Japan; [Arai, Hajime] Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan		Iihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Fukuoka, Japan.	kiihara@ns.med.kyushu-u.ac.jp	Onozuka, Daisuke/F-5067-2014; arimura, koichi/ABI-1968-2020	Onozuka, Daisuke/0000-0001-9596-9188; arimura, koichi/0000-0003-2455-9506; Kinoshita, Manabu/0000-0001-7923-6902; Uozumi, Yoichi/0000-0002-5985-2764; Ota, Takahiro/0000-0002-5108-6719; Iwama, Toru/0000-0002-9426-284X	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H28-Shinkin-Ippan-001]; Japan Agency for Medical Research and DevelopmentJapan Agency for Medical Research and Development (AMED) [17ek0210088h0001, 18ek0210088h0002, JP18ek0210088]; KAKENHI grant from the Japan Society for the Promotion of Science [25293314, 18H02914]	J-ASPECT Study (principal investigator: K. I.) was supported by Grantsin-Aid from the Japanese Ministry of Health, Labor and Welfare (H28-Shinkin-Ippan-001). This research is partially supported by the Japan Agency for Medical Research and Development (17ek0210088h0001, 18ek0210088h0002, JP18ek0210088) and a KAKENHI grant (25293314, 18H02914) from the Japan Society for the Promotion of Science. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had the final responsibility for the decision to submit for publication.	Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bobeff EJ, 2019, WORLD NEUROSURG, V128, pE129, DOI 10.1016/j.wneu.2019.04.060; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2000, J NEUROL NEUROSUR PS, V68, P396; Iihara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096819; Iihara K, 2014, J STROKE CEREBROVASC, V23, P1001, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.016; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kurogi R, 2018, J NEUROSURG, V128, P1318, DOI 10.3171/2016.12.JNS161039; Kurogi R, 2018, NEUROLOGY, V90, pE1143, DOI 10.1212/WNL.0000000000005207; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Leyens L, 2017, GENET EPIDEMIOL, V41, P51, DOI 10.1002/gepi.22012; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nakamura K, 2016, CIRC J, V80, P2289, DOI 10.1253/circj.CJ-16-0973; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Shigematsu K, 2013, BMJ OPEN, V3, P10; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suehiro E, 2019, WORLD NEUROSURG, V127, pE1221, DOI 10.1016/j.wneu.2019.04.108; Suehiro E, 2011, WORLD NEUROSURG, V75, P563, DOI 10.1016/j.wneu.2010.09.013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Wada T, 2017, INJURY, V48, P1423, DOI 10.1016/j.injury.2017.05.003; Yasunaga H, 2005, INT HEART J, V46, P855, DOI 10.1536/ihj.46.855	37	4	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2019	130						E26	E46		10.1016/j.wneu.2019.05.140			21	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JB0MH	WOS:000488248200005	31132488				2022-02-06	
J	Christensen, J; Eyolfson, E; Salberg, S; Bhatt, D; Weerawardhena, H; Tabor, J; Mychasiuk, R				Christensen, Jennaya; Eyolfson, Eric; Salberg, Sabrina; Bhatt, Dhyey; Weerawardhena, Himanthri; Tabor, Jason; Mychasiuk, Richelle			When Two Wrongs Make a Right: The Effect of Acute and Chronic Binge Drinking on Traumatic Brain Injury Outcomes in Young Adult Female Rats	JOURNAL OF NEUROTRAUMA			English	Article						binge drinking; concussion; inflammation; late adolescence; pre-frontal cortex	ALCOHOL-USE DISORDERS; LEVEL-DEPENDENT RESPONSE; ADOLESCENT BRAIN; NEUROTROPHIC FACTOR; HIPPOCAMPAL VOLUME; SUBSTANCE-ABUSE; HEAD-INJURY; ETHANOL; MODEL; CONCUSSION	Alcohol is the most commonly abused drug by young adults across North America. Although alcohol consumption itself incurs a risk of neurological damage, it is also a significant risk factor for traumatic brain injury (TBI). TBI among young adults is described as a modern healthcare epidemic. The drastic changes occurring within their neurological networks put young adults at greater risk for developing long-term post-traumatic deficits. Contradictory findings have been indicated regarding the effects of alcohol consumption on TBI outcomes in adults, with some studies demonstrating detrimental effects, whereas others suggest neuroprotective abilities. However, little is known about the effects of alcohol consumption on TBI outcomes during the sensitive stage of early adulthood. Young adult female Sprague-Dawley rats were randomly assigned to one of six experimental conditions: Pre-injury alcohol+TBI; Pre-injury alcohol+Sham; Pre- and Post-injury alcohol+TBI; Pre- and Post-injury alcohol+Sham; No alcohol+TBI; No alcohol+Sham. Alcohol consumption groups received an amount of 10% v/v ethanol solution based on the animals' weight. Following the injury, the rats were subjected to a behavioral test battery to assess post-concussive symptomology. Overall, chronic binge drinking significantly improved TBI outcomes related to motor coordination and balance, whereas binge drinking in general significantly decreased anxiety-like behaviors. Additionally, in many cases, chronic binge drinking appears to return the TBI animal's behavioral outcomes to levels comparable to those of the no alcohol sham animals. Thus, the results suggest that alcohol may exhibit neuroprotective abilities in the context of early adulthood TBI.	[Christensen, Jennaya; Eyolfson, Eric; Salberg, Sabrina; Bhatt, Dhyey; Weerawardhena, Himanthri; Tabor, Jason; Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp, Dept Psychol,Res Inst, Calgary, AB, Canada; [Christensen, Jennaya; Salberg, Sabrina; Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia		Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Richelle.mychasiuk@monash.edu		Eyolfson, Eric/0000-0002-2201-5444	Alberta Children's Hospital Research Institute; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); National Scientific and Engineering Research Council	Funding was provided by the Alberta Children's Hospital Research Institute, Canadian Institute of Health Research, and National Scientific and Engineering Research Council.	Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Banerjee Niladri, 2014, Indian J Hum Genet, V20, P20, DOI 10.4103/0971-6866.132750; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Becker HC, 2000, ALCOHOL RES HEALTH, V24, P105; Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Berry C, 2011, AM SURGEON, V77, P1416; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bocchio M, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00024; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Caldwell LC, 2005, ALCOHOL ALCOHOLISM, V40, P194, DOI 10.1093/alcalc/agh134; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cervera-Juanes R, 2016, MOL PSYCHIATR, V21, P472, DOI 10.1038/mp.2015.93; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Clark DB, 2008, ALCOHOL CLIN EXP RES, V32, P375, DOI 10.1111/j.1530-0277.2007.00601.x; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; Folkerts M.M., 1998, J NEUROTRAUM, V15, P870; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Gilchrist J., 2011, MMWR-MORBID MORTAL W, V60, P1337; Gilpin NW, 2015, BIOL PSYCHIAT, V77, P859, DOI 10.1016/j.biopsych.2014.09.008; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gutjahr E, 2001, J SUBST ABUSE, V13, P239, DOI 10.1016/S0899-3289(01)00086-4; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hansson AC, 2018, NEUROPSYCHOPHARMACOL, V43, P1235, DOI 10.1038/npp.2017.257; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Johnston L.D., 2003, FOCUS, V1, P213, DOI [https://doi.org/10.1176/foc.1.2.213, DOI 10.1176/FOC.1.2.213, 10.1176/foc.1.2.213]; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Kuntsche E, 2004, SOC SCI MED, V59, P113, DOI 10.1016/j.socscimed.2003.10.009; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Livy DJ, 2003, ALCOHOL, V29, P165, DOI 10.1016/S0741-8329(03)00025-9; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Marcinkiewcz CA, 2016, NATURE, V537, P97, DOI 10.1038/nature19318; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; MCCLINTOCK MK, 1981, AM ZOOL, V21, P243; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Mihic S.J., 1995, PHARM EFFECTS ETHANO; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Mychasiuk R., 2018, J NEUROTRAUM, V35, P1; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Novati A, 2011, NEUROSCIENCE, V190, P145, DOI 10.1016/j.neuroscience.2011.06.027; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Paul P, 2017, J ADDICT DIS, V36, P48, DOI 10.1080/10550887.2016.1140434; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roehrs T, 2001, SLEEP MED REV, V5, P287, DOI 10.1053/smrv.2001.0162; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Schellekens AFA, 2013, ADDICT BIOL, V18, P344, DOI 10.1111/j.1369-1600.2012.00438.x; Schweinsburg BC, 2003, AM J PSYCHIAT, V160, P1180, DOI 10.1176/appi.ajp.160.6.1180; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Tapert SF, 1999, J INT NEUROPSYCH SOC, V5, P481, DOI 10.1017/S1355617799566010; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Tapert SF, 2004, ALCOHOL CLIN EXP RES, V28, P1577, DOI 10.1097/01.ALC.0000141812.81234.A6; Tate PS, 1999, BRAIN INJURY, V13, P767; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Tehse J., 2018, EUR J NEUROSCI, V49, P1; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916	108	4	4	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					273	285		10.1089/neu.2019.6656		SEP 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000488237200001	31418318				2022-02-06	
J	Furlan, JC; Craven, BC; Fehlings, MG				Furlan, Julio C.; Craven, B. Catharine; Fehlings, Michael G.			Is there any gender or age-related discrepancy in the waiting time for each step in the surgical management of acute traumatic cervical spinal cord injury?	JOURNAL OF SPINAL CORD MEDICINE			English	Article; Proceedings Paper	8th National Spinal Cord Injury Conference - Sex and Gender, Health of Women	OCT 17-19, 2019	Niagara Falls, CANADA			Spinal cord injury; Acute spine trauma; Neurotrauma; Age; Gender	LENGTH-OF-STAY; UNITED-STATES; CHANGING DEMOGRAPHICS; PATIENT GENDER; OUTCOMES; IMPACT; CARE; SEX; EPIDEMIOLOGY; MORBIDITIES	Context/Objective: Prior studies indicate that patient?s gender and age can influence treatment choices during spine disease management. This study examines whether individual?s gender and age at injury onset influence the waiting time for each step in the surgical management of patients with acute traumatic cervical spinal cord injury (atcSCI). Design: Retrospective cohort study. Setting: Quaternary spine trauma center. Participants: This study included consecutive individuals with atcSCI admitted from August/2002 to October/2008 who were enrolled in the Surgical Trial in Acute Spinal Cord Injury Study (STASCIS). Interventions: Spinal cord decompression. Outcome Measures: Data on the periods of time for each step in the surgical management were analyzed to explore the potential effects of gender and age at injury onset. Results: There were 64 individuals with atcSCI (17 women, 47 men; age range: 18?78 years; mean age: 50.5???2.1 years). Older age was associated with longer stay in the acute spine center, but this association was cofounded by major pre-existing medical co-morbidities. Age did not significantly affect the waiting time for each step in the surgical management of these individuals with atcSCI. Women underwent surgical assessment earlier than men. Gender did not influence other key steps in the surgical management. Conclusion: The study results suggest that older age at injury onset was associated with longer stay in the acute spine care center, and women had a shorter waiting time for surgical assessment than men. Nevertheless, no other age or gender bias was identified in the waiting times for the steps in the management of atcSCI.	[Furlan, Julio C.; Craven, B. Catharine] Univ Toronto, Div Phys Med & Rehabil, Dept Med, Toronto, ON, Canada; [Furlan, Julio C.; Craven, B. Catharine] Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Spinal Program, Toronto, ON, Canada		Furlan, JC (corresponding author), 520 Sutherland Dr,Room 206-J, Toronto, ON M4G 3V9, Canada.	jcfurlan@gmail.com	Craven, Beverley/D-5001-2015; Furlan, Julio/Q-8290-2018	Craven, Beverley/0000-0001-8234-6803; Furlan, Julio/0000-0002-2038-0018; Fehlings, Michael/0000-0002-5722-6364	Wings for Life [WFL-CA-0916]	This work was supported by Wings for Life [WFL-CA-0916].	Amaranto DJ, 2009, J VASC SURG, V50, P1340, DOI 10.1016/j.jvs.2009.07.089; CHARLES ED, 1978, PARAPLEGIA, V15, P302, DOI 10.1038/sc.1977.46; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Craven BC, 2017, J SPINAL CORD MED, V40, P676, DOI 10.1080/10790268.2017.1368962; Cummins J, 2006, SPINE, V31, P806, DOI 10.1097/01.brs.0000207473.09030.0d; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dykes DC, 2009, CLIN ORTHOP RELAT R, V467, P2598, DOI 10.1007/s11999-009-0993-5; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Ellemers N, 2018, ANNU REV PSYCHOL, V69, P275, DOI 10.1146/annurev-psych-122216-011719; Fargen Kyle M, 2014, World Neurosurg, V82, pe21, DOI 10.1016/j.wneu.2014.03.030; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Ferguson MK, 2017, ANN THORAC SURG, V104, P284, DOI 10.1016/j.athoracsur.2017.01.066; FINE PR, 1987, INQUIRY-J HEALTH CAR, V24, P147; Furlan JC, 2009, SPINAL CORD, V47, P674, DOI 10.1038/sc.2009.23; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Furlan JC, 2012, TRAUMATIC BRAIN SPIN, P216; Furlan JC, 2013, AGING CLIN EXP RES, V25, P463, DOI 10.1007/s40520-013-0066-1; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Furlan JC, 2013, J NEUROTRAUM, V30, P487, DOI 10.1089/neu.2012.2539; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Furlan JC, 2009, J NEUROTRAUM, V26, P1361, DOI [10.1089/neu.2008.0764, 10.1089/neu.2008-0764]; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Furlan JC, 2009, J NEUROTRAUM, V26, P209, DOI 10.1089/neu.2008.0663; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; Greenwald BD, 2001, ARCH PHYS MED REHAB, V82, P1181, DOI 10.1053/apmr.2001.24891; Herren C, 2014, ORTHOPADE, V43, P1043, DOI 10.1007/s00132-014-3033-4; Hershman DL, 2008, JNCI-J NATL CANCER I, V100, P199, DOI 10.1093/jnci/djm320; Imai K, 1996, J CLIN EPIDEMIOL, V49, P505, DOI 10.1016/0895-4356(95)00576-5; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McCammon JR, 2011, J SPINAL CORD MED, V34, P6, DOI 10.1179/107902610X12923394765733; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; McCutcheon BA, 2015, J NEUROSURG, V123, P406, DOI 10.3171/2015.3.JNS131356; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; Nair BR, 2003, MED J AUSTRALIA, V179, P659; Nelson AR, 2003, UNEQUAL TREATMENT CO; NSCIC, 2016, SPIN CORD INJ FACTS; Nuno M, 2013, SPINE J, V13, P116, DOI 10.1016/j.spinee.2012.10.005; Politi MC, 2010, PATIENT EDUC COUNS, V80, P155, DOI 10.1016/j.pec.2009.10.030; Radke HRM, 2016, AM PSYCHOL, V71, P863, DOI 10.1037/a0040345; Santry HP, 2012, SURG CLIN N AM, V92, P137, DOI 10.1016/j.suc.2011.11.006; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Scivoletto G, 2004, CLIN REHABIL, V18, P709, DOI 10.1191/0269215504cr749oa; Shugarman LR, 2009, MED CARE, V47, P774, DOI 10.1097/MLR.0b013e3181a393fe; Shun PLW, 2017, AUST OCCUP THER J, V64, P149, DOI 10.1111/1440-1630.12327; Taylor BA, 2005, SPINE, V30, P359, DOI 10.1097/01.brs.0000152115.79236.6e; Van Den Berg M, 2011, J NEUROTRAUM, V28, P469, DOI 10.1089/neu.2010.1608; YEKUTIEL M, 1989, PARAPLEGIA, V27, P58, DOI 10.1038/sc.1989.9	52	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	SEP 30	2019	42			1	SI		S233	S241		10.1080/10790268.2019.1614291			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	JB8LC	WOS:000488819700026	31573451	Green Published			2022-02-06	
J	Sheng, CX; Peng, WJ; Xia, ZA; Wang, Y				Sheng, Chenxia; Peng, Weijun; Xia, Zian; Wang, Yang			Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method	XENOBIOTICA			English	Article						Hydroxysafflor yellow A; Xuebijing injection; pharmacokinetics; traumatic brain injury; biological fluids	INJECTION; NEUROPROTECTION; MANAGEMENT	Hydroxysafflor yellow A (HSYA) is the most pharmaceutically relevant compound in Xuebijing (XBJ) for traumatic brain injury (TBI) treatment. We aimed to investigate biofluids pharmacokinetics of HSYA from XBJ to ensure the drug safety and to guide the clinical use. A sensitive, rapid and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was applied to investigate pharmacokinetics of HSYA in TBI patients after intravenous administration of XBJ. Non-compartmental methods using DAS 3.0 software were applied to analyse the pharmacokinetic parameters. A similar half-life (Plasma(t1/2): 14.55 +/- 3.51 h vs. CSFt1/2: 15.73 +/- 3.63) was observed. HSYA reached the peak level rapidly, but exhibited a strongly slow absorption phase from blood to cerebrospinal fluid (CSF, Plasma(Tmax): 0.69 +/- 0.26 h vs. CSFTmax: 4.0 +/- 2.62 h). HSYA exhibited much higher C-max (Plasma(Cmax): 9342.76 +/- 2489.23 mu g/L vs. CSFCmax: 98.08 +/- 14.51 mu g/L) and AUC(0-t) (Plasma(AUC0-t): 57490.5 +/- 5560.3 mu g h/L vs. CSFAUC0-t: 1851.6 +/- 269.1 mu g h/L), yet a shorter CL (Plasma(CL): 0.02 +/- 0.002 L/h/kg vs. CSFCL: 0.55 +/- 0.01 L/h/kg) in plasma than in CSF. The AUC(CSF)/AUC(plasma) of HSYA was almost 3.37%. In summary, the results demonstrate that part of HSYA come across blood-brain barrier after XBJ administration. This study provides evidence for better understanding the pharmacokinetics and potential for clinical guidance of XBJ for TBI treatment.	[Sheng, Chenxia; Xia, Zian; Wang, Yang] Cent South Univ, Xiangya Hosp, Inst Integrat Med, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China; [Sheng, Chenxia; Peng, Weijun] Cent South Univ, Xiangya Hosp 2, Dept Tradit Chinese Med, Changsha, Hunan, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Inst Integrat Med, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017T100614, 2016M600639]	This research was supported by supported by the National Natural Science Foundation of China (No. 81673719), and the Project funded by China Postdoctoral Science Foundation (Nos. 2017T100614 and 2016M600639).	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Aylward LL, 2013, ENVIRON HEALTH PERSP, V121, P39, DOI 10.1289/ehp.1205544; Chen YY, 2015, J PHARMACEUT BIOMED, V112, P60, DOI 10.1016/j.jpba.2015.04.023; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Fu CY, 2019, J ETHNOPHARMACOL, V245, DOI 10.1016/j.jep.2019.112149; Guo Y, 2014, BIOMED CHROMATOGR, V28, P1090, DOI 10.1002/bmc.3124; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Jiang Tao, 2012, Journal of Third Military Medical University, V34, P307; Kou K, 2014, WORLD J EMERG MED, V5, P245, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.001; Liu Yuanyan, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/147362; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Scheff SW, 2017, J NEUROTRAUM, V34, P1491, DOI 10.1089/neu.2016.4718; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Sun ML, 2009, J ALTERN COMPLEM MED, V15, P1375, DOI 10.1089/acm.2009.0049; Wang L, 2016, J SURG RES, V202, P147, DOI 10.1016/j.jss.2015.12.041; Wang P, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1282-8; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Watzlawick R, 2016, JAMA NEUROL, V73, P149, DOI 10.1001/jamaneurol.2015.3627; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yuan X, 2009, J JIANGSU U MED EDIT, V19, P35; Zhao Wei, 2014, Sichuan Da Xue Xue Bao Yi Xue Ban, V45, P863; Zhong Y, 2018, EVID-BASED COMPL ALT, V2018, P1; Zuo LH, 2017, J PHARMACEUT BIOMED, V137, P220, DOI 10.1016/j.jpba.2017.01.024	27	4	5	3	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	MAY 3	2020	50	5					545	551		10.1080/00498254.2019.1668983		SEP 2019	7	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	KT2RP	WOS:000487627000001	31524030				2022-02-06	
J	Ali, B; Lawrence, BA; Miller, T; Allison, J				Ali, Bina; Lawrence, Bruce A.; Miller, Ted; Allison, Jennifer			Products and activities associated with non-fatal traumatic brain injuries in children and adolescents - United States 2010-2013	BRAIN INJURY			English	Article						Emergency department visit; TBI; NEISS; NEISS-AIP	FALLS	Background: Traumatic brain injury (TBI) is prevalent in children and adolescents ages <1-19 years, yet we have limited understanding of consumer products that are associated with TBIs in children and adolescents of varying ages. To address this gap, we combined two data sources to investigate leading products and activities associated with TBIs in children and adolescents in different developmental age groups (i.e. <1, 1-4, 5-9, 10-14, and 15-19 years). Methods: We analysed data from the National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP), augmented with product information from the National Electronic Injury Surveillance System (NEISS), for the years 2010 through 2013. Results: From 2010 to 2013, children and adolescents aged <1-19 years accounted for 4.1 million non-fatal TBI-related emergency department visits. TBIs from home furnishings and fixtures, primarily beds, were highest among infants aged <1 year and children aged 1-4 years. TBIs from sports/recreation, especially bicycles and football, were highest among those aged 5-9 years, 10-14 years, and 15-19 years. Conclusions: The combined NEISS and NEISS-AIP data allow us to comprehensively examine products and activities that contribute to emergency department visits for TBIs in children and adolescents. Our findings indicate priority areas for TBI prevention and intervention.	[Ali, Bina; Lawrence, Bruce A.; Miller, Ted] Pacific Inst Res & Evaluat, 11720 Beltsville Dr,Suite 900, Beltsville, MD 20705 USA; [Allison, Jennifer] Hlth Imperat, Brockton, MA USA		Ali, B (corresponding author), Pacific Inst Res & Evaluat, 11720 Beltsville Dr,Suite 900, Beltsville, MD 20705 USA.	bali@pire.org		Miller, Ted/0000-0002-0958-2639			Ali B, 2019, GLOB PEDIAT HLTH, V6, DOI [10.1177/2333794X18822996, DOI 10.1177/2333794X18822996]; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Ballesteros MF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040616; Bowman R, 2015, 19 TRIENN C INT ERG; Britton Jeffrey W, 2005, WMJ, V104, P33; Bull MJ, 2001, PEDIATRICS, V108, P1030; Centers for Disease Control and Prevention, 2017, COST INJ DAT; Centers for Disease Control and Prevention, 2017, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Hall J.E., 2016, COMPREHENSIVE TECHNI; Johnson DA, 2010, P INT C CONT ERG HUM; Kendrick Denise, 1800, Evid Based Child Health, V8, P761, DOI 10.1002/ebch.1911; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lawrence BA, 2015, INJURY PREV, V21, P23, DOI 10.1136/injuryprev-2014-041220; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mack KA, 2007, INJURY PREV, V13, P137, DOI 10.1136/ip.2006.013193; Mack KA, 2010, AM J LIFESTYLE MED, V4, P75, DOI 10.1177/1559827609348476; Miller TR, 2009, BRAIN TRAUMA CRITICA, P445; Norton C, 2004, ARCH DIS CHILD, V89, P103, DOI 10.1136/adc.2002.013045; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Parikh SN, 2010, PEDIATRICS, V126, P352, DOI 10.1542/peds.2010-0333; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U. S. Consumer Product Safety Commission, 2017, NEISS NAT EL INJ SUR; US Consumer Product Safety Commission, 2013, NEISS COD MAN; Vish NL, 2005, INJURY PREV, V11, P300, DOI 10.1136/ip.2005.008664; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Young B, 2013, ACCIDENT ANAL PREV, V60, P158, DOI 10.1016/j.aap.2013.08.001; Zimmerman GM, 2013, AM J PUBLIC HEALTH, V103, P435, DOI 10.2105/AJPH.2012.300931	30	4	4	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1425	1429		10.1080/02699052.2019.1631483			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000480248800004	31355679				2022-02-06	
J	Schmidt, JD; Lempke, LB; Devos, H; Lynall, RC				Schmidt, Julianne D.; Lempke, Landon B.; Devos, Hannes; Lynall, Robert C.			Post-concussion driving management among athletic trainers	BRAIN INJURY			English	Article						Mild traumatic brain injury; concussion; motor vehicle collision; best practices; motor vehicle crash; impaired driving	CESSATION	Primary objective: To describe and compare athletic trainer (AT) post-concussion driving management practices and opinions. Research design: Cross-sectional. Methods & procedures: A survey was sent via email to 8,723 ATs (10.8% response rate[945/8723]) to capture demographics, management practices, and opinions (agreement on a seven-point Likert scale). We used Kruskal-Wallis tests to compare the percentage of patients instructed to refrain from driving across the highest earned a degree, setting, and years certified (alpha = 0.05). Main outcomes & results: When asked whether they recommended patients with concussion refrain from driving, 58.5%(n = 553/945) of ATs responded "sometimes", 37.9%(n = 358/945) responded "always", and 3.6%(n = 34/945) responded "never". ATs responding "sometimes" or "always" estimated that they instruct 57.6 +/- 37.6% of patients with concussion to refrain from driving. ATs most commonly: recommended that patients refrain from driving until symptom resolution(44.7%,n = 399/892); utilized their clinical exam (patient interview/history) to determine when a patient could resume driving(64.9%,n = 579/892); and provided instructions verbally(94.2%,n = 840/892). High school(60.5 +/- 37.6%) and clinical ATs(66.5 +/- 31.2%) trended toward higher percentages of patients they instruct to refrain from driving relative to college(52.3 +/- 38.2%; chi(2)(2) = 5.92,p = .052). Conclusions: ATs recommend driving restrictions to some, but not all, patients with concussion. Overall, ATs recognize post-concussion driving dangers, but do not strongly endorse refraining from driving after a concussion. High school and clinical ATs may manage more adolescent novice drivers and, therefore, act more conservatively.	[Schmidt, Julianne D.; Lempke, Landon B.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Devos, Hannes] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Lempke, Landon/C-4800-2018; Devos, Hannes/I-6852-2019; Lynall, Robert/M-2888-2014	Lempke, Landon/0000-0003-0007-1362; Devos, Hannes/0000-0002-8853-6840; Lynall, Robert/0000-0002-0785-6640			Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Coulombe BJ, 2019, J ATHL TRAINING, V54, P142, DOI 10.4085/1062-6050-86-17; Devos H, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.1535; Fuermaier ABM, 2018, BMC GERIATR, V18, P1; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Klein TA, 2017, J PEDIATR HEALTH CAR, V31, P441, DOI 10.1016/j.pedhc.2016.11.004; Lempke LB, 2018, J ATH TRAIN; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Mazerolle SM, 2018, J ATHL TRAINING, V53, P788, DOI 10.4085/1062-6050-311-17; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moore JB, 2018, B J SPORTS MED, V5, P495; Owens Katherine, 2009, P43, DOI 10.1007/978-3-7643-9923-8_3; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Savage JL, 2018, J ATHL TRAINING, V53, P983, DOI 10.4085/1062-6050-394-17; Schmidt JD, 2018, J NEUROTRAUM, V35, P2418, DOI 10.1089/neu.2018.5707; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Stuart Emily A, 2016, Pediatr Qual Saf, V1, pe006, DOI 10.1097/pq9.0000000000000006; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Williamson CL, 2018, J ATHL TRAINING, V53, P990, DOI 10.4085/1062-6050-234-17; Windsor TD, 2007, GERONTOLOGIST, V47, P215, DOI 10.1093/geront/47.2.215	25	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1652	1659		10.1080/02699052.2019.1664765		SEP 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000486953300001	31526055				2022-02-06	
J	Staib-Lasarzik, I; Nagel, N; Sebastiani, A; Griemert, EV; Thal, SC				Staib-Lasarzik, Irina; Nagel, Nadine; Sebastiani, Anne; Griemert, Eva-Verena; Thal, Serge C.			Analgesic treatment limits surrogate parameters for early stress and pain response after experimental subarachnoid hemorrhage	BMC NEUROSCIENCE			English	Article						Pain; Analgesia; Subarachnoid hemorrhage; Traumatic brain injury; Perioperative analgesia; Buprenorphine; Carprofen	FILAMENT PERFORATION MODEL; SUSTAINED-RELEASE; BUPRENORPHINE; MICE; INDUCTION; RECOVERY	Background In animal research, authorities require a classification of anticipated pain levels and a perioperative analgesia protocol prior to approval of the experiments. However, data on this topic is rare and so is the reported use of analgesics. We determined surrogate parameters of pain and general well-being after subarachnoid hemorrhage (SAH), as well as the potential for improvement by different systemic analgesia paradigms. Brain injury was induced by filament perforation to mimic SAH. Sham-operated mice were included as surgical control groups with either neck or no-neck preparation. Mice with controlled cortical impact (CCI) injury were included as a control group with traumatic brain injury (TBI), but without neck preparation. Mice were randomized to buprenorphine, carprofen, meloxicam, or vehicle treatment. 24 h after SAH, CCI or sham surgery, pain and stress levels were assessed with a visual assessment score and the amount of food intake was recorded. Results Neck preparation, which is required to expose the surgical field for SAH induction, already increased pain/stress levels and sham surgeries for both CCI and SAH reduced food intake. Pain/stress levels were higher and food intake was lower after SAH compared with CCI. Pain/stress levels after CCI without analgesic treatment were similar to levels after SAH sham surgery. Pain treatment with buprenorphine was effective to reduce pain after SAH, whereas lower pain/stress intensity levels after CCI were not improved. Conclusion This study emphasizes the importance of pain and stress assessment after surgeries and the efficacy of buprenorphine to improve pain and comfort levels after experimental SAH.	[Staib-Lasarzik, Irina; Nagel, Nadine; Sebastiani, Anne; Griemert, Eva-Verena; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729			Adamson TW, 2010, J AM ASSOC LAB ANIM, V49, P610; Buhler D, 2014, TRANSL STROKE RES, V5, P653, DOI 10.1007/s12975-014-0366-6; Clark TS, 2014, J AM ASSOC LAB ANIM, V53, P387; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Flecknell PA, 1999, LAB ANIM, V33, P169, DOI 10.1258/002367799780578381; Griemert EV, 2019, ANN NEUROL, V85, P667, DOI 10.1002/ana.25458; Han SM, 2017, PAIN PHYSICIAN, V20, pE593; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Henke JHJ, 2013, FACHINFORMATION SCHM; Jirkof P, 2015, LAB ANIM-UK, V49, P177, DOI 10.1177/0023677214562849; Kendall LV, 2014, J AM ASSOC LAB ANIM, V53, P478; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Muroi C, 2016, J CLIN NEUROSCI, V28, P141, DOI 10.1016/j.jocn.2015.10.045; Neulen A, 2019, TRANSL STROKE RES, V10, P319, DOI 10.1007/s12975-018-0647-6; Pinkernell S, 2016, LAB ANIM-UK, V50, P442, DOI 10.1177/0023677216675010; Roughan JV, 2016, EUR J PAIN, V20, P231, DOI 10.1002/ejp.712; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Sarabia-Estrada R, 2017, LAB ANIMAL, V46, P242, DOI 10.1038/laban.1277; Sasaki K, 2017, NEUROSCI LETT, V653, P173, DOI 10.1016/j.neulet.2017.05.047; Schucany WR, 2006, COMMUN STAT-THEOR M, V35, P2275, DOI 10.1080/03610920600853308; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thomas C, 2016, MOL IMAGING, V15, DOI 10.1177/1536012116639189; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231	29	4	4	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	SEP 18	2019	20	1							49	10.1186/s12868-019-0531-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IY9OU	WOS:000486723500001	31533626	Green Published, gold			2022-02-06	
J	de Grau, S; Post, A; Hoshizaki, TB; Gilchrist, MD				de Grau, Santiago; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Effects of surface compliance on the dynamic response and strains sustained by a player's helmeted head during ice hockey impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Ice hockey; helmet performance; compliance; brain injury risk; concussion; linear acceleration; rotational acceleration; maximum principal strain	SYSTEMATIC VIDEO ANALYSIS; MAXIMUM PRINCIPAL STRAIN; TRAUMATIC BRAIN-INJURY; ACCIDENT RECONSTRUCTION; INTRACRANIAL-PRESSURE; CORPUS-CALLOSUM; LEAGUE NHL; ACCELERATION; CONCUSSION; PREDICTORS	In hockey, players experience different compliances during impacts to the head, from stiff ice to compliant collisions against other players. The objective of this study was to examine the effect of striking compliance in ice hockey impacts and its influence on dynamic response and brain tissue strain. Three striking caps of low, medium, and high compliances were used to impact a helmeted 50th-percentile Hybrid III headform. The headform was impacted at five locations at three velocities, representative of collision scenarios in hockey. The dependent variables, peak resultant linear and rotational acceleration as well as maximum principal strain were analyzed using a multivariate analysis of variance to determine significant differences between the compliances. The results indicated a significant effect of compliance on the responses of the headform. As expected, low-impact compliance resulted in higher linear and rotational accelerations when compared to the medium and high compliance conditions. However, while the linear and rotational acceleration responses of the medium and high compliance conditions would indicate a low chance of brain injury, the maximum principal strain magnitudes indicated a high likelihood of concussion. Medium- and high-impact compliances are a factor that has not been considered when designing and testing helmet technology in sport, with current methods reflective of low compliance surfaces, that is, those with high stiffness and rigidity. The results of this study demonstrate that an impact compliance is an important factor in producing brain injury and should be considered when certifying helmets through standard testing to mitigate the risk of brain injury.	[de Grau, Santiago; Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Room A106,200 Lees Ave, Ottawa, ON K1N 6N5, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Sch Human Kinet, Room A106,200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			Canadian Standards Association (CSA), 2015, Z262115 CSA; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ho J, 2008, THESIS; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kendall M, 2012, P IRCOBI C DUBL 12 1; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, P 20 ESV C LYON 18 2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li XG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33393-z; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Nahum A, 1977, 21 STAPP CAR CRASH C; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rousseau P., 2014, THESIS; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Van Lierde C, 2005, THESIS; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, 39 STAPP CAR CRASH C	47	4	4	3	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	MAR	2020	234	1					98	106	1754337119871866	10.1177/1754337119871866		SEP 2019	9	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	KL2MZ	WOS:000491086700001					2022-02-06	
J	Kusec, A; Velikonja, D; DeMatteo, C; Harris, JE				Kusec, Andrea; Velikonja, Diana; DeMatteo, Carol; Harris, Jocelyn E.			Motivation in rehabilitation and acquired brain injury: can theory help us understand it?	DISABILITY AND REHABILITATION			English	Article						Motivation; Self-determination Theory; acquired brain injury; traumatic brain injury; measurement	SELF-DETERMINATION THEORY; QUESTIONNAIRE MOT-Q; INTRINSIC MOTIVATION; PSYCHOMETRIC PROPERTIES; IMPAIRED AWARENESS; ENGAGEMENT; THERAPY; INTERVENTIONS; ANXIETY; DISORDERS	Background: In acquired brain injury (ABI) populations, low motivation to engage in rehabilitation is associated with poor rehabilitation outcomes. Motivation in ABI is thought to be influenced by internal and external factors. This is consistent with Self-determination Theory, which posits that motivation is intrinsic and extrinsic. This paper discusses the benefit of using Self-determination Theory to guide measurement of motivation in ABI. Methods: Using a narrative review of the Self-determination Theory literature and clinical rehabilitation research, this paper discusses the unique role intrinsic and extrinsic motivation has in healthcare settings and the importance of understanding both when providing rehabilitation in ABI. Results: Based on the extant literature, it is possible that two independently developed measures of motivation for ABI populations, the Brain Injury Rehabilitation Trust Motivation Questionnaire-Self and the Motivation for Traumatic Brain Injury Rehabilitation Questionnaire, may assess intrinsic and extrinsic motivation, respectively. Conclusion: Intrinsic and extrinsic motivation in ABI may be two equally important but independent factors that could provide a comprehensive understanding of motivation in individuals with ABI. This increased understanding could help facilitate behavioural approaches in rehabilitation.	[Kusec, Andrea; DeMatteo, Carol; Harris, Jocelyn E.] McMaster Univ, Inst Appl Hlth Sci, Sch Rehabil Sci, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada; [Velikonja, Diana] Acquired Brain Injury Program, Hamilton Hlth Sci, Hamilton, ON, Canada; [Velikonja, Diana] McMaster Univ, DeGroote Sch Med, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada		Harris, JE (corresponding author), McMaster Univ, Inst Appl Hlth Sci, Sch Rehabil Sci, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada.	jharris@mcmaster.ca	Harris, Jocelyn Ellen/ABE-7420-2021	Harris, Jocelyn Ellen/0000-0002-3293-1833	Toronto Rehab Scholarship in Rehabilitation-related Research for Graduate Students with Disabilities; McMaster University; Acquired Brain Injury inpatient service; Acquired Brain Injury outpatient service	The present research was supported by the Toronto Rehab Scholarship in Rehabilitation-related Research for Graduate Students with Disabilities, awarded to the first author. Funding for study-related expenses was provided by McMaster University. Acquired Brain Injury inpatient and outpatient services for their support of this study.	Andrewes HE, 2014, BRAIN INJURY, V28, P965, DOI 10.3109/02699052.2014.888764; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Baldwin BT, 1919, PSYCHOL BULL, V16, P267, DOI 10.1037/h0070987; Bandura A, 1986, SOCIAL FDN THOUGHT A; Barch DM, 2008, J ABNORM PSYCHOL, V117, P776, DOI 10.1037/a0013944; Beck AT., 1979, COGNITIVE THERAPY DE; Boosman H, 2016, NEUROPSYCHOL REHABIL, V26, P87, DOI 10.1080/09602011.2014.1001409; Brett CE, 2017, NEUROPSYCHOL REHABIL, V27, P959, DOI 10.1080/09602011.2015.1090459; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Buckworth J, 2007, PSYCHOL SPORT EXERC, V8, P441, DOI 10.1016/j.psychsport.2006.06.007; Cerasoli CP, 2014, PSYCHOL BULL, V140, P980, DOI 10.1037/a0035661; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Choi J, 2014, SCHIZOPHR RES, V153, P209, DOI 10.1016/j.schres.2014.01.027; Cullimore AR., 1921, MOD HOSP, V17, P537; Danzl Megan M, 2012, J Allied Health, V41, P35; Davis JE., 1932, OCCUP THER REHABIL, V11, P367; Deci E, 2002, HDB SELF DETERMINATI; Deci E. L., 2012, OXFORD HDB HUMAN MOT, P85, DOI DOI 10.1093/OXFORDHB/9780195399820.013.0006; Deci E.L., 1985, INTRINSIC MOTIVATION; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; DECI EL, 1971, J PERS SOC PSYCHOL, V18, P105, DOI 10.1037/h0030644; DeHope E, 1999, NEUROREHABILITATION, V13, P3; Dixon G, 2007, CLIN REHABIL, V21, P230, DOI 10.1177/0269215506071784; Drieschner KH, 2004, CLIN PSYCHOL REV, V23, P1115, DOI 10.1016/j.cpr.2003.09.003; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fortier MS, 2002, J HEALTH PSYCHOL, V17, P87; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P563, DOI 10.1080/09602011.2012.676284; Jochems EC, 2016, CLIN PSYCHOL PSYCHOT, V23, P438, DOI 10.1002/cpp.1971; Jones L. F., 2002, MOTIVATING OFFENDERS, P31; Kusec A, 2018, REHAB PSYCHOL, V63, P92; Law M., 1987, CAN J OCCUP THER, V54, P133, DOI [DOI 10.1177/000841748705400308, 10.1177/000841748705400308]; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lequerica AH, 2006, REHABIL PSYCHOL, V51, P331, DOI 10.1037/0090-5550.51.4.331; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Lequerica AH, 2009, DISABIL REHABIL, V31, P753, DOI 10.1080/09638280802309095; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Lucas SE, 2005, AUSTR OCCUPATIONAL T, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; MacDonald GA, 2012, NZ J PHYSIOTHERAPY, V41, P112; Maclean N, 2000, SOC SCI MED, V50, P495; Maclean N, 2002, STROKE, V33, P444, DOI 10.1161/hs0202.102367; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Reiss S, 2012, TEACH PSYCHOL, V39, P152, DOI 10.1177/0098628312437704; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sheldon KM, 1996, PERS SOC PSYCHOL B, V22, P1270, DOI 10.1177/01461672962212007; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Smeets SMJ, 2014, NEUROPSYCHOLOGY, V28, P717, DOI 10.1037/neu0000068; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Stalder-Luthy F, 2013, ARCH PHYS MED REHAB, V94, P1386, DOI 10.1016/j.apmr.2013.02.013; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40	65	4	4	3	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	SEP 11	2019	41	19					2343	2349		10.1080/09638288.2018.1467504			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IE7WH	WOS:000472585200013	29693464				2022-02-06	
J	Korley, FK; Peacock, WF; Eckner, JT; Maio, R; Levin, S; Bechtold, KT; Peters, M; Roy, D; Falk, HJ; Hall, AJ; Van Meter, TE; Gonzalez, R; Diaz-Arrastia, R				Korley, Frederick K.; Peacock, W. Frank; Eckner, James T.; Maio, Ronald; Levin, Scott; Bechtold, Kathleen T.; Peters, Matthew; Roy, Durga; Falk, Hayley J.; Hall, Anna J.; Van Meter, Timothy E.; Gonzalez, Richard; Diaz-Arrastia, Ramon			Clinical Gestalt for Early Prediction of Delayed Functional and Symptomatic Recovery From Mild Traumatic Brain Injury Is Inadequate	ACADEMIC EMERGENCY MEDICINE			English	Article; Early Access							ACUTE CONCUSSION; HEAD-INJURY; CHILDREN		[Korley, Frederick K.; Maio, Ronald; Falk, Hayley J.] Univ Michigan, Med Sch, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Med Sch, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Gonzalez, Richard] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Peacock, W. Frank] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Levin, Scott; Hall, Anna J.] Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD USA; [Bechtold, Kathleen T.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Peters, Matthew; Roy, Durga] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Van Meter, Timothy E.] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA		Korley, FK (corresponding author), Univ Michigan, Med Sch, Dept Emergency Med, Ann Arbor, MI 48109 USA.	korley@med.umich.edu			ImmunArray	The HeadSMART cohort was funded by ImmunArray.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	10	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.												10.1111/acem.13844		SEP 2019	4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IX6XK	WOS:000485828100001	31397520				2022-02-06	
J	Windle, K; Sullivan, KA				Windle, Kristy; Sullivan, Karen A.			Towards an embedded symptom validity indicator for the rivermead postconcussion symptom questionnaire	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Mild traumatic brain injury; post concussion symptoms; rivermead post concussion symptoms questionnaire; symptom validity test	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; RECOGNITION MEMORY TEST; COMMON DATA ELEMENTS; CLINICAL UTILITY; SERVICE MEMBERS; RESPONSE BIAS; PERFORMANCE; SCALE	This simulation study aimed to develop and test an embedded symptom validity indicator for use with the Rivermead Post Concussion Symptoms Questionnaire (RPQ). Seven mild traumatic brain injury (mTBI) experts assisted in generating a shortlist of 15 atypical postconcussion symptoms. A modified RPQ (mRPQ) was constructed by embedding these items with the 16 standard RPQ items. Eighty-four mTBI simulators completed the mRPQ after random allocation to a symptom-exaggeration condition (ES group; n = 46) or simulation-only condition (S group; n = 38). They also completed the Test of Memory Malingering (TOMM) and the Recognition Memory Test (RMT), and the groups were re-formed and compared using modified criteria for Malingered Neurocognitive Dysfunction (mMND). There was no significant group by item-type interaction for either grouping methods (i.e. as allocated or as reclassified). Exploratory analyses of the main effects showed that ES group had higher mRPQ scores than the S group, and standard symptoms were endorsed more than atypical symptoms. If further developed, the mRPQ could eventually aid the screening of PCS over-reporting.	[Windle, Kristy; Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Brisbane, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Brisbane, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology (QUT); QUT Human Research Ethics Committee [1800000471]; QUT health and safety risk assessment process [1011]	The authors thank the School of Psychology and Counselling, Queensland University of Technology (QUT) for funding the gift cards and flyers for this project and the expert reviewers who volunteered to review the items, and Deborah Anderson for assisting with the operationalization of the mMND criteria. This project was approved by the QUT Human Research Ethics Committee (Approval # 1800000471) and the QUT health and safety risk assessment process (Approval # 1011). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Armistead-Jehle P, 2018, ARCH CLIN NEUROPSYCH, V33, P120, DOI 10.1093/arclin/acx031; Ashendorf L, 2019, J CLIN EXP NEUROPSYC, V41, P432, DOI 10.1080/13803395.2019.1567693; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Bodapati AS, 2019, CLIN NEUROPSYCHOL, V33, P539, DOI 10.1080/13854046.2018.1482003; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Copeland CT, 2016, ARCH CLIN NEUROPSYCH, V31, P18, DOI 10.1093/arclin/acv065; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Deng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21689; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Garcia-Willingham N. E., 2018, CLIN ASSESSMENT MALI, P329; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gordon KE, 2018, BRAIN INJURY, V32, P843, DOI 10.1080/02699052.2018.1463105; Guidotti L. M., 2013, MILD TRAUMATIC BRAIN, P145; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Merckelbach H, 2019, CURR DIR PSYCHOL SCI, V28, P321, DOI 10.1177/0963721419837681; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Millis S. R., 2003, DETECTION RESPONSE B, V2, P151; Millis S. R., 2003, J FORENSIC NEUROPSYC, V2, P147, DOI [10.1300/J151v02n03_07, DOI 10.1300/J151V02N03_07]; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Nelson N.W., 2013, MILD TRAUMATIC BRAIN, P119; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rogers R., 2018, CLIN ASSESSMENT MALI, V2018; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P691, DOI 10.1016/S0887-6177(01)00171-8; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26; Thompson HJ, 2015, ANNU REV NURS RES-SE, V33, P1, DOI 10.1891/0739-6686.33.1; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Warrington E, 1984, RECOGNITION MEMORY T, V1; Widows M. R., 2005, STRUCTURED INVENTORY; [No title captured]	63	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 3	2021	28	5					512	524		10.1080/23279095.2019.1660880		SEP 2019	13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TZ3RO	WOS:000485108500001	34380355				2022-02-06	
J	Atlan, LS; Margulies, SS				Atlan, Lorre S.; Margulies, Susan S.			Frequency-Dependent Changes in Resting State Electroencephalogram Functional Networks after Traumatic Brain Injury in Piglets	JOURNAL OF NEUROTRAUMA			English	Article						EEG; functional network; pediatric brain injury; porcine; resting state	CEREBRAL-BLOOD-FLOW; ROTATIONAL HEAD-INJURY; POSTCONCUSSIONAL-SYNDROME; QUANTITATIVE EEG; SPECTRAL-ANALYSIS; SLEEP EEG; CONNECTIVITY; ISOFLURANE; NEWBORN; OXYGEN	Traumatic brain injury (TBI) is a major health concern in children, as it can cause chronic cognitive and behavioral deficits. The lack of objective involuntary metrics for the diagnosis of TBI makes prognosis more challenging, especially in the pediatric context, in which children are often unable to articulate their symptoms. Resting state electroencephalograms (EEG), which are inexpensive and non-invasive, and do not require subjects to perform cognitive tasks, have not yet been used to create functional brain networks in relation to TBI in children or non-human animals; here we report the first such study. We recorded resting state EEG in awake piglets before and after TBI, from which we generated EEG functional networks from the alpha (8-12 Hz), beta (16.5-25 Hz), broad (1-35 Hz), delta (1-3.5 Hz), gamma (30-35 Hz), sigma (13-16 Hz), and theta (4-7.5 Hz) frequency bands. We hypothesize that mild TBI will induce persistent frequency-dependent changes in the 4-week-old piglet at acute and chronic time points. Hyperconnectivity was found in several frequency band networks after TBI. This study serves as proof of concept that the study of EEG functional networks in awake piglets may be useful for the development of diagnostic metrics for TBI in children.	[Atlan, Lorre S.; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Georgia Tech, UA Whitaker Biomed Engn Bldg,313 Ferst Dr, Atlanta, GA 30332 USA.	susan.margulies@gatech.edu					Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; [Anonymous], 2015, MATLAB R; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Atlan LS, 2018, J NEUROSCI RES, V96, P536, DOI 10.1002/jnr.24108; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Boersma M, 2011, HUM BRAIN MAPP, V32, P413, DOI 10.1002/hbm.21030; Borich MR, 2015, J NEUROL PHYS THER, V39, P43, DOI 10.1097/NPT.0000000000000072; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; CUCCHIARA RF, 1974, ANESTHESIOLOGY, V40, P571, DOI 10.1097/00000542-197406000-00011; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davison A. C., 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.1017/CBO9780511802843]; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; Duhaime A. C., 1998, PATHOPHYSIOLOGY, V5, P236, DOI DOI 10.1016/50928-4680(98)81216-9; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fallani FD, 2010, INT J BIFURCAT CHAOS, V20, P905, DOI 10.1142/S0218127410026198; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; FENTON GW, 1994, J ROY SOC MED, V87, P499; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Fulop SA, 2006, J ACOUST SOC AM, V119, P360, DOI 10.1121/1.2133000; Gao X, 2008, J STAT PLAN INFER, V138, P2574, DOI 10.1016/j.jspi.2007.10.015; Gavilanes AWD, 2001, CLIN NEUROPHYSIOL, V112, P52, DOI 10.1016/S1388-2457(00)00499-5; Gazzellini S, 2017, DEV NEUROREHABIL, V20, P393, DOI 10.1080/17518423.2016.1216470; GELMAN S, 1984, ANESTH ANALG, V63, P557; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hertle Daniel, 2012, Acta Neurochir Suppl, V114, P383, DOI 10.1007/978-3-7091-0956-4_74; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ioroi T, 2002, EXP BRAIN RES, V144, P172, DOI 10.1007/s00221-002-1030-z; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Knyazev GG, 2017, PERS INDIV DIFFER, V118, P39, DOI 10.1016/j.paid.2017.03.012; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; Konietschke F, 2015, J STAT SOFTW, V64; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; Kramer MA, 2011, J NEUROSCI, V31, P15757, DOI 10.1523/JNEUROSCI.2287-11.2011; Lee DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058748; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Maltese M.R., 2012, THESIS, P1; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Moeller JJ, 2011, ARCH NEUROL-CHICAGO, V68, P1595, DOI 10.1001/archneurol.2011.1080; Musso F, 2010, NEUROIMAGE, V52, P1149, DOI 10.1016/j.neuroimage.2010.01.093; Nadlonek NA, 2015, J PEDIATR SURG, V50, P1338, DOI 10.1016/j.jpedsurg.2015.03.060; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nishida K, 2013, CLIN NEUROPHYSIOL, V124, P1106, DOI 10.1016/j.clinph.2013.01.005; Nunez PL, 2015, CLIN NEUROPHYSIOL, V126, P110, DOI 10.1016/j.clinph.2014.04.003; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2016, CLIN NEUROPHYSIOL, V127, P3, DOI 10.1016/j.clinph.2015.07.005; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Nuwer MR, 1996, BRAIN TOPOGR, V8, P201, DOI 10.1007/BF01184770; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; OLSEN KS, 1993, ACTA NEUROCHIR, V125, P83, DOI 10.1007/BF01401832; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pareja JCM, 2016, METHODS MOL BIOL, V1462, P345, DOI 10.1007/978-1-4939-3816-2_19; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Pevzner A, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00030; Porter S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00373; R Development Core Team, 2012, R LANG ENV STAT COMP; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saby JN, 2012, DEV NEUROPSYCHOL, V37, P253, DOI 10.1080/87565641.2011.614663; Saito T, 2005, PHYSIOL BEHAV, V84, P725, DOI 10.1016/j.physbeh.2005.02.018; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith JH, 2005, ACTA ANAESTH SCAND, V49, P23, DOI 10.1111/j.1399-6576.2004.00535.x; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; VONBIERBRAUER A, 1992, EEG-EMG-Z ELEK ELEKT, V23, P151; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Zheng L., 2012, CHIN J CONT NEUROL N, V12, P558	105	4	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2558	2578		10.1089/neu.2017.5574			21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000485289000010	30909806	Green Published			2022-02-06	
J	Bernstein, JPK; Calamia, M; Mullenix, S				Bernstein, John P. K.; Calamia, Matthew; Mullenix, Shelly			Predictors of Collegiate Student-Athletes' Concussion-Related Knowledge and Behaviors	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Concussion; Mild traumatic brain injury; Head injury; Knowledge	HIGH-SCHOOL; IMPACT; DEPRESSION; ATTITUDES; PLAYERS; COACHES; PROGRAM	Objective: This study aimed to explore student-athletes' concussion-related knowledge and attitudes toward reporting symptoms, demographic predictors of knowledge and attitudes, and determine whether responses to the survey changed following an online educational intervention. Methods: A total of 108 Division I student-athletes enrolled at a large southern university completed a survey evaluating knowledge regarding concussion-related terminology, symptoms and recovery trajectories, as well as attitudes toward reporting symptoms following a possible concussion. Student-athletes completed the questionnaire both 24-48 h before and one week after reviewing the educational presentation. Results: At baseline, participants correctly identified 72% of concussion symptoms included in the questionnaire, as well as correctly identified 75% of items related to the typical recovery trajectory post-concussion. A total of 54% of baseline attitudes toward reporting symptoms matched clinical best practices. Multiple analysis of variance (MANOVA) revealed that male sex and non-Caucasian race were associated with worse baseline knowledge of concussion symptoms. Concussion knowledge was not associated with attitudes toward reporting symptoms. Paired samples t-tests indicated that knowledge of concussion-related terminology improved modestly following the educational presentation. Conclusions: Some subsets of collegiate student-athletes show relatively lower knowledge about symptoms of concussion than others. As a result, these groups may benefit from increased educational efforts to ensure they recognize when a concussion may have occurred. Additionally, as knowledge and attitudes were unrelated and the intervention had a modest effect on knowledge but not attitudes, future work should explore interventions that are designed to directly alter attitudes.	[Bernstein, John P. K.; Calamia, Matthew] Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA; [Mullenix, Shelly] Louisiana State Univ, Dept Athlet, Baton Rouge, LA 70803 USA		Bernstein, JPK (corresponding author), Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA.	jberns3@lsu.edu		Papanikolaou, Alexandros/0000-0002-0251-0990; Calamia, Matthew/0000-0002-7252-7181			Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2014, REQUIRING ATHLETES A; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hunt C, 2018, CAN J NEUROL SCI, V45, P283, DOI 10.1017/cjn.2017.299; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Scramstad C, 2017, CAN J NEUROL SCI, V44, P207, DOI 10.1017/cjn.2016.325; Shirazi M, 2015, CAN J NEUROLOGL SCI, V42, pS39; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Tator CH, 2009, CAN J NEUROL SCI, V36, P269, DOI 10.1017/S0317167100006922; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	37	4	4	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	SEP	2019	46	5					575	584	PII S0317167119000763	10.1017/cjn.2019.76			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IW5YW	WOS:000485055100012	31124763	Bronze			2022-02-06	
J	Bouzat, P; Ageron, FX; Thomas, M; Vallot, C; Hautefeuille, S; Schilte, C; Payen, JF				Bouzat, Pierre; Ageron, Francois-Xavier; Thomas, Marine; Vallot, Cecile; Hautefeuille, Serge; Schilte, Clotilde; Payen, Jean-Francois			Modeling the Influence of Age on Neurological Outcome and Quality of Life One Year after Traumatic Brain Injury: A Prospective Multi-Center Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						outcome; quality of life; severe trauma; traumatic brain injury	EXTERNAL VALIDATION; FOLLOW-UP; MORTALITY; POPULATION; EPIDEMIOLOGY; PROGNOSIS; IMPACT; CRASH; RISK	After traumatic brain injury (TBI), the relationship between age and outcome at 1 year, including quality of life, has been poorly explored. The aim of our study was to describe this relationship in a cohort of TBI patients in a regional trauma system. Consecutive TBI patients with severe lesions on initial brain computed tomography (CT) scan were included from July 2014 to July 2016 in two French level-1 trauma centers. The primary outcome was the mortality at 1 year and secondary outcomes were Glasgow Outcome Scale-Extended (GOS-E) and quality of life using the Short Form Health Survey (SF-12). The relationship between age and outcome was modeled using the generalized linear model (GLM). Within the study period, 427 patients with TBI and type 3 Abbreviated Injury Scale (AIS) lesions were included. Finally, 380 patients were assessed for mortality. Ninety-six (25%) patients died at 1 year. The detailed neurological status was available for 317 patients. One year after the trauma, 141 (44%) patients had a favorable outcome (GOS-E 7 and 8), whereas 53 (17%) patients had a moderate disability (GOS-E 5-6), 27 (9%) patients had a severe disability or were in a vegetative state (GOS-E 2-4), and 96 (30%) patients had died (GOS-E 1). After 70 years of age, a dramatic increase in the odds of death and poor neurological outcome was found using GLM. No difference according to age was found for the quality of life. After TBI, the mortality at 1 year dramatically increased with age after 70 years. For elderly survivors, impairment of quality of life was not different from younger patients.	[Bouzat, Pierre; Thomas, Marine; Schilte, Clotilde; Payen, Jean-Francois] Grenoble Univ Hosp, Grenoble Alps Trauma Ctr, Dept Anesthesiol & Intens Care Med, Grenoble, France; [Bouzat, Pierre; Payen, Jean-Francois] Grenoble Alps Univ, Grenoble Neurosci Inst, INSERM 1216, Grenoble, France; [Ageron, Francois-Xavier; Vallot, Cecile] RENAU Northern French Alps Emergency Network, Dept Publ Hlth, Annecy, France; [Ageron, Francois-Xavier; Vallot, Cecile; Hautefeuille, Serge] Annecy Hosp, Dept Intens Care, Annecy, France		Bouzat, P (corresponding author), Hop Albert Michallon, Pole Anesthesie Reanimat, BP 217, F-38043 Grenoble, France.	PBouzat@chu-grenoble.fr	Bouzat, Pierre/AAC-4105-2019	Bouzat, Pierre/0000-0003-4667-6738			Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bouzat P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0835-7; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gauss T, 2019, ANAESTH CRIT CARE PA, V38, P121, DOI 10.1016/j.accpm.2018.05.005; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Kiely JM, 2006, J SURG RES, V132, P214, DOI 10.1016/j.jss.2006.02.004; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schumacher R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0801-7; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457	29	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2506	2512		10.1089/neu.2019.6432			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000485289000004	30990114				2022-02-06	
J	Chao, LL				Chao, Linda L.			Improvements in Gulf War Illness Symptoms After Near-Infrared Transcranial and Intranasal Photobiomodulation: Two Case Reports	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; LIGHT; VETERANS; IRRADIATION; EXPOSURES; TOXICITY; COMPLEX; TIME	At least one-fourth of US veterans who served in the 1990-1991 Gulf War (GW) are affected by the chronic symptomatic illness known as Gulf War illness (GWI). This condition typically includes some combination of fatigue, headaches, cognitive dysfunction, musculoskeletal pain, and respiratory, gastrointestinal and dermatologic complaints. To date, effective treatments for GWI have been elusive. Photobiomodulation (PBM) describes the non-pharmacological, non-thermal use of light to stimulate, heal, and protect tissue that has either been injured, is degenerating, or else is at risk of dying. Significant benefits have been reported following application of transcranial PBM to humans with acute stoke, traumatic brain injury (TBI), and dementia. This report describes the first documentation of improved GWI symptoms in two GW veterans following 12 weeks of PBM treatments.	[Chao, Linda L.] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, 4150 Clement St 114M, San Francisco, CA 94121 USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA		Chao, LL (corresponding author), San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, 4150 Clement St 114M, San Francisco, CA 94121 USA.; Chao, LL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Chao, LL (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.				 [1I01CX000798]	.VA grant No. 1I01CX000798 entitled "Longitudinal Assessment of Gulf War Veterans with Suspected Sarin Exposure."	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; Boonswang N Ab, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.08.2011.4689; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Golomb BA, 2012, NATURE PRECEEDINGS; Golomb BA, 2014, NEURAL COMPUT, V26, P2594, DOI 10.1162/NECO_a_00659; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hayley AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112238; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Institute of Medicine (IOM), 2014, CHRON MULT ILL GULF; Institute of Medicine (IOM), 2010, GULF WAR HLTH HLTH E, V8; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2013, TRANSL STROKE RES, V4, P704, DOI 10.1007/s12975-013-0303-0; Lee HI, 2016, RESTOR NEUROL NEUROS, V34, P201, DOI 10.3233/RNN-150559; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; Linnane AW, 2002, ANN NY ACAD SCI, V959, P396, DOI 10.1111/j.1749-6632.2002.tb02110.x; Linnane AW, 2002, ANN NY ACAD SCI, V959, P463; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Mease PJ, 2011, ARTHRIT CARE RES, V63, P821, DOI 10.1002/acr.20449; Milatovic D, 2006, THESCIENTIFICWORLDJO, V6, P295, DOI 10.1100/tsw.2006.38; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; [Research Advisory Committee on Gulf War Veterans Illness (RAC GWVI) Research Advisory Committee], 2008, SCI FIND REC, P465; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Salehpour F, 2017, REV NEUROSCIENCE, V28, P441, DOI 10.1515/revneuro-2016-0087; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele L, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-4; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; U.S. Department of Veterans Affairs, GULF WAR VET MED UN; Waypa GB, 2016, MOL ASPECTS MED, V47-48, P76, DOI 10.1016/j.mam.2016.01.002; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yan XD, 2017, LASER MED SCI, V32, P169, DOI 10.1007/s10103-016-2099-0; Yang M, 2009, CURR MED RES OPIN, V25, P2487, DOI 10.1185/03007990903167415; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002	59	4	4	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2019	184	9-10					E565	E571		10.1093/milmed/usz037			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JN5MC	WOS:000496941400022	30916762	hybrid			2022-02-06	
J	Daskas, N; Sharples, P; Likeman, M; Lightman, S; Crowne, EC				Daskas, N.; Sharples, P.; Likeman, M.; Lightman, S.; Crowne, E. C.			Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							LUTEINIZING-HORMONE; PITUITARY-FUNCTION; GH SECRETION; CHILDREN; HYPOPITUITARISM; ADOLESCENTS; RELIABILITY; DEFICIENCY; INVENTORY; VALIDITY	Context: Traumatic brain injury (TBI) is a recognised cause of hypopituitarism in adults but the prevalence after childhood TBI remains controversial. Objective: To investigate long-term endocrine outcomes and quality of life (PedsQL and QoL-AGHDA (Quality of Life in Adult Growth Hormone Deficiency Assessment)) following childhood TBI. Design: Prospective study. Methods: Participants with moderate/severe TBI (n = 31) and controls (n = 17). Mean (range) age: 19.8 +/- 4.2 (11-26), time post TBI: 9 (7-11) years. Detailed endocrine evaluation of stimulated (insulin tolerance test (ITT)) and spontaneous GH secretion (overnight profile) was undertaken in the TBI group; QoL and neuroimaging in both groups. Results: No participant had seizures, short stature, precocious puberty or hypothyroidism. In 6/25 the ITT GH response was below age-defined cut-offs and cortisol <500 nmol/L in 2/25. Mean spontaneous GH secretion was <3.1 mu g/L in 16/22 but peak GH was low only in 1/22 profiles. One patient had abnormal spontaneous and stimulated GH secretion and hypogonadism. Fatigue and depression scores were higher in TBI patients (P = .011 and P = .020). Fatigue correlated with measures of spontaneous but not stimulated GH secretion. Overall QoL (PedsQL) did not differ between groups but specific attributes of health state (cognition, memory) were impaired in TBI patients. Pituitary neuroimaging was normal in all participants. Conclusions: Fatigue and depression were common 8-10 years post childhood TBI. One individual had GHD (1/22) using rigorous diagnostic criteria. A single ITT potentially over-diagnosed GHD in 25% (6/25) without clear correlation with symptoms underlying the importance of using two diagnostic tests in TBI survivors.	[Daskas, N.; Crowne, E. C.] Univ Hosp Bristol, Dept Paediat Endocrinol, Bristol, Avon, England; [Sharples, P.] Univ Hosp Bristol, Dept Paediat Neurol, Bristol, Avon, England; [Likeman, M.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Lightman, S.] Univ Hosp Bristol, Dept Radiol, Bristol, Avon, England		Crowne, EC (corresponding author), Univ Hosp Bristol, Dept Paediat Endocrinol, Bristol, Avon, England.	Liz.Crowne@UHBristol.nhs.uk			Merck-Serono Inc.; 'Above Beyond'; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N014391/1] Funding Source: UKRI	Merck-Serono Inc. (unrestricted educational grant) and 'Above & Beyond' (charitable funds).	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; BERCU BB, 1986, J CLIN ENDOCR METAB, V63, P709, DOI 10.1210/jcem-63-3-709; Binder G, 2011, GROWTH HORM IGF RES, V21, P212, DOI 10.1016/j.ghir.2011.05.007; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Cella M, 2010, J PSYCHOSOM RES, V69, P17, DOI 10.1016/j.jpsychores.2009.10.007; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Dassa Y, 2019, EUR J ENDOCRINOL, V180, P283, DOI 10.1530/EJE-19-0034; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GATEWOODCOLWELL G, 1989, PSYCHOL REP, V65, P1163, DOI 10.2466/pr0.1989.65.3f.1163; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Johnson ML, 2008, ANAL BIOCHEM, V381, P8, DOI 10.1016/j.ab.2008.07.001; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Koltowska-Haggstrom M, 2005, HORM RES, V64, P46, DOI 10.1159/000087444; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Leal-Cerro A, 1999, J CLIN ENDOCR METAB, V84, P3378, DOI 10.1210/jc.84.9.3378; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Pincus SM, 1996, P NATL ACAD SCI USA, V93, P14100, DOI 10.1073/pnas.93.24.14100; Radetti G, 2007, CLIN ENDOCRINOL, V67, P78, DOI 10.1111/j.1365-2265.2007.02842.x; Schneider Harald J, 2007, Pediatr Endocrinol Rev, V4, P205; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; ZADIK Z, 1992, J CLIN ENDOCR METAB, V74, P801, DOI 10.1210/jc.74.4.801	27	4	4	0	4	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	SEP	2019	181	3					331	338		10.1530/EJE-19-0166			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	IU9TQ	WOS:000483923800018	31319378	Bronze, Green Submitted			2022-02-06	
J	Honarvar, F; Hojati, V; Bakhtiari, N; Vaezi, G; Javan, M				Honarvar, Fatemeh; Hojati, Vida; Bakhtiari, Nuredin; Vaezi, Gholamhassan; Javan, Mohammad			Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice	IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Multiple sclerosis; Myelin protection; Myelination; Ursolic acid; Corpus callosum; Mouse	EARLY BRAIN-INJURY; REMYELINATION FAILURE; OXIDATIVE STRESS; OLIGODENDROCYTE; EXCITOTOXICITY; PROMOTES; DEFICITS; PATHWAY	Neuronal survival in multiple sclerosis (MS) and other demyelinating diseases depends on the preservation of myelin and remyelination of axons. Myelin protection is the main purpose to decrease myelin damage in the central nervous system (CNS). Ursolic acid (UA) as a natural product in apple is suggested to protect neural cells. This study is the first to demonstrate an effect for UA on CNS myelin loss induced by cuprizone toxin. In the current study, we hypothesized that daily treatment with UA in drinking water (1 mg/mL) prevents myelin damage by 6 weeks administration of CPZ in mice pellet which lead to corpus callosum axonal demyelination. We assessed the myelin content and the number of myelinating cells in corpus callosum by FluoroMyelin and luxol fast blue staining as well as by immunostaining against MBP and Olig2. Our finding indicated that UA could decrease the extent of demyelination area and enhanced myelin stain intensity within CC and protected oligodendrocyte lineage cells against cuprizone toxin. We could conclude that inyelinated structures could be protected by UA in corpus callosum, which provide favorable evidence for the possibility of application of UA in demyelinating diseases and traumatic injuries.	[Honarvar, Fatemeh; Hojati, Vida; Vaezi, Gholamhassan] Islamic Azad Univ, Dept Biol, Damghan Branch, Damghan, Iran; [Bakhtiari, Nuredin] Fac Biol Sci, Dept Biochem, North Tehran Branch, Tehran, Iran; [Javan, Mohammad] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Javan, Mohammad] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Brain & Cognit Sci, Cell Sci Res Ctr, Tehran, Iran		Hojati, V (corresponding author), Islamic Azad Univ, Dept Biol, Damghan Branch, Damghan, Iran.; Javan, M (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.; Javan, M (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Dept Brain & Cognit Sci, Cell Sci Res Ctr, Tehran, Iran.	v.hojati@damghaniau.ac.ir; mjavan@modares.ac.ir	Hojati, Vida/AAQ-3422-2021; Javan, Mohammad/C-6758-2008	Hojati, Vida/0000-0002-0408-389X; Javan, Mohammad/0000-0003-2045-6171	Tarbiat Modares University; NIMAD institute	This study was supported by Tarbiat Modares University and a grant from NIMAD institute provided to M. Javan.	Aktas O, 2019, J CORTEX, V2, P14; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; Chari DM, 2002, MULT SCLER J, V8, P271, DOI 10.1191/1352458502ms842oa; Checker R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031318; Colla ARS, 2015, EUR J PHARMACOL, V758, P171, DOI 10.1016/j.ejphar.2015.03.077; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Ghasemi-Kasman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127878; Harlow DE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00257; Hong SY, 2012, MOLECULES, V17, P10831, DOI 10.3390/molecules170910831; Huang HC, 2009, MOL CARCINOGEN, V48, P517, DOI 10.1002/mc.20490; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Kashyap D, 2016, LIFE SCI, V146, P201, DOI 10.1016/j.lfs.2016.01.017; Khanghahi AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203785; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Liu B, 2013, NEURAL REGEN RES, V8, P2510, DOI 10.3969/j.issn.1673-5374.2013.27.002; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Motavaf M, 2017, CELL MOL NEUROBIOL, V37, P1335, DOI 10.1007/s10571-017-0472-6; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Piaton G, 2009, PROG BRAIN RES, V175, P453, DOI 10.1016/S0079-6123(09)17530-1; Pourabdolhossein F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106378; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Sahu S, 2018, J NUTR BIOCHEM, V55, P219, DOI 10.1016/j.jnutbio.2018.01.016; Seyedsadr MS, 2019, NEUROBIOL DIS, V124, P189, DOI 10.1016/j.nbd.2018.11.018; Shih YH, 2004, NEUROSCI LETT, V362, P136, DOI 10.1016/j.neulet.2004.03.011; Szakiel A, 2012, PHYTOCHEM REV, V11, P263, DOI 10.1007/s11101-012-9241-9; Tasaki I, 1939, AM J PHYSIOL, V127, P211, DOI 10.1152/ajplegacy.1939.127.2.211; Tognatta R, 2016, NEUROPHARMACOLOGY, V110, P539, DOI 10.1016/j.neuropharm.2016.04.026; Wozniak L, 2015, MOLECULES, V20, P20614, DOI 10.3390/molecules201119721; Wu DM, 2013, TOXICOL APPL PHARM, V271, P127, DOI 10.1016/j.taap.2013.04.038; Xiang LP, 2015, ONCOTARGET, V6, P9295, DOI 10.18632/oncotarget.3261; Xu HY, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00008; Yazdi A, 2015, NEUROSCIENCE, V311, P34, DOI 10.1016/j.neuroscience.2015.10.013; Zare L, 2019, IRAN J PHARM RES, V18, P286; Zare L, 2018, REGEN MED, V13, P803, DOI 10.2217/rme-2017-0155; Zhang TT, 2014, NEUROSCI LETT, V579, P12, DOI 10.1016/j.neulet.2014.07.005	37	4	5	2	2	SHAHEED BEHESHTI UNIV, SCH PHARMACY	TEHRAN	NO 10 SHAMS ALLEY, VALI-E ASR ST, TEHRAN, 00000, IRAN	1735-0328	1726-6890		IRAN J PHARM RES	Iran. J. Pharm. Res.	FAL	2019	18	4					1978	1988		10.22037/ijpr.2019.112181.13582			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KG8FZ	WOS:000510185000028	32184863				2022-02-06	
J	Jang, SH; Kim, SH; Lee, HD				Jang, Sung Ho; Kim, Seong Ho; Lee, Han Do			Traumatic axonal injury of the cingulum in patients with mild traumatic brain injury: a diffusion tensor tractography study	NEURAL REGENERATION RESEARCH			English	Article						mild traumatic brain injury; brain trauma; diffusion tensor tractography; diffusion tensor imaging; cognitive impairment; cingulum; memory; Glasgow Coma Scale; neural regeneration	CORTICORETICULAR PATHWAY; COGNITIVE COMPLAINTS; TRACKING; MEMORY	The cingulum, connecting the orbitofrontal cortex to the medial temporal lobe, involves in diverse cognition functions including attention, memory, and motivation. To investigate the relationship between the cingulum injury and cognitive impairment in patients with chronic mild traumatic brain injury, we evaluated the integrity between the anterior cingulum and the basal forebrain using diffusion tensor tractography in 73 patients with chronic mild traumatic brain injury (39 males, 34 females, age 43.29 +/- 11.42 years) and 40 healthy controls (22 males, 18 females, age 40.11 +/- 16.81 years). The patients were divided into three subgroups based on the integrity between the anterior cingulum and the basal forebrain on diffusion tensor tractography: subgroup A (n = 19 patients) - both sides of the anterior cingulum were intact; subgroup B (n = 36 patients) - either side of the anterior cingulum was intact; and subgroup C (18 patients) - both sides of the anterior cingulum were discontinued. There were significant differences in total Memory Assessment Scale score between subgroups A and B and between subgroups A and C. There were no significant differences in diffusion tensor tractography parameters (fractional anisotropy, apparent diffusion coefficient, and fiber volume) between patients and controls. These findings suggest that the integrity between the anterior cingulum and the basal forebrain, but not diffusion tensor tractography parameter, can be used to predict the cognitive function of patients with chronic mild traumatic brain injury.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Daegu, South Korea; [Kim, Seong Ho] Yeungnam Univ, Dept Neurosurg, Coll Med, Daegu, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Daegu, South Korea.	lhd890221@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (to SHJ and SHK).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Jang SH, 2015, AM J PHYS MED REHAB, V94, pE86, DOI 10.1097/PHM.0000000000000317; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Jang SH, 2010, NEURAL REGEN RES, V5, P1829, DOI 10.3969/j.issn.1673-5374.2010.23.011; Kim JW, 2015, NEURAL REGEN RES, V10, P1876, DOI 10.4103/1673-5374.170321; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurki T, 2014, NEURORADIOLOGY, V56, P833, DOI 10.1007/s00234-014-1410-7; Kwon HG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00366; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; van Huijzen, 2008, HUMAN CENTRAL NERVOU; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wechsler D, 1981, WECHSLER ADULT INTEL; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yang DS, 2016, AM J PHYS MED REHAB, V95, pE34, DOI 10.1097/PHM.0000000000000413; Yoo JS, 2014, BRAIN INJURY, V28, P1257, DOI 10.3109/02699052.2014.901557	47	4	5	0	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP	2019	14	9					1556	1561		10.4103/1673-5374.255977			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HY3XE	WOS:000468060200020	31089054	Green Published, gold			2022-02-06	
J	Kim, DY; Pyun, SB				Kim, Doo Young; Pyun, Sung-Bom			Prediction of functional outcome and discharge destination in patients with traumatic brain injury after post-acute rehabilitation	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injuries; patient discharge; recovery of function; rehabilitation; traumatic	OLDER-ADULTS; ACUTE-CARE; EPIDEMIOLOGY; DISORDERS; RECOVERY; IMPACT	As the survival rate of traumatic brain injury increases, the burden of care for patients with traumatic brain injury is emerging as a socioeconomic issue and the discharge destination is one of the important outcome measures in the post-acute rehabilitation unit. To investigate the predictors of functional outcome and discharge destination in patients with traumatic brain injury after post-acute rehabilitation. A retrospective review was performed on 86 patients who were admitted to the rehabilitation unit between January 2010 and June 2017. Multiple regression analysis was used as a statistical method to identify the factors affecting Modified Barthel Index and discharge destination. The number of days from traumatic brain injury onset to rehabilitation unit admission (odds ratio = 0.959, P = 0.049), brain surgery for traumatic brain injury management (odds ratio = 0.160, P = 0.021), initial Glasgow Coma Scale score (odds ratio = 1.269, P = 0.022) and Mini-Mental State Examination score at admission (odds ratio = 1.245, P < 0.001) were the predictive factors for higher Modified Barthel Index after rehabilitation. Underlying vascular risk factors (odds ratio = 0.138, P = 0.015), Modified Barthel Index score after rehabilitation (odds ratio = 1.085, P < 0.001) and deductible-free insurance (odds ratio = 0.211, P = 0.032) were the predictive factors of home discharge. The functional outcome of patients with traumatic brain injury after rehabilitation was related to the severity of initial injury, cognitive function at admission and rehabilitation timing. The discharge destination after rehabilitation was related to functional outcome, insurance issues and underlying vascular risk factors.	[Kim, Doo Young] Catholic Kwandong Univ, Int St Marys Hosp, Dept Phys Med & Rehabil, Incheon, South Korea; [Pyun, Sung-Bom] Korea Univ, Coll Med, Dept Phys Med & Rehabil, 73 Inchon Ro, Seoul 02841, South Korea; [Pyun, Sung-Bom] Korea Univ, Brain Convergence Res Ctr, Aphasia Res & Neurorehabil Lab, Seoul, South Korea		Pyun, SB (corresponding author), Korea Univ, Coll Med, Dept Phys Med & Rehabil, 73 Inchon Ro, Seoul 02841, South Korea.	rmpyun@korea.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1A2C2003020]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1A2C2003020).	Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Frank M, 2010, EUR NEUROL, V63, P227, DOI 10.1159/000279491; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Li YM, 2017, J CLIN NEUROSCI, V44, P107, DOI 10.1016/j.jocn.2017.05.026; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Omar M, 2017, J CRIT CARE, V41, P1, DOI 10.1016/j.jcrc.2017.04.031; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Yang SN, 2012, J KOREAN MED SCI, V27, P691, DOI 10.3346/jkms.2012.27.6.691	24	4	4	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2019	42	3					256	262		10.1097/MRR.0000000000000353			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	JI6DJ	WOS:000493557000011	31033582				2022-02-06	
J	Klieverik, VM; Miller, KJ; Han, KS; Singhal, A; Vassilyadi, M; Touchette, CJ; Weil, AG; Woerdeman, PA				Klieverik, Vita M.; Miller, Kai J.; Han, Kuo Sen; Singhal, Ash; Vassilyadi, Michael; Touchette, Charles J.; Weil, Alexander G.; Woerdeman, Peter A.			Cranioplasties following craniectomies in children-a multicenter, retrospective cohort study	CHILDS NERVOUS SYSTEM			English	Article						Cranial reconstruction; Long-term; Complications; Pediatric neurosurgery	TRAUMATIC BRAIN-INJURY; BONE FLAP RESORPTION; DECOMPRESSIVE CRANIECTOMY; HYDROXYAPATITE CEMENT; TITANIUM MESH; EXPERIENCE; OUTCOMES; DEFECTS; REPAIR; PLATES	Objective Complications following pediatric cranioplasty after craniectomy with either autologous bone flaps or cranial implants are reported to be common, particularly bone flap resorption. However, only sparse data are available regarding cranioplasty strategies, complications, and outcomes. This manuscript describes a Canadian-Dutch multicenter pediatric cohort study with autografts and cranial implant cranioplasties following craniectomies for a variety of indications. Methods The study included all children (< 18 years) who underwent craniectomy and subsequent cranioplasty surgeries from 2008 to 2014 (with a minimum of 1-year follow-up) at four academic hospitals with a dedicated pediatric neurosurgical service. Data were collected regarding initial diagnosis, age, time interval between craniectomy and cranioplasty, bone flap storage method, type of cranioplasty for initial procedure (and redo if applicable), and the postoperative outcome including surgical site infection, wound breakdowns, bone flap resorption, and inadequate fit/disfigurement. Results Sixty-four patients (46 males, average age 9.7 +/- 5.5 years) were eligible for inclusion, with mean follow-up of 82.3 +/- 31.2 months after craniectomy. Forty cranioplasties (62.5%) used autologous bone re-implant, 23 (57.5%) of which showed resorption. On average, resorption was documented at 434 days (range 62-2796 days) after reimplantation. In 20 cases, a revision cranioplasty was needed. In 24 of the post-craniectomy cases (37.5%), a cranial implant was used with one of ten different implant types. Implant loosening prompted a complete revision cranioplasty in 2 cases (8.3%). Cranial implants were associated with low morbidity and lower reoperation dates compared to the autologous cranioplasties. Conclusion The most prominent finding in this multicenter cohort study was that bone flap resorption in children remains a common and widespread problem following craniectomy. Cranioplasty strategies varied between centers and evolved over time within centers. Cranial implants were associated with low morbidity and low reoperation rates. Still, longer term and prospective multicenter cohort studies are needed to optimize cranioplasty strategies in children after craniectomies.	[Klieverik, Vita M.; Miller, Kai J.; Han, Kuo Sen; Woerdeman, Peter A.] Univ Med Ctr Utrecht, Dept Neurosurg, Div Neurosci, Brain Ctr Rudolf Magnus, Heidelberglaan 100,Room G03-124, NL-3484 CX Utrecht, Netherlands; [Singhal, Ash] British Columbia Childrens Hosp, Div Pediat Neurosurg, Vancouver, BC, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Div Neurosurg, Ottawa, ON, Canada; [Touchette, Charles J.; Weil, Alexander G.] Univ Montreal, Div Pediat Neurosurg, Dept Surg, St Justine Hosp, Montreal, PQ, Canada		Woerdeman, PA (corresponding author), Univ Med Ctr Utrecht, Dept Neurosurg, Div Neurosci, Brain Ctr Rudolf Magnus, Heidelberglaan 100,Room G03-124, NL-3484 CX Utrecht, Netherlands.	p.a.woerdeman@umcutrecht.nl		Singhal, Ash/0000-0002-0061-9570	Van Wagenen Foundation	KJM is supported by the Van Wagenen Foundation.	Bowers CA, 2015, J NEUROSURG-PEDIATR, V16, P439, DOI 10.3171/2015.2.PEDS14536; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Chao MT, 2009, PLAST RECONSTR SURG, V123, P976, DOI 10.1097/PRS.0b013e31819ba46f; Choi SH, 1998, PEDIATR NEUROSURG, V29, P324, DOI 10.1159/000028747; Cohen AJ, 2004, J CRANIOFAC SURG, V15, P469, DOI 10.1097/00001665-200405000-00025; Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679; Ducic J, 2002, J ORAL MAXIL SURG, V60, P272, DOI 10.1053/joms.2002.30575; Eppley BL, 2003, J CRANIOFAC SURG, V14, P209, DOI 10.1097/00001665-200303000-00014; Fiaschi P, 2016, J NEUROSURG-PEDIATR, V17, P705, DOI 10.3171/2015.10.PEDS15489; Frassanito P, 2018, CHILD NERV SYST, V34, P2283, DOI 10.1007/s00381-018-3905-8; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Fu KJ, 2016, J CRANIOFAC SURG, V27, P593, DOI 10.1097/SCS.0000000000002491; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2; Ma IT, 2018, J CRANIOFAC SURG, V29, P99, DOI 10.1097/SCS.0000000000004045; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Pang DL, 2005, J NEUROSURG, V102, P36, DOI 10.3171/ped.2005.102.1.0036; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Rocque BG, 2018, J NEUROSURG PEDIAT, V8, P1; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Taggard DA, 2001, PEDIATR NEUROSURG, V34, P149, DOI 10.1159/000056010; Waqas M, 2017, PEDIATR NEUROSURG, V52, P77, DOI 10.1159/000452808; Williams L, 2016, J CRANIO MAXILL SURG, V44, P789, DOI 10.1016/j.jcms.2016.03.010	26	4	4	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2019	35	9					1473	1480		10.1007/s00381-018-4024-2			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IR9HA	WOS:000481753100010	30554262				2022-02-06	
J	Knott, RJ; Harris, A; Higgins, A; Nichol, A; French, C; Little, L; Haddad, S; Presneill, J; Arabi, Y; Bailey, M; Cooper, DJ; Duranteau, J; Huet, O; Mak, A; McArthur, C; Pettila, V; Skrifvars, MB; Vallance, S; Varma, D; Wills, J; Bellomo, R				Knott, Rachel J.; Harris, Anthony; Higgins, Alisa; Nichol, Alistair; French, Craig; Little, Lorraine; Haddad, Samir; Presneill, Jeffrey; Arabi, Yaseen; Bailey, Michael; Cooper, D. James; Duranteau, Jacques; Huet, Olivier; Mak, Anne; McArthur, Colin; Pettila, Ville; Skrifvars, Markus B.; Vallance, Shirley; Varma, Dinesh; Wills, Judy; Bellomo, Rinaldo		EPO-TBI Investigators; ANZICS Clinical Trials Grp	Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis	JOURNAL OF NEUROTRAUMA			English	Article						cost-effectiveness; erythropoietin; multi-national trial; QALYs; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURY; MODERATE; RESUSCITATION; CARE	The EPO-TBI multi-national randomized controlled trial found that erythropoietin (EPO), when compared to placebo, did not affect 6-month neurological outcome, but reduced illness severity-adjusted mortality in patients with traumatic brain injury (TBI), making the cost-effectiveness of EPO in TBI uncertain. The current study uses patient-level data from the EPO-TBI trial to evaluate the cost-effectiveness of EPO in patients with moderate or severe TBI from the healthcare payers' perspective. We addressed the issue of transferability in multi-national trials by estimating costs and effects for specific geographical regions of the study (Australia/New Zealand, Europe, and Saudi Arabia). Unadjusted mean quality-adjusted life-years (QALYs; 95% confidence interval [CI]) at 6 months were 0.027 (0.020-0.034; p < 0.001) higher in the EPO group, with an adjusted QALY increment of 0.014 (0.000-0.028; p = 0.04). Mean unadjusted costs (95% CI) were $US5668 (-9191 to -2144; p = 0.002) lower in the treatment group; controlling for baseline IMPACT-TBI score and regional heterogeneity reduced this difference to $2377 (-12,446 to 7693; p = 0.64). For a willingness-to-pay threshold of $US50,000 per QALY, 71.8% of replications were considered cost-effective. Therefore, we did not find evidence that EPO was significantly cost-effective in the treatment of moderate or severe TBI at 6-month follow-up.	[Knott, Rachel J.; Harris, Anthony] Monash Univ, Monash Business Sch, Ctr Hlth Econ, Melbourne, Vic, Australia; [Higgins, Alisa; Nichol, Alistair; Little, Lorraine; Haddad, Samir; Presneill, Jeffrey; Arabi, Yaseen; Bailey, Michael; Cooper, D. James; Huet, Olivier; Mak, Anne; McArthur, Colin; Pettila, Ville; Vallance, Shirley; Wills, Judy; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Level 3,553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Nichol, Alistair; Presneill, Jeffrey; Cooper, D. James; Mak, Anne; Vallance, Shirley; Varma, Dinesh; Wills, Judy] The Alfred, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Clin Res Ctr, St Vincents Univ Hosp, Dublin, Ireland; [French, Craig; Bellomo, Rinaldo] Western Hlth, Melbourne, Vic, Australia; [French, Craig; Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Haddad, Samir] Natl Guard Hlth Affairs, King Abdulaziz Med City, Riyadh, Saudi Arabia; [Presneill, Jeffrey] Univ Queensland, Brisbane, Qld, Australia; [Presneill, Jeffrey] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Duranteau, Jacques] Univ Paris Sud, Hop Univ Paris Sud, Hop Bicetre, AP HP,Dept Anesthesie Reanimat, Paris, France; [Huet, Olivier] CHU La Cavale Blanche, Dept Anaesthesiol & Intens Care Med, Brest, France; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Pettila, Ville; Skrifvars, Markus B.] Univ Helsinki, Helsinki, Finland; [Pettila, Ville; Skrifvars, Markus B.] Helsinki Univ Hosp, Helsinki, Finland; [Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic, Australia		Higgins, A (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Level 3,553 St Kilda Rd, Melbourne, Vic 3004, Australia.	lisa.higgins@monash.edu	Higgins, Alisa/AAM-8088-2020; Arabi, Yaseen/ABF-3316-2020; French, Craig/ABF-5087-2020; Cooper, D. James/G-7961-2013	Higgins, Alisa/0000-0001-8295-7559; Arabi, Yaseen/0000-0001-5735-6241; French, Craig/0000-0003-1363-9711; Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair/0000-0002-4689-1238; Harris, Anthony/0000-0003-1641-3320			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2015, NAT HOSP COST DAT CO; Australian Bureau of Statistics, 2016, 6401 0 CONS PRIC IND; Australian Government Department of Health and Ageing, 2016, PAYM RAT; Australian Government Department of Health and Ageing, 2010, REP OP AG CAR ACT 19; Chui BK, 2012, J TRAUMA ACUTE CARE, V73, P195, DOI 10.1097/TA.0b013e31824ba1da; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dolan P., 1995, SOCIAL TARIFF EUROQO; Glick H., 2014, EC EVALUATION CLIN T, Vsecond; Green J, 2015, DEV AUSTR NATL SUBAC; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; National Blood Authority Australia, 2014, ANN REP 2013 14; National Costing Collection Pricing Program, 2014, NZ CAS FRAM PUBL FUN; National Institute of Statistics and Economic Studies, 2016, ANN CONS PRIC IND BA; New Zealand Casemix Project Group, 2015, NZ CAS SYST OV V 1 2; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Novack TA, 2000, BRAIN INJURY, V14, P987; NSW Government Ministry of Health, 2011, NSW COSTS CAR STAND; [OECD OECD. Stat], 2016, TABL 4 PPPS EXCH RAT; PHARMAC, 2015, COST RES MAN VERS 2; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Productivity Commission, 2011, 53 PROD COMM; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Statistics New Zealand, 2015, CONS PRIC IND JUN 20; Taylor C, 2016, LANCET RESP MED, V4, P818, DOI 10.1016/S2213-2600(16)30120-5; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; THURMAN D, 2001, HEAD TRAUMA BASIC PR; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	34	4	4	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2541	2548		10.1089/neu.2018.6229			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000485289000008	30907230	Green Accepted			2022-02-06	
J	Madouh, FA; Ramesh, KT				Madouh, Fatma A.; Ramesh, K. T.			The Influence of Shear Anisotropy in mTBI: A White Matter Constitutive Model	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Shear anisotropy; Constitutive-model; TBI; Injury	DIFFUSE AXONAL INJURY; BRAIN-TISSUE; HEAD; DAMAGE; CRITERION; EQUATIONS; BEHAVIOR; TRAUMA; STEM	We examine the influence of shear anisotropy of brain tissue on the potential for mild traumatic brain injury. First we develop a new constitutive description for the white matter in the brain that can capture the anisotropic behavior of the white matter in both tension and shear. The material parameters for the models are determined using a set of three experiments already published in the literature. The calibrated and parameterized model is then implemented in a computational (finite element) model of the head. This computational model is two-dimensional and is used to simulate a previously published injury-causing event in the National Hockey League, using axonal strain as criterion to assess the level of diffuse axonal injury. It is demonstrated that the inclusion of shear anisotropy affects both the nature and the extent of predicted injury. Further, the locations of the predicted injury are more consistent with observations in the literature.	[Madouh, Fatma A.; Ramesh, K. T.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Ramesh, K. T.] Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD USA		Ramesh, KT (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	ramesh@jhu.edu	Ramesh, KT/D-5451-2009	Ramesh, KT/0000-0003-2659-4698	Kuwait University; National Institute of Neurological Disorders and Strokes, National Institutes of Health [R01NS055951]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	The first author (FM) appreciates the support of Kuwait University through a scholarship. The second author (KTR) acknowledges support from the National Institute of Neurological Disorders and Strokes, National Institutes of Health (Project #R01NS055951). The authors also thank Dr. Andrew Knutsen and Dr. Dzung Pham from the Henry Jackson Foundation for sharing tagged-MRI experimental data from Knutsen et al., J Biomechanics (2014). The authors also appreciate discussions and support from Dr. Shailesh Ganpule.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; DVBIC, 2018, DEF VET BRAIN INJ CT; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Estes M. S., 1970, 4 ASME BIOM C; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Holzapfel G. A., 2000, NONLINEAR SOLID MECH, pxiv; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King AI, 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Ruan J. S., 1993, 01487191 SAE; SHUGAR TA, 1975, J ENG MECH DIV-ASCE, V101, P223; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Spencer A, 1972, DEFORMATIONS FIBRE R; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Taylor P. A., 2009, J BIOMECH ENG-T ASME, V131; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Ward C., 1980, 26 STAPP CAR CRASH C; Ward C. C, 1975, 01487191 SAE; Watanabe D, 2009, J COMPUT SCI TECHNOL, V3, P252, DOI 10.1299/jcst.3.252; Willmott CJ, 2012, INT J CLIMATOL, V32, P2088, DOI 10.1002/joc.2419; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; ZHOU C, 1994, 38 STAPP CAR CRASH C	47	4	4	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		1960	1970		10.1007/s10439-019-02321-1			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300009	31309368	Green Accepted			2022-02-06	
J	Mendiratta, P; Dayama, N; Wei, JY; Prodhan, P; Prodhan, P				Mendiratta, Priya; Dayama, Neeraj; Wei, Jeanne Y.; Prodhan, Pallavi; Prodhan, Parthak			Status Epilepticus among Older Adults in the United States	GERIATRICS			English	Article						older adults; status epilepticus; outcomes	CONVULSIVE STATUS EPILEPTICUS; ONSET STATUS EPILEPTICUS; MORTALITY	Objective: This study aimed to identify temporal time trends and risk factors associated with mortality for hospitalized older adults with status epilepticus (SE). Design: A retrospective study was performed. Setting: Hospitalized patients were identified utilizing an administrative database-The Nationwide Inpatient Sample database from 1998 through September 2015. Patients: Patients were older adults 65 years and older with SE. Interventions: No interventions were undertaken. Measurements and Main Results: Demographic, temporal trends, clinical characteristics, and outcome data were abstracted. The results indicated that hospitalized elderly Americans with SE increased over the 11-year study period. Univariate and multivariate analyses were performed to evaluate risk factors associated with mortality in the study cohort. From the weighted sample, 130,109 subjects were included. Overall mortality was 19%. For age subgroups, the mortality was highest for the >85 years age group (24.1%) compared to the 65-75 years (19%) and 75-85 years (23%) age groups. Among investigated etiologies, the three most common causes of SE were acute ischemic stroke (11.2% of total) followed by non-traumatic brain hemorrhage (5.4%) and malignant brain lesions (4.9%). The highest mortality by etiology was noted for acute traumatic brain injury (TBI) (31.5%), non-traumatic brain hemorrhage (31%), and acute ischemic stroke (AIS) (30.1%). Multivariate analysis indicated that non-survivors when compared to survivors were more like to have the following characteristics: older age group, acute TBI, brain neoplasms, non-traumatic brain hemorrhage, AIS and central nervous system (CNS) infections, and utilization of mechanical ventilation. Associated conditions significantly increasing risk of mortality were sodium imbalance, cardiac arrest, anoxic brain injury, pneumonia, and sepsis. Comorbidities associated with increased risk of mortality included valvular heart disease, renal failure, liver disease, and neoplasms. Conclusions: The number of hospitalized elderly Americans with SE increased over the 11-year study period. Overall mortality was 19%, with even higher mortality among various patient subsets. Several demographic and co-morbid factors are associated with increased mortality in this age group.	[Mendiratta, Priya; Wei, Jeanne Y.; Prodhan, Pallavi] Univ Arkansas Med Sci, Dept Geriatr, Coll Med, Little Rock, AR 72205 USA; [Dayama, Neeraj] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA; [Prodhan, Parthak] Univ Arkansas Med Sci, Pediat Crit Care Med, Coll Med, Little Rock, AR 72205 USA		Mendiratta, P (corresponding author), Univ Arkansas Med Sci, Dept Geriatr, Coll Med, Little Rock, AR 72205 USA.	PMENDIRATTA@UAMS.EDU	Dayama, Neeraj/AAD-4264-2022; Dayama, Neeraj/AAT-5206-2020				Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Dham BS, 2014, NEUROCRIT CARE, V20, P476, DOI 10.1007/s12028-013-9935-x; Elixhauser R., HCUP METHODS SERIES; Gaspard N, 2018, EPILEPSIA, V59, P745, DOI 10.1111/epi.14022; Hui ACF, 2005, EPILEPTIC DISORD, V7, P27; Jayalakshmi S, 2015, SEIZURE-EUR J EPILEP, V29, P104, DOI 10.1016/j.seizure.2015.03.011; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Malter MP, 2017, SEIZURE-EUR J EPILEP, V51, P114, DOI 10.1016/j.seizure.2017.08.006; Rohracher A, 2016, EPILEPSY RES, V127, P317, DOI 10.1016/j.eplepsyres.2016.08.016; Fernandez IS, 2018, SEIZURE-EUR J EPILEP, V61, P186, DOI 10.1016/j.seizure.2018.08.015; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Sinha S, 2013, J CLIN NEUROSCI, V20, P423, DOI 10.1016/j.jocn.2012.02.050; Strzelczyk A, 2017, EPILEPSIA, V58, P1533, DOI 10.1111/epi.13837; Vilella L, 2018, ACTA NEUROL SCAND, V137, P321, DOI 10.1111/ane.12867; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070; Yoshimura H, 2018, SEIZURE-EUR J EPILEP, V61, P23, DOI 10.1016/j.seizure.2018.07.013	17	4	4	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2308-3417		GERIATRICS-BASEL	Geriatrics	SEP	2019	4	3							45	10.3390/geriatrics4030045			9	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	JA8OX	WOS:000488112300006	31340576	Green Published, Green Submitted, gold			2022-02-06	
J	Miller, RA; Rogers, RR; Williams, TD; Marshall, MR; Moody, JR; Hensarling, RW; Ballmann, CG				Miller, Rachel A.; Rogers, Rebecca R.; Williams, Tyler D.; Marshall, Mallory R.; Moody, Justin R.; Hensarling, Robert W.; Ballmann, Christopher G.			Effects of Protective American Football Headgear on Peripheral Vision Reaction Time and Visual Target Detection in Division I NCAA Football Players	SPORTS			English	Article						college football; dynavision; football helmet; eye shield; visor; facemask	CONCUSSION; HELMETS; EVOLUTION; GOGGLES; EYEWEAR; INJURY; FIELD	The purpose of this study was to examine the effects of protective football headgear on peripheral vision reaction time and visual target detection. Twenty-five Division I NCAA football players (age = 20.5 yrs +/- 0.9, height = 185.9 cm +/- 6.8, body mass = 99.2 kg +/- 19.2, BMI = 29.6 +/- 4.5) participated. In a crossover counterbalanced study design, subjects participated in one visit with three conditions: Baseline (BL) without headgear, helmet only (HO), helmet with an eye shield (HE). Subjects completed a 1-min peripheral vision reaction time test for each condition separated by 3-min recovery periods. Tests were administered using a 64 light Dynavision D2 Visuomotor board. Target detection (total hit score) was higher during BL than HO (p < 0.001) and HE (p < 0.001). Average (p < 0.001), peak (p < 0.001), minimum (p < 0.001), and median (p < 0.001) peripheral reaction times were faster during BL than HO and HE. No significant differences were observed for any measures between HO and HE conditions (p > 0.05). Findings indicate that protective football headgear impaired reaction time to peripheral visual stimuli. The addition of an eye shield to the helmet had a small non-significant effect on reaction time and target detection. These results may hold important implications in helmet design and player safety.	[Miller, Rachel A.; Rogers, Rebecca R.; Williams, Tyler D.; Marshall, Mallory R.; Moody, Justin R.; Hensarling, Robert W.; Ballmann, Christopher G.] Samford Univ, Dept Kinesiol, Birmingham, AL 35229 USA		Ballmann, CG (corresponding author), Samford Univ, Dept Kinesiol, Birmingham, AL 35229 USA.	rachrach977@gmail.com; rrogers1@samford.edu; twilli11@samford.edu; mmarshal@samford.edu; jrmoody@samford.edu; rwhensar@samford.edu; cballman@samford.edu	Moody, Justin/ABC-7989-2020	Ballmann, Christopher/0000-0002-7839-8894			American College of Sports Medicine, 2017, ACSMS EXERCISE TESTI; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Brenton J, 2019, J SPORT SCI, V37, P2114, DOI 10.1080/02640414.2019.1621510; Clark JF., 2015, OPTOM VIS PERFORM, P116; Cohen J., 2013, STAT POWER ANAL BEHA; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DAWSON ML, 1988, PERCEPT MOTOR SKILL, V67, P115, DOI 10.2466/pms.1988.67.1.115; Gammons MR, 2013, CURR SPORT MED REP, V12, P377, DOI 10.1249/JSR.0000000000000016; Gonzalez-Alvarez C, 2007, OPHTHAL PHYSL OPT, V27, P265, DOI 10.1111/j.1475-1313.2007.00476.x; Hitzeman S A, 1993, Optom Clin, V3, P145; Ing E, 2002, CAN J OPHTHALMOL, V37, P161, DOI 10.1016/S0008-4182(02)80058-8; Kauffman DC, 2015, J SPORT SCI, V33, P1117, DOI 10.1080/02640414.2014.987156; KRAMER MR, 2017, BRIT J SPORT MED, V51, pA65, DOI DOI 10.1136/BJSPORTS-2016-097270.168; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; MCKNIGHT AJ, 1995, ACCIDENT ANAL PREV, V27, P493, DOI 10.1016/0001-4575(95)00008-N; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Ruedl G, 2011, WILD ENVIRON MED, V22, P148, DOI 10.1016/j.wem.2010.12.010; SCHNEIDER RC, 1965, J AMER MED ASSOC, V192, P616, DOI 10.1001/jama.1965.03080200034010; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Stine C.D., 1982, THESIS; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Washington RL, 2004, PEDIATRICS, V113, P619; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wilkins L, 2019, J SPORT SCI, V37, P13, DOI 10.1080/02640414.2018.1479944	27	4	4	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4663		SPORTS	Sports	SEP	2019	7	9							213	10.3390/sports7090213			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	JC3KR	WOS:000489178100018	31527412	Green Published, gold			2022-02-06	
J	Ramey, WL; Walter, CM; Zeller, J; Dumont, TM; Lemole, GM; Hurlbert, RJ				Ramey, Wyatt L.; Walter, Christina M.; Zeller, Jeffrey; Dumont, Travis M.; Lemole, G. Michael; Hurlbert, R. John			Neurotrauma From Border Wall Jumping: 6 Years at the Mexican-American Border Wall	NEUROSURGERY			English	Article						Cost analysis; Emigration and immigration; Socioeconomic factors; Spinal cord injury (SCI); Traumatic brain injury (TBI)	FALLS; HEIGHT	BACKGROUND The border between the United States (US) and Mexico is an international boundary spanning 3000 km, where unauthorized crossings occur regularly. We examine patterns of neurotrauma, health care utilization, and financial costs at our level 1 trauma center incurred by patients from wall-jumping into the US. OBJECTIVE To determine the clinical and socioeconomic consequences from neurotrauma as a result of jumping over the US-Mexico border wall. METHODS Medical records of patients at (Banner University of Arizona Medical Center - Tucson) were retrospectively reviewed from January 2012 through December 2017. Demographics, clinical status, radiographic findings, treatment, length of stay, and financial data were analyzed for all patients suffering neurotrauma during that time. RESULTS Over 6 yr, 64 patients sustained cranial or spinal injuries directly from jumping or falling onto US soil from the border wall. Fifty (78%) suffered spinal injuries, 15 (23%) experienced cranial injury, and 1 patient had both. Total medical charges were available in 36 patients and summed $3.6 M, of which 22% was reimbursed, an amount significantly lower than expected from more conventional trauma. Neurotrauma steadily declined over the 6-yr observation period, dropping in 2017 to 6% of rates observed in 2012. CONCLUSION In the Southern US, neurotrauma from unauthorized border crossings occurs commonly as a result of wall-jumping. These injuries represent a clinical and costly extreme of border-related trauma, and future efforts from both sides of the border wall are needed to decrease the detrimental impacts felt both by immigrants and surrounding health care systems.	[Ramey, Wyatt L.; Walter, Christina M.; Zeller, Jeffrey; Dumont, Travis M.; Lemole, G. Michael; Hurlbert, R. John] Banner Univ, Arizona Med Ctr, Dept Surg, Div Neurosurg, Tucson, AZ USA		Hurlbert, RJ (corresponding author), Univ Arizona, 1501 N Campbell Ave,Room 4303,POB 245070, Tucson, AZ 85724 USA.	rjhurlbert@surgery.arizona.edu					Agence France-Presse, 2010, US MEX OP 1 NEW BORD; Burk DR, 2017, ORTHOPEDICS, V40, pE432, DOI 10.3928/01477447-20170117-05; Department of Homeland Security, 2017, SW BORD MIGR FY2018; Department of Homeland Security, 2011, APPR US BORD PATR 20; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; El Universal MX Nacion, 2007, MUER CINIC MIL EM 13; GUPTA SM, 1982, AM J FOREN MED PATH, V3, P35, DOI 10.1097/00000433-198203000-00008; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Preparedness News. U.S, 2017, PREPAREDNESS NEWS; SCALEA T, 1986, J TRAUMA, V26, P706, DOI 10.1097/00005373-198608000-00005; United States Government Accountability Office, 2013, DHSS PROGR CHALL SEC; United States Government Accountability Office, 2006, ILLEGAL IMMIGRATION; Velmahos GC, 2006, J AM COLL SURGEONS, V203, P605, DOI 10.1016/j.jamcollsurg.2006.07.002	13	4	4	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2019	85	3					E502	E508		10.1093/neuros/nyz050			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JD0YR	WOS:000489702900038	30873543				2022-02-06	
J	Rokad, D; Jin, HJ; Anantharam, V; Kanthasamy, A; Kanthasamy, AG				Rokad, Dharmin; Jin, Huajun; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.			Exosomes as Mediators of Chemical-Induced Toxicity	CURRENT ENVIRONMENTAL HEALTH REPORTS			English	Article						Environmental toxicants; Exosomes; Metals; Pesticides; Toxicity; Misfolded proteins; Neurotoxicity	TRAUMATIC BRAIN-INJURY; PRION PROTEIN; EXTRACELLULAR VESICLES; STEM-CELLS; PATHOGENESIS; BIOGENESIS; RELEVANCE; EXPOSURE; DISEASE; ASSOCIATION	Purpose of ReviewThis review provides information regarding how exosomes may contribute to environmental chemical-induced pathogenesis of chronic diseases. In connecting exosome biology to environmental toxicology and disease pathogenesis, we address vital questions regarding what constitutes exosomal cargo, how toxicants influence exosomal cargo, and how environmental stimuli influence exosomal physiological and pathological functions.Recent FindingsRecent studies in the field demonstrate that exosomal cargo changes depending on external stimuli, which has consequences for the microenvironment of recipient cells.SummaryBased on recent findings, it is evident that exosomal cargo comprises various biological molecules including proteins, nucleic acids, and lipid molecules. Misfolded proteins and miRNA are examples of exosomal cargo molecules that can be altered by toxicants, ultimately changing the microenvironment of recipient cells in ways that are conducive to pathological processes. It will be crucial to map out the key signaling pathways that toxicants target to modulate exosomal cargo and their release.	[Rokad, Dharmin; Jin, Huajun; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Parkinson Disorders Res Program, 1222 Vet Med Bldg, Ames, IA 50011 USA		Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Parkinson Disorders Res Program, 1222 Vet Med Bldg, Ames, IA 50011 USA.	rokaddd@iastate.edu; egb761@iastate.edu; anantram@iastate.edu; arthik@iastate.edu; akanthas@iastate.edu		Kanthasamy, Anumantha/0000-0002-6454-4264	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES026892, ES019267, ES025991, NS088206]; W. E. Lloyd Endowed Chair and Eminent Scholar in Veterinary Medicine and Armbrust Endowment; Salisbury Endowed Chair; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES026892, R01ES025991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088206] Funding Source: NIH RePORTER	This review was financially supported by the National Institutes of Health R01 grants [ES026892, ES019267, and ES025991] to A. G.K. and NS088206 to A. K. The W. E. Lloyd Endowed Chair and Eminent Scholar in Veterinary Medicine and Armbrust Endowment to A.G.K. and the Salisbury Endowed Chair to A.K. are also acknowledged.	Abd Elmageed ZY, 2014, STEM CELLS, V32, P983, DOI 10.1002/stem.1619; Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Badi SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01610; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Chen C, 2017, CANCER LETT, V388, P21, DOI 10.1016/j.canlet.2016.11.027; Choi CJ, 2006, NEUROTOXICOLOGY, V27, P777, DOI 10.1016/j.neuro.2006.06.004; Choi CJ, 2010, TOXICOL SCI, V115, P535, DOI 10.1093/toxsci/kfq049; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; Cordazzo C, 2014, INFLAMM RES, V63, P539, DOI 10.1007/s00011-014-0723-7; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Ghidoni R, 2008, MED HYPOTHESES, V70, P1226, DOI 10.1016/j.mehy.2007.12.003; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; Goldman SM, 2014, ANNU REV PHARMACOL, V54, P141, DOI 10.1146/annurev-pharmtox-011613-135937; Gonda A, 2019, MOL CANCER RES, V17, P337, DOI 10.1158/1541-7786.MCR-18-0891; Grad LI, 2014, PRION, V8, P331, DOI 10.4161/19336896.2014.983398; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; Harischandra DS, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau4543; Harischandra DS, 2018, NEUROTOXICOLOGY, V64, P267, DOI 10.1016/j.neuro.2017.04.007; Harischandra DS, 2017, TOXICOL SCI, V158, P3, DOI 10.1093/toxsci/kfx074; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Kanthasamy AG, 2012, TOXICOL LETT, V214, P288, DOI 10.1016/j.toxlet.2012.09.008; Kanthasamy AG, 2005, NEUROTOXICOLOGY, V26, P701, DOI 10.1016/j.neuro.2004.07.010; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kim DS, 2017, NEUROTOXICOLOGY, V59, P231, DOI 10.1016/j.neuro.2016.04.012; Ko J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31215; Lakhal S, 2011, BIOESSAYS, V33, P737, DOI 10.1002/bies.201100076; Langley MR, 2018, NEUROTOXICOLOGY, V64, P240, DOI 10.1016/j.neuro.2017.06.002; Manne S, 2019, J NEUROIMMUNE PHARM; Mutschelknaus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152213; Ngwa HA, 2011, TOXICOL APPL PHARM, V256, P227, DOI 10.1016/j.taap.2011.07.018; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Revenfeld ALS, 2014, CLIN THER, V36, P830, DOI 10.1016/j.clinthera.2014.05.008; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rokad D, 2017, BRAIN RES BULL, V133, P60, DOI 10.1016/j.brainresbull.2016.12.003; Samanta S, 2018, ACTA PHARMACOL SIN, V39, P501, DOI 10.1038/aps.2017.162; Sarkar S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat9900; Sarkar S, 2018, NEUROTOXICOLOGY, V64, P204, DOI 10.1016/j.neuro.2017.05.009; Sinha MS, 2018, ACTA NEUROPATHOL, V136, P41, DOI 10.1007/s00401-018-1868-1; Song C, 2011, NEUROTOXICOLOGY, V32, P586, DOI 10.1016/j.neuro.2011.05.018; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Xu Y, 2015, ARCH TOXICOL, V89, P1071, DOI 10.1007/s00204-014-1291-x; Yamashita T, 2018, BIOL PHARM BULL, V41, P835, DOI 10.1248/bpb.b18-00133; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	64	4	4	4	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2196-5412		CURR ENV HLTH REP	Curr.. Environ. Health Rep.	SEP	2019	6	3					73	79		10.1007/s40572-019-00233-9			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	ME8KV	WOS:000544903000001	31102182	Green Accepted			2022-02-06	
J	Selioutski, O; Roberts, D; Hamilton, R; Ghosh, H; Nickels, J; Toro, FK; Kruppenbacher, M; Auinger, P; Kaplan, PW; Birbeck, GL				Selioutski, Olga; Roberts, Debra; Hamilton, Ross; Ghosh, Hia; Nickels, Jean; Toro, Francesca Konig; Kruppenbacher, Matthew; Auinger, Peggy; Kaplan, Peter W.; Birbeck, Gretchen L.			Continuous EEG Monitoring Predicts a Clinically Meaningful Recovery Among Adult Inpatients	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Continuous EEG monitoring; ICU; Outcomes	TRAUMATIC BRAIN-INJURY; STATUS EPILEPTICUS; OUTCOME PREDICTION; CRITICALLY-ILL; CONSCIOUSNESS; PROGNOSIS; PATTERNS; COMA	Purpose: Continuous EEG (cEEG) monitoring is primarily used for diagnosing seizures and status epilepticus, and for prognostication after cardiorespiratory arrest. The purpose of this study was to investigate whether cEEG could predict survival and meaningful recovery. Methods: The authors reviewed inpatient cEEG reports obtained between January 2013 and November 2015 and recorded demographics, preadmission modified Rankin Scale, history of preexisting epilepsy, Glasgow Coma Scale for those admitted to the intensive care unit, and EEG data (posterior dominant rhythm, reactivity, epileptiform discharges, seizures, and status epilepticus). Associations between clinical outcomes (death vs. survival or clinically meaningful recovery [inpatient rehabilitation, home-based rehabilitation, or home] vs. other [death, skilled nursing facility]) and cEEG findings were assessed with logistic regression models. P < 0.05 was considered significant. Results: For 218 cEEG reports (197 intensive care unit admits), the presence of at least a unilateral posterior dominant rhythm was associated with survival (odds ratio for death, 0.38; 95% confidence interval, 0.19-0.77; P = 0.01) and with a clinically meaningful outcome (odds ratio, 3.26; 95% confidence interval, 1.79-5.93; P < 0.001); posterior dominant rhythm remained significant after adjusting for preadmission disability. Those with preexisting epilepsy had better odds of a meaningful recovery (odds ratio, 3.31; 95% CI, 1.34-8.17; P = 0.001). Treated seizures and status epilepticus were not associated with a worse mortality (P = 0.6) or disposition (P = 0.6). High Glasgow Coma Scale (>= 12) at intensive care unit admission was associated with a clinically meaningful recovery (odds ratio, 16.40; 95% confidence interval, 1.58-170.19; P = 0.02). Conclusions: Continuous EEG findings can be used to prognosticate survival and functional recovery, and provide guidance in establishing goals of care.	[Selioutski, Olga; Birbeck, Gretchen L.] Univ Rochester, Sch Med & Dent, Dept Neurol, Epilepsy Div, Rochester, NY 14642 USA; [Roberts, Debra] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Hamilton, Ross] R Hamilton Naval Hosp Camp Pendleton, Oceanside, CA USA; [Ghosh, Hia] Univ Rochester, Rochester, NY USA; [Nickels, Jean] Univ Rochester, Dept Phys Med & Rehabil, Rochester, NY USA; [Toro, Francesca Konig] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Kruppenbacher, Matthew] Rochester Reg Hlth Spine Ctr, Rochester, NY USA; [Auinger, Peggy] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Hlth & Technol, Rochester, NY 14642 USA; [Kaplan, Peter W.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Selioutski, O (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol, UR Epilepsy Ctr,Med Ctr, 601 Elmwood Ave,POB 673, Rochester, NY 14642 USA.	olga_selioutski@urmc.rochester.edu					Alvarez V, 2015, EPILEPSIA, V56, P933, DOI 10.1111/epi.12996; Amorim E, 2016, RESUSCITATION, V109, P121, DOI 10.1016/j.resuscitation.2016.08.012; Bateman DE, 2001, J NEUROL NEUROSUR PS, V71, P13; Bauer G, 2013, J CLIN NEUROPHYSIOL, V30, P477, DOI 10.1097/WNP.0b013e3182a73e47; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Elmer J, 2016, ANN NEUROL, V80, P175, DOI 10.1002/ana.24697; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; FISCH BJ, 1999, FISCH SPEHLMANNS EEG; Hack D, 2017, AM J EMERG MED, V35, P949, DOI 10.1016/j.ajem.2017.01.060; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hofmeijer J, 2014, CLIN NEUROPHYSIOL, V125, P947, DOI 10.1016/j.clinph.2013.10.017; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kaplan PW, 1999, CLIN NEUROPHYSIOL, V110, P205, DOI 10.1016/S1388-2457(98)00046-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche S, 2013, HDB ICU EEG MONITORI; Leitinger M, 2015, EPILEPSY BEHAV, V49, P158, DOI 10.1016/j.yebeh.2015.05.007; Monteiro ML, 2016, NEUROCRIT CARE, V24, P153, DOI 10.1007/s12028-015-0215-9; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; Postels DG, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2355-9; Rossetti AO, 2017, CLIN NEUROPHYS PRACT, V2, P76, DOI 10.1016/j.cnp.2017.03.001; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rossetti AO, 2008, J NEUROL, V255, P1561, DOI 10.1007/s00415-008-0989-1; Sutter R, 2014, EUR J NEUROL, V21, P1268, DOI 10.1111/ene.12436; Sutter R, 2015, J CLIN NEUROPHYSIOL, V32, P456, DOI 10.1097/WNP.0000000000000164; SYNEK VM, 1988, CLIN ELECTROENCEPHAL, V19, P160, DOI 10.1177/155005948801900310; Tatum WO, 2016, J CLIN NEUROPHYSIOL, V33, P328, DOI 10.1097/WNP.0000000000000319; TEASDALE G, 1974, LANCET, V2, P81; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084	31	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	SEP	2019	36	5					358	364		10.1097/WNP.0000000000000594			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT1MM	WOS:000500762100007	31491786				2022-02-06	
J	Seno, S; Tomura, S; Ono, K; Tanaka, Y; Ikeuchi, H; Saitoh, D				Seno, Soichiro; Tomura, Satoshi; Ono, Kenichiro; Tanaka, Yoshihiro; Ikeuchi, Hisashi; Saitoh, Daizoh			Poor prognostic factors in elderly patients aged 75 years old or older with mild traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Prognostic factor; Mild traumatic brain injury; Elderly patient; Dementia; Cancer	HEAD-INJURY; MRC CRASH; MORTALITY; OUTCOMES; SURGERY; TRIAL; RISK; PREDICTORS; MANAGEMENT; FRAILTY	The incidence of traumatic brain injury (TBI) in elderly patients is increasing. We retrospectively investigated the poor prognostic factors at discharge in elderly patients aged 75 years or older admitted to hospital with mild TBI. We continuously enrolled 83 patients aged 75 years or older with mild TBI, in a private general Japanese hospital. The Glasgow Coma Scale scores on admission were within the range of 13-15. Patients with good recovery or moderate disability were included in the "good outcome" group, and those with severe disability, in a persistent vegetative state, or who died were included in the "poor outcome" group. We performed statistical analyses using 8 parameters. We conducted a univariate analysis on each item. Next, we conducted a logistic regression analysis on variables where the p < 0.20 in the univariate analysis. Elderly patients had a poor prognosis when they had dementia (odds ratio [OR]: 20.357, 95% confidence interval [CI]: 2.075-199.683, p = 0.010), cancer (OR: 14.005, 95% CI: 1.262-154.444, p = 0.032), or a history of antithrombotic therapy before admission (OR: 6.673, 95% CI: 1.072-41.526, p = 0.042). When elderly patients aged 75 years or older with mild TBI have the 3 poor prognostic factors of dementia, cancer, or a history of antithrombotic therapy, their outcomes might be worse compared to other elderly patients. Elderly patients who have these factors should be carefully managed. (C) 2019 Elsevier Ltd. All rights reserved.	[Seno, Soichiro; Tomura, Satoshi; Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan; [Ono, Kenichiro] Mishuku Hosp, Dept Neurosurg, Tokyo, Japan; [Seno, Soichiro; Tanaka, Yoshihiro; Ikeuchi, Hisashi; Saitoh, Daizoh] Natl Def Med Coll, Dept Traumatol & Crit Care Med, Saitama, Japan		Seno, S (corresponding author), Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan.; Seno, S (corresponding author), Natl Def Med Coll, Dept Traumatol & Crit Care Med, Saitama, Japan.	res310@ndmc.ac.jp	Tanaka, Yoshihiro/Z-2905-2019	Tanaka, Yoshihiro/0000-0002-7468-8886			Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Cabinet Office, 2016, ANN REP AG SOC; Cancelliere C, 2014, ARCH PHYS MED REHAB, V95, P5201, DOI [10.1016/japmr.201310010, DOI 10.1016/JAPMR.201310010]; Carroll LJ, 2014, ARCH PHYS MED REHAB, V95, P5152, DOI [10.1016/.apmr.2013.08.300, DOI 10.1016/.APMR.2013.08.300]; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Charry JD, 2017, WORLD NEUROSURG, V101, P554, DOI 10.1016/j.wneu.2017.02.051; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Edwards P, 2005, LANCET, V365, P1957; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Godbolt AK, 2014, ARCH PHYS MED REHAB, V95, P5245, DOI [10.1016/j.apmr.7o13.06.03Q, DOI 10.1016/J.APMR.7O13.06.03Q]; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058292; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Le Maguet P, 2014, INTENS CARE MED, V40, P674, DOI 10.1007/s00134-014-3253-4; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Ouchi Y, 2017, GERIATR GERONTOL INT, V17, P1045, DOI 10.1111/ggi.13118; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Sandstrom CK, 2018, NEUROIMAG CLIN N AM, V28, P471, DOI 10.1016/j.nic.2018.03.008; Statistics Bureau Ministry of Internal Affairs and Communications, 2017, CURRENT POPULATION E; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Suehiro E, 2014, CLIN NEUROL NEUROSUR, V127, P97, DOI 10.1016/j.clineuro.2014.10.007; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Zhang XW, 2017, CANCER J, V23, P201, DOI 10.1097/PPO.0000000000000270	36	4	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2019	67						124	128		10.1016/j.jocn.2019.06.007			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU2MD	WOS:000483413600022	31221574				2022-02-06	
J	Tanev, KS; Federico, LE; Terry, DP; Clark, EL; Iverson, GL				Tanev, Katoyan S.; Federico, Lydia E.; Terry, Douglas P.; Clark, Erika L.; Iverson, Grant L.			Cognitive Impairment and Predicting Response to Treatment in an Intensive Clinical Program for Post-9/11 Veterans With Posttraumatic Stress Disorder	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							VERBAL MEMORY; RELAXATION RESPONSE; BRAIN-INJURY; IRAQ; PSYCHOTHERAPY; AFGHANISTAN; PTSD; EFFICACY; VALIDITY; THERAPY	Objective: This study examined whether objectively measured pretreatment cognitive impairment predicted worse response to treatment for posttraumatic stress disorder. Participants were 113 veterans and active duty service members who participated in a new multidisciplinary 2-week intensive clinical program that included individual trauma-focused cognitive-behavioral therapy, group psychotherapy, psychoeducation, skills-building groups, and complementary and alternative medicine treatments (mean age: 39.7 years [SD=8.5]; 20% women). Methods: Prior to treatment, participants completed a brief computerized cognitive battery (CNS Vital Signs) and were operationalized as having cognitive impairment if they scored in the <= 5th percentile on two or more of five core cognitive domains. Participants completed measures of traumatic stress, depression, cognitive self-efficacy, and satisfaction with their ability to participate in social roles before and after treatment. Results: There were no significant correlations between pretreatment individual cognitive test scores and change in the clinical outcome measures. One-half of the study sample (49.6%) met criteria for cognitive impairment. In a mixed multivariate analysis of variance, the interaction between cognitive impairment and time was not significant (F=0.83, df=4, 108, p=0.51), indicating that the pre- to posttreatment changes in outcome scores were not significantly different for the cognitively impaired group compared with the cognitively intact group. The multivariate main effect for time was significant (F=36.75, df=4, 108, p<0.001). Follow-up univariate tests revealed significant improvement in traumatic stress, depression, cognitive self-efficacy, and satisfaction with social roles after treatment. Conclusions: Cognitive impairment was not associated with worse response to treatment in veterans with severe and complex mental health problems. Veterans with and without cognitive impairment reported large improvements in symptoms and functioning after treatment.	[Tanev, Katoyan S.; Federico, Lydia E.; Terry, Douglas P.; Clark, Erika L.; Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA 02215 USA; [Tanev, Katoyan S.; Federico, Lydia E.; Terry, Douglas P.; Clark, Erika L.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA 02114 USA; [Tanev, Katoyan S.; Federico, Lydia E.; Clark, Erika L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Inst, Boston, MA 02115 USA		Tanev, KS (corresponding author), Red Sox Fdn, Home Base, Boston, MA 02215 USA.; Tanev, KS (corresponding author), Massachusetts Gen Hosp Program, Boston, MA 02114 USA.; Tanev, KS (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA.	ktanev@mgh.harvard.edu			NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1K23MH097844-01A1]; Wounded Warrior Project	Supported in part by an NIMH career development award grant to Dr. Tanev (grant 1K23MH097844-01A1).; The Home Base Program (study site) is supported philanthropically by the Wounded Warrior Project and is part of the Warrior Care Network.	Beaudreau SA, 2015, AM J GERIAT PSYCHIAT, V23, P215, DOI 10.1016/j.jagp.2014.09.003; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bruder GE, 2014, J AFFECT DISORDERS, V166, P108, DOI 10.1016/j.jad.2014.04.057; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; CNS Vital Signs, 2017, CNS VIT SIGNS BRIEF; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Cukor J, 2010, ANN NY ACAD SCI, V1208, P82, DOI 10.1111/j.1749-6632.2010.05793.x; Elbogen EB, 2012, MIL MED, V177, P669, DOI 10.7205/MILMED-D-11-00388; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Gonzalez A, 2016, EUR J INTEGR MED, V8, P756, DOI 10.1016/j.eujim.2016.05.002; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haagen JFG, 2015, CLIN PSYCHOL REV, V40, P184, DOI 10.1016/j.cpr.2015.06.008; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Harvey Margaret M, 2017, Focus (Am Psychiatr Publ), V15, P378, DOI 10.1176/appi.focus.20170022; Harvey MM, 2018, COGNIT BEHAV PRACT; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P254, DOI 10.1080/09084280903297594; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P207, DOI 10.1080/09084280903098778; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kelsall HL, 2015, EPIDEMIOL REV, V37, P38, DOI 10.1093/epirev/mxu014; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Milenkovic Tatjana, 2013, Med Glas (Zenica), V10, P120; Mueser KT, 2018, PSYCHIAT RES, V259, P110, DOI 10.1016/j.psychres.2017.10.016; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; Niles BL, 2018, PSYCHOL SERV, V15, P496, DOI 10.1037/ser0000175; Park ER, 2013, PSYCHOSOMATICS, V54, P165, DOI 10.1016/j.psym.2012.09.001; Puetz TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126529; Rizvi SL, 2009, BEHAV RES THER, V47, P737, DOI 10.1016/j.brat.2009.06.003; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Zalta AK, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1816-6	39	4	4	0	4	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2019	31	4					337	345		10.1176/appi.neuropsych.18090208			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JD7SI	WOS:000490181300007	31018812	Bronze			2022-02-06	
J	Tulsky, DS; Tyner, CE; Boulton, AJ; Kisala, PA; Heinemann, AW; Roth, EJ; Carlozzi, NE				Tulsky, David S.; Tyner, Callie E.; Boulton, Aaron J.; Kisala, Pamela A.; Heinemann, Allen W.; Roth, Elliot J.; Carlozzi, Noelle E.			Development of the TBI-QOL Headache Pain Item Bank and Short Form	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						headache; health-related quality of life; patient-reported outcome measures; psychometrics; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; RESPONSE THEORY; MIGRAINE DISABILITY; NATURAL-HISTORY; IMPACT; PREVALENCE; RELIABILITY; SYMPTOMS	Objective: To develop, calibrate, and evaluate the test-retest reliability of a new patient-reported outcome measure of headache pain relevant for individuals with traumatic brain injury (TBI). Setting: Six TBI Model Systems rehabilitation centers in the United States. Participants: Adults with medically confirmed documentation of TBI. Design: Cross-sectional calibration field testing and test-retest reliability analyses. Main Measures: Traumatic Brain Injury-Quality of Life Headache Pain item bank. Results: Thirteen headache pain items were calibrated as a unidimensional measure using data from 590 participants. The new measure was reliable (alpha = .98; item-total correlation range: 0.71-0.91). Item parameter estimates were estimated using Samejima's Graded Response Model and a 10-item calibrated short form was created. Simulation testing confirmed that both the computer-adaptive test and the short-form administrations were equivalent to the full item bank. One- to-2-week test-retest reliability of the computer-adaptive test was high (Pearson r and intraclass correlation coefficients = 0.81). Approximately two-thirds of the sample reported at least 1 headache symptom. Conclusion: The Traumatic Brain Injury-Quality of Life Headache Pain item bank and short form provide researchers and clinicians with reliable measures of the subjective experience of headache symptoms for individuals with a history of TBI.	[Tulsky, David S.; Tyner, Callie E.; Boulton, Aaron J.; Kisala, Pamela A.] Univ Delaware, Ctr Hlth Assessment Res & Translat, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA; [Heinemann, Allen W.; Roth, Elliot J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heinemann, Allen W.; Roth, Elliot J.] Shirley Ryan AbilityLab, Chicago, IL USA; [Carlozzi, Noelle E.] Univ Michigan, Med Sch, Dept Phys Med & Rehabil, Ann Arbor, MI USA		Tulsky, DS (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tyner, Callie/0000-0003-2945-392X; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038, H133A120100]	This study was supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this manuscript was provided by NIDILRR grant # H133A120100.	Anderson K, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/693925; Armstrong TS, 2004, J NURS SCHOLARSHIP, V36, P197, DOI 10.1111/j.1547-5069.2004.04038.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner J, 2007, IRTFIT MACRO ITEM FI; Bjorner JB, 2014, QUAL LIFE RES, V23, P217, DOI 10.1007/s11136-013-0451-4; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Broderick JE, 2008, PAIN, V139, P146, DOI 10.1016/j.pain.2008.03.024; Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Brown M.W., 1993, SOCIOL METHOD RES, P136; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Carlozzi N.E., ARCH PHYS MED REHABI; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DODD BG, 1993, EDUC PSYCHOL MEAS, V53, P61, DOI 10.1177/0013164493053001005; Dumke HA, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000244; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Hird A, 2010, SUPPORT CARE CANCER, V18, P335, DOI 10.1007/s00520-009-0657-8; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim SH, 2007, J EDUC MEAS, V44, P93, DOI 10.1111/j.1745-3984.2007.00029.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kisala PA, 2019, J HEAD TRAUMA REHAB, V34, P289, DOI 10.1097/HTR.0000000000000530; Kisala PA, 2019, HEALTH PSYCHOL, V38, P435, DOI 10.1037/hea0000685; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lipton RB, 2001, HEADACHE, V41, P854; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Magnus BE, 2016, QUAL LIFE RES, V25, P1655, DOI 10.1007/s11136-015-1221-2; Martins Hugo André de Lima, 2012, Dement. neuropsychol., V6, P53, DOI 10.1590/S1980-57642012DN06010009; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Muthen B. O., 1998, MPLUS USERS GUIDE, V7th; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Novack T, 2000, ORIENTATION LOG; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; PROMIS, PROMIS INSTR DEV VAL; Revicki DA, 2009, PAIN, V146, P158, DOI 10.1016/j.pain.2009.07.029; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; THISSEN D, 1995, APPL PSYCH MEAS, V19, P39, DOI 10.1177/014662169501900105; THISSEN D, 2003, MULTILOG VERSION 7 C; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P281, DOI 10.1097/HTR.0000000000000531; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tyner CE, ARCH PHYS MED REHABI; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P1, DOI 10.1097/00001199-199902000-00003	66	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		298	307		10.1097/HTR.0000000000000532			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100011	31498229				2022-02-06	
J	Zolnikov, TR; Ramirez-Ortiz, D; Moraes, H; Cruvinel, VRN; Dominguez, A; Galato, D				Zolnikov, Tara Rava; Ramirez-Ortiz, Daisy; Moraes, Hayssa; Nogueira Cruvinel, Vanessa Resende; Dominguez, Aldira; Galato, Dayani			Continued Medical Waste Exposure of Recyclable Collectors Despite Dumpsite Closures in Brazil	JOURNAL OF HEALTH AND POLLUTION			English	Article						recyclable material collectors; recyclable collectors; healthcare waste; occupational health and safety; qualitative research; Brazil	INFORMAL SECTOR; SOLID-WASTE; HEPATITIS-B; HEALTH; MANAGEMENT; RECYCLERS; HAZARDS; SAFETY; WORK; CARE	Background. Brasilia, the capital of Brazil, currently has the largest dumpsite of the Americas at Estrutural, with over 30 million tons of waste accumulated. Recyclable waste collectors are a group of workers who, in addition to having a low socioeconomic status and residing in vulnerable areas, work sorting garbage in inadequate and unsanitary areas. This profession puts individuals at risk, resulting in death, mutilation, and disease for workers. Objectives. The aim of this study was to understand the effects of waste on recyclable collectors, along with their perceptions of associated risks. Methods. A qualitative study was conducted, using interviews with 34 participants at Estrutural. Results. Collectors were exposed to several hazards, including biological, physical, and more extreme hazards (e.g. being run over by waste trucks). Personal protective equipment was not adequately used, exposing recyclable collectors to injury. Accidents included cuts, burns, skin lesions, eyes lesions, and arm, leg, head, feet, and hand injuries and amputations. Often, homecare remedies and collected medical waste (e.g. pain killers) were used on these injuries instead of seeking out proper medical care. Conclusions. Recyclable collectors were aware of occupational hazards, but lacked education on the risks and consequences associated with exposure to medical hazards. Moreover, Brazil recently formally closed all dumpsites, complicating this issue. The findings of the present study confirm the need to address these hazards to provide a safe working environment for waste pickers. Participant Consent. Obtained	[Zolnikov, Tara Rava] Natl Univ, San Diego, CA 92123 USA; [Ramirez-Ortiz, Daisy] Florida Int Univ, Miami, FL 33199 USA; [Moraes, Hayssa; Nogueira Cruvinel, Vanessa Resende; Dominguez, Aldira; Galato, Dayani] Univ Brasilia, Brasilia, DF, Brazil		Zolnikov, TR (corresponding author), Natl Univ, San Diego, CA 92123 USA.	tarazolnikov@gmail.com		Cruvinel, vanessa/0000-0003-1518-4167; Galato, Dayani/0000-0002-9295-8018; Ramirez Ortiz, Daisy/0000-0002-5374-3348; Dominguez, Aldira/0000-0002-6481-6055; Zolnikov, Tara/0000-0002-0106-1214			Alves SB, 2012, REV BRAS ENFERM, V65, P128, DOI 10.1590/S0034-71672012000100019; [Anonymous], 2015, RELATORIO DOS SERVIC; [Anonymous], 2014, FOLHA UBERABA   0731; [Anonymous], 2013, AN JARAGUA      0529; Binion E, 2012, INT J OCCUP ENV HEAL, V18, P43, DOI 10.1179/1077352512Z.0000000001; Cardoso CC, 2009, REV TER OCUP U SAO P, V20, P36; CAVALCANTE S., 2007, REV MAL ESTAR SUBJEC, V7, P211; Corrao CRN, 2013, SCI WORLD J, DOI 10.1155/2013/692083; Dall'Agnol CM, 2007, REV LAT-AM ENFERM, V15, P729, DOI 10.1590/S0104-11692007000700003; Dias S, WASTE PICKERS; Dias SM., 2011, STATISTICS ON WASTE; Fergutz O, 2011, ENVIRON URBAN, V23, P597, DOI 10.1177/0956247811418742; Ferreira J A, 2001, Cad Saude Publica, V17, P689, DOI 10.1590/S0102-311X2001000300023; Mol MPG, 2015, CAD SAUDE PUBLICA, V31, pS295, DOI 10.1590/0102-311X00083814; Graudenz Gustavo Silveira, 2009, Rev. bras. saúde ocup., V34, P106; Gutberlet J, 2013, INT J ENV RES PUB HE, V10, P4607, DOI 10.3390/ijerph10104607; Hasan MM, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/6879751; Hoefel Maria da Graça, 2013, Rev. bras. epidemiol., V16, P774, DOI 10.1590/S1415-790X2013000300020; International Labour Organization, 2013, WOM MEN INF EC STAT; Kuijer PPFM, 2010, AM J IND MED, V53, P1040, DOI 10.1002/ajim.20870; Linzner R, 2013, PROC INST CIV ENG-WA, V166, P69, DOI 10.1680/warm.12.00012; Medeiros Luiza Ferreira Rezende de, 2006, Psicol. Soc., V18, P62, DOI 10.1590/S0102-71822006000200009; Meira SR, 2016, THESIS; Mendes AA, 2012, CIENC CUIDE SAUDE, V11; Miura Paula Orchiucci, 2013, Psicol. Soc., V25, P331; Moreira AMM, 2013, WASTE MANAGE, V33, P162, DOI 10.1016/j.wasman.2012.09.018; Moura A., 2011, THESIS; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Nastasi BK, 2005, J SCHOOL PSYCHOL, V43, P177, DOI 10.1016/j.jsp.2005.04.003; Cruvinel VRN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6879-x; Patwary MA, 2011, SAFETY SCI, V49, P1200, DOI 10.1016/j.ssci.2011.04.001; Rauf MUA, 2013, J PAK MED ASSOC, V63, P798; Santana PS, 2013, REV ENFERM CONT, V2, P82; Silva Carlos Ernando da, 2005, Eng. Sanit. Ambient., V10, P146, DOI 10.1590/S1413-41522005000200008; Tapia Carmen Elisa Villalobos, 2009, Rev Gaucha Enferm, V30, P228; Campos HKT, 2014, RESOUR CONSERV RECY, V85, P130, DOI 10.1016/j.resconrec.2013.10.017; Wilson DC, 2006, HABITAT INT, V30, P797, DOI 10.1016/j.habitatint.2005.09.005; Ziraba AK, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0166-4; Zolnikov TR, 2018, WASTE MANAGE, V80, P26, DOI 10.1016/j.wasman.2018.08.047	39	4	6	1	13	PURE EARTH BLACKSMITH INST	NEW YORK	475 RIVERSIDE DR, STE 860, NEW YORK, NY 10115 USA		2156-9614		J HEALTH POLLUT	J. Health Pollut.	SEP	2019	9	23							190905	10.5696/2156-9614-9.23.190905			10	Environmental Sciences; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	IT0TF	WOS:000482559200004	31497368	Green Submitted, Green Published, gold			2022-02-06	
J	Vos, L; Poritz, JMP; Ngan, E; Leon-Novelo, L; Sherer, M				Vos, Leia; Poritz, Julia M. P.; Ngan, Esther; Leon-Novelo, Luis; Sherer, Mark			The relationship between resilience, emotional distress, and community participation outcomes following traumatic brain injury	BRAIN INJURY			English	Article						Resilience; traumatic brain injury; emotional distress; community integration	SPINAL-CORD-INJURY; POSITIVE PSYCHOLOGY; LIFE SATISFACTION; REHABILITATION; INTEGRATION; DISABILITY; MODEL; EPIDEMIOLOGY; IMPAIRMENT; PEOPLE	Purpose/Objective: To determine how resilience is associated with social participation outcomes in persons with traumatic brain injury (TBI), in the context of emotional distress, demographics, and injury-related factors. Setting: Individuals with a history of TBI recruited the following stay at three rehabilitation facilities in the USA. Participants: 201 community-dwelling persons with medically documented TBI ranging in severity from mild to severe. Design: Prospective cohort observational study. Data were collected at two time points, approximately 6 months apart. Main Measures: TBI-QOL; PART-O Results: Resilience at baseline was moderately to strongly correlated with baseline psychological distress variables (r(s)= -.66) and social participation variables (r(s) =.33 to.57). In regression analyses, resilience was directly associated with social participation outcomes and formed a significant interaction with emotional distress in some models. Resilience failed to show a relationship with social participation at 6-month follow-up, when controlling for baseline social participation. Conclusions: Though related to emotional distress, self-reported resilience makes a unique contribution to predicting outcomes over time following brain injury, and may impact the relationship between stress and negative participation outcomes. As such, it is possible interventions that promote resilience may mitigate distress and promote community integration.	[Vos, Leia; Poritz, Julia M. P.; Sherer, Mark] Zablocki VA Med Ctr, Brain Injury Res Ctr, TIRR Mem Hermann, Milwaukee, WI USA; [Vos, Leia] Zablocki VA Med Ctr, Neuropsychol, Milwaukee, WI USA; [Vos, Leia; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Ngan, Esther; Leon-Novelo, Luis] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA		Vos, L (corresponding author), TIRR Mem Hermann Hosp, BIRC, 1333 Moursund, Houston, TX 77030 USA.	leia.demaagd@gmail.com	Vos, Leia/AAJ-8364-2020		National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90RT5007, 90DP0028]	The contents of this article were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90RT5007 and 90DP0028). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Bashant J., 2014, J LEADERSHIP INSTRUC, V13, P14; Battalio SL, 2017, ARCH PHYS MED REHAB, V98, P1158, DOI 10.1016/j.apmr.2016.11.012; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Duckworth AL, 2005, ANNU REV CLIN PSYCHO, V1, P629, DOI 10.1146/annurev.clinpsy.1.102803.144154; Edward K.L., 2005, J AM PSYCHIAT NURSES, V11, P241, DOI [10.1177/1078390305281177, DOI 10.1177/1078390305281177]; Fairchild AJ, 2009, PREV SCI, V10, P87, DOI 10.1007/s11121-008-0109-6; Fleming J, 1999, BRAIN INJURY, V13, P417; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Johnson JL, 1999, RESILIENCE DEV POSIT, P179, DOI [10.1007/0-306-47167-1_9, DOI 10.1007/B108350]; Kaplan H, 1999, RESILIENCE DEV POSIT, P179; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Locatelli SM, 2017, REHABIL PSYCHOL, V62, P334, DOI 10.1037/rep0000153; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Luthar SS, 2007, DEV PSYCHOPATHOL, V19, P931, DOI 10.1017/S0954579407000454; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; Meredith Lisa S, 2011, Rand Health Q, V1, P2; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Poritz JMP, 2020, ARCH PHYS MED REHAB, V101, P54, DOI 10.1016/j.apmr.2017.11.018; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P62, DOI 10.1016/j.apmr.2017.04.016; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; Silverman AM, 2015, ARCH PHYS MED REHAB, V96, P1262, DOI 10.1016/j.apmr.2015.02.023; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Victorson D, 2015, J SPINAL CORD MED, V38, P366, DOI 10.1179/2045772315Y.0000000016; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Whisman MA, 2005, J FAM PSYCHOL, V19, P111, DOI 10.1037/0893-3200.19.1.111; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	57	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1615	1623		10.1080/02699052.2019.1658132		AUG 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000483973700001	31456432				2022-02-06	
J	Shimba, K; Chang, CH; Asahina, T; Moriya, F; Kotani, K; Jimbo, Y; Gladkov, A; Antipova, O; Pigareva, Y; Kolpakov, V; Mukhina, I; Kazantsev, V; Pimashkin, A				Shimba, Kenta; Chang, Chih-Hsiang; Asahina, Takahiro; Moriya, Fumika; Kotani, Kiyoshi; Jimbo, Yasuhiko; Gladkov, Arseniy; Antipova, Oksana; Pigareva, Yana; Kolpakov, Vladimir; Mukhina, Irina; Kazantsev, Victor; Pimashkin, Alexey			Functional Scaffolding for Brain Implants: Engineered Neuronal Network by Microfabrication and iPSC Technology	FRONTIERS IN NEUROSCIENCE			English	Article						human induced pluripotent stem cell; microelectrode array; microfabrication; neuronal network; 3D scaffold brain implant; neural tissue engineering; microfluidics	NEURAL PROGENITOR CELLS; THETA OSCILLATIONS; DYNAMICS; TRANSPLANTATION; PATTERNS	Neuroengineering methods can be effectively used in the design of new approaches to treat central nervous system and brain injury caused by neurotrauma, ischemia, or neurodegenerative disorders. During the last decade, significant results were achieved in the field of implant (scaffold) development using various biocompatible and biodegradable materials carrying neuronal cells for implantation into the injury site of the brain to repair its function. Neurons derived from animal or human induced pluripotent stem (iPS) cells are expected to be an ideal cell source, and induction methods for specific cell types have been actively studied to improve efficacy and specificity. A critical goal of neuro-regeneration is structural and functional restoration of the injury site. The target treatment area has heterogeneous and complex network topology with various types of cells that need to be restored with similar neuronal network structure to recover correct functionality. However, current scaffold-based technology for brain implants operates with homogeneous neuronal cell distribution, which limits recovery in the damaged area of the brain and prevents a return to fully functional biological tissue. In this study, we present a neuroengineering concept for designing a neural circuit with a pre-defined unidirectional network architecture that provides a balance of excitation/inhibition in the scaffold to form tissue similar to that in the injured area using various types of iPS cells. Such tissue will mimic the surrounding niche in the injured site and will morphologically and topologically integrate into the brain, recovering lost function.	[Shimba, Kenta; Chang, Chih-Hsiang; Asahina, Takahiro; Moriya, Fumika; Kotani, Kiyoshi; Jimbo, Yasuhiko] Univ Tokyo, Sch Engn, Dept Precis Engn, Tokyo, Japan; [Gladkov, Arseniy; Antipova, Oksana; Pigareva, Yana; Kolpakov, Vladimir; Mukhina, Irina; Pimashkin, Alexey] NI Lobachevsky State Univ Nizhny Novgorod, Ctr Translat Technol, Dept Neuroengn, Nizhnii Novgorod, Russia; [Gladkov, Arseniy; Mukhina, Irina] Privolzhsky Res Med Univ, Cent Res Lab, Dept Mol & Cellular Technol, Nizhnii Novgorod, Russia; [Kazantsev, Victor; Pimashkin, Alexey] NI Lobachevsky State Univ Nizhny Novgorod, Dept Neurotechnol, Nizhnii Novgorod, Russia		Pimashkin, A (corresponding author), NI Lobachevsky State Univ Nizhny Novgorod, Ctr Translat Technol, Dept Neuroengn, Nizhnii Novgorod, Russia.; Pimashkin, A (corresponding author), NI Lobachevsky State Univ Nizhny Novgorod, Dept Neurotechnol, Nizhnii Novgorod, Russia.	pimashkin@neuro.nnov.ru	Ivanovich, Vladimir Kolpakov/E-6109-2017; Gladkov, Arseniy A/B-7451-2013; Kolpakov, Vladimir/AAM-7215-2021; Kazantsev, Victor B/L-1424-2013; Pigareva, Yana/AAM-7211-2021	Ivanovich, Vladimir Kolpakov/0000-0001-9658-7034; Gladkov, Arseniy A/0000-0002-1831-808X; Kazantsev, Viktor/0000-0002-2881-6648; Shimba, Kenta/0000-0003-1156-260X	RFBRRussian Foundation for Basic Research (RFBR) [19-58-50005\ 19]; Japan-Russia Research Cooperative Program	This study was funded by RFBR, project number 19-58-50005\ 19, and Japan-Russia Research Cooperative Program.	Akopova TA, 2015, MENDELEEV COMMUN, V25, P280, DOI 10.1016/j.mencom.2015.07.017; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Balyabin AV, 2017, SOVREM TEHNOL MED, V9, P106, DOI 10.17691/stm2017.9.4.13; Bao WL, 2003, J NEUROPHYSIOL, V90, P333, DOI 10.1152/jn.00715.2002; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Chen F, 2018, J COLLOID INTERF SCI, V521, P261, DOI 10.1016/j.jcis.2018.02.053; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fantuzzo JA, 2019, DEV DYNAM, V248, P65, DOI 10.1002/dvdy.24665; Fischer Y, 1999, J PHYSIOL-LONDON, V519, P405, DOI 10.1111/j.1469-7793.1999.0405m.x; Frega M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05489; Gal A, 2010, J NEUROSCI, V30, P16332, DOI 10.1523/JNEUROSCI.4859-10.2010; Gladkov A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192468; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Iida S, 2018, BIOCHEM BIOPH RES CO, V501, P152, DOI 10.1016/j.bbrc.2018.04.197; Jin Y, 2016, NEUROSCIENCE, V320, P69, DOI 10.1016/j.neuroscience.2016.01.066; Keren H, 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP36837; Kim JH, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/04/P04019; le Feber J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008871; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Medvedeva EV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082366; Mobini S, 2019, BIOMATERIALS, V198, P146, DOI 10.1016/j.biomaterials.2018.05.012; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305; Pimashkin A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00087; Pimashkin A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00046; Schrader S, 2008, J NEUROPHYSIOL, V100, P2165, DOI 10.1152/jn.01245.2007; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Shahaf G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000228; Shimba K, 2019, IEEE T BIO-MED ENG, V66, P2538, DOI 10.1109/TBME.2019.2891310; Shimba K, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9997-y; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Timashev PS, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/3/035001; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16; Wang TY, 2012, J BIOMATER APPL, V27, P369, DOI 10.1177/0885328212443297	41	4	4	3	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 29	2019	13								890	10.3389/fnins.2019.00890			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT7DP	WOS:000483036200001	31555074	gold, Green Published			2022-02-06	
J	Ratliff, WA; Saykally, JN; Mervis, RF; Lin, XY; Cao, CH; Citron, BA				Ratliff, Whitney A.; Saykally, Jessica N.; Mervis, Ronald F.; Lin, Xiaoyang; Cao, Chuanhai; Citron, Bruce A.			Behavior, protein, and dendritic changes after model traumatic brain injury and treatment with nanocoffee particles	BMC NEUROSCIENCE			English	Article						Traumatic brain injury; Closed head injury; Coffee; Caffeine; Golgi stain	COGNITIVE DEFICITS; CAFFEINE CONSUMPTION; NEURONAL LOSS; EXPRESSION; COFFEE; ACTIVATION; INHIBITION; IMPAIRMENT; MEMORY; STABILITY	Background Traumatic brain injury (TBI) is a widespread public health problem and a signature injury of our military in modern conflicts. Despite the long-term effects of even mild brain injuries, an effective treatment remains elusive. Coffee and several of its compounds, including caffeine, have been identified as having neuroprotective effects in studies of neurodegenerative disease. Given the molecular similarities between TBI and neurodegenerative disease, we have devised a study to test a nanocoffee extract in the treatment of a mouse model of mild TBI. Results After a single injury and two subsequent injections of nanocoffee, we identified treatment as being associated with improved behavioral outcomes, favorable molecular signaling changes, and dendritic changes suggestive of improved neuronal health. Conclusions We have identified coffee extracts as a potential viable multifaceted treatment approach to target the secondary injury associated with TBI.	[Ratliff, Whitney A.; Saykally, Jessica N.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Res & Dev, 151 Bldg,22 Rm 123,10000 Bay Pines Blvd, Bay Pines, FL 33744 USA; [Ratliff, Whitney A.; Saykally, Jessica N.; Citron, Bruce A.] USF Coll Med, Dept Mol Med, 12901 Bruce B Downs Blvd,MDC 7, Tampa, FL 33612 USA; [Mervis, Ronald F.] NeuroStruct Analyt Inc, Columbus, OH USA; [Mervis, Ronald F.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Aging & Brain Repair, 2 Tampa Gen Circle, Tampa, FL 33606 USA; [Lin, Xiaoyang; Cao, Chuanhai] USF, Coll Pharm, Hlth Byrd Alzheimers Inst, 4001 E Fletcher Ave, Tampa, FL 33613 USA; [Lin, Xiaoyang; Cao, Chuanhai] USF Coll Pharm, Dept Pharmaceut Sci, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Citron, Bruce A.] VA New Jersey Hlth Care Syst, Res & Dev, Bldg 16,Rm 16-176,385 Tremont Ave,Mailstop 15, E Orange, NJ 07018 USA; [Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07101 USA		Cao, CH (corresponding author), USF, Coll Pharm, Hlth Byrd Alzheimers Inst, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	ccao@health.usf.edu	Ratliff, Whitney/L-3556-2016	Ratliff, Whitney/0000-0002-5461-7802	Department of Veterans Affairs [Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development] [I01RX001520]; Congressionally Directed Gulf War Illness Research Program [W81XWH-16-1-0626]; Florida Department of Health James and Esther King Biomedical Research Program [4KB14]; Bay Pines Foundation; Veterans Biomedical Research Institute	This study was supported by the Department of Veterans Affairs [Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development (I01RX001520)], the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the Florida Department of Health James and Esther King Biomedical Research Program (4KB14), The Bay Pines Foundation, and the Veterans Biomedical Research Institute. The funding sources had no involvement in study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Ang BT, 2003, J NEUROSURG, V99, P125, DOI 10.3171/jns.2003.99.1.0125; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Cao CH, 2011, J ALZHEIMERS DIS, V25, P323, DOI 10.3233/JAD-2011-110110; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dall'lgna OP, 2003, BRIT J PHARMACOL, V138, P1207, DOI 10.1038/sj.bjp.0705185; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazeli W, 2017, EXP NEUROL, V295, P88, DOI 10.1016/j.expneurol.2017.05.013; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fumimoto R, 2012, J PHARMACOL SCI, V118, P479, DOI 10.1254/jphs.11212FP; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Geraets L, 2006, BIOCHEM PHARMACOL, V72, P902, DOI 10.1016/j.bcp.2006.06.023; Hameleers PAHM, 2000, HUM PSYCHOPHARM CLIN, V15, P573, DOI 10.1002/hup.218; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x; Malone JI, 2008, PEDIATR DIABETES, V9, P531, DOI 10.1111/j.1399-5448.2008.00431.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vila-Luna S, 2012, NEUROSCIENCE, V202, P384, DOI 10.1016/j.neuroscience.2011.11.053; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zeitlin R, 2011, BRAIN RES, V1417, P127, DOI 10.1016/j.brainres.2011.08.036; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	50	4	4	1	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	AUG 22	2019	20	1							44	10.1186/s12868-019-0525-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT7DB	WOS:000483034700001	31438853	gold, Green Published			2022-02-06	
J	Novakovic-Agopian, T; Kornblith, E; Abrams, G; McQuaid, JR; Posecion, L; Burciaga, J; D'Esposito, M; Chen, AJW				Novakovic-Agopian, Tatjana; Kornblith, Erica; Abrams, Gary; McQuaid, John R.; Posecion, Lainie; Burciaga, Joaquin; D'Esposito, Mark; Chen, Anthony J. W.			Long-term effects of executive function training among veterans with chronic TBI	BRAIN INJURY			English	Article						Traumatic brain injury; Veterans; cognitive rehabilitation; long-term follow-up	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; SELF-EFFICACY; MANAGEMENT; INTERVENTIONS; SATISFACTION; METAANALYSIS; AFGHANISTAN; AWARENESS; OUTCOMES	Objective: To investigate long-term effects of GOALS executive function training in Veterans with chronic TBI. In a recently completed study Veterans with chronic TBI showed improvement immediately post-GOALS but not control training on measures of executive function, functional task performance, and emotion regulation. We now examine the long-term maintenance of post-GOALS training changes in the same sample. Setting: San Francisco VA Health Care System (SFVAHCS), and VA Northern California Health-Care System (VANCHS) in Martinez. Participants and Design: 24 Veterans with chronic TBI were assessed at baseline, post-GOALS training, and long-term follow-up 6+ months following completion of training with a structured telephone interview, neuropsychological and complex functional performance measures, and self-report measures of daily and emotional functioning. Results: Participants reported an increased likelihood of involvement in competitive employment/volunteering at follow-up (61%) compared to baseline (26%; chi 2 = 5.66, p < .01, = .35). Repeated measures MANOVAS indicated improvement on attention/executive function (F = 13.85, p < .01, partial eta 2 = .42), complex functional task performance (GPS Total: F = 9.12, p < .01, partial eta 2 = .38) and daily functioning (MPAI Total: F = 3.23, p < .05, partial eta 2 = .21), and reduction in overall mood disturbance (POMS Total: F = 3.42, p < .05, partial eta 2 = .22) at follow-up relative to baseline. Discussion: Training in attention regulation applied to participant-defined goals is associated with meaningful long-term improvement in cognitive skills, emotion regulation, and daily functioning in Veterans with chronic TBI.	[Novakovic-Agopian, Tatjana; Kornblith, Erica; McQuaid, John R.; Posecion, Lainie; Burciaga, Joaquin] San Francisco VA Hlth Care Syst, Mental Hlth Serv, San Francisco, CA USA; [Novakovic-Agopian, Tatjana; McQuaid, John R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Novakovic-Agopian, Tatjana; D'Esposito, Mark; Chen, Anthony J. W.] Vet Adm Northern Calif Hlth Care Syst, Neurol Serv, Martinez, CA USA; [Abrams, Gary] San Francisco VA Hlth Care Syst, Neurol Serv, San Francisco, CA USA; [Abrams, Gary] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [D'Esposito, Mark; Chen, Anthony J. W.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Novakovic-Agopian, T (corresponding author), San Francisco VA Hlth Care Syst, San Francisco, CA 94121 USA.	tatjana.novakovic-agopian@ucsf.edu			Department of Veterans Affairs Rehabilitation Research & Development ServiceUS Department of Veterans Affairs [B74, VA 1IO1RX001111-01A1]	This work was supported by the Department of Veterans Affairs Rehabilitation Research & Development Service [Merit Review Awards: VANCHCS Project #B74, and VA 1IO1RX001111-01A1].	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Binder D, 2009, BRAIN HLTH ED UNPUB; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diez-Cirarda M, 2018, EUR J NEUROL, V25, P5, DOI 10.1111/ene.13472; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Haskins E.C., 2012, COGNITIVE REHABILITA; Heaton RK, 2004, COMPREHENSIVE NORMS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Keane T.M., 1991, PCL M DSM 4; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Loya F, 2017, REHABIL RES PRACT, V2017, DOI 10.1155/2017/8379347; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 2008, MAYO PORTLAND ADAPTA; McNair DM, 1992, MANUAL PROFILE MOOD; Miller KJ, 2017, MIL MED, V182, P137, DOI 10.7205/MILMED-D-16-00175; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Nezu CM., 2007, SOLVING LIFES PROBLE; Novakovic-Agopian T, 2007, GOAL ORIENTED UNPUB; Novakovic-Agopian T, 2018, J NEUROTRAUM, V35, P2784, DOI 10.1089/neu.2017.5529; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stuss D, 1988, CLIN NEUROPSYCHOL, V1, P139, DOI DOI 10.1080/13854048708520046; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Turner GR, 2020, AGING MENT HEALTH, V24, P464, DOI 10.1080/13607863.2018.1534080; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Vasterling J, 2007, PTSD NEUROCOGNITION, V18, P1; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083	57	4	4	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2019	33	12					1513	1521		10.1080/02699052.2019.1645357		AUG 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ8NK	WOS:000482284800001	31423838				2022-02-06	
J	Genova, HM; Haight, A; Natsheh, JY; DeLuca, J; Lengenfelder, J				Genova, Helen M.; Haight, Alison; Natsheh, Joman Y.; DeLuca, John; Lengenfelder, Jean			The Relationship Between Social Communication and Social Functioning in Pediatric TBI: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						pediatric; traumatic brain injury; social communication; social cognition; theory of mind	TRAUMATIC BRAIN-INJURY; PROBLEM-SOLVING SKILLS; AUTISTIC TRAITS; CHILDREN; OUTCOMES; PREDICTORS; ABILITY; TERM; NEUROSCIENCE; ASSOCIATION	Objective: Social communication presents a significant difficulty for children with traumatic brain injury (TBI). Although several measures are used to examine social communication, there is no gold-standard assessment tool. The present pilot study examined the ability of the Social Communication Disorders Checklist (SCDC) to detect social communication difficulties in pediatric TBI. Further, we examined the relationship between social communication and social functioning as assessed by parental ratings of behavior and objective measures of social cognition. Methods: Sixteen children with pediatric TBI and 20 age, education and sex matched healthy controls (HCs) participated. All participants participated in a neuropsychological evaluation and parents filled out questionnaires. Parents rated their children's social communication abilities using the SCDC, as well as the Behavior Assessment System for Children, Second Edition (BASC-2). The pediatric subjects completed a task of social cognition, specifically Theory of Mind (ToM). Results: The pediatric TBI group had significantly lower scores on the SCDC compared to the HCs (p = 0.001). In the pediatric group, SCDC scores correlated significantly with scores on the BASC-2, as well as performance on the ToM task, indicating that children with lower parent-rated social communication abilities also had lower scores on the objective measure of social cognition. Conclusions: These data provide preliminary evidence that children with TBI have difficulties with social communication, as evidenced by lower scores on the SCDC, and that SCDC scores correlate with subjective and objective measures of social cognition and behavior in pediatric TBI.	[Genova, Helen M.; Haight, Alison; Natsheh, Joman Y.; DeLuca, John; Lengenfelder, Jean] Kessler Fdn, E Hanover, NJ 07936 USA; [Genova, Helen M.; Natsheh, Joman Y.; DeLuca, John; Lengenfelder, Jean] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Natsheh, Joman Y.] Childrens Specialized Hosp Res Ctr, New Brunswick, NJ USA		Genova, HM (corresponding author), Kessler Fdn, E Hanover, NJ 07936 USA.; Genova, HM (corresponding author), Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA.	hgenova@kesslerfoundation.org			Children's Specialized Hospital	The authors would like to acknowledge Children's Specialized Hospital for financial support in performing this research.	Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bolte S, 2011, J AUTISM DEV DISORD, V41, P66, DOI 10.1007/s10803-010-1024-9; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Ciccia AH, 2018, NEUROREHABILITATION, V42, P331, DOI 10.3233/NRE-172384; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; DZURILLA TJ, 1998, MANUAL SOCIAL PROBLE; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Ezpeleta L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139346; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Gresham FM., 1990, SOCIAL SKILLS RATING; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Mandy W, 2018, J CHILD PSYCHOL PSYC, V59, P1143, DOI 10.1111/jcpp.12913; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Robinson EB, 2011, J AUTISM DEV DISORD, V41, P1733, DOI 10.1007/s10803-011-1202-4; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Stergiakouli E, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0131-2; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P493, DOI 10.1017/S1355617713000398; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	35	4	4	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 14	2019	10								850	10.3389/fneur.2019.00850			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IQ4OO	WOS:000480730300001	31474925	Green Published, gold			2022-02-06	
J	Lancaster, K; Venkatesan, UM; Lengenfelder, J; Genova, HM				Lancaster, Katie; Venkatesan, Umesh M.; Lengenfelder, Jean; Genova, Helen M.			Default Mode Network Connectivity Predicts Emotion Recognition and Social Integration After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; emotion recognition; resting state functional connectivity; default mode network; community integration; TBI; DMN	STATE FUNCTIONAL CONNECTIVITY; COMMUNITY INTEGRATION; NONVERBAL-COMMUNICATION; INDIVIDUAL-DIFFERENCES; ATTENTION DEFICITS; OUTCOMES; METAANALYSIS; PERCEPTION; FMRI; DISCONNECTION	Moderate-severe traumatic brain injury (TBI) may result in difficulty with emotion recognition, which has negative implications for social functioning. As aspects of social cognition have been linked to resting-state functional connectivity (RSFC) in the default mode network (DMN), we sought to determine whether DMN connectivity strength predicts emotion recognition and level of social integration in TBI. To this end, we examined emotion recognition ability of 21 individuals with TBI and 27 healthy controls in relation to RSFC between DMN regions. Across all participants, decreased emotion recognition ability was related to increased connectivity between dorsomedial prefrontal cortex (dmPFC) and temporal regions (temporal pole and parahippocampal gyrus). Furthermore, within the TBI group, connectivity between dmPFC and parahippocampal gyrus predicted level of social integration on the Community Integration Questionnaire, an important index of post-injury social functioning in TBI. This finding was not explained by emotion recognition ability, indicating that DMN connectivity predicts social functioning independent of emotion recognition. These results advance our understanding of the neural underpinnings of emotional and social processes in both healthy and injured brains, and suggest that RSFC may be an important marker of social outcomes in individuals with TBI.	[Lancaster, Katie; Lengenfelder, Jean; Genova, Helen M.] Kessler Fdn, W Orange, NJ 07052 USA; [Lancaster, Katie; Lengenfelder, Jean; Genova, Helen M.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Venkatesan, Umesh M.] Moss Rehabil Res Inst, Elkins Pk, PA USA		Genova, HM (corresponding author), Kessler Fdn, W Orange, NJ 07052 USA.	hgenova@kesslerfoundation.org			New Jersey Commission on Brain Injury Research [CBIR13IRG026]; William Randolph Hearst Foundation Fellowship	This work was supported by Research Grant CBIR13IRG026 of the New Jersey Commission on Brain Injury Research [JL and HG] and a William Randolph Hearst Foundation Fellowship [KL].	Allen TA, 2017, EUR J PERSONALITY, V31, P599, DOI 10.1002/per.2133; Andrews-Hanna JR, 2014, NEUROIMAGE, V91, P324, DOI 10.1016/j.neuroimage.2014.01.032; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Beucke JC, 2014, BRIT J PSYCHIAT, V205, P376, DOI 10.1192/bjp.bp.113.137380; Binder AS, 2019, J INT NEUROPSYCH SOC, V25, P890, DOI 10.1017/S1355617719000559; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Bzdok D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00232; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Dacosta-Aguayo R, 2014, HUM BRAIN MAPP, V35, P3819, DOI 10.1002/hbm.22439; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dodell-Feder D, 2014, SCHIZOPHR RES, V156, P87, DOI 10.1016/j.schres.2014.03.031; Doninger NA, 2003, REHABIL PSYCHOL, V48, P67, DOI 10.1037/0090-5550.48.2.67; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Du L, 2017, J AFFECT DISORDERS, V215, P213, DOI 10.1016/j.jad.2017.02.027; Fox JM, 2017, J ABNORM PSYCHOL, V126, P392, DOI 10.1037/abn0000253; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Genova HM, 2016, J INT NEUROPSYCH SOC, V22, P83, DOI 10.1017/S1355617715001137; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guo H, 2019, WORLD NEUROSURG, V121, pE630, DOI 10.1016/j.wneu.2018.09.178; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hofer A, 2009, EUR PSYCHIAT, V24, P27, DOI 10.1016/j.eurpsy.2008.06.008; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Irani F, 2012, SCHIZOPHR RES, V137, P203, DOI 10.1016/j.schres.2012.01.023; Jastorff J, 2015, HUM BRAIN MAPP, V36, P4184, DOI 10.1002/hbm.22910; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Killgore WDS, 2017, SOC COGN AFFECT NEUR, V12, P1624, DOI 10.1093/scan/nsx088; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kuceyeski A, 2016, NEUROIMAGE-CLIN, V11, P635, DOI 10.1016/j.nicl.2016.04.006; Leppanen JM, 2001, SCAND J PSYCHOL, V42, P429, DOI 10.1111/1467-9450.00255; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mars RB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00189; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; Mazaika P, 2007, HUMAN BRAIN MAPPING; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Noonan MP, 2018, BEHAV BRAIN RES, V355, P12, DOI 10.1016/j.bbr.2018.02.019; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Patel KR, 2018, BRAIN STRUCT FUNCT, V223, P2519, DOI 10.1007/s00429-018-1619-z; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Puig J, 2018, STROKE, V49, P2353, DOI 10.1161/STROKEAHA.118.021319; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Sambataro F, 2014, PSYCHOL MED, V44, P2041, DOI 10.1017/S0033291713002596; Schilbach L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030920; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Varo C, 2019, ACTA PSYCHIAT SCAND, V139, P369, DOI 10.1111/acps.13014; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Wang TL, 2018, CORTEX, V107, P148, DOI 10.1016/j.cortex.2017.09.006; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Xiao H, 2017, BRAIN INJURY, V31, P1331, DOI 10.1080/02699052.2017.1319576; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43105	82	4	4	2	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 9	2019	10								825	10.3389/fneur.2019.00825			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IP7XC	WOS:000480260500001	31447760	Green Published, gold			2022-02-06	
J	Statz, JK; Ciarlone, SL; Goodrich, JA; McCarron, RM; Walker, PB; Norris, JN; Ahlers, ST; Tschiffely, AE				Statz, Jonathan K.; Ciarlone, Stephanie L.; Goodrich, Jessica A.; McCarron, Richard M.; Walker, Peter B.; Norris, Jacob N.; Ahlers, Stephen T.; Tschiffely, Anna E.			Affective profiling for anxiety-like behavior in a rodent model of mTBI	BEHAVIOURAL BRAIN RESEARCH			English	Article						mTBI; PTSD; Blast; Anxiety; Behavior	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; FKBP5 POLYMORPHISMS; AMYGDALA; FEAR; INCREASES; SYMPTOMS; STATHMIN; HEALTH	Mild traumatic brain injury is a common outcome of blast exposure, and current literature indicates high rates of comorbid posttraumatic stress disorder (PTSD) in military personnel. Blast-exposed rats display PTSD-like behavior, suggesting relationships may exist between PTSD and blast exposure. Other studies demonstrate the roles of stathmin and corticosterone associated with fear- and anxiety-like behaviors in rodent models. Furthermore, studies have observed ranges of responses to both physical and psychological trauma in animal populations (Elder 2012, Ritov 2016). This study exposed rodents to repeated blast overpressure (BOP) and analyzed behavioral responses and molecular variables at 3 weeks and 6 months after exposure. We applied a modified version of a previously reported behavioral profiling approach that separates "affected" and "unaffected" rats based on the presence of anxiety-like behaviors (Ritov, 2016). We report that "affected" 3 week animals showed higher plasma corticosterone and amygdalar stathmin levels, while "affected" 6 month animals had lower prefrontal cortex stathmin. Higher corticosterone also paralleled anxiety behavior in "affected" 3 week animals, which was not observed in 6 month animals, indicating possible negative feedback loop mechanisms. Elevated levels of amygdalar stathmin correlated with anxiety behaviors in "affected" 3 week and 6 month animals, indicating sustained molecular changes. We conclude that this unique analysis may provide more information about response to blast. This type of analysis should also be considered when treating clinical populations, since individual differences may affect behavioral and long-term outcomes. Future studies should elucidate relationships of stress and fear responses in the context of BOP.	[Statz, Jonathan K.; Ciarlone, Stephanie L.; Goodrich, Jessica A.; McCarron, Richard M.; Walker, Peter B.; Ahlers, Stephen T.; Tschiffely, Anna E.] Naval Med Res Ctr, Dept Neurotrauma, Operat & Undersea Med Directorate, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Statz, Jonathan K.; Ciarlone, Stephanie L.; Goodrich, Jessica A.] Henry M Jackson Fdn Adv Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Norris, Jacob N.] SPAWAR Syst Ctr Pacific, Cyber Sci & Technol Dept, 53560 Hull St, San Diego, CA USA		Statz, JK (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Operat & Undersea Med Directorate, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.; Statz, JK (corresponding author), Henry M Jackson Fdn Adv Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA.	jonathan.k.statz.ctr@mail.mil; stephanie.l.ciarlone2.ctr@mail.mil; jessica.a.goodrich.ctr@mail.mil; richard.m.mccarron.civ@mail.mil; peter.b.walker1@navy.mil; jacob.norris.mil@mail.mil; stephen.t.ahlers.civ@mail.mil; anna.e.tschiffely.civ@mail.mil			Office of Naval ResearchOffice of Naval Research [601152 N.0000.000, A1308]	This work was supported/funded by the Office of Naval Research, work unit number 601152 N.0000.000.A1308.	Ahlers S. T., 2012, FRONT NEUROL, P3; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Ferrer A, 2018, J PSYCHIATR RES, V104, P227, DOI 10.1016/j.jpsychires.2018.08.003; Galatzer-Levy IR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.38; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jia M., 2012, J VISUAL EXP JOVE, V68; Kavushansky A, 2006, J NEUROSCI RES, V84, P1580, DOI 10.1002/jnr.21058; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Marek R, 2013, J PHYSIOL-LONDON, V591, P2381, DOI 10.1113/jphysiol.2012.248575; Martel G, 2016, J NEUROSCI, V36, P1185, DOI 10.1523/JNEUROSCI.4541-14.2016; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mouthaan J, 2014, PSYCHONEUROENDOCRINO, V45, P179, DOI 10.1016/j.psyneuen.2014.04.001; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Pelletier JG, 2005, LEARN MEMORY, V12, P96, DOI 10.1101/lm.88605; Perez-Garcia G., 2016, BEHAV BRAIN RES; Pietrzak RH, 2010, J AFFECT DISORDERS, V126, P230, DOI 10.1016/j.jad.2010.03.021; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Ritov G, 2016, MOL PSYCHIATR, V21, P630, DOI 10.1038/mp.2015.169; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Steudte-Schmiedgen S, 2015, PSYCHONEUROENDOCRINO, V59, P123, DOI 10.1016/j.psyneuen.2015.05.007; Tsai J, 2016, J AFFECT DISORDERS, V189, P269, DOI 10.1016/j.jad.2015.08.076; Uchida S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5389; Watkins LE, 2016, PSYCHONEUROENDOCRINO, V69, P98, DOI 10.1016/j.psyneuen.2016.04.001; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	30	4	4	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 5	2019	368						101	109	111895	10.1016/j.bbr.2019.04.009			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	IE9PA	WOS:000472705300011	30978410	Bronze			2022-02-06	
J	Kim, JY; Kim, HJ; Choi, HS; Park, SY; Kim, DY				Kim, Jun Yup; Kim, Hyun Jung; Choi, Hyo Seon; Park, So Young; Kim, Deog Young			Effects of Cerebrolysin (R) in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study	FRONTIERS IN NEUROLOGY			English	Article						Cerebrolysin; stroke; consciousness level; minimally conscious state; clinical study	NERVE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; CHRONIC DISORDERS; AMANTADINE; PROTEIN; COMA	Introduction: The neurotrophic drug Cerebrolysin is composed of low-molecular-weight peptides and amino acids and has been shown to have neuroprotective and neuroplastic properties. Cerebrolysin has been reported to promote the recovery of motor functions in central nervous system disorders; however, the effects on the consciousness improvements in post-stroke patients have not yet been studied extensively. Therefore, we aimed to examine the effectiveness of Cerebrolysin on improving the consciousness level of stroke patients with minimally conscious state (MCS). Materials and Methods: In this retrospective study we included ischemic and/or hemorrhagic stroke patients with MCS according to the Coma Recovery Scale-Revised (CRS-R), who were admitted to our hospital between 2014 and 2017. All patients received comprehensive rehabilitation therapy including physical and occupational therapy. We compared patients treated with Cerebrolysin against patients who did not receive Cerebrolysin. Patients were included in the verum group if they received 10 mL of Cerebrolysin IV for at least 20 days. CRS-R scores were assessed at admission and discharge. Results: Of 1,531 patients screened, 75 were included in the study (Cerebrolysin, n = 43; control, n = 32). Baseline characteristics were similar between groups. At discharge, similar to 2 months after onset of stroke, Cerebrolysin-treated patients improved significantly in the CRS-R (p = 0.010) after adjustment for confounders using linear mixed model (LMM), especially in the Oromotor (p = 0.003) and Arousal subscales (p = 0.038). No safety issues were observed. Conclusion: This retrospective study suggests that Cerebrolysin may improve the level of consciousness in stroke patients with MCS, which should be further investigated in a well-designed, double-blind, placebo-controlled, randomized trial.	[Kim, Jun Yup; Kim, Hyun Jung; Kim, Deog Young] Yonsei Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Kim, Jun Yup; Kim, Hyun Jung; Park, So Young; Kim, Deog Young] Yonsei Univ, Coll Med, Res Inst Rehabil Med, Seoul, South Korea; [Choi, Hyo Seon] Eulji Univ, Dept Rehabil Med, Nowon Eulji Med Ctr, Seoul, South Korea		Kim, DY (corresponding author), Yonsei Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea.; Kim, DY (corresponding author), Yonsei Univ, Coll Med, Res Inst Rehabil Med, Seoul, South Korea.	kimdy@yuhs.ac		Kim, Jun Yup/0000-0001-5255-6279; Choi, Hyoseon/0000-0002-2781-2557; kim, deog young/0000-0001-7622-6311			AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bornstein NM, 2018, NEUROL SCI, V39, P629, DOI 10.1007/s10072-017-3214-0; Clauss RP, 2010, MED HYPOTHESES, V75, P287, DOI 10.1016/j.mehy.2010.03.005; Clauss R, 2014, CURR PHARM DESIGN, V20, P4140; DREYFUS CF, 1989, TRENDS PHARMACOL SCI, V10, P145, DOI 10.1016/0165-6147(89)90166-1; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; Gharagozli K, 2017, J Med Life, V10, P153; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Heiss WD, 2012, STROKE, V43, P630, DOI 10.1161/STROKEAHA.111.628537; Institute for Metrics and Health Evaluation, 2016, GLOB BURD DIS RES TO; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; Li J, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0666-4; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; de Azua SR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-27; Sattin D, 2018, INT CLIN PSYCHOPHARM, V33, P163, DOI 10.1097/YIC.0000000000000214; SCACCIANOCE S, 1993, NEUROENDOCRINOLOGY, V58, P202, DOI 10.1159/000126534; Schneider WN, 1999, BRAIN INJURY, V13, P863; SPILLANTINI MG, 1989, P NATL ACAD SCI USA, V86, P8555, DOI 10.1073/pnas.86.21.8555; Thonnard M, 2013, FUNCT NEUROL, V28, P259, DOI 10.11138/FNeur/2013.28.4.259; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; World Health Organization, 2018, TOP 10 CAUS DEATH; Worzniak M, 1997, J FAM PRACTICE, V44, P495; Wronski R, 2000, J NEURAL TRANSM-SUPP, P263; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Ziganshina LE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007026.pub5	32	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 2	2019	10								803	10.3389/fneur.2019.00803			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IN4IL	WOS:000478638400001	31428035	Green Published, gold			2022-02-06	
J	Alexander, SL; Gunnarsson, CA; Weerasooriya, T				Alexander, Stephen L.; Gunnarsson, C. Allan; Weerasooriya, Tusit			Influence of the mesostructure on the compressive mechanical response of adolescent porcine cranial bone	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article							TRABECULAR BONE; INFANT SKULL; BEHAVIOR; DENSITY; SUTURE; MODEL	The Gottingen minipig has been used as a surrogate in impact experiments designed to better understand the mechanisms by which mechanical loading induces traumatic brain injury (TBI). However, the relationship between mechanical response and structural morphology of the minipig cranium must be understood relative to the human skull in order to accurately scale any quantitative results, such as injury thresholds, from non-human TBI experiments to the human anatomy. In this study, bone specimens were dissected from the crania of adolescent Gottingen minipigs. These specimens were small cubes that contained the entire thickness of the skull. The microstructure of these skull specimens was quantified at the micron-length scale using micro-computed tomography (micro-CT). The skull was found to be highly porous near the skin-side surface and became less porous nearer the brain-side surface. The skull specimens were then loaded in quasi-static compression to obtain their mechanical response. The surface strain distribution on the specimen face was measured during loading using digital image correlation (DIC). The 2-D strain field formed a gradient of iso-strain bands along the thickness (depth) dimension from the skin-most to brain-most sides of the skull. The variation of the minipig microstructure along the thickness differed significantly from that of the adult human skull; thus the mechanical load transmission through the minipig skull is expected to be quite different from that of the human skull. The objective was to develop the methodology of relating the microstructure, as quantified by the bone volume fraction (BVF), to the mechanical response. The specimen was modeled by discretizing the depth dimension into a series of layers, which enabled the calibration of a power law relating the depth-dependent BVF to the depth-varying modulus. The relationship was used to predict moduli values for the adolescent minipig skull to provide updated, biofidelic parameters for finite element simulations at varying levels of complexity. Moreover, the methodology outlined in this paper can be applied to other skulls with different structural variations, such as the human.	[Alexander, Stephen L.] SURVICE Engn Co, 4695 Millennium Dr, Belcamp, MD 21017 USA; [Gunnarsson, C. Allan; Weerasooriya, Tusit] Army Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD 21005 USA		Weerasooriya, T (corresponding author), Army Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD 21005 USA.	stephen.alexander@survice.com; carey.a.gunnarsson.civ@mail.mil; tusit.weerasooriya.civ@mail.mil			U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL)	This research was funded by the U.S. Army Research Laboratory.	Alexander Stephen L, 2016, ARLTR7845; Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Baumer TG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000081; Boruah S., 2013, P IRCOBI C, V13, P497; Boruah S, 2017, J MECH BEHAV BIOMED, V65, P688, DOI 10.1016/j.jmbbm.2016.09.041; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Cowin SC, 1997, J BIOMECH, V30, P1191, DOI 10.1016/S0021-9290(97)85609-6; Ellegaard Gottingen Minipigs, 2014, GROWTH CURV GROWTH D, V42, P3; Gibson L. J., 1997, CELLULAR SOLIDS STRU, V2nd, DOI DOI 10.1017/CBO9781139878326; GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0; Gunnarsson C. A, 2015, P 2015 INT MECH ENG; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013; Jung M, 2009, LAB ANIM-UK, V43, P191, DOI 10.1258/la.2008.007149; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Matsuura M, 2008, BIOMECH MODEL MECHAN, V7, P27, DOI 10.1007/s10237-006-0073-7; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Mow V.C., 2005, BASIC ORTHOPAEDIC BI; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Rahmoun J, 2014, MECH RES COMMUN, V60, P7, DOI 10.1016/j.mechrescom.2014.04.001; Ranslow AN, 2016, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2015, VOL 3; ROBBINS DH, 1969, EXP MECH, V9, P236, DOI 10.1007/BF02326542; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Thompson KA., 2016, ASME 2016 INT MECH E; Wu D, 2018, ACTA BIOMATER, V78, P1, DOI 10.1016/j.actbio.2018.08.001	30	4	4	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	AUG	2019	96						96	107		10.1016/j.jmbbm.2019.04.010			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	IE2VT	WOS:000472243400011	31029999				2022-02-06	
J	Cherian, AK; Tronson, NC; Parikh, V; Kucinski, A; Blakely, RD; Sarter, M				Cherian, Ajeesh Koshy; Tronson, Natalie C.; Parikh, Vinay; Kucinski, Aaron; Blakely, Randy D.; Sarter, Martin			Repetitive Mild Concussion in Subjects With a Vulnerable Cholinergic System: Lasting Cholinergic-Attentional Impairments in CHT+/- Mice	BEHAVIORAL NEUROSCIENCE			English	Article						acetylcholine; choline transporter; concussion; traumatic brain injury; attention	TRAUMATIC BRAIN-INJURY; REDUCED EVOKED RELEASE; BASAL FOREBRAIN; ACETYLCHOLINE-RELEASE; COGNITIVE DEFICITS; PREFRONTAL CORTEX; TRANSPORTER; CAPACITY; PERFORMANCE; TASK	Previous research emphasized the impact of traumatic brain injury on cholinergic systems and associated cognitive functions. Here we addressed the converse question: Because of the available evidence indicating cognitive and neuronal vulnerabilities in humans expressing low-capacity cholinergic systems or with declining cholinergic systems, do injuries cause more severe cognitive decline in such subjects, and what cholinergic mechanisms contribute to such vulnerability? Using mice heterozygous for the choline transporter (CHT+/- mice) as a model for a limited cholinergic capacity, we investigated the cognitive and neuronal consequences of repeated, mild concussion injuries (rmCc). After five rmCc, and compared with wild type (WT) mice, CHT+/- mice exhibited severe and lasting impairments in sustained attention performance, consistent with effects of cholinergic losses on attention. However, rmCc did not affect the integrity of neuronal cell bodies and did not alter the density of cortical synapses. As a cellular mechanism potentially responsible for the attentional impairment in CHT+/- mice, we found that rmCc nearly completely attenuated performance-associated, CHT-mediated choline transport. These results predict that subjects with an already vulnerable cholinergic system will experience severe and lasting cognitive-cholinergic effects after even relatively mild injuries. If confirmed in humans, such subjects may be excluded from, or receive special protection against, activities involving injury risk. Moreover, the treatment and long-term outcome of traumatic brain injuries may benefit from determining the status of cholinergic systems and associated cognitive functions.	[Cherian, Ajeesh Koshy; Tronson, Natalie C.] Univ Michigan, Dept Psychol & Neurosci Program, Ann Arbor, MI 48109 USA; [Parikh, Vinay] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Parikh, Vinay] Temple Univ, Neurosci Program, Philadelphia, PA 19122 USA; [Kucinski, Aaron; Sarter, Martin] Univ Michigan, Dept Psychol, 530 Church St,4030 East Hall, Ann Arbor, MI 48109 USA; [Blakely, Randy D.] Florida Atlantic Univ, Charles E Schmidt Coll Med, FAU Brain Inst, Boca Raton, FL 33431 USA; [Sarter, Martin] Univ Michigan, Neurosci Program, 530 Church St,4030 East Hall, Ann Arbor, MI 48109 USA		Sarter, M (corresponding author), Univ Michigan, Neurosci Program, 530 Church St,4030 East Hall, Ann Arbor, MI 48109 USA.	msarter@umich.edu	Parikh, Vinay/M-1439-2016	Sarter, Martin/0000-0003-0441-9936; Blakely, Randy/0000-0002-2182-6966; Tronson, Natalie/0000-0001-5676-1579	PHS grant [MH086530]; Dystonia Medical Research Foundation	Ajeesh Koshy Cherian, Natalie C. Tronson, and Martin Sarter designed research. Ajeesh Koshy Cherian, Natalie C. Tronson, and Vinay Parikh performed research. Aaron Kucinski analyzed the data. Randy D. Blakely contributed reagents/analytical tools. Ajeesh Koshy Cherian, Natalie C. Tronson, Randy D. Blakely, and Martin Sarter wrote the article. This research was supported by PHS grant MH086530 (Martin Sarter) and the Dystonia Medical Research Foundation (Randy D. Blakely). We thank Marc Bradshaw (University of Michigan) for designing, building, and estimating the force of the impact device used in this study. A preprint of this article was posted online on bioRxiv (http://dx.doi.org/10.1101/521484).	Apparsundaram S, 2005, J NEUROSCI, V25, P3851, DOI 10.1523/JNEUROSCI.0205-05.2005; Ballinger EC, 2016, NEURON, V91, P1199, DOI 10.1016/j.neuron.2016.09.006; Berry AS, 2015, NEUROIMAGE, V108, P386, DOI 10.1016/j.neuroimage.2014.12.036; Berry AS, 2014, J COGNITIVE NEUROSCI, V26, P1981, DOI 10.1162/jocn_a_00607; Bohnen NI, 2009, NEUROLOGY, V73, P1670, DOI 10.1212/WNL.0b013e3181c1ded6; Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Burk JA, 2001, NEUROSCIENCE, V105, P899, DOI 10.1016/S0306-4522(01)00233-0; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DECKER MW, 1988, J NEUROSCI, V8, P90; Demeter E, 2008, NEUROPSYCHOLOGY, V22, P787, DOI 10.1037/a0013712; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; English BA, 2009, J NEURODEV DISORD, V1, P252, DOI 10.1007/s11689-009-9033-8; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Field RH, 2012, J NEUROSCI, V32, P6288, DOI 10.1523/JNEUROSCI.4673-11.2012; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Greenwald AG, 1996, PSYCHOPHYSIOLOGY, V33, P175, DOI 10.1111/j.1469-8986.1996.tb02121.x; Gritton HJ, 2016, P NATL ACAD SCI USA, V113, pE1089, DOI 10.1073/pnas.1516134113; Gritton HJ, 2012, LEARN MEMORY, V19, P126, DOI 10.1101/lm.023499.111; Gritton HJ, 2009, BEHAV NEUROSCI, V123, P937, DOI 10.1037/a0017128; Hahn MK, 2008, GENES BRAIN BEHAV, V7, P487, DOI 10.1111/j.1601-183X.2007.00384.x; Hampel H, 2018, BRAIN, V141, P1917, DOI 10.1093/brain/awy132; Howe WM, 2017, J NEUROSCI, V37, P3215, DOI 10.1523/JNEUROSCI.2737-16.2017; Howe WM, 2013, J NEUROSCI, V33, P8742, DOI 10.1523/JNEUROSCI.5809-12.2013; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kim K, 2019, NEUROIMAGE, V190, P107, DOI 10.1016/j.neuroimage.2017.12.012; Kim K, 2017, NEUROIMAGE, V149, P295, DOI 10.1016/j.neuroimage.2017.02.006; Koshy Cherian A., 2015, SOC NEUR ANN M CHIC; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; MESSIER C, 1990, BEHAV BRAIN RES, V39, P135, DOI 10.1016/0166-4328(90)90100-S; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Paolone G, 2013, NEUROPHARMACOLOGY, V75, P274, DOI 10.1016/j.neuropharm.2013.07.032; Paolone G, 2013, J NEUROSCI, V33, P8321, DOI 10.1523/JNEUROSCI.0709-13.2013; Paolone G, 2012, J NEUROSCI, V32, P12115, DOI 10.1523/JNEUROSCI.2271-12.2012; Parikh V, 2006, NEUROSCIENCE, V141, P379, DOI 10.1016/j.neuroscience.2006.03.055; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Parikh V, 2013, J NEUROSCI, V33, P2326, DOI 10.1523/JNEUROSCI.4993-12.2013; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Peters MS, 2011, BEHAV BRAIN RES, V225, P574, DOI 10.1016/j.bbr.2011.08.025; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sarter M, 2019, CURR OPIN PSYCHOL, V29, P102, DOI 10.1016/j.copsyc.2018.12.026; Sarter M, 2016, J PHYSIOL-PARIS, V110, P10, DOI 10.1016/j.jphysparis.2016.07.001; Sarter M, 2016, NEUROBIOL LEARN MEM, V130, P135, DOI 10.1016/j.nlm.2016.02.008; Sarter M, 2014, EXP NEUROL, V257, P120, DOI 10.1016/j.expneurol.2014.04.032; Sarter M, 2014, EUR J NEUROSCI, V39, P1912, DOI 10.1111/ejn.12515; Sarter M, 2012, NEUROPHARMACOLOGY, V62, P1544, DOI 10.1016/j.neuropharm.2010.12.001; Sarter M, 2011, BEHAV NEUROSCI, V125, P825, DOI 10.1037/a0026227; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	63	4	4	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7044	1939-0084		BEHAV NEUROSCI	Behav. Neurosci.	AUG	2019	133	4					448	459		10.1037/bne0000310			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	IH8BN	WOS:000474729500010	30896190	Green Submitted, Green Accepted			2022-02-06	
J	Egbohou, P; Mouzou, T; Tchetike, P; Sama, HD; Assenouwe, S; Akala-Yoba, G; Randolph, L; Tomta, K				Egbohou, Pilakimwe; Mouzou, Tabana; Tchetike, Pikabalo; Sama, Hamza Doles; Assenouwe, Sarakawabalo; Akala-Yoba, Gnimdou; Randolph, Lonlongnon; Tomta, Kadjika			Epidemiology of Pediatric Traumatic Brain Injury at Sylvanus Olympio University Hospital of Lome in Togo	ANESTHESIOLOGY RESEARCH AND PRACTICE			English	Article							HEAD-INJURY; CARE; CHILDREN; EXPERIENCE; MORTALITY	Introduction. Severe pediatric traumatic brain injury (pTBI) is a leading cause of disability and death in children worldwide. Children victims of pTBI are admitted to the Sylvanus Olympio University Hospital (SOUH) at the multipurpose Intensive Care Unit (ICU). We aimed in this study to describe the epidemiologic characteristics and outcomes of pTBI patients admitted in this ICU. Patients and Methods. This study was conducted at the ICU of SOUH of Lome. It was a retrospective study based on patients' records from 0 to 15years old admitted during the period from 1 January 2012 to 30 June 2018 (5years and 6months). Results. We recorded 91 pTBI included in the study. The mean age was 7.7 +/- 4.3years. The male predominated with 67.0%. Road traffic accidents were the most common cause (79.1%), followed by falls (19.8%). The average pediatric Glasgow Coma Scale (pGCS) was 6.6 +/- 1.4, with a mean Injury Severity Score (ISS) of 23.1 +/- 8.4. The most common brain injuries found in the CT scan were brain edema (72.9%), skull fracture (69.5%), and brain contusion (55.9%). The average duration under mechanical ventilation was 2.1 +/- 2.9days, and the mean ICU stay was 4.9 +/- 4.4days. Overall mortality was 31.9% (29 cases). Factors significantly associated (p<0.05) with death were hypotension (51.7%), anemia (43.1%), hyperthermia (46.7%), GCS<6 (64%), and ISS>20 (48.9%). Conclusion. pTBI mortality remains high in SOUH ICU. Factors associated with mortality were secondary systemic insults, worse GCS<6, and ISS>20.	[Egbohou, Pilakimwe; Mouzou, Tabana; Tchetike, Pikabalo; Sama, Hamza Doles; Assenouwe, Sarakawabalo; Akala-Yoba, Gnimdou; Randolph, Lonlongnon; Tomta, Kadjika] Univ Lome, Sylvanus Olympio Univ Hosp, Anesthesiol & Intens Care Dept, Lome, Togo		Egbohou, P (corresponding author), Univ Lome, Sylvanus Olympio Univ Hosp, Anesthesiol & Intens Care Dept, Lome, Togo.	egbohou@gmail.com		EGBOHOU, Pilakimwe/0000-0002-5881-5937; Sama, Hamza D./0000-0001-5365-8154			Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; [Anonymous], 2007, NEUR DIS PUBL HLTH C; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Assiry KA, 2014, ONLINE J MED MED SCI, V5, P44; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Debas HT, 2015, ESSENTIAL SURG DIS C, V1; Debenham S, 2017, PREHOSP DISASTER MED, V32, P593, DOI 10.1017/S1049023X17006811; Delaney PG, 2018, WORLD J SURG, V42, P2293, DOI 10.1007/s00268-018-4467-3; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; El-Menyar A, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0159-9; Grivna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068636; He SR, 2014, AM J PUBLIC HEALTH, V104, pE79, DOI 10.2105/AJPH.2013.301607; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Ibrahim NA, 2017, PREHOSP DISASTER MED, V32, P424, DOI 10.1017/S1049023X17006410; Kiragu AW, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00155; Leggate JRS, 1989, BRIT J NEUROSURG, V3, P533, DOI 10.3109/02688698909002844; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Mendy J., 2014, REV AFR ANESTH MED U, V19, P59; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; WALKER ML, 1984, CHILD BRAIN, V11, P387; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237	27	4	5	2	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-6962	1687-6970		ANESTHESIOL RES PRAC	Anesthesiol. Res. Pract.	AUG 1	2019	2019								4038319	10.1155/2019/4038319			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	IS1TH	WOS:000481936600001	31467523	Green Submitted, Green Published, gold			2022-02-06	
J	Gaudet, LA; Eliyahu, L; Beach, J; Mrazik, M; Cummings, G; Voaklander, DC; Rowe, BH				Gaudet, L. A.; Eliyahu, L.; Beach, J.; Mrazik, M.; Cummings, G.; Voaklander, D. C.; Rowe, B. H.			Workers' recovery from concussions presenting to the emergency department	OCCUPATIONAL MEDICINE-OXFORD			English	Article						Accident and emergency departments; concussion; injury; occupational health	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SYMPTOMS; RETURN; SPORT; PREDICTION; COMPLAINTS; MODERATE; RISK	Background The emergency department (ED) is the first point of care for many patients with concussion, and post-concussion syndrome can impact vocational outcomes like successful return to work. Evaluation of concussion in general adult populations is needed. Aims To document the occurrence and outcomes of work-related concussion presenting to the EL) for treatment. Methods This study enrolled adults presenting with concussion to three urban Canadian EDs. Baseline ED interviews, physician questionnaires and patient phone interviews at 30 and 90 days documented work-related events, El) management, discharge advice, patient adherence and symptom severity. Work-related injury and return to work were modelled using logistic or linear regression, as appropriate. Results Overall, 172 enrolled workers completed at least one follow-up. Work-related concussions were uncommon (n = 28). Most employees (80%) missed at least 1 day of work (median = 7; interquartile range: 3-14). Most (91%) employees returned to work within 90 days, while 41% reported persistent symptoms. Manual labour and self-reported history of attention deficit hyperactivity disorder were associated with work-related concussion, while days of missed work increased with marital status (divorced), history of sleep disorder and physician's advice to avoid work. Conclusions Work-related concussions are infrequent; however, most workers who sustain a concussion will miss work, and many return while still experiencing symptoms. Work-related concussion and days of missed work are mainly affected by non-modifiable factors. Workers, employers and the workers' compensation system should take necessary precautions to ensure that workers return to work safely and successfully following a concussion.	[Gaudet, L. A.; Cummings, G.; Rowe, B. H.] Univ Alberta, Fac Med & Dent, Dept Emergency Med, Edmonton, AB, Canada; [Eliyahu, L.] Univ Alberta, Fac Med & Dent, Dept Family Med, Edmonton, AB, Canada; [Beach, J.] Coll Phys & Surg Alberta, Edmonton, AB, Canada; [Beach, J.] Univ Alberta, Fac Med & Dent, Div Prevent Med, Edmonton, AB, Canada; [Beach, J.; Voaklander, D. C.; Rowe, B. H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Mrazik, M.] Univ Alberta, Dept Educ Psychol, Edmonton, AB, Canada; [Rowe, B. H.] Alberta Hlth Serv, Edmonton, AB, Canada		Rowe, BH (corresponding author), Univ Alberta Hosp, Dept Emergency Med, Room 1G1-43 WMC,8440-112th St, Edmonton, AB T6G 2B7, Canada.	brian.rowe@ualberta.ca			Workers' Compensation Board of Alberta; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [501100000024]; Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHRCanadian Institutes of Health Research (CIHR) [501100000024]; Health Quality Council of Alberta (HQCA) Studentship; Walter H. Johns Graduate Fellowship from the University of Alberta [501100000190]; Tier I Canada Research Chair in Evidence-based Emergency Medicine from the CIHR through the Government of Canada (Ottawa, Ontario) [501100000024, 501100001804, 501100000023]; CIHRCanadian Institutes of Health Research (CIHR) [501100000024, 501100000028]	This work was supported by the Workers' Compensation Board of Alberta and the Canadian Institutes of Health Research (CIHR) (funder ID: 501100000024). L.E. was supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR (funder ID: 501100000024), the Health Quality Council of Alberta (HQCA) Studentship and the Walter H. Johns Graduate Fellowship from the University of Alberta (funder ID: 501100000190). At the time of the study, B.H.R. was supported by a Tier I Canada Research Chair (funder ID: 501100001804) in Evidence-based Emergency Medicine from the CIHR (funder ID: 501100000024) through the Government of Canada (Ottawa, Ontario) (funder ID: 501100000023). His research is currently supported by CIHR (funder ID: 501100000024) as the Scientific Director of the Institute of Circulatory and Respiratory Health (funder ID: 501100000028). The sponsors assume no responsibility for the conduct and opinions expressed in this manuscript.	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; Bottari C, 2017, NEUROPSYCHOL REHABIL, V27, P871, DOI 10.1080/09602011.2015.1110528; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Chang VH, 2011, PM&R, V3, pS387, DOI 10.1016/j.pmrj.2011.08.007; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meurer D, 2002, CJEM, V4, P151; Pourat N, 2007, J OCCUP ENVIRON MED, V49, P618, DOI 10.1097/JOM.0b013e318074bb57; Rowe B, 2003, ACAD EMERG MED, V10, P537; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002	28	4	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480	1471-8405		OCCUP MED-OXFORD	Occup. Med.-Oxf.	AUG	2019	69	6					419	427		10.1093/occmed/kqz089			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JI3LH	WOS:000493365900009	31340019	Green Published			2022-02-06	
J	Hota, S; Ng, M; Hilliard, D; Burgess, J				Hota, Salini; Ng, Matthew; Hilliard, Dashaunda; Burgess, Jessica			Thromboelastogram-Guided Resuscitation for Patients with Traumatic Brain Injury on Novel Anticoagulants	AMERICAN SURGEON			English	Article								Traumatic brain injuries in patients on antithrombotic agents carry significant morbidity. Initial therapy is centered around reversal of these agents. The thromboelastogram (TEG) maps the clotting cascade to guide reversal. A retrospective chart review was conducted for 118 patients presenting with a traumatic brain injury while on antithrombotics. Patients were divided between those who received a TEG on arrival and those who did not. The primary endpoint was overall mortality. Secondary endpoints included blood product utilization, and outcomes associated with specific novel anticoagulants. Mortality in the control group was 20.3 per cent compared with 18.5 per cent in the TEG group (P = 0.81). For less severe injuries, the control group mortality was 3.8 per cent and the TEG group mortality was 8.7 per cent (P = 0.64). For more severe injuries, mortality in the control versus TEG groups were 31.6 per cent and 25.8 per cent, respectively (P = 0.73). Blood product utilization was significantly lower in the TEG group (P = 0.002). Overall mortality was not significantly different between the groups. However, when stratified by severity of injury, mortality was reduced in the TEG-guided group in severely injured patients. Blood product utilization was significantly reduced with TEG-guided reversal. Trauma centers can improve the utilization of blood products in reversal of antithrombotics with the use of TEG.	[Hota, Salini; Ng, Matthew; Burgess, Jessica] Eastern Virginia Med Sch, Dept Surg, 825 Fairfax Ave,Suite 610, Norfolk, VA 23507 USA; [Hilliard, Dashaunda] Eastern Virginia Med Sch, Healthcare Analyt & Delivery Sci Inst, Norfolk, VA 23507 USA		Hota, S (corresponding author), Eastern Virginia Med Sch, Dept Surg, 825 Fairfax Ave,Suite 610, Norfolk, VA 23507 USA.	HotaS@evms.edu					Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Bose E, 2015, JNP-J NURSE PRACT, V11, P702, DOI 10.1016/j.nurpra.2015.05.006; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Glass NE, 2019, J SURG RES, V235, P615, DOI 10.1016/j.jss.2018.10.021; Semon G., 2014, SURG CRITICAL CAROMB; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Walsh M, 2016, CURR DRUG TARGETS, V17, P954, DOI 10.2174/1389450117666160310153211	7	4	4	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2019	85	8					861	864					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IW7RU	WOS:000485192500039	31560304				2022-02-06	
J	LeBlond, E; Smith-Paine, J; Riemersma, JJ; Horn, PS; Wade, SL; Kurowski, BG				LeBlond, Elizabeth; Smith-Paine, Julia; Riemersma, Jacqlyn J.; Horn, Paul S.; Wade, Shari L.; Kurowski, Brad G.			Influence of Methylphenidate on Long-Term Neuropsychological and Everyday Executive Functioning After Traumatic Brain Injury in Children with Secondary Attention Problems	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Attentional control; processing speed; cross-over; reaction time; pediatric; ADHD	DEFICIT HYPERACTIVITY DISORDER; BEHAVIOR RATING INVENTORY; DEFICIT/HYPERACTIVITY DISORDER; ADOLESCENTS; ADHD; CHILDHOOD; OUTCOMES; SURVIVORS; IMPACT; PERFORMANCE	Objective: To investigate the effects of methylphenidate on long-term executive and neuropsychological functioning in children with attention problems following TBI, as well as the relationship between methylphenidate associated changes in lab-based neuropsychological measures of attentional control, processing speed, and executive functioning and parent- or self-report measures of everyday executive functioning. Method: 26 children aged 6-17 years, who were hospitalized for moderate-to-severe blunt head trauma 6 or more months previously, were recruited from a large children's hospital medical center. Participants were randomized into a double-masked, placebo-controlled cross-over clinical trial. Participants completed a comprehensive neuropsychological battery and parent- and self-report ratings of everyday executive functioning at baseline, and at 4 weeks and 8 weeks following upward titration of medication to an optimal dose or while administered a placebo. Results: Methylphenidate was associated with significant improvements in processing speed, sustained attention, and both lab-based and everyday executive functioning. Significant treatment-by-period interactions were found on a task of sustained attention. Participants who were randomized to the methylphenidate condition for the first treatment period demonstrated random or erratic responding, with slower and more variable response times when given placebo during the second period. Conclusion: Results indicate that methylphenidate treatment is associated with positive outcomes in processing speed, sustained attention, and both lab-based and everyday measures of executive functioning compared to placebo group. Additionally, results suggest sustained attention worsens when discontinuing medication. (JINS, 2019, 25, 740-749)	[LeBlond, Elizabeth; Smith-Paine, Julia; Wade, Shari L.] Univ Cincinnati, McMicken Coll Arts & Sci, Psychol Dept, 2600 Clifton Ave,155 B McMicken Hall, Cincinnati, OH 45221 USA; [LeBlond, Elizabeth; Smith-Paine, Julia; Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Riemersma, Jacqlyn J.; Horn, Paul S.; Wade, Shari L.; Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, 3230 Eden Ave, Cincinnati, OH USA; [Horn, Paul S.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, 3333 Burnet Ave,MLC 2015, Cincinnati, OH 45229 USA; [Horn, Paul S.] Univ Cincinnati, McMicken Coll Arts & Sci, Dept Math & Sci, 2600 Clifton Ave,155 B McMicken Hall, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol, 3230 Eden Ave, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Rehabil Med, 3230 Eden Ave, Cincinnati, OH USA		LeBlond, E (corresponding author), Univ Cincinnati, McMicken Coll Arts & Sci, Psychol Dept, 2600 Clifton Ave,155 B McMicken Hall, Cincinnati, OH 45221 USA.	leblonei@mail.uc.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) grant; Cincinnati Children's Research Foundation; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services	This project was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) grant (grant number REDACTED FOR BLIND REVIEW) and, in part, by the Cincinnati Children's Research Foundation; the National Center for Advancing Translational Sciences of the National Institutes of Health under Award (grant number REDACTED FOR BLIND REVIEW); and the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant number REDACTED FOR BLIND REVIEW). This study is registered with clinicaltrials.gov, registration number REDACTED FOR BLIND REVIEW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other supporting agencies. No competing financial interests exist. All authors of this manuscript have no conflicts of interest to disclose.	Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P802, DOI 10.1097/01.chi.0000128791.10014.ac; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Baumgaertel, 2003, VANDERBILT ADHD TEAC; Berridge CW, 2006, BIOL PSYCHIAT, V60, P1111, DOI 10.1016/j.biopsych.2006.04.022; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Charach Alice, 2008, Expert Rev Neurother, V8, P1563, DOI 10.1586/14737175.8.10.1563; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Conners C. K., 2000, CONNERS CONTINUOUS P; Conners CK., 1995, CONNERS CONTINUOUS P; Conners CK, 2004, CONTINUOUS PERFORMAN; D'Agati E, 2012, BRAIN DEV-JPN, V34, P812, DOI 10.1016/j.braindev.2012.03.001; De la Torre GG, 2017, J CLIN EXP NEUROPSYC, V39, P563, DOI 10.1080/13803395.2016.1249828; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Ibrahim K, 2015, J ATTEN DISORD, V19, P551, DOI 10.1177/1087054714548035; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Konrad K, 2004, J AM ACAD CHILD PSY, V43, P191, DOI 10.1097/00004583-200402000-00015; Kurowski B.G., 2018, THE JOURNAL OF HEAD, V34, pE1; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lavigne JV, 2012, J DEV BEHAV PEDIATR, V33, P336, DOI 10.1097/DBP.0b013e31824afea1; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Parisi P, 2010, BRAIN DEV-JPN, V32, P10, DOI 10.1016/j.braindev.2009.03.005; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Swanson J, 2011, NEUROPSYCHOPHARMACOL, V36, P207, DOI 10.1038/npp.2010.160; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Volkow N D, 2002, J Atten Disord, V6 Suppl 1, pS31; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wasserman Rachel M, 2016, Top Spinal Cord Inj Rehabil, V22, P253, DOI 10.1310/sci2204-253; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D., 2003, WISC IV ADMINISTRATI; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; [No title captured]	75	4	4	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2019	25	7					740	749	PII S1355617719000444	10.1017/S1355617719000444			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IP7QY	WOS:000480244300009	31178001	Green Accepted			2022-02-06	
J	Lele, A; Kannan, N; Vavilala, MS; Sharma, D; Mossa-Basha, M; Agyem, K; Mock, C; Pandey, RM; Dash, HH; Mahapatra, A; Gupta, D				Lele, Abhijit; Kannan, Nithya; Vavilala, Monica S.; Sharma, Deepak; Mossa-Basha, Mahmud; Agyem, Kwesi; Mock, Charles; Pandey, R. M.; Dash, H. H.; Mahapatra, Ashok; Gupta, Deepak		CHIRAG Collaborative Head Injury	Patients Who Benefit from Intracranial Pressure Monitoring without Cerebrospinal Fluid Drainage After Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Brain injury; Intracranial pressure; Monitoring; Outcomes; Trauma	INTENSIVE-CARE; HEAD-INJURY; DISCHARGE DISPOSITION; MORTALITY; OUTCOMES; CLASSIFICATION; MANAGEMENT; IMPACT	BACKGROUND: India has a high traumatic brain injury (TBI) burden and intracranial pressure monitoring (ICP) remains controversial but some patients may benefit. OBJECTIVE: To examine the association between ICP monitor placement and outcomes, and identify Indian patients with severe TBI who benefit from ICP monitoring METHODS: We conducted a secondary analysis of a prospective cohort study at a level 1 Indian trauma center. Patients over 18 yr with severe TBI (admission Glasgow coma scale score < 8) who received tracheal intubation for at-least 48 h were examined. Propensity-based analysis using inverse probability weighting approach was used to examine ICP monitor placement within 72 h of admission and outcomes. Outcomes were in-hospital mortality and Glasgow Outcome Scale (GOS) score at discharge, 3, 6, and 12 mo. Death, vegetative, or major impairment defined unfavorable outcome. RESULTS: The 200 patients averaged 36 [18 to 85] yr of age and average injury severity score of 31.4 [2 to 73]. ICP monitors were placed in 126 (63%) patients. Patients with ICP monitor placement experienced lower in-hospital mortality (adjusted relative risk [aRR]; 0.50 [0.29, 0.87]) than patients without ICP monitoring. However, there was no benefit at 3, 6, and 12 mo. With ICP monitor placement, absence of cerebral edema (aRR 0.54, 95% confidence interval 0.35-0.84), and absence of intraventricular hemorrhage (aRR 0.52, 95% confidence interval 0.33-0.82) were associated with reduced unfavorable outcomes. CONCLUSION: ICPmonitor placement without cerebrospinal fluid drainage within 72 h of admission was associated with reduced in-patient mortality. Patients with severe TBI but without cerebral edema and without intraventricular hemorrhage may benefit from ICP monitoring.	[Sharma, Deepak] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Lele, Abhijit; Kannan, Nithya; Vavilala, Monica S.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Mossa-Basha, Mahmud; Agyem, Kwesi] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Mock, Charles] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Mock, Charles] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Pandey, R. M.] All India Inst Med Sci, Dept Epidemiol, New Delhi, India; [Dash, H. H.; Mahapatra, Ashok; Gupta, Deepak] Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi, India		Gupta, D (corresponding author), Jai Prakash Apex Trauma Ctr, Dept Neurosurg, Ring Rd, New Delhi 110029, India.	drdeepakgupta@gmail.com		Mossa-Basha, Mahmud/0000-0001-7798-8158	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R21NS077444-02]; Department of Biotechnology [DBT N-1349]	The source of support for this work including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript was NINDS 5R21NS077444-02 (Vavilala) and Department of Biotechnology DBT N-1349 (Mahapatra/Gupta). The study was performed at Jai Prakash Narayan Apex Trauma Center, New Delhi, India (data collection) and at the University of Washington (data analysis). Dr Vavilala, MD had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Lazaridis C, 2015, J CRIT CARE, V30, P1258, DOI 10.1016/j.jcrc.2015.08.003; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Santhanam R, 2007, NEUROL INDIA, V55, P349; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Suehiro E, 2017, J NEUROTRAUM, V34, P2230, DOI 10.1089/neu.2016.4948; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Violence and Injury Prevention, 2017, VIOLENCE INJURY PREV	28	4	4	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2019	85	2					231	239		10.1093/neuros/nyy247			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JH9QR	WOS:000493103500084	30053135				2022-02-06	
J	Rege, SD; Royes, L; Tsai, B; Zhang, GL; Yang, X; Gomez-Pinilla, F				Rege, Shraddha D.; Royes, Luiz; Tsai, Brandon; Zhang, Guanglin; Yang, Xia; Gomez-Pinilla, Fernando			Brain Trauma Disrupts Hepatic Lipid Metabolism: Blame It on Fructose?	MOLECULAR NUTRITION & FOOD RESEARCH			English	Article						fructose; growth hormone; insulin signaling; lipids; traumatic brain injuries	GROWTH-HORMONE; FATTY LIVER; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; DIETARY FRUCTOSE; GLYCEMIC CONTROL; INJURY; EXPRESSION; RECEPTOR; MITOCHONDRIAL	Scope The action of brain disorders on peripheral metabolism is poorly understood. The impact of traumatic brain injury (TBI) on peripheral organ function and how TBI effects can be influenced by the metabolic perturbation elicited by fructose ingestion are studied. Methods and Results It is found that TBI affects glucose metabolism and signaling proteins for insulin and growth hormone in the liver; these effects are exacerbated by fructose ingestion. Fructose, principally metabolized in the liver, potentiates the action of TBI on hepatic lipid droplet accumulation. Studies in isolated cultured hepatocytes identify GH and fructose as factors for the synthesis of lipids. The liver has a major role in the synthesis of lipids used for brain function and repair. TBI results in differentially expressed genes in the hypothalamus, primarily associated with lipid metabolism, providing cues to understand central control of peripheral alterations. Fructose-fed TBI animals have elevated levels of markers of inflammation, lipid peroxidation, and cell energy metabolism, suggesting the pro-inflammatory impact of TBI and fructose in the liver. Conclusion Results reveal the impact of TBI on systemic metabolism and the aggravating action of fructose. The hypothalamic-pituitary-growth axis seems to play a major role in the regulation of the peripheral TBI pathology.	[Rege, Shraddha D.; Royes, Luiz; Tsai, Brandon; Zhang, Guanglin; Yang, Xia; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Royes, Luiz] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, BR-97105 Santa Maria, RS, Brazil		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.; Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	; Gokul, Krishna/H-3365-2019	Tsai, Brandon/0000-0002-7372-3504; Gokul, Krishna/0000-0001-5869-2204	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK104363] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050465] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK104363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465] Funding Source: NIH RePORTER		Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Agrawal R, 2016, J CEREBR BLOOD F MET, V36, P941, DOI 10.1177/0271678X15606719; Alwahsh SM, 2017, ARCH TOXICOL, V91, P1545, DOI 10.1007/s00204-016-1892-7; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Baxter RC, 1999, GROWTH HORM IGF RES, V9, P67, DOI 10.1016/S1096-6374(99)80013-6; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Botezelli JD, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-43; Brooks NL, 2007, J BIOL CHEM, V282, P35069, DOI 10.1074/jbc.M700484200; Caruso M, 2014, DIABETES, V63, P1933, DOI 10.2337/db13-1872; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Contreras B, 1999, ENDOCRINOLOGY, V140, P4725, DOI 10.1210/en.140.10.4725; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Fehrenbach E, 2006, SPORTS MED, V36, P373, DOI 10.2165/00007256-200636050-00001; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hui HX, 2009, PANCREAS, V38, P706, DOI 10.1097/MPA.0b013e3181a7c6e5; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; JANSSON JO, 1984, ENDOCRINOLOGY, V114, P1287, DOI 10.1210/endo-114-4-1287; Jauch-Chara K, 2014, NEUROSCIENCE, V283, P202, DOI 10.1016/j.neuroscience.2014.04.059; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Ji SN, 1999, J BIOL CHEM, V274, P13434, DOI 10.1074/jbc.274.19.13434; Jimenez-Maldonado A, 2018, BBA-MOL BASIS DIS, V1864, P24, DOI 10.1016/j.bbadis.2017.10.012; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Karaca Z, 2016, PROG MOL BIOL TRANSL, V138, P167, DOI 10.1016/bs.pmbts.2015.10.010; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Lindberg-Larsen R, 2007, J CLIN ENDOCR METAB, V92, P1724, DOI 10.1210/jc.2006-2276; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; Meng QY, 2016, EBIOMEDICINE, V7, P157, DOI 10.1016/j.ebiom.2016.04.008; Munzberg H, 2016, HANDB EXP PHARMACOL, V233, P173, DOI 10.1007/164_2015_33; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Roder PV, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.6; Rosenfeld RG, 2004, EUR J ENDOCRINOL, V151, pS11, DOI 10.1530/eje.0.151S011; ROSS RJM, 1995, EUR J ENDOCRINOL, V132, P655, DOI 10.1530/eje.0.1320655; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rowan MP, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0310-8; Sakharova AA, 2008, J CLIN ENDOCR METAB, V93, P2755, DOI 10.1210/jc.2008-0079; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Steneberg P, 2015, J BIOL CHEM, V290, P19034, DOI 10.1074/jbc.M115.640292; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; ter Horst KW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090981; Theytaz F, 2014, NUTRIENTS, V6, P2632, DOI 10.3390/nu6072632; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Volynets V, 2010, J LIPID RES, V51, P3414, DOI 10.1194/jlr.M007179; Vos MB, 2013, HEPATOLOGY, V57, P2525, DOI 10.1002/hep.26299; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651	68	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1613-4125	1613-4133		MOL NUTR FOOD RES	Mol. Nutr. Food Res.	AUG	2019	63	15			SI				1801054	10.1002/mnfr.201801054			10	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	IN8DZ	WOS:000478912100008	31087499	Bronze, Green Accepted			2022-02-06	
J	Sadeh, N; Spielberg, JM; Logue, MW; Hayes, JP; Wolf, EJ; McGlinchey, RE; Milberg, WP; Schichman, SA; Stone, A; Miller, MW				Sadeh, Naomi; Spielberg, Jeffrey M.; Logue, Mark W.; Hayes, Jasmeet P.; Wolf, Erika J.; McGlinchey, Regina E.; Milberg, William P.; Schichman, Steven A.; Stone, Annjanette; Miller, Mark W.			Linking genes, circuits, and behavior: network connectivity as a novel endophenotype of externalizing	PSYCHOLOGICAL MEDICINE			English	Article						Alcohol use; disinhibition; neural circuits; polygenic risk score; substance use	SUBSTANCE USE DISORDERS; TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; POSTTRAUMATIC-STRESS; ANTISOCIAL-BEHAVIOR; RESPONSE-INHIBITION; ALCOHOL DEPENDENCE; DISINHIBITION; IMPULSIVITY; AMYGDALA	Background Externalizing disorders are known to be partly heritable, but the biological pathways linking genetic risk to the manifestation of these costly behaviors remain under investigation. This study sought to identify neural phenotypes associated with genomic vulnerability for externalizing disorders. Methods One-hundred fifty-five White, non-Hispanic veterans were genotyped using a genome-wide array and underwent resting-state functional magnetic resonance imaging. Genetic susceptibility was assessed using an independently developed polygenic score (PS) for externalizing, and functional neural networks were identified using graph theory based network analysis. Tasks of inhibitory control and psychiatric diagnosis (alcohol/substance use disorders) were used to measure externalizing phenotypes. Results A polygenic externalizing disorder score (PS) predicted connectivity in a brain circuit (10 nodes, nine links) centered on left amygdala that included several cortical [bilateral inferior frontal gyrus (IFG) pars triangularis, left rostral anterior cingulate cortex (rACC)] and subcortical (bilateral amygdala, hippocampus, and striatum) regions. Directional analyses revealed that bilateral amygdala influenced left prefrontal cortex (IFG) in participants scoring higher on the externalizing PS, whereas the opposite direction of influence was observed for those scoring lower on the PS. Polygenic variation was also associated with higher Participation Coefficient for bilateral amygdala and left rACC, suggesting that genes related to externalizing modulated the extent to which these nodes functioned as communication hubs. Conclusions Findings suggest that externalizing polygenic risk is associated with disrupted connectivity in a neural network implicated in emotion regulation, impulse control, and reinforcement learning. Results provide evidence that this network represents a genetically associated neurobiological vulnerability for externalizing disorders.	[Sadeh, Naomi; Spielberg, Jeffrey M.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Sadeh, Naomi; Logue, Mark W.; Hayes, Jasmeet P.; Wolf, Erika J.; Miller, Mark W.] VA Boston Healthcare Syst, Behav Sci Div, Natl Ctr PTSD, Boston, MA 02130 USA; [Spielberg, Jeffrey M.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Logue, Mark W.] Boston Univ, Sch Med, Dept Biomed Genet, Boston, MA 02118 USA; [Hayes, Jasmeet P.; Wolf, Erika J.; Miller, Mark W.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Educ & Clin Ctr, Translat Res Ctr TBI & Stress Disorders & Geriatr, Boston, MA USA; [McGlinchey, Regina E.; Milberg, William P.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Schichman, Steven A.; Stone, Annjanette] Cent Arkansas Vet Healthcare Syst, Res Serv, Pharmacogen Anal Lab, Little Rock, AR USA		Sadeh, N (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.; Sadeh, N (corresponding author), VA Boston Healthcare Syst, Behav Sci Div, Natl Ctr PTSD, Boston, MA 02130 USA.	nsadeh@udel.edu	Miller, Mark Webber/G-7322-2011; Hayes, Jasmeet/AAN-4150-2020; Spielberg, Jeffrey/D-1402-2014	Miller, Mark Webber/0000-0001-6393-8563; Hayes, Jasmeet/0000-0002-5157-0666; Spielberg, Jeffrey/0000-0001-8348-7157; Wolf, Erika/0000-0003-2666-2435	NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [2P20GM103653-06-6527]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH102834]; Translational Research Center for TBI and Stress Disorders (National Network Research Center) [B9254-C]; United States Department of Veterans Affairs, Clinical Sciences Research and Development ProgramUS Department of Veterans Affairs; NIH from the National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [U10AA008401]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); Cooperative Studies Program, Department of Veterans AffairsUS Department of Veterans Affairs; Pharmacogenomics Analysis Laboratory, Research and Development Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103653] Funding Source: NIH RePORTER	This research was supported in part by NIGMS grant 2P20GM103653-06-6527, NIMH grant R21MH102834, and the Translational Research Center for TBI and Stress Disorders (National Network Research Center B9254-C) and the Cooperative Studies Program, Department of Veterans Affairs. This research is the result of work supported with resources and the use of facilities at the Pharmacogenomics Analysis Laboratory, Research and Development Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas. This work was also supported by a Career Development Award to EJW from the United States Department of Veterans Affairs, Clinical Sciences Research and Development Program. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States Government. We would like to thank the Collaborative Study on the Genetics of Alcoholism (COGA) who supplied data for calculating the polygenic risk scores used in this study. COGA Principal Investigators B. Porjesz, V. Hesselbrock, H. Edenberg, and L. Bierut, includes 11 different centers: University of Connecticut (V. Hesselbrock); Indiana University (H.J. Edenberg, J. Nurnberger Jr., and T. Foroud); University of Iowa (S. Kuperman and J. Kramer); SUNY Downstate (B. Porjesz); Washington University in St. Louis (L. Bierut, J. Rice, K. Bucholz, and A. Agrawal); University of California at San Diego (M. Schuckit); Rutgers University (J. Tischfield and A. Brooks); University of Texas Medical Center in San Antonio (L. Almasy), Virginia Commonwealth University (D. Dick), Mount Sinai School of Medicine (A. Goate), and Howard University (R. Taylor). Other COGA collaborators include: L. Bauer (University of Connecticut); D. Koller, S. O'Connor, L. Wetherill, and X. Xuei (Indiana University); Grace Chan (University of Iowa); D. Chorlian, N. Manz, K. Chella, and A. Pandey (SUNY Downstate); J.-C. Wang (Mount Sinai School of Medicine); and F. Aliev (Virginia Commonwealth University). A. Parsian and M. Reilly are the NIAAA Staff Collaborators. COGA continues to be inspired by memories of Henri Begleiter and Theodore Reich, founding PI and Co-PI of COGA, and also owes a debt of gratitude to other past organizers of COGA, including Ting-Kai Li, currently a consultant with COGA, P. Michael Conneally, Raymond Crowe, and Wendy Reich, for their critical contributions. This national collaborative study is supported by NIH Grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA).	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Baskin-Sommers AR, 2012, BIOL PSYCHOL, V91, P48, DOI 10.1016/j.biopsycho.2012.05.001; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bender-deMoll S., 2006, J SOCIAL STRUCTURE, V7, P1; Cardenas VA, 2011, BIOL PSYCHIAT, V70, P561, DOI 10.1016/j.biopsych.2011.04.003; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; DeVito EE, 2013, NEUROPSYCHOPHARMACOL, V38, P1854, DOI 10.1038/npp.2013.92; Dom G, 2005, BRIT J PSYCHIAT, V187, P209, DOI 10.1192/bjp.187.3.209; Douglas KR, 2010, ADDICT BEHAV, V35, P7, DOI 10.1016/j.addbeh.2009.07.004; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Eaton WW, 2013, AM J EPIDEMIOL, V178, P1366, DOI 10.1093/aje/kwt219; Enoch MA, 2012, CURR PSYCHIAT REP, V14, P150, DOI 10.1007/s11920-011-0252-9; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; First M.B., 1994, STRUCTURED CLIN INTE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Foell J, 2016, SOC COGN AFFECT NEUR, V11, P1102, DOI 10.1093/scan/nsv080; Fornito A, 2015, EUR NEUROPSYCHOPHARM, V25, P733, DOI 10.1016/j.euroneuro.2014.02.011; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Glenn AL, 2012, BIOL PSYCHIAT, V72, P817, DOI 10.1016/j.biopsych.2012.04.027; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Heitzeg MM, 2014, NEUROPSYCHOPHARMACOL, V39, P3077, DOI 10.1038/npp.2014.161; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Karoly HC, 2013, ANN NY ACAD SCI, V1282, P71, DOI 10.1111/nyas.12074; Korponay C, 2017, BIOL PSYCHIAT-COGN N, V2, P149, DOI 10.1016/j.bpsc.2016.07.004; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213; Little K, 2015, J ABNORM PSYCHOL, V124, P834, DOI 10.1037/abn0000101; LUNTZ BK, 1994, AM J PSYCHIAT, V151, P670; Miller GA, 2013, ANNU REV CLIN PSYCHO, V9, P177, DOI 10.1146/annurev-clinpsy-050212-185540; National Institute on Drug Abuse, 2015, TRENDS STAT; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nikolova YS, 2016, MOL PSYCHIATR, V21, P348, DOI 10.1038/mp.2015.85; Odgers CL, 2007, ARCH GEN PSYCHIAT, V64, P476, DOI 10.1001/archpsyc.64.4.476; Pagliaccio D, 2015, J ABNORM PSYCHOL, V124, P817, DOI 10.1037/abn0000094; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramsey JD, 2014, NEUROIMAGE, V84, P986, DOI 10.1016/j.neuroimage.2013.09.062; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sadeh N, 2016, CLIN PSYCHOL SCI, V4, P545, DOI 10.1177/2167702615613310; Sadeh N, 2015, HUM BRAIN MAPP, V36, P3076, DOI 10.1002/hbm.22829; Sadeh N, 2013, SOC COGN AFFECT NEUR, V8, P235, DOI 10.1093/scan/nsr092; Salvatore JE, 2015, CLIN PSYCHOL SCI, V3, P189, DOI 10.1177/2167702614534211; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; Shehzad Z, 2012, NEUROIMAGE, V60, P2158, DOI 10.1016/j.neuroimage.2012.01.097; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Spielberg JM, 2017, HUM BRAIN MAPP, V38, P3249, DOI 10.1002/hbm.23587; Spielberg JM, 2015, P NATL ACAD SCI USA, V112, P10020, DOI 10.1073/pnas.1500048112; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Young SE, 2009, J ABNORM PSYCHOL, V118, P117, DOI 10.1037/a0014657; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009	61	4	5	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	AUG	2019	49	11					1905	1913		10.1017/S0033291718002672			9	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	IM0DN	WOS:000477655600015	30207258	Green Accepted			2022-02-06	
J	Ungar, OJ; Shilo, S; Anat, W; Cavel, O; Handzel, O; Oron, Y				Ungar, Omer J.; Shilo, Shahaf; Anat, Wengier; Cavel, Oren; Handzel, Ophir; Oron, Yahav			Blast-Induced Cholesteatomas After Spontaneous Tympanic Membrane Healing	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						blast injury; acquired cholesteatoma; cholesteatoma behind intact tympanic membrane	INJURIES; EAR; ETIOLOGY; COMBAT; NECK; IRAQ; HEAD	Objectives: To characterize blast-induced cholesteatomas (BIC) in terms of symptoms, presentation, and location within the middle ear cleft (MEC). Design: A search for all English language articles in "MEDLINE" via "PubMed" and "Google Scholar" was conducted. Results: A total of 67 ears with BIC were included. Fifty-eight ears in which the traumatic perforation failed to spontaneously close were excluded, leaving seven case reports (eight patients, nine ears) for statistical analysis. Time between blast exposure to spontaneous tympanic membrane (TM) closure was 16 days to 10 months. Time between blast exposure and cholesteatoma diagnosis was 5 months to 4 years. The cholesteatomas were diagnosed due to symptoms in two ears, as asymptomatic finding on physical examination in one ear and as asymptomatic finding in axial imaging in three ears. Conclusions: BICs can develop behind intact tympanic membrane or along with TM perforation. Based on the current review, when a TM perforation and spontaneous healing were documented, after blast exposure, MRI scan is an integral component of the follow-up. The optimal timing for MRI performance after blast exposure, is yet to be identified.	[Ungar, Omer J.; Shilo, Shahaf; Anat, Wengier; Cavel, Oren; Handzel, Ophir; Oron, Yahav] Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck Surg & Maxillofacial, 6 Weizmann St, IL-6423906 Tel Aviv, Israel; [Ungar, Omer J.; Shilo, Shahaf; Anat, Wengier; Cavel, Oren; Handzel, Ophir; Oron, Yahav] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel		Ungar, OJ (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck Surg & Maxillofacial, 6 Weizmann St, IL-6423906 Tel Aviv, Israel.	ungaromer@gmail.com	Ungar, Omer Jacob/V-1157-2019	Ungar, Omer Jacob/0000-0002-5904-1291; Shilo, Shahaf/0000-0001-6474-7435			BERGER G, 1994, J LARYNGOL OTOL, V108, P395, DOI 10.1006/jssc.1994.1057; Breeze J, 2011, J LARYNGOL OTOL, V125, P13, DOI 10.1017/S0022215110002215; Breeze J, 2009, J R Army Med Corps, V155, P274; BRUINS WR, 1991, J LARYNGOL OTOL, V105, P890, DOI 10.1017/S002221510011775X; Darley DS, 2010, DISASTER MED PUBLIC, V4, P145, DOI 10.1001/dmphp.D-08-00057R2; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GRISTWOOD RE, 1976, CLIN OTOLARYNGOL, V1, P169, DOI 10.1111/j.1365-2273.1976.tb00869.x; Helling ER, 2004, MIL MED, V169, P872, DOI 10.7205/MILMED.169.11.872; HINOHIRA Y, 1994, ACTA OTO-LARYNGOL, V114, P533, DOI 10.3109/00016489409126099; Horrocks C L, 2001, J R Army Med Corps, V147, P28; Hostetler SG, 2005, AM J SPORT MED, V33, P1065, DOI 10.1177/0363546504271748; KERR AG, 1975, J LARYNGOL OTOL, V89, P131, DOI 10.1017/S002221510008018X; KRONENBERG J, 1993, AM J OTOL, V14, P92; KRONENBERG J, 1988, AM J OTOL, V9, P127; Lou ZC, 2011, CLIN OTOLARYNGOL, V36, P450, DOI 10.1111/j.1749-4486.2011.02387.x; Lou ZC, 2012, AM J OTOLARYNG, V33, P549, DOI 10.1016/j.amjoto.2012.01.010; McFeely WJ, 1999, OTOLARYNG HEAD NECK, V121, P367, DOI 10.1016/S0194-5998(99)70222-6; Medina M, 2014, Rev Laryngol Otol Rhinol (Bord), V135, P211; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Paran H, 1996, J TRAUMA, V40, P472, DOI 10.1097/00005373-199603000-00029; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Rustemeyer J, 2007, BRIT J ORAL MAX SURG, V45, P556, DOI 10.1016/j.bjoms.2007.01.003; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SEAMAN RW, 1971, ARCHIV OTOLARYNGOL, V94, P440; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; SMYTH GDL, 1985, LARYNGOSCOPE, V95, P92; Tanaka Y, 1998, LARYNGOSCOPE, V108, P537, DOI 10.1097/00005537-199804000-00014; TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P159, DOI 10.1098/rspa.1950.0049; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	31	4	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	DEC	2019	128	12					1147	1151	0003489419865568	10.1177/0003489419865568		AUG 2019	5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	JL2ZF	WOS:000485965700001	31366214				2022-02-06	
J	Wang, QR; Lu, YY; Su, YJ; Qin, H; Zhang, L; Wu, MK; Zhang, CL; Wu, CH				Wang, Qing-Rui; Lu, Ying-Yi; Su, Ying-Ju; Qin, Hao; Zhang, Li; Wu, Ming-Kung; Zhang, Cong-Liang; Wu, Chieh-Hsin			Migraine and traumatic brain injury: a cohort study in Taiwan	BMJ OPEN			English	Article							COGNITIVE DYSFUNCTION; RISK; HEADACHE; STROKE; IMPACT; DEPRESSION; CONCUSSION; OUTCOMES; ATTACKS	Objective Traumatic brain injury is now a major contributor to the global healthcare burden. Migraine is another debilitating disease with a global health impact. While most researchers agree that traumatic brain injury is a risk factor for migraine, whether migraine is a risk factor for traumatic brain injury still remains under debate. We therefore aimed to investigate whether migraine was a risk factor for developing traumatic brain injury. Study design Retrospective population-based cohort study. Setting Data for people who had been diagnosed with migraine were retrieved from Taiwan's National Health Insurance Research Database. Participants We identified 7267 patients with newly diagnosed migraine during 1996-2010. The migraineurs to non-migraineurs ratio was set at 1: 4 to enhance the power of statistical tests. Primary and secondary outcome measures We used multivariate Cox proportional hazard regression models to assess the effects of migraines on the risk of traumatic brain injury after adjusting for potential confounders. Results The overall traumatic brain injury risk was 1.78 times greater in the migraine group compared with the non-migraine group after controlling for covariates. Additionally, patients with previous diagnoses of alcohol-attributed disease, mental disorders and diabetes mellitus had a significantly higher traumatic brain injury risk compared with those with no history of these diagnoses. Conclusions This study of a population-based database indicated that migraine is a traumatic brain injury risk factor. Greater attention to migraine-targeted treatment modalities may reduce traumatic brain injury-related morbidity and mortality.	[Wang, Qing-Rui] Qinghe Cty Cent Hosp Hebei Prov, Dept Neurosurg, Qinghe, Hebei, Peoples R China; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lu, Ying-Yi] Shu Zen Jr Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan; [Lu, Ying-Yi] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Su, Ying-Ju] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Qin, Hao] Zaozhuang Municipal Hosp, Dept Neurosurg, Zaozhuang, Shandong, Peoples R China; [Zhang, Li] Soochow Univ, Affiliated Zhangjiagang Hosp, Dept Neurosurg, Zhangjiagang, Jiangsu, Peoples R China; [Wu, Ming-Kung] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Wu, Ming-Kung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Zhang, Cong-Liang] Hebei Quyang Renji Hosp, Dept Cardiol, Quyang, Hebei, Peoples R China; [Wu, Chieh-Hsin] Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Wu, Chieh-Hsin] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan		Wu, CH (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan.; Wu, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan.	wujoeys@gmail.com			Kaohsiung Medical University Hospital [KMUH105-5M17, KMUH106-6T09]	This study was supported by grants from the Kaohsiung Medical University Hospital (KMUH105-5M17 and KMUH106-6T09).	Anderson K, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/693925; [Anonymous], 2010, TRAUMATIC BRAIN INJU; Antonaci F, 2011, J HEADACHE PAIN, V12, P115, DOI 10.1007/s10194-010-0282-4; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Chou YC, 2014, J HEAD TRAUMA REHAB, V29, P514, DOI 10.1097/HTR.0000000000000007; Chuang CS, 2013, NEUROEPIDEMIOLOGY, V41, P139, DOI 10.1159/000353559; Chung KH, 2015, J CLIN SLEEP MED, V11, P542, DOI 10.5664/jcsm.4700; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Feigin VL, 2007, HDB CLIN NEUROEPIDEM; Gil-Gouveia R, 2015, CEPHALALGIA, V35, P662, DOI 10.1177/0333102414553823; Gil-Gouveia R, 2015, J NEUROL, V262, P654, DOI 10.1007/s00415-014-7603-5; GOLINKOFF M, 1989, J AFFECT DISORDERS, V17, P105, DOI 10.1016/0165-0327(89)90032-3; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Hong CH, 2016, INT J MOL SCI, V18; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KUNY S, 1995, PSYCHOPATHOLOGY, V28, P190, DOI 10.1159/000284922; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lin CH, 2015, BONE, V72, P9, DOI 10.1016/j.bone.2014.11.007; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mongini F, 2003, CEPHALALGIA, V23, P186, DOI 10.1046/j.1468-2982.2003.00519.x; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; SILBERSTEIN SD, 1995, CEPHALALGIA, V15, P358, DOI 10.1046/j.1468-2982.1995.1505358.x; The Lancet Neurology, 2010, LANCET NEUROLOGY, V9; Tung YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129043; Wang SH, 2019, J AM ACAD DERMATOL, V80, P1006, DOI 10.1016/j.jaad.2018.11.049; Wu CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171999; Wu CH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8030676; Wu CH, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3090-8; Yang CP, 2016, OPHTHALMOLOGY, V123, P191, DOI 10.1016/j.ophtha.2015.09.003; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987; Yang YJ, 2018, AM J MENS HEALTH, V12, P913, DOI 10.1177/1557988317750970; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	48	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2019	9	7							e027251	10.1136/bmjopen-2018-027251			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW8US	WOS:000485269700052	31366644	gold, Green Published			2022-02-06	
J	Ahonle, ZJ; Barnes, M; Romero, S; Sorrells, AM; Brooks, GI				Ahonle, Zaccheus J.; Barnes, Marcia; Romero, Sergio; Sorrells, Audrey M.; Brooks, Gene I.			State-Federal Vocational Rehabilitation in Traumatic Brain Injury: What Predictors Are Associated With Employment Outcomes?	REHABILITATION COUNSELING BULLETIN			English	Article						vocational rehabilitation; traumatic brain injury; race; ethnicity; employment	AFRICAN-AMERICAN; SERVICES; CLIENTS; WORK; SAMPLE; DISABILITIES; DISPARITIES; CONSUMERS; SUCCESS; PEOPLE	This study identified predictors of employment for individuals with traumatic brain injury (TBI). Data from 4,923 individuals with TBI were extracted from the Rehabilitation Services Administration's Case Service Report (RSA-911) database. A multiple logistic regression model using demographics, disability-related variables, vocational rehabilitation (VR) service variables, and their interactions correctly classified 69.5% of the cases as successfully employed or not successfully employed. The model explained approximately 27.1% of the variance in employment outcomes. Results indicated that level of education, race/ethnicity, age at application, preemployment status, Supplemental Security Income (SSI), Social Security Disability Insurance (SSDI), comorbid depression, and case expenditure were significantly associated with employment outcomes (all p <= .05). VR variables that showed the most significant positive effect on employment outcomes were on-the-job support, job placement, and on-the-job training. Race/ethnicity moderated the effect of college training, supported employment, transportation, and extended evaluation or work trial assessment services on employment outcomes. The findings have implications for promoting the use of those VR services that are strongly related to employment outcomes for persons with TBI. They also point to the need for rehabilitation personnel to address some of the demographic and disability-related barriers to successful employment.	[Ahonle, Zaccheus J.; Romero, Sergio] Univ Florida, Gainesville, FL USA; [Ahonle, Zaccheus J.; Romero, Sergio] Ctr Innovat Disabil & Rehabil Res CINDRR, Gainesville, FL USA; [Barnes, Marcia] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Sorrells, Audrey M.; Brooks, Gene I.] Univ Texas Austin, Austin, TX 78712 USA		Ahonle, ZJ (corresponding author), Univ Florida, Dept Occupat Therapy, 1225 Ctr Dr,Room 2101, Gainesville, FL 32611 USA.	zahonle@phhp.ufl.edu	Ahonle, Zaccheus/AAY-9737-2020	Ahonle, Zaccheus/0000-0003-2898-4200			Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; ATKINS BJ, 1980, J REHABIL, V46, P40; Bellini J, 2003, REHABIL COUNS BULL, V46, P164, DOI 10.1177/00343552030460030501; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Bureau of Labor Statistics, 2013, PERS DIS BARR EMPL T; Bureau of Labor Statistics, 2018, PERS DIS LAB FORC CH; BUTLER RW, 1988, PROF PSYCHOL-RES PR, V19, P536, DOI 10.1037/0735-7028.19.5.536; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P55; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Crisp R, 2005, J REHABIL, V71, P30; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Dooley D, 1996, ANNU REV PUBL HEALTH, V17, P449, DOI 10.1146/annurev.pu.17.050196.002313; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; FEISTPRICE S, 1995, REHABIL COUNS BULL, V39, P119; Fidell L.S., 2001, USING MULTIVARIATE S; Gajewski P, 2017, EUR J PUBLIC HEALTH, V27, P1038, DOI 10.1093/eurpub/ckx180; Gamble D, 2003, J REHABIL, V69, P31; Gamble D., 2002, J APPL REHABILITATIO, V33, P41, DOI DOI 10.1891/0047-2220.33.3.41; Gamble D, 2003, J VOCATIONAL REHABIL, V19, P47; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Harley D. A., 2002, J REHABILITATION ADM, V25, P137; Hennessey JC, 1997, SOC SECUR BULL, V60, P3; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Keith T.Z., 2006, MULTIPLE REGRESSION; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Martin FH, 2010, REHABIL COUNS BULL, V54, P26, DOI 10.1177/0034355209360420; Moore CL, 2016, REHABIL COUNS BULL, V59, P158, DOI 10.1177/0034355215579917; Noone Peter, 2011, Occup Med (Lond), V61, P71, DOI 10.1093/occmed/kqq173; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Pete JP, 2015, J VOCAT REHABIL, V43, P149, DOI 10.3233/JVR-150764; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; Rehabilitation Services Administration, 2012, RSA911 RSAPD US DEP; Rosenthal D. A., 2001, EFFECTS GENDER RACE; Schonbrun S. L., 2004, J APPL REHABILITATIO, V35, P14; Schonbrun SL, 2007, J REHABIL, V73, P26; Skeel RL, 2003, REHABIL PSYCHOL, V48, P145, DOI 10.1037/0090-5550.48.3.145; Szymanski E.M., 2010, WORK DISABILITY CONT; Tucker MS, 2017, REHABIL COUNS BULL, V60, P215, DOI 10.1177/0034355216660279; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Weathers RR, 2011, J POLICY ANAL MANAG, V30, P708, DOI 10.1002/pam.20611; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201; Wheaton JE, 1996, REHABIL COUNS BULL, V40, P116; Whitfield HW, 2008, REHABIL COUNS BULL, V51, P190, DOI 10.1177/0034355207311316; Wilson KB, 2005, J COUNS DEV, V83, P86, DOI 10.1002/j.1556-6678.2005.tb00583.x; [No title captured]	53	4	4	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.	APR	2020	63	3					143	155	0034355219864684	10.1177/0034355219864684		JUL 2019	13	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	LA4EN	WOS:000481230700001					2022-02-06	
J	Weatherall, A; Poynter, E; Garner, A; Lee, A				Weatherall, Andrew; Poynter, Elwyn; Garner, Alan; Lee, Anna			Near-infrared spectroscopy monitoring in a pre-hospital trauma patient cohort: An analysis of successful signal collection	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						clinical monitoring; near-infrared spectroscopy; trauma; traumatic brain injury	CEREBRAL OXYGEN-SATURATION; BRAIN-INJURY; BLOOD-FLOW; AUTOREGULATION; GUIDELINES; MANAGEMENT; OXIMETRY; IMPACT; LIGHT	Background Noninvasive monitoring of cerebral physiology could potentially guide pre-hospital management of patients with traumatic injuries. Near-infrared spectroscopy (NIRS) is one such modality but the consistency of monitoring performance remains unclear. This study assessed the proportion of successful signal collection during pre-hospital care. Methods As part of a prospective observational study, an independent study observer placed three sensors for a Nonin 7610 NIRS device; two on the forehead and one on the forearm. NIRS records were analysed for time of adequate monitoring signal in each sensor (>70% of total pre-hospital time). We also compared pre-hospital scene and transport times for patients with or without NIRS monitoring. Results Sixty-three patients with monitoring sensors applied were compared to 255 patients where no study observer was on board and 97 without NIRS monitoring for various reasons within the same time period. The proportion of pre-hospital time with successful monitoring (>70%) was 71.4% (45 of 63) for all three sensors, with at least two sensors functional in 90.4% (57 of 63). The median (interquartile range) scene time was 19 (11-23) minutes in patients with NIRS monitoring compared to 18 (11-27) minutes without NIRS monitoring (P = .570). There was no difference in the median (interquartile range) total pre-hospital time between patients with or without monitoring sensors (72 [59-89] versus 72 [59-80] minutes; P = .605). Conclusions In this pre-hospital observational feasibility study with dedicated personnel an acceptable proportion of measurement time was achieved in over 90% of monitored subjects. Addition of NIRS monitoring did not alter pre-hospital scene or transport times in this research setting.	[Weatherall, Andrew; Poynter, Elwyn; Garner, Alan] CareFlight, 4 Barden St, Northmead, NSW 2152, Australia; [Weatherall, Andrew] Univ Sydney, Discipline Child & Adolescent Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [Lee, Anna] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Sha Tin, Hong Kong, Peoples R China		Weatherall, A (corresponding author), CareFlight, 4 Barden St, Northmead, NSW 2152, Australia.	andrew.weatherall@careflight.org	Garner, Alan/AAN-1513-2020; Lee, Anna/B-2773-2009; Weatherall, Andrew David/AAK-2208-2021	Garner, Alan/0000-0002-4010-9137; Lee, Anna/0000-0003-2864-0045; Weatherall, Andrew/0000-0001-6070-9466	Australian and New Zealand College of Anaesthetists [15/024]; Falck Foundation for Prehospital Medicine	Funding for this research has been obtained from the Australian and New Zealand College of Anaesthetists (Project Grant 15/024) and the Falck Foundation for Prehospital Medicine. Neither funding body had any role in study design, collection and interpretation of data or writing of this manuscript.	Access Economics, 2009, ACC EC, P1; Ameloot K, 2015, RESUSCITATION, V90, P121, DOI 10.1016/j.resuscitation.2015.03.001; Angerman S, 2018, ACTA ANAESTH SCAND, V62, P1139, DOI 10.1111/aas.13146; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bhatia R, 2007, J NEUROSURG ANESTH, V19, P97, DOI 10.1097/ANA.0b013e318031376d; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Elwell CE, 2011, PHILOS T R SOC A, V369, P4358, DOI 10.1098/rsta.2011.0302; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Haesen J, 2018, RESUSCITATION, V126, P179, DOI 10.1016/j.resuscitation.2018.01.042; Jakkula P, 2018, INTENS CARE MED, V44, P2112, DOI 10.1007/s00134-018-5453-9; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mille T, 2004, EUR J VASC ENDOVASC, V27, P646, DOI 10.1016/j.ejvs.2004.02.012; Prosen G, 2018, RESUSCITATION, V129, P141, DOI 10.1016/j.resuscitation.2018.05.014; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; Santo KC, 2008, ANESTH ANALG, V107, P793, DOI 10.1213/ane.0b013e31818042d6; Schewe JC, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0058-y; Schober P, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1846830; Su XWW, 2011, PEDIATR RES, V70, P181, DOI 10.1203/PDR.0b013e3182226b75; Weatherall A, 2012, ACTA ANAESTH SCAND, V56, P172, DOI 10.1111/j.1399-6576.2011.02591.x; Weatherall A, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0057-z; Zaouter C, 2010, BRIT J ANAESTH, V105, P873, DOI 10.1093/bja/aeq330; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	29	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JAN	2020	64	1					117	123		10.1111/aas.13444		JUL 2019	7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	PR7MB	WOS:000479337100001	31287156				2022-02-06	
J	Anto-Ocrah, M; Bazarian, J; Lewis, V; Jones, CM; Jusko, TA; Van Wijngaarden, E				Anto-Ocrah, Martina; Bazarian, Jeff; Lewis, Vivian; Jones, Courtney Marie; Jusko, Todd A.; Van Wijngaarden, Edwin			Risk of female sexual dysfunction following concussion in women of reproductive age	BRAIN INJURY			English	Article						Concussion; women; sexual function; gender	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; RELATIVE RISK; MILD; SYMPTOMS; HEALTH; PREDICTORS; TBI; HYPOPITUITARISM; OUTCOMES	Objectives: Traumatic Brain Injury (TBI) has frequently been associated with changes in sexual functioning. The TBI and sexuality literature, however, has limited generalizability to concussed females, who often use the emergency department (ED) as their first line of care after head injury. Primary Objective: The primary objective of this study was to evaluate the impact of concussions on female sexual functioning. Secondary Objective: Secondarily, we evaluated if concussed women with sexual dysfunction also report more post-concussion symptoms (PCS) and/or mood changes. Research Design: This was a prospective cohort, with outcomes assessed at 6-10 weeks after ED enrollment. Methods and Procedures: Sexual dysfunction was defined as <= 45 on the Brain Injury Questionnaire on Sexuality (BIQS). The Rivermead Post-concussion Symptoms Questionnaire (RPQ) and the Hospital Anxiety and Depression Scale (HADS) assessed PCS and post-injury mood, respectively. Main Outcomes & Results: Eighty-nine eumenorrheic females (8-14 menstrual cycles/year) completed the study; 31(36%) had concussions, and 55(64%) were extremity injured. Concussed women had 70% increased risk of sexual dysfunction (adj.RR:1.70, 95% CI: 1.04,2.76; p = .03) versus extremity injured. Of clinical relevance, concussed women with sexual dysfunction also reported more PCS symptoms (adj.beta = 5.5, 95% CI: -6.7,18.2; p = .37) and mood scores (adj.beta = 8.0; 95% CI: -0.4, 16.4; p = .06). Conclusions: This study highlights the need for more research and interventions for one of the fastest growing subgroups within the TBI population.	[Anto-Ocrah, Martina; Bazarian, Jeff; Jones, Courtney Marie] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14627 USA; [Anto-Ocrah, Martina; Lewis, Vivian] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY USA; [Anto-Ocrah, Martina; Bazarian, Jeff] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Bazarian, Jeff; Jones, Courtney Marie; Jusko, Todd A.; Van Wijngaarden, Edwin] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA		Anto-Ocrah, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14627 USA.	martina_ocrah@urmc.rochester.edu					Abar B, 2018, WEST J EMERG MED, V19, P606, DOI 10.5811/westjem.2017.12.36721; Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; [Anonymous], 2007, NEUR DIS PUBL HLTH C; [Anonymous], 2017, MMWR-MORBID MORTAL W, V66, P1; Anto-Ocrah M, 2019, AM J EMERG MED, V37, P1200, DOI 10.1016/j.ajem.2018.11.002; Basson R, 2002, J SEX MARITAL THER, V28, P17, DOI 10.1080/00926230252851168; Basson R, 2002, BJOG-INT J OBSTET GY, V109, P357, DOI 10.1016/S1470-0328(02)91002-5; Basson R, 2001, J SEX MARITAL THER, V27, P33, DOI 10.1080/00926230152035831; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bellamkonda E, 2014, BRAIN INJURY, V28, P1063, DOI 10.3109/02699052.2014.896473; Berman JR, 2002, WORLD J UROL, V20, P111, DOI 10.1007/s00345-002-0281-4; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Borreli L, 2014, BRAIN SEX BRAIN FUNC; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention Division of Unintentional Injury Prevention, 2015, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2015, TRAUM BRAIN INJ US E; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Crowe SF, 1999, BRAIN INJURY, V13, P347; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DENNERSTEIN L, 1994, PSYCHONEUROENDOCRINO, V19, P293, DOI 10.1016/0306-4530(94)90067-1; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Erekson EA, 2013, MENOPAUSE, V20, P110, DOI 10.1097/gme.0b013e31825a27ab; Estrada A, 2013, FERTILITY       0501; Evidence Based Review of Moderate To Severe Acquired Brain Injury (ERABI), 2016, CHAR HOSP ANX DEPR S; Flynn KE, 2016, J SEX MED, V13, P1642, DOI 10.1016/j.jsxm.2016.08.011; Giles KR, 2009, J SEX MED, V6, P2761, DOI 10.1111/j.1743-6109.2009.01425.x; Goldstein I, 2016, SEXUAL MED CENTRAL M; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Iaccarino M, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0211; Kalmbach DA, 2014, J SEX MED, V11, P2915, DOI 10.1111/jsm.12692; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Kontos Anthony P, 2016, Pediatr Neurol Briefs, V30, P19, DOI 10.15844/pedneurbriefs-30-3-2; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Leiblum SR, 2006, MENOPAUSE, V13, P46, DOI 10.1097/01.gme.0000172596.76272.06; Leo P, 2016, TRANSLATIONAL RES TR; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Masters W.H., 1966, HUMAN SEXUAL RESPONS; McAnulty RD, 2006, SEX SEXUALITY SEXUAL; McCool ME, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-75; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meston CM, 2002, J SEX MARITAL THER, V28, P155, DOI 10.1080/00926230252851276; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Moreno MA, 2017, JAMA PEDIATR, V171, P924, DOI 10.1001/jamapediatrics.2017.1893; Nappi RE, 2009, MATURITAS, V63, P138, DOI 10.1016/j.maturitas.2009.03.021; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Nowosielski K, 2016, ARCH SEX BEHAV, V45, P291, DOI 10.1007/s10508-015-0611-4; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Roney JR, 2013, HORM BEHAV, V63, P636, DOI 10.1016/j.yhbeh.2013.02.013; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sandfort TGM, 2004, ARCH SEX BEHAV, V33, P181, DOI 10.1023/B:ASEB.0000026618.16408.e0; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Strizzi J, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/247479; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; The National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH), 2016, NINDS COMM DAT  0226; Turner D, 2015, CURR OPIN PSYCHIATR, V28, P180, DOI 10.1097/YCO.0000000000000144; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; West SL, 2004, ANN REV SEX RES, V15, P40; West TA, 2014, J FAM PRACTICE, V63, P11; Wiglusz MS, 2016, EPILEPSY BEHAV, V58, P97, DOI 10.1016/j.yebeh.2016.03.003; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	96	4	4	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1449	1459		10.1080/02699052.2019.1644377		JUL 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000477546600001	31322004				2022-02-06	
J	Graham, K; Searle, A; Van Hooff, M; Lawrence-Wood, E; McFarlane, A				Graham, Kristin; Searle, Amelia; Van Hooff, Miranda; Lawrence-Wood, Ellie; McFarlane, Alexander			The Value of Physical Symptoms in Screening For Posttraumatic Stress Disorder in the Military	ASSESSMENT			English	Article						military; physical symptoms; posttraumatic stress; receiver operating characteristic curve	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; COMORBID CHRONIC PAIN; SOMATIC SYMPTOMS; GULF-WAR; US MILITARY; CLINICAL-ASSESSMENTS; PTSD CHECKLIST; PRIMARY-CARE; RISK-FACTORS	Physical symptoms are highly comorbid with posttraumatic stress disorder (PTSD). As PTSD is underdiagnosed, this study explored the value of self-reported physical symptoms in screening for 30-day PTSD in military personnel. Two physical symptom scales were constructed using items from a 67-item health symptom checklist, clinical interviews were used as the diagnostic reference standard, and diagnostic utility of physical symptoms was compared with the current gold standard screen, the PTSD checklist (PCL). Receiver operating characteristic analyses showed that both a 9-item and a 10-item physical symptom scale were of value in predicting PTSD (areas under the curve 0.81 and 0.85). Importantly, two thirds of PTSD positive personnel missed by the PCL were captured with physical symptoms scales, and when physical symptoms were added to the PCL, prediction was improved (areas under the curve 0.90 to 0.92). Our findings highlight the value of including assessing physical symptoms in PTSD screening.	[Graham, Kristin; Searle, Amelia; Van Hooff, Miranda; Lawrence-Wood, Ellie; McFarlane, Alexander] Univ Adelaide, Adelaide, SA, Australia		Graham, K (corresponding author), Univ Adelaide, Ctr Traumat Stress Studies, Level 1,Helen Mayo North,30 Frome Rd, Adelaide, SA 5000, Australia.	kristin.graham@adelaide.edu.au	graham, kristin/AAB-7157-2019	graham, kristin/0000-0002-1864-1856; Van Hooff, Miranda/0000-0002-9376-3714	Australian Rotary Health ANZAC Scholarship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an Australian Rotary Health ANZAC Scholarship.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andreski P, 1998, PSYCHIAT RES, V79, P131, DOI 10.1016/S0165-1781(98)00026-2; Assareh N, 2016, BEHAV NEUROSCI, V130, P406, DOI 10.1037/bne0000151; Baglioni C, 2016, PSYCHOL BULL, V142, P969, DOI 10.1037/bul0000053; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Bekhuis E, 2016, J AFFECT DISORDERS, V205, P112, DOI 10.1016/j.jad.2016.06.030; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Bryan CJ, 2012, ARCH SUICIDE RES, V16, P95, DOI 10.1080/13811118.2012.667321; Bush NE, 2013, SUICIDE LIFE-THREAT, V43, P262, DOI 10.1111/sltb.12012; Clapp JD, 2008, PAIN, V138, P301, DOI 10.1016/j.pain.2008.01.001; Clarke DM, 2008, MED J AUSTRALIA, V189, P560, DOI 10.5694/j.1326-5377.2008.tb02180.x; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Davy C., 2012, MIDDLE E AREA OPERAT; Dobson A., 2012, MIDDLE E AREA OPERAT; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Green B.L., 2004, TRAUMA HLTH PHYS HLT, P13, DOI DOI 10.1037/10723-002; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Grupe DW, 2016, PSYCHOL MED, V46, P1885, DOI 10.1017/S0033291716000374; Gulden A, 2010, J NERV MENT DIS, V198, P762, DOI 10.1097/NMD.0b013e3181f49c0a; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Harden L, 2018, J ROY ARMY MED CORPS, V164, P352, DOI 10.1136/jramc-2018-000921; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Herran A, 1999, BRIT MED J, V318, P1558, DOI 10.1136/bmj.318.7197.1558; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Honest H, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-4; Hyman J, 2012, AM J PUBLIC HEALTH, V102, pS138, DOI 10.2105/AJPH.2011.300484; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelsall HL, 2004, OCCUP ENVIRON MED, V61, P1006, DOI 10.1136/oem.2003.009258; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kessler RC, 2013, INT J METH PSYCH RES, V22, P303, DOI 10.1002/mpr.1398; Kilshaw S, 2008, CULT MED PSYCHIAT, V32, P219, DOI 10.1007/s11013-008-9088-0; King's Centre for Military Health Research, 2010, KINGS CTR MIL HLTH R; Kirmayer Laurence J., 1988, BIOMEDICINE EXAMINED, P57; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Krakow B, 2001, AM J PSYCHIAT, V158, P2043, DOI 10.1176/appi.ajp.158.12.2043; LANDRINE H, 1992, HEALTH PSYCHOL, V11, P267, DOI 10.1037/0278-6133.11.4.267; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Magruder K, 2015, EPIDEMIOL PSYCH SCI, V24, P415, DOI 10.1017/S2045796014000365; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; McFarlane A., 2011, MENTAL HLTH AUSTR DE; Meltzer EC, 2012, J BEHAV HEALTH SER R, V39, P190, DOI 10.1007/s11414-011-9263-x; Metraux S, 2013, AM J PUBLIC HEALTH, V103, pS255, DOI 10.2105/AJPH.2013.301432; NEWMAN SC, 1990, PSYCHOL MED, V20, P183, DOI 10.1017/S0033291700013362; Nicholson C., 2006, REV PTSD CHECKLIST; O'Donnell M., 2014, AUSTR DEFENCE FORCE; O'Toole BI, 2009, AM J EPIDEMIOL, V170, P318, DOI 10.1093/aje/kwp146; Outcalt SD, 2016, J REHABIL RES DEV, V53, P37, DOI 10.1682/JRRD.2014.10.0237; Outcalt SD, 2014, J REHABIL RES DEV, V51, P559, DOI 10.1682/JRRD.2013.06.0134; Pereira MG, 2020, J MENT HEALTH, V29, P69, DOI 10.1080/09638237.2018.1487532; Pietrzak RH, 2014, PSYCHOL MED, V44, P2085, DOI 10.1017/S0033291713002924; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Quartana PJ, 2015, J PSYCHOSOM RES, V78, P478, DOI 10.1016/j.jpsychores.2014.11.017; Rabellino D, 2017, HUM BRAIN MAPP, V38, P4898, DOI 10.1002/hbm.23702; Reiser B, 2000, STAT MED, V19, P2115, DOI 10.1002/1097-0258(20000830)19:16<2115::AID-SIM529>3.0.CO;2-M; Rona RJ, 2004, J MED SCREEN, V11, P148, DOI 10.1258/0969141041732193; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schlenger WE, 2015, AM J EPIDEMIOL, V182, P980, DOI 10.1093/aje/kwv217; Schnurr P. P., 2015, EVIDENCE BASED TREAT, P87, DOI DOI 10.1007/978-3-319-07109-1_5; Searle AK, 2015, INT J METH PSYCH RES, V24, P32, DOI 10.1002/mpr.1460; Shapley M, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515412; Sim M. R., 2003, AUSTR GULF WAR VETER, V2; Sim M. R., 2003, AUSTR GULF WAR VETER, V1; Sim M. R., 2003, AUSTR GULF WAR VETER, V3; Simon G, 1996, PSYCHOSOM MED, V58, P481, DOI 10.1097/00006842-199609000-00010; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; StataCorp, 2015, STAT STAT SOFTW REL; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thome J, 2017, HUM BRAIN MAPP, V38, P27, DOI 10.1002/hbm.23340; Tucker PM, 2007, AM J PSYCHIAT, V164, P230, DOI 10.1176/appi.ajp.164.2.230; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; van Boxtel G.J.M., 2018, SLEEP COMBAT RELATED, P253, DOI [10.1007/978-1-4939-7148-0_22, DOI 10.1007/978-1-4939-7148-0_22]; Van Hooff M., 2012, PREVALENCE LIFETIME; Van Hooff M., 2018, MENTAL HLTH PREVALEN; Van Hooff M, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23950; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wagner AW, 2000, J TRAUMA STRESS, V13, P41, DOI 10.1023/A:1007716813407; Waller M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-88; Weathers F. W., 1993, 9 ANN CONV INT SOC T; WESTERMEYER J, 1989, HOSP COMMUNITY PSYCH, V40, P245; Westermeyer JJ, 2010, PSYCHIAT SERV, V61, P1132, DOI 10.1176/ps.2010.61.11.1132; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	100	4	4	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	SEP	2020	27	6					1139	1150	1073191119864662	10.1177/1073191119864662		JUL 2019	12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	MS8QP	WOS:000477334900001	31328529				2022-02-06	
